PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ahn, E; Choi, G; Kang, H; Baek, C; Jung, Y; Woo, Y; Lee, S; Chang, Y				Ahn, EunJin; Choi, GeunJoo; Kang, Hyun; Baek, ChongWha; Jung, YongHun; Woo, YoungCheol; Lee, SangSeok; Chang, YeoGoo			Palonosetron and Ramosetron Compared for Effectiveness in Preventing Postoperative Nausea and Vomiting: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							EFFICACY; MANAGEMENT; ONDANSETRON; GRANISETRON; ANALGESIA; EVALUATE; PLACEBO; SAFETY; PAIN	Previous randomized controlled trials have reported conflicting findings on the superiority of palonosetron over ramosetron for preventing postoperative nausea and vomiting (PONV). Therefore, the present systematic review was registered in PROSPERO (CRD42016038120) and performed to compare the efficacy of perioperative administration of palonosetron to that of ramosetron for preventing PONV. We searched MEDLINE, EMBASE, and CENTRAL to identify all randomized controlled trials that compared the effectiveness of perioperative administration of palonosetron to that of ramosetron. The primary endpoints were defined as the incidence of postoperative nausea (PON), postoperative vomiting (POV), and PONV. A total of 695 patients were included in the final analysis. Subgroup analysis was performed through administration times which were divided into two phases: the early phase of surgery and the end of surgery. Combined analysis did not show differences between palonosetron and ramosetron in the overall incidence of PON, POV or PONV. Palonosetron was more effective than ramosetron, when the administration time for the 5-HT3 receptor antagonist was during the early phase of the operation. Otherwise, ramosetron was more effective than palonosetron, when the administration time was at the end of surgery. However, the quality of evidence for each outcome was low or very low and number of included studies was small, limiting our confidence in findings.	[Ahn, EunJin; Lee, SangSeok] Inje Univ, Seoul Paik Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Choi, GeunJoo; Kang, Hyun; Baek, ChongWha; Jung, YongHun; Woo, YoungCheol] Chung Ang Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Chang, YeoGoo] Inje Univ, Seoul Paik Hosp, Dept Gen Surg, Seoul, South Korea	Inje University; Chung Ang University; Chung Ang University Hospital; Inje University	Kang, H (corresponding author), Chung Ang Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea.	roman00@naver.com	Lee, Sangseok/AAF-5091-2021; Kang, Hyun/AAE-7872-2020	Lee, Sangseok/0000-0001-7023-3668; Kang, Hyun/0000-0003-2844-5880; Woo, Young-Cheol/0000-0001-7318-4814; Baek, Chong Wha/0000-0001-9917-8738	Basic Science Research Program through the National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology [NRF-2015R1A2A01005153]	Basic Science Research Program through the National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation (NRF) of Korea, funded by the Ministry of Education, Science and Technology (NRF-2015R1A2A01005153).	BUNCE KT, 1992, BRIT J ANAESTH, V69, pS60, DOI 10.1093/bja/69.supplement_1.60S; Candiotti KA, 2008, ANESTH ANALG, V107, P445, DOI 10.1213/ane.0b013e31817b5ebb; Choi JB, 2014, YONSEI MED J, V55, P1430, DOI [10.3349/YMJ.2014.55.5.1430, 10.3349/ymj.2014.55.5.1430]; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Dolin SJ, 2002, BRIT J ANAESTH, V89, P409, DOI 10.1093/bja/aef207; Eriksson H, 1996, ANESTH ANALG, V82, P533, DOI 10.1097/00000539-199603000-00019; Fujii Y, 2008, CURR DRUG SAF, V3, P27, DOI 10.2174/157488608783333934; Gan TJ, 2014, ANESTH ANALG, V118, P85, DOI 10.1213/ANE.0000000000000002; Golembiewski J, 2005, AM J HEALTH-SYST PH, V62, P1247, DOI 10.1093/ajhp/62.12.1247; Habib AS, 2004, CAN J ANAESTH, V51, P326, DOI 10.1007/BF03018236; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Kim SH, 2015, J ANESTH, V29, P585, DOI 10.1007/s00540-015-1981-4; Kim SH, 2013, KOREAN J ANESTHESIOL, V64, P517, DOI 10.4097/kjae.2013.64.6.517; Kim WO, 2011, KOREAN J ANESTHESIOL, V61, P405, DOI 10.4097/kjae.2011.61.5.405; Kovac AL, 2008, ANESTH ANALG, V107, P439, DOI 10.1213/ane.0b013e31817abcd3; Lee S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/951474; Lee WS, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0102-0; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Naing C, 2012, J EVID-BASED MED, V5, P232; Park JW, 2012, KOREAN J ANESTHESIOL, V63, P334, DOI 10.4097/kjae.2012.63.4.334; Park SK, 2013, KOREAN J ANESTHESIOL, V64, P133, DOI 10.4097/kjae.2013.64.2.133; Roh GU, 2014, SPINE, V39, pE543, DOI 10.1097/BRS.0000000000000236; Shin YS, 2011, EUROPEAN J ANAESTHES, V28, P139; Song YK, 2013, J ANESTH, V27, P29, DOI 10.1007/s00540-012-1473-8; Suman C, 2015, J OBSTET GYN INDIA, V65, P28, DOI 10.1007/s13224-014-0612-6; Swaika Sarbari, 2011, Anesth Essays Res, V5, P182, DOI 10.4103/0259-1162.94761; Wu SJ, 2013, SURG LAPARO ENDO PER, V23, P79, DOI 10.1097/SLE.0b013e31827549e8; Yang SY, 2012, KOREAN J ANESTHESIOL, V62, P260, DOI 10.4097/kjae.2012.62.3.260; Yatoo FA, 2016, J EVOL MED DENT SCI-, V5, P1229, DOI 10.14260/jemds/2016/287	29	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168509	10.1371/journal.pone.0168509	http://dx.doi.org/10.1371/journal.pone.0168509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992509	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842600072
J	Sagy, I; Vodonos, A; Novack, V; Rogachev, B; Haviv, YS; Barski, L				Sagy, Iftach; Vodonos, Alina; Novack, Victor; Rogachev, Boris; Haviv, Yosef S.; Barski, Leonid			The Combined Effect of High Ambient Temperature and Antihypertensive Treatment on Renal Function in Hospitalized Elderly Patients	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; ACUTE KIDNEY INJURY; 2003 HEAT-WAVE; OLDER-ADULT; MORTALITY; DISEASE; OUTCOMES; IMPACT; DEATH; FLUID	Background The aging kidney manifests structural, functional as well as pharmacological changes, rendering elderly patients more susceptible to adverse environmental influences on their health, dehydration in particular. Hypothesis Higher temperature is associated with renal function impairment in patients 65 years and older who routinely take thiazide and/or ACE-inhibitors/ARBs. Methods We obtained health data of patients older than 65 who were admitted to a large tertiary center during the years 2006-011, with a previous diagnosis of hypertension, and treated with thiazide, ACE-inhibitors/ARBs or both. We collected environmental data of daily temperature, available from collaborative public and governmental institutions. In order to estimate the effect of daily temperature on renal function we performed linear mixed models, separately for each treatment group and creatinine change during hospital admission. Results We identified 26,286 admissions for 14, 268 patients with a mean age of 75.6 (+/- 6.9) years, of whom 53.6% were men. Increment in daily temperature on admission of 5 degrees C had significant effect on creatinine increase in the no treatment (baseline creatinine adjusted 0.824 mg/dL, % change 1.212, % change 95% C. I 0.082-2.354) and dual treatment groups (baseline creatinine adjusted 1.032mg/dL, % change 3.440, % change 95% C. I 1.227-5.700). Sub-analysis stratified by advanced age, chronic kidney disease and primary diagnosis on hospital admission, revealed a significant association within patients admitted due to acute infection and treated with dual therapy. Conclusion Whereas previous studies analyzed sporadic climate effects during heat waves and/or excluded older population taking anti-hypertensive medications, the present study is novel by showing a durable association of temperature and decreased renal function specifically in elderly patients taking anti-hypertensive medications.	[Sagy, Iftach; Vodonos, Alina; Novack, Victor] Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel; [Sagy, Iftach; Novack, Victor; Rogachev, Boris; Haviv, Yosef S.; Barski, Leonid] Soroka Univ, Med Ctr, Div Internal Med, Beer Sheva, Israel; [Sagy, Iftach; Vodonos, Alina; Novack, Victor; Rogachev, Boris; Haviv, Yosef S.; Barski, Leonid] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Rogachev, Boris; Haviv, Yosef S.] Soroka Univ, Med Ctr, Dept Nephrol, Beer Sheva, Israel	Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Sagy, I (corresponding author), Soroka Univ, Med Ctr, Clin Res Ctr, Beer Sheva, Israel.; Sagy, I (corresponding author), Soroka Univ, Med Ctr, Div Internal Med, Beer Sheva, Israel.; Sagy, I (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel.	iftachsagy@gmail.com	sagy, iftach/AAS-3372-2020					Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Alpert P, 2004, INT J CLIMATOL, V24, P1013, DOI 10.1002/joc.1037; Argaud L, 2007, ARCH INTERN MED, V167, P2177, DOI 10.1001/archinte.167.20.ioi70147; Berger JR, 2016, ADV CHRONIC KIDNEY D, V23, P36, DOI 10.1053/j.ackd.2015.08.005; Bi P, 2011, ASIA-PAC J PUBLIC HE, V23, p27S, DOI 10.1177/1010539510391644; Birnie K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0606-x; CROSS NB, 2009, COCHRANE DATABASE SY, V3; El-Sharkawy AM, 2014, CLIN NUTR, V33, P6, DOI 10.1016/j.clnu.2013.11.010; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Glassock RJ, 2016, NEPHRON, V132; Hasegawa H, 2013, KIDNEY BLOOD PRESS R, V37, P521, DOI 10.1159/000355732; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Jerkic Mirjana, 2001, International Urology and Nephrology, V32, P539, DOI 10.1023/A:1014484101427; Joe L, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030299; Klenk J, 2010, AGE AGEING, V39, P245, DOI 10.1093/ageing/afp248; Lancaster KJ, 2003, ANN EPIDEMIOL, V13, P525, DOI 10.1016/S1047-2797(03)00004-8; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Li MM, 2015, INT J ENV RES PUB HE, V12, P5256, DOI 10.3390/ijerph120505256; Lindstrom SJ, 2013, INTERN MED J, V43, P1246, DOI 10.1111/imj.12275; Miller M, 1997, BAILLIERE CLIN ENDOC, V11, P367, DOI 10.1016/S0950-351X(97)80347-3; Nielsen SE, 2012, DIABETIC MED, V29, pE184, DOI 10.1111/j.1464-5491.2012.03585.x; Palevsky PM, 2013, AM J KIDNEY DIS, V61, P649, DOI 10.1053/j.ajkd.2013.02.349; Rey G, 2009, EUR J EPIDEMIOL, V24, P495, DOI 10.1007/s10654-009-9374-3; Roberts G, 2015, CLIN KIDNEY J, V8, P673, DOI 10.1093/ckj/sfv080; Siew ED, 2012, CLIN J AM SOC NEPHRO, V7, P712, DOI 10.2215/CJN.10821011; Singri N, 2003, JAMA-J AM MED ASSOC, V289, P747, DOI 10.1001/jama.289.6.747; Vandentorren S, 2006, EUR J PUBLIC HEALTH, V16, P583, DOI 10.1093/eurpub/ckl063; Velasquez KMR, 2014, PRIMARY CARE, V41, P857, DOI 10.1016/j.pop.2014.08.006; Westerterp KR, 2005, BRIT J NUTR, V93, P199, DOI 10.1079/BJN20041310; Winquist A, 2016, ENVIRON RES, V147, P314, DOI 10.1016/j.envres.2016.02.022; Zhang K, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-11	32	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168504	10.1371/journal.pone.0168504	http://dx.doi.org/10.1371/journal.pone.0168504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992525	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600070
J	Wang, L; Qu, MY; Chen, Y; Zhou, YX; Wan, Z				Wang, Lin; Qu, Moying; Chen, Yao; Zhou, Yaxiong; Wan, Zhi			Statins Have No Additional Benefit for Pulmonary Hypertension: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; ARTERIAL-HYPERTENSION; OXIDATIVE STRESS; PLASMA ENDOTHELIN-1; SIMVASTATIN; DYSFUNCTION; ATORVASTATIN; INFLAMMATION; PRAVASTATIN; GUIDELINES	Objectives We performed a meta-analysis to explore the effects of adding statins to standard treatment on adult patients of pulmonary hypertension (PH). Methods A systematic search up to December, 2015 of Medline, EMBASE, Cochrane Database of Systematic reviews and Cochrane Central Register of Controlled Trials was performed to identify randomized controlled trials with PH patients treated with statins. Results Five studies involving 425 patients were included into this meta-analysis. The results of our analysis showed that the statins can't significantly increase 6-minute walking distance (6MWD, mean difference [MD] = -0.33 [CI: -18.25 to 17.59]), decrease the BORG dyspnea score (MD = -0.72 [CI: -2.28 to 0.85]), the clinical worsening risk (11% in statins vs. 10.1% in controls, Risk ratio = 1.06 [CI: 0.61, 1.83]), or the systolic pulmonary arterial pressure (SPAP) (MD = -0.72 [CI: -2.28 to 0.85]). Subgroup analysis for PH due to COPD or non-COPD also showed no significance. C Conclusions Statins have no additional beneficial effect on standard therapy for PH, but the results from subgroup of PH due to COPD seem intriguing and further study with larger sample size and longer follow-up is suggested.	[Wang, Lin] Chengdu Shang Jin Nan Fu Hosp, Dept Cardiol, Chengdu, Sichuan, Peoples R China; [Qu, Moying] Sichuan Univ, Dept Cardiol, West China Hosp, Chengdu, Sichuan, Peoples R China; [Chen, Yao; Zhou, Yaxiong; Wan, Zhi] Sichuan Univ, Dept Emergency, West China Hosp, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Wan, Z (corresponding author), Sichuan Univ, Dept Emergency, West China Hosp, Chengdu, Sichuan, Peoples R China.	303680215@qq.com		Wang, Lin/0000-0001-8642-0003; Wan, Zhi/0000-0002-3124-0125				Ali OF, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-137; Antoniu SA, 2012, EXPERT OPIN THER TAR, V16, P355, DOI 10.1517/14728222.2012.671811; Barreto AC, 2008, BRAZ J MED BIOL RES, V41, P657, DOI 10.1590/S0100-879X2008000800003; Can U, 2015, J CHIN MED ASSOC, V78, P702, DOI 10.1016/j.jcma.2015.08.004; Chaouat A, 2009, CHEST, V136, P678, DOI 10.1378/chest.08-2420; Chen L, 2011, HYPERTENSION, V57, P343, DOI 10.1161/HYPERTENSIONAHA.110.157032; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Fraidenburg D, 2013, HIGH ALT MED BIOL, V14, P134, DOI 10.1089/ham.2013.1007; Fujii T, 1999, RESPIRATION, V66, P212, DOI 10.1159/000029380; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Golpe R, 2014, HEART LUNG, V43, P72, DOI 10.1016/j.hrtlng.2013.08.007; Guerard P, 2006, N-S ARCH PHARMACOL, V373, P401, DOI 10.1007/s00210-006-0082-1; Hermida N, 2014, ANTIOXID REDOX SIGN, V20, P1216, DOI 10.1089/ars.2013.5537; Ikeda T, 2010, J CARDIOVASC PHARM, V55, P39, DOI 10.1097/FJC.0b013e3181c0419c; Kao PN, 2005, CHEST, V127, P1446, DOI 10.1378/chest.127.4.1446; Kawut SM, 2011, CIRCULATION, V123, P2985, DOI 10.1161/CIRCULATIONAHA.110.015693; King WT, 2011, PEDIATR PULM, V46, P261, DOI 10.1002/ppul.21361; Lee TM, 2009, CLIN SCI, V116, P497, DOI 10.1042/CS20080241; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Margaritis M, 2014, ANTIOXID REDOX SIGN, V20, P1198, DOI 10.1089/ars.2013.5430; Matura L, 2013, AM J RESP CRITICAL C, V187; Moosavi SAJ, 2013, IRAN RED CRESCENT ME, V15, P649, DOI 10.5812/ircmj.8267; Murata T, 2005, ARTERIOSCL THROM VAS, V25, P2335, DOI 10.1161/01.ATV.0000186184.33537.48; Pinho-Gomes AC, 2014, ANTIOXID REDOX SIGN, V20, P1268, DOI 10.1089/ars.2013.5542; Reed RM, 2011, COPD, V8, P96, DOI 10.3109/15412555.2011.558545; Shahmiri Shahab Shahabi, 2009, Lijec Vjesn, V131 Suppl 6, P12; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Taraseviciene-Stewart L, 2006, AM J PHYSIOL-LUNG C, V291, pL668, DOI 10.1152/ajplung.00491.2005; Vaidya B, 2015, J CONTROL RELEASE, V211, P118, DOI 10.1016/j.jconrel.2015.05.287; Wiegman CH, 2015, J ALLERGY CLIN IMMUN, V136, P769, DOI 10.1016/j.jaci.2015.01.046; Wilkins MR, 2010, AM J RESP CRIT CARE, V181, P1106, DOI [10.1164/rccm.200911-1699OC, 10.1164/rccm.2009111-699OC]; Xing XQ, 2007, MED HYPOTHESES, V68, P1108, DOI 10.1016/j.mehy.2006.09.034; Zeng WJ, 2012, EUR RESPIR J, V40, P67, DOI 10.1183/09031936.00149011	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168101	10.1371/journal.pone.0168101	http://dx.doi.org/10.1371/journal.pone.0168101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992469	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600035
J	Kalyanam, J; Quezada, M; Poblete, B; Lanckriet, G				Kalyanam, Janani; Quezada, Mauricio; Poblete, Barbara; Lanckriet, Gert			Prediction and Characterization of High-Activity Events in Social Media Triggered by Real-World News	PLOS ONE			English	Article							POPULARITY	On-line social networks publish information on a high volume of real-world events almost instantly, becoming a primary source for breaking news. Some of these real-world events can end up having a very strong impact on on-line social networks. The effect of such events can be analyzed from several perspectives, one of them being the intensity and characteristics of the collective activity that it produces in the social platform. We research 5,234 real-world news events encompassing 43 million messages discussed on the Twitter microblogging service for approximately 1 year. We show empirically that exogenous news events naturally create collective patterns of bursty behavior in combination with long periods of inactivity in the network. This type of behavior agrees with other patterns previously observed in other types of natural collective phenomena, as well as in individual human communications. In addition, we propose a methodology to classify news events according to the different levels of intensity in activity that they produce. In particular, we analyze the most highly active events and observe a consistent and strikingly different collective reaction from users when they are exposed to such events. This reaction is independent of an event's reach and scope. We further observe that extremely high-activity events have characteristics that are quite distinguishable at the beginning stages of their outbreak. This allows us to predict with high precision, the top 8% of events that will have the most impact in the social network by just using the first 5% of the information of an event's lifetime evolution. This strongly implies that high-activity events are naturally prioritized collectively by the social network, engaging users early on, way before they are brought to the mainstream audience.	[Kalyanam, Janani; Lanckriet, Gert] Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA; [Quezada, Mauricio; Poblete, Barbara] Univ Chile, Dept Comp Sci, Santiago, Chile	University of California System; University of California San Diego; Universidad de Chile	Kalyanam, J (corresponding author), Univ Calif San Diego, Dept Elect & Comp Engn, La Jolla, CA 92093 USA.	jkalyana@ucsd.edu	Poblete, Bárbara/G-3562-2016; Poblete, Barbara/H-8450-2013	Poblete, Barbara/0000-0002-7669-645X	National Science Foundation [CCF 0830535, IIS 1054960]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [11121511]; Millennium Nucleus Center for Semantic Web Research [NC120004]; Comision Nacional de Ciencia y Tecnologia [2015/21151445]; Yahoo Faculty Research Engagement Program	National Science Foundation(National Science Foundation (NSF)); Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Nucleus Center for Semantic Web Research; Comision Nacional de Ciencia y Tecnologia; Yahoo Faculty Research Engagement Program	This work was supported by National Science Foundation CCF 0830535, GL; National Science Foundation, IIS 1054960, GL; Fondo Nacional de Desarrollo Cientifico y Tecnologico, 11121511, BP; Millennium Nucleus Center for Semantic Web Research, NC120004, BP; Comision Nacional de Ciencia y Tecnologia, 2015/21151445, MQ; and Yahoo Faculty Research Engagement Program, JK, GL.	Ahmed M., 2013, PROC 6 ACM INT C WEB, P607; [Anonymous], P INT C WEB INT MIN, DOI DOI 10.1145/1988688.1988766; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Berger J, 2012, J MARKETING RES, V49, P192, DOI 10.1509/jmr.10.0353; Castillo C., 2014, PROC 17 ACM C COMPUT, P211, DOI [10.1145/2531602.2531623, DOI 10.1145/2531602.2531623]; dos Reis Julio Cesar, 2015, CORR; Fei-Fei L, 2005, PROC CVPR IEEE, P524; Gao L, 2014, ARXIV14011274; Gaugaz Julien, 2012, Advances in Information Retrieval. Proceedings of the 34th European Conference on IR Research (ECIR 2012), P50, DOI 10.1007/978-3-642-28997-2_5; Guerini M, 2011, ICWSM; Karsai M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00397; Kwak H., 2010, PROC 19 INT C WORLD, P591, DOI 10.1145/1772690.1772751; Lerman K., 2010, P 19 INT C WORLD WID, P621, DOI DOI 10.1145/1772690.1772754; Li CT, 2016, INFORM SCIENCES, V339, P310, DOI 10.1016/j.ins.2016.01.009; Liu Q, 2015, INFORM MANAGE-AMSTER, V52, P764, DOI 10.1016/j.im.2015.01.002; Iribarren JL, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.046116; Mills AJ, 2012, J PUBLIC AFF, V12, P162, DOI 10.1002/pa.1418; Pinto H., 2013, P 6 ACM INT C WEB SE, P365, DOI DOI 10.1145/2433396.2433443; Suh B, 2010, 2010 IEEE 2 INT C SO, V2, P177, DOI [10.1109/SocialCom.2010.33, DOI 10.1109/SOCIALCOM.2010.33]; Szabo G, 2010, COMMUN ACM, V53, P80, DOI 10.1145/1787234.1787254; Tan P.-N., 2019, INTRO DATA MINING, V2nd ed.; Tatar A, 2014, J INTERNET SERV APPL, V5, DOI 10.1186/s13174-014-0008-y; Vaizman Y, 2014, IEEE-ACM T AUDIO SPE, V22, P1483, DOI 10.1109/TASLP.2014.2337842; Yan Q, 2013, ABSTR APPL ANAL, DOI 10.1155/2013/953406	24	15	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0166694	10.1371/journal.pone.0166694	http://dx.doi.org/10.1371/journal.pone.0166694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992437	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000006
J	Obidzinski, A; Medrzycki, P; Kolaczkowska, E; Ciurzycki, W; Marciszewska, K				Obidzinski, Artur; Medrzycki, Piotr; Kolaczkowska, Ewa; Ciurzycki, Wojciech; Marciszewska, Katarzyna			Do David and Goliath Play the Same Game? Explanation of the Abundance of Rare and Frequent Invasive Alien Plants in Urban Woodlands in Warsaw, Poland	PLOS ONE			English	Article							SPECIES-RICHNESS; SAMPLE-SIZE; TEMPERATE; FRAMEWORK; PERFORMANCE; COEXISTENCE; ECOLOGY; SUCCESS; FORESTS; MODELS	Invasive Alien Plants occur in numbers differing by orders of magnitude at subsequent invasion stages. Effective sampling and quantifying niches of rare invasive plants are quite problematic. The aim of this paper is an estimation of the influence of invasive plants frequency on the explanation of their local abundance. We attempted to achieve it through: (1) assessment of occurrence of self-regenerating invasive plants in urban woodlands, (2) comparison of Random Forest modelling results for frequent and rare species. We hypothesized that the abundance of frequent species would be explained better than that of rare ones and that both rare and frequent species share a common hierarchy of the most important determinants. We found 15 taxa in almost two thirds of 1040 plots with a total number of 1068 occurrences. There were recorded 6 taxa of high frequency-Prunus serotina, Quercus rubra, Acer negundo, Robinia pseudoacacia, Impatiens parviflora and Solidago spp.-and 9 taxa of low frequency: Acer saccharinum, Amelanchier spicata, Cornus spp., Fraxinus spp., Parthenocissus spp., Syringa vulgaris, Echinocystis lobata, Helianthus tuberosus, Reynoutria spp. Random Forest's models' quality grows with the number of occurrences of frequent taxa but not of the rare ones. Both frequent and rare taxa share a similar hierarchy of predictors' importance: Land use > Tree stand > Seed source and, for frequent taxa, Forest properties as well. We conclude that there is an 'explanation jump' at higher species frequencies, but rare species are surprisingly similar to frequent ones in their determinant's hierarchy, with differences conforming with their respective stages of invasion.	[Obidzinski, Artur; Ciurzycki, Wojciech; Marciszewska, Katarzyna] Warsaw Univ Life Sci, Fac Forestry, Dept Forest Bot, Warsaw, Poland; [Medrzycki, Piotr] Univ Ecol & Management, Fac Ecol, Lab Appl Plant Ecol, Warsaw, Poland; [Kolaczkowska, Ewa] Polish Acad Sci, Inst Geog & Spatial Org, Dept Geoecol & Climatol, Warsaw, Poland	Warsaw University of Life Sciences; Polish Academy of Sciences	Obidzinski, A (corresponding author), Warsaw Univ Life Sci, Fac Forestry, Dept Forest Bot, Warsaw, Poland.	artur.obidzinski@wl.sggw.pl		MARCISZEWSKA, KATARZYNA/0000-0002-8550-7390; Kolaczkowska, Ewa/0000-0001-9553-7350	Warsaw Municipal Forests Company [506-01-0325-00-02]	Warsaw Municipal Forests Company	The research was financed exclusively with a research grant No 506-01-0325-00-02 awarded by Warsaw Municipal Forests Company (http://lasymiejskie.waw.pl) to the Faculty of Forestry, Warsaw University of Life Sciences. AO, PM, WC & KM received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczyk A. B., 2011, Prace i Studia Geograficzne, V47, P355; Adamowski W, 2002, PHYTOCOENOSIS S, V14, P1; Adamowski W, 1998, PHYTOCOENOSIS S, V10, P211; Bartelink HH, 1998, ECOL MODEL, V105, P213, DOI 10.1016/S0304-3800(97)00165-8; Bertaud A, 2004, C WINDS SOC CH UNPUB; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2006, RANDOMFOREST BREIMAN; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; Cape JN, 2004, ENVIRON POLLUT, V132, P469, DOI 10.1016/j.envpol.2004.05.009; Carboni M, 2011, J VEG SCI, V22, P751, DOI 10.1111/j.1654-1103.2011.01303.x; Castri F. di, 1990, Biological invasions in Europe and the Mediterranean Basin., P3; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Chojnacki J, 1991, ZRO ZNICOWANIE PRZES; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Duguay S, 2007, LANDSCAPE ECOL, V22, P589, DOI 10.1007/s10980-006-9050-x; Essl F, 2012, BIOL INVASIONS, V14, P1331, DOI 10.1007/s10530-011-0156-y; Essl F, 2011, BASIC APPL ECOL, V12, P1, DOI 10.1016/j.baae.2010.10.003; Evans JS, 2011, PREDICTIVE SPECIES AND HABITAT MODELING IN LANDSCAPE ECOLOOGY: CONCEPTS AND APPLICATIONS, P139, DOI 10.1007/978-1-4419-7390-0_8; Foxcroft LC, 2008, ENVIRON MANAGE, V41, P32, DOI 10.1007/s00267-007-9027-9; Franklin J, 2009, MAPPING SPECIES DIST; Gavier-Pizarro GI, 2010, ECOL APPL, V20, P1913, DOI 10.1890/09-2168.1; Georges D, 2013, EXAMPLE SPECIES DIST; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Hammer O, 2012, REFERENCE MANUAL; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HOBBS RJ, 1995, CONSERV BIOL, V9, P761, DOI 10.1046/j.1523-1739.1995.09040761.x; Hubbell Stephen P., 2001, V32, pi; Kalisz P, 2009, THESIS; Knight KS, 2008, DIVERS DISTRIB, V14, P666, DOI 10.1111/j.1472-4642.2008.00468.x; Kowarik I, 2005, CROP FERALITY AND VOLUNTEERISM, P97; Kowarik I, 1992, VERH BOT VER BERLIN, V3; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kursa MB, 2010, FUND INFORM, V101, P271, DOI 10.3233/FI-2010-288; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Landenberger Rick E., 2009, Urban Ecosystems, V12, P437, DOI 10.1007/s11252-009-0087-x; Lee PK, 2005, CHEMOSPHERE, V60, P672, DOI 10.1016/j.chemosphere.2005.01.048; Liendo D, 2015, PLANT BIOSYST, V149, P289, DOI 10.1080/11263504.2013.822434; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Malinowski K, 2012, THESIS; Matuszkiewicz W, 2005, PRZEWODNIK OZNACZANI; Menuz DR, 2013, BIOL INVASIONS, V15, P1601, DOI 10.1007/s10530-012-0395-6; Menuz DR, 2014, ECOGRAPHY, V37, P1; Milbau A, 2009, BIOL INVASIONS, V11, P941, DOI 10.1007/s10530-008-9306-2; Miller ME, 2006, PLANT SOIL, V288, P1, DOI 10.1007/s11104-006-0058-4; Morawski W, 1980, OBJASNIENIA SZCZEGOL; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Pedrotti F, 2013, GEOBOTANY STUDIES; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Pickett STA, 2008, BIOSCIENCE, V58, P139, DOI 10.1641/B580208; Pino J, 2005, BIOL CONSERV, V122, P339, DOI 10.1016/j.biocon.2004.08.006; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Questad EJ, 2008, ECOL LETT, V11, P717, DOI 10.1111/j.1461-0248.2008.01186.x; R Core Team, 2021, R LANGUAGE ENV STAT; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Romaniak O, 2009, THESIS; Sarnacka Z, 1980, OBJASNIENIA SZCZEGOL; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Snyder RE, 2003, ECOL LETT, V6, P301, DOI 10.1046/j.1461-0248.2003.00434.x; Stanczak J, 2013, POPULATION; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Sudnik-Wojcikowska B, 2011, PLANTS AND HABITATS OF EUROPEAN CITIES, P499; Sung CY, 2011, LANDSCAPE URBAN PLAN, V100, P278, DOI 10.1016/j.landurbplan.2010.12.014; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; THUILLER W, 2005, GLOBAL CHANGE BIOL, V11, P2234, DOI DOI 10.1111/J.1365-2486.2005.01018.X; Tokarska-Guzik B, 2012, GEN DYR OCHR SROD WA; VanDerWal J, 2011, SDM TOOLS SPECIES DI; Vidra RL, 2008, RESTOR ECOL, V16, P217, DOI 10.1111/j.1526-100X.2008.00387.x; Von Holle B, 2007, BIOL CONSERV, V136, P33, DOI 10.1016/j.biocon.2006.10.044; Weng QH, 2004, REMOTE SENS ENVIRON, V89, P467, DOI 10.1016/j.rse.2003.11.005; Wierzbicka M, 1998, ENVIRON POLLUT, V101, P415, DOI 10.1016/S0269-7491(98)00012-8; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Yang RY, 2007, BOT STUD, V48, P453	79	5	5	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168365	10.1371/journal.pone.0168365	http://dx.doi.org/10.1371/journal.pone.0168365			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992516	Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000041
J	Cella, K; Carmona, L; Ekimova, I; Chichvarkhin, A; Schepetov, D; Gosliner, TM				Cella, Kristen; Carmona, Leila; Ekimova, Irina; Chichvarkhin, Anton; Schepetov, Dimitry; Gosliner, Terrence M.			A Radical Solution: The Phylogeny of the Nudibranch Family Fionidae	PLOS ONE			English	Article							GASTROPODA NUDIBRANCHIA; TERGIPEDIDAE GASTROPODA; SPECIES DELIMITATION; MOLLUSCA; OPISTHOBRANCHIA; CEPHALASPIDEA; SYSTEMATICS; DIVERSITY; SEA; AEOLIDINA	Tergipedidae represents a diverse and successful group of aeolid nudibranchs, with approximately 200 species distributed throughout most marine ecosystems and spanning all biogeographical regions of the oceans. However, the systematics of this family remains poorly understood since no modern phylogenetic study has been undertaken to support any of the proposed classifications. The present study is the first molecular phylogeny of Tergipedidae based on partial sequences of two mitochondrial (COI and 16S) genes and one nuclear gene (H3). Maximum likelihood, maximum parsimony and Bayesian analysis were conducted in order to elucidate the systematics of this family. Our results do not recover the traditional Tergipedidae as monophyletic, since it belongs to a larger clade that includes the families Eubranchidae, Fionidae and Calmidae. This newly recovered clade is here referred to as Fionidae, the oldest name for this taxon. In addition, the present molecular phylogeny does not recover the traditional systematic relationships at a generic level, and therefore, systematic changes are required. We recognize the following clades within Fionidae: Calma, Cuthona, Cuthonella, Eubranchus, Fiona, Murmania, Tenellia, Tergipes, Tergiposacca gen. nov., Rubramoena gen. nov. and Abronica gen. nov. The type species of Tergiposacca, T. longicerata nov. sp. is described. The other two new genera have a previously described species as their type species. Most of these taxa, with the exceptions of Eubranchus, Tergipes and Fiona are composed of radically different constituent species from their traditional membership, but appear to be supported by morphological synapomorphies as well as molecular data. Aenigmastyletus, Catriona, Phestilla, Tenellia and Trinchesia are nested within other clades and, thus are here considered as synonyms of the larger clades. The phylogenetic position and validity of Myja, Guyvalvoria, Leostyletus and Subcuthona still need to be tested in future studies when material becomes available.	[Cella, Kristen; Gosliner, Terrence M.] Calif Acad Sci, Dept Invertebrate Zool, San Francisco, CA 94118 USA; [Carmona, Leila] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Ekimova, Irina; Chichvarkhin, Anton] Far Eastern Fed Univ, Vladivostok, Russia; [Ekimova, Irina] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Chichvarkhin, Anton] Russian Acad Sci, AV Zhirmunsky Inst Marine Biol, Vladivostok, Russia; [Schepetov, Dimitry] Natl Res Univ, Higher Sch Econ, Moscow, Russia	California Academy of Sciences; University of Gothenburg; Far Eastern Federal University; Lomonosov Moscow State University; Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; HSE University (National Research University Higher School of Economics)	Carmona, L (corresponding author), Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden.	leilacarmonabarnosi@gmail.com	Chichvarkhin, Anton/J-1253-2014; Schepetov, Dimitry M/S-5444-2018; Ekimova, Irina/AAT-4377-2020; Carmona, Leila/L-8021-2014; Ekimova, Irina/L-3958-2015	Chichvarkhin, Anton/0000-0001-8017-6783; Schepetov, Dimitry M/0000-0002-1195-0461; Ekimova, Irina/0000-0002-1846-0780; Carmona, Leila/0000-0002-2070-4684; Ekimova, Irina/0000-0002-1846-0780	Conchologists of America Grant [CGL2010-17187]; Lerner-Grey Grant for Marine Research the Arthur Nelson Graduate Scholarship; California Academy of Sciences Graduate Assistantship Program in Research and Education; Far East Program [15-I-6-014o]; Russian Science Foundation [14-50-00034, 15-29-02456]; Swedish Taxonomy Initiative [2015-7 4.3]; National Science Foundation [DEB 12576304, REU 1358680]; Basic Research Program of the National Research University Higher School of Economics; Direct For Biological Sciences [1257630] Funding Source: National Science Foundation	Conchologists of America Grant; Lerner-Grey Grant for Marine Research the Arthur Nelson Graduate Scholarship; California Academy of Sciences Graduate Assistantship Program in Research and Education; Far East Program; Russian Science Foundation(Russian Science Foundation (RSF)); Swedish Taxonomy Initiative; National Science Foundation(National Science Foundation (NSF)); Basic Research Program of the National Research University Higher School of Economics; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the research grants (CGL2010-17187), Conchologists of America Grant, the Lerner-Grey Grant for Marine Research the Arthur Nelson Graduate Scholarship and the California Academy of Sciences Graduate Assistantship Program in Research and Education. This contribution was partially funded by Far East Program grant #15-I-6-014o to AC, and Russian Science Foundation grant 14-50-00034 to IE. Sequencing of Russian specimens was funded by Russian Science Foundation grant 14-50-00034 to IE and Russian Foundation for Basic Research grant 15-29-02456 to AC. Sequencing of Swedish, Irish and Scottish specimens was funded by the Swedish Taxonomy Initiative grant dha 2015-7 4.3. This research was also supported by two grants from National Science Foundation: DEB 12576304 grant to Terrence Gosliner, Richard Mooi, Luis Rocha and Gary Williams to inventory the biodiversity of the Verde Island Passage and REU 1358680 to Richard Mooi, which supported Elise Ongs participation in this project. Support from the Basic Research Program of the National Research University Higher School of Economics is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder J., 1854, ANN MAG NAT HIST, V2, P102, DOI DOI 10.1080/037454809494312; ALDER J., 1843, ANN MAGAZINE NATURAL, V12, P233, DOI DOI 10.1080/03745484309442517; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1855, MONOGRAPH BRIT NUDIB; Baba K., 1961, Publications of the Seto Marine Biological Laboratory, V9, P367; Behrens DW, 2008, INDOPACIFIC NUDIBRAN; Bergh L. S. R., 1884, ZOOLOGY, V10, P1; BERGH L. S. R., 1896, REV SUISSE ZOOL, V4, P385; Bergh R., 1890, Zoologischer Jahresbericht, Vv, P1; Betti F., 2011, REGNO NUDIBRANCHI GU; Bouchet P, 2005, MALACOLOGIA, V47, P1; Bouchet P., 2015, TERGIPEDIDAE BERGH 1; Bouchet P, 2015, PHESTILLA SIBOGAE BE; Bouchet P, 2016, TERGIPES; Bouchet P, 2015, CUTHONA; Bragt PH, 2002, CUTHONA RUBESCENS CO; BROWN GH, 1980, ZOOL J LINN SOC-LOND, V69, P225, DOI 10.1111/j.1096-3642.1980.tb01124.x; BURN R, 1973, Proceedings of the Royal Society of Victoria, V86, P39; Caballer M, 2013, EUBRANCHIDAE ODHNER; Calado G, 2002, J MOLLUS STUD, V68, P311, DOI 10.1093/mollus/68.4.311; Camacho-Garcia Y., 2005, FIELD GUIDE SEA SLUG; Camacho-Garcia YE, 2014, MOL PHYLOGENET EVOL, V71, P113, DOI 10.1016/j.ympev.2013.11.010; Camara S, 2014, J MOLLUS STUD, V80, P642, DOI 10.1093/mollus/eyu015; Carmona L, 2014, ZOOL J LINN SOC-LOND, V171, P108, DOI 10.1111/zoj12129; Carmona L, 2014, HELGOLAND MAR RES, V68, P37, DOI 10.1007/s10152-013-0367-y; Carmona L, 2014, ZOOL J LINN SOC-LOND, V170, P132, DOI 10.1111/zoj12098; Carmona L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063000; Cervera J. L., 2004, Boletin Instituto Espanol de Oceanografia, V20, P5; Churchill CKC, 2014, INVERTEBR SYST, V28, P174, DOI 10.1071/IS13038; Churchill CKC, 2014, MAR BIOL, V161, P899, DOI 10.1007/s00227-014-2389-7; Churchill CKC, 2013, P R SOC B, V280, P1471; Debelius H, 2007, NUDIBRANCHS WORLD; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edmunds M, 2016, J CONCHOL, V42, P23; Eliot CA, 1910, MONOGRAPH BRIT NUDIB; Evans TJ, 1922, Q J MICROSC SCI, V66, P439; Evertsen Jussi, 2013, Fauna Norvegica, V32, P45, DOI 10.5324/fn.v31i0.1576; Goddard J., 2003, RE WHICH IS EUBRANCH; Gofas S, 2015, CUTHONELLA BERGH; Gosliner T.M., 1992, P 7 INT COR REEF S G, P702; Gosliner Terrence M., 2004, Proceedings of the California Academy of Sciences, V55, P125; GOSLINER TM, 1979, PAC SCI, V33, P37; Gosliner TM, 1981, ANN S AFR MUS, V82, P102; Gosliner TM., 2015, NUDIBRANCH SEA SLUG; Gosliner TM., 1987, NUDIBRANCHS SO AFRIC; Hamatani I, 1993, JPN J MALACOL, V52, P127; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ICZN, 1999, INT CODE ZOOLOGICAL; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kienberger K, 2016, ZOOL J LINN SOC-LOND, V177, P481, DOI 10.1111/zoj.12379; Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531; Lindsay T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154265; LUNDIN K., 2015, SVENSKA NAKENSNACKOR; MacFarland F. M., 1966, Memoirs of the California Academy of Sciences, V6, P1; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Malaquias MAE, 2008, ACTA ZOOL-STOCKHOLM, V89, P205, DOI 10.1111/j.1463-6395.2007.00308.x; Marcus, 1961, Veliger Suppl, V3, P1; Martynov A.V., 2006, Ruthenica, V16, P73; Martynov A.V., 2000, Ruthenica, V10, P5; Martynov AV, 1998, ZOOL ZH, V77, P763; MARTYNOV AV, 1992, ZOOL ZH, V71, P18; Martynov AV, 2006, MARINE BRACKISH WATE, P268; Martynov AV, 2011, OPISTHOBRANCH MOLLUS; Martynov AV, 2005, CATALOGUE MOLLUSCS R, P177; Martynov AV, 2015, P 15 INT SCI C PETR, P55; MILLEN SV, 1986, CAN J ZOOL, V64, P1356, DOI 10.1139/z86-202; MILLER MC, 1977, ZOOL J LINN SOC-LOND, V60, P197, DOI 10.1111/j.1096-3642.1977.tb01027.x; Miller MC, 2004, J NAT HIST, V38, P1183, DOI 10.1080/0022293031000077699; Miller MC, 2006, VITA MARINA, V3, P69; Moller H. P. C., 1842, INDEX MOLLUSCORUM GR; Montagu G, 1808, T LINN SOC LOND, V9, P81, DOI DOI 10.1111/J.1096-3642.1804.TB00282.X; Nylander JAA, 2004, PROGRAM DISTRIBUTED; Oskars TR, 2015, MOL PHYLOGENET EVOL, V89, P130, DOI 10.1016/j.ympev.2015.04.011; Padula V, 2014, J MOLLUS STUD, V80, P575, DOI 10.1093/mollus/eyu052; Picton B.E., 1994, FIELD GUIDE NUDIBRAN; PICTON BE, 1978, J CONCHOL, V29, P345; Pittman C, 2014, CUTHONA SP 13; Platts E., 1985, N ATLANTIC NUDIBRANC, V2, P150; Pola M, 2006, ANN ZOOL FENN, V43, P52; Pola M, 2010, MOL PHYLOGENET EVOL, V56, P931, DOI 10.1016/j.ympev.2010.05.003; Prkic J, 2014, MEDITERR MAR SCI, V15, P423, DOI 10.12681/mms.709; Pruvot-Fol A, 1951, ARCH ZOOLOGIE EXPT G, V88, P1; Pruvot-Fol A., 1954, MOLLUSQUES OPISTHOBR, V58; Pruvot-Fol A, 1948, B MUS NATL HIST NAT, V20, P273; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; RUDMAN WB, 1981, ZOOL J LINN SOC-LOND, V71, P373, DOI 10.1111/j.1096-3642.1981.tb01136.x; Rudman WB, 2005, CUTHONA PUSTULATA AL; Shine J., 2012, NUDIBRANCHS NE; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thiele J., 1931, HDB SYSTEMATICSCHEN; Thompson TE., 1984, BIOL OPISTHOBRANCH M, V2; Volodchenko N. I., 1941, Investigations of the Far East Seas of USSR, V1, P53; Willan R.C., 1979, Tane, V25, P141; WILLIAMS GC, 1979, ZOOL J LINN SOC-LOND, V67, P203, DOI 10.1111/j.1096-3642.1979.tb01112.x; Wilson NG, 2015, ZOOL J LINN SOC-LOND, V175, P119, DOI 10.1111/zoj.12266; Yorifuji M, 2012, ZOOL SCI, V29, P359, DOI 10.2108/zsj.29.359; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	104	31	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167800	10.1371/journal.pone.0167800	http://dx.doi.org/10.1371/journal.pone.0167800			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977703	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400032
J	Dupont, C; Maduro, C; Den Braanker, H; Boers, R; Kurek, D; Gribnau, J				Dupont, Catherine; Maduro, Cheryl; Den Braanker, Hannah; Boers, Ruben; Kurek, Dorota; Gribnau, Joost			Characterization of Histone Modifications Associated with Inactive X-Chromosome in Trophoblast Stem Cells, eXtra-Embryonic Endoderm Cells and in In Vitro Derived Undifferentiated and Differentiated Epiblast Like Stem Cells	PLOS ONE			English	Article							XIST RNA; MOUSE EMBRYOS; GIANT-CELLS; METHYLATION; CHROMATIN; PROTEINS; DNA; METHYLTRANSFERASE; GENES; H3	In mouse, X-chromosome inactivation (XCI) can either be imprinted or random. Imprinted XCI (iXCI) is considered unstable and depending on continuous Xist expression, whereas random XCI (rXCI) is stably maintained even in the absence of Xist. Here we have systematically examined epigenetic modifications associated with the inactive X-chromosome (Xi) in Trophoblast Stem cells, eXtra-Embryonic Endoderm Cells, undifferentiated and differentiated Epiblast Like Stem Cells in order to understand intrinsic differences in epigenetic mechanisms involved in silencing of the inactive X-chromosome in lineages presenting iXCI and rXCI. Whereas euchromatic histone modifications are predominantly lost from the Xi territory in all cell types, the accumulation of heterochromatic modifications diverges in between the analysed cell lineages. Particularly, only the Xi of multipotent Trophoblast (iXCI) and Epiblast stem cells (rXCI) display a visible accumulation of Polycomb Repressive Complexes (PRCs), in contrast to the Xi in differentiated Epiblast Like Stem Cells and eXtra-embryonic Endoderm cells. Despite this, the histone modifications catalysed by PRCs, ubH2AK119 and H3K27me3, remain the best heterochromatic markers for the Xi in all assessed lineages. Heterochromatic chromatin modifications associated with the Xi are a reflection of the epigenetic landscape of the entire genome of the assessed cell regardless whether XCI is imprinted or random.	[Dupont, Catherine; Maduro, Cheryl; Den Braanker, Hannah; Boers, Ruben; Kurek, Dorota; Gribnau, Joost] Erasmus MC, Dept Dev Biol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Dupont, C; Gribnau, J (corresponding author), Erasmus MC, Dept Dev Biol, Rotterdam, Netherlands.	c.dupont@erasmusmc.nl; j.gribnau@erasmusmc.nl	Boers, Ruben/AAF-8181-2020	Boers, Ruben/0000-0002-3377-2897; Dupont, Catherine/0000-0002-6228-1202; Kurek, Dorota/0000-0002-7168-8944				BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; Chaumeil J, 2002, CYTOGENET GENOME RES, V99, P75, DOI 10.1159/000071577; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Corbel C, 2013, DEVELOPMENT, V140, P861, DOI 10.1242/dev.087429; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; Fang J, 2004, J BIOL CHEM, V279, P52812, DOI 10.1074/jbc.C400493200; Gayen S, 2015, CELL REP, V11, P1251, DOI 10.1016/j.celrep.2015.04.039; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; Heard E, 2001, CELL, V107, P727, DOI 10.1016/S0092-8674(01)00598-0; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Kalantry S, 2006, NAT CELL BIOL, V8, P195, DOI 10.1038/ncb1351; Keohane AM, 1996, DEV BIOL, V180, P618, DOI 10.1006/dbio.1996.0333; Kohlmaier A, 2004, PLOS BIOL, V2, P991, DOI 10.1371/journal.pbio.0020171; KRATZER PG, 1983, CELL, V33, P37, DOI 10.1016/0092-8674(83)90332-X; KRUMLAUF R, 1986, NATURE, V319, P224, DOI 10.1038/319224a0; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Mak W, 2002, CURR BIOL, V12, P1016, DOI 10.1016/S0960-9822(02)00892-8; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Mermoud JE, 2002, CURR BIOL, V12, P247, DOI 10.1016/S0960-9822(02)00660-7; Merzouk S, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-11; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276, 10.1126/science.aab2276 aab2276]; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Moindrot B, 2015, CELL REP, V12, P562, DOI 10.1016/j.celrep.2015.06.053; Monfort A, 2015, CELL REP, V12, P554, DOI 10.1016/j.celrep.2015.06.067; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Ohhata T, 2008, DEVELOPMENT, V135, P227, DOI 10.1242/dev.008490; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Okamoto I, 2009, CHROMOSOME RES, V17, P659, DOI 10.1007/s10577-009-9057-7; Patrat C, 2009, P NATL ACAD SCI USA, V106, P5198, DOI 10.1073/pnas.0810683106; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; RASTAN S, 1982, J EMBRYOL EXP MORPH, V71, P11; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Senner CE, 2012, STEM CELLS, V30, P2732, DOI 10.1002/stem.1249; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314	42	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167154	10.1371/journal.pone.0167154	http://dx.doi.org/10.1371/journal.pone.0167154			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977710	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400012
J	Hasan, MM; Alam, MW; Wahid, KA; Miah, S; Lukong, KE				Hasan, Md. Mehedi; Alam, Mohammad Wajih; Wahid, Khan A.; Miah, Sayem; Lukong, Kiven Erique			A Low-Cost Digital Microscope with Real-Time Fluorescent Imaging Capability	PLOS ONE			English	Article							COUNTING BACTERIA; TUBERCULOSIS; DIAGNOSIS	This paper describes the development of a prototype of a low-cost digital fluorescent microscope built from commercial off-the-shelf (COTS) components. The prototype was tested to detect malignant tumor cells taken from a living organism in a preclinical setting. This experiment was accomplished by using Alexa Fluor 488 conjugate dye attached to the cancer cells. Our prototype utilizes a torch along with an excitation filter as a light source for fluorophore excitation, a dichroic mirror to reflect the excitation and pass the emitted green light from the sample under test and a barrier filter to permit only appropriate wavelength. The system is designed out of a microscope using its optical zooming property and an assembly of exciter filter, dichroic mirror and transmitter filter. The microscope is connected to a computer or laptop through universal serial bus (USB) that allows real-time transmission of captured florescence images; this also offers real-time control of the microscope. The designed system has comparable features of high-end commercial fluorescent microscopes while reducing cost, power, weight and size.	[Hasan, Md. Mehedi; Alam, Mohammad Wajih; Wahid, Khan A.] Univ Saskatchewan, Dept Elect & Comp Engn, Saskatoon, SK, Canada; [Miah, Sayem; Lukong, Kiven Erique] Univ Saskatchewan, Dept Biochem, Coll Med, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan	Wahid, KA (corresponding author), Univ Saskatchewan, Dept Elect & Comp Engn, Saskatoon, SK, Canada.	khan.wahid@usask.ca	ALAM, MOHAMMAD Wajih/Z-5310-2019	ALAM, MOHAMMAD Wajih/0000-0002-9737-2032	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Foundation for Innovation (CFI); WED	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); WED	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) to KAW, the Canada Foundation for Innovation (CFI) to KAW, and the WED to KAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babbitt GA, 2013, J MICROBIOL BIOL EDU, V14, P121, DOI 10.1128/jmbe.v14i1.530; Cropotova J, 2016, FOOD CHEM, V194, P175, DOI 10.1016/j.foodchem.2015.07.146; Goetz M, 2010, GASTROENTEROLOGY, V138, P828, DOI 10.1053/j.gastro.2010.01.009; HOBBIE JE, 1977, APPL ENVIRON MICROB, V33, P1225, DOI 10.1128/AEM.33.5.1225-1228.1977; Kivihya-Ndugga LEA, 2003, INT J TUBERC LUNG D, V7, P1163; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; Lisle JT, 2004, APPL ENVIRON MICROB, V70, P5343, DOI 10.1128/AEM.70.9.5343-5348.2004; Miller AR, 2010, PROC SPIE, V7556, DOI 10.1117/12.848605; Miller AR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011890; Perkins MD, 2006, LANCET, V367, P942, DOI 10.1016/S0140-6736(06)68386-4; Shirley A, 2014, CHEMIST, V87, P1; Thor labs, 2016, LONGP DICHR MIRR BEA; Wang C, 2008, J OPT SOC AM B, V25, P976, DOI 10.1364/JOSAB.25.000976; Wang TD, 2004, CLIN GASTROENTEROL H, V2, P744, DOI 10.1016/S1542-3565(04)00345-3	14	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167863	10.1371/journal.pone.0167863	http://dx.doi.org/10.1371/journal.pone.0167863			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977709	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400037
J	Marotta, A; Tinazzi, M; Cavedini, C; Zampini, M; Fiorio, M				Marotta, Angela; Tinazzi, Michele; Cavedini, Clelia; Zampini, Massimiliano; Fiorio, Mirta			Individual Differences in the Rubber Hand Illusion Are Related to Sensory Suggestibility	PLOS ONE			English	Article							BODY-OWNERSHIP; BRAIN; EXPERIENCES; THATS; LIMB	In the rubber hand illusion (RHI), watching a rubber hand being stroked in synchrony with one's own hidden hand may induce a sense of ownership over the rubber hand. The illusion relies on bottom-up multisensory integration of visual, tactile, and proprioceptive information, and on top-down processes through which the rubber hand is incorporated into pre-existing representations of the body. Although the degree of illusory experience varies largely across individuals, the factors influencing individual differences are unknown. We investigated whether sensory suggestibility might modulate susceptibility to the RHI. Sensory suggestibility is a personality trait related to how individuals react to sensory information. Because of its sensory nature, this trait could be relevant for studies using the RHI paradigm. Seventy healthy volunteers were classified by Sensory Suggestibility Scale (SSS) scores as having high or low suggestibility and assigned to either a high-(High-SSS) or a low-suggestibility (Low-SSS) group. Two components of the RHI were evaluated in synchronous and asynchronous stroking conditions: subjective experience of sense of ownership over the rubber hand via a 9-statement questionnaire, and proprioceptive drift as measured with a ruler. The High-SSS group was generally more susceptible to the subjective component; in the synchronous condition, they rated the statement assessing the sense of ownership higher than the Low-SSS group. The scores for this statement significantly correlated with the total SSS score, indicating that the higher the sensory suggestibility, the stronger the sense of ownership. No effect of sensory suggestibility on proprioceptive drift was observed, suggesting that the effect is specific for the subjective feeling of ownership. This study demonstrates that sensory suggestibility may contribute to participants' experience of the illusion and should be considered when using the RHI paradigm.	[Marotta, Angela; Tinazzi, Michele; Cavedini, Clelia; Fiorio, Mirta] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy; [Zampini, Massimiliano] Univ Trento, Dept Psychol & Cognit Sci, Rovereto, Italy; [Zampini, Massimiliano] Univ Trento, Ctr Mind Brain Sci, Trento, Italy	University of Verona; University of Trento; University of Trento	Marotta, A; Fiorio, M (corresponding author), Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.	angela.marotta@univr.it; mirta.fiorio@univr.it	Marotta, Angela/K-4562-2016; Marotta, Angela/AAB-4418-2021; Zampini, Massimiliano/AAR-1311-2020; TINAZZI, Michele/J-7134-2018	Marotta, Angela/0000-0002-0738-0240; Zampini, Massimiliano/0000-0001-5950-7365; TINAZZI, Michele/0000-0002-2370-7063; Fiorio, Mirta/0000-0002-6356-0211; Marotta, Angela/0000-0002-2083-3005				Abdulkarim Z, 2016, ATTEN PERCEPT PSYCHO, V78, P707, DOI 10.3758/s13414-015-1016-0; Asai T, 2011, CONSCIOUS COGN, V20, P1744, DOI 10.1016/j.concog.2011.02.005; Bekrater-Bodmann R, 2012, BRAIN RES, V1452, P130, DOI 10.1016/j.brainres.2012.03.001; Bertamini M, 2014, CONSCIOUS COGN, V27, P89, DOI 10.1016/j.concog.2014.04.010; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Costantini M, 2007, CONSCIOUS COGN, V16, P229, DOI 10.1016/j.concog.2007.01.001; De Pascalis V, 2002, PAIN, V96, P393, DOI 10.1016/S0304-3959(01)00485-7; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Fiorio M, 2011, BRAIN, V134, P1428, DOI 10.1093/brain/awr026; Germine L, 2013, PSYCHIAT RES, V207, P45, DOI 10.1016/j.psychres.2012.11.022; Gheorghiu V.A., 2000, SUGGESTION SUGGESTIB, P1; Gheorghiu V. A., 2008, CONT HYPNOSIS, V25, P78, DOI DOI 10.1002/CH.357; Gheorghiu VA, 1995, HYPNOSIS CONNECTING, P14; Gheorghiu VA, 1976, REV ROUMAINE SCI SOC, V20, P29; Gheorghiu VA, 2001, CONT HYPNOSIS, V18, P21, DOI DOI 10.1002/ch.213; Haans A, 2012, ACTA PSYCHOL, V141, P169, DOI 10.1016/j.actpsy.2012.07.016; Holle H, 2011, COGN NEUROSCI-UK, V2, P171, DOI 10.1080/17588928.2011.603828; Ionta S, 2013, COGN AFFECT BEHAV NE, V13, P197, DOI 10.3758/s13415-012-0120-z; Kallai J, 2015, PSYCHIAT RES, V229, P410, DOI 10.1016/j.psychres.2015.05.109; Kilteni K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00141; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Lund K, 2015, J PSYCHOSOM RES, V79, P663, DOI 10.1016/j.jpsychores.2015.05.002; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Netter P., 1989, SUGGESTION SUGGESTIB, P123; Newport R, 2010, EXP BRAIN RES, V204, P385, DOI 10.1007/s00221-009-2104-y; Ocklenburg S, 2011, LATERALITY, V16, P174, DOI 10.1080/13576500903483515; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Polczyk R, 2006, INT J CLIN EXP HYP, V54, P392, DOI 10.1080/00207140600856764; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Slater M, 2009, FRONT NEUROSCI-SWITZ, V3, P214, DOI 10.3389/neuro.01.029.2009; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P2740, DOI 10.1016/j.neuropsychologia.2010.05.021; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Walsh E, 2015, PERCEPTION, V44, P709, DOI 10.1177/0301006615594266	37	58	59	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168489	10.1371/journal.pone.0168489	http://dx.doi.org/10.1371/journal.pone.0168489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977783	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400112
J	Mattos, RT; Medeiros, NI; Menezes, CA; Fares, RCG; Franco, EP; Dutra, WO; Rios-Santos, F; Correa-Oliveira, R; Gomes, JAS				Mattos, Rafael T.; Medeiros, Nayara I.; Menezes, Carlos A.; Fares, Rafaelle C. G.; Franco, Eliza P.; Dutra, Walderez O.; Rios-Santos, Fabricio; Correa-Oliveira, Rodrigo; Gomes, Juliana A. S.			Chronic Low-Grade Inflammation in Childhood Obesity Is Associated with Decreased IL-10 Expression by Monocyte Subsets	PLOS ONE			English	Article							INNATE IMMUNITY; ADIPOSE-TISSUE; CD36; DIFFERENTIATION; ANGIOGENESIS; MACROPHAGES; ACTIVATION; TLR4	Chronic low-grade inflammation is related to the development of comorbidities and poor prognosis in obesity. Monocytes are main sources of cytokines and play a pivotal role in inflammation. We evaluated monocyte frequency, phenotype and cytokine profile of monocyte subsets, to determine their association with the pathogenesis of childhood obesity. Children with obesity were evaluated for biochemical and anthropometric parameters. Monocyte subsets were characterized by flow cytometry, considering cytokine production and activation/ recognition molecules. Correlation analysis between clinical parameters and immunological data delineated the monocytes contribution for low-grade inflammation. We observed a higher frequency of non-classical monocytes in the childhood obesity group ( CO) than normal-weight group ( NW). All subsets displayed higher TLR4 expression in CO, but their recognition and antigen presentation functions seem to be diminished due to lower expression of CD40, CD80/86 and HLA-DR. All subsets showed a lower expression of IL-10 in CO and correlation analyses showed changes in IL-10 expression profile. The lower expression of IL-10 may be decisive for the maintenance of the low-grade inflammation status in CO, especially for alterations in non-classical monocytes profile. These cells may contribute to supporting inflammation and loss of regulation in the immune response of children with obesity.	[Mattos, Rafael T.; Medeiros, Nayara I.; Franco, Eliza P.; Dutra, Walderez O.; Gomes, Juliana A. S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Lab Biol Interacoes Celulares, Belo Horizonte, MG, Brazil; [Medeiros, Nayara I.; Fares, Rafaelle C. G.; Correa-Oliveira, Rodrigo] Fiocruz MS, Ctr Pesquisa Rene Rachou, Lab Imunol Celular & Mol, Belo Horizonte, MG, Brazil; [Menezes, Carlos A.] Univ Estadual Santa Cruz, Dept Genet, Ilheus, BA, Brazil; [Menezes, Carlos A.] Unimed, Serv Med Prevent, Aracaju, SE, Brazil; [Dutra, Walderez O.; Correa-Oliveira, Rodrigo] Univ Fed Mato Grasso, INCT DT, Cuiaba, MT, Brazil; [Rios-Santos, Fabricio] Univ Fed Mato Grasso, Fac Med, Dept Ciencias Basicas Saude, Cuiaba, MT, Brazil; [Fares, Rafaelle C. G.] US FDA, Ctr Biol Evaluat & Res Silver Spring, Rockville, MD 20857 USA	Universidade Federal de Minas Gerais; Fundacao Oswaldo Cruz; Universidade Estadual de Santa Cruz; US Food & Drug Administration (FDA)	Gomes, JAS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Lab Biol Interacoes Celulares, Belo Horizonte, MG, Brazil.	juliana@icb.ufmg.br	Dutra, Walderez Ornelas/CAH-1502-2022; Medeiros, Nayara I/F-3273-2018; Gomes, Juliana A. S./M-4083-2017; Duarte, Graziela Biude Silva/Q-7728-2016	Dutra, Walderez Ornelas/0000-0002-7586-9996; Medeiros, Nayara I/0000-0002-5791-4802; Gomes, Juliana A. S./0000-0002-8332-2907; Fares Gusmao, Rafaelle/0000-0002-2186-4145; Correa-Oliveira, Rodrigo/0000-0001-6419-9459	FAPEMIG; FAPEMIG/PROBIC; CNPq PQ Fellowship program	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG/PROBIC(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq PQ Fellowship program	RTM and NIM are received financial support from FAPEMIG. EPF received fellowship from FAPEMIG/PROBIC. WOD, RCO and JASG received financial support from CNPq PQ Fellowship program.	Al-Sharea A, 2016, THROMB HAEMOSTASIS, V115, P762, DOI 10.1160/TH15-07-0571; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Ayina CNA, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0264-x; Bleau C, 2015, DIABETES-METAB RES, V31, P545, DOI 10.1002/dmrr.2617; BRAY GA, 1992, AM J CLIN NUTR, V55, P488, DOI 10.1093/ajcn/55.2.488s; BROOKE OG, 1985, HUM NUTR-APPL NUTR, V39A, P304; Cao DY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23132; Carolan E, 2014, J CLIN ENDOCR METAB, V99, pE474, DOI 10.1210/jc.2013-3529; Cheng SB, 2015, AM J REPROD IMMUNOL, V73, P487, DOI 10.1111/aji.12329; Chow DC, 2016, HIV CLIN TRIALS, V17, P114, DOI 10.1080/15284336.2016.1162386; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Gaur P, 2016, CLIN EXP IMMUNOL; Groen B, 2015, SCI REP-UK, V5, DOI 10.1038/srep13618; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Ingersoll MA, 2011, TRENDS IMMUNOL, V32, P470, DOI 10.1016/j.it.2011.05.001; Ip B, 2016, OBESITY, V24, P102, DOI 10.1002/oby.21243; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; Koleva Daniela Iv, 2013, Folia Med (Plovdiv), V55, P25; Kopp A, 2009, OBESITY, V17, P648, DOI 10.1038/oby.2008.607; Kuczmarski RJ, 2000, VITAL HLTH STAT, V11, P1; MALEFYT RD, 1991, J EXP MED, V174, P1209; Milner JJ, 2015, J IMMUNOL, V194, P4846, DOI 10.4049/jimmunol.1402295; Milner JJ, 2012, P NUTR SOC, V71, P298, DOI 10.1017/S0029665112000158; Poitou C, 2011, ARTERIOSCL THROM VAS, V31, P2322, DOI 10.1161/ATVBAHA.111.230979; Schaeffler A, 2009, IMMUNOLOGY, V126, P233, DOI 10.1111/j.1365-2567.2008.02892.x; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; van Greevenbroek MMJ, 2013, NETH J MED, V71, P174; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Williams DW, 2015, J LEUKOCYTE BIOL, V97, P401, DOI 10.1189/jlb.5A0714-347R; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	39	31	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168610	10.1371/journal.pone.0168610	http://dx.doi.org/10.1371/journal.pone.0168610			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977792	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400122
J	Oh, SY; Fong, JJ; Park, MS; Lim, YW				Oh, Seung-Yoon; Fong, Jonathan J.; Park, Myung Soo; Lim, Young Woon			Distinctive Feature of Microbial Communities and Bacterial Functional Profiles in Tricholoma matsutake Dominant Soil	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; HELPER PSEUDOMONAS-FLUORESCENS; III SECRETION; ECTOMYCORRHIZAL SYMBIOSIS; LACCARIA-BICOLOR; PINUS-SYLVESTRIS; GENE-EXPRESSION; FAIRY RING; S-ITO; FOREST	Tricholoma matsutake, the pine mushroom, is a valuable forest product with high economic value in Asia, and plays an important ecological role as an ectomycorrhizal fungus. Around the host tree, T. matsutake hyphae generate a distinctive soil aggregating environment called a fairy ring, where fruiting bodies form. Because T. matsutake hyphae dominate the soil near the fairy ring, this species has the potential to influence the microbial community. To explore the influence of T. matsutake on the microbial communities, we compared the microbial community and predicted bacterial function between two different soil types D T. matsutake dominant and T. matsutake minor. DNA sequence analyses showed that fungal and bacterial diversity were lower in the T. matsutake dominant soil compared to T. matsutake minor soil. Some microbial taxa were significantly more common in the T. matsutake dominant soil across geographic locations, many of which were previously identified as mycophillic or mycorrhiza helper bacteria. Between the two soil types, the predicted bacterial functional profiles (using PICRUSt) had significantly distinct KEGG modules. Modules for amino acid uptake, carbohydrate metabolism, and the type III secretion system were higher in the T. matsutake dominant soil than in the T. matsutake minor soil. Overall, similar microbial diversity, community structure, and bacterial functional profiles of the T. matsutake dominant soil across geographic locations suggest that T. matsutake may generate a dominance effect.	[Oh, Seung-Yoon; Park, Myung Soo; Lim, Young Woon] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Fong, Jonathan J.] Lingnan Univ, Sci Unit, Tuen Mun, Hong Kong, Peoples R China	Seoul National University (SNU); Lingnan University	Lim, YW (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea.	ywlim@snu.ac.kr	Oh, Seung-Yoon/H-4958-2018	Oh, Seung-Yoon/0000-0002-9745-1849; FONG, Jonathan/0000-0002-3648-6730	National Institute of Forest Science [FP 0801-2009-01]	National Institute of Forest Science(National Institute of Forest Science (NIFOS), Republic of South Korea)	This study was supported by the National Institute of Forest Science (FP 0801-2009-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreote FD, 2009, WORLD J MICROB BIOT, V25, P1065, DOI 10.1007/s11274-009-9990-9; Antony-Babu S, 2014, ENVIRON MICROBIOL, V16, P2831, DOI 10.1111/1462-2920.12294; Bakker MG, 2013, FEMS MICROBIOL ECOL, V83, P596, DOI 10.1111/1574-6941.12017; Barberan A, 2012, ISME J, V6, P343, DOI 10.1038/ismej.2011.119; Bending GD, 2002, FEMS MICROBIOL ECOL, V39, P219, DOI 10.1111/j.1574-6941.2002.tb00924.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boersma FGH, 2010, SOIL BIOL BIOCHEM, V42, P2137, DOI 10.1016/j.soilbio.2010.08.009; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carvalhais LC, 2013, METHOD ENZYMOL, V531, P251, DOI 10.1016/B978-0-12-407863-5.00013-7; Chen L-x, 2014, ISME J, pe245; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Corrigan A, 2015, APPL ENVIRON MICROB, V81, P3460, DOI 10.1128/AEM.04194-14; CROMACK K, 1988, AGR ECOSYST ENVIRON, V24, P161, DOI 10.1016/0167-8809(88)90063-1; Cusano AM, 2011, ENV MICROBIOL REP, V3, P203, DOI 10.1111/j.1758-2229.2010.00209.x; de Voogd NJ, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv019; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Deveau A, 2007, NEW PHYTOL, V175, P743, DOI 10.1111/j.1469-8137.2007.02148.x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Frey-Klett P, 2007, NEW PHYTOL, V176, P22, DOI 10.1111/j.1469-8137.2007.02191.x; Frey-Klett P, 2005, NEW PHYTOL, V165, P317, DOI 10.1111/j.1469-8137.2004.01212.x; FreyKlett P, 1997, APPL ENVIRON MICROB, V63, P139, DOI 10.1128/AEM.63.1.139-144.1997; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GRIFFITHS RP, 1991, PLANT SOIL, V134, P255, DOI 10.1007/BF00012043; GRIFFITHS RP, 1994, SOIL BIOL BIOCHEM, V26, P331, DOI 10.1016/0038-0717(94)90282-8; Guerin-Laguette Alexis, 2003, Mycological Progress, V2, P37, DOI 10.1007/s11557-006-0042-7; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hall IR, 2003, TRENDS BIOTECHNOL, V21, P433, DOI 10.1016/S0167-7799(03)00204-X; Halsey JA, 2016, ANTON LEEUW INT J G, V109, P1353, DOI 10.1007/s10482-016-0734-1; Hrynkiewicz K, 2009, BIOL FERT SOILS, V45, P385, DOI 10.1007/s00374-008-0346-7; Izumi H, 2011, ENVIRON MICROBIOL, V13, P819, DOI 10.1111/j.1462-2920.2010.02393.x; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; KANG A-S, 1989, Korean Journal of Mycology, V17, P51; Kataoka R, 2012, J MICROBIOL, V50, P199, DOI 10.1007/s12275-012-1371-7; Kim M, 2014, J APPL MICROBIOL, V117, P699, DOI 10.1111/jam.12572; Kim M, 2013, J MICROBIOL BIOTECHN, V23, P1347, DOI 10.4014/jmb.1306.06068; Kirst ME, 2015, APPL ENVIRON MICROB, V81, P783, DOI 10.1128/AEM.02712-14; Kluber LA, 2011, SOIL BIOL BIOCHEM, V43, P1042, DOI 10.1016/j.soilbio.2011.01.022; Kluber LA, 2010, SOIL BIOL BIOCHEM, V42, P1607, DOI 10.1016/j.soilbio.2010.06.001; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Koo Chang Duck, 2003, [Journal of Korean Society of Forest Science, 한국산림과학회지], V92, P632; KOPE HH, 1990, CAN J BOT, V68, P1254, DOI 10.1139/b90-159; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee C-Y, 1997, KOREAN J MYCOL, V25, P226; Leveau JHJ, 2008, NEW PHYTOL, V177, P859, DOI 10.1111/j.1469-8137.2007.02325.x; LI CY, 1992, PLANT SOIL, V140, P35, DOI 10.1007/BF00012804; Lian CL, 2006, NEW PHYTOL, V171, P825, DOI 10.1111/j.1469-8137.2006.01801.x; Ma B, 2015, J APPL MICROBIOL, V118, P890, DOI 10.1111/jam.12756; Matsushita Norihisa, 2005, Mycoscience, V46, P90, DOI 10.1007/s10267-004-0220-x; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; 김인엽, 2005, [The Korean Journal of Mycology, 한국균학회지], V33, P22; Muyzer G., 1996, MOL MICROBIAL ECOLOG, P1; Nazir R, 2010, SOIL BIOL BIOCHEM, V42, P2146, DOI 10.1016/j.soilbio.2010.08.019; Nazir R, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00598; Nazir R, 2010, FEMS MICROBIOL ECOL, V71, P169, DOI 10.1111/j.1574-6941.2009.00807.x; Nguyen NH, 2015, MICROB ECOL, V69, P914, DOI 10.1007/s00248-015-0574-y; OGAWA M, 1976, T MYCOL SOC JPN, V17, P492; OHARA H, 1967, NATURE, V213, P528, DOI 10.1038/213528a0; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Preston GM, 2007, CELL HOST MICROBE, V2, P291, DOI 10.1016/j.chom.2007.10.004; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; R Core Team, 2014, R A LANGUAGE AND ENV; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Requena N, 1997, NEW PHYTOL, V136, P667, DOI 10.1046/j.1469-8137.1997.00786.x; 유영현, 2011, [The Korean Journal of Mycology, 한국균학회지], V39, P223; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sabella E, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1083-6; SASEK V, 1967, FOLIA MICROBIOL, V12, P515, DOI 10.1007/BF02875713; Sharpton TJ, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00209; Simon A, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv116; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI, V3rd, DOI DOI 10.1097/00010694-198403000-00011; SONG H-S, 1991, Korean Journal of Mycology, V19, P109; Summerbell RC, 2005, STUD MYCOL, P191, DOI 10.3114/sim.53.1.191; Takakura Y, 2015, CAN J MICROBIOL, V61, P447, DOI 10.1139/cjm-2014-0843; Timonen S, 2006, CAN J MICROBIOL, V52, P769, DOI 10.1139/W06-016; Tominaga Y., 1963, Bulletin of the Hiroshima Agricultural College, Hiroshima, V2, P105; Trappe M. J., 2012, Diversity, V4, P196, DOI 10.3390/d4020196; Uroz S, 2012, APPL ENVIRON MICROB, V78, P3020, DOI 10.1128/AEM.06742-11; Vaario LM, 2011, APPL ENVIRON MICROB, V77, P8523, DOI 10.1128/AEM.05839-11; Vik U, 2013, SCI REP-UK, V3, DOI 10.1038/srep03471; Viollet A, 2011, FEMS MICROBIOL ECOL, V75, P457, DOI 10.1111/j.1574-6941.2010.01021.x; Voronina EY, 2011, MICROBIOLOGY+, V80, P584, DOI 10.1134/S0026261711040217; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Yun, 1997, Economic Botany, V51, P311, DOI 10.1007/BF02862101; Warmink JA, 2009, ENVIRON MICROBIOL, V11, P300, DOI 10.1111/j.1462-2920.2008.01767.x; Warmink JA, 2008, ISME J, V2, P887, DOI 10.1038/ismej.2008.41; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yang XF, 2012, FUNGAL DIVERS, V56, P189, DOI 10.1007/s13225-012-0163-z; Zhang MZ, 2014, FEMS MICROBIOL ECOL, V89, P516, DOI 10.1111/1574-6941.12350	93	32	34	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168573	10.1371/journal.pone.0168573	http://dx.doi.org/10.1371/journal.pone.0168573			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977803	gold, Green Submitted, Green Published			2022-12-27	WOS:000391217400118
J	Dunoyer-Geindre, S; Rivier-Cordey, AS; Caetano, C; Fish, RJ; Kruithof, EKO				Dunoyer-Geindre, Sylvie; Rivier-Cordey, Anne-Sophie; Caetano, Carlos; Fish, Richard J.; Kruithof, Egbert K. O.			Effect of Regulatory Element DNA Methylation on Tissue-Type Plasminogen Activator Gene Expression	PLOS ONE			English	Article							HUMAN ENDOTHELIAL-CELLS; CPG METHYLATION; IN-VIVO; T-PA; PROMOTER; IDENTIFICATION; BINDING; PROTEIN; STIMULATION; GENERATION	Expression of the tissue-type plasminogen activator gene (t-PA; gene name PLAT) is regulated, in part, by epigenetic mechanisms. We investigated the relationship between PLAT methylation and PLAT expression in five primary human cell types and six transformed cell lines. CpG methylation was analyzed in the proximal PLAT gene promoter and near the multihormone responsive enhancer (MHRE) -7.3 kilobase pairs upstream of the PLAT transcriptional start site (TSS,-7.3 kb). In Bowes melanoma cells, the PLAT promoter and the MHRE were fully unmethylated and t-PA secretion was extremely high. In other cell types the region from-647 to-366 was fully methylated, whereas an unmethylated stretch of DNA from -121 to + 94 was required but not sufficient for detectable t-PA mRNA and t-PA secretion. DNA methylation near the MHRE was not correlated with t-PA secretion. Specific methylation of the PLAT promoter region -151 to +151, inserted into a firefly luciferase reporter gene, abolished reporter gene activity. The region -121 to +94 contains two well-described regulatory elements, a PMA-responsive element (CRE) near-106 and a GC-rich region containing an Sp1 binding site near +59. Methylation of double-stranded DNA oligonucleotides containing the CRE or the GC-rich region had little or no effect on transcription factor binding. Methylated CpGs may attract co-repressor complexes that contain histone deacetylases (HDAC). However, reporter gene activity of methylated plasmids was not restored by the HDAC inhibitor trichostatin. In conclusion, efficient PLAT gene expression requires a short stretch of unmethylated CpG sites in the proximal promoter.	[Dunoyer-Geindre, Sylvie; Rivier-Cordey, Anne-Sophie; Caetano, Carlos; Kruithof, Egbert K. O.] Univ Geneva, Univ Med Ctr, Div Angiol & Hemostasis, Geneva, Switzerland; [Fish, Richard J.] Univ Geneva, Univ Med Ctr, Dept Genet Med & Dev, Geneva, Switzerland	University of Geneva; University of Geneva	Dunoyer-Geindre, S (corresponding author), Univ Geneva, Univ Med Ctr, Div Angiol & Hemostasis, Geneva, Switzerland.	Sylvie.Geindre@unige.ch	Kruithof, Egbert/AGR-4755-2022		Swiss National Science Foundation [320000-118125, 310030-133099, 31003A - 149269]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (www.SNF.ch) grants nos. 320000-118125, 310030-133099 and 31003A - 149269. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMANT M, 1995, J IMMUNOL, V155, P4868; Arts J, 1997, NUCLEIC ACIDS RES, V25, P311, DOI 10.1093/nar/25.2.311; ARTS J, 1995, BIOCHEM J, V310, P171, DOI 10.1042/bj3100171; Benarroch EE, 2007, NEUROLOGY, V69, P799, DOI 10.1212/01.wnl.0000269668.08747.78; BULENS F, 1995, J BIOL CHEM, V270, P7167, DOI 10.1074/jbc.270.13.7167; Bulens F, 1997, J BIOL CHEM, V272, P663; Clouaire T, 2008, CELL MOL LIFE SCI, V65, P1509, DOI 10.1007/s00018-008-7324-y; Collen D, 2009, ARTERIOSCL THROM VAS, V29, P1151, DOI 10.1161/ATVBAHA.108.179655; Costa M, 2000, FEBS LETT, V482, P75, DOI 10.1016/S0014-5793(00)02030-5; Costa M, 1998, EUR J BIOCHEM, V258, P123, DOI 10.1046/j.1432-1327.1998.2580123.x; DEGEN SJF, 1986, J BIOL CHEM, V261, P6972; dos Santos JM, 2015, METABOLISM, V64, P1619, DOI 10.1016/j.metabol.2015.09.013; Dunoyer-Geindre S, 2001, THROMB HAEMOSTASIS, V85, P903; Dunoyer-Geindre S, 2011, CARDIOVASC RES, V90, P457, DOI 10.1093/cvr/cvr028; Fineschi S, 2006, FASEB J, V20, P562, DOI 10.1096/fj.05-4870fje; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; FISHER R, 1985, J BIOL CHEM, V260, P1223; Gao S, 2005, THROMB HAEMOSTASIS, V94, P651, DOI 10.1160/TH05-02-0114; GILES AR, 1990, THROMB HAEMOSTASIS, V63, P476; HENDERSON BR, 1992, FEBS LETT, V309, P130, DOI 10.1016/0014-5793(92)81080-6; HOLLER M, 1988, GENE DEV, V2, P1127, DOI 10.1101/gad.2.9.1127; Huber D, 2002, BLOOD, V99, P3637, DOI 10.1182/blood.V99.10.3637; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jern C, 1999, ARTERIOSCL THROM VAS, V19, P454, DOI 10.1161/01.ATV.19.2.454; Keating ST, 2015, CIRC RES, V116, P715, DOI 10.1161/CIRCRESAHA.116.303936; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; KOOISTRA T, 1987, BIOCHEM J, V247, P605, DOI 10.1042/bj2470605; Kruithof EKO, 2014, THROMB HAEMOSTASIS, V112, P243, DOI 10.1160/TH13-06-0517; Kruithof EKO, 1997, THROMB HAEMOSTASIS, V77, P905; Kwak SH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.7; Lal G, 2009, BLOOD, V114, P3727, DOI 10.1182/blood-2009-05-219584; Larsson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031573; LAUG WE, 1992, INT J CANCER, V52, P298, DOI 10.1002/ijc.2910520224; Lemarchant S, 2012, NEUROPHARMACOLOGY, V62, P749, DOI 10.1016/j.neuropharm.2011.10.020; Lu HY, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00085; Magnusson M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141805; Marullo M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r9; MEDCALF RL, 1990, J BIOL CHEM, V265, P14618; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; Olsson M, 2016, GENE REGUL SYST BIO, V10, P9, DOI 10.4137/GRSB.S30241; Ortolano S, 2013, RECENT PATENTS ENDOC, V7, P65, DOI 10.2174/187221413804660962; Pan W, 2008, J THROMB HAEMOST, V6, P976, DOI 10.1111/j.1538-7836.2008.02977.x; Pawlak R, 2002, J CLIN INVEST, V109, P1529, DOI 10.1172/JCI200215961; Pham NL, 2004, ARTERIOSCL THROM VAS, V24, P982, DOI 10.1161/01.ATV.0000126679.70877.d0; Riviere G, 2011, EPIGENETICS-US, V6, P479, DOI 10.4161/epi.6.4.14961; Ronn T, 2015, EPIGENOMICS-UK, V7, P451, DOI 10.2217/epi.15.7; Samson AL, 2006, NEURON, V50, P673, DOI 10.1016/j.neuron.2006.04.013; Svennerholm K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097260; Vivien D, 2011, J CEREBR BLOOD F MET, V31, P2119, DOI 10.1038/jcbfm.2011.127; Wolffe AP, 2000, BIOCHEM SOC T, V28, P379, DOI 10.1042/0300-5127:0280379; Xu SB, 2009, J CANCER RES CLIN, V135, P1791, DOI 10.1007/s00432-009-0627-z; Xu XG, 2015, ONCOTARGET, V6, P13925, DOI 10.18632/oncotarget.4215; Yamashita R, 2011, GENOME RES, V21, P775, DOI 10.1101/gr.110254.110; Yepes M, 2009, TRENDS NEUROSCI, V32, P48, DOI 10.1016/j.tins.2008.09.006	56	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167588	10.1371/journal.pone.0167588	http://dx.doi.org/10.1371/journal.pone.0167588			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973546	gold, Green Submitted, Green Published			2022-12-27	WOS:000392754300034
J	Gorst, SL; Gargon, E; Clarke, M; Smith, V; Williamson, PR				Gorst, Sarah L.; Gargon, Elizabeth; Clarke, Mike; Smith, Valerie; Williamson, Paula R.			Choosing Important Health Outcomes for Comparative Effectiveness Research: An Updated Review and Identification of Gaps	PLOS ONE			English	Review								Background The COMET (Core Outcome Measures in Effectiveness Trials) Initiative promotes the development and application of core outcome sets (COS), including relevant studies in an online database. In order to keep the database current, an annual search of the literature is undertaken. This study aimed to update a previous systematic review, in order to identify any further studies where a COS has been developed. Furthermore, no prioritization for COS development has previously been undertaken, therefore this study also aimed to identify COS relevant to the world's most prevalent health conditions. Methods The methods used in this updated review followed the same approach used in the original review and the previous update. A survey was also sent to the corresponding authors of COS identified for inclusion in this review, to ascertain what lessons they had learnt from developing their COS. Additionally, the COMET database was searched to identify COS that might be relevant to the conditions with the highest global prevalence. Results Twenty-five reports relating to 22 new studies were eligible for inclusion in the review. Further improvements were identified in relation to the description of the scope of the COS, use of the Delphi technique, and the inclusion of patient participants within the development process. Additionally, 33 published and ongoing COS were identified for 13 of the world's most prevalent conditions. Conclusion The development of a reporting guideline and minimum standards should contribute towards future improvements in development and reporting of COS. This study has also described a first approach to identifying gaps in existing COS, and to priority setting area. Important gaps have been identified, on the basis of global burden of disease, and the development and application of COS in these areas should be considered a priority.	[Gorst, Sarah L.; Gargon, Elizabeth; Williamson, Paula R.] Univ Liverpool, Dept Biostat, MRC North West Hub Trials Methodol Res NWHTMR, Liverpool, Merseyside, England; [Clarke, Mike] Queens Univ Belfast, Northern Ireland Network Trials Methodol Res, Belfast, Antrim, North Ireland; [Smith, Valerie] Trinity Coll Dublin, Sch Nursing & Midwifery, Dublin, Ireland	University of Liverpool; Queens University Belfast; Trinity College Dublin	Gorst, SL (corresponding author), Univ Liverpool, Dept Biostat, MRC North West Hub Trials Methodol Res NWHTMR, Liverpool, Merseyside, England.	sgorst@liverpool.ac.uk	Smith, Valerie/AFQ-3592-2022; Williamson, Paula R/B-6425-2016	Smith, Valerie/0000-0003-2249-6038; Williamson, Paula R/0000-0001-9802-6636	NIHR (National Institute for Health Research) [NF-SI_0513-10025]; Medical Research Council [MR/K025635/1, G0901530] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10025] Funding Source: researchfish; MRC [G0901530, MR/K025635/1] Funding Source: UKRI	NIHR (National Institute for Health Research)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the NIHR (National Institute for Health Research), grant number NF-SI_0513-10025. The funders had no role in study design,data collection and analysis, decision to publish,or preparation of the manuscript.	Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Gargon E, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0019-9; Gargon E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099111; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Gorst SL, PLOS ONE; Kirkham JJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002148; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Tunis SR, 2016, J COMP EFFECT RES, V5, P193, DOI 10.2217/cer-2015-0007; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132	10	45	45	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168403	10.1371/journal.pone.0168403	http://dx.doi.org/10.1371/journal.pone.0168403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973622	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300080
J	Puig, MS; Pallares, JM; Zapata, LP; Puigcerver, L; Canete, J; Super, H				Sole Puig, Maria; Marco Pallares, Josep; Perez Zapata, Laura; Puigcerver, Laura; Canete, Josep; Super, Hans			Attentional Selection Accompanied by Eye Vergence as Revealed by Event-Related Brain Potentials	PLOS ONE			English	Article							SUPERIOR COLLICULUS; NEURAL MECHANISMS; MOVEMENTS; DYNAMICS; CONVERGENCE; NEURONS; CORTEX; STIMULATION; INHIBITION; DISORDERS	Neural mechanisms of attention allow selective sensory information processing. Top-down deployment of visual-spatial attention is conveyed by cortical feedback connections from frontal regions to lower sensory areas modulating late stimulus responses. A recent study reported the occurrence of small eye vergence during orienting top-down attention. Here we assessed a possible link between vergence and attention by comparing visual event related potentials (vERPs) to a cue stimulus that induced attention to shift towards the target location to the vERPs to a no-cue stimulus that did not trigger orienting attention. The results replicate the findings of eye vergence responses during orienting attention and show that the strength and time of eye vergence coincide with the onset and strength of the vERPs when subjects oriented attention. Our findings therefore support the idea that eye vergence relates to and possibly has a role in attentional selection.	[Sole Puig, Maria; Marco Pallares, Josep; Perez Zapata, Laura; Super, Hans] Univ Barcelona, Dept Cognit Dev & Educ Psychol, Barcelona, Spain; [Marco Pallares, Josep; Super, Hans] Univ Barcelona, Neurosci Inst, Barcelona, Spain; [Marco Pallares, Josep; Puigcerver, Laura; Super, Hans] Hosp St Joan de Deu, Pediat Res Inst, Barcelona, Spain; [Canete, Josep] Consorci Sanitari Maresme, Dept Mental Hlth, Mataro, Spain; [Super, Hans] Pg Lluis Co, ICREA, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; ICREA	Super, H (corresponding author), Univ Barcelona, Dept Cognit Dev & Educ Psychol, Barcelona, Spain.; Super, H (corresponding author), Univ Barcelona, Neurosci Inst, Barcelona, Spain.; Super, H (corresponding author), Hosp St Joan de Deu, Pediat Res Inst, Barcelona, Spain.; Super, H (corresponding author), Pg Lluis Co, ICREA, Barcelona, Spain.	hans.super@icrea.cat	CAÑETE, JOSE/H-6715-2014	CAÑETE, JOSE/0000-0002-1368-6801; Super, Hans/0000-0001-9328-0096; Sole Puig, Maria/0000-0002-4331-3432	Ministry of Economy, Spain; ICREA Funding Source: Custom	Ministry of Economy, Spain; ICREA(ICREA)	The sole funder of the study is Ministry of Economy, Spain. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez TL, 2014, FRONT INTEGR NEUROSC, V8, DOI 10.3389/fnint.2014.00050; Betta E, 2007, VISION RES, V47, P428, DOI 10.1016/j.visres.2006.09.010; Bichot NP, 2006, PROG BRAIN RES, V155, P147, DOI 10.1016/S0079-6123(06)55009-5; Bucci MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033458; Chaturvedi V, 2000, EXP BRAIN RES, V132, P72, DOI 10.1007/s002219900221; Chella F, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/3/036016; Coubard OA, 2013, EUR J NEUROSCI, V38, P3384, DOI 10.1111/ejn.12356; EIMER M, 1994, PERCEPT PSYCHOPHYS, V55, P667, DOI 10.3758/BF03211681; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Galfano G, 2004, EXP BRAIN RES, V159, P400, DOI 10.1007/s00221-004-2111-y; Gamlin PD, 2000, NATURE, V407, P1003, DOI 10.1038/35039506; Gamlin PDR, 2002, ANN NY ACAD SCI, V956, P264, DOI 10.1111/j.1749-6632.2002.tb02825.x; Ghajar J, 2009, NEUROSCIENTIST, V15, P232, DOI 10.1177/1073858408326429; GNADT JW, 1995, J NEUROPHYSIOL, V73, P280, DOI 10.1152/jn.1995.73.1.280; Granet DB, 2005, STRABISMUS, V13, P163, DOI 10.1080/09273970500455436; Grau C, 2007, NEUROIMAGE, V36, P522, DOI 10.1016/j.neuroimage.2007.03.027; Heinrich H, 2014, NEUROSCI LETT, V582, P49, DOI 10.1016/j.neulet.2014.08.050; Hickey C, 2009, J COGNITIVE NEUROSCI, V21, P760, DOI 10.1162/jocn.2009.21039; Hopf JM, 2000, CLIN NEUROPHYSIOL, V111, P1241, DOI 10.1016/S1388-2457(00)00313-8; Johnston BA, 2014, HUM BRAIN MAPP, V35, P5179, DOI 10.1002/hbm.22542; JUDGE SJ, 1986, J NEUROPHYSIOL, V55, P915, DOI 10.1152/jn.1986.55.5.915; Ko HK, 2010, NAT NEUROSCI, V13, P1549, DOI 10.1038/nn.2663; Krauzlis RJ, 2013, ANNU REV NEUROSCI, V36, P165, DOI 10.1146/annurev-neuro-062012-170249; Laubrock J, 2005, VISION RES, V45, P721, DOI 10.1016/j.visres.2004.09.029; Esposito FL, 2016, EUR PSYCHIAT, V33, pS135, DOI 10.1016/j.eurpsy.2016.01.211; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MAYS LE, 1984, J NEUROPHYSIOL, V51, P1091, DOI 10.1152/jn.1984.51.5.1091; Mazza V, 2009, CORTEX, V45, P879, DOI 10.1016/j.cortex.2008.10.009; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; Muller NG, 2003, J NEUROSCI, V23, P3561; Nitta T, 2008, PROG BRAIN RES, V171, P173, DOI 10.1016/S0079-6123(08)00623-7; Nobre AC, 2000, NEUROPSYCHOLOGIA, V38, P964, DOI 10.1016/S0028-3932(00)00015-4; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; RUGG MD, 1987, NEUROPSYCHOLOGIA, V25, P85, DOI 10.1016/0028-3932(87)90045-5; Puig MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145281; Puig MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072041; Puig MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052955; Super H, 2003, J NEUROSCI, V23, P3407; Super H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021641; Suzuki S, 2004, NEUROSCI RES, V49, P39, DOI 10.1016/j.neures.2004.01.009; van der Togt C, 2006, CEREB CORTEX, V16, P136, DOI 10.1093/cercor/bhi093; Van Velzen J, 2003, PSYCHOPHYSIOLOGY, V40, P827, DOI 10.1111/1469-8986.00083; Versino M, 1996, BRAIN, V119, P1933, DOI 10.1093/brain/119.6.1933; Williams MA, 2008, NAT NEUROSCI, V11, P1439, DOI 10.1038/nn.2218; Woodman GF, 2009, BRAIN RES, V1297, P101, DOI 10.1016/j.brainres.2009.08.011; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698; Woodman GF, 2003, J EXP PSYCHOL HUMAN, V29, P121, DOI 10.1037/0096-1523.29.1.121; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	50	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167646	10.1371/journal.pone.0167646	http://dx.doi.org/10.1371/journal.pone.0167646			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973591	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300036
J	Xie, ZJ; Shah, F; Tu, SX; Xu, CX; Cao, WD				Xie, Zhijian; Shah, Farooq; Tu, Shuxin; Xu, Changxu; Cao, Weidong			Chinese Milk Vetch as Green Manure Mitigates Nitrous Oxide Emission from Monocropped Rice System in South China	PLOS ONE			English	Article							RESIDUE INCORPORATION; CROPPING SYSTEMS; USE EFFICIENCY; CH4 EMISSIONS; GAS INTENSITY; N2O EMISSIONS; COVER CROPS; SOIL; FERTILIZER; TERM	Monocropped rice system is an important intensive cropping system for food security in China. Green manure (GM) as an alternative to fertilizer N (FN) is useful for improving soil quality. However, few studies have examined the effect of Chinese milk vetch (CMV) as GM on nitrous oxide (N2O) emission from monocropped rice field in south China. Therefore, a pot-culture experiment with four treatments (control, no FN and CMV; CMV as GM alone, M; fertilizer N alone, FN; integrating fertilizer N with CMV, NM) was performed to investigate the effect of incorporating CMV as GM on N2O emission using a closed chamber-gas chromatography (GC) technique during the rice growing periods. Under the same N rate, incorporating CMV as GM (the treatments of M and NM) mitigated N2O emission during the growing periods of rice plant, reduced the NO3- content and activities of nitrate and nitrite reductase as well as the population of nitrifying bacteria in top soil at maturity stage of rice plant versus FN pots. The global warming potential (GWP) and greenhouse gas intensity (GHGI) of N2O from monocropped rice field was ranked as M<NM<FN. However, the treatment of NM increased rice grain yield and soil NH4+ content, which were dramatically decreased in the M pots, over the treatment of FN. Hence, it can be concluded that integrating FN with CMV as GM is a feasible tactic for food security and N2O mitigation in the monocropped rice based system.	[Xie, Zhijian; Shah, Farooq; Xu, Changxu] Jiangxi Acad Agr Sci, Inst Soil & Fertilizer & Resources Environm, Natl Engn & Technol Res Ctr Red Soil Improvement, Nanchang, Jiangxi, Peoples R China; [Xie, Zhijian; Tu, Shuxin] Huazhong Agr Univ, Coll Resources & Environm, Microelement Res Ctr, Wuhan, Hubei, Peoples R China; [Shah, Farooq] Abdul Wali Khan Univ Mardan, Dept Agr, Khyber Pakhtunkhwa, Pakistan; [Xie, Zhijian; Tu, Shuxin] Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Hubei, Peoples R China; [Cao, Weidong] CAAS, Inst Agr Resources & Reg Planning, Beijing, Peoples R China	Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS	Xu, CX (corresponding author), Jiangxi Acad Agr Sci, Inst Soil & Fertilizer & Resources Environm, Natl Engn & Technol Res Ctr Red Soil Improvement, Nanchang, Jiangxi, Peoples R China.; Tu, SX (corresponding author), Huazhong Agr Univ, Coll Resources & Environm, Microelement Res Ctr, Wuhan, Hubei, Peoples R China.; Tu, SX (corresponding author), Hubei Collaborat Innovat Ctr Grain Ind, Jingzhou, Hubei, Peoples R China.	stu@mail.hzau.edu.cn; changxux@sina.com	Zhang, Kevin/F-5215-2010; Shah, Farooq/GVT-6352-2022	Tu, Shuxin/0000-0001-7180-1794	Special Fund for Agro-Scientific Research in the Public Interest [201103005, 201303106, 201503123]; National Science Foundation [41471407]	Special Fund for Agro-Scientific Research in the Public Interest; National Science Foundation(National Science Foundation (NSF))	This study was funded by the Special Fund for Agro-Scientific Research in the Public Interest (Project no., 201103005, 201303106, 201503123) and the National Science Foundation (41471407). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELMAGID HM, 1987, SOIL BIOL BIOCHEM, V19, P421, DOI 10.1016/0038-0717(87)90033-2; Alexander M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P815; BARNES H, 1951, ANALYST, V76, P599, DOI 10.1039/an9517600599; Bedada W, 2014, AGR ECOSYST ENVIRON, V195, P193, DOI 10.1016/j.agee.2014.06.017; Bouwman L, 2010, NITROUS OXIDE CLIMAT; Braker G, 2000, APPL ENVIRON MICROB, V66, P2096, DOI 10.1128/AEM.66.5.2096-2104.2000; BREMNER J. M., 1965, Monographs of the American Society of Agronomists, V9, P1179; Burney JA, 2010, P NATL ACAD SCI USA, V107, P12052, DOI 10.1073/pnas.0914216107; Butterbach-Bahl K, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0122; Cassman KG, 2002, AMBIO, V31, P132, DOI 10.1639/0044-7447(2002)031[0132:ANUEAN]2.0.CO;2; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Cheng SH, 2007, ANN BOT-LONDON, V100, P959, DOI 10.1093/aob/mcm121; COCHRAN WG, 1950, BIOMETRICS, V6, P105, DOI 10.2307/3001491; Davidson EA, 2009, NAT GEOSCI, V2, P659, DOI 10.1038/NGEO608; Del Grosso SJ, 2006, J ENVIRON QUAL, V35, P1451, DOI 10.2134/jeq2005.0160; Ding WX, 2013, SCI TOTAL ENVIRON, V465, P115, DOI 10.1016/j.scitotenv.2012.11.020; Fageria NK, 2005, COMMUN SOIL SCI PLAN, V36, P2733, DOI 10.1080/00103620500303939; FAO, 2004, FAO STAT YB; FIRESTONE MK, 1989, LIFE SCI R, V47, P7; Frolking S, 2004, GLOBAL CHANGE BIOL, V10, P1180, DOI 10.1111/j.1529-8817.2003.00798.x; Gabriel JL, 2011, EUR J AGRON, V34, P133, DOI 10.1016/j.eja.2010.11.006; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gao B, 2015, AGR ECOSYST ENVIRON, V203, P46, DOI 10.1016/j.agee.2015.01.020; Groenigen JWV, 2011, EUR J SOIL SCI, V61, P903; Gunapala N, 1998, SOIL BIOL BIOCHEM, V30, P805, DOI 10.1016/S0038-0717(97)00162-4; HARGROVE WL, 1986, AGRON J, V78, P70, DOI 10.2134/agronj1986.00021962007800010016x; Herzog T., 2006, TARGET INTENSITY AN; IFA/FAO, 2001, GLOB EST GAS EM NH3; IPCC, 2013, CLIM CHANG 2013 PHYS, DOI [10.18203/2319-2003.ijbcp20175200, DOI 10.1017/CBO9781107415324]; Ishii S, 2011, ISME J, V5, P1936, DOI 10.1038/ismej.2011.69; Kearney J, 2010, PHILOS T R SOC B, V365, P2793, DOI 10.1098/rstb.2010.0149; Lee CH, 2010, AGR ECOSYST ENVIRON, V138, P343, DOI 10.1016/j.agee.2010.05.011; Lin H., 2014, ADV MAT RES, V955-959, P3552, DOI [DOI 10.4028/www.scientific.net/AMR.955-959.3552, 10.4028/www.scientific.net/AMR.955-959.3552]; Liu YL, 2015, ATMOS ENVIRON, V116, P92, DOI 10.1016/j.atmosenv.2015.06.018; Lu R.K, 2000, ANAL METHOD SOIL AGR; Meng HQ, 2013, J INTEGR AGR, V12, P2092, DOI 10.1016/S2095-3119(13)60398-6; Miao YX, 2010, REV AGRON SUSTAIN DE, V31, P397, DOI [10.1051/agro/2010034, DOI 10.1051/AGR0/2010034]; Migliorati MD, 2015, AGR ECOSYST ENVIRON, V204, P27, DOI 10.1016/j.agee.2015.02.007; Minamikawa K, 2010, GLOBAL CHANGE BIOL, V16, P796, DOI 10.1111/j.1365-2486.2009.01931.x; Morgan MF, 1930, SCIENCE, V71, P343, DOI 10.1126/science.71.1839.343; Mosier AR, 2006, J ENVIRON QUAL, V35, P1584, DOI 10.2134/jeq2005.0232; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nishimura S, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002207; NORMAN RJ, 1985, SOIL SCI SOC AM J, V49, P1182, DOI 10.2136/sssaj1985.03615995004900050022x; Peng SB, 2006, FIELD CROP RES, V96, P37, DOI 10.1016/j.fcr.2005.05.004; Philippot L, 2009, PLANT SOIL, V321, P61, DOI 10.1007/s11104-008-9796-9; Poeplau C., 2015, GERODERMA REG, V4, P126, DOI DOI 10.1016/J.GEODRS.2015.01.004; Ravishankara A. R., 2009, Science (Washington), V326, P123, DOI 10.1126/science.1176985; Rodriguez-Lado L, 2015, PROCEDIA ENVIRON SCI, V27, P45, DOI 10.1016/j.proenv.2015.07.112; Santoro AE, 2011, SCIENCE, V333, P1282, DOI 10.1126/science.1208239; Sanz-Cobena A, 2014, SCI TOTAL ENVIRON, V466, P164, DOI 10.1016/j.scitotenv.2013.07.023; Schmidt EL, 1982, METHOD SOIL ANAL 2, P1011; Snyder CS, 2009, AGR ECOSYST ENVIRON, V133, P247, DOI 10.1016/j.agee.2009.04.021; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Tabatabai MA, 1982, METHODS SOIL ANAL 2, P775; Tang HM, 2015, ENVIRON SCI POLLUT R, V22, P12689, DOI 10.1007/s11356-015-4557-9; Tejada M, 2008, BIORESOURCE TECHNOL, V99, P1758, DOI 10.1016/j.biortech.2007.03.052; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang JY, 2011, AGR ECOSYST ENVIRON, V141, P437, DOI 10.1016/j.agee.2011.04.009; West TO, 2007, CLIMATIC CHANGE, V80, P25, DOI [10.1007/s10584-006-9173-8, 10.1007/s105S4-006-9173-8]; Wrage N, 2004, RAPID COMMUN MASS SP, V18, P1201, DOI 10.1002/rcm.1461; Xie ZJ, 2016, FIELD CROP RES, V188, P142, DOI 10.1016/j.fcr.2016.01.006; Xu ZJ, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI [10.1029/2004GB002233, 10.1029/2003GB002167]; Yao ZS, 2012, AGR ECOSYST ENVIRON, V152, P1, DOI 10.1016/j.agee.2012.02.004; Yao ZS, 2009, SOIL BIOL BIOCHEM, V41, P2131, DOI 10.1016/j.soilbio.2009.07.025; Zhang Hongwei, 2012, AISS, V4, P155; Zhang JE, 2008, ARCH ENVIRON CON TOX, V54, P167, DOI 10.1007/s00244-007-9014-4; Zhang WF, 2013, P NATL ACAD SCI USA, V110, P8375, DOI 10.1073/pnas.1210447110; Zhao YC, 2014, ENVIRON SCI POLLUT R, V21, P7586, DOI 10.1007/s11356-014-2671-8; ZHENG X., 2000, CHEMOSPH GLOB CHANG, V2, P207, DOI DOI 10.1016/S1465-9972(99)00056-2; Zhu B, 2012, J INTEGR AGR, V11, P1537, DOI 10.1016/S2095-3119(12)60154-3	71	5	10	11	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168134	10.1371/journal.pone.0168134	http://dx.doi.org/10.1371/journal.pone.0168134			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959949	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900039
J	Gong, YX; Li, L; Gong, DC; Yin, H; Zhang, JZ				Gong, Yuxuan; Li, Li; Gong, Decai; Yin, Hao; Zhang, Juzhong			Biomolecular Evidence of Silk from 8,500 Years Ago	PLOS ONE			English	Article							PROTEIN; MECHANISM; STRENGTH; FIBROIN; JIAHU; SITE	Pottery, bone implements, and stone tools are routinely found at Neolithic sites. However, the integrity of textiles or silk is susceptible to degradation, and it is therefore very difficult for such materials to be preserved for 8,000 years. Although previous studies have provided important evidence of the emergence of weaving skills and tools, such as figuline spinning wheels and osseous lamellas with traces of filament winding, there is a lack of direct evidence proving the existence of silk. In this paper, we explored evidence of prehistoric silk fibroin through the analysis of soil samples collected from three tombs at the Neolithic site of Jiahu. Mass spectrometry was employed and integrated with proteomics to characterize the key peptides of silk fibroin. The direct biomolecular evidence reported here showed the existence of prehistoric silk fibroin, which was found in 8,500-year-old tombs. Rough weaving tools and bone needles were also excavated, indicating the possibility that the Jiahu residents may possess the basic weaving and sewing skills in making textile. This finding may advance the study of the history of silk, and the civilization of the Neolithic Age.	[Gong, Yuxuan; Gong, Decai; Zhang, Juzhong] Univ Sci & Technol China, Dept Hist Sci & Sci Archaeol, Hefei, Peoples R China; [Li, Li] Shandong Univ, Inst Cultural Heritage, Jinan, Peoples R China; [Yin, Hao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Shandong University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Gong, DC (corresponding author), Univ Sci & Technol China, Dept Hist Sci & Sci Archaeol, Hefei, Peoples R China.	gdclucky@ustc.edu.cn		Li, Li/0000-0001-5033-0911				Ajisawa A., 1998, J SERICULTURAL SCI J, V67, P91, DOI [DOI 10.11416/KONTYUSHIGEN1930.67.91, 10.11416/kontyushigen1930.67.91]; [Anonymous], CURRENT PROTOCOLS PR; Balter M, 2009, SCIENCE, V325, P1329, DOI 10.1126/science.325_1329a; Calvert P, 1998, NATURE, V393, P309, DOI 10.1038/30610; de Souza GA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r72; Huang N., 2002, 7000 YEAR CHINESE SI; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; Kanerva S, 2013, ORG GEOCHEM, V56, P1, DOI 10.1016/j.orggeochem.2012.12.003; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; Ki CS, 2009, MACROMOL RES, V17, P935, DOI 10.1007/BF03218639; Kvavadze E, 2009, SCIENCE, V325, P1359, DOI 10.1126/science.1175404; Li L, 2015, PLOS ONE; Li X, 2003, ANTIQUITY, V77, P31, DOI 10.1017/S0003598X00061329; Lu QA, 2011, BIOMACROMOLECULES, V12, P1080, DOI 10.1021/bm101422j; Luo WH, 2014, THESIS; McGovern PE, 2004, P NATL ACAD SCI USA, V101, P17593, DOI 10.1073/pnas.0407921102; Oonk S, 2012, ORG GEOCHEM, V50, P57, DOI 10.1016/j.orggeochem.2012.06.012; Scheibel T, 2005, CURR OPIN BIOTECH, V16, P427, DOI 10.1016/j.copbio.2005.05.005; Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a; Solazzo C, 2012, PHOTOCHEM PHOTOBIOL, V88, P1217, DOI 10.1111/j.1751-1097.2012.01167.x; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Wadbua P, 2010, INT J BIOL MACROMOL, V46, P493, DOI 10.1016/j.ijbiomac.2010.03.007; Wang XK, 1999, CHINESE SCI BULL, V44, P295, DOI 10.1007/BF02885476; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zhang JZ, 1999, NATURE, V401, P366, DOI 10.1038/43865; Zhang JZ, 2015, WUYANG JIAHU; Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078; Zhu ZY, 2014, ARCHAEOMETRY, V56, P681, DOI 10.1111/arcm.12029	28	30	32	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168042	10.1371/journal.pone.0168042	http://dx.doi.org/10.1371/journal.pone.0168042			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EI8HA	27941996	gold, Green Submitted, Green Published			2022-12-27	WOS:000392745600048
J	Pollak, A; Lechowicz, U; Kedra, A; Stawinski, P; Rydzanicz, M; Furmanek, M; Brzozowska, M; Mrowka, M; Skarzynski, H; Skarzynski, PH; Oldak, M; Ploski, R				Pollak, Agnieszka; Lechowicz, Urszula; Kedra, Anna; Stawinski, Piotr; Rydzanicz, Malgorzata; Furmanek, Mariusz; Brzozowska, Malgorzata; Mrowka, Maciej; Skarzynski, Henryk; Skarzynski, Piotr H.; Oldak, Monika; Ploski, Rafal			Novel and De Novo Mutations Extend Association of POU3F4 with Distinct Clinical and Radiological Phenotype of Hearing Loss	PLOS ONE			English	Article							X-LINKED DEAFNESS; COCHLEAR IMPLANTATION; IMPAIRMENT; GENE; PROTEIN; DFN3; PRESERVATION; CHILDREN; SPECTRUM; BRAIN-4	POU3F4 mutations (DFNX2) are the most prevalent among non-syndromic X-linked hearing loss (HL) identified to date. Clinical manifestations of DFNX2 usually comprise congenital HL either sensorineural or mixed, a tendency towards perilymphatic gusher during otologic surgery and temporal bone malformations. The aim of the present study was to screen for POU3F4 mutations in a group of 30 subjects with a suggestive clinical phenotype as well as a group (N = 1671-2018) of unselected hearing loss patients. We also planned to analyze audiological and radiological features in patients with HL caused by POU3F4 defects. The molecular techniques used to detect POU3F4 mutations included whole exome sequencing (WES), Sanger sequencing and real-time polymerase chain reaction. Hearing status was assessed with pure-tone audiometry and auditory brainstem response. Computer tomography scans were evaluated to define the pattern of structural changes in the temporal bones. Six novel (p.Gln27*, p.Glu187*, p.Leu217*, p.Gln275*, p.Gln306*, p.Val324Asp) and two known (p.Ala116fs141*, p.Leu208*) POU3F4 mutations were detected in the studied cohort. All probands with POU3F4 defects suffered from bilateral, prelingual, severe to profound HL. Morphological changes of the temporal bone in these patients presented a similar pattern, including malformations of the internal auditory canal, vestibular aqueduct, modiolus and vestibule. Despite different localization in the POU3F4 gene all mutations severely impair the protein structure affecting at least one functional POU3F4 domain, and results in similar and severe clinical manifestations. Sequencing of the entire POU3F4 gene is recommended in patients with characteristic temporal bone malformations. Results of POU3F4 mutation testing are important not only for a proper genetic counseling, but also for adequate preparation and conduction of a surgical procedure.	[Pollak, Agnieszka; Lechowicz, Urszula; Stawinski, Piotr; Oldak, Monika] Inst Physiol & Pathol Hearing, Dept Genet, Warsaw, Poland; [Kedra, Anna; Rydzanicz, Malgorzata; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Kedra, Anna] Med Univ Warsaw, Postgrad Sch Mol Med, Warsaw, Poland; [Furmanek, Mariusz] Inst Physiol & Pathol Hearing, World Hearing Ctr, Bioimaging Res Ctr, Warsaw, Poland; [Furmanek, Mariusz] Med Ctr Postgrad Educ, Dept Radiol & Diagnost Imaging, Warsaw, Poland; [Brzozowska, Malgorzata] Med Univ Warsaw, Dept Forens Med, Warsaw, Poland; [Mrowka, Maciej; Skarzynski, Henryk; Skarzynski, Piotr H.] Inst Physiol & Pathol Hearing, Oto Rhino Laryngol Surg Clin, Warsaw, Poland; [Skarzynski, Piotr H.] Med Univ Warsaw, Dept Heart Failure & Cardiac Rehabil, Warsaw, Poland; [Skarzynski, Piotr H.] Inst Sensory Organs, Kajetany, Poland	Institute of Physiology & Hearing Pathology; Medical University of Warsaw; Medical University of Warsaw; Institute of Physiology & Hearing Pathology; Centre of Postgraduate Medical Education - Poland; Medical University of Warsaw; Institute of Physiology & Hearing Pathology; Medical University of Warsaw	Oldak, M (corresponding author), Inst Physiol & Pathol Hearing, Dept Genet, Warsaw, Poland.; Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.	m.oldak@ifps.org.pl; rploski@wp.pl	Skarzynski, Piotr H./A-9642-2012; Lechowicz, Urszula/ABB-9967-2020; Mrowka, Maciej/S-7930-2016	Skarzynski, Piotr H./0000-0002-4978-1915; Ploski, Rafal/0000-0001-6286-5526; Lechowicz, Urszula/0000-0002-2645-8779; Mrowka, Maciej/0000-0003-4346-9290; Pollak, Agnieszka/0000-0002-2847-1782; Rydzanicz, Malgorzata/0000-0002-6969-0535; Skarzynski, Henryk/0000-0001-7141-9851; Oldak, Monika/0000-0002-4216-9141	Narodowe Centrum Nauki [NCN 2011/03/D/NZ5/05592, 2012/05/N/NZ5/02629, 2013/09/D/NZ5/00251]; NCBiR project INNOSENSE, STRATEGMED Program	Narodowe Centrum Nauki(National Science Centre, Poland); NCBiR project INNOSENSE, STRATEGMED Program	Funding was received from Narodowe Centrum Nauki (grants NCN 2011/03/D/NZ5/05592, 2012/05/N/NZ5/02629 and 2013/09/D/NZ5/00251) and from NCBiR project "Integrated system of tools designed for diagnostics and telerehabilitation of the sense organs disorders (hearing, vision, speech, balance, taste, smell)" INNOSENSE, STRATEGMED Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BITNERGLINDZICZ M, 1995, HUM MOL GENET, V4, P1467, DOI 10.1093/hmg/4.8.1467; Cremers F, 2008, OXFORD MONOGRAPHS ME, V54, P1042; Duman D, 2012, FRONT BIOSCI-LANDMRK, V17, P2213, DOI 10.2741/4046; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Friedman RA, 1997, ANN OTO RHINOL LARYN, V106, P320; Gong WX, 2014, INT J PEDIATR OTORHI, V78, P1756, DOI 10.1016/j.ijporl.2014.08.013; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Hoefsloot LH, 2013, EUR J HUM GENET, V21, P1325, DOI 10.1038/ejhg.2013.83; Huebner AK, 2011, AM J HUM GENET, V88, P621, DOI 10.1016/j.ajhg.2011.04.007; Jin H, 1996, NAT GENET, V14, P177, DOI 10.1038/ng1096-177; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kumar G, 2003, AM J NEURORADIOL, V24, P1130; Lee HK, 2009, PHYSIOL GENOMICS, V39, P195, DOI 10.1152/physiolgenomics.00100.2009; Liu XZ, 2013, INT J AUDIOL, V52, P23, DOI 10.3109/14992027.2012.736032; Marlin S, 2009, CLIN GENET, V76, P558, DOI 10.1111/j.1399-0004.2009.01215.x; MATHIS JM, 1992, EMBO J, V11, P2551, DOI 10.1002/j.1460-2075.1992.tb05320.x; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Moteki H, 2015, ANN OTO RHINOL LARYN, V124, p169S, DOI 10.1177/0003489415575042; Parzefall T, 2013, HUM MUTAT, V34, P1102, DOI 10.1002/humu.22339; Ploski R, 2014, CIRC RES, V114, pE2, DOI 10.1161/CIRCRESAHA.114.302662; Pollak A, 2007, AM J MED GENET A, V143A, P2534, DOI 10.1002/ajmg.a.31982; Pourova R, 2010, ANN HUM GENET, V74, P299, DOI 10.1111/j.1469-1809.2010.00581.x; Rost S, 2014, EUR J HUM GENET, V22, P208, DOI 10.1038/ejhg.2013.108; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Sennaroglu L, 2006, OTOL NEUROTOL, V27, P615, DOI 10.1097/01.mao.0000224090.94882.b4; Skarzynski H, 2016, J LARYNGOL OTOL, V130, P332, DOI 10.1017/S0022215115003436; Skarzynski H, 2012, J HEAR SCI, V2, P11; Skarzynski H, 2010, MED SCI MONITOR, V16, pCR555; Song MH, 2010, CLIN GENET, V78, P524, DOI 10.1111/j.1399-0004.2010.01426.x; Stankovic KM, 2010, ANN OTO RHINOL LARYN, V119, P815, DOI 10.1177/000348941011901205; Tan XF, 2010, CELL BIOL INT, V34, P877, DOI 10.1042/CBI20100214; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; VanCamp G, 1997, AM J HUM GENET, V60, P758	34	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0166618	10.1371/journal.pone.0166618	http://dx.doi.org/10.1371/journal.pone.0166618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941975	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600004
J	Maisonnasse, P; Bordet, E; Bouguyon, E; Bertho, N				Maisonnasse, Pauline; Bordet, Elise; Bouguyon, Edwige; Bertho, Nicolas			Broncho Alveolar Dendritic Cells and Macrophages Are Highly Similar to Their Interstitial Counterparts	PLoS One			English	Article							INFLUENZA-VIRUS; MONOCYTES; LINEAGE; MODEL; PIGS	In human medicine, bronchoalveolar lavage is the main non-traumatic procedure allowing an insight into the respiratory Dendritic Cells (DC) and Macrophages populations. However, it has never been demonstrated in a relevant model that alveolar DC subpopulations were comparable to their interstitial counterparts. In a precedent work we observed that respiratory pig DC and Macrophages were more similar to the human ones than to the mouse ones. In the present work, thanks to our animal model, we were able to collect the rare bronchoalveolar DC and compare them to their interstitial counterparts. We observed that DC presented very similar gene-expression patterns in the alveolar and interstitial compartments, validating the study of human bronchoalveolar DC as surrogate of their interstitium counterparts.	[Maisonnasse, Pauline; Bordet, Elise; Bouguyon, Edwige; Bertho, Nicolas] INRA, Virol & Immunol Mol, Domaine Vilvert, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Bertho, N (corresponding author), INRA, Virol & Immunol Mol, Domaine Vilvert, Jouy En Josas, France.	nicolas.bertho@jouy.inra.fr	BERTHO, Nicolas/B-8167-2019	BERTHO, Nicolas/0000-0002-6732-3483; Maisonnasse, Pauline/0000-0002-0555-207X	Fondation du souffle	Fondation du souffle	Dr. Pauline Maisonnasse was supported by Fondation du souffle. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Dong J, 2015, ALLERGY, V70, P921, DOI 10.1111/all.12631; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Greer AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099084; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Maisonnasse P., 2015, MUCOSAL IMMUNOL; Marquet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016320; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Manh TPV, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00299; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	16	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167315	10.1371/journal.pone.0167315	http://dx.doi.org/10.1371/journal.pone.0167315			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992536	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600014
J	Walker, S; Bellhouse, C; Fairley, CK; Bilardi, JE; Chow, EPF				Walker, Sandra; Bellhouse, Clare; Fairley, Christopher K.; Bilardi, Jade E.; Chow, Eric P. F.			Pharyngeal Gonorrhoea: The Willingness of Australian Men Who Have Sex with Men to Change Current Sexual Practices to Reduce Their Risk of Transmission-A Qualitative Study	PLOS ONE			English	Article							NEISSERIA-GONORRHOEAE; CHLAMYDIA-TRACHOMATIS; TRANSMITTED-DISEASES; SAN-FRANCISCO; PREVALENCE; INFECTIONS; CALIFORNIA; BEHAVIORS; INCREASES; SAMPLE	Background The pharynx is a common site of gonorrhoea among men who have sex with men (MSM) and may serve as a reservoir for infection, with saliva implicated in transmission possibly through oral sex, kissing, and rimming. Reducing sexual activities involving saliva may reduce pharyngeal gonorrhoea. This study aimed to explore MSM's views and knowledge of pharyngeal gonorrhoea and their willingness to change saliva transmitting sexual practices. MSM were also asked their views on using alcohol-containing mouthwash to potentially reduce transmission. Methods Using a qualitative descriptive approach, 30 MSM who were part of a larger study (GONE) conducted at the Melbourne Sexual Health Centre agreed to take part in semi-structured interviews between 14th May and 8th September 2015. The 10 interviews conducted face to face and 20 by telephone, lasted between 20-45 minutes. Data were analysed using qualitative content analysis. Results Most men considered pharyngeal gonorrhoea to be a non-serious sexually transmitted infection and attributed transmission primarily to oral sex. Almost all men reported they would not stop kissing, oral sex, or consider using condoms for oral sex to reduce their risk of pharyngeal gonorrhoea. Kissing and oral sex were commonly practised and considered enjoyable low risk sexual activities. Men were more likely to consider stopping sexual activities they did not enjoy or practice often, in particular insertive rimming. If proven effective, the majority of men reported they would use alcohol-containing mouthwash to reduce or prevent their risk of pharyngeal gonorrhoea. Conclusion Findings from this study suggest MSM are unlikely to stop saliva transmitting sexual practices they enjoy and consider low risk. Men would, however, consider using alcohol-containing mouthwash if found to be effective, highlighting the importance of exploring innovative strategies to reduce pharyngeal gonorrhoea.	[Walker, Sandra; Fairley, Christopher K.; Bilardi, Jade E.; Chow, Eric P. F.] Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia; [Walker, Sandra; Bellhouse, Clare; Fairley, Christopher K.; Bilardi, Jade E.; Chow, Eric P. F.] Melbourne Sexual Hlth Ctr, Alfred Hlth, Melbourne, Vic, Australia; [Bilardi, Jade E.] Univ Melbourne, Dept Practice, Melbourne, Vic, Australia	Monash University; University of Melbourne	Walker, S (corresponding author), Monash Univ, Cent Clin Sch, Fac Med Nursing & Hlth Sci, Melbourne, Vic, Australia.; Walker, S (corresponding author), Melbourne Sexual Hlth Ctr, Alfred Hlth, Melbourne, Vic, Australia.	swalker@mshc.org.au	Chow, Eric P.F./W-6684-2019	Chow, Eric P.F./0000-0003-1766-0657; Christopher, Fairley/0000-0001-9081-1664; Bilardi, Jade/0000-0003-0461-2605	National Health and Medical Research Council (NHMRC) [568971]; Australian NHMRC [1013135, 1091226]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this project was, in part, supplied by a National Health and Medical Research Council (NHMRC) programme grant (number 568971). JB and EPFC are supported by the Early Career Fellowships from the Australian NHMRC (JB: 1013135; EPFC: 1091226).	Arrington-Sanders R, 2016, J HOMOSEXUAL, V63, P968, DOI 10.1080/00918369.2015.1113836; Benn PD, 2007, SEX TRANSM INFECT, V83, P106, DOI 10.1136/sti.2006.021329; Bernstein KT, 2009, CLIN INFECT DIS, V49, P1793, DOI 10.1086/648427; Bissessor M, 2011, J CLIN MICROBIOL, V49, P4304, DOI 10.1128/JCM.05341-11; Blomquist PB, 2014, FUTURE MICROBIOL, V9, P189, DOI 10.2217/fmb.13.155; Booth A., COREQ CONSOLIDATED C; Butler LM, 2009, JAIDS-J ACQ IMM DEF, V50, P162, DOI 10.1097/QAI.0b013e31819388a9; CDC, 2013, ANTIBIOTIC RESISTANC; Cheung KT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156160; Chow EP, 2015, SEX TRANSM INFECT; Chow EP, 2016, SEX TRANSM INFECT, V92; Chow EP, 2016, SEX TRANSM INFECT; Chow EPF, 2015, SEX TRANSM DIS, V42, P81, DOI 10.1097/OLQ.0000000000000232; Cornelisse VJ, 2016, SEXUAL HLTH; Deguchi T, 2012, ANTIMICROB AGENTS CH, V56, P4039, DOI 10.1128/AAC.00505-12; Dilley JW, 2003, SEX TRANSM DIS, V30, P874, DOI 10.1097/01.OLQ.0000091137.49974.79; Feier IO, 2010, MED EVOLUTION, P79; HALLQVIST L, 1975, BRIT J VENER DIS, V51, P395; Hui BB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133202; Katz DA, 2016, SEX TRANSM DIS, V43, P249, DOI 10.1097/OLQ.0000000000000423; Kent CK, 2005, CLIN INFECT DIS, V41, P67, DOI 10.1086/430704; Kinghorn G, 2010, SEX TRANSM INFECT, V86, P413, DOI 10.1136/sti.2010.043349; Lafferty WE, 1997, SEX TRANSM DIS, V24, P272, DOI 10.1097/00007435-199705000-00007; Lahra MM, 2013, SEX TRANSM INFECT, V89, P19, DOI 10.1136/sextrans-2012-050906; Lister NA, 2003, SEX TRANSM DIS, V30, P886, DOI 10.1097/01.OLQ.0000099160.26205.22; Marcus JL, 2011, SEX TRANSM DIS, V38, P922, DOI 10.1097/OLQ.0b013e31822a2b2e; Marcus U, 2006, SEX TRANSM DIS, V33, P11, DOI 10.1097/01.olq.0000187224.10428.31; Mayring P., 2000, FORUM QUALITATIVE SO, V1, P1, DOI [10.17169/fqs-1.2.1089, DOI 10.17169/FQS-22.2.3826]; Morris SR, 2006, CLIN INFECT DIS, V43, P1284, DOI 10.1086/508460; Neergaard MA, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-52; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Papp JR, 2007, DIAGN MICR INFEC DIS, V59, P259, DOI 10.1016/j.diagmicrobio.2007.05.010; Phipps W, 2005, AIDS PATIENT CARE ST, V19, P495, DOI 10.1089/apc.2005.19.495; Prestage G, 2009, PLEASURE HLTH PASH S; QSR International, 1999, NVIVO QUAL DAT AN SO; Richters J, 2003, CULT HEALTH SEX, V5, P37, DOI 10.1080/713804637; Rosenberger JG, 2011, J SEX MED, V8, P3040, DOI 10.1111/j.1743-6109.2011.02438.x; Sandelowski M., 2000, RES NURS HLTH, V23; Teddlie C, 2007, J MIXED METHODS RES, V1; Templeton DJ, 2010, SEX TRANSM INFECT, V86, P90, DOI 10.1136/sti.2009.036814; The Kirby Institute, 2013, HIV VIR HEP SEX TRAN; WILLMOTT FE, 1974, BRIT J VENER DIS, V50, P317; World Health Organisation, 2012, GLOB ACT PLAN CONTR	43	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0164033	10.1371/journal.pone.0164033	http://dx.doi.org/10.1371/journal.pone.0164033			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992427	Green Published, gold			2022-12-27	WOS:000392842600001
J	Zhang, JS; Liu, X; Wang, JD; Xiong, Y; Li, J; Li, XX; Zhao, J; You, QS; Huang, Y; Tsai, F; Baum, L; Jhanji, V; Wan, XH				Zhang, Jing Shang; Liu, Xue; Wang, Jin Da; Xiong, Ying; Li, Jing; Li, Xiao Xia; Zhao, Jing; You, Qi Sheng; Huang, Yao; Tsai, Frank; Baum, Larry; Jhanji, Vishal; Wan, Xiu Hua			Outcomes of Phacoemulsification Using Different Size of Clear Corneal Incision in Eyes with Previous Radial Keratotomy	PLoS One			English	Article							OCULAR INTEGRITY; CATARACT-SURGERY; DEHISCENCE	Objective To evaluate visual outcomes and complications after phacoemulsification in eyes with cataract and previous radial keratotomy (RK) cuts using different sizes of clear corneal incisions. Methods The study was a retrospective study. Thirty eyes with cataract and previous RK underwent phacoemulsification and intraocular lens (IOL) implantation. Among them 7 eyes had 8 RK cuts, 13 eyes had 12 RK cuts, and 10 eyes had 16 RK cuts. Phacoemulsification and IOL implantation were performed through a 2.0-3.2 mm clear corneal incision by a single surgeon. In the 8 RK cuts group, 3.2 mm clear corneal incisions were used in 4 eyes, and 3.0 mm clear corneal incisions were used in 3 eyes. In the 12 RK cuts group, 3.2 mm clear corneal incisions were used in 6 eyes, and 2.2 mm clear corneal incisions were used in 7 eyes. In the 16 RK cuts group, 3.2 mm clear corneal incisions were used in 5 eyes, and 2.0 mm clear corneal incisions were used in 5 eyes. Patients were followed up 1 day, 1 week, 1 month, 3 months, 6 months, 1 year, 2 years, and 3 years postoperatively and were examined for the dehiscence of RK cuts during or after the surgery, post-operative best-corrected visual acuity (BCVA), corneal astigmatism, corneal endothelial cell density and complications. Results Successful phacoemulsification with IOL implantation was performed in all eyes. No wound dehiscence was noted in any eyes with 8 or 12 RK cuts. Wound dehiscence was noted in 2 eyes with 16 RK cuts. The dehiscence of RK cuts was closed successfully by injecting an air bubble with or without viscoelastic agent into the anterior chamber at the end of surgery. During the follow-up, the cuts were well apposed in all eyes, and no new dehiscence of RK cuts was noted. At the last follow-up, mean BCVA (0.2 +/- 0.18 logMAR) was better than pre-operative BCVA(0.45 +/- 0.19 logMAR) (P < 0.001). There was no significant difference between the long-term preoperative and postoperative mean corneal astigmatism (P = 0.3). However, there was a significant reduction in postoperative corneal endothelial cell density (1866.5 +/- 773.9 / mm(2) vs 2421.7 +/- 655.7/mm(2)) (P < 0.001). Conclusions Phacoemulsification and IOL implantation with clear corneal incisions in eyes with previous RK were associated with good surgical outcomes. Wound dehiscence was not specificaly related to the size of clear corneal incision during phacoemulsification in these eyes.	[Zhang, Jing Shang; Liu, Xue; Wang, Jin Da; Li, Xiao Xia; Zhao, Jing; You, Qi Sheng; Wan, Xiu Hua] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Key Lab Ophthalmol & Visual Sci,Beijing I, Beijing, Peoples R China; [Xiong, Ying; Li, Jing; Huang, Yao] Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Key Lab Ophthalmol & Visual Sci, Beijing, Peoples R China; [You, Qi Sheng; Tsai, Frank] Univ Calif San Diego, Jacobs Retina Ctr, Shiley Eye Inst, San Diego, CA 92103 USA; [Baum, Larry] Univ Hong Kong, Ctr Genom Sci, Hong Kong, Hong Kong, Peoples R China; [Jhanji, Vishal] Chinese Univ Hong Kong, Dept Ophthalmol & Visual Sci, Hong Kong, Hong Kong, Peoples R China	Capital Medical University; Capital Medical University; University of California System; University of California San Diego; University of Hong Kong; Chinese University of Hong Kong	Wan, XH (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Beijing Tongren Eye Ctr, Beijing Key Lab Ophthalmol & Visual Sci,Beijing I, Beijing, Peoples R China.	xiuhuawan@163.com	Baum, Lawrence/B-1005-2013; You, Qisheng/AAG-7153-2020	Baum, Lawrence/0000-0002-5345-9355; You, Qisheng/0000-0003-0743-7320; Li, Jing/0000-0001-9392-6600	Beijing New Star of Science and Technology [H020821380190, Z131102000413025]; Fund of Work Committee for Women and Children of China State Department [2014108]; National Natural Science Fund Projects of China [30471861]	Beijing New Star of Science and Technology; Fund of Work Committee for Women and Children of China State Department; National Natural Science Fund Projects of China(National Natural Science Foundation of China (NSFC))	This work was supported by Beijing New Star of Science and Technology (H020821380190, Z131102000413025), Fund of Work Committee for Women and Children of China State Department (2014108), and the National Natural Science Fund Projects of China (30471861). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behl S, 2001, J CATARACT REFR SURG, V27, P1132, DOI 10.1016/S0886-3350(01)00763-5; BINDER PS, 1987, AM J OPHTHALMOL, V103, P432, DOI 10.1016/S0002-9394(14)77767-0; Budak K, 1998, J CATARACT REFR SURG, V24, P278, DOI 10.1016/S0886-3350(98)80211-3; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Day A, 2007, EYE, V21, P886, DOI 10.1038/sj.eye.6702762; Freeman M, 2004, EYE, V18, P101, DOI 10.1038/sj.eye.6700526; FYODOROV SN, 1979, ANN OPHTHALMOL, V11, P1885; LARSON BC, 1983, OPHTHALMOLOGY, V90, P660; [刘雪 Liu Xue], 2015, [眼科, Ophthalmology in China], V24, P373; LUTTRULL JK, 1982, ARCH OPHTHALMOL-CHIC, V100, P319; McCarthy M, 2011, OPHTHALMOLOGY, V118, P940, DOI 10.1016/j.ophtha.2010.08.048; Peacock LW, 1997, OPHTHALMOLOGY, V104, P1079, DOI 10.1016/S0161-6420(97)30182-1; Wang L, 2015, OPHTHALMOLOGY, V122, P2443, DOI 10.1016/j.ophtha.2015.08.037; WARING GO, 1985, AM J OPHTHALMOL, V100, P218, DOI 10.1016/S0002-9394(14)75010-X; Wilczynski Michal, 2011, Klin Oczna, V113, P314; 章伟利, 2015, [中华眼视光学与视觉科学杂志, Chinese Journal of Optometry Ophthalmology and Visual Science], V17, P60; 宋慧, 2009, [中华眼科杂志, Chinese Journal of Ophthalmology], V45, P848	17	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0165474	10.1371/journal.pone.0165474	http://dx.doi.org/10.1371/journal.pone.0165474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992428	Green Published, gold			2022-12-27	WOS:000392842600005
J	Duran, J; Oyarce, C; Pavez, M; Valladares, D; Basualto-Alarcon, C; Lagos, D; Barrientos, G; Troncoso, MF; Ibarra, C; Estrada, M				Duran, Javier; Oyarce, Cesar; Pavez, Mario; Valladares, Denisse; Basualto-Alarcon, Carla; Lagos, Daniel; Barrientos, Genaro; Francisca Troncoso, Mayarling; Ibarra, Cristian; Estrada, Manuel			GSK-3 beta/NFAT Signaling Is Involved in Testosterone-Induced Cardiac Myocyte Hypertrophy	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; ANDROGEN-RECEPTOR; BETA-CATENIN; CARDIOMYOCYTE HYPERTROPHY; CARDIOVASCULAR-DISEASE; MUSCLE DEVELOPMENT; KINASE 3; IN-VIVO; PATHWAY; CALCINEURIN	Testosterone induces cardiac hypertrophy through a mechanism that involves a concerted crosstalk between cytosolic and nuclear signaling pathways. Nuclear factor of activated T-cells (NFAT) is associated with the promotion of cardiac hypertrophy, glycogen synthase kinase-3 beta (GSK-3 beta) is considered to function as a negative regulator, mainly by modulating NFAT activity. However, the role played by calcineurin-NFAT and GSK-3 beta signaling in testosterone-induced cardiac hypertrophy has remained unknown. Here, we determined that testosterone stimulates cardiac myocyte hypertrophy through NFAT activation and GSK-3 beta inhibition. Testosterone increased the activity of NFAT-luciferase (NFAT-Luc) in a time-and dose-dependent manner, with the activity peaking after 24 h of stimulation with 100 nM testosterone. NFAT-Luc activity induced by testosterone was blocked by the calcineurin inhibitors FK506 and cyclosporine A and by 11R-VIVIT, a specific peptide inhibitor of NFAT. Conversely, testosterone inhibited GSK-3 beta activity as determined by increased GSK-3 beta phosphorylation at Ser9 and beta-catenin protein accumulation, and also by reduction in beta-catenin phosphorylation at residues Ser33, Ser37, and Thr41. GSK-3 beta inhibition with 1-azakenpaullone or a GSK-3 beta-targeting siRNA increased NFAT-Luc activity, whereas overexpression of a constitutively active GSK-3 beta mutant (GSK-3 beta S9A) inhibited NFAT-Luc activation mediated by testosterone. Testosterone-induced cardiac myocyte hypertrophy was established by increased cardiac myocyte size and [H-3]-leucine incorporation (as a measurement of cellular protein synthesis). Calcineurin-NFAT inhibition abolished and GSK-3 beta inhibition promoted the hypertrophy stimulated by testosterone. GSK-3 beta activation by GSK-3 beta S9A blocked the increase of hypertrophic markers induced by testosterone. Moreover, inhibition of intracellular androgen receptor prevented testosterone-induced NFAT-Luc activation. Collectively, these results suggest that cardiac myocyte hypertrophy induced by testosterone involves a cooperative mechanism that links androgen signaling with the recruitment of NFAT through calcineurin activation and GSK-3 beta inhibition.	[Duran, Javier; Oyarce, Cesar; Pavez, Mario; Valladares, Denisse; Lagos, Daniel; Barrientos, Genaro; Francisca Troncoso, Mayarling; Estrada, Manuel] Univ Chile, Fac Med, Inst Ciencias Biomed, Lab Endocrinol Celular,Programa Fisiol & Biofis, Santiago, Chile; [Basualto-Alarcon, Carla] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Anat & Biol Desarrollo, Santiago, Chile; [Ibarra, Cristian] AstraZeneca R&D, Heart Failure Bioscience Dept, Cardiovasc & Metab Dis CVMD, Innovat Med & Early Dev iMED Biotech Unit, Molndal, Sweden	Universidad de Chile; Universidad de Chile; AstraZeneca	Estrada, M (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Lab Endocrinol Celular,Programa Fisiol & Biofis, Santiago, Chile.	iestrada@med.uchile.cl	Valladares-Ide, Denisse/AAE-6675-2019; Pavez-Giani, Mario/AAD-5347-2022; Estrada, Manuel/AAS-5605-2020; Estrada, Manuel/C-1269-2014; Pavez-Giani, Mario/AAV-3110-2021	Pavez-Giani, Mario/0000-0002-3330-9384; Estrada, Manuel/0000-0001-7877-8160; Estrada, Manuel/0000-0001-7877-8160; Valladares-Ide, Denisse/0000-0001-7625-7978	Fondo Nacional de Cienciay Tecnologia (FONDECYT) [1151118]; CONICYT	Fondo Nacional de Cienciay Tecnologia (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by Fondo Nacional de Cienciay Tecnologia (FONDECYT grant 1151118 to ME). JD, CO, and MP thank CONICYT for their PhD fellowships. I also confirm that AstraZeneca did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamirano F, 2009, J ENDOCRINOL, V202, P299, DOI 10.1677/JOE-09-0044; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Campbell S E, 1993, Blood Press, V2, P213, DOI 10.3109/08037059309077553; Chen X, 2006, MOL CELL BIOL, V26, P4462, DOI 10.1128/MCB.02157-05; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Church DR, 2005, PROSTATE, V63, P155, DOI 10.1002/pros.20172; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Estrada M, 2003, ENDOCRINOLOGY, V144, P3586, DOI 10.1210/en.2002-0164; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gu SC, 2014, CELL PHYSIOL BIOCHEM, V34, P1402, DOI 10.1159/000366346; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hardt SE, 2004, CARDIOVASC RES, V63, P500, DOI 10.1016/j.cardiores.2004.03.015; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ibarra C, 2013, CIRC RES, V112, P236, DOI 10.1161/CIRCRESAHA.112.273839; Ikeda Y, 2012, J ENDOCRINOL, V214, P1, DOI 10.1530/JOE-12-0126; Kenessey A, 2006, J BIOL CHEM, V281, P20666, DOI 10.1074/jbc.M512671200; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Kloner RA, 2016, J CARDIOVASC PHARM T; Kloner RA, 2016, J AM COLL CARDIOL, V67, P545, DOI 10.1016/j.jacc.2015.12.005; Li HJ, 2007, CARDIOVASC RES, V73, P130, DOI 10.1016/j.cardiores.2006.10.014; Liao WQ, 2005, FEBS J, V272, P1845, DOI 10.1111/j.1742-4658.2005.04614.x; Liu PY, 2003, ENDOCR REV, V24, P313, DOI 10.1210/er.2003-0005; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Markou T, 2008, CELL SIGNAL, V20, P206, DOI 10.1016/j.cellsig.2007.10.004; Marsh JD, 1998, CIRCULATION, V98, P256, DOI 10.1161/01.CIR.98.3.256; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Michels G, 2008, FRONT NEUROENDOCRIN, V29, P182, DOI 10.1016/j.yfrne.2007.08.004; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Neal JW, 2001, J BIOL CHEM, V276, P3666, DOI 10.1074/jbc.M004888200; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; Papasozomenos SC, 2002, P NATL ACAD SCI USA, V99, P1140, DOI 10.1073/pnas.032646799; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Periyasamy S, 2007, ENDOCRINOLOGY, V148, P4716, DOI 10.1210/en.2007-0145; Qin WP, 2015, MOL CELL ENDOCRINOL, V399, P336, DOI 10.1016/j.mce.2014.09.025; Satomi-Kobayashi S, 2004, CIRC J, V68, P247, DOI 10.1253/circj.68.247; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Shaw M, 1999, FEBS LETT, V461, P120, DOI 10.1016/S0014-5793(99)01434-9; Singh R, 2009, ENDOCRINOLOGY, V150, P1259, DOI 10.1210/en.2008-0858; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; van de Wijngaart DJ, 2012, MOL CELL ENDOCRINOL, V352, P57, DOI 10.1016/j.mce.2011.08.007; Vicencio JM, 2006, ENDOCRINOLOGY, V147, P1386, DOI 10.1210/en.2005-1139; Welsh GI, 1998, FEBS LETT, V421, P125, DOI 10.1016/S0014-5793(97)01548-2; Wyce A, 2010, MOL ENDOCRINOL, V24, P1665, DOI 10.1210/me.2010-0138; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yao YY, 2008, CARDIOVASC RES, V80, P354, DOI 10.1093/cvr/cvn223; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zhang CG, 2009, BIOCHEM BIOPH RES CO, V390, P258, DOI 10.1016/j.bbrc.2009.09.101; Zhua YM, 2013, BRAIN RES, V1494, P1, DOI 10.1016/j.brainres.2012.11.047	59	23	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168255	10.1371/journal.pone.0168255	http://dx.doi.org/10.1371/journal.pone.0168255			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977752	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400082
J	Kai, M; Niinuma, T; Kitajima, H; Yamamoto, E; Harada, T; Aoki, H; Maruyama, R; Toyota, M; Sasaki, Y; Sugai, T; Tokino, T; Nakase, H; Suzuki, H				Kai, Masahiro; Niinuma, Takeshi; Kitajima, Hiroshi; Yamamoto, Eiichiro; Harada, Taku; Aoki, Hironori; Maruyama, Reo; Toyota, Mutsumi; Sasaki, Yasushi; Sugai, Tamotsu; Tokino, Takashi; Nakase, Hiroshi; Suzuki, Hiromu			TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells	PLOS ONE			English	Article							ADAPTER PROTEIN GRB10; EPIGENETIC INACTIVATION; DNA METHYLATION; PROMOTER METHYLATION; ISLAND METHYLATION; FAMILY PROTEINS; POOR-PROGNOSIS; 5-HYDROXYMETHYLCYTOSINE; EXPRESSION; METASTASIS	Aberrant DNA methylation is commonly observed in colorectal cancer (CRC), but the underlying mechanism is not fully understood. 5-hydroxymethylcytosine levels and TET1 expression are both reduced in CRC, while epigenetic silencing of TET1 is reportedly associated with the CpG island methylator phenotype. In the present study, we aimed to clarify the relationship between loss of TET1 and aberrant DNA methylation in CRC. Stable TET1 knockdown clones were established using Colo320DM cells, which express high levels of TET1, and HCT116 cells, which express TET1 at a level similar to that in normal colonic tissue. Infinium HumanMethylation450 BeadChip assays revealed increased levels of 5-methylcytosine at more than 10,000 CpG sites in TET1-depleted Colo320DM cells. Changes in DNA methylation were observed at various positions within the genome, including promoters, gene bodies and intergenic regions, and the altered methylation affected expression of a subset of genes. By contrast, TET1 knockdown did not significantly affect DNA methylation in HCT116 cells. However, TET1 depletion was associated with attenuated effects of 5-aza-2'-deoxycytidine on gene expression profiles in both cell lines. These results suggest that loss of TET1 may induce aberrant DNA methylation and may attenuate the effect of 5-aza-2'-deoxycytidine in CRC cells.	[Kai, Masahiro; Niinuma, Takeshi; Kitajima, Hiroshi; Yamamoto, Eiichiro; Harada, Taku; Aoki, Hironori; Maruyama, Reo; Toyota, Mutsumi; Suzuki, Hiromu] Sapporo Med Univ, Sch Med, Dept Mol Biol, Sapporo, Hokkaido, Japan; [Yamamoto, Eiichiro; Nakase, Hiroshi] Sapporo Med Univ, Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Sasaki, Yasushi; Tokino, Takashi] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Med Genome Sci, Sapporo, Hokkaido, Japan; [Sugai, Tamotsu] Iwate Med Univ, Dept Mol Diagnost Pathol, Morioka, Iwate, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Iwate Medical University	Suzuki, H (corresponding author), Sapporo Med Univ, Sch Med, Dept Mol Biol, Sapporo, Hokkaido, Japan.	hsuzuki@sapmed.ac.jp	Sasaki, Yasushi/AAA-3079-2019; Tokino, Takashi/AAI-9887-2021; Nakase, Hiroshi/AAZ-4425-2020	Sasaki, Yasushi/0000-0002-3500-8059; 	Japan Society for the Promotion of Science [JSPS KAKENHI15H04299, JSPS KAKENHI 15K18431, JSPS KAKENHI 15K19339]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Grant-in-Aid for Scientific Research (B) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html) (JSPS KAKENHI15H04299, H.Suzuki) and Grants-in-Aid for Young Investigators (B) from Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/index.html) (JSPS KAKENHI 15K18431, T. Harada; JSPS KAKENHI 15K19339, H. Aoki).	Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; Bai RY, 1998, ONCOGENE, V17, P941, DOI 10.1038/sj.onc.1202024; Bernert B, 2011, J BIOL CHEM, V286, P42349, DOI 10.1074/jbc.M111.278598; Bharadwaj AG, 2009, AM J PATHOL, V174, P1027, DOI 10.2353/ajpath.2009.080501; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Bu FF, 2015, ONCOTARGET, V6, P2120, DOI 10.18632/oncotarget.2940; Chapman CG, 2015, SCI REP-UK, V5, DOI 10.1038/srep17568; Chen XB, 2010, DIGEST DIS SCI, V55, P2219, DOI 10.1007/s10620-009-0992-0; Cimmino L, 2011, CELL STEM CELL, V9, P193, DOI 10.1016/j.stem.2011.08.007; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dong WJ, 2014, BIOCHEM BIOPH RES CO, V453, P772, DOI 10.1016/j.bbrc.2014.10.016; Dong XY, 2015, EXP MOL PATHOL, V98, P192, DOI 10.1016/j.yexmp.2015.01.013; Estecio MRH, 2007, GENOME RES, V17, P1529, DOI 10.1101/gr.6417007; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Ichimura N, 2015, CANCER PREV RES, V8, P702, DOI 10.1158/1940-6207.CAPR-14-0306; Igarashi S, 2010, CLIN CANCER RES, V16, P5114, DOI 10.1158/1078-0432.CCR-10-0581; Kazi JU, 2013, MOL ONCOL, V7, P402, DOI 10.1016/j.molonc.2012.11.003; Kebache S, 2007, J BIOL CHEM, V282, P21873, DOI 10.1074/jbc.M611066200; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kohi S, 2016, CLIN EXP METASTAS, V33, P225, DOI 10.1007/s10585-015-9771-9; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Kulis M, 2012, NAT GENET, V44, P1236, DOI 10.1038/ng.2443; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Liu Chunhua, 2013, P 2013 IEEE INT S IN, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0062828; Lu B, 2008, CLIN CANCER RES, V14, P7405, DOI 10.1158/1078-0432.CCR-08-0409; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Mirmohammadsadegh A, 2004, CELLS TISSUES ORGANS, V177, P119, DOI 10.1159/000079985; Murata A, 2015, ONCOTARGET, V6, P23372, DOI 10.18632/oncotarget.4281; Nakajima T, 2009, INT J CANCER, V124, P905, DOI 10.1002/ijc.24018; Neri F, 2015, ONCOGENE, V34, P4168, DOI 10.1038/onc.2014.356; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Okino K, 2005, ONCOL REP, V13, P1069; Okuda H, 2012, CANCER RES, V72, P537, DOI 10.1158/0008-5472.CAN-11-1678; OOI J, 1995, ONCOGENE, V10, P1621; Park J, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500661; Rawluszko-Wieczorek AA, 2015, J CANCER RES CLIN, V141, P1379, DOI 10.1007/s00432-014-1901-2; Sajadian SO, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0133-x; Sato H, 2007, CARCINOGENESIS, V28, P2459, DOI 10.1093/carcin/bgm178; Seshagiri S, 2012, NATURE, V488, P660, DOI 10.1038/nature11282; Shen LL, 2007, CANCER RES, V67, P11335, DOI 10.1158/0008-5472.CAN-07-1502; Shtivelman E, 1997, ONCOGENE, V14, P2167, DOI 10.1038/sj.onc.1201059; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Suzuki H, 2014, BIOCHEM BIOPH RES CO, V455, P35, DOI 10.1016/j.bbrc.2014.07.007; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Varley KE, 2013, GENOME RES, V23, P555, DOI 10.1101/gr.147942.112; Wu BK, 2014, CELL REP, V9, P1827, DOI 10.1016/j.celrep.2014.10.063; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349	54	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168281	10.1371/journal.pone.0168281	http://dx.doi.org/10.1371/journal.pone.0168281			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977763	gold, Green Submitted, Green Published			2022-12-27	WOS:000391217400087
J	Okagawa, Y; Takada, K; Arihara, Y; Kikuchi, S; Osuga, T; Nakamura, H; Kamihara, Y; Hayasaka, N; Usami, M; Murase, K; Miyanishi, K; Kobune, M; Kato, J				Okagawa, Yutaka; Takada, Kohichi; Arihara, Yohei; Kikuchi, Shohei; Osuga, Takahiro; Nakamura, Hajime; Kamihara, Yusuke; Hayasaka, Naotaka; Usami, Makoto; Murase, Kazuyuki; Miyanishi, Koji; Kobune, Masayoshi; Kato, Junji			Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							REACTIVE ALPHA-FETOPROTEIN; ENDOTHELIAL GROWTH-FACTOR; CANCER; SORAFENIB	Background The prognosis of advanced hepatocellular carcinoma (HCC) is dismal, underscoring the need for novel effective treatments. The alpha 1,6-fucosyltransferase (fucosyltransferase 8, FUT8) has been reported to accelerate malignant potential in HCC. Our study aimed to investigate the regulation of FUT8 expression by p53 and develop a novel therapeutic strategy for targeting HCC cells using L-fucose-mediated drug delivery. Methods Binding sites for p53 were searched for within the FUT8 promoter region. FUT8 expression was assessed by immunoblotting. Chromatin immunoprecipitation (ChIP) assays were performed to analyze p53 binding to the FUT8 promoter. The delivery of Cy5.5-encapsulated L-fucose-liposomes (Fuc-Lip-Cy5.5) to a Lens Culinaris agglutinin-reactive fraction of a-fetoprotein (AFP-L3)-expressing HCC cells was analyzed by flow cytometry. The induction of FUT8 by histone deacetylase inhibitor (HDACi) -inducing acetylated -p53 was evaluated by immunoblotting. Flow cytometric analysis was performed to assess whether the activation of p53 by HDACi affected the uptake of Fuc-Lip-Cy5.5 by HCC cells. The cytotoxicity of an L-fucose-bound liposome carrying sorafenib (Fuc-Lip-sorafenib) with HDACi was assessed in vivo and in vitro. Results The knock down of p53 with siRNA led to decreased FUT8 expression. ChIP assays revealed p53 binds to the FUT8 promoter region. Flow cytometric analyses demonstrated the specific uptake of Fuc-Lip-Cy5.5 into AFP-L3-expressing HCC cells in a p53- and FUT8- dependent manner. HDACi upregulated the uptake of Fuc-Lip-Cy5.5 by HCC cells by increasing FUT8 via acetylated -p53. The addition of a HDACi increased apoptosis induced by Fuc-Lip-sorafenib in HCC cells. Conclusions Our findings reveal that FUT8 is a p53 target gene and suggest that p53 activated by HDACi induces Fuc-Lip-sorafenib uptake by HCC cells, highlighting this pathway as a promising therapeutic intervention for HCC.	[Okagawa, Yutaka; Takada, Kohichi; Arihara, Yohei; Kikuchi, Shohei; Osuga, Takahiro; Nakamura, Hajime; Kamihara, Yusuke; Hayasaka, Naotaka; Usami, Makoto; Murase, Kazuyuki; Miyanishi, Koji; Kobune, Masayoshi; Kato, Junji] Sapporo Med Univ, Dept Med Oncol & Hematol, Sch Med, Sapporo, Hokkaido, Japan	Sapporo Medical University	Kato, J (corresponding author), Sapporo Med Univ, Dept Med Oncol & Hematol, Sch Med, Sapporo, Hokkaido, Japan.	jkato@sapmed.ac.jp	Kikuchi, Shohei/AAF-6775-2020	Kikuchi, Shohei/0000-0002-0961-6253; Miyanishi, Koji/0000-0002-6466-3458				Abou-Alfa GK, 2006, J CLIN ONCOL, V24, P4293, DOI 10.1200/JCO.2005.01.3441; Ahmed KM, 2013, CANCER RES, V73, P3737, DOI 10.1158/0008-5472.CAN-12-3537; Bouchard MJ, 2011, CANCER LETT, V305, P123, DOI 10.1016/j.canlet.2010.11.014; Chan LH, 2015, MOL CELLS, V38, P202, DOI 10.14348/molcells.2015.2356; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Cheng JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087011; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gong WD, 2005, CLIN CANCER RES, V11, P1386, DOI 10.1158/1078-0432.CCR-04-0487; HUTCHINSON WL, 1991, HEPATOLOGY, V13, P683, DOI 10.1002/hep.1840130412; Lathia C, 2006, CANCER CHEMOTH PHARM, V57, P685, DOI 10.1007/s00280-005-0068-6; Moriwaki H, 1997, CLIN CANCER RES, V3, P727; Muinelo-Romay L, 2008, INT J CANCER, V123, P641, DOI 10.1002/ijc.23521; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Nakagawa T, 2008, J PROTEOME RES, V7, P2222, DOI 10.1021/pr700841q; Noda K, 2003, CANCER RES, V63, P6282; Oka H, 2001, J GASTROEN HEPATOL, V16, P1378, DOI 10.1046/j.1440-1746.2001.02643.x; Olivier M, 2002, HUM MUTAT, V19, P607, DOI 10.1002/humu.10081; Osuga T., 2016, J NATL CANC I, V108; Siu LL, 2006, CLIN CANCER RES, V12, P144, DOI 10.1158/1078-0432.CCR-05-1571; Strumberg D, 2005, J CLIN ONCOL, V23, P965, DOI 10.1200/JCO.2005.06.124; Tada T, 2005, LIVER INT, V25, P848, DOI 10.1111/j.1478-3231.2005.01111.x; TAKETA K, 1990, GASTROENTEROLOGY, V99, P508, DOI 10.1016/0016-5085(90)91034-4; TAKETA K, 1990, HEPATOLOGY, V12, P1420, DOI 10.1002/hep.1840120625; Takimoto R, 2005, CANCER BIOL THER, V4, P421; Terui T, 2003, CANCER RES, V63, P8948; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Wang MY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06145; Wang X, 2015, CANC RES; YAMAZAKI N, 1994, METHOD ENZYMOL, V242, P56; Yoshida M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039545; Zhang MF, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-110; Zhao XY, 2015, J NANOMATER, V2015, DOI 10.1155/2015/104193; Zoller H, 2016, METABOLISM, V65, P1151, DOI 10.1016/j.metabol.2016.01.010	33	6	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168355	10.1371/journal.pone.0168355	http://dx.doi.org/10.1371/journal.pone.0168355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977808	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400100
J	Rabago, CA; Whitehead, JA; Wilken, JM				Rabago, Christopher A.; Whitehead, Jennifer Aldridge; Wilken, Jason M.			Evaluation of a Powered Ankle-Foot Prosthesis during Slope Ascent Gait	PLOS ONE			English	Article							TO-STEP TRANSITION; INCLINED WALKWAY; AMPUTEE WALKING; LOCOMOTION; SURFACES; SYSTEM; KINEMATICS; KINETICS; ENERGY; LEVEL	Passive prosthetic feet lack active plantarflexion and push-off power resulting in gait deviations and compensations by individuals with transtibial amputation (TTA) during slope ascent. We sought to determine the effect of active ankle plantarflexion and push-off power provided by a powered prosthetic ankle-foot (PWR) on lower extremity compensations in individuals with unilateral TTA as they walked up a slope. We hypothesized that increased ankle plantarflexion and push-off power would reduce compensations commonly observed with a passive, energy-storing-returning prosthetic ankle-foot (ESR). We compared the temporal spatial, kinematic, and kinetic measures of ten individuals with TTA (age: 30.2 +/- 5.3 yrs) to matched abled-bodied (AB) individuals during 5 E slope ascent. The TTA group walked with an ESR and separately with a PWR. The PWR produced significantly greater prosthetic ankle plantarflexion and push-off power generation compared to an ESR and more closely matched AB values. The PWR functioned similar to a passive ESR device when transitioning onto the prosthetic limb due to limited prosthetic dorsiflexion, which resulted in similar deviations and compensations. In contrast, when transitioning off the prosthetic limb, increased ankle plantarflexion and push-off power provided by the PWR contributed to decreased intact limb knee extensor power production, lessening demand on the intact limb knee.	[Rabago, Christopher A.; Whitehead, Jennifer Aldridge; Wilken, Jason M.] Brooke Army Med Ctr, Dept Rehabil Med, Ctr Intrepid, Jbsa Ft Sam Houston, TX 78234 USA; [Rabago, Christopher A.; Whitehead, Jennifer Aldridge; Wilken, Jason M.] Extrem Trauma & Amputat Ctr Excellence, Jbsa Ft Sam Houston, TX 78234 USA	San Antonio Military Medical Center; United States Department of Defense; United States Army	Rabago, CA (corresponding author), Brooke Army Med Ctr, Dept Rehabil Med, Ctr Intrepid, Jbsa Ft Sam Houston, TX 78234 USA.; Rabago, CA (corresponding author), Extrem Trauma & Amputat Ctr Excellence, Jbsa Ft Sam Houston, TX 78234 USA.	Christopher.A.Rabago.civ@mail.mil	Wilken, Jason/ABA-3309-2021	Wilken, Jason/0000-0002-5556-7667; Rabago, Christopher/0000-0002-4484-0613	Telemedicine & Advanced Technology Research Center [W81K00-09-P-1129]; Military Amputee Research Program [W81XWH-06-2-0073]; BADER Consortium; Department of Defense; Congressionally Directed Medical Research Program cooperative agreement [W81XWH-11-2-0222]; DoD Defense Health Programs' Center for Rehabilitation Sciences Research [NF90UG]	Telemedicine & Advanced Technology Research Center; Military Amputee Research Program; BADER Consortium; Department of Defense(United States Department of Defense); Congressionally Directed Medical Research Program cooperative agreement; DoD Defense Health Programs' Center for Rehabilitation Sciences Research(United States Department of Defense)	This study was supported with funding to JWM by the Telemedicine & Advanced Technology Research Center (W81K00-09-P-1129), http://www.tatrc.org; the Military Amputee Research Program (W81XWH-06-2-0073); BADER Consortium, a Department of Defense, Congressionally Directed Medical Research Program cooperative agreement (W81XWH-11-2-0222); and the DoD Defense Health Programs' Center for Rehabilitation Sciences Research (NF90UG), http://crsr.org/.	Aldridge JM, 2012, GAIT POSTURE, V36, P291, DOI 10.1016/j.gaitpost.2012.03.013; Au S, 2008, NEURAL NETWORKS, V21, P654, DOI 10.1016/j.neunet.2008.03.006; Collins SH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009307; Crimin A, 2014, J ENG MED, V228, P908, DOI [10.1177/0954411914549392, DOI 10.1177/0954411914549392]; Eilenberg M. F., 2010, NEURAL SYSTEMS REHAB, V18, P164, DOI DOI 10.1109/TNSRE.2009.2039620; Esposito ER, 2016, PROSTHET ORTHOT INT, V40, P311, DOI 10.1177/0309364614564021; Esposito ER, 2014, CLIN BIOMECH, V29, P1186, DOI 10.1016/j.clinbiomech.2014.09.005; Ferris AE, 2012, ARCH PHYS MED REHAB, V93, P1911, DOI 10.1016/j.apmr.2012.06.009; Fradet L, 2010, GAIT POSTURE, V32, P191, DOI 10.1016/j.gaitpost.2010.04.011; Gates DH, 2013, CLIN BIOMECH, V28, P467, DOI 10.1016/j.clinbiomech.2013.03.005; Hansen AH, 2004, HUM MOVEMENT SCI, V23, P807, DOI 10.1016/j.humov.2004.08.023; HOLM S, 1979, SCAND J STAT, V6, P65; Houdijk H, 2009, GAIT POSTURE, V30, P35, DOI 10.1016/j.gaitpost.2009.02.009; Lay AN, 2007, J BIOMECH, V40, P1276, DOI 10.1016/j.jbiomech.2006.05.023; Lay AN, 2006, J BIOMECH, V39, P1621, DOI 10.1016/j.jbiomech.2005.05.005; LeMoyne R., 2015, ADV PROSTHETIC TECHN; Lewis CL, 2008, J BIOMECH, V41, P2082, DOI 10.1016/j.jbiomech.2008.05.013; Markowitz J, 2011, PHILOS T R SOC B, V366, P1621, DOI 10.1098/rstb.2010.0347; McIntosh AS, 2006, J BIOMECH, V39, P2491, DOI 10.1016/j.jbiomech.2005.07.025; Neptune RR, 2004, GAIT POSTURE, V19, P194, DOI 10.1016/S0966-6362(03)00062-6; Pierrynowski MR, 2001, GAIT POSTURE, V13, P193, DOI 10.1016/S0966-6362(01)00097-2; Vaughan CL, 2005, GAIT POSTURE, V21, P350, DOI 10.1016/j.gaitpost.2004.01.011; Vickers DR, 2008, GAIT POSTURE, V27, P518, DOI 10.1016/j.gaitpost.2007.06.008; Vrieling AH, 2008, GAIT POSTURE; Wilken JM, 2012, GAIT POSTURE, V35, P301, DOI 10.1016/j.gaitpost.2011.09.105; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Zmitrewicz RJ, 2007, J BIOMECH, V40, P1824, DOI 10.1016/j.jbiomech.2006.07.009	27	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0166815	10.1371/journal.pone.0166815	http://dx.doi.org/10.1371/journal.pone.0166815			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977681	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400007
J	Wu, ZY; Wang, C; Zhang, Z; Liu, WL; Xu, HS; Wang, HQ; Wang, Y; Zhang, W; Wang, SL				Wu, Ziyu; Wang, Chao; Zhang, Zhan; Liu, Wenlou; Xu, Hengsen; Wang, Huanqiang; Wang, Yun; Zhang, Wei; Wang, Shou-Lin			High Expression of Derlin-1 Is Associated with the Malignancy of Bladder Cancer in a Chinese Han Population	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-SURFACE; PROMOTES; DISLOCATION; APOPTOSIS; PROTEINS; HYPOXIA	Derlin-1 is overexpressed in various types of solid tumors and has an important function in cancer progression. However, its expression pattern in and association with the clinicopathological characteristics of human bladder cancer remain unclear. In the present study, 3 pairs of fresh samples of bladder cancer tissue and paracancerous tissue were first detected by liquid chromatography tandem mass spectrometry (UPLC-MS/MS) to screen for differentially expressed proteins. Following bioinformatics analysis and assessments by qRT-PCR and western blotting, Derlin-1 was selected as a candidate protein and was then validated in samples from patients with bladder cancer by immunohistochemistry and western blotting. The results showed that the bladder cancer tissues exhibited higher levels of Derlin-1 expression than the paracancerous tissues (P < 0.05). Positive expression of Derlin-1 was significantly correlated with tumor stage, histological grade, and lymph node metastasis (P < 0.001) but was not correlated with other clinicopathological parameters including patient age (P = 0.758) and gender (P = 0.831). Besides, Derlin-1 was highly expressed in BC cell lines (um-uc-3 and T24), and the interference of Derlin-1 could reverse EMT progression, inhibit the tumor migration and invasion in T24 cells. Further, patients with positive Derlin-1 expression had shorter overall survival than those with negative expression (P < 0.001). Taken together, our results demonstrated that Derlin-1 was overexpressed in bladder cancer and was associated with the malignancy of bladder cancer.	[Wu, Ziyu; Wang, Chao; Zhang, Zhan; Xu, Hengsen; Wang, Huanqiang; Wang, Yun; Wang, Shou-Lin] Nanjing Med Univ, Sch Publ Hlth, 101 Longmian Ave, Nanjing, Jiangsu, Peoples R China; [Wu, Ziyu] Xuzhou Med Univ, Dept Urol, Huaian Hosp, Huaian, Peoples R China; [Liu, Wenlou] Wuhan Univ, Dept Oncol, Zhongnan Hosp, Wuhan, Peoples R China; [Zhang, Wei] Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Xuzhou Medical University; Wuhan University; Nanjing Medical University	Wang, SL (corresponding author), Nanjing Med Univ, Sch Publ Hlth, 101 Longmian Ave, Nanjing, Jiangsu, Peoples R China.; Zhang, W (corresponding author), Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	wangshl@njmu.edu.cn; zhang_wei5919@126.com	Zhang, Zhan/AAR-6278-2020	Zhang, Zhan/0000-0002-9685-5753	Huai'an Technology R&D program on Social Development [HAS2013025]; National Natural Science Foundation of China [81372956, 81573194]; Natural Science Foundation of Jiangsu province [BK20151555]; Natural Science Foundation of Jiangsu Universities [14KJA330002]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China	Huai'an Technology R&D program on Social Development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Natural Science Foundation of Jiangsu Universities; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China	This work was supported by Huai'an Technology R&D program on Social Development (HAS2013025), National Natural Science Foundation of China (81372956, 81573194), Natural Science Foundation of Jiangsu province (BK20151555), Natural Science Foundation of Jiangsu Universities (14KJA330002), and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), China.	Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bohnenberger H, 2015, JOVE-J VIS EXP, DOI 10.3791/52435; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Cho SM, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-491; Cho S, 2013, BIOCHEM BIOPH RES CO, V430, P787, DOI 10.1016/j.bbrc.2012.11.068; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Dong QZ, 2013, AM J PATHOL, V182, P954, DOI 10.1016/j.ajpath.2012.11.019; Eble JN, 2004, PATHOLOGY GENETICS T; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Geiger T, 2010, NAT METHODS, V7, P383, DOI 10.1038/nmeth.1446; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; Koong AC, 2006, CANCER BIOL THER, V5, P756, DOI 10.4161/cbt.5.7.2973; Le QT, 2004, CANCER METAST REV, V23, P293, DOI 10.1023/B:CANC.0000031768.89246.d7; Lei CY, 2015, UROLOGIC ONCOLOGY; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Parkin DM, 2008, SCAND J UROL NEPHROL, V42, P12, DOI 10.1080/03008880802285032; Ran YL, 2008, CLIN CANCER RES, V14, P6538, DOI 10.1158/1078-0432.CCR-08-0476; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shan YJ, 2013, J NUTR BIOCHEM, V24, P1062, DOI 10.1016/j.jnutbio.2012.08.004; Sun C, 2012, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2012-46; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Tan XM, 2015, MOL CELL BIOCHEM, V408, P205, DOI 10.1007/s11010-015-2496-x; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Wang J, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1849; Wu CL, 2016, ONCOTARGET, V7, P26593, DOI 10.18632/oncotarget.8557; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	29	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168351	10.1371/journal.pone.0168351	http://dx.doi.org/10.1371/journal.pone.0168351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977784	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400099
J	Aizpurua, O; Alberdi, A; Aihartza, J; Garin, I				Aizpurua, Ostaizka; Alberdi, Antton; Aihartza, Joxerra; Garin, Inazio			Fishing Technique of Long-Fingered Bats Was Developed from a Primary Reaction to Disappearing Target Stimuli	PLOS ONE			English	Article							MYOTIS-CAPACCINII BONAPARTE; INNATE; PREY; BEHAVIOR; ECHOLOCATION; PLASTICITY; PISCIVORY	Behavioral plasticity is a key feature allowing animals to broaden their dietary niche when novel food resources become available, and long-fingered bats provide an appropriate model system to study the underpinnings of behavioral plasticity, since although generally being an insectivorous species, some individuals have been reported to catch fish. Aiming to get insight into the origin of fishing behavior in long-fingered bats, we studied in the field the differences in sensorial and mechanical reactions to insect-like (stationary) and fish-like (temporary) prey stimuli between well-known piscivorous and strictly insectivorous individuals. Both piscivorous and insectivorous individuals exhibited a qualitatively similar reaction to temporary target stimuli (longer and deeper dips and terminal echolocation phase skewed towards buzz I compared to stationary stimuli). Nevertheless, the quantitative differences observed in the sensorial and mechanical features (the intensity of the shift was significantly greater in piscivorous than in insectivorous individuals) show that piscivorous individuals have honed their capture technique likely enhancing the fishing success. Thus, our results suggest that the fishing technique was developed from a primary reaction shared by all long-fingered bats. All individuals seem to be mechanically and sensorially adapted to detect and capture fish, although under appropriate environmental conditions, they would further improve their technique by experience and/or social learning.	[Aizpurua, Ostaizka; Alberdi, Antton] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen K, Denmark; [Aizpurua, Ostaizka; Alberdi, Antton; Aihartza, Joxerra; Garin, Inazio] Univ Basque Country, Fac Sci & Technol, Dept Zool & Anim Cell Biol, UPV EHU, Leioa, The Basque Coun, Spain	University of Copenhagen; University of Basque Country	Aizpurua, O (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen K, Denmark.; Aizpurua, O (corresponding author), Univ Basque Country, Fac Sci & Technol, Dept Zool & Anim Cell Biol, UPV EHU, Leioa, The Basque Coun, Spain.	ostaizka.aizpurua@snm.ku.dk	Aihartza, Joxerra/GSO-2446-2022; Aizpurua, Ostaizka/V-9490-2019; Aihartza, Joxerra/Z-3061-2019; Garin, Inazio/B-8115-2009; Alberdi, Antton/M-2423-2017	Aizpurua, Ostaizka/0000-0001-8053-3672; Aihartza, Joxerra/0000-0003-0882-8964; Alberdi, Antton/0000-0002-2875-6446	Ministerio de Ciencia e Innovacion (MICINN) project [CGL2009-12393]; University of The Basque Country (UPV/EHU) [INF09/15]; Basque Government [IT385-07, IT301-10, BFI-2009-252, BFI-2010-190]	Ministerio de Ciencia e Innovacion (MICINN) project; University of The Basque Country (UPV/EHU); Basque Government(Basque Government)	This study was part of the Ministerio de Ciencia e Innovacion (MICINN) project CGL2009-12393. The University of The Basque Country (UPV/EHU) (INF09/15) and the Basque Government (IT385-07 and IT301-10) funded this study and provided grant support to O.A. and A.A. (BFI-2009-252, BFI-2010-190, Doktore berriak eta Ikertraile doktoreak espezializatreko kontratatzeko laguntzak). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihartza J, 2008, ACTA CHIROPTEROL, V10, P287, DOI 10.3161/150811008X414863; Aihartza JR, 2003, ACTA CHIROPTEROL, V5, P193, DOI 10.3161/001.005.0204; Aizpurua O, 2015, SCI REP-UK, V5, DOI 10.1038/srep12392; Aizpurua O, 2014, J EXP BIOL, V217, P3318, DOI 10.1242/jeb.104992; Aizpurua O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080163; Almenar D, 2006, ACTA CHIROPTEROL, V8, P157, DOI 10.3161/1733-5329(2006)8[157:HSASUB]2.0.CO;2; Almenar David, 2009, Endangered Species Research, V8, P69, DOI 10.3354/esr00183; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Bateson P, 2007, DEV PSYCHOBIOL, V49, P818, DOI 10.1002/dev.20277; Biscardi S, 2007, J ZOOL, V273, P372, DOI 10.1111/j.1469-7998.2007.00337.x; Geberl C, 2015, P NATL ACAD SCI USA, V112, P4122, DOI 10.1073/pnas.1424457112; Greif S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1110; Heyes CM., 1996, SOCIAL LEARNING ANIM; Jablonski PG, 2006, BEHAV ECOL, V17, P925, DOI 10.1093/beheco/arl039; Jakobsen L, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00089; Jakobsen L, 2010, P NATL ACAD SCI USA, V107, P13930, DOI 10.1073/pnas.1006630107; Levin E, 2006, MAMM BIOL, V71, P139, DOI 10.1016/j.mambio.2006.01.002; Nelson DA, 2000, P NATL ACAD SCI USA, V97, P13348, DOI 10.1073/pnas.240457797; Odling-Smee L, 2003, ANIM BEHAV, V65, P701, DOI 10.1006/anbe.2003.2082; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Reader SM, 2003, ANIM BIOL, V53, P147, DOI 10.1163/157075603769700340; Riffell JA, 2008, P NATL ACAD SCI USA, V105, P3404, DOI 10.1073/pnas.0709811105; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Wright GS, 2011, ANIM BEHAV, V82, P1075, DOI 10.1016/j.anbehav.2011.07.044	24	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167164	10.1371/journal.pone.0167164	http://dx.doi.org/10.1371/journal.pone.0167164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973529	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300018
J	Beck, ON; Taboga, P; Grabowski, AM				Beck, Owen N.; Taboga, Paolo; Grabowski, Alena M.			Characterizing the Mechanical Properties of Running-Specific Prostheses	PLOS ONE			English	Article							LEG STIFFNESS; STRIDE FREQUENCY; SPEED; GRAVITY; FORCE; POWER; KNEE	The mechanical stiffness of running-specific prostheses likely affects the functional abilities of athletes with leg amputations. However, each prosthetic manufacturer recommends prostheses based on subjective stiffness categories rather than performance based metrics. The actual mechanical stiffness values of running-specific prostheses (i.e. kN/m) are unknown. Consequently, we sought to characterize and disseminate the stiffness values of running-specific prostheses so that researchers, clinicians, and athletes can objectively evaluate prosthetic function. We characterized the stiffness values of 55 running-specific prostheses across various models, stiffness categories, and heights using forces and angles representative of those measured from athletes with transtibial amputations during running. Characterizing prosthetic force-displacement profiles with a 2nd degree polynomial explained 4.4% more of the variance than a linear function (p< 0.001). The prosthetic stiffness values of manufacturer recommended stiffness categories varied between prosthetic models (p< 0.001). Also, prosthetic stiffness was 10% to 39% less at angles typical of running 3 m/s and 6 m/s (10 degrees-25 degrees) compared to neutral (0 degrees) (p< 0.001). Furthermore, prosthetic stiffness was inversely related to height in J-shaped (p< 0.001), but not C-shaped, prostheses. Running-specific prostheses should be tested under the demands of the respective activity in order to derive relevant characterizations of stiffness and function. In all, our results indicate that when athletes with leg amputations alter prosthetic model, height, and/ or sagittal plane alignment, their prosthetic stiffness profiles also change; therefore variations in comfort, performance, etc. may be indirectly due to altered stiffness.	[Beck, Owen N.; Taboga, Paolo; Grabowski, Alena M.] Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA; [Grabowski, Alena M.] Eastern Colorado Healthcare Syst, Dept Vet Affairs, Denver, CO USA	University of Colorado System; University of Colorado Boulder	Beck, ON (corresponding author), Univ Colorado, Dept Integrat Physiol, Boulder, CO 80309 USA.	Owen.Beck@colorado.edu		GRABOWSKI, ALENA/0000-0002-4432-618X; TABOGA, PAOLO/0000-0001-6529-8299	BADER Consortium, a Department of Defense Congressionally Directed Medical Research Programs cooperative agreement [W81XWH-11-2-0222]	BADER Consortium, a Department of Defense Congressionally Directed Medical Research Programs cooperative agreement	This project was supported by the BADER Consortium, a Department of Defense Congressionally Directed Medical Research Programs cooperative agreement (W81XWH-11-2-0222), http://www.defense.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Orthopedic Specialty Hospital in Murray, Utah. We also thank Freedom Innovations, Ossur, and Ottobock for donating the running -specific prostheses used in this study. This project was supported by the BADER Consortium, a Department of Defense Congressionally Directed Medical Research Programs cooperative agreement (W81XWH-11-2-0222). The authors have no conflicts of interest to disclose.	ALEXANDER RM, 1991, J EXP BIOL, V160, P55; [Anonymous], 2006, PROSTHETICS STRUCTUR; [Anonymous], 2014, INSTR US FLEX RUN, P1; [Anonymous], FITT GUID TT SPORTS, P9; [Anonymous], 2014, CAT CAT INF, P2; Arampatzis A, 1999, J BIOMECH, V32, P1349, DOI 10.1016/S0021-9290(99)00133-5; Arellano CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115637; Arellano CJ, 2011, J BIOMECH, V44, P1291, DOI 10.1016/j.jbiomech.2011.01.002; Baum BS, 2013, ARCH PHYS MED REHAB, V94, P1776, DOI 10.1016/j.apmr.2013.03.010; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; Bruggemann Gert-Peter., 2008, SPORTS TECHNOLOGY, V1, P220, DOI [10.1002/jst.63, DOI 10.1002/JST.63, DOI 10.1080/19346182.2008.9648476]; CAVAGNA GA, 1964, J APPL PHYSIOL, V19, P249, DOI 10.1152/jappl.1964.19.2.249; CAVANAGH PR, 1982, MED SCI SPORT EXER, V14, P30, DOI 10.1249/00005768-198201000-00006; Chang YH, 2001, J BIOMECH, V34, P679, DOI 10.1016/S0021-9290(00)00196-2; CZERNIECKI JM, 1991, J BIOMECH, V24, P63, DOI 10.1016/0021-9290(91)90327-J; Dyer BTJ, 2014, ASSIST TECHNOL, V26, P157, DOI 10.1080/10400435.2014.888599; Farley CT, 1996, J BIOMECH, V29, P181, DOI 10.1016/0021-9290(95)00029-1; FARLEY CT, 1993, J EXP BIOL, V185, P71; Grabowski AM, 2010, BIOL LETTERS, V6, P201, DOI 10.1098/rsbl.2009.0729; Grabowski AM, 2008, J APPL BIOMECH, V24, P288, DOI 10.1123/jab.24.3.288; Grabowski AM, 2009, BIOL LETT; HE JP, 1991, J APPL PHYSIOL, V71, P863, DOI 10.1152/jappl.1991.71.3.863; Hobara H, 2013, J BIOMECH, V46, P2483, DOI 10.1016/j.jbiomech.2013.07.009; Kuitunen S, 2002, MED SCI SPORT EXER, V34, P166, DOI 10.1097/00005768-200201000-00025; McGowan CP, 2012, J R SOC INTERFACE, V9, P1975, DOI 10.1098/rsif.2011.0877; MCMAHON TA, 1990, J BIOMECH, V23, P65, DOI 10.1016/0021-9290(90)90042-2; Morin JB, 2005, J APPL BIOMECH, V21, P167, DOI 10.1123/jab.21.2.167; Nolan Lee, 2008, Foot Ankle Surg, V14, P125, DOI 10.1016/j.fas.2008.05.007; Pilkey W.D, 2002, ANAL DESIGN ELASTIC; Snyder KL, 2011, J EXP BIOL, V214, P2089, DOI 10.1242/jeb.053157; Weyand PG, 2009, J APPL PHYSIOL, V107, P903, DOI 10.1152/japplphysiol.00174.2009	31	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168298	10.1371/journal.pone.0168298	http://dx.doi.org/10.1371/journal.pone.0168298			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973573	gold, Green Published, Green Submitted			2022-12-27	WOS:000392754300074
J	Heisz, JJ; Tejada, MGM; Paolucci, EM; Muir, C				Heisz, Jennifer J.; Tejada, Mary Grace M.; Paolucci, Emily M.; Muir, Cameron			Enjoyment for High-Intensity Interval Exercise Increases during the First Six Weeks of Training: Implications for Promoting Exercise Adherence in Sedentary Adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MODERATE; MOTIVATION; OBESE	This is the first study to show that enjoyment for high-intensity interval exercise increases with chronic training. Prior acute studies typically report high-intensity interval training (HIT) as being more enjoyable than moderate continuous training (MCT) unless the high-intensity intervals are too strenuous or difficult to complete. It follows that exercise competency may be a critical factor contributing to the enjoyment of HIT, and therefore building competency through chronic training may be one way to increase its enjoyment. To test this, we randomly assigned sedentary young adults to six weeks of HIT or MCT, and tracked changes in their enjoyment for the exercise. Enjoyment for HIT increased with training whereas enjoyment for MCT remained constant and lower. Changes in exercise enjoyment were predicted by increases in workload, suggesting that strength adaptions may be important for promoting exercise enjoyment. The results point to HIT as a promising protocol for promoting exercise enjoyment and adherence in sedentary young adults.	[Heisz, Jennifer J.; Tejada, Mary Grace M.; Paolucci, Emily M.] McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada; [Muir, Cameron] Brock Univ, Ctr Neurosci, Dept Psychol, St Catharines, ON, Canada	McMaster University; Brock University	Heisz, JJ (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON, Canada.	heiszjj@mcmaster.ca	Heisz, Jennifer/AAD-9608-2022		Natural Sciences and Engineering Research Council of Canada [296518]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by the Natural Sciences and Engineering Research Council of Canada Discovery Grant #296518 to JJH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; CARMODY T P, 1980, Journal of Behavioral Medicine, V3, P163, DOI 10.1007/BF00844988; Dishman R., 1982, HEALTH PSYCHOL, V3, P237, DOI DOI 10.1037/0278-6133.1.3.237; DISHMAN RK, 1980, J APPL SOC PSYCHOL, V10, P115, DOI 10.1111/j.1559-1816.1980.tb00697.x; Field A., 2013, DISCOVERING STAT USI; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Hackney AC, 1999, CLIN PHYSIOL, V19, P178; Hackney Anthony C, 2006, Expert Rev Endocrinol Metab, V1, P783, DOI 10.1586/17446651.1.6.783; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Hill EE, 2008, J ENDOCRINOL INVEST, V31, P587, DOI 10.1007/BF03345606; Hu L, 2007, INT J BEHAV MED, V14, P92, DOI 10.1007/BF03004174; Jung ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114541; Kendzierski D., 1991, J SPORT EXERCISE PSY; Little JP, 2014, APPL PHYSIOL NUTR ME, V39, P835, DOI 10.1139/apnm-2013-0512; Markland D, 1999, J SPORT EXERCISE PSY, V21, P351, DOI 10.1123/jsep.21.4.351; MARKLAND D, 1993, PERS INDIV DIFFER, V15, P289, DOI 10.1016/0191-8869(93)90219-S; Martinez N, 2015, J SPORT EXERCISE PSY, V37, P138, DOI 10.1123/jsep.2014-0212; NICHOLLS JG, 1984, PSYCHOL REV, V91, P328, DOI 10.1037/0033-295X.91.3.328; Oliveira BRR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079965; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Ward B. W., 2013, EARLY RELEASE SELECT; Wisloff U, 2009, EXERC SPORT SCI REV, V37, P139, DOI 10.1097/JES.0b013e3181aa65fc	24	58	62	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168534	10.1371/journal.pone.0168534	http://dx.doi.org/10.1371/journal.pone.0168534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973594	gold, Green Published, Green Submitted			2022-12-27	WOS:000392754300083
J	Kjaer, MA; Ruyter, B; Berge, GM; Sun, YJ; Ostbye, TKK				Kjaer, Marte Avranden; Ruyter, Bente; Berge, Gerd Marit; Sun, Yajing; Ostbye, Tone-Kari Knutsdatter			Regulation of the Omega-3 Fatty Acid Biosynthetic Pathway in Atlantic Salmon Hepatocytes	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; ALPHA-LINOLENIC ACID; DIETARY VEGETABLE-OIL; RAPESEED OIL; ACYL DESATURASE; FISH-OIL; BETA-OXIDATION; DELTA-6 DESATURASES; LIVER-CELLS; MURRAY COD	Limited availability of the n-3 fatty acids EPA and DHA have led to an interest in better understanding of the n-3 biosynthetic pathway and its regulation. The biosynthesis of alphalinolenic acid to EPA and DHA involves several complex reaction steps including desaturation-, elongation-and peroxisomal beta-oxidation enzymes. The aims of the present experiments were to gain more knowledge on how this biosynthesis is regulated over time by different doses and fatty acid combinations. Hepatocytes isolated from salmon were incubated with various levels and combinations of oleic acid, EPA and DHA. Oleic acid led to a higher expression of the Delta 6 fatty acid desaturase (fad) genes Delta 6fad_a, Delta 6fad_b, Delta 6fad_c and the elongase genes elovl2 compared with cells cultured in medium enriched with DHA. Further, the study showed rhythmic variations in expression over time. Levels were reached where a further increase in specific fatty acids given to the cells not stimulated the conversion further. The gene expression of Delta 6fad_a_ and Delta 6fad_b responded similar to fatty acid treatment, suggesting a co-regulation of these genes, whereas Delta 5fad and Delta 6fad_c showed a different regulation pattern. EPA and DHA induced different gene expression patterns, especially of Delta 6fad_a. Addition of radiolabelled alpha-linolenic acid to the hepatocytes confirmed a higher degree of elongation and desaturation in cells treated with oleic acid compared to cells treated with DHA. This study suggests a complex regulation of the conversion process of n-3 fatty acids. Several factors, such as that the various gene copies are differently regulated, the gene expression show rhythmic variations and gene expression only affected to a certain level, determines when you get the maximum conversion of the beneficial n-3 fatty acids.	[Kjaer, Marte Avranden; Ruyter, Bente; Sun, Yajing; Ostbye, Tone-Kari Knutsdatter] Nofima, As, Norway; [Berge, Gerd Marit] Nofima, Sunndalsora, Norway	Nofima; Nofima	Ostbye, TKK (corresponding author), Nofima, As, Norway.	tone-kari.ostbye@nofima.no		Ostbye, Tone-Kari Knutsdatter/0000-0001-5173-7115	Norwegian Research Council [NFR-207621/E40]; Nofima	Norwegian Research Council(Research Council of NorwayEuropean Commission); Nofima(Nofima)	This work was funded by The Norwegian Research Council (grant no. NFR-207621/E40, www.forskningsradet.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nofima provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ACTISDATO SM, 1973, LIPIDS, V8, P1, DOI 10.1007/BF02533231; Alhazzaa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073719; Bell JG, 2002, J NUTR, V132, P222, DOI 10.1093/jn/132.2.222; BELL JG, 1993, PROSTAG LEUKOTR ESS, V49, P665, DOI 10.1016/0952-3278(93)90075-8; Bell JG, 2001, J NUTR, V131, P1535, DOI 10.1093/jn/131.5.1535; Bell JG, 2003, AQUACULTURE, V218, P515, DOI 10.1016/S0044-8486(02)00462-3; Betancor MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106739; BRENNER R R, 1981, Progress in Lipid Research, V20, P41, DOI 10.1016/0163-7827(81)90012-6; Burdge GC, 2002, BRIT J NUTR, V88, P355, DOI 10.1079/BJN2002662; CHRISTIANSEN R, 1976, FEBS LETT, V62, P313, DOI 10.1016/0014-5793(76)80083-X; DANNEVIG BH, 1985, COMP BIOCHEM PHYS B, V82, P683, DOI 10.1016/0305-0491(85)90508-5; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis DS, 2007, J AGR FOOD CHEM, V55, P1582, DOI 10.1021/jf062153x; Francis DS, 2009, AQUAC RES, V40, P1123, DOI 10.1111/j.1365-2109.2009.02208.x; Gibson RA, PROSTAGLANDINS LEUKO; Goyens PLL, 2005, J LIPID RES, V46, P1474, DOI 10.1194/jlr.M400514-JLR200; Gregory MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029662; Harnack K, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-8; Hastings N, 2004, MAR BIOTECHNOL, V6, P463, DOI 10.1007/s10126-004-3002-8; HOSHI M, 1973, J LIPID RES, V14, P599; Izquierdo MS, 2008, FISH PHYSIOL BIOCHEM, V34, P117, DOI 10.1007/s10695-007-9152-7; Kjaer MA, 2008, LIPIDS, V43, P813, DOI 10.1007/s11745-008-3208-z; Kjaer MA, 2008, BBA-MOL CELL BIOL L, V1781, P112, DOI 10.1016/j.bbalip.2007.12.004; Leaver MJ, 2008, REV FISH SCI, V16, P73, DOI 10.1080/10641260802325278; Li YY, 2010, P NATL ACAD SCI USA, V107, P16840, DOI 10.1073/pnas.1008429107; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MARRA CA, 1992, MOL CELL BIOCHEM, V117, P107, DOI 10.1007/BF00230749; MASON ME, 1964, ANAL CHEM, V36, P583, DOI 10.1021/ac60209a008; Monroig O, 2011, COMP BIOCHEM PHYS B, V159, P206, DOI 10.1016/j.cbpb.2011.04.007; Morais S, 2012, BBA-MOL CELL BIOL L, V1821, P660, DOI 10.1016/j.bbalip.2011.12.011; Moya-Falcon C, 2004, COMP BIOCHEM PHYS B, V139, P657, DOI 10.1016/j.cbpc.2004.08.009; Moya-Falon C, 2005, LIPIDS, V40, P709, DOI 10.1007/s11745-005-1434-9; NARCE M, 1988, J CHROMATOGR, V448, P249, DOI 10.1016/S0021-9673(01)84587-8; Pawlosky RJ, 2001, J LIPID RES, V42, P1257; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ruyter B, 2003, LIPIDS, V38, P833, DOI 10.1007/s11745-003-1133-6; Ruyter B, 2000, AQUACULT NUTR, V6, P109; Ruyter B, 2000, FISH PHYSIOL BIOCHEM, V23, P151, DOI 10.1023/A:1007893317923; Ruyter B, 1999, LIPIDS, V34, P1167, DOI 10.1007/s11745-999-0468-3; Sargent John R., 2002, P181; Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5; SMALL GM, 1985, BIOCHEM J, V227, P205, DOI 10.1042/bj2270205; Sprecher H, 1995, J LIPID RES, V36, P2471; Thanuthong T, 2011, LIPIDS, V46, P1111, DOI 10.1007/s11745-011-3607-4; Thomassen MS, 2012, AQUACULTURE, V360, P78, DOI 10.1016/j.aquaculture.2012.07.001; Tocher DR, 2000, FISH PHYSIOL BIOCHEM, V23, P59, DOI 10.1023/A:1007807201093; Tocher DR, 2002, FISH PHYSIOL BIOCHEM, V26, P157, DOI 10.1023/A:1025416731014; Tocher DR, 2001, COMP BIOCHEM PHYS B, V130, P257, DOI 10.1016/S1096-4959(01)00429-8; Tocher DR, 2003, LIPIDS, V38, P723, DOI 10.1007/s11745-003-1120-y; Torstensen BE, 2004, LIPIDS, V39, P153, DOI 10.1007/s11745-004-1213-7; Tu WC, 2010, PROSTAG LEUKOTR ESS, V83, P61, DOI 10.1016/j.plefa.2010.04.001; Turchini GM, 2011, FOOD CHEM, V124, P609, DOI 10.1016/j.foodchem.2010.06.083; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Zheng XZ, 2009, COMP BIOCHEM PHYS B, V154, P255, DOI 10.1016/j.cbpb.2009.06.010; Zheng XZ, 2005, BBA-MOL CELL BIOL L, V1734, P13, DOI 10.1016/j.bbalip.2005.01.006; Zheng XZ, 2005, LIPIDS, V40, P13, DOI 10.1007/s11745-005-1355-7	60	29	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168230	10.1371/journal.pone.0168230	http://dx.doi.org/10.1371/journal.pone.0168230			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973547	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000392754300067
J	Zhao, F; Wang, N; Yi, YL; Lin, PF; Tang, KQ; Wang, AH; Jin, YP				Zhao, Fan; Wang, Nan; Yi, Yanglei; Lin, Pengfei; Tang, Keqiong; Wang, Aihua; Jin, Yaping			Knockdown of CREB3/Luman by shRNA in Mouse Granulosa Cells Results in Decreased Estradiol and Progesterone Synthesis and Promotes Cell Proliferation	PLOS ONE			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR LUMAN; UNFOLDED PROTEIN RESPONSE; SIMPLEX-VIRUS VP16; GENE-EXPRESSION; FOLLICULAR DEVELOPMENT; CYCLE ARREST; IN-VITRO; APOPTOSIS	Luman (also known as LZIP or CREB3) is a transcription factor and a member of the cAMP responsive element-binding (CREB) family proteins. Although Luman has been detected in apoptotic granulosa cells and disorganized atretic bodies, the physiological function of Luman in follicular development has not been reported. Our objective is to determine the role of Luman in folliculogenesis by knocking down Luman expression in mouse GCs (granulosa cells) using shRNA. Luman expression was successfully knocked down in mouse GCs at the mRNA and protein level, as confirmed by real-time quantitative PCR, western blot and immunofluorescence staining, respectively. Knockdown of Luman significantly decreased the concentrations of estradiol (E2) and progesterone (P4) in cell culture medium. Furthermore, Luman knockdown promoted cell proliferation but had no effect on cell apoptosis. To elucidate the regulatory mechanism underlying the effects of Luman knockdown on steroid synthesis and cell cycle, we measured the mRNA and protein expression levels of several related genes. The expression of Star, Cyp19a1, and Cyp1b1, which encode steroidogenic enzymes, was down-regulated, while that of Cyp11a1 and Runx2, which also encode steroidogenic enzymes, was up-regulated. The expression of the cell cycle factors Cyclin A1, Cyclin B1, Cyclin D2, and Cyclin E was significantly up-regulated. Among apoptosis-related genes, only Bcl-2 was down-regulated, while Caspase 3, Bax and p53 were not significantly affected, suggesting that Luman knockdown may regulate cell cycle activity and hormone secretion at the transcriptional and translational level in mouse GCs. The expression of two important genes associated with folliculogenesis in mouse GCs, Has2 and Ptgs2, were also significantly altered by Luman knockdown. In conclusion, the findings of this study indicate that Luman regulates mouse GCs modulation of steroid synthesis, cell cycle activity and other regulators of folliculogenesis.	[Zhao, Fan; Wang, Nan; Lin, Pengfei; Tang, Keqiong; Jin, Yaping] Northwest A&F Univ, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China; [Zhao, Fan; Wang, Nan; Lin, Pengfei; Tang, Keqiong; Wang, Aihua; Jin, Yaping] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Yi, Yanglei] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Jin, YP (corresponding author), Northwest A&F Univ, Key Lab Anim Biotechnol, Minist Agr, Yangling, Shaanxi, Peoples R China.	yapingjin@163.com	yi, yi/HHY-7381-2022	zhao, fan/0000-0001-9547-7116; Jin, Yaping/0000-0001-5708-3159	Specialized Natural Science Basic Research Plan in Shaanxi Province, China [2014JQ3096]	Specialized Natural Science Basic Research Plan in Shaanxi Province, China	This work was funded by the Specialized Natural Science Basic Research Plan in Shaanxi Province, China (2014JQ3096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2009, REPRODUCTION, V138, P629, DOI 10.1530/REP-09-0144; Baufeld A, 2013, CELL TISSUE RES, V354, P869, DOI 10.1007/s00441-013-1712-9; Boone DL, 1998, BIOL REPROD, V58, P1533, DOI 10.1095/biolreprod58.6.1533; Chan CP, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-6; Chen FL, 2014, PLASMID, V76, P24, DOI 10.1016/j.plasmid.2014.08.004; Cox N, 1996, J REPROD FERTILITY S, V52, P31; DenBoer LM, 2005, BIOCHEM BIOPH RES CO, V331, P113, DOI 10.1016/j.bbrc.2005.03.141; Eleveld-Trancikova D, 2010, MOL IMMUNOL, V47, P1963, DOI 10.1016/j.molimm.2010.04.019; Freiman RN, 1997, GENE DEV, V11, P3122, DOI 10.1101/gad.11.23.3122; Fuchimoto D, 2001, BIOL REPROD, V65, P986, DOI 10.1095/biolreprod65.4.986; Gillio-Meina C, 2005, BIOL REPROD, V72, P1194, DOI 10.1095/biolreprod.104.035246; GUTHRIE HD, 1995, BIOL REPROD, V52, P920, DOI 10.1095/biolreprod52.4.920; Hsueh AJW, 2015, ENDOCR REV, V36, P1, DOI 10.1210/er.2014-1020; Jang SW, 2007, J BIOL CHEM, V282, P11092, DOI 10.1074/jbc.M607962200; Jiang JY, 2003, FRONT BIOSCI-LANDMRK, V8, pD222, DOI 10.2741/949; Jin DY, 2000, EMBO J, V19, P729, DOI 10.1093/emboj/19.4.729; Kim HC, 2010, CELL MOL LIFE SCI, V67, P3499, DOI 10.1007/s00018-010-0388-5; Kim MR, 2004, BBA-MOL CELL RES, V1644, P205, DOI 10.1016/j.bbamcr.2003.10.012; Ko J, 2004, FASEB J, V18, P890, DOI 10.1096/fj.03-0867fje; Kolb G, 2008, J VIROL, V82, P9555, DOI 10.1128/JVI.01174-08; Kugu K, 1998, CELL DEATH DIFFERENT, V5; Lan XL, 2013, THERIOGENOLOGY, V80, P138, DOI 10.1016/j.theriogenology.2013.02.024; Liang GQ, 2006, MOL CELL BIOL, V26, P7999, DOI 10.1128/MCB.01046-06; Lim H, 1997, CELL, V91, P197, DOI 10.1016/S0092-8674(00)80402-X; Lu R, 1997, MOL CELL BIOL, V17, P5117, DOI 10.1128/MCB.17.9.5117; Lu R, 2000, J VIROL, V74, P934, DOI 10.1128/JVI.74.2.934-943.2000; Matsuda F, 2012, J REPROD DEVELOP, V58, P44, DOI 10.1262/jrd.2011-012; MCNATTY KP, 1984, J REPROD FERTIL, V72, P39, DOI 10.1530/jrf.0.0720039; Molden S, 1756, GLOB LIB WOMENS MED; Pan ZX, 2012, MOL BIOL REP, V39, P10823, DOI 10.1007/s11033-012-1976-2; Papamentzelopoulou M, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-99; Park ES, 2010, MOL ENDOCRINOL, V24, P846, DOI 10.1210/me.2009-0392; Polyak K, 1996, GENE DEV, V10, P1945, DOI 10.1101/gad.10.15.1945; Pradeep PK, 2002, ENDOCRINOLOGY, V143, P2930, DOI 10.1210/en.143.8.2930; Raggo C, 2002, MOL CELL BIOL, V22, P5639, DOI 10.1128/MCB.22.16.5639-5649.2002; Riaz H, 2014, J STEROID BIOCHEM, V141, P150, DOI 10.1016/j.jsbmb.2014.02.001; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; Rose RE, 1997, GENETICS, V146, P595; Saito A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1971; Sanecka A, 2012, MOL IMMUNOL, V50, P66, DOI 10.1016/j.molimm.2011.12.003; Sifer C, 2002, EUR J OBSTET GYN R B, V103, P150, DOI 10.1016/S0301-2115(02)00043-X; Sung HJ, 2008, EXP MOL MED, V40, P332, DOI 10.3858/emm.2008.40.3.332; Tse E, 2000, P NATL ACAD SCI USA, V97, P12266, DOI 10.1073/pnas.97.22.12266; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; Xu XG, 2013, VET MICROBIOL, V164, P212, DOI 10.1016/j.vetmic.2013.01.034; Yang YZ, 2013, THERIOGENOLOGY, V79, P633, DOI 10.1016/j.theriogenology.2012.11.017; Ye J, 2013, BBA-BIOMEMBRANES, V1828, P2926, DOI 10.1016/j.bbamem.2013.05.005; Zhen YH, 2014, J STEROID BIOCHEM, V143, P90, DOI 10.1016/j.jsbmb.2014.02.013	48	23	25	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168246	10.1371/journal.pone.0168246	http://dx.doi.org/10.1371/journal.pone.0168246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973579	Green Submitted, Green Published, gold			2022-12-27	WOS:000392754300069
J	Rizvi, W; Fayazuddin, M; Singh, O; Naeem, SS; Moin, S; Akhtar, K; Kumar, A				Rizvi, Waseeem; Fayazuddin, Mohd; Singh, Ompal; Naeem, Syed Shariq; Moin, Shagufta; Akhtar, Kafil; Kumar, Anil			Cytokine Attenuation and Free Radical Scavenging Activity of a New Flavanone7,4 '-Dihydroxy-3 '',3 ''-Dimethyl-(5,6-Pyrano-2 ''-One)-8-(3 ''',3 '''-Dimethyl Allyl)-Isolated from Mallotus philippensis: Possible Mechanism for Its Anti-Inflammatory Activity	PLoS One			English	Article							INDUCED PAW EDEMA; LIPID PEROXIDES; CARRAGEENAN; BIOLOGY; LEUKOTRIENES; INFLAMMATION; JAPONICUS; DISEASE; ASSAY; RATS	Mallotus philippensis L.(MP) commonly known as Kamala tree in Hindi, is a small to medium-sized monoecious tree. The objective of the study was to evaluate the anti-inflammatory activity of MPand a new flavanoneisolated from it by using in vivo models of inflammation. Albino wistar rats of either sex weighing 150-200g were used. Seven groups were made (n = 6), namely normal control group (normal saline, 1 ml/kg), standard control group (acetylsalicylic acid, 100 mg/kg), methanol crude extract (300 and 500 mg/kg), ethylacetate fraction (300 and 500 mg/kg) and active compound 4 (new flavanone, 50 mg/kg). The anti-inflammatory activity was studied using carrageenan induced paw edema method and cotton pellet granuloma method. Levels of cytokines (TNF-alpha, IL-1and IL-6) and activity of antioxidant enzymeslike catalase and glutathione peroxidase were estimated. It was found that the methanol extract, ethylacetate fraction and Flavanonedemonstrated significant reduction in paw edema in carrageenan induced paw edema method as compared to control. They also diminished the serum TNF-alpha, IL-6 and IL-1 levels. Significantly attenuated the malondialdehyde levels and increased the activities of catalase and glutathione peroxidase in paw tissue. Similarly there was asignificant decrease in granuloma formation in cotton pellet induced granuloma method. In conclusion, MP extracts and the newflavanone-possess anti-inflammatory activity and this might be due to the inhibition of various cytokines and increased free radical scavenging activity.	[Rizvi, Waseeem; Fayazuddin, Mohd; Naeem, Syed Shariq; Kumar, Anil] Aligarh Muslim Univ, Jawaharlal NehruMed Coll, Dept Pharmacol, Aligarh, Uttar Pradesh, India; [Singh, Ompal] Aligarh Muslim Univ, Chem Res Unit, Dept Res Unani Med, Aligarh, Uttar Pradesh, India; [Moin, Shagufta] Aligarh Muslim Univ, Jawaharlal NehruMed Coll, Dept Biochem, Aligarh, Uttar Pradesh, India; [Akhtar, Kafil] Aligarh Muslim Univ, Jawaharlal NehruMed Coll, Dept Pathol, Aligarh, Uttar Pradesh, India; [Fayazuddin, Mohd] Raichur Inst Med Sci, Dept Pharmacol, Raichur, India	Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University; Aligarh Muslim University	Rizvi, W (corresponding author), Aligarh Muslim Univ, Jawaharlal NehruMed Coll, Dept Pharmacol, Aligarh, Uttar Pradesh, India.	waseemnakhat@gmail.com	Akhtar, Kafil/AAA-9467-2021	Akhtar, Kafil/0000-0002-3482-1195	University Grant Commission, New Delhi, India	University Grant Commission, New Delhi, India(University Grants Commission, India)	Funded by University Grant Commission, New Delhi, India (http//www.ugcnetonline.in/).	Arfan M, 2007, J FOOD LIPIDS, V14, P280, DOI 10.1111/j.1745-4522.2007.00086.x; ARMSTRONG D, 1994, ADV EXP MED BIOL, V366, P43; Bignotto L, 2009, BRIT J NUTR, V102, P126, DOI 10.1017/S0007114508137886; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chang CT, 2011, FOOD CHEM, V127, P1131, DOI 10.1016/j.foodchem.2011.01.114; Chattopadhyay D, 2002, J ETHNOPHARMACOL, V82, P229, DOI 10.1016/S0378-8741(02)00165-4; Chaturvedi P, 2008, EVID-BASED COMPL ALT, V5, P55, DOI 10.1093/ecam/nel077; DAWSON J, 1991, INT J TISSUE REACT, V13, P171; Dmitrieva OS, 2016, BIOCHEMISTRY-MOSCOW+, V81, P80, DOI 10.1134/S0006297916020024; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gangwar M., 2012, INT J PHARM PHARM SC, V4, P643; Hewageegana H, 2014, J NATL SCI FOUND SRI, V42, P291; Huang GJ, 2012, J NAT PROD, V75, P54, DOI 10.1021/np200512a; Ishii R, 2003, BBA-GEN SUBJECTS, V1620, P108, DOI 10.1016/S0304-4165(02)00514-7; Jayweera D.M.A., 2006, MED PLANTS INDIGENOU, P225; Kim HS, 2000, J ETHNOPHARMACOL, V69, P79, DOI 10.1016/S0378-8741(99)00137-3; Kirtikar K.R., 1975, INDIAN MED PLANTS, VIII, P2266; Lee YM, 2009, J MOL MED, V87, P1251, DOI 10.1007/s00109-009-0532-6; Liao CH, 2011, FOOD CHEM, V125, P930, DOI 10.1016/j.foodchem.2010.09.082; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Manandhar NP, 2000, PLANT PEOPLE NEPAL; Narayana K. Raj, 2001, Indian Journal of Pharmacology, V33, P2; OHISHI N, 1985, BIOCHEM INT, V10, P205; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pankajoudhia, 2001, MED HERBS CHHATTISGA; Sharma J. N., 2006, Inflammopharmacology, V14, P10, DOI 10.1007/s10787-006-1496-6; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; SWINGLE KF, 1972, J PHARMACOL EXP THER, V183, P226; VINEGAR R, 1969, J PHARMACOL EXP THER, V166, P96; WINTER CA, 1957, J AM PHARM ASSOC, V46, P515, DOI 10.1002/jps.3030460902; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544	32	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167294	10.1371/journal.pone.0167294	http://dx.doi.org/10.1371/journal.pone.0167294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941980	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600012
J	Embaby, AM; Melika, RR; Hussein, A; El-Kamel, AH; Marey, HS				Embaby, Amira M.; Melika, Ramy R.; Hussein, Ahmed; El-Kamel, Amal H.; Marey, Heba S.			A Novel Non-Cumbersome Approach Towards Biosynthesis of Pectic-Oligosaccharides by Non-Aflatoxigenic Aspergillus sp Section Flavi Strain EGY1 DSM 101520 through Citrus Pectin Fermentation	PLOS ONE			English	Article							PREBIOTIC PROPERTIES; POLYGALACTURONASE; ENZYME; HEALTH	Pectic-Oligosaccharides (POS) have a growing potential in food and feed industries. To satisfy the demand of worldwide markets from POS and avoid the shortcomings of currently applied methodologies encountered in their preparation, the present study highlights a novel robust approach for POS biosynthesis. In the current approach, Aspergillus sp.section Flavi strain EGY1 DSM 101520 was grown on citrus pectin-based medium as a core POS production medium. POS' levels accumulated in the fungal fermentation broth were optimized through a three step sequential statistical mathematical methodology; Plackett-Burman design (PBD), Box-Behnken design (BBD) and canonical analysis. Three key determinants namely citrus pectin, peptone and NaH2PO4 were pointed out by PBD to impose significant consequences (P<0.05) on the process outcome (POS' levels). Optimal levels of these key determinants along with maximal of POS' levels were set by BBD and canonical analysis to be 2.28% (w/v) citrus pectin, 0.026% (w/v) peptone and 0.28% (w/v) NaH2PO4 to achieve a net amount of 1.3 g POS /2.28 g citrus pectin. Through this approach, a yield of 57% (w/w) POS of the total citrus pectin was obtained after 24 h of fungal growth on optimized citrus pectin based medium. A fold enhancement of 13 times in POS' levels released in the fermentation fungal broth was realized by the end of the optimization strategy. This novel robust approach is considered a new insight towards POS biosynthesis via efficient, rapid and non-cumbersome procedure. To the best of authors' knowledge, the present work is the first article underlining detailed POS production from the fermentation broth of a fungus growing on citrus pectin-based medium.	[Embaby, Amira M.; Melika, Ramy R.; Hussein, Ahmed] Univ Alexandria, Inst Grad Studies & Res, Dept Biotechnol, Alexandria, Egypt; [Hussein, Ahmed] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX USA; [El-Kamel, Amal H.] Univ Alexandria, Fac Pharm, Dept Pharmaceut, Alexandria, Egypt; [Marey, Heba S.] Univ Alexandria, Inst Grad Studies & Res, Dept Environm Studies, Alexandria, Egypt; [Marey, Heba S.] Univ Alberta, Dept Civil & Environm Engn, Edmonton, AB, Canada	Egyptian Knowledge Bank (EKB); Alexandria University; Texas Tech University System; Texas Tech University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; University of Alberta	Embaby, AM (corresponding author), Univ Alexandria, Inst Grad Studies & Res, Dept Biotechnol, Alexandria, Egypt.	Amira.Embaby@alexu.edu.eg	Embaby, Amira M./AAD-5080-2021	Elkamel, Amal/0000-0001-8773-5365; Hussein, Ahmed/0000-0002-6887-2927; Embaby, Amira/0000-0001-8068-4200				[Anonymous], 2001, COMPENDIUM METHODS M; Babbar N, 2016, CRIT REV BIOTECHNOL, V36, P594, DOI 10.3109/07388551.2014.996732; Box G. E., 1960, TECHNOMETRICS, V2, P455, DOI [10.2307/1266454, DOI 10.2307/1266454, 10.1080/00401706.1960.10489912, DOI 10.1080/00401706.1960.10489912]; Chen J, 2013, CARBOHYD POLYM, V91, P175, DOI 10.1016/j.carbpol.2012.08.021; Combo AMM, 2013, INT J BIOL MACROMOL, V52, P148, DOI 10.1016/j.ijbiomac.2012.09.006; Dagnino EO, 2009, 2 JORN INV ING NEA P; Demir H, 2016, J SCI FOOD AGR, V96, P3575, DOI 10.1002/jsfa.7543; Dung VK, 2015, TAP CHI SINH HOC, V37; Embaby AM, 2015, J BIOPROCESS BIOTECH, V5, P231, DOI DOI 10.4172/2155-9821.1000231; Embaby Amira M, 2014, ScientificWorldJournal, V2014, P396304, DOI 10.1155/2014/396304; Embaby AM, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-327; Gomez B, 2014, J CHEM TECHNOL BIOTE; Gomez B, 2014, J AGR FOOD CHEM, V62, P9769, DOI 10.1021/jf503475b; Gullon B, 2013, TRENDS FOOD SCI TECH, V30, P153, DOI 10.1016/j.tifs.2013.01.006; Hadj-Taieb N, 2011, APPL BIOCHEM BIOTECH, V165, P1652, DOI 10.1007/s12010-011-9384-y; Holck J, 2011, PROCESS BIOCHEM, V46, P1039, DOI 10.1016/j.procbio.2011.01.013; Irshad M, 2014, NAT PROD COMMUN, V9, P1649; Kuhnel S, 2010, BIORESOURCE TECHNOL, V101, P8300, DOI 10.1016/j.biortech.2010.05.070; Lama-Munoz A, 2012, FOOD HYDROCOLLOID, V28, P92, DOI 10.1016/j.foodhyd.2011.11.008; Leijdekkers AGM, 2013, BIORESOURCE TECHNOL, V128, P518, DOI 10.1016/j.biortech.2012.10.126; Maller Alexandre, 2011, Enzyme Res, V2011, P289206, DOI 10.4061/2011/289206; Manderson K, 2005, APPL ENVIRON MICROB, V71, P8383, DOI 10.1128/AEM.71.12.8383-8389.2005; Martin N, 2010, Mikrobiologiia, V79, P321; Martinez M, 2010, IND ENG CHEM RES, V49, P8470, DOI 10.1021/ie101066m; Martinez M, 2009, IND ENG CHEM RES, V48, P4681, DOI 10.1021/ie8017753; Mata-Gomez MA, 2015, J SCI FOOD AGR, V95, P1554, DOI 10.1002/jsfa.6864; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mohamed SA, 2013, J MICROBIOL, V51, P605, DOI 10.1007/s12275-013-3016-x; Monteiro AC., 2009, OPEN BIOTECHNOL J, V3, P9, DOI [10.2174/1874070700903010009, DOI 10.2174/1874070700903010009]; Myers R.H., 1976, RESPONSE SURFACE MET; Olano-Martin E, 2003, ANTICANCER RES, V23, P341; Olano-Martin E, 2001, J FOOD SCI, V66, P966, DOI 10.1111/j.1365-2621.2001.tb08220.x; Pedrolli D.B., 2014, ENZYME RES, V2014, P1, DOI DOI 10.1155/2014/353915; PLACKETT RL, 1946, BIOMETRIKA 4, V33, P305, DOI DOI 10.1093/BIOMET/33.4.305; Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003; Reda A. B., 2008, Journal of Applied Sciences Research, P1708; Rehman HU, 2012, CARBOHYD POLYM, V90, P387, DOI 10.1016/j.carbpol.2012.05.055; Sohail M, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.28594; Tamburini E, 2003, ENVIRON MICROBIOL, V5, P730, DOI 10.1046/j.1462-2920.2003.00462.x; Tepe O, 2014, ENVIRON SCI POLLUT R, V21, P9911, DOI 10.1007/s11356-014-2833-8; Xu SX, 2015, LETT APPL MICROBIOL, V60, P181, DOI 10.1111/lam.12357; Zhu L., 2005, THESIS	42	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167981	10.1371/journal.pone.0167981	http://dx.doi.org/10.1371/journal.pone.0167981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992459	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600027
J	Ferrari, S; Horri, K; Allal, F; Vergnet, A; Benhaim, D; Vandeputte, M; Chatain, B; Begout, ML				Ferrari, Sebastien; Horri, Khaled; Allal, Francois; Vergnet, Alain; Benhaim, David; Vandeputte, Marc; Chatain, Beatrice; Begout, Marie-Laure			Heritability of Boldness and Hypoxia Avoidance in European Seabass, Dicentrarchus labrax	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; STRESS-COPING STYLES; SALMON SALMO-SALAR; RAINBOW-TROUT; INDIVIDUAL-DIFFERENCES; ATLANTIC SALMON; RISK-TAKING; BEHAVIORAL PLASTICITY; CONFINEMENT STRESS; REARING CONDITIONS	To understand the genetic basis of coping style in European seabass, fish from a full factorial mating (10 females x 50 males) were reared in common garden and individually tagged. Individuals coping style was characterized through behavior tests at four different ages, categorizing fish into proactive or reactive: a hypoxia avoidance test (at 255 days post hatching, dph) and 3 risk-taking tests (at 276, 286 and 304 dph). We observed significant heritability of the coping style, higher for the average of risk-taking scores (h(2) = 0.45 +/- 0.14) than for the hypoxia avoidance test (h(2) = 0.19 +/- 0.10). The genetic correlations between the three risk-taking scores were very high (r(A) = 0.96-0.99) showing that although their repeatability was moderately high (r(P) = 0.64-0.72), successive risk-taking tests evaluated the same genetic variation. A mild genetic correlation between the results of the hypoxia avoidance test and the average of risk-taking scores (0.45 +/- 0.27) suggested that hypoxia avoidance and risk-taking tests do not address exactly the same behavioral and physiological responses. Genetic correlations between weight and risk taking traits showed negative values whatever the test used in our population i.e. reactive individual weights were larger. The results of this quantitative genetic analysis suggest a potential for the development of selection programs based on coping styles that could increase seabass welfare without altering growth performances. Overall, it also contributes to a better understanding of the origin and the significance of individual behavioral differences.	[Ferrari, Sebastien; Begout, Marie-Laure] IFREMER, Pl Gaby Coll, Fisheries Lab, Lhoumeau, France; [Horri, Khaled; Allal, Francois; Vergnet, Alain; Chatain, Beatrice] IFREMER, MARBEC UMR9190, Chemin Maguelone, Palavas Les Flots, France; [Benhaim, David] Normandie Univ, UNICAEN, LUSAC, Cherbourg, France; [Benhaim, David] Conservatoire Natl Arts & Metiers Intechmer, Cherbourg, France; [Vandeputte, Marc] Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France; [Vandeputte, Marc] IFREMER, L3AS, Chemin Maguelone, Palavas Les Flots, France	Ifremer; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Universite de Caen Normandie; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Ifremer	Ferrari, S; Begout, ML (corresponding author), IFREMER, Pl Gaby Coll, Fisheries Lab, Lhoumeau, France.	sebferrari@hotmail.fr; Marie.Laure.Begout@ifremer.fr	Begout, Marie-Laure/L-7730-2019; Allal, F./Q-8075-2018; Benhaim, David/A-9991-2019; Vandeputte, Marc/I-7218-2019; Vandeputte, Marc/A-4734-2011	Begout, Marie-Laure/0000-0003-1416-3479; Allal, F./0000-0002-8232-904X; Vandeputte, Marc/0000-0001-9929-4587; Vandeputte, Marc/0000-0001-9929-4587; Horri, Khaled/0000-0002-8408-7531	European Commission under the 7th Framework Program [265957 COPEWELL, FP7-KBBE-2010-4]; Conseil General de la Charente-Maritime	European Commission under the 7th Framework Program(European Commission); Conseil General de la Charente-Maritime(Region Nouvelle-Aquitaine)	This research project was supported by the European Commission under the 7th Framework Program FP7-KBBE-2010-4 Contract No. 265957 COPEWELL. The PhD work of Sebastien Ferrari was supported by the Conseil General de la Charente-Maritime.	Adriaenssens B, 2011, BEHAV ECOL, V22, P135, DOI 10.1093/beheco/arq185; [Anonymous], 1994, ESTIMATION AMELIORAT; [Anonymous], 1997, GENETICS ANAL QUANTI; Ariyomo TO, 2013, BEHAV GENET, V43, P161, DOI 10.1007/s10519-013-9585-y; Bolhuis JE, 2004, BEHAV BRAIN RES, V152, P351, DOI 10.1016/j.bbr.2003.10.024; Brelin D, 2005, ANN NY ACAD SCI, V1040, P239, DOI 10.1196/annals.1327.033; Brown C, 2007, J FISH BIOL, V71, P1590, DOI 10.1111/j.1095-8649.2007.01627.x; Brown C, 2007, BEHAV ECOL SOCIOBIOL, V62, P237, DOI 10.1007/s00265-007-0458-3; Careau V, 2012, PHYSIOL BIOCHEM ZOOL, V85, P543, DOI 10.1086/666970; Castanheira MF, 2017, REV AQUACULT, V9, P23, DOI 10.1111/raq.12100; Castanheira MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062037; Chapuis H, 2010, P 9 WORLD C GEN APPL; Chervet N, 2011, INT J EVOLUTIONARY B, V2011, P15; Coleman K, 1998, ANIM BEHAV, V56, P927, DOI 10.1006/anbe.1998.0852; Daule S, 2014, AQUACULTURE, V420, pS42, DOI 10.1016/j.aquaculture.2013.05.036; Ruiz-Gomez MD, 2011, PHYSIOL BEHAV, V102, P317, DOI 10.1016/j.physbeh.2010.11.023; DEBOER SF, 1990, PHYSIOL BEHAV, V47, P691, DOI 10.1016/0031-9384(90)90079-J; Dingemanse NJ, 2012, J EVOLUTION BIOL, V25, P485, DOI 10.1111/j.1420-9101.2011.02439.x; Dupont-Nivet M, 2002, AQUACULTURE, V204, P361, DOI 10.1016/S0044-8486(01)00839-0; Dupont-Nivet M, 2008, AQUACULTURE, V275, P81, DOI 10.1016/j.aquaculture.2007.12.032; Falconer D. S., 1996, INTRO QUANTITATIVE G; Ferrari S., 2014, THESIS; Ferrari S, 2015, APPL ANIM BEHAV SCI, V167, P74, DOI 10.1016/j.applanim.2015.03.006; FEVOLDEN SE, 1993, AQUACULTURE, V118, P205, DOI 10.1016/0044-8486(93)90457-A; FEVOLDEN SE, 1993, AQUACULTURE, V109, P215, DOI 10.1016/0044-8486(93)90164-T; FEVOLDEN SE, 1991, AQUACULTURE, V95, P53, DOI 10.1016/0044-8486(91)90072-F; Fevolden SE, 2002, AQUACULTURE, V205, P61, DOI 10.1016/S0044-8486(01)00660-3; Fevolden Svein Erik, 1993, Aquaculture, V111, P293, DOI 10.1016/0044-8486(93)90050-9; Fox J., 2019, R COMPANION APPL REG, V.; Gilmour A. R., 2015, ASREML USER GUIDE RE; Grima L, 2010, AQUACULTURE, V302, P169, DOI 10.1016/j.aquaculture.2010.02.016; Herrera M, 2014, APPL ANIM BEHAV SCI, V155, P101, DOI 10.1016/j.applanim.2014.03.001; Huntingford FA, 2010, J FISH BIOL, V76, P1576, DOI 10.1111/j.1095-8649.2010.02582.x; Huntingford FA, 2004, J FISH BIOL, V65, P122, DOI 10.1111/j.0022-1112.2004.00562.x; Huntingford FA, 2005, BEHAVIOUR, P1; Killen SS, 2012, FUNCT ECOL, V26, P134, DOI 10.1111/j.1365-2435.2011.01920.x; Koolhaas JM, 2008, BRAIN BEHAV IMMUN, V22, P662, DOI 10.1016/j.bbi.2007.11.006; Koolhaas JM, 2007, BRAIN BEHAV EVOLUT, V70, P218, DOI 10.1159/000105485; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kortet R, 2014, BEHAV ECOL SOCIOBIOL, V68, P927, DOI 10.1007/s00265-014-1705-z; Laursen DC, 2011, APPL ANIM BEHAV SCI, V132, P211, DOI 10.1016/j.applanim.2011.03.011; MacKenzie S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005314; Martins CIM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028084; Martins CIM, 2005, AQUAC RES, V36, P1509, DOI 10.1111/j.1365-2109.2005.01372.x; Mazue GPF, 2015, BEHAV ECOL, V26, P900, DOI 10.1093/beheco/arv030; McKenzie DJ, 2015, J EXP BIOL, V218, P3762, DOI 10.1242/jeb.122903; Menu B, 2005, AQUAC RES, V36, P41, DOI 10.1111/j.1365-2109.2004.01181.x; Millot S, 2009, J FISH BIOL, V75, P1733, DOI 10.1111/j.1095-8649.2009.02425.x; Millot S., 2008, THESIS; Millot S, 2014, BEHAV GENET, P1; Silva PIM, 2010, APPL ANIM BEHAV SCI, V124, P75, DOI 10.1016/j.applanim.2010.01.008; Nakagawa S, 2010, BIOL REV, V85, P935, DOI 10.1111/j.1469-185X.2010.00141.x; Overli O, 2006, PHYSIOL BEHAV, V87, P506, DOI 10.1016/j.physbeh.2005.11.012; Overli O, 2005, INTEGR COMP BIOL, V45, P463, DOI 10.1093/icb/45.3.463; Overli O, 2004, HORM BEHAV, V45, P324, DOI 10.1016/j.yhbeh.2004.01.001; Overli O, 2004, HORM BEHAV, V45, P235, DOI 10.1016/j.yhbeh.2003.12.002; Overli O, 2002, J EXP BIOL, V205, P391; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Overli O, 2006, AQUACULTURE, V261, P776, DOI 10.1016/j.aquaculture.2006.08.049; Pottinger T. G., 1997, Fish stress and health in aquaculture., P171; Pottinger TG, 1999, GEN COMP ENDOCR, V116, P122, DOI 10.1006/gcen.1999.7355; Pottinger TG, 2001, HORM BEHAV, V40, P419, DOI 10.1006/hbeh.2001.1707; Pottinger TG, 2003, CEFAS, V36, P14; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Rexroad CE, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-97; Ruiz-Gomez MD, 2008, HORM BEHAV, V54, P534, DOI 10.1016/j.yhbeh.2008.05.005; Saillant E, 2006, AQUACULTURE, V254, P139, DOI 10.1016/j.aquaculture.2005.10.018; Saillant E, 2003, AQUACULTURE, V221, P183, DOI 10.1016/S0044-8486(02)00539-2; Schjolden J, 2006, J FISH BIOL, V68, P920, DOI 10.1111/1095-8649.2006.00935.x; Sih A, 2012, ECOL LETT, V15, P278, DOI 10.1111/j.1461-0248.2011.01731.x; Sundstrom LF, 2004, BEHAV ECOL, V15, P192, DOI 10.1093/beheco/arg089; van Oers K, 2005, BEHAVIOUR, V142, P1185, DOI 10.1163/156853905774539364; Vandeputte M, 2007, AQUACULTURE, V272, pS315, DOI 10.1016/j.aquaculture.2007.07.195; Vandeputte M, 2006, MOL ECOL NOTES, V6, P265, DOI 10.1111/j.1471-8286.2005.01167.x; Vandeputte M, 2016, AQUACULTURE, V455, P1, DOI 10.1016/j.aquaculture.2016.01.003; Vandeputte M, 2001, AQUACULTURE, V202, P329, DOI 10.1016/S0044-8486(01)00782-7; Vandeputte M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00432; Vandeputte M, 2014, AQUACULTURE, V424, P239, DOI 10.1016/j.aquaculture.2014.01.005; Vandeputte M, 2011, AQUACULTURE, V314, P80, DOI 10.1016/j.aquaculture.2011.01.043; Vandeputte M, 2009, AQUACULTURE, V286, P20, DOI 10.1016/j.aquaculture.2008.09.008; vanRaaij MTM, 1996, HORM BEHAV, V30, P85, DOI 10.1006/hbeh.1996.0012; Volckaert FAM, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-15; White JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068900; Wilson ADM, 2010, BEHAV ECOL SOCIOBIOL, V64, P703, DOI 10.1007/s00265-009-0888-1; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wright D, 2006, BEHAV GENET, V36, P271, DOI 10.1007/s10519-005-9029-4	87	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168506	10.1371/journal.pone.0168506	http://dx.doi.org/10.1371/journal.pone.0168506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992517	Green Published, gold			2022-12-27	WOS:000392842600071
J	Tsai, SB; Chen, KY; Zhao, HR; Wei, YM; Wang, CK; Zheng, YX; Chang, LC; Wang, JT				Tsai, Sang-Bing; Chen, Kuan-Yu; Zhao, Hongrui; Wei, Yu-Min; Wang, Cheng-Kuang; Zheng, Yuxiang; Chang, Li-Chung; Wang, Jiangtao			Using a Mixed Model to Explore Evaluation Criteria for Bank Supervision: A Banking Supervision Law Perspective	PLOS ONE			English	Article							CORPORATE SOCIAL-RESPONSIBILITY; MANUFACTURING CORPORATIONS; DECISION-MAKING; GROWTH TRENDS; CHINA; INDUSTRY; PERFORMANCE; FORECAST; DEMATEL	Financial supervision means that monetary authorities have the power to supervise and manage financial institutions according to laws. Monetary authorities have this power because of the requirements of improving financial services, protecting the rights of depositors, adapting to industrial development, ensuring financial fair trade, and maintaining stable financial order. To establish evaluation criteria for bank supervision in China, this study integrated fuzzy theory and the decision making trial and evaluation laboratory (DEMATEL) and proposes a fuzzy-DEMATEL model. First, fuzzy theory was applied to examine bank supervision criteria and analyze fuzzy semantics. Second, the fuzzy-DEMATEL model was used to calculate the degree to which financial supervision criteria mutually influenced one another and their causal relationship. Finally, an evaluation criteria model for evaluating bank and financial supervision was established.	[Tsai, Sang-Bing; Zheng, Yuxiang] Shanghai Maritime Univ, Sch Econ Management, Shanghai, Peoples R China; [Tsai, Sang-Bing; Wang, Cheng-Kuang] Nankai Univ, Sch Law, Tianjin, Peoples R China; [Tsai, Sang-Bing; Wang, Cheng-Kuang; Chang, Li-Chung; Wang, Jiangtao] Univ Elect Sci & Technol China, Zhongshan Inst, Guangzhou, Guangdong, Peoples R China; [Tsai, Sang-Bing] Dalian Univ Technol, Sch Business, Dalian, Peoples R China; [Chen, Kuan-Yu; Zhao, Hongrui] Nankai Univ, Sch Business, Tianjin, Peoples R China; [Wei, Yu-Min] Nankai Univ, Coll Tourism & Serv Management, Tianjin, Peoples R China; [Chang, Li-Chung] Guangzhou Vocat Coll Sci & Technol, Guangzhou, Guangdong, Peoples R China	Shanghai Maritime University; Nankai University; University of Electronic Science & Technology of China; Dalian University of Technology; Nankai University; Nankai University	Tsai, SB (corresponding author), Shanghai Maritime Univ, Sch Econ Management, Shanghai, Peoples R China.; Tsai, SB (corresponding author), Nankai Univ, Sch Law, Tianjin, Peoples R China.; Tsai, SB (corresponding author), Univ Elect Sci & Technol China, Zhongshan Inst, Guangzhou, Guangdong, Peoples R China.; Tsai, SB (corresponding author), Dalian Univ Technol, Sch Business, Dalian, Peoples R China.	sangbing@hotmail.com; johnny_joan0305@yahoo.com.tw; jjzxzhr@sina.com; weyumin888@126.com; richardkuang@yahoo.com.tw; zyxln@163.com	Chang, Li-Chung/I-8750-2014; CHEN, KUANYU/ADS-2415-2022; Tsai, Sang-Bing/C-2978-2014	Chang, Li-Chung/0000-0002-5256-644X; CHEN, KUANYU/0000-0003-0528-982X; Tsai, Sang-Bing/0000-0001-6988-5829	National Social Science Fund of China [12BYJ125]; Provincial Nature Science Foundation of Guangdong [2015A030310271, 2015A030313679]; Academic Scientific Research Foundation for High-level Researcher, University of Electronic Science Technology of China, Zhongshan Institute [415YKQ08]	National Social Science Fund of China; Provincial Nature Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Academic Scientific Research Foundation for High-level Researcher, University of Electronic Science Technology of China, Zhongshan Institute	This work was supported by National Social Science Fund of China (No. 12BYJ125), Provincial Nature Science Foundation of Guangdong (No. 2015A030310271 and 2015A030313679), Academic Scientific Research Foundation for High-level Researcher, University of Electronic Science Technology of China, Zhongshan Institute (No. 415YKQ08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi V, 2012, J BANK FINANC, V36, P3213, DOI 10.1016/j.jbankfin.2011.10.020; Aldlaigan A.H., 2001, INT J BANK MARK, V19, P232, DOI [10.1108/EUM0000000006022, DOI 10.1108/EUM0000000006022]; Bah R., 2001, J BUS FINAN ACCOUNT, V28, P671, DOI [DOI 10.1111/1468-5957.00389, https://doi.org/10.1111/1468-5957.00389]; Bansal Shipra, 2014, OPEN J FINANCE, V3, P1; Berger AN, 2009, J BANK FINANC, V33, P113, DOI 10.1016/j.jbankfin.2007.05.016; Bernhofer L, 2014, INT J TECHNOL MANAGE, V65, P125, DOI 10.1504/IJTM.2014.060955; Calvo GA, 2000, J INT ECON, V51, P79, DOI 10.1016/S0022-1996(99)00038-0; Chen W. C., 2015, APPL MATH INFORM SCI, V9, P2207; Fontela E., 1976, DEMATEL 1976 REPORT; Gabus A., 1973, PERCEPTIONS WORLD PR; Guo JJ, 2015, S AFR J IND ENG, V26, P56, DOI 10.7166/26-2-956; Guo WF, 2015, INT J PROD RES, V53, P665, DOI 10.1080/00207543.2014.972525; Tzeng GH, 2007, EXPERT SYST APPL, V32, P1028, DOI 10.1016/j.eswa.2006.02.004; Hu DQ, 2003, FINANCIAL SUPERVISIO; Huarng K, 2006, PHYSICA A, V363, P481, DOI 10.1016/j.physa.2005.08.014; Jan P. K., 2001, J BANK FINANC, V25, P3; Jian Y., 2010, CHINA BANKING SUPERV; Jorion P, 2007, FINANCIAL RISK MANAG; Lee YC, 2014, INT J PROD RES, V299, P1395; Lee YC, 2014, PENSEE, V76, P190; Lee YC, 2011, AFR J BUS MANAGE, V5, P2312; Lee YC, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016641011; Lee YC, 2010, EXPERT SYST APPL, V37, P1745, DOI 10.1016/j.eswa.2009.07.034; Lin CJ, 2008, EXPERT SYST APPL, V34, P205, DOI 10.1016/j.eswa.2006.08.012; Mora N, 2014, J MONEY CREDIT BANK, V46, P469, DOI 10.1111/jmcb.12113; Opricovic S, 2003, INT J UNCERTAIN FUZZ, V11, P635, DOI 10.1142/S0218488503002387; Qiang L., 2010, CHINESE FINANCIAL LA; Qu QZ, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/361275; Swami MB, 2014, OPEN J FINANCE, V6, P1; Taiwan Academy of Banking and Finance, 2012, BANK INT CONTR AUD; Thi H. T. D., 2007, INT REV FINANC ANAL, V16, P471; Tsai SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154071; Tsai SB, 2016, CLEAN TECHNOL ENVIR, V18, P563, DOI 10.1007/s10098-015-1017-7; Tsai SB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129153; Tsai SB, 2015, P I MECH ENG B-J ENG, V229, P135, DOI 10.1177/0954405414558740; Tsai SB, 2014, P I MECH ENG B-J ENG, V228, P931, DOI 10.1177/0954405413509079; Tsai SB, 2013, S AFR J IND ENG, V24, P112; Tsai SB, 2013, APPL MECH MATER, V437, P1012, DOI 10.4028/www.scientific.net/AMM.437.1012; Tsai SB, 2016, RENEWABLE SUSTAINABL; Tsaur RC, 2011, EXPERT SYST APPL, V38, P9164, DOI 10.1016/j.eswa.2011.01.059; Tzeng, 2008, INT J OPER RES, V3, P160, DOI DOI 10.1080/14783361003606852; Wang RC, 2004, EUR J OPER RES, V154, P563, DOI 10.1016/S0377-2217(02)00729-4; Wu WW, 2007, EXPERT SYST APPL, V32, P499, DOI 10.1016/j.eswa.2005.12.005; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X; Zhou J, 2017, IEEE T SYST MAN CY-S, V47, P2809, DOI 10.1109/TSMC.2016.2519860	45	21	21	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167710	10.1371/journal.pone.0167710	http://dx.doi.org/10.1371/journal.pone.0167710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992449	Green Submitted, Green Published, gold			2022-12-27	WOS:000392842600019
J	Appaduray, MA; Masedunskas, A; Bryce, NS; Lucas, CA; Warren, SC; Timpson, P; Stear, JH; Gunning, PW; Hardeman, EC				Appaduray, Mark A.; Masedunskas, Andrius; Bryce, Nicole S.; Lucas, Christine A.; Warren, Sean C.; Timpson, Paul; Stear, Jeffrey H.; Gunning, Peter W.; Hardeman, Edna C.			Recruitment Kinetics of Tropomyosin Tpm3.1 to Actin Filament Bundles in the Cytoskeleton Is Independent of Actin Filament Kinetics	PLOS ONE			English	Article							MUSCLE ALPHA-TROPOMYOSIN; AMINO-TERMINUS; IN-VITRO; F-ACTIN; JASPLAKINOLIDE; DYNAMICS; TROPONIN; ISOFORMS; REVEALS; POLYMERIZATION	The actin cytoskeleton is a dynamic network of filaments that is involved in virtually every cellular process. Most actin filaments in metazoa exist as a co-polymer of actin and tropomyosin (Tpm) and the function of an actin filament is primarily defined by the specific Tpm isoform associated with it. However, there is little information on the interdependence of these co-polymers during filament assembly and disassembly. We addressed this by investigating the recovery kinetics of fluorescently tagged isoform Tpm3.1 into actin filament bundles using FRAP analysis in cell culture and in vivo in rats using intracellular intravital microscopy, in the presence or absence of the actin-targeting drug jasplakinolide. The mobile fraction of Tpm3.1 is between 50% and 70% depending on whether the tag is at the C-or N-terminus and whether the analysis is in vivo or in cultured cells. We find that the continuous dynamic exchange of Tpm3.1 is not significantly impacted by jasplakinolide, unlike tagged actin. We conclude that tagged Tpm3.1 may be able to undergo exchange in actin filament bundles largely independent of the assembly and turnover of actin.	[Appaduray, Mark A.; Masedunskas, Andrius; Bryce, Nicole S.; Lucas, Christine A.; Stear, Jeffrey H.; Gunning, Peter W.; Hardeman, Edna C.] UNSW Australia, Sch Med Sci, Cellular & Genet Med Unit, Sydney, NSW, Australia; [Warren, Sean C.; Timpson, Paul] Garvan Inst Med Res, Kinghorn Canc Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; Garvan Institute of Medical Research	Hardeman, EC (corresponding author), UNSW Australia, Sch Med Sci, Cellular & Genet Med Unit, Sydney, NSW, Australia.	e.hardeman@unsw.edu.au	Gunning, Peter W/E-9058-2010; Warren, Sean C./A-9392-2016; Timpson, Paul/A-9429-2016	Warren, Sean C./0000-0002-5253-7147; Hardeman, Edna/0000-0003-1649-7712; Timpson, Paul/0000-0002-5514-7080; Bryce, Nicole/0000-0001-9799-7393; Stear, Jeffrey/0000-0002-2255-8297; Gunning, Peter/0000-0003-0833-3128	Australian National and Medical Research Council (NHMRC) [APP1026616, APP1079866]; Australian Research Council (ARC) Linkage, Infrastructure, Equipment and Facilities (LIEF) [LE140100166]; Kids' Cancer Project	Australian National and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC) Linkage, Infrastructure, Equipment and Facilities (LIEF)(Australian Research Council); Kids' Cancer Project	This work was supported by Australian National and Medical Research Council (NHMRC) Project Grants APP1026616 (PWG, ECH) and APP1079866 (ECH, AM, PWG), Australian Research Council (ARC) Linkage, Infrastructure, Equipment and Facilities (LIEF) grant LE140100166 (PWG, ECH), and funding from the The Kids' Cancer Project (AM, NSB, PWG, ECH).	Bach CTT, 2009, MOL CELL BIOL, V29, P1506, DOI 10.1128/MCB.00857-08; Barua B, 2012, P NATL ACAD SCI USA, V109, P18425, DOI 10.1073/pnas.1212754109; Brooker HR, 2016, FEBS LETT, V590, P3111, DOI 10.1002/1873-3468.12346; Bryce NS, 2003, MOL BIOL CELL, V14, P1002, DOI 10.1091/mbc.E02-04-0244; Bubb MR, 2000, J BIOL CHEM, V275, P5163, DOI 10.1074/jbc.275.7.5163; CHO YJ, 1990, J BIOL CHEM, V265, P538; Coscoy S, 2002, P NATL ACAD SCI USA, V99, P12813, DOI 10.1073/pnas.192084599; Erami Z, 2016, CELL REP, V14, P152, DOI 10.1016/j.celrep.2015.12.020; Fritzsche M, 2013, MOL BIOL CELL, V24, P757, DOI 10.1091/mbc.E12-06-0485; Greenfield NJ, 2003, BIOCHEMISTRY-US, V42, P614, DOI 10.1021/bi026989e; Gunning P, 2008, PHYSIOL REV, V88, P1, DOI 10.1152/physrev.00001.2007; Gunning PW, 2015, J CELL SCI, V128, P2965, DOI 10.1242/jcs.172502; Gunning PW, 2005, TRENDS CELL BIOL, V15, P333, DOI 10.1016/j.tcb.2005.04.007; HEALD RW, 1988, J BIOL CHEM, V263, P5254; HELFMAN DM, 1984, J BIOL CHEM, V259, P4136; Holzinger A, 2009, METHODS MOL BIOL, V586, P71, DOI 10.1007/978-1-60761-376-3_4; Johnson M, 2014, CURR BIOL, V24, P1525, DOI 10.1016/j.cub.2014.05.034; Lehrer SS, 2014, J MUSCLE RES CELL M, V35, P153, DOI 10.1007/s10974-014-9383-z; Li Y, 2002, P NATL ACAD SCI USA, V99, P7378, DOI 10.1073/pnas.102179999; Martin C, 2010, J STRUCT BIOL, V170, P286, DOI 10.1016/j.jsb.2009.12.016; Masedunskas Andrius, 2013, Methods Mol Biol, V931, P153, DOI 10.1007/978-1-62703-056-4_9; Maytum R, 2000, BIOCHEMISTRY-US, V39, P11913, DOI 10.1021/bi000977g; Murakoshi H, 2008, BRAIN CELL BIOL, V36, P31, DOI 10.1007/s11068-008-9024-9; NOVY RE, 1993, CELL MOTIL CYTOSKEL, V26, P248, DOI 10.1002/cm.970260308; Palm T, 2003, BIOPHYS J, V84, P3181, DOI 10.1016/S0006-3495(03)70042-3; PITTENGER MF, 1992, J CELL BIOL, V118, P841, DOI 10.1083/jcb.118.4.841; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; SANDERS C, 1985, J BIOL CHEM, V260, P7264; Schevzov G, 2005, J HISTOCHEM CYTOCHEM, V53, P557, DOI 10.1369/jhc.4A6505.2005; Schevzov Galina, 2011, Bioarchitecture, V1, P135; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/NMETH.2413, 10.1038/nmeth.2413]; Stehn JR, 2013, CANCER RES, V73, P5169, DOI 10.1158/0008-5472.CAN-12-4501; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tojkander S, 2011, CURR BIOL, V21, P539, DOI 10.1016/j.cub.2011.03.007; Vlahovich N, 2009, MOL BIOL CELL, V20, P400, DOI 10.1091/mbc.E08-06-0616; von der Ecken J, 2015, NATURE, V519, P114, DOI 10.1038/nature14033; Wang JS, 2014, CYTOSKELETON, V71, P513, DOI 10.1002/cm.21189; WEGNER A, 1979, J MOL BIOL, V131, P839, DOI 10.1016/0022-2836(79)90204-3	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168203	10.1371/journal.pone.0168203	http://dx.doi.org/10.1371/journal.pone.0168203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977753	Green Submitted, gold, Green Published			2022-12-27	WOS:000391217400076
J	Fransen, K; Haslam, SA; Mallett, CJ; Steffens, NK; Peters, K; Boen, F				Fransen, Katrien; Haslam, S. Alexander; Mallett, Cliff J.; Steffens, Niklas K.; Peters, Kim; Boen, Filip			Leading from the Centre: A Comprehensive Examination of the Relationship between Central Playing Positions and Leadership in Sport	PLOS ONE			English	Article							SOCIAL NETWORK ANALYSIS; INTRA-TEAM COMMUNICATION; ATHLETE LEADERSHIP; SOCCER PLAYERS; BASEBALL; TABLES; SCALE	Research aims The present article provides a comprehensive examination of the relationship between playing position and leadership in sport. More particularly, it explores links between leadership and a player's interactional centrality-defined as the degree to which their playing position provides opportunities for interaction with other team members. This article examines this relationship across different leadership roles, team sex, and performance levels. Results Study 1 (N = 4443) shows that athlete leaders (and the task and motivational leader in particular) are more likely than other team members to occupy interactionally central positions in a team. Players with high interactional centrality were also perceived to be better leaders than those with low interactional centrality. Study 2 (N = 308) established this link for leadership in general, while Study 3 (N = 267) and Study 4 (N = 776) revealed that the same was true for task, motivational, and external leadership. This relationship is attenuated in sports where an interactionally central position confers limited interactional advantages. In other words, the observed patterns were strongest in sports that are played on a large field with relatively fixed positions (e.g., soccer), while being weaker in sports that are played on a smaller field where players switch positions dynamically (e.g., basketball, ice hockey). Beyond this, the pattern is broadly consistent across different sports, different sexes, and different levels of skill. Conclusions The observed patterns are consistent with the idea that positions that are interactionally central afford players greater opportunities to do leadership D either through communication or through action. Significantly too, they also provide a basis for them to be seen to do leadership by others on their team. Thus while it is often stated that "leadership is an action, not a position," it is nevertheless the case that, when it comes to performing that action, some positions are more advantageous than others.	[Fransen, Katrien; Boen, Filip] Katholieke Univ Leuven, Dept Kinesiol, Leuven, Belgium; [Haslam, S. Alexander; Steffens, Niklas K.; Peters, Kim] Univ Queensland, Sch Psychol, St Lucia, Qld, Australia; [Mallett, Cliff J.] Univ Queensland, Sch Human Movement & Nutr Sci, St Lucia, Qld, Australia	KU Leuven; University of Queensland; University of Queensland	Fransen, K (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Leuven, Belgium.	Katrien.Fransen@kuleuven.be	Haslam, Alex/AAA-2512-2019; Boen, Filip/D-8057-2018; Steffens, Niklas/D-3609-2016; Mallett, Clifford J/D-6106-2012; Fransen, Katrien/AAL-7589-2020	Haslam, Alex/0000-0001-9523-7921; Boen, Filip/0000-0002-5295-4776; Steffens, Niklas/0000-0002-3990-2592; Mallett, Clifford J/0000-0003-4843-2083; Fransen, Katrien/0000-0001-6294-7257	Internal Funds KU Leuven	Internal Funds KU Leuven	This research was supported by a grant from Internal Funds KU Leuven, awarded to Katrien Fransen.	Altman D.G., 1991, PRACTICAL STATISTIC; Balkundi P, 2011, J APPL PSYCHOL, V96, P1209, DOI 10.1037/a0024890; Bass B. M., 1990, BASS STOGDILLS HDB L; Boone J, 2012, J STRENGTH COND RES, V26, P2051, DOI 10.1519/JSC.0b013e318239f84f; Bourbousson J, 2010, J APPL SPORT PSYCHOL, V22, P150, DOI 10.1080/10413201003664657; Campbell I, 2007, STAT MED, V26, P3661, DOI 10.1002/sim.2832; Clemente F., J PHYS ED SPORT, V15, P212; CLEMENTE FM, 2015, J PHYS ED SPORT, V15, P272; Clemente FM, 2016, P I MECH EN IN PRESS; Clemente FMC, 2015, INT J PERFORM ANAL S, V15, P1; Clemmer J., 2009, GROWING SPEED CHANGE; COCHRAN WG, 1952, ANN MATH STAT, V23, P315, DOI 10.1214/aoms/1177729380; Cotterill ST, 2016, INT REV SPORT EXER P, V9, P116, DOI 10.1080/1750984X.2015.1124443; Fletcher D, 2009, PSYCHOL SPORT EXERC, V10, P427, DOI 10.1016/j.psychsport.2009.03.009; Fransen K, 2016, ATHL INSIGH IN PRESS; Fransen K, 2015, J SPORT EXERCISE PSY, V37, P274, DOI 10.1123/jsep.2014-0259; Fransen K, 2015, SOC NETWORKS, V43, P28, DOI 10.1016/j.socnet.2015.04.003; Fransen K, 2014, J SPORT SCI, V32, P1389, DOI 10.1080/02640414.2014.891291; Fransen K, 2014, INT J SPORT PSYCHOL, V45, P121, DOI 10.7352/IJSP.2014.45.121; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Gil SM, 2007, J STRENGTH COND RES, V21, P438; GRUSKY O, 1963, SOCIOMETRY, V26, P345, DOI 10.2307/2786074; Haslam SA, 2011, NEW PSYCHOLOGY OF LEADERSHIP: IDENTITY, INFLUENCE, AND POWER, P1; Haslam S. Alexander, 2001, PSYCHOL ORG SOCIAL I; Haslam SA, 2004, PSYCHOL ORG SOCIAL I, P80; Hoppe B, 2010, LEADERSHIP QUART, V21, P600, DOI 10.1016/j.leaqua.2010.06.004; KLONSKY BG, 1991, PERCEPT MOTOR SKILL, V72, P943, DOI 10.2466/PMS.72.3.943-946; Lee M. J., 1983, J SPORT BEHAV, V6, P59; Loy JW, 1990, PSYCHOL SOCIOLOGY SP, P93; Melnick M. J., 1996, International Review for the Sociology of Sport, V31, P91, DOI 10.1177/101269029603100105; Onag Z, 2014, PROCD SOC BEHV, V150, P420, DOI 10.1016/j.sbspro.2014.09.042; Richardson JTE, 2011, STAT MED, V30, P890, DOI 10.1002/sim.4116; Roy G, 1974, THESIS; Smith JA, 2013, SOC NETWORKS, V35, P652, DOI 10.1016/j.socnet.2013.09.003; Sparrowe RT, 2001, ACAD MANAGE J, V44, P316, DOI 10.2307/3069458; Steffens NK, 2014, LEADERSHIP QUART, V25, P1001, DOI 10.1016/j.leaqua.2014.05.002; Sullivan PJ, 2011, J APPL SOC PSYCHOL, V41, P471, DOI 10.1111/j.1559-1816.2010.00722.x; Sutanto J, 2011, LONG RANGE PLANN, V44, P421, DOI 10.1016/j.lrp.2011.09.001; Tofanelli D., 2012, COMMUNICATION ORG; Tropp K.J., 1979, J SPORT PSYCHOL, V1, P228, DOI 10.1123/jsp.1.3.228; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478; Xia CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129542; Xia CY, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/58002	43	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168150	10.1371/journal.pone.0168150	http://dx.doi.org/10.1371/journal.pone.0168150			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977734	gold, Green Published			2022-12-27	WOS:000391217400069
J	Bose, C; Shah, SV; Karaduta, OK; Kaushal, GP				Bose, Chhanda; Shah, Sudhir V.; Karaduta, Oleg K.; Kaushal, Gur P.			Carbamylated Low-Density Lipoprotein (cLDL)-Mediated Induction of Autophagy and Its Role in Endothelial Cell Injury	PLOS ONE			English	Article							PROTEIN CARBAMYLATION; AMINO-ACIDS; DEATH; PROLIFERATION; MORTALITY; ADHESION; DISEASE; STRESS; UREMIA; TYPE-2	Patients with chronic kidney disease (CKD) have high risk of cardiovascular complications. Plasma levels of carbamylated proteins produced by urea-derived isocyanate or thiocyanate are elevated in CKD patients and that they are significant predictors of cardiovascular events and all-cause mortality. Carbamylated LDL (cLDL) has pro-atherogenic properties and is known to affect major biological processes relevant to atherosclerosis including endothelial cell injury. The underlying mechanisms of cLDL-induced endothelial cell injury are not well understood. Although autophagy has been implicated in atherosclerosis, cLDL-mediated induction of autophagy and its role in endothelial cell injury is unknown. Our studies demonstrate that human coronary artery endothelial cells (HCAECs) respond to cLDL by specific induction of key autophagy proteins including LC3-I, beclin-1, Atg5, formation of lipid-conjugated LC3-II protein, and formation of punctate dots of autophagosome-associated LC3-II. We demonstrated that autophagy induction is an immediate response to cLDL and occurred in a dose and time-dependent manner. Inhibition of cLDL-induced autophagy by a specific siRNA to LC3 as well as by an autophagy inhibitor provided protection from cLDL-induced cell death and DNA fragmentation. Our studies demonstrate that autophagy plays an important role in cLDL-mediated endothelial cell injury and may provide one of the underlying mechanisms for the pathogenesis of cLDL-induced atherosclerosis in CKD patients.	[Bose, Chhanda; Shah, Sudhir V.; Kaushal, Gur P.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Bose, Chhanda; Shah, Sudhir V.; Kaushal, Gur P.] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA; [Karaduta, Oleg K.; Kaushal, Gur P.] Univ Arkansas Med Sci, Dept Biochem, Little Rock, AR 72205 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Kaushal, GP (corresponding author), Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA.; Kaushal, GP (corresponding author), Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA.; Kaushal, GP (corresponding author), Univ Arkansas Med Sci, Dept Biochem, Little Rock, AR 72205 USA.	kaushalgurp@uams.edu			Department of Veterans Affairs [BX000444, BX001519]; National Institutes of Health-NIDDK grant [DK081690]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081690] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001519, I01BX000444] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health-NIDDK grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	VA Merit Award (BX000444) to GPK from Department of Veterans Affairs, VA Merit Award (BX001519) to SVS from Depertment of Veterans Affairs, and National Institutes of Health-NIDDK grant (DK081690) to GPK.	Apostolov EO, 2007, AM J PHYSIOL-HEART C, V292, pH1836, DOI 10.1152/ajpheart.01079.2006; Apostolov EO, 2007, ARTERIOSCL THROM VAS, V27, P826, DOI 10.1161/01.ATV.0000258795.75121.8a; Apostolov EO, 2011, AM J PHYSIOL-HEART C, V300, pH1997, DOI 10.1152/ajpheart.01311.2010; Apostolov EO, 2010, J AM SOC NEPHROL, V21, P1852, DOI 10.1681/ASN.2010040365; Asci G, 2008, NEPHROLOGY, V13, P480, DOI 10.1111/j.1440-1797.2008.00948.x; Berg AH, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005218; Carracedo J, 2011, FASEB J, V25, P1314, DOI 10.1096/fj.10-173377; Chandrika BB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140025; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; Drechsler C, 2015, KIDNEY INT, V87, P1201, DOI 10.1038/ki.2014.429; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Fulda S, 2015, ONCOGENE, V34, P5105, DOI 10.1038/onc.2014.458; Gajjala PR, 2015, NEPHROL DIAL TRANSPL, V30, P1814, DOI 10.1093/ndt/gfv048; Gatica D, 2015, CIRC RES, V116, P456, DOI 10.1161/CIRCRESAHA.114.303788; Gillery P, 2014, CLIN CHEM LAB MED, V52, P33, DOI 10.1515/cclm-2012-0880; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Klionsky DJ, 2013, J INNATE IMMUN, V5, P427, DOI 10.1159/000351979; Kobayashi S, 2015, BBA-MOL BASIS DIS, V1852, P252, DOI 10.1016/j.bbadis.2014.05.020; Koeth RA, 2013, J AM SOC NEPHROL, V24, P853, DOI 10.1681/ASN.2012030254; Kraus LM, 2001, KIDNEY INT, V59, pS102, DOI 10.1046/j.1523-1755.2001.59780102.x; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nilsson L, 1996, CLIN CHEM, V42, P482; NOBLE RP, 1968, J LIPID RES, V9, P693; Ok E, 2005, KIDNEY INT, V68, P173, DOI 10.1111/j.1523-1755.2005.00391.x; Shiu SWM, 2014, CLIN SCI, V126, P175, DOI 10.1042/CS20130369; Son JN, 2011, INT J CARDIOL, V146, P428, DOI 10.1016/j.ijcard.2010.10.098; Speer T, 2014, EUR HEART J, V35, P3021, DOI 10.1093/eurheartj/ehu111; STARK GR, 1960, J BIOL CHEM, V235, P3177; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Trepanier DJ, 1996, CLIN BIOCHEM, V29, P347, DOI 10.1016/0009-9120(96)00038-0; Varga ZV, 2015, BBA-MOL BASIS DIS, V1852, P232, DOI 10.1016/j.bbadis.2014.06.030; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Wiersma JJ, 2008, MED SCI MONITOR, V14, pCR406; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014	40	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0165576	10.1371/journal.pone.0165576	http://dx.doi.org/10.1371/journal.pone.0165576			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973558	gold, Green Submitted, Green Published			2022-12-27	WOS:000392754300004
J	Kollmann, M; Schmidt, R; Heuer, CM; Schachtner, J				Kollmann, Martin; Schmidt, Rovenna; Heuer, Carsten M.; Schachtner, Joachim			Variations on a Theme: Antennal Lobe Architecture across Coleoptera	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; SCHISTOCERCA-GREGARIA ORTHOPTERA; COCKROACH PERIPLANETA-AMERICANA; TACHYKININ-RELATED PEPTIDES; OLFACTORY RECEPTOR NEURONS; LIBELLULA-DEPRESSA ODONATA; INSECT MUSHROOM BODIES; DROSOPHILA-MELANOGASTER; SEXUAL-DIMORPHISM; LADYBIRD BEETLE	Beetles comprise about 400,000 described species, nearly one third of all known animal species. The enormous success of the order Coleoptera is reflected by a rich diversity of lifestyles, behaviors, morphological, and physiological adaptions. All these evolutionary adaptions that have been driven by a variety of parameters over the last about 300 million years, make the Coleoptera an ideal field to study the evolution of the brain on the interface between the basic bauplan of the insect brain and the adaptions that occurred. In the current study we concentrated on the paired antennal lobes (AL), the part of the brain that is typically responsible for the first processing of olfactory information collected from olfactory sensilla on antenna and mouthparts. We analyzed 63 beetle species from 22 different families and thus provide an extensive comparison of principal neuroarchitecture of the AL. On the examined anatomical level, we found a broad diversity including AL containing a wide range of glomeruli numbers reaching from 50 to 150 glomeruli and several species with numerous small glomeruli, resembling the microglomerular design described in acridid grasshoppers and diving beetles, and substructures within the glomeruli that have to date only been described for the small hive beetle, Aethina tumida. A first comparison of the various anatomical features of the AL with available descriptions of lifestyle and behaviors did so far not reveal useful correlations. In summary, the current study provides a solid basis for further studies to unravel mechanisms that are basic to evolutionary adaptions of the insect olfactory system.	[Kollmann, Martin; Schmidt, Rovenna; Heuer, Carsten M.; Schachtner, Joachim] Philipps Univ Marburg, Dept Biol Anim Physiol, Marburg, Germany; [Schmidt, Rovenna] Justus Liebig Univ Giessen, Inst Vet Anat Histol & Embryol, Giessen, Germany; [Heuer, Carsten M.] Fraunhofer Inst Nat Wissensch Tech Trendanalysen, Euskirchen, Germany	Philipps University Marburg; Justus Liebig University Giessen; Fraunhofer Gesellschaft	Schachtner, J (corresponding author), Philipps Univ Marburg, Dept Biol Anim Physiol, Marburg, Germany.	Joachim.schachtner@biologie.uni-marburg.de	Schachtner, Joachim/AAG-1101-2020	Schachtner, Joachim/0000-0001-7268-0699				Abjornsson K, 1997, OECOLOGIA, V111, P166, DOI 10.1007/s004420050221; Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; AHRENS D, 2014, P ROY SOC B-BIOL SCI, V281, DOI DOI 10.1098/RSPB.2014.1470; Al Abassi S, 1998, CELL MOL LIFE SCI, V54, P876, DOI 10.1007/s000180050215; Al Abassi S, 2000, J CHEM ECOL, V26, P1765, DOI 10.1023/A:1005555300476; [Anonymous], 2001, LEARN MEMORY, V8, P53, DOI [10.1101/lm.38801, DOI 10.1101/LM.38801]; Anton S., 1999, INSECT OLFACTION; ARNOLD G, 1985, CELL TISSUE RES, V242, P593, DOI 10.1007/BF00225425; Bense U, 1994, LONGHORN BEETLES ILL; Binzer M, 2014, J COMP NEUROL, V522, P337, DOI 10.1002/cne.23399; Brandt R, 2005, J COMP NEUROL, V492, P1, DOI 10.1002/cne.20644; BROCKMANN A, 1995, INT J INSECT MORPHOL, V24, P405, DOI 10.1016/0020-7322(95)00010-2; Browne J, 1998, SYST ENTOMOL, V23, P307, DOI 10.1046/j.1365-3113.1998.00059.x; Browne J, 1999, SYST ENTOMOL, V24, P51, DOI 10.1046/j.1365-3113.1999.00067.x; Carlsson MA, 2010, J COMP NEUROL, V518, P3359, DOI 10.1002/cne.22405; Chapman A. D., 2009, NUMBER LIVING SPECIE; CHASE R, 1986, CELL TISSUE RES, V246, P567, DOI 10.1007/BF00215198; Couto A, 2016, J COMP NEUROL, V524, P2335, DOI 10.1002/cne.23975; Crespo JG, 2012, ARTHROPOD STRUCT DEV, V41, P227, DOI 10.1016/j.asd.2012.02.008; Crowson RA, 1981, BIOL COLEOPTERA; Dacks AM, 2006, J COMP NEUROL, V498, P727, DOI 10.1002/cne.21076; Dacks AM, 2011, CHEM SENSES, V36, P209, DOI 10.1093/chemse/bjq121; Dahanukar A, 2005, CURR OPIN NEUROBIOL, V15, P423, DOI 10.1016/j.conb.2005.06.001; Davis ALV, 2002, J BIOGEOGR, V29, P1217, DOI 10.1046/j.1365-2699.2002.00776.x; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; de Bruyne M, 2006, BIOESSAYS, V28, P23, DOI 10.1002/bies.20338; de Bruyne M, 2010, J COMP PHYSIOL A, V196, P97, DOI 10.1007/s00359-009-0496-6; Dippel S, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0304-z; Dreyer D, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/neuro.06.003.2010; ERNST KD, 1983, CELL TISSUE RES, V229, P1, DOI 10.1007/BF00217877; Erwin TL, 1985, TAXONOMY PHYLOGENY Z, P437; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Farris SM, 2008, ARTHROPOD STRUCT DEV, V37, P492, DOI 10.1016/j.asd.2008.05.005; Farris SM, 2005, P NATL ACAD SCI USA, V102, P17394, DOI 10.1073/pnas.0508430102; FISCHER DC, 1986, ENTOMOL EXP APPL, V40, P3, DOI 10.1007/BF00187017; FONTA C, 1993, CHEM SENSES, V18, P101, DOI 10.1093/chemse/18.2.101; Foottit R.G., 2009, INSECT BIODIVERSITY, DOI 10.1002/9781118945582; Fusca D, 2015, J COMP NEUROL, V523, P1569, DOI 10.1002/cne.23757; Galizia CG, 2014, EUR J NEUROSCI, V39, P1784, DOI 10.1111/ejn.12558; Galizia CG, 2010, ANNU REV ENTOMOL, V55, P399, DOI 10.1146/annurev-ento-112408-085442; Galizia CG, 1999, CELL TISSUE RES, V295, P383, DOI 10.1007/s004410051245; Gencer NS, 2009, PHYTOPARASITICA, V37, P217, DOI 10.1007/s12600-009-0032-9; Gerstmeier R., 2003, EXTRA VORRATSSCHADLI; GOLL WOLFGANG, 1967, Z MORPHOL OKOL TIERE, V59, P143, DOI 10.1007/BF00407612; Gomez-Zurita J, 2008, CLADISTICS, V24, P34, DOI 10.1111/j.1096-0031.2007.00167.x; Grimaldi David, 2005, pi; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Hansson BS, 1996, J COMP PHYSIOL A, V179, P157, DOI 10.1007/BF00222783; Hanstrom B, 1940, INKRETORISCHE ORGANE, V18, P1; HATFIELD L D, 1976, International Journal of Insect Morphology and Embryology, V5, P279, DOI 10.1016/0020-7322(76)90028-3; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Herbst C, 2011, CHEMOECOLOGY, V21, P19, DOI 10.1007/s00049-010-0061-3; Heuer CM, 2012, ARTHROPOD STRUCT DEV, V41, P199, DOI 10.1016/j.asd.2012.02.005; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; HODGSON ES, 1953, THE BIOLOGICAL BULLE, V105, P115, DOI DOI 10.2307/1538560; HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401; Horn H, 2000, UNSERE HAUFIGSTEN SC; Hu JH, 2011, ARTHROPOD STRUCT DEV, V40, P420, DOI 10.1016/j.asd.2011.03.003; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Ignell R, 2001, BRAIN BEHAV EVOLUT, V57, P1, DOI 10.1159/000047222; Ignell R, 2001, CELL TISSUE RES, V306, P143, DOI 10.1007/s004410100434; Ignell R, 2009, P NATL ACAD SCI USA, V106, P13070, DOI 10.1073/pnas.0813004106; Iperti G., 1965, 90EME C SOC SAV NIC, V2, P544; Iwasaki M, 1995, ZOOL SCI, V12, P725, DOI 10.2108/zsj.12.725; JOURDAN H, 1995, INT J INSECT MORPHOL, V24, P307, DOI 10.1016/0020-7322(95)98584-Z; Jung JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081361; Kelber C, 2009, BRAIN BEHAV EVOLUT, V73, P273, DOI 10.1159/000230672; Keller A, 2003, CURR OPIN NEUROBIOL, V13, P103, DOI 10.1016/S0959-4388(03)00011-4; Kim MY, 1998, CELL TISSUE RES, V294, P351, DOI 10.1007/s004410051185; Klagges BRE, 1996, J NEUROSCI, V16, P3154; Ko KI, 2015, ELIFE, V4, DOI 10.7554/eLife.08298; Kollmann M, 2016, CELL TISSUE RES, V363, P679, DOI 10.1007/s00441-015-2282-9; Kollmann M, 2011, ARTHROPOD STRUCT DEV, V40, P304, DOI 10.1016/j.asd.2011.02.003; Kollmann M, 2011, CELL TISSUE RES, V343, P343, DOI 10.1007/s00441-010-1099-9; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; KOONTZ MA, 1987, CELL TISSUE RES, V249, P39, DOI 10.1007/BF00215416; Kreissl S, 2010, J COMP NEUROL, V518, P1391, DOI 10.1002/cne.22343; Kristoffersen L, 2008, CHEM SENSES, V33, P771, DOI 10.1093/chemse/bjn044; Kuebler LS, 2010, J COMP NEUROL, V518, P352, DOI 10.1002/cne.22217; Kuhnle K. F., 1913, Jenaische Zeitschrift fuer Naturwissenschaft, V50; Kukalova-Peck J, 2012, EUR J ENTOMOL, V109, P633, DOI 10.14411/eje.2012.075; Kurylas AE, 2008, CELL TISSUE RES, V333, P125, DOI 10.1007/s00441-008-0620-x; Lau T. F. S., 2007, Journal of Asia-Pacific Entomology, V10, P27; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Lin C, 2012, J COMP NEUROL, V520, P2562, DOI [10.1002/cne.23092, 10.1002/cne.23158]; Maddison DR, 1999, SYST ENTOMOL, V24, P103, DOI 10.1046/j.1365-3113.1999.00088.x; Magro A, 2010, MOL PHYLOGENET EVOL, V54, P833, DOI 10.1016/j.ympev.2009.10.022; Marshall DC, 1002, ANN ENTOMOLOGICAL SO, V94, P386; Missbach C, 2011, ARTHROPOD STRUCT DEV, V40, P317, DOI 10.1016/j.asd.2011.03.004; MOBBS PG, 1982, PHILOS T ROY SOC B, V298, P309, DOI 10.1098/rstb.1982.0086; Mysore K, 2009, ARTHROPOD STRUCT DEV, V38, P485, DOI 10.1016/j.asd.2009.06.001; Nagel KI, 2015, NAT NEUROSCI, V18, P56, DOI 10.1038/nn.3895; Nakanishi A, 2010, J COMP NEUROL, V518, P2186, DOI 10.1002/cne.22326; Nassel DR, 2000, NATURWISSENSCHAFTEN, V87, P439, DOI 10.1007/s001140050756; NISHIKAWA M, 1995, J COMP NEUROL, V361, P165, DOI 10.1002/cne.903610113; Ochieng' SA, 1999, PHYSIOL ENTOMOL, V24, P28, DOI 10.1046/j.1365-3032.1999.00107.x; Ochieng SA, 1998, CELL TISSUE RES, V291, P525, DOI 10.1007/s004410051022; Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Panov A. A., 2013, ENTOMOLOGICAL REV, V94, P654; PARETO A, 1972, Z ZELLFORSCH MIK ANA, V131, P109, DOI 10.1007/BF00307204; Piersanti S, 2014, J INSECT PHYSIOL, V62, P26, DOI 10.1016/j.jinsphys.2014.01.006; RAKSHPAL R, 1959, PARASITOLOGY, V49, P232, DOI 10.1017/S0031182000026846; Raupach MJ, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-26; Rebora M, 2008, ARTHROPOD STRUCT DEV, V37, P504, DOI 10.1016/j.asd.2008.03.003; Rebora M, 2013, ZOOLOGY, V116, P205, DOI 10.1016/j.zool.2013.04.001; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Sarkar N, 2013, ARTHROPOD-PLANT INTE, V7, P339, DOI 10.1007/s11829-013-9249-0; Schachtner J, 2005, ARTHROPOD STRUCT DEV, V34, P257, DOI 10.1016/j.asd.2005.04.003; Schaller M, 2000, EUR J ENTOMOL, V97, P155, DOI 10.14411/eje.2000.029; Schwalb H. H., 1961, Zoologische Jahrbuecher Jena Systematik, V88, P399; SHANBHAG SR, 1995, CELL TISSUE RES, V282, P237, DOI 10.1007/BF00319115; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Siju KP, 2014, J COMP NEUROL, V522, P592, DOI 10.1002/cne.23434; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Sinakevitch IT, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00070; SMITH CM, 1976, INT J INSECT MORPHOL, V5, P349, DOI 10.1016/0020-7322(76)90010-6; Smith DM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0060; Smith VS, 2001, ZOOL J LINN SOC-LOND, V132, P81, DOI [10.1006/zjls.2000.0264, 10.1111/j.1096-3642.2001.tb02272.x]; Stacconi MVR, 2014, CHEM SENSES, V39, P282, DOI 10.1093/chemse/bjt114; Steinbrecht RA, 1996, CIBA F SYMP, V200, P158; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Strausfeld NJ, 2009, J COMP NEUROL, V513, P265, DOI 10.1002/cne.21948; Strausfeld NJ, 1998, BRAIN BEHAV EVOLUT, V52, P186, DOI 10.1159/000006563; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Tanaka NK, 2012, J COMP NEUROL, V520, P4067, DOI 10.1002/cne.23142; Tegoni M, 2004, TRENDS BIOCHEM SCI, V29, P257, DOI 10.1016/j.tibs.2004.03.003; Utz S, 2008, DEV NEUROBIOL, V68, P123, DOI 10.1002/dneu.20579; VEENSTRA JA, 1995, HISTOCHEM CELL BIOL, V104, P337, DOI 10.1007/BF01458127; VISSER JH, 1986, ANNU REV ENTOMOL, V31, P121, DOI 10.1146/annurev.en.31.010186.001005; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wertz Adrian, 2006, Frontiers in Zoology, V3, P1; Whiteman NK, 2008, TRENDS ECOL EVOL, V23, P473, DOI 10.1016/j.tree.2008.05.010; Wilson RI, 2013, ANNU REV NEUROSCI, V36, P217, DOI 10.1146/annurev-neuro-062111-150533; Winther AME, 2006, MOL CELL NEUROSCI, V31, P399, DOI 10.1016/j.mcn.2005.10.010; Winther AME, 2010, FLY, V4, P167, DOI 10.4161/fly.4.2.11467; Yoritsune A, 2012, INVERTEBR NEUROSCI, V12, P103, DOI 10.1007/s10158-012-0137-6; Zahradnik J., 2010, ILLUSTRIERTES LEXIKO; Zahradnik J., 1985, BESTIMMUNGSBUCH BIOL	145	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166253	10.1371/journal.pone.0166253	http://dx.doi.org/10.1371/journal.pone.0166253			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973569	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300008
J	Chan, DK; Rouse, SL				Chan, Dylan K.; Rouse, Stephanie L.			Sound-Induced Intracellular Ca2+ Dynamics in the Adult Hearing Cochlea	PLOS ONE			English	Article							HAIR CELL-DEATH; MAMMALIAN COCHLEA; INNER-EAR; SUPPORTING CELLS; GJB2 DEFICIENCY; IN-VITRO; ATP; NOISE; ORGAN; CALCIUM	Ca2+ signaling has been implicated in the initial pathophysiologic mechanisms underlying the cochlea's response to acoustic overstimulation. Intracellular Ca2+ signaling (ICS) waves, which occur in glia and retinal cells in response to injury to activate cell regulatory pathways, have been proposed as an early event in cochlear injury. Disruption of ICS activity is thought to underlie Connexin 26-associated hearing loss, the most common genetic form of deafness, and downstream sequelae of ICS wave activity, such as MAP kinase pathway activation, have been implicated in noise-induced hearing loss. However, ICS waves have only been observed in neonatal cochlear cultures and are thought to be quiescent after the onset of hearing. In this study, we employ an acute explant model of an adult, hearing cochlea that retains many in vivo physiologic features to investigate Ca2+ changes in response to sound. We find that both slow monotonic changes in intracellular Ca2+ concentration as well as discrete ICS waves occur with acoustic overstimulation. The ICS waves share many intrinsic features with their better-described neonatal counterparts, including ATP and gap-junction dependence, and propagation velocity and distance. This identification of ICS wave activity in the adult, hearing cochlea thus confirms and characterizes an important early detection mechanism for cochlear trauma and provides a target for interventions for noise-induced and Connexin 26-associated hearing loss.	[Chan, Dylan K.; Rouse, Stephanie L.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Chan, DK (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA.	dylan.chan@ucsf.edu		Rouse, Stephanie/0000-0002-2967-3351	National Institute on Deafness and Other Communication Disorders (NIDCD) [R03DC015082]; American Hearing Research Foundation (AHRF); American Association for Otolaryngology-Head and Neck Surgery/American Neurotology Society (AAO-HNS/ANS); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC015082] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); American Hearing Research Foundation (AHRF); American Association for Otolaryngology-Head and Neck Surgery/American Neurotology Society (AAO-HNS/ANS); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support was provided by: 1) National Institute on Deafness and Other Communication Disorders (NIDCD; https://www.nidcd.nih.gov): R03DC015082; 2) American Hearing Research Foundation (AHRF; http://american-hearing.org): 2015 Research Award; 3) American Association for Otolaryngology-Head and Neck Surgery/American Neurotology Society (AAO-HNS/ANS; http://www.entnet.org): 2014 Herb Silverstein Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmi F, 2008, P NATL ACAD SCI USA, V105, P18770, DOI [10.1073/pnas.0800793105, 10.1073/pnas.080079310S]; Battaglia A, 2003, NEUROSCIENCE, V122, P1025, DOI 10.1016/j.neuroscience.2003.08.041; Beltramello M, 2005, NAT CELL BIOL, V7, P63, DOI 10.1038/ncb1205; Ceriani F, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-20; Chan DK, 2005, BIOPHYS J, V89, P4382, DOI 10.1529/biophysj.105.070474; Chan DK, 2005, NAT NEUROSCI, V8, P149, DOI 10.1038/nn1385; Chan DK, 2014, LARYNGOSCOPE, V124, pE34, DOI 10.1002/lary.24332; Chen J, 2014, BIOCHEM BIOPH RES CO, V448, P28, DOI 10.1016/j.bbrc.2014.04.016; Chung JW, 2007, ANESTH ANALG, V104, P1404, DOI 10.1213/01.ane.0000261508.24083.6c; Crispino G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023279; De Bock M, 2014, BBA-MOL CELL RES, V1843, P2211, DOI 10.1016/j.bbamcr.2014.04.016; Esterberg R, 2013, J NEUROSCI, V33, P7513, DOI 10.1523/JNEUROSCI.4559-12.2013; Fridberger A, 1998, P NATL ACAD SCI USA, V95, P7127, DOI 10.1073/pnas.95.12.7127; Gale JE, 2004, CURR BIOL, V14, P526, DOI 10.1016/j.cub.2004.03.002; Horvath T, 2016, NEUROCHEM RES, V41, P364, DOI 10.1007/s11064-015-1818-4; Housley GD, 2013, P NATL ACAD SCI USA, V110, P7494, DOI 10.1073/pnas.1222295110; Kopke RD, 2007, HEARING RES, V226, P114, DOI 10.1016/j.heares.2006.10.008; Lahne M, 2008, J NEUROSCI, V28, P4918, DOI 10.1523/JNEUROSCI.4914-07.2008; Lee HY, 2016, J NEUROSCI, V36, P8160, DOI 10.1523/JNEUROSCI.1157-16.2016; Maeda Y, 2012, PLOS ONE, V8; Majumder P, 2010, PURINERG SIGNAL, V6, P167, DOI 10.1007/s11302-010-9192-9; Munoz DJB, 2001, ACTA OTO-LARYNGOL, V121, P10; Newman EA, 2005, J NEUROSCI, V25, P5502, DOI 10.1523/JNEUROSCI.1354-05.2005; Nickel R, 2008, CURR OPIN OTOLARYNGO, V16, P452, DOI 10.1097/MOO.0b013e32830e20b0; Piazza V, 2007, CELL CALCIUM, V41, P77, DOI 10.1016/j.ceca.2006.05.005; Robles L, 2001, PHYSIOL REV, V81, P1305, DOI 10.1152/physrev.2001.81.3.1305; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; Wang J, 2003, J NEUROSCI, V23, P8596; Yan D, 2013, P NATL ACAD SCI USA, V110, P2228, DOI 10.1073/pnas.1222285110; Zhou XX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030301; Zhu Y, 2015, NEUROSCIENCE, V284, P719, DOI 10.1016/j.neuroscience.2014.10.061	31	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167850	10.1371/journal.pone.0167850	http://dx.doi.org/10.1371/journal.pone.0167850			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959894	Green Submitted, gold, Green Published			2022-12-27	WOS:000392753900018
J	Notaro, M; Schummer, M; Zhong, YF; Vavrus, S; Van Den Elsen, L; Coluccy, J; Hoving, C				Notaro, Michael; Schummer, Michael; Zhong, Yafang; Vavrus, Stephen; Van Den Elsen, Lena; Coluccy, John; Hoving, Christopher			Projected Influences of Changes in Weather Severity on Autumn-Winter Distributions of Dabbling Ducks in the Mississippi and Atlantic Flyways during the Twenty-First Century	PLOS ONE			English	Article							LAURENTIAN GREAT-LAKES; CLIMATE-CHANGE; ANAS-PLATYRHYNCHOS; ICE COVER; EFFECT SNOWSTORMS; EFFECT SNOWFALL; BLACK DUCK; EL-NINO; SURVIVAL; TEMPERATURE	Projected changes in the relative abundance and timing of autumn-winter migration are assessed for seven dabbling duck species across the Mississippi and Atlantic Flyways for the mid-and late 21(st) century. Species-specific observed relationships are established between cumulative weather severity in autumn-winter and duck population rate of change. Dynamically downscaled projections of weather severity are developed using a highresolution regional climate model, interactively coupled to a one-dimensional lake model to represent the Great Lakes and associated lake-effect snowfall. Based on the observed relationships and downscaled climate projections of rising air temperatures and reduced snow cover, delayed autumn-winter migration is expected for all species, with the least delays for the Northern Pintail and the greatest delays for the Mallard. Indeed, the Mallard, the most common and widespread duck in North America, may overwinter in the Great Lakes region by the late 21 st century. This highlights the importance of protecting and restoring wetlands across the mid-latitudes of North America, including the Great Lakes Basin, because dabbling ducks are likely to spend more time there, which would impact existing wetlands through increased foraging pressure. Furthermore, inconsistency in the timing and intensity of the traditional autumn-winter migration of dabbling ducks in the Mississippi and Atlantic Flyways could have social and economic consequences to communities to the south, where hunting and birdwatching would be affected.	[Notaro, Michael; Vavrus, Stephen] Univ Wisconsin Madison, Nelson Inst Ctr Climat Res, Madison, WI 53706 USA; [Schummer, Michael] SUNY Coll Oswego, Dept Biol Sci, Oswego, NY 13126 USA; [Zhong, Yafang] Univ Wisconsin Madison, Space Sci & Engn Ctr, Madison, WI USA; [Van Den Elsen, Lena] Long Point Waterfowl Bird Studies Canada, Port Rowan, ON, Canada; [Coluccy, John] Ducks Unltd, Ann Arbor, MI USA; [Hoving, Christopher] Michigan Dept Nat Resources, Wildlife Div, Lansing, MI USA	University of Wisconsin System; University of Wisconsin Madison; State University of New York (SUNY) System; State University of New York (SUNY) - Oswego; University of Wisconsin System; University of Wisconsin Madison	Notaro, M (corresponding author), Univ Wisconsin Madison, Nelson Inst Ctr Climat Res, Madison, WI 53706 USA.	mnotaro@wisc.edu	Schummer, Michael/FDB-4240-2022		Northeast Climate Science Center; National Oceanic and Atmospheric Administration; National Science Foundation; Great Lakes Restoration Initiative through the Environmental Protection Agency; Gulf Coastal Plains and Ozarks Landscape Conservation Cooperative; Long Point Waterfowl; Ontario Federation of Anglers and Hunters; University of Western Ontario through the Western Graduate Research Scholarship	Northeast Climate Science Center; National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); National Science Foundation(National Science Foundation (NSF)); Great Lakes Restoration Initiative through the Environmental Protection Agency; Gulf Coastal Plains and Ozarks Landscape Conservation Cooperative; Long Point Waterfowl; Ontario Federation of Anglers and Hunters; University of Western Ontario through the Western Graduate Research Scholarship	The research was funded by the Northeast Climate Science Center, National Oceanic and Atmospheric Administration, National Science Foundation, Great Lakes Restoration Initiative through the Environmental Protection Agency, Gulf Coastal Plains and Ozarks Landscape Conservation Cooperative, Long Point Waterfowl, Ontario Federation of Anglers and Hunters, and the University of Western Ontario through the Western Graduate Research Scholarship.; The research was funded by the Northeast Climate Science Center, National Oceanic and Atmospheric Administration, National Science Foundation, Great Lakes Restoration Initiative through the Environmental Protection Agency, Gulf Coastal Plains and Ozarks Landscape Conservation Cooperative, Long Point Waterfowl, Ontario Federation of Anglers and Hunters, and the University of Western Ontario through the Western Graduate Research Scholarship. Modeling contributions from Dr. Val Bennington are acknowledged. We acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modeling groups for producing and making available their model output. For CMIP, the U.S. Department of Energy's Program for Climate Model Diagnosis and Intercomparison provides coordinating support and led development of software infrastructure in partnership with the Global Organization for Earth System Science Portals. Computational resources were provided through the National Center for Atmospheric Research and the Teragrid from the University of Texas at Austin and the University of Illinois at Urbana-Champaign. Comments from Dr. Matthew Guillemain and an anonymous reviewer are greatly appreciated. Publication of the Nelson Institute Center for Climatic Research.	Albright J.J., 1983, Transactions of the Northeast Fish and Wildlife Conference, V40, P118; Alerstam T., 1990, P331; ANDERSON HARRY G., 1959, ILLINOIS NAT HIST SURV BULL, V27, P289; Ankney C.D., 1996, 7 INT WAT S I WETL W, P50; Anthes N, 2004, BIRD STUDY, V51, P203, DOI 10.1080/00063650409461355; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Baldassarre G.A., 2006, WATERFOWL ECOLOGY MA; Baldassarre G. A., 2014, DUCKS GEESE SWANS N, V1; Barshep Y, 2012, ORNIS FENNICA, V89, P120; Bellrose F, 1980, DUCKS GEESE SWANS N; Bellrose F. C, 1970, Bull. Ill. nat. Hist. Surv., V30, P167; Bengtsson D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100764; Bennington V, 2014, J CLIMATE, V27, P2886, DOI 10.1175/JCLI-D-13-00110.1; Blums P, 2002, J ANIM ECOL, V71, P438, DOI 10.1046/j.1365-2656.2002.00613.x; Bossenmaier EF, 1958, WILDLIFE MONOGRAPHS, V1; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Brommer JE, 2004, ANN ZOOL FENN, V41, P391; Brook RW, 2009, J WILDLIFE MANAGE, V73, P98, DOI 10.2193/2007-424; Browne DM, 2007, CONSERVING WATERFOWL; Burnett AW, 2003, J CLIMATE, V16, P3535, DOI [10.1175/1520-0442(2003)016<3535:IGLSDT>2.0.CO;2, 10.1175/1520-0442(2003)016&lt;3535:IGLSDT&gt;2.0.CO;2]; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CALDER WA, 1974, AVIAN ENERGETICS, P86; Cox RR, 1998, J WILDLIFE MANAGE, V62, P124, DOI 10.2307/3802270; Crick HQP, 2004, IBIS, V146, P48, DOI 10.1111/j.1474-919X.2004.00327.x; Dahl T.E., 1990, WETLAND LOSSES US 17; Dahl TE, 2006, FISH; Dalby L, 2013, IBIS, V155, P80, DOI 10.1111/j.1474-919X.2012.01257.x; Fuller K, 1995, GREAT LAKES ENV ATLA; Giorgi F, 2012, CLIM RES, V52, P7, DOI 10.3354/cr01018; Grado SC, 2001, WILDLIFE SOC B, V29, P846; Green AW, 2008, J WILDLIFE MANAGE, V72, P1328, DOI 10.2193/2007-028; Guillemain Matthieu, 2015, Wildfowl, V65, P51; Guillemain M, 2015, J ORNITHOL, V156, P647, DOI 10.1007/s10336-015-1171-z; Guillemain M, 2013, WILDLIFE BIOL, V19, P404, DOI 10.2981/12-118; Gunnarsson G, 2004, CAN J ZOOL, V82, P1698, DOI 10.1139/Z04-153; Gunnarsson G, 2012, IBIS, V154, P307, DOI 10.1111/j.1474-919X.2011.01206.x; Gwinner E, 2003, CURR OPIN NEUROBIOL, V13, P770, DOI 10.1016/j.conb.2003.10.010; Hartmann DL, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P159; Hatzofe O, 2002, ISRAEL J ZOOL, V48, P351, DOI 10.1560/F9CC-X3UM-XJBJ-FPW6; HAVERA SP, 1999, SPECIAL PUBLICATION, V21; Henderson E, 2005, 20019 US FISH WILDL; Hitch AT, 2007, CONSERV BIOL, V21, P534, DOI 10.1111/j.1523-1739.2006.00609.x; Hostetler S.W., 1991, CLIM DYNAM, V6, P43, DOI DOI 10.1007/BF00210581; HOSTETLER SW, 1990, WATER RESOUR RES, V26, P2603, DOI 10.1029/90WR01240; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Huntley B., 2007, CLIMATIC ATLAS EUROP; Inkley D. B., 2004, WILDLIFE SOC TECHNIC; Johnson Douglas H., 1992, P446; Johnson WC, 2005, BIOSCIENCE, V55, P863, DOI 10.1641/0006-3568(2005)055[0863:VONPWT]2.0.CO;2; JORDE DG, 1983, J WILDLIFE MANAGE, V47, P1044, DOI 10.2307/3808163; Keller V, 2005, ENTWICKLUNG WASSERVO; Kershaw M, 2002, MIGRATION ATLAS MOVE, P204; KOSKIMIES JUKKA, 1964, AUK, V81, P281; Kunkel KE, 2009, J GREAT LAKES RES, V35, P23, DOI 10.1016/j.jglr.2008.11.003; La Sorte FA, 2007, ECOLOGY, V88, P1803, DOI 10.1890/06-1072.1; Lehikoinen A, 2013, GLOBAL CHANGE BIOL, V19, P2071, DOI 10.1111/gcb.12200; Lensink CJ, 1964, 89 US FISH WILDL SER, V89; Longcore JR, 2000, BIRDS N AM; LOVVORN JR, 1994, J ANIM ECOL, V63, P11, DOI 10.2307/5578; Mallory ML, 2003, J BIOGEOGR, V30, P441, DOI 10.1046/j.1365-2699.2003.00819.x; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; Menne MJ, 2012, J ATMOS OCEAN TECH, V29, P897, DOI 10.1175/JTECH-D-11-00103.1; Moller A.P., 2011, EFFECTS CLIMATE CHAN; Newton I, 2007, IBIS, V149, P453, DOI 10.1111/j.1474-919X.2007.00704.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Newton I., 1998, POPULATION LIMITATIO; NICHOLS JD, 1983, AUK, V100, P932, DOI 10.1093/auk/100.4.932; Nilsson Leif, 1984, Wildfowl, V35, P71; Nilsson Leif, 2008, Ornis Svecica, V18, P135; Notaro M, 2015, J CLIMATE, V28, P9721, DOI 10.1175/JCLI-D-14-00847.1; Notaro M, 2015, J CLIMATE, V28, P1661, DOI 10.1175/JCLI-D-14-00467.1; Notaro M, 2014, J CLIMATE, V27, P6526, DOI 10.1175/JCLI-D-13-00520.1; Notaro M, 2013, MON WEATHER REV, V141, P1990, DOI 10.1175/MWR-D-11-00369.1; Notaro M, 2013, J CLIMATE, V26, P789, DOI 10.1175/JCLI-D-12-00140.1; Palmer, 1976, HDB N AM BIRDS 1, V2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PATTERSON JC, 1988, LIMNOL OCEANOGR, V33, P323, DOI 10.4319/lo.1988.33.3.0323; Pearse AT, 2007, THESIS; Price J. T., 2000, PREPARING CHANGING C, P65; Price JT, 2002, BIRD CONSERVATION, V17, P12; Raty O, 2014, CLIM DYNAM, V42, P2287, DOI 10.1007/s00382-014-2130-8; Rebetez M, 1996, THEOR APPL CLIMATOL, V54, P99, DOI 10.1007/BF00865152; Reinecke K.J., 1989, P203; Ridgill S.C., 1990, INT WATERFOWL WETLAN, V13; RUSCH DH, 1989, WILDLIFE SOC B, V17, P379; Sauter A, 2010, IBIS, V152, P600, DOI 10.1111/j.1474-919X.2010.01028.x; Schummer Michael L., 2014, Wildfowl, P451; Schummer ML, 2010, J WILDLIFE MANAGE, V74, P94, DOI 10.2193/2008-524; Scott D.A., 1996, ATLAS ANATIDAE POPUL; Sedinger JS, 2006, ECOLOGY, V87, P151, DOI 10.1890/04-1013; Sparks T. H., 2001, ESSEX BIRD REPORT, V1999, P154; Suter W., 1991, Ornithologische Beobachter, V88, P111; Svazas S, 2001, OISEAUX MIGRATEURS P; Svazas Saulius, 2001, Acta Zoologica Lituanica, V11, P235; TALENT LG, 1983, CONDOR, V85, P74, DOI 10.2307/1367893; Temple S.A., 1987, Passenger Pigeon, V49, P70; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thornton PE, 1999, AGR FOREST METEOROL, V93, P211, DOI 10.1016/S0168-1923(98)00126-9; Thornton PE, DAYMET ANN CLIMATE S; Thorup K, 2007, OECOLOGIA, V151, P697, DOI 10.1007/s00442-006-0608-8; U. S. Fish & Wildlife Service, 2013, 20111 US FISH WILDL; Van Cleave K, 2014, LIMNOL OCEANOGR, V59, P1889, DOI 10.4319/lo.2014.59.6.1889; Van Den Elsen L, 2013, ESTIMATED EFFECTS CL; Van Den Elsen LM, 2016, THESIS; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Vavrus S, 2013, MON WEATHER REV, V141, P148, DOI 10.1175/MWR-D-12-00107.1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wang J, 2012, J CLIMATE, V25, P1318, DOI 10.1175/2011JCLI4066.1	108	26	26	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167506	10.1371/journal.pone.0167506	http://dx.doi.org/10.1371/journal.pone.0167506			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959911	Green Submitted, Green Published, gold			2022-12-27	WOS:000392753900009
J	Enanoria, WTA; Liu, FC; Zipprich, J; Harriman, K; Ackley, S; Blumberg, S; Worden, L; Porco, TC				Enanoria, Wayne T. A.; Liu, Fengchen; Zipprich, Jennifer; Harriman, Kathleen; Ackley, Sarah; Blumberg, Seth; Worden, Lee; Porco, Travis C.			The Effect of Contact Investigations and Public Health Interventions in the Control and Prevention of Measles Transmission: A Simulation Study	PLOS ONE			English	Article							HUMAN PLASMA FRACTIONATION; IMMUNE SERUM GLOBULIN; INFECTIOUS-DISEASES; EPIDEMIC; OUTBREAK; PROPHYLAXIS; ELIMINATION; VACCINATION; QUARANTINE; PRODUCTS	Background Measles cases continue to occur despite its elimination status in the United States. To control transmission, public health officials confirm the measles diagnosis, identify close contacts of infectious cases, deliver public health interventions (i.e., post-exposure prophylaxis) among those who are eligible, and follow-up with the close contacts to determine overall health outcomes. A stochastic network simulation of measles contact tracing was conducted using existing agent-based modeling software and a synthetic population with high levels of immunity in order to estimate the impact of different interventions in controlling measles transmission. Methods and Findings The synthetic population was created to simulate California's population in terms of population demographics, household, workplace, school, and neighborhood characteristics using California Department of Finance 2010 census data. Parameters for the model were obtained from a review of the literature, California measles case surveillance data, and expert opinion. Eight different scenarios defined by the use of three different public health interventions were evaluated: (a) post-exposure measles, mumps, and rubella (MMR) vaccine, (b) post-exposure immune globulin (IG), and (c) voluntary isolation and home quarantine in the presence or absence of public health response delays. Voluntary isolation and home quarantine coupled with one or two other interventions had the greatest reduction in the number of secondary cases infected by the index case and the probability of escape situations (i.e., the outbreak continues after 90 days). Conclusions Interrupting contact patterns via voluntary isolation and home quarantine are particularly important in reducing the number of secondary cases infected by the index case and the probability of uncontrolled outbreaks.	[Enanoria, Wayne T. A.; Ackley, Sarah; Porco, Travis C.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Liu, Fengchen; Ackley, Sarah; Blumberg, Seth; Worden, Lee; Porco, Travis C.] Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA; [Zipprich, Jennifer; Harriman, Kathleen] Calif Dept Publ Hlth, Div Communicable Dis Control, Immunizat Branch, Richmond, CA USA; [Porco, Travis C.] Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; California Department of Public Health; University of California System; University of California San Francisco	Porco, TC (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.; Porco, TC (corresponding author), Univ Calif San Francisco, Francis I Proctor Fdn Res Ophthalmol, San Francisco, CA 94143 USA.; Porco, TC (corresponding author), Univ Calif San Francisco, Dept Ophthalmol, San Francisco, CA 94143 USA.	travis.porco@ucsf.edu			Models of Infectious Disease Agent Study (MIDAS) grant from the National Institute of General Medical Sciences at the National Institutes of Health [U01GM087728]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491, U01GM087728] Funding Source: NIH RePORTER	Models of Infectious Disease Agent Study (MIDAS) grant from the National Institute of General Medical Sciences at the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by a Models of Infectious Disease Agent Study (MIDAS) grant from the National Institute of General Medical Sciences at the National Institutes of Health to the University of California, San Francisco (Award Number U01GM087728). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839; Black CL, 2013, MMWR-MORBID MORTAL W, V62, P733; BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Blumberg S, 2015, PLOS CURR; Blumberg S, 2014, AM J EPIDEMIOL, V179, P1375, DOI 10.1093/aje/kwu068; Brewer DD, 2005, SEX TRANSM DIS, V32, P78, DOI 10.1097/01.olq.0000153574.38764.0e; Britton T, 2009, MATH BIOSCI, V222, P109, DOI 10.1016/j.mbs.2009.10.001; California Department of Public Health, 2006, VACC PREV DIS IMMM C; Centers for Disease Control and Prevention, 2012, EPIDEMIOLOGY PREVENT; Cowling BJ, 2008, EPIDEMIOL INFECT, V136, P562, DOI 10.1017/S0950268807008722; Dayan GH, 2005, PEDIATRICS, V116, pE1, DOI 10.1542/peds.2004-2512; Demicheli V, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004407.pub2; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Eames KTD, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-141; Fiebelkorn AP, 2010, J INFECT DIS, V202, P1520, DOI 10.1086/656914; FINE PEM, 1994, AM J EPIDEMIOL, V139, P77, DOI 10.1093/oxfordjournals.aje.a116937; Flint J, 2003, Can Commun Dis Rep, V29, P105; Grefenstette JJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-940; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; House T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000721; James L, 2006, PUBLIC HEALTH, V120, P20, DOI 10.1016/j.puhe.2005.10.005; Jezek Z, 1988, HUMAN MONKEYPOX; Katz SL, 2004, J INFECT DIS, V189, pS43, DOI 10.1086/377696; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Liu FC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1766-6; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; McLean Huang, 2011, Morbidity and Mortality Weekly Report, V60, P666; McQuillan GM, 2007, J INFECT DIS, V196, P1459, DOI 10.1086/522866; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; Muller J, 2000, MATH BIOSCI, V164, P39, DOI 10.1016/S0025-5564(99)00061-9; Ordman CW, 1944, J CLIN INVEST, V23, P541, DOI 10.1172/JCI101519; Orenstein WA, 2004, J INFECT DIS, V189, pS1, DOI 10.1086/377693; Papania M, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.5.e59; Papania MJ, 2014, JAMA PEDIATR, V168, P148, DOI 10.1001/jamapediatrics.2013.4342; Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50; Porco TC, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-34; Reynolds DL, 2008, EPIDEMIOL INFECT, V136, P997, DOI 10.1017/S0950268807009156; Salathe M, 2008, J R SOC INTERFACE, V5, P1505, DOI 10.1098/rsif.2008.0271; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Sippl-Swezey N, 2014, COMPUT MATH METHOD M, V2014, DOI 10.1155/2014/952381; Stokes J, 1944, J CLIN INVEST, V23, P531, DOI 10.1172/JCI101518; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Uzicanin A, 2011, J INFECT DIS, V204, pS133, DOI 10.1093/infdis/jir102; Vogel C, 2008, J TRAVEL MED, V15, P65, DOI 10.1111/j.1708-8305.2008.00182.x; Watson JC, 1998, MMWR RECOMM REP, V47, P1; WILLCOX RR, 1966, BRIT J VENER DIS, V42, P167; Wu JY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1018; WYKOFF RF, 1988, JAMA-J AM MED ASSOC, V259, P3563, DOI 10.1001/jama.259.24.3563; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Young MK, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010056.pub2; Zipprich J, 2015, MMWR-MORBID MORTAL W, V64, P153	51	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167160	10.1371/journal.pone.0167160	http://dx.doi.org/10.1371/journal.pone.0167160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941976	Green Published, Green Submitted, gold			2022-12-27	WOS:000392745600010
J	Levchenko, M; Lorenzi, I; Dudek, J				Levchenko, Mariia; Lorenzi, Isotta; Dudek, Jan			The Degradation Pathway of the Mitophagy Receptor Atg32 Is Re-Routed by a Posttranslational Modification	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; AUTOPHAGOSOME FORMATION; MITOCHONDRIAL PROTEIN; VACUOLAR HYDROLASES; SELECTIVE AUTOPHAGY; MEDIATES MITOPHAGY; CONJUGATION SYSTEM; IN-VIVO; YEAST; FISSION	The outer mitochondrial membrane protein Atg32 is the central receptor for mitophagy, the mitochondria-specific form of autophagy. Atg32 is an unstable protein, and is rapidly degraded under conditions in which mitophagy is not induced. Here we show that Atg32 undergoes a posttranslational modification upon induction of mitophagy. The modification is dependent on the core autophagic machinery, including Atg8, and on the mitophagy-specific adaptor protein Atg11. The modified Atg32 is targeted to the vacuole where it becomes stabilized when vacuolar proteases are deficient. Interestingly, we find that this degradation pathway differs from the degradation pathway of non-modified Atg32, which neither involves vacuolar proteases, nor the proteasome. These analyses reveal that a posttranslational modification discriminates a form of Atg32 targeting mitochondria for mitophagy from that, which escapes mitophagy by rapid degradation.	[Levchenko, Mariia; Lorenzi, Isotta; Dudek, Jan] Georg August Univ, Dept Cellular Biochem, Gottingen, Germany	University of Gottingen	Dudek, J (corresponding author), Georg August Univ, Dept Cellular Biochem, Gottingen, Germany.	Jan.Dudek@med.uni-goettingen.de		Levchenko, Maria/0000-0003-0706-515X	Boehringer Ingelheim Fonds; Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences; Deutsche Forschungsgemeinschaft (DFG)	Boehringer Ingelheim Fonds(Boehringer Ingelheim); Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by the "Boehringer Ingelheim Fonds" (ML) and the "Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences".; This study was supported by the "Boehringer Ingelheim Fonds" (ML) and the "Gottingen Graduate School for Neurosciences, Biophysics, and Molecular Biosciences". We also thank the Deutsche Forschungsgemeinschaft (DFG) for funding, Dr. Blanche Schwappach for the Pgk1 antibody, Dr. Michael Thumm and Dr. Peter Rehling for discussion.	Aoki Y, 2011, MOL BIOL CELL, V22, P3206, DOI 10.1091/mbc.E11-02-0145; Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bhatia-Kissova I, 2010, FEMS YEAST RES, V10, P1023, DOI 10.1111/j.1567-1364.2010.00659.x; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Farre JC, 2013, EMBO REP, V14, P441, DOI 10.1038/embor.2013.40; Frazier AE, 2006, J CELL BIOL, V172, P553, DOI 10.1083/jcb.200505060; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Germain D, 2008, MOL MICROBIOL, V70, P1334, DOI 10.1111/j.1365-2958.2008.06502.x; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Harding TM, 1996, J BIOL CHEM, V271, P17621, DOI 10.1074/jbc.271.30.17621; HEINEMEYER W, 1991, EMBO J, V10, P555, DOI 10.1002/j.1460-2075.1991.tb07982.x; HILT W, 1993, J BIOL CHEM, V268, P3479; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Janke C, 2004, VERSATILE TOOLBOX PC, P1; Jin MY, 2014, FEBS LETT, V588, P2457, DOI 10.1016/j.febslet.2014.06.015; Jin MY, 2013, CELL, V152, P368, DOI 10.1016/j.cell.2013.01.004; JONES EW, 1982, GENETICS, V102, P665; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanki T, 2013, EMBO REP, V14, P788, DOI 10.1038/embor.2013.114; Kanki T, 2011, ANTIOXID REDOX SIGN, V14, P1989, DOI 10.1089/ars.2010.3762; Kanki T, 2009, AUTOPHAGY, V5, P1201, DOI 10.4161/auto.5.8.9747; Kanki T, 2009, AUTOPHAGY, V5, P1186, DOI 10.4161/auto.5.8.9854; Kanki T, 2009, MOL BIOL CELL, V20, P4730, DOI 10.1091/mbc.E09-03-0225; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kraft C, 2012, CURR OPIN CELL BIOL, V24, P496, DOI 10.1016/j.ceb.2012.05.001; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Kurihara Y, 2012, J BIOL CHEM, V287, P3265, DOI 10.1074/jbc.M111.280156; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Livnat-Levanon N, 2011, BBA-GENE REGUL MECH, V1809, P80, DOI 10.1016/j.bbagrm.2010.07.005; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Mao K, 2013, DEV CELL, V26, P9, DOI 10.1016/j.devcel.2013.05.024; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Mendl N, 2011, J CELL SCI, V124, P1339, DOI 10.1242/jcs.076406; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Muller M, 2015, CELL REP, V10, P1215, DOI 10.1016/j.celrep.2015.01.044; Murakawa T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8527; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Neutzner A, 2008, ANN NY ACAD SCI, V1147, P242, DOI 10.1196/annals.1427.012; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Otsu K, 2015, AUTOPHAGY, V11, P1932, DOI 10.1080/15548627.2015.1084459; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Rehling P, 2003, SCIENCE, V299, P1747, DOI 10.1126/science.1080945; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Takeda K, 2010, AUTOPHAGY, V6, P564, DOI 10.4161/auto.6.4.11948; Teter SA, 2001, J BIOL CHEM, V276, P2083, DOI 10.1074/jbc.C000739200; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Wang K.X., 2013, J COMPUT INF SYST, V9, P1; Welter E, 2013, FEBS J, V280, P4970, DOI 10.1111/febs.12468; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; ZUBENKO GS, 1983, P NATL ACAD SCI-BIOL, V80, P510, DOI 10.1073/pnas.80.2.510	66	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168518	10.1371/journal.pone.0168518	http://dx.doi.org/10.1371/journal.pone.0168518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992522	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000056
J	Keister, LA; Vallejo, JA; Aronson, B				Keister, Lisa A.; Vallejo, Jody Agius; Aronson, Brian			Chinese Immigrant Wealth: Heterogeneity in Adaptation	PLOS ONE			English	Article							STATUS ATTAINMENT; SEGMENTED ASSIMILATION; LIFE-CYCLE; 2ND-GENERATION; MOBILITY; DETERMINANTS	Chinese immigrants are a diverse and growing group whose members provide a unique opportunity to examine within-immigrant group differences in adaptation. In this paper, we move beyond thinking of national-origin groups as homogenous and study variation among Chinese immigrants in wealth ownership, a critical indicator of adaptation that attracts relatively little attention in the immigration literature. We develop an analytical approach that considers national origin, tenure in the U.S., and age to examine heterogeneity in economic adaptation among the immigrant generation. Our results show that variations among Chinese immigrants explain within-group differences in net worth, asset ownership, and debt. These differences also account for important variation between Chinese immigrants, natives, and other immigrant groups and provide important, new insight into the processes that lead to immigrant adaptation and long-term class stability.	[Keister, Lisa A.; Aronson, Brian] Duke Univ, Dept Sociol, Durham, NC 27706 USA; [Vallejo, Jody Agius] Univ Southern Calif, Dept Sociol, Los Angeles, CA USA	Duke University; University of Southern California	Keister, LA (corresponding author), Duke Univ, Dept Sociol, Durham, NC 27706 USA.	Lkeister@soc.duke.edu	Aronson, Brian/W-4402-2019	Aronson, Brian/0000-0001-5304-1971	National Science Foundation [SES-1322738]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD065563] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Science Foundation, SES-1322738 (JAV).	Alba R. D., 2003, REMAKING AM MAINSTRE; Alba R, 2016, J ETHN MIGR STUD, V42, P3, DOI 10.1080/1369183X.2015.1083770; Alba R, 2014, ETHNIC RACIAL STUD, V37, P446, DOI 10.1080/01419870.2013.786111; Alba R, 2011, SOC FORCES, V89, P763; [Anonymous], FINANCIAL TIMES; Bean F. D., 2015, PARENTS PAPERS PROGR; Bean FD, 2011, INT MIGR REV, V45, P348, DOI 10.1111/j.1747-7379.2011.00851.x; Bean Frank D., 2003, AM NEWCOMERS DYNAMIC; Brown SK, 2007, CITY COMMUNITY, V6, P193, DOI 10.1111/j.1540-6040.2007.00213.x; Cai G., 2002, QUALITATIVE SOCIOLOG, V25, P419, DOI DOI 10.1023/A:1016090131463; CAMPBELL RT, 1980, AM J SOCIOL, V86, P618, DOI 10.1086/227284; Chakravarty S. R., 2013, ECONOPHYSICS INCOME; Charles KK, 2003, J POLIT ECON, V111, P1155, DOI 10.1086/378526; Chatterjee A, 2007, EUR PHYS J B, V60, P135, DOI 10.1140/epjb/e2007-00343-8; Chi PSK, 1994, E W CHINAS GROWTH CH; Chow GC., 2015, CHINAS EC TRANSFORMA; Chua A, 2015, TRIPLE PACKAGE 3 UNL; Conley Dalton., 2008, WEALTH MOBILITY VOLA; Elder G.H., 1995, EXAMINING LIVES CONT, P101, DOI [DOI 10.1037/10176-003, 10.1037/10176-003]; Fan CC, 2003, CHINESE DIASPORA SPA; Feliciano C, 2006, UNEQUAL ORIGINS IMMI; Gold TB, 1987, STATE SOC TAIWAN MIR; Guthrie Doug, 1999, DRAGON 3 PIECE SUIT; HALLER AO, 1973, SOCIOL EDUC, V46, P51, DOI 10.2307/2112205; Haller W, 2011, SOC FORCES, V89, P733, DOI 10.1353/sof.2011.0003; Hansen MN, 2014, SOC FORCES, V93, P457, DOI 10.1093/sf/sou078; Hao L., 2007, COLOR LINES COUNTRY; Harbaugh R., 2004, C RIS CHIN REV PERC; Hirschl Thomas A., 2010, RACE SOCIAL PROBLEMS, V2, P125, DOI DOI 10.1007/S12552-010-9033-Z; Hoeffel EM., 2012, ASIAN POPULATION 201; Hooper K., 2015, CHINESE IMMIGRANTS U; Hsiao FST, 2015, EC DEV TAIWAN EARLY; Jimenez TR, 2010, REPLENISHED ETHNICITY: MEXICAN AMERICANS, IMMIGRATION, AND IDENTITY, P1; Kasinitz Philip, 2008, INHERITING CITY CHIL; Keister L.A, 2000, WEALTH AM TRENDWEA; Keister LA, 2014, SOC FORCES, V89, P763; Keister LA, 2005, GETTING RICH AM NEW; Keister LA, 2014, ANNU REV SOCIOL, V40, P347, DOI 10.1146/annurev-soc-070513-075314; KERCKHOFF AC, 1976, SOC FORCES, V55, P368, DOI 10.2307/2576228; Kesiter L., 2014, SOC CURR, V1, P13, DOI DOI 10.1177/2329496513510900; Khan SR, 2012, ANNU REV SOCIOL, V38, P361, DOI 10.1146/annurev-soc-071811-145542; Kim EM., 1999, 4 ASIAN TIGERS EC DE; Lan PC, 2002, J FAM ISSUES, V23, P812, DOI 10.1177/019251302236596; Lardy Nicholas R., 1998, CHINAS UNFINISHED EC; Lee J., 2015, ASIAN AM ACHIEVEMENT; LOPEZ DE, 2001, ETHNICITIES CHILDREN; MODIGLIANI F, 1986, AM ECON REV, V76, P297; Modigliani F, 2004, J ECON LIT, V42, P145, DOI 10.1257/002205104773558074; Mulligan CB, 1997, PARENTAL PRIOROTIES; Naughton B, 2006, CHINESE EC TRANSITIO; Naughton Barry, 1996, GROWING OUT PLAN CHI; ORAND AM, 1990, ANNU REV SOCIOL, V16, P241, DOI 10.1146/annurev.so.16.080190.001325; Orrenius P, 2012, INT MIGR REV, V46, P456, DOI 10.1111/j.1747-7379.2012.00893.x; Pareschi L., 2014, INTERACTING MULTIAGE; Park J, 2010, DEMOGRAPHY, V47, P369; Perlmann J., 2005, ITALIANS THEN MEXICA; Pew, 2012, RIS AS AM; PORTES A, 1993, ANN AM ACAD POLIT SS, V530, P74, DOI 10.1177/0002716293530001006; Rumbaut R.G., 2001, LEGACIES STORY IMMIG; Rumbaut RG, 2008, ANN AM ACAD POLIT SS, V620, P196, DOI 10.1177/0002716208322957; SORENSEN AB, 1979, AM J SOCIOL, V85, P361, DOI 10.1086/227014; Telles E.E., 2008, GENERATIONS EXCLUSIO; Treas J., 1995, POPULATION B, V50, P1; Vallejo Jody Agius, 2012, BARRIOS BURBS MAKING; Waldinger R, 2016, J ETHN MIGR STUD, V42, P23, DOI 10.1080/1369183X.2015.1113742; Walters NP, 2011, NEWLY ARRIVED FOREIG; Wang S, 2005, INT MIGRATION; Warren JR, 1997, AM SOCIOL REV, V62, P561, DOI 10.2307/2657426; Waters MC, 2010, ETHNIC RACIAL STUD, V33, P1168, DOI 10.1080/01419871003624076; Waters MC, 2005, ANNU REV SOCIOL, V31, P105, DOI 10.1146/annurev.soc.29.010202.100026; Wolff EN, 2010, REV EC I, V2, P53; Wong Janelle, 2011, ASIAN AM POLITICAL P; Xie Y, 2012, ASIAN AM DEMOGRAPHIC; Yang DT, 2013, NBER CONF R, P249; Yiu J, 2013, INT MIGR REV, V47, P573, DOI 10.1111/imre.12037; Zhao X., 2010, NEW CHINESE AM CLASS; Zhou M, 1997, ANNU REV SOCIOL, V23, P63, DOI 10.1146/annurev.soc.23.1.63; Zhou M, 2009, ASIAN AMER HIST CULT, P1; Zhou M., 2007, RETHINKING MIGRATION; Zhou M, 2008, AMERASIA J, V34, P55, DOI 10.17953/amer.34.3.y08124j33ut846v0; Zhou Min, 1992, CHINATOWN SOCIOECONO	81	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168043	10.1371/journal.pone.0168043	http://dx.doi.org/10.1371/journal.pone.0168043			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977737	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400051
J	Yang, N; Zou, DS; Yang, MY; Lin, ZG				Yang, Ning; Zou, Dongsheng; Yang, Manyuan; Lin, Zhonggui			Variations in Soil Microbial Biomass Carbon and Soil Dissolved Organic Carbon in the Re-Vegetation of Hilly Slopes with Purple Soil	PLOS ONE			English	Article							RESPIRATION; DYNAMICS	Crust restoration is increasingly being done but we lack quantitative information on soil improvements. The study aimed to elucidate the dynamics involving soil microbial biomass carbon and soil dissolved organic carbon in the re-vegetation chronosequences of a hillslope land with purple soil in Hengyang, Hunan Province. The soil can cause serious disasters with both soil erosion and seasonal drought, and also becomes a typical representative of ecological disaster area in South China. Using the space-for-time method, we selected six typical sampling plots, designated as follows: grassplot community, meadow thicket community, frutex community, frutex and arbor community, arbor community, and top-level vegetation community. These plots were established to analyze the changes in soil microbial biomass carbon, soil microbial quotien, dissolved organic carbon, dissolved organic carbon/soil organic carbon, and soil basal respiration in 0-10, 10-20, and 20-40 cm soil layers. The relationships of these parameters with soils physic-chemical properties were also determined. The ecological environment of the 6 plant communities is similar and typical; they denoted six different successive stages of restoration on hillslopes with purple soils in Hengyang, Hunan Province. The soil microbial biomass carbon and soil basal respiration contents decreased with increasing soil depth but increased with re-vegetation. By contrast, soil microbial quotient increased with increasing soil depth and re-vegetation. From 0-10 cm soil layer to 20-40 cm soil layer, the dissolved organic carbon content decreased in different re-vegetation stages. In the process of re-vegetation, the dissolved organic carbon content increased in the 0-10 and 10-20 cm soil layers, whereas the dissolved organic carbon content decreased after an initial increase in the 20-40 cm soil layers. Meanwhile, dissolved organic carbon/soil organic carbon increased with increasing soil depth but decreased with re-vegetation. Significant correlations existed among soil microbial biomass carbon, soil microbial quotient, dissolved organic carbon, soil basal respiration and soil physic-chemical properties associated with soil fertility. The results showed that re-vegetation was conducive to the soil quality improvement and the accumulation of soil organic carbon pool of the hillslope land with purple soil in Hengyang, Hunan Province.	[Yang, Ning; Yang, Manyuan; Lin, Zhonggui] Hunan Environm Biol Polytech Coll, Coll Landscape Architecture, Hengyang, Peoples R China; [Yang, Ning; Zou, Dongsheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China	Hunan Agricultural University	Zou, DS (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Hunan, Peoples R China.	cndongshengzou@126.com			Project of the Hunan Provincial Science and Technology Department [S2006N332]; Scientific Research Project of the Education Department of Hunan Province [16C0559]; Forestry Science and Technology Project of Hunan Province [XLK201341]; Agricultural Science and Technology Support Project of Hengyang City, Hunan Province [2014KN27]; Support Project for Young Teachers in Colleges and Universities of Hunan Province; Nanyue Scholar Fund Project of Hunan Vocational College of Environment and Biology	Project of the Hunan Provincial Science and Technology Department; Scientific Research Project of the Education Department of Hunan Province; Forestry Science and Technology Project of Hunan Province; Agricultural Science and Technology Support Project of Hengyang City, Hunan Province; Support Project for Young Teachers in Colleges and Universities of Hunan Province; Nanyue Scholar Fund Project of Hunan Vocational College of Environment and Biology	This work was financially supported by the Project of the Hunan Provincial Science and Technology Department (S2006N332), Scientific Research Project of the Education Department of Hunan Province (16C0559), Forestry Science and Technology Project of Hunan Province (XLK201341), Agricultural Science and Technology Support Project of Hengyang City, Hunan Province (2014KN27), Support Project for Young Teachers in Colleges and Universities of Hunan Province, and Nanyue Scholar Fund Project of Hunan Vocational College of Environment and Biology.; This work was financially supported by the Project of the Hunan Provincial Science and Technology Department (S2006N332), Scientific Research Project of the Education Department of Hunan Province (16C0559), Forestry Science and Technology Project of Hunan Province (XLK201341), Agricultural Science and Technology Support Project of Hengyang City, Hunan Province (2014KN27), Support Project for Young Teachers in Colleges and Universities of Hunan Province, and Nanyue Scholar Fund Project of Hunan Vocational College of Environment and Biology.	Bao S.D., 2000, AGROCHEMICAL ANAL SO, P22; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Gong C, 2011, J ECOL, V30, P1935; Harris JA, 2003, EUR J SOIL SCI, V54, P801, DOI 10.1046/j.1351-0754.2003.0559.x; Huang Zong-sheng, 2012, Yingyong Shengtai Xuebao, V23, P2715; Institute of Soil Science Chinese Academy of Sciences, 1985, RS METH SOIL MICR; Jiang P, 2005, FORESTRY SCI, V41, P10; Kalbitz K, 2000, SOIL SCI, V165, P277, DOI 10.1097/00010694-200004000-00001; Kent M., 2012, VEGETATION DESCRIPTI, V2nd ed.; Li L.-Q., 2007, CHINESE J ORG CHEM, V27, P519; Liu HS, 2006, APPL SOIL ECOL, V32, P284, DOI 10.1016/j.apsoil.2005.08.001; [刘爽 Liu Shuang], 2010, [生态学报, Acta Ecologica Sinica], V30, P3135; [刘占锋 Liu Zhanfeng], 2007, [生态学报, Acta Ecologica Sinica], V27, P1011; Lu R.Q., 2000, ANAL METHODS SOIL AG, P12; Montserrat G, 2006, APPL SOIL ECOL, V34, P52, DOI 10.1016/j.apsoil.2005.12.005; Rai A, 2016, ECOL ENG, V93, P76, DOI 10.1016/j.ecoleng.2016.05.014; Shao Y, 2002, NATURAL SCI EDITION, V33, P541; Singh AK, 2016, GEODERMA, V277, P41, DOI 10.1016/j.geoderma.2016.05.004; SINGH JS, 1989, NATURE, V338, P499, DOI 10.1038/338499a0; Thurman E. M., 1985, ORGANIC GEOCHEMISTRY; Traore S, 2007, APPL SOIL ECOL, V35, P660, DOI 10.1016/j.apsoil.2006.09.004; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wang QK, 2005, J FORESTRY RES, V16, P23, DOI DOI 10.1007/BF02856848; Wei Yuan, 2009, Research of Agricultural Modernization, V30, P487; [杨满元 Yang Manyuan], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P229; [杨宁 Yang Ning], 2013, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V19, P1516; [杨宁 Yang Ning], 2012, [农业现代化研究, Research of Agricultural Modernization], V33, P757; [易志刚 YI Zhigang], 2006, [生态环境, Ecology and Environment], V15, P611; Zhang Jiang-shan, 2005, Journal of Forestry Research (Harbin), V16, P205, DOI 10.1007/BF02856815; Zhao B, 2006, J ECOLOGICAL ENV, V22, P239; Zhou GM, 2006, PEDOSPHERE, V16, P525, DOI 10.1016/S1002-0160(06)60084-2	31	14	14	8	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0166536	10.1371/journal.pone.0166536	http://dx.doi.org/10.1371/journal.pone.0166536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977678	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400003
J	Choi, HY; Huh, KH; Lee, JG; Song, MK; Kim, MS; Kim, YS; Kim, BS				Choi, Hoon Young; Huh, Kyu Ha; Lee, Jae Geun; Song, Mi Kyung; Kim, Myoung Soo; Kim, Yu Seun; Kim, Beom Seok			Variability of the Estimated Glomerular Filtration Rate in the First Year after Kidney Transplantation Is an Independent Risk Factor for Poor Renal Allograft Outcomes: A Retrospective Cohort Study	PLOS ONE			English	Article							GRAFT-SURVIVAL; DISEASE; PROGRESSION; FAILURE; POSTTRANSPLANT; REJECTION; DEATH; EPIDEMIOLOGY; NEPHROPATHY; PREDICTOR	Renal function in the first year after kidney transplantation (KT) can predict long-term renal graft survival. This study investigated whether estimated glomerular filtration rate (eGFR) variability during the first year after KT is a risk factor for poor renal allograft outcomes. This retrospective cohort study included 3077 patients who underwent repeated eGFR measurements for 1 year after KT at Severance Hospital Transplantation Center between 1979 and 2012. The eGFR variability during the first year after KT was the predictor. The patients were divided into four quartile groups of eGFR variability according to the coefficient of variation for eGFR (eGFR-CV). We selected a cutoff of eGFR-CV for graft failure and performed the sensitivity analyses. The graft outcome was worse in the highest quartile group of eGFR variability than in the other groups among all patients (Q4: HR 1.631, 95% CI 1.278-2.081; p < 0.0001) and among patients without AR (Q4: HR 1.425, 95% CI 1.024-1.982; p = 0.0358) after adjusting for eGFR at 1 year after KT and other covariates. Additionally, all-cause mortality was higher in this highest quartile group than in the other groups among all patients but not among patients without AR. Higher eGFR-CVs than the cutoff were significantly associated with a high risk of graft failure among all patients (HR 1.670, 95% CI 1.395-2.000; p < 0.0001) and among patients without AR (HR 1.899, 95% CI 1.457-2.477; p < 0.0001) after fully adjusting for covariates. For all-cause mortality, a higher eGFR-CV was an independent risk factor among all patients but not among patients without AR after adjusting for covariates. eGFR variability in the first year after KT is an independent risk factor for poor renal allograft outcomes.	[Choi, Hoon Young; Kim, Beom Seok] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Huh, Kyu Ha; Lee, Jae Geun; Kim, Myoung Soo; Kim, Yu Seun] Yonsei Univ Hlth Syst, Severance Hosp, Dept Transplantat Surg, Seoul, South Korea; [Huh, Kyu Ha; Lee, Jae Geun; Kim, Myoung Soo; Kim, Yu Seun; Kim, Beom Seok] Yonsei Univ, Coll Med, Res Inst Transplantat, Seoul, South Korea; [Song, Mi Kyung] Yonsei Univ, Coll Med, Dept Biostat, Collaborat Unit, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, BS (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	docbsk@yuhs.ac		CHOI, HOON YOUNG/0000-0002-4245-0339; Huh, Kyu Ha/0000-0003-1364-6989; Lee, Jae Geun/0000-0002-6722-0257; Kim, Yu Seun/0000-0002-5105-1567; Kim, Beom Seok/0000-0002-5732-2583; Kim, Myoun Soo/0000-0002-8975-8381				Al-Aly Z, 2012, KIDNEY INT, V82, P1208, DOI 10.1038/ki.2012.276; Bestard O, 2010, CURR OPIN ORGAN TRAN, V15, P467, DOI 10.1097/MOT.0b013e32833b9ccb; Choi HY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002682; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; First MR, 2003, NEPHROL DIAL TRANSPL, V18, P3, DOI 10.1093/ndt/gfg1027; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hariharan S, 2002, KIDNEY INT, V62, P311, DOI 10.1046/j.1523-1755.2002.00424.x; Hartmann LC, 2007, INT J CANCER, V121, P938, DOI 10.1002/ijc.22811; Jevnikar AM, 2008, CLIN J AM SOC NEPHRO, V3, pS56, DOI 10.2215/CJN.03040707; Kasiske BL, 2011, AM J KIDNEY DIS, V57, P466, DOI 10.1053/j.ajkd.2010.10.054; Kasiske BL, 2005, AM J TRANSPLANT, V5, P1405, DOI 10.1111/j.1600-6143.2005.00853.x; Kasiske BL, 2001, AM J KIDNEY DIS, V38, P1065, DOI 10.1053/ajkd.2001.28605; Levey AS, 2014, AM J KIDNEY DIS, V63, P820, DOI 10.1053/j.ajkd.2013.12.006; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1996, AM J KIDNEY DIS, V27, P652, DOI 10.1016/S0272-6386(96)90099-2; Li C, 2009, NAT REV NEPHROL, V5, P513, DOI 10.1038/nrneph.2009.113; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Loupy A, 2015, J AM SOC NEPHROL, V26, P1721, DOI 10.1681/ASN.2014040399; Moreso F, 2006, AM J TRANSPLANT, V6, P747, DOI 10.1111/j.1600-6143.2005.01230.x; Naesens M, 2016, J AM SOC NEPHROL, V27, P281, DOI 10.1681/ASN.2015010062; Naesens M, 2014, TRANSPLANTATION, V98, P427, DOI 10.1097/TP.0000000000000183; Ojo AO, 2000, KIDNEY INT, V57, P307, DOI 10.1046/j.1523-1755.2000.00816.x; Perkins RM, 2012, KIDNEY INT, V82, P1332, DOI 10.1038/ki.2012.281; Salvadori M, 2003, TRANSPL P, V35, P2863, DOI 10.1016/j.transproceed.2003.10.070; Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c; Sellares J, 2012, AM J TRANSPLANT, V12, P388, DOI 10.1111/j.1600-6143.2011.03840.x; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Traitanon O, 2014, CURR OPIN NEPHROL HY, V23, P625, DOI 10.1097/MNH.0000000000000064; Tseng CL, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0025-5; Waden J, 2009, DIABETES, V58, P2649, DOI 10.2337/db09-0693; Wilflingseder J, 2015, NEPHROL DIAL TRANSPL, V30, P910, DOI 10.1093/ndt/gfu280; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421	32	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168337	10.1371/journal.pone.0168337	http://dx.doi.org/10.1371/journal.pone.0168337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973553	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300078
J	Dijkstra, AR; Alkema, W; Starrenburg, MJC; Hugenholtz, J; van Hijum, SAFT; Bron, PA				Dijkstra, Annereinou R.; Alkema, Wynand; Starrenburg, Marjo J. C.; Hugenholtz, Jeroen; van Hijum, Sacha A. F. T.; Bron, Peter A.			Strain-Dependent Transcriptome Signatures for Robustness in Lactococcus lactis	PLOS ONE			English	Article							ACID BACTERIA; GENE-EXPRESSION; RESPIRATION METABOLISM; STREPTOCOCCUS-LACTIS; OXIDATIVE STRESS; STARTER CULTURES; GROWTH-RATE; HEAT-SHOCK; SURVIVAL; FERMENTATION	Recently, we demonstrated that fermentation conditions have a strong impact on subsequent survival of Lactococcus lactis strain MG1363 during heat and oxidative stress, two important parameters during spray drying. Moreover, employment of a transcriptome- phenotype matching approach revealed groups of genes associated with robustness towards heat and/or oxidative stress. To investigate if other strains have similar or distinct transcriptome signatures for robustness, we applied an identical transcriptome-robustness phenotype matching approach on the L. lactis strains IL1403, KF147 and SK11, which have previously been demonstrated to display highly diverse robustness phenotypes. These strains were subjected to an identical fermentation regime as was performed earlier for strain MG1363 and consisted of twelve conditions, varying in the level of salt and/or oxygen, as well as fermentation temperature and pH. In the exponential phase of growth, cells were harvested for transcriptome analysis and assessment of heat and oxidative stress survival phenotypes. The variation in fermentation conditions resulted in differences in heat and oxidative stress survival of up to five 10-log units. Effects of the fermentation conditions on stress survival of the L. lactis strains were typically strain-dependent, although the fermentation conditions had mainly similar effects on the growth characteristics of the different strains. By association of the transcriptomes and robustness phenotypes highly strain-specific transcriptome signatures for robustness towards heat and oxidative stress were identified, indicating that multiple mechanisms exist to increase robustness and, as a consequence, robustness of each strain requires individual optimization. However, a relatively small overlap in the transcriptome responses of the strains was also identified and this generic transcriptome signature included genes previously associated with stress (ctsR and lplL) and novel genes, including nanE and genes encoding transport proteins. The transcript levels of these genes can function as indicators of robustness and could aid in selection of fermentation parameters, potentially resulting in more optimal robustness during spray drying.	[Dijkstra, Annereinou R.; Alkema, Wynand; van Hijum, Sacha A. F. T.; Bron, Peter A.] Kluyver Ctr Genom Ind Fermentat, Delft, Netherlands; [Dijkstra, Annereinou R.; Alkema, Wynand; Starrenburg, Marjo J. C.; van Hijum, Sacha A. F. T.; Bron, Peter A.] NIZO Food Res, Ede, Netherlands; [Dijkstra, Annereinou R.; Hugenholtz, Jeroen] Univ Amsterdam, Swammerdam Inst Life Sci, Sci Pk 904, Xh Amsterdam, Netherlands; [Alkema, Wynand; van Hijum, Sacha A. F. T.] Radboudumc, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [van Hijum, Sacha A. F. T.; Bron, Peter A.] TI Food & Nutr, Nieuwe Kanaal 9A, Pa Wageningen, Netherlands	NIZO Food Research; University of Amsterdam; Radboud University Nijmegen; Top Institute Food & Nutrition	Hugenholtz, J (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Sci Pk 904, Xh Amsterdam, Netherlands.	jeroen.hugenholtz@wur.nl	Alkema, Wynand/G-5826-2018; van Hijum, Sacha/F-6445-2014	Alkema, Wynand/0000-0002-5523-9217; van Hijum, Sacha/0000-0003-0741-2991	Kluyver centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO)	Kluyver centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO)	AD was funded by the Kluyver centre for Genomics of Industrial Fermentation which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSIT N, 1993, APPL ENVIRON MICROB, V59, P1893, DOI 10.1128/AEM.59.6.1893-1897.1993; Boyaval P, 1989, DAIRY SCI TECHNOL, V69, P87; Bron Peter A, 2011, Bioeng Bugs, V2, P80, DOI 10.4161/bbug.2.2.13910; CHOPIN A, 1984, PLASMID, V11, P260, DOI 10.1016/0147-619X(84)90033-7; Cretenet M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1054; Dijkstra AR, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0148-6; Dijkstra AR, 2014, APPL ENVIRON MICROB, V80, P603, DOI 10.1128/AEM.03434-13; Dressaire C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-343; Fernandez M, 2002, J BACTERIOL, V184, P82, DOI 10.1128/JB.184.1.82-90.2002; Frees D, 2003, INT J FOOD MICROBIOL, V87, P293, DOI 10.1016/S0168-1605(03)00104-1; GASSON MJ, 1983, J BACTERIOL, V154, P1; Gaudu P, 2003, MOL MICROBIOL, V50, P183, DOI 10.1046/j.1365-2958.2003.03700.x; Ghandi A, 2012, J FOOD ENG, V113, P194, DOI 10.1016/j.jfoodeng.2012.06.005; Kelly WJ, 1998, INT J FOOD MICROBIOL, V45, P85, DOI 10.1016/S0168-1605(98)00135-4; Kim WS, 1999, FEMS MICROBIOL LETT, V171, P57, DOI [10.1111/j.1574-6968.1999.tb13412.x, 10.1016/S0378-1097(98)00578-3]; Koch B, 1998, J BACTERIOL, V180, P3873, DOI 10.1128/JB.180.15.3873-3881.1998; Leroy F, 2004, TRENDS FOOD SCI TECH, V15, P67, DOI 10.1016/j.tifs.2003.09.004; Makarova K, 2006, P NATL ACAD SCI USA, V103, P15611, DOI 10.1073/pnas.0607117103; Mostertz J, 2004, MICROBIOL-SGM, V150, P497, DOI 10.1099/mic.0.26665-0; Nielsen AK, 2010, J MOL MICROB BIOTECH, V18, P162, DOI 10.1159/000315457; O'Connor K, 2009, P NATL ACAD SCI USA, V106, P17522, DOI 10.1073/pnas.0906160106; Pedersen MB, 2012, ANNU REV FOOD SCI T, V3, P37, DOI 10.1146/annurev-food-022811-101255; Peighambardoust SH, 2011, TRENDS FOOD SCI TECH, V22, P215, DOI 10.1016/j.tifs.2011.01.009; Rallu F, 1996, ANTON LEEUW INT J G, V70, P243, DOI 10.1007/BF00395935; Rezaiki L, 2004, MOL MICROBIOL, V53, P1331, DOI 10.1111/j.1365-2958.2004.04217.x; Santivarangkna C, 2008, J APPL MICROBIOL, V105, P1, DOI 10.1111/j.1365-2672.2008.03744.x; Sieuwerts S, 2008, LETT APPL MICROBIOL, V47, P275, DOI 10.1111/j.1472-765X.2008.02417.x; Siezen RJ, 2011, MICROB BIOTECHNOL, V4, P383, DOI 10.1111/j.1751-7915.2011.00247.x; Teuber M, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 4, THIRD EDITION, P205, DOI 10.1007/0-387-30744-3_7; van de Guchte M, 2002, ANTON LEEUW INT J G, V82, P187, DOI 10.1023/A:1020631532202; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; Varmanen P, 2000, MICROBIOL-UK, V146, P1447, DOI 10.1099/00221287-146-6-1447; Xie Y, 2004, APPL ENVIRON MICROB, V70, P6738, DOI 10.1128/AEM.70.11.6738-6747.2004; Zakrzewska A, 2011, MOL BIOL CELL, V22, P4435, DOI 10.1091/mbc.E10-08-0721	34	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167944	10.1371/journal.pone.0167944	http://dx.doi.org/10.1371/journal.pone.0167944			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973578	gold, Green Published, Green Submitted			2022-12-27	WOS:000392754300049
J	Neilands, PD; Jelbert, SA; Breen, AJ; Schiestl, M; Taylor, AH				Neilands, P. D.; Jelbert, S. A.; Breen, A. J.; Schiestl, M.; Taylor, A. H.			How Insightful Is 'Insight'? New Caledonian Crows Do Not Attend to Object Weight during Spontaneous Stone Dropping	PLOS ONE			English	Article							ANIMAL COGNITION; ET-AL.; TOOL; END; RAVENS; DEVIL; BIRDS	It is highly difficult to pinpoint what is going through an animal's mind when it appears to solve a problem by 'insight'. Here, we searched for an information processing error during the emergence of seemingly insightful stone dropping in New Caledonian crows. We presented these birds with the platform apparatus, where a heavy object needs to be dropped down a tube and onto a platform in order to trigger the release of food. Our results show New Caledonian crows exhibit a weight inattention error: they do not attend to the weight of an object when innovating stone dropping. This suggests that these crows do not use an understanding of force when solving the platform task in a seemingly insightful manner. Our findings showcase the power of the signature-testing approach, where experiments search for information processing biases, errors and limits, in order to make strong inferences about the functioning of animal minds.	[Neilands, P. D.; Taylor, A. H.] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Jelbert, S. A.] Univ Cambridge, Dept Psychol, Cambridge, England; [Breen, A. J.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Schiestl, M.] Max Planck Inst Sci Human Hist, Jena, Germany	University of Auckland; University of Cambridge; University of St Andrews	Neilands, PD (corresponding author), Univ Auckland, Sch Psychol, Auckland, New Zealand.	pnei460@aucklanduni.ac.nz	Taylor, Alex H/D-6428-2012	Breen, Alexis/0000-0002-2331-0920; Jelbert, Sarah/0000-0002-7503-0648	Rutherford Discovery Fellowship from the Royal Society of New Zealand; ERC	Rutherford Discovery Fellowship from the Royal Society of New Zealand(Royal Society of New Zealand); ERC(European Research Council (ERC)European Commission)	Work was funded by a Rutherford Discovery Fellowship from the Royal Society of New Zealand (AHT). SAJ would like to thank the ERC for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1956, LEARNING INSTINCT AN; Ash IK, 2006, PSYCHON B REV, V13, P66, DOI 10.3758/BF03193814; Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; Bogale BA, 2012, ANIM COGN, V15, P285, DOI 10.1007/s10071-011-0439-9; Boogert NJ, 2013, P NATL ACAD SCI USA, V110, pE273, DOI 10.1073/pnas.1219664110; Cuthill Innes C., 2006, P3; Dymond S, 2013, P NATL ACAD SCI USA, V110, pE336, DOI 10.1073/pnas.1218931110; Fleck JI, 2013, J COGN PSYCHOL, V25, P436, DOI 10.1080/20445911.2013.779248; Hanus D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019555; Haslam M, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0421; Heinrich B, 2005, ETHOLOGY, V111, P962, DOI 10.1111/j.1439-0310.2005.01133.x; Heinrich B., 2000, EVOLUTION COGNITION; Heyes C, 2012, PHILOS T R SOC B, V367, P2695, DOI 10.1098/rstb.2012.0217; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; Kacelnik A, 2009, P NATL ACAD SCI USA, V106, P10071, DOI 10.1073/pnas.0904735106; Kenward B, 2004, IBIS, V146, P652, DOI 10.1111/j.1474-919x.2004.00299.x; Kohler W., 1927, MENTALITY APES, V2nd ed.; Mendes N, 2007, BIOL LETTERS, V3, P453, DOI 10.1098/rsbl.2007.0198; Range F, 2008, ACTA ETHOL, V11, P34, DOI 10.1007/s10211-008-0039-0; Schuck-Paim C, 2009, ANIM COGN, V12, P287, DOI 10.1007/s10071-008-0190-z; Seed A, 2012, PHILOS T R SOC B, V367, P2743, DOI 10.1098/rstb.2012.0222; Seed A, 2010, CURR BIOL, V20, pR1032, DOI 10.1016/j.cub.2010.09.042; Seed AM, 2013, CURR BIOL, V23, pR67, DOI 10.1016/j.cub.2012.11.043; Shettleworth SJ, 2012, CAN J EXP PSYCHOL, V66, P217, DOI 10.1037/a0030674; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Shettleworth SJ, 2009, CURR BIOL, V19, pR1039, DOI 10.1016/j.cub.2009.10.022; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Taylor AH, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0796; Taylor AH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0837; Taylor AH, 2014, WIRES COGN SCI, V5, P361, DOI 10.1002/wcs.1286; Taylor AH, 2013, P NATL ACAD SCI USA, V110, pE337, DOI 10.1073/pnas.1219586110; Taylor AH, 2013, P NATL ACAD SCI USA, V110, pE274, DOI 10.1073/pnas.1220564110; Taylor AH, 2012, P ROY SOC B-BIOL SCI, V279, P4977, DOI 10.1098/rspb.2012.1998; Taylor AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009345; Taylor AH, 2009, CURR BIOL, V19, pR731, DOI 10.1016/j.cub.2009.07.055; Turing A.M., 1950, MIND, P433, DOI DOI 10.1093/MIND/LIX.236.433; von Bayern AMP, 2009, CURR BIOL, V19, P1965, DOI 10.1016/j.cub.2009.10.037; Weisberg RW, 2015, THINK REASONING, V21, P5, DOI 10.1080/13546783.2014.886625; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018	39	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167419	10.1371/journal.pone.0167419	http://dx.doi.org/10.1371/journal.pone.0167419			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973610	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300029
J	Spooner, L; Fernandes, K; Martins, D; Juurlink, D; Mamdani, M; Paterson, JM; Singh, S; Gomes, T				Spooner, Luke; Fernandes, Kimberly; Martins, Diana; Juurlink, David; Mamdani, Muhammad; Paterson, J. Michael; Singh, Samantha; Gomes, Tara			High-Dose Opioid Prescribing and Opioid-Related Hospitalization: A Population-Based Study	PLOS ONE			English	Article							CHRONIC NONCANCER PAIN; GUIDELINE; MORTALITY; THERAPY; FLORIDA; DEATHS	Aims To examine the impact of national clinical practice guidelines and provincial drug policy interventions on prevalence of high-dose opioid prescribing and rates of hospitalization for opioid toxicity. Design Interventional time-series analysis. Setting Ontario, Canada, from 2003 to 2014. Participants Ontario Drug Benefit (ODB) beneficiaries aged 15 to 64 years from 2003 to 2014. Interventions Publication of Canadian clinical practice guidelines for use of opioids in chronic non-cancer pain (May 2010) and implementation of Ontario's Narcotics Safety and Awareness Act (NSAA; November 2011). Measurements Three outcomes were explored: the rate of opioid use among ODB beneficiaries, the prevalence of opioid prescriptions exceeding 200 mg and 400 mg morphine equivalents per day, and rates of opioid-related emergency department visits and hospital admissions. Findings Over the 12 year study period, the rate of opioid use declined 15.2%, from 2764 to 2342 users per 10,000 ODB eligible persons. The rate of opioid use was significantly impacted by the Canadian clinical practice guidelines (p-value =.03) which led to a decline in use, but no impact was observed by the enactment of the NSAA (p-value =.43). Among opioid users, the prevalence of high-dose prescribing doubled (from 4.2% to 8.7%) over the study period. By 2014, 40.9% of recipients of long-acting opioids exceeded daily doses of 200 mg morphine or equivalent, including 55.8% of long-acting oxycodone users and 76.3% of transdermal fentanyl users. Moreover, in the last period, 18.7% of long-acting opioid users exceeded daily doses of 400 mg morphine or equivalent. Rates of opioid-related emergency department visits and hospital admissions increased 55.0% over the study period from 9.0 to 14.0 per 10,000 ODB beneficiaries from 2003 to 2013. This rate was not significantly impacted by the Canadian clinical practice guidelines (p-value = .68) or enactment of the NSAA (p-value = .59). Conclusions Although the Canadian clinical practice guidelines for use of opioids in chronic non-cancer pain led to a decline in opioid prescribing rates among ODB beneficiaries these guidelines and subsequent Ontario legislation did not result in a significant change in rates of opioid-related hospitalizations. Given the prevalence of high dose opioid prescribing in this population, this suggests that improved strategies and programs for the safe prescribing of longacting opioids are needed.	[Spooner, Luke] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC, Canada; [Fernandes, Kimberly; Martins, Diana; Juurlink, David; Mamdani, Muhammad; Paterson, J. Michael; Singh, Samantha; Gomes, Tara] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Juurlink, David] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON, Canada; [Mamdani, Muhammad] St Michaels Hosp, Dept Med, Toronto, ON, Canada; [Mamdani, Muhammad; Paterson, J. Michael; Gomes, Tara] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Mamdani, Muhammad; Gomes, Tara] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Mamdani, Muhammad; Gomes, Tara] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Singh, Samantha] McMaster Univ, Dept Family Med, Hamilton, ON, Canada	University of British Columbia; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University	Gomes, T (corresponding author), Inst Clin Evaluat Sci, Toronto, ON, Canada.; Gomes, T (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.; Gomes, T (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada.; Gomes, T (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.	GomesT@smh.ca		Gomes, Tara/0000-0002-1468-1965	Ontario Ministry of Health and Long-Term Care (MOHLTC) Health System Research Fund; Institute for Clinical Evaluative Sciences (ICES) - MOHLTC; Ontario MOHLTC	Ontario Ministry of Health and Long-Term Care (MOHLTC) Health System Research Fund; Institute for Clinical Evaluative Sciences (ICES) - MOHLTC; Ontario MOHLTC(Ministry of Health and Long-Term Care, Ontario)	This study was supported by a grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC) Health System Research Fund. It also was supported by the Institute for Clinical Evaluative Sciences (ICES), an independent, non-profit research institute funded by an annual grant from the MOHLTC. The opinions, results, and conclusions reported in this article are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. Parts of this material are based on data and information compiled and provided by the Canadian Institute for Health Information (CIHI). However, the analyses, conclusions, opinions and statements expressed herein are those of the authors and not necessarily those of CIHI. The Ontario MOHLTC provided support in the form of a research grant for MM, DJ, TG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Ms. Fernandes had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Barbera L, 2012, J CLIN ONCOL, V30, P1095, DOI 10.1200/JCO.2011.37.3068; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Boscarino JA, 2011, J ADDICT DIS, V30, P185, DOI 10.1080/10550887.2011.581961; Boudreau D, 2009, PHARMACOEPIDEM DR S, V18, P1166, DOI 10.1002/pds.1833; Chou R, 2015, ANN INTERN MED, V162, P276, DOI 10.7326/M14-2559; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Clarke EA, 1991, IARC SCI PUBL, P246; Delcher C, 2015, DRUG ALCOHOL DEPEN, V150, P63, DOI 10.1016/j.drugalcdep.2015.02.010; Dowell D, 2016, JAMA-J AM MED ASSOC, V315, P1624, DOI 10.1001/jama.2016.1464; Franklin GM, 2012, AM J IND MED, V55, P325, DOI 10.1002/ajim.21998; Fulton-Kehoe D, 2013, AM J IND MED, V56, P1452, DOI 10.1002/ajim.22266; Gilmour Stuart, 2006, BMC Med Res Methodol, V6, P16, DOI 10.1186/1471-2288-6-16; Gomes T, 2013, JAMA INTERN MED, V173, P196, DOI 10.1001/2013.jamainternmed.733; Gomes Tara, 2011, Open Med, V5, pe13; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Kahan M, 2011, CAN FAM PHYSICIAN, V57, P1257; Kenan Kristen, 2012, Open Med, V6, pe41; National Opioid Use Guideline Group (NOUGG), 2010, CAN GUID SAT EFF US; Paone D, 2015, MMWR-MORBID MORTAL W, V64, P491; Saunders KW, 2010, J GEN INTERN MED, V25, P310, DOI 10.1007/s11606-009-1218-z; Surratt HL, 2014, PHARMACOEPIDEM DR S, V23, P314, DOI 10.1002/pds.3553	21	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167479	10.1371/journal.pone.0167479	http://dx.doi.org/10.1371/journal.pone.0167479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973601	Green Submitted, Green Published, gold			2022-12-27	WOS:000392754300031
J	Tsai, FF; Fan, SZ; Lin, YS; Huang, NE; Yeh, JR				Tsai, Feng-Fang; Fan, Shou-Zen; Lin, Yi-Shiuan; Huang, Norden E.; Yeh, Jia-Rong			Investigating Power Density and the Degree of Nonlinearity in Intrinsic Components of Anesthesia EEG by the Hilbert-Huang Transform: An Example Using Ketamine and Alfentanil	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; TIME-FREQUENCY ANALYSIS; GENERAL-ANESTHESIA; SERIES; SIGNAL; WAVES	Empirical mode decomposition (EMD) is an adaptive filter bank for processing nonlinear and non-stationary signals, such as electroencephalographic (EEG) signals. EMD works well to decompose a time series into a set of intrinsic mode functions with specific frequency bands. An IMF therefore represents an intrinsic component on its correspondingly intrinsic frequency band. The word of 'intrinsic' means the frequency is totally adaptive to the nature of a signal. In this study, power density and nonlinearity are two critical parameters for characterizing the amplitude and frequency modulations in IMFs. In this study, a nonlinearity level is quantified using degree of waveform distortion (DWD), which represents the characteristic of waveform distortion as an assessment of the intra-wave modulation of an IMF. In the application of anesthesia EEG analysis, the assessments of power density and DWD for a set of IMFs represent dynamic responses in EEG caused by two different anesthesia agents, Ketamine and Alfentanil, on different frequency bands. Ketamine causes the increase of power density and the decrease of nonlinearity on gamma-band neuronal oscillation, which cannot be found EEG responses of group B using Alfentanil. Both agents cause an increase of power density and a decrease of nonlinearity on beta-band neuronal oscillation accompany with a loss of consciousness. Moreover, anesthesia agents cause the decreases of power density and nonlinearity (i.e. DWD) for the low-frequency IMFs.	[Tsai, Feng-Fang; Fan, Shou-Zen; Lin, Yi-Shiuan] Natl Taiwan Univ Hosp, Dept Anesthesiol, Taipei, Taiwan; [Tsai, Feng-Fang; Fan, Shou-Zen] Natl Taiwan Univ, Coll Med, Dept Anesthesiol, Taipei, Taiwan; [Tsai, Feng-Fang] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Rey Inst Nonlinear Dynam Med, Boston, MA USA; [Huang, Norden E.; Yeh, Jia-Rong] Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Taoyuan, Taiwan; [Huang, Norden E.; Yeh, Jia-Rong] Natl Cent Univ, Res Ctr Adapt Data Anal, Taoyuan, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; National Central University; National Central University	Yeh, JR (corresponding author), Natl Cent Univ, Ctr Dynam Biomarkers & Translat Med, Taoyuan, Taiwan.; Yeh, JR (corresponding author), Natl Cent Univ, Res Ctr Adapt Data Anal, Taoyuan, Taiwan.	yehjr65@gmail.com		Fan, Shou-Zen/0000-0002-6849-8453	Ministry of Science and Technology (Taiwan, R.O. C) [MOST 103-2911-1-008-001]; Office of Naval Research [N62909-15-1-N128, 105-N3341]; National Taiwan University Hospital [105-N3341]	Ministry of Science and Technology (Taiwan, R.O. C)(Ministry of Science and Technology, Taiwan); Office of Naval Research(Office of Naval Research); National Taiwan University Hospital(National Taiwan University)	Authors wish to thank the support from Ministry of Science and Technology (Taiwan, R.O. C), Grant No MOST 103-2911-1-008-001, and Office of Naval Research, Grand No N62909-15-1-N128. In addition, authors appreciate the support from National Taiwan University Hospital with Grant No.105-N3341.Office of Naval Research, Grand No N62909-15-1-N128. In addition, authors appreciate the support from National Taiwan University Hospital with Grant No.105-N3341.; Authors wish to thank the support from Ministry of Science and Technology (Taiwan, R.O.C), Grant No MOST 103-2911-1-008-001, and Office of Naval Research, Grand No N62909-15-1-N128. In addition, authors appreciate the support from National Taiwan University Hospital with Grant No.105-N3341.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Blanco S, 1998, PHYS REV E, V57, P932, DOI 10.1103/PhysRevE.57.932; Deering R, 2005, INT CONF ACOUST SPEE, P485; FARGE M, 1992, ANNU REV FLUID MECH, V24, P395, DOI 10.1146/annurev.fl.24.010192.002143; Flandrin P, 2004, IEEE SIGNAL PROC LET, V11, P112, DOI 10.1109/LSP.2003.821662; Hazarika N, 1997, IEEE T SIGNAL PROCES, V45, P829, DOI 10.1109/78.564171; Huang NE, 1999, ANNU REV FLUID MECH, V31, P417, DOI 10.1146/annurev.fluid.31.1.417; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Huang NE, 2013, QUANTIFICATION NONLI; Huang NE, 2009, ADV DATA SCI ADAPT, V1, P177, DOI 10.1142/S1793536909000096; Huang YX, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/40010; Hudetz AG, 2012, BRAIN CONNECT, V2, P291, DOI 10.1089/brain.2012.0107; O'Connor MF, 2001, ANESTHESIOLOGY, V94, P520, DOI 10.1097/00000542-200103000-00025; Oweis RJ, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-38; Recart A, 2003, ANESTH ANALG, V97, P1667, DOI 10.1213/01.ANE.0000087041.63034.8C; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Tatum William O, 2014, Neurodiagn J, V54, P3; Tzallas AT, 2009, IEEE T INF TECHNOL B, V13, P703, DOI 10.1109/TITB.2009.2017939; Vakkuri A, 2004, ACTA ANAESTH SCAND, V48, P145, DOI 10.1111/j.0001-5172.2004.00323.x; Veltcheva A, 2016, OCEAN ENG, V115, P30, DOI 10.1016/j.oceaneng.2016.01.031; Wang YT, 2012, APPL MATH INFORM SCI, V6, P689; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047; Yeh JR, 2010, ADV DATA SCI ADAPT, V2, P135, DOI 10.1142/S1793536910000422	26	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168108	10.1371/journal.pone.0168108	http://dx.doi.org/10.1371/journal.pone.0168108			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973590	Green Submitted, Green Published, gold			2022-12-27	WOS:000392754300055
J	Nie, ZJ; Gu, RB; Du, FK; Shao, NL; Xu, P; Xu, GC				Nie, Zhi-Juan; Gu, Ruo-Bo; Du, Fu-Kuan; Shao, Nai-Lin; Xu, Pao; Xu, Gang-Chun			Monogonont Rotifer, Brachionus calyciflorus, Possesses Exceptionally Large, Fragmented Mitogenome	PLOS ONE			English	Article							MITOCHONDRIAL-DNA SEQUENCE; GENOME; RNA; GENES; PHYLOGENY	In contrast to the highly conserved mitogenomic structure and organisation in most animals (including rotifers), the two previously sequenced monogonont rotifer mitogenomes were fragmented into two chromosomes similar in size, each of which possessed one major noncoding region (mNCR) of about 4-5 Kbp. To further explore this phenomenon, we have sequenced and analysed the mitogenome of one of the most studied monogonont rotifers, Brachionus calyciflorus. It is also composed of two circular chromosomes, but the chromosome-I is extremely large (27 535 bp; 3 mNCRs), whereas the chromosome-II is relatively small (9 833 bp; 1 mNCR). With the total size of 37 368 bp, it is one of the largest metazoan mitogenomes ever reported. In comparison to other monogononts, gene distribution between the two chromosomes and gene order are different and the number of mNCRs is doubled. Atp8 was not found (common in rotifers), and Cytb was present in two copies (the first report in rotifers). A high number (99) of SNPs indicates fast evolution of the Cytb-1 copy. The four mNCRs (5.3-5.5 Kb) were relatively similar. Publication of this sequence shall contribute to the understanding of the evolutionary history of the unique mitogenomic organisation in this group of rotifers.	[Nie, Zhi-Juan; Gu, Ruo-Bo; Du, Fu-Kuan; Shao, Nai-Lin; Xu, Pao; Xu, Gang-Chun] Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Minist Agr, Key Lab Freshwater Fisheries & Germplasm Resource, Wuxi, Peoples R China	Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs	Xu, GC (corresponding author), Chinese Acad Fishery Sci, Freshwater Fisheries Res Ctr, Minist Agr, Key Lab Freshwater Fisheries & Germplasm Resource, Wuxi, Peoples R China.	xugc@ffrc.cn			Jiangsu Agriculture Science and Technology Innovation Fund [JASTIF] [CX(13)2039]; Three New Projects of Agricultural Aquaculture Program of Jiangsu Province [D2015-14]	Jiangsu Agriculture Science and Technology Innovation Fund [JASTIF]; Three New Projects of Agricultural Aquaculture Program of Jiangsu Province	This study was supported by the Jiangsu Agriculture Science and Technology Innovation Fund [JASTIF; grant no. CX(13)2039] and Three New Projects of Agricultural Aquaculture Program of Jiangsu Province (grant no. D2015-14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armstrong MR, 2000, GENETICS, V154, P181; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Breton S, 2014, TRENDS GENET, V30, P555, DOI 10.1016/j.tig.2014.09.002; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; Declerck SAJ, 2016, HYDROBIOLOGIA; Gilbert JJ, 2005, HYDROBIOLOGIA, V546, P257, DOI 10.1007/s10750-005-4205-3; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Hwang DS, 2014, MITOCHONDR DNA, V25, P29, DOI 10.3109/19401736.2013.775274; Judson OP, 1996, TRENDS ECOL EVOL, V11, pA41; Kitazaki K., 2010, Journal of Botany, V2010, P620137, DOI 10.1155/2010/620137; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lasek-Nesselquist E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043554; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Liu YG, 2013, COMP BIOCHEM PHYS D, V8, P72, DOI 10.1016/j.cbd.2012.12.003; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pont-Kingdon G, 2000, J MOL EVOL, V51, P404, DOI 10.1007/s002390010103; Rand DM, 2009, GENOME RES, V19, P700, DOI 10.1101/gr.091132.109; Sammler S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-35; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schuster G, 2009, PROG MOL BIOL TRANSL, V85, P393, DOI 10.1016/S0079-6603(08)00810-6; Segers H., 2002, FRESHWATER INVERTEBR, P106; Serra M, 1997, HYDROBIOLOGIA, V358, P63, DOI 10.1023/A:1003155617297; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Sielaff M, 2016, MOL PHYLOGENET EVOL, V96, P79, DOI 10.1016/j.ympev.2015.11.017; Smith DR, 2007, J MOL EVOL, V65, P380, DOI 10.1007/s00239-007-9016-x; Sorensen MV, 2006, MOL PHYLOGENET EVOL, V40, P585, DOI 10.1016/j.ympev.2006.04.001; Steinauer ML, 2005, J MOL EVOL, V60, P706, DOI 10.1007/s00239-004-0159-8; Stelzer CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012854; Suga K, 2008, MOL BIOL EVOL, V25, P1129, DOI 10.1093/molbev/msn058; Vasileiadou K, 2009, MAR BIOTECHNOL, V11, P53, DOI 10.1007/s10126-008-9119-4; Wallace RL, 2010, AQUAT ECOL-SAN DIEGO, P173, DOI 10.1016/B978-0-12-374855-3.00008-X; Watanabe KI, 1999, J MOL BIOL, V286, P645, DOI 10.1006/jmbi.1998.2523; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Wu ZQ, 2015, P NATL ACAD SCI USA, V112, P10185, DOI 10.1073/pnas.1421397112; Xiang XL, 2011, MOL PHYLOGENET EVOL, V59, P386, DOI 10.1016/j.ympev.2011.02.011	37	7	7	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168263	10.1371/journal.pone.0168263	http://dx.doi.org/10.1371/journal.pone.0168263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959933	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900052
J	Atkin, AJ; Foley, L; Corder, K; Ekelund, U; van Sluijs, EMF				Atkin, Andrew J.; Foley, Louise; Corder, Kirsten; Ekelund, Ulf; van Sluijs, Esther M. F.			Determinants of Three-Year Change in Children's Objectively Measured Sedentary Time	PLOS ONE			English	Article							PHYSICAL-ACTIVITY LEVELS; YOUNG-PEOPLE; FAMILY HOME; BEHAVIOR; INTERVENTIONS; ADOLESCENTS; HEALTH	Background Sedentary behaviours (SB) are highly prevalent in young people and may be adversely associated with physical and mental health. Understanding of the modifiable determinants of SB is necessary to inform the design of behaviour change interventions but much of the existing research is cross-sectional and focussed upon screen-based behaviours. Purpose To examine the social, psychological and environmental determinants of change in children's objectively measured sedentary time from age 11 to 14 years. Methods Data are from the second (2008) and third (2011) waves of assessment in the Sport, Physical Activity, and Eating Behaviour: Environmental Determinants in Young People (SPEEDY) study, conducted in the county of Norfolk, United Kingdom. Longitudinal data on accelerometer assessed sedentary time were available for 316 (53.5% female, 11.2 +/- 0.3 years at baseline) and 264 children after-school and at the weekend respectively. Information on 14 candidate determinants, including school travel mode and electronic media ownership, was self-reported. Change in the proportion of registered time spent sedentary was used as the outcome variable in cross-classified linear regression models, adjusted for age, sex, body mass index and baseline sedentary time. Simple and multiple models were run and interactions with sex explored. Results Daily sedentary time increased by 30-40 minutes after-school and at the weekend from baseline to follow-up. Participants who travelled to school by cycle exhibited smaller increases in after-school sedentary time (beta; 95%CI for change in% time spent sedentary: -3.3;-6.7,-0.07). No significant determinants of change in weekend sedentary time were identified. Conclusions Time spent sedentary increased during the three-year duration of follow-up but few of the variables examined were significantly associated with changes in sedentary time. Children's mode of school travel may influence changes in their sedentary time over this period and should be examined further, alongside broader efforts to identify modifiable determinants of SB during childhood.	[Atkin, Andrew J.; Foley, Louise; Corder, Kirsten; Ekelund, Ulf; van Sluijs, Esther M. F.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC Epidemiol Unit, Cambridge Biomed Campus, Cambridge, England; [Atkin, Andrew J.; Foley, Louise; Corder, Kirsten; Ekelund, Ulf; van Sluijs, Esther M. F.] Univ Cambridge, Sch Clin Med, Inst Metab Sci, UKCRC Ctr Diet & Act Res CEDAR, Cambridge Biomed Campus, Cambridge, England; [Ekelund, Ulf] Norwegian Sch Sports Sci, Dept Sports Med, Ulleval Stad, Oslo, Norway	University of Cambridge; University of Cambridge; Norwegian School of Sport Sciences; University of Oslo	Atkin, AJ (corresponding author), Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC Epidemiol Unit, Cambridge Biomed Campus, Cambridge, England.; Atkin, AJ (corresponding author), Univ Cambridge, Sch Clin Med, Inst Metab Sci, UKCRC Ctr Diet & Act Res CEDAR, Cambridge Biomed Campus, Cambridge, England.	aa595@medschl.cam.ac.uk	Ekelund, Ulf/AAE-8471-2019	Ekelund, Ulf/0000-0003-2115-9267; van Sluijs, Esther/0000-0001-9141-9082; Atkin, Andrew/0000-0002-3819-3448	Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration Public Health Research Centre of Excellence [RES-590-28-0002]; British Heart Foundation; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust, under the UK Clinical Research Collaboration; Medical Research Council (Unit Programme) [MC_UU_12015/7, MC_UU_12015/3, MC_UU_12015/4]; National Prevention Research Initiative; Cancer Research United Kingdom; Department of Health; Diabetes United Kingdom; Health and Social Care Research and Development Office for Northern Ireland; Chief Scientist Office; Scottish Government Health Directorates; Welsh Assembly Government; World Cancer Research Fund; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [G0501294, MR/K023187/1, MC_UP_1001/2, MC_UU_12015/6, MC_UU_12015/3, MC_UU_12015/7] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UU_12015/7, G0501294, MC_UU_12015/6, MC_UP_1001/2, MR/K023187/1, MC_UU_12015/3] Funding Source: UKRI	Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust, under the UK Clinical Research Collaboration(Wellcome Trust); Medical Research Council (Unit Programme)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Prevention Research Initiative(Diabetes UK); Cancer Research United Kingdom(Cancer Research UK); Department of Health; Diabetes United Kingdom(Diabetes UK); Health and Social Care Research and Development Office for Northern Ireland; Chief Scientist Office; Scottish Government Health Directorates; Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was supported by the Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration Public Health Research Centre of Excellence (RES-590-28-0002). Funding from the British Heart Foundation, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The SPEEDY study was funded by the Medical Research Council (Unit Programme number MC_UU_12015/7, MC_UU_12015/3, MC_UU_12015/4) and the National Prevention Research Initiative, consisting of the following funding partners: British Heart Foundation; Cancer Research United Kingdom; Department of Health; Diabetes United Kingdom; Economic and Social Research Council; Medical Research Council; Health and Social Care Research and Development Office for Northern Ireland; Chief Scientist Office, Scottish Government Health Directorates; Welsh Assembly Government; and World Cancer Research Fund.	[Anonymous], 2011, START ACT STAY ACT R; Atkin AJ, 2014, AM J PREV MED; Atkin AJ, 2016, PREV MED, V87, P167, DOI 10.1016/j.ypmed.2016.02.040; Atkin AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067627; Baranowski T, 1998, AM J PREV MED, V15, P266, DOI 10.1016/S0749-3797(98)00080-4; Basterfield L, 2011, PEDIATRICS, V127, pE24, DOI 10.1542/peds.2010-1935; Bibby P., 2004, DEV NEW CLASSIFICATI; Biddle SJH, 2014, BRIT J SPORT MED, V48, P182, DOI 10.1136/bjsports-2013-093078; Brug J, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0293-2; Chinapaw M, 2015, PREV MED, V70, P1, DOI 10.1016/j.ypmed.2014.10.029; Cooper AR, 2005, AM J PREV MED, V29, P179, DOI 10.1016/j.amepre.2005.05.009; Cooper AR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0274-5; Corder K, 2015, BRIT J SPORT MED, V49, P730, DOI 10.1136/bjsports-2013-093190; Corder K, 2010, PEDIATRICS, V126, pE926, DOI 10.1542/peds.2010-0048; Council on Communications and Media, 2011, Pediatrics, V128, P201, DOI 10.1542/peds.2011-1066; Craggs C, 2011, AM J PREV MED, V40, P645, DOI 10.1016/j.amepre.2011.02.025; Craig R, 2008, HLTH SURVEY ENGLAND, V1; Davison K. K., 2008, Preventing Chronic Disease, V5, pA100; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Fitzmaurice G, 2001, NUTRITION, V17, P360, DOI 10.1016/S0899-9007(00)00593-1; Forde C, 2015, GAMES HEALTH J, V4, P312, DOI 10.1089/g4h.2014.0135; Granich J, 2010, HEALTH EDUC RES, V25, P199, DOI 10.1093/her/cyn025; Griffiths LJ, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002893; Harding SK, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0204-6; Kaiser Family Foundation, 2010, GENERATION M2 MEDIA; Klitsie T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1092; Maitland C, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0157-1; Maitland C, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-99; Mitchell JA, 2014, AM J LIFESTYLE MED, V8, P173, DOI 10.1177/1559827613498700; Norman GJ, 2005, PEDIATRICS, V116, P908, DOI 10.1542/peds.2004-1814; Norman GJ, 2004, PSYCHOL HEALTH, V19, P561, DOI 10.1080/08870440410001722930; Pate RR, 2011, BRIT J SPORT MED, V45, P906, DOI 10.1136/bjsports-2011-090192; Ridgers ND, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-15; Sallis J.F., 2002, HLTH BEHAV HLTH ED T, V3rd ed., P462; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Stierlin AS, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0291-4; Straker LM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002629; Suchert V, 2015, PREV MED, V76, P48, DOI 10.1016/j.ypmed.2015.03.026; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P65, DOI 10.1139/H11-013; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Uijtdewilligen L, 2011, BRIT J SPORT MED, V45, P896, DOI 10.1136/bjsports-2011-090197; van Sluijs EMF, 2009, PREV MED, V48, P519, DOI 10.1016/j.ypmed.2009.03.002; van Sluijs EMF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-388	44	9	9	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167826	10.1371/journal.pone.0167826	http://dx.doi.org/10.1371/journal.pone.0167826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942036	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000392745600034
J	Bhagirath, D; Zhao, XS; Mirza, S; West, WW; Band, H; Band, V				Bhagirath, Divya; Zhao, Xiangshan; Mirza, Sameer; West, William W.; Band, Hamid; Band, Vimla			Mutant PIK3CA Induces EMT in a Cell Type Specific Manner	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; IDENTIFICATION; TRANSFORMATION; PHENOTYPES; DRIVERS; GROWTH; GENES	Breast cancer is characterized into different molecular subtypes, and each subtype is characterized by differential gene expression that are associated with distinct survival outcomes in patients. PIK3CA mutations are commonly associated with most breast cancer subtypes. More recently PIK3CA mutations have been shown to induce tumor heterogeneity and are associated with activation of EGFR-signaling and reduced relapse free survival in basal subtype of breast cancer. Thus, understanding what determines PIK3CA induced heterogeneity and oncogenesis, is an important area of investigation. In this study, we assessed the effect of mutant PIK3CA together with mutant Ras plus mutant p53 on oncogenic behavior of two distinct stem/progenitor breast cell lines, designated as K5+/K19- and K5+/K19+. Constructs were ectopically overexpressed in K5+/K19- and K5+/K19+ stem/progenitor cells, followed by various in-vitro and in-vivo analyses. Oncogene combination m-Ras/m-p53/m-PIK3CA efficiently transformed both K5+/K19- and K5+/K19+ cell lines in-vitro, as assessed by anchorage-independent soft agar colony formation assay. Significantly, while this oncogene combination induced a complete epithelial-to-mesenchymal transition (EMT) in K5+/K19- cell line, mostly epithelial phenotype with minor EMT component was seen in K5+/K19+ cell line. However, both K5+/K19- and K5+/K19+ transformed cells exhibited increased invasion and migration abilities. Analyses of CD44 and CD24 expression showed both cell lines had tumor-initiating CD44(+)/CD24(low) cell population, however transformed K5+/K19- cells had more proportion of these cells. Significantly, both cell types exhibited in-vivo tumorigenesis, and maintained their EMT and epithelial nature in-vivo in mice tumors. Notably, while both cell types exhibited increase in tumor-initiating cell population, differential EMT phenotype was observed in these cell lines. These results suggest that EMT is a cell type dependent phenomenon and does not dictate oncogenesis.	[Bhagirath, Divya; Zhao, Xiangshan; Mirza, Sameer; Band, Hamid; Band, Vimla] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [West, William W.; Band, Hamid] Univ Nebraska, Med Ctr, Coll Med, Pathol & Microbiol, Omaha, NE USA; [Band, Hamid] Univ Nebraska, Med Ctr, Eppley Inst Canc & Allied Dis, Omaha, NE USA; [West, William W.; Band, Hamid; Band, Vimla] Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Band, V (corresponding author), Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.; Band, V (corresponding author), Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	vband@unmc.edu	Band, Hamid/AAF-4701-2020; Bhagirath, Divya/X-1416-2019		NIH [CA116552, CA87986, CA105489, CA96844, CA144027]; Department of Defense [W81WH-11-1-0167, W81XWH-07-1-0351, W81XWH-11-1-0171]; NCI Cancer Center Support Grant [P30CA036727]; Susan Komen Foundation for breast cancer research; NATIONAL CANCER INSTITUTE [R01CA096844, P30CA036727, R01CA105489, R01CA116552, R01CA144027, R01CA087986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan Komen Foundation for breast cancer research(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH grants CA116552, CA87986 and CA105489 to HB, and CA96844 and CA144027 to VB; Department of Defense grants W81WH-11-1-0167 to HB, and W81XWH-07-1-0351 and W81XWH-11-1-0171 to VB. We acknowledge support to the UNMC Core Facility from the NCI Cancer Center Support Grant (P30CA036727) to Fred & Pamela Buffett Cancer Center and the Nebraska Research Initiative. SM received a postdoctoral fellowship from Susan Komen Foundation for breast cancer research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; Bhagirath D, 2015, ONCOTARGET, V6, P9018, DOI 10.18632/oncotarget.3379; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Johnson JPS, 2014, CANCER GENOM PROTEOM, V11, P115; Keller PJ, 2012, P NATL ACAD SCI USA, V109, P2772, DOI 10.1073/pnas.1017626108; Kiemer AK, 2001, ONCOGENE, V20, P6679, DOI 10.1038/sj.onc.1204872; Kim H, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-51; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martin YD, 2015, CELL REP, V13, P2456, DOI 10.1016/j.celrep.2015.11.025; Melchor L, 2014, J PATHOL, V233, P124, DOI 10.1002/path.4345; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Soundararajan R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11766; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Van Keymeulen A, 2015, NATURE, V525, P119, DOI 10.1038/nature14665; Wang GM, 2013, CANCER RES, V73, P3248, DOI 10.1158/0008-5472.CAN-12-1578; Young CD, 2015, MOL CELL PROTEOMICS, V14, P1959, DOI 10.1074/mcp.M115.049783; Zhao X, PLOS ONE, V7, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE.]; Zhao XS, 2012, BREAST CANCER RES TR, V134, P171, DOI 10.1007/s10549-011-1946-8; Zhao Xiangshan, 2011, J Carcinog, V10, P39, DOI 10.4103/1477-3163.91415; Zhao XS, 2010, P NATL ACAD SCI USA, V107, P14146, DOI 10.1073/pnas.1009030107	30	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167064	10.1371/journal.pone.0167064	http://dx.doi.org/10.1371/journal.pone.0167064			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941987	Green Published, Green Submitted, gold			2022-12-27	WOS:000392745600008
J	Gaucher, JF; Reille-Seroussi, M; Gagey-Eilstein, N; Broussy, S; Coric, P; Seijo, B; Lascombe, MB; Gautier, B; Liu, WQ; Huguenot, F; Inguimbert, N; Bouaziz, S; Vidal, M; Broutin, I				Gaucher, Jean-Francois; Reille-Seroussi, Marie; Gagey-Eilstein, Nathalie; Broussy, Sylvain; Coric, Pascale; Seijo, Bili; Lascombe, Marie-Bernard; Gautier, Benoit; Liu, Wang-Quing; Huguenot, Florent; Inguimbert, Nicolas; Bouaziz, Serge; Vidal, Michel; Broutin, Isabelle			Biophysical Studies of the Induced Dimerization of Human VEGF Receptor 1 Binding Domain by Divalent Metals Competing with VEGF-A	PLOS ONE			English	Article							GROWTH-FACTOR BINDING; PEPTIDE ANTAGONIST; CRYSTAL-STRUCTURE; TRACE-ELEMENTS; COPPER; ANGIOGENESIS; PROTEINS; MODEL; COORDINATION; SCATTERING	Angiogenesis is tightly regulated through the binding of vascular endothelial growth factors (VEGFs) to their receptors (VEGFRs). In this context, we showed that human VEGFR1 domain 2 crystallizes in the presence of Zn2+, Co2+ or Cu2+ as a dimer that forms via metalion interactions and interlocked hydrophobic surfaces. SAXS, NMR and size exclusion chromatography analyses confirm the formation of this dimer in solution in the presence of Co2+, Cd2+ or Cu2+. Since the metal-induced dimerization masks the VEGFs binding surface, we investigated the ability of metal ions to displace the VEGF-A binding to hVEGFR1: using a competition assay, we evidenced that the metals displaced the VEGF-A binding to hVEGFR1 extracellular domain binding at micromolar level.	[Gaucher, Jean-Francois; Coric, Pascale; Seijo, Bili; Lascombe, Marie-Bernard; Bouaziz, Serge; Broutin, Isabelle] Univ Paris 05, Fac Pharm, Sorbonne Paris Cite, CNRS,UMR 8015, Paris, France; [Reille-Seroussi, Marie; Gagey-Eilstein, Nathalie; Broussy, Sylvain; Gautier, Benoit; Liu, Wang-Quing; Huguenot, Florent; Vidal, Michel] Univ Paris 05, Fac Pharm, Sorbonne Paris Cite, CNRS,UMR 8638, Paris, France; [Inguimbert, Nicolas] Univ Perpignan, CNRS, USR 3278, Ctr Rech Insulaire & Observ Environm,CRIOBE, Via Domitia, Perpignan, France; [Vidal, Michel] Hop Cochin, AP HP, UF Pharmacocinet & Pharmacochim, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Perpignan Via Domitia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Gaucher, JF (corresponding author), Univ Paris 05, Fac Pharm, Sorbonne Paris Cite, CNRS,UMR 8015, Paris, France.	jean-francois.gaucher@parisdescartes.fr	Inguimbert, Nicolas/N-3703-2015; Bouaziz, Serge/ABA-8712-2020; bouaziz, serge/C-1401-2014; Broussy, Sylvain/AAX-1833-2020; Broutin, Isabelle/A-2003-2017; Vidal, Michel/ABA-3396-2020; LIU, Wang-Qing/V-5422-2017	Inguimbert, Nicolas/0000-0002-0309-9048; Bouaziz, Serge/0000-0001-7792-8307; Broussy, Sylvain/0000-0003-3098-5317; CORIC, Pascale/0000-0001-8484-1381; Broutin, isabelle/0000-0001-9862-1232; Reille-Seroussi, Marie/0000-0002-4136-1297; Vidal, Michel/0000-0002-4858-1591; LIU, Wang-Qing/0000-0003-0511-3058; Gautier, Benoit/0000-0002-8249-2525; huguenot, florent/0000-0001-8400-0857	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by: 1- Centre National de la Recherche Scientifique (CNRS), http://www.cnrs.fr: JFG MRS NGE SBr PC BS MBL BG WQL FH NI SBo MV IB. The CNRS had no role in study design, data collection and analysis,	Ahmadova Z, 2014, ANTICANCER RES, V34, P2123; Ascone I, 2006, P 13 INT C XRAY ABS, DOI [10.1093/nar/gkq535PMID:20542909, DOI 10.1093/NAR/GKQ535]; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Boyaud F, 2013, ORG LETT, V15, P3898, DOI 10.1021/ol401645m; Brozzo MS, 2012, BLOOD, V119, P1781, DOI 10.1182/blood-2011-11-390922; Buckley WT, 2008, BIOMETALS, V21, P601, DOI 10.1007/s10534-008-9146-7; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Cudmore MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1977; Czisch M, 1998, J MAGN RESON, V134, P158, DOI 10.1006/jmre.1998.1483; D'Andrea LD, 2010, DALTON T, V39, P7625, DOI 10.1039/c002439b; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; DISALVO J, 1995, J BIOL CHEM, V270, P7717, DOI 10.1074/jbc.270.13.7717; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairbrother WJ, 1998, BIOCHEMISTRY-US, V37, P17754, DOI 10.1021/bi981931e; Fedorova A, 2011, CHEM BIOL, V18, P839, DOI 10.1016/j.chembiol.2011.05.011; Feillet-Coudray C, 2005, AM J CLIN NUTR, V82, P103, DOI 10.1093/ajcn/82.1.103; Finney L, 2009, CLIN EXP PHARMACOL P, V36, P88, DOI 10.1111/j.1440-1681.2008.04969.x; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gautier B, 2011, CHEM BIOL, V18, P1631, DOI 10.1016/j.chembiol.2011.10.016; Goncalves V, 2008, J PEPT SCI, V14, P767, DOI 10.1002/psc.965; Goncalves V, 2007, ANAL BIOCHEM, V366, P108, DOI 10.1016/j.ab.2007.03.027; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hemmingsen L, 2004, J BIOL INORG CHEM, V9, P591, DOI 10.1007/s00775-004-0553-0; Huang K, 2001, INT J BIOCHEM CELL B, V33, P315, DOI 10.1016/S1357-2725(01)00019-X; Iyer S, 2010, J BIOL CHEM, V285, P23779, DOI 10.1074/jbc.M110.130658; Janek T, 2016, COLLOID SURFACE B, V146, P498, DOI 10.1016/j.colsurfb.2016.06.055; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kay Alan R, 2004, BMC Physiol, V4, P4, DOI 10.1186/1472-6793-4-4; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kenrick SA, 2010, PROTEIN ENG DES SEL, V23, P9, DOI 10.1093/protein/gzp065; Kleckner IR, 2011, BBA-PROTEINS PROTEOM, V1814, P942, DOI 10.1016/j.bbapap.2010.10.012; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Li QF, 2014, J NUTR BIOCHEM, V25, P44, DOI 10.1016/j.jnutbio.2013.08.013; Li S, 2012, EXP BIOL MED, V237, P77, DOI 10.1258/ebm.2011.011267; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Mac Gabhann F, 2007, BIOPHYS CHEM, V128, P125, DOI 10.1016/j.bpc.2007.03.010; Malgieri G, 2011, BIOPOLYMERS, V95, P801, DOI 10.1002/bip.21680; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris LA, 2002, J CHEM SOC PERK T 2, P1072, DOI 10.1039/b201823n; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Pan B, 2002, J MOL BIOL, V316, P769, DOI 10.1006/jmbi.2001.5370; Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Qin ZY, 2011, METALLOMICS, V3, P28, DOI 10.1039/c0mt00048e; Rahimi N, 2000, J BIOL CHEM, V275, P16986, DOI 10.1074/jbc.M000528200; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Reille-Seroussi M, 2015, BIOCHEMISTRY-US, V54, P5147, DOI 10.1021/acs.biochem.5b00722; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rukgauer M, 1997, J TRACE ELEM MED BIO, V11, P92; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Saghiri MA, 2015, CRIT REV ONCOL HEMAT, V96, P143, DOI 10.1016/j.critrevonc.2015.05.011; Shoshan MS, 2013, INORG CHEM, V52, P2993, DOI 10.1021/ic302404w; Starovasnik MA, 1999, J MOL BIOL, V293, P531, DOI 10.1006/jmbi.1999.3134; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Tsai YCI, 2016, FEBS J, V283, P1921, DOI 10.1111/febs.13711; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Zheng LL, 2015, PHARMACOL THERAPEUT, V148, P66, DOI 10.1016/j.pharmthera.2014.11.014; Zhou Y, 2009, CARDIOVASC RES, V84, P54, DOI 10.1093/cvr/cvp178; Zilberberg L, 2003, J BIOL CHEM, V278, P35564, DOI 10.1074/jbc.M304435200	74	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167755	10.1371/journal.pone.0167755	http://dx.doi.org/10.1371/journal.pone.0167755			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942001	Green Published, Green Submitted, gold			2022-12-27	WOS:000392745600030
J	Huang, JJ; Gardenier, JC; Hespe, GE; Nores, GDG; Kataru, RP; Ly, CL; Martinez-Corral, I; Ortega, S; Mehrara, BJ				Huang, Jung-Ju; Gardenier, Jason C.; Hespe, Geoffrey E.; Nores, Gabriela D. Garcia; Kataru, Raghu P.; Ly, Catherine L.; Martinez-Corral, Ines; Ortega, Sagrario; Mehrara, Babak J.			Lymph Node Transplantation Decreases Swelling and Restores Immune Responses in a Transgenic Model of Lymphedema	PLOS ONE			English	Article							POSTMASTECTOMY LYMPHEDEMA; REGENERATION; DIFFERENTIATION; ADIPOGENESIS; RESTORATION; EXPRESSION; IMPROVES; FLAP	Introduction Secondary lymphedema is a common complication of cancer treatment and recent studies have demonstrated that lymph node transplantation (LNT) can decrease swelling, as well as the incidence of infections. However, although these results are exciting, the mechanisms by which LNT improves these pathologic findings of lymphedema remain unknown. Using a transgenic mouse model of lymphedema, this study sought to analyze the effect of LNT on lymphatic regeneration and T cell-mediated immune responses. Methods We used a mouse model in which the expression of the human diphtheria toxin receptor is driven by the FLT4 promoter to enable the local ablation of the lymphatic system through subdermal hindlimb diphtheria toxin injections. Popliteal lymph node dissection was subsequently performed after a two-week recovery period, followed by either orthotopic LNT or sham surgery after an additional two weeks. Hindlimb swelling, lymphatic vessel regeneration, immune cell trafficking, and T cell-mediated immune responses were analyzed 10 weeks later. Results LNT resulted in a marked decrease in hindlimb swelling, fibroadipose tissue deposition, and decreased accumulation of perilymphatic inflammatory cells, as compared to controls. In addition, LNT induced a marked lymphangiogenic response in both capillary and collecting lymphatic vessels. Interestingly, the resultant regenerated lymphatics were abnormal in appearance on lymphangiography, but LNT also led to a notable increase in dendritic cell trafficking from the periphery to the inguinal lymph nodes and improved adaptive immune responses. Conclusions LNT decreases pathological changes of lymphedema and was shown to potently induce lymphangiogenesis. Lymphatic vessels induced by LNT were abnormal in appearance, but were functional and able to transport antigen-presenting cells. Animals treated with LNT have an increased ability to mount T cell-mediated immune responses when sensitized to antigens in the affected hindlimb.	[Huang, Jung-Ju; Gardenier, Jason C.; Hespe, Geoffrey E.; Nores, Gabriela D. Garcia; Kataru, Raghu P.; Ly, Catherine L.; Mehrara, Babak J.] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, 1275 York Ave, New York, NY 10021 USA; [Huang, Jung-Ju] Chang Gung Univ, Chang Gung Mem Hosp, Div Reconstruct Microsurg, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan; [Martinez-Corral, Ines] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Ortega, Sagrario] Spanish Natl Canc Res Ctr, Transgen Mice Unit, Biotechol Programme, Madrid, Spain	Memorial Sloan Kettering Cancer Center; Chang Gung Memorial Hospital; Chang Gung University; Uppsala University; Centro Nacional de Investigaciones Oncologicas (CNIO)	Mehrara, BJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Div Plast & Reconstruct Surg, 1275 York Ave, New York, NY 10021 USA.	mehrarab@mskcc.org	Martinez-Corral, Ines/F-1799-2016; Kataru, Raghu P/AAB-9990-2022	Martinez-Corral, Ines/0000-0001-9194-2412; Kataru, Raghu/0000-0003-1315-7982; Huang, Jung-ju/0000-0001-9568-7834	National Institutes of Health [R01 HL111130-01, R21-CA194882, T32 CA9501-27, T32 CA9501-29]; Plastic Surgery Foundation [312436]; Plastic Surgery Foundation/American Society for Reconstructive Microsurgery [350627]; Ministry of Science and Innovation of Spain [BIO2009-09488]; National Institutes of Health/National Cancer Institute Cancer Center [P30 CA008748]; Molecular Cytology Core at Memorial Sloan Kettering Cancer Center [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748, T32CA009501, R21CA194882] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Plastic Surgery Foundation; Plastic Surgery Foundation/American Society for Reconstructive Microsurgery; Ministry of Science and Innovation of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Institutes of Health/National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Molecular Cytology Core at Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health R01 HL111130-01 and R21-CA194882 (http://grants.nih.gov/grants/oer.htm) awarded to B.J.M.; Plastic Surgery Foundation Pilot Grant 312436 and Research Fellowship Grant 312436 (http://www.thepsf.org/research/psf-grant-funding.htm) to J.C.G.; Plastic Surgery Foundation/American Society for Reconstructive Microsurgery Combined Research Grant 350627 (http://www.thepsf.org/research/psf-grant-funding.htm) and National Institutes of Health T32 CA9501-27 grant (https://grants.nih.gov/grants/oer.htm) to G.D.G.N.; National Institutes of Health T32 CA9501-29 grant (https://grants.nih.gov/grants/oer.htm) to C.L.L.; Ministry of Science and Innovation of Spain Grant BIO2009-09488 to S.O.; and National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30 CA008748. The funders had no role in study design, data collection and analysis, design to publish, or preparation of the manuscript.; The authors are grateful to Mesruh Turkekul, Sho Fujisawa, and Yevgeniy Romin of the Molecular Cytology Core at Memorial Sloan Kettering Cancer Center for assistance with both histology and tissue imaging (Core Grant P30 CA008748).	Ahmed RL, 2008, J CLIN ONCOL, V26, P5689, DOI 10.1200/JCO.2008.16.4731; [Anonymous], 1997, COMPOSITE GRAFTS; Aschen S, 2012, PLAST RECONSTR SURG, V129, P838, DOI 10.1097/PRS.0b013e3182450b47; Aschen SZ, 2014, PLAST RECONSTR SURG, V133, P301, DOI 10.1097/01.prs.0000436840.69752.7e; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Baker A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2638; Becker C, 2006, ANN SURG, V243, P313, DOI 10.1097/01.sla.0000201258.10304.16; Becker C, 2015, J RECONSTRUCTIVE MIC; Becker C, 2012, CLIN PLAST SURG, V39, P385, DOI 10.1016/j.cps.2012.08.002; Blum KS, 2010, BREAST CANCER RES TR, V120, P59, DOI 10.1007/s10549-009-0367-4; Blum KS, 2013, BREAST CANCER RES TR, V139, P81, DOI 10.1007/s10549-013-2537-7; Carlson JA, 2014, CLIN DERMATOL, V32, P599, DOI 10.1016/j.clindermatol.2014.04.007; Chang DW, 2016, PLAST RECONSTR SURG, V138, p209S, DOI 10.1097/PRS.0000000000002683; CHEN HC, 1990, BRIT J PLAST SURG, V43, P578, DOI 10.1016/0007-1226(90)90123-H; Cheng MH, 2013, PLAST RECONSTR SURG, V131, P1286, DOI 10.1097/PRS.0b013e31828bd3b3; Cheng MH, 2012, GYNECOL ONCOL, V126, P93, DOI 10.1016/j.ygyno.2012.04.017; Cornelissen AJ, 2016, J SURG ONCOL; Davies-Venn CA, 2012, MOL IMAGING BIOL, V14, P301, DOI 10.1007/s11307-011-0499-x; Forster R, 2012, TRENDS IMMUNOL, V33, P271, DOI 10.1016/j.it.2012.02.007; Gardenier JC, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.84095; Gharb BB, 2011, ANN PLAS SURG, V67, P589, DOI 10.1097/SAP.0b013e3181f88e8a; Hadamitzky C, 2009, J VASC RES, V46, P389, DOI 10.1159/000194269; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; Joseph WJ, 2014, PLAST RECONSTR SURG, V134, P60, DOI 10.1097/PRS.0000000000000286; Kataru RP, 2011, IMMUNITY, V34, P96, DOI 10.1016/j.immuni.2010.12.016; Kurt H, 2016, MODERN PATHOL, V29, P75, DOI 10.1038/modpathol.2015.135; Lahteenvuo M, 2011, CIRCULATION, V123, P613, DOI 10.1161/CIRCULATIONAHA.110.965384; Lin CH, 2009, PLAST RECONSTR SURG, V123, P1265, DOI 10.1097/PRS.0b013e31819e6529; Martin-Romero C, 2000, CELL IMMUNOL, V199, P15, DOI 10.1006/cimm.1999.1594; Mihara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032234; Nettles MK, 2016, INT J RADIAT ONCOL, V96, pE507, DOI 10.1016/j.ijrobp.2016.06.1899; Nores GDG, 2016, INT J OBESITY, V40, P1582, DOI 10.1038/ijo.2016.96; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Petrek JA, 2001, CANCER, V92, P1368, DOI 10.1002/1097-0142(20010915)92:6<1368::AID-CNCR1459>3.0.CO;2-9; Robinson HA, 2013, JOVE-J VIS EXP, DOI 10.3791/4326; Saaristo AM, 2012, ANN SURG, V255, P468, DOI 10.1097/SLA.0b013e3182426757; Savetsky IL, 2015, J INVEST DERMATOL, V135, P2742, DOI 10.1038/jid.2015.283; Sharkey AR, 2016, MICROSURGERY; SHESOL BF, 1979, PLAST RECONSTR SURG, V63, P817, DOI 10.1097/00006534-197963060-00007; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Thomas SN, 2012, J IMMUNOL, V189, P2181, DOI 10.4049/jimmunol.1103545; Tobbia D, 2009, PLAST RECONSTR SURG, V124, P777, DOI 10.1097/PRS.0b013e3181b03787; Torrisi JS, 2015, LYMPHAT RES BIOL, V13, P46, DOI 10.1089/lrb.2014.0022; Vignes S, 2013, EUR J VASC ENDOVASC, V45, P516, DOI 10.1016/j.ejvs.2012.11.026; Zampell JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049940; Zampell JC, 2012, PLAST RECONSTR SURG, V129, P825, DOI 10.1097/PRS.0b013e3182450b2d; Zampell JC, 2012, AM J PHYSIOL-CELL PH, V302, pC392, DOI 10.1152/ajpcell.00306.2011	47	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168259	10.1371/journal.pone.0168259	http://dx.doi.org/10.1371/journal.pone.0168259			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942023	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600059
J	Chiu, TF; Chuang, YW; Lin, CL; Yu, TM; Chung, MC; Li, CY; Chung, CJ; Ho, WC				Chiu, Ting-Fang; Chuang, Ya-Wen; Lin, Cheng-Li; Yu, Tung-Min; Chung, Mu-Chi; Li, Chi-Yuan; Chung, Chi-Jung; Ho, Wen-Chao			Long-Term Outcomes of Systemic Lupus Erythematous Patients after Pregnancy: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							RENAL-DISEASE; NEPHRITIS	Background Data on long-term maternal outcomes in patients with systemic lupus erythematosus (SLE) are lacking. The study aimed to explore the relationships among SLE, pregnancy, outcomes of end-stage renal disease (ESRD), and overall mortality. Methods We established a retrospective cohort study consisting of four cohorts: pregnant (case cohort) and nonpregnant SLE patients, as well as pregnant and nonpregnant non-SLE patients. One case cohort and three comparison cohorts were matched by age at first pregnancy and index date of pregnancy by using the Taiwan National Health Insurance Research Dataset. All study subjects were selected based on the index date to the occurrence of ESRD or overall death. Cox proportional hazard regression models and Kaplan-Meier curves were used in the analysis. Results SLE pregnant patients exhibited significantly increased risk of ESRD after adjusting for other important confounders, including immunosuppressant and parity (HR = 3.19, 95% CI: 1.35-7.52 for pregnant non-SLE; and HR = 2.77, 95% CI: 1.24-6.15 for nonpregnant non-SLE patients). No significant differences in ESRD incidence were observed in pregnant and nonpregnant SLE patients. Pregnant SLE patients exhibited better clinical condition at the baseline and a significantly lower risk of overall mortality than nonpregnant SLE patients. Conclusions Our data support current recommendations for SLE patients to avoid pregnancy until disease activity is quiescent. Multicenter recruitment and clinical information can be used to further examine the association of SLE and ESRD (or mortality) after pregnancy.	[Chiu, Ting-Fang] Taipei City Hosp, Dept Pediat, Zhongxiao Branch, Taipei, Taiwan; [Chuang, Ya-Wen; Yu, Tung-Min; Chung, Mu-Chi] Taichung Vet Gen Hosp, Div Nephrol, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ & Hosp, Coll Med, Dept Med, Taichung, Taiwan; [Li, Chi-Yuan] China Med Univ Hosp, Dept Anesthesiol, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ, Coll Publ Hlth, Dept Hlth Risk Management, Taichung, Taiwan; [Chung, Chi-Jung] China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Ho, Wen-Chao] China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan	Taipei City Hospital; Taichung Veterans General Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Ho, WC (corresponding author), China Med Univ, Coll Publ Hlth, Dept Publ Hlth, Taichung, Taiwan.	wcho@mail.cmu.edu.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW104-TDU-B-212-113002]; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project [BM104010092]; NRPB (The National Radiological Protection Board) Stroke Clinical Trial Consortium [MOST 103-2325-B-039-006]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project; NRPB (The National Radiological Protection Board) Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW104-TDU-B-212-113002), China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM104010092), NRPB (The National Radiological Protection Board) Stroke Clinical Trial Consortium (MOST 103-2325-B-039-006), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal Surabhi, 2009, Curr Rheumatol Rep, V11, P241; Aluvihare VR, 2004, NAT IMMUNOL, V5, P266, DOI 10.1038/ni1037; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; Cavallasca JA, 2008, CLIN RHEUMATOL, V27, P41, DOI 10.1007/s10067-007-0649-3; Chakravarty EF, 2005, AM J OBSTET GYNECOL, V192, P1897, DOI 10.1016/j.ajog.2005.02.063; Chapman AB, 1998, KIDNEY INT, V54, P2056, DOI 10.1046/j.1523-1755.1998.00217.x; Clowse MEB, 2007, RHEUM DIS CLIN N AM, V33, P237, DOI 10.1016/j.rdc.2007.01.002; Clowse MEB, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.012; DERKSEN RHWM, 1994, LUPUS, V3, P149, DOI 10.1177/096120339400300304; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; HOSTETTER TH, 1981, AM J PHYSIOL, V241, pF85, DOI 10.1681/ASN.V1261315; Hou S, 1999, AM J KIDNEY DIS, V33, P235, DOI 10.1016/S0272-6386(99)70296-9; Moroni G, 2002, AM J KIDNEY DIS, V40, P713, DOI 10.1053/ajkd.2002.35678; Ramin SM, 2006, OBSTET GYNECOL, V108, P1531, DOI 10.1097/01.AOG.0000246790.84218.44; Ritchie J, 2012, LUPUS, V21, P534, DOI 10.1177/0961203311434939; Ruiz-Irastorza G, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2764; Schrier RW, 2010, J AM SOC NEPHROL, V21, P570, DOI 10.1681/ASN.2009060653; Smyth A, 2010, CLIN J AM SOC NEPHRO, V5, P2060, DOI 10.2215/CJN.00240110; Stanhope TJ, 2012, CLIN J AM SOC NEPHRO, V7, P2089, DOI 10.2215/CJN.12441211; Wang IK, 2013, CAN MED ASSOC J, V185, P207, DOI 10.1503/cmaj.120230; Wong Chiong-Hee, 2006, Taiwan J Obstet Gynecol, V45, P120	22	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167946	10.1371/journal.pone.0167946	http://dx.doi.org/10.1371/journal.pone.0167946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992461	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600026
J	Merida-Vieyra, J; De Colsa, A; Castaneda, YC; Barbosa, PA; Andrade, AA				Merida-Vieyra, Jocelin; De Colsa, Agustin; Calderon Castaneda, Yair; Arzate Barbosa, Patricia; Aquino Andrade, Alejandra			First Report of Group CTX-M-9 Extended Spectrum Beta-Lactamases in Escherichia coli Isolates from Pediatric Patients in Mexico	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; URINARY-TRACT-INFECTIONS; CTX-M; ANTIMICROBIAL SUSCEPTIBILITY; HEALTHY HUMANS; ENTEROBACTERIACEAE; EPIDEMIOLOGY; ESBL; EMERGENCE; GENES	The aim of this study was to identify the presence of group CTX-M-9 extended spectrum beta-lactamases (ESBL) in clinical Escherichia coli isolates from pediatric patients. A total of 404 non-repeated positive ESBL E. coli isolates were collected from documented clinical infections in pediatric patients over a 2-year period. The identification and susceptibility profiles were determined using an automated system. Isolates that suggested ESBL production based on their resistance profiles to third and fourth generation cephalosporin and monobactam were selected. ESBL production was phenotypically confirmed using a diffusion method with cefotaxime and ceftazidime discs alone and in combination with clavulanic acid. bla(ESBL) gene identification was performed through PCR amplification and sequencing. Pulsed Field Gel Electrophoresis (PFGE) and Multilocus Sequence Typing (MLST) were performed to establish the clonal relationships of the E. coli isolates. CTX-M-9-type ESBLs were detected in 2.5% of the isolates. The subtypes corresponded to bla(CTX-M-14) (n = 4) and bla(CTX-M-27) (n = 6). Additionally, coexistence with other beta-lactamases was observed. A clonal relationship was established in three isolates; the rest were classified as non-related. We found seven different sequence type (ST) in CTX-M-9-producing E. coli isolates. ST38 was the most frequent. This study is the first report in Mexico to document the presence of group CTX-M-9 ESBLs in E. coli isolates from pediatric patients.	[Merida-Vieyra, Jocelin; De Colsa, Agustin; Aquino Andrade, Alejandra] INP, Mol Microbiol Lab, Mexico City, DF, Mexico; [Merida-Vieyra, Jocelin] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Microbiol, Mexico City, DF, Mexico; [De Colsa, Agustin] INP, Pediat Infect Dis Dept, Mexico City, DF, Mexico; [Calderon Castaneda, Yair; Arzate Barbosa, Patricia] INP, Clin Bacteriol Lab, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico	Andrade, AA (corresponding author), INP, Mol Microbiol Lab, Mexico City, DF, Mexico.	alejandra.aquino@infecto.mx			National Council of Science and Technology (CONACyT) [FOSISS 2012-1-181041]	National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the National Council of Science and Technology (CONACyT) FOSISS 2012-1-181041. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktar F, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7240864; Alcantar-Curiel D, 2004, CLIN INFECT DIS, V38, P1067, DOI 10.1086/382354; Allocati N, 2013, INT J ENV RES PUB HE, V10, P6235, DOI 10.3390/ijerph10126235; Bajaj P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00417; Bartoloni A, 2013, CLIN MICROBIOL INFEC, V19, P356, DOI 10.1111/j.1469-0691.2012.03807.x; Blanco VM, 2016, ENFERM INFEC MICR CL, V34, P559, DOI 10.1016/j.eimc.2015.11.017; Bonnet R, 2003, J ANTIMICROB CHEMOTH, V52, P29, DOI 10.1093/jac/dkg256; Brolund A, 2014, CLIN MICROBIOL INFEC, V20, pO344, DOI 10.1111/1469-0691.12413; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Cai JC, 2014, ANTIMICROB AGENTS CH, V58, P1146, DOI 10.1128/AAC.00912-13; Delgado DYC, 2016, BRAZ J INFECT DIS, V20, P627, DOI 10.1016/j.bjid.2016.07.001; Canton R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00110; Castanheira M, 2016, ANTIMICROB AGENTS CH, V60, P4770, DOI 10.1128/AAC.00540-16; Cheng MF, 2015, PEDIATR INFECT DIS J, V34, P469, DOI 10.1097/INF.0000000000000623; Clinical Laboratory Standards Institute, 2015, M100S25 CLSI S, V35; Cornejo-Juarez P, 2016, SUPPORT CARE CANCER, V24, P253, DOI 10.1007/s00520-015-2772-z; D'Andrea MM, 2013, INT J MED MICROBIOL, V303, P305, DOI 10.1016/j.ijmm.2013.02.008; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Dhanji H, 2012, ANTIMICROB AGENTS CH, V56, P3376, DOI 10.1128/AAC.00313-12; Fair RJ, 2014, PERSPECT MED CHEM, V6, P25, DOI 10.4137/PMC.S14459; Garrido A, 2014, MICROB DRUG RESIST, V20, P301, DOI 10.1089/mdr.2013.0109; Garza-Gonzalez E, 2011, J MED MICROBIOL, V60, P84, DOI 10.1099/jmm.0.022970-0; Guenther S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053039; Guo SY, 2015, MICROBES INFECT, V17, P266, DOI 10.1016/j.micinf.2014.12.016; Hayakawa K, 2013, ANTIMICROB AGENTS CH, V57, P4010, DOI 10.1128/AAC.02516-12; Ho PL, 2012, DIAGN MICR INFEC DIS, V73, P182, DOI 10.1016/j.diagmicrobio.2012.03.009; Hu YY, 2013, APPL ENVIRON MICROB, V79, P5988, DOI 10.1128/AEM.01740-13; Jeong SH, 2015, DIAGN MICR INFEC DIS, V82, P70, DOI 10.1016/j.diagmicrobio.2015.02.001; Jones RN, 2013, BRAZ J INFECT DIS, V17, P672, DOI 10.1016/j.bjid.2013.07.002; Kim S, 2016, J MICROBIOL BIOTECHN, V26, P1643, DOI 10.4014/jmb.1603.03063; Liu HH, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00335; Liu X, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01057; Lukac PJ, 2015, CLIN INFECT DIS, V60, P1389, DOI 10.1093/cid/civ020; McGrath EJ, 2011, INDIAN J PEDIATR, V78, P176, DOI 10.1007/s12098-010-0253-4; Minarini LAR, 2009, DIAGN MICR INFEC DIS, V65, P202, DOI 10.1016/j.diagmicrobio.2009.05.021; Miranda-Romero AL, 2016, DIAGN MICROBIOL INFE; Mora A, 2011, INT J ANTIMICROB AG, V37, P16, DOI 10.1016/j.ijantimicag.2010.09.012; Morfin-Otero R, 2013, MICROB DRUG RESIST, V19, P378, DOI 10.1089/mdr.2012.0263; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Muller A, 2016, SCI TOTAL ENVIRON, V541, P667, DOI 10.1016/j.scitotenv.2015.09.135; Murray TS, 2015, CURR OPIN PEDIATR, V27, P124, DOI 10.1097/MOP.0000000000000182; Navarro F, 2007, FEMS MICROBIOL LETT, V273, P120, DOI 10.1111/j.1574-6968.2007.00791.x; Oteo J, 2012, ANTIMICROB AGENTS CH, V56, P54, DOI 10.1128/AAC.05103-11; Oteo J, 2009, INT J ANTIMICROB AG, V34, P173, DOI 10.1016/j.ijantimicag.2009.03.006; Pitout JDD, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00009; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rodrigues C, 2016, J ANTIMICROB CHEMOTH, V71, P1120, DOI 10.1093/jac/dkv443; Rodriguez I, 2014, INT J ANTIMICROB AG, V43, P553, DOI 10.1016/j.ijantimicag.2014.02.019; Rodriguez-Bano J, 2010, J CLIN MICROBIOL, V48, P1726, DOI 10.1128/JCM.02353-09; Sader HS, 2016, INT J ANTIMICROB AG, V48, P144, DOI 10.1016/j.ijantimicag.2016.04.021; Sader HS, 2014, DIAGN MICR INFEC DIS, V78, P443, DOI 10.1016/j.diagmicrobio.2013.11.025; Salles MJC, 2013, EPIDEMIOL INFECT, V141, P2459, DOI 10.1017/S095026881300191X; Schaufler K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00336; Sennati S, 2012, ANTIMICROB AGENTS CH, V56, P6003, DOI 10.1128/AAC.00745-12; Shaikh S, 2015, SAUDI J BIOL SCI, V22, P90, DOI 10.1016/j.sjbs.2014.08.002; Shibasaki M, 2016, J INFECT CHEMOTHER, V22, P395, DOI 10.1016/j.jiac.2016.03.001; Silva-Sanchez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077968; Song W, 2009, J MED MICROBIOL, V58, P261, DOI 10.1099/jmm.0.004507-0; Stoesser N, 2016, MBIO, V7, DOI 10.1128/mBio.02162-15; Suzuki S, 2009, J ANTIMICROB CHEMOTH, V63, P72, DOI 10.1093/jac/dkn463; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Yamamoto T, 2011, J INFECT CHEMOTHER, V17, P435, DOI 10.1007/s10156-011-0232-3; Zhang J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0659-0; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao WH, 2013, CRIT REV MICROBIOL, V39, P79, DOI 10.3109/1040841X.2012.691460; Zurfluh K, 2015, APPL ENVIRON MICROB, V81, P3115, DOI 10.1128/AEM.00258-15	68	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168608	10.1371/journal.pone.0168608	http://dx.doi.org/10.1371/journal.pone.0168608			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992527	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600079
J	Liu, JJ; Sniezko, R; Murray, M; Wang, N; Chen, H; Zamany, A; Sturrock, RN; Savin, D; Kegley, A				Liu, Jun-Jun; Sniezko, Richard; Murray, Michael; Wang, Ning; Chen, Hao; Zamany, Arezoo; Sturrock, Rona N.; Savin, Douglas; Kegley, Angelia			Genetic Diversity and Population Structure of Whitebark Pine (Pinus albicaulis Engelm.) in Western North America	PLOS ONE			English	Article							BLISTER RUST; POSTGLACIAL COLONIZATION; ROCKY-MOUNTAINS; HOST-RESISTANCE; MONTICOLA; SEED; DNA; ASSOCIATION; GENERATION; CHALLENGES	Whitebark pine (WBP, Pinus albicaulis Engelm.) is an endangered conifer species due to heavy mortality from white pine blister rust (WPBR, caused by Cronartium ribicola) and mountain pine beetle (Dendroctonus ponderosae). Information about genetic diversity and population structure is of fundamental importance for its conservation and restoration. However, current knowledge on the genetic constitution and genomic variation is still limited for WBP. In this study, an integrated genomics approach was applied to characterize seed collections from WBP breeding programs in western North America. RNA-seq analysis was used for de novo assembly of the WBP needle transcriptome, which contains 97,447 protein-coding transcripts. Within the transcriptome, single nucleotide polymorphisms (SNPs) were discovered, and more than 22,000 of them were non-synonymous SNPs (ns-SNPs). Following the annotation of genes with ns-SNPs, 216 ns-SNPs within candidate genes with putative functions in disease resistance and plant defense were selected to design SNP arrays for high-throughput genotyping. Among these SNP loci, 71 were highly polymorphic, with sufficient variation to identify a unique genotype for each of the 371 individuals originating from British Columbia (Canada), Oregon and Washington (USA). A clear genetic differentiation was evident among seed families. Analyses of genetic spatial patterns revealed varying degrees of diversity and the existence of several genetic subgroups in the WBP breeding populations. Genetic components were associated with geographic variables and phenotypic rating of WPBR disease severity across landscapes, which may facilitate further identification of WBP genotypes and gene alleles contributing to local adaptation and quantitative resistance to WPBR. The WBP genomic resources developed here provide an invaluable tool for further studies and for exploitation and utilization of the genetic diversity preserved within this endangered conifer and other five-needle pines.	[Liu, Jun-Jun; Wang, Ning; Chen, Hao; Zamany, Arezoo; Sturrock, Rona N.] Nat Resources Canada, Canadian Forest Serv, Pacific Forestry Ctr, 506 West Burnside Rd, Victoria, BC, Canada; [Sniezko, Richard; Savin, Douglas; Kegley, Angelia] US Forest Serv, USDA, Dorena Genet Resource Ctr, 34963 Shoreview Rd, Cottage Grove, OR USA; [Murray, Michael] Minist Forests Lands & Nat Resource Operat, Nelson, BC, Canada; [Wang, Ning] Qinghai Univ, Acad Agr & Forestry Sci, 253 Ningda Rd, Xining, Qinghai, Peoples R China	Natural Resources Canada; Canadian Forest Service; United States Department of Agriculture (USDA); United States Forest Service; Qinghai University	Liu, JJ (corresponding author), Nat Resources Canada, Canadian Forest Serv, Pacific Forestry Ctr, 506 West Burnside Rd, Victoria, BC, Canada.	Jun-Jun.Liu@Canada.Ca	Chen, Hao/GLQ-8407-2022; Liu, Jun-Jun/T-4300-2019	Liu, Jun-Jun/0000-0002-9745-8258	Genomics Research & Development Initiative of the Canadian Forest Service (CFS-GRDI); CFS A-based fund; CFS-PFC DG's fund; US-FS; Ministry of Forests, Lands, and Natural Resource Operations; China Scholarship Council	Genomics Research & Development Initiative of the Canadian Forest Service (CFS-GRDI)(Natural Resources CanadaCanadian Forest Service); CFS A-based fund(Natural Resources CanadaCanadian Forest Service); CFS-PFC DG's fund(Natural Resources CanadaCanadian Forest Service); US-FS; Ministry of Forests, Lands, and Natural Resource Operations; China Scholarship Council(China Scholarship Council)	JJL received funding from the Genomics Research & Development Initiative of the Canadian Forest Service (CFS-GRDI), CFS A-based fund, and CFS-PFC DG's fund for this work. RAS received the base funding from US-FS that allowed continuous collaboration between CFS and US-FS. MM received both base and project research funding from the Ministry of Forests, Lands, and Natural Resource Operations. NW was supported partly by the China Scholarship Council.	AUBRY C.A., 2008, WHITEBARK PINE RESTO; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bower AD, 2008, AM J BOT, V95, P66, DOI 10.3732/ajb.95.1.66; Bruederle LP, 1998, CAN J BOT, V76, P83, DOI 10.1139/cjb-76-1-83; Callaway RM, 1998, OIKOS, V82, P561, DOI 10.2307/3546376; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Eckert AJ, 2013, MOL ECOL, V22, P5635, DOI 10.1111/mec.12514; Eckert AJ, 2009, GENETICS, V183, P289, DOI 10.1534/genetics.109.103895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FARNES PE, 1990, USDA INTERM, V270, P302; Friedline CJ, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-015-0866-x; Gabriel Stacey, 2009, Curr Protoc Hum Genet, VChapter 2, DOI 10.1002/0471142905.hg0212s60; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamlin J, 2011, US FOR SERV RMRS-P, V63, P133; Hansen A, 2016, FORESTS, V7, DOI 10.3390/f7030054; Holliday JA, 2010, NEW PHYTOL, V188, P501, DOI 10.1111/j.1469-8137.2010.03380.x; Jorgensen SM, 1997, CAN J FOREST RES, V27, P1574, DOI 10.1139/cjfr-27-10-1574; Krakowski J, 2003, CONSERV GENET, V4, P581, DOI 10.1023/A:1025667700479; Ledig FT, 1997, EVOLUTION, V51, P1815, DOI [10.2307/2411004, 10.1111/j.1558-5646.1997.tb05105.x]; Liu J-J, 2016, BMC GENOMIC IN PRESS; Liu JJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0380-6; Liu JJ, 2014, CONSERV GENET RESOUR, V6, P647, DOI 10.1007/s12686-014-0168-x; Liu JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-884; Liu JJ, 2013, PLANTA, V237, P43, DOI 10.1007/s00425-012-1747-2; Mahalovich MF, 2011, US FOR SERV RMRS-P, V63, P118; Mitton JB, 2006, MANAG FOR ECOSYST, V9, P147; Murray MP, 2014, P 61 ANN W INT FOR D, P35; Nadeau S, 2015, AM J BOT, V102, P1342, DOI 10.3732/ajb.1500160; Neale DB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r59; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrier X., 2003, GENETIC DIVERSITY CU, P43; Pritchard JK, 2000, GENETICS, V155, P945; Rajora OP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158691; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Resler LM, 2008, ARCT ANTARCT ALP RES, V40, P161, DOI 10.1657/1523-0430(06-116)[RESLER]2.0.CO;2; Richardson BA, 2002, CAN J FOREST RES, V32, P1103, DOI [10.1139/x02-037, 10.1139/X02-037]; Richardson BA, 2002, MOL ECOL, V11, P215, DOI 10.1046/j.1365-294X.2002.01435.x; Rogers DL, 1999, EVOLUTION, V53, P74, DOI 10.2307/2640921; Schoettle AW, 2007, J FOREST RES-JPN, V12, P327, DOI 10.1007/s10310-007-0024-x; Shi WT, 2010, MOL BIOL EVOL, V27, P385, DOI 10.1093/molbev/msp243; Smith CM, 2013, CAN J FOREST RES, V43, P90, DOI 10.1139/cjfr-2012-0127; Sniezko RA, 2011, US FOR SERV RMRS-P, V63, P246; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Syring JV, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00484; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Tomback DF, 2010, FOREST PATHOL, V40, P186, DOI 10.1111/j.1439-0329.2010.00655.x; Tomback D.F., 2001, WHITEBARK PINE COMMU; USFWS, 2011, FED REGISTER, V76, P42631; ZAVARIN E, 1991, BIOCHEM SYST ECOL, V19, P147, DOI 10.1016/0305-1978(91)90038-2	51	15	16	4	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167986	10.1371/journal.pone.0167986	http://dx.doi.org/10.1371/journal.pone.0167986			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992468	gold, Green Published, Green Submitted			2022-12-27	WOS:000392758000020
J	Nippert, F; Schreckenberg, R; Hess, A; Weber, M; Schluter, KD				Nippert, Franziska; Schreckenberg, Rolf; Hess, Antonia; Weber, Martin; Schlueter, Klaus-Dieter			The Effects of Swiprosin-1 on the Formation of Pseudopodia-Like Structures and beta-Adrenoceptor Coupling in Cultured Adult Rat Ventricular Cardiomyocytes	PLOS ONE			English	Article							LONG-TERM CULTURES; CARDIAC MYOCYTES; MYOCARDIAL-INFARCTION; CELL-CULTURE; REGENERATION; CALCINEURIN; MECHANISMS; DEDIFFERENTIATION; STIMULATION; HYPERTROPHY	Background Recent findings suggest that adult terminally differentiated cardiomyocytes adapt to stress by cellular de-and redifferentiation. In the present study we tested the hypothesis that swiprosin-1 is a key player in this process. Furthermore, the relationship between swiprosin-1 and beta-adrenoceptor coupling was analyzed. Methods In order to study the function of swiprosin-1 in adult rat ventricular cardiomyocytes (ARVC) they were isolated and cultured in a medium containing 20% fetal calf serum (FCS). Changes in cell morphology of ARVC during cultivation were quantified by light and confocal laser scan microscopy. Small interfering RNA (siRNA) was used to reduce the expression of swiprosin-1. The impact of calcium on swiprosin-1 dependent processes was investigated with Bapta-AM. Immunoblot techniques and qRT-PCR were performed to measure mRNA and protein expression. Results In culture, ARVC first lost their contractile elements, which was followed by a formation of pseudopodia-like structures (spreading). Swiprosin-1 was detected in ARVC at all time points. However, swiprosin-1 expression was increased when ARVC started to spread. Reduction of swiprosin-1 expression with siRNA delayed ARVC spreading. Similarly, Bapta-AM attenuated swiprosin-1 expression and spreading of ARVC. Furthermore, swiprosin-1 expression correlated with the expression of G protein-coupled receptor kinase 2 (GRK2). Moreover, silencing of swiprosin-1 was associated with a down regulation of GRK2 and caused a sensitization of beta-adrenergic receptors. Conclusion Swiprosin-1 is required for ARVC to adapt to culture conditions. Additionally, it seems to be involved in the desensitization of beta-adrenergic receptors. Assuming that ARVC adapt to cardiac stress in a similar way, swiprosin-1 may play a key role in cardiac remodeling.	[Nippert, Franziska; Schreckenberg, Rolf; Hess, Antonia; Weber, Martin; Schlueter, Klaus-Dieter] Justus Liebig Univ, Inst Physiol, Giessen, Germany	Justus Liebig University Giessen	Nippert, F (corresponding author), Justus Liebig Univ, Inst Physiol, Giessen, Germany.	Franziska.Nippert@physiologie.med.uni-giessen.de		Petersen, Antonia/0000-0002-0957-6474	Deutsche Forschungsgemeinschaft [Schl 324/7-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft (grant Schl 324/7-1; Klaus-Dieter Schluter). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anwar A, 2008, PFLUG ARCH EUR J PHY, V457, P485, DOI 10.1007/s00424-008-0520-7; BUGAISKY LB, 1989, CIRC RES, V64, P493, DOI 10.1161/01.RES.64.3.493; DECKER ML, 1991, CIRC RES, V69, P86, DOI 10.1161/01.RES.69.1.86; Dutting S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-2; EPPENBERGER ME, 1988, DEV BIOL, V130, P1, DOI 10.1016/0012-1606(88)90408-3; EPPENBERGEREBERHARDT M, 1990, DEV BIOL, V139, P269, DOI 10.1016/0012-1606(90)90296-U; Fiedler B, 2005, EXPERT OPIN THER TAR, V9, P963, DOI 10.1517/14728222.9.5.963; Fiedler B, 2004, CARDIOVASC RES, V63, P450, DOI 10.1016/j.cardiores.2004.04.002; Fontana M, 2007, BRIT J PHARMACOL, V151, P779, DOI 10.1038/sj.bjp.0707300; Heineke J, 2005, P NATL ACAD SCI USA, V102, P1655, DOI 10.1073/pnas.0405488102; HILENSKI LL, 1991, CELL TISSUE RES, V264, P577, DOI 10.1007/BF00319047; Howard PA, 2000, AM FAM PHYSICIAN, V62, P1853; Huh YH, 2013, CELL MOL LIFE SCI, V70, P4841, DOI 10.1007/s00018-013-1447-5; Joshi-Mukherjee R, 2013, J MOL CELL CARDIOL, V65, P76, DOI 10.1016/j.yjmcc.2013.09.009; Kezerashvili A, 2012, CURR CARDIOL REV, V8, P77, DOI 10.2174/157340312801215764; Kubin T, 2011, CELL STEM CELL, V9, P420, DOI 10.1016/j.stem.2011.08.013; Kwon MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071626; LANGE R, 1983, AM J CARDIOL, V51, P1759, DOI 10.1016/0002-9149(83)90224-2; Leri A, 2011, TRENDS CARDIOVAS MED, V21, P52, DOI 10.1016/j.tcm.2012.02.006; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Lim HW, 1999, NAT MED, V5, P246, DOI 10.1038/6430; Mason RP, 2009, J CARDIOVASC PHARM, V54, P123, DOI 10.1097/FJC.0b013e3181ad207b; Najafi A, 2016, EUR J CLIN INVEST, V46, P362, DOI 10.1111/eci.12598; Poling J, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0396-3; Poling J, 2012, CELL CYCLE, V11, P439, DOI 10.4161/cc.11.3.19024; Schluter K.-D, 2016, CARDIOMYOCYTES ACTIV, DOI [10.1007/978-3-319-31251-4, DOI 10.1007/978-3-319-31251-4]; Schluter KD, 2000, CIRC RES, V86, P946, DOI 10.1161/01.RES.86.9.946; Schluter KD, 1995, AM J PHYSIOL, V269, P6; Schluter KD, 2005, PROTEIN TYROSINE KIN, P305; Schreckenberg R, 2015, PFLUG ARCH EUR J PHY, V467, P379, DOI 10.1007/s00424-014-1498-y; SCHWARZFELD TA, 1981, J MOL CELL CARDIOL, V13, P563, DOI 10.1016/0022-2828(81)90327-8; Szibor M, 2014, CELL MOL LIFE SCI, V71, P1907, DOI 10.1007/s00018-013-1535-6; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Zhou XJ, 1996, MOL CELL BIOCHEM, V164, P211, DOI 10.1007/BF00408660	34	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167655	10.1371/journal.pone.0167655	http://dx.doi.org/10.1371/journal.pone.0167655			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992454	Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000014
J	Infantes, E; Crouzy, C; Moksnes, PO				Infantes, Eduardo; Crouzy, Caroline; Moksnes, Per-Olav			Seed Predation by the Shore Crab Carcinus maenas: A Positive Feedback Preventing Eelgrass Recovery?	PLOS ONE			English	Article							ZOSTERA-MARINA; SEAGRASS ECOSYSTEMS; NUTRIENT ENRICHMENT; COASTAL ECOSYSTEMS; RESTORATION; ABUNDANCE; BAY; VEGETATION; SELECTION; SUCCESS	There is an increasing interest to restore the ecosystem services that eelgrass provides, after their continuous worldwide decline. Most attempts to restore eelgrass using seeds are challenged by very high seed losses and the reasons for these losses are not all clear. We assess the impact of predation on seed loss and eelgrass establishment, and explore methods to decrease seed loss during restoration in the Swedish northwest coast. In a laboratory study we identified three previously undescribed seed predators, the shore crab Carcinus maenas, the hermit crab Pagurus bernhardus and the sea urchin Strongylocentrotus droebachiensis, of which shore crabs consumed 2-7 times more seeds than the other two species. The importance of shore crabs as seed predators was supported in field cage experiments where one enclosed crab caused 73% loss of seeds over a 1-week period on average (similar to 21 seeds per day). Seedling establishment was significantly higher (14%) in cages that excluded predators over an 8-month period than in uncaged plots and cages that allowed predators but prevented seed-transport (0.5%), suggesting that seed predation constitutes a major source of seed loss in the study area. Burying the seeds 2 cm below the sediment surface prevented seed predation in the laboratory and decreased predation in the field, constituting a way to decrease seed loss during restoration. Shore crabs may act as a key feedback mechanism that prevent the return of eelgrass both by direct consumption of eelgrass seeds and as a predator of algal mesograzers, allowing algal mats to overgrow eelgrass beds. This shore crab feedback mechanism could become self-generating by promoting the growth of its own nursery habitat (algal mats) and by decreasing the nursery habitat (seagrass meadow) of its dominant predator (cod). This double feedback-loop is supported by a strong increase of shore crab abundance in the last decades and may partly explain the regime shift in vegetation observed along the Swedish west coast.	[Infantes, Eduardo; Crouzy, Caroline; Moksnes, Per-Olav] Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden; [Infantes, Eduardo; Crouzy, Caroline] Kristineberg 566, SE-45178 Fiskebackskil, Sweden; [Moksnes, Per-Olav] Box 461, SE-40530 Gothenburg, Sweden	University of Gothenburg	Infantes, E (corresponding author), Univ Gothenburg, Dept Marine Sci, Gothenburg, Sweden.; Infantes, E (corresponding author), Kristineberg 566, SE-45178 Fiskebackskil, Sweden.	eduardo.infantes@marine.gu.se	Infantes, Eduardo/D-6105-2019	Infantes, Eduardo/0000-0002-9724-9237	FORMAS [212-2011-758, 231-2014-735]	FORMAS(Swedish Research Council Formas)	FORMAS grant Dnr. 212-2011-758 and FORMAS grant Dnr. 231-2014-735.	ADAMS SM, 1976, T AM FISH SOC, V105, P514, DOI 10.1577/1548-8659(1976)105<514:FEOEFC>2.0.CO;2; Baden S, 2003, AMBIO, V32, P374, DOI 10.1639/0044-7447(2003)032[0374:VSZMLI]2.0.CO;2; Baden S, 2012, MAR ECOL PROG SER, V451, P61, DOI 10.3354/meps09585; Baden S, 2010, LIMNOL OCEANOGR, V55, P1435, DOI 10.4319/lo.2010.55.3.1435; Carstensen J, 2011, ENVIRON SCI TECHNOL, V45, P9122, DOI 10.1021/es202351y; Cole SG, 2016, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00121; Davis RC, 1998, RESTOR ECOL, V6, P297, DOI 10.1046/j.1526-100X.1998.00634.x; Delefosse M, 2012, J SEA RES, V71, P41, DOI 10.1016/j.seares.2012.04.006; Duarte CM, 2009, ESTUAR COAST, V32, P29, DOI 10.1007/s12237-008-9111-2; DUARTE CM, 1995, OPHELIA, V41, P87, DOI 10.1080/00785236.1995.10422039; Duffy JE, 2014, MARINE COMMUNITY ECOLOGY AND CONSERVATION, P271; Eriander L, 2016, J EXP MAR BIOL ECOL, V479, P76, DOI 10.1016/j.jembe.2016.03.005; Eriksson BK, 2011, AMBIO, V40, P786, DOI 10.1007/s13280-011-0158-0; Eriksson BK, 2011, MAR BIOL, V158, P747, DOI 10.1007/s00227-010-1602-6; Fishman JR, 1996, J EXP MAR BIOL ECOL, V198, P11, DOI 10.1016/0022-0981(95)00176-X; Frederiksen M, 2004, AQUAT BOT, V78, P147, DOI 10.1016/j.aquabot.2003.10.003; Gallopin G, 2005, ECOSYSTEMS HUMAN WEL; Garbary DJ, 2014, MAR BIOL, V161, P3, DOI 10.1007/s00227-013-2323-4; Govers LL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0812; Granger SL., 2000, BIOL MAR MEDITERR, V7, P55; Green E.P., 2003, WORLD ATLAS SEAGRASS; Heck KL, 2000, LIMNOL OCEANOGR, V45, P1041, DOI 10.4319/lo.2000.45.5.1041; Holbrook SJ, 2000, MAR BIOL, V136, P739, DOI 10.1007/s002270050733; Hughes AR, 2009, FRONT ECOL ENVIRON, V7, P242, DOI 10.1890/080041; Infantes E, 2016, MAR ECOL PROG SER, V546, P31, DOI 10.3354/meps11615; Kallstrom B, 2008, AQUAT BOT, V88, P148, DOI 10.1016/j.aquabot.2007.09.005; Krause-Jensen D, 2008, ECOL INDIC, V8, P515, DOI 10.1016/j.ecolind.2007.06.004; Malyshev A, 2011, ICES J MAR SCI, V68, P1852, DOI 10.1093/icesjms/fsr126; Marion SR, 2012, MAR ECOL PROG SER, V448, P197, DOI 10.3354/meps09612; Marion SR, 2010, RESTOR ECOL, V18, P514, DOI 10.1111/j.1526-100X.2010.00692.x; Moksnes P-O, 1999, THESIS; Moksnes PO, 2008, OIKOS, V117, P763, DOI 10.1111/j.0030-1299.2008.16521.x; Moksnes PO, 1998, MAR ECOL PROG SER, V166, P211, DOI 10.3354/meps166211; Moksnes PO, 2004, ECOLOGY, V85, P1343, DOI 10.1890/02-0750; MOORE KA, 1993, AQUAT BOT, V45, P79, DOI 10.1016/0304-3770(93)90054-Z; Munkes B, 2005, AQUAT SCI, V67, P372, DOI 10.1007/s00027-005-0761-x; Nakaoka M, 2002, AQUAT BOT, V72, P99, DOI 10.1016/S0304-3770(01)00213-3; Neckles HA, 2015, NORTHEAST NAT, V22, P478, DOI 10.1656/045.022.0305; Nyqvist A, 2009, AMBIO, V38, P85, DOI 10.1579/0044-7447-38.2.85; Nystrom M, 2012, ECOSYSTEMS, V15, P695, DOI 10.1007/s10021-012-9530-6; Ostman O, 2015, J APPL ECOL, V53, P1138; Ostman O, 2016, J APPL ECOL; Pihl L, 1999, J SEA RES, V41, P281, DOI 10.1016/S1385-1101(99)00004-0; PIHL L, 1985, MAR ECOL PROG SER, V22, P169, DOI 10.3354/meps022169; PIHL L, 1982, J EXP MAR BIOL ECOL, V57, P273, DOI 10.1016/0022-0981(82)90197-6; Pihl L., 1995, Netherlands Journal of Aquatic Ecology, V29, P349, DOI 10.1007/BF02084234; Ropes J. W., 1968, FISHERY B FISH WILDL, V67, P183; Short FT, 2000, ECOL ENG, V15, P239, DOI 10.1016/S0925-8574(00)00079-3; Short FT, 2002, MAR ECOL PROG SER, V227, P253, DOI 10.3354/meps227253; Sokal R.R., 1995, BIOL RES; Sumoski SE, 2012, MAR ECOL PROG SER, V471, P1, DOI 10.3354/meps10145; SwAM, 2012, GOD HAVSM 2020 INL B; Traber MS, 2003, ECOLOGICAL RESTORATI, V21, P213; Tulipani DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103346; Tulp I, 2012, MAR ECOL PROG SER, V458, P141, DOI 10.3354/meps09743; Uchida M, 2014, J BIOSCI BIOENG, V118, P646, DOI 10.1016/j.jbiosc.2014.05.017; Valdemarsen T, 2011, J EXP MAR BIOL ECOL, V410, P45, DOI 10.1016/j.jembe.2011.10.006; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; van der Heide T, 2007, ECOSYSTEMS, V10, P1311, DOI 10.1007/s10021-007-9099-7; van der Heide T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016504; van Katwijk MM, 2016, J APPL ECOL, V53, P567, DOI 10.1111/1365-2664.12562; WASSENBERG TJ, 1990, AUST J MAR FRESH RES, V41, P301; WASSENBERG TJ, 1987, AUST J MAR FRESH RES, V38, P169, DOI 10.1071/MF9870169; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; WIGAND C, 1988, ESTUARIES, V11, P180, DOI 10.2307/1351970; Williams SL, 2001, ECOL APPL, V11, P1472, DOI 10.1890/1051-0761(2001)011[1472:RGDIET]2.0.CO;2	66	21	22	6	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168128	10.1371/journal.pone.0168128	http://dx.doi.org/10.1371/journal.pone.0168128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977802	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400064
J	Jung, NH; Gleich, B; Gattinger, N; Hoess, C; Haug, C; Siebner, HR; Mall, V				Jung, Nikolai H.; Gleich, Bernhard; Gattinger, Norbert; Hoess, Catrina; Haug, Carolin; Siebner, Hartwig R.; Mall, Volker			Quadri-Pulse Theta Burst Stimulation using Ultra-High Frequency Bursts - A New Protocol to Induce Changes in Cortico-Spinal Excitability in Human Motor Cortex	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; DEPENDENT SYNAPTIC PLASTICITY; HOMEOSTATIC PLASTICITY; TERM DEPRESSION; HALF-SINE; METAPLASTICITY; DIRECTION; NETWORKS; CIRCUITS; MEMORY	Patterned transcranial magnetic stimulation (TMS) such as theta burst stimulation (TBS) or quadri-pulse stimulation (QPS) can induce changes in cortico-spinal excitability, commonly referred to as long-term potentiation (LTP)-like and long-term depression (LTD)-like effects in human motor cortex (M1). Here, we aimed to test the plasticity-inducing capabilities of a novel protocol that merged TBS and QPS. 360 bursts of quadri-pulse TBS (qTBS) were continuously given to M1 at 90% of active motor threshold (1440 full-sine pulses). In a first experiment, stimulation frequency of each burst was set to 666 Hz to mimic the rhythmicity of the descending cortico-spinal volleys that are elicited by TMS (i.e., I-wave periodicity). In a second experiment, burst frequency was set to 200 Hz to maximize postsynaptic Ca2+ influx using a temporal pattern unrelated to I-wave periodicity. The second phase of sinusoidal TMS pulses elicited either a posterior-anterior (PA) or anterior-posterior (AP) directed current in M1. Motor evoked potentials (MEPs) were recorded before and after qTBS to probe changes in cortico-spinal excitability. PA-qTBS at 666 Hz caused a decrease in PAMEP amplitudes, whereas AP-qTBS at 666 Hz induced an increase in mean AP-MEP amplitudes. At a burst frequency of 200 Hz, PA-qTBS and AP-qTBS produced an increase in cortico- spinal excitability outlasting for at least 60 minutes in PA- and AP-MEP amplitudes, respectively. Continuous qTBS at 666 Hz or 200 Hz can induce lasting changes in corticospinal excitability. Induced current direction in the brain appears to be relevant when qTBS targets I-wave periodicity, corroborating that high-fidelity spike timing mechanisms are critical for inducing bi-directional plasticity in human M1.	[Jung, Nikolai H.; Hoess, Catrina; Haug, Carolin; Mall, Volker] Tech Univ Munich, Dept Pediat, Heiglhofstr 63, Munich, Germany; [Gleich, Bernhard; Gattinger, Norbert] Tech Univ Munich IMETUM, Zentralinst Med Tech, Boltzmannstr 11, Garching, Germany; [Siebner, Hartwig R.] Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Kettegaard Alle 30, Hvidovre, Denmark; [Siebner, Hartwig R.] Copenhagen Univ Hosp Bispebjerg, Dept Neurol, Copenhagen, Denmark	Technical University of Munich; Technical University of Munich; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital	Mall, V (corresponding author), Tech Univ Munich, Dept Pediat, Heiglhofstr 63, Munich, Germany.	volker.mall@tum.de	Gleich, Bernhard/D-4803-2009	Gleich, Bernhard/0000-0002-0574-7678	Lundbeck Foundation [R59-A5399]; Novo Nordisk Foundation Interdisciplinary Synergy Program "Biophysically adjusted state-informed cortex stimulation (BASICS) [NNF14OC0011413]; Novo Nordisk Fonden [NNF14OC0011413] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation Interdisciplinary Synergy Program "Biophysically adjusted state-informed cortex stimulation (BASICS); Novo Nordisk Fonden(Novo Nordisk Foundation)	Hartwig R. Siebner received financial support from the Lundbeck Foundation [Grant of Excellence "Mapping, Modulation and Modeling the Control of Actions"; grant number R59-A5399] and the Novo Nordisk Foundation Interdisciplinary Synergy Program 2014 ["Biophysically adjusted state-informed cortex stimulation (BASICS); grant number NNF14OC0011413]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 2008, NAT REV NEUROSCI, V9, P387, DOI 10.1038/nrn2356; Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Buschler A, 2012, HIPPOCAMPUS, V22, P2238, DOI 10.1002/hipo.22041; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Cash RFH, 2013, J NEUROPHYSIOL, V109, P106, DOI 10.1152/jn.00584.2011; Cash RFH, 2009, EXP BRAIN RES, V193, P1, DOI 10.1007/s00221-008-1590-7; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Delvendahl I, 2014, BRAIN STIMUL, V7, P49, DOI 10.1016/j.brs.2013.08.002; Delvendahl I, 2010, CLIN NEUROPHYSIOL, V121, P594, DOI 10.1016/j.clinph.2009.09.034; Di Lazzaro V, 2008, J PHYSIOL-LONDON, V586, P3871, DOI 10.1113/jphysiol.2008.152736; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V565, P945, DOI 10.1113/jphysiol.2005.087288; Di Lazzaro V, 2012, BRAIN STIMUL, V5, P512, DOI 10.1016/j.brs.2011.07.008; Di Lazzaro V, 2001, J PHYSIOL-LONDON, V537, P1047, DOI 10.1113/jphysiol.2001.012572; Grover LM, 2009, LEARN MEMORY, V16, P69, DOI 10.1101/lm.1179109; Hamada M, 2008, J PHYSIOL-LONDON, V586, P3927, DOI 10.1113/jphysiol.2008.152793; Hamada M, 2014, J NEUROSCI, V34, P12837, DOI 10.1523/JNEUROSCI.1960-14.2014; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Jung NH, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-139; Karabanov A, 2015, BRAIN STIMUL, V8, P442, DOI 10.1016/j.brs.2015.01.404; Kenney J, 2013, NEUROPHARMACOLOGY, V74, P108, DOI 10.1016/j.neuropharm.2013.02.017; Lang N, 2004, BIOL PSYCHIAT, V56, P634, DOI 10.1016/j.biopsych.2004.07.017; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Siebner HR, 2004, J NEUROSCI, V24, P3379, DOI 10.1523/JNEUROSCI.5316-03.2004; Simeoni S, 2016, BRAIN STIMUL, V9, P148, DOI 10.1016/j.brs.2015.10.007; Sommer M, 2006, CLIN NEUROPHYSIOL, V117, P838, DOI 10.1016/j.clinph.2005.10.029; Sommer M, 2013, BRAIN STIMUL, V6, P363, DOI 10.1016/j.brs.2012.07.003; Thickbroom GW, 2011, BRAIN STIMUL, V4, P77, DOI 10.1016/j.brs.2010.04.002; Wankerl K, 2010, J NEUROSCI, V30, P6197, DOI 10.1523/JNEUROSCI.4673-09.2010; Ziemann U, 2001, BRAIN, V124, P1171, DOI 10.1093/brain/124.6.1171; Ziemann U, 2008, BRAIN STIMUL, V1, P164, DOI 10.1016/j.brs.2008.06.006	34	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168410	10.1371/journal.pone.0168410	http://dx.doi.org/10.1371/journal.pone.0168410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977758	Green Submitted, gold, Green Published			2022-12-27	WOS:000391217400106
J	Korner, A; Tscharaktschiew, N; Schindler, R; Schulz, K; Rudolph, U				Koerner, Andre; Tscharaktschiew, Nadine; Schindler, Rose; Schulz, Katrin; Rudolph, Udo			The Everyday Moral Judge - Autobiographical Recollections of Moral Emotions	PLOS ONE			English	Article							QUALITATIVE RESEARCH; APPRAISAL; SCHADENFREUDE; ACHIEVEMENT; STATEMENT; ANGER; ENVY	Moral emotions are typically elicited in everyday social interactions and regulate social behavior. Previous research in the field of attribution theory identified ought (the moral standard of a given situation or intended goal), goal-attainment (a goal can be attained vs. not attained) and effort (high vs. low effort expenditure) as cognitive antecedents of moral emotions. In contrast to earlier studies, mainly relying on thought experiments, we investigated autobiographical recollections of N = 312 participants by means of an online study. We analyzed a diverse range of moral emotions, i.e., admiration, anger, contempt, indignation, pride, respect, schadenfreude, and sympathy, by using a mixed-method approach. Qualitative and quantitative methods clearly corroborate the important role of ought, goal-attainment, and effort as eliciting conditions of moral emotions. Furthermore, we built categorical systems based on our participants' descriptions of real-life situations, allowing for more fine-grained distinctions between seemingly similar moral emotions. We thus identify additional prerequisites explaining more subtle differences between moral emotion clusters as they emerge from our analyses (i.e., cluster 1: admiration, pride, and respect; cluster 2: anger, contempt, and indignation; cluster 3: schadenfreude and sympathy). Results are discussed in the light of attributional theories of moral emotions, and implications for future research are derived.	[Koerner, Andre; Tscharaktschiew, Nadine; Schindler, Rose; Rudolph, Udo] Tech Univ Chemnitz, Dept Gen Psychol & Biopsychol, Chemnitz, Germany; [Schulz, Katrin] SRH Fachhsch Gesundheit Gera, Gera, Germany	Technische Universitat Chemnitz	Korner, A (corresponding author), Tech Univ Chemnitz, Dept Gen Psychol & Biopsychol, Chemnitz, Germany.	andre.koerner@allpsy2.de	Korner, Andre/F-8491-2015	Korner, Andre/0000-0002-6630-3368	German Research Foundation/DFG; Technische Universitat Chemnitz	German Research Foundation/DFG(German Research Foundation (DFG)); Technische Universitat Chemnitz	The publication costs of this article were funded by the German Research Foundation/DFG and the Technische Universitat Chemnitz in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algoe SB, 2009, J POSIT PSYCHOL, V4, P105, DOI 10.1080/17439760802650519; Ben-Ze'ev A., 1992, IYYUN, V41, P41; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Chipperfield JG, 2009, INT J AGING HUM DEV, V68, P215, DOI 10.2190/AG.68.3.c; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; Denzin N. K, 1989, RES ACT THEORETICAL; Drummond JJ, 2006, HUSSERL STUD, V22, P1, DOI 10.1007/s10743-006-9001-z; Dwyer S, 2003, MONIST, V86, P181, DOI 10.5840/monist20038628; Ellsworth PC, 2003, SER AFFECTIVE SCI, P572; Feather NT, 2011, MOTIV EMOTION, V35, P1, DOI 10.1007/s11031-011-9202-4; Feather NT, 2002, PERS SOC PSYCHOL B, V28, P953, DOI 10.1177/01467202028007008; Fischer AH, 2007, J PERS SOC PSYCHOL, V93, P103, DOI 10.1037/0022-3514.93.1.103; Fischer K.W., 1995, SELF CONSCIOUS EMOTI; Flick U., 2011, TRIANGULATION; FRIJDA NH, 1989, J PERS SOC PSYCHOL, V57, P212, DOI 10.1037/0022-3514.57.2.212; Frijda NH., 1987, EMOTIONS STUDIES EMO; Giner-Sorolla R, 2012, JUDGING PASSIONS; Glaser B., 1999, DISCOVERY GROUNDED T; Hareli S, 2002, EDUC PSYCHOL, V37, P183, DOI 10.1207/S15326985EP3703_4; Heider F., 1958, PSYCHOL INTERPERSONA, P79, DOI [10.1037/10628-004, DOI 10.1037/10628-004]; Hutcherson CA, 2011, J PERS SOC PSYCHOL, V100, P719, DOI 10.1037/a0022408; JOHNSON R. B., 2004, EDUC RESEARCHER, V33, P14, DOI 10.3102/0013189X033007014; Kidd SA, 2002, PSYCHOL METHODS, V7, P126, DOI 10.1037//1082-989X.7.1.126; Kuckartz U, 2010, QUALITATIVE EVALUATI; Kuckartz U, 2010, EINFUHRIUNG COMPUTER; Li J., 2007, SELF CONSCIOUS EMOTI, P224; MASSEY SJ, 1983, J HIST PHILOS, V21, P57; MASSEY SJ, 1983, ETHICS, V93, P246, DOI 10.1086/292432; Matteucci MC, 2004, EUR J PSYCHOL EDUC, V19, P147, DOI 10.1007/BF03173229; Matteucci MC., 2007, SOC PSYCHOL EDUC, V10, P29, DOI [10.1007/s11218-006-9011-x, DOI 10.1007/S11218-006-9011-X]; Mayring P., 2015, QUALITATIVE INHALTSA, Vtwelfth; Moher D, 2002, ALTERN THER HEALTH M, V8, P96; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Moors A, 2013, EMOT REV, V5, P119, DOI 10.1177/1754073912468165; Nelissen RMA, 2007, J EXP SOC PSYCHOL, V43, P280, DOI 10.1016/j.jesp.2006.01.009; Ostlund U, 2011, INT J NURS STUD, V48, P369, DOI 10.1016/j.ijnurstu.2010.10.005; Powell H, 2008, PSYCHOL SCHOOLS, V45, P291, DOI 10.1002/pits.20296; Reips UD, 2002, EXP PSYCHOL, V49, P243, DOI 10.1027//1618-3169.49.4.243; Rozin P, 1999, J PERS SOC PSYCHOL, V76, P574, DOI 10.1037/0022-3514.76.4.574; Rudolph U, 2004, COGNITION EMOTION, V18, P815, DOI 10.1080/02699930341000248; Rudolph U., 2013, INT J ADV PSYCHOL, V2, P69; Rudolph U, 2014, EMOT REV, V6, P344, DOI 10.1177/1754073914534507; Schindler R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137669; Schulz K, 2013, BRIT J DEV PSYCHOL, V31, P363, DOI 10.1111/bjdp.12013; Sedlmeier P., 2013, FORSCHUNGSMETHODEN S; Shamay-Tsoory SG, 2009, BIOL PSYCHIAT, V66, P864, DOI 10.1016/j.biopsych.2009.06.009; SKOWRONSKI JJ, 1987, J PERS SOC PSYCHOL, V52, P689, DOI 10.1037/0022-3514.52.4.689; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tangney JP, 2007, ANNU REV PSYCHOL, V58, P345, DOI 10.1146/annurev.psych.56.091103.070145; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tooby J, 2010, HDB EMOTIONS, P114; Tscharaktschiew N., 2014, ACTIONS OUTCOMES EVA; Unkelbach C, 2008, J PERS SOC PSYCHOL, V95, P36, DOI 10.1037/0022-3514.95.1.36; van Dijk WW, 2006, EMOTION, V6, P156, DOI 10.1037/1528-3542.6.1.156; von Elm E, 2007, PREV MED, V45, P247, DOI 10.1016/j.ypmed.2007.08.012; Weiner B., 1995, JUDGMENTS RESPONSIBI; Weiner B., 2006, SOCIAL MOTIVATION JU; [No title captured]; [No title captured]	59	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167224	10.1371/journal.pone.0167224	http://dx.doi.org/10.1371/journal.pone.0167224			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977699	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400016
J	Le Bras, Y; Jouma'a, J; Picard, B; Guinet, C				Le Bras, Yves; Jouma'a, Joffrey; Picard, Baptiste; Guinet, Christophe			How Elephant Seals (Mirounga leonina) Adjust Their Fine Scale Horizontal Movement and Diving Behaviour in Relation to Prey Encounter Rate	PLOS ONE			English	Article							BREATH-HOLD DIVERS; FORAGING SUCCESS; MARINE PREDATOR; WEDDELL SEALS; STROKING PATTERNS; FEEDING-BEHAVIOR; ANIMAL BEHAVIOR; TEMPERATURE; PENGUINS; FISH	Understanding the diving behaviour of diving predators in relation to concomitant prey distribution could have major practical applications in conservation biology by allowing the assessment of how changes in fine scale prey distribution impact foraging efficiency and ultimately population dynamics. The southern elephant seal (Mirounga leonina, hereafter SES), the largest phocid, is a major predator of the southern ocean feeding on myctophids and cephalopods. Because of its large size it can carry bio-loggers with minimal disturbance. Moreover, it has great diving abilities and a wide foraging habitat. Thus, the SES is a well suited model species to study predator diving behaviour and the distribution of ecologically important prey species in the Southern Ocean. In this study, we examined how SESs adjust their diving behaviour and horizontal movements in response to fine scale prey encounter densities using high resolution accelerometers, magnetometers, pressure sensors and GPS loggers. When high prey encounter rates were encountered, animals responded by (1) diving and returning to the surface with steeper angles, reducing the duration of transit dive phases (thus improving dive efficiency), and (2) exhibiting more horizontally and vertically sinuous bottom phases. In these cases, the distance travelled horizontally at the surface was reduced. This behaviour is likely to counteract horizontal displacement from water currents, as they try to remain within favourable prey patches. The prey encounter rate at the bottom of dives decreased with increasing diving depth, suggesting a combined effect of decreased accessibility and prey density with increasing depth. Prey encounter rate also decreased when the bottom phases of dives were spread across larger vertical extents of the water column. This result suggests that the vertical aggregation of prey can regulate prey density, and as a consequence impact the foraging success of SESs. To our knowledge, this is one of only a handful of studies showing how the vertical distributions and structure of prey fields influence the prey encounter rates of a diving predator.	[Le Bras, Yves; Jouma'a, Joffrey; Picard, Baptiste; Guinet, Christophe] UMR, Ctr Etude Biol Chize, CNRS ULR, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS)	Le Bras, Y (corresponding author), UMR, Ctr Etude Biol Chize, CNRS ULR, Villiers En Bois, France.	yves.lebras@cebc.cnrs.fr	Guinet, Christophe/AAR-8457-2020	Baptiste, Picard/0000-0001-9565-9446	 [ANR-11-BSV7-0022];  [ANR-07-VULN-0005]	; 	This work was supported by: http://www.poitou-charentes.fr/accueil.html; http://www.deux-sevres.com/deux-sevres/default.aspx; http://www.agence-nationale-recherche.fr/?Project=ANR-11-BSV7-0022; http://www.agence-nationale-recherche.fr/?Projet=ANR-07-VULN-0005; http://www.fondation.total.com/; https://cnes.fr/fr.	Ainley DG, 2009, ANTARCT SCI, V21, P317, DOI 10.1017/S0954102009001953; [Anonymous], 2014, R LANG ENV STAT COMP; Aoki K, 2011, J EXP BIOL, V214, P2973, DOI 10.1242/jeb.055137; Austin D, 2006, ECOLOGY, V87, P3095, DOI 10.1890/0012-9658(2006)87[3095:LMDAHT]2.0.CO;2; Bailleul F, 2008, J ANIM ECOL, V77, P948, DOI 10.1111/j.1365-2656.2008.01407.x; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Barton K., 2016, MUMIN MULTIMODEL INF; Bost CA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9220; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cherel Y, 2008, MAR ECOL PROG SER, V370, P239, DOI 10.3354/meps07673; Collins MA, 2006, ADV MAR BIOL, V50, P191, DOI 10.1016/S0065-2881(05)50003-8; Cornick LA, 2003, CAN J ZOOL, V81, P1799, DOI 10.1139/Z03-179; Cribari-Neto F, 2010, BETA REGRESSION IN R; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Della Penna A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18063; Doniol-Valcroze T, 2011, BEHAV ECOL; Dragon A-C, 2011, THESIS; Dragon AC, 2012, MAR ECOL PROG SER, V447, P243, DOI 10.3354/meps09498; Dragon AC, 2010, PROG OCEANOGR, V87, P61, DOI 10.1016/j.pocean.2010.09.025; Sala JE, 2011, POLAR BIOL, V34, P1197, DOI 10.1007/s00300-011-0981-6; Farrell E, 2013, ANIMAL TRACK RECONST; Foo D, 2016, ANIM BEHAV, V112, P127, DOI 10.1016/j.anbehav.2015.11.028; Fossette S, 2008, J ANIM ECOL, V77, P236, DOI 10.1111/j.1365-2656.2007.01344.x; Gallon S, 2013, DEEP-SEA RES PT II, V88-89, P14, DOI 10.1016/j.dsr2.2012.09.002; Gaspar P, 2006, P ROY SOC B-BIOL SCI, V273, P2697, DOI 10.1098/rspb.2006.3623; Genin A, 2015, MAR MAMMAL SCI, V31, P1452, DOI 10.1111/mms.12235; Goldbogen JA, 2015, FUNCT ECOL, V29, P951, DOI 10.1111/1365-2435.12395; Guinet C, 1996, ANTARCT SCI, V8, P23, DOI 10.1017/S0954102096000053; Guinet C, 2014, MAR ECOL PROG SER, V499, P285, DOI 10.3354/meps10660; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Halsey LG, 2007, POLAR BIOL, V30, P991, DOI 10.1007/s00300-007-0257-3; Hanuise N, 2013, J ZOOL, V290, P181, DOI 10.1111/jzo.12026; Hanuise N, 2010, J EXP BIOL, V213, P3874, DOI 10.1242/jeb.044057; Hassrick JL, 2007, DEEP-SEA RES PT II, V54, P369, DOI 10.1016/j.dsr2.2006.12.001; HINDELL MA, 1991, AUST J MAR FRESH RES, V42, P115; Hindell MA, 2003, J APPL ECOL, V40, P703, DOI 10.1046/j.1365-2664.2003.00832.x; Hindell MA, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1213; Hooker SK, 2002, MAR MAMMAL SCI, V18, P680, DOI 10.1111/j.1748-7692.2002.tb01066.x; Iwata T, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0227; Jaud T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047444; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Jouma'a J, 2015, FUNCT ECOL; Kahru M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030430; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kirkman SP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152370; KOCK KH, 1987, ENVIRON INT, V13, P37, DOI 10.1016/0160-4120(87)90042-0; Kooyman G.L., 1989, DIVERSE DIVERS PHYSL; Kuhn CE, 2009, J ANIM ECOL, V78, P513, DOI 10.1111/j.1365-2656.2008.01509.x; Lascelles BG, 2016, DIVERS DISTRIB, V22, P422, DOI 10.1111/ddi.12411; Lawson GL., 2015, ANIM BIOTELEM, V3, P22, DOI [10.1186/s40317-015-0054-7, DOI 10.1186/S40317-015-0054-7]; Le Bras Y., 2016, RBL BIOL TOOLS DIVIN; Lund U., 2012, TOPICS CIRCULAR STAT; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McIntyre T, 2014, AFR J MAR SCI, V36, P409, DOI 10.2989/1814232X.2014.976655; McIntyre T, 2013, POLAR BIOL, V36, P1693, DOI 10.1007/s00300-013-1384-7; McIntyre T, 2011, MAR BIOL, V158, P2125, DOI 10.1007/s00227-011-1719-2; McMahon CR, 2000, VET REC, V146, P251, DOI 10.1136/vr.146.9.251; MCNAMARA J, 1982, THEOR POPUL BIOL, V21, P269, DOI 10.1016/0040-5809(82)90018-1; Miller PJO, 2012, J EXP BIOL, V215, P3622, DOI 10.1242/jeb.070128; Mitani Y, 2010, BIOL LETTERS, V6, P163, DOI 10.1098/rsbl.2009.0719; Naimi B, 2021, RTS RATER TIME SERIE; Naito Y, 2010, POLAR SCI, V4, P309, DOI 10.1016/j.polar.2010.05.009; Naito Y, 2013, FUNCT ECOL, V27, P710, DOI 10.1111/1365-2435.12083; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Pakhomov E., 2010, REPORT ADVISORY PANE; Pakhomov EA, 1996, MAR ECOL PROG SER, V134, P1, DOI 10.3354/meps134001; PARKER GA, 1976, AM NAT, V110, P1055, DOI 10.1086/283126; Pinheiro J, 2015, NLME LINEAR NONLINEA; Richard G, 2014, J EXP BIOL, V217, P2609, DOI 10.1242/jeb.088542; Robinson PW, 2007, DEEP-SEA RES PT II, V54, P356, DOI 10.1016/j.dsr2.2006.11.020; Robinson PW, 2010, J ANIM ECOL, V79, P1146, DOI 10.1111/j.1365-2656.2010.01735.x; RODHOUSE PG, 1995, BIOL BULL, V189, P77, DOI 10.2307/1542457; Ropert-Coudert Y, 2001, POLAR BIOL, V24, P467, DOI 10.1007/s003000100235; Sato K, 2003, J EXP BIOL, V206, P1461, DOI 10.1242/jeb.00265; Sato K, 2004, J EXP BIOL, V207, P4057, DOI 10.1242/jeb.01265; Schreer JF, 2001, ECOL MONOGR, V71, P137, DOI 10.1890/0012-9615(2001)071[0137:CDPOPA]2.0.CO;2; signal developers, 2013, SIGNAL DEV SIGNAL SI; Sparling CE, 2007, ANIM BEHAV, V74, P207, DOI 10.1016/j.anbehav.2006.06.022; Stephens D.W., 1986, pi; Strass VH, 2002, DEEP-SEA RES PT II, V49, P3735, DOI 10.1016/S0967-0645(02)00109-1; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Thompson D, 2001, ANIM BEHAV, V61, P287, DOI 10.1006/anbe.2000.1539; Tremblay Y, 2000, MAR ECOL PROG SER, V204, P257, DOI 10.3354/meps204257; Vacquie-Garcia J, 2015, DEEP-SEA RES PT II, V113, P145, DOI 10.1016/j.dsr2.2014.10.029; Vacquie-Garcia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043565; Venables WN., 2007, MODERN APPL STAT S; Viviant M, 2016, FUNCT ECOL; Viviant M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088503; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Watanabe Y, 2006, J EXP BIOL, V209, P3269, DOI 10.1242/jeb.02402; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Williams A, 1997, MAR BIOL, V130, P259, DOI 10.1007/s002270050246; Wilson RP, 2002, MAR BIOL, V140, P17, DOI 10.1007/s002270100659	96	19	19	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167226	10.1371/journal.pone.0167226	http://dx.doi.org/10.1371/journal.pone.0167226			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973587	Green Submitted, Green Published, gold			2022-12-27	WOS:000392754300021
J	Zahedi, A; Monis, P; Aucote, S; King, B; Paparini, A; Jian, FC; Yang, RC; Oskam, C; Ball, A; Robertson, I; Ryan, U				Zahedi, Alireza; Monis, Paul; Aucote, Sarah; King, Brendon; Paparini, Andrea; Jian, Fuchun; Yang, Rongchang; Oskam, Charlotte; Ball, Andrew; Robertson, Ian; Ryan, Una			Zoonotic Cryptosporidium Species in Animals Inhabiting Sydney Water Catchments	PLOS ONE			English	Article							SPORADIC HUMAN CRYPTOSPORIDIOSIS; GENETIC-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; QUANTITATIVE PCR; RABBIT GENOTYPE; IDENTIFICATION; GIARDIA; PARVUM; HOMINIS; TRANSMISSION	Cryptosporidium is one of the most common zoonotic waterborne parasitic diseases worldwide and represents a major public health concern of water utilities in developed nations. As animals in catchments can shed human-infectious Cryptosporidium oocysts, determining the potential role of animals in dissemination of zoonotic Cryptosporidium to drinking water sources is crucial. In the present study, a total of 952 animal faecal samples from four dominant species (kangaroos, rabbits, cattle and sheep) inhabiting Sydney's drinking water catchments were screened for the presence of Cryptosporidium using a quantitative PCR (qPCR) and positives sequenced at multiple loci. Cryptosporidium species were detected in 3.6% (21/576) of kangaroos, 7.0% (10/142) of cattle, 2.3% (3/128) of sheep and 13.2% (14/106) of rabbit samples screened. Sequence analysis of a region of the 18S rRNA locus identified C. macropodum and C. hominis in 4 and 17 isolates from kangaroos respectively, C. hominis and C. parvum in 6 and 4 isolates respectively each from cattle, C. ubiquitum in 3 isolates from sheep and C. cuniculus in 14 isolates from rabbits. All the Cryptosporidium species identified were zoonotic species with the exception of C. macropodum. Subtyping using the 5' half of gp60 identified C. hominis IbA10G2 (n = 12) and IdA15G1 (n = 2) in kangaroo faecal samples; C. hominis IbA10G2 (n = 4) and C. parvum IIaA18G3R1 (n = 4) in cattle faecal samples, C. ubiquitum subtype XIIa (n = 1) in sheep and C. cuniculus VbA23 (n = 9) in rabbits. Additional analysis of a subset of samples using primers targeting conserved regions of the MIC1 gene and the 3' end of gp60 suggests that the C. hominis detected in these animals represent substantial variants that failed to amplify as expected. The significance of this finding requires further investigation but might be reflective of the ability of this C. hominis variant to infect animals. The finding of zoonotic Cryptosporidium species in these animals may have important implications for the management of drinking water catchments to minimize risk to public health.	[Zahedi, Alireza; Paparini, Andrea; Yang, Rongchang; Oskam, Charlotte; Robertson, Ian; Ryan, Una] Murdoch Univ, Sch Vet & Life Sci, Vector & Waterborne Pathogen Res Grp, Perth, WA, Australia; [Monis, Paul; King, Brendon] South Australian Water Corp, Australian Water Qual Ctr, Adelaide, SA, Australia; [Monis, Paul; Aucote, Sarah; King, Brendon] Flinders Univ S Australia, Sch Med, Bedford Pk, SA, Australia; [Jian, Fuchun] Henan Agr Univ, Zhengzhou, Henan, Peoples R China; [Ball, Andrew] WaterNSW, Sydney, NSW, Australia	Murdoch University; Flinders University South Australia; Henan Agricultural University	Zahedi, A (corresponding author), Murdoch Univ, Sch Vet & Life Sci, Vector & Waterborne Pathogen Res Grp, Perth, WA, Australia.	a.zahediabdi@murdoch.edu.au	Yang, Rongchang/AAJ-4557-2020; Paparini, Andrea/T-8057-2019; Ball, Andrew S/I-3389-2013; Monis, Paul T/B-8539-2011; Oskam, Charlotte/N-4097-2018	Monis, Paul T/0000-0002-9052-4742; Oskam, Charlotte/0000-0001-8886-2120; Zahedi, Alireza/0000-0002-0165-3797; Robertson, Ian/0000-0002-4255-4752; Paparini, Andrea/0000-0002-1105-5184; Yang, Rongchang/0000-0003-2563-2015; Ryan, Una/0000-0003-2710-9324	Australian Research Council Linkage Grant [LP130100035]; WaterNSW	Australian Research Council Linkage Grant(Australian Research Council); WaterNSW	This study was financially supported by an Australian Research Council Linkage Grant number LP130100035. WaterNSW are an Industry Partner on this ARC Linkage grant and the funder contributed financial support in the form of salaries for authors [AP] and laboratory work. WaterNSW played a significant role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of WaterNSW authors [AB] are articulated in the 'author contributions' section.	Abeywardena H, 2015, ADV PARASIT, V88, P243, DOI 10.1016/bs.apar.2015.02.001; Abeywardena H, 2013, INFECT GENET EVOL, V20, P96, DOI 10.1016/j.meegid.2013.07.019; Abeywardena H, 2013, ELECTROPHORESIS, V34, P2259, DOI 10.1002/elps.201300146; Abeywardena H, 2012, INFECT GENET EVOL, V12, P1984, DOI 10.1016/j.meegid.2012.08.004; Alagappan A, 2008, J MICROBIOL METH, V75, P535, DOI 10.1016/j.mimet.2008.08.007; Alves M, 2003, J CLIN MICROBIOL, V41, P2744, DOI 10.1128/JCM.41.6.2744-2747.2003; ANOFEL Cryptosporidium National Network, 2010, Euro Surveill, V15, P19642; Baldursson S, 2011, WATER RES, V45, P6603, DOI 10.1016/j.watres.2011.10.013; Bhalchandra S, 2013, INFECT IMMUN, V81, P3356, DOI 10.1128/IAI.00436-13; Caccio S, 2001, INT J PARASITOL, V31, P1082, DOI 10.1016/S0020-7519(01)00233-8; Chalmers RM, 2011, EMERG INFECT DIS, V17, P536, DOI 10.3201/eid1703.100410; Chalmers RM, 2009, EMERG INFECT DIS, V15, P829, DOI 10.3201/eid1505.081419; Chalmers RM, 2005, INT J PARASITOL, V35, P397, DOI 10.1016/j.ijpara.2005.01.001; Cinque K, 2008, WATER SCI TECHNOL, V58, P127, DOI 10.2166/wst.2008.632; Cox P, 2005, APPL ENVIRON MICROB, V71, P5929, DOI 10.1128/AEM.71.10.5929-5934.2005; Davies CM, 2003, APPL ENVIRON MICROB, V69, P2842, DOI 10.1128/AEM.69.5.2842-2847.2003; Dowle M, 2013, VET PARASITOL, V198, P197, DOI 10.1016/j.vetpar.2013.08.017; Elwin K, 2012, EPIDEMIOL INFECT, V140, P673, DOI 10.1017/S0950268811000860; Feng YY, 2007, VET PARASITOL, V144, P1, DOI 10.1016/j.vetpar.2006.10.001; Feng YY, 2014, J CLIN MICROBIOL, V52, P524, DOI 10.1128/JCM.02973-13; Guo YQ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1517-1; Hadfield SJ, 2011, J CLIN MICROBIOL, V49, P918, DOI 10.1128/JCM.01733-10; Hill NJ, 2008, APPL ENVIRON MICROB, V74, P5549, DOI 10.1128/AEM.00809-08; Holubova N, 2016, PARASITOL RES, V115, P2243, DOI 10.1007/s00436-016-4967-8; Jex AR, 2008, J CLIN MICROBIOL, V46, P2252, DOI 10.1128/JCM.00116-08; Jex AR, 2007, ELECTROPHORESIS, V28, P3875, DOI 10.1002/elps.200700279; Jex AR, 2012, MOL CELL PROBE, V26, P11, DOI 10.1016/j.mcp.2011.10.004; Josephine SYN, 2012, EXP PARASITOL, V130, P437, DOI 10.1016/j.exppara.2012.01.014; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; King BJ, 2007, PARASITOLOGY, V134, P309, DOI 10.1017/S0031182006001491; King BJ, 2005, APPL ENVIRON MICROB, V71, P3848, DOI 10.1128/AEM.71.7.3848-3857.2005; Koehler AV, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0492-8; Koehler AV, 2014, ELECTROPHORESIS, V35, P2600, DOI 10.1002/elps.201400225; Koehler AV, 2013, ELECTROPHORESIS, V34, P1720, DOI 10.1002/elps.201300100; Kvac M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147090; Li N, 2014, EMERG INFECT DIS, V20, P217, DOI 10.3201/eid2002.121797; Li XD, 2015, INT J PARASITOL-PAR, V4, P343, DOI 10.1016/j.ijppaw.2015.08.005; McCarthy S, 2008, EXP PARASITOL, V118, P596, DOI 10.1016/j.exppara.2007.10.014; Molloy SF, 2010, AM J TROP MED HYG, V82, P608, DOI 10.4269/ajtmh.2010.09-0624; Morgan UM, 1997, J PARASITOL, V83, P825, DOI 10.2307/3284275; Ng J, 2008, EXP PARASITOL, V119, P192, DOI 10.1016/j.exppara.2008.01.010; Ng J, 2011, EXP PARASITOL, V128, P138, DOI 10.1016/j.exppara.2011.02.013; Ng J, 2011, VET PARASITOL, V176, P145, DOI 10.1016/j.vetpar.2010.10.056; Ng JSY, 2010, EXP PARASITOL, V125, P325, DOI 10.1016/j.exppara.2010.02.012; Ng-Hublin JSY, 2015, EPIDEMIOL INFECT, V143, P1037, DOI 10.1017/S095026881400106X; Ng-Hublin JSY, 2013, J CLIN MICROBIOL, V51, P2463, DOI 10.1128/JCM.00424-13; Nolan MJ, 2013, WATER RES, V47, P1726, DOI 10.1016/j.watres.2012.12.027; Nolan MJ, 2010, INFECT GENET EVOL, V10, P1179, DOI 10.1016/j.meegid.2010.07.020; O'Brien E, 2008, EXP PARASITOL, V118, P118, DOI 10.1016/j.exppara.2007.05.012; Operario DJ, 2015, AM J TROP MED HYG, V92, P45, DOI 10.4269/ajtmh.14-0488; Park Jae-Hwan, 2006, Korean Journal of Parasitology, V44, P27, DOI 10.3347/kjp.2006.44.1.27; Peng MM, 2003, PARASITOL RES, V90, P175, DOI 10.1007/s00436-003-0834-5; Power ML, 2004, INFECT GENET EVOL, V4, P59, DOI 10.1016/j.meegid.2004.01.002; Power ML, 2011, FEMS MICROBIOL LETT, V314, P34, DOI 10.1111/j.1574-6968.2010.02134.x; Power ML, 2005, APPL ENVIRON MICROB, V71, P6159, DOI 10.1128/AEM.71.10.6159-6164.2005; Puleston RL, 2014, J WATER HEALTH, V12, P41, DOI 10.2166/wh.2013.097; Putignani L, 2008, MOL BIOCHEM PARASIT, V157, P98, DOI 10.1016/j.molbiopara.2007.09.004; Robertson B, 2002, EPIDEMIOL INFECT, V128, P419, DOI 10.1017/S0950268802006933; Robinson G, 2008, EMERG INFECT DIS, V14, P1800, DOI 10.3201/eid1411.080239; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Ryan U, 2015, INT J PARASITOL, V45, P367, DOI 10.1016/j.ijpara.2015.01.009; Ryan U, 2012, PARASITOLOGY, V139, P1673, DOI 10.1017/S0031182012001151; Segura R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121753; Sharma P, 2013, INT J INFECT DIS, V 17, pE601, DOI 10.1016/j.ijid.2012.12.003; Silva SOS, 2013, EXP PARASITOL, V135, P551, DOI 10.1016/j.exppara.2013.09.003; Smith HV, 2005, VET REC, V156, P710, DOI 10.1136/vr.156.22.710; Strong WB, 2000, INFECT IMMUN, V68, P4117, DOI 10.1128/IAI.68.7.4117-4134.2000; Swaffer BA, 2014, WATER RES, V67, P310, DOI 10.1016/j.watres.2014.08.055; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Triggs B., 2004, TRACKS SCATS OTHER T; U. S. Environment Protection Agency, 2012, 1623 US EPA OFF WAT; Vermeulen ET, 2015, INT J PARASITOL-PAR, V4, P190, DOI 10.1016/j.ijppaw.2015.02.005; Waldron LS, 2009, EXP PARASITOL, V122, P124, DOI 10.1016/j.exppara.2009.02.006; Waldron LS, 2009, APPL ENVIRON MICROB, V75, P108, DOI 10.1128/AEM.01341-08; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7766, DOI 10.1128/AEM.00616-11; Waldron LS, 2011, APPL ENVIRON MICROB, V77, P7757, DOI 10.1128/AEM.00615-11; Waldron LS, 2010, EMERG INFECT DIS, V16, P2006, DOI 10.3201/eid1612.100715; Webber MA, 2014, ZOONOSES PUBLIC HLTH, V61, P324, DOI 10.1111/zph.12074; Xiao LH, 2000, APPL ENVIRON MICROB, V66, P5492, DOI 10.1128/AEM.66.12.5492-5498.2000; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018; Yang RC, 2014, INT J PARASITOL, V44, P1105, DOI 10.1016/j.ijpara.2014.08.004; Yang RC, 2014, VET PARASITOL, V200, P50, DOI 10.1016/j.vetpar.2013.11.014; Yang RC, 2013, EXP PARASITOL, V135, P142, DOI 10.1016/j.exppara.2013.06.014; Yang RC, 2011, VET PARASITOL, V179, P22, DOI 10.1016/j.vetpar.2011.02.011; Yoder JS, 2010, EXP PARASITOL, V124, P31, DOI 10.1016/j.exppara.2009.09.020; Zahedi A, 2016, INT J PARASITOL-PAR, V5, P88, DOI 10.1016/j.ijppaw.2015.12.001; Zhou L, 2003, J CLIN MICROBIOL, V41, P5254, DOI 10.1128/JCM.41.11.5254-5257.2003	87	37	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168169	10.1371/journal.pone.0168169	http://dx.doi.org/10.1371/journal.pone.0168169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973572	gold, Green Published, Green Accepted			2022-12-27	WOS:000392754300061
J	Diaz, EH; Yachnin, J; Gronberg, H; Lindberg, J				Diaz, Emanuela Henao; Yachnin, Jeffrey; Gronberg, Henrik; Lindberg, Johan			The In Vitro Stability of Circulating Tumour DNA	PLOS ONE			English	Article							CELL-FREE DNA; PLASMA	Objective DNA from apoptotic cancer cells, present in the circulation, has the potential to facilitate genomic profiling and disease monitoring. However, only low fractions of total cell-free DNA originates from cancer cells, limiting the applicability of circulating tumour DNA (ctDNA). Optimal sample processing is consequently of uttermost importance. Therefore, we evaluated the in vitro stability of ctDNA. Experimental design Blood was collected in 10 ml EDTA or Streck tubes. Three conditions (EDTA and Streck tubes in room temperature, EDTA tubes at five degrees) and four time points (plasma harvested from blood aliquots of each 10 ml tube in a time series up to 24 h) were investigated. Each condition was evaluated in five metastatic prostate cancer patients. Subsequently, three additional patients were collected enabling investigation of the in vitro stability in EDTA tubes up to 48 h. Methods The in vitro stability of ctDNA was interrogated by low-pass whole genome sequencing which allows for the identification of somatic copy-number alterations (CNAs). In silico simulations demonstrated that non-parametric testing could detect a 1% contamination by white blood cell DNA. Mutational profiling was performed by targeted, in-solution based hybridization capture and subsequent sequencing. The allelic fraction of individual mutations was used as an estimate of the in vitro stability. Results Somatic CNAs were detected in all patients. Surprisingly, the ctDNA levels at zero hours were not significantly different to 24 or 48 hour in vitro incubation in any investigated condition. Subsequently, mutational profiling corroborated the conclusions from the CNA analysis. Conclusions The stability of ctDNA simplifies logistics without the requirement of immediate processing or applying fixatives to prevent white blood cell lysis.	[Diaz, Emanuela Henao; Lindberg, Johan] Karolinska Inst, Dept Med Epidemiol & Biostat, Sci Life Lab, Stockholm, Sweden; [Yachnin, Jeffrey] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Yachnin, Jeffrey] Univ Hosp, Stockholm, Sweden; [Gronberg, Henrik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Lindberg, J (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Sci Life Lab, Stockholm, Sweden.	johan.lindberg@ki.se		Lindberg, Johan/0000-0003-3610-6774	AstraZeneca-Karolinska Insitutet Joint Research Program in Translational Science [2360/12]; Swedish Research Council [K2010-70X-20430-04-3]; Swedish Cancer Foundation [09-0677]	AstraZeneca-Karolinska Insitutet Joint Research Program in Translational Science; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation	This study was supported by AstraZeneca-Karolinska Insitutet Joint Research Program in Translational Science (grant number 2360/12); the Swedish Research Council (grant number K2010-70X-20430-04-3) and the Swedish Cancer Foundation (grant number 09-0677). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett AN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025202; Buysse K, 2013, CLIN BIOCHEM, V46, P1783, DOI 10.1016/j.clinbiochem.2013.07.020; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Fernando MR, 2010, PRENAT DIAGN, V30; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Hodgkinson CL, 2014, NAT MED, P1; Jahr S, 2001, CANCER RES, V61, P1659; Kang Q, 2016, CLIN BIOCHEM, P1; Lai ZW, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw227; Le DT, 2015, NEW ENGL J MED; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindberg J, 2013, EUR UROL, V63, P347, DOI 10.1016/j.eururo.2012.03.050; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; Newman AM, 2014, NAT MED, P1; Norton SE, 2013, CLIN BIOCHEM, V46, P1561, DOI 10.1016/j.clinbiochem.2013.06.002; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rothwell DG, 2015, MOL ONCOLOGY, P1; Scheinin I, 2014, GENOME RES, V24, P2022, DOI 10.1101/gr.175141.114; Snyder MW, 2016, CELL, V164, P57, DOI 10.1016/j.cell.2015.11.050; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Team R.C, R LANG ENV STAT COMP	27	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168153	10.1371/journal.pone.0168153	http://dx.doi.org/10.1371/journal.pone.0168153			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959945	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900040
J	Moon, Y; Kwon, J; Jeong, DW; Lee, JY; Lee, JR; Han, S; Kook, MS				Moon, Yeji; Kwon, Junki; Jeong, Da Woon; Lee, Jin Young; Lee, Jong Rak; Han, Seungbong; Kook, Michael S.			Circadian Patterns of Intraocular Pressure Fluctuation among Normal-Tension Glaucoma Optic Disc Phenotypes	PLOS ONE			English	Article							OCULAR PERFUSION-PRESSURE; OPEN-ANGLE GLAUCOMA; VISUAL-FIELD PROGRESSION; RISK-FACTOR; COHERENCE TOMOGRAPHY; NOCTURNAL ELEVATION; CHOROIDAL THICKNESS; DIURNAL-VARIATION; 24-HOUR PATTERN; BLOOD-PRESSURE	Objective To characterize the 24-h habitual-position intraocular pressure (IOP) patterns of optic disc phenotypes (ODPs) in untreated normal-tension glaucoma (NTG) and the relationships between nocturnal IOP elevation and various clinical factors. Design Prospective, cross-sectional, observational study. Methods Eighty-two NTG patients with focal ischemic (FI) ODP and 82 age-and disease severity-matched NTG patients with myopic glaucomatous (MG) ODP were recruited prospectively over 3 years. The IOP was recorded 11 times over a 24-hour (h) period by a single ophthalmologist using a hand-held tonometer (TonoPen (R) XL). A cosinor model was used to describe the 24-h IOP rhythm. Associations between nocturnal IOP elevation and both ocular and demographic variables were evaluated using the generalized estimating equation (GEE). Results Mean habitual-position IOP was significantly higher during nighttime than daytime in the FI group (16.44 vs. 14.23 mmHg, P < 0.001), but not in the MG group (15.91 vs. 15.70 mmHg, P = 0.82). The FI group also exhibited a significantly higher peak IOP during sleeping hours (P = 0.01) and lower trough IOP during the 24-h period than the MG group (P < 0.01). The MG group showed a significantly higher peak IOP during waking hours than the FI group (P < 0.01). Therefore, 24-h IOP fluctuation range was significantly higher in the FI group than the MG group (P = 0.013). In the FI group, peak habitual-position IOP and the highest frequency of IOP peaks occurred during sleeping hours (12 AM-6 AM). By contrast, IOP peaks in the MG group occurred during morning hours (8 AM-12 PM). The FI group showed an overall nocturnal acrophase in habitual-position IOP, with 45 patients (54.9%) having a nocturnal acrophase; 10 (12.2%), a diurnal acrophase; and 27 (32.9%), no evident acrophase. By contrast, the MG group showed no evident peak in habitual-position IOP, with 9 patients (10.9%) having a nocturnal acrophase; 43 (52.4%), a diurnal acrophase; and 30 (36.6%), no evident acrophase. In multivariate modeling using the GEE, ODP (P < 0.001) and spherical equivalent (SE, P = 0.001) were independently associated with nocturnal IOP elevation. Conclusions Based on 24-h habitual-position IOP data, FI is associated with significant nocturnal IOP elevation, while no such nocturnal IOP elevation is observed in MG ODP. In untreated NTG, there are also significant differences in the 24-h IOP pattern between FI and MG ODPs.	[Moon, Yeji; Kwon, Junki; Jeong, Da Woon; Lee, Jin Young; Lee, Jong Rak; Kook, Michael S.] Univ Ulsan, Dept Ophthalmol, Coll Med, Asan Med Ctr, Seoul, South Korea; [Han, Seungbong] Gachon Univ, Dept Appl Stat, Seongnam Si, Gyeonggi Do, South Korea	University of Ulsan; Gachon University	Kook, MS (corresponding author), Univ Ulsan, Dept Ophthalmol, Coll Med, Asan Med Ctr, Seoul, South Korea.	mskook@amc.seoul.kr		Moon, Yeji/0000-0002-9553-2231				Bagga H, 2009, CURR OPIN OPHTHALMOL, V20, P79, DOI 10.1097/ICU.0b013e32831eef4f; Barkana Y, 2006, ARCH OPHTHALMOL-CHIC, V124, P793, DOI 10.1001/archopht.124.6.793; Bhan A, 2002, INVEST OPHTH VIS SCI, V43, P1389; Blondeau P, 2001, J GLAUCOMA, V10, P18, DOI 10.1097/00061198-200102000-00005; Broadway DC, 1998, BRIT J OPHTHALMOL, V82, P862, DOI 10.1136/bjo.82.8.862; Chen FK, 2012, INVEST OPHTH VIS SCI, V53, P975, DOI 10.1167/iovs.11-8771; Choi J, 2006, INVEST OPHTH VIS SCI, V47, P831, DOI 10.1167/iovs.05-1053; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P104, DOI 10.1167/iovs.06-0615; De Moraes CG, 2012, AM J OPHTHALMOL, V154, P702, DOI 10.1016/j.ajo.2012.04.015; Deokule SP, 2009, OPHTHALMOLOGY, V116, P833, DOI 10.1016/j.ophtha.2008.10.034; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jeong DW, 2014, INVEST OPHTH VIS SCI, V55, P2148, DOI 10.1167/iovs.13-13607; Kida T, 2006, INVEST OPHTH VIS SCI, V47, P4422, DOI 10.1167/iovs.06-0507; Kim CS, 2011, OPHTHALMOLOGY, V118, P1024, DOI 10.1016/j.ophtha.2010.10.016; Kim YJ, 2013, EXP EYE RES, V115, P65, DOI 10.1016/j.exer.2013.06.010; Kleinstein RN, 2003, ARCH OPHTHALMOL-CHIC, V121, P1141, DOI 10.1001/archopht.121.8.1141; Kook MS, 2002, GRAEF ARCH CLIN EXP, V240, P448, DOI 10.1007/s00417-002-0472-0; Kook MS, 2001, BRIT J OPHTHALMOL, V85, P1167, DOI 10.1136/bjo.85.10.1167; Lam CSY, 2004, OPTOMETRY VISION SCI, V81, P317, DOI 10.1097/01.opx.0000134905.98403.18; Lee J, 2014, J GLAUCOMA, V23, P553, DOI 10.1097/IJG.0b013e31829484c6; Lee JR, 2016, J GLAUCOMA, V25, P330, DOI 10.1097/IJG.0000000000000218; Lee YR, 2012, INVEST OPHTH VIS SCI, V53, P881, DOI 10.1167/iovs.11-7846; Lin LLK, 1999, OPTOMETRY VISION SCI, V76, P275, DOI 10.1097/00006324-199905000-00013; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P4439, DOI 10.1167/iovs.03-0349; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P1586, DOI 10.1167/iovs.02-0666; Liu JHK, 1998, INVEST OPHTH VIS SCI, V39, P2707; Liu JHK, 1999, INVEST OPHTH VIS SCI, V40, P2912; Liu JHK, 2002, INVEST OPHTH VIS SCI, V43, P2351; Liu JHK, 2014, INVEST OPHTH VIS SCI, V55, P7398, DOI 10.1167/iovs.14-14464; Mallery JS, 2002, GASTROINTEST ENDOSC, V56, P218, DOI 10.1067/mge.2002.125826; MCBRIEN NA, 1994, EXP EYE RES, V59, P475, DOI 10.1006/exer.1994.1133; McBrien NA, 2001, INVEST OPHTH VIS SCI, V42, P2179; Moon Y, 2015, INVEST OPHTH VIS SCI, V56, P5271, DOI 10.1167/iovs.15-17062; Na JH, 2012, GRAEF ARCH CLIN EXP, V250, P595, DOI 10.1007/s00417-011-1864-9; Nakazawa T, 2010, JPN J OPHTHALMOL, V54, P291, DOI 10.1007/s10384-010-0816-y; Nicolela MT, 1996, OPHTHALMOLOGY, V103, P640, DOI 10.1016/S0161-6420(96)30640-4; Noel C, 2001, OPHTHALMOLOGY, V108, P139, DOI 10.1016/S0161-6420(00)00411-5; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Reis ASC, 2012, OPHTHALMOLOGY, V119, P294, DOI 10.1016/j.ophtha.2011.07.040; Renard E, 2010, INVEST OPHTH VIS SCI, V51, P882, DOI 10.1167/iovs.09-3668; Sakata R, 2013, INVEST OPHTH VIS SCI, V54, P5313, DOI 10.1167/iovs.13-11792; Sakata R, 2013, J GLAUCOMA, V22, P250, DOI 10.1097/IJG.0b013e31823298fb; Sit AJ, 2008, INVEST OPHTH VIS SCI, V49, P1473, DOI 10.1167/iovs.07-1139; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Sung KR, 2009, INVEST OPHTH VIS SCI, V50, P5266, DOI 10.1167/iovs.09-3716; Vincent SJ, 2013, INVEST OPHTH VIS SCI, V54, P2445, DOI 10.1167/iovs.12-11434; YAMAGAMI J, 1993, OPHTHALMOLOGY, V100, P643; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	51	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168030	10.1371/journal.pone.0168030	http://dx.doi.org/10.1371/journal.pone.0168030			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959943	gold, Green Submitted, Green Published			2022-12-27	WOS:000392753900034
J	Ueda, K; Kasao, M; Shimamura, M; Haruta, H; Nitta, S; Kaneko, M; Uemura, Y; Morita, H; Komuro, I; Shirai, T				Ueda, Kazutaka; Kasao, Masashi; Shimamura, Motoaki; Haruta, Hironori; Nitta, Shuya; Kaneko, Mitsunobu; Uemura, Yukari; Morita, Hiroyuki; Komuro, Issei; Shirai, Tetsuro			Impact of Oral Treatment on Physical Function in Older Patients Hospitalized for Heart Failure: A Randomized Clinical Trial	PLOS ONE			English	Article							MORTALITY; SURVIVAL; PREDICTION; VALIDATION; TOLVAPTAN; OUTCOMES; FRAILTY	Background Frailty is a characteristic of older patients with heart failure, who undergo functional decline during hospitalization. At present, continuous intravenous infusion of diuretics is widely used for the treatment of hospitalized patients with heart failure. In this prospective, randomized, open-label controlled trial, we tested whether an early switch from continuous intravenous infusion therapy to oral treatment with diuretics prevents functional decline in patients hospitalized for heart failure. Methods A total of 59 patients hospitalized for heart failure were randomized to either continuous intravenous infusion (n = 30) or oral medication (n = 29) within 48 h of admission. The primary outcome was the Barthel index, a universally utilized scale to assess the functional status of patients in their activities of daily living, assessed at 10 days. Secondary outcomes included the number of daily steps counted using pedometers and average hospital costs. Results Barthel index scores were significantly higher in the oral medication group than in the intravenous group (78.1 +/- 20.8 vs. 59.6 +/- 34.2, P = 0.029). The number of daily steps was significantly higher in the oral treatment group relative to the intravenous group (P < 0.001), and the average hospital costs were similar between the randomized groups. Multivariate analysis revealed that oral medication was a significant independent predictor of Barthel index score at day 10, and the number of daily steps was significantly associated with the patient's functional outcome. Conclusions This trial showed that, in patients hospitalized for heart failure, oral medication increased functional independence during hospitalization compared with sustained continuous intravenous infusion, most likely because the release from the infusion line enabled the patients to be more mobile. Notably, these beneficial effects were achieved without increasing hospital costs.	[Ueda, Kazutaka; Kasao, Masashi; Shimamura, Motoaki; Haruta, Hironori; Nitta, Shuya; Kaneko, Mitsunobu; Shirai, Tetsuro] Tokyo Metropolitan Police Hosp, Dept Cardiol, Tokyo, Japan; [Ueda, Kazutaka; Morita, Hiroyuki; Komuro, Issei] Tokyo Univ Hosp, Dept Cardiovasc Med, Tokyo, Japan; [Uemura, Yukari] Tokyo Univ Hosp, Clin Res Support Ctr, Cent Coordinating Unit, Biostat Div, Tokyo, Japan	University of Tokyo; University of Tokyo	Ueda, K (corresponding author), Tokyo Metropolitan Police Hosp, Dept Cardiol, Tokyo, Japan.	uedak-tky@umin.ac.jp		ueda, kazutaka/0000-0002-0509-1840	Nakatomi Foundation	Nakatomi Foundation	This work was supported by a grant from The Nakatomi Foundation, and the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all the nurses in the cardiology ward at Tokyo Metropolitan Police Hospital for data collection. This work was supported by a grant from The Nakatomi Foundation. The authors have no conflicts of interest to declare.	Aaronson KD, 1997, CIRCULATION, V95, P2660, DOI 10.1161/01.CIR.95.12.2660; Afilalo J, 2014, J AM COLL CARDIOL, V63, P747, DOI 10.1016/j.jacc.2013.09.070; Barnes DE, 2013, J GEN INTERN MED, V28, P261, DOI 10.1007/s11606-012-2226-y; Bootsma AM, 2013, J AM MED DIR ASSOC, V14, P147; Chiarantini D, 2010, J CARD FAIL, V16, P390, DOI 10.1016/j.cardfail.2010.01.004; Collard RM, 2012, J AM GERIATR SOC, V60, P1487, DOI 10.1111/j.1532-5415.2012.04054.x; Formiga F, 2007, CARDIOLOGY, V108, P73, DOI 10.1159/000095885; Klein L, 2005, CIRCULATION, V111, P2454, DOI 10.1161/01.CIR.0000165065.82609.3D; Koelling TM, 2004, AM HEART J, V147, P74, DOI 10.1016/j.ahj.2003.07.021; Kortebein P, 2007, JAMA-J AM MED ASSOC, V297, P1772, DOI 10.1001/jama.297.16.1772-b; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; MAHONEY F I, 1965, Md State Med J, V14, P61; Mozaffarian D, 2015, CIRCULATION, V131, P434, DOI 10.1161/CIR.0000000000000157; Peacock WF, 2009, CARDIOLOGY, V113, P12, DOI 10.1159/000164149; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Suzuki S, 2013, J CLIN PHARMACOL, V53, P1277, DOI 10.1002/jcph.197	18	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167933	10.1371/journal.pone.0167933	http://dx.doi.org/10.1371/journal.pone.0167933			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959941	gold, Green Published, Green Submitted			2022-12-27	WOS:000392753900025
J	Dietrich, N; Kolibabka, M; Busch, S; Bugert, P; Kaiser, U; Lin, J; Fleming, T; Morcos, M; Klein, T; Schlotterer, A; Hammes, HP				Dietrich, Nadine; Kolibabka, Matthias; Busch, Stephanie; Bugert, Petra; Kaiser, Ulrike; Lin, Jihong; Fleming, Thomas; Morcos, Michael; Klein, Thomas; Schlotterer, Andrea; Hammes, Hans-Peter			The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy	PLOS ONE			English	Article							RECEPTOR AGONISTS; OXIDATIVE STRESS; METHYLGLYOXAL; PATHWAYS; INTERLEUKIN-1-BETA; DEGENERATION; LIRAGLUTIDE; ACTIVATION; BIOLOGY; CELLS	Background/aims Dipeptidyl peptidase 4 (DPP4) inhibitors improve glycemic control in type 2 diabetes, however, their influence on the retinal neurovascular unit remains unclear. Methods Vasculo-and neuroprotective effects were assessed in experimental diabetic retinopathy and high glucose-cultivated C. elegans, respectively. In STZ-diabetic Wistar rats (diabetes duration of 24 weeks), DPP4 activity (fluorometric assay), GLP-1 (ELISA), methylglyoxal (LC-MS/MS), acellular capillaries and pericytes (quantitative retinal morphometry), SDF-1a and heme oxygenase-1 (ELISA), HMGB-1, Iba1 and Thy1.1 (immunohistochemistry), nuclei in the ganglion cell layer, GFAP (western blot), and IL-1beta, Icam1, Cxcr4, catalase and beta-actin (quantitative RT-PCR) were determined. In C. elegans, neuronal function was determined using worm tracking software. Results Linagliptin decreased DPP4 activity by 77% and resulted in an 11.5-fold increase in active GLP-1. Blood glucose and HbA(1c) were reduced by 13% and 14% and retinal methylglyoxal by 66%. The increase in acellular capillaries was diminished by 70% and linagliptin prevented the loss of pericytes and retinal ganglion cells. The rise in Iba-1 positive microglia was reduced by 73% with linagliptin. In addition, the increase in retinal Il1b expression was decreased by 65%. As a functional correlate, impairment of motility (body bending frequency) was significantly prevented in C. elegans. Conclusion Our data suggest that linagliptin has a protective effect on the microvasculature of the diabetic retina, most likely due to a combination of neuroprotective and antioxidative effects of linagliptin on the neurovascular unit.	[Dietrich, Nadine; Kolibabka, Matthias; Busch, Stephanie; Bugert, Petra; Kaiser, Ulrike; Lin, Jihong; Morcos, Michael; Schlotterer, Andrea; Hammes, Hans-Peter] Heidelberg Univ, Univ Med Mannheim, Med Dept 5, Mannheim, Germany; [Fleming, Thomas] Heidelberg Univ, Dept Med 1, Heidelberg, Germany; [Klein, Thomas] Boehringer Ingelheim Pharma GmbH & Co KG, Dept CardioMetab Dis Res, Biberach, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Boehringer Ingelheim	Hammes, HP (corresponding author), Heidelberg Univ, Univ Med Mannheim, Med Dept 5, Mannheim, Germany.	hp.hammes@umm.de	Schlotterer, Andrea/GWC-7442-2022; Hammes, Hans-Peter/S-3719-2019; Kolibabka, Matthias/T-5812-2017	Kolibabka, Matthias/0000-0001-6741-5436	German Research Foundation (International Research Training group) [880, 1874]; German Research Foundation (Collaborative Research Center 1118) [GRK 1874-1]; Boehringer Ingelheim	German Research Foundation (International Research Training group); German Research Foundation (Collaborative Research Center 1118); Boehringer Ingelheim(Boehringer Ingelheim)	This work was supported by fellowships from the German Research Foundation (International Research Training group 880 and 1874), a grant from the German Research Foundation (Collaborative Research Center 1118, Project C03), "Reactive metabolites as cause of diabetic complications" and GRK 1874-1 "DIAMICOM", and a grant from Boehringer Ingelheim; https://www.klinikum.uni-heidelberg.de/Willkommen.132204.0.html, http://www.umm.uni-heidelberg.de/ag/grk880/, http://www.umm.uni-heidelberg.de/ag/grk1874/. The funder provided support in the form of salaries for authors ND and PB. The specific roles of these authors are articulated in the 'author contribution' section.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Antonetti DA, 2012, NEW ENGL J MED, V366, P1227, DOI 10.1056/NEJMra1005073; Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Butler JM, 2005, J CLIN INVEST, V115, P86, DOI 10.1172/JCI200522869; Castilho AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042428; Chrysant SG, 2012, AM J CARDIOL, V109, P1681, DOI 10.1016/j.amjcard.2012.01.398; Deshane J, 2007, J EXP MED, V204, P605, DOI 10.1084/jem.20061609; Dietrich Nadine, 2012, Methods Mol Biol, V933, P291, DOI 10.1007/978-1-62703-068-7_19; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Giacco F, 2015, DIABETES, V64, P3273, DOI 10.2337/db15-0084; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Giordano CR, 2015, INVEST OPHTH VIS SCI, V56, P3095, DOI 10.1167/iovs.14-16194; Gupta SK, 2011, J OCUL PHARMACOL TH, V27, P123, DOI 10.1089/jop.2010.0123; Haluzik M, 2013, INT J ENDOCRINOL, V2013, DOI [10.1155/2013/, DOI 10.1155/2013/985102]; Hammes HP, 2003, NAT MED, V9, P294, DOI 10.1038/nm834; Hernandez C, 2016, DIABETES, V65, P172, DOI 10.2337/db15-0443; Ishibashi Y, 2010, BIOCHEM BIOPH RES CO, V391, P1405, DOI 10.1016/j.bbrc.2009.12.075; Kimura R, 2009, NEUROSCIENCE, V162, P1212, DOI 10.1016/j.neuroscience.2009.05.025; Kowluru RA, 2004, INVEST OPHTH VIS SCI, V45, P4161, DOI 10.1167/iovs.04-0633; Kowluru RA, 2004, BRIT J OPHTHALMOL, V88, P1343, DOI 10.1136/bjo.2003.038133; Kroller-Schon S, CARDIOVASC RES; Li YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032008; Liu Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031406, 10.1371/journal.pone.0048083]; Lu M, 1999, INVEST OPHTH VIS SCI, V40, P1808; MCLELLAN AC, 1992, ANAL BIOCHEM, V206, P17, DOI 10.1016/S0003-2697(05)80005-3; McVicar CM, 2011, DIABETES, V60, P2995, DOI 10.2337/db11-0026; Mendler M, 2012, EXP CLIN ENDOCR DIAB, V120, P182, DOI 10.1055/s-0032-1304570; Morcos M, 2008, AGING CELL, V7, P260, DOI 10.1111/j.1474-9726.2008.00371.x; Mustata GT, 2005, DIABETES, V54, P517, DOI 10.2337/diabetes.54.2.517; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Oeseburg H, 2010, ARTERIOSCL THROM VAS, V30, P1407, DOI 10.1161/ATVBAHA.110.206425; Pfister F, 2008, DIABETES, V57, pA234, DOI 10.2337/db08-0325; Rabbani N, 2011, SEMIN CELL DEV BIOL, V22, P309, DOI 10.1016/j.semcdb.2011.02.015; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Schwartz EA, 2010, ATHEROSCLEROSIS, V212, P217, DOI 10.1016/j.atherosclerosis.2010.05.028; Silva RLE, 2007, FASEB J, V21, P3219, DOI 10.1096/fj.06-7359com; Takai S, 2014, J PHARM SCI; Tang J, 2011, PROG RETIN EYE RES, V30, P343, DOI 10.1016/j.preteyeres.2011.05.002; Thomas L, 2008, J PHARMACOL EXP THER, V325, P175, DOI 10.1124/jpet.107.135723; Ussher JR, 2012, ENDOCR REV, V33, P187, DOI 10.1210/er.2011-1052; Vincent JA, 2007, DIABETES, V56, P224, DOI 10.2337/db06-0427; Wang J, 2014, ACTA DIABETOL, V51, P813, DOI 10.1007/s00592-014-0616-9; Wang Q, 2011, CELL PHYSIOL BIOCHEM, V27, P769, DOI 10.1159/000330085; Wongchai K, 2016, HORM METAB RES, V48, P70, DOI 10.1055/s-0035-1549876; Zhang Y, 2011, INVEST OPHTH VIS SCI, V52, P278, DOI 10.1167/iovs.09-4727; Zong HL, 2011, CURR DIABETES REP, V11, P244, DOI 10.1007/s11892-011-0198-7	49	38	41	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167853	10.1371/journal.pone.0167853	http://dx.doi.org/10.1371/journal.pone.0167853			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942008	Green Submitted, Green Published, gold			2022-12-27	WOS:000392745600035
J	Herring, G; Eagles-Smith, CA; Wagner, MT				Herring, Garth; Eagles-Smith, Collin A.; Wagner, Mason T.			Ground Squirrel Shooting and Potential Lead Exposure in Breeding Avian Scavengers	PLOS ONE			English	Article							COEUR-DALENE RIVER; BULLET FRAGMENTS; RIFLE BULLETS; PB EXPOSURE; BLOOD-LEAD; GROWTH; WILDLIFE; EAGLES; SHOT; APPLICABILITY	Recreational ground squirrel shooting is a popular activity throughout the western United States and serves as a tool for managing ground squirrel populations in agricultural regions. Belding's ground squirrels (Spermophilus beldingi) are routinely shot in California, Nevada, and Oregon across habitats that overlap with breeding avian scavengers. Ground squirrels shot with lead (Pb)-based bullets may pose a risk to avian scavengers if they consume carcasses containing Pb fragments. To assess the potential risk to breeding avian scavengers we developed a model to estimate the number, mass, and distribution of Pb fragments in shot ground squirrels using radiographic images. Eighty percent of shot carcasses contained detectible Pb fragments with an average of 38.6 mg of Pb fragments. Seven percent of all carcasses contained Pb fragment masses exceeding a lethal dose for a model raptor nestling (e.g. American kestrel Falco sparverius). Bullet type did not influence the number of fragments in shot ground squirrels, but did influence the mass of fragments retained. Belding's ground squirrels shot with .17 Super Mag and unknown ammunition types contained over 28 and 17 times more mass of Pb fragments than those shot with .22 solid and .22 hollow point bullets, respectively. Ground squirrel body mass was positively correlated with both the number and mass of Pb fragments in carcasses, increasing on average by 76% and 56% respectively across the range of carcass masses. Although the mass of Pb retained in ground squirrel carcasses was small relative to the original bullet mass, avian scavenger nestlings that frequently consume shot ground squirrels may be at risk for Pb-induced effects (e.g., physiology, growth, or survival). Using modeling efforts we found that if nestling golden eagles (Aquila chrysaetos), red-tailed hawks (Buteo jamaicensis), and Swainson's hawks (B. swainsoni) consumed shot ground squirrels proportionately to the nestling's mass, energy needs, and diet, 100% of the nestling period would exceed a 50% reduction in delta-aminolevulinic acid dehydratase production threshold, the last 13-27% of the nestling stage would exceed a reduced growth rate threshold, but no nestlings would be expected to exceed a level of Pb ingestion that would be lethal.	[Herring, Garth; Eagles-Smith, Collin A.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR 97330 USA; [Wagner, Mason T.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA	United States Department of the Interior; United States Geological Survey; Oregon State University	Herring, G (corresponding author), US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR 97330 USA.	gherring@usgs.gov	Herring, Garth/AAF-6604-2019; Eagles-Smith, Collin/AAH-3811-2019; Eagles-Smith, Collin/T-8580-2019	Eagles-Smith, Collin/0000-0003-1329-5285; Herring, Garth/0000-0003-1106-4731	Western Golden Eagle Conservation Strategy; U.S. Fish and Wildlife Service [4500063135]; U.S. Geological Survey (Ecosystems Mission Area and Contaminant Biology Program)	Western Golden Eagle Conservation Strategy; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); U.S. Geological Survey (Ecosystems Mission Area and Contaminant Biology Program)	This research was funded by the Western Golden Eagle Conservation Strategy, U.S. Fish and Wildlife Service (Grant number: 4500063135, Grantee: CAE), and U.S. Geological Survey (Ecosystems Mission Area and Contaminant Biology Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, CONSERVATION BLACK T; BARLTROP D, 1979, ARCH ENVIRON HEALTH, V34, P280, DOI 10.1080/00039896.1979.10667414; Bechard MJ, 2010, SWAINSONS HAWK BUTEO; Behmke S, 2015, ENVIRON INT, V79, P51, DOI 10.1016/j.envint.2015.03.010; Berglund AMM, 2010, ENVIRON POLLUT, V158, P1368, DOI 10.1016/j.envpol.2010.01.005; Bingham RJ, 2015, WILDLIFE SOC B, V39, P94, DOI 10.1002/wsb.527; BURGER J, 1994, FUND APPL TOXICOL, V23, P553, DOI 10.1006/faat.1994.1140; Caudell JN, 2013, WILDLIFE SOC B, V37, P824, DOI 10.1002/wsb.311; Caudell Joe N., 2012, Human-Wildlife Interactions, V6, P105; Chase L, 2016, PLOS ONE, V10; Church ME, 2006, ENVIRON SCI TECHNOL, V40, P6143, DOI 10.1021/es060765s; Cochrane JF, 2015, ECOL APPL, V25, P1518, DOI 10.1890/14-0996.1; COLLOPY MW, 1984, AUK, V101, P753, DOI 10.2307/4086902; Craighead D, 2008, J WILDLIFE MANAGE, V72, P240, DOI 10.2193/2007-120; Cruz-Martinez L, 2015, HUM-WILDL INTERACT, V9, P211; Douglas-Stroebel E, 2004, ENVIRON POLLUT, V131, P215, DOI 10.1016/j.envpol.2004.02.002; DUKE GE, 1976, COMP BIOCHEM PHYS A, V53, P1, DOI 10.1016/S0300-9629(76)80001-1; Fair JM, 2002, ARCH ENVIRON CON TOX, V42, P77; Finkelstein ME, 2003, ENVIRON SCI TECHNOL, V37, P3256, DOI 10.1021/es026272e; Finkelstein ME, 2012, P NATL ACAD SCI USA, V109, P11449, DOI 10.1073/pnas.1203141109; Franson JC, 2014, ECOTOXICOLOGY, V23, P1722, DOI 10.1007/s10646-014-1337-0; Franson JC, 2003, WATERBIRDS, V26, P345, DOI 10.1675/1524-4695(2003)026[0345:LFWAOF]2.0.CO;2; FRANSON JC, 1982, VET HUM TOXICOL, V24, P421; GRUE CE, 1986, ENVIRON POLLUT A, V42, P157, DOI 10.1016/0143-1471(86)90005-X; Haig SM, 2014, CONDOR, V116, P408, DOI 10.1650/CONDOR-14-36.1; Hansen James A., 2011, Integrated Environmental Assessment and Management, V7, P587, DOI 10.1002/ieam.201; Harmata A. R., 1995, INTERMT J SCI, V1, P1; HENNY CJ, 1994, ENVIRON MONIT ASSESS, V29, P267, DOI 10.1007/BF00547991; Hoffman DJ, ARCH ENV CONTAM TOXI, V14, P89; Hoogland JL, 2003, J MAMMAL, V84, P1254, DOI 10.1644/BME-008; HOOGLAND JL, 2003, WILD MAMMALS N AM BI, P232; Hunt WG, 2006, WILDLIFE SOC B, V34, P167, DOI 10.2193/0091-7648(2006)34[167:BFIDRI]2.0.CO;2; Hunt WG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005330; KALINOWSKI S A, 1981, Wildlife Society Bulletin, V9, P268; Knopper LD, 2006, J WILDLIFE MANAGE, V70, P295, DOI 10.2193/0022-541X(2006)70[295:COSRGS]2.0.CO;2; Knott J, 2010, SCI TOTAL ENVIRON, V409, P95, DOI 10.1016/j.scitotenv.2010.08.053; Kochert M. N., 2002, GOLDEN EAGLE AQUILA; Krone Oliver, 2009, P289, DOI 10.4080/ilsa.2009.0207; Lambertucci SA, 2011, BIOL CONSERV, V144, P1464, DOI 10.1016/j.biocon.2011.01.015; LAWLER EM, 1991, ARCH ENVIRON CON TOX, V21, P78, DOI 10.1007/BF01055560; Legagneux P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111546; Madry MM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/3/034003; Mateo R, 2014, ENVIRON INT, V63, P163, DOI 10.1016/j.envint.2013.11.006; McBride TJ, 2004, J RAPTOR RES, V38, P118; Mills L. S., 2012, CONSERVATION WILDLIF; Nadjafzadeh M, 2015, EUR J WILDLIFE RES, V61, P763, DOI 10.1007/s10344-015-0953-1; OLENDORFF RR, 1974, CONDOR, V76, P466, DOI 10.2307/1365822; PARKER JW, 1976, CONDOR, V78, P557, DOI 10.2307/1367108; Pauli JN, 2007, J WILDLIFE MANAGE, V71, P103, DOI 10.2193/2005-620; PLATT J B, 1976, American Birds, V30, P783; Pokras Mark A., 2009, P283; Preston CR, 2009, RED TAILED HAWK BUTE; R Development Core Team, 2012, R LANG ENV STAT COMP; REDIG PT, 1991, ARCH ENVIRON CON TOX, V21, P72, DOI 10.1007/BF01055559; Scheuhammer AM, 1998, ECOTOXICOLOGY, V7, P37, DOI 10.1023/A:1008855617453; SCHMUTZ J K, 1989, Journal of Raptor Research, V23, P147; SCHMUTZ JK, 1989, CONDOR, V91, P362, DOI 10.2307/1368315; Schulz JH, 2006, J WILDLIFE MANAGE, V70, P413, DOI 10.2193/0022-541X(2006)70[413:ALTIMD]2.0.CO;2; Schwartz BS, 2000, NEUROLOGY, V55, P1144, DOI 10.1212/WNL.55.8.1144; SPRINGER MA, 1983, OHIO J SCI, V83, P13; Stauber E, 2010, J AVIAN MED SURG, V24, P279, DOI 10.1647/2009-006.1; Stephens Robert M., 2007, Intermountain Journal of Sciences, V13, P116; Stewart WF, 1999, NEUROLOGY, V52, P1610, DOI 10.1212/WNL.52.8.1610; USDA United Stated Department of Agriculture, 2015, CROP PRODUCTION; Vallverdu-Coll N, 2015, ENVIRON SCI TECHNOL, V49, P3839, DOI 10.1021/es505148d; Vermeulen A, 2015, SCI TOTAL ENVIRON, V508, P297, DOI 10.1016/j.scitotenv.2014.11.095; Vosburgh TC, 1998, J WILDLIFE MANAGE, V62, P363, DOI 10.2307/3802300; Whisson DA, 1999, WILDLIFE SOC B, V27, P178; Whisson DA, 2000, P USDA NAT WILDL RES, P104; White C, 2006, J WILDLIFE MANAGE, V70, P539, DOI 10.2193/0022-541X(2006)70[539:IEOEHO]2.0.CO;2; Whitfield DP, 2004, BIOL CONSERV, V118, P249, DOI 10.1016/j.biocon.2003.09.003	71	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167926	10.1371/journal.pone.0167926	http://dx.doi.org/10.1371/journal.pone.0167926			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942006	gold, Green Submitted, Green Published			2022-12-27	WOS:000392745600039
J	Kazmierczak, PM; Todica, A; Gildehaus, FJ; Hirner-Eppeneder, H; Brendel, M; Eschbach, RS; Hellmann, M; Nikolaou, K; Reiser, MF; Wester, HJ; Kropf, S; Rominger, A; Cyran, CC				Kazmierczak, Philipp M.; Todica, Andrei; Gildehaus, Franz-Josef; Hirner-Eppeneder, Heidrun; Brendel, Matthias; Eschbach, Ralf S.; Hellmann, Magdalena; Nikolaou, Konstantin; Reiser, Maximilian F.; Wester, Hans-Juergen; Kropf, Saskia; Rominger, Axel; Cyran, Clemens C.			Ga-68-TRAP-(RGD)(3) Hybrid Imaging for the In Vivo Monitoring of alpha(v)beta(3)-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer	PLoS One			English	Article							HUMAN TUMOR XENOGRAFTS; F-18-FDG PET/CT; VEGF; GROWTH; RADIOPHARMACEUTICALS; ANTIBODIES; EFFICACY; MODEL	Objectives To investigate Ga-68-TRAP-(RGD)3 hybrid imaging for the in vivo monitoring of alpha(v)beta(3)-integrin expression as biomarker of anti-angiogenic therapy effects in experimental breast cancer. Materials and Methods Human breast cancer (MDA-MB-231) xenografts were implanted orthotopically into the mammary fat pads of n = 25 SCID mice. Transmission/emission scans (53 min to 90 min after i.v. injection of 20 MBq Ga-68-TRAP-(RGD)3) were performed on a dedicated small animal PET before (day 0, baseline) and after (day 7, follow-up) a 1-week therapy with the VEGF antibody bevacizumab or placebo (imaging cohort n = 13; therapy n = 7, control n = 6). The target-to-background ratio (TBR, VOlmaxtumor/VOlmeanmuscie) served as semiquantitative measure of tumor radiotracer uptake. Unenhanced CT data sets were subsequently acquired for anatomic coregistration and morphology-based tumor response assessments (CT volumetry). The imaging results were validated by multiparametric ex vivo immunohistochemistry (alpha(v)beta(3)-integrin, microvascular density CD31, proliferation Ki-67, apoptosis TUNEL) conducted in a dedicated immunohistochemistry cohort (n = 12). Results Ga-68-TRAP-(RGD)(3) binding was significantly reduced under VEGF inhibition and decreased in all bevacizumab-treated animals (ATBRfollow-up/baseline: therapy-1.07 0.83, control +0.32 1.01, p = 0.022). No intergroup difference in tumor volume development between day 0 and day 7 was observed (Delta TBRvolumetherapy 134 77 pL, AvoluMecontrol 132 56 pL, p = 1.000).Immunohistochemistry revealed a significant reduction of a,133-integrin expression (308 135 vs. 635 325, p = 0.03), microvascular density (CD31, 168 108 vs. 432 70, p = 0.002), proliferation (Ki-67, 5,195 1,002 vs. 7,574 418, p = 0.004) and significantly higher apoptosis (TUNEL, 14,432 1,974 vs. 3,776 1,378, p = 0.002) in the therapy compared to the control group. Conclusions Ga-68-TRAP-(RGD)3 hybrid imaging allows for the in vivo assessment of a,133-integrin expression as biomarker of anti-angiogenic therapy effects in experimental breast cancer.	[Kazmierczak, Philipp M.; Hirner-Eppeneder, Heidrun; Eschbach, Ralf S.; Hellmann, Magdalena; Reiser, Maximilian F.; Cyran, Clemens C.] Ludwig Maximilians Univ Munchen, Hosp Munich, Inst Clin Radiol, Expt Radiol Lab, Munich, Germany; [Todica, Andrei; Gildehaus, Franz-Josef; Brendel, Matthias; Rominger, Axel] Ludwig Maximilians Univ Munchen, Hosp Munich, Dept Nucl Med, Munich, Germany; [Nikolaou, Konstantin] Univ Hosp Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Wester, Hans-Juergen] Tech Univ Munich, Lehrstuhl Pharmazeut Radiochem, D-80290 Munich, Germany; [Kropf, Saskia] SCINTOMICS GmbH, Furstenfeldbruck, Germany	University of Munich; University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technical University of Munich	Kazmierczak, PM (corresponding author), Ludwig Maximilians Univ Munchen, Hosp Munich, Inst Clin Radiol, Expt Radiol Lab, Munich, Germany.	philipp.kazmierczak@med.lmu.de	Rominger, Axel/K-5891-2019	Rominger, Axel/0000-0002-1954-736X	German Federal Ministry of Education and Research (BMBF) [01EX1021X]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was funded by the German Federal Ministry of Education and Research (BMBF, www.bmbf.de) Excellence Cluster M4 (01EX1021X) (received by CCC and KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study received no funding from Scintomics GmbH.	Arjaans M., 2016, ONCOTARGET; Bagri A, 2010, CLIN CANCER RES, V16, P3887, DOI 10.1158/1078-0432.CCR-09-3100; Beer AJ, 2014, JACC-CARDIOVASC IMAG, V7, P178, DOI 10.1016/j.jcmg.2013.12.003; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Camacho X, 2013, ONCOLOGY-BASEL, V84, P200, DOI 10.1159/000338961; Chen HJ, 2016, THERANOSTICS, V6, P78, DOI 10.7150/thno.13242; Gaertner FC, 2010, Q J NUCL MED MOL IMA; Gerber HP, 2007, P NATL ACAD SCI USA, V104, P3478, DOI 10.1073/pnas.0611492104; Gulyas B, 2012, Q J NUCL MED MOL IM, V56, P173; Heijmen L, 2014, CONTRAST MEDIA MOL I, V9, P237, DOI 10.1002/cmmi.1564; Hollanders K, 2015, CURR EYE RES, V40, P611, DOI 10.3109/02713683.2014.943910; Kazmierczak PM, 2014, RADIOLOGE, V54, P117, DOI 10.1007/s00117-013-2547-9; Kazmierczak PM, 2016, INVEST RADIOL; Kenny LM, 2008, J NUCL MED, V49, P879, DOI 10.2967/jnumed.107.049452; Laitinen I, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-38; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Lopez-Rodriguez V, 2016, J NUCL MED, V57, P404, DOI 10.2967/jnumed.115.161653; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Morgan RA, 2012, MOL THER, V20, P882, DOI 10.1038/mt.2012.73; Notni J, 2013, NUCL MED BIOL, V40, P33, DOI 10.1016/j.nucmedbio.2012.08.006; Notni J, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-28; Notni J, 2011, CHEM-EUR J, V17, P14718, DOI 10.1002/chem.201103503; Rahbar K, 2016, J NUCL MED, V57, P563, DOI 10.2967/jnumed.115.169243; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Rylova SN, 2014, J NUCL MED, V55, P1878, DOI 10.2967/jnumed.114.137570; Santhanam P, 2015, EUR J NUCL MED MOL I, V42, P1144, DOI 10.1007/s00259-015-3027-4; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Shi JY, 2014, MOL PHARMACEUT, V11, P3915, DOI 10.1021/mp5003202; Spicks C, 2016, J NUCL MED, V57, P420, DOI 10.2967/jnumed.115.158808; Taherian A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-293; Wang H, 2016, RADIOLOGY; Withofs N, 2015, J NUCL MED, V56, P361, DOI 10.2967/jnumed.114.149021; Yoon HJ, 2014, EUR J NUCL MED MOL I, V41, P1534, DOI 10.1007/s00259-014-2744-4; Zhang Wei, 2002, Angiogenesis, V5, P35, DOI 10.1023/A:1021540120521	34	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168248	10.1371/journal.pone.0168248	http://dx.doi.org/10.1371/journal.pone.0168248			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992512	Green Submitted, Green Published, gold			2022-12-27	WOS:000392842600043
J	Kirschmer, N; Bandleon, S; von Ehrlich-Treuenstatt, V; Hartmann, S; Schaaf, A; Lamprecht, AK; Miranda-Laferte, E; Langsenlehner, T; Ritter, O; Eder, P				Kirschmer, Nadine; Bandleon, Sandra; von Ehrlich-Treuenstaett, Viktor; Hartmann, Sonja; Schaaf, Alice; Lamprecht, Anna-Karina; Miranda-Laferte, Erick; Langsenlehner, Tanja; Ritter, Oliver; Eder, Petra			TRPC4 alpha and TRPC4 beta Similarly Affect Neonatal Cardiomyocyte Survival during Chronic GPCR Stimulation	PLoS One			English	Article							PATHOLOGICAL CARDIAC-HYPERTROPHY; RAT VENTRICULAR MYOCYTES; CA2+ CHANNELS; TRPC CHANNELS; SARCOPLASMIC-RETICULUM; HEART-FAILURE; HEK293 CELLS; ACTIVATION; EXPRESSION; LOCALIZATION	The Transient Receptor Potential Channel Subunit 4 (TRPC4) has been considered as a crucial Ca2+ component in cardiomyocytes promoting structural and functional remodeling in the course of pathological cardiac hypertrophy. TRPC4 assembles as homo or hetero-tetramer in the plasma membrane, allowing a non-selective Na+ and Ca2+ influx. Gaq protein coupled receptor (GPCR) stimulation is known to increase TRPC4 channel activity and a TRPC4-mediated Ca2+ influx which has been regarded as ideal Ca2+ source for calcineurin and subsequent nuclear factor of activated T-cells (NFAT) activation. Functional properties of TRPC4 are also based on the expression of the TRPC4 splice variants TRPC4 alpha and TRPC4 beta. Aim of the present study was to analyze cytosolic Ca2+ signals, signaling, hypertrophy and vitality of cardiomyocytes in dependence on the expression level of either TRPC4 alpha or TRPC4 beta. The analysis of Ca2+ transients in neonatal rat cardiomyocytes (NRCs) showed that TRPC4 alpha and TRPC4 beta affected Ca2+ cycling in beating cardiomyocytes with both splice variants inducing an elevation of the Ca2+ transient amplitude at baseline and TRPC4 beta increasing the Ca2+ peak during angiotensin II (Ang II) stimulation. NRCs infected with TRPC4 beta (Ad-CV) also responded with a sustained Ca2+ influx when treated with Ang II under non-pacing conditions. Consistent with the Ca2+ data, NRCs infected with TRPC4 alpha (Ad-C4 beta) showed an elevated calcineurin/NFAT activity and a baseline hypertrophic phenotype but did not further develop hypertrophy during chronic Ang II/phenylephrine stimulation. Down-regulation of endogenous TRPC4 alpha reversed these effects, resulting in less hypertrophy of NRCs at baseline but a markedly increased hypertrophic enlargement after chronic agonist stimulation. Ad-CV NRCs did not exhibit baseline calcineurin/NFAT activity or hypertrophy but responded with an increased calcineurin/NFAT activity after GPCR stimulation. However, this effect was not translated into an increased propensity towards hypertrophy but rather less hypertrophy during GPCR stimulation. Further analyses revealed that, although hypertrophy was preserved in Ad-C4 alpha NRCs and even attenuated in Ad-C4 beta NRCs, cardiomyocytes had an increased apoptosis rate and thus were less viable after chronic GPCR stimulation. These findings suggest that TRPC4 alpha and TRPC4 beta differentially affect Ca2+ signals, calcineurin/NFAT signaling and hypertrophy but similarly impair cardiomyocyte viability during GPCR stimulation.	[Kirschmer, Nadine; Bandleon, Sandra; von Ehrlich-Treuenstaett, Viktor; Schaaf, Alice; Lamprecht, Anna-Karina; Eder, Petra] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Kirschmer, Nadine; Bandleon, Sandra; von Ehrlich-Treuenstaett, Viktor; Schaaf, Alice; Lamprecht, Anna-Karina; Eder, Petra] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr Wurzburg, Wurzburg, Germany; [Hartmann, Sonja] Univ Florida, Dept Pharmaceut, Ctr Pharmacometr & Syst Pharmacol, Coll Pharm, Orlando, FL USA; [Miranda-Laferte, Erick] Univ Wurzburg, Inst Physiol, Wurzburg, Germany; [Langsenlehner, Tanja] Med Univ Graz, Dept Therapeut Radiol & Oncol, Graz, Austria; [Ritter, Oliver] Univ Hosp Brandenburg, Brandenburg Med Sch, Dept Cardiol & Pulmol, Brandenburg, Germany	University of Wurzburg; University of Wurzburg; State University System of Florida; University of Florida; University of Wurzburg; Medical University of Graz	Eder, P (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany.; Eder, P (corresponding author), Univ Hosp Wurzburg, Comprehens Heart Failure Ctr Wurzburg, Wurzburg, Germany.	Eder_P@ukw.de			Bundesministerium fur Bildung and Forschung, Germany [01E01004, 01E01504]; Deutsche Forschungsgemeinschaft [ED 266/1-1]	Bundesministerium fur Bildung and Forschung, Germany(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Support was provided by the Bundesministerium fur Bildung and Forschung, Germany: 01E01004 (NK, SB, AS, PE) and 01E01504 (SB, AS, PE) and the Deutsche Forschungsgemeinschaft: ED 266/1-1 (PE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; BASSANI RA, 1995, BIOPHYS J, V68, P2015, DOI 10.1016/S0006-3495(95)80378-4; Brenner JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000802; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Camors E, 2012, J MOL CELL CARDIOL, V52, P1240, DOI 10.1016/j.yjmcc.2012.02.010; Cooley N, 2014, MOL PHARMACOL, V86, P399, DOI 10.1124/mol.114.093690; Correll RN, 2014, CIRC RES, V114, P249, DOI 10.1161/CIRCRESAHA.114.302293; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; Dietrich A, 2003, J BIOL CHEM, V278, P47842, DOI 10.1074/jbc.M302983200; Eder P, 2007, CARDIOVASC RES, V73, P111, DOI 10.1016/j.cardiores.2006.10.016; Eder P, 2011, CIRC RES, V108, P265, DOI 10.1161/CIRCRESAHA.110.225888; Freichel M, 2014, HANDB EXP PHARMACOL, V222, P85, DOI 10.1007/978-3-642-54215-2_5; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Gorbe A, 2010, BASIC RES CARDIOL, V105, P643, DOI 10.1007/s00395-010-0097-0; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; Jiang Y, 2014, CELL TISSUE RES, V355, P201, DOI 10.1007/s00441-013-1733-4; Kuwahara K, 2006, J CLIN INVEST, V116, P3114, DOI 10.1172/JCI27702; Li HL, 2010, J BIOL CHEM, V285, P39171, DOI 10.1074/jbc.M110.149690; Liu QH, 2006, MOL CELL BIOL, V26, P3785, DOI 10.1128/MCB.26.10.3785-3797.2006; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Londono JEC, 2015, EUR HEART J, V36, P2257, DOI 10.1093/eurheartj/ehv250; Makarewich CA, 2014, CIRC RES, V115, P567, DOI 10.1161/CIRCRESAHA.115.303831; McKay RR, 2000, BIOCHEM J, V351, P735, DOI 10.1042/0264-6021:3510735; Mery L, 2002, J CELL SCI, V115, P3497; Nakayama H, 2006, FASEB J, V20, P1660, DOI 10.1096/fj.05-5560com; Obukhov AG, 2004, J CELL PHYSIOL, V201, P227, DOI 10.1002/jcp.20057; Otsuguro KI, 2008, J BIOL CHEM, V283, P10026, DOI 10.1074/jbc.M707306200; Sabourin J, 2016, J BIOL CHEM, V291, P13394, DOI 10.1074/jbc.M115.693911; Saito S, 2000, J BIOL CHEM, V275, P34528, DOI 10.1074/jbc.M002844200; Satoh S, 2007, MOL CELL BIOCHEM, V294, P205, DOI 10.1007/s11010-006-9261-0; Schaefer M, 2002, J BIOL CHEM, V277, P3752, DOI 10.1074/jbc.M109850200; Seth M, 2009, CIRC RES, V105, P1023, DOI 10.1161/CIRCRESAHA.109.206581; Wu X, 2010, P NATL ACAD SCI USA, V107, P7000, DOI 10.1073/pnas.1001825107; Yamada H, 2000, NEUROSCI LETT, V285, P111, DOI 10.1016/S0304-3940(00)01033-8; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	35	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168446	10.1371/journal.pone.0168446	http://dx.doi.org/10.1371/journal.pone.0168446			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992507	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600058
J	Marco-Mendez, C; Wessel, C; Scheffel, W; Ferrero-Vicente, L; Fernandez-Torquemada, Y; Cebrian, J; Heck, KL; Sanchez-Lizaso, JL				Marco-Mendez, Candela; Wessel, Caitlin; Scheffel, Whitney; Ferrero-Vicente, Luis; Fernandez-Torquemada, Yolanda; Cebrian, Just; Heck, Kenneth L.; Luis Sanchez-Lizaso, Jose			Lack of Impact of Posidonia oceanica Leaf Nutrient Enrichment on Sarpa salpa Herbivory: Additional Evidence for the Generalist Consumer Behavior of This Cornerstone Mediterranean Herbivore	PLOS ONE			English	Article							TURTLEGRASS THALASSIA-TESTUDINUM; FISH HERBIVORY; TROPHIC ROLE; SEA-URCHINS; PATCH SIZE; SEAGRASS; RESPONSES; MEADOW; CONSUMPTION; PATTERNS	The fish Sarpa salpa (L.) is one of the main macroherbivores in the western Mediterranean. Through direct and indirect mechanisms, this herbivore can exert significant control on the structure and functional dynamics of seagrass beds and macroalgae. Past research has suggested nutritional quality of their diet influences S. salpa herbivory, with the fish feeding more intensively and exerting greater top down control on macrophytes with higher internal nutrient contents. However recent findings have questioned this notion and shown that herbivores do not preferentially feed on macrophytes with higher nutrient contents, but rather feed on a wide variety of them with no apparent selectivity. To contribute to this debate, we conducted a field fertilization experiment where we enriched leaves of the seagrass Posidonia oceanica, a staple diet for S. salpa, and examined the response by the herbivore. These responses included quantification of leaf consumption in fertilized and non-fertilized/control plots within the bed, and food choice assays where fertilized and non-fertilized/control leaves were simultaneously offered to the herbivore. Despite the duration of leaf exposure to herbivores (30 days) and abundant schools of S. salpa observed around the plots, leaf consumption was generally low in the plots examined. Consumption was not higher on fertilized than on non-fertilized leaves. Food choice experiments did not show strong evidence for selectivity of enriched leaves. These results add to a recent body of work reporting a broad generalist feeding behavior by S. salpa with no clear selectivity for seagrass with higher nutrient content. In concert, this and other studies suggest S. salpa is often generalist consumers not only dictated by diet nutrient content but by complex interactions between other traits of nutritional quality, habitat heterogeneity within their ample foraging area, and responses to predation risk.	[Marco-Mendez, Candela; Ferrero-Vicente, Luis; Fernandez-Torquemada, Yolanda; Luis Sanchez-Lizaso, Jose] Univ Alicante, Dept Marine Sci & Appl Biol, Alicante, Spain; [Marco-Mendez, Candela; Ferrero-Vicente, Luis] Marine Res Ctr Santa Pola CIMAR, Alicante, Spain; [Wessel, Caitlin; Scheffel, Whitney; Cebrian, Just; Heck, Kenneth L.] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Wessel, Caitlin; Scheffel, Whitney; Cebrian, Just; Heck, Kenneth L.] Univ S Alabama, Dept Marine Sci, Mobile, AL 36688 USA	Universitat d'Alacant; Dauphin Island Sea Lab; University of South Alabama	Marco-Mendez, C (corresponding author), Univ Alicante, Dept Marine Sci & Appl Biol, Alicante, Spain.; Marco-Mendez, C (corresponding author), Marine Res Ctr Santa Pola CIMAR, Alicante, Spain.	candela.marco@ua.es	Lizaso, José Luis L Sánchez/J-4939-2017; Fernández-Torquemada, Yolanda/C-4289-2015; MARCO-MENDEZ, CANDELA/AGZ-0310-2022	Lizaso, José Luis L Sánchez/0000-0002-3927-5699; Fernández-Torquemada, Yolanda/0000-0003-0533-4109; Marco-Mendez, Candela/0000-0003-4278-5363	Department of Marine Science and Applied Biology (University of Alicante); University of South Alabama (Alabama, USA)	Department of Marine Science and Applied Biology (University of Alicante); University of South Alabama (Alabama, USA)	This research was co-funded by the Department of Marine Science and Applied Biology (University of Alicante) and the University of South Alabama (Alabama, USA) in a collaborative agreement.	Alcoverro T, 2004, ECOGRAPHY, V27, P361, DOI 10.1111/j.0906-7590.2004.03736.x; Alcoverro T, 1997, AQUAT BOT, V56, P93, DOI 10.1016/S0304-3770(96)01098-4; Alcoverro T, 2000, MAR ECOL PROG SER, V194, P13, DOI 10.3354/meps194013; Boudouresque CF, 1982, DECOUVERTE HERBIER P, P79; Bowman J, 2002, CONSERV ECOL, V6; Bukovinszky T, 2005, OIKOS, V109, P435, DOI 10.1111/j.0030-1299.2005.13707.x; CAMP DK, 1973, BIOSCIENCE, V23, P37, DOI 10.2307/1296366; Cebrian J, 1996, MAR ECOL PROG SER, V130, P147, DOI 10.3354/meps130147; Cebrian J, 2004, AQUAT ECOL SER, V2, P153; Cebrian J, 1998, AQUAT BOT, V60, P67, DOI 10.1016/S0304-3770(97)00070-3; Cohen J.E., 1988, STAT POWER ANAL BEHA; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cornell HV, 2003, AM NAT, V161, P507, DOI 10.1086/368346; Delgado O, 1997, OCEANOL ACTA, V20, P557; Den Hartog C., 1970, VERH KON NED AKAD WE, V59; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FRITZ RS, 1992, PLANT RESISTANCE HER; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Goldenberg SU, 2014, J FISH BIOL, V84, P1474, DOI 10.1111/jfb.12371; Havelange S, 1997, MAR ECOL-P S Z N I, V18, P289, DOI 10.1111/j.1439-0485.1997.tb00443.x; Hemminga M.A., 2000, SEAGRASS ECOLOGY, DOI 10.1017/CBO9780511525551; Hughes R.N., 1980, Oceanography and Marine Biology an Annual Review, V18, P423; Jadot C, 2006, ICES J MAR SCI, V63, P128, DOI 10.1016/j.icesjms.2005.06.010; Jadot C, 2002, AQUAT LIVING RESOUR, V15, P343, DOI 10.1016/S0990-7440(02)01193-2; Kirsch KD, 2002, MAR ECOL PROG SER, V227, P71, DOI 10.3354/meps227071; KLUMPP DW, 1993, AQUAT BOT, V45, P205, DOI 10.1016/0304-3770(93)90022-O; KLUMPP DW, 1983, MAR ECOL PROG SER, V12, P207, DOI 10.3354/meps012207; Leoni V, 2006, J EXP MAR BIOL ECOL, V339, P1, DOI 10.1016/j.jembe.2006.05.017; Lizaso JLS, 2000, ENVIRON CONSERV, V27, P144, DOI 10.1017/S0376892900000187; Marco-Mendez C, 2016, ESTUAR COAST SHELF S; Marco-Mendez C, 2015, ESTUAR COAST SHELF S, V154, P94, DOI 10.1016/j.ecss.2014.12.043; Marco-Mendez C, 2012, MAR ECOL PROG SER, V460, P91, DOI 10.3354/meps09781; Mariani S, 1999, MAR ECOL PROG SER, V189, P295, DOI 10.3354/meps189295; MCCLANAHAN TR, 1994, J EXP MAR BIOL ECOL, V184, P237, DOI 10.1016/0022-0981(94)90007-8; MORAN N, 1980, J THEOR BIOL, V86, P247, DOI 10.1016/0022-5193(80)90004-1; PAUL VJ, 1990, MAR ECOL PROG SER, V60, P23, DOI 10.3354/meps060023; Perez M, 2008, MAR POLLUT BULL, V56, P869, DOI 10.1016/j.marpolbul.2008.02.001; Prado P, 2008, MAR ECOL PROG SER, V371, P11, DOI 10.3354/meps07662; Prado P, 2008, MAR ECOL PROG SER, V359, P89, DOI 10.3354/meps07438; Prado P, 2007, MAR ECOL PROG SER, V340, P63, DOI 10.3354/meps340063; Prado P, 2011, MAR BIOL, V158, P1473, DOI 10.1007/s00227-011-1664-0; Prado P, 2010, MAR ECOL PROG SER, V409, P229, DOI 10.3354/meps08585; Romero J., 1989, INT WORKSHOP POSIDON, V2, P85; Ruiz JM, 2010, MAR ENVIRON RES, V69, P118, DOI 10.1016/j.marenvres.2009.09.002; Ruiz JM, 2001, MAR POLLUT BULL, V42, P749, DOI 10.1016/S0025-326X(00)00215-0; Ruiz JM, 2009, BOT MAR; Sparks EL, 2015, ESTUAR COAST, V38, P988, DOI 10.1007/s12237-014-9858-6; Steele L, 2014, ANIM BIODIV CONSERV, V37, P49; Stergiou KI, 2001, REV FISH BIOL FISHER, V11, P217, DOI 10.1023/A:1020556722822; Taylor RB, 2002, OECOLOGIA, V132, P68, DOI 10.1007/s00442-002-0944-2; THAYER GW, 1984, ESTUARIES, V7, P351, DOI 10.2307/1351619; Tomas F, 2005, MAR ECOL PROG SER, V301, P95, DOI 10.3354/meps301095; Tomas F, 2005, MAR ECOL PROG SER, V287, P115, DOI 10.3354/meps287115; Tomas F, 2011, ESTUAR COAST SHELF S, V92, P27, DOI 10.1016/j.ecss.2010.12.004; Tuya F, 2013, MAR ECOL PROG SER, V490, P23, DOI 10.3354/meps10448; Underwood A.J, 1997, EXPT ECOLOGY THEIR L; Verges A, 2007, MAR ECOL PROG SER, V343, P107, DOI 10.3354/meps06885; Verges A, 2011, OECOLOGIA, V166, P381, DOI 10.1007/s00442-010-1830-y; VERLAQUE M, 1990, OCEANOL ACTA, V13, P373; VERMAAT JE, 1995, MAR ECOL PROG SER, V124, P215, DOI 10.3354/meps124215; ZIEMAN JC, 1974, AQUACULTURE, V4, P139, DOI 10.1016/0044-8486(74)90029-5	61	5	5	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168398	10.1371/journal.pone.0168398	http://dx.doi.org/10.1371/journal.pone.0168398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992498	gold, Green Published			2022-12-27	WOS:000392842600055
J	Pan, XL; Wang, HY; Zhang, DZ; Xun, S; Ouyang, MZ; Fan, WT; Guo, YS; Wu, Y; Huang, SG; Bi, K; Lei, M				Pan, Xiaolong; Wang, Haiyan; Zhang, Dezhao; Xun, Shuang; Ouyang, Mengzhu; Fan, Wentao; Guo, Yunsheng; Wu, Ye; Huang, Shanguo; Bi, Ke; Lei, Ming			Microwave Bandpass Filter Based on Mie-Resonance Extraordinary Transmission	PLOS ONE			English	Article							WIDE-BAND	Microwave bandpass filter structure has been designed and fabricated by filling the periodically metallic apertures with dielectric particles. The microwave cannot transmit through the metallic subwavelength apertures. By filling the metallic apertures with dielectric particles, a transmission passband with insertion loss 2 dB appears at the frequency of 10-12 GHz. Both simulated and experimental results show that the passband is induced by the Mie resonance of the dielectric particles. In addition, the passband frequency can be tuned by the size and the permittivity of the dielectric particles. This approach is suitable to fabricate the microwave bandpass filters.	[Pan, Xiaolong; Wang, Haiyan; Zhang, Dezhao; Wu, Ye; Huang, Shanguo; Bi, Ke; Lei, Ming] Beijing Univ Posts & Telecommun, State Key Lab Informat Photon & Opt Commun, Beijing, Peoples R China; [Pan, Xiaolong; Wang, Haiyan; Zhang, Dezhao; Wu, Ye; Huang, Shanguo; Bi, Ke; Lei, Ming] Beijing Univ Posts & Telecommun, Sch Sci, Beijing, Peoples R China; [Xun, Shuang; Ouyang, Mengzhu; Fan, Wentao] Beijing Univ Posts & Telecommun, Sch Informat & Commun Engn, Beijing, Peoples R China; [Guo, Yunsheng] Inner Mongolia Univ Sci & Technol, Dept Phys, Baotou, Peoples R China	Beijing University of Posts & Telecommunications; Beijing University of Posts & Telecommunications; Beijing University of Posts & Telecommunications; Inner Mongolia University of Science & Technology	Bi, K; Lei, M (corresponding author), Beijing Univ Posts & Telecommun, State Key Lab Informat Photon & Opt Commun, Beijing, Peoples R China.; Bi, K; Lei, M (corresponding author), Beijing Univ Posts & Telecommun, Sch Sci, Beijing, Peoples R China.		Bi, Ke/C-1175-2011	Bi, Ke/0000-0002-3357-5754	National "973" Program of China [2012CB315604]; National Natural Science Foundation of China [51402163, 61575028, 61574020, 51221291, 61376018]; Fundamental Research Funds for the Central Universities [2015RC18]; Fund of IPOC BUPT, China; China Postdoctoral Science Foundation [2013M530042, 2014T70075]; Fund of State Key Laboratory of Information Photonics and Optical Communications (Beijing University of Posts and Telecommunications), China	National "973" Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fund of IPOC BUPT, China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fund of State Key Laboratory of Information Photonics and Optical Communications (Beijing University of Posts and Telecommunications), China	This work was supported by the National "973" Program of China under Grant No. 2012CB315604; the National Natural Science Foundation of China under Grant Nos. 51402163, 61575028, 61574020 and 51221291 and 61376018; the Fundamental Research Funds for the Central Universities under Grant No. 2015RC18 and the Fund of IPOC BUPT, China; the China Postdoctoral Science Foundation under Grant Nos. 2013M530042 and 2014T70075; the Fund of State Key Laboratory of Information Photonics and Optical Communications (Beijing University of Posts and Telecommunications), China.	Aydin K, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.013904; Bethe HA, 1944, PHYS REV, V66, P163, DOI 10.1103/PhysRev.66.163; Bi K., 2015, APPL PHYS LETT, V106, P203; Bonache J, 2006, IEEE T MICROW THEORY, V54, P265, DOI 10.1109/TMTT.2005.861664; de Abajo FJGI, 2002, OPT EXPRESS, V10, P1475, DOI 10.1364/OE.10.001475; Dykhne A, 2003, PHYS REV B, V67, P920; Garcia-Vidal F, 2005, PHYS REV LETT, V95, P85; Gil M, 2007, IEEE T MICROW THEORY, V55, P1296, DOI 10.1109/TMTT.2007.897755; Hunter IC, 2002, IEEE T MICROW THEORY, V50, P794, DOI 10.1109/22.989963; Kim J, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.115126; Liu Y, 2012, INT J NONLIN SCI NUM, V13, P1; Lockyear MJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2824458; MATTHAEI GL, 1965, IEEE T MICROW THEORY, VMT13, P203, DOI 10.1109/TMTT.1965.1125965; Navarro-Cia M, 2009, PROG ELECTROM RES LE, V12, P141, DOI 10.2528/PIERL09102106; Ndao A, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4832227; Shinada S, 2003, APPL PHYS LETT, V83, P836, DOI 10.1063/1.1597979; Webb K J, 2006, PHYS REV B, V73; Wheeler MS, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.193103; Xiao BG, 2016, OPT COMMUN, V374, P13, DOI 10.1016/j.optcom.2016.04.019; Zhang FL, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.195119; Zhao HJ, 2009, OPT EXPRESS, V17, P13373, DOI 10.1364/OE.17.013373; Zhao Q, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.027402	22	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0166696	10.1371/journal.pone.0166696	http://dx.doi.org/10.1371/journal.pone.0166696			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992440	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600009
J	Monecke, S; Gavier-Widen, D; Hotzel, H; Peters, M; Guenther, S; Lazaris, A; Loncaric, I; Muller, E; Reissig, A; Ruppelt-Lorz, A; Shore, AC; Walter, B; Coleman, DC; Ehricht, R				Monecke, Stefan; Gavier-Widen, Dolores; Hotzel, Helmut; Peters, Martin; Guenther, Sebastian; Lazaris, Alexandros; Loncaric, Igor; Mueller, Elke; Reissig, Annett; Ruppelt-Lorz, Antje; Shore, Anna C.; Walter, Birgit; Coleman, David C.; Ehricht, Ralf			Diversity of Staphylococcus aureus Isolates in European Wildlife	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; VIRULENCE-ASSOCIATED GENES; METHICILLIN-RESISTANT; MOLECULAR CHARACTERIZATION; MECA HOMOLOG; CLONAL COMPLEXES; ANTIMICROBIAL SUSCEPTIBILITY; ANTIBIOTIC-RESISTANCE; RAPID DETECTION; SLAUGHTER PIGS	Staphylococcus aureus is a well-known colonizer and cause of infection among animals and it has been described from numerous domestic and wild animal species. The aim of the present study was to investigate the molecular epidemiology of S. aureus in a convenience sample of European wildlife and to review what previously has been observed in the subject field. 124 S. aureus isolates were collected from wildlife in Germany, Austria and Sweden; they were characterized by DNA microarray hybridization and, for isolates with novel hybridization patterns, by multilocus sequence typing (MLST). The isolates were assigned to 29 clonal complexes and singleton sequence types (CC1, CC5, CC6, CC7, CC8, CC9, CC12, CC15, CC22, CC25, CC30, CC49, CC59, CC88, CC97, CC130, CC133, CC398, ST425, CC599, CC692, CC707, ST890, CC1956, ST2425, CC2671, ST2691, CC2767 and ST2963), some of which (ST2425, ST2691, ST2963) were not described previously. Resistance rates in wildlife strains were rather low and mecA-MRSA isolates were rare (n = 6). mecC-MRSA (n = 8) were identified from a fox, a fallow deer, hares and hedgehogs. The common cattle-associated lineages CC479 and CC705 were not detected in wildlife in the present study while, in contrast, a third common cattle lineage, CC97, was found to be common among cervids. No Staphylococcus argenteus or Staphylococcus schweitzeri-like isolates were found. Systematic studies are required to monitor the possible transmission of human-and livestock-associated S. aureus/MRSA to wildlife and vice versa as well as the possible transmission, by unprotected contact to animals. The prevalence of S. aureus/MRSA in wildlife as well as its population structures in different wildlife host species warrants further investigation.	[Monecke, Stefan; Ruppelt-Lorz, Antje] Tech Univ Dresden, IMMH, Dresden, Germany; [Monecke, Stefan; Mueller, Elke; Reissig, Annett; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan; Mueller, Elke; Reissig, Annett; Ehricht, Ralf] InfectoGnostics Res Campus, Jena, Germany; [Gavier-Widen, Dolores] Natl Vet Inst SVA, Dept Pathol & Wildlife Dis, Uppsala, Sweden; [Gavier-Widen, Dolores] Swedish Univ Agr Sci SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Hotzel, Helmut] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Inst Bacterial Infect & Zoonoses, Jena, Germany; [Peters, Martin] Chem & Veterina Runtersuchungsamt Westfalen, Standort Arnsberg, Arnsberg, Germany; [Guenther, Sebastian; Walter, Birgit] Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, Berlin, Germany; [Lazaris, Alexandros; Shore, Anna C.; Coleman, David C.] Univ Dublin, Dublin Dent Univ Hosp, Trinity Coll Dublin, Microbiol Res Unit, Dublin, Ireland; [Loncaric, Igor] Univ Vet Med, Inst Microbiol, Vienna, Austria	Technische Universitat Dresden; Alere; National Veterinary Institute SVA; Swedish University of Agricultural Sciences; Friedrich Loeffler Institute; Free University of Berlin; Trinity College Dublin; University of Veterinary Medicine Vienna	Monecke, S (corresponding author), Tech Univ Dresden, IMMH, Dresden, Germany.; Monecke, S (corresponding author), Alere Technol GmbH, Jena, Germany.; Monecke, S (corresponding author), InfectoGnostics Res Campus, Jena, Germany.	monecke@rocketmail.com	Coleman, David C./C-2008-2009; Guenther, Sebastian/O-5005-2014	Coleman, David C./0000-0003-1797-2888; Hotzel, Helmut/0000-0002-2413-296X; Guenther, Sebastian/0000-0003-0173-7314; Walther, Birgit/0000-0003-3112-5722	EU [222633]; Network "Rodent associated pathogens" (NaUPa-Net) [01KI1018]; German Research Foundation [GU 1283/3-1]; InfectoGnostics Research Campus Jena	EU(European Commission); Network "Rodent associated pathogens" (NaUPa-Net); German Research Foundation(German Research Foundation (DFG)); InfectoGnostics Research Campus Jena	A part of the work (by D. Gavier-Widen and partially by R. Ehricht) was founded by the EU (Wildtech project; EU 7th Framework Program for Research and Technological Development, grant agreement no. 222633), another (by B. Walter and S. Guenther) by the Network "Rodent associated pathogens" (NaUPa-Net Grant 01KI1018). S. Guenther was funded by a Grant of the German Research Foundation (Grant GU 1283/3-1). For the other authors, there was no external funding, and their institutions covered the costs of experiments performed in the respective units and granted the time needed to perform this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the InfectoGnostics Research Campus Jena and Prof. E. Jacobs (IMMH Dresden) for support.	Abbott Y, 2010, VET REC, V166, P451, DOI 10.1136/vr.b4814; Abdel-moein KA, 2012, TRANSBOUND EMERG DIS, V59, P331, DOI 10.1111/j.1865-1682.2011.01273.x; Abdel-Moein KA, 2011, VECTOR-BORNE ZOONOT, V11, P627, DOI 10.1089/vbz.2010.0272; Abdulgader SM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00348; Aklilu E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043329; Akobi B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-279; Alba P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137143; Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bar-Gal GK, 2015, VET MICROBIOL, V176, P143, DOI 10.1016/j.vetmic.2015.01.007; Basset P, 2013, J HOSP INFECT, V83, P257, DOI 10.1016/j.jhin.2012.12.004; Bath GF, 2011, J S AFR VET ASSOC, V82, P227; Battisti A, 2010, VET MICROBIOL, V142, P361, DOI 10.1016/j.vetmic.2009.10.008; Bengtsson B, 2011, SVARM 2011 SWEDISH V; Blomfeldt A, 2013, J CLIN MICROBIOL, V51, P345, DOI 10.1128/JCM.02571-12; Boost M, 2013, ZOONOSES PUBLIC HLTH, V60, P572, DOI 10.1111/zph.12034; Briscoe JA, 2008, J AVIAN MED SURG, V22, P336, DOI 10.1647/2008-014.1; Budd KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134592; CAMPBELL GA, 1981, J WILDLIFE DIS, V17, P177, DOI 10.7589/0090-3558-17.2.177; Chen CJ, 2007, DIAGN MICR INFEC DIS, V59, P287, DOI 10.1016/j.diagmicrobio.2007.05.015; Chen MMS, 2016, ONE HLTH; CLAUSEN B, 1980, J WILDLIFE DIS, V16, P475, DOI 10.7589/0090-3558-16.4.475; CLSI, 2019, PERFORMANCE STANDARD, V28th edn; COLEMAN D, 1991, MOL MICROBIOL, V5, P933, DOI 10.1111/j.1365-2958.1991.tb00768.x; COLEMAN DC, 1989, J GEN MICROBIOL, V135, P1679; COLGROVE G S, 1976, Journal of Wildlife Diseases, V12, P271; Conceicao T, 2016, MICROB DRUG RESIST, V22, P22, DOI 10.1089/mdr.2015.0236; Porrero MC, 2014, ENV MICROBIOL REP, V6, P705, DOI 10.1111/1758-2229.12191; Porrero MC, 2014, APPL ENVIRON MICROB, V80, P4865, DOI 10.1128/AEM.00647-14; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Coombs GW, 2006, EMERG INFECT DIS, V12, P241; Couto I, 1996, MICROB DRUG RESIST, V2, P377, DOI 10.1089/mdr.1996.2.377; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; Cuny C, 2006, Euro Surveill, V11, P44; Cuny C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024360; Cuny C, 2010, INT J MED MICROBIOL, V300, P109, DOI 10.1016/j.ijmm.2009.11.002; Davis R, 2013, GENOME ANNOUNC, V1; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; de Sousa MA, 2003, J CLIN MICROBIOL, V41, P159, DOI [10.1128/JCM.41.1.159-163.2002, 10.1128/JCM.41.1.159-163.2003]; Drougka E, 2015, OPEN VET J, V5, P148; Ebner R, 2013, J FOOD PROTECT, V76, P1471, DOI 10.4315/0362-028X.JFP-13-009; Egyir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089716; El-Ashker M, 2015, J DAIRY SCI, V98, P7450, DOI 10.3168/jds.2015-9432; Elbir H, 2010, J INFECT DEV COUNTR, V4, P235, DOI 10.3855/jidc.632; Elstrom P, 2011, NORM VET N; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Eriksson J, 2013, VET MICROBIOL, V163, P110, DOI 10.1016/j.vetmic.2012.12.006; Espinosa-Gongora C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101988; Faires MC, 2009, EMERG INFECT DIS; Fall C, 2012, FOODBORNE PATHOG DIS, V9, P962, DOI 10.1089/fpd.2012.1197; Fessler AT, 2011, APPL ENV MICROBIOL; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gharsa H, 2015, VECTOR-BORNE ZOONOT, V15, P109, DOI 10.1089/vbz.2014.1655; Gharsa H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-203; Gharsa H, 2012, VET MICROBIOL, V156, P367, DOI 10.1016/j.vetmic.2011.11.009; Gomez P, 2016, J ANTIMICROB CHEMOTH, V71, P53, DOI 10.1093/jac/dkv314; Gomez P, 2014, J ANTIMICROB CHEMOTH, V69, P2061, DOI 10.1093/jac/dku100; Gomez-Sanz E, 2010, FOODBORNE PATHOG DIS, V7, P1269, DOI 10.1089/fpd.2010.0610; Gonzalez-Candela M, 2006, J WILDLIFE DIS, V42, P325, DOI 10.7589/0090-3558-42.2.325; Guardabassi L, 2009, EMERG INFECT DIS, V15, P1998, DOI 10.3201/eid1512.090378; Guenther S, 2013, ANTIMICROB AGENTS CH, V57, P2424, DOI 10.1128/AAC.02321-12; HAJEK V, 1988, RES VET SCI, V44, P242, DOI 10.1016/S0034-5288(18)30848-8; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Harrison EM, 2013, ANTIMICROB AGENTS CH, V57, P1524, DOI 10.1128/AAC.01882-12; Holtfreter S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071142; Hower S, 2013, MICROB ECOL, V65, P1024, DOI 10.1007/s00248-013-0178-3; Huijsdens Xander W, 2006, Ann Clin Microbiol Antimicrob, V5, P26, DOI 10.1186/1476-0711-5-26; Hukkanen RR, 2003, COMPARATIVE MED, V53, P548; Ito T, 2012, ANTIMICROB AGENTS CH, V56, P4997, DOI 10.1128/AAC.01199-12; Janssen D., 2009, Morbidity and Mortality Weekly Report, V58, P194; Kaneko J, 1997, BIOSCI BIOTECH BIOCH, V61, P541, DOI 10.1271/bbb.61.541; Kinnevey PM, 2014, ANTIMICROB AGENTS CH, V58, P1907, DOI 10.1128/AAC.02653-13; Kodikara D. S., 1999, Veterinary Ophthalmology, V2, P191; Lahuerta-Marin A, 2016, VET MICROBIOL, V182, P131, DOI 10.1016/j.vetmic.2015.11.019; LAUKOVA A, 1995, VET MED-CZECH, V40, P317; Laurent F, 2012, EMERG INFECT DIS, V18, P1465, DOI 10.3201/eid1809.111920; Li GH, 2015, FOODBORNE PATHOG DIS, V12, P203, DOI 10.1089/fpd.2014.1850; Linares JA, 2001, AVIAN DIS, V45, P1068, DOI 10.2307/1592891; Loncaric I, 2014, VET DERMATOL, V25, P147, DOI 10.1111/vde.12116; Loncaric I, 2014, VET MICROBIOL, V168, P381, DOI 10.1016/j.vetmic.2013.11.022; Loncaric I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084048; Loncaric I, 2013, J ANTIMICROB CHEMOTH, V68, P2222, DOI 10.1093/jac/dkt186; Losito P, 2005, POULTRY SCI, V84, P1802, DOI 10.1093/ps/84.11.1802; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Luzzago C, 2014, VET MICROBIOL, V170, P157, DOI 10.1016/j.vetmic.2014.01.016; MARSHALL MM, 1983, J WILDLIFE DIS, V19, P98, DOI 10.7589/0090-3558-19.2.98; McBurney S, 2000, J WILDLIFE DIS, V36, P788, DOI 10.7589/0090-3558-36.4.788; Meemken D, 2013, APPL ENVIRON MICROB, V79, P1739, DOI 10.1128/AEM.03189-12; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2014, PLOS ONE; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2007, VET MICROBIOL, V125, P128, DOI 10.1016/j.vetmic.2007.05.016; Monecke S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162654; Monecke S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066166; Monecke S, 2013, J CLIN MICROBIOL, V51, P487, DOI 10.1128/JCM.02285-12; Monecke S, 2013, VET MICROBIOL, V162, P806, DOI 10.1016/j.vetmic.2012.10.018; Monecke S, 2012, ANTIMICROB AGENTS CH, V56, P5547, DOI 10.1128/AAC.00574-12; Monecke S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-146; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Monecke S, 2011, VET MICROBIOL, V150, P309, DOI 10.1016/j.vetmic.2011.02.001; Montgomery JM, 2002, J WILDLIFE DIS, V38, P545, DOI 10.7589/0090-3558-38.3.545; Moon DC, 2015, FOODBORNE PATHOG DIS, V12, P327, DOI 10.1089/fpd.2014.1868; Moremi N, 2012, J INFECT DEV COUNTR, V6, P620, DOI 10.3855/jidc.2093; Neela V, 2009, J CLIN MICROBIOL, V47, P4138, DOI 10.1128/JCM.01363-09; Nowakiewicz A, 2016, COMP IMMUNOL MICROB, V44, P21, DOI 10.1016/j.cimid.2015.11.003; Overesch G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-30; Paterson GK, 2012, J ANTIMICROB CHEMOTH, V67, P2809, DOI 10.1093/jac/dks329; Petersen A, 2013, CLIN MICROBIOL INFEC, V19, pE16, DOI 10.1111/1469-0691.12036; PLOMMET MG, 1969, J COMP PATHOL, V79, P425, DOI 10.1016/0021-9975(69)90062-0; Porrero MC, 2013, VET J, V198, P127, DOI 10.1016/j.tvjl.2013.06.004; Power E, 2002, VET REC, V150, P819; PRATTIS SM, 1990, LAB ANIM SCI, V40, P402; Pyzik E, 2012, POL J VET SCI, V15, P767, DOI 10.2478/v10181-012-0116-1; Rainard P, 2003, CLIN DIAGN LAB IMMUN, V10, P272, DOI 10.1128/CDLI.10.2.272-277.2003; Robb A, 2013, VET MICROBIOL, V162, P300, DOI 10.1016/j.vetmic.2012.09.003; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Robinson DA, 2005, LANCET, V365, P1256, DOI 10.1016/S0140-6736(05)74814-5; ROUNDTREE P. M., 1958, MED JOUR AUSTRALIA II, V45, P789; RYAN MJ, 1979, J WILDLIFE DIS, V15, P533, DOI 10.7589/0090-3558-15.4.533; Sabat AJ, 2012, J CLIN MICROBIOL, V50, P3374, DOI 10.1128/JCM.01121-12; Sasaki T, 2012, J CLIN MICROBIOL, V50, P2152, DOI 10.1128/JCM.06739-11; Scerri J, 2013, J EPIDEMIOL GLOB HEA, V3, P165, DOI 10.1016/j.jegh.2013.05.003; Schaumburg F, 2012, ENV MICROBIOL REP, V4, P141, DOI 10.1111/j.1758-2229.2011.00316.x; Schaumburg F, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.12.001; Schaumburg F, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0286-3; Schlotter K, 2014, J DAIRY SCI, V97, P2782, DOI 10.3168/jds.2013-7378; Schlotter K, 2013, BERL MUNCH TIERARZTL, V126, P37, DOI 10.2376/0005-9366-126-37; Schlotter K, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-42; Senok A., 2016, New Microbes and New Infections, V14, P13, DOI 10.1016/j.nmni.2016.07.009; Senok A, 2016, INT J INFECT DIS, V51, P31, DOI 10.1016/j.ijid.2016.08.016; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Shuiep ES, 2009, RES VET SCI, V86, P211, DOI 10.1016/j.rvsc.2008.07.011; Siebert U, 2002, VET REC, V150, P273, DOI 10.1136/vr.150.9.273; Silvanose CD, 1999, AVIAN PATHOL, V28, P94, DOI 10.1080/03079459995109; Silvanose CD, 2001, AVIAN DIS, V45, P447, DOI 10.2307/1592986; Simpson VR, 2013, VET MICROBIOL, V162, P987, DOI 10.1016/j.vetmic.2012.10.025; Simpson VR, 2010, VET REC, V167, P59, DOI 10.1136/vr.b4887; Sing A, 2008, NEW ENGL J MED, V358, P1200, DOI 10.1056/NEJMc0706805; Siqueira DB, 2010, J ZOO WILDLIFE MED, V41, P526, DOI 10.1638/2009-0079.1; Smith EM, 2014, INFECT GENET EVOL, V22, P208, DOI 10.1016/j.meegid.2013.09.008; SMITH JMB, 1965, J HYG-CAMB, V63, P285, DOI 10.1017/S0022172400045162; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Sousa M, 2014, VET MICROBIOL, V171, P436, DOI 10.1016/j.vetmic.2014.02.034; Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x; Strommenger B, 2006, J ANTIMICROB CHEMOTH, V57, P461, DOI 10.1093/jac/dki471; Thornton SM, 1998, J ZOO WILDLIFE MED, V29, P171; Ulrich RG, 2008, PARASITOL RES, V103, pS121, DOI 10.1007/s00436-008-1054-9; Unnerstad HE, 2012, MRSA PAVISAD HOS SVE, P35; Unnerstad HE, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-6; van Duijkeren E, 2008, VET MICROBIOL, V126, P383, DOI 10.1016/j.vetmic.2007.07.021; van Elk CE, 2012, VET MICROBIOL, V156, P343, DOI 10.1016/j.vetmic.2011.10.034; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; Vancraeynest D, 2006, J VET MED B, V53, P418, DOI 10.1111/j.1439-0450.2006.00977.x; Vandendriessche S, 2013, J ANTIMICROB CHEMOTH, V68, P1510, DOI 10.1093/jac/dkt047; Vincze S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085656; Wagenaar JA, 2009, VET MICROBIOL, V139, P405, DOI 10.1016/j.vetmic.2009.06.014; Walther B, 2008, VET MICROBIOL, V127, P171, DOI 10.1016/j.vetmic.2007.07.018; Walther B, 2012, EMERG INFECT DIS, V18, P2017, DOI 10.3201/eid1812.120238; Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08; Wang X, 2014, FOODBORNE PATHOG DIS, V11, P281, DOI 10.1089/fpd.2013.1643; Weese JS, 2006, VET MICROBIOL, V115, P148, DOI 10.1016/j.vetmic.2006.01.004; Weese JS, 2005, EMERG INFECT DIS, V11, P430, DOI 10.3201/eid1103.040481; WOBESER G, 1992, J WILDLIFE DIS, V28, P215, DOI 10.7589/0090-3558-28.2.215; Wulf M, 2006, EMERG INFECT DIS, V12, P1939; Yamada T, 2005, VET MICROBIOL, V110, P97, DOI 10.1016/j.vetmic.2005.07.006; Ye XH, 2015, AM J INFECT CONTROL, V43, P676, DOI 10.1016/j.ajic.2015.03.026; Zou D, 2000, BIOSCI BIOTECH BIOCH, V64, P2631, DOI 10.1271/bbb.64.2631	167	65	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168433	10.1371/journal.pone.0168433	http://dx.doi.org/10.1371/journal.pone.0168433			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992523	gold, Green Published, Green Submitted			2022-12-27	WOS:000392758000050
J	Chang, WT; Chen, JS; Tsai, MH; Tsai, WC; Juang, JN; Liu, PY				Chang, Wei-Ting; Chen, Jung-San; Tsai, Meng-Hang; Tsai, Wei-Chuan; Juang, Jer-Nan; Liu, Ping-Yen			Interplay of Aging and Hypertension in Cardiac Remodeling: A Mathematical Geometric Model	PLOS ONE			English	Article							HEART-FAILURE; ELASTIC-MODULUS; MAGNETIC-RESONANCE; AORTIC-WALL; STRESS; RATS; ATHEROSCLEROSIS; DISTENSIBILITY; DEFORMATION; INDIVIDUALS	Hypertensive disorder can cause cardiac deformities. Elastic characteristic parameters, like Young's modulus of elasticity (E) derived from a traditional cylindrical model, increase significantly with aging. However, the geometric and component changes of aging hearts because of chronic hypertension remain unknown. To better describe the effects, we propose an elliptical elastic and mathematical model to evaluate myocardial stiffness. Ninetysix hypertensive patients (HTNPos) (men: 59.3%; age >= 65 years: 20.8%) were enrolled and compared with normotensive controls (HTNNeg) (n = 47, 48.9%). HTNPos patients had a thicker interventricular septum in diastole (IVSd) (HTNPos : 0.96 +/- 0.21 cm vs. HTNNeg : 0.77 +/- 0.15; p = 0.005) and higher intracardiac pressure (e/e': 9.06 +/- 4.85 cm vs. 7.76 +/- 3.41; p = 0.01), especially the elderly (>65 years) (IVSd: 1.03 +/- 0.19 cm, e/e': 11.39 +/- 1.99; p = 0.006 and 0.01, respectively). Nevertheless, the internal dimension decreased more significantly in the HTNPos rather than in the HTNNeg elderly (5.23 +/- 0.46 vs. 4.74 +/- 0.69 cm; p = 0.02). We found different directions of cardiac remodeling with normotensive and hypertensive loads. Different from the longitudinal and circumferential strain, E and Poisson's ratio (.) are values that directly present the rigidity of myocardium. E was significantly higher in the elderly (8011.92 +/- 2431.85 vs. 6052.43 +/- 3121.50; p = 0.02), whereas. was significantly higher in all HTNPos patients (0.73 +/- 0.12 vs. 0.61 +/- 0.07; p < 0.001). Because E and. reflected the material changes of myocardium in the HTNPos elderly, the proposed elliptical mathematical heart model better describes the geometric deformity induced by aging and hypertension.	[Chang, Wei-Ting] Chi Mei Med Ctr, Div Cardiol, Internal Med, Tainan, Taiwan; [Chang, Wei-Ting; Chen, Jung-San; Tsai, Meng-Hang; Juang, Jer-Nan] Natl Cheng Kung Univ, Dept Engn Sci, Tainan, Taiwan; [Chang, Wei-Ting] Southern Taiwan Univ Sci & Technol, Dept Biotechnol, Tainan, Taiwan; [Tsai, Wei-Chuan; Liu, Ping-Yen] Natl Cheng Kung Univ Hosp, Div Cardiol, Internal Med, Tainan, Taiwan; [Liu, Ping-Yen] Natl Cheng Kung Univ, Inst Clin Med, Tainan, Taiwan; [Liu, Ping-Yen] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan	Chi Mei Hospital; National Cheng Kung University; Southern Taiwan University of Science & Technology; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; China Medical University Taiwan	Juang, JN (corresponding author), Natl Cheng Kung Univ, Dept Engn Sci, Tainan, Taiwan.; Liu, PY (corresponding author), Natl Cheng Kung Univ Hosp, Div Cardiol, Internal Med, Tainan, Taiwan.; Liu, PY (corresponding author), Natl Cheng Kung Univ, Inst Clin Med, Tainan, Taiwan.; Liu, PY (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.	jjuang@mail.ncku.edu.tw; larry@mail.ncku.edu.tw		Liu, Ping-Yen/0000-0002-3643-5204	Headquarters of University Advancement at the National Cheng Kung University; Health Promotion Program: Blood Pressure Control from Health Promotion Administration, Ministry of Health and Welfare, Taiwan, ROC; Ministry of Science and Technology, Taiwan [MOST 103-2628-B-006-002-MY4, 105-2314-B-006-057-MY3, 103-2221-E-006-032]; National Cheng Kung University Hospital	Headquarters of University Advancement at the National Cheng Kung University; Health Promotion Program: Blood Pressure Control from Health Promotion Administration, Ministry of Health and Welfare, Taiwan, ROC; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Cheng Kung University Hospital	This research was supported in part by the Headquarters of University Advancement at the National Cheng Kung University; Health Promotion Program: Blood Pressure Control from Health Promotion Administration, Ministry of Health and Welfare, Taiwan, ROC; grants from Ministry of Science and Technology, Taiwan (MOST 103-2628-B-006-002-MY4, 105-2314-B-006-057-MY3, 103-2221-E-006-032) and a grant from National Cheng Kung University Hospital (2012-2015, P.Y.L.). The investigator (P.Y.L.) was granted by A Landmark Project to Promote Innovation & Competitiveness of Clinical Trials by the Excellent Clinical Trial and Research Center in National Cheng Kung University Hospital, Ministry of Health and Welfare, Taiwan.	Alter P, 2008, PFLUG ARCH EUR J PHY, V455, P627, DOI 10.1007/s00424-007-0323-2; ANVERSA P, 1986, J AM COLL CARDIOL, V8, P1441, DOI 10.1016/S0735-1097(86)80321-7; Arnett DK, 2000, AM J HYPERTENS, V13, P317, DOI 10.1016/S0895-7061(99)00281-2; Bayoumi AM, 2009, AL KHWARIZMI ENG J, V5, P66; Bezie Y, 1998, ARTERIOSCL THROM VAS, V18, P1027, DOI 10.1161/01.ATV.18.7.1027; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Celic V, 2014, AM J CARDIOL, V113, P832, DOI 10.1016/j.amjcard.2013.11.031; Chang WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097455; Cheng S, 2010, CIRCULATION, V122, P570, DOI 10.1161/CIRCULATIONAHA.110.937821; DART A, 1993, EUR HEART J, V14, P1465, DOI 10.1093/eurheartj/14.11.1465; Elgeti T, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-44; Gill P.E., 1981, PRACTICAL OPTIMIZATI; HOOD WP, 1969, CIRC RES, V24, P575; ISNARD RN, 1989, J AM COLL CARDIOL, V13, P399, DOI 10.1016/0735-1097(89)90518-4; Jaarsma T, 1999, EUR J HEART FAIL, V1, P151, DOI 10.1016/S1388-9842(99)00007-0; KIM HC, 1985, IEEE T BIO-MED ENG, V32, P503, DOI 10.1109/TBME.1985.325567; Kouzu H, 2011, J AM SOC ECHOCARDIOG, V24, P192, DOI 10.1016/j.echo.2010.10.020; LAURENT S, 1994, HYPERTENSION, V23, P878, DOI 10.1161/01.HYP.23.6.878; LAURENT S, 1994, ARTERIOSCLER THROMB, V14, P1223, DOI 10.1161/01.ATV.14.7.1223; Lieber SC, 2004, AM J PHYSIOL-HEART C, V287, pH645, DOI 10.1152/ajpheart.00564.2003; Lin J, 2008, EXP GERONTOL, V43, P296, DOI 10.1016/j.exger.2007.12.005; Marque V, 1999, HYPERTENSION, V34, P415, DOI 10.1161/01.HYP.34.3.415; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; Nikitin NP, 2006, INT J CARDIOL, V108, P76, DOI 10.1016/j.ijcard.2005.04.009; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Roman MJ, 1996, J AM COLL CARDIOL, V28, P751, DOI 10.1016/0735-1097(96)00225-2; ROMAN MJ, 1992, CIRCULATION, V86, P1909, DOI 10.1161/01.CIR.86.6.1909; TRESCH DD, 1995, J AM GERIATR SOC, V43, P1035, DOI 10.1111/j.1532-5415.1995.tb05570.x; WARSHAW DM, 1979, CIRC RES, V45, P250, DOI 10.1161/01.RES.45.2.250; WONG AYK, 1968, AM HEART J, V75, P649, DOI 10.1016/0002-8703(68)90325-6; Yoneyama K, 2012, CIRCULATION, V126, P2481, DOI 10.1161/CIRCULATIONAHA.112.093146	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168071	10.1371/journal.pone.0168071	http://dx.doi.org/10.1371/journal.pone.0168071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977729	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400053
J	Gilder, AS; Wang, L; Natali, L; Karimi-Mostowfi, N; Brifault, C; Gonias, SL				Gilder, Andrew S.; Wang, Lei; Natali, Letizia; Karimi-Mostowfi, Nicki; Brifault, Coralie; Gonias, Steven L.			Pertussis Toxin Is a Robust and Selective Inhibitor of High Grade Glioma Cell Migration and Invasion	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CANCER STEM-CELLS; PLASMINOGEN-ACTIVATOR RECEPTOR; UROKINASE RECEPTOR; EGF RECEPTOR; MUTANT EGFR; UPAR; RESISTANCE; TUMOR; MICE	In high grade glioma (HGG), extensive tumor cell infiltration of normal brain typically precludes identifying effective margins for surgical resection or irradiation. Pertussis toxin (PT) is a multimeric complex that inactivates diverse G(i/o) G-protein coupled receptors (GPCRs). Despite the broad continuum of regulatory events controlled by GPCRs, PT may be applicable as a therapeutic. We have shown that the urokinase receptor (uPAR) is a major driver of HGG cell migration. uPAR-initiated cell-signaling requires a G(i/o) GPCR, N-formyl Peptide Receptor 2 (FPR2), as an essential co-receptor and is thus, PT-sensitive. Herein, we show that PT robustly inhibits migration of three separate HGG-like cell lines that express a mutated form of the EGF Receptor (EGFR), EGFRvIII, which is constitutively active. PT also almost completely blocked the ability of HGG cells to invade Matrigel. In the equivalent concentration range (0.01-1.0 mu g/mL), PT had no effect on cell survival and only affected proliferation of one cell line. Neutralization of EGFRvIII expression in HGG cells, which is known to activate uPAR-initiated cell-signaling, promoted HGG cell migration. The increase in HGG cell migration, induced by EGFRvIII neutralization, was entirely blocked by silencing FPR2 gene expression or by treating the cells with PT. When U87MG HGG cells were cultured as suspended neurospheres in serum-free, growth factor-supplemented medium, uPAR expression was increased. HGG cells isolated from neurospheres migrated through Transwell membranes without loss of cell contacts; this process was inhibited by PT by >90%. PT also inhibited expression of vimentin by HGG cells; vimentin is associated with epithelial-mesenchymal transition and worsened prognosis. We conclude that PT may function as a selective inhibitor of HGG cell migration and invasion.	[Gilder, Andrew S.; Wang, Lei; Natali, Letizia; Karimi-Mostowfi, Nicki; Brifault, Coralie; Gonias, Steven L.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Wang, Lei] Xuzhou Med Univ, Dept Histol & Embryol, Xuzhou, Jiangsu, Peoples R China; [Natali, Letizia] Univ Pisa, Dept Pharm, Pisa, Italy	University of California System; University of California San Diego; Xuzhou Medical University; University of Pisa	Gonias, SL (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	sgonias@ucsd.edu		brifault, coralie/0000-0002-9831-4491	NIH [R01 CA169096]; NATIONAL CANCER INSTITUTE [R01CA169096] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant R01 CA169096 to SLG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; BOKOCH GM, 1983, J BIOL CHEM, V258, P2072; Chaichana K, 2006, STEM CELLS, V24, P2851, DOI 10.1634/stemcells.2006-0399; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; D'Alessio S, 2009, FRONT BIOSCI-LANDMRK, V14, P4575, DOI 10.2741/3550; Gonias SL, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00154; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Heimberger AB, 2005, CLIN CANCER RES, V11, P1462, DOI 10.1158/1078-0432.CCR-04-1737; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hu J, 2015, ONCOGENE, V34, P4078, DOI 10.1038/onc.2014.336; Hu JJ, 2011, P NATL ACAD SCI USA, V108, P15984, DOI 10.1073/pnas.1113416108; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jo MJ, 2005, J BIOL CHEM, V280, P17449, DOI 10.1074/jbc.M413141200; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Kost CK, 1999, CLIN EXP PHARMACOL P, V26, P449; Ksiazkiewicz M, 2010, IMMUNOBIOLOGY, V215, P737, DOI 10.1016/j.imbio.2010.05.019; LINTHICUM DS, 1982, CELL IMMUNOL, V73, P299, DOI 10.1016/0008-8749(82)90457-9; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Locht C, 2011, FEBS J, V278, P4668, DOI 10.1111/j.1742-4658.2011.08237.x; Magana-Maldonado R, 2014, J CANCER RES CLIN, V140, P291, DOI 10.1007/s00432-013-1565-3; Manning TJ, 2000, CELL MOTIL CYTOSKEL, V45, P185, DOI 10.1002/(SICI)1097-0169(200003)45:3<185::AID-CM2>3.0.CO;2-G; Mazar AP, 2011, CURR PHARM DESIGN, V17, P1970; Mukasa A, 2010, P NATL ACAD SCI USA, V107, P2616, DOI 10.1073/pnas.0914356107; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Oppermann M, 2004, CELL SIGNAL, V16, P1201, DOI 10.1016/j.cellsig.2004.04.007; Orozco-Morales M, 2012, J CANCER RES CLIN, V138, P23, DOI 10.1007/s00432-011-1069-y; Otto T, 1999, UROLOGY, V54, P458, DOI 10.1016/S0090-4295(99)00154-5; Pala Andrej, 2012, Cancers (Basel), V4, P523, DOI 10.3390/cancers4020523; Persson M, 2014, MOL PHARMACEUT, V11, P2796, DOI 10.1021/mp500177c; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Ruoslahti E, 1996, GLYCOBIOLOGY, V6, P489, DOI 10.1093/glycob/6.5.489; Schildge Sebastian, 2013, J Vis Exp, DOI 10.3791/50079; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Silbergeld DL, 1997, J NEUROSURG, V86, P525, DOI 10.3171/jns.1997.86.3.0525; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Stahle M, 2003, J CELL SCI, V116, P3835, DOI 10.1242/jcs.00679; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; SUGAWA N, 1990, P NATL ACAD SCI USA, V87, P8602, DOI 10.1073/pnas.87.21.8602; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Webb DJ, 2000, J CELL SCI, V113, P123; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wykosky J, 2015, CANCER RES, V75, P394, DOI 10.1158/0008-5472.CAN-14-2004; YONG T, 1993, J NEUROIMMUNOL, V45, P47, DOI 10.1016/0165-5728(93)90162-R; Yu SC, 2008, CANCER LETT, V265, P124, DOI 10.1016/j.canlet.2008.02.010; Zhao J, 2016, APPL IMMUNOHISTOCHEM	49	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168418	10.1371/journal.pone.0168418	http://dx.doi.org/10.1371/journal.pone.0168418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977780	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400107
J	Guillemaud, T; Lombaert, E; Bourguet, D				Guillemaud, Thomas; Lombaert, Eric; Bourguet, Denis			Conflicts of Interest in GM Bt Crop Efficacy and Durability Studies	PLOS ONE			English	Article							BIOMEDICAL-RESEARCH	Public confidence in genetically modified (GM) crop studies is tenuous at best in many countries, including those of the European Union in particular. A lack of information about the effects of ties between academic research and industry might stretch this confidence to the breaking point. We therefore performed an analysis on a large set of research articles (n = 672) focusing on the efficacy or durability of GM Bt crops and ties between the researchers carrying out these studies and the GM crop industry. We found that ties between researchers and the GM crop industry were common, with 40% of the articles considered displaying conflicts of interest (COI). In particular, we found that, compared to the absence of COI, the presence of a COI was associated with a 50% higher frequency of outcomes favorable to the interests of the GM crop company. Using our large dataset, we were able to propose possible direct and indirect mechanisms behind this statistical association. They might notably include changes of authorship or funding statements after the results of a study have been obtained and a choice in the topics studied driven by industrial priorities.	[Guillemaud, Thomas; Lombaert, Eric] Univ Nice Sophia Antipolis, INRA, CNRS, UMR 1355 7254,Inst Sophia Agrobiotech, Sophia Antipolis, France; [Bourguet, Denis] Montpellier SupAgro, Ctr Biol Gest Populat, UMR 1062, INRA,IRD,CIRAD,CS, 755 Ave Campus Agropolis, Montferrier Sur Lez, France	Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD)	Guillemaud, T (corresponding author), Univ Nice Sophia Antipolis, INRA, CNRS, UMR 1355 7254,Inst Sophia Agrobiotech, Sophia Antipolis, France.	guillem@sophia.inra.fr	; guillemaud, thomas/B-4899-2012	Bourguet, Denis/0000-0002-2109-5323; guillemaud, thomas/0000-0003-0451-1644				Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Angell M., 2005, TRUTH DRUG CO THEY D; Auguie B, 2017, GRIDEXTRA MISCELLANE; Barbour V, 2008, PLOS MED, V5, P1299, DOI 10.1371/journal.pmed.0050199; BARNES DE, 1995, JAMA-J AM MED ASSOC, V274, P248, DOI 10.1001/jama.274.3.248; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Bouzidi R, 2011, ORTHOPEDICS, V34, P932, DOI 10.3928/01477447-20111021-01; Campbell EG, 2006, NEW ENGL J MED, V355, P2321, DOI 10.1056/NEJMsa061457; Diels J, 2011, FOOD POLICY, V36, P197, DOI 10.1016/j.foodpol.2010.11.016; Field MJ., 2009, CONFLICT INTEREST ME; Krimsky S., 2004, SCI PRIVATE INTEREST; Krimsky S, 2013, SCI TECHNOL HUM VAL, V38, P566, DOI 10.1177/0162243912456271; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Loewenstein G, 2012, JAMA-J AM MED ASSOC, V307, P669, DOI 10.1001/jama.2012.154; Sanchez MA, 2015, NAT BIOTECHNOL, V33, P135, DOI 10.1038/nbt.3133; Shrader-Frechette K, 2011, SCI ENG ETHICS, V17, P75, DOI 10.1007/s11948-009-9181-y	17	8	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167777	10.1371/journal.pone.0167777	http://dx.doi.org/10.1371/journal.pone.0167777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977705	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400031
J	Neuprez, A; Delcour, JP; Fatemi, F; Gillet, P; Crielaard, JM; Bruyere, O; Reginster, JY				Neuprez, Audrey; Delcour, Jean-Pierre; Fatemi, Firouzeh; Gillet, Philippe; Crielaard, Jean-Michel; Bruyere, Olivier; Reginster, Jean-Yves			Patients' Expectations Impact Their Satisfaction following Total Hip or Knee Arthroplasty	PLOS ONE			English	Article							REPLACEMENT; OUTCOMES; PROJECTIONS; DEMAND	Introduction The objective of this study was to assess the number and magnitude of preoperative expectations and to correlate them with the degree of satisfaction expressed one year after Total Hip Arthroplasty (THA) or Total Knee Arthroplasty (TKA), in patients with severe and painful osteoarthritis (OA). Materials and Methods Preoperative expectations (within 20 days prior to surgery) and postoperative satisfaction (one year after the intervention) were measured using the previously validated French version of the Hospital for Special Surgery Hip or Knee Replacement Expectations Survey. Postoperative satisfaction was measured using a specific scale, following the same methodology as that used for the assessment of expectations. Prediction of the satisfaction of the patients was performed using multivariate linear regression modelling. Results A total of 138 patients (80 THA and 58 TKA) completed the two parts of the study. The expectations score (mean +/- SD) (range 0-100) was 72.58 +/- 12.63 before THA and 69.10 +/- 13.72 before TKA (p = 0.13). The number of expectations expressed was 14.34 +/- 1.32 (out of a potential maximum of 18) before THA and 14.70 +/- 2.29 (out of a potential maximum of 19) before TKA. After 1 year, THA generated a significantly higher degree of satisfaction compared to TKA (69.70 +/- 14.46 v 60.44 +/- 17.54, p < 0.001) (range 0-100). The pre-operative expectations score was the single best positive predictor of the post-surgery satisfaction assessment both for TKA and THA. Conclusion Patients undergoing total joint arthroplasty for end-stage OA have a high level of expectations, before both THA and TKA. While both types of interventions significantly improve essential and non-essential activities, the rate of satisfaction is significantly greater post THA. Preoperative expectations are a major contributor to the final degree of satisfaction, one year after surgery. These results re-emphasize the need for an optimal preoperative interaction between health care providers and patients, to allow patients a chance to foresee a reasonable outcome after TJA.	[Neuprez, Audrey; Bruyere, Olivier; Reginster, Jean-Yves] Univ Liege, Dept Publ Hlth Epidemiol & Hlth Econ, B-4000 Liege, Belgium; [Neuprez, Audrey; Crielaard, Jean-Michel] CHU, Motil Sci Dept, Phys Med & Sport Traumatol Serv, Liege, Belgium; [Delcour, Jean-Pierre] CHBAH, Dept Orthopaed Surg, Seraing, Belgium; [Fatemi, Firouzeh] CHC, Dept Orthopaed Surg, Liege, Belgium; [Gillet, Philippe] CHU, Dept Orthopaed Surg, Liege, Belgium	University of Liege; University of Liege; University of Liege	Neuprez, A (corresponding author), Univ Liege, Dept Publ Hlth Epidemiol & Hlth Econ, B-4000 Liege, Belgium.; Neuprez, A (corresponding author), CHU, Motil Sci Dept, Phys Med & Sport Traumatol Serv, Liege, Belgium.	audrey.neuprez@chu.ulg.ac.be	Bruyere, Olivier/H-8302-2019	Bruyere, Olivier/0000-0003-4269-9393				Anakwe RE, 2011, J ARTHROPLASTY, V26, P209, DOI 10.1016/j.arth.2010.03.013; Baumann C, 2006, J BONE JOINT SURG BR, V88B, P366, DOI 10.1302/0301-620X.88B3.17025; Bruyere O, 2014, SEMIN ARTHRITIS RHEU, V44, P253, DOI 10.1016/j.semarthrit.2014.05.014; Culliford D, 2015, OSTEOARTHR CARTILAGE, V23, P594, DOI 10.1016/j.joca.2014.12.022; Gandhi R, 2009, J ARTHROPLASTY, V24, P716, DOI 10.1016/j.arth.2008.05.016; Ghomrawi Hassan M K, 2011, HSS J, V7, P229; Haanstra TM, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-152; Harris IA, 2013, J ARTHROPLASTY, V28, P722, DOI 10.1016/j.arth.2012.07.044; Hooper G, 2014, NEW ZEAL MED J, V127, P82; Jones CA, 2007, RHEUM DIS CLIN N AM, V33, P71, DOI 10.1016/j.rdc.2006.12.008; Jourdan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030195; Koenen P, 2014, ARCH ORTHOP TRAUM SU, V134, P925, DOI 10.1007/s00402-014-2012-x; Kurtz SM, 2014, J BONE JOINT SURG AM, V96A, P624, DOI 10.2106/JBJS.M.00285; Lim Jason B T, 2015, Eur J Orthop Surg Traumatol, V25, P1007, DOI 10.1007/s00590-015-1635-0; Lingard EA, 2006, J BONE JOINT SURG AM, V88A, P1201, DOI 10.2106/JBJS.E.00147; Mahomed NN, 2002, J RHEUMATOL, V29, P1273; Mancuso CA, 1997, J ARTHROPLASTY, V12, P387, DOI 10.1016/S0883-5403(97)90194-7; Mancuso CA, 2003, J ARTHROPLASTY, V18, P872, DOI 10.1016/S0883-5403(03)00276-6; Mancuso CA, 2008, CLIN ORTHOP RELAT R, V466, P424, DOI 10.1007/s11999-007-0052-z; Naal FD, 2015, QUAL LIFE RES, V24, P2917, DOI 10.1007/s11136-015-1042-3; Nemes S, 2015, ACTA ORTHOP, V86, P426, DOI 10.3109/17453674.2015.1034608; Neuprez A, 2015, J ORTHOP, V12, P46, DOI 10.1016/j.jor.2014.06.002; Palazzo C, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-53; Scott CEH, 2012, J BONE JOINT SURG BR, V94B, P974, DOI 10.1302/0301-620X.94B7.28219; Scott CEH, 2010, J BONE JOINT SURG BR, V92B, P1253, DOI 10.1302/0301-620X.92B9.24394; Tilbury C, 2016, J ARTHROPLASTY; van den Akker-Scheek I, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-242; Yoo JH, 2011, J BONE JOINT SURG BR, V93B, P337, DOI 10.1302/0301-620X.93B3.25168	28	70	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167911	10.1371/journal.pone.0167911	http://dx.doi.org/10.1371/journal.pone.0167911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977711	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400040
J	Sun, XY; Bernabe, E; Liu, XN; Gallagher, JE; Zheng, SG				Sun, Xiangyu; Bernabe, Eduardo; Liu, Xuenan; Gallagher, Jennifer Elizabeth; Zheng, Shuguo			Determinants of Catastrophic Dental Health Expenditure in China	PLOS ONE			English	Article							OUT-OF-POCKET; HOUSEHOLD SURVEYS; ORAL-HEALTH; CARE; PERFORMANCE; INEQUALITY; SYSTEM; INDIA	This study explored catastrophic health expenditure in China, due to out-of-pocket payments for dental care, and its associated individual-and contextual-level factors. We pooled data from 31,566 adults who participated in the third National Oral Health Survey with province-level data from different sources. We defined catastrophic dental health expenditure (CDHE) as payments for dental services and/or medication for dental problems during the last year that exceeded the 10% and 20% of the household income. The association of individual and contextual factors with catastrophic dental health expenditure was evaluated using two-level logistic regression models with individuals nested within provinces. Socioeconomic position (education and household income), household size and dental status (pain in teeth or mouth and number of teeth) were the individual-level factors associated with CDHE among the full sample of participants; and, also, among those who used dental services in the past year. Greater gross domestic product per capita was the only contextual factor associated with CDHE, and only at the lower income threshold. This study shows that out-of-pocket expenses for dental services may put a considerable, and unnecessary, burden on households' finances. Our findings also help characterise those households more likely to face catastrophic expenditure on health if they have to pay for dental services.	[Sun, Xiangyu; Liu, Xuenan; Zheng, Shuguo] Peking Univ, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing Key Lab Digital Stomatol, Dept Prevent Dent,Sch & Hosp Stomatol, Beijing, Peoples R China; [Sun, Xiangyu; Bernabe, Eduardo; Gallagher, Jennifer Elizabeth] Guys Hosp, Kings Coll London, Inst Dent, Populat & Patient Hlth Div, London, England; [Sun, Xiangyu; Bernabe, Eduardo; Gallagher, Jennifer Elizabeth] Kings Coll Hosp London, Kings Coll London, Inst Dent, Populat & Patient Hlth Div, London, England; [Sun, Xiangyu; Bernabe, Eduardo; Gallagher, Jennifer Elizabeth] St Thomas Hosp, Kings Coll London, Inst Dent, Populat & Patient Hlth Div, London, England	Peking University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Zheng, SG (corresponding author), Peking Univ, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing Key Lab Digital Stomatol, Dept Prevent Dent,Sch & Hosp Stomatol, Beijing, Peoples R China.; Gallagher, JE (corresponding author), Guys Hosp, Kings Coll London, Inst Dent, Populat & Patient Hlth Div, London, England.; Gallagher, JE (corresponding author), Kings Coll Hosp London, Kings Coll London, Inst Dent, Populat & Patient Hlth Div, London, England.; Gallagher, JE (corresponding author), St Thomas Hosp, Kings Coll London, Inst Dent, Populat & Patient Hlth Div, London, England.	jenny.gallagher@kcl.ac.uk; zhengsg86@gmail.com	Sun, Xiangyu/T-8264-2019; Bernabe, Eduardo/R-3441-2017; Zheng, Shuguo/AAO-7612-2020	Bernabe, Eduardo/0000-0002-1858-3713; Gallagher, Jennifer Elizabeth/0000-0001-5068-8008				[Anonymous], 2008, ANAL HLTH EQUITY USI; Arsenijevic J, 2013, SOC SCI MED, V78, P17, DOI 10.1016/j.socscimed.2012.11.014; Bank WW, 2014, MON PROGR UN HLTH CO; Brinda EM, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-5; BUHMANN B, 1988, REV INCOME WEALTH, P115; Cai TJ, 2013, SOCIOL METHODOL, V43, P178, DOI 10.1177/0081175012460221; Carle AC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-49; Fang PQ, 2010, HEALTH POLICY, V94, P14, DOI 10.1016/j.healthpol.2009.08.002; Goryakin Y, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0107-1; Hsiao W, 2014, UNIVERSAL HLTH COVER; Hu DY, 2011, INT J ORAL SCI, V3, P7, DOI 10.4248/IJOS11006; Kavosi Z, 2012, HEALTH POLICY PLANN, V27, P613, DOI 10.1093/heapol/czs001; Kim Y, 2011, HEALTH POLICY, V100, P239, DOI 10.1016/j.healthpol.2010.08.008; Lavado RF, 2013, B WORLD HEALTH ORGAN, V91, P519, DOI 10.2471/BLT.12.115535; Liang L., 2013, LONG MARCH UNIVERSAL; LIBERATOS P, 1988, EPIDEMIOL REV, V10, P87, DOI 10.1093/oxfordjournals.epirev.a036030; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Lin HC, 2001, COMMUNITY DENT ORAL, V29, P319, DOI 10.1034/j.1600-0528.2001.290501.x; Liu YL, 2008, LANCET, V372, P1914, DOI 10.1016/S0140-6736(08)61362-8; Lu CL, 2009, B WORLD HEALTH ORGAN, V87, P238, DOI 10.2471/BLT.08.054379; Knaul FM, 2011, SALUD PUBLICA MEXICO, V53, pS85; Masood M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123075; Meng QY, 2015, LANCET, V386, P1484, DOI 10.1016/S0140-6736(15)00342-6; National Bureau of Statistics of China, 2006, NAT STAT YB 2005; Raban MZ, 2013, B WORLD HEALTH ORGAN, V91, P726, DOI 10.2471/BLT.12.113100; Rabe-Hesketh S, 2006, J R STAT SOC A STAT, V169, P805, DOI 10.1111/j.1467-985X.2006.00426.x; Sahin I, 2014, EUR J HLTH EC; Wagstaff A, 2008, POLICY RES WORKING P, V4554; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2016, WORLD HLTH STAT 2016; World Health Organization, 2015, TRACK UN HLTH COV 1; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th edn, p., P19; Xie Y, 2014, P NATL ACAD SCI USA, V111, P6928, DOI 10.1073/pnas.1403158111; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Xu LXC, 2000, CHINA ECON REV, V11, P149, DOI 10.1016/S1043-951X(00)00015-8; Yang GH, 2013, LANCET, V381, P1987, DOI 10.1016/S0140-6736(13)61097-1; Yip W, 2008, HEALTH AFFAIR, V27, P921, DOI 10.1377/hlthaff.27.4.921; Yu H, 2015, HEALTH POLICY, V119, P1145, DOI 10.1016/j.healthpol.2015.07.008; Zhu L, 2005, INT DENT J, V55, P231, DOI 10.1111/j.1875-595X.2005.tb00321.x	40	12	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168341	10.1371/journal.pone.0168341	http://dx.doi.org/10.1371/journal.pone.0168341			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977756	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400097
J	Tette, EMA; Neizer, ML; Nyarko, MY; Sifah, EK; Sagoe-Moses, IA; Nartey, ET				Tette, Edem M. A.; Neizer, Margaret L.; Nyarko, Mame Yaa; Sifah, Eric K.; Sagoe-Moses, Isabella A.; Nartey, Edmund T.			Observations from Mortality Trends at The Children's Hospital, Accra, 2003-2013	PLOS ONE			English	Article							CONJUGATE VACCINE; MALARIA; QUALITY; CARE; MALNUTRITION; GUIDELINES; PNEUMONIA; SURVIVAL; EFFICACY; GAMBIA	Objective Facility-based studies provide an unparalleled opportunity to assess interventions deployed in hospitals to reduce child mortality which is not easily captured in the national data. We examined mortality trends at the Princess Marie Louise Children's Hospital (PML) and related it to interventions deployed in the hospital and community to reduce child mortality and achieve the Millennium Development Goal 4 (MDG 4). Methods The study was a cross-sectional review of data on consecutive patients who died at the hospital over a period of 11 years, between 2003 and 2013. The total admissions for each year, the major hospital-based and population-based interventions, which took place within the period, were also obtained. Results Out of a total of 37,012 admissions, 1,314 (3.6%) deaths occurred and admissions tripled during the period. The average annual change in mortality was -7.12% overall, -7.38% in under-fives, and -1.47% in children >= 5 years. The majority of the deaths, 1,187 (90.3%), occurred in under-fives. The observed decrease in under-five (and overall) mortality rate occurred in a specific and peculiar pattern. Most of the decrease occurred during the period between 2003 and 2006. After that there was a noticeable increase from 2006 to 2008. Then, the rate slowly decreased until the end of the study period in 2013. There was a concomitant decline in malaria mortality following a pattern similar to the decline observed in other parts of the continent during this period. Several interventions might have contributed to the reduction in mortality including the change in malaria treatment policy, improved treatment of malnutrition and increasing paediatric input. Conclusion Under-fives mortality at PML has declined considerably; however, the reduction in mortality in older children has been minimal and thus requires special attention. Data collection for mortality reviews should be planned and commissioned regularly in hospitals to assess the effects of interventions and understand the context in which they occur. This will provide benchmarks and an impetus for improving care, identify shortfalls and ensure that the gains in child survival are maintained.	[Tette, Edem M. A.; Neizer, Margaret L.; Nyarko, Mame Yaa; Sifah, Eric K.] Princess Marie Louis Childrens Hosp PML, Accra, Ghana; [Tette, Edem M. A.] Univ Ghana, Sch Publ Hlth, Dept Community Hlth, Legon, Ghana; [Sagoe-Moses, Isabella A.] Ghana Hlth Serv, Family Hlth Div, Accra, Ghana; [Nartey, Edmund T.] Univ Ghana, Sch Med & Dent, Ctr Trop Clin Pharmacol & Therapeut, Accra, Ghana	University of Ghana; Ghana Health Service; University of Ghana	Tette, EMA (corresponding author), Princess Marie Louis Childrens Hosp PML, Accra, Ghana.; Tette, EMA (corresponding author), Univ Ghana, Sch Publ Hlth, Dept Community Hlth, Legon, Ghana.	edemenator@googlemail.com			Building Stronger Universities Initiative Platform on Human Health (BSU-PHH) [002]	Building Stronger Universities Initiative Platform on Human Health (BSU-PHH)	Building Stronger Universities Initiative Platform on Human Health (BSU-PHH) funded the study (Grant number 002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoola O O, 2005, West Afr J Med, V24, P175; BAMGBOYE E A, 1990, African Journal of Medicine and Medical Sciences, V19, P127; Bawaskar HS, 2003, LANCET, V361, P1224, DOI 10.1016/S0140-6736(03)12931-5; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Blanchet N J, 2012, Ghana Med J, V46, P76; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Bryce J, 2013, LANCET, V382, P1049, DOI 10.1016/S0140-6736(13)61753-5; Campbell D, 2004, J TROP PEDIATRICS, V50, P158, DOI 10.1093/tropej/50.3.158; Campbell H, 2008, PEDIATRICS, V121, pE984, DOI 10.1542/peds.2007-1395; Campbell H, 2016, LANCET GLOB HEALTH, V4, pE8, DOI 10.1016/S2214-109X(15)00286-7; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Commey JO, 1991, GHANA MED J, V25, P334; Cowgill KD, 2006, JAMA-J AM MED ASSOC, V296, P671, DOI 10.1001/jama.296.6.671; Currie J, 1996, J POLIT ECON, V104, P1263, DOI 10.1086/262059; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Daga S, 2016, J PERINATOL; Deen JL, 2003, B WORLD HEALTH ORGAN, V81, P237; Desai M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106197; English M, 2005, ARCH DIS CHILD, V90, P974, DOI 10.1136/adc.2005.074468; Ezeonwu BU, 2014, ANN MED HEALTH SCI R, V4, P239, DOI 10.4103/2141-9248.141966; Fisker AB, 2015, PEDIATR INFECT DIS J, V34, P1369, DOI 10.1097/INF.0000000000000896; Fraser J, 2014, LANCET, V384, P894, DOI 10.1016/S0140-6736(13)61089-2; Gove S, 1999, ARCH DIS CHILD, V81, P473, DOI 10.1136/adc.81.6.473; Gyamfi S, 2009, GHANA DEMOGRAPHIC HL; Jackson AA, 2006, ARCH DIS CHILD, V91, P706, DOI 10.1136/adc.2006.095596; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Julien M, 1995, J TROP PEDIATRICS, V41, P366, DOI 10.1093/tropej/41.6.366; Krug A, 2004, SAMJ S AFR MED J, V94, P202; Krug A, 2004, SAMJ S AFR MED J, V94, P198; Lanzieri TM, 2011, INT J INFECT DIS, V15, pE206, DOI 10.1016/j.ijid.2010.11.007; Lund N, 2015, CLIN INFECT DIS, V61, P1504, DOI 10.1093/cid/civ617; Molyneux E, 2006, B WORLD HEALTH ORGAN, V84, P314, DOI 10.2471/BLT.04.019505; Murni IK, 2015, ARCH DIS CHILD, V100, P454, DOI 10.1136/archdischild-2014-307297; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; NDPC/GoG UNDP, 2012, 2010 GHAN MILL DEV G; Nolan T, 2001, LANCET, V357, P106, DOI 10.1016/S0140-6736(00)03542-X; OBERKLAID F, 1991, ARCH DIS CHILD, V66, P1093, DOI 10.1136/adc.66.9.1093; PANA, 2005, GHAN WITHDR NEW MAL; Penazzato M, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004772.pub3; Pronovost PJ, 2004, LANCET, V363, P1061, DOI 10.1016/S0140-6736(04)15843-1; Requejo J, 2013, COUNTDOWN 2015 MATER; Robison JA, 2012, PEDIATRICS, V130, pE676, DOI 10.1542/peds.2012-0026; Sakai R, 2016, HEALTH SERV RES, V51, P530, DOI 10.1111/1475-6773.12354; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Schoeps A, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.27327; Scott SP, 2014, NUTRIENTS, V6, P5915, DOI 10.3390/nu6125915; Tette EMA, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0682-y; Tette EMA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150387; Tette EMA, 2014, INT AFFAIRS GLOBAL S, P21; Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1; Whitty CJM, 2013, PRINCIPLES MED AFRIC, P182; WHO, 2015, GLOB TECHN STRAT MAL; Witter S, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-20; Yankey S-AG, 2009, ANTIMALARIAL DRUG PO	55	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167947	10.1371/journal.pone.0167947	http://dx.doi.org/10.1371/journal.pone.0167947			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977713	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400041
J	Wilbiks, JMP; Dyson, BJ				Wilbiks, Jonathan M. P.; Dyson, Benjamin J.			The Dynamics and Neural Correlates of Audio-Visual Integration Capacity as Determined by Temporal Unpredictability, Proactive Interference, and SOA	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORKING-MEMORY; ATTENTION; PERCEPTION; COMPONENT; LIMITS; INDEX; ERP	Over 5 experiments, we challenge the idea that the capacity of audio-visual integration need be fixed at 1 item. We observe that the conditions under which audio-visual integration is most likely to exceed 1 occur when stimulus change operates at a slow rather than fast rate of presentation and when the task is of intermediate difficulty such as when low levels of proactive interference (3 rather than 8 interfering visual presentations) are combined with the temporal unpredictability of the critical frame (Experiment 2), or, high levels of proactive interference are combined with the temporal predictability of the critical frame (Experiment 4). Neural data suggest that capacity might also be determined by the quality of perceptual information entering working memory. Experiment 5 supported the proposition that audiovisual integration was at play during the previous experiments. The data are consistent with the dynamic nature usually associated with cross-modal binding, and while audio-visual integration capacity likely cannot exceed uni-modal capacity estimates, performance may be better than being able to associate only one visual stimulus with one auditory stimulus.	[Wilbiks, Jonathan M. P.; Dyson, Benjamin J.] Ryerson Univ, Dept Psychol, Toronto, ON, Canada; [Wilbiks, Jonathan M. P.] Mt Allison Univ, Dept Psychol, Sackville, NB, Canada; [Dyson, Benjamin J.] Univ Sussex, Sch Psychol, Falmer, England	Toronto Metropolitan University; Mount Allison University; University of Sussex	Wilbiks, JMP (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.; Wilbiks, JMP (corresponding author), Mt Allison Univ, Dept Psychol, Sackville, NB, Canada.	jwilbiks@mta.ca		Wilbiks, Jonathan/0000-0002-6882-5215	Ontario Graduate Scholarship; Ontario Ministry of Research and Innovation	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario)	JMPW was funded by an Ontario Graduate Scholarship. BJD was supported by an Early Researcher Award granted by Ontario Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler RF., 2014, INTERACT COMPUT; ANDERSON KJ, 1990, PSYCHOL BULL, V107, P96, DOI 10.1037/0033-2909.107.1.96; Andrade GN, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.63; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Calvert GA, 2004, J PHYSIOL-PARIS, V98, P191, DOI 10.1016/j.jphysparis.2004.03.018; Chan YM, 2014, FRONT AGING NEUROSCI, V6, P1; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Crowder R.G., 1976, PRINCIPLES LEARNING; Drew T, 2013, COGNITION, V126, P213, DOI 10.1016/j.cognition.2012.10.003; Dyson BJ, 2004, J ACOUST SOC AM, V115, P280, DOI 10.1121/1.1631945; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Holcombe AO, 2013, J VISION, V13, DOI 10.1167/13.1.12; Kane MJ, 2000, J EXP PSYCHOL LEARN, V26, P336, DOI 10.1037//0278-7393.26.2.336; Kawachi Y, 2014, J VISION, V14, DOI 10.1167/14.8.16; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; LUCK SJ, 1990, ELECTROEN CLIN NEURO, V75, P528, DOI 10.1016/0013-4694(90)90139-B; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Mazza V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017453; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Van der Burg E, 2008, J EXP PSYCHOL HUMAN, V34, P1053, DOI 10.1037/0096-1523.34.5.1053; Van der Burg E, 2013, PSYCHOL SCI, V24, P345, DOI 10.1177/0956797612452865; Van der Burg E, 2011, NEUROIMAGE, V55, P1208, DOI 10.1016/j.neuroimage.2010.12.068; van Wassenhove V, 2007, NEUROPSYCHOLOGIA, V45, P598, DOI 10.1016/j.neuropsychologia.2006.01.001; Verleger R, 2005, J PSYCHOPHYSIOL, V19, P165, DOI 10.1027/0269-8803.19.3.165; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Vogel EK, 2000, PSYCHOPHYSIOLOGY, V37, P190, DOI 10.1111/1469-8986.3720190; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; WASSERMAN EA, 1983, LEARN MOTIV, V14, P406, DOI 10.1016/0023-9690(83)90025-5; Wilbiks JMP, 2013, MULTISENS RES, V26, P561, DOI 10.1163/22134808-00002432; WOLDORFF MG, 1993, PSYCHOPHYSIOLOGY, V30, P98, DOI 10.1111/j.1469-8986.1993.tb03209.x; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y	37	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168304	10.1371/journal.pone.0168304	http://dx.doi.org/10.1371/journal.pone.0168304			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977790	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000391217400091
J	Zhang, AD; Liu, DD; Hua, CM; Yan, A; Liu, BH; Wu, MJ; Liu, YH; Huang, LL; Ali, I; Gan, YB				Zhang, Aidong; Liu, Dongdong; Hua, Changmei; Yan, An; Liu, Bohan; Wu, Minjie; Liu, Yihua; Huang, Linli; Ali, Imran; Gan, Yinbo			The Arabidopsis Gene zinc finger protein 3(ZFP3) Is Involved in Salt Stress and Osmotic Stress Response	PLOS ONE			English	Article							REGULATES TRICHOME INITIATION; WRKY TRANSCRIPTION FACTORS; HIGH-SALINITY STRESS; PROLINE ACCUMULATION; DROUGHT TOLERANCE; ABIOTIC STRESSES; ABSCISIC-ACID; WATER-STRESS; PLANTS; EXPRESSION	Plants are continuously challenged by various abiotic and biotic stresses. To tide over these adversities, plants evolved intricate regulatory networks to adapt these unfavorable environments. So far, many researchers have clarified the molecular and genetic pathways involved in regulation of stress responses. However, the mechanism through which these regulatory networks operate is largely unknown. In this study, we cloned a C2H2-type zinc finger protein gene ZFP3 from Arabidopsis thaliana and investigated its function in salt and osmotic stress response. Our results showed that the expression level of ZFP3 was highly suppressed by NaCl, mannitol and sucrose. Constitutive expression of ZFP3 enhanced tolerance of plants to salt and osmotic stress while the zfp3 mutant plants displays reduced tolerance in Arabidopsis. Gain-and Loss-of-function studies of ZFP3 showed that ZFP3 significantly changes proline accumulation and chlorophyll content. Furthermore, over-expression of ZFP3 induced the expressions of stress-related gene KIN1, RD22, RD29B and AtP5CS1. These results suggest that ZFP3 is involved in salt and osmotic stress response.	[Zhang, Aidong; Liu, Dongdong; Hua, Changmei; Yan, An; Liu, Bohan; Wu, Minjie; Liu, Yihua; Huang, Linli; Ali, Imran; Gan, Yinbo] Zhejiang Univ, Zhejiang Key Lab Crop Germplasm, Dept Agron, Coll Agr & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Gan, YB (corresponding author), Zhejiang Univ, Zhejiang Key Lab Crop Germplasm, Dept Agron, Coll Agr & Biotechnol, Hangzhou, Zhejiang, Peoples R China.	ygan@zju.edu.cn	Liu, Bohan/D-4731-2015; Liu, Bohan/G-4704-2017; Gan, Yinbo/N-1480-2015	Liu, Bohan/0000-0002-8318-9667; Liu, Bohan/0000-0002-8318-9667; 	Seven Agricultural Crop Breeding Program [2016YFD0100700]; Major State Basic Research Development Program (973 Program) [2015CB150200]; Zhejiang Provincial Natural Science Foundation of China [LZ15C020001]; National Natural Science Foundation of China [31570183, 31529001]	Seven Agricultural Crop Breeding Program; Major State Basic Research Development Program (973 Program)(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was funded by Seven Agricultural Crop Breeding Program (2016YFD0100700); Major State Basic Research Development Program (973 Program, grant no. 2015CB150200); Zhejiang Provincial Natural Science Foundation of China (Grant No. LZ15C020001) and National Natural Science Foundation of China (Grant No. 31570183; 31529001).	An LJ, 2012, PLANT J, V72, P474, DOI 10.1111/j.1365-313X.2012.05094.x; Bao SJ, 2011, BOTANY, V89, P647, DOI [10.1139/B11-053, 10.1139/b11-053]; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Borsani O, 2001, PLANT PHYSIOL, V126, P1024, DOI 10.1104/pp.126.3.1024; Cai SQ, 2008, PLANT PHYSIOL, V146, P1305, DOI 10.1104/pp.107.110908; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Chrispeels HE, 2000, PLANT MOL BIOL, V42, P279, DOI 10.1023/A:1006352809700; Ciftci-Yilmaz S, 2008, CELL MOL LIFE SCI, V65, P1150, DOI 10.1007/s00018-007-7473-4; Ciftci-Yilmaz S, 2007, J BIOL CHEM, V282, P9260, DOI 10.1074/jbc.M611093200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Deuschle K, 2004, PLANT CELL, V16, P3413, DOI 10.1105/tpc.104.023622; Dobra J, 2010, J PLANT PHYSIOL, V167, P1360, DOI 10.1016/j.jplph.2010.05.013; Fabro G, 2004, MOL PLANT MICROBE IN, V17, P343, DOI 10.1094/MPMI.2004.17.4.343; Gan YB, 2007, DEVELOPMENT, V134, P2073, DOI 10.1242/dev.005017; Gan YB, 2006, PLANT CELL, V18, P1383, DOI 10.1105/tpc.106.041533; Han GL, 2014, PLANT MOL BIOL, V86, P237, DOI 10.1007/s11103-014-0226-5; Hong ZL, 2000, PLANT PHYSIOL, V122, P1129, DOI 10.1104/pp.122.4.1129; Hua XJ, 1997, PLANT PHYSIOL, V114, P1215, DOI 10.1104/pp.114.4.1215; Joseph MP, 2014, PLANT PHYSIOL, V165, P1203, DOI 10.1104/pp.113.234294; Jung YJ, 2013, PLANT BIOLOGY, V15, P274, DOI 10.1111/j.1438-8677.2012.00631.x; Kodaira KS, 2011, PLANT PHYSIOL, V157, P742, DOI 10.1104/pp.111.182683; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Li MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23101; Lv WT, 2011, PLANT PHYSIOL, V156, P1921, DOI 10.1104/pp.111.175810; Meng D, 2016, PLANT PHYSIOL BIOCH, V103, P71, DOI 10.1016/j.plaphy.2016.02.006; Mittler R, 2006, FEBS LETT, V580, P6537, DOI 10.1016/j.febslet.2006.11.002; Moon SJ, 2015, PLANT MOL BIOL, V89, P421, DOI 10.1007/s11103-015-0378-y; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; Nakashima K, 2009, PLANT PHYSIOL, V149, P88, DOI 10.1104/pp.108.129791; Milla MA, 2006, PLANT MOL BIOL, V61, P13, DOI 10.1007/s11103-005-5798-7; Sakamoto H, 2000, GENE, V248, P23, DOI 10.1016/S0378-1119(00)00133-5; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Signorelli S, 2013, PLANT PHYSIOL BIOCH, V70, P195, DOI 10.1016/j.plaphy.2013.05.028; Sun LL, 2013, J ZHEJIANG UNIV-SC B, V14, P563, DOI 10.1631/jzus.B1200349; Sun LL, 2015, NEW PHYTOL, V206, P220, DOI 10.1111/nph.13218; Tang LL, 2013, PLANT PHYSIOL BIOCH, V71, P22, DOI 10.1016/j.plaphy.2013.06.024; Tian B, 2010, IEEE INT C ULTR ICUW, V1, P1, DOI DOI 10.1111/J.1438-8677.2009.00276.X; Tian MM, 2015, PLANT J, V82, P81, DOI 10.1111/tpj.12797; Xu SM, 2007, PLANT CELL REP, V26, P497, DOI 10.1007/s00299-006-0248-9; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; Yan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085208; Zang DD, 2015, PLANT SCI, V235, P111, DOI 10.1016/j.plantsci.2015.02.016; Zhang LN, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01174; Zhou ZJ, 2013, NEW PHYTOL, V198, P699, DOI 10.1111/nph.12211; Zhou ZJ, 2012, PLANT SIGNAL BEHAV, V7, P28, DOI 10.4161/psb.7.1.18404; Zhou ZJ, 2011, PLANT PHYSIOL, V157, P673, DOI 10.1104/pp.111.180281; Zhu J., TRENDS PLANT SCI, V6, P66	49	32	36	4	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168367	10.1371/journal.pone.0168367	http://dx.doi.org/10.1371/journal.pone.0168367			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977750	Green Submitted, gold, Green Published			2022-12-27	WOS:000391217400101
J	Nunez-Torres, R; Macias, J; Mancebo, M; Frias, M; Dolci, G; Tellez, F; Merino, D; Merchante, N; Gomez-Mateos, J; Guaraldi, G; Rivero-Juarez, A; Pineda, JA; Real, LM				Nunez-Torres, Rocio; Macias, Juan; Mancebo, Maria; Frias, Mario; Dolci, Giovanni; Tellez, Francisco; Merino, Dolores; Merchante, Nicolas; Gomez-Mateos, Jesus; Guaraldi, Giovanni; Rivero-Juarez, Antonio; Pineda, Juan A.; Real, Luis M.		HEPAVIR-Esteatosis Study Grp	The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; LIVER FIBROSIS PROGRESSION; HIV-INFECTED PATIENTS; TRANSIENT ELASTOGRAPHY; DISEASE; IMPACT; METAANALYSIS; STIFFNESS; RISK; SUSCEPTIBILITY	Contradictory data about the impact of the rs738409 steatosis-related polymorphism within PNPLA3 gene on liver fibrosis progression in HIV/hepatitis C virus (HIV/HCV)-coinfected patients have been reported. Our objective was to test whether this, and other polymorphisms previously related to fatty liver disease in HIV infection linked to SAMM50 or LPPR4 genes, influence liver fibrosis progression in HIV/HCV-coinfected individuals. Three hundred and thirty two HIV/HCV-coinfected patients who consecutively attended four Spanish university hospitals from November 2011 to July 2013 were included. A liver stiffness cut-off of 14.6 kPa, as determined by transient elastography, was used to diagnose cirrhosis. Liver stiffness progression was studied in 171 individuals who had two available LS determinations without anti-HCV treatment between them. Moreover, 28 HIV/HCV-coinfected patients who underwent liver transplant, as well as 19 non-cirrhotic coinfected individuals used as controls, were included in an additional study. Only rs738409 was associated with cirrhosis: 45 (29.6%) of 152 G allele carriers versus 36 (20.0%) of 180 CC carriers showed cirrhosis (multivariate p = 0.018; adjusted odds ratio = 1.98; 95% confidence interval = 1.12-3.50). Also, 21 (30.4%) of 69 G allele carriers versus 16 (15.7%) of 102 CC patients showed significant liver stiffness progression (adjusted p-value = 0.015; adjusted odds ratio = 2.89; 95% confidence interval = 1.23-6.83). Finally, the proportion of rs738409 G allele carriers was significantly higher in transplanted individuals than in controls (p = 0.044, odds ratio = 3.43; 95% confidence interval = 1.01-11.70). Our results strongly suggest that the rs738409 polymorphism is associated with liver fibrosis progression in HIV/HCV-coinfected patients.	[Nunez-Torres, Rocio; Macias, Juan; Mancebo, Maria; Merchante, Nicolas; Gomez-Mateos, Jesus; Pineda, Juan A.; Real, Luis M.] Valme Univ Hosp, Unit Infect Dis & Microbiol, Seville, Spain; [Nunez-Torres, Rocio; Macias, Juan; Mancebo, Maria; Merchante, Nicolas; Gomez-Mateos, Jesus; Real, Luis M.] Inst Biomed Sevilla IBIS, Seville, Spain; [Frias, Mario; Rivero-Juarez, Antonio] Reina Sofia Univ Hosp, Infect Dis Unit, Cordoba, Spain; [Frias, Mario; Rivero-Juarez, Antonio] Univ Cordoba, IMIBC, Cordoba, Spain; [Dolci, Giovanni; Guaraldi, Giovanni] Univ Modena & Reggio Emilia, Clin & Infect Dis, Dept Med & Surg Sci Adults & Children, Modena, Italy; [Tellez, Francisco] La Linea Concepc Hosp, Infect Dis Unit, Cadiz, Spain; [Merino, Dolores] Huelva Univ Hosp, Infect Dis Unit, Huelva, Spain	Hospital Valme; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Hospital Universitario Reina Sofia - Cordoba; Universidad de Cordoba; Universita di Modena e Reggio Emilia	Real, LM (corresponding author), Valme Univ Hosp, Unit Infect Dis & Microbiol, Seville, Spain.; Real, LM (corresponding author), Inst Biomed Sevilla IBIS, Seville, Spain.	lmreal67b@gmail.com	Macias, Juan/I-9133-2019; Pineda, Juan A./AAO-9312-2021; Guaraldi, Giovanni/J-9467-2018; Rivero, Antonio/ABE-5294-2020; Real, Luis M/K-9646-2014; Rivero-Juarez, Antonio/E-4528-2019; Frias, Mario/AAL-6494-2021	Macias, Juan/0000-0002-4778-790X; Pineda, Juan A./0000-0002-3751-0296; Real, Luis M/0000-0003-4932-7429; Rivero-Juarez, Antonio/0000-0002-5813-6889; Tellez, Francisco/0000-0002-9997-6761; Merchante, Nicolas/0000-0003-1120-8942; Dolci, Giovanni/0000-0001-9948-652X	Consejeria de Salud, Junta de Andalucia [PI-0118-2013, PI-0481-2012, AC-0095-2013, RH-0024-2013, B-0037, C-0009-2015]; Instituto de Salud Carlos III [RD12/0017/0012, EC11-2086, I3SNS]; Ministerio de Economia y Competitividad; Gilead fellowship program [GLDL13-00145]	Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Economia y Competitividad(Spanish Government); Gilead fellowship program(Gilead Sciences)	This work was supported by: PI-0118-2013, PI-0481-2012, AC-0095-2013, RH-0024-2013, B-0037 and C-0009-2015, Consejeria de Salud, Junta de Andalucia, http://www.juntadeandalucia.es/salud/sites/csalud/portal/index.jsp; RD12/0017/0012, EC11-2086, I3SNS, Instituto de Salud Carlos III, http://www.isciii.es/; PTA2014-09009-I, Ministerio de Economia y Competitividad, http://www.mineco.gob.es/portal/site/mineco/; and GLDL13- 00145, Gilead fellowship program, https://www.fellowshipgilead.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro P, 2006, CLIN INFECT DIS, V42, P1032, DOI 10.1086/501021; Boursier J, 2015, HEPATOLOGY, V61, P18, DOI 10.1002/hep.27445; Bureau C, 2008, ALIMENT PHARM THER, V27, P1261, DOI 10.1111/j.1365-2036.2008.03701.x; Corpechot C, 2012, HEPATOLOGY, V56, P198, DOI 10.1002/hep.25599; Fan JH, 2015, GUT LIVER; Gonzalez FA, 2015, HIV MED, V16, P211, DOI 10.1111/hiv.12197; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Jimenez-Sousa MA, 2016, AIDS, V30, P465, DOI 10.1097/QAD.0000000000000908; Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322; Krawczyk M, 2011, J HEPATOL, V55, P299, DOI 10.1016/j.jhep.2010.10.042; Leite Andrea G B, 2015, J Int Assoc Provid AIDS Care, V14, P463, DOI 10.1177/2325957415587571; Macias J, 2004, AIDS, V18, P767, DOI [10.1097/01.aids.0000111417.91384.fd, 10.1097/00002030-200403260-00007]; Macias J, 2006, ANTIVIR THER, V11, P839; Macias J, 2015, AIDS, V29, P1927, DOI 10.1097/QAD.0000000000000799; Macias J, 2014, AIDS, V28, P1279, DOI 10.1097/QAD.0000000000000248; Macias J, 2009, HEPATOLOGY, V50, P1056, DOI 10.1002/hep.23136; Mandorfer M, 2015, LIVER INT, V35, P876, DOI 10.1111/liv.12615; Merchante N, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1291-3; Merchante N, 2012, HEPATOLOGY, V56, P228, DOI 10.1002/hep.25616; Min HK, 2014, AM J PHYSIOL-GASTR L, V307, pG66, DOI 10.1152/ajpgi.00335.2013; Petta S, 2015, ALIMENT PHARM THER, V41, P939, DOI 10.1111/apt.13169; Pradat P, 2007, LIVER INT, V27, P335, DOI 10.1111/j.1478-3231.2006.01430.x; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Romeo S, 2010, CURR OPIN LIPIDOL, V21, P247, DOI 10.1097/MOL.0b013e328338ca61; Rueger S, 2015, GUT, V64, P1605, DOI 10.1136/gutjnl-2014-306997; Sagnelli C, 2016, CLIN MICROBIOL INFEC, V22, P372, DOI 10.1016/j.cmi.2015.11.025; Scheiner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143429; Singal AG, 2014, AM J GASTROENTEROL, V109, P325, DOI 10.1038/ajg.2013.476; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Speliotes EK, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001324; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Vergara S, 2007, CLIN INFECT DIS, V45, P969, DOI 10.1086/521857; Yasui K, 2015, J GASTROENTEROL, V50, P887, DOI 10.1007/s00535-014-1018-z	34	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168265	10.1371/journal.pone.0168265	http://dx.doi.org/10.1371/journal.pone.0168265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973562	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300070
J	Parker, RA; Weir, CJ; Rubio, N; Rabinovich, R; Pinnock, H; Hanley, J; McCloughan, L; Drost, EM; Mantoani, LC; MacNee, W; McKinstry, B				Parker, Richard A.; Weir, Christopher J.; Rubio, Noah; Rabinovich, Roberto; Pinnock, Hilary; Hanley, Janet; McCloughan, Lucy; Drost, Ellen M.; Mantoani, Leandro C.; MacNee, William; McKinstry, Brian			Application of Mixed Effects Limits of Agreement in the Presence of Multiple Sources of Variability: Exemplar from the Comparison of Several Devices to Measure Respiratory Rate in COPD Patients	PLOS ONE			English	Article							BLAND-ALTMAN METHOD	Introduction The Bland-Altman limits of agreement method is widely used to assess how well the measurements produced by two raters, devices or systems agree with each other. However, mixed effects versions of the method which take into account multiple sources of variability are less well described in the literature. We address the practical challenges of applying mixed effects limits of agreement to the comparison of several devices to measure respiratory rate in patients with chronic obstructive pulmonary disease (COPD). Methods Respiratory rate was measured in 21 people with a range of severity of COPD. Participants were asked to perform eleven different activities representative of daily life during a laboratory- based standardised protocol of 57 minutes. A mixed effects limits of agreement method was used to assess the agreement of five commercially available monitors (Camera, Photoplethysmography (PPG), Impedance, Accelerometer, and Chest-band) with the current gold standard device for measuring respiratory rate. Results Results produced using mixed effects limits of agreement were compared to results from a fixed effects method based on analysis of variance (ANOVA) and were found to be similar.The Accelerometer and Chest-band devices produced the narrowest limits of agreement (-8.63 to 4.27 and -9.99 to 6.80 respectively) with mean bias -2.18 and -1.60 breaths per minute. These devices also had the lowest within-participant and overall standard deviations ( 3.23 and 3.29 for Accelerometer and 4.17 and 4.28 for Chest-band respectively). Conclusions The mixed effects limits of agreement analysis enabled us to answer the question of which devices showed the strongest agreement with the gold standard device with respect to measuring respiratory rates. In particular, the estimated within-participant and overall standard deviations of the differences, which are easily obtainable from the mixed effects model results, gave a clear indication that the Accelerometer and Chest-band devices performed best.	[Parker, Richard A.; Weir, Christopher J.; Hanley, Janet; McKinstry, Brian] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh Clin Trials Unit, Edinburgh, Midlothian, Scotland; [Rubio, Noah; Rabinovich, Roberto; Drost, Ellen M.; Mantoani, Leandro C.; MacNee, William] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, ELEGI, Edinburgh, Midlothian, Scotland; [Pinnock, Hilary] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Allergy & Resp Res Grp, Edinburgh, Midlothian, Scotland; [Hanley, Janet] Edinburgh Napier Univ, Sch Nursing Midwifery & Social Care, Edinburgh, Midlothian, Scotland; [McCloughan, Lucy; McKinstry, Brian] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, E Hlth Res Grp, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; Edinburgh Napier University; University of Edinburgh	Parker, RA (corresponding author), Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh Clin Trials Unit, Edinburgh, Midlothian, Scotland.	richard.parker@ed.ac.uk	Mantoani, Leandro Cruz/AAW-4370-2021	Mantoani, Leandro Cruz/0000-0003-3347-3632; Hanley, Janet/0000-0003-1728-0136; McKinstry, Brian/0000-0001-9581-0468; Weir, Christopher/0000-0002-6494-4903; Parker, Richard/0000-0002-2658-5022	Chief Scientist Office (Scotland) [CZH/4/826]; NHS Lothian via the Edinburgh Health Services Research Unit; Chief Scientist Office [CZH/4/826, ARPG/07/03] Funding Source: researchfish	Chief Scientist Office (Scotland); NHS Lothian via the Edinburgh Health Services Research Unit; Chief Scientist Office	This project was funded by the Chief Scientist Office (Scotland) [reference number CZH/4/826]. RAP, CJW, BM, JH were supported in this work by NHS Lothian via the Edinburgh Health Services Research Unit. Neither the Chief Scientist Office nor NHS Lothian had any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biancofiore G, 2011, ANESTH ANALG, V113, P515, DOI 10.1213/ANE.0b013e31822401b2; Bland JM, 2007, J BIOPHARM STAT, V17, P571, DOI 10.1080/10543400701329422; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown H, 2015, APPL MIXED MODELS ME; Carkeet A, 2016, STAT METHODS MED RES; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Carstensen B., 2008, INT J BIOSTAT, V4, P16, DOI DOI 10.2202/1557-4679.1107; Columb MO., 2008, CURR ANAESTH CRIT CA, V19, P328, DOI [DOI 10.1016/J.CACC.2008.07.001, 10.1016/j.cacc.2008.07.001]; Hamilton C, 2010, J CLIN MONIT COMPUT, V24, P173, DOI 10.1007/s10877-010-9230-8; Thai HT, 2013, PHARM STAT, V12, P129, DOI 10.1002/pst.1561; Hofman CS, 2015, J CLIN EPIDEMIOL, V68, P939, DOI 10.1016/j.jclinepi.2015.02.015; Liu L, 2015, J INTERDISCIP MATH, V18, P681, DOI 10.1080/09720502.2015.1108055; Lopez-Campos JL, 2016, RESPIROLOGY, V21, P14, DOI 10.1111/resp.12660; Mantha S, 2000, ANESTH ANALG, V90, P593, DOI 10.1097/00000539-200003000-00018; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; Olofsen E, 2015, J CLIN MONIT COMPUT, V29, P127, DOI 10.1007/s10877-014-9577-3; Pinheiro J, R PACKAGE VERSION; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; R Core Team, 2015, R LANG ENV STAT COMP; Rubio N, 2016, INTERNATIONAL JOURNA; Stang P, 2000, CHEST, V117, p354S, DOI 10.1378/chest.117.5_suppl_2.354S; Zou GY, 2013, STAT METHODS MED RES, V22, P630, DOI 10.1177/0962280211402548	23	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168321	10.1371/journal.pone.0168321	http://dx.doi.org/10.1371/journal.pone.0168321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973556	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300076
J	Chowdhury, S; Yung, E; Pintilie, M; Muaddi, H; Chaib, S; Yeung, M; Fusciello, M; Sykes, J; Pitcher, B; Hagenkort, A; Mckee, T; Vellanki, R; Chen, E; Bristow, RG; Wouters, BG; Koritzinsky, M				Chowdhury, Sanjana; Yung, Eric; Pintilie, Melania; Muaddi, Hala; Chaib, Selim; Yeung, ManTek; Fusciello, Manlio; Sykes, Jenna; Pitcher, Bethany; Hagenkort, Anna; Mckee, Trevor; Vellanki, Ravi; Chen, Eric; Bristow, Robert G.; Wouters, Bradly G.; Koritzinsky, Marianne			MATE2 Expression Is Associated with Cancer Cell Response to Metformin	PLOS ONE			English	Article							CATION TRANSPORTER 1; GENETIC-VARIATION; POPULATION PHARMACOKINETICS; THERAPEUTIC RESPONSE; DIABETES-MELLITUS; RENAL CLEARANCE; BREAST-CANCER; TUMOR HYPOXIA; VARIANTS; POLYMORPHISMS	Background There is great interest in repurposing the commonly prescribed anti-diabetic drug metformin for cancer therapy. Intracellular uptake and retention of metformin is affected by the expression of organic cation transporters (OCT) 1-3 and by multidrug and toxic compound extrusion (MATE) 1-2. Inside cells, metformin inhibits mitochondrial function, which leads to reduced oxygen consumption and inhibition of proliferation. Reduced oxygen consumption can lead to improved tumor oxygenation and radiation response. Purpose Here we sought to determine if there is an association between the effects of metformin on inhibiting oxygen consumption, proliferation and expression of OCTs and MATEs in a panel of 19 cancer cell lines. Results There was relatively large variability in the anti-proliferative response of different cell lines to metformin, with a subset of cell lines being very resistant. In contrast, all cell lines demonstrated sensitivity to the inhibition of oxygen consumption by metformin, with relatively small variation. The expression of OCT1 correlated with expression of both OCT2 and OCT3. OCT1 and OCT2 were relatively uniformly expressed, whereas expression of OCT3, MATE1 and MATE2 showed substantial variation across lines. There were statistically significant associations between resistance to inhibition of proliferation and MATE2 expression, as well as between sensitivity to inhibition of oxygen consumption and OCT3 expression. One cell line (LNCaP) with high OCT3 and low MATE2 expression in concert, had substantially higher intracellular metformin concentration than other cell lines, and was exquisitely sensitive to both anti-proliferative and anti-respiratory effects. In all other celllines, the concentration of metformin required to inhibit oxygen consumption acutely in vitro was substantially higher than that achieved in the plasma of diabetic patients. However, administering anti-diabetic doses of metformin to tumor-bearing mice resulted in intratumoral accumulation of metformin and reduced hypoxic tumor fractions. Conclusions All cancer cells are susceptible to inhibition of oxygen consumption by metformin, which results in reduced hypoxic tumor fractions beneficial for the response to radiotherapy. High MATE2 expression may result in resistance to the anti-proliferative effect of metformin and should be considered as a negative predictive biomarker in clinical trials.	[Chowdhury, Sanjana; Yung, Eric; Pintilie, Melania; Muaddi, Hala; Chaib, Selim; Yeung, ManTek; Fusciello, Manlio; Sykes, Jenna; Pitcher, Bethany; Hagenkort, Anna; Mckee, Trevor; Vellanki, Ravi; Chen, Eric; Bristow, Robert G.; Wouters, Bradly G.; Koritzinsky, Marianne] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Chowdhury, Sanjana; Yung, Eric; Muaddi, Hala; Bristow, Robert G.; Koritzinsky, Marianne] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Chaib, Selim; Fusciello, Manlio; Hagenkort, Anna; Wouters, Bradly G.] Maastricht Univ, Maastricht, Netherlands; [Bristow, Robert G.; Wouters, Bradly G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Bristow, Robert G.; Wouters, Bradly G.; Koritzinsky, Marianne] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Maastricht University; University of Toronto; University of Toronto	Koritzinsky, M (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada.; Koritzinsky, M (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.; Koritzinsky, M (corresponding author), Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada.	mkoritzi@uhnresearch.ca	Vellanki, Ravi/M-8738-2019; Muaddi, Hala/AAE-1264-2021; McKee, Trevor David/N-4308-2019; Wouters, Bradly/T-1525-2017	Vellanki, Ravi/0000-0002-5081-3187; Muaddi, Hala/0000-0001-9721-2808; McKee, Trevor David/0000-0002-2195-6146; Wouters, Bradly/0000-0002-8187-592X; Bristow, Robert/0000-0002-8553-9544; Chaib, Selim/0000-0003-0497-2002; Fusciello, Manlio/0000-0002-7166-3018; Koritzinsky, Marianne/0000-0003-0547-2480	Ontario Ministry of Health and Long Term Care; Princess Margaret Cancer Foundation; Prostate Cancer Canada [20R17798]; Terry Fox Research Institute (New Frontiers Research Program) [PPG14-1036]	Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Princess Margaret Cancer Foundation(University of Toronto); Prostate Cancer Canada; Terry Fox Research Institute (New Frontiers Research Program)	This work was financially supported by the Ontario Ministry of Health and Long Term Care, the Princess Margaret Cancer Foundation, Prostate Cancer Canada (PG# 20R17798 to RGB and MK) and the Terry Fox Research Institute (New Frontiers Research Program PPG14-1036; to M.K, R.G.B and B.G.W). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank Dr. R. Grenman at Turku University Hospital for providing cell lines 16A/B, 19A/B and 74A/B and Stephen Chung for technical assistance. This work was financially supported by the Ontario Ministry of Health and Long Term Care, the Princess Margaret Cancer Foundation, Prostate Cancer Canada (PG# 20R17798 to RGB and MK) and the Terry Fox Research Institute (New Frontiers Research Program PPG14-1036; to M.K, R.G.B and B.G.W). The views hereby expressed do not necessarily reflect the views of these organizations.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Becker ML, 2009, PHARMACOGENOMICS J, V9, P242, DOI 10.1038/tpj.2009.15; Becker MSL, 2009, DIABETES, V58, P745, DOI 10.2337/db08-1028; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Cai H, 2016, INT J CANCER, V138, P2281, DOI 10.1002/ijc.29965; Chandel NS, 2016, CELL METAB, V23, P569, DOI 10.1016/j.cmet.2016.03.010; Chen EC, 2015, MOL PHARMACOL, V88, P75, DOI 10.1124/mol.114.096776; Chen Y, 2009, PHARMACOGENET GENOM, V19, P497, DOI 10.1097/FPC.0b013e32832cc7e9; Choi JH, 2011, CLIN PHARMACOL THER, V90, P674, DOI 10.1038/clpt.2011.165; Christensen MMH, 2013, PHARMACOGENET GENOM, V23, P526, DOI 10.1097/FPC.0b013e328364a57d; Christensen MMH, 2011, PHARMACOGENET GENOM, V21, P837, DOI 10.1097/FPC.0b013e32834c0010; Diepart C, 2012, CANCER RES, V72, P482, DOI 10.1158/0008-5472.CAN-11-1755; Dowling RJO, 2016, CELL METAB, V23, P567, DOI 10.1016/j.cmet.2016.03.006; Dujic T, 2016, DIABETIC MED, V33, P511, DOI 10.1111/dme.13040; Dujic T, 2015, DIABETES, V64, P1786, DOI 10.2337/db14-1388; Duong JK, 2013, CLIN PHARMACOKINET, V52, P373, DOI 10.1007/s40262-013-0046-9; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Gandini S, 2014, CANCER PREV RES, V7, P867, DOI 10.1158/1940-6207.CAPR-13-0424; Hockel M, 1996, CANCER RES, V56, P4509; Jablonski KA, 2010, DIABETES, V59, P2672, DOI 10.2337/db10-0543; Jang IS, 2014, BIOCOMPUT-PAC SYM, P63; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Joshua AM, 2014, PROSTATE CANCER P D, V17, P252, DOI 10.1038/pcan.2014.20; Kelly CJ, 2014, RADIOTHER ONCOL, V111, P72, DOI 10.1016/j.radonc.2014.02.007; Ko EM, 2014, GYNECOL ONCOL, V132, P438, DOI 10.1016/j.ygyno.2013.11.021; Koepsell H, 2007, PHARM RES-DORDR, V24, P1227, DOI 10.1007/s11095-007-9254-z; Koritzinsky M, 2005, RADIOTHER ONCOL, V76, P177, DOI 10.1016/j.radonc.2005.06.036; Koritzinsky M, 2015, INT J RADIAT ONCOL, V93, P454, DOI 10.1016/j.ijrobp.2015.06.003; Kreso Antonija, 2008, Curr Protoc Stem Cell Biol, VChapter 3, DOI 10.1002/9780470151808.sc0301s7; Lalau JD, 2011, CLIN DRUG INVEST, V31, P435, DOI 10.2165/11588310-000000000-00000; Laskov I, 2014, GYNECOL ONCOL, V134, P607, DOI 10.1016/j.ygyno.2014.06.014; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Margel D, 2013, JOURNAL OF CLINICAL; Milosevic M, 2012, CLIN CANCER RES, V18, P2108, DOI 10.1158/1078-0432.CCR-11-2711; Mitsuhashi A, 2014, CANCER-AM CANCER SOC, V120, P2986, DOI 10.1002/cncr.28853; Motohashi H, 2013, AAPS J, V15, P581, DOI 10.1208/s12248-013-9465-7; Muaddi H, 2013, RADIOTHERAPY ONCOLOG; Niraula S, 2012, BREAST CANCER RES TR, V135, P821, DOI 10.1007/s10549-012-2223-1; Nordsmark M, 2005, RADIOTHER ONCOL, V77, P18, DOI 10.1016/j.radonc.2005.06.038; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pelis RM, 2014, CURR TOP MEMBR, V73, P233, DOI 10.1016/B978-0-12-800223-0.00006-2; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Rieken M, 2013, BJU INT, V112, P1105, DOI 10.1111/bju.12448; SECOMB TW, 1995, ACTA ONCOL, V34, P313, DOI 10.3109/02841869509093981; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Skinner HD, 2013, CANCER MED-US, V2, P99, DOI 10.1002/cam4.54; Skinner HD, 2013, ACTA ONCOL, V52, P1002, DOI 10.3109/0284186X.2012.718096; Song IS, 2008, CLIN PHARMACOL THER, V84, P559, DOI 10.1038/clpt.2008.61; Stocker SL, 2013, CLIN PHARMACOL THER, V93, P186, DOI 10.1038/clpt.2012.210; Tkac I, 2013, DIABETES OBES METAB, V15, P189, DOI 10.1111/j.1463-1326.2012.01691.x; Tzvetkov MV, 2009, CLIN PHARMACOL THER, V86, P299, DOI 10.1038/clpt.2009.92; van den Beucken T, 2013, J CELL BIOL; van den Beucken T, 2011, RADIOTHER ONCOL, V99, P379, DOI 10.1016/j.radonc.2011.05.058; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; Wheaton WW, 2014, ELIFE, V3, DOI 10.7554/eLife.02242; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Wouters BG, 2002, EUR J CANCER, V38, P240, DOI 10.1016/S0959-8049(01)00361-6; Wu W, 2014, BRIT J CANCER, V111, P628, DOI 10.1038/bjc.2014.307; Yoon H, 2013, AAPS J, V15, P571, DOI 10.1208/s12248-013-9460-z; Zannella VE, 2013, CLIN CANC RES	64	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0165214	10.1371/journal.pone.0165214	http://dx.doi.org/10.1371/journal.pone.0165214			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959931	Green Submitted, gold, Green Published			2022-12-27	WOS:000392753900001
J	Swartz, L; Bantjes, J; Rall, D; Ferreira, S; Blauwet, C; Derman, W				Swartz, Leslie; Bantjes, Jason; Rall, Divan; Ferreira, Suzanne; Blauwet, Cheri; Derman, Wayne			"A More Equitable Society": The Politics of Global Fairness in Paralympic Sport	PLoS One			English	Article							OSCAR PISTORIUS; CYBORG	The Paralympic Movement explicitly sets out to create a more equitable society and promote participation for all and fairness in disability sport. This is primarily achieved through the use of a range of interventions with less attention given to how economic factors may hinder access and achievement in Paralympic sport. We investigated how country-level economic variables influence the level of participation and achievement in the 2015 International Paralympic Committee (IPC) Athletics Championships held in Doha. We used multiple regression analysis to show how levels of participation and achievement in the Championships were significantly determined by economic factors independent of population size. Our data show that in spite of the ideals of inclusion and fairness within the Paralympic Movement and the considerable effort expended on the use of technologies to achieve this, economic factors continue to exert a statistically significant influence on both the level of participation and achievement of Paralympic athletes. LMICs participate at lower levels and achieve fewer medals when compared to HICs. These differences are particularly marked in events that have a high cost of participation. Our findings raise questions regarding the use of current technologies and the level to which they are able to truly disrupt the politics of global inequality in sport.	[Swartz, Leslie] Univ Stellenbosch, Dept Psychol, Alan J Flisher Ctr Publ Mental Hlth, Stellenbosch, South Africa; [Bantjes, Jason; Rall, Divan] Univ Stellenbosch, Dept Psychol, Stellenbosch, South Africa; [Ferreira, Suzanne] Univ Stellenbosch, Dept Sport Sci, Stellenbosch, South Africa; [Blauwet, Cheri] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Blauwet, Cheri] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Derman, Wayne] Univ Stellenbosch, Inst Sport & Exercise Med, Cape Town, South Africa; [Derman, Wayne] Int Olymp Comm IOC, Res Ctr, Cape Town, South Africa	Stellenbosch University; Stellenbosch University; Stellenbosch University; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Stellenbosch University	Swartz, L (corresponding author), Univ Stellenbosch, Dept Psychol, Alan J Flisher Ctr Publ Mental Hlth, Stellenbosch, South Africa.	Lswartz@sun.ac.za	Swartz, Leslie/A-5168-2008; Derman, Wayne/ABD-6557-2020; Bantjes, Jason/T-8294-2019	Swartz, Leslie/0000-0003-1741-5897; Bantjes, Jason/0000-0002-3626-9883	National Research Foundation of South Africa [85423]; Medical Research Council of South Africa (MRC career award); Kelley Adaptive Sports Research Institute	National Research Foundation of South Africa(National Research Foundation - South Africa); Medical Research Council of South Africa (MRC career award); Kelley Adaptive Sports Research Institute	This work is based on research supported in part by the National Research Foundation of South Africa (Grant specific unique reference number (UID) 85423) (LS). JB is supported by the Medical Research Council of South Africa (MRC career award). CB is supported by the Kelley Adaptive Sports Research Institute. The Grantholders (LS, CB and JB) acknowledge that opinions, findings and conclusions or recommendations expressed in any publication generated by the NRF, the Kelley Adaptive Sports Research Institute and MRC supported research are that of the authors, and that the NRF and/or the Kelley Adaptive Sports Research Institute and/or MRC accept no liability whatsoever in this regard. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, PARALYMPIC MOVEMENT; Braye S, 2013, DISABIL SOC, V28, P984, DOI 10.1080/09687599.2012.748648; Chauliac MS, 2015, EUROPEAN J PUBLIC HL, V25; Halsey LG, 2009, SPORT SOC, V12, P1353, DOI 10.1080/17430430903204892; Hodges CEM, 2014, PROJECT REPORT; Howe PD, 2011, SOCIOLOGY, V45, P868, DOI 10.1177/0038038511413421; International Paralympic Commitee, 2015, IPC ATHL CLASS COD; International Paralympic Committee, 2016, INTR PAR MOV; International Paralympic Committee, LAYM GUID PAR CLASS; International Paralympic Committee, 2011, INT PAR COMM ANN REP; Obbard K, 2016, J POP CULT, V49, P417, DOI 10.1111/jpcu.12392; SHAKESPEARE T, 1994, DISABIL SOC, V9, P283, DOI 10.1080/09687599466780341; Shakespeare T., 2012, DISABILITY RIGHTS WR; Shibli S., 2012, Managing Leisure, V17, P274, DOI 10.1080/13606719.2012.674399; Swartz L, 2008, DISABIL SOC, V23, P187, DOI 10.1080/09687590701841232; United Nations, 2008, CONV RIGHTS PERS DIS; Vagenas G, 2012, SPORT MANAG REV, V15, P211, DOI 10.1016/j.smr.2011.07.001; WHO, 2011, WORLD REPORT ON DISABILITY, P1; World Bank, 2016, DATA; Young Stella, 2012, THE DRUM        0703	20	5	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167481	10.1371/journal.pone.0167481	http://dx.doi.org/10.1371/journal.pone.0167481			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27941981	Green Published, Green Submitted, gold			2022-12-27	WOS:000392745600018
J	Zhang, WJ; He, WL; Shi, YJ; Gu, HF; Li, M; Liu, ZM; Feng, YL; Zheng, NZ; Xie, CM; Zhang, YN				Zhang, Weijing; He, Weiling; Shi, Yongjie; Gu, Haifeng; Li, Min; Liu, Zhimin; Feng, Yanling; Zheng, Nianzhen; Xie, Chuanmiao; Zhang, Yanna			High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma	PLOS ONE			English	Article							LYMPH-NODE METASTASES; FOLLOW-UP; CANCER; KINESIN; ANTIGEN; IDENTIFICATION; INHIBITION; ACTIVATION; PROTEIN; GROWTH	Background The kinesin family member 20a (KIF20A) protein has been implicated in the development and progression of many human cancers; however, its precise function and role in cervical cancer remain largely unclear. This study aimed to investigate the expression profile and prognostic value of KIF20A in patients with early-stage cervical squamous cell carcinoma. Methods We examined the mRNA and protein levels of KIF20A in eight cervical cancer cell lines and eight paired cervical cancer samples, compared with normal cervical epithelial cells and adjacent normal cervical tissues, respectively. Immunohistochemistry was performed to detect the expression of KIF20A in paraffin-embedded specimens from 169 early-stage cervical squamous cell carcinoma patients. Statistical analyses were applied to analyze the association between KIF20A expression and clinical variables, as well with patient survival. Results The mRNA and protein expression levels of KIF20A were significantly elevated in cervical cancer cell lines and lesions compared with normal cells and corresponding normal tissues (P < 0.05). Immunohistochemistry analysis in 169 cervical cancer cases revealed that increased KIF20A expression was strongly associated with human papillomavirus (HPV) infection (P = 0.008), clinical stage (P = 0.001), tumor recurrence (P = 0.016), vital status (P < 0.001), the property of the surgical margin (P = 0.032), the lymphovascular space involvement (P = 0.014), and pelvic lymph node metastasis (P = 0.001). The overall survival and disease-free survival of patients with high levels of KIF20A expression were significantly poorer than those with low KIF20A expression. KIF20A was an independent survival prognostic factor, as evidenced by univariate and multivariate analysis. Conclusions Our results illustrate that elevated KIF20A expression correlates with HPV infection, clinical stage, tumor recurrence, lymphovascular space involvement, pelvic lymph node metastasis, and poor outcome in early-stage cervical squamous cell carcinoma patients. KIF20A aberrant expression is a novel independent unfavorable prognostic factor and may present a potential therapeutic target for cervical cancer.	[Zhang, Weijing; Gu, Haifeng; Li, Min; Liu, Zhimin; Feng, Yanling; Xie, Chuanmiao; Zhang, Yanna] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China; [He, Weiling] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Guangzhou, Guangdong, Peoples R China; [Shi, Yongjie] Guangzhou Med Univ, Affiliated Hosp 2, Clin Examinat Dept, Guangzhou, Guangdong, Peoples R China; [Zheng, Nianzhen] Sun Yat Sen Univ, Zhongshan Med Sch, Eight Year Program, Guangzhou, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University	Xie, CM; Zhang, YN (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.	xiechm@sysucc.org.cn; zhangyn@sysucc.org.cn	Zhang, Weijing/GQA-9455-2022					[Anonymous], 2003, WHO CLASSIFICATION T; Bedkowska Grazyna Ewa, 2007, Postepy Hig Med Dosw (Online), V61, P122; Benedet JL, 2000, INT J GYNECOL OBSTET, V70, P209; Biewenga P, 2011, CANCER-AM CANCER SOC, V117, P768, DOI 10.1002/cncr.25658; Cesur O, 2015, VIRUSES-BASEL, V7, P3443, DOI 10.3390/v7072780; Chang TC, 2004, CANCER, V101, P164, DOI 10.1002/cncr.20349; Claerhout S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024662; de Moraes GN, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.26; DiSaia PJ, 2002, CLIN GYNECOLOGIC ONC, P53; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Duk JM, 1996, J CLIN ONCOL, V14, P111, DOI 10.1200/JCO.1996.14.1.111; Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580; Esajas MD, 2001, J CLIN ONCOL, V19, P3960, DOI 10.1200/JCO.2001.19.19.3960; Exertier P, 2013, ONCOTARGET, V4, P2302, DOI 10.18632/oncotarget.1490; Fang H, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.968467; Gaarenstroom KN, 2000, GYNECOL ONCOL, V77, P164, DOI 10.1006/gyno.2000.5732; Gadducci A, 2008, CRIT REV ONCOL HEMAT, V66, P10, DOI 10.1016/j.critrevonc.2007.09.002; Gasnereau I, 2012, AM J PATHOL, V180, P131, DOI 10.1016/j.ajpath.2011.09.040; Hacker NF, 2015, BEREK HACKERS GYNECO, P326; Ho JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039469; Ikeda S, 2012, J OBSTET GYNAECOL RE, V38, P1260, DOI 10.1111/j.1447-0756.2012.01862.x; Imai K, 2011, BRIT J CANCER, V104, P300, DOI 10.1038/sj.bjc.6606052; KATO H, 1977, CANCER, V40, P1621, DOI 10.1002/1097-0142(197710)40:4<1621::AID-CNCR2820400435>3.0.CO;2-I; Kim HJ, 2015, RADIAT ONCOL J, V33, P126, DOI 10.3857/roj.2015.33.2.126; Kitagawa M, 2014, CELL REP, V7, P166, DOI 10.1016/j.celrep.2014.02.034; Lai F, 2000, GENE, V248, P117, DOI 10.1016/S0378-1119(00)00135-9; Landoni F, 2014, GYNECOL ONCOL, V132, P611, DOI 10.1016/j.ygyno.2013.12.010; Lee SH, 2010, J CELL BIOL, V191, P1069, DOI 10.1083/jcb.201003095; Lekskul Navamol, 2015, Asian Pac J Cancer Prev, V16, P4719; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122361; Lin YJ, 2016, ASIAN NURS RES, V10, P45, DOI 10.1016/j.anr.2016.01.001; Liu F. L., 2016, ONCOTARGET; Liu LX, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0183-5; Lu Y, 2011, AM J TRANSL RES, V3, P8; Markowska Janina, 2007, Ginekol Pol, V78, P715; Mori S, 2015, BIOCHEM BIOPH RES CO, V460, P555, DOI 10.1016/j.bbrc.2015.03.068; Pishas KI, 2015, SCI REP-UK, V5, DOI 10.1038/srep11465; Porika M, 2010, ASIAN PAC J CANCER P, V11, P1745; Reichert N, 2010, MOL CELL BIOL, V30, P2896, DOI 10.1128/MCB.00028-10; Richardson LA, 2015, CANCER CYTOPATHOL; Shang C, 2016, ONCOL REP; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stangel D, 2015, J SURG RES, V197, P91, DOI 10.1016/j.jss.2015.03.070; Taniuchi K, 2005, CANCER RES, V65, P105; Taniuchi K, 2014, NEOPLASIA, V16, P1082, DOI 10.1016/j.neo.2014.10.007; Tomita Y, 2013, CLIN CANCER RES, V19, P4508, DOI 10.1158/1078-0432.CCR-13-0197; Wonsey DR, 2005, CANCER RES, V65, P5181, DOI 10.1158/0008-5472.CAN-04-4059; Yamashita J, 2012, ACTA DERM-VENEREOL, V92, P593, DOI 10.2340/00015555-1416; Yeh SA, 1999, GYNECOL ONCOL, V72, P10, DOI 10.1006/gyno.1998.5217; Yoon SM, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-78; Yuan SH, 2008, CLIN CANCER RES, V14, P5571, DOI 10.1158/1078-0432.CCR-08-0346; Zhang LF, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-4; Zhang W, 2016, ONCOGENE; Zhang W., 2015, TUMOUR BIOL; Zhang WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144360; Zou JX, 2014, MOL CANCER RES, V12, P539, DOI 10.1158/1541-7786.MCR-13-0459; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	57	38	42	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167449	10.1371/journal.pone.0167449	http://dx.doi.org/10.1371/journal.pone.0167449			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941992	Green Published, Green Submitted, gold			2022-12-27	WOS:000392745600017
J	Gable, TD; Windels, SK; Bruggink, JG; Homkes, AT				Gable, Thomas D.; Windels, Steve K.; Bruggink, John G.; Homkes, Austin T.			Where and How Wolves (Canis lupus) Kill Beavers (Castor canadensis)	PLoS One			English	Article							GRAY WOLVES; CENTRAL ONTARIO; WOLF DIET; SYSTEM; PREDATION; QUEBEC; LANDSCAPE; CANADA; RATES; DEER	Beavers (Castor canadensis) can be a significant prey item for wolves (Canis lupus) in boreal ecosystems due to their abundance and vulnerability on land. How wolves hunt beavers in these systems is largely unknown, however, because observing predation is challenging. We inferred how wolves hunt beavers by identifying kill sites using clusters of locations from GPS-collared wolves in Voyageurs National Park, Minnesota. We identified 22 sites where wolves from 4 different packs killed beavers. We classified these kill sites into 8 categories based on the beaver-habitat type near which each kill occurred. Seasonal variation existed in types of kill sites as 7 of 12 (58%) kills in the spring occurred at sites below dams and on shorelines, and 8 of 10 (80%) kills in the fall occurred near feeding trails and canals. From these kill sites we deduced that the typical hunting strategy has 3 components: 1) waiting near areas of high beaver use (e.g., feeding trails) until a beaver comes near shore or ashore, 2) using vegetation, the dam, or other habitat features for concealment, and 3) immediately attacking the beaver, or ambushing the beaver by cutting off access to water. By identifying kill sites and inferring hunting behavior we have provided the most complete description available of how and where wolves hunt and kill beavers.	[Gable, Thomas D.; Bruggink, John G.; Homkes, Austin T.] Northern Michigan Univ, Dept Biol, Marquette, MI 49855 USA; [Windels, Steve K.] Voyageurs Natl Pk, Int Falls, MN USA	Northern Michigan University	Gable, TD (corresponding author), Northern Michigan Univ, Dept Biol, Marquette, MI 49855 USA.	thomasd.gable@gmail.com			Northern Michigan University; Voyageurs National Park; National Park Service Great Lakes Research and Education Center; Wolf Park; Rainy Lake Conservancy	Northern Michigan University; Voyageurs National Park; National Park Service Great Lakes Research and Education Center; Wolf Park; Rainy Lake Conservancy	Northern Michigan University (nmu.edu, JGB) provided financial support by supporting TDG as a graduate assistant. Voyageurs National Park (nps.gov/voya, SKW) provided both financial and logistical support for this project. National Park Service Great Lakes Research and Education Center (nps.gov/rlc/greatlakes, SKW), Wolf Park (wolfpark.org, TDG), and the Rainy Lake Conservancy (rainylakeconservancy.org, SKW) all provided financial support for this project. Financial support also came from the contribution of 58 individual donors via a crowd-funding campaign (crowd-funding site: experiment.com, TDG).	ALEKSIUK M, 1969, CAN J ZOOLOG, V47, P471, DOI 10.1139/z69-086; Bailey RG, 1980, MISCELLANEOUS PUBLIC, V1391; Baker BW, 2014, WILD MAMMALS N AM BI, P288; Barber-Meyer S.M, 2015, CAN WILDL BIOL MANAG, V4, P163; Basey JM, 1995, CAN J ZOOL, V73, P2197, DOI 10.1139/z95-260; Buech RR, 1995, CAN J ZOOL, V73, P2133, DOI 10.1139/z95-250; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; Demma DJ, 2007, J WILDLIFE MANAGE, V71, P2767, DOI 10.2193/2006-382; ESRI, 2015, ARCMAP GIS VER 10 2; Forbes GJ, 1996, CAN J ZOOL, V74, P1511, DOI 10.1139/z96-165; Franke A, 2006, ECOL MODEL, V197, P237, DOI 10.1016/j.ecolmodel.2006.02.043; Fuller T. K., 1989, WILDLIFE MONOGR, V105, P3; Haber GC., 1977, THESIS; Hall A.M., 1971, THESIS; Hop K, 2001, FINAL REPORT USGS NP; Huggard D. J., 1991, THESIS; JOHNSTON CA, 1990, LANDSCAPE ECOL, V4, P5, DOI 10.1007/BF02573947; Johnston CA, 2015, J WILDLIFE MANAGE, V79, P1072, DOI 10.1002/jwmg.927; Kallemeyn L. W., 2003, 20030001 US GEOL SUR; Latham ADM, 2013, ECOGRAPHY, V36, P1276, DOI 10.1111/j.1600-0587.2013.00035.x; Latham ADM, 2009, THESIS; Mech L.D., 1966, FAUNA NATL PARKS US, V7, P1; Mech L.D., 2015, WOLVES HUNT BEHAV WO; Mech LD, 2007, ARCTIC, V60, P145; Mech L. David, 2003, P131; Mech LD., 1970, WOLF ECOLOGY BEHAV E; Messier F, 1985, OECOLOGIA, V65, P503, DOI 10.1007/BF00379664; Morehouse AT, 2011, FRONT ECOL ENVIRON, V9, P440, DOI 10.1890/100172; Nichols Theodore C., 2015, Canadian Field-Naturalist, V129, P290; Palacios V, 2011, EUR J WILDLIFE RES, V57, P149, DOI 10.1007/s10344-010-0408-7; Peterson R. O., 1977, NAT PARK SERV SCI MO, V11, P1; PETERSON RO, 1988, J MAMMAL, V69, P89, DOI 10.2307/1381751; Peterson Rolf O., 2003, P104; POTVIN F, 1992, CAN J ZOOL, V70, P180, DOI 10.1139/z92-026; Romanski M.C, 2010, THESIS MICHIGAN TECH; Sand H, 2005, WILDLIFE SOC B, V33, P914, DOI 10.2193/0091-7648(2005)33[914:UGTAGC]2.0.CO;2; Sand H, 2008, OECOLOGIA, V156, P53, DOI 10.1007/s00442-008-0969-2; Shelton P.C, 1966, THESIS; Sikes RS, 2016, J MAMMAL, V92, P235, DOI DOI 10.1644/10-MAMM-F-355.1; SLOUGH BG, 1978, J WILDLIFE MANAGE, V42, P644, DOI 10.2307/3800833; Smith DW, 1988, EFFECTS REGULATED LA; THURBER JM, 1993, J MAMMAL, V74, P879, DOI 10.2307/1382426; Tremblay JP, 2001, ALCES-N AM MOOSE CON, V37, P1; VOIGT DR, 1976, J WILDLIFE MANAGE, V40, P663, DOI 10.2307/3800561; Webb NF, 2008, J WILDLIFE MANAGE, V72, P798, DOI 10.2193/2006-566; Wiebe N, 2009, ARCTIC, V62, P399; Windels SK, 2015, 2015 VOYAGEURS NATL, V2015/971; Zimmermann B, 2007, J WILDLIFE MANAGE, V71, P1177, DOI 10.2193/2006-306	48	32	32	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0165537	10.1371/journal.pone.0165537	http://dx.doi.org/10.1371/journal.pone.0165537			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992441	Green Submitted, gold, Green Published			2022-12-27	WOS:000392842600006
J	Ling, J; Lopez-Dee, ZP; Cottell, C; Wolfe, L; Nye, D				Ling, Jun; Lopez-Dee, Zenaida P.; Cottell, Colby; Wolfe, Laura; Nye, Derek			Regulation of mRNA Translation Is a Novel Mechanism for Phthalate Toxicity	PLOS ONE			English	Article							N-BUTYL PHTHALATE; CARNITINE PALMITOYLTRANSFERASE; INITIATION; DI(2-ETHYLHEXYL)PHTHALATE; INHIBITION; EXPOSURE; RIBOSOME; BINDING; LIVER; RATS	Phthalates are a group of plasticizers that are widely used in many consumer products and medical devices, thus generating a huge burden to human health. Phthalates have been known to cause a number of developmental and reproductive disorders functioning as endocrine modulators. They are also involved in carcinogenesis with mechanisms less understood. To further understand the molecular mechanisms of phthalate toxicity, in this study we reported a new effect of phthalates on mRNA translation/protein synthesis, a key regulatory step of gene expression. Butyl benzyl phthalate (BBP) was found to directly inhibit mRNA translation in vitro but showed a complicated pattern of affecting mRNA translation in cells. In human kidney embryonic cell (HEK-293T), BBP increased cap-dependent mRNA translation at lower concentrations but showed inhibitory effect at higher concentrations. Cap-independent translation was not affected. On the other hand, mono (2-ethylhexyl) phthalate (MEHP) as a major metabolite of another important phthalate di (2-ethylhexyl) phthalate (DEHP) inhibited both can-dependent and -independent mRNA translation in vivo. In contrast, BBP and MEHP exhibited an overall promoting effect on mRNA translation in cancer cells. Mechanistic studies identified that the level and phosphorylation of eIF4E-BP (eIF4E binding protein) and the amount of eIF4GI in eIF4F complex were altered in accordance with the effect of BBP on translation. BBP was also identified to directly bind to eIF4E, providing a further mechanism underlying the regulation of mRNA by phthalate. At the cellular level BBP inhibited normal cell growth but slightly promoted cancer cells (HT29) growth. Overall, this study provides the first evidence that phthalates can directly regulate mRNA translation as a novel mechanism to mediate their biological toxicities.	[Ling, Jun; Lopez-Dee, Zenaida P.; Cottell, Colby; Wolfe, Laura; Nye, Derek] Commonwealth Med Coll, Dept Basic Sci, Scranton, PA 18509 USA; [Cottell, Colby; Wolfe, Laura] Marywood Univ, Dept Sci, Scranton, PA USA; [Nye, Derek] Wilkes Univ, Dept Biol, Wilkes Barre, PA USA; [Nye, Derek] Penn State Hershey Coll Med, Univ Dr, Hershey, PA USA	Geisinger Commonwealth School of Medicine; Wilkes University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Ling, J (corresponding author), Commonwealth Med Coll, Dept Basic Sci, Scranton, PA 18509 USA.	jling@tcmc.edu		Nye, Derek/0000-0003-0539-075X	Commonwealth Medical College	Commonwealth Medical College	This research is supported by the startup funds of The Commonwealth Medical College to JL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker MG, 2009, J MOL BIOL, V385, P491, DOI 10.1016/j.jmb.2008.10.029; Andaya A, 2014, INT J MOL SCI, V15, P11523, DOI 10.3390/ijms150711523; BRADY PS, 1987, BIOCHEM J, V246, P641, DOI 10.1042/bj2460641; Byrd MP, 2005, J BIOL CHEM, V280, P18610, DOI 10.1074/jbc.M414014200; Caldwell JC, 2012, MUTAT RES-REV MUTAT, V751, P82, DOI 10.1016/j.mrrev.2012.03.001; CHAPIN RE, 1988, TOXICOL APPL PHARM, V92, P467, DOI 10.1016/0041-008X(88)90186-X; Clemens MJ, 2000, CELL DEATH DIFFER, V7, P603, DOI 10.1038/sj.cdd.4400695; Department of Health and Human Services & Centers for Disease Control and Prevention, 2005, 3 NAT REP HUM EXP EN, P253; Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.200600243; GANNING AE, 1989, TOXICOL LETT, V48, P185, DOI 10.1016/0378-4274(89)90173-2; GARBERG P, 1991, CARCINOGENESIS, V12, P7, DOI 10.1093/carcin/12.1.7; Guyton KZ, 2009, ENVIRON HEALTH PERSP, V117, P1664, DOI 10.1289/ehp.0900758; Hauser R, 2005, OCCUP ENVIRON MED, V62, DOI 10.1136/oem.2004.017590; Herrero O, 2016, CHEMOSPHERE, V144, P1874, DOI 10.1016/j.chemosphere.2015.10.051; Herreros MA, 2013, ENVIRON TOXICOL PHAR, V36, P1141, DOI 10.1016/j.etap.2013.09.020; Huang PC, 2014, ENVIRON SCI POLLUT R, V21, P13964, DOI 10.1007/s11356-014-3260-6; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kamrin MA, 2009, J TOXICOL ENV HEAL B, V12, P157, DOI 10.1080/10937400902729226; LeFebvre AK, 2006, J BIOL CHEM, V281, P22917, DOI 10.1074/jbc.M605418200; Ling J, 2005, EMBO J, V24, P4094, DOI 10.1038/sj.emboj.7600868; Ling J, 2008, J BIOL CHEM, V283, P30585, DOI 10.1074/jbc.M803548200; Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139, DOI 10.1289/ehp.5658; Lu HC, 2016, TOXICOL LETT, V241, P95, DOI 10.1016/j.toxlet.2015.11.009; MATHEWS MB, 2007, COLD SPRING HARB MON, V48, P1; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Merrick WC, 2004, GENE, V332, P1, DOI 10.1016/j.gene.2004.02.051; Moral R, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-5; National Toxicology Program, 1997, Natl Toxicol Program Tech Rep Ser, V458, P1; OZASA H, 1983, J BIOCHEM-TOKYO, V94, P543, DOI 10.1093/oxfordjournals.jbchem.a134385; Pichon X, 2012, CURR PROTEIN PEPT SC, V13, P294, DOI 10.2174/138920312801619475; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Ren HZ, 2010, TOXICOL SCI, V113, P45, DOI 10.1093/toxsci/kfp251; Rusyn I, 2006, CRIT REV TOXICOL, V36, P459, DOI 10.1080/10408440600779065; Shu L, 2016, J SEP SCI, V39, P3163, DOI 10.1002/jssc.201600364; Singh S, 2011, GENOMICS, V97, P148, DOI 10.1016/j.ygeno.2010.11.008; Spade DJ, 2014, TOXICOL SCI, V138, P148, DOI 10.1093/toxsci/kft266; Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007; Wang SW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.420; Wang Y, 2016, TOXICOL IN VITRO, V32, P86, DOI 10.1016/j.tiv.2015.12.012; Wang YY, 2016, ZOOKEYS, P1, DOI 10.3897/zookeys.603.9125; Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241; Wilson VS, 2008, INT J ANDROL, V31, P178, DOI 10.1111/j.1365-2605.2007.00861.x; Xiao-Feng Z, 2009, INT J TOXICOL, V28, P448, DOI 10.1177/1091581809342596	43	7	9	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167914	10.1371/journal.pone.0167914	http://dx.doi.org/10.1371/journal.pone.0167914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992464	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842600025
J	Marin-Webb, V; Jessen, H; Kopp, U; Jessen, AB; Hahn, K				Marin-Webb, Victor; Jessen, Heiko; Kopp, Ute; Jessen, Arne B.; Hahn, Katrin			Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; COGNITIVE IMPAIRMENT; INFECTED PATIENTS; PREVALENCE; HIV/AIDS; COHORT; VALIDITY; CHINA; RISK	Background HIV-associated neurocognitive disorders (HAND) are widely present among people living with HIV. Especially its milder forms, asymptomatic neurocognitive impairment (ANI) and mild neurocognitive disorder (MND), remain highly prevalent worldwide. Diagnosing these conditions is subject to a time and resource consuming neuropsychological assessment. Selecting patients at a higher risk of cognitive impairment by using a simple but effective screening tool helps to organise access to further neuropsychological diagnosis. The International HIV Dementia Scale (IHDS) has until now been a well-established screening tool in African and American countries, however these populations' demographics defer significantly from ours, so using the same parameters could be ineffective. Objectives To calculate the prevalence of this condition among people attending an HIV outpatient clinic in Berlin and to validate the use of the IHDS as a screening tool for HAND in a Germanspeaking population. Methods We screened 480 HIV-infected patients using the IHDS, 89% of them were on a stable antiretroviral treatment. Ninety of them completed a standardised neuropsychological battery of tests and a specific cognitive complaints questionnaire. The same procedure was applied to a control group of 30 HIV-negative participants. HAND diagnosis was established according to the Frascati criteria. Results The overall prevalence of HAND in our cohort was 43% (20% ANI, 17% MND and 6% HIV associated dementia). The optimal cut-off on the IHDS for detecting HAND cases was set at 11 and achieved both a sensitivity and a specificity of 80%. When specifically screening for the more severe form of HAND, HIV -associated dementia, a cut-off value of 10 offered an increase in both sensitivity (94%) and specificity (86%). The Youden Index for diagnostic accuracy was 0.6 and 0.8, respectively. Conclusions The prevalence of HAND was comparable to the reported by recent studies performed in countries with a similar economic development. The study confirms the IHDS to be a useful HAND screening tool in primary care settings and establishes new recommendations for its use in German-speaking countries.	[Marin-Webb, Victor; Jessen, Heiko; Jessen, Arne B.] Praxis Jessen 2 Kollegen, Berlin, Germany; [Marin-Webb, Victor; Kopp, Ute; Hahn, Katrin] Charite, Dept Neurol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hahn, K (corresponding author), Charite, Dept Neurol, Berlin, Germany.	katrin.hahn@charite.de	Jessen, Heiko/P-2192-2019	Hahn, Katrin/0000-0002-6013-0072	"la Caixa" Banking Foundation; German Academic Exchange Service (DAAD)	"la Caixa" Banking Foundation(La Caixa Foundation); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by "la Caixa" Banking Foundation and the German Academic Exchange Service (DAAD) thanks to their joint post-graduate fellowship programme and is part of VMW's doctoral studies at Charite Medical School; www.obrasociallacaixa.org/en/educacion-becas; www.daad.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Antinori A, 2013, CLIN INFECT DIS, V56, P1004, DOI 10.1093/cid/cis975; Aschenbrenner A, 2000, RWT REGENSBURGER WOR; Bonnet F, 2013, AIDS, V27, P391, DOI 10.1097/QAD.0b013e32835b1019; Brickenkamp R, 2009, TEST D2 REVISION D2; Brouillette MJ, 2015, AIDS, V29, P895, DOI 10.1097/QAD.0000000000000152; Canestri A, 2010, CLIN INFECT DIS, V50, P773, DOI 10.1086/650538; Cicchetti D. V., 2004, METHODOLOGICAL BIOST; Cysique LA, 2010, HIV MED, V11, P642, DOI 10.1111/j.1468-1293.2010.00834.x; Cysique LA, 2004, J NEUROVIROL, V10, P350, DOI 10.1080/13550280490521078; Cysique LA, 2014, J NEUROVIROL, V20, P258, DOI 10.1007/s13365-014-0242-x; Dang C, 2015, INT J INFECT DIS, V33, P56, DOI 10.1016/j.ijid.2014.12.042; Fogel GB, 2015, J NEUROVIROL, V21, P56, DOI 10.1007/s13365-014-0296-9; Gisslen M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-356; Grant I, 2014, NEUROLOGY, V82, P2055, DOI 10.1212/WNL.0000000000000492; H?rting, 2000, WECHSLER GEDACHTNIST; Haddow LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061826; Heaton K, 2009, NEUROPSYCHOLOGICAL A; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton R.K., 2004, REVISED COMPREHENSIV; Heaton RK, 2008, J NEUROVIROL, V14, P536, DOI 10.1080/13550280802378880; Helmstaedter C, 2001, VMLT VERBALER LERN U; Joska JA, 2011, AIDS PATIENT CARE ST, V25, P95, DOI 10.1089/apc.2010.0292; Kwasa J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032898; Lawler K, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-15; Letendre Scott L, 2010, Top HIV Med, V18, P45; McDonnell J, 2014, JAIDS-J ACQ IMM DEF, V67, P120, DOI 10.1097/QAI.0000000000000273; Moore DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047310; Morgan EE, 2008, J CLIN EXP NEUROPSYC, V30, P83, DOI 10.1080/13803390701233865; Munoz-Moreno JA, 2008, AIDS RES HUM RETROV, V24, P1301, DOI 10.1089/aid.2007.0310; Munnoz-Moreno JA, 2013, JAIDS-J ACQ IMM DEF, V63, P585, DOI 10.1097/QAI.0b013e31829e1408; Neubauer A, 2006, ZAHLEN SYMBOL TEST K, P77; Overton ET, 2011, AIDS BEHAV, V15, P1902, DOI 10.1007/s10461-011-0033-9; POWER C, 1995, J ACQ IMMUN DEF SYND, V8, P273, DOI 10.1097/00042560-199503010-00008; Robbins RN, 2011, AIDS PATIENT CARE ST, V25, P587, DOI 10.1089/apc.2011.0154; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Sacktor NC, 2005, AIDS, V19, P1367; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; Singh D, 2008, Afr J Psychiatry (Johannesbg), V11, P282; Skinner S, 2009, HIV MED, V10, P246, DOI 10.1111/j.1468-1293.2008.00679.x; Spreen O., 1991, PROFILE TEST RESULTS; Strauss E, 2006, COMPENDIUM NEUROPSYC; Tozzi V, 2005, J NEUROVIROL, V11, P265, DOI 10.1080/13550280590952790; Trites R., 2002, GROOVED PEGBOARD TES; UNAIDS, 2013, GLOBAL REPORT UNAIDS; University of Munich, 2008, AKT KONS TESTN NEUR; Valcour V, 2004, NEUROLOGY, V63, P822, DOI 10.1212/01.WNL.0000134665.58343.8D; Valcour V, 2011, CLIN INFECT DIS, V53, P836, DOI 10.1093/cid/cir524; Villaverde ML, 1993, ESTUDIO COMUNITARIO; Wolfram H, 1989, FARBE WORT INTERTERE, P205; Wolfram H, 1989, NICHTVERBALER INTELL, P63; Zipursky AR, 2013, AIDS, V27, P2385, DOI 10.1097/QAD.0b013e328363bf56	52	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168225	10.1371/journal.pone.0168225	http://dx.doi.org/10.1371/journal.pone.0168225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992497	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600042
J	Witte, AK; Mester, P; Fister, S; Witte, M; Schoder, D; Rossmanith, P				Witte, Anna Kristina; Mester, Patrick; Fister, Susanne; Witte, Matthias; Schoder, Dagmar; Rossmanith, Peter			A Systematic Investigation of Parameters Influencing Droplet Rain in the Listeria monocytogenes prfA Assay - Reduction of Ambiguous Results in ddPCR	PLoS One			English	Article							POLYMERASE-CHAIN-REACTION; TIME QUANTITATIVE PCR; DNA COPY NUMBER; DIGITAL PCR; QUANTIFICATION	The droplet digital polymerase chain reaction (ddPCR) determines DNA amounts based upon the pattern of positive and negative droplets, according to Poisson distribution, without the use of external standards. However, division into positive and negative droplets is often not clear because a part of the droplets has intermediate fluorescence values, appearing as "rain" in the plot. Despite the droplet rain, absolute quantification with ddPCR is possible, as shown previously for the prfA assay in quantifying Listeria monocytogenes. Nevertheless, reducing the rain, and thus ambiguous results, promotes the accuracy and credibility of ddPCR. In this study, we extensively investigated chemical and physical parameters for optimizing the prfA assay for ddPCR. While differences in the concentration of all chemicals and the dye, quencher and supplier of the probe did not alter the droplet pattern, changes in the PCR cycling program, such as prolonged times and increased cycle numbers, improved the assay.	[Witte, Anna Kristina; Mester, Patrick; Fister, Susanne; Schoder, Dagmar; Rossmanith, Peter] Univ Vet Med, Inst Milk Hyg, Dept Farm Anim & Vet Publ Hlth, Christian Doppler Lab Monitoring Microbial Contam, Vienna, Austria; [Witte, Matthias] Graz Univ, Dept Psychol, Graz, Austria; [Schoder, Dagmar; Rossmanith, Peter] Univ Vet Med, Inst Milk Hyg, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria	University of Veterinary Medicine Vienna; University of Graz; University of Veterinary Medicine Vienna	Rossmanith, P (corresponding author), Univ Vet Med, Inst Milk Hyg, Dept Farm Anim & Vet Publ Hlth, Christian Doppler Lab Monitoring Microbial Contam, Vienna, Austria.; Rossmanith, P (corresponding author), Univ Vet Med, Inst Milk Hyg, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria.	peter.rossmanith@vetmeduni.ac.at	Mester, Patrick-Julian/ABC-1614-2020	Mester, Patrick-Julian/0000-0002-3193-4987; Witte, Anna Kristina/0000-0001-6471-0763	Austrian Federal Ministry of Science, Research and Economy	Austrian Federal Ministry of Science, Research and Economy	The financial support by the Austrian Federal Ministry of Science, Research and Economy is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	D'Agostino M, 2004, J FOOD PROTECT, V67, P1646, DOI 10.4315/0362-028X-67.8.1646; Dingle TC, 2013, CLIN CHEM, V59, P1670, DOI 10.1373/clinchem.2013.211045; Dong LH, 2014, ANAL BIOANAL CHEM, V406, P1701, DOI 10.1007/s00216-013-7546-1; Dreo T, 2014, ANAL BIOANAL CHEM, V406, P6513, DOI 10.1007/s00216-014-8084-1; Duewer DL, 2015, ANAL BIOANAL CHEM, V407, P9061, DOI 10.1007/s00216-015-9073-8; Fu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep12715; Gerdes Lars, 2016, Biomol Detect Quantif, V7, P9, DOI 10.1016/j.bdq.2015.12.003; Hilscher C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni181; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Jones M, 2014, J VIROL METHODS, V202, P46, DOI 10.1016/j.jviromet.2014.02.020; Karlin-Neumann G, 2013, DRUG DISCOV WORLD, V15; Kim YH, 2008, BIOTECHNIQUES, V44, P495, DOI 10.2144/000112705; Kiselinova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085999; Koppel R, 2015, EUR FOOD RES TECHNOL, V241, P427, DOI 10.1007/s00217-015-2475-1; Kramer MF, 2001, CURR PROTOC TOXICOL; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Laurie MT, 2013, BIOTECHNIQUES, V55, P61, DOI 10.2144/000114063; Markoulatos P, 2002, J CLIN LAB ANAL, V16, P47, DOI 10.1002/jcla.2058; MORISSET D, 2013, PLOS ONE, V8; Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x; Rossmanith P, 2006, RES MICROBIOL, V157, P763, DOI 10.1016/j.resmic.2006.03.003; Rothrock M. J., 2013, ADV MICROBIOL-IRVINE, V3, P403, DOI [10.4236/aim.2013.35055, DOI 10.4236/AIM.2013.35055]; Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943; Trypsteen W, 2015, ANAL BIOANAL CHEM, V407, P5827, DOI 10.1007/s00216-015-8773-4; Witte AK, ANAL BIOANA IN PRESS; Witwer KW, 2013, RNA BIOL, V10, P1080, DOI 10.4161/rna.25246	26	32	32	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168179	10.1371/journal.pone.0168179	http://dx.doi.org/10.1371/journal.pone.0168179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992475	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600040
J	Fan, BL; Zhang, AP; Yang, Y; Ma, QL; Li, XM; Zhao, CM				Fan, Baoli; Zhang, Aiping; Yang, Yi; Ma, Quanlin; Li, Xuemin; Zhao, Changming			Long-Term Effects of Xerophytic Shrub Haloxylon ammodendron Plantations on Soil Properties and Vegetation Dynamics in Northwest China	PLOS ONE			English	Article							HORQIN SANDY LAND; NORTHERN CHINA; TENGGER DESERT; INNER-MONGOLIA; SHORTGRASS STEPPE; RESTORATION; DESERTIFICATION; REGION; DUNES; NITROGEN	The xerophytic desert shrub Haloxylon ammodendron (C. A. Mey.) Bunge. is distributed naturally in Asian and African deserts, and is widely used for vegetation restoration in the desert regions of Northern China. However, there are limited long-term chrono-sequence studies on the impact of changed soil properties and vegetation dynamics following establishment of this shrub on mobile sand dunes. In Minqin County, Gansu Province, we investigated soil properties and herbaceous vegetation development of 10, 20, 30, 40, 50-yearold H. ammodendron plantations on mobile sand dunes. Soil sampling at two depths (0-5 and 5-20 cm) under the shrubs determined SOC, nutrition and soil physical characteristics. The results showed that: establishment of H. ammodendron had improved soil physio-chemical properties, increased thickness of soil crusts and coverage of biological soil crusts (BSCs), and promoted development of topsoil over an extended period of 5 decades. Soil texture and soil nutrition improved along the chrono-sequence according to three distinct phases: i) an initial fast development from 0 to 10 years, ii) a stabilizing phase from 10 to 30 years followed by iii) a relatively marked restoration development in 40 and 50-year-old plantations. Meanwhile, herbaceous community coverage also markedly increased in 30-year-old plantations. However, both soil and vegetation restoration were very slow due to low annual precipitation in Minqin county compared to other Northern China sand afforestation sites. Canonical Correspondence Analysis results demonstrated that herbaceous plant development was closely associated with changes in soil texture (increased clay and silt percentage) and availability of soil nutrients. Thus our results indicated that selection of the long-lived shrub H. ammodendron is an essential and effective tool in arid desert re-vegetation.	[Fan, Baoli; Zhang, Aiping; Yang, Yi; Zhao, Changming] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China; [Fan, Baoli; Ma, Quanlin; Li, Xuemin] Gansu Desert Control Res Inst, State Key Lab Desertificat & Aeolian Sand Disaste, Lanzhou, Gansu, Peoples R China	Lanzhou University	Zhao, CM (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China.	zhaochm@lzu.edu.cn			National Natural Science Foundation of China [31360098, 31522013, 31270754]; Fundament Research and Innovation Group Program of Gansu Province [145RJIA335]; Fundament Research Funds for the Central Universities [Izujbky-2016-ct10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundament Research and Innovation Group Program of Gansu Province; Fundament Research Funds for the Central Universities	This study was supported by the National Natural Science Foundation of China (No. 31360098, 31522013, 31270754), the Fundament Research and Innovation Group Program of Gansu Province (145RJIA335) and the Fundament Research Funds for the Central Universities (Izujbky-2016-ct10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brotherson J.D., 1983, W N AM NAT, V43, P73; Burke A, 2014, J ARID ENVIRON, V100, P18, DOI 10.1016/j.jaridenv.2013.10.002; Cao SX, 2008, ENVIRON SCI TECHNOL, V42, P1826, DOI 10.1021/es0870597; Cao SX, 2010, NATURE, V465, P31, DOI 10.1038/465031d; DANIN A, 1989, Ecologia Mediterranea, V15, P55; Delgado-Baquerizo M, 2013, NATURE, V502, P672, DOI 10.1038/nature12670; Dodd MB, 1997, PLANT ECOL, V133, P13, DOI 10.1023/A:1009759421640; Dodd MB, 2002, PLANT ECOL, V158, P127, DOI 10.1023/A:1015525303754; Dong ZB, 2010, GEOMORPHOLOGY, V116, P58, DOI 10.1016/j.geomorph.2009.10.008; Donohue RJ, 2007, HYDROL EARTH SYST SC, V11, P983, DOI 10.5194/hess-11-983-2007; Du JH, 2010, INT J BIOMETEOROL, V54, P583, DOI 10.1007/s00484-010-0315-3; Duan ZH, 2004, GEOMORPHOLOGY, V59, P237, DOI 10.1016/j.geomorph.2003.07.019; ELDEMERDASH MA, 1995, J ARID ENVIRON, V30, P161, DOI 10.1016/S0140-1963(05)80067-9; Gao GL, 2014, ECOL INDIC, V43, P236, DOI 10.1016/j.ecolind.2014.03.001; Gregory SO, 2001, J ARID ENVIRON, V47, P123; Guo YR, 2008, ENVIRON GEOL, V54, P653, DOI 10.1007/s00254-007-1130-y; Institute of Soil Science Chinese Academy of Sciences (ISSCAS), 1978, PHYS CHEM AN METH SO, P7; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lee KE, 1977, IMPACT HERBIVORES AR, P173; Li XR, 2007, GEOMORPHOLOGY, V88, P254, DOI 10.1016/j.geomorph.2006.11.009; Li XR, 2007, PLANT SOIL, V300, P221, DOI 10.1007/s11104-007-9407-1; Li XR, 2010, HYDROL PROCESS, V24, P3621, DOI 10.1002/hyp.7791; Li XR, 2006, ECOL ENG, V28, P149, DOI 10.1016/j.ecoleng.2006.05.020; Li XR, 2004, J ARID ENVIRON, V57, P1, DOI 10.1016/S0140-1963(03)00089-2; Li YL, 2009, ECOL ENG, V35, P118, DOI 10.1016/j.ecoleng.2008.09.013; [马全林 MA QuanLin], 2007, [生态学报, Acta Ecologica Sinica], V27, P5057, DOI 10.1016/S1872-2032(08)60014-1; Miao RH, 2015, ECOL ENG, V74, P164, DOI 10.1016/j.ecoleng.2014.10.004; Miki T, 2002, ECOL LETT, V5, P624, DOI 10.1046/j.1461-0248.2002.00347.x; Mitchell DJ, 1998, J ARID ENVIRON, V39, P239, DOI 10.1006/jare.1998.0396; Moberly C, 2004, SER INT C EC REST VI, P24; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; OSU SCAS, 2004, OSU RES HELP CHIN RE; PARKINSON JA, 1975, COMMUN SOIL SCI PLAN, V6, P1, DOI 10.1080/00103627509366539; PATRICIA M, 2000, RESTORATION ECOLOGY, V9, P71; Potthoff M, 2005, RESTOR ECOL, V13, P61, DOI 10.1111/j.1526-100X.2005.00008.x; Pyankov VI, 1999, PLANT CELL PHYSIOL, V40, P125, DOI 10.1093/oxfordjournals.pcp.a029519; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Shirato Y, 2004, SOIL SCI PLANT NUTR, V50, P537, DOI 10.1080/00380768.2004.10408510; Su YZ, 2007, ECOL ENG, V29, P117, DOI 10.1016/j.ecoleng.2005.10.015; Su YZ, 2003, ECOL ENG, V20, P223, DOI 10.1016/S0925-8574(03)00042-9; Sun DF, 2006, J ENVIRON MANAGE, V79, P348, DOI 10.1016/j.jenvman.2005.08.004; Tavili A, 2009, INT J ENVIRON RES, V3, P239; Tobe K, 2000, AUST J BOT, V48, P455, DOI 10.1071/BT99013; Tornquist CG, 1999, AGR ECOSYST ENVIRON, V73, P19, DOI 10.1016/S0167-8809(99)00004-3; URQUIAGA S, 1992, SOIL SCI SOC AM J, V56, P105, DOI 10.2136/sssaj1992.03615995005600010017x; Wang WJ, 2011, GLOBAL CHANGE BIOL, V17, P2657, DOI 10.1111/j.1365-2486.2011.02447.x; Wang XP, 2006, ECOL RES, V21, P415, DOI 10.1007/s11284-005-0135-9; Wortley L, 2013, RESTOR ECOL, V21, P537, DOI 10.1111/rec.12028; Wu B, 2002, J ARID ENVIRON, V50, P429, DOI 10.1006/jare.2001.0847; Zhang ZS, 2008, J ARID ENVIRON, V72, P964, DOI 10.1016/j.jaridenv.2007.11.010; Zhao HL, 2007, ECOL ENG, V31, P1, DOI 10.1016/j.ecoleng.2007.04.010; Zhao HL, 2011, GEODERMA, V160, P367, DOI 10.1016/j.geoderma.2010.10.005; Zhu S., 2012, J GEOGR GEOL, V4, P69, DOI [10.5539/jgg.v4n3p69, DOI 10.5539/JGG.V4N3P69]; Zuo XA, 2008, SOIL TILL RES, V99, P202, DOI 10.1016/j.still.2008.02.008; Zuo XA, 2009, PLANT SOIL, V318, P153, DOI 10.1007/s11104-008-9826-7	55	15	24	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168000	10.1371/journal.pone.0168000	http://dx.doi.org/10.1371/journal.pone.0168000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992458	Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000022
J	Wilunda, C; Scanagatta, C; Putoto, G; Takahashi, R; Montalbetti, F; Segafredo, G; Betran, AP				Wilunda, Calistus; Scanagatta, Chiara; Putoto, Giovanni; Takahashi, Risa; Montalbetti, Francesca; Segafredo, Giulia; Betran, Ana Pilar			Barriers to Institutional Childbirth in Rumbek North County, South Sudan: A Qualitative Study	PLOS ONE			English	Article							FACILITY-BASED DELIVERY; HEALTH-CARE	Background South Sudan has one of the world's poorest health indicators due to a fragile health system and a combination of socio-cultural, economic and political factors. This study was conducted to identify barriers to utilisation of institutional childbirth services in Rumbek North County. Methods Data were collected through 14 focus group discussions with 169 women and 45 men, and 18 key informant interviews with community leaders, staff working in health facilities, traditional birth attendants, and the staff of the County Health Department. Data were analysed using inductive content analysis. Results The barriers to institutional childbirth were categorised under four main themes: 1) Issues related to access and lack of resources: long distance to health facilities, lack of transportation means, referral problems, flooding and poor roads, and payments in health facilities; 2) Issues related to the socio-cultural context and conflict: insecurity, influence of the husband, lack of birth preparedness, domestic chores of women, influence of culture; 3) Perceptions about pregnancy and childbirth: perceived benefit of institutional childbirth, low childbirth risk perception, and medicalisation of childbirth including birth being perceived to be natural, undesirable birth practices, privacy concerns, and fear of caesarean section; and 4) Perceptions about the quality of care: inadequate health facility infrastructure and perceived neglect during admission. Conclusions Multiple factors hinder institutional childbirth in Rumbek North. Some of the factors such as insecurity and poor roads are outside the scope of the health sector and will require a multi-sectoral approach if childbirth services are to be made accessible to women. Detailed recommendations to increase utilisation of childbirth services in the county have been suggested.	[Wilunda, Calistus] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmaco Epidemiol, Kyoto, Japan; [Scanagatta, Chiara; Putoto, Giovanni; Segafredo, Giulia] Doctors Africa CUAMM, Padua, Italy; [Takahashi, Risa] Tenri Hlth Care Univ, Dept Nursing Sci, Fac HealthCare, Nara, Japan; [Montalbetti, Francesca] Doctors Africa CUAMM, Maper, South Sudan; [Betran, Ana Pilar] WHO, Dept Reprod Hlth & Res, UNDP UNFPA UNICEF WHO World Bank Special Programm, Geneva, Switzerland	Kyoto University; The World Bank; United Nations Population Fund; World Health Organization	Wilunda, C (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmaco Epidemiol, Kyoto, Japan.	calistuswilunda@yahoo.co.uk	Putoto, Giovanni/ABG-2069-2020	Wilunda, Calistus/0000-0002-6606-6534	Health Pooled Fund	Health Pooled Fund	This study had no specific funding but was implemented as part of a primary healthcare project funded by the Health Pooled Fund http://www.hpfsouthsudan.org/.	Acacia Consultants, 2010, BAS FORM RES REP MAT; Ajzen I., 1985, ACTION CONTROL, P11, DOI [10.1007/978-3-642-69746-3_2, DOI 10.1007/978-3-642-69746-3_2]; BBC Media Action, 2013, UND KNOWL ATT BEL PR; Betran AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148343; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Chigbu CO, 2007, BJOG-INT J OBSTET GY, V114, P1261, DOI 10.1111/j.1471-0528.2007.01440.x; Domberger S, 1997, OXFORD REV ECON POL, V13, P67, DOI 10.1093/oxrep/13.4.67; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gebrehiwot T, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-113; Green A, 2014, LANCET, V384, P1252, DOI 10.1016/S0140-6736(14)61755-4; Griffiths P, 2001, J BIOSOC SCI, V33, P339, DOI 10.1017/S002193200100339X; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Ministry of Health, 2009, BAS PACK HLTH NUTR S; Ministry of Health & National Bureau of Statistics & UNICEF, 2013, REP S SUD SUD SUD HO, P1; MoH, 2007, MAT REPR HLTH POL SO; Moyer CA, 2014, MATERN CHILD HLTH J, V18, P109, DOI 10.1007/s10995-013-1240-y; Mugo N, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015581190; Mugo NS, 2016, MATERN CHILD HLTH J, V20, P1266, DOI 10.1007/s10995-016-1928-x; Mwangome FK, 2012, RURAL REMOTE HEALTH, V12; National Bureau of Statistics, 2011, S SUD STAT YB 2011; Pyone T, 2014, INT J GYNECOL OBSTET, V127, P41, DOI 10.1016/j.ijgo.2014.04.009; Reliefweb, 2014, IRNA REP AM MAP MAL; Republic of South Sudan Ministry of Health, 2012, HLTH SECT DEV PLAN 2; Story WT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-28; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; United Nations, 2016, SUST DEV GOALS 2015; WHO (World Health Organization), 2015, TRENDS MATERNAL MORT; Wilson A., 2011, BMJ, V343; Wilunda C, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-259; World Health Organization, 1978, DECL ALM AT INT C PR	33	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168083	10.1371/journal.pone.0168083	http://dx.doi.org/10.1371/journal.pone.0168083			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977745	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400055
J	Wrozyna, C; Neubauer, TA; Meyer, J; Piller, WE				Wrozyna, Claudia; Neubauer, Thomas A.; Meyer, Juliane; Piller, Werner E.			Shape Variation in Neotropical Cytheridella (Ostracoda) Using Semilandmarks-Based Geometric Morphometrics: A Methodological Approach and Possible Biogeographical Implications	PLOS ONE			English	Article							LATE MIOCENE; SOLIMOES FORMATION; CRUSTACEA; INVERTEBRATES; POPULATIONS; CYPRIDEIS; EVOLUTION	Geometric morphometrics offer effective methods to obtain information about shape and shape variability. In ostracodology, landmark-based methods are, however, not well established. To test the applicability of geometric morphometric analyses for ostracods, we investigated shape variation among recent and fossil populations of the genus Cytheridella using a combination of landmarks and semilandmarks. The study focuses on the species' intraspecific morphological variability on a supra-regional scale, comparing living populations from Florida, Yucata A n, Colombia and Brazil. We performed Generalized least-squares Procrustes Analysis on 508 adult and juvenile specimens (valves) including stages A-1 to A-4. The analyses show that the primary pattern in shape variation is ontogenetic allometry, supporting a clear separation of adults and juveniles. Shape changes are relatively small during ontogeny from A-4 to A-1. Greatest modification of valve shape occurs during the last molt phase. Insufficient differentiation of sexes is caused by females with less developed brood pouches. Disentangling size-and non-size-dependent shape changes reveals regional differences between populations of the species C. ilosvayi and supports its taxonomic distinction from a fossil relative (C. danielopoli). The distribution of regional morphotypes of C. ilosvayi in Florida, Mexico, and Brazil are congruent with fly ways of water birds.	[Wrozyna, Claudia; Meyer, Juliane; Piller, Werner E.] Graz Univ, Inst Earth Sci, NAWI Graz Geoctr, Graz, Austria; [Neubauer, Thomas A.] Nat Hist Museum Vienna, Geol Paleontol Dept, Vienna, Austria; [Neubauer, Thomas A.] Justus Liebig Univ, Dept Anim Ecol & Systemat, Giessen, Germany	University of Graz; Justus Liebig University Giessen	Wrozyna, C (corresponding author), Graz Univ, Inst Earth Sci, NAWI Graz Geoctr, Graz, Austria.	claudia.wrozyna@uni-graz.at	Neubauer, Thomas A./I-1889-2019	Neubauer, Thomas A./0000-0002-1398-9941; Wrozyna, Claudia/0000-0003-1416-7058	Austrian Science Fund (FWF) [P26554]; Austrian Science Fund (FWF) [P 26554] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work is financed through the Austrian Science Fund (http://www.fwf.ac.at/; FWF-project P26554). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello G, 2007, ACTA PALAEONTOL POL, V52, P563; Baltanas A, 2002, BIOL J LINN SOC, V75, P9, DOI 10.1046/j.1095-8312.2002.00001.x; Baltanas A, 2000, HYDROBIOLOGIA, V419, P65, DOI 10.1023/A:1003994209369; Baltanas Angel, 2011, Joannea Geologie und Palaeontologie, V11, P235; BaltanuYs A., 2003, PALEONTOLOGICAL SOC, V9, P101, DOI DOI 10.1017/S1089332600002175; Boere CG, 2006, WATERBIRDS WORLD, P40; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bookstein FL, 1996, B MATH BIOL, V58, P313, DOI 10.1016/0092-8240(95)00329-0; Bookstein FL, 1991, MORPHOMETRIC TOOLS L; Brochet AL, 2010, HYDROBIOLOGIA, V637, P255, DOI 10.1007/s10750-009-9975-6; CRAMPTON JS, 1995, LETHAIA, V28, P179, DOI 10.1111/j.1502-3931.1995.tb01611.x; Danielopol Dan L., 2011, Joannea Geologie und Palaeontologie, V11, P273; Danielopol Dan L., 2008, Senckenbergiana Lethaea, V88, P183; Danielopol DL, 2014, GEOECOMARINA, V20, P5; Elewa AMT, 2004, MORPHOMETRICS: APPLICATIONS IN BIOLOGY AND PALEONTOLOGY, P7; Elewa AMT, 2003, PALAEONT ELEC, V6, P11; Frisch D, 2007, AQUAT SCI, V69, P568, DOI 10.1007/s00027-007-0915-0; Gitter F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0109360; Green AJ, 2013, LIMNETICA, V32, P39; Gross M, 2013, J S AM EARTH SCI, V42, P216, DOI 10.1016/j.jsames.2012.10.002; Gross M, 2011, J S AM EARTH SCI, V32, P169, DOI 10.1016/j.jsames.2011.05.004; Gross Martin, 2008, Senckenbergiana Lethaea, V88, P161; Gueziec A, 1996, NATO ADV SCI INST SE, V284, P253; Gunz P, 2005, STAT GEOMETRIC RECON; Gunz P, 2013, HYSTRIX, V24, P1; Gunz P, 2007, J HUM EVOL, V52, P262, DOI 10.1016/j.jhevol.2006.08.010; Haines AJ, 2000, PALAEONTOLOGY, V43, P765, DOI 10.1111/1475-4983.00148; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Horne DJ, 1998, ERGEB LIMNOL, V52, P549; Kaesler R.L., 1988, Developments in Palaeontology and Stratigraphy, V11, P207; Karanovic I., 2012, CRUSTACEA OSTRACODA; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Ligios Silvia, 2012, Revue de Micropaleontologie, V55, P171, DOI 10.1016/j.revmic.2012.09.002; LOHMANN GP, 1983, J INT ASS MATH GEOL, V15, P659, DOI 10.1007/BF01033230; MacLeod N, 1999, PALEOBIOLOGY, V25, P107; Maddocks R.F., 1988, Developments in Palaeontology and Stratigraphy, V11, P219; MANESS T R, 1987, University of Kansas Paleontological Contributions Paper, P1; Mesquita-Joanes F., 2012, DEV QUATERNARY SCI, V17, P5, DOI DOI 10.1016/B978-0-444-53636-5.00002-0; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Munoz J, 2013, PEERJ, V1, DOI 10.7717/peerj.200; Namiotko T, 2012, INT REV HYDROBIOL, V97, P356, DOI 10.1002/iroh.201211496; Neubauer TA, 2014, PALAEOGEOGR PALAEOCL, V414, P116, DOI 10.1016/j.palaeo.2014.08.015; Neubauer TA, 2013, BIOL J LINN SOC, V110, P320, DOI 10.1111/bij.12120; Neubauer TA, 2013, PALAEOGEOGR PALAEOCL, V370, P117, DOI 10.1016/j.palaeo.2012.11.025; PURPER I, 1974, AN ACAD BRAS CIENC, V46, P635; Reyment RA, 1997, B MATH BIOL, V59, P63; Reyment Richard A., 1993, Revista Espanola de Paleontologia, V8, P125; Rohlf F. J., 2013, TPSDIG DIGITIZE LAND; Rohlf F. J., 2015, TPSRELW RELATIVE WAR; Rohlf F. J., 2015, TPSUTIL FILE UTILITY; ROHLF FJ, 1990, ANNU REV ECOL SYST, V21, P299, DOI 10.1146/annurev.es.21.110190.001503; SCHWEITZER PN, 1986, PALEOBIOLOGY, V12, P290, DOI 10.1017/S0094837300013798; Sheets H. David, 2006, Frontiers in Zoology, V3, pUnpaginated, DOI 10.1186/1742-9994-3-15; Tanaka G, 2009, BIOL J LINN SOC, V97, P810, DOI 10.1111/j.1095-8312.2009.01222.x; Webster M, 2010, PALEONTOLOGICAL SOC, V,, P163, DOI DOI 10.1017/S1089332600001868; Wrozyna C, 2014, CRUSTACEANA, V87, P1043, DOI 10.1163/15685403-00003342	56	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168438	10.1371/journal.pone.0168438	http://dx.doi.org/10.1371/journal.pone.0168438			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977765	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400108
J	Nordgren, H; Aaltonen, K; Raunio-Saarnisto, M; Sukura, A; Vapalahti, O; Sironen, T				Nordgren, Heli; Aaltonen, Kirsi; Raunio-Saarnisto, Mirja; Sukura, Antti; Vapalahti, Olli; Sironen, Tarja			Experimental Infection of Mink Enforces the Role of Arcanobacterium phocae as Causative Agent of Fur Animal Epidemic Necrotic Pyoderma (FENP)	PLOS ONE			English	Article							ALEUTIAN DISEASE; PATHOGENESIS	Fur Animal Epidemic Necrotic Pyoderma (FENP) is a severe, often lethal infectious disease affecting all three fur animal species: mink (Neovision vision), foxes (Vulpes lagopus) and finnraccoons (Nyctereutes procyonoides). Previous studies showed an association between Arcanobacterium phocae and FENP. An experimental infection was conducted to confirm the ability of A. phocae to infect mink either alone or concurrently with a novel Streptococcus sp. found together with A. phocae in many cases of FENP. Different inoculation methods were tested to study possible routes of transmission. Typical signs, and gross- and histopathological findings for FENP were detected when naive mink were infected with the tissue extract of mink with FENP, using a subcutaneous/intradermal infection route. Edema, hemorrhage, necrosis and pus formation were detected in the infection site. A pure culture preparation of A. phocae alone or concurrently with the novel Streptococcus sp. caused severe acute signs of lethargy, apathy and anorexia and even mortality. The histopathological findings were similar to those found in naturally occurring cases of FENP. In contrast, the perorally infected mink presented no clinical signs nor any gross-or histopathological lesions. This study showed that A. phocae is able to cause FENP. The study also indicated that predisposing factors such as the environment, the general condition of the animals, temperature and skin trauma contribute to the development of the disease.	[Nordgren, Heli] FFBA Finnish Breeders Assoc, Vantaa, Finland; [Nordgren, Heli] Fin Furlab FFBA, Vaasa, Finland; [Nordgren, Heli; Aaltonen, Kirsi; Sukura, Antti; Vapalahti, Olli; Sironen, Tarja] Univ Helsinki, Dept Vet Biosci, Fac Vet Med, Helsinki, Finland; [Aaltonen, Kirsi; Vapalahti, Olli; Sironen, Tarja] Univ Helsinki, Dept Virol, Fac Med, Helsinki, Finland; [Raunio-Saarnisto, Mirja] Finnish Food Safety Author, Evira, Seinajoki, Finland; [Vapalahti, Olli] Hosp Dist Helsinki & Uusimaa, HUSLAB, Dept Virol & Immunol, Helsinki, Finland	University of Helsinki; University of Helsinki; Finnish Food Authority; University of Helsinki; Helsinki University Central Hospital	Nordgren, H (corresponding author), FFBA Finnish Breeders Assoc, Vantaa, Finland.; Nordgren, H (corresponding author), Fin Furlab FFBA, Vaasa, Finland.; Nordgren, H (corresponding author), Univ Helsinki, Dept Vet Biosci, Fac Vet Med, Helsinki, Finland.	heli.nordgren@helsinki.fi		Aaltonen, Kirsi/0000-0001-8901-6866; Sironen, Tarja/0000-0002-2344-2755; Vapalahti, Olli/0000-0003-2270-6824; Sukura, Antti Kalle Kalervo/0000-0002-8992-1695	Finnish Fur Breeders association (STKL) OV; Reino Rinne Foundation OV	Finnish Fur Breeders association (STKL) OV; Reino Rinne Foundation OV	This work was funded by Finnish Fur Breeders association (STKL) OV and Reino Rinne Foundation OV. Heli Nordgren was affiliated to FFBA Finnish Fur Breeders Association during the course of the study. FFBA Finnish Fur Breeders Association provided support in the form of salary for author HN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Brojer C., 2002, THESIS; Chalmers G, 2015, CAN J VET RES, V79, P129; Johnson SP, 2003, J WILDLIFE DIS, V39, P136, DOI 10.7589/0090-3558-39.1.136; Jost BH, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-239; Nordgren H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110210; PORTER DD, 1969, J EXP MED, V130, P575, DOI 10.1084/jem.130.3.575; PORTER DD, 1973, AM J PATHOL, V71, P331; Ramos CP, 1997, INT J SYST BACTERIOL, V32, P419	8	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168129	10.1371/journal.pone.0168129	http://dx.doi.org/10.1371/journal.pone.0168129			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973532	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300058
J	Okemoto, K; Maekawa, K; Tajima, Y; Tohkin, M; Saito, Y				Okemoto, Kazuo; Maekawa, Keiko; Tajima, Yoko; Tohkin, Masahiro; Saito, Yoshiro			Cross-Classification of Human Urinary Lipidome by Sex, Age, and Body Mass Index	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; ARACHIDONIC-ACID; FATTY-ACIDS; QUANTIFICATION; IDENTIFICATION; HYPERTENSION; METABOLITES; MEDIATORS	Technological advancements in past decades have led to the development of integrative analytical approaches to lipidomics, such as liquid chromatography-mass spectrometry (LC/MS), and information about biogenic lipids is rapidly accumulating. Although several cohort-based studies have been conducted on the composition of urinary lipidome, the data on urinary lipids cross-classified by sex, age, and body mass index (BMI) are insufficient to screen for various abnormalities. To promote the development of urinary lipid metabolomebased diagnostic assay, we analyzed 60 urine samples from healthy white adults (young (c.a., 30 years) and old (c.a., 60 years) men/women) using LC/MS. Women had a higher urinary concentration of omega-3 12-lipoxygenase (LOX)-generated oxylipins with anti-inflammatory activity compared to men. In addition, young women showed increased abundance of poly-unsaturated fatty acids (PUFAs) and cytochrome P450 (P450)-produced oxylipins with anti-hypertensive activity compared with young men, whereas elderly women exhibited higher concentration of 5-LOX-generated anti-inflammatory oxylipins than elderly men. There were no significant differences in urinary oxylipin levels between young and old subjects or between subjects with low and high BMI. Our findings suggest that sex, but neither ages nor BMI could be a confounding factor for measuring the composition of urinary lipid metabolites in the healthy population. The information showed contribute to the development of reliable biomarker findings from urine.	[Okemoto, Kazuo; Maekawa, Keiko; Tajima, Yoko; Saito, Yoshiro] Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo, Japan; [Okemoto, Kazuo; Tajima, Yoko; Tohkin, Masahiro] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan	National Institute of Health Sciences - Japan; Nagoya City University	Maekawa, K (corresponding author), Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo, Japan.	maekawa@nihs.go.jp			Ministry of Health, Labour, and Welfare; Japan Agency for Medical Research and development, AMED	Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED))	This study was supported in part by "Accelerating regulatory science initiative" from the Ministry of Health, Labour, and Welfare and in part by Grants from Japan Agency for Medical Research and development, AMED(YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, FULL LENGTH BLOOD DO; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Bruins MJ, 2013, J LIPID RES, V54, P1598, DOI 10.1194/jlr.M034918; Buckley ML, 2015, BBA-MOL BASIS DIS, V1852, P1498, DOI 10.1016/j.bbadis.2015.04.011; Burdge GC, 2005, REPROD NUTR DEV, V45, P581, DOI 10.1051/rnd:2005047; Chiabrando C, 1999, J BIOL CHEM, V274, P1313, DOI 10.1074/jbc.274.3.1313; CLOUET P, 1991, PROSTAGLANDINS, V42, P39; CUNNINGHAM FM, 1985, PROSTAGLANDINS, V30, P497, DOI 10.1016/0090-6980(85)90122-4; de Pinho PG, 2015, BIOANALYSIS; Dobrian AD, 2011, PROG LIPID RES, V50, P115, DOI 10.1016/j.plipres.2010.10.005; Flachs P, 2011, DIABETOLOGIA, V54, P2626, DOI 10.1007/s00125-011-2233-2; Fu J, 2016, ANAL BIOANALYTICAL C; Fuller M, 2005, CLIN CHEM, V51, P688, DOI 10.1373/clinchem.2004.041418; Garcia V, 2015, PROSTAG OTH LIPID M, V116, P124, DOI 10.1016/j.prostaglandins.2014.12.001; Hao CM, 2007, KIDNEY INT, V71, P1105, DOI 10.1038/sj.ki.5002192; Imig JD, 1999, BRIT J PHARMACOL, V127, P1399, DOI 10.1038/sj.bjp.0702662; Imig JD, 2015, HYPERTENSION, V65, P476, DOI 10.1161/HYPERTENSIONAHA.114.03585; Ishikawa M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091806; Kasumov T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126910; Klawitter J, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-165; KUMLIN M, 1990, ARCH BIOCHEM BIOPHYS, V282, P254, DOI 10.1016/0003-9861(90)90114-E; Lee H, 2014, BIOCHEM BIOPH RES CO, V453, P268, DOI 10.1016/j.bbrc.2014.05.111; Levison BS, 2013, FREE RADICAL BIO MED, V59, P2, DOI 10.1016/j.freeradbiomed.2013.03.001; McDaniel JC, 2011, WOUND REPAIR REGEN, V19, P189, DOI 10.1111/j.1524-475X.2010.00659.x; Nakagawa K, 2006, J CLIN INVEST, V116, P1696, DOI 10.1172/JCI27546; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Pasikanti KK, 2013, J PROTEOME RES, V12, P3865, DOI 10.1021/pr4000448; Saito K, 2013, METABOLOMICS, V10; Sasaki A, 2015, ANAL BIOANAL CHEM, V407, P1625, DOI 10.1007/s00216-014-8412-5; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shao SY, 2013, DNA CELL BIOL, V32, P41, DOI 10.1089/dna.2012.1874; Simmons DL, 2004, PHARMACOL REV, V56, P387, DOI 10.1124/pr.56.3.3; Stachowska E, 2007, J AGR FOOD CHEM, V55, P5335, DOI 10.1021/jf0701077; Suzuki N, 2003, J CHROMATOGR B, V783, P383, DOI 10.1016/S1570-0232(02)00666-9; Tessaro FHG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/568408; Tsalik EL, 2015, KIDNEY INT; Zhang HY, 2010, ANAL BIOCHEM, V399, P302, DOI 10.1016/j.ab.2009.12.024; Zhao YY, 2015, ADV CLIN CHEM, V68, P153, DOI 10.1016/bs.acc.2014.11.002; Zosmer A, 2002, J STEROID BIOCHEM, V81, P369, DOI 10.1016/S0960-0760(02)00116-4	39	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168188	10.1371/journal.pone.0168188	http://dx.doi.org/10.1371/journal.pone.0168188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973561	gold, Green Published, Green Submitted			2022-12-27	WOS:000392754300063
J	Rosenberg, BL; Kellar, JA; Labno, A; Matheson, DHM; Ringel, M; VonAchen, P; Lesser, RI; Li, Y; Dimick, JB; Gawande, AA; Larsson, SH; Moses, H				Rosenberg, Barry L.; Kellar, Joshua A.; Labno, Anna; Matheson, David H. M.; Ringel, Michael; VonAchen, Paige; Lesser, Richard I.; Li, Yue; Dimick, Justin B.; Gawande, Atul A.; Larsson, Stefan H.; Moses, Hamilton, III			Quantifying Geographic Variation in Health Care Outcomes in the United States before and after Risk-Adjustment	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; PATIENT SAFETY INDICATORS; QUALITY-OF-CARE; SMALL-AREA VARIATIONS; MEDICARE BENEFICIARIES; REGIONAL-VARIATIONS; ADMINISTRATIVE DATA; SURGICAL MORTALITY; RATES; SURGERY	Background Despite numerous studies of geographic variation in healthcare cost and utilization at the local, regional, and state levels across the U.S., a comprehensive characterization of geographic variation in outcomes has not been published. Our objective was to quantify variation in US health outcomes in an all-payer population before and after risk-adjustment. Methods and Findings We used information from 16 independent data sources, including 22 million all-payer inpatient admissions from the Healthcare Cost and Utilization Project (which covers regions where 50% of the U.S. population lives) to analyze 24 inpatient mortality, inpatient safety, and prevention outcomes. We compared outcome variation at state, hospital referral region, hospital service area, county, and hospital levels. Risk-adjusted outcomes were calculated after adjusting for population factors, co-morbidities, and health system factors. Even after risk-adjustment, there exists large geographical variation in outcomes. The variation in healthcare outcomes exceeds the well publicized variation in US healthcare costs. On average, we observed a 2.1-fold difference in risk-adjusted mortality outcomes between top-and bottom-decile hospitals. For example, we observed a 2.3-fold difference for risk-adjusted acute myocardial infarction inpatient mortality. On average a 10.2-fold difference in risk-adjusted patient safety outcomes exists between top and bottom-decile hospitals, including an 18.3-fold difference for risk-adjusted Central Venous Catheter Bloodstream Infection rates. A 3.0-fold difference in prevention outcomes exists between top-and bottom-decile counties on average; including a 2.2-fold difference for risk-adjusted congestive heart failure admission rates. The population, co-morbidity, and health system factors accounted for a range of R-2 between 18-64% of variability in mortality outcomes, 3-39% of variability in patient safety outcomes, and 22-70% of variability in prevention outcomes. Conclusion The amount of variability in health outcomes in the U.S. is large even after accounting for differences in population, co-morbidities, and health system factors. These findings suggest that: 1) additional examination of regional and local variation in risk-adjusted outcomes should be a priority; 2) assumptions of uniform hospital quality that underpin rationale for policy choices ( such as narrow insurance networks or antitrust enforcement) should be challenged; and 3) there exists substantial opportunity for outcomes improvement in the US healthcare system.	[Rosenberg, Barry L.; Kellar, Joshua A.; Labno, Anna; Matheson, David H. M.; Ringel, Michael; VonAchen, Paige; Lesser, Richard I.; Larsson, Stefan H.] Boston Consulting Grp Inc, Boston, MA 02109 USA; [Li, Yue] Univ Rochester, Med Ctr, Dept Publ Hlth Sci, New York, NY USA; [Dimick, Justin B.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA; [Dimick, Justin B.] Univ Michigan, Dept Surg, Ann Arbor, MI USA; [Gawande, Atul A.] Brigham & Womens Hosp, Ariadne Labs, 75 Francis St, Boston, MA 02115 USA; [Gawande, Atul A.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Moses, Hamilton, III] Aler Inst & Aler Advisors LLC, North Garden, VA USA; [Moses, Hamilton, III] Johns Hopkins Sch Med, Baltimore, MD USA	Boston Consulting Group (BCG); University of Rochester; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Rosenberg, BL (corresponding author), Boston Consulting Grp Inc, Boston, MA 02109 USA.	rosenberg.barry@bcg.com			Boston Consulting Group	Boston Consulting Group	The authors received no external sponsorship or specific funding for this work. BLR, JAK, AL, DHMM, MR, PV, RL and SHL are employees of The Boston Consulting Group. The Boston Consulting Group provided support in the form of salaries for authors BLR, JAK, AL, DHMM, MR, PV, RL and SHL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. HM is principal of Alerion Institute and Alerion Advisors. Alerion Institute and Alerion Advisors provided support in the form of salary for author HM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Agency for Healthcare Research and Quality, 2013, PREV QUAL IND PQI PA; Agency for Healthcare Research and Quality, 2013, INP QUAL IND IQI PAR; Agency for Healthcare Research and Quality, 2013, QUAL IND SOFTW INSTR; Agency for Healthcare Research and Quality, 2013, PAT SAF IND PSI PAR, V5; AHRQ, 2006, PREV QUAL IND PQI CO; Al-Sahaf M, 2015, J THORAC DIS, V7, pS152, DOI 10.3978/j.issn.2072-1439.2015.04.08; [Anonymous], 2003, SUPPLY SENSITIVE CAR; [Anonymous], 2013, DARTMOUTH ATLAS HLTH; [Anonymous], 2013, END IND COMP MEAS; [Anonymous], AHRQ QUAL IND BOOST; Ash AS, 2012, STAT ISSUES ASSESSIN; Bernal-Delgado E, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-19; Borzecki AM, 2010, MED CARE, V48, P694, DOI 10.1097/MLR.0b013e3181e419e3; Chen J, STE; CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003; Cooper Z., 2015, PRICE AINT RIGHT HOS; Crighton EJ, 2007, EPIDEMIOL INFECT, V135, P253, DOI 10.1017/S095026880600690X; Curry LA, 2011, ANN INTERN MED, V154, P384, DOI 10.7326/0003-4819-154-6-201103150-00003; Dartmouth Institute for Health Policy and Clinical Practice, 2013, DARTM ATL HLTH CAR D; Davies JM, 2015, NEUROSURG CLIN N AM, V26, P207, DOI 10.1016/j.nec.2014.11.015; Department for Health and Human Services, 2010, ANN FISH STAT 2010, P2; Department for Health and Human Services, 2010, AHRQ QUAL IND AHRQ Q; Dimick JB, 2010, HEALTH SERV RES, V45, P1614, DOI 10.1111/j.1475-6773.2010.01158.x; Dimick JB, 2009, HEALTH AFFAIR, V28, P1189, DOI 10.1377/hlthaff.28.4.1189; Divi V, 2015, HEAD NECK; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Friedman J., 2009, REGULARIZATION PATHS; Gareth J., INTRO STAT LEARNING; GITTELSOHN A, 1995, HEALTH SERV RES, V30, P295; Glance LG, 2010, MED CARE, V48, P466, DOI 10.1097/MLR.0b013e3181d568f7; Goldman M, 2015, JAMA-J AM MED ASSOC, V10032, P5; Gonzalez AA, 2014, JAMA SURG, V149, P119, DOI 10.1001/jamasurg.2013.3649; Gundersen C, 2014, APPL ECON PERSPECT P, V36, P373, DOI 10.1093/aepp/ppu018; Hartley IR, 2013, CONSIDERATION ICD 9; HCUP, 2013, AV DAT EL 1988 2009, P1; Heijink R, 2015, HEALTH ECON, V24, P164, DOI 10.1002/hec.3287; Helmer DA, 2003, DIABETES CARE, V26, P3017, DOI 10.2337/diacare.26.11.3017; Holt JB, 2011, INT J CHRONIC OBSTR, V6, P321, DOI 10.2147/COPD.S19945; Houchens RL., 2014, HCUP NIS RELATED REP; Hussey PM, 2006, EVALUATION USE AHRQ; Institute of Medicine (IOM), 2012, GEOGR ADJ MED PAYM P; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; Jha AK, 2005, NEW ENGL J MED, V353, P265, DOI 10.1056/NEJMsa051249; Jones D., 2014, IMPROVING AHRQ QUALI; Kenney GM, 2012, HEALTH AFFAIR, V31, P899, DOI 10.1377/hlthaff.2012.0159; Kitazawa Takefumi, 2014, BMC Res Notes, V7, P117, DOI 10.1186/1756-0500-7-117; Kittelsen SAC, 2015, HEALTH ECON, V24, P140, DOI 10.1002/hec.3260; Klausen HH, 2012, RESP MED, V106, P1778, DOI 10.1016/j.rmed.2012.08.010; Kotter T, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-21; Krim SR, 2011, AM HEART J, V162, P988, DOI 10.1016/j.ahj.2011.09.006; Kroch E, 2016, J HEALTHC QUAL, V38, P106, DOI 10.1097/JHQ.0000000000000003; Krumholz HM, 2015, JAMA-J AM MED ASSOC, V314, P355, DOI 10.1001/jama.2015.8035; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Lougheed AD, 2006, CHEST, V129, P909, DOI 10.1378/chest.129.4.909; Magan P, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-42; Mannien J, 2011, J THORAC CARDIOV SUR, V141, P899, DOI 10.1016/j.jtcvs.2010.09.047; Marcin JP, 2008, HEALTH SERV RES, V43, P174, DOI 10.1111/j.1475-6773.2007.00740.x; Margaret E, 2011, GEOGRAPHIC ADJUSTMEN; McKellar MR, 2016, HEALTH SERV RES; McKellara M, 2012, GEOGRAPHIC VARIATION; Meddings JA, 2013, ANN INTERN MED, V159, P505, DOI 10.7326/0003-4819-159-8-201310150-00003; Menendez ME, 2014, CLIN ORTHOP RELAT R, V472, P2878, DOI 10.1007/s11999-014-3686-7; Miller MR, 2005, MEASUREMENT ACCREDIT, P239; Mokdad AH, 2009, ANNU REV PUBL HEALTH, V30, P43, DOI 10.1146/annurev.publhealth.031308.100226; MORRIS RD, 1994, CHEST, V106, P1172, DOI 10.1378/chest.106.4.1172; Moses H, 2013, JAMA-J AM MED ASSOC, V310, P1947, DOI 10.1001/jama.2013.281425; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Murrell P., 2006, R NEWS, P6; Newhouse J.P., 2013, VARIATION HLTH CARE; Nunez-Smith M, 2011, ARCH INTERN MED, V171, P1528, DOI 10.1001/archinternmed.2011.284; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; Ogunniyi MO, 2012, AM J MED SCI, V343, P71, DOI 10.1097/MAJ.0b013e318223bbd4; Olsho L, 2016, EVALUATION AHRQS ON; Philipson TJ, 2010, BROOKINGS PAP ECO AC, P325; PHILLIPS KA, 1995, MED CARE, V33, P502, DOI 10.1097/00005650-199505000-00005; Pierannunzi C, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-49; Polancich S, 2006, AM J MED QUAL, V21, P262, DOI 10.1177/1062860606288244; Quan HD, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003716; Rosen AB, 2000, MORTALITY, P36; Rosen AK, 2006, MED CARE, V44, P850, DOI 10.1097/01.mlr.0000220686.82472.9c; Rosenthal GE, 1997, J GEN INTERN MED, V12, P416, DOI 10.1046/j.1525-1497.1997.00073.x; Ryan A, 2012, HEALTH SERV RES, V47, P1699, DOI 10.1111/j.1475-6773.2012.01382.x; Sheiner L., 2014, 2014 BROOKINGS PANEL; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Stephen Zuckerman, 2010, N ENGL J MED; Studnicki J, 2013, AM J MED QUAL, V28, P525, DOI 10.1177/1062860613480826; Sutherland JM, 2009, NEW ENGL J MED, V361, P1227, DOI 10.1056/NEJMp0907172; Wang J, 2009, DIABETES CARE, V32, P1213, DOI 10.2337/dc08-2211; WENNBERG J, 1973, SCIENCE, V182, P1102, DOI 10.1126/science.182.4117.1102; Wennberg JE, 2003, HLTH AFF, V22; Wennberg JE, 1998, DARTMOUTH ATLAS HLTH; Wennberg JE, 2014, HEALTH POLICY, V114, P1, DOI 10.1016/j.healthpol.2013.11.010; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	97	50	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166762	10.1371/journal.pone.0166762	http://dx.doi.org/10.1371/journal.pone.0166762			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973617	Green Submitted, gold, Green Published			2022-12-27	WOS:000392754300013
J	Jiang, X; Jiang, XY; Feng, Y; Xu, RH; Wang, QT; Deng, HT				Jiang, Xu; Jiang, Xiaoyong; Feng, Yun; Xu, Renhua; Wang, Qingtao; Deng, Haiteng			Proteomic Analysis of eIF5B Silencing-Modulated Proteostasis	PLOS ONE			English	Article							TRANSLATION INITIATION-FACTOR; AGE-DEPENDENT DECREASE; LIFE-SPAN EXTENSION; PROTEIN-SYNTHESIS; REGULATES MTOR; FACTOR 5B; AUTOPHAGY; RNA; TRANSCRIPTION; EXPRESSION	Protein translational machinery is an important component of the proteostasis network that maintains cellular proteostasis and regulates aging and other cellular processes. Ample evidence indicates that inhibition of translation initiation factor activities enhances stress resistance in model organisms. Eukaryotic translation initiation factor 5B (eIF5B) acts by joining the pre-40S subunit with the 60S ribosomal unit to form an 80S-like complex during protein translational initiation. Reduced eIF5B expression may disrupt proteostasis and trigger cellular processes associated with stress responses. In this study, the physiological effects of altered eIF5B expression were examined in 293T and HepG2 cells. Cells with eIF5B-knock-down (eIF5B-KN) grew more slowly than control cells, and had a lower level of intracellular reactive oxygen species (ROS), increased resistance to oxidative stress and enhanced autophagy. Proteomic analysis showed that eIF5B knockdown resulted in upregulation of 88 proteins and downregulation of 130 proteins compared with control cells. The differentially expressed proteins were associated with diverse cellular processes including amino acid metabolism, RNA processing and protein metabolism, and DNA synthesis. Autonomous downregulation of the mitogen-activated protein kinase (MAPK) signaling pathway was identified as confirmed by western blotting and qPCR. We proposed that deactivation of MAPK pathway modulated proteostasis and induced prolonged S-phase of the cell-cycle, contributing to the slow growth of eIF5B-KN cells. eIF5B silencing also inactivated the mTOR pathway, downregulated glutamine transporters, enhanced autophagy, and decreased 28S rRNA and 5.8S rRNA expression levels which were reversed by restoration of eIF5B expression. Taken together, these results suggest that eIF5B silencing provides a negative feedback to deactivate MAPK signaling, leading to reduced cell growth. These findings provide a useful resource to further biological exploration of the functions of protein synthesis in regulation of proteostasis and stress responses.	[Jiang, Xu; Jiang, Xiaoyong; Feng, Yun; Deng, Haiteng] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing, Peoples R China; [Xu, Renhua] Binzhou Med Univ, Sch Nursing, Yantai, Peoples R China; [Wang, Qingtao] Capital Med Univ, Beijing Chaoyang Hosp, Beijing, Peoples R China	Tsinghua University; Binzhou Medical University; Capital Medical University	Deng, HT (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing, Peoples R China.	dht@tsinghua.edu.cn	Jiang, Xu/GQH-7192-2022	Jiang, Xu/0000-0002-2283-6322; Deng, Haiteng/0000-0001-9496-1280	National Natural Science Foundation of China [31270871]; Ministry of Education of China [2012Z02293]; Chinese Ministry of Science and Technology [2014CBA02005, 2014AA020907]; Global Science Alliance Program of Thermo-Fisher Scientific	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Global Science Alliance Program of Thermo-Fisher Scientific	This work was supported by the National Natural Science Foundation of China 31270871 (HTD), the Ministry of Education of China 2012Z02293 (HTD) and the Chinese Ministry of Science and Technology (2014CBA02005 and 2014AA020907) and the Global Science Alliance Program of Thermo-Fisher Scientific. The funders had not played a role in study design, data collection and analysis.	Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Avissar NE, 2008, DIGEST DIS SCI, V53, P2113, DOI 10.1007/s10620-007-0120-y; Chen D, 2007, AGING CELL, V6, P525, DOI 10.1111/j.1474-9726.2007.00305.x; Chen R, 2014, J CELL BIOL, V206, P173, DOI 10.1083/jcb.201403009; Chen YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127788; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; de Breyne S, 2008, VIROLOGY, V378, P118, DOI 10.1016/j.virol.2008.05.019; En-Nia A, 2005, J BIOL CHEM, V280, P7702, DOI 10.1074/jbc.M413353200; Franchi-Gazzola R, 1999, J BIOL CHEM, V274, P28922, DOI 10.1074/jbc.274.41.28922; Galmozzi E, 2012, MED HYPOTHESES, V79, P471, DOI 10.1016/j.mehy.2012.06.026; Guegan JP, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/328372; Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x; Hiraishi H, 2013, MOL CELL BIOL, V33, P3540, DOI 10.1128/MCB.00771-13; Hu YD, 2014, J PROTEOME RES, V13, P786, DOI 10.1021/pr4010597; KIMBALL SR, 1992, BIOCHEM J, V286, P263, DOI 10.1042/bj2860263; Kitano S, 1998, AM J PHYSIOL-CELL PH, V275, pC146, DOI 10.1152/ajpcell.1998.275.1.C146; Lebaron S, 2012, NAT STRUCT MOL BIOL, V19, P744, DOI 10.1038/nsmb.2308; Lee JH, 2002, P NATL ACAD SCI USA, V99, P16689, DOI 10.1073/pnas.262569399; Lee S, 2014, P NATL ACAD SCI USA, V111, pE4315, DOI 10.1073/pnas.1320477111; MAKRIDES SC, 1983, BIOL REV, V58, P343, DOI 10.1111/j.1469-185X.1983.tb00394.x; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; MOLDAVE K, 1979, FED PROC, V38, P1979; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Pisareva VP, 2014, NUCLEIC ACIDS RES, V42, P12052, DOI 10.1093/nar/gku877; Poillet-Perez L, 2015, REDOX BIOL, V4, P184, DOI 10.1016/j.redox.2014.12.003; Rogers AN, 2011, CELL METAB, V14, P55, DOI 10.1016/j.cmet.2011.05.010; Strunk BS, 2012, CELL, V150, P111, DOI 10.1016/j.cell.2012.04.044; Tavernarakis N, 2008, TRENDS CELL BIOL, V18, P228, DOI 10.1016/j.tcb.2008.02.004; Thakor N, 2012, NUCLEIC ACIDS RES, V40, P541, DOI 10.1093/nar/gkr701; VARGAS R, 1983, MECH AGEING DEV, V21, P183, DOI 10.1016/0047-6374(83)90073-8; Wang Jue, 2010, Sarcoma, V2010, P454792, DOI 10.1155/2010/454792; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WEBSTER GC, 1983, MECH AGEING DEV, V22, P121, DOI 10.1016/0047-6374(83)90105-7; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhou KI, 2011, AGING-US, V3, P733, DOI 10.18632/aging.100367	39	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168387	10.1371/journal.pone.0168387	http://dx.doi.org/10.1371/journal.pone.0168387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959964	gold, Green Published, Green Submitted			2022-12-27	WOS:000392753900062
J	Konig, SU; Schumann, F; Keyser, J; Goeke, C; Krause, C; Wache, S; Lytochkin, A; Ebert, M; Brunsch, V; Wahn, B; Kaspar, K; Nagel, SK; Meilinger, T; Bulthoff, H; Wolbers, T; Buchel, C; Konig, P				Koenig, Sabine U.; Schumann, Frank; Keyser, Johannes; Goeke, Caspar; Krause, Carina; Wache, Susan; Lytochkin, Aleksey; Ebert, Manuel; Brunsch, Vincent; Wahn, Basil; Kaspar, Kai; Nagel, Saskia K.; Meilinger, Tobias; Buelthoff, Heinrich; Wolbers, Thomas; Buechel, Christian; Koenig, Peter			Learning New Sensorimotor Contingencies: Effects of Long-Term Use of Sensory Augmentation on the Brain and Conscious Perception	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; CROSS-MODAL PLASTICITY; PATH-INTEGRATION; HUMAN NAVIGATION; PARIETAL CORTEX; VISUAL-CORTEX; POSTERIOR PARIETAL; CAUDATE-NUCLEUS; SLEEP STATES; BLIND	Theories of embodied cognition propose that perception is shaped by sensory stimuli and by the actions of the organism. Following sensorimotor contingency theory, the mastery of lawful relations between own behavior and resulting changes in sensory signals, called sensorimotor contingencies, is constitutive of conscious perception. Sensorimotor contingency theory predicts that, after training, knowledge relating to new sensorimotor contingencies develops, leading to changes in the activation of sensorimotor systems, and concomitant changes in perception. In the present study, we spell out this hypothesis in detail and investigate whether it is possible to learn new sensorimotor contingencies by sensory augmentation. Specifically, we designed an fMRI compatible sensory augmentation device, the feelSpace belt, which gives orientation information about the direction of magnetic north via vibrotactile stimulation on the waist of participants. In a longitudinal study, participants trained with this belt for seven weeks in natural environment. Our EEG results indicate that training with the belt leads to changes in sleep architecture early in the training phase, compatible with the consolidation of procedural learning as well as increased sensorimotor processing and motor programming. The fMRI results suggest that training entails activity in sensory as well as higher motor centers and brain areas known to be involved in navigation. These neural changes are accompanied with changes in how space and the belt signal are perceived, as well as with increased trust in navigational ability. Thus, our data on physiological processes and subjective experiences are compatible with the hypothesis that new sensorimotor contingencies can be acquired using sensory augmentation.	[Koenig, Sabine U.; Schumann, Frank; Keyser, Johannes; Goeke, Caspar; Krause, Carina; Wache, Susan; Lytochkin, Aleksey; Ebert, Manuel; Brunsch, Vincent; Wahn, Basil; Kaspar, Kai; Nagel, Saskia K.; Koenig, Peter] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany; [Schumann, Frank] Univ Paris 05, Lab Psychol Percept, Paris, France; [Kaspar, Kai] Univ Cologne, Dept Psychol, Cologne, Germany; [Meilinger, Tobias; Buelthoff, Heinrich] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Wolbers, Thomas] German Ctr Neurodegenerat Dis DZNE, Aging & Cognit Res Grp, Magdeburg, Germany; [Buechel, Christian] Hamburg Univ Hosp Eppendorf, Dept Syst Neurosci, NeuroImage Nord, Hamburg, Germany; [Koenig, Peter] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany	University Osnabruck; UDICE-French Research Universities; Universite Paris Cite; University of Cologne; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Hamburg; University Medical Center Hamburg-Eppendorf	Konig, SU (corresponding author), Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany.	sabkoeni@uos.de	Wahn, Basil/AAV-5770-2021; Bülthoff, Heinrich/AAC-8818-2019; Bülthoff, Heinrich H/J-6579-2012; König, Peter/ABB-2380-2020; Meilinger, Tobias/C-3969-2014	Bülthoff, Heinrich H/0000-0003-2568-0607; König, Peter/0000-0003-3654-5267; Meilinger, Tobias/0000-0002-1326-1213; Keyser, Johannes/0000-0001-8343-4362; Wahn, Basil/0000-0002-0318-7160; Wolbers, Thomas/0000-0003-2943-8949; Schumann, Frank/0000-0001-9262-4539	Deutsche Forschungsgemeinschaft [KO 3359/4-1]; European Research Council [269716]; CAN [W911NF-10-2-0022]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); CAN	Funded by KO 3359/4-1 Deutsche Forschungsgemeinschaft (http.//www.dfg.de/) PK. #269716 European Research Council (https://erc.europa.eu/) PK. #W911NF-10-2-0022 CAN PK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud S, 2014, RESTOR NEUROL NEUROS, V32, P247, DOI 10.3233/RNN-130338; Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; Amedi A, 2002, CEREB CORTEX, V12, P1202, DOI 10.1093/cercor/12.11.1202; Amedi A, 2001, NAT NEUROSCI, V4, P324, DOI 10.1038/85201; Amedi A, 2007, NAT NEUROSCI, V10, P687, DOI 10.1038/nn1912; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Auvray M, 2007, PERCEPTION, V36, P416, DOI 10.1068/p5631; BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bermejo F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00679; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; Borkenau P., 1993, NEO FUNF FAKTOREN IN; Bremmer F, 2002, EUR J NEUROSCI, V16, P1554, DOI 10.1046/j.1460-9568.2002.02207.x; Bremmer F, 2001, NEURON, V29, P287, DOI 10.1016/S0896-6273(01)00198-2; Buchel C, 1998, BRAIN, V121, P409, DOI 10.1093/brain/121.3.409; BURTON H, 1993, SOMATOSENS MOT RES, V10, P297, DOI 10.3109/08990229309028839; Burton H, 2005, ADAPTIVE CHANGES EAR, P3359; Campus C, 2012, J NEUROPHYSIOL, V107, P2713, DOI 10.1152/jn.00624.2011; Cheung A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000992; Cholewiak RW, 2004, PERCEPT PSYCHOPHYS, V66, P970, DOI 10.3758/BF03194989; Clark A, 1999, TRENDS COGN SCI, V3, P345, DOI 10.1016/S1364-6613(99)01361-3; Clark A., 2006, PSYCHE, V12, P1, DOI DOI 10.1016/J.CONCOG.2009.03.005; Clark D, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/fhurn.2015.00297, 10.3389/fnhum.2015.00297]; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; CORBETTA M, 1995, SCIENCE, V270, P802, DOI 10.1126/science.270.5237.802; Creem-Regehr SH, 2009, NEUROBIOL LEARN MEM, V91, P166, DOI 10.1016/j.nlm.2008.10.004; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Cunnington R, 2005, HUM MOVEMENT SCI, V24, P644, DOI 10.1016/j.humov.2005.10.001; Darwin C, 1873, NATURE, V7, P360, DOI [10.1038/007360c0, DOI 10.1038/007360C0]; Dayan E, 2011, NEURON, V72, P443, DOI 10.1016/j.neuron.2011.10.008; Deroy Ophelia, 2012, Front Psychol, V3, P457, DOI 10.3389/fpsyg.2012.00457; Dijkerman HC, 2007, BEHAV BRAIN SCI, V30, P189, DOI 10.1017/S0140525X07001392; Doeller CF, 2014, CEREB CORTEX, P132; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; Ehinger BV, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00071; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ellmore TM, 2004, SPAT COGN COMPUT, V4, P255; Engel AK, 2013, TRENDS COGN SCI, V17, P202, DOI 10.1016/j.tics.2013.03.006; Fogel SM, 2007, BEHAV BRAIN RES, V180, P48, DOI 10.1016/j.bbr.2007.02.037; Foulke E., 1982, SPATIAL ABILITIES DE, P55; Foulke E., 1971, AM FDN BLIND RES B, V23, P1; Francis ST, 2000, NEUROIMAGE, V11, P188, DOI 10.1006/nimg.2000.0541; Frisch K.v., 1949, Experientia Basel, V5, P142, DOI 10.1007/BF02174424; FUJITA N, 1993, GEOGR ANAL, V25, P295; Gassert R, 2006, CONCEPT MAGN RESON B, V29B, P191, DOI 10.1002/cmr.b.20070; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Hassenzahl M., 2003, MENSCH COMPUTER, P187, DOI DOI 10.1097/00001756-200303030-00034; HENNEVIN E, 1971, CR ACAD SCI D NAT, V273, P2595; Iacoboni M, 2006, NEUROPSYCHOLOGIA, V44, P2691, DOI 10.1016/j.neuropsychologia.2006.04.029; Iaria G, 2003, J NEUROSCI, V23, P5945; Iaria G, 2007, EUR J NEUROSCI, V25, P890, DOI 10.1111/j.1460-9568.2007.05371.x; Iber C, 2007, J CLIN SLEEP MED, V3, P107; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; Johansen-Berg H, 2000, NEUROREPORT, V11, P1237, DOI 10.1097/00001756-200004270-00019; Jones LA, 2008, HUM FACTORS, V50, P90, DOI 10.1518/001872008X250638; Jonides J, 2004, NAT NEUROSCI, V7, P10, DOI 10.1038/nn0104-10; Karcher SM, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00037; Karnath HO, 2006, BRAIN, V129, P293, DOI 10.1093/brain/awh698; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kaspar K, 2014, CONSCIOUS COGN, V28, P47, DOI 10.1016/j.concog.2014.06.006; Kassubek J, 2001, COGNITIVE BRAIN RES, V10, P207, DOI 10.1016/S0926-6410(00)00037-9; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; Keyser J., 2010, THESIS; Konig P, 2013, BEHAV BRAIN SCI, V36, P219, DOI 10.1017/S0140525X12002294; Kuhl J., 1994, VOLITION PERSONALITY, P47; LECONTE P, 1971, CR ACAD SCI D NAT, V273, P86; Lenay C, 1997, SECOND INTERNATIONAL CONFERENCE ON COGNITIVE TECHNOLOGY, PROCEEDINGS, P44, DOI 10.1109/CT.1997.617681; Lenay C., 2003, TOUCHING KNOWING COG, P275, DOI [10.1075/aicr.53.22len, DOI 10.1075/AICR.53.22LEN]; Levy-Tzedek S, 2012, RESTOR NEUROL NEUROS, V30, P313, DOI 10.3233/RNN-2012-110219; LOHMANN KJ, 1995, J EXP BIOL, V198, P2041; LOOMIS JM, 1993, J EXP PSYCHOL GEN, V122, P73, DOI 10.1037/0096-3445.122.1.73; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; Maguire EA, 1997, J NEUROSCI, V17, P7103; Maldjian JA, 1999, BRAIN RES, V824, P291, DOI 10.1016/S0006-8993(99)01126-9; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mallot H., 2006, SPAT COGN COMPUT, V6, P295; Mangen A, 2010, ADVANCES IN HAPTICS, P385; Maquet P, 2001, SCIENCE, V294, P1048, DOI 10.1126/science.1062856; Marr D., 1982, VISION COMPUTATIONAL; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Merkle T, 2008, J EXP BIOL, V211, P3370, DOI 10.1242/jeb.022715; MITTELSTAEDT ML, 1980, NATURWISSENSCHAFTEN, V67, P566, DOI 10.1007/BF00450672; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Morgan LK, 2011, J NEUROSCI, V31, P1238, DOI 10.1523/JNEUROSCI.4667-10.2011; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Munzer S, 2011, DIAGNOSTICA, V57, P111, DOI 10.1026/0012-1924/a000040; Nagel SK, 2005, J NEURAL ENG, V2, pR13, DOI 10.1088/1741-2560/2/4/R02; Neuper C, 2006, PROG BRAIN RES, V159, P211, DOI 10.1016/S0079-6123(06)59014-4; Noe E A, 2004, ACTION PERCEPTION; Norimoto H, 2015, CURR BIOL, V25, P1091, DOI 10.1016/j.cub.2015.02.063; O'Regan J.K., 2011, WHY RED DOESNT SOUND; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; ORBAN GA, 1995, P NATL ACAD SCI USA, V92, P993, DOI 10.1073/pnas.92.4.993; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; PENFIELD W, 1951, AMA ARCH NEUROL PSY, V66, P289, DOI 10.1001/archneurpsyc.1951.02320090038004; Perfetti B, 2011, J NEUROSCI, V31, P14810, DOI 10.1523/JNEUROSCI.1319-11.2011; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Poldrack RA, 2000, NEUROIMAGE, V12, P1, DOI 10.1006/nimg.2000.0596; Proulx MJ, 2014, NEUROSCI BIOBEHAV R, V41, P1, DOI 10.1016/j.neubiorev.2014.03.004; Ptito M, 2005, BRAIN, V128, P606, DOI 10.1093/brain/awh380; Ptito M, 2012, NEURAL PLAST, V2012; Ritz T, 2002, NEURON, V34, P503, DOI 10.1016/S0896-6273(02)00707-9; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Roder B, 2004, CURR BIOL, V14, P121, DOI 10.1016/j.cub.2003.12.054; Roder B, 2002, EUR J NEUROSCI, V16, P930, DOI 10.1046/j.1460-9568.2002.02147.x; Sadato N, 2002, NEUROIMAGE, V16, P389, DOI 10.1006/nimg.2002.1111; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sampaio E, 2001, BRAIN RES, V908, P204, DOI 10.1016/S0006-8993(01)02667-1; Schumann F., 2012, SENSORIMOTOR ACCOUNT; Schwenkreis P, 2007, EUR J NEUROSCI, V26, P3291, DOI 10.1111/j.1460-9568.2007.05894.x; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; Smith C, 2001, SLEEP MED REV, V5, P491, DOI 10.1053/smrv.2001.0164; Spiers HJ, 2006, NEUROIMAGE, V31, P1826, DOI 10.1016/j.neuroimage.2006.01.037; Striem-Amit E, 2012, CEREB CORTEX, V22, P1698, DOI 10.1093/cercor/bhr253; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; TANJI J, 1994, NEUROSCI RES, V19, P251, DOI 10.1016/0168-0102(94)90038-8; Tashakkori A, 2010, HDB MIXED METHODS SO, P913; Tse ZTH, 2009, P I MECH ENG H, V223, P497, DOI 10.1243/09544119JEIM529; Twisk JWR., 2006, APPL MULTILEVEL ANAL, DOI [10.1017/CBO9780511610806, DOI 10.1017/CBO9780511610806]; Tyler Mitchell, 2003, J Integr Neurosci, V2, P159, DOI 10.1142/S0219635203000263; Varela FJ, 2017, EMBODIED MIND COGNIT; Voss P, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-113; Wahn B, 2016, FRONT INTEGR NEUROSC, V10, DOI 10.3389/fnint.2016.00013; Wahn B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01084; Wahn B, 2015, MULTISENS RES, V28, P371, DOI 10.1163/22134808-00002482; Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031; Wander JD, 2013, P NATL ACAD SCI USA, V110, P10818, DOI 10.1073/pnas.1221127110; Ward J, 2010, CONSCIOUS COGN, V19, P492, DOI 10.1016/j.concog.2009.10.006; Wehner R, 1997, EXS, V84, P145; Weiss S, 1996, NEUROSCI LETT, V209, P17, DOI 10.1016/0304-3940(96)12581-7; Werth E, 1997, ELECTROEN CLIN NEURO, V103, P535, DOI 10.1016/S0013-4694(97)00070-9; WHITE BW, 1970, PERCEPT PSYCHOPHYS, V7, P22; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Wolbers T, 2007, J NEUROSCI, V27, P9408, DOI 10.1523/JNEUROSCI.2146-07.2007; Wolpert DM, 1998, NAT NEUROSCI, V1, P529, DOI 10.1038/2245; Zeitlhofer J., 1993, Brain Topography, V6, P123, DOI 10.1007/BF01191077; Ziemke T, 2003, PROCEEDINGS OF THE TWENTY-FIFTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, PTS 1 AND 2, P1305	140	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0166647	10.1371/journal.pone.0166647	http://dx.doi.org/10.1371/journal.pone.0166647			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	27959914	gold, Green Submitted, Green Published			2022-12-27	WOS:000392753900003
J	Nkhoma, ET; Rosenblatt, L; Myers, J; Villasis-Keever, A; Coumbis, J				Nkhoma, Ella T.; Rosenblatt, Lisa; Myers, Joel; Villasis-Keever, Angelina; Coumbis, John			Real-World Assessment of Renal and Bone Safety among Patients with HIV Infection Exposed to Tenofovir Disoproxil Fumarate-Containing Single-Tablet Regimens	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ANTIRETROVIRAL THERAPY; INTESTINAL-ABSORPTION; PROTEASE INHIBITORS; INITIAL TREATMENT; KIDNEY-FUNCTION; DOUBLE-BLIND; ALAFENAMIDE; COBICISTAT; ADULTS	Objectives Tenofovir disoproxil fumarate (TDF)-containing antiretroviral regimens have been associated with an increased incidence of renal and bone adverse outcomes. Here, we estimated the real-world incidence of renal and bone adverse outcomes among patients with HIV infection receiving different TDF-containing single-tablet regimens (STRs). Methods This cohort study used US health insurance data spanning the years 2008-2014. We identified HIV-infected patients aged >= 18 years (all HIV patients) and those with >= 6 months of continuous enrollment prior to initiating efavirenz/emtricitabine/TDF (EFV/FTC/TDF), rilpivirine/FTC/TDF (RPV/FTC/TDF) or elvitegravir/cobicistat/FTC/TDF (EVG/COBI/FTC/TDF). Renal adverse outcomes were identified using renal International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) diagnosis codes. Bone adverse outcomes were identified using ICD-9-CM diagnosis codes for fracture. Incidence rates (IRs) and associated 95% confidence intervals (CIs) were estimated assuming a Poisson distribution, and outcomes between STRs were compared using IR ratios (IRRs) and IR differences (IRDs). Results We identified 9876 and 10,383 eligible patients for the renal and fracture analyses, respectively. Observed IRs for renal adverse outcomes were 9.7, 10.5, 13.6, and 18.0 per 1000 person-years among those receiving EFV/FTC/TDF, RPV/FTC/TDF, or EVG/COBI/FTC/TDF, or all HIV patients, respectively. Corresponding values for IRs of fracture were 3.4, 3.6, 7.2, and 4.4 per 1000 person-years, respectively. Renal adverse outcomes with EFV/FTC/TDF were significantly less frequent than with EVG/COBI/FTC/TDF (IRD -3.96; 95% CI: -7.31, -1.06). No IRR differences were identified for the renal analysis. Fractures with EFV/FTC/TDF were significantly less frequent than with EVG/COBI/FTC/TDF (IRR 0.47; 95% CI: 0.27, 0.81 and IRD -3.85; 95% CI: -5.02, -2.78). Conclusions In this large real-world database, observed IRs for renal adverse outcomes with TDF-containing STRs were lower or similar to those for all HIV patients, with the lowest IRs observed among patients receiving EFV/FTC/TDF. Compared with all HIV patients, the observed IR for fracture was higher with EVG/COBI/FTC/TDF, comparable with RPV/FTC/TDF, and lower with EFV/FTC/TDF.	[Nkhoma, Ella T.] Bristol Myers Squibb, Global Pharmacovigilance & Epidemiol, Pennington, NJ 08534 USA; [Rosenblatt, Lisa] Bristol Myers Squibb, US Hlth Econ & Outcomes Res, Plainsboro, NJ USA; [Myers, Joel; Villasis-Keever, Angelina] Bristol Myers Squibb, Res & Dev, Plainsboro, NJ USA; [Coumbis, John] Bristol Myers Squibb, Global Pharmacovigilance & Epidemiol, Hopewell, NJ USA	Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb	Nkhoma, ET (corresponding author), Bristol Myers Squibb, Global Pharmacovigilance & Epidemiol, Pennington, NJ 08534 USA.	ella.nkhoma@bms.com			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	This study was supported by Bristol-Myers Squibb, the manufacturer of efavirenz. All authors are employees of Bristol-Myers Squibb. The specific roles of these authors are articulated in the 'author contributions' section. Medical writing assistance was provided by Julian Martins of inScience Communications, Springer Healthcare, which was funded by Bristol-Myers Squibb. No additional external funding received for this study.	Astuti N, 2014, INFECT DIS THER, V3, P1, DOI 10.1007/s40121-014-0024-z; Bedimo R, 2012, AIDS, V26, P825, DOI 10.1097/QAD.0b013e32835192ae; Bristol-Myers Squibb Company, 2015, PRESCR INF SUSTIVA; Bristol-Myers Squibb Company, PRESCR INF REYATAZ A; Cooper RD, 2010, CLIN INFECT DIS, V51, P496, DOI 10.1086/655681; Custodio J, 2013, 14 INT WORKSH CLIN P; Dong HV, 2014, AIDS, V28, P2119, DOI 10.1097/QAD.0000000000000363; Droste JAH, 2006, JAIDS-J ACQ IMM DEF, V41, P37, DOI 10.1097/01.qai.0000191997.70034.80; Dursteler-Macfarland KM, 2011, DRUG ALCOHOL REV, V30, P577, DOI 10.1111/j.1465-3362.2010.00242.x; Fafin C, 2012, NEPHRON CLIN PRACT, V120, pC205, DOI 10.1159/000342377; Flandre P, 2011, CLIN J AM SOC NEPHRO, V6, P1700, DOI 10.2215/CJN.09191010; German P, 2012, JAIDS-J ACQ IMM DEF, V61, P32, DOI 10.1097/QAI.0b013e3182645648; German P, 2010, JAIDS-J ACQ IMM DEF, V55, P323, DOI 10.1097/QAI.0b013e3181eb376b; Gilead Sciences, 2013, PRESCR INF TRUVADA E; Gilead Sciences, 2015, PRESCR INF HARVONI L; Gilead Sciences, 2015, PRESCR INF COMPLERA; Gilead Sciences, 2015, PRESCR INF VIREAD TE; Gilead Sciences, 2015, PRESCR INF STRIBILD; Hansen L., 2016, TRUVEN HLTH MARKETSC; Hemkens LG, 2015, HIV CLIN TRIALS, V16, P178, DOI 10.1179/1945577115Y.0000000004; Johnson & Johnson, 2015, PRESCR INF OLYSIO SI; Kim EY, 2009, FORENSIC SCI INT, V188, P75, DOI 10.1016/j.forsciint.2009.03.016; Laprise C, 2013, CLIN INFECT DIS, V56, P567, DOI 10.1093/cid/cis937; Lepist EI, 2012, ANTIMICROB AGENTS CH, V56, P5409, DOI 10.1128/AAC.01089-12; Maggi P, 2014, AIDS REV, V16, P144; Mills A, 2016, LANCET INFECT DIS, V16, P43, DOI 10.1016/S1473-3099(15)00348-5; Mills A, 2015, JAIDS-J ACQ IMM DEF, V69, P439, DOI 10.1097/QAI.0000000000000618; Pasoto SG, 2012, RHEUMATOL INT, V32, P3149, DOI 10.1007/s00296-011-2154-x; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Rijnders B, 2015, 15 EUR AIDS C OCT 21; Ruane PJ, 2013, JAIDS-J ACQ IMM DEF, V63, P449, DOI 10.1097/QAI.0b013e3182965d45; Sax Paul E, 2014, J Acquir Immune Defic Syndr, V67, P52, DOI 10.1097/QAI.0000000000000225; Sax PE, 2015, LANCET, V385, P2606, DOI 10.1016/S0140-6736(15)60616-X; Scherzer R, 2012, AIDS, V26, P867, DOI 10.1097/QAD.0b013e328351f68f; Shamblaw D, 2015, SWITCHING ATRIPLA AT; Shiau S, 2013, AIDS, V27, P1949, DOI 10.1097/QAD.0b013e328361d241; The Henry J. Kaiser Family Foundation, 2014, HLTH INS COV TOT POP; Thompson M, 2015, SWITCHING TDF TAF BA; Tonelli M, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0155-5; Tong L, 2007, ANTIMICROB AGENTS CH, V51, P3498, DOI 10.1128/AAC.00671-07; van Lunzen J, 2016, AIDS, V30, P251, DOI 10.1097/QAD.0000000000000911; Winston A, 2015, CURR OPIN INFECT DIS, V28, P17, DOI 10.1097/QCO.0000000000000117; Winston J, 2014, HIV CLIN TRIALS, V15, P231, DOI 10.1310/hct1506-231; Wohl DA, 2014, JAIDS-J ACQ IMM DEF, V65, pE118, DOI 10.1097/QAI.0000000000000057	44	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0166982	10.1371/journal.pone.0166982	http://dx.doi.org/10.1371/journal.pone.0166982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941989	Green Submitted, gold, Green Published			2022-12-27	WOS:000392745600006
J	Torres, PC; Morsello, C; Parry, L; Pardini, R				Torres, Patricia Carignano; Morsello, Carla; Parry, Luke; Pardini, Renata			Who Cares about Forests and Why? Individual Values Attributed to Forests in a Post-Frontier Region in Amazonia	PLOS ONE			English	Article							CULTURAL ECOSYSTEM SERVICES; WILDLIFE CONSUMPTION; RURAL HOUSEHOLDS; CONSERVATION; BUSHMEAT; ATTITUDE; BIODIVERSITY; PERCEPTIONS; MANAGEMENT; INSIGHTS	Understanding the multiple ways people value forests is important, as individual values regarding nature have been shown to partly determine willingness to participate in conservation initiatives. As individual values are influenced by past experiences, the way people value forests may be related to the ecosystem services they use and receive. We here aim to investigate if people value forests because of material and non-material benefits forest provide (material and non-material values), and if these values are defined by previous experiences associated with using forest resources and having frequent contact with forests. By interviewing 363 residents across 20 landscapes varying in forest cover in a post-frontier region in Amazonia, we evaluated: (1) if the use of forest resources-especially bushmeat, important for sustenance and cash income in virtually all tropical forests-is associated with attributing higher material value to forests; (2) whether the contact with forest (estimated by local forest cover and visits to forests) is associated with attributing higher non-material value to forests. As expected, respondents from households where hunting occurs and bushmeat consumption is more frequent attributed higher material value to forests, and those living in more deforested landscapes and that visited forests less often attributed lower non-material value to forests. The importance of bushmeat in shaping the way people value forests suggests that encouraging the sustainable use of this product will encourage forest conservation. Results also point to a potential dangerous reinforcing cycle: low forest cover and the loss of contact with forests may erode forest values and facilitate further deforestation. Engaging rural communities in forest conservation initiatives is challenging yet urgent in degraded landscapes, although harnessing appreciation for bushmeat could offer a starting point.	[Torres, Patricia Carignano] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Cidade Univ, Sao Paulo, SP, Brazil; [Morsello, Carla] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo, SP, Brazil; [Parry, Luke] Univ Lancaster, Lancaster Environm Ctr, Lancaster, Lancs, England; [Parry, Luke] Fed Univ Para, NAEA, Belem, Para, Brazil; [Pardini, Renata] Univ Sao Paulo, Inst Biociencias, Dept Zool, Cidade Univ, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Lancaster University; Universidade Federal do Para; Universidade de Sao Paulo	Torres, PC (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Ecol, Cidade Univ, Sao Paulo, SP, Brazil.	patriciactorres@gmail.com	Morsello, Carla/D-7393-2012; Carignano Torres, Patricia/F-2794-2016; Pardini, Renata/C-4095-2012; Parry, Luke/ABD-4194-2021	Morsello, Carla/0000-0001-7548-6541; Carignano Torres, Patricia/0000-0003-0426-8277; Pardini, Renata/0000-0002-3769-8401; Parry, Luke/0000-0003-0330-9516	INCT - Biodiversidade e Uso da Terra na Amazonia [CNPq 574008/2008-0]; Embrapa [SEG: 02.08.06.005.00]; UK government Darwin Initiative [17-023]; Nature Conservancy; Natural Environment Research Council (NERC) [NE/F01614X/1, NE/G000816/1]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/19108-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/19606-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [308205/2014-6]; NERC [NE/F01614X/1, NE/G000816/1] Funding Source: UKRI; Natural Environment Research Council [NE/G000816/1, NE/F01614X/1, ceh010010] Funding Source: researchfish	INCT - Biodiversidade e Uso da Terra na Amazonia; Embrapa(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); UK government Darwin Initiative; Nature Conservancy; Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by INCT - Biodiversidade e Uso da Terra na Amazonia (CNPq 574008/2008-0), Embrapa (SEG: 02.08.06.005.00), the UK government Darwin Initiative (17-023), the Nature Conservancy, the Natural Environment Research Council (NERC) (NE/F01614X/1 and NE/G000816/1) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(2011/19108-0). PCT had doctoral scholarships from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (2011/19606-0). RP had a research fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (308205/2014-6) during the development of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Albrechtsen L, 2005, ENVIRON CONSERV, V32, P340, DOI 10.1017/S0376892906002694; Angelsen A, 2014, WORLD DEV, V64, pS12, DOI 10.1016/j.worlddev.2014.03.006; [Anonymous], 2005, EC HUM WELL BEING SY; [Anonymous], 2014, R LANG ENV STAT COMP; ARCURY TA, 1990, ENVIRON BEHAV, V22, P387, DOI 10.1177/0013916590223004; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bhagwat SA, 2009, ENVIRON VALUE, V18, P417, DOI 10.3197/096327109X12532653285731; Brancalion PHS, 2014, RESTOR ECOL, V22, P65, DOI 10.1111/rec.12025; Brashares JS, 2011, P NATL ACAD SCI USA, V108, P13931, DOI 10.1073/pnas.1011526108; Brown G, 2000, FOREST SCI, V46, P240; Brown G, 2012, APPL SPAT ANAL POLIC, V5, P317, DOI 10.1007/s12061-011-9072-x; Burnhan KP, 2002, MODEL SELECTION MULT; Carifio J., 2007, J SOCIAL SCI, V3, P106, DOI DOI 10.3844/JSSP.2007.106.116; Castro E, 2004, DINAMICA ATORES USO, V179; Chan KMA, 2012, ECOL ECON, V74, P8, DOI 10.1016/j.ecolecon.2011.11.011; Coomes OT, 2004, ECOL ECON, V51, P47, DOI 10.1016/j.ecolecon.2004.04.004; CORTINA JM, 1993, J APPL PSYCHOL, V78, P98, DOI 10.1037/0021-9010.78.1.98; Crawley M.J., 2007, R BOOK; D'Antona AO, 2006, POPUL ENVIRON, V27, P373, DOI 10.1007/s11111-006-0031-4; de Merode E, 2004, BIOL CONSERV, V118, P573, DOI 10.1016/j.biocon.2003.10.005; De Vaus, 2002, SURVEYS SOCIAL RES; Dietz T, 2005, ANNU REV ENV RESOUR, V30, P335, DOI 10.1146/annurev.energy.30.050504.144444; Dunlap RE, 2000, J SOC ISSUES, V56, P425, DOI 10.1111/0022-4537.00176; Fa JE, 2009, ANIM CONSERV, V12, P599, DOI 10.1111/j.1469-1795.2009.00289.x; Fearnside PM, 2005, CONSERV BIOL, V19, P680, DOI 10.1111/j.1523-1739.2005.00697.x; Foerster S, 2012, CONSERV BIOL, V26, P335, DOI 10.1111/j.1523-1739.2011.01802.x; Fonseca WD, SANTAREM MOMENTOS HI; Fulton D.C., 1996, HUMAN DIMENSIONS WIL, V1, P24, DOI DOI 10.1080/10871209609359060; Futemma C, 2003, HUM ECOL, V31, P369, DOI 10.1023/A:1025067721480; George D, 2003, SPSS WINDOWS STEP ST; Godoy R, 2010, ANIM CONSERV, V13, P265, DOI 10.1111/j.1469-1795.2009.00330.x; Hicks CC, 2015, CONSERV BIOL, V29, P1471, DOI 10.1111/cobi.12550; IBGE, 2010, CENS DEM; Ives CD, 2014, J ENVIRON MANAGE, V144, P67, DOI 10.1016/j.jenvman.2014.05.013; Jax K, 2013, ECOL ECON, V93, P260, DOI 10.1016/j.ecolecon.2013.06.008; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Justus J, 2009, TRENDS ECOL EVOL, V24, P187, DOI 10.1016/j.tree.2008.11.011; Kareiva P, 2003, AM SCI, V91, P344, DOI 10.1511/2003.26.869; Kareiva P, 2007, SCI AM, V297, P50, DOI 10.1038/scientificamerican1007-50; Kijazi MH, 2010, FOREST POLICY ECON, V12, P357, DOI 10.1016/j.forpol.2010.02.007; Likert R, 1932, ARCH PSYCHOL, V22, P3; Lockwood M, 1999, ENVIRON VALUE, V8, P381, DOI 10.3197/096327199129341888; Lockwood M., 2005, Australasian Journal of Environmental Management, V12, P8; Luckert M., 2002, UNCOVERING HIDDEN HA; Maio G.R., 2003, HDB SOCIAL PSYCHOL, P283, DOI DOI 10.1007/0-387-36921-X_12; Marvier M, 2014, CONSERV BIOL, V28, P1, DOI 10.1111/cobi.12206; Mascia MB, 2003, CONSERV BIOL, V17, P649, DOI 10.1046/j.1523-1739.2003.01738.x; Meijaard E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073008; Michalski F, 2007, CONSERV BIOL, V21, P1626, DOI 10.1111/j.1523-1739.2007.00797.x; Miller JR, 2005, TRENDS ECOL EVOL, V20, P430, DOI 10.1016/j.tree.2005.05.013; Milner-Gulland EJ, 2003, TRENDS ECOL EVOL, V18, P351, DOI 10.1016/S0169-5347(03)00123-X; Nepstad DC, 2006, CONSERV BIOL, V20, P1595, DOI 10.1111/j.1523-1739.2006.00510.x; Nesheim I, 2006, HUM ECOL, V34, P99, DOI 10.1007/s10745-005-9004-y; Olson JM, 2005, HANDBOOK OF ATTITUDES, P223; Oppenheim A. N., 1992, QUESTIONNAIRE DESIGN; Paletto A, 2013, ENVIRON MANAGE, V51, P414, DOI 10.1007/s00267-012-9974-7; Parry L, 2014, CONSERV LETT, V7, P565, DOI 10.1111/conl.12151; Peres CA, 2007, BIOTROPICA, V39, P304, DOI 10.1111/j.1744-7429.2007.00272.x; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; RAMCILOVIC-SUOMINEN S., 2013, VOLUME, V12, P235, DOI DOI 10.1007/S11842-012-9209-Z; Revelle W., 2014, PSYCH PROCEDURES PER; Reyers B, 2012, BIOSCIENCE, V62, P503, DOI 10.1525/bio.2012.62.5.12; Rokeach M., 1973, NATURE HUMAN VALUES; Schultz PW, 1999, J ENVIRON PSYCHOL, V19, P255; Schultz PW, 2001, J ENVIRON PSYCHOL, V21, P327; SCHWARTZ SH, 1994, J SOC ISSUES, V50, P19, DOI 10.1111/j.1540-4560.1994.tb01196.x; Seymour E, 2010, AUSTRALAS J ENV MAN, V17, P142, DOI 10.1080/14486563.2010.9725261; Soares B, 2014, SCIENCE, V344, P363, DOI 10.1126/science.1246663; STERN PC, 1995, J APPL SOC PSYCHOL, V25, P1611, DOI 10.1111/j.1559-1816.1995.tb02636.x; Tabachnick B. G., 2001, USING MULTIVARIATE S; Tarrant MA, 2002, ENVIRON MANAGE, V30, P692, DOI 10.1007/s00267-002-2722-7; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Tomicevic J, 2010, FOREST POLICY ECON, V12, P157, DOI 10.1016/j.forpol.2009.09.006; Torres PC, 2014, THESIS; Turner WR, 2004, BIOSCIENCE, V54, P585, DOI 10.1641/0006-3568(2004)054[0585:GUATSO]2.0.CO;2; Xu JY, 2006, J ENVIRON MANAGE, V78, P362, DOI 10.1016/j.jenvman.2005.05.003; Zhang WZ, 2014, BIOL CONSERV, V177, P109, DOI 10.1016/j.biocon.2014.06.011; Zuur Alain F., 2009, P1; [No title captured]	81	6	6	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167691	10.1371/journal.pone.0167691	http://dx.doi.org/10.1371/journal.pone.0167691			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27942038	Green Published, Green Submitted, gold			2022-12-27	WOS:000392745600025
J	Tuttolomondo, A; Di Raimondo, D; Bellia, C; Clemente, G; Pecoraro, R; Maida, C; Simonetta, I; Vassallo, V; Di Bona, D; Gulotta, E; Ciaccio, M; Pinto, A				Tuttolomondo, Antonino; Di Raimondo, Domenico; Bellia, Chiara; Clemente, Giuseppe; Pecoraro, Rosaria; Maida, Carlo; Simonetta, Irene; Vassallo, Valerio; Di Bona, Danilo; Gulotta, Eliana; Ciaccio, Marcello; Pinto, Antonio			Immune-Inflammatory and Metabolic Effects of High Dose Furosemide plus Hypertonic Saline Solution (HSS) Treatment in Cirrhotic Subjects with Refractory Ascites	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; CHRONIC LIVER-DISEASE; CHRONIC HEPATITIS-C; NONALCOHOLIC STEATOHEPATITIS; DECOMPENSATED CIRRHOSIS; VIRUS-INFECTION; LEPTIN LEVELS; CYTOKINES; FIBROSIS; RESISTANCE	Introduction Patients with chronic liver diseases are usually thin as a result of hypermetabolism and malnutrition expressed by reduced levels of leptin and impairment of other adyponectins such as visfatin. Aims We evaluated the metabolic and inflammatory effects of intravenous high-dose furosemide plus hypertonic saline solutions (HSS) compared with repeated paracentesis and a standard oral diuretic schedule, in patients with cirrhosis and refractory ascites. Methods 59 consecutive cirrhotic patients with refractory ascites unresponsive to outpatient treatment. Enrolled subjects were randomized to treatment with intravenous infusion of furosemide (125-250mg/bid) plus small volumes of HSS from the first day after admission until 3 days before discharge (Group A, n: 38), or repeated paracentesis from the first day after admission until 3 days before discharge (Group B, n: 21). Plasma levels of ANP, BNP, Leptin, visfatin, IL-1 beta, TNF-a, IL-6 were measured before and after the two type of treatment. Results Subjects in group A were observed to have a significant reduction of serum levels of TNF-alpha, IL-1 beta, IL-6, ANP, BNP, and visfatin, thus regarding primary efficacy endpoints, in Group A vs. Group B we observed higher Delta-TNF-alpha, Delta-IL-1 beta, Delta-IL-6, Delta-ANP, Delta-BNP, Delta-visfatin, Delta-Leptin at discharge. Discussion Our findings underline the possible inflammatory and metabolic effect of saline overload correction in treatment of cirrhosis complications such as refractory ascites, suggesting a possible role of inflammatory and metabolic-nutritional variables as severity markers in these patients.	[Tuttolomondo, Antonino; Di Raimondo, Domenico; Clemente, Giuseppe; Pecoraro, Rosaria; Maida, Carlo; Simonetta, Irene; Vassallo, Valerio; Pinto, Antonio] Univ Palermo, Dipartimento Biomed Med Interna & Specialist DiBi, UOC Med Interna & Stroke Care, I-90133 Palermo, Italy; [Bellia, Chiara; Ciaccio, Marcello] Univ Palermo, Azienda Osped Univ Policlin, Dipartimento Biopatol & Biotecnol Med & Forensi, Sez Biochim Clin,UOC CoreLab, Palermo, Italy; [Bellia, Chiara; Ciaccio, Marcello] Univ Palermo, Azienda Osped Univ Policlin, Dipartimento Biopatol & Biotecnol Med & Forensi, UOC CoreLab,Med Mol Clin, Palermo, Italy; [Di Bona, Danilo] Univ Bari, Dipartimento Emergenze & Trapianti Organo, Sch & Chair Allergol, I-70121 Bari, Italy; [Gulotta, Eliana] Univ Palermo, Policlin Univ Paolo Giaccone, Dipartimento Chirurg Gen & Urgenza, I-90133 Palermo, Italy	University of Palermo; University of Palermo; Policlinico Paolo Giaccone; University of Palermo; Policlinico Paolo Giaccone; Universita degli Studi di Bari Aldo Moro; University of Palermo; Policlinico Paolo Giaccone	Tuttolomondo, A (corresponding author), Univ Palermo, Dipartimento Biomed Med Interna & Specialist DiBi, UOC Med Interna & Stroke Care, I-90133 Palermo, Italy.	bruno.tuttolomondo@unipa.it	Bellia, Chiara/AAO-3725-2020; Simonetta, Irene/HDM-7402-2022; Di Raimondo, Domenico/AAB-2379-2019; Di+Raimondo, Domenico/AFM-3500-2022	Bellia, Chiara/0000-0003-0611-9363; Simonetta, Irene/0000-0003-1574-104X; Di Raimondo, Domenico/0000-0002-4529-3703; Di+Raimondo, Domenico/0000-0002-4529-3703; maida, carlo/0000-0002-4868-9033; Pinto, Antonio/0000-0002-8083-3699				Arroyo V, 1996, HEPATOLOGY, V23, P164, DOI 10.1053/jhep.1996.v23.ajhep0230164; BAC DJ, 1995, LIVER, V15, P265; beda UA, 2010, HEPATOLOGY, V52, P2086, DOI [10.1002/hep.23961, DOI 10.1002/HEP.23961]; Cacciarelli TV, 1996, HEPATOLOGY, V24, P6, DOI 10.1053/jhep.1996.v24.pm0008707283; Choi S, 2005, CURR OPIN GASTROEN, V21, P702, DOI 10.1097/01.mog.0000182863.96421.47; Coombes JD, 2016, BBA-MOL BASIS DIS, V1862, P135, DOI 10.1016/j.bbadis.2015.10.028; Farrell GC, 2014, LIVER INT, V34, P1084, DOI 10.1111/liv.12335; Figueiredo A, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/539412; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Giannini E, 2004, DIGEST DIS SCI, V49, P275, DOI 10.1023/B:DDAS.0000017451.48031.b6; Guglielmi FW, 2005, DIGEST LIVER DIS, V37, P681, DOI 10.1016/j.dld.2005.03.010; Henriksen JH, 2003, GUT, V52, P1511, DOI 10.1136/gut.52.10.1511; Hsu CS, 2015, HEPATOL INT, V9, P231, DOI 10.1007/s12072-015-9616-2; Jovicic N, 2015, PLOS ONE, V28; Kalafateli M, 2015, WORLD J GASTROENTERO, V21, P3020, DOI 10.3748/wjg.v21.i10.3020; Kitaoka S, 2003, HEPATO-GASTROENTEROL, V50, P1569; Li Z, HEPATOLOGY, V42, P880, DOI DOI 10.1002/HEP; Licata G, 2009, ALIMENT PHARM THER, V30, P227, DOI 10.1111/j.1365-2036.2009.04040.x; Missale G, 1997, HEPATOLOGY, V26, P792, DOI 10.1053/jhep.1997.v26.pm0009303515; Phillip V, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-18; Pimenta J, 2010, LIVER INT, V30, P1059, DOI 10.1111/j.1478-3231.2010.02266.x; Polyzos SA, 2015, METABOLISM, V64, P60, DOI 10.1016/j.metabol.2014.10.012; Prieto-Frias C, 2016, EUR J GASTROEN HEPAT, V28, P139, DOI 10.1097/MEG.0000000000000516; PRUIMBOOM WM, 1995, INT J IMMUNOPHARMACO, V17, P375, DOI 10.1016/0192-0561(95)00015-T; RECTOR WG, 1990, GASTROENTEROLOGY, V99, P766, DOI 10.1016/0016-5085(90)90966-5; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Santetti D, 2015, WORLD J GASTROENTERO, V21, P8927, DOI 10.3748/wjg.v21.i29.8927; Schoeller DA, 1997, J CLIN INVEST, V100, P1882, DOI 10.1172/JCI119717; Simsek H, 1996, J INT MED RES, V24, P239, DOI 10.1177/030006059602400302; Tuttolomondo A, 2011, NUTR METAB CARDIOVAS, V21, P372, DOI 10.1016/j.numecd.2009.10.014; Vanni E, 2009, HEPATOLOGY, V50, P697, DOI 10.1002/hep.23031; Wong F, 2001, CLIN SCI, V101, P621, DOI 10.1042/CS20010183; Zekri ARN, 2005, WORLD J GASTROENTERO, V11, P6624, DOI 10.3748/wjg.v11.i42.6624	34	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0165443	10.1371/journal.pone.0165443	http://dx.doi.org/10.1371/journal.pone.0165443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941973	gold, Green Published, Green Submitted			2022-12-27	WOS:000392745600003
J	Bae, K; Cho, GE; Yoon, JM; Kang, SW				Bae, Kunho; Cho, Ga Eun; Yoon, Je Moon; Kang, Se Woong			Optical Coherence Tomographic Features and Prognosis of Pneumatic Displacement for Submacular Hemorrhage	PLoS One			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; POLYPOIDAL CHOROIDAL VASCULOPATHY; ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; SUBRETINAL HEMORRHAGE; INTRAVITREAL INJECTION; NATURAL-HISTORY; EXPANSILE GAS; MANAGEMENT; LESIONS	Purpose To identify prognostic factors, including optical coherence tomographic features, of visual outcome in exudative age-related macular degeneration with submacular hemorrhage treated with pneumatic displacement. Methods This retrospective interventional case series included 37 eyes with exudative age-related macular degeneration and submacular hemorrhage, all of which underwent pneumatic displacement. The best-corrected visual acuity (BCVA) was measured at diagnosis and at 3 and 6 months after treatment. In addition to demographic and funduscopic parameters, tomographic features such as reflectance of the submacular hemorrhage were analyzed with regard to BCVA at 6 months. Results After pneumatic displacement and a subsequent treatment such as laser or anti-vascular endothelial growth factor therapy, the BCVA at 3 and 6 months improved significantly (P < 0.001, respectively). Higher baseline BCVA (P < 0.001), shorter symptom duration (P = 0.007), and younger age (P = 0.014) were significant positive prognostic factors on regression analysis. Among optical coherence tomography characteristics, reflectance of the submacular hemorrhage, the shortest radius of the submacular hemorrhage centered on the fovea, and defects in the ellipsoid zone, and external limiting membrane affected the BCVA at 6 months (P < 0.05). Conclusion A favorable visual outcome was demonstrated after initial pneumatic displacement and subsequent treatment for submacular hemorrhage. The submacular hemorrhages exhibiting lower reflectance on optical coherence tomography and a smaller shortest radius from the foveal center were found to be good candidates for pneumatic displacement.	[Bae, Kunho; Cho, Ga Eun; Yoon, Je Moon; Kang, Se Woong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Kang, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Ophthalmol, Seoul, South Korea.	swkang@skku.edu						Avery RL, 1996, RETINA-J RET VIT DIS, V16, P183, DOI 10.1097/00006982-199616030-00001; BENNETT SR, 1990, AM J OPHTHALMOL, V109, P33, DOI 10.1016/S0002-9394(14)75575-8; Bressler NM, 2004, OPHTHALMOLOGY, V111, P1993, DOI 10.1016/j.ophtha.2004.07.023; Chen CY, 2007, RETINA-J RET VIT DIS, V27, P321, DOI 10.1097/01.iae.0000237586.48231.75; Chen SN, 2003, OPHTHALMOLOGY, V110, P704, DOI 10.1016/S0161-6420(02)01979-6; Fang IM, 2009, EYE, V23, P397, DOI 10.1038/sj.eye.6703017; Fujikawa M, 2013, RETINA-J RET VIT DIS, V33, P1908, DOI 10.1097/IAE.0b013e318287d99d; Hassan AS, 1999, OPHTHALMOLOGY, V106, P1900, DOI 10.1016/S0161-6420(99)90399-8; Hattenbach LO, 2001, OPHTHALMOLOGY, V108, P1485, DOI 10.1016/S0161-6420(01)00648-0; Honda S, 2009, OPHTHALMOLOGICA, V223, P333, DOI 10.1159/000221837; Kamei M, 1996, AM J OPHTHALMOL, V121, P267, DOI 10.1016/S0002-9394(14)70274-0; Kim JH, 2014, OPHTHALMOLOGY, V121, P926, DOI 10.1016/j.ophtha.2013.11.004; Kim JH, 2013, AM J OPHTHALMOL, V156, P974, DOI 10.1016/j.ajo.2013.06.013; Kokame GT, 2000, AM J OPHTHALMOL, V129, P546, DOI 10.1016/S0002-9394(99)00474-2; Krepler K, 2000, RETINA-J RET VIT DIS, V20, P251, DOI 10.1097/00006982-200005000-00004; Mayer WJ, 2013, ACTA OPHTHALMOL, V91, P274, DOI 10.1111/j.1755-3768.2011.02264.x; Meyer CH, 2008, ACTA OPHTHALMOL, V86, P490, DOI 10.1111/j.1600-0420.2007.01125.x; Mizutani T, 2011, GRAEF ARCH CLIN EXP, V249, P1153, DOI 10.1007/s00417-011-1649-1; Ohji M, 1998, ARCH OPHTHALMOL-CHIC, V116, P1326, DOI 10.1001/archopht.116.10.1326; Olivier S, 2004, OPHTHALMOLOGY, V111, P1201, DOI 10.1016/j.ophtha.2003.10.020; Schulze SD, 2002, GRAEF ARCH CLIN EXP, V240, P717, DOI 10.1007/s00417-002-0516-5; Scupola A, 1999, OPHTHALMOLOGICA, V213, P97, DOI 10.1159/000027400; Shin JY, 2015, AM J OPHTHALMOL, V159, P904, DOI 10.1016/j.ajo.2015.01.024; Sho K, 2003, ARCH OPHTHALMOL-CHIC, V121, P1392, DOI 10.1001/archopht.121.10.1392; Yamashiro K, 2012, AM J OPHTHALMOL, V154, P125, DOI 10.1016/j.ajo.2012.01.010	25	6	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168474	10.1371/journal.pone.0168474	http://dx.doi.org/10.1371/journal.pone.0168474			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992524	Green Submitted, Green Published, gold			2022-12-27	WOS:000392842600064
J	Breil, T; Wenning, D; Teufel, U; Hoffmann, GF; Ries, M				Breil, Thomas; Wenning, Daniel; Teufel, Ulrike; Hoffmann, Georg F.; Ries, Markus			An Assessment of Publication Status of Pediatric Liver Transplantation Studies	PLOS ONE			English	Article							HOMOTRANSPLANTATION	Introduction Pediatric liver transplantation is a highly specialized, challenging field. Selective reporting may introduce bias into evidence based clinical decision making, but the precise extent of unpublished data in pediatric liver transplantation is unknown today. We therefore assessed the public availability of completed clinical trials in pediatric liver transplantation. Methods We determined the proportion of published and unpublished preregistered, completed pediatric liver transplantation studies on ClinicalTrials.gov. The major trial and literature databases, i.e., clinicaltrials.gov, Pubmed, and Google Scholar were searched for publications. In addition, principal investigators or sponsors were contacted directly. STROBE criteria were applied for the descriptive analysis. Results Out of N = 33 studies focusing on pediatric liver transplantation registered as completed until March 2014 on clinicaltrials.gov, N = 19 (58%) studies were published until February 2015, whereas N =14 (42%) studies remained unpublished. The unpublished trials contain data from N = 2105 (35%) patients out of a total population of N = 6044 study participants. Median timetopublication, i.e., the period from completion of the trial until public availability of the data was 23 IQR 10 to 28 months. Most pertinent key questions in pediatric liver transplantation, i.e., surgical procedures, immunosuppression, concomitant infections, and graft rejection were addressed in 48% of studies (N = 16/33), half of which were published. Conclusion Half of the clinical trials in pediatric liver transplantation focused on key questions such as surgical procedures, immunosuppression, concomitant infections, and graft rejection. There is still a considerable amount of unpublished studies results in pediatric liver transplantation. Time from study completion to publication was almost twice as long as the 12 months mandatory FDAAA-timeline with a trend towards acceleration over time. The data should serve as a baseline for future progress in the field. More stringent publication of completed trials and materials. and focused multicenter research should be encouraged.	[Breil, Thomas; Wenning, Daniel; Teufel, Ulrike; Hoffmann, Georg F.] Univ Heidelberg Hosp, Ctr Pediat & Adolescent Med, Pediat Gastroenterol & Hepatol, Heidelberg, Germany; [Ries, Markus] Univ Heidelberg Hosp, Ctr Pediat & Adolescent Med, Pediat Neurol & Metab Med, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Ries, M (corresponding author), Univ Heidelberg Hosp, Ctr Pediat & Adolescent Med, Pediat Neurol & Metab Med, Heidelberg, Germany.	markus.ries@uni-heidelberg.de	Ries, Markus/AAE-4934-2020	Ries, Markus/0000-0002-5054-5741				Abramson O, 2000, Clin Liver Dis, V4, P533, DOI 10.1016/S1089-3261(05)70125-2; Anderson ML, 2015, NEW ENGL J MED, V372, P1031, DOI 10.1056/NEJMsa1409364; Choudhary NS, 2013, J CLIN EXP HEPATOL, V3, P150, DOI 10.1016/j.jceh.2013.04.005; Crandall WV, 2012, PEDIATRICS, V129, pE1030, DOI 10.1542/peds.2011-1700; FDAAA, 2007, SEC 801 EXP CLIN TRI; Haddad EM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005161; International Committee of Medical Journal Editors (ICMJE), 2016, REC COND REP ED PUBL; Jones CW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6104; Lampert A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144973; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; STARZL TE, 1979, PEDIATRICS, V63, P825; STARZL TE, 1968, ANN SURG, V168, P392, DOI 10.1097/00000658-196809000-00009; STARZL TE, 1963, SURG GYNECOL OBSTET, V117, P659; Yazigi NA, 2013, PEDIATR GASTROENTERO, V16, P207, DOI 10.5223/pghn.2013.16.4.207	14	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168251	10.1371/journal.pone.0168251	http://dx.doi.org/10.1371/journal.pone.0168251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992485	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600044
J	Ferrario, C; Strepponi, I; Esfahani, K; Charamis, H; Langleben, A; Scarpi, E; Nanni, O; Miller, WH; Panasci, LC				Ferrario, Cristiano; Strepponi, Ivan; Esfahani, Khashayar; Charamis, Helen; Langleben, Adrian; Scarpi, Emanuela; Nanni, Oriana; Miller, Wilson H., Jr.; Panasci, Lawrence C.			Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer	PLOS ONE			English	Article							DOUBLE-BLIND; III TRIAL; PLACEBO; CAPECITABINE; BEVACIZUMAB; PACLITAXEL; EFFICACY; TARGETS; PATHWAY; SAFETY	Background Preclinical models have reported a synergistic interaction between sorafenib and vinorelbine. We investigated the toxicity, efficacy, and pharmacokinetics interaction of this combination as first-line treatment for patients with metastatic breast cancer. Methods Patients were HER2-negative and treated with vinorelbine 30 mg/m(2) IV days 1,8 every 21 plus daily oral sorafenib. In the phase I portion (3+3 design) patients received sorafenib 200 mg BID (cohort 1) or 400 mg BID (cohort 2). In the phase II expansion, 21 more evaluable patients were planned to receive the maximum tolerated dose (MTD). Pharmacokinetic analysis was performed in 6 patients: blood concentrations were compared for each drug in the presence or absence of the other drug. Results In cohort 1, one patient experienced a dose-limiting toxicity (DLT) (grade 3 pancreatitis), requiring the expansion of this cohort to 6 patients, without further documented DLTs. In cohort 2, one patient of six experienced a grade 4 DLT (asymptomatic rise in amylase not requiring drug discontinuation), establishing this dose level as the MTD (sorafenib 400 mg BID). After expansion at the MTD, a total of 27 patients (median age 57) were treated for a median of 8 cycles. One grade 5 febrile neutropenia occurred. With repeated cycles, 52% of patients required at least 1 dose reduction of either drug. One patient experienced a sustained grade 3 fatigue resulting in treatment discontinuation. The response rate was 30%. Median PFS was 5.7 months (95% CI 4.4-7.6), and clinical benefit (absence of disease progression at 6 months) was 48%. PK analysis showed a significant interaction between the two drugs, resulting in a higher Cmax of vinorelbine in the presence of sorafenib. Conclusion The combination of sorafenib and vinorelbine at full doses is feasible but not devoid of toxicity, likely also due to a significant PK interaction.	[Ferrario, Cristiano; Esfahani, Khashayar; Charamis, Helen; Langleben, Adrian; Miller, Wilson H., Jr.; Panasci, Lawrence C.] McGill Univ, Dept Med Oncol, Montreal, PQ, Canada; [Strepponi, Ivan] Sede Secondaria Cell Therapeut, Dept Cell Therapeut, Bresso, Italy; [Scarpi, Emanuela; Nanni, Oriana] Ist Sci Romagnolo Studio Cura Tumori, Dept Stat, Rome, Italy	McGill University; IRCCS Meldola (IRST)	Ferrario, C; Esfahani, K (corresponding author), McGill Univ, Dept Med Oncol, Montreal, PQ, Canada.	cristianoferrario@gmail.com; Khashayar.esfahani@mail.mcgill.ca	Scarpi, Emanuela/AAD-7036-2019; nanni, oriana/K-3240-2016	Scarpi, Emanuela/0000-0001-7230-9267; nanni, oriana/0000-0001-7338-2896	Bayer Pharmaceutical [12661]	Bayer Pharmaceutical	The study is funded by Bayer Pharmaceutical (Grant number 12661; https://www.bayer.ca.). The funder provided support in the form of research materials for author LP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Baselga J, 2012, J CLIN ONCOL, V30, P1484, DOI 10.1200/JCO.2011.36.7771; Bianchi G, 2009, ANTI-CANCER DRUG, V20, P616, DOI 10.1097/CAD.0b013e32832b2ea0; Brufsky AM, 2011, J CLIN ONCOL, V29, P4286, DOI 10.1200/JCO.2010.34.1255; Carter CA, 2007, CANCER CHEMOTH PHARM, V59, P183, DOI 10.1007/s00280-006-0257-y; Gradishar WJ, 2013, EUR J CANCER, V49, P312, DOI 10.1016/j.ejca.2012.08.005; Hilger RA, 2002, ONKOLOGIE, V25, P511, DOI 10.1159/000068621; Luu T, 2014, CLIN BREAST CANCER, V14, P94, DOI 10.1016/j.clbc.2013.10.013; Mano M, 2006, CANCER TREAT REV, V32, P106, DOI 10.1016/j.ctrv.2005.12.008; Mariani G, 2011, EUR J CANCER, V47, P10, DOI 10.1016/S0959-8049(11)70116-2; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Moreno-Aspitia A, 2009, J CLIN ONCOL, V27, P11, DOI 10.1200/JCO.2007.15.5242; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Rossari JR, 2012, J ONCOL, V2012, DOI 10.1155/2012/417673; Schwartzberg LS, 2013, CLIN CANCER RES, V19, P2745, DOI 10.1158/1078-0432.CCR-12-3177; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443	17	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167906	10.1371/journal.pone.0167906	http://dx.doi.org/10.1371/journal.pone.0167906			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992451	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600024
J	Jia, PL; Zhang, LH; Chen, JJ; Zhao, PJ; Zhang, MM				Jia, Pengli; Zhang, Longhao; Chen, Jingjing; Zhao, Pujing; Zhang, Mingming			The Effects of Clinical Decision Support Systems on Medication Safety: An Overview	PLOS ONE			English	Article							PHYSICIAN ORDER ENTRY; ADVERSE DRUG EVENTS; PATIENT OUTCOMES; PRIMARY-CARE; INTERVENTIONS; MANAGEMENT; IMPACT; ERRORS; PERFORMANCE; REMINDERS	Background The clinical decision support system(CDSS) has potential to improving medication safety. However, the effects of the intervention were conflicting and uncertain. Meanwhile, the reporting and methodological quality of this field were unknown. Objective The aim of this overview is to evaluate the effects of CDSS on medication safety and to examine the methodological and reporting quality. Methods PubMed, Embase and Cochrane Library were searched to August 2015. Systematic reviews (SRs) investigating the effects of CDSS on medication safety were included. Outcomes were determined in advance and assessed separately for process of care and patient outcomes. The methodological quality was assessed by Assessment of Multiple Systematic Reviews (AMSTAR) and the reporting quality was examined by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Results Twenty systematic reviews, consisting of 237 unique randomized controlled trials(RCTs) and 176 non-RCTs were included. Evidence that CDSS significantly impacted process of care was found in 108 out of 143 unique studies of the 16 SRs examining this effect (75%). Only 18 out of 90 unique studies of the 13 SRs reported significantly evidence that CDSS positively impacted patient outcomes (20%). Ratings for the overall scores of AMSTAR resulted in a mean score of 8.3 with a range of scores from 7.5 to 10.5. The reporting quality was varied. Some contents were particularly strong. However, some contents were poor. Conclusions CDSS reduces medication error by obviously improving process of care and inconsistently improving patient outcomes. Larger samples and longer-term studies are required to ensure more reliable evidence base on the effects of CDSS on patient outcomes. The methodological and reporting quality were varied and some realms need to be improved.	[Jia, Pengli; Zhang, Longhao; Zhao, Pujing; Zhang, Mingming] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Peoples R China; [Chen, Jingjing] Zhejiang Chinese Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Hangzhou, Zhejiang, Peoples R China	Sichuan University; Zhejiang Chinese Medical University	Zhang, MM (corresponding author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Peoples R China.	mingming-zhang@163.com			National Natural Science Foundation [70973083]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation NO. 70973083.	Alldred DP, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009095.pub2; Bates DW, 2003, NEW ENGL J MED, V348, P2526, DOI 10.1056/NEJMsa020847; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bayoumi I, 2014, INT J MED INFORM, V83, P406, DOI 10.1016/j.ijmedinf.2014.03.003; Bennett JW, 2003, MED J AUSTRALIA, V178, P217, DOI 10.5694/j.1326-5377.2003.tb05166.x; Berner ES, 2009, CLIN DECISION SUPPOR; Brahma DK, 2013, J PHARMACOL PHARMACO, V4, P91, DOI 10.4103/0976-500X.110872; Chiang SJ, 2010, CLIN DECISION SUPPOR; FERYLEMONNIER E, 1995, INTENS CARE MED, V21, P356, DOI 10.1007/BF01705416; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Ge L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085908; Gillaizeau F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002894.pub3; Haynes RB, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-12; Hemens BJ, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-89; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Jaspers MWM, 2011, J AM MED INFORM ASSN, V18, P327, DOI 10.1136/amiajnl-2011-000094; JOHNSTON ME, 1994, ANN INTERN MED, V120, P135, DOI 10.7326/0003-4819-120-2-199401150-00007; Julie B, 2012, COCHRANE DB SYST REV; Kaushal R, 2003, ARCH INTERN MED, V163, P1409, DOI 10.1001/archinte.163.12.1409; Keers RN, 2014, DRUG SAFETY, V37, P317, DOI 10.1007/s40264-014-0152-0; Kuperman GJ, 2007, J AM MED INFORM ASSN, V14, P29, DOI 10.1197/jamia.M2170; Lainer M, 2013, INT J QUAL HEALTH C, V25, P590, DOI 10.1093/intqhc/mzt043; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Lees KR, 2003, QJM-INT J MED, V96, P143, DOI 10.1093/qjmed/hcg019; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Loganathan M, 2011, AGE AGEING, V40, P150, DOI 10.1093/ageing/afq161; Manias E, 2012, BRIT J CLIN PHARMACO, V74, P411, DOI 10.1111/j.1365-2125.2012.04220.x; Montesi G, 2009, BRIT J CLIN PHARMACO, V67, P651, DOI 10.1111/j.1365-2125.2009.03422.x; Nieuwlaat R, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-90; Papageorgiou SN, 2014, EUR J ORTHODONT, V36, P74, DOI 10.1093/ejo/cjt008; Pearson Sallie-Anne, 2009, BMC Health Serv Res, V9, P154, DOI 10.1186/1472-6963-9-154; Robertson Jane, 2010, Int J Pharm Pract, V18, P69; Sahota N, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-91; Sandars J, 2003, FAM PRACT, V20, P231, DOI 10.1093/fampra/cmg301; Schedlbauer A, 2009, J AM MED INFORM ASSN, V16, P531, DOI 10.1197/jamia.M2910; Seo HJ, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-129; Sequeira-Byron P, 2011, J APPL ORAL SCI, V19, P440, DOI 10.1590/S1678-77572011000500002; Shamliyan TA, 2008, HEALTH SERV RES, V43, P32, DOI 10.1111/j.1475-6773.2007.00751.x; Shea BJ, 2007, BMC MED RES METHODOL, V15, P7, DOI [10.1186/1471-2288-7-10, DOI 10.1186/1471-2288-7-10]; Shojania Kaveh G, 2009, Cochrane Database Syst Rev, pCD001096, DOI 10.1002/14651858.CD001096.pub2; Tawadrous D, 2011, AM J KIDNEY DIS, V58, P903, DOI 10.1053/j.ajkd.2011.07.022; Teich JM, 2005, J AM MED INFORM ASSN, V12, P365, DOI 10.1197/jamia.M1822; Vervloet M, 2012, J AM MED INFORM ASSN, V19, P696, DOI 10.1136/amiajnl-2011-000748; Walton R, 1999, BRIT MED J, V318, P984, DOI 10.1136/bmj.318.7189.984; Wolfstadt JI, 2008, J GEN INTERN MED, V23, P451, DOI 10.1007/s11606-008-0504-5	46	38	39	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167683	10.1371/journal.pone.0167683	http://dx.doi.org/10.1371/journal.pone.0167683			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977697	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400028
J	Park, SY; Kim, HY; Park, HJ; Shin, HK; Hong, KW; Kim, CD				Park, So Youn; Kim, Hae Young; Park, Hee Jeong; Shin, Hwa Kyoung; Hong, Ki Whan; Kim, Chi Dae			Concurrent Treatment with Taxifolin and Cilostazol on the Lowering of beta-Amyloid Accumulation and Neurotoxicity via the Suppression of P-JAK2/P-STAT3/NF-kappa B/BACE1 Signaling Pathways	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; TRANSCRIPTION FACTOR; ADHESION MOLECULES; TERMINAL FRAGMENT; ENDOTHELIAL-CELLS; A-BETA; EXPRESSION	Taxifolin is a potent flavonoid that exerts anti-oxidative effect, and cilostazol increases intracellular cAMP levels by inhibiting phosphodiesterase 3 that shows antiinflammatory actions. BACE1 (beta-site APP cleaving enzyme 1) is the rate-limiting enzyme responsible for the beta-cleavage of amyloid precursor proteins to A beta peptides. In this study, endogenous A beta and C99 accumulation was explored in N2a Swe cells exposed to 1% FBS medium. Increased A beta and C99 levels were significantly attenuated by taxifolin alone and in combination with cilostazol. Increased phosphorylated JAK2 at Tyr1007/1008 (P-JAK), phosphorylated STAT3 at Tyr 705 (P-STAT3) expressions and increased expressions of BACE1 mRNA and protein in the activated N2a Swe cells were significantly attenuated by taxifolin (10 similar to 50 mu M), cilostazol (10 similar to 50 mu M) alone and in combination at minimum concentrations. In these cells, decreased cytosol I kappa B alpha expression was elevated, and increased nuclear NF-kappa B p65 level and nuclear NF-kappa B p65 DNA binding activity were significantly reduced by taxifolin and cilostazol in a similar manner. Following STAT3 gene (similar to 70% reduction) knockdown in N2a cells, A beta-induced nuclear NF-kappa B and BACE1 expressions were not observed. Taxifolin, cilostazol, or resveratrol significantly stimulated SIRT1 protein expression. In SIRT1 gene-silenced (similar to 50%) N2a cells, taxifolin, cilostazol, and resveratrol all failed to suppress A beta(1-42)-stimulated P-STAT3 and BACE1 expression. Consequently, taxifolin and cilostazol were found to significantly decrease lipopolysaccharide (1-10 mu g/ml)-induced iNOS and COX-2 expressions, and nitrite production in cultured BV-2 microglia cells and to increase N2a cell viability. In conclusion, taxifolin and cilostazol strongly inhibited amyloidogenesis in a synergistic manner by suppressing P-JAK2/P-STAT3-coupled NF kappa.B-linked BACE1 expression via the upregulation of SIRT1.	[Park, So Youn; Kim, Chi Dae] Pusan Natl Univ, Sch Med, Dept Pharmacol, Gyeongsangnam Do, South Korea; [Park, So Youn; Kim, Hae Young; Park, Hee Jeong; Hong, Ki Whan; Kim, Chi Dae] Pusan Natl Univ, Gene & Cell Therapy Res Ctr Vessel Associated Dis, Gyeongsangnam Do, South Korea; [Shin, Hwa Kyoung] Pusan Natl Univ, Div Meridian & Struct Med, Gyeongsangnam Do, South Korea	Pusan National University; Pusan National University; Pusan National University	Kim, CD (corresponding author), Pusan Natl Univ, Sch Med, Dept Pharmacol, Gyeongsangnam Do, South Korea.; Kim, CD (corresponding author), Pusan Natl Univ, Gene & Cell Therapy Res Ctr Vessel Associated Dis, Gyeongsangnam Do, South Korea.	chidkim@pusan.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2016R1A2B2011509, NRF-2016R1C1B2007691]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2016R1A2B2011509 and NRF-2016R1C1B2007691).	Anekonda TS, 2006, J NEUROCHEM, V96, P305, DOI 10.1111/j.1471-4159.2005.03492.x; Bauer MKA, 1997, EUR J BIOCHEM, V243, P726, DOI 10.1111/j.1432-1033.1997.00726.x; Buggia-Prevot V, 2008, J BIOL CHEM, V283, P10037, DOI 10.1074/jbc.M706579200; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chittezhath M, 2008, MOL CANCER THER, V7, P1817, DOI 10.1158/1535-7163.MCT-08-0256; Cho HJ, 2009, BIOCHEM BIOPH RES CO, V386, P175, DOI 10.1016/j.bbrc.2009.06.006; Choi SH, 2009, TRENDS PHARMACOL SCI, V30, P174, DOI 10.1016/j.tips.2009.01.002; Ferrer I, 1998, NEUROPATH APPL NEURO, V24, P271; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Fusco S, 2012, P NATL ACAD SCI USA, V109, P621, DOI 10.1073/pnas.1109237109; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Julien C, 2009, J NEUROPATH EXP NEUR, V68, P48, DOI 10.1097/NEN.0b013e3181922348; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kim YM, 1997, BIOCHEM BIOPH RES CO, V236, P655, DOI 10.1006/bbrc.1997.7031; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Lee HR, 2014, J NEUROSCI RES, V92, P1581, DOI 10.1002/jnr.23421; Lee HR, 2014, J NEUROSCI RES, V92, P206, DOI 10.1002/jnr.23310; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Maezawa I, 2004, J NEUROCHEM, V91, P1312, DOI 10.1111/j.1471-4159.2004.02818.x; ONeill LAJ, 1997, TRENDS NEUROSCI, V20, P252, DOI 10.1016/S0166-2236(96)01035-1; Paris D, 2007, NEUROSCI LETT, V415, P11, DOI 10.1016/j.neulet.2006.12.029; Park SY, 2006, J PHARMACOL EXP THER, V317, P1238, DOI 10.1124/jpet.105.098509; Park SH, 2011, BIOCHEM BIOPH RES CO, V408, P602, DOI 10.1016/j.bbrc.2011.04.068; Park SY, 2005, J PHARMACOL EXP THER, V312, P1241, DOI 10.1124/jpet.104.077826; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Sastre M, 2006, INT J DEV NEUROSCI, V24, P167, DOI 10.1016/j.ijdevneu.2005.11.014; Shimmyo Y, 2008, NEUROREPORT, V19, P1329, DOI 10.1097/WNR.0b013e32830b8ae1; Stockley JH, 2006, FEBS LETT, V580, P6550, DOI 10.1016/j.febslet.2006.10.076; Valerio A, 2006, EUR J NEUROSCI, V23, P1711, DOI 10.1111/j.1460-9568.2006.04722.x; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang YH, 2006, J BIOMED SCI, V13, P127, DOI 10.1007/s11373-005-9031-0; Weidmann AE, 2012, EUR J PHARMACOL, V684, P19, DOI 10.1016/j.ejphar.2012.03.035; Yeo SJ, 2003, J BIOL CHEM, V278, P40590, DOI 10.1074/jbc.M306280200; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	42	18	19	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168286	10.1371/journal.pone.0168286	http://dx.doi.org/10.1371/journal.pone.0168286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977755	Green Published, gold			2022-12-27	WOS:000391217400088
J	Phillips, AN; Cambiano, V; Nakagawa, F; Bansi-Matharu, L; Sow, PS; Ehrenkranz, P; Ford, D; Mugurungi, O; Apollo, T; Murungu, J; Bangsberg, DR; Revill, P				Phillips, Andrew N.; Cambiano, Valentina; Nakagawa, Fumiyo; Bansi-Matharu, Loveleen; Sow, Papa Salif; Ehrenkranz, Peter; Ford, Deborah; Mugurungi, Owen; Apollo, Tsitsi; Murungu, Joseph; Bangsberg, David R.; Revill, Paul			Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; MIDDLE-INCOME COUNTRIES; DRUG-RESISTANCE; VIROLOGICAL FAILURE; SOUTH-AFRICA; VIRAL LOAD; HIV CARE; COHORT; PATTERNS; PEOPLE	Background Interventions based around objective measurement of adherence to antiretroviral drugs for HIV have potential to improve adherence and to enable differentiation of care such that clinical visits are reduced in those with high adherence. It would be useful to understand the approximate upper limit of cost that could be considered for such interventions of a given effectiveness in order to be cost effective. Such information can guide whether to implement an intervention in the light of a trial showing a certain effectiveness and cost. Methods An individual-based model, calibrated to Zimbabwe, which incorporates effects of adherence and resistance to antiretroviral therapy, was used to model the potential impact of adherence monitoring-based interventions on viral suppression, death rates, disability adjusted life years and costs. Potential component effects of the intervention were: enhanced average adherence when on ART, reduced risk of ART discontinuation, and reduced risk of resistance acquisition. We considered a situation in which viral load monitoring is not available and one in which it is. In the former case, it was assumed that care would be differentiated based on the adherence level, with fewer clinic visits in those demonstrated to have high adherence. In the latter case, care was assumed to be primarily differentiated according to viral load level. The maximum intervention cost required to be cost effective was calculated based on a cost effectiveness threshold of $500 per DALY averted. Findings In the absence of viral load monitoring, an adherence monitoring-based intervention which results in a durable 6% increase in the proportion of ART experienced people with viral load < 1000 cps/mL was cost effective if it cost up to $ 50 per person-year on ART, mainly driven by the cost savings of differentiation of care. In the presence of viral load monitoring availability, an intervention with a similar effect on viral load suppression was cost-effective when costing $23-$32 per year, depending on whether the adherence intervention is used to reduce the level of need for viral load measurement. Conclusion The cost thresholds identified suggest that there is clear scope for adherence monitoring-based interventions to provide net population health gain, with potential cost-effective use in situations where viral load monitoring is or is not available. Our results guide the implementation of future adherence monitoring interventions found in randomized trials to have health benefit.	[Phillips, Andrew N.; Cambiano, Valentina; Nakagawa, Fumiyo; Bansi-Matharu, Loveleen] UCL, Res Dept Infect & Populat Hlth, London, England; [Sow, Papa Salif; Ehrenkranz, Peter] Bill & Melinda Gates Fdn, Seattle, WA USA; [Ford, Deborah] UCL, Inst Clin Trials & Methodol, London, England; [Mugurungi, Owen; Apollo, Tsitsi; Murungu, Joseph] Minist Hlth Child Care, Harare, Zimbabwe; [Bangsberg, David R.] Portland State Univ, Oregon Hlth Sci Univ, Sch Publ Hlth, Portland, OR 97207 USA; [Revill, Paul] Univ York, Ctr Hlth Econ, York, N Yorkshire, England	University of London; University College London; Bill & Melinda Gates Foundation; University of London; University College London; Oregon Health & Science University; Portland State University; University of York - UK	Phillips, AN (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	andrew.phillips@ucl.ac.uk	Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807; Revill, Paul/0000-0001-8632-0600	Bill & Melinda Gates Foundation [42889]; Medical Research Council [MC_UU_12023/23] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Bill & Melinda Gates Foundation, Investment ID 42889. PSS and PE from the Foundation determined the overall study question in collaboration with the other authors. PSS and PE from the Foundation encouraged manuscript submission but this was the final decision of AP with all the authors.	Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Bangsberg DR, 2006, AIDS, V20, P223, DOI 10.1097/01.aids.0000199825.34241.49; Bangsberg DR, 2004, J ANTIMICROB CHEMOTH, V53, P696, DOI 10.1093/jac/dkh162; Blaschke TF, 2012, ANNU REV PHARMACOL, V52, P275, DOI 10.1146/annurev-pharmtox-011711-113247; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Cambiano V, 2014, AIDS, V28, pS15, DOI 10.1097/QAD.0000000000000082; Cambiano V, 2010, AIDS, V24, P1153, DOI 10.1097/QAD.0b013e32833847af; Campbell JI, 2015, CURR HIV-AIDS REP, V12, P523, DOI 10.1007/s11904-015-0282-8; Carrieri P, 2001, J ACQ IMMUN DEF SYND, V28, P232, DOI 10.1097/00042560-200111010-00005; Chaiyachati KH, 2014, AIDS, V28, pS187, DOI 10.1097/QAD.0000000000000252; Chi BH, 2009, INT J EPIDEMIOL, V38, P746, DOI 10.1093/ije/dyp004; Claxton K, 2010, 54 U YORK CTR HLTH E, P54; Daniels MJ, 1997, STAT MED, V16, P1965, DOI 10.1002/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.3.CO;2-D; Demonceau J, 2013, DRUGS, V73, P545, DOI 10.1007/s40265-013-0041-3; Duncombe C, 2015, TROP MED INT HEALTH, V20, P430, DOI 10.1111/tmi.12460; El-Khatib Z, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-88; Fox MP, 2012, JAIDS-J ACQ IMM DEF, V60, P428, DOI 10.1097/QAI.0b013e3182557785; Genberg BL, 2012, AIDS, V26, P1415, DOI 10.1097/QAD.0b013e328354bed6; Glass TR, 2010, JAIDS-J ACQ IMM DEF, V54, P197, DOI 10.1097/QAI.0b013e3181ca48bf; Grund B for the SMART Study Group, 2006, 16 INT AIDS C AUG 13; Haberer JE, 2016, 11 INT C HIV TREAT P; Haberer JE, 2013, AIDS, V27, P2166, DOI 10.1097/QAD.0b013e328363b53f; Hamers RL, 2011, LANCET INFECT DIS, V11, P750, DOI 10.1016/S1473-3099(11)70149-9; Hassan AS, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-9; Hoffmann CJ, 2014, TROP MED INT HEALTH, V19, P236, DOI 10.1111/tmi.12237; Hoffmann CJ, 2009, CLIN INFECT DIS, V49, P1928, DOI 10.1086/648444; Hoffmann CJ, 2013, TROP MED INT HLTH; Hyle EP, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001725; Johannessen A, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-108; Kessler J, 2015, VALUE HEALTH, V18, P946, DOI 10.1016/j.jval.2015.09.2940; Kleeberger CA, 2004, AIDS, V18, P683, DOI 10.1097/00002030-200403050-00013; Kobin AB, 2011, ANN PHARMACOTHER, V45, P372, DOI 10.1345/aph.1P587; Kranzer K, 2011, TROP MED INT HEALTH, V16, P1297, DOI 10.1111/j.1365-3156.2011.02828.x; Kranzer K, 2010, JAIDS-J ACQ IMM DEF, V55, pE17, DOI 10.1097/QAI.0b013e3181f275fd; Lazo M, 2007, CLIN INFECT DIS, V45, P1377, DOI 10.1086/522762; Levine AJ, 2005, AIDS BEHAV, V9, P355, DOI 10.1007/s10461-005-9009-y; Li JZ, 2014, AIDS, V28, P181, DOI 10.1097/QAD.0000000000000123; Mackie NE, 2010, J INFECT DIS, V201, P1303, DOI 10.1086/651618; Mannheimer S, 2002, CLIN INFECT DIS, V34, P1115, DOI 10.1086/339074; Mathes T, 2013, INT J TECHNOL ASSESS, V29, P227, DOI 10.1017/S0266462313000317; Meresse M, 2014, HIVMED; MSF Access Campaign, 2014, UNT WEB ANT PRIC RED; Nakagawa F, 2012, AIDS, V26, P335, DOI 10.1097/QAD.0b013e32834dcec9; Orrell C, 2007, ANTIVIR THER, V12, P83; Orrell C, 2015, JAIDS-J ACQ IMM DEF, V70, P495, DOI 10.1097/QAI.0000000000000770; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pellowski JA, 2012, CURR HIV-AIDS REP, V9, P326, DOI 10.1007/s11904-012-0133-9; Petersen ML, 2007, CLIN INFECT DIS, V45, P908, DOI 10.1086/521250; Phillips AN, 1997, AIDS, V11, P169, DOI 10.1097/00002030-199702000-00006; Phillips A, 2015, NATURE, V528, pS68, DOI 10.1038/nature16046; Phillips AN, 2011, AIDS, V25, P843, DOI 10.1097/QAD.0b013e328344037a; Roberts T, 2016, CLIN INFECT DIS; Rosenblum M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007196; Rutstein SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124748; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Siapka M, 2014, B WORLD HEALTH ORGAN, V92, P499, DOI 10.2471/BLT.13.127639; Tagar E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108304; Tassie JM, 2010, JAIDS-J ACQ IMM DEF, V54, P437, DOI 10.1097/QAI.0b013e3181d73e1b; Tran D.-X. T., 2014, BIOMEDICAL RES THERA, V1, P1, DOI DOI 10.1039/C4P00104D; Usitalo A, 2014, AIDS CARE, V26, P107, DOI 10.1080/09540121.2013.802280; von Wyl V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077691; Wandeler G, 2012, JAIDS-J ACQ IMM DEF, V59, pE9, DOI 10.1097/QAI.0b013e31823edb6a; Ware NC, 2016, AIDS, V30, P1287, DOI 10.1097/QAD.0000000000001035; Woods E, COUNTRY LEVEL COST E	64	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167654	10.1371/journal.pone.0167654	http://dx.doi.org/10.1371/journal.pone.0167654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977702	Green Published, Green Accepted, gold			2022-12-27	WOS:000391217400025
J	Yan, ZM; Liu, XS; Liu, Y; Han, Y; Lin, M; Wang, WM; Guan, XB; Zhu, SR; Zhang, HD; Wang, QT; Chou, LH; Zhu, XH; Hua, H				Yan, Zhimin; Liu, Xiaosong; Liu, Yang; Han, Ying; Lin, Mei; Wang, Wenmei; Guan, Xiaobing; Zhu, Shengrong; Zhang, Handong; Wang, Qintao; Chou, Lihong; Zhu, Xinghao; Hua, Hong			The Efficacy and Safety of Miconazole Nitrate Mucoadhesive Tablets versus Itraconazole Capsules in the Treatment of Oral Candidiasis: An Open-Label, Randomized, Multicenter Trial	PLOS ONE			English	Article							OROPHARYNGEAL CANDIDIASIS; BUCCAL TABLET; PREVENTION; GUIDELINES; RESISTANCE; BLIND; GEL	Background Oral candidiasis (OC) is a common oral fungal infection. Recently, miconazole mucoadhesive tablets have been gaining attention for OC treatment. Despite trials in patients with human immunodeficiency virus and cancer, evidence of its application in the large-scale, general population with OC is lacking. This study aimed to evaluate the efficacy and safety of miconazole nitrate mucoadhesive tablets in comparison with itraconazole capsules for OC treatment. Methods The study was a randomized, open-label, parallel-armed, multicenter clinical trial. Totally, 343 patients diagnosed with OC, who met the inclusion criteria, were randomly assigned to either a treatment group that received miconazole nitrate mucoadhesive tablets (10 mg) once daily or a control group that received itraconazole capsules (100 mg QD) for 2 weeks, and were followed up for 2 weeks. The clinical cure, improvement of clinical symptoms/signs, mycologic cure, and safety were evaluated. Results The mucoadhesive tablets (n = 171) did not show inferiority to itraconazole (n = 172) in the treatment of OC. At the end of the 14-day treatment, the clinical cure rates were 45.29% and 41.76% in the miconazole and itraconazole groups, respectively (P = 0.3472). At the end of the 14-day follow-up, the clinical cure rates were 51.18% and 41.76% in the miconazole and itraconazole groups, respectively (P = 0.0329). Adverse events occurred in 53 subjects (33 in the miconazole group and 20 in the itraconazole group). There was no statistical difference in the safety profile between miconazole and itraconazole (P = 0.0533). Thrombocytopenic purpura, although rare, occurred in one patient in the miconazole group and was considered a drug-related, severe adverse event. Conclusion Miconazole nitrate mucoadhesive tablets may be as effective as systemic itraconazole capsule for OC treatment. Physicians should be cautious about thrombocytopenic purpura occurring as a rare and serious adverse event of miconazole nitrate.	[Yan, Zhimin; Liu, Xiaosong; Liu, Yang; Han, Ying; Hua, Hong] Peking Univ, Sch & Hosp Stomatol, Dept Oral Med, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China; [Lin, Mei] Sichuan Univ, West China Sch Stomatol, Dept Oral Med, Chengdu, Peoples R China; [Wang, Wenmei] Nanjing Univ, Sch Med, Dept Oral Med, Inst & Hosp Dent, Nanjing, Jiangsu, Peoples R China; [Guan, Xiaobing] Capital Med Univ, Beijing Stomatol Hosp, Dept Periodont & Oral Med, Beijing, Peoples R China; [Zhu, Shengrong] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Stomatol, Tongji Med Coll, Wuhan, Peoples R China; [Zhang, Handong] Huazhong Univ Sci & Technol, Union Hosp, Dept Stomatol, Tongji Med Coll, Wuhan, Peoples R China; [Wang, Qintao] Fourth Mil Med Univ, Sch Stomatol, Dept Periodontol, Xian, Peoples R China; [Chou, Lihong] China Med Univ, Hosp Stomatol, Shenyang, Peoples R China; [Zhu, Xinghao] Wenzhou Med Univ, Affiliated Hosp 1, Dept Stomatol, Wenzhou, Peoples R China	Peking University; Sichuan University; Nanjing University; Capital Medical University; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Air Force Military Medical University; China Medical University; Wenzhou Medical University	Hua, H (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Oral Med, Natl Engn Lab Digital & Mat Technol Stomatol, Beijing, Peoples R China.; Lin, M (corresponding author), Sichuan Univ, West China Sch Stomatol, Dept Oral Med, Chengdu, Peoples R China.	linmei2k@163.com; honghua68@hotmail.com						Bensadoun RJ, 2008, CANCER, V112, P204, DOI 10.1002/cncr.23152; BOUCKAERT S, 1992, EUR J CLIN PHARMACOL, V43, P137, DOI 10.1007/BF01740659; Cardot JM, 2004, BRIT J CLIN PHARMACO, V58, P345, DOI 10.1111/j.1365-2125.2004.02154.x; Fothergill Annette W, 2006, Expert Rev Anti Infect Ther, V4, P171, DOI 10.1586/14787210.4.2.171; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hoepelman IM, 1996, INT J ANTIMICROB AG, V6, P155, DOI 10.1016/0924-8579(95)00050-X; [华红 Hua Hong], 2004, [中国新药与临床杂志, Chinese Journal of New Drugs and Clinical Remedies], V23, P335; KF S DG A D M Group C, 2010, OPEN MED, V8, P18, DOI DOI 10.7326/0003-4819-152-11-201006010-00232; Kulak-Ozkan Y, 2002, J ORAL REHABIL, V29, P300, DOI 10.1046/j.1365-2842.2002.00816.x; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pappas PG, 2004, CLIN INFECT DIS, V38, P161, DOI 10.1086/380796; Patton LL, 2001, ORAL SURG ORAL MED O, V92, P170, DOI 10.1067/moe.2001.116600; Prentice AG, 2005, J ANTIMICROB CHEMOTH, V56, P17; Quatresooz P, 2008, EXPERT OPIN PHARMACO, V9, P1927, DOI [10.1517/14656566.9.11.1927, 10.1517/14656566.9.11.1927 ]; Ruhnke M, 2000, J ANTIMICROB CHEMOTH, V46, P291, DOI 10.1093/jac/46.2.291; Samaranayake L P, 1988, Dent Update, V15, P227; Van Roey J, 2004, JAIDS-J ACQ IMM DEF, V35, P144, DOI 10.1097/00126334-200402010-00007; Vazquez JA, 2010, HIV CLIN TRIALS, V11, P186, DOI 10.1310/hct1104-186	19	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167880	10.1371/journal.pone.0167880	http://dx.doi.org/10.1371/journal.pone.0167880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977721	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400039
J	Hussain, MM; Rahman, MM; Asiri, AM				Hussain, Mohammad M.; Rahman, Mohammed M.; Asiri, Abdullah M.			Efficient 2-Nitrophenol Chemical Sensor Development Based on Ce2O3 Nanoparticles Decorated CNT Nanocomposites for Environmental Safety	PLOS ONE			English	Article							COPPER-OXIDE NANOCRYSTALS; ELECTROCHEMICAL DETECTION; SILVER NANOPARTICLES; CATALYTIC-REDUCTION; 4-NITROPHENOL; ZNO; TEMPERATURE; OXIDATION; POLYMER; PRECIPITATION	Ce2O3 nanoparticle decorated CNT nanocomposites (Ce2O3. CNT NCs) were prepared by a wet-chemical method in basic medium. The Ce2O3. CNT NCs were examined using FTIR, UV/Vis, Field-Emission Scanning Electron Microscopy (FESEM), X-ray electron dispersive spectroscopy (XEDS), X-ray photoelectron spectroscopy (XPS), and powder X-ray diffraction (XRD). A selective 2-nitrophenol (2-NP) sensor was developed by fabricating a thinlayer of NCs onto a flat glassy carbon electrode (GCE, surface area = 0.0316 cm 2). Higher sensitivity including linear dynamic range (LDR), long-term stability, and enhanced electrochemical performances towards 2-NP were achieved by a reliable current-voltage (I-V) method. The calibration curve was found linear (R-2 = 0.9030) over a wide range of 2-NP concentration (100 pM similar to 100.0 mM). Limit of detection (LOD) and sensor sensitivity were calculated based on noise to signal ratio (similar to 3N/S) as 60 +/- 0.02 pM and 1.6x10(-3) mu A mu M-1 cm(-2) respectively. The Ce2O3. CNT NCs synthesized by a wet-chemical process is an excellent way of establishing nanomaterial decorated carbon materials for chemical sensor development in favor of detecting hazardous compounds in health-care and environmental fields at broad-scales. Finally, the efficiency of the proposed chemical sensors can be applied and utilized in effectively for the selective detection of toxic 2-NP component in environmental real samples with acceptable and reasonable results.	[Hussain, Mohammad M.; Rahman, Mohammed M.; Asiri, Abdullah M.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia; [Hussain, Mohammad M.; Rahman, Mohammed M.; Asiri, Abdullah M.] King Abdulaziz Univ, Ctr Excellence Adv Mat Res CEAMR, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Rahman, MM (corresponding author), King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah, Saudi Arabia.; Rahman, MM (corresponding author), King Abdulaziz Univ, Ctr Excellence Adv Mat Res CEAMR, Jeddah, Saudi Arabia.	mmrahman@kau.edu.sa	Hussain, Mohammad Musarraf/P-9590-2016; Rahman, Mohammed M./H-5823-2012; Asiri, Abdullah M./C-3458-2009	Hussain, Mohammad Musarraf/0000-0001-9270-0474; Rahman, Mohammed M./0000-0003-2773-1244; Asiri, Abdullah M./0000-0001-7905-3209				Ahmad M, 2015, J RARE EARTH, V33, P255, DOI 10.1016/S1002-0721(14)60412-9; Ahmad T, 2015, J MOL STRUCT, V1084, P9, DOI 10.1016/j.molstruc.2014.12.015; Ammar S., 2007, J ENV ENG MANAGE, V17, P89; Aoul A. T, 2012, PHYS CHEM CHEM PHYS, V14, P4463, DOI [10.1039/c2cp24069f, DOI 10.1039/C2CP24069F]; Baneshi J, 2014, CERAM INT, V40, P14177, DOI 10.1016/j.ceramint.2014.06.005; Barton LE, 2015, ENVIRON POLLUT, V203, P122, DOI 10.1016/j.envpol.2015.03.035; Cretu V, 2016, J MATER CHEM A, V4, P6527, DOI 10.1039/c6ta01355d; Dahle JT, 2015, CHEMOSPHERE, V119, P1365, DOI 10.1016/j.chemosphere.2014.02.027; Dos Santos ML, 2008, MATER LETT, V62, P4509, DOI 10.1016/j.matlet.2008.08.011; Duan XY, 2014, J TAIWAN INST CHEM E, V45, P2975, DOI 10.1016/j.jtice.2014.08.031; Faisal M, 2011, APPL SURF SCI, V258, P672, DOI 10.1016/j.apsusc.2011.07.067; Faisal M, 2011, CHEM ENG J, V173, P178, DOI 10.1016/j.cej.2011.07.067; Fang JH, 2008, J RARE EARTH, V26, P153, DOI 10.1016/S1002-0721(08)60056-3; Fang J, 2011, DALTON T, V40, P3122, DOI 10.1039/c0dt01651a; Gao YX, 2015, CATAL SCI TECHNOL, V5, P1568, DOI 10.1039/c4cy01220h; Han WL, 2014, COLLOID SURFACE A, V460, P422, DOI 10.1016/j.colsurfa.2014.03.017; Holken I, 2016, ACS APPL MATER INTER, V8, P20491, DOI 10.1021/acsami.6b06387; Hu T, 2007, CHINESE J CATAL, V28, P844, DOI 10.1016/S1872-2067(07)60069-2; Huang DS, 2015, NEW J CHEM, V39, P4685, DOI 10.1039/c5nj00673b; Hussain M. M., 2016, J ENV SCI; Hussain MM, 2016, RSC ADV, V6, P80511, DOI 10.1039/c6ra12256f; Isichei T. O., 2014, Environment and Pollution, V3, P99; Keyvanloo K, 2012, APPL CATAL A-GEN, V417, P53, DOI 10.1016/j.apcata.2011.12.024; Khan SB, 2014, J TAIWAN INST CHEM E, V45, P2770, DOI 10.1016/j.jtice.2014.07.005; Khan SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085290; Khan SB, 2012, INT J ELECTROCHEM SC, V7, P10965; Lee BN, 2002, WATER ENVIRON RES, V74, P28, DOI 10.2175/106143002X139721; Li JH, 2012, J HAZARD MATER, V201, P250, DOI 10.1016/j.jhazmat.2011.11.076; Li L, 2011, INT J HYDROGEN ENERG, V36, P8839, DOI 10.1016/j.ijhydene.2011.04.137; Liu JX, 2010, ANAL CHEM, V82, P7380, DOI 10.1021/ac101510b; Liu XY, 2010, B KOREAN CHEM SOC, V31, P1182, DOI 10.5012/bkcs.2010.31.5.1182; Lu WY, 2015, MATER LETT, V154, P33, DOI 10.1016/j.matlet.2015.04.051; Lupan O., J MAT CHEM; Lupan O, 2016, SENSOR ACTUAT B-CHEM, V224, P434, DOI 10.1016/j.snb.2015.10.042; Nistor C, 2001, ANAL CHIM ACTA, V426, P185, DOI 10.1016/S0003-2670(00)00825-4; Ogi T, 2012, CHEM ENG J, V210, P461, DOI 10.1016/j.cej.2012.09.033; Pawar RC, 2010, SENSOR ACTUAT B-CHEM, V151, P212, DOI 10.1016/j.snb.2010.09.019; Pedrosa VD, 2003, J BRAZIL CHEM SOC, V14, P530, DOI 10.1590/S0103-50532003000400007; Periyat P, 2011, RSC ADV, V1, P1794, DOI 10.1039/c1ra00524c; Rahman MM, 2016, RSC ADV, V6, P65338, DOI 10.1039/c6ra11582a; Rahman MM, 2015, RSC ADV, V5, P63252, DOI 10.1039/c5ra08224b; Rahman MM, 2013, ELECTROCHIM ACTA, V112, P422, DOI 10.1016/j.electacta.2013.08.164; Rahman MM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-60; Rajendran R, 2014, J MATER CHEM A, V2, P18480, DOI 10.1039/c4ta03996c; Rajgure AV, 2014, CERAM INT, V40, P5837, DOI 10.1016/j.ceramint.2013.11.025; Ribeiro RS, 2013, APPL CATAL B-ENVIRON, V140, P356, DOI 10.1016/j.apcatb.2013.04.031; Sarycheva AS, 2014, MATER LETT, V121, P66, DOI 10.1016/j.matlet.2014.01.101; Scandurra G, 2014, SENSORS-BASEL, V14, P8926, DOI 10.3390/s140508926; Shaari N, 2012, J RARE EARTH, V30, P651, DOI 10.1016/S1002-0721(12)60107-0; Shin HJ, 2011, SYNTHETIC MET, V161, P1284, DOI 10.1016/j.synthmet.2011.04.024; Vilian ATE, 2015, ANAL METHODS-UK, V7, P5627, DOI [10.1039/C5AY01005E, 10.1039/c5ay01005e]; Wang CC, 2007, SENSOR ACTUAT B-CHEM, V122, P591, DOI 10.1016/j.snb.2006.07.003; Wang F, 2009, MICROCHIM ACTA, V165, P1, DOI 10.1007/s00604-009-0136-4; Wang YZ, 2014, APPL SURF SCI, V292, P608, DOI 10.1016/j.apsusc.2013.12.017; Wu H, 2015, CATAL SCI TECHNOL, V5, P1888, DOI 10.1039/c4cy01158a; Xu JQ, 2008, SENSOR ACTUAT B-CHEM, V132, P334, DOI 10.1016/j.snb.2008.01.062; Zhang DS, 2013, RSC ADV, V3, P8811, DOI 10.1039/c3ra41400k; Zhang Y, 2015, PHYS CHEM CHEM PHYS, V17, P14656, DOI 10.1039/c5cp00373c; Zhao XH, 2015, RSC ADV, V5, P49534, DOI 10.1039/c5ra07821k; Zhou W, 2015, RSC ADV, V5, P50505, DOI 10.1039/c5ra04647e; Zhu ZK, 2014, J HAZARD MATER, V279, P436, DOI 10.1016/j.jhazmat.2014.07.030	61	46	46	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166265	10.1371/journal.pone.0166265	http://dx.doi.org/10.1371/journal.pone.0166265			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973600	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300009
J	Lafoux, A; Baudry, C; Bonhomme, C; Le Ruyet, P; Huchet, C				Lafoux, Aude; Baudry, Charlotte; Bonhomme, Cecile; Le Ruyet, Pascale; Huchet, Corinne			Soluble Milk Protein Supplementation with Moderate Physical Activity Improves Locomotion Function in Aging Rats	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; FRAIL ELDERLY-PEOPLE; SKELETAL-MUSCLE MASS; DOUBLE-BLIND; RESISTANCE EXERCISE; AMINO-ACIDS; FOOD-INTAKE; STRENGTH; SARCOPENIA; HEALTH	Aging is associated with a loss of muscle mass and functional capacity. Present study was designed to compare the impact of specific dairy proteins on muscular function with or without a low-intensity physical activity program on a treadmill in an aged rat model. We investigated the effects of nutritional supplementation, five days a week over a 2-month period with a slow digestible protein, casein or fast digestible proteins, whey or soluble milk protein, on strength and locomotor parameters in sedentary or active aged Wistar RjHan rats (17-19 months of age). An extensive gait analysis was performed before and after protein supplementation. After two months of protein administration and activity program, muscle force was evaluated using a grip test, spontaneous activity using an openfield and muscular mass by specific muscle sampling. When aged rats were supplemented with proteins without exercise, only minor effects of different diets on muscle mass and locomotion were observed: higher muscle mass in the casein group and improvement of stride frequencies with soluble milk protein. By contrast, supplementation with soluble milk protein just after physical activity was more effective at improving overall skeletal muscle function in old rats compared to casein. For active old rats supplemented with soluble milk protein, an increase in locomotor activity in the open field and an enhancement of static and dynamic gait parameters compared to active groups supplemented with casein or whey were observed without any differences in muscle mass and forelimb strength. These results suggest that consumption of soluble milk protein as a bolus immediately after a low intensity physical activity may be a suitable nutritional intervention to prevent decline in locomotion in aged rats and strengthen the interest to analyze the longitudinal aspect of locomotion in aged rodents.	[Lafoux, Aude; Huchet, Corinne] Univ Nantes, INSERM Inst Thorax U1087, Therassay, Nantes, France; [Baudry, Charlotte; Le Ruyet, Pascale] LACTALIS Rech & Dev, Retiers, France; [Bonhomme, Cecile] LACTALIS Nutr Sante, Torce, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Lafoux, A (corresponding author), Univ Nantes, INSERM Inst Thorax U1087, Therassay, Nantes, France.	aude.lafoux@univ-nantes.fr			Lactalis	Lactalis	This study was supported by Lactalis. The funder had a role in study design (discussion and agreement) and correction of the manuscript. Aude Lafoux and Corinne Huchet have nothing to declare. Charlotte Baudry, Cecile Bonhomme and Pascale Le Ruyet are employed by Lactalis company.	Abourachid A, 2003, CR BIOL, V326, P625, DOI 10.1016/S1631-0691(03)00170-7; Babault N, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-36; Bauer J, 2013, J AM MED DIR ASSOC, V14, P542, DOI 10.1016/j.jamda.2013.05.021; Bauer JM, 2008, J AM MED DIR ASSOC, V9, P545, DOI 10.1016/j.jamda.2008.04.010; Bauer JM, 2015, J AM MED DIR ASSOC, V16, P740, DOI 10.1016/j.jamda.2015.05.021; Beasley JM, 2013, J AM GERIATR SOC, V61, P1863, DOI 10.1111/jgs.12503; Binder EF, 2002, J AM GERIATR SOC, V50, P1921, DOI 10.1046/j.1532-5415.2002.50601.x; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; CAMPBELL WW, 1995, AM J PHYSIOL-ENDOC M, V268, pE1143, DOI 10.1152/ajpendo.1995.268.6.E1143; Clark BC, 2008, J GERONTOL A-BIOL, V63, P829, DOI 10.1093/gerona/63.8.829; Dangin M, 2003, J PHYSIOL-LONDON, V549, P635, DOI 10.1113/jphysiol.2002.036897; Dangin M, 2001, AM J PHYSIOL-ENDOC M, V280, pE340, DOI 10.1152/ajpendo.2001.280.2.E340; De Luca A., 2008, USE GRIP STRENGTH ME; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Dreyer HC, 2005, J AM COLL NUTR, V24, p140S, DOI 10.1080/07315724.2005.10719455; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5, DOI 10.1093/gerona/50A.Special_Issue.5; FIATARONE MA, 1994, NEW ENGL J MED, V330, P1769, DOI 10.1056/NEJM199406233302501; FIATARONE MA, 1993, J GERONTOL, V48, P77, DOI 10.1093/geronj/48.Special_Issue.77; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Gryson C, 2014, J AM MED DIR ASS; HILDEBRAND M, 1977, J MAMMAL, V58, P131, DOI 10.2307/1379571; Hildebrand M., 1966, Folia Biotheoretica, VNo. 6, P9; Holm L, 2006, J ORTHOP RES, V24, P2114, DOI 10.1002/jor.20147; Holm L, 2008, J APPL PHYSIOL, V105, P274, DOI 10.1152/japplphysiol.00935.2007; Houston DK, 2008, AM J CLIN NUTR, V87, P150, DOI 10.1093/ajcn/87.1.150; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Janssen I, 2011, CLIN GERIATR MED, V27, P355, DOI 10.1016/j.cger.2011.03.004; Kalapotharakos VI, 2004, J AGING PHYS ACTIV, V12, P131, DOI 10.1123/japa.12.2.131; Kanneboyinna N, 2008, BEHAV LOCOMOTOR MEAS; Karelis AD, 2015, J NUTR HEALTH AGING, V19, P531, DOI 10.1007/s12603-015-0442-y; Kukuljan S, 2009, J APPL PHYSIOL, V107, P1864, DOI 10.1152/japplphysiol.00392.2009; Mikkelsen UR, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0758-3; Miyazaki Y, 2014, MOL NUTR FOOD RES, V58, P2046, DOI 10.1002/mnfr.201400100; Morley JE, 2008, J NUTR HEALTH AGING, V12, P452, DOI 10.1007/BF02982705; Morley JE, 2001, J LAB CLIN MED, V137, P231, DOI 10.1067/mlc.2001.113504; Morley JE, 2010, J AM MED DIR ASSOC, V11, P391, DOI 10.1016/j.jamda.2010.04.014; Mosoni L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109098; Newman AB, 2003, J AM GERIATR SOC, V51, P323, DOI 10.1046/j.1532-5415.2003.51105.x; O'Connell K, 2008, EXP GERONTOL, V43, P958, DOI 10.1016/j.exger.2008.07.006; Raj IS, 2010, EXP GERONTOL, V45, P81, DOI 10.1016/j.exger.2009.10.013; Rieu I, 2007, NUTRITION, V23, P323, DOI 10.1016/j.nut.2006.12.013; Rolland YM, 2007, J GERONTOL A-BIOL, V62, P330, DOI 10.1093/gerona/62.3.330; Roth S M, 2000, J Nutr Health Aging, V4, P143; Roubenoff R, 2001, JAMA-J AM MED ASSOC, V286, P1230, DOI 10.1001/jama.286.10.1230; SCHLETTW.D, 1970, GERONTOLOGY, V16, P111, DOI 10.1159/000211762; Scott D, 2010, J AM GERIATR SOC, V58, P2129, DOI 10.1111/j.1532-5415.2010.03147.x; Shephard RJ, 2013, J AM GERIATR SOC, V61, P1887, DOI 10.1111/jgs.12505; Szulc P, 2004, AM J CLIN NUTR, V80, P496, DOI 10.1093/ajcn/80.2.496; Tieland M, 2012, J AM MED DIR ASSOC, V13, P720, DOI 10.1016/j.jamda.2012.07.005; Tieland M, 2012, J AM MED DIR ASSOC, V13, P713, DOI 10.1016/j.jamda.2012.05.020; Verdijk LB, 2009, AM J CLIN NUTR, V89, P608, DOI 10.3945/ajcn.2008.26626; Vidal K, 2014, EUR J NUTR, V53, P963, DOI 10.1007/s00394-013-0600-0; Volek JS, 2013, J AM COLL NUTR, V32, P122, DOI 10.1080/07315724.2013.793580; Walker DK, 2011, MED SCI SPORT EXER, V43, P2249, DOI 10.1249/MSS.0b013e318223b037; Welle S, 1998, AM J PHYSIOL-ENDOC M, V274, pE677, DOI 10.1152/ajpendo.1998.274.4.E677; Zhu K, 2015, J NUTR, V145, P2520, DOI 10.3945/jn.115.218297	56	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167707	10.1371/journal.pone.0167707	http://dx.doi.org/10.1371/journal.pone.0167707			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973615	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300041
J	An, RP; Xiang, XL; Yang, Y; Yan, H				An, Ruopeng; Xiang, Xiaoling; Yang, Yan; Yan, Hai			Mapping the Prevalence of Physical Inactivity in US States, 1984-2015	PLOS ONE			English	Article							OBESITY; TRENDS; INTERVENTIONS	Background Physical inactivity is a leading cause of morbidity, disability and premature mortality in the U.S. and worldwide. This study aimed to map the prevalence of physical inactivity across U.S. states over the past three decades, and estimate the over-time adjusted changes in the prevalence of physical inactivity in each state. Methods Individual-level data (N = 6,701,954) were taken from the 1984-2015 Behavioral Risk Factor Surveillance System (BRFSS), an annually repeated cross-sectional survey of state-representative adult population. Prevalence of self-reported leisure-time physical inactivity was estimated by state and survey year, accounting for the BRFSS sampling design. Logistic regressions were performed to estimate the changes in the prevalence of physical inactivity over the study period for each state, adjusting for individual characteristics including sex, age, race/ethnicity, education, marital status, and employment status. Results The prevalence of leisure-time physical inactivity varied substantially across states and survey years. In general, the adjusted prevalence of physical inactivity gradually declined over the past three decades in a majority of states. However, a substantial proportion of American adults remain physically inactive. Among the 50 states and District of Columbia, 45 had over a fifth of their adult population without any leisure-time physical activity, and 8 had over 30% without physical activity in 2015. Moreover, the adjusted prevalence of physical inactivity in several states (Arizona, North Carolina, North Dakota, Utah, West Virginia, and Wyoming) remained largely unchanged or even increased (Minnesota and Ohio) over the study period. Conclusions Although the prevalence of physical inactivity declined over the past three decades in a majority of states, the rates remain substantially high and vary considerably across states. Closely monitoring and tracking physical activity level using the state physical activity maps can help guide policy and program development to promote physical activity and reduce the burden of chronic disease.	[An, Ruopeng; Yang, Yan; Yan, Hai] Univ Illinois, Coll Appl Hlth Sci, Dept Kinesiol & Community Hlth, Champaign, IL 61801 USA; [Xiang, Xiaoling] Northwestern Univ, Feinburg Sch Med, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Feinberg School of Medicine	An, RP (corresponding author), Univ Illinois, Coll Appl Hlth Sci, Dept Kinesiol & Community Hlth, Champaign, IL 61801 USA.	ran5@illinois.edu	Yan, Hai/I-5585-2019	An, Ruopeng/0000-0001-9632-0209; Xiang, Xiaoling/0000-0002-4926-4707	University of Illinois at Urbana-Champaign Campus Research Board [RB15126, RB15204]	University of Illinois at Urbana-Champaign Campus Research Board	This work was supported in part by grants from University of Illinois at Urbana-Champaign Campus Research Board (https://crb.research.illinois.edu/) (Grant No. RB15126 and No. RB15204). There was no additional external funding received for this study.	Abioye AI, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/0778-7367-71-20; Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; [Anonymous], 2001, MMWR Recomm Rep, V50, P1, DOI 10.1103/PhysRevE.106.055304; Artinian NT, 2010, CIRCULATION, V122, P406, DOI 10.1161/CIR.0b013e3181e8edf1; Buehler James W, 2004, MMWR Recomm Rep, V53, P1; Carlson SA, 2010, AM J PREV MED, V39, P305, DOI 10.1016/j.amepre.2010.06.006; Carlson SA, 2009, J PHYS ACT HEALTH, V6, pS18, DOI 10.1123/jpah.6.s1.s18; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P991; Centers for Disease Control and Prevention, 2014, AB BRFSS; Centers for Disease Control and Prevention, 2011, DAT US GUID BRFSS PH; Centers for Disease Control and Prevention, 2015, BEH RISK FACT SURV S; Chalabaev A, 2013, PSYCHOL SPORT EXERC, V14, P136, DOI 10.1016/j.psychsport.2012.10.005; Dhalwani NN, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0330-9; Dwyer-Lindgren L, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-7; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Harris CD, 2013, MMWR-MORBID MORTAL W, V62, P326; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Macassa G., 2016, International Journal of Medical Science and Public Health, V5, P102; Moore LV, 2012, RES Q EXERCISE SPORT, V83, P587; Pettee KK, 2006, MED SCI SPORT EXER, V38, P541, DOI 10.1249/01.mss.0000191346.95244.f7; Riebe D, 2009, J AGING HEALTH, V21, P1159, DOI 10.1177/0898264309350076; Saffer H, 2013, J HUM CAPITAL, V7, P378, DOI 10.1086/671200; Sallis JF, 2012, CIRCULATION, V125, P729, DOI 10.1161/CIRCULATIONAHA.110.969022; Soler RE, 2010, AM J PREV MED, V38, pS292, DOI 10.1016/j.amepre.2009.10.028; Strohacker K, 2014, ANN BEHAV MED, V48, P92, DOI 10.1007/s12160-013-9577-4; Sun F, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-449; Thacker Stephen B, 2012, MMWR Suppl, V61, P3; Tuso Phillip, 2015, Perm J, V19, P84, DOI 10.7812/TPP/14-242; United States Government Accountability Office, 2004, EM INF DIS REV STAT; Ward ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150735; Williams G, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003926; Zimmerman EWS, 2014, UNDERSTANDING RELATI	32	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168175	10.1371/journal.pone.0168175	http://dx.doi.org/10.1371/journal.pone.0168175			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	27959906	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900046
J	Clark, SD; Nabity, MB; Cianciolo, RE; Dufek, B; Cosgrove, D				Clark, Sabrina D.; Nabity, Mary B.; Cianciolo, Rachel E.; Dufek, Brianna; Cosgrove, Dominic			X-Linked Alport Dogs Demonstrate Mesangial Filopodial Invasion of the Capillary Tuft as an Early Event in Glomerular Damage	PLOS ONE			English	Article							BASEMENT-MEMBRANE NEPHROPATHY; CHRONIC KIDNEY-DISEASE; LARGE ANIMAL-MODELS; MOUSE MODEL; HEREDITARY NEPHRITIS; RENAL-DISEASE; IV COLLAGEN; KNOCKOUT; CANINE; MICE	Background X-linked Alport syndrome (XLAS), caused by mutations in the type IV collagen COL4A5 gene, accounts for approximately 80% of human Alport syndrome. Dogs with XLAS have a similar clinical progression. Prior studies in autosomal recessive Alport mice demonstrated early mesangial cell invasion as the source of laminin 211 in the glomerular basement membrane (GBM), leading to proinflammatory signaling. The objective of this study was to verify this process in XLAS dogs. Methods XLAS dogs and WT littermates were monitored with serial clinicopathologic data and kidney biopsies. Biopsies were obtained at set milestones defined by the onset of microalbuminuria (MA), overt proteinuria, onset of azotemia, moderate azotemia, and euthanasia. Kidney biopsies were analyzed by histopathology, immunohistochemistry, and electron microscopy. Results XLAS dogs showed progressive decrease in renal function and progressive increase in interstitial fibrosis and glomerulosclerosis (based on light microscopy and immunostaining for fibronectin). The only identifiable structural abnormality at the time of microalbuminuria was ultrastructural evidence of mild segmental GBM multilamination, which was more extensive when overt proteinuria developed. Co-localization studies showed that mesangial laminin 211 and integrin alpha 8 beta 1 accumulated in the GBM at the onset of overt proteinuria and coincided with ultrastructural evidence of mild cellular interpositioning, consistent with invasion of the capillary loops by mesangial cell processes. Conclusion In a large animal model, the induction of mesangial filopodial invasion of the glomerular capillary loop leading to the irregular deposition of laminin 211 is an early initiating event in Alport glomerular pathology.	[Clark, Sabrina D.; Nabity, Mary B.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Cianciolo, Rachel E.] Ohio State Univ, Dept Vet Biosci, Columbus, OH 43210 USA; [Dufek, Brianna; Cosgrove, Dominic] Boys Town Natl Res Hosp, Ctr Basic Res, Omaha, NE 68131 USA	Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; Boys Town National Research Hospital	Clark, SD (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA.	svobornik@cvm.tamu.edu		Clark, Sabrina/0000-0002-6431-4776	IDEXX Laboratories, Inc.; Morris Animal Foundation [D14CA-904]	IDEXX Laboratories, Inc.; Morris Animal Foundation	Funding support for the clinicopathological data was provided by IDEXX Laboratories, Inc. Fellowship funding for Dr. Clark in part is provided by Morris Animal Foundation (Grant ID# D14CA-904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2007, J AM SOC NEPHROL, V18, P2465, DOI 10.1681/ASN.2007030328; Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; Casal M, 2006, EUR J HUM GENET, V14, P266, DOI 10.1038/sj.ejhg.5201535; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Cosgrove D, 2000, AM J PATHOL, V157, P1649, DOI 10.1016/S0002-9440(10)64802-X; Cosgrove D, 2012, PEDIATR NEPHROL, V27, P885, DOI 10.1007/s00467-011-1868-z; Cox ML, 2003, MAMM GENOME, V14, P396, DOI 10.1007/s00335-002-2253-9; Dehoux JP, 2007, FRONT BIOSCI-LANDMRK, V12, P4864, DOI 10.2741/2434; Delimont D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099083; Dufek B, 2016, KIDNEY INT; Gunwar S, 1998, J BIOL CHEM, V273, P8767, DOI 10.1074/jbc.273.15.8767; Hartner A, 1999, KIDNEY INT, V56, P1468, DOI 10.1046/j.1523-1755.1999.00662.x; HOFFSTEN PE, 1975, J LAB CLIN MED, V86, P920; Hohenester E, 2013, CELL ADHES MIGR, V7, P56, DOI 10.4161/cam.21831; JANSEN B, 1984, AM J PATHOL, V116, P175; Kashtan CE, 1999, MEDICINE, V78, P338, DOI 10.1097/00005792-199909000-00005; Kashtan CE, 2002, NEPHROL DIAL TRANSPL, V17, P1359, DOI 10.1093/ndt/17.8.1359; Kashtan CE, 2001, J AM SOC NEPHROL, V12, P252, DOI 10.1681/ASN.V122252; Kashtan CE., 2002, CURR DIAGN PATHOL, V8, P349; Kashtan CE, 2013, PEDIATR NEPHROL, V28, P5, DOI 10.1007/s00467-012-2138-4; Korstanje R, 2014, KIDNEY INT, V85, P1461, DOI 10.1038/ki.2013.493; Lees GE, 1999, AM J VET RES, V60, P373; Lu W, 1999, GENOMICS, V61, P113, DOI 10.1006/geno.1999.5943; Meehan DT, 2009, KIDNEY INT, V76, P968, DOI 10.1038/ki.2009.324; Miner JH, 2012, EXP CELL RES, V318, P973, DOI 10.1016/j.yexcr.2012.02.031; Miner JH, 1998, CURR OPIN NEPHROL HY, V7, P13; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; Nabity MB, 2015, J VET INTERN MED, V29, P1036, DOI 10.1111/jvim.12835; Nabity MB, 2012, J VET INTERN MED, V26, P282, DOI 10.1111/j.1939-1676.2012.00891.x; Noone D, 2013, PEDIATR NEPHROL, V28, P1025, DOI 10.1007/s00467-012-2272-z; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Randles MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35068; Rao VH, 2006, AM J PATHOL, V169, P32, DOI 10.2353/ajpath.2006.050896; Rao VH, 2003, KIDNEY INT, V63, P1736, DOI 10.1046/j.1523-1755.2003.00939.x; Rheault MN, 2004, J AM SOC NEPHROL, V15, P1466, DOI 10.1097/01.ASN.0000130562.90255.8F; Sachs N, 2012, J CLIN INVEST, V122, P348, DOI 10.1172/JCI58878; SAKAI T, 1987, ANAT EMBRYOL, V176, P373; Savige J, 2013, J AM SOC NEPHROL, V24, P364, DOI 10.1681/ASN.2012020148; Shearin AL, 2010, DIS MODEL MECH, V3, P27, DOI 10.1242/dmm.004358; Suh JH, 2013, NAT REV NEPHROL, V9, P470, DOI 10.1038/nrneph.2013.109; Thorner PS, 2007, NEPHRON CLIN PRACT, V106, pC82, DOI 10.1159/000101802; Zallocchi M, 2013, AM J PATHOL, V183, P1269, DOI 10.1016/j.ajpath.2013.06.015; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100	44	8	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168343	10.1371/journal.pone.0168343	http://dx.doi.org/10.1371/journal.pone.0168343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959966	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900059
J	Eichmeier, A; Kominkova, M; Kominek, P; Baranek, M				Eichmeier, Ales; Kominkova, Marcela; Kominek, Petr; Baranek, Miroslav			Comprehensive Virus Detection Using Next Generation Sequencing in Grapevine Vascular Tissues of Plants Obtained from the Wine Regions of Bohemia and Moravia (Czech Republic)	PLOS ONE			English	Article							PINOT-GRIS-VIRUS; PITTING-ASSOCIATED-VIRUS; 1ST REPORT; SMALL RNAS; REVEALS; VARIABILITY; EVOLUTION; INFECTION; DISCOVERY; VARIANTS	Comprehensive next generation sequencing virus detection was used to detect the whole spectrum of viruses and viroids in selected grapevines from the Czech Republic. The novel NGS approach was based on sequencing libraries of small RNA isolated from grapevine vascular tissues. Eight previously partially-characterized grapevines of diverse varieties were selected and subjected to analysis: Chardonnay, Laurot, Guzal Kara, and rootstock Kober 125AA from the Moravia wine-producing region; plus Muller-Thurgau and Pinot Noir from the Bohemia wine-producing region, both in the Czech Republic. Using next generation sequencing of small RNA, the presence of 8 viruses and 2 viroids were detected in a set of eight grapevines; therefore, confirming the high effectiveness of the technique in plant virology and producing results supporting previous data on multiple infected grapevines in Czech vineyards. Among the pathogens detected, the Grapevine rupestris vein feathering virus and Grapevine yellow speckle viroid 1 were recorded in the Czech Republic for the first time.	[Eichmeier, Ales; Baranek, Miroslav] Mendel Univ Brno, Fac Hort, Mendeleum Dept Genet, Lednice, Czech Republic; [Kominkova, Marcela; Kominek, Petr] Crop Res Inst, Ruzyne, Czech Republic	Mendel University in Brno; Czech Crop Research Institute (CRI)	Eichmeier, A (corresponding author), Mendel Univ Brno, Fac Hort, Mendeleum Dept Genet, Lednice, Czech Republic.	ales.eichmeier@mendelu.cz	Eichmeier, Aleš/F-1209-2016; Baránek, Miroslav/E-8371-2016; Kominek, Petr/AAD-1578-2019	Eichmeier, Aleš/0000-0001-7358-3903; Baránek, Miroslav/0000-0002-1583-3588; Kominkova, Marcela/0000-0002-5989-5852; Kominek, Petr/0000-0001-7651-5236	COST [FA1407]; Ministry of Education, Youth and Sports; Ministry of Agriculture	COST(European Cooperation in Science and Technology (COST)); Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	This work was supported by COST FA1407, http://www.cost.eu/COST_Actions/fa/FA1407; Ministry of Education, Youth and Sports, http.//www.msmt.cz/index.php?lang=2; Ministry of Agriculture, http://eagri.cz/public/web/en/mze/ministry/.	Al Rwahnih M, 2009, VIROLOGY, V387, P395, DOI 10.1016/j.virol.2009.02.028; Alabi OJ, 2010, J GEN VIROL, V91, P265, DOI 10.1099/vir.0.014423-0; Andrews S., 2010, FASTQC QUALITY CONTR; Baranek M, 2009, GENET MOL BIOL, V32, P834, DOI 10.1590/S1415-47572009005000079; Beber R., 2013, J PLANT PATHOL, V95, P36; Broeckx BJG, 2015, SCI REP-UK, V5, DOI 10.1038/srep12810; Cepin U, 2010, J VIROL METHODS, V170, P47, DOI 10.1016/j.jviromet.2010.08.018; Cho I. S., 2013, New Disease Reports, V27, P10, DOI 10.5197/j.2044-0588.2013.027.010; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Eichmeier A, 2016, J PLANT PATHOL, V98, P155; Eichmeier A., 2014, International Journal of Virology, V10, P263, DOI 10.3923/ijv.2014.263.271; Giampetruzzi A, 2012, VIRUS RES, V163, P262, DOI 10.1016/j.virusres.2011.10.010; Glasa M, 2015, VIRUS GENES, V51, P112, DOI 10.1007/s11262-015-1201-1; Glasa M, 2014, ARCH VIROL, V159, P2103, DOI 10.1007/s00705-014-2031-5; Glasa M, 2011, J PHYTOPATHOL, V159, P805, DOI 10.1111/j.1439-0434.2011.01845.x; Gola EM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00263; Goszczynski DE, 2003, EUR J PLANT PATHOL, V109, P397, DOI 10.1023/A:1023555018700; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Jones RAC, 2009, VIRUS RES, V141, P113, DOI 10.1016/j.virusres.2008.07.028; Kominek P, 2008, J PLANT PATHOL, V90, P357; Kominek P, 2005, VIRUS GENES, V31, P247, DOI 10.1007/s11262-005-3236-1; Kominek P, 2009, ACTA VIROL, V53, P281, DOI 10.4149/av_2009_04_281; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lu C, 2007, METHODS, V43, P110, DOI 10.1016/j.ymeth.2007.05.002; Mascher M, 2013, PLANT J, V76, P494, DOI 10.1111/tpj.12294; Matousek J, 2003, PLANT SOIL ENVIRON, V49, P168, DOI 10.17221/4109-PSE; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; MINAFRA A, 1994, J VIROL METHODS, V47, P175, DOI 10.1016/0166-0934(94)90076-0; Morelli M, 2014, J PLANT PATHOL, V96, P439; Ong SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049662; Pantaleo V, 2010, VIROLOGY, V408, P49, DOI 10.1016/j.virol.2010.09.001; Plesko IM, 2014, PLANT DIS, V98, P1014, DOI 10.1094/PDIS-11-13-1137-PDN; Sabanadzovic S, 2000, ARCH VIROL, V145, P553, DOI 10.1007/s007050050046; Sahana AB, 2013, PLANT DIS, V97, P1517, DOI 10.1094/PDIS-05-13-0494-PDN; Saldarelli P, 2015, PHYTOPATHOLOGY, V105, P555, DOI 10.1094/PHYTO-09-14-0241-R; Subramanya Sastry K, 2013, SEED BORNE PLANT VIR, P285, DOI DOI 10.1007/978-81-322-0813-6_9; Szychowski JA, 1998, VIROLOGY, V248, P432, DOI 10.1006/viro.1998.9292; Terlizzi F, 2011, ANN APPL BIOL, V159, P478, DOI 10.1111/j.1744-7348.2011.00512.x; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Valenzano DR, 2015, CELL, V163, P1539, DOI 10.1016/j.cell.2015.11.008; Ward LI, 2011, PLANT DIS, V95, P617, DOI 10.1094/PDIS-12-10-0927; Wu QF, 2010, P NATL ACAD SCI USA, V107, P1606, DOI 10.1073/pnas.0911353107; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	45	36	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167966	10.1371/journal.pone.0167966	http://dx.doi.org/10.1371/journal.pone.0167966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959951	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900027
J	Limgala, RP; Ioanou, C; Plassmeyer, M; Ryherd, M; Kozhaya, L; Austin, L; Abidoglu, C; Unutmaz, D; Alpan, O; Goker-Alpan, O				Limgala, Renuka Pudi; Ioanou, Chidima; Plassmeyer, Matthew; Ryherd, Mark; Kozhaya, Lina; Austin, Lauren; Abidoglu, Cem; Unutmaz, Derya; Alpan, Oral; Goker-Alpan, Ozlem			Time of Initiating Enzyme Replacement Therapy Affects Immune Abnormalities and Disease Severity in Patients with Gaucher Disease	PLoS One			English	Article							HUMAN TH17 CELLS; DENDRITIC CELLS; SCORING SYSTEM; MOUSE MODEL; HIV; INFECTION; DIAGNOSIS; MYELOMA; ADULTS; GOALS	Gaucher disease (GD) patients often present with abnormalities in immune response that may be the result of alterations in cellular and/or humoral immunity. However, how the treatment and clinical features of patients impact the perturbation of their immunological status remains unclear. To address this, we assessed the immune profile of 26 GD patients who were part of an enzyme replacement therapy (ERT) study. Patients were evaluated clinically for onset of GD symptoms, duration of therapy and validated outcome measures for ERT. According to DS3 disease severity scoring system criteria, they were assigned to have mild, moderate or severe GD. Flow cytometry based immunophenotyping was performed to analyze subsets of T, B, NK, NKT and dendritic cells. GD patients showed multiple types of immune abnormalities associated to T and B lymphocytes with respect to their subpopulations as well as memory and activation markers. Skewing of CD4 and CD8 T cell numbers resulting in lower CD4/CD8 ratio and an increase in overall T cell activation were observed. A decrease in the overall B cells and an increase in NK and NKT cells were noted in the GD patients compared to controls. These immune alterations do not correlate with GD clinical type or level of biomarkers. However, subjects with persistent immune alterations, especially in B cells and DCs correlate with longer delay in initiation of ERT (Delta TX). Thus, while ERT may reverse some of these immune abnormalities, the immune cell alterations become persistent if therapy is further delayed. These findings have important implications in understanding the immune disruptions before and after treatment of GD patients.	[Limgala, Renuka Pudi; Ioanou, Chidima; Goker-Alpan, Ozlem] Lysosomal & Rare Disorders Res & Treatment Ctr, Fairfax, VA USA; [Limgala, Renuka Pudi; Plassmeyer, Matthew; Ryherd, Mark; Austin, Lauren; Alpan, Oral] O&O Alpan LLC, Amerimmune, Fairfax, VA 22030 USA; [Kozhaya, Lina; Abidoglu, Cem; Unutmaz, Derya] Jackson Lab Genom Med, Farmington, CT USA	Jackson Laboratory	Limgala, RP (corresponding author), Lysosomal & Rare Disorders Res & Treatment Ctr, Fairfax, VA USA.; Limgala, RP (corresponding author), O&O Alpan LLC, Amerimmune, Fairfax, VA 22030 USA.	rlimgala@ldrtc.org		Limgala, Renuka/0000-0001-6957-6284	Amerimmune, O O Alpan, LLC	Amerimmune, O O Alpan, LLC	Amerimmune, O & O Alpan, LLC provided support in the form of salaries to authors [RPL, MP, MR, LA and OA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ayto Robert, 2013, Critical Reviews in Oncogenesis, V18, P247; Baumgarth N, 2000, J IMMUNOL METHODS, V243, P77, DOI 10.1016/S0022-1759(00)00229-5; Bennett LL, 2013, ANN PHARMACOTHER, V47, P1182, DOI 10.1177/1060028013500469; Charrow J, 2015, AM J HEMATOL, V90, pS19, DOI 10.1002/ajh.24056; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Goker-Alpan O, 2010, THER CLIN RISK MANAG, V6, P315; Hemann EA, 2014, IMMUNOL RES, V59, P66, DOI 10.1007/s12026-014-8530-3; Hivroz C, 2012, CRIT REV IMMUNOL, V32, P139, DOI 10.1615/CritRevImmunol.v32.i2.30; Lu W, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20052; Mistry PK, 2009, BRIT J HAEMATOL, V147, P561, DOI 10.1111/j.1365-2141.2009.07872.x; Mistry PK, 2007, AM J HEMATOL, V82, P697, DOI 10.1002/ajh.20908; Mackern-Oberti JP, 2015, AUTOIMMUN REV, V14, P127, DOI 10.1016/j.autrev.2014.10.010; Pandey MK, 2014, MOL GENET METAB, V111, P163, DOI 10.1016/j.ymgme.2013.09.002; Pandey Manoj Kumar, 2013, Critical Reviews in Oncogenesis, V18, P197; Pandey MK, 2012, MOL GENET METAB, V106, P310, DOI 10.1016/j.ymgme.2012.04.020; Pastores GM, 2004, SEMIN HEMATOL, V41, P4, DOI 10.1053/j.seminhematol.2004.07.009; Pavlova EV, 2013, J PATHOL, V231, P88, DOI 10.1002/path.4227; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356; Rawlings SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126917; Rodic P, 2013, BLOOD CELL MOL DIS, V50, P222, DOI 10.1016/j.bcmd.2012.11.012; Serrano-Villar S, 2015, LANCET HIV, V2, pE76, DOI 10.1016/S2352-3018(15)00018-1; Sonder SU, 2016, BLOOD CELL MOL DIS, V59, P8, DOI 10.1016/j.bcmd.2016.02.003; Thomas AS, 2014, BRIT J HAEMATOL, V165, P427, DOI 10.1111/bjh.12804; Weinreb N, 2008, AM J HEMATOL, V83, P890, DOI 10.1002/ajh.21280; Weinreb NJ, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0280-3; Weinreb NJ, 2010, GENET MED, V12, P44, DOI 10.1097/GIM.0b013e3181c39194; Zimran A, 2014, PEDIATR ENDOCR REV P, V12, P82	28	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168135	10.1371/journal.pone.0168135	http://dx.doi.org/10.1371/journal.pone.0168135			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942037	Green Submitted, gold, Green Published			2022-12-27	WOS:000392745600053
J	Ngoi, CN; Price, MA; Fields, B; Bonventure, J; Ochieng, C; Mwashigadi, G; Hassan, AS; Thiong'o, AN; Micheni, M; Mugo, P; Graham, S; Sanders, EJ				Ngoi, Carolyne N.; Price, Matt A.; Fields, Barry; Bonventure, Juma; Ochieng, Caroline; Mwashigadi, Grace; Hassan, Amin S.; Thiong'o, Alexander N.; Micheni, Murugi; Mugo, Peter; Graham, Susan; Sanders, Eduard J.			Dengue and Chikungunya Virus Infections among Young Febrile Adults Evaluated for Acute HIV-1 Infection in Coastal Kenya	PLOS ONE			English	Article							ARBOVIRAL INFECTIONS; SEEKING CARE; RT-PCR; FEVER; MALARIA; TIME; ILLNESS; RISK	Background Fever is common among patients seeking care in sub-Saharan Africa (sSA), but causes other than malaria are rarely diagnosed. We assessed dengue and chikungunya virus infections among young febrile adults evaluated for acute HIV infection (AHI) and malaria in coastal Kenya. Methods We tested plasma samples obtained in a cross-sectional study from febrile adult patients aged 18-35 years evaluated for AHI and malaria at urgent care seeking at seven health facilities in coastal Kenya in 2014-2015. Dengue virus (DENV) and chikungunya virus (CHIKV) were amplified using quantitative real-time reverse-transcription polymerase chain reaction. We conducted logistic regression analyses to determine independent predictors of dengue virus infection. Results 489 samples that were negative for both AHI and malaria were tested, of which 43 (8.8%, 95% confidence interval [CI]: 6.4-11.7) were positive for DENV infection. No participant was positive for CHIKV infection. DENV infections were associated with clinic visits in the rainy season (adjusted odds ratio (AOR) = 3.0, 95% CI: 1.3-6.5) and evaluation at a private health facility (AOR 5.2, 95% CI: 2.0-13.1) or research health facility (AOR = 25.6, 95% CI: 8.9-73.2) instead of a public health facility. Conclusion A high prevalence of DENV infections was found in febrile young adult patients evaluated for AHI. Our data suggests that DENV, along with AHI and malaria, should be considered in the differential diagnosis of the adult patient seeking care for fever in coastal Kenya.	[Ngoi, Carolyne N.; Mwashigadi, Grace; Hassan, Amin S.; Thiong'o, Alexander N.; Micheni, Murugi; Mugo, Peter; Graham, Susan; Sanders, Eduard J.] Kenya Med Res Inst KEMRI, Ctr Geog Med Res Coast, Kilifi, Kenya; [Price, Matt A.] Int AIDS Vaccine Initiat IAVI New York, New York, NY USA; [Price, Matt A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Fields, Barry; Bonventure, Juma] Ctr Dis Control & Prevent CDC, Div Global Hlth Protect, Ctr Global Hlth, Nairobi, Kenya; [Ochieng, Caroline] Kenya Med Res Inst KEMRI CDC, Nairobi, Kenya; [Graham, Susan] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Graham, Susan] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Graham, Susan] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Sanders, Eduard J.] Univ Oxford, Nuffield Dept Med, Headington, England	Kenya Medical Research Institute; International AIDS Vaccine Initiative; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford	Ngoi, CN (corresponding author), Kenya Med Res Inst KEMRI, Ctr Geog Med Res Coast, Kilifi, Kenya.	ngoicarol@gmail.com	Price, Matt/AAK-6881-2021	Price, Matt/0000-0002-2918-1373; Hassan, Amin S./0000-0001-5296-4264	University of California at San Francisco International Traineeships in AIDS Prevention Studies (ITAPS), U.S. National Institutes of Mental Health [R25 MH064712]; Wellcome Trust [077092]; American people through the United States Agency for International Development (USAID); NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER	University of California at San Francisco International Traineeships in AIDS Prevention Studies (ITAPS), U.S. National Institutes of Mental Health; Wellcome Trust(Wellcome TrustEuropean Commission); American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We wish to acknowledge the support from the University of California at San Francisco International Traineeships in AIDS Prevention Studies (ITAPS), U.S. National Institutes of Mental Health R25 MH064712. The KEMRI-Wellcome Trust Research Programme at the Centre for Geographical Medicine Research-Kilifi is supported by core funding from the Wellcome Trust (#077092). This study was made possible in part by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government. This manuscript was submitted for publication with permission from the Director of the Kenya Medical Research Institute (KEMRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkus JE, 2016, J ACQUIR IMMUNE DEFI; Carme B, 2009, EMERG INFECT DIS, V15, P668, DOI 10.3201/eid1504.080891; Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530; Crump JA, 2014, T ROY SOC TROP MED H, V108, P61, DOI 10.1093/trstmh/trt120; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Crump JA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4847; Ellis EM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003733; Garrett NJ, 2016, J ACQUIR IMMUNE DEFI; Grobusch MP, 2006, CLIN MICROBIOL INFEC, V12, P395, DOI 10.1111/j.1469-0691.2006.01353.x; JOHNSON BK, 1982, E AFR MED J, V59, P781; Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005; LaBeaud AD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003436; Lanciotti Robert S, 2003, Adv Virus Res, V61, P67, DOI 10.1016/S0065-3527(03)61002-X; Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371; Mwangangi JM, 2012, PARASITOL RES, V110, P61, DOI 10.1007/s00436-011-2449-6; Ninphanomchai S, 2014, INT J ENV RES PUB HE, V11, P10694, DOI 10.3390/ijerph111010694; Nkoghe D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001517; Prins HAB, 2014, INT HEALTH, V6, P82, DOI 10.1093/inthealth/ihu024; Riswari SF, 2016, J CLIN VIROL, V74, P61, DOI 10.1016/j.jcv.2015.11.017; Sanders EJ, 2015, AIDS, V29, pS221, DOI 10.1097/QAD.0000000000000924; Sanders EJ, 2014, AIDS, V28, P1357, DOI 10.1097/QAD.0000000000000245; Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311; Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203	25	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167508	10.1371/journal.pone.0167508	http://dx.doi.org/10.1371/journal.pone.0167508			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942016	Green Published, Green Submitted, gold			2022-12-27	WOS:000392745600019
J	Tanka-Salamon, A; Komorowicz, E; Szabo, L; Tenekedjiev, K; Kolev, K				Tanka-Salamon, Anna; Komorowicz, Erzsebet; Szabo, Laszlo; Tenekedjiev, Kiril; Kolev, Krasimir			Free Fatty Acids Modulate Thrombin Mediated Fibrin Generation Resulting in Less Stable Clots	PLoS One			English	Article							CRYSTAL-STRUCTURE; COMPLEX; STABILITY; PLASMA; HISTONES; OMEGA-3-FATTY-ACIDS; ENVIRONMENT; INHIBITORS; ARTERIAL; POSITION	Upon platelet activation, free fatty acids are released at the stage of thrombus formation, but their effects on fibrin formation are largely unexplored. Our objective was to characterize the kinetic effects of fatty acids on thrombin activity, as well as the structural and mechanical properties of the resultant fibrin clots. Thrombin activity on fibrinogen was followed by turbidimetry and detailed kinetic characterization was performed using a fluorogenic short peptide substrate. The viscoelastic properties of fibrin were measured with rotatory oscillation rheometer, whereas its structure was analyzed with scanning electron microscopy (SEM). In turbidimetric assays of fibrin generation, oleate and stearate at physiologically relevant concentrations (60-600 mu M) produced a bell-shaped inhibitory dose response, increasing 10- to 30-fold the time to half-maximal clotting. Oleate inhibited thrombin activity on a short peptide substrate according to a mixed-type inhibitor pattern (a 9-fold increase of the Michaelis constant, Km and a 20% decrease of the catalytic constant), whereas stearate resulted in only a minor (15%) drop in the catalytic constant without any change in the Km. Morphometric analysis of SEM images showed a 73% increase in the median fiber diameter in the presence of stearate and a 20% decrease in the presence of oleate. Concerning the viscoelastic parameters of the clots, storage and loss moduli, maximal viscosity and critical shear stress decreased by 32-65% in the presence of oleate or stearate, but loss tangent did not change indicating decreased rigidity, higher deformability and decreased internal resistance to shear stress. Our study provides evidence that free fatty acids (at concentrations comparable to those reported in thrombi) reduce the mechanical stability of fibrin through modulation of thrombin activity and the pattern of fibrin assembly.	[Tanka-Salamon, Anna; Komorowicz, Erzsebet; Kolev, Krasimir] Semmelweis Univ, Dept Med Biochem, Budapest, Hungary; [Szabo, Laszlo] Hungarian Acad Sci, Res Ctr Nat Sci, IMEC, Budapest, Hungary; [Tenekedjiev, Kiril] Nikola Vaptsarov Naval Acad, Varna, Bulgaria; [Tenekedjiev, Kiril] Univ Tasmania, Australian Maritime Coll, Newnham, Australia	Semmelweis University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; IMEC; Nikola Vaptsarov Naval Academy; University of Tasmania	Kolev, K (corresponding author), Semmelweis Univ, Dept Med Biochem, Budapest, Hungary.	Krasimir.Kolev@eok.sote.hu	Kolev, Krasimir/A-3517-2008; Tenekedjiev, Kiril/D-8141-2012; Kolev, Krasimir/J-7648-2019	Kolev, Krasimir/0000-0002-5612-004X; Tenekedjiev, Kiril/0000-0003-3549-0671; Kolev, Krasimir/0000-0002-5612-004X	Hungarian Scientific Research Fund [OTKA 112612]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund (http://www.otka.hu/) Grant OTKA 112612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; CHANG JY, 1986, BIOCHEM J, V240, P797, DOI 10.1042/bj2400797; Dag O, 2012, SCI WORLD J, DOI 10.1100/2012/673483; Douglass EF, 2013, J AM CHEM SOC, V135, P6092, DOI 10.1021/ja311795d; Fraser DA, 1999, RHEUMATOLOGY, V38, P948, DOI 10.1093/rheumatology/38.10.948; Fuentes-Prior P, 2000, NATURE, V404, P518, DOI 10.1038/35006683; FuentesPrior P, 1997, P NATL ACAD SCI USA, V94, P11845, DOI 10.1073/pnas.94.22.11845; GRUTTER MG, 1990, EMBO J, V9, P2361, DOI 10.1002/j.1460-2075.1990.tb07410.x; HIGAZI AA, 1994, BIOCHEM J, V300, P251, DOI 10.1042/bj3000251; HOGG PJ, 1990, J BIOL CHEM, V265, P248; Idicula T, 2012, ACUTE ISCHEMIC STROK, P145; Kanicky JR, 2002, J COLLOID INTERF SCI, V256, P201, DOI 10.1006/jcis.2001.8009; Larson MK, 2013, AM J PHYSIOL-CELL PH, V304, pC273, DOI 10.1152/ajpcell.00174.2012; Longstaff C, 2015, J THROMB HAEMOST, V13, pS98, DOI 10.1111/jth.12935; LONGSTAFF C, 1993, THROMB HAEMOSTASIS, V69, P430; Longstaff C, 2016, THROMB HAEMOSTASIS, V115, P591, DOI 10.1160/TH15-03-0214; Longstaff C, 2013, J BIOL CHEM, V288, P6946, DOI 10.1074/jbc.M112.404301; Longstaff C, 2011, BLOOD, V117, P661, DOI 10.1182/blood-2010-06-290338; Lundblad R L, 1976, Methods Enzymol, V45, P156; Lyaker Michael R, 2013, Int J Crit Illn Inj Sci, V3, P77, DOI 10.4103/2229-5151.109429; Maalej N, 1996, CIRCULATION, V93, P1201, DOI 10.1161/01.CIR.93.6.1201; Man BL, 2009, STROKE, V40, P3211, DOI 10.1161/STROKEAHA.109.557041; MARCUS AJ, 1969, J LIPID RES, V10, P108; McBane RD, 2000, THROMB HAEMOSTASIS, V84, P83, DOI 10.1055/s-0037-1613972; Melzig MF, 2005, PLANTA MED, V71, P787, DOI 10.1055/s-2005-871253; Nikolova N.D., 2013, THEORY APPL MONTE CA, P1, DOI DOI 10.5772/53049; Pancak J, 2016, NEUROENDOCRINOL LETT, V37, P137; Phang M, 2014, J NUTR BIOCHEM, V25, P997, DOI 10.1016/j.jnutbio.2014.05.001; Rabai G, 2007, J THROMB HAEMOST, V5, P1265, DOI 10.1111/j.1538-7836.2007.02556.x; Ryan EA, 1999, BIOPHYS J, V77, P2813, DOI 10.1016/S0006-3495(99)77113-4; Scarsi M, 1999, PROTEINS, V37, P565, DOI 10.1002/(SICI)1097-0134(19991201)37:4<565::AID-PROT7>3.0.CO;2-V; Scheraga HA, 2004, BIOPHYS CHEM, V112, P117, DOI 10.1016/j.bpc.2004.07.011; Schwartz RS, 2009, J AM COLL CARDIOL, V54, P2167, DOI 10.1016/j.jacc.2009.07.042; Sila Cathy, 2014, Handb Clin Neurol, V119, P41, DOI 10.1016/B978-0-7020-4086-3.00004-7; Slatter DA, 2016, CELL METAB, V23, P930, DOI 10.1016/j.cmet.2016.04.001; Stanek F, 2013, INT ANGIOL, V32, P52; Tanka-Salamon A, 2008, FEBS J, V275, P1274, DOI 10.1111/j.1742-4658.2008.06288.x; Tucker TJ, 1998, J MED CHEM, V41, P3210, DOI 10.1021/jm9801713; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; VANDELOCHT A, 1995, EMBO J, V14, P5149, DOI 10.1002/j.1460-2075.1995.tb00199.x; Vanschoonbeek K, 2004, ARTERIOSCL THROM VAS, V24, P1734, DOI 10.1161/01.ATV.0000137119.28893.0b; Varju I, 2011, J THROMB HAEMOST, V9, P979, DOI 10.1111/j.1538-7836.2011.04203.x; Varju I, 2015, THROMB HAEMOSTASIS, V113, P1289, DOI 10.1160/TH14-08-0669; Viskupicova J, 2012, J ENZYM INHIB MED CH, V27, P800, DOI 10.3109/14756366.2010.616860; Weisel JW, 2007, J THROMB HAEMOST, V5, P116, DOI 10.1111/j.1538-7836.2007.02504.x; Weisel J. W., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P161, DOI 10.2174/187152508784871963; Wolberg AS, 2010, HAEMOPHILIA, V16, P7, DOI 10.1111/j.1365-2516.2010.02253.x; Yamada Tsuyoshi, 2012, BMC Res Notes, V5, P372, DOI 10.1186/1756-0500-5-372; Yeromonahos C, 2012, ARTERIOSCL THROM VAS, V32, P1320, DOI 10.1161/ATVBAHA.112.245308; Zhou ZG, 2012, CHINESE MED J-PEKING, V125, P2775, DOI 10.3760/cma.j.issn.0366-6999.2012.15.024	50	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167806	10.1371/journal.pone.0167806	http://dx.doi.org/10.1371/journal.pone.0167806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942000	Green Published, Green Submitted, gold			2022-12-27	WOS:000392745600032
J	Wu, YQ; Zhao, D; Zhuang, JN; Zhang, FQ; Xu, C				Wu, Yaqin; Zhao, Dan; Zhuang, Jiabao; Zhang, Fuqiang; Xu, Chun			Caspase-8 and Caspase-9 Functioned Differently at Different Stages of the Cyclic Stretch-Induced Apoptosis in Human Periodontal Ligament Cells	PLoS One			English	Article							ALKALINE-PHOSPHATASE ACTIVITY; MECHANICAL-STRESS; EXTRACELLULAR-MATRIX; MEDIATED APOPTOSIS; GENE-EXPRESSION; TOOTH MOVEMENT; DEATH; ACTIVATION; CLEAVAGE; RECEPTOR	Background Human periodontal ligament (PDL) cells underwent apoptosis after mechanical stretch loading. However, the exact signalling pathway remains unknown. This study aimed to elucidate how the apoptotic caspases functioned in the cyclic stretch-induced apoptosis in human PDL cells. Materials and Methods In the present study, 20% cyclic stretch was selected to load the cells for 6 or 24 h. The following parameters were analyzed: apoptotic rates, the protein levels of caspase-3, -7, -8 and -9 and the activities of caspase-8 and -9. Subsequently, the influences of caspase-8 and caspase-9 inhibitors on the apoptotic rate and the protein level of the activated caspase-3 were assessed as well. Results The apoptotic rates increased in response to cyclic stretch, but the cells entered different apoptotic stages after 6 and 24 h stretches. Caspase-3, -7, -8 and -9 were all activated after stretch loading. The stretch-induced apoptosis and the protein level of the activated caspase-3 were inhibited after inhibiting both caspase-8 and caspase-9 in both 6 and 24 h stretched cells and after inhibiting caspase-9 in 24 h stretched cells. Conclusion Caspase-8 and -9 functioned differently at different apoptotic stages in human PDL cells after cyclic stretch.	[Wu, Yaqin; Zhao, Dan; Zhuang, Jiabao; Zhang, Fuqiang; Xu, Chun] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Prosthodont, Shanghai, Peoples R China; [Wu, Yaqin; Zhao, Dan; Zhuang, Jiabao; Zhang, Fuqiang; Xu, Chun] Shanghai Key Lab Stomatol, Shanghai, Peoples R China; [Wu, Yaqin; Zhao, Dan; Zhuang, Jiabao; Zhang, Fuqiang; Xu, Chun] Shanghai Res Inst Stomatol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Xu, C (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Prosthodont, Shanghai, Peoples R China.; Xu, C (corresponding author), Shanghai Key Lab Stomatol, Shanghai, Peoples R China.; Xu, C (corresponding author), Shanghai Res Inst Stomatol, Shanghai, Peoples R China.	imxuchun@163.com		Xu, Chun/0000-0003-2212-631X	National Natural Science Foundation of China [31470903, 31270991, 30900282]; Shanghai Pujiang Program [13PJD021]; Science and Technology Commission of Shanghai [10QA1404200, 08411961500, 07ZR14070]; Shanghai Summit & Plateau Disciplines; Shanghai Leading Academic Discipline Project [S30206-sms02, T0202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Summit & Plateau Disciplines; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National Natural Science Foundation of China (grant numbers 31470903, 31270991, 30900282); Shanghai Pujiang Program (grant number 13PJD021); Science and Technology Commission of Shanghai (grant numbers 10QA1404200, 08411961500, 07ZR14070); Shanghai Summit & Plateau Disciplines; Shanghai Leading Academic Discipline Project (grant numbers S30206-sms02, T0202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelrazzak AB, 2011, RADIAT RES, V176, P346, DOI 10.1667/RR2509.1; Bantel H, 2005, FEBS LETT, V579, P5559, DOI 10.1016/j.febslet.2005.09.020; Bian ZM, 2011, INVEST OPHTH VIS SCI, V52, P8646, DOI 10.1167/iovs.11-7570; Chiba M, 2004, CELL BIOCHEM FUNCT, V22, P249, DOI 10.1002/cbf.1097; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gamonal J, 2001, J PERIODONTOL, V72, P517, DOI 10.1902/jop.2001.72.4.517; Hao Y, 2009, ARCH ORAL BIOL, V54, P864, DOI 10.1016/j.archoralbio.2009.05.012; Hatai T, 2001, ORAL DIS, V7, P287, DOI 10.1034/j.1601-0825.2001.00663.x; Kaku M, 2005, J PERIODONTAL RES, V40, P59, DOI 10.1111/j.1600-0765.2004.00773.x; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Krippner-Heidenreich A, 2001, BIOCHEM J, V358, P705, DOI 10.1042/0264-6021:3580705; Lee SI, 2012, CLIN EXP IMMUNOL, V168, P113, DOI 10.1111/j.1365-2249.2011.04549.x; Lee SK, 2008, J ENDODONT, V34, P1364, DOI 10.1016/j.joen.2008.08.024; Leone A, 2012, FOLIA HISTOCHEM CYTO, V50, P497, DOI [10.5603/20320, 10.5603/FHC.2012.0070]; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li X, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1292-z; Lin YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093926; Lu M, 2014, SCIENCE, V345, P98, DOI 10.1126/science.1254312; Lucas H, 2010, J DENT RES, V89, P29, DOI 10.1177/0022034509350708; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Ma JY, 2015, ARCH ORAL BIOL, V60, P447, DOI 10.1016/j.archoralbio.2014.11.019; Mabuchi R, 2002, J PERIODONTAL RES, V37, P118, DOI 10.1034/j.1600-0765.2001.10602.x; Maneshi MM, 2015, J NEUROTRAUM, V32, P1020, DOI 10.1089/neu.2014.3677; Matsuda N, 1998, ARCH ORAL BIOL, V43, P987, DOI 10.1016/S0003-9969(98)00079-X; McCulloch CAG, 2000, PERIODONTOL 2000, V24, P56, DOI 10.1034/j.1600-0757.2000.2240104.x; Momoi T, 2004, J CHEM NEUROANAT, V28, P101, DOI 10.1016/j.jchemneu.2004.05.008; Moraco AH, 2014, SEMIN IMMUNOL, V26, P497, DOI 10.1016/j.smim.2014.10.001; Ozaki S, 2005, J PERIODONTAL RES, V40, P110, DOI 10.1111/j.1600-0765.2004.00782.x; Pileczki Valentina, 2016, Clujul Med, V89, P50, DOI 10.15386/cjmed-512; Qu T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089040; Raychaudhuri S, 2010, APOPTOSIS, V15, P401, DOI 10.1007/s10495-009-0436-5; Reno F, 2003, BIOMATERIALS, V24, P3941, DOI 10.1016/S0142-9612(03)00276-X; Saminathan A, 2012, J PERIODONTAL RES, V47, P212, DOI 10.1111/j.1600-0765.2011.01423.x; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Srivastava SK, 2015, BRIT J CANCER, V113, P660, DOI 10.1038/bjc.2015.252; Stel AJ, 2007, J IMMUNOL, V178, P2287, DOI 10.4049/jimmunol.178.4.2287; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Tu HP, 2009, J PERIODONTAL RES, V44, P767, DOI 10.1111/j.1600-0765.2008.01189.x; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075973; Wu MH, 2014, FISH SHELLFISH IMMUN, V41, P625, DOI 10.1016/j.fsi.2014.10.017; Xu C, 2011, J PERIODONTAL RES, V46, P742, DOI 10.1111/j.1600-0765.2011.01397.x; Xu C, 2012, ARCH ORAL BIOL, V57, P1602, DOI 10.1016/j.archoralbio.2012.07.002; Yamaguchi M, 1996, J DENT RES, V75, P889, DOI 10.1177/00220345960750030501; Zhong W, 2008, ORAL DIS, V14, P270, DOI 10.1111/j.1601-0825.2007.01375.x; Zhu Q, 2012, BBA-MOL CELL BIOL L, V1821, P1453, DOI 10.1016/j.bbalip.2012.08.005	46	26	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168268	10.1371/journal.pone.0168268	http://dx.doi.org/10.1371/journal.pone.0168268			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942018	gold, Green Submitted, Green Published			2022-12-27	WOS:000392745600061
J	Tordiffe, ASW; Wachter, B; Heinrich, SK; Reyers, F; Mienie, LJ				Tordiffe, Adrian S. W.; Wachter, Bettina; Heinrich, Sonja K.; Reyers, Fred; Mienie, Lodewyk J.			Comparative Serum Fatty Acid Profiles of Captive and Free-Ranging Cheetahs (Acinonyx jubatus) in Namibia	PLoS One			English	Article							MEAT QUALITY; HUMAN METABOLISM; DIETARY-INTAKE; PLASMA; DISEASE; BLOOD; STORAGE; LIVER; CATS; DESATURASE	Cheetahs (Acinonyx jubatus) are highly specialised large felids, currently listed as vulnerable on the IUCN red data list. In captivity, they are known to suffer from a range of chronic non-infectious diseases. Although low heterozygosity and the stress of captivity have been suggested as possible causal factors, recent studies have started to focus on the contribution of potential dietary factors in the pathogenesis of these diseases. Fatty acids are an important component of the diet, not only providing a source of metabolisable energy, but serving other important functions in hormone production, cellular signalling as well as providing structural components in biological membranes. To develop a better understanding of lipid metabolism in cheetahs, we compared the total serum fatty acid profiles of 35 captive cheetahs to those of 43 free-ranging individuals in Namibia using gas chromatography-mass spectrometry. The unsaturated fatty acid concentrations differed most remarkably between the groups, with all of the polyunsaturated and monounsaturated fatty acids, except arachidonic acid and hypogeic acid, detected at significantly lower concentrations in the serum of the free-ranging animals. The influence of age and sex on the individual fatty acid concentrations was less notable. This study represents the first evaluation of the serum fatty acids of free-ranging cheetahs, providing critical information on the normal fatty acid profiles of free-living, healthy individuals of this species. The results raise several important questions about the potential impact of dietary fatty acid composition on the health of cheetahs in captivity.	[Tordiffe, Adrian S. W.] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, Onderstepoort, South Africa; [Tordiffe, Adrian S. W.] Natl Zool Gardens South Africa, Dept Res & Sci Serv, Pretoria, South Africa; [Tordiffe, Adrian S. W.; Mienie, Lodewyk J.] North West Univ, Fac Nat Sci, Ctr Human Metab, Potchefstroom, South Africa; [Wachter, Bettina; Heinrich, Sonja K.] Leibniz Inst Zoo & Wildlife Res, Dept Evolutionary Ecol, Berlin, Germany; [Reyers, Fred] Idexx Labs Pty Ltd, Woodmead Willow Off Pk, Johannesburg, South Africa	University of Pretoria; National Research Foundation - South Africa; National Zoological Gardens of South Africa; North West University - South Africa; Leibniz Institut fur Zoo und Wildtierforschung	Tordiffe, ASW (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, Onderstepoort, South Africa.; Tordiffe, ASW (corresponding author), Natl Zool Gardens South Africa, Dept Res & Sci Serv, Pretoria, South Africa.; Tordiffe, ASW (corresponding author), North West Univ, Fac Nat Sci, Ctr Human Metab, Potchefstroom, South Africa.	adrian.tordiffe@up.ac.za	Tordiffe, Adrian/T-4517-2017; Wachter, Bettina/AAJ-9663-2020	Tordiffe, Adrian/0000-0001-5416-3153; Heinrich, Sonja/0000-0002-8934-009X; Mienie, Japie/0000-0003-0860-5285; Wachter, Bettina/0000-0002-0414-2298	Messerli Foundation (Switzerland); Leibniz Institute for Zoo and Wildlife Research (Germany); Idexx Laboratories (Pty) Ltd, a commercial laboratory	Messerli Foundation (Switzerland); Leibniz Institute for Zoo and Wildlife Research (Germany); Idexx Laboratories (Pty) Ltd, a commercial laboratory	Funding was received by BW and SKH from the Messerli Foundation (Switzerland) and Leibniz Institute for Zoo and Wildlife Research (Germany) for the sampling of the free-ranging cheetahs. Other aspects of the study were supported by North West University, the AfriCat Foundation and the National Zoological Gardens of South Africa. FR is employed and receives a salary from Idexx Laboratories (Pty) Ltd, a commercial laboratory. All funders provided support in the form of salaries and/or research materials for authors (ASWT, BW, SKH, FR and LJM), but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are specified in the 'author contribution' section.	Attie AD, 2002, J LIPID RES, V43, P1899, DOI 10.1194/jlr.M200189-JLR200; AZA Nutrition Advisory Group, 2013, CHEET SPEC SURV PLAN; Banskalieva V, 2000, SMALL RUMINANT RES, V37, P255, DOI 10.1016/S0921-4488(00)00128-0; Bauer JE, 1997, P NUTR SOC, V56, P1013, DOI 10.1079/PNS19970106; Bauer JE, 1999, WIEN TIERARZTL MONAT, V86, P38; Bissett C., 2004, THESIS; Bolton LA, 1999, VET PATHOL, V36, P14, DOI 10.1354/vp.36-1-14; Caro T., 1994, CHEETAHS SERENGETI P; Chamberlin A, 2011, BRIT J NUTR, V106, pS131, DOI 10.1017/S0007114511001826; Chen ZY, 1996, BRIT J NUTR, V75, P583, DOI 10.1079/BJN19960161; Cunnane SC, 2001, AM J CLIN NUTR, V73, P709; DAVIDSON BC, 1986, PROG LIPID RES, V25, P97, DOI 10.1016/0163-7827(86)90021-4; DAVIDSON BC, 1986, S AFR J ZOOL, V21, P161; Depauw S, 2013, J ANIM PHYSIOL AN N, V97, P146, DOI 10.1111/j.1439-0396.2011.01252.x; Depauw S, 2012, ZOO BIOL, V31, P629, DOI 10.1002/zoo.20427; Dierenfeld E.S., 2002, NATL AGR LIB, VZ7994, pZ65; DOUGHERTY RM, 1987, AM J CLIN NUTR, V45, P443, DOI 10.1093/ajcn/45.2.443; EATON KA, 1993, VET PATHOL, V30, P55, DOI 10.1177/030098589303000107; Gil-Campos M, 2008, BRIT J NUTR, V99, P909, DOI 10.1017/S0007114507831722; GOSSELIN SJ, 1988, VET PATHOL, V25, P48, DOI 10.1177/030098588802500107; Hall DJ, 2014, J FELINE MED SURG, V16, P631, DOI 10.1177/1098612X13516478; HIRSCH EZ, 1976, CLIN CHEM, V22, P445; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hoffman LC, 2007, MEAT SCI, V76, P768, DOI 10.1016/j.meatsci.2007.02.019; Hoffman LC, 2006, MEAT SCI, V74, P197, DOI 10.1016/j.meatsci.2006.04.005; HORROBIN DF, 1993, AM J CLIN NUTR, V57, P732; JUDD JT, 1989, J AM COLL NUTR, V8, P386; Kaur G, 2011, PROG LIPID RES, V50, P28, DOI 10.1016/j.plipres.2010.07.004; Kihara A, 2012, J BIOCHEM, V152, P387, DOI 10.1093/jb/mvs105; Kohli P, 2009, BRIT J PHARMACOL, V158, P960, DOI 10.1111/j.1476-5381.2009.00290.x; Kremmyda LS, 2011, BIOMED PAP, V155, P195, DOI 10.5507/bp.2011.052; LOPES SM, 1991, AM J CLIN NUTR, V53, P628, DOI 10.1093/ajcn/53.3.628; Lorenzo JM, 2014, MEAT SCI, V96, P1478, DOI 10.1016/j.meatsci.2013.12.006; Marker LL, 2003, S AFR J WILDL RES, V33, P43; MCGANN AM, 1991, CLIN CHIM ACTA, V197, P265, DOI 10.1016/0009-8981(91)90147-5; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; Mills MGL, 2004, WILDLIFE BIOL, V10, P177, DOI 10.2981/wlb.2004.024; Miyazaki M, 2003, PROSTAG LEUKOTR ESS, V68, P113, DOI 10.1016/S0952-3278(02)00261-2; Munson L, 2005, J WILDLIFE DIS, V41, P542, DOI 10.7589/0090-3558-41.3.542; Munson L, 1999, J ZOO WILDLIFE MED, V30, P342; MUNSON L, 1993, ZOO BIOL, V12, P105, DOI 10.1002/zoo.1430120110; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; OBRIEN SJ, 1983, SCIENCE, V221, P459, DOI 10.1126/science.221.4609.459; Papendick RE, 1997, VET PATHOL, V34, P549, DOI 10.1177/030098589703400602; PARK YW, 1993, J FOOD SCI, V58, P245, DOI 10.1111/j.1365-2621.1993.tb04248.x; PAWLOSKY R, 1994, J LIPID RES, V35, P2032; Polidori P, 2009, MEAT SCI, V82, P469, DOI 10.1016/j.meatsci.2009.03.001; Robert N., 2009, IBERIAN LYNX EX SITU, P265; ROGIERS V, 1978, CLIN CHIM ACTA, V84, P49, DOI 10.1016/0009-8981(78)90475-8; SAMPSON D, 1975, CLIN CHIM ACTA, V61, P1, DOI 10.1016/0009-8981(75)90391-5; Simopoulos AP, 1999, AM J CLIN NUTR, V70, p560S, DOI 10.1093/ajcn/70.3.560s; SINCLAIR AJ, 1979, LIPIDS, V14, P932, DOI 10.1007/BF02533508; Taha AY, 2005, METABOLISM, V54, P1127, DOI 10.1016/j.metabol.2005.03.018; Terio KA, 2012, VET PATHOL, V49, P824, DOI 10.1177/0300985811412620; Terio KA, 2004, J WILDLIFE DIS, V40, P259, DOI 10.7589/0090-3558-40.2.259; Thalwitzer S, 2010, CLIN VACCINE IMMUNOL, V17, P232, DOI 10.1128/CVI.00345-09; Tvrzicka E, 2011, BIOMED PAP, V155, P117, DOI 10.5507/bp.2011.038; Venn-Watson SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132117; Verhoeven NM, 2001, PROG LIPID RES, V40, P453, DOI 10.1016/S0163-7827(01)00011-X; Wanders RJ, 2008, ANONYMOUS LAB GUIDE, P221; Whitehouse-Tedd KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120903; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019	62	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167608	10.1371/journal.pone.0167608	http://dx.doi.org/10.1371/journal.pone.0167608			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992457	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600016
J	Vargas, T; Moreno-Rubio, J; Herranz, J; Cejas, P; Molina, S; Mendiola, M; Burgos, E; Custodio, AB; De Miguel, M; Martin-Hernandez, R; Reglero, G; Feliu, J; de Molina, AR				Vargas, Teodoro; Moreno-Rubio, Juan; Herranz, Jesus; Cejas, Paloma; Molina, Susana; Mendiola, Marta; Burgos, Emilio; Custodio, Ana B.; De Miguel, Maria; Martin-Hernandez, Roberto; Reglero, Guillermo; Feliu, Jaime; Ramirez de Molina, Ana			3 ' UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients	PLoS One			English	Article							BODY-MASS INDEX; COLORECTAL-CANCER; ADJUVANT CHEMOTHERAPY; METABOLIC SYNDROME; STAGE-II; LIPID-METABOLISM; RISK; PROGNOSIS; SURVIVAL; CARCINOMA	Strong evidence suggests that lipid metabolism (LM) has an essential role in tumor growth to support special energetic and structural requirements of tumor cells. Recently, overexpression of LM-related genes, apolipoproteins related to metabolic syndrome, and ACSL/SCD network involved in fatty acid activation have been proposed as prognostic markers of colon cancer (CC). Furthermore, activation of this latter lipid network has been recently demonstrated to confer invasive and stem cell properties to tumor cells promoting tumor aggressiveness and patient relapse. With the aim of elucidating whether any genetic variation within these genes could influence basal expression levels and consequent susceptibility to relapse, we genotype, in 284 CC patients, 57 polymorphisms located in the 7 genes of these lipid networks previously associated with worse clinical outcome of CC patients (ABCA1, ACSL1, AGPAT1, APOA2, APOC1, APOC2 and SCD), some of them related to CC aggressiveness. After adjusting with clinical confounding factors and multiple comparisons, an association between genotype and disease-free survival (DFS) was shown for rs8086 in 3'-UTR of ACSL1 gene (HR 3.08; 95% CI 1.69-5.63; adjusted p = 0.046). Furthermore, the risk T/T genotype had significantly higher ACSL1 gene expression levels than patients carrying C/T or C/C genotype (means = 5.34; 3.73; 2.37 respectively; p-value (ANOVA) = 0.019), suggesting a functional role of this variant. Thus, we have identified a "risk genotype" of ACSL1 gene that confers constitutive high levels of the enzyme, which is involved in the activation of fatty acids through conversion to acyl-CoA and has been recently related to increased invasiveness of tumor cells. These results suggest that rs8086 of ACSL1 could be a promising prognostic marker in CC patients, reinforcing the relevance of LM in the progression of CC.	[Vargas, Teodoro; Moreno-Rubio, Juan; Molina, Susana; Reglero, Guillermo; Ramirez de Molina, Ana] CEI UAM CSIC, IMDEA Food Inst, Mol Oncol, Madrid, Spain; [Moreno-Rubio, Juan] Infanta Sofia Univ Hosp, POL, Madrid, Spain; [Moreno-Rubio, Juan; Cejas, Paloma; De Miguel, Maria] La Paz Univ Hosp IdiPAZ, Translat Oncol Lab, Madrid, Spain; [Herranz, Jesus; Martin-Hernandez, Roberto] CEI UAM CSIC, IMDEA Food Inst, Biostat & Bioinformat Unit, Madrid, Spain; [Cejas, Paloma] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Burgos, Emilio] La Paz Univ Hosp IdiPAZ, Dept Pathol, Madrid, Spain; [Custodio, Ana B.; Feliu, Jaime] La Paz Univ Hosp IdiPAZ, Med Oncol, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Hospital Universitario Infanta Sofia; Hospital Universitario La Paz; Consejo Superior de Investigaciones Cientificas (CSIC); Harvard University; Dana-Farber Cancer Institute; Hospital Universitario La Paz; Hospital Universitario La Paz	de Molina, AR (corresponding author), CEI UAM CSIC, IMDEA Food Inst, Mol Oncol, Madrid, Spain.	ana.ramirez@imdea.org	MARTIN-HERNANDEZ, ROBERTO/M-8161-2014; de Molina, Ana Ramirez/AAA-3848-2019; Molina, Susana/M-8969-2014; Reglero, Guillermo/K-6658-2014; Moreno-Rubio, Juan/M-4597-2015	MARTIN-HERNANDEZ, ROBERTO/0000-0002-2723-6289; Molina, Susana/0000-0001-7737-5562; Reglero, Guillermo/0000-0002-7730-3486; Moreno-Rubio, Juan/0000-0003-3335-8749	Ministerio de Economia y Competitividad (Plan Nacional I+D+i) [AGL2013-48943-C2]; Comunidad de Madrid (ALIBIRD-CM) [P2013/ABI-2728]; European Union Structural Funds	Ministerio de Economia y Competitividad (Plan Nacional I+D+i); Comunidad de Madrid (ALIBIRD-CM)(Comunidad de Madrid); European Union Structural Funds(European Commission)	This work was funded by the Ministerio de Economia y Competitividad (Plan Nacional I+D+i AGL2013-48943-C2); Comunidad de Madrid (P2013/ABI-2728. ALIBIRD-CM); and European Union Structural Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absenger G, 2014, PHARMACOGENOMICS J, V14, P130, DOI 10.1038/tpj.2013.15; Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; GLOBOCAN_Project, GLOBOCAN 2012 EST CA; Gong ZH, 2009, INT J COLORECTAL DIS, V24, P647, DOI 10.1007/s00384-009-0656-8; Hahn-Stromberg V, 2014, APMIS, V122, P636, DOI 10.1111/apm.12211; Hull M, 2013, GUT; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Kazama S, 2015, ANTICANCER RES, V35, P2983; Kim JH, 2007, CANCER EPIDEM BIOMAR, V16, P1543, DOI 10.1158/1055-9965.EPI-07-0199; Liesenfeld DB, 2015, AM J CLIN NUTR; Lu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111061; Mashima T, 2009, CANCER SCI, V100, P1556, DOI 10.1111/j.1349-7006.2009.01203.x; Ning Y, 2014, MOL CANCER THER, V13, P528, DOI 10.1158/1535-7163.MCT-13-0646; Pais R, 2009, WORLD J GASTROENTERO, V15, P5141, DOI 10.3748/wjg.15.5141; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sanchez-Martinez R, 2015, ONCOTARGET, V6, P38719, DOI 10.18632/oncotarget.5340; Sinicrope FA, 2013, CANCER-AM CANCER SOC, V119, P1528, DOI 10.1002/cncr.27938; Sinicrope FA, 2010, CLIN CANCER RES, V16, P1884, DOI 10.1158/1078-0432.CCR-09-2636; Suh KW, 2005, J GASTROINTEST SURG, V9, P336, DOI 10.1016/j.gassur.2004.09.030; Szkandera J, 2014, CLIN CANCER RES, V20, P1687, DOI 10.1158/1078-0432.CCR-13-1517; Vargas T, 2015, ONCOTARGET, V6, P7348, DOI 10.18632/oncotarget.3130; Vargas T, 2014, MOL ONCOL, V8, P1469, DOI 10.1016/j.molonc.2014.05.015; Vymetalkova V, 2014, MUTAGENESIS, V29, P259, DOI 10.1093/mutage/geu014; Wang YBN, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0975-7; Watson MA, 2003, CLIN SCI, V104, P537, DOI 10.1042/CS20020329; Wilkening S, 2008, CARCINOGENESIS, V29, P1202, DOI 10.1093/carcin/bgn101; Zaanan A, 2014, J CANCER, V5, P425, DOI 10.7150/jca.8594	28	19	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168423	10.1371/journal.pone.0168423	http://dx.doi.org/10.1371/journal.pone.0168423			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992526	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600057
J	Chevaleyre, C; Riou, M; Brea, D; Vandebrouck, C; Barc, C; Pezant, J; Melo, S; Olivier, M; Delaunay, R; Boulesteix, O; Berthon, P; Rossignol, C; Gaillard, JB; Becq, F; Gauthier, F; Si-Tahar, M; Meurens, F; Berri, M; Caballero-Posadas, I; Attucci, S				Chevaleyre, Claire; Riou, Mickael; Brea, Deborah; Vandebrouck, Clarisse; Barc, Celine; Pezant, Jeremy; Melo, Sandrine; Olivier, Michel; Delaunay, Remy; Boulesteix, Olivier; Berthon, Patricia; Rossignol, Christelle; Gaillard, Julien Burlaud; Becq, Frederic; Gauthier, Francis; Si-Tahar, Mustapha; Meurens, Francois; Berri, Mustapha; Caballero-Posadas, Ignacio; Attucci, Sylvie			The Pig: A Relevant Model for Evaluating the Neutrophil Serine Protease Activities during Acute Pseudomonas aeruginosa Lung Infection	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CYSTIC-FIBROSIS; MOUSE MODELS; IN-VIVO; MECHANICAL VENTILATION; INFLAMMATORY RESPONSE; PNEUMONIA; ELASTASE; LIPOPOLYSACCHARIDE; PROTEINASE-3	The main features of lung infection and inflammation are a massive recruitment of neutrophils and the subsequent release of neutrophil serine proteases (NSPs). Anti-infectious and/or anti-inflammatory treatments must be tested on a suitable animal model. Mice models do not replicate several aspects of human lung disease. This is particularly true for cystic fibrosis (CF), which has led the scientific community to a search for new animal models. We have shown that mice are not appropriate for characterizing drugs targeting neutrophil-dependent inflammation and that pig neutrophils and their NSPs are similar to their human homologues. We induced acute neutrophilic inflammatory responses in pig lungs using Pseudomonas aeruginosa, an opportunistic respiratory pathogen. Blood samples, nasal swabs and bronchoalveolar lavage fluids (BALFs) were collected at 0, 3, 6 and 24 h post-insfection (p.i.) and biochemical parameters, serum and BAL cytokines, bacterial cultures and neutrophil activity were evaluated. The release of proinflammatory mediators, biochemical and hematological blood parameters, cell recruitment and bronchial reactivity, peaked at 6h p.i.. We also used synthetic substrates specific for human neutrophil proteases to show that the activity of pig NSPs in BALFs increased. These proteases were also detected at the surface of lung neutrophils using anti-human NSP antibodies. Pseudomonas aeruginosa-induced lung infection in pigs results in a neutrophilic response similar to that described for cystic fibrosis and ventilator-associated pneumonia in humans. Altogether, this indicates that the pig is an appropriate model for testing anti-infectious and/or anti-inflammatory drugs to combat adverse proteolytic effects of neutrophil in human lung diseases.	[Chevaleyre, Claire; Melo, Sandrine; Olivier, Michel; Berthon, Patricia; Rossignol, Christelle; Berri, Mustapha; Caballero-Posadas, Ignacio] Univ Tours, ISP, INRA, UMR 1282, Nouzilly, France; [Riou, Mickael; Barc, Celine; Pezant, Jeremy; Delaunay, Remy; Boulesteix, Olivier] INRA, Plateforme Infectiol Expt UE PFIE 1277, Nouzilly, France; [Brea, Deborah; Gauthier, Francis; Si-Tahar, Mustapha; Attucci, Sylvie] Ctr Etud Pathol Resp, INSERM, UMR 1100, Tours, France; [Vandebrouck, Clarisse; Becq, Frederic] Univ Poitiers, CNRS, Lab Signalisat & Transports Ion Membranaires, Poitiers, France; [Gaillard, Julien Burlaud] Univ Tours, Dept Microscopies Plateau Technol Anal Syst Biol, Tours, France; [Meurens, Francois] Nantes Atlantic Natl Coll Vet Med Food Sci & Engn, Oniris, BioEpAR, Nantes 3, France	INRAE; Universite de Tours; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Universite de Tours; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Attucci, S (corresponding author), Ctr Etud Pathol Resp, INSERM, UMR 1100, Tours, France.	attucci@univ-tours.fr	Becq, Frederic/P-9233-2016; Meurens, Francois JMA/J-3829-2019; SI-TAHAR, Mustapha/L-4149-2014; Si-Tahar, Mustapha/W-8034-2019; vandebrouck, clarisse/P-9463-2016	Becq, Frederic/0000-0003-3915-0973; Meurens, Francois JMA/0000-0002-0353-4871; SI-TAHAR, Mustapha/0000-0002-5792-7742; Si-Tahar, Mustapha/0000-0002-5792-7742; Barc, Celine/0000-0002-5912-4652; Vandebrouck, clarisse/0000-0002-9401-0546; Caballero, Ignacio/0000-0002-0628-4134	Region Centre Val de Loire [201100067854]; Vaincre la Mucoviscidose [RF20110600573]	Region Centre Val de Loire(Region Centre-Val de Loire); Vaincre la Mucoviscidose	Region Centre Val de Loire (Grant no 201100067854) MR. Vaincre la Mucoviscidose (Grant noRF20110600573) SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner B, 2010, J MOL MED, V88, P653, DOI 10.1007/s00109-010-0610-9; Attucci S, 2002, BIOCHEM J, V366, P965, DOI 10.1042/BJ20020321; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Balows A, 1991, MANUAL CLIN MICROBIO; Brea D, 2012, BIOCHEM J, V447, P363, DOI 10.1042/BJ20120818; Cole N, 2001, INFECT IMMUN, V69, P4116, DOI 10.1128/IAI.69.6.4116-4119.2001; Collie D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067677; Conese Massimo, 2003, J Cyst Fibros, V2, P129, DOI 10.1016/S1569-1993(03)00063-8; Cook DP, 2016, AM J RESP CRIT CARE, V193, P417, DOI 10.1164/rccm.201508-1562OC; Corvol H, 2003, AM J PHYSIOL-LUNG C, V284, pL997, DOI 10.1152/ajplung.00156.2002; Craig A, 2009, INFECT IMMUN, V77, P568, DOI 10.1128/IAI.00832-08; Downey DG, 2009, THORAX, V64, P81, DOI 10.1136/thx.2007.082388; Drescher B, 2013, VIRUS RES, V171, P1, DOI 10.1016/j.virusres.2012.11.002; Elferink Ronald Oude, 2009, J Hepatol, V50, P838, DOI 10.1016/j.jhep.2008.12.014; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Greene CM, 2009, BRIT J PHARMACOL, V158, P1048, DOI 10.1111/j.1476-5381.2009.00448.x; Griese M, 2008, EUR RESPIR J, V32, P783, DOI 10.1183/09031936.00146807; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; Hajjar E, 2007, FEBS LETT, V581, P5685, DOI 10.1016/j.febslet.2007.11.029; Hansen MS, 2010, J COMP PATHOL, V143, P120, DOI 10.1016/j.jcpa.2010.01.012; Kalupov T, 2009, J BIOL CHEM, V284, P34084, DOI 10.1074/jbc.M109.042903; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Korkmaz B, 2005, AM J RESP CELL MOL, V32, P553, DOI 10.1165/rcmb.2004-0374OC; Korkmaz B, 2004, AM J RESP CELL MOL, V30, P801, DOI 10.1165/rcmb.2003-0139OC; Korkmaz B, 2013, INT IMMUNOPHARMACOL, V17, P1198, DOI 10.1016/j.intimp.2013.07.003; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Bassi GL, 2014, ANESTHESIOLOGY, V120, P1205, DOI 10.1097/ALN.0000000000000222; Luna CM, 2007, CHEST, V132, P523, DOI 10.1378/chest.07-0185; Natarajan S, 2008, J IMMUNOL, V181, P8402, DOI 10.4049/jimmunol.181.12.8402; Ng HP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106813; Norez C, 2014, PULM PHARMACOL THER, V27, P38, DOI 10.1016/j.pupt.2013.06.008; Parameswaran GI, 2012, FUTURE MICROBIOL, V7, P1129, DOI [10.2217/fmb.12.88, 10.2217/FMB.12.88]; PAVAUX C, 1987, RECL MED VET, V163, P341; Petit-Bertron AF, 2008, CYTOKINE, V41, P54, DOI 10.1016/j.cyto.2007.10.012; Pham CTN, 2008, INT J BIOCHEM CELL B, V40, P1317, DOI 10.1016/j.biocel.2007.11.008; Piriou-Guzylack L, 2008, VET RES, V39, DOI 10.1051/vetres:2008030; Quint JK, 2007, J ALLERGY CLIN IMMUN, V119, P1065, DOI 10.1016/j.jaci.2006.12.640; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Riou M, 2010, INT J ANTIMICROB AG, V36, P513, DOI 10.1016/j.ijantimicag.2010.08.005; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Sibila O, 2008, EUR RESPIR J, V32, P1037, DOI 10.1183/09031936.00009208; Sibila O, 2007, EUR RESPIR J, V30, P1167, DOI 10.1183/09031936.00053607; Sousa AM, 2014, PATHOGENS, V3, P680, DOI 10.3390/pathogens3030680; Stockley RA, 1999, AM J RESP CRIT CARE, V160, pS49, DOI 10.1164/ajrccm.160.supplement_1.13; Stoltz DA, 2015, NEW ENGL J MED, V372, P351, DOI 10.1056/NEJMra1300109; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Takao K, 2015, P NATL ACAD SCI USA, V112, P1167, DOI 10.1073/pnas.1401965111; Vandebrouck C, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-113; Vaneker M, 2007, ANESTHESIOLOGY, V107, P419, DOI 10.1097/01.anes.0000278908.22686.01; Wilke M, 2011, J CYST FIBROS, V10, pS152, DOI 10.1016/S1569-1993(11)60020-9; Wilkinson TS, 2012, CHEST, V142, P1425, DOI 10.1378/chest.11-3273; Williams BJ, 2010, RESPIROLOGY, V15, P1037, DOI 10.1111/j.1440-1843.2010.01819.x; Yipp BG, 2012, NAT MED, V18, P1386, DOI 10.1038/nm.2847	54	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168577	10.1371/journal.pone.0168577	http://dx.doi.org/10.1371/journal.pone.0168577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992534	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000060
J	Lemaitre, G; Houix, O; Voisin, F; Misdariis, N; Susini, P				Lemaitre, Guillaume; Houix, Olivier; Voisin, Frederic; Misdariis, Nicolas; Susini, Patrick			Vocal Imitations of Non-Vocal Sounds	PLOS ONE			English	Article							QUALITY; SPEECH; NOISE; IDENTIFICATION; CONSEQUENCES; DESCRIPTORS; DIMENSIONS; PERCEPTION; MECHANISMS; BEHAVIOR	Imitative behaviors are widespread in humans, in particular whenever two persons communicate and interact. Several tokens of spoken languages (onomatopoeias, ideophones, and phonesthemes) also display different degrees of iconicity between the sound of a word and what it refers to. Thus, it probably comes at no surprise that human speakers use a lot of imitative vocalizations and gestures when they communicate about sounds, as sounds are notably difficult to describe. What is more surprising is that vocal imitations of non-vocal everyday sounds (e.g. the sound of a car passing by) are in practice very effective: listeners identify sounds better with vocal imitations than with verbal descriptions, despite the fact that vocal imitations are inaccurate reproductions of a sound created by a particular mechanical system (e.g. a car driving by) through a different system (the voice apparatus). The present study investigated the semantic representations evoked by vocal imitations of sounds by experimentally quantifying how well listeners could match sounds to category labels. The experiment used three different types of sounds: recordings of easily identifiable sounds (sounds of human actions and manufactured products), human vocal imitations, and computational "auditory sketches" (created by algorithmic computations). The results show that performance with the best vocal imitations was similar to the best auditory sketches for most categories of sounds, and even to the referent sounds themselves in some cases. More detailed analyses showed that the acoustic distance between a vocal imitation and a referent sound is not sufficient to account for such performance. Analyses suggested that instead of trying to reproduce the referent sound as accurately as vocally possible, vocal imitations focus on a few important features, which depend on each particular sound category. These results offer perspectives for understanding how human listeners store and access long-term sound representations, and sets the stage for the development of human-computer interfaces based on vocalizations.	[Lemaitre, Guillaume; Houix, Olivier; Voisin, Frederic; Misdariis, Nicolas; Susini, Patrick] STMS IRCAM CNRS UPMC, Equipe Percept & Design Sonores, Inst Rech & Coordinat Acoust Mus, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Lemaitre, G (corresponding author), STMS IRCAM CNRS UPMC, Equipe Percept & Design Sonores, Inst Rech & Coordinat Acoust Mus, Paris, France.	GuillaumeJLemaitre@gmail.com	Voisin, Frédéric/AAS-6265-2020; Voisin, Frédéric/Q-7318-2017	Voisin, Frédéric/0000-0002-7879-5304; Voisin, Frédéric/0000-0002-7879-5304; Lemaitre, Guillaume/0000-0001-5442-6857	Future and Emerging Technologies (FET) programme within European Commission [618067]	Future and Emerging Technologies (FET) programme within European Commission	This work was financed by the Future and Emerging Technologies (FET) programme within the Seventh Framework Programme for Research of the European Commission (grant number: 618067, SkAT-VG).	Agus TR, 2012, J ACOUST SOC AM, V131, P4124, DOI 10.1121/1.3701865; Agus TR, 2010, NEURON, V66, P610, DOI 10.1016/j.neuron.2010.04.014; Aucouturier J.-J., 2012, 13 INT SOC MUSIC INF, P397; Augoyard JF, 2001, ESPACE URBAIN METHOD, P127; Bernardini N, 2000, P COST G 6 C DIG AUD; Brass M, 2005, TRENDS COGN SCI, V9, P489, DOI 10.1016/j.tics.2005.08.007; Caclin A, 2006, J COGNITIVE NEUROSCI, V18, P1959, DOI 10.1162/jocn.2006.18.12.1959; Camacho A, 2008, J ACOUST SOC AM, V124, P1638, DOI 10.1121/1.2951592; Cartwright M, 2015, CHI 2015: PROCEEDINGS OF THE 33RD ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P43, DOI 10.1145/2702123.2702387; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; Corballis MC, 2002, HAND MOUTH ORIGINS L; de Saussure F., 1916, COURS LINGUISTIQUE G; De Torcy T, 2014, LOGOP PHONIATR VOCO, V39, P38, DOI 10.3109/14015439.2013.784801; Del Piccolo A, 2016, J MULTIMODAL USER IN, P1; Delle Monache S., 2015, P 21 INT C AUD DISPL, P58; Esling P, 2013, IEEE T AUDIO SPEECH, V21, P2057, DOI 10.1109/TASL.2013.2265086; Eysenck M. W., 2000, COGNITIVE PSYCHOL ST, V4; Assaneo MF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028317; Gentilucci M, 2007, NEUROPSYCHOLOGIA, V45, P608, DOI 10.1016/j.neuropsychologia.2006.04.004; Gillet O, 2005, J INTELL INF SYST, V24, P159, DOI 10.1007/s10844-005-0321-9; Helgason P., 2014, P FONETIK, P83; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Houix O, 2016, P AUD MOSTL; Houix O, 2012, J EXP PSYCHOL-APPL, V18, P52, DOI 10.1037/a0026240; Hutchins S, 2012, MUSIC PERCEPT, V30, P147, DOI 10.1525/MP.2012.30.2.147; Ih JG, 2003, NOISE CONTROL ENG J, V51, P244, DOI 10.3397/1.2839720; Isnard V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150313; Iwasaki N, 2007, SEKAI NO NIHONGO KYO, V17, P53; Jeon JY, 2007, APPL ACOUST, V68, P1118, DOI 10.1016/j.apacoust.2006.06.005; KLINGHOLZ F, 1993, J VOICE, V7, P118, DOI 10.1016/S0892-1997(05)80340-6; Kuhl PK, 1996, J ACOUST SOC AM, V100, P2425, DOI 10.1121/1.417951; Ku┬hler W., 1947, GESTALT PSYCHOL; Larsson M, 2015, ANIM COGN, V18, P993, DOI 10.1007/s10071-015-0885-x; Leite RP, 2009, APPL ACOUST, V70, P636, DOI 10.1016/j.apacoust.2008.06.010; Lemaitre G, 2016, J ACOUST SOC AM, V139, P290, DOI 10.1121/1.4939738; Lemaitre G, 2015, APPL ACOUST, V95, P1, DOI 10.1016/j.apacoust.2015.02.011; Lemaitre G, 2014, LECT NOTES COMPUT SC, V8905, P558, DOI 10.1007/978-3-319-12976-1_34; Lemaitre G, 2014, J ACOUST SOC AM, V135, P862, DOI 10.1121/1.4861245; Lemaitre G, 2013, EXP BRAIN RES, V226, P253, DOI 10.1007/s00221-013-3430-7; Lemaitre G, 2012, J ACOUST SOC AM, V131, P1337, DOI 10.1121/1.3675946; Lemaitre G, 2011, ECOL PSYCHOL, V23, P267, DOI 10.1080/10407413.2011.617225; Lemaitre G, 2010, J EXP PSYCHOL-APPL, V16, P16, DOI 10.1037/a0018762; Lemaitre G, 2009, ACTA ACUST UNITED AC, V95, P356, DOI 10.3813/AAA.918158; Lesaffre M, 2004, COMPUTING MUSICOLOGY, V13, P129; Ma WY, 2015, P NATL ACAD SCI USA, V112, P14563, DOI 10.1073/pnas.1515087112; Macmillan NA, 2005, DETECTION THEORY USE; Mantell JT, 2013, COGNITION, V127, P177, DOI 10.1016/j.cognition.2012.12.008; Marchetto E, 2015, INT CONF DIGIT AUDIO, P207; MCADAMS S, 1995, PSYCHOL RES-PSYCH FO, V58, P177, DOI 10.1007/BF00419633; McAdams S., 1993, THINKING SOUND COGNI, P146, DOI DOI 10.1093/ACPROF:OSO/9780198522577.003.0006; Meltzoff A. N, 2002, THE IMITATIVE MIND D, V6; Mercado E, 2014, COMP COGN BEHAV REV, V9, DOI 10.3819/ccbr.2014.90002; Miller RM, 2010, ATTEN PERCEPT PSYCHO, V72, P1614, DOI 10.3758/APP.72.6.1614; Misdariis N., 2012, P ACOUSTICS 2012 NAN, P1045; Misdariis N, 2010, EURASIP J AUDIO SPEE, DOI 10.1155/2010/362013; Moore BCJ, 2003, J PHONETICS, V31, P563, DOI 10.1016/S0095-4470(03)00011-1; Nielsen A, 2011, CAN J EXP PSYCHOL, V65, P115, DOI 10.1037/a0022268; Ohno M, 2004, P 18 INT C AC ICA 20, P3295; Pachet F, 2009, EURASIP J AUDIO SPEE, DOI 10.1155/2009/153017; Pardo JS, 2006, J ACOUST SOC AM, V119, P2382, DOI 10.1121/1.2178720; Parizet E, 2004, ACTA ACUST UNITED AC, V90, P987; Parizet E, 2008, APPL ACOUST, V69, P12, DOI 10.1016/j.apacoust.2006.09.004; Patel Aniruddh D, 2003, P 15 INT C PHON SCI, P925; Patil K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002759; Peeters G, 2011, J ACOUST SOC AM, V130, P2902, DOI 10.1121/1.3642604; Peeters G, 2010, IEEE T AUDIO SPEECH, V18, P675, DOI 10.1109/TASL.2009.2038809; Perlman M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150152; Pfordresher PQ, 2007, MUSIC PERCEPT, V25, P95, DOI 10.1525/MP.2007.25.2.95; Pfordresher PQ, 2014, COGNITIVE PSYCHOL, V70, P31, DOI 10.1016/j.cogpsych.2013.12.005; Pfordresher PQ, 2010, J ACOUST SOC AM, V128, P2182, DOI 10.1121/1.3478782; Porcello T, 2004, SOC STUD SCI, V34, P733, DOI 10.1177/0306312704047328; Pressnitzer D, 2015, ENCY COMPUTATIONAL N, P128; Revis J, 2013, J VOICE, V27, DOI 10.1016/j.jvoice.2013.01.008; Rhodes Richard, 1994, SOUND SYMBOLISM, P276, DOI [10.1017/CBO9780511751806.019, DOI 10.1017/CB09780511751806.019]; Rocchesso Davide, 2015, ACM Interactions, V22, P32, DOI 10.1145/2685501; Roebel A., 2008, J ACOUST SOC AM, V123, P3803, DOI [10.1121/1.2935499, DOI 10.1121/1.2935499]; Sapthavee A, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2013.11.007; Sato T, 2005, P FOR AC BUD HUNG, P1763; Schmidtke DS, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00080; Schwarz D, 1999, P ICMC, P351; Siedenburg K, 2016, J NEW MUSIC RES, V45, P27, DOI 10.1080/09298215.2015.1132737; Sobkowiak W., 1990, STUDIA ANGLICA POSNA, V23, P15; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Stanton N., 1999, HUMAN FACTORS AUDITO; Subiaul F, 2012, DEV PSYCHOL, V48, P1165, DOI 10.1037/a0026646; Suied C, 2008, J EXP PSYCHOL-APPL, V14, P201, DOI 10.1037/1076-898X.14.3.201; Suied C, 2013, LECT NOTES COMPUT SC, V7900, P154, DOI 10.1007/978-3-642-41248-6_9; Sundaram S, 2008, 2008 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOLS 1-4, P1341, DOI 10.1109/ICME.2008.4607691; Takada M, 2001, P INT C AC ICA 2001; Takada M, 2010, EURASIP J AUDIO SPEE, DOI 10.1155/2010/674248; Takada M, 2006, ACOUST SCI TECHNOL, V27, P67, DOI 10.1250/ast.27.67; WARD PH, 1969, ANN OTO RHINOL LARYN, V78, P771, DOI 10.1177/000348946907800409; Wilson M, 2001, PSYCHOL BULL, V127, P543, DOI 10.1037/0033-2909.127.4.543; WRIGHT P, 1971, J APPL PSYCHOL, V55, P244, DOI 10.1037/h0031025; YANG XW, 1992, IEEE T INFORM THEORY, V38, P824, DOI 10.1109/18.119739; Yoshida H, 2012, J COGN DEV, V13, P232, DOI 10.1080/15248372.2011.573515; Zentall TR, 2003, CURR DIR PSYCHOL SCI, V12, P91, DOI 10.1111/1467-8721.01237; Zuchowski R., 1998, STUD ANGLICA POSNANI, V33, P475	99	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168167	10.1371/journal.pone.0168167	http://dx.doi.org/10.1371/journal.pone.0168167			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EI8LN	27992480	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000029
J	Kim, K; Kim, K; Park, SM				Kim, Keyhoon; Kim, Kyuwoong; Park, Sang Min			Association between the Prevalence of Metabolic Syndrome and the Level of Coffee Consumption among Korean Women	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; DECAFFEINATED COFFEE; PROSPECTIVE COHORT; INSULIN-SECRETION; RISK; ADULTS; CAFFEINE; POPULATION; DISEASE	Background As coffee consumption is increasing remarkably over the past decade, the health effects concerning the coffee drinking has gained a wide attention across the nation. However, there is not a true consensus regarding the effects of coffee on metabolic disease. Therefore, this study aims to examine the association between coffee intake and the risk of metabolic syndrome in Korean women Methods We used publicly accessible datasets collected through Korean National Health and Nutrition Examination Survey (KNHANES). Among 20,435 individuals from five consecutive years' worth of data from 2007 to 2011, only 15,691 subjects qualified for statistical analysis upon applying the exclusion criteria. We carried out the statistical analysis utilizing SPSS Statistics version 13.0 (IBM Corp., Armonk, NY.) and STATA statistical software release 13.0 (STATA Corp., College Station, TX). Results We found that the frequency of coffee intake inversely correlates with the prevalence of metabolic syndrome in women. Upon adjusting for life-style factors, socioeconomic status, and nutritional profile, the subjects from the highest coffee consumption quartile exhibited 40% lower odds of suffering from metabolic syndrome compared to those in the control (OR = 0.75; 95% CI = 0.67 +/- 0.84; P for trend < 0.001). Also, we observed that age-and BMI-adjusted HOMA-IR decreased as the coffee consumption increased (P for trend < 0.001). Conclusion The findings of our study suggest that coffee consumption might be associated with reduction of metabolic syndrome in Korean women. To elucidate this cross-sectional association between coffee consumption and metabolic syndrome in women, cohort studies are warranted to confirm this relationship.	[Kim, Keyhoon; Park, Sang Min] Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea; [Kim, Kyuwoong; Park, Sang Min] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Biomed Sci Bldg, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Dept Med, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Biomed Sci Bldg, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea.	smpark.snuh@gmail.com	Park, Sang Min/V-9194-2019		National Research Foundation of Korea	National Research Foundation of Korea(National Research Foundation of Korea)	We would like to thank Korea Centers for Disease Control and Prevention for providing the national health survey data and the participants of KNHANES. Kyuwoong Kim received a scholarship from the BK21-plus education program provided by the National Research Foundation of Korea. We would also like to thank Ha Young Chung for professional scientific editing.	Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020; Antuna-Puente B, 2011, DIABETES METAB, V37, P179, DOI 10.1016/j.diabet.2011.01.002; Bae YJ, 2010, NUTR RES PRACT, V4, P121, DOI 10.4162/nrp.2010.4.2.121; Bamia C, 2015, INT J CANCER, V136, P1899, DOI 10.1002/ijc.29214; Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7; Choi E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147762; Ciol MA, 2006, ARCH PHYS MED REHAB, V87, P299, DOI 10.1016/j.apmr.2005.09.021; Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925; Erem C, 2008, ENDOCRINE, V33, P9, DOI 10.1007/s12020-008-9044-3; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Gallus S, 2002, ANN EPIDEMIOL, V12, P202, DOI 10.1016/S1047-2797(01)00304-0; Health NIO, 2001, NIH PUBLICATION, V1, P3670; Health UDo Services H., 2010, NIH PUB; Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033; Jiang X., 2013, EUROPEAN J NUTR, V53, P25, DOI DOI 10.1007/S00394-013-0603-X; Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lann D, 2007, MED CLIN N AM, V91, P1063, DOI 10.1016/j.mcna.2007.06.012; Lee JH, 2016, KOREAN J FAM MED, V37, P7, DOI 10.4082/kjfm.2016.37.1.7; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Lof M, 2015, EUR J EPIDEMIOL, V30, P1027, DOI 10.1007/s10654-015-0052-3; Loftfield E, 2015, AM J EPIDEMIOL, V182, P1010, DOI 10.1093/aje/kwv146; Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452; Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068; Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481; Morakinyo A O, 2013, Niger J Physiol Sci, V28, P179; Muzio F, 2005, DIABETES CARE, V28, P1485, DOI 10.2337/diacare.28.6.1485; Nordenvall C, 2015, CLIN GASTROENTEROL H, V13, P1096, DOI 10.1016/j.cgh.2014.09.029; Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083; Park HS, 2008, OBES REV, V9, P104, DOI 10.1111/j.1467-789X.2007.00421.x; Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Rhee JJ, 2016, AM J CLIN NUTR, V103, P210, DOI 10.3945/ajcn.115.120147; Riediger ND, 2011, CAN MED ASSOC J, V183, pE1127, DOI 10.1503/cmaj.110070; Rodrigues AD, 2013, CLIMACTERIC, V16, P96, DOI 10.3109/13697137.2012.659099; Ross GW, 2000, JAMA-J AM MED ASSOC, V283, P2674, DOI 10.1001/jama.283.20.2674; Siller AB, 2006, P 31 ANN SAS US GROU; Song F, 2016, NFS J, V4, P9, DOI DOI 10.1016/J.NFS.2016.04.002; Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053; Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390	40	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167007	10.1371/journal.pone.0167007	http://dx.doi.org/10.1371/journal.pone.0167007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977716	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400010
J	Cullen, L; Stanton, JC; Lima, F; Uezu, A; Perilli, MLL; Akcakaya, HR				Cullen, Laury, Jr.; Stanton, Jessica C.; Lima, Fernando; Uezu, Alexandre; Perilli, Miriam L. L.; Akcakaya, H. Resit			Implications of Fine-Grained Habitat Fragmentation and Road Mortality for Jaguar Conservation in the Atlantic Forest, Brazil	PLOS ONE			English	Article							POPULATION VIABILITY ANALYSIS; PANTHERA-ONCA; CONSEQUENCES; LANDSCAPE; MODEL; METAPOPULATION; RESPONSES; SELECTION; DYNAMICS; SAVE	Jaguar (Panthera onca) populations in the Upper Parana A River, in the Brazilian Atlantic Forest region, live in a landscape that includes highly fragmented areas as well as relatively intact ones. We developed a model of jaguar habitat suitability in this region, and based on this habitat model, we developed a spatially structured metapopulation model of the jaguar populations in this area to analyze their viability, the potential impact of road mortality on the populations' persistence, and the interaction between road mortality and habitat fragmentation. In more highly fragmented populations, density of jaguars per unit area is lower and density of roads per jaguar is higher. The populations with the most fragmented habitat were predicted to have much lower persistence in the next 100 years when the model included no dispersal, indicating that the persistence of these populations are dependent to a large extent on dispersal from other populations. This, in turn, indicates that the interaction between road mortality and habitat fragmentation may lead to source-sink dynamics, whereby populations with highly fragmented habitat are maintained only by dispersal from populations with less fragmented habitat. This study demonstrates the utility of linking habitat and demographic models in assessing impacts on species living in fragmented landscapes.	[Cullen, Laury, Jr.; Lima, Fernando; Uezu, Alexandre] IPE, Nazare Paulista, SP, Brazil; [Stanton, Jessica C.; Akcakaya, H. Resit] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY USA; [Lima, Fernando] Univ Estadual Paulista, UNESP, Inst Biosci, Programa Postgrad Ecol Biodiversidade, Sao Paulo, Brazil; [Perilli, Miriam L. L.] Inst Conservacao Carnivoros Neotropicais Procarni, Sao Paulo, Brazil; [Perilli, Miriam L. L.] Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Ecol, Vicosa, MG, Brazil	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universidade Estadual Paulista; Universidade Federal de Vicosa	Cullen, L (corresponding author), IPE, Nazare Paulista, SP, Brazil.	laurycullen@gmail.com	Lima, Fernando/E-8023-2016; Uezu, Alexandre/G-5435-2014; Perilli, Miriam/AGX-1402-2022; Akcakaya, H. Resit/A-7830-2008	Lima, Fernando/0000-0002-8644-9647; Perilli, Miriam/0000-0002-4986-8041; Akcakaya, H. Resit/0000-0002-8679-5929; Stanton, Jessica/0000-0002-6225-3703	Boticario Group Foundation in Brazil; Scott Neotropical Fund of the Lincoln Park Zoological Society; Wildlife Trust, IdeaWild Grant Program; World Wildlife Fund/U.S, DICE Small Grant Program; Liz Claiborne Art Ortenberg Foundation; Ashoka Foundation; Conservation, Food and Health Foundation; Fauna and Flora International; Woodland Park Zoo; Whitley Awards; Rolex Awards; Durrell Wildlife Conservation Trust; Rufford Small Grant Program; Ridgeway Trust; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Center for Latin American Studies (University of Florida); Fundo Brasileiro para a Biodiversidade - Tropical Forest Conservation Act agreement (FUNBio/TFCA); National Aeronautics and Space Administration through the NASA Biodiversity Program [NNX09AK19G]; National Science Foundation [DEB-1146198]; Division Of Environmental Biology [1146198] Funding Source: National Science Foundation	Boticario Group Foundation in Brazil; Scott Neotropical Fund of the Lincoln Park Zoological Society; Wildlife Trust, IdeaWild Grant Program; World Wildlife Fund/U.S, DICE Small Grant Program; Liz Claiborne Art Ortenberg Foundation; Ashoka Foundation; Conservation, Food and Health Foundation; Fauna and Flora International; Woodland Park Zoo; Whitley Awards; Rolex Awards; Durrell Wildlife Conservation Trust; Rufford Small Grant Program; Ridgeway Trust; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Center for Latin American Studies (University of Florida); Fundo Brasileiro para a Biodiversidade - Tropical Forest Conservation Act agreement (FUNBio/TFCA); National Aeronautics and Space Administration through the NASA Biodiversity Program; National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for field work was provided by the Boticario Group Foundation in Brazil (http://www.fundacaogrupoboticario.org.br/en/), The Scott Neotropical Fund of the Lincoln Park Zoological Society (http://www.clevelandmetroparks.com/Main/Home.aspx), The Species Survival Fund from Wildlife Trust, IdeaWild Grant Program (http://www.ideawild.org/), World Wildlife Fund/U.S, DICE Small Grant Program, The Liz Claiborne Art Ortenberg Foundation (http://www.lcaof.org/), The Ashoka Foundation (http://brasil.ashoka.org/), Conservation, Food and Health Foundation (http://cfhfoundation.grantsmanagement08.com/), 100% Fund from Fauna and Flora International, The Woodland Park Zoo (http://www.zoo.org/), The Whitley Awards (http://whitleyaward.org/), The Rolex Awards (http://www.rolexawards.com/), Durrell Wildlife Conservation Trust (https://www.durrell.org/wildlife/), The Rufford Small Grant Program (http://www.rufford.org/) and Ridgeway Trust. All the above mentioned funding was received by LC. Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) provided support during LC PhD and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Center for Latin American Studies (University of Florida) during the post-doctoral studies of LC. LC, FL, AU and MLLP received financial support for data and metadata management, curation and analysis from Fundo Brasileiro para a Biodiversidade - Tropical Forest Conservation Act agreement (FUNBio/TFCA). Contributions of HRA and JCS were supported in part by the National Aeronautics and Space Administration under Grant No. NNX09AK19G awarded through the NASA Biodiversity Program, and the National Science Foundation under Grant No. DEB-1146198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya H. R., 2005, APPL BIOMATHEMATICS; Akcakaya HR, 1998, BIODIVERS CONSERV, V7, P875, DOI 10.1023/A:1008867602813; AKCAKAYA HR, 1995, BIOL CONSERV, V73, P169, DOI 10.1016/0006-3207(95)00054-8; Akcakaya HR, 1997, CONSERV BIOL, V11, P422, DOI 10.1046/j.1523-1739.1997.96164.x; AKCAKAYA HR, 1991, ECOL MODEL, V54, P133; Akcakaya HR, 2004, SPECIES CONSERVATION; Akcakaya HR, 2000, RES POPUL ECOL KYOTO, V42; Beisiegel B, 2012, CAT NEWS; Boron V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153973; Brodie JF, 2015, MAMM BIOL, V80, P7, DOI 10.1016/j.mambio.2014.06.001; Cattarino L, 2013, LANDSCAPE ECOL, V28, P1321, DOI 10.1007/s10980-013-9881-1; Cavalcanti SMC, 2010, J MAMMAL, V91, P722, DOI 10.1644/09-MAMM-A-171.1; CIESIN, 2004, GLOB RUR URB MAPP PR; Coppolillo P, 2004, BIOL CONSERV, V115, P419, DOI 10.1016/S0006-3207(03)00159-9; Crawshaw P., 2004, HUM DIMENS WILDL, V9, P329; Cullen Jr L, 2005, BRAZAIL NAT E CONSER, V3, P124; Cullen Jr L, 2006, JAGUARS LANDSCAPE DE; Cullen L, 2013, ZOOLOGIA-CURITIBA, V30, P379, DOI 10.1590/S1984-46702013000400003; De Angelo C, 2011, ORYX, V45, P534, DOI 10.1017/S0030605310000840; Eigenbrod F, 2008, BIOL CONSERV, V141, P35, DOI 10.1016/j.biocon.2007.08.025; Eizirik E, 2002, JAGUAR NUEVO MILENIO; FAHRIG L, 2009, ECOL SOC, V14; Fordham DA, 2013, NAT CLIM CHANGE, V3, P899, DOI 10.1038/NCLIMATE1954; Haag T, 2010, MOL ECOL, V19, P4906, DOI 10.1111/j.1365-294X.2010.04856.x; Haag T, 2009, GENETICA CONSERVACAO; Haines AM, 2006, BIOL CONSERV, V132, P424, DOI 10.1016/j.biocon.2006.04.035; IMS RA, 1993, BIOL CONSERV, V63, P261, DOI 10.1016/0006-3207(93)90722-D; Kuemmerle T, 2011, J APPL ECOL, V48, P317, DOI 10.1111/j.1365-2664.2010.01954.x; Lambeck RJ., 1997, CONSERV BIOL, P849; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; LEADERWILLIAMS N, 2000, PRIORITIES CONSERVAT, P53; MILLER B., 2002, JAGUAR NUEVO MILENIO; Mona S, 2014, HEREDITY, V112, P291, DOI 10.1038/hdy.2013.105; Paula RC, 2011, SERIE ESPECIES AMEAC; Paviolo A, 2008, ORYX, V42, P554, DOI 10.1017/S0030605308000641; Placci G, 2003, BIODIVERSITY VISION, V116; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Redford KH, 2003, CONSERV BIOL, V17, P116, DOI 10.1046/j.1523-1739.2003.01467.x; ROLSTAD J, 1991, BIOL J LINN SOC, V42, P149, DOI 10.1111/j.1095-8312.1991.tb00557.x; Root Karen V., 2004, P491; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; Vynne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028939; Wielgus RB, 2002, BIOL CONSERV, V106, P381, DOI 10.1016/S0006-3207(01)00265-8; Wultsch C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162377; Zanin M, 2015, EUR J WILDLIFE RES, V61, P529, DOI 10.1007/s10344-015-0924-6; Zeller, 2007, JAGUARS NEW MILLENNI, P1	46	20	23	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167372	10.1371/journal.pone.0167372	http://dx.doi.org/10.1371/journal.pone.0167372			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973584	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300027
J	Koester, D; Schack, T				Koester, Dirk; Schack, Thomas			Action Priority: Early Neurophysiological Interaction of Conceptual and Motor Representations	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; CONTINGENT NEGATIVE-VARIATION; LANGUAGE COMPREHENSION; PREHENSION MOVEMENTS; BRAIN POTENTIALS; WORKING-MEMORY; VISUAL INPUT; TIME-COURSE; SELECTIVE PERTURBATION; VOLUNTARY MOVEMENT	Handling our everyday life, we often react manually to verbal requests or instruction, but the functional interrelations of motor control and language are not fully understood yet, especially their neurophysiological basis. Here, we investigated whether specific motor representations for grip types interact neurophysiologically with conceptual information, that is, when reading nouns. Participants performed lexical decisions and, for words, executed a grasp-and-lift task on objects of different sizes involving precision or power grips while the electroencephalogram was recorded. Nouns could denote objects that require either a precision or a power grip and could, thus, be (in) congruent with the performed grasp. In a control block, participants pointed at the objects instead of grasping them. The main result revealed an event-related potential (ERP) interaction of grip type and conceptual information which was not present for pointing. Incongruent compared to congruent conditions elicited an increased positivity (100-200 ms after noun onset). Grip type effects were obtained in response-locked analyses of the grasping ERPs (100-300 ms at left anterior electrodes). These findings attest that grip type and conceptual information are functionally related when planning a grasping action but such an interaction could not be detected for pointing. Generally, the results suggest that control of behaviour can be modulated by task demands; conceptual noun information (i.e., associated action knowledge) may gain processing priority if the task requires a complex motor response.	[Koester, Dirk; Schack, Thomas] Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp Biomech, Bielefeld, Germany; [Koester, Dirk; Schack, Thomas] Univ Bielefeld, Cluster Excellence Cognit Interact Technol CITEC, Bielefeld, Germany; [Schack, Thomas] Univ Bielefeld, Res Inst Cognit & Robot, CoR Lab, Bielefeld, Germany	University of Bielefeld; University of Bielefeld; University of Bielefeld	Koester, D (corresponding author), Univ Bielefeld, Fac Psychol & Sport Sci, Neurocognit & Act Res Grp Biomech, Bielefeld, Germany.; Koester, D (corresponding author), Univ Bielefeld, Cluster Excellence Cognit Interact Technol CITEC, Bielefeld, Germany.	dkoester@cit-ec.uni-bielefeld.de	Koester, Dirk/B-2438-2008	Koester, Dirk/0000-0003-3940-8559	Cluster of Excellence Cognitive Interaction Technology "CITEC" at Bielefeld University - German Research Foundation [EXC 277]	Cluster of Excellence Cognitive Interaction Technology "CITEC" at Bielefeld University - German Research Foundation	This work was funded by the Cluster of Excellence Cognitive Interaction Technology "CITEC" (EXC 277) at Bielefeld University, which is funded by the German Research Foundation (http://www.dfg.de) and performed by the Neurocognition and Action Research Group - Biomechanics (www.neurocognition.de) . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsel BD, 2013, NEUROIMAGE, V77, P1, DOI 10.1016/j.neuroimage.2013.03.058; Andres M, 2008, CURR DIR PSYCHOL SCI, V17, P313, DOI 10.1111/j.1467-8721.2008.00597.x; Baayen R. H, 1995, CELEX LEXICAL DATABA; Bach P, 2009, SOC NEUROSCI-UK, V4, P212, DOI 10.1080/17470910802362546; Barber H, 2005, J COGNITIVE NEUROSCI, V17, P137, DOI 10.1162/0898929052880101; Begliomini C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001108; Begliomini C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00676; Blasing BE, 2014, FRONT PSYCHOL, V5, DOI [10.3389/fpsyg.2014.01008, 10.3389/fpsyg.2014.01500]; Borghi AM, 2009, BRAIN RES, V1253, P117, DOI 10.1016/j.brainres.2008.11.064; Boulenger V, 2008, J PHYSIOL-PARIS, V102, P130, DOI 10.1016/j.jphysparis.2008.03.015; Boulenger V, 2006, J COGNITIVE NEUROSCI, V18, P1607, DOI 10.1162/jocn.2006.18.10.1607; Bozzacchi C, 2012, BIOL PSYCHOL, V89, P503, DOI 10.1016/j.biopsycho.2011.12.020; Burnod Y, 1999, EXP BRAIN RES, V129, P325, DOI 10.1007/s002210050902; CARNAHAN H, 1993, HUM MOVEMENT SCI, V12, P219, DOI 10.1016/0167-9457(93)90016-I; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; CORBALLIS MC, 1992, COGNITION, V44, P197, DOI 10.1016/0010-0277(92)90001-X; Corballis MC, 1991, EVOLUTION GENERATIVE; Dambacher M, 2006, BRAIN RES, V1084, P89, DOI 10.1016/j.brainres.2006.02.010; Dambacher M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005047; De Sanctis T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065508; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Elliot AJ, 2010, J EXP PSYCHOL GEN, V139, P399, DOI 10.1037/a0019689; Elliott D, 2001, PSYCHOL BULL, V127, P342, DOI 10.1037//0033-2909.127.3.342; Fiebach CJ, 2006, CORTEX, V42, P499, DOI 10.1016/S0010-9452(08)70386-1; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; Fischer MH, 2008, Q J EXP PSYCHOL, V61, P825, DOI 10.1080/17470210701623605; Freude G, 1987, Psychiatr Neurol Med Psychol (Leipz), V39, P449; Gentilucci M, 2000, EXP BRAIN RES, V133, P468, DOI 10.1007/s002210000431; Gentilucci M, 2008, Q J EXP PSYCHOL, V61, P944, DOI 10.1080/17470210701625683; Gibson J.J., 1986, ECOLOGICAL APPROACH; Girardi G, 2010, J EXP PSYCHOL HUMAN, V36, P330, DOI 10.1037/a0017180; Glover S, 2004, BEHAV BRAIN SCI, V27, P3; Glover S, 2004, EXP BRAIN RES, V154, P103, DOI 10.1007/s00221-003-1659-2; Glover S, 2002, EXP BRAIN RES, V146, P383, DOI 10.1007/s00221-002-1222-6; Goldenberg G, 2009, BRAIN, V132, P1645, DOI 10.1093/brain/awp080; Goldin-Meadow S, 1998, NATURE, V391, P279, DOI 10.1038/34646; Grafton ST, 2010, EXP BRAIN RES, V204, P475, DOI 10.1007/s00221-010-2315-2; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Gratton G., 1983, CLIN NEUROPHYSIOL, V55, P468, DOI DOI 10.1016/0013-4694(83)90135-9; Gunter TC, 2004, NEUROSCI LETT, V372, P52, DOI 10.1016/j.neulet.2004.09.011; Gunter TC, 2000, J COGNITIVE NEUROSCI, V12, P556, DOI 10.1162/089892900562336; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Hauk O, 2008, J PHYSIOL-PARIS, V102, P50, DOI 10.1016/j.jphysparis.2008.03.013; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Heister J, 2011, PSYCHOL RUNDSCH, V62, P10, DOI 10.1026/0033-3042/a000029; Hillyard SA, 1998, CURR OPIN NEUROBIOL, V8, P202, DOI 10.1016/S0959-4388(98)80141-4; HILLYARD SA, 1999, ATTENTION SPACE ACTI, P31; Horchak OV, 2014, COGN SYST RES, V29-30, P66, DOI 10.1016/j.cogsys.2013.09.002; Ikeda A, 1997, ELECTROEN CLIN NEURO, V102, P142, DOI 10.1016/S0921-884X(96)95067-5; JAKOBSON LS, 1991, EXP BRAIN RES, V86, P199; JEANNEROD M, 1984, J MOTOR BEHAV, V16, P235; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; Kaan E, 2002, J PSYCHOLINGUIST RES, V31, P165, DOI 10.1023/A:1014978917769; Koester D, 2004, J COGNITIVE NEUROSCI, V16, P1647, DOI 10.1162/0898929042568541; Koester D, 2008, NEUROIMAGE, V42, P1622, DOI 10.1016/j.neuroimage.2008.06.043; Kok A, 1997, BIOL PSYCHOL, V45, P19, DOI 10.1016/S0301-0511(96)05221-0; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; KUTAS M, 1980, BRAIN RES, V202, P95, DOI 10.1016/0006-8993(80)90646-0; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Leuthold H, 1996, J EXP PSYCHOL GEN, V125, P307, DOI 10.1037/0096-3445.125.3.307; Leuthold H, 2004, J PSYCHOPHYSIOL, V18, P77, DOI 10.1027/0269-8803.18.23.77; Lindemann O, 2006, J EXP PSYCHOL HUMAN, V32, P633, DOI 10.1037/0096-1523.32.3.633; Logan SW, 2011, ACTA PSYCHOL, V137, P292, DOI 10.1016/j.actpsy.2011.03.009; Luck S.J., 2005, INTRO EVENT RELATED; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Miller GA, 1960, PLANS STRUCTURE BEHA; Mordkoff JT, 2000, PSYCHOPHYSIOLOGY, V37, P347; Moreau D, 2013, ACTA PSYCHOL, V142, P356, DOI 10.1016/j.actpsy.2013.01.011; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Naatanen R., 2018, ATTENTION BRAIN FUNC; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Pastra K, 2012, PHILOS T R SOC B, V367, P103, DOI 10.1098/rstb.2011.0123; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; PAULIGNAN Y, 1991, EXP BRAIN RES, V83, P502; Penolazzi B, 2007, BIOL PSYCHOL, V74, P374, DOI 10.1016/j.biopsycho.2006.09.008; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; Proverbio AM, 2011, NEUROPSYCHOLOGIA, V49, P2711, DOI 10.1016/j.neuropsychologia.2011.05.019; Proverbio AM, 2009, NEUROSCI LETT, V459, P142, DOI 10.1016/j.neulet.2009.05.012; R Development Core Team, 2005, R LANG ENV STAT COMP; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; ROSENBAUM DA, 1992, J EXP PSYCHOL LEARN, V18, P1058, DOI 10.1037/0278-7393.18.5.1058; Schack T, 2013, NEW IDEAS PSYCHOL, V31, P258, DOI 10.1016/j.newideapsych.2013.04.003; Sell AJ, 2011, BRAIN LANG, V117, P39, DOI 10.1016/j.bandl.2010.07.003; Sereno SC, 2003, PSYCHOL SCI, V14, P328, DOI 10.1111/1467-9280.14471; Sereno SC, 1998, NEUROREPORT, V9, P2195, DOI 10.1097/00001756-199807130-00009; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Spiegel MA, 2013, J EXP PSYCHOL HUMAN, V39, P1326, DOI 10.1037/a0031398; Spiegel MA, 2012, NEUROSCI LETT, V509, P82, DOI 10.1016/j.neulet.2011.12.033; Springer A, 2010, Q J EXP PSYCHOL, V63, P2141, DOI 10.1080/17470211003721659; STEKLIS HD, 1976, ANN NY ACAD SCI, V280, P445, DOI 10.1111/j.1749-6632.1976.tb25508.x; Thompson JJ, 2016, NEW IDEAS PSYCHOL, V43, P28, DOI 10.1016/j.newideapsych.2016.03.002; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Tucker M, 2004, ACTA PSYCHOL, V116, P185, DOI 10.1016/j.actpsy.2004.01.004; Vainio L, 2007, BRAIN COGNITION, V65, P195, DOI 10.1016/j.bandc.2007.07.004; van de Kamp C, 2007, EXP BRAIN RES, V182, P27, DOI 10.1007/s00221-007-0968-2; van Elk M, 2010, BIOL PSYCHOL, V85, P134, DOI 10.1016/j.biopsycho.2010.06.004; Van Petten C, 1999, J EXP PSYCHOL LEARN, V25, P394, DOI 10.1037/0278-7393.25.2.394; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; van Schie HT, 2007, BRAIN RES, V1148, P183, DOI 10.1016/j.brainres.2007.02.085; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Weigelt M, 2009, ACTA PSYCHOL, V132, P68, DOI 10.1016/j.actpsy.2009.06.005; Westerholz J, 2014, NEUROSCI LETT, V575, P85, DOI 10.1016/j.neulet.2014.05.022; Westerholz J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093116; Westerholz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068501; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Woodworth RS, 1899, PSYCHOL REV-MONOGR S, V3, P1; World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053; ZELAZNIK HN, 1983, J MOTOR BEHAV, V15, P217	111	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0165882	10.1371/journal.pone.0165882	http://dx.doi.org/10.1371/journal.pone.0165882			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973539	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300005
J	Monteiro, MLG; Marsico, ET; Soares, MS; Magalhaes, AO; Canto, ACVCS; Costa-Lima, BRC; Alvares, TS; Junior, CAC				Monteiro, Maria Lucia G.; Marsico, Eliane T.; Soares Junior, Manoel S.; Magalhaes, Amanda O.; Canto, Anna Carolina V. C. S.; Costa-Lima, Bruno R. C.; Alvares, Thiago S.; Conte Junior, Carlos A.			Nutritional Profile and Chemical Stability of Pasta Fortified with Tilapia (Oreochromis niloticus) Flour	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; HEAT-TREATMENT; QUALITY CHARACTERISTICS; INACTIVATION KINETICS; MODIFIED ATMOSPHERE; KONJAC GLUCOMANNAN; PROTEIN OXIDATION; MAILLARD REACTION; WATER STATE; SHELF-LIFE	Physicochemical parameters of pasta enriched with tilapia (Oreochromis niloticus) flour were investigated. Five formulations were prepared with different concentrations of tilapia flour as partial substitute of wheat flour: pasta without tilapia flour (PTF0%), pasta with 6% (PTF6%), 12% (PTF12%), 17% (PTF17%), and 23% (PTF23%) of tilapia flour. The formulations were assessed for proximate composition, fatty acid and amino acid profile on day 1 whereas, instrumental color parameters (L*, a* and b* values), pH, water activity (a(w)), and lipid and protein oxidation were evaluated on days 1, 7, 14, and 21 of storage at 25 degrees C. Fortification with tilapia flour increased (p < 0.05) protein, lipid, ash, total essential amino acids, and total polyunsaturated fatty acids contents. In addition, supplementation of pasta with tilapia flour decreased (p < 0.05) lightness and water activity while redness, yellowness, pH values, and lipid oxidation were increased (p < 0.05) in a level-dependent manner. Nevertheless, all formulations were exhibited storage stability at 25 degrees C. In general, protein oxidation was greater (p < 0.05) in the pasta containing 12%, 17%, and 23% of tilapia flour than their counterparts, and the storage promoted an increase (p < 0.05) on the carbonyl content in all formulations. Thus, pasta with 6% of tilapia flour has the potential to be a technological alternative to food industry for the nutritional enrichment of traditional pasta with negligible negative effects on the chemical stability of the final product during 21 days at 25 degrees C.	[Monteiro, Maria Lucia G.; Marsico, Eliane T.; Canto, Anna Carolina V. C. S.; Costa-Lima, Bruno R. C.; Conte Junior, Carlos A.] Univ Fed Fluminense, Dept Food Technol, Rio De Janeiro, Brazil; [Soares Junior, Manoel S.; Magalhaes, Amanda O.] Univ Fed Goias, Sch Agron, Dept Food Engn, Goiania, Go, Brazil; [Alvares, Thiago S.] Univ Fed Rio de Janeiro, Inst Nutr, Rio De Janeiro, Brazil; [Conte Junior, Carlos A.] Univ Fed Rio de Janeiro, Inst Chem, Rio De Janeiro, Brazil	Universidade Federal Fluminense; Universidade Federal de Goias; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Monteiro, MLG (corresponding author), Univ Fed Fluminense, Dept Food Technol, Rio De Janeiro, Brazil.	mariaguerra@id.uff.br	Conte-Junior, Carlos A./J-5815-2014; Marsico, Eliane/AAQ-7766-2021; Júnior, Manoel Soares Soares/ABH-9440-2020; Alvares, Thiago/AAO-7782-2020; Alvares, Thiago/GSJ-3655-2022	Conte-Junior, Carlos A./0000-0001-6133-5080; Júnior, Manoel Soares Soares/0000-0001-8728-4592; Marsico, Eliane/0000-0001-9452-5462; Reis, AlessanRSS/0000-0001-8486-7469	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/111.673/2013, E-26/010.001954/2014, E-26/201.185/2014, E-26/110.094/2014, E-26/010.001961/2014, E-26/010.001911/2014, E-26/101.403/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [311361/2013-7, 401922/2013-8, 313917/2013-2, 442102/2014-3, 441987/2014-1]; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES) [E-26/101.403/2014]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES)	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) grant numbers E-26/111.673/2013; E-26/010.001954/2014; E-26/201.185/2014; E-26/110.094/2014; E-26/010.001961/2014; E-26/010.001911/2014 and E-26/101.403/2014 Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - grant numbers 311361/2013-7, 401922/2013-8, 313917/2013-2, 442102/2014-3 and 441987/2014-1 Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (CAPES) - grant number E-26/101.403/2014 (CAPES/FAPERJ E-45 - PAPDRJ/2013) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful for the financial support provided by the Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), grant numbers E-26/111.673/2013; E-26/010.001954/2014; E-26/201.185/2014; E-26/110.094/2014; E-26/010.001961/2014; E-26/010.001911/2014 and E-26/101.403/2014; as well as the Conselho Nacional de Desenvolvimento Cientifico e TecnolOgico (CNPq) grant numbers 311361/20137, 401922/2013-8, 313917/2013-2, 442102/2014-3 and 441987/2014-1; and the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), grant number E-26/101.403/2014 (CAPES/FAPERJ E-45-PAPDRJ/2013).	Adeleke R. O., 2010, Pakistan Journal of Nutrition, V9, P535; AIDOO ES, 1973, CEREAL SCI TODAY, V18, P302; American Diabetes Association, 2014, GLYC IND DIAB; American Diabetes Association, 2014, PROT FOODS; AMSA, 2012, AMSA MEAT COLOR MEAS; Anbudhasan P, 2014, FISH TECHNOL, V51, P242; [Anonymous], 1973, MILLENNIUM ECOSYSTEM; AOAC, 2012, OFF METH AN AOAC; Armenteros M, 2009, MEAT SCI, V83, P104, DOI 10.1016/j.meatsci.2009.04.007; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bonomi F, 2012, FOOD CHEM, V135, P348, DOI 10.1016/j.foodchem.2012.05.026; Bradley RL, 2010, FOOD ANALYSIS, FOURTH EDITION, P85, DOI 10.1007/978-1-4419-1478-1_6; Bustos MC, 2015, RSC ADV, V5, P30780, DOI 10.1039/c4ra11857j; Cavazza A, 2013, FOOD BIOPROCESS TECH, V6, P2721, DOI 10.1007/s11947-012-0906-6; Chelh I, 2007, MEAT SCI, V76, P210, DOI 10.1016/j.meatsci.2006.10.028; Chin S. F., 1992, Journal of Food Composition and Analysis, V5, P185, DOI 10.1016/0889-1575(92)90037-K; CHIOU SH, 1989, J CHROMATOGR-BIOMED, V491, P424, DOI 10.1016/S0378-4347(00)82861-3; Conforti FD, 2006, INT J FOOD SCI TECH, V41, P95, DOI 10.1111/j.1365-2621.2006.01410.x; Conte-Junior C. A., 2008, MODERN MULTIDISCIPLI, P356; Conte-Junior CA, 2007, REV COMPLUTENSE CIEN, V1, P482; de Oliveira IS, 2015, FOOD CONTROL, V50, P38, DOI 10.1016/j.foodcont.2014.08.018; De Pili T, 2014, ITAL J FOOD SCI, V26, P183; Devi N. L., 2013, International Food Research Journal, V20, P219; Dickinson E, 2008, SOFT MATTER, V4, P932, DOI 10.1039/b718319d; Distaam EM, 2001, CEREAL FOOD WORLD, V46, P522; Goes ESD, 2016, FOOD SCI TECH-BRAZIL, V36, P76, DOI 10.1590/1678-457X.0020; Doxastakis G, 2007, FOOD CHEM, V101, P57, DOI 10.1016/j.foodchem.2005.12.054; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ; Gaie-Levrel F, 2011, PHYS CHEM CHEM PHYS, V13, P7024, DOI 10.1039/c0cp02798g; Gatti R, 2010, J PHARMACEUT BIOMED, V53, P207, DOI 10.1016/j.jpba.2009.12.031; GomezGuillen C, 1997, FOOD CHEM, V58, P81, DOI 10.1016/S0308-8146(96)00217-8; Monteiro MLG, 2012, CIENC RURAL, V42, P737, DOI 10.1590/S0103-84782012000400027; Hall CA, 2005, J FOOD SCI, V70, pC483, DOI 10.1111/j.1365-2621.2005.tb11505.x; Hedegaard RV, 2013, WOODHEAD PUBL FOOD S, V255, P409, DOI 10.1533/9780857098672.2.409; Helrick K., 1990, OFF METH AN, V15 th ed.; Hong SR, 2012, STARCH-STARKE, V64, P511, DOI 10.1002/star.201100170; International Pasta Organization-Survey, 2014, WORLD PAST IND 2013; International Pasta Organization-Survey, 2013, WORLD PAST IND 2012; Jayasena V, 2010, J FOOD QUALITY, V33, P709, DOI 10.1111/j.1745-4557.2010.00353.x; Kadam SU, 2012, J TEXTURE STUD, V43, P268, DOI 10.1111/j.1745-4603.2011.00336.x; Karlsdottir MG, 2014, FOOD CHEM, V164, P476, DOI 10.1016/j.foodchem.2014.05.068; Kishino S, 2002, BIOSCI BIOTECH BIOCH, V66, P2283, DOI 10.1271/bbb.66.2283; Kumar SB, 2014, TRENDS FOOD SCI TECH, V35, P32, DOI 10.1016/j.tifs.2013.10.007; Laroque D, 2008, FOOD CHEM, V111, P1032, DOI 10.1016/j.foodchem.2008.05.033; Liu JJ, 2013, FOOD RES INT, V51, P437, DOI 10.1016/j.foodres.2013.01.002; Lodi A, 2008, FOOD CHEM, V110, P554, DOI 10.1016/j.foodchem.2008.02.032; Monteiro MLG, 2013, FOOD SCI NUTR, V1, P298, DOI 10.1002/fsn3.41; MARCONI E, 1995, AMINO ACIDS, V8, P201, DOI 10.1007/BF00806493; Marti A, 2014, LWT-FOOD SCI TECHNOL, V59, P1100, DOI 10.1016/j.lwt.2014.06.039; Mercier Y, 1998, MEAT SCI, V48, P301, DOI 10.1016/S0309-1740(97)00113-7; Monteiro MLG, 2014, FOOD SCI TECHNOL RES, V20, P571, DOI 10.3136/fstr.20.571; Monteiro MLG, 2012, J AQUACULTURE RES DE, V3, P1; Oliver CN, 1982, EXPERIENCES BIOCH PE, P233; Petenuci ME, 2010, CIENC AGROTEC, V34, P1279, DOI 10.1590/S1413-70542010000500028; Petitot M, 2009, TRENDS FOOD SCI TECH, V20, P521, DOI 10.1016/j.tifs.2009.06.005; Rosenvold K, 2003, MEAT SCI, V64, P219, DOI 10.1016/S0309-1740(02)00186-9; del Pulgar JS, 2012, MEAT SCI, V90, P828, DOI 10.1016/j.meatsci.2011.11.024; Sandhu KS, 2008, LWT-FOOD SCI TECHNOL, V41, P1000, DOI 10.1016/j.lwt.2007.07.012; Schneedorferova I, 2015, FOOD CHEM, V176, P205, DOI 10.1016/j.foodchem.2014.12.058; Seda O.G.U.R., 2014, J FOOD NUTR RES, V2, P985, DOI [10.12691/jfnr-2-12-20, DOI 10.12691/JFNR-2-12-20]; Serventi L, 2009, J SCI FOOD AGR, V89, P73, DOI 10.1002/jsfa.3412; Shaviklo GR, 2010, J SCI FOOD AGR, V90, P2133, DOI 10.1002/jsfa.4062; Shogren RL, 2006, J FOOD SCI, V71, pS428, DOI 10.1111/j.1750-3841.2006.00061.x; Stephany M, 2016, LWT-FOOD SCI TECHNOL, V68, P36, DOI 10.1016/j.lwt.2015.11.052; Stevanato FB, 2010, J FOOD PROCESS PRES, V34, P373, DOI 10.1111/j.1745-4549.2009.00429.x; Svec I, 2008, CZECH J FOOD SCI, V26, P421, DOI 10.17221/83/2008-CJFS; Tang X, 2012, NUTRITION, V28, P1180, DOI 10.1016/j.nut.2012.03.011; Thachil MT, 2014, INT J FOOD SCI TECH, V49, P309, DOI 10.1111/ijfs.12333; USDA - United States Department of Agriculture, 2009, NAT NUTR DAT; Verardo V, 2009, FOOD CHEM, V114, P472, DOI 10.1016/j.foodchem.2008.09.074; Vhangani LN, 2013, FOOD CHEM, V137, P92, DOI 10.1016/j.foodchem.2012.09.030; WARMBIER HC, 1976, J FOOD SCI, V41, P981, DOI 10.1111/j.1365-2621.1976.tb14372.x; Wojtowicz A, 2014, LWT-FOOD SCI TECHNOL, V59, P1175, DOI 10.1016/j.lwt.2014.06.010; Wong CW, 2015, FOOD ENG SER, P41, DOI 10.1007/978-1-4939-2578-0_4; Wust J, 2016, FOOD FUNCT, V7, P2526, DOI [10.1039/c5fo01550b, 10.1039/C5FO01550B]; Xu B, 2016, J FOOD PROCESS ENG, V39, P247, DOI 10.1111/jfpe.12216; YIN MC, 1993, J FOOD SCI, V58, P1273, DOI 10.1111/j.1365-2621.1993.tb06164.x; Zhang M, 2016, CROP SCI, V56, P1; Zhang T, 2016, FOOD RES INT, V83, P152, DOI 10.1016/j.foodres.2016.03.007; Zhou ZK, 2007, FOOD RES INT, V40, P209, DOI 10.1016/j.foodres.2006.10.006	80	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168270	10.1371/journal.pone.0168270	http://dx.doi.org/10.1371/journal.pone.0168270			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973565	Green Submitted, Green Published, gold			2022-12-27	WOS:000392754300072
J	Munafo, J; Wade, MG; Stergiou, N; Stoffregen, TA				Munafo, Justin; Wade, Michael G.; Stergiou, Nick; Stoffregen, Thomas A.			The Rim and the Ancient Mariner: The Nautical Horizon Affects Postural Sway in Older Adults	PLOS ONE			English	Article							DETRENDED FLUCTUATION ANALYSIS; STANDING BODY SWAY; PERFORMANCE; MOTION; WOMEN; YOUNG; TIME; VARIABILITY; STABILITY; ATTENTION	On land, the spatial magnitude of postural sway (i.e., the amount of sway) tends to be greater when participants look at the horizon than when they look at nearby targets. By contrast, on ships at sea, the spatial magnitude of postural sway in young adults has been greater when looking at nearby targets and less when looking at the horizon. Healthy aging is associated with changes in the movement patterns of the standing body sway, and these changes typically are interpreted in terms of age-related declines in the ability to control posture. To further elucidate the mechanisms associated with these changes we investigated control of posture in a setting that poses substantial postural challenges; standing on a ship at sea. In particular, we explored postural sway on a ship at sea when older adults looked at the horizon or at nearby targets. We evaluated the kinematics of the center of pressure in terms of spatial magnitude (i.e., the amount of sway) and multifractality (a measure of temporal dynamics). We found that looking at the horizon significantly affected the multifractality of standing body, but did not systematically influence the spatial magnitude of sway. We discuss the results in terms of age-related changes in the perception and control of dynamic body orientation.	[Munafo, Justin; Wade, Michael G.; Stoffregen, Thomas A.] Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA; [Stergiou, Nick] Univ Nebraska Omaha, Dept Biomech, Omaha, NE USA; [Stergiou, Nick] Univ Nebraska Omaha, Ctr Res Human Movement Variabil, Omaha, NE USA	University of Minnesota System; University of Minnesota Twin Cities; University of Nebraska System; University of Nebraska Omaha; University of Nebraska System; University of Nebraska Omaha	Stoffregen, TA (corresponding author), Univ Minnesota, Sch Kinesiol, Minneapolis, MN 55455 USA.	tas@umn.edu	Stoffregen, Thomas/ABC-8710-2021		University of Minnesota; University of Minnesota Diversity of Views and Experiences (DOVE) program; Center for Research in Human Movement Variability of the University of Nebraska Omaha; NIH [P20GM109090, R15HD086828]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R15HD086828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109090] Funding Source: NIH RePORTER	University of Minnesota(University of Minnesota System); University of Minnesota Diversity of Views and Experiences (DOVE) program; Center for Research in Human Movement Variability of the University of Nebraska Omaha; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research was funded by a Grant in Aid of Research from the University of Minnesota. Justin Munafo's participation was supported by a fellowship from the University of Minnesota Diversity of Views and Experiences (DOVE) program. Nick Stergiou's participation was supported by the Center for Research in Human Movement Variability of the University of Nebraska Omaha and the NIH (P20GM109090 and R15HD086828). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We extend our thanks to Nathan Blessing and ISE. In addition, we thank Samuel Taylor Coleridge, for poetic inspiration. Dr. Stergiou is supported by the Center for Research in Human Movement Variability of the University of Nebraska Omaha and the NIH (P20GM109090 and R15HD086828).	Balasubramaniam R, 2000, GAIT POSTURE, V11, P12, DOI 10.1016/S0966-6362(99)00051-X; Beer T., 1997, ENV OCEANOGRAPHY; Birren J. E., 1980, AGING 1980S PSYCHOL, P293; BLES W, 1980, ACTA OTO-LARYNGOL, V89, P534, DOI 10.3109/00016488009127171; Chen FC, 2012, J EXP PSYCHOL-APPL, V18, P203, DOI 10.1037/a0026661; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cruise Lines International Association Inc, 2010, 2010 CLIA CRUIS MARK; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; Hirata RP, 2010, CLIN BIOMECH, V25, P931, DOI 10.1016/j.clinbiomech.2010.06.001; Ihlen EAF, 2013, J BIOMECH, V46, P484, DOI 10.1016/j.jbiomech.2012.10.016; Ihlen EAF, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00141; Ihlen EAF, 2010, J EXP PSYCHOL GEN, V139, P436, DOI 10.1037/a0019098; Jor'dan AJ, 2015, NEUROSCI LETT, V593, P101, DOI 10.1016/j.neulet.2015.03.014; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Kelty-Stephen DG, 2013, ECOL PSYCHOL, V25, P1, DOI 10.1080/10407413.2013.753804; Kim JW, 2010, GERIATR GERONTOL INT, V10, P191, DOI 10.1111/j.1447-0594.2009.00582.x; Kinsella-Shaw JM, 2006, J MOTOR BEHAV, V38, P251, DOI 10.3200/JMBR.38.4.251-264; Koslucher F, 2016, EXP BRAIN RES, V234, P2709, DOI 10.1007/s00221-016-4675-8; Lajoie Y, 2004, ARCH GERONTOL GERIAT, V38, P11, DOI 10.1016/S0167-4943(03)00082-7; Lee DN, 1975, J HUMAN MOVEMENT STU, V1, P87, DOI DOI 10.3758/BF03199297; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Mayo AM, 2011, PSYCHOL SCI, V22, P118, DOI 10.1177/0956797610392927; Melzer I, 2004, AGE AGEING, V33, P602, DOI 10.1093/ageing/afh218; Merlo A, 2012, GAIT POSTURE, V36, P662, DOI 10.1016/j.gaitpost.2012.06.016; Munafo J, 2016, EXP BRAIN RES, V234, P2721, DOI 10.1007/s00221-016-4676-7; Munafo J, 2015, ECOL PSYCHOL, V27, P127, DOI 10.1080/10407413.2015.1027127; NASHNER LM, 1985, BEHAV BRAIN SCI, V8, P135, DOI 10.1017/S0140525X00020008; Palatinus Z, 2014, J EXP PSYCHOL HUMAN, V40, P1808, DOI 10.1037/a0037247; PAULUS W, 1989, EXP BRAIN RES, V78, P243; Prado JM, 2007, GERONTOLOGY, V53, P274, DOI 10.1159/000102938; Redfern MS, 2007, J ANXIETY DISORD, V21, P704, DOI 10.1016/j.janxdis.2006.09.002; Redfern MS, 2001, GAIT POSTURE, V14, P211, DOI 10.1016/S0966-6362(01)00144-8; Riccio G. E., 1993, VARIABILITY MOTOR CO; Riccio G. E., 1995, LOCAL APPL ECOLOGICA, P122; Roller CA, 2002, NEUROBIOL AGING, V23, P117, DOI 10.1016/S0197-4580(01)00264-0; Shimizu Y, 2002, FRACTALS, V10, P103, DOI 10.1142/S0218348X02001130; Simeonov P., 2001, INJURY PREVENT S1, V7, pi50, DOI DOI 10.1136/IP.7.SUPPL_1.I50; Stevens SC, 2002, MAR TECHNOL SNAME N, V39, P29; Stoffregen T. A., 2016, KINES REV, V5, P23, DOI DOI 10.1123/KR.2015-0049; Stoffregen TA, 2000, HUM MOVEMENT SCI, V19, P203, DOI 10.1016/S0167-9457(00)00009-9; Stoffregen TA, 1999, J EXP PSYCHOL HUMAN, V25, P1641; Stoffregen TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066949; Stoffregen TA, 2011, ECOL PSYCHOL, V23, P19, DOI 10.1080/10407413.2011.539102; Sullivan EV, 2009, NEUROBIOL AGING, V30, P793, DOI 10.1016/j.neurobiolaging.2007.08.021; Thurner S, 2000, PHYS REV E, V62, P4018, DOI 10.1103/PhysRevE.62.4018; Turvey MT, 2014, J MOTOR BEHAV, V46, P143, DOI 10.1080/00222895.2013.798252; van Emmerik REA, 2002, EXERC SPORT SCI REV, V30, P177, DOI 10.1097/00003677-200210000-00007; van Wegen EEH, 2002, HUM MOVEMENT SCI, V21, P61, DOI 10.1016/S0167-9457(02)00077-5; Varlet M, 2015, EXP BRAIN RES, V233, P1607, DOI 10.1007/s00221-015-4235-7; Varlet M, 2014, J EXP PSYCHOL HUMAN, V40, P2310, DOI 10.1037/a0038197; Voelcker-Rehage C, 2008, EUR REV AGING PHYS A, V5, P5, DOI 10.1007/s11556-008-0030-9; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Yu YW, 2013, GAIT POSTURE, V37, P103, DOI 10.1016/j.gaitpost.2012.06.021; Yu YW, 2010, AVIAT SPACE ENVIR MD, V81, P375, DOI 10.3357/ASEM.2638.2010	56	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166900	10.1371/journal.pone.0166900	http://dx.doi.org/10.1371/journal.pone.0166900			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973576	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300015
J	Sun, XY; Yu, ZW; Cai, ZY; Yu, LY; Lv, YY				Sun, Xiaoyi; Yu, Zhenwei; Cai, Zhengyuan; Yu, Lingyan; Lv, Yuanyuan			Voriconazole Composited Polyvinyl Alcohol/Hydroxypropyl-beta-Cyclodextrin Nanofibers for Ophthalmic Delivery	PLOS ONE			English	Article							IN-VIVO EVALUATION; OCULAR INSERTS; DRUG-RELEASE; SUSTAINED-RELEASE; ANTIFUNGAL DRUGS; CYCLOSPORINE-A; VITRO; STABILITY; FORMULATION; SOLUBILITY	Voriconazole (VRC) incorporated in composited polyvinyl alcohol (PVA)/hydroxypropyl-beta cyclodextrin (HP beta CD) blended nanofibers were produced via electrospinning for efficient ophthalmic delivery. The VRC loading capacity increased with increasing HP beta CD content. The optimal solution for electrospinning consisted of 8% (w/v) PVA, 4% (w/v) HP beta CD and 0.5% (w/v) VRC. The nanofibers exhibited bead- free average fiber diameters of 307 +/- 31 nm and VRC was released in vitro in a sustained manner. The VRC nanofibers were characterized by infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC) and scanning electron microscopy (SEM). The proton nuclear magnetic resonance (H-1-NMR) was used to analyze the molar ratio of HP beta CD/VRC in the nanofibers. Compared with a VRC solution, the nanofibers significantly prolonged the half life, and increased the bioavailability of VRC in rabbit tears. No obvious signs of irritation were observed after application in the conjunctival sac. VRC nanofibers are promising for ophthalmic drug delivery and further pharmacodynamics studies are needed.	[Sun, Xiaoyi; Cai, Zhengyuan; Lv, Yuanyuan] Zhejiang Univ City Coll, Dept Pharm, Huzhou St, Hangzhou, Zhejiang, Peoples R China; [Yu, Zhenwei] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Hangzhou, Zhejiang, Peoples R China; [Yu, Lingyan] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University City College; Zhejiang University; Zhejiang University	Lv, YY (corresponding author), Zhejiang Univ City Coll, Dept Pharm, Huzhou St, Hangzhou, Zhejiang, Peoples R China.; Yu, ZW (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med, Hangzhou, Zhejiang, Peoples R China.	zhenweiyu84@126.com; lvyy@zucc.edu.cn		YU, Zhenwei/0000-0002-3776-2290	Public Welfare Technology Research and Social Development Project of Zhejiang [2013C33234]; National Nature Science Foundation of China [81402872, 51303155]; Natural Science Foundation of Zhejiang Province of China [LQ16H120004, LY17H160002]; Health and Family Planning Commission of Zhejiang, China [2014RCA012]	Public Welfare Technology Research and Social Development Project of Zhejiang; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province of China(Natural Science Foundation of Zhejiang Province); Health and Family Planning Commission of Zhejiang, China	This work was supported by Public Welfare Technology Research and Social Development Project of Zhejiang (2013C33234: http://www.zjkjt.gov.cn/ to ZWY),the National Nature Science Foundation of China (81402872 to XYS, 51303155 to YYL:http://www.nsfc.gov.cn/), Natural Science Foundation of Zhejiang Province of China (LQ16H120004 to LYY and LY17H160002 to XYS:http://www.zjnsf.gov.cn/), and Health and Family Planning Commission of Zhejiang, China (2014RCA012 to ZWY:http://www.zjwst.gov.cn/).	Amoros-Reboredo P, 2015, AM J HEALTH-SYST PH, V72, P479, DOI 10.2146/ajhp140127; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; DiDomenico B, 1999, CURR OPIN MICROBIOL, V2, P509, DOI 10.1016/S1369-5274(99)00009-0; DILUCCIO RC, 1994, J PHARM SCI, V83, P104, DOI 10.1002/jps.2600830124; Dupuis A, 2009, ANTIMICROB AGENTS CH, V53, P798, DOI 10.1128/AAC.01126-08; Duxfield L, 2015, DRUG DEV IND PHARM; Gower EW, 2010, OPHTHALMOLOGY, V117, P2263, DOI 10.1016/j.ophtha.2010.03.048; Goyal R., 2015, J CONTROL RELEASE; Hermans K, 2014, INT J PHARMACEUT, V472, P10, DOI 10.1016/j.ijpharm.2014.06.017; Higuchi T., 1965, ADV ANAL CHEM INSTRU, V4, P117; Iyer Sandhya A, 2006, Eye Contact Lens, V32, P267, DOI 10.1097/01.icl.0000249595.27520.2e; Jain D, 2011, DRUG DEV IND PHARM, V37, P167, DOI 10.3109/03639045.2010.502533; Jayaraman P, 2015, ADV DRUG DELIVER REV, V94, P77, DOI 10.1016/j.addr.2015.09.007; Jeong S, 2009, ANTIMICROB AGENTS CH, V53, P541, DOI 10.1128/AAC.01123-08; Karn PR, 2014, INT J NANOMED, V9, P3791, DOI 10.2147/IJN.S65601; Kumar R, 2014, COLLOID SURFACE B, V117, P82, DOI 10.1016/j.colsurfb.2014.02.007; Lat Asma, 2011, Infect Drug Resist, V4, P43, DOI 10.2147/IDR.S12714; Li GX, 2015, INT J CLIN EXP MED, V8, P12949; Loftssona T, 1996, ADV DRUG DELIV REV, V36, P59; Luke DR, 2010, J PHARM SCI-US, V99, P3291, DOI 10.1002/jps.22109; Miletic T, 2013, CARBOHYD POLYM, V98, P122, DOI 10.1016/j.carbpol.2013.05.084; Morrison PWJ, 2013, MOL PHARMACEUT, V10, P756, DOI 10.1021/mp3005963; Nafee NA, 2003, INT J PHARMACEUT, V264, P1, DOI 10.1016/S0378-5173(03)00371-5; Negishi J, 2010, EUR J PHARM SCI, V41, P617, DOI 10.1016/j.ejps.2010.09.001; Nivoix Y, 2008, CLIN PHARMACOKINET, V47, P779, DOI 10.2165/0003088-200847120-00003; Pahuja P, 2014, CURR DRUG DELIV, V11, P223, DOI 10.2174/1567201810666131224105205; Pawar P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/341218; Peeters J, 2002, J PHARM SCI, V91, P1414, DOI 10.1002/jps.10126; de Sa FAP, 2015, COLLOID SURFACE B, V133, P331, DOI 10.1016/j.colsurfb.2015.06.036; Reynolds TD, 2002, DRUG DEV IND PHARM, V28, P457, DOI 10.1081/DDC-120003007; SAETTONE MF, 1995, ADV DRUG DELIVER REV, V16, P95, DOI 10.1016/0169-409X(95)00014-X; Schulze J, 2016, ACTA BIOMATER; Sebe I, 2015, INT J PHARMACEUT, V494, P516, DOI 10.1016/j.ijpharm.2015.08.054; Shivaprakash MR, 2011, MYCOSES, V54, pE583, DOI 10.1111/j.1439-0507.2010.01996.x; Shukr M, 2014, ARCH PHARM RES, V37, P882, DOI 10.1007/s12272-013-0317-x; Shukr MH, 2016, J MICROENCAPSUL, V33, P71, DOI 10.3109/02652048.2015.1128489; Siafaka PI, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030282; Sun XZ, 2013, CARBOHYD POLYM, V94, P147, DOI 10.1016/j.carbpol.2012.12.064; Szente L, 1999, ADV DRUG DELIVER REV, V36, P17, DOI 10.1016/S0169-409X(98)00092-1; Taepaiboon P, 2006, NANOTECHNOLOGY, V17, P2317, DOI 10.1088/0957-4484/17/9/041; Tonglairoum P, 2016, AAPS PHARM SCI TECH; Tonglairoum P, 2014, PHARM RES-DORDR, V31, P1893, DOI 10.1007/s11095-013-1291-1; Xu JK, 2010, J BIOMAT SCI-POLYM E, V21, P1023, DOI 10.1163/156856209X463690; Yang W, 2010, EUR J PHARM SCI, V39, P336, DOI 10.1016/j.ejps.2010.01.001	44	40	40	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167961	10.1371/journal.pone.0167961	http://dx.doi.org/10.1371/journal.pone.0167961			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6ZW	27974859	Green Published, gold, Green Submitted			2022-12-27	WOS:000398960300001
J	Sampson, DM; Alonso-Caneiro, D; Chew, AL; Lamey, T; McLaren, T; De Roach, J; Chen, FK				Sampson, Danuta M.; Alonso-Caneiro, David; Chew, Avenell L.; Lamey, Tina; McLaren, Terri; De Roach, John; Chen, Fred K.			Enhanced Visualization of Subtle Outer Retinal Pathology by En Face Optical Coherence Tomography and Correlation with Multi-Modal Imaging	PLOS ONE			English	Article							LAYER SEGMENTATION; AUTOMATIC SEGMENTATION; OCT; IMAGES; DISEASE; THICKNESS	Purpose To present en face optical coherence tomography (OCT) images generated by graphsearch theory algorithm-based custom software and examine correlation with other imaging modalities. Methods En face OCT images derived from high density OCT volumetric scans of 3 healthy subjects and 4 patients using a custom algorithm (graph-search theory) and commercial software (Heidelberg Eye Explorer software (Heidelberg Engineering)) were compared and correlated with near infrared reflectance, fundus autofluorescence, adaptive optics flood-illumination ophthalmoscopy (AO-FIO) and microperimetry. Results Commercial software was unable to generate accurate en face OCT images in eyes with retinal pigment epithelium (RPE) pathology due to segmentation error at the level of Bruch's membrane (BM). Accurate segmentation of the basal RPE and BM was achieved using custom software. The en face OCT images from eyes with isolated interdigitation or ellipsoid zone pathology were of similar quality between custom software and Heidelberg Eye Explorer software in the absence of any other significant outer retinal pathology. En face OCT images demonstrated angioid streaks, lesions of acute macular neuroretinopathy, hydroxychloroquine toxicity and Bietti crystalline deposits that correlated with other imaging modalities. Conclusions Graph-search theory algorithm helps to overcome the limitations of outer retinal segmentation inaccuracies in commercial software. En face OCT images can provide detailed topography of the reflectivity within a specific layer of the retina which correlates with other forms of fundus imaging. Our results highlight the need for standardization of image reflectivity to facilitate quantification of en face OCT images and longitudinal analysis.	[Sampson, Danuta M.; Chew, Avenell L.; Lamey, Tina; De Roach, John; Chen, Fred K.] Univ Western Australia, Ctr Ophthalmol & Vis Sci, Crawley, WA, Australia; [Sampson, Danuta M.; Chew, Avenell L.; Chen, Fred K.] Lions Eye Inst, Nedlands, WA, Australia; [Alonso-Caneiro, David] Queensland Univ Technol, Sch Optometry & Vis Sci, Contact Lens & Visual Opt Lab, Brisbane, Qld, Australia; [Lamey, Tina; McLaren, Terri; De Roach, John] Sir Charles Gairdner Hosp, Dept Med Technol & Phys, Nedlands, WA, Australia; [Chen, Fred K.] Royal Perth Hosp, Dept Ophthalmol, Perth, WA, Australia	University of Western Australia; Lions Eye Institute; University of Western Australia; Queensland University of Technology (QUT); University of Western Australia; Royal Perth Hospital; University of Western Australia	Chen, FK (corresponding author), Univ Western Australia, Ctr Ophthalmol & Vis Sci, Crawley, WA, Australia.	fred.chen@lei.org.au	Sampson, Danuta/AAN-6075-2021; LAMEY, TINA/AAL-6401-2021; , Fred/B-8158-2013; Sampson, Danuta M/A-5873-2016	LAMEY, TINA/0000-0002-4608-4073; , Fred/0000-0003-2809-9930; Alonso-Caneiro, David/0000-0002-7754-6592; Sampson, Danuta M/0000-0003-4737-6606	Ophthalmic Research Institute of Australia; Global Ophthalmology Award Program Bayer; National Health & Medical Research Council [APP1054712, 37812900]; Retina Australia; Health Department of Western Australia	Ophthalmic Research Institute of Australia; Global Ophthalmology Award Program Bayer; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Retina Australia; Health Department of Western Australia	This study was supported by the Ophthalmic Research Institute of Australia (DMS, FKC); Global Ophthalmology Award Program Bayer (FKC); National Health & Medical Research Council (Early Career Fellowship; APP1054712, FKC; Equipment Grant: 37812900, FKC); Retina Australia (FKC, JDR, TL, TM); and Health Department of Western Australia (FKC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Affortit AS, 2015, RETINA-J RET VIT DIS, V35, P1049, DOI 10.1097/IAE.0000000000000362; Alonso-Caneiro D, 2013, BIOMED OPT EXPRESS, V4, P2795, DOI 10.1364/BOE.4.002795; Chen HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09269; Chen Q, 2014, RETINA-J RET VIT DIS, V34, P996, DOI 10.1097/IAE.0000000000000018; Chiu SJ, 2010, OPT EXPRESS, V18, P19413, DOI 10.1364/OE.18.019413; De Roach JN, 2013, CLIN EXP OPHTHALMOL, V41, P476, DOI 10.1111/ceo.12020; Fabritius T, 2009, OPT EXPRESS, V17, P15659, DOI 10.1364/OE.17.015659; Fernandez DC, 2005, OPT EXPRESS, V13, P10200, DOI 10.1364/OPEX.13.010200; Francis AW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145628; Garvin MK, 2009, IEEE T MED IMAGING, V28, P1436, DOI 10.1109/TMI.2009.2016958; Girkin C., 2005, ESSENTIAL HRT PRIMER, P1; Gliem Martin, 2013, Frontiers in Genetics, V4, P14, DOI 10.3389/fgene.2013.00014; Gorczynska I, 2009, BRIT J OPHTHALMOL, V93, P603, DOI 10.1136/bjo.2007.136101; Haeker M, 2007, PROC SPIE, V6512, DOI 10.1117/12.710231; Hariri AH, 2016, JAMA OPHTHALMOL, V134, P628, DOI 10.1001/jamaophthalmol.2016.0502; Heiferman MJ, 2015, RETINA-J RET VIT DIS, V35, P2593, DOI 10.1097/IAE.0000000000000666; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; Issa PC, 2009, INVEST OPHTH VIS SCI, V50, P5913, DOI 10.1167/iovs.09-3541; Itoh Y, 2016, BRIT J OPHTHALMOL, V100, P295, DOI 10.1136/bjophthalmol-2015-307105; KLIEN BA, 1947, AM J OPHTHALMOL, V30, P955; Mansour AM, 2007, EUR J OPHTHALMOL, V17, P680, DOI 10.1177/112067210701700434; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Mesiwala NK, 2015, J OPHTHALMIC INFLAMM, V5, DOI 10.1186/s12348-015-0053-0; Mishra A, 2009, OPT EXPRESS, V17, P23719, DOI 10.1364/OE.17.023719; Mohammad F, 2014, J OPHTHALMOL, V2014, P1; Muthiah MN, 2014, BRIT J OPHTHALMOL, V98, P1073, DOI 10.1136/bjophthalmol-2013-304615; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Novais EA, 2016, OSLI RETINA, V47, P201, DOI 10.3928/23258160-20160229-01; Pilotto E, 2015, INVEST OPHTH VIS SCI, V56, P8120, DOI 10.1167/iovs.15-17366; Pisano ED, 1998, J DIGIT IMAGING, V11, P193, DOI 10.1007/BF03178082; Puche N, 2014, GRAEF ARCH CLIN EXP, V252, P555, DOI 10.1007/s00417-013-2493-2; Read SA, 2015, RETINA-J RET VIT DIS, V35, P1223, DOI 10.1097/IAE.0000000000000464; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sallo FB, 2012, INVEST OPHTH VIS SCI, V53, P6145, DOI 10.1167/iovs.12-10580; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi F, 2015, IEEE T MED IMAGING, V34, P441, DOI 10.1109/TMI.2014.2359980; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Tavtigian SV, 2008, HUM MUTAT, V29, P1342, DOI 10.1002/humu.20896; Thevenaz P, 2007, MICROSC RES TECHNIQ, V70, P135, DOI 10.1002/jemt.20393; Toto L, 2013, CLIN EXP OPTOM, V96, P39, DOI 10.1111/j.1444-0938.2012.00784.x; Vermeer KA, 2014, BIOMED OPT EXPRESS, V5, P322, DOI 10.1364/BOE.5.000322; Vermeer KA, 2011, BIOMED OPT EXPRESS, V2, P1743, DOI 10.1364/BOE.2.001743; Wojtkowski M, 2010, APPL OPTICS, V49, pD30, DOI 10.1364/AO.49.000D30; Wojtkowski M, 2009, OPT EXPRESS, V17, P4189, DOI 10.1364/OE.17.004189; Yang Q, 2010, OPT EXPRESS, V18, P21293, DOI 10.1364/OE.18.021293; Yazdanpanah A, 2011, IEEE T MED IMAGING, V30, P484, DOI 10.1109/TMI.2010.2087390	47	9	10	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168275	10.1371/journal.pone.0168275	http://dx.doi.org/10.1371/journal.pone.0168275			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959968	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900053
J	Gershengorn, HB; Xu, YC; Chan, CW; Armony, M; Gong, MN				Gershengorn, Hayley B.; Xu, Yunchao; Chan, Carri W.; Armony, Mor; Gong, Michelle N.			The Impact of Adding a Physician Assistant to a Critical Care Outreach Team	PLOS ONE			English	Article							RAPID RESPONSE TEAMS; NURSE-PRACTITIONERS; INPATIENT; SYSTEMS; TIME	Rationale Hospitals are increasingly using critical care outreach teams (CCOTs) to respond to patients deteriorating outside intensive care units (ICUs). CCOT staffing is variable across hospitals and optimal team composition is unknown. Objectives To assess whether adding a critical care medicine trained physician assistant (CCM-PA) to a critical care outreach team (CCOT) impacts clinical and process outcomes. Methods We performed a retrospective study of two cohorts-one with a CCM-PA added to the CCOT (intervention hospital) and one with no staffing change (control hospital)-at two facilities in the same system. All adults in the emergency department and hospital for whom CCOT consultation was requested from October 1, 2012-March 16, 2013 (pre-intervention) and January 5-March 31, 2014 (post-intervention) were included. We performed difference-in-differences analyses comparing pre- to post-intervention periods in the intervention versus control hospitals to assess the impact of adding the CCM-PA to the CCOT. Measurements and Main Results Our cohort consisted of 3,099 patients (control hospital: 792 pre- and 595 post-intervention; intervention hospital: 1114 pre- and 839 post-intervention). Intervention hospital patients tended to be younger, with fewer comorbidities, but with similar severity of acute illness. Across both periods, hospital mortality (p = 0.26) and hospital length of stay (p = 0.64) for the intervention vs control hospitals were similar, but time-to-transfer to the ICU was longer for the intervention hospital (13.3-17.0 vs 11.5-11.6 hours, p = 0.006). Using the difference-in-differences approach, we found a 19.2% reduction (95 confidence interval: 6.7%-31.6%, p = 0.002) in the time-to-transfer to the ICU associated with adding the CCM-PA to the CCOT; we found no difference in hospital mortality (p = 0.20) or length of stay (p = 0.52). Conclusions Adding a CCM-PA to the CCOT was associated with a notable reduction in time-to-transfer to the ICU; hospital mortality and length of stay were not impacted.	[Gershengorn, Hayley B.; Gong, Michelle N.] Montefiore Med Ctr, Albert Einstein Coll Med, Div Crit Care Med, Bronx, NY 10467 USA; [Gershengorn, Hayley B.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Xu, Yunchao; Armony, Mor] NYU, Stern Sch Business, Dept Informat Operat & Management Sci, New York, NY USA; [Chan, Carri W.] Columbia Business Sch, Div Decis Risk & Operat, New York, NY USA; [Gong, Michelle N.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; New York University; Columbia University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Gershengorn, HB (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Div Crit Care Med, Bronx, NY 10467 USA.; Gershengorn, HB (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA.	hgershen@montefiore.org	Chan, Carri W/J-3237-2016	Gershengorn, Hayley/0000-0002-7360-2489	National Science Foundation [CMII 1233547]; National Heart Lung Blood Institute [U01 HL122998, U01 HL123009, UH2 HL125119]	National Science Foundation(National Science Foundation (NSF)); National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Science Foundation (CMII 1233547) for CWC; National Heart Lung Blood Institute (U01 HL122998, U01 HL123009, UH2 HL125119) for MNG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie A, 2005, REV ECON STUD, V72, P1, DOI 10.1111/0034-6527.00321; Alvarez AA, 2013, MED INTENSIVA, V37, P12, DOI 10.1016/j.medin.2012.08.006; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2014, 2013 AAPA ANN SURVEY; [Anonymous], 2011, AG HEALTHC RES QUAL; ASHENFELTER O, 1985, REV ECON STAT, V67, P648, DOI 10.2307/1924810; Bing-Hua YU, 2014, AM J SURG, V208, P268, DOI 10.1016/j.amjsurg.2013.08.044; Cardoso LTQ, 2011, CRIT CARE, V15, DOI 10.1186/cc9975; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; Chan PS, 2010, ARCH INTERN MED, V170, P18, DOI 10.1001/archinternmed.2009.424; Cretikos M A, 2005, Minerva Anestesiol, V71, P259; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; DUBAYBO BA, 1991, CHEST, V99, P89, DOI 10.1378/chest.99.1.89; Edelson DP, 2011, J HOSP MED, V6, P475, DOI 10.1002/jhm.886; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Escobar GJ, 2008, MED CARE, V46, P232, DOI 10.1097/MLR.0b013e3181589bb6; Garland A, 2013, CHEST, V143, P214, DOI 10.1378/chest.12-1531; Gershengorn HB, 2012, AM J RESP CRIT CARE, V185, P600, DOI 10.1164/rccm.201107-1261CP; Gershengorn HB, 2011, CHEST; Harris Steve, 2015, Lancet, V385 Suppl 1, pS40, DOI 10.1016/S0140-6736(15)60355-5; Health Care Protocol: Rapid Response Team, 2011, HLTH CARE PROTOCOL R; Jones D, 2009, CRIT CARE, V13, DOI 10.1186/cc7996; Kapu AN, 2014, CRIT CARE NURSE, V34, P51, DOI 10.4037/ccn2014847; Kawar Eyad, 2011, JAAPA, V24, P36; Kleinpell RM, 2008, CRIT CARE MED, V36, P2888, DOI 10.1097/CCM.0b013e318186ba8c; Laurens NH, 2010, INT J NURS PRACT, V16, P533, DOI 10.1111/j.1440-172X.2010.01879.x; McGaughey J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005529; McNeill G, 2013, RESUSCITATION, V84, P1652, DOI 10.1016/j.resuscitation.2013.08.006; Morris DS, 2012, RESUSCITATION; Niven DJ, CRIT CARE MED, V201; Puymirat E, 2015, EUR HEART J ACUTE CA; Repasky TM, 2005, J EMERG NURS, V31, P376, DOI 10.1016/j.jen.2005.06.025; Rothberg MB, 2012, J HOSP MED, V7, P98, DOI 10.1002/jhm.953; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Society of Critical Care Medicine, 2014, COMP CRIT CAR PROF; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Winters BD, 2013, ANN INTERN MED, V158, P417, DOI 10.7326/0003-4819-158-5-201303051-00009	37	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167959	10.1371/journal.pone.0167959	http://dx.doi.org/10.1371/journal.pone.0167959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942002	gold, Green Published, Green Submitted			2022-12-27	WOS:000392745600040
J	Huang, Y; Tang, W; Mu, Y; Li, XH; Liu, Z; Wang, YP; Li, MR; Li, Q; Dai, L; Liang, J; Zhu, J				Huang, Yan; Tang, Wen; Mu, Yi; Li, Xiaohong; Liu, Zheng; Wang, Yanping; Li, Mingrong; Li, Qi; Dai, Li; Liang, Juan; Zhu, Jun			The Sex Ratio at Birth for 5,338,853 Deliveries in China from 2012 to 2015: A Facility-Based Study	PLoS One			English	Article							MARRIAGE SQUEEZE; RECENT INCREASE; AGE	Objective The accuracy of a population-based sex ratio at birth (SRB) in China has long been questioned. To depict a more accurate profile, the present study used data from a national surveillance system for health facility births to explore the characteristics of SRB in China. Methods Data from China's National Maternal Near Miss Surveillance System between 2012 and 2015 were used. We restricted the analysis to live births of >= 28 completed gestational weeks or >= 1000 g birth weight. The strength of association between obstetric characteristics and SRB was examined using logistic regression, taking into account the sampling strategy and clustering of births within health facilities. Results There were 2,785,513 boys and 2,549,269 girls born alive between 2012 and 2015 in 441 health facilities. The SRB was 111.04 in 2012, 110.16 in 2013, 108.79 in 2014, and 109.53 in 2015. The SRB was high in the eastern region, especially in rural areas. The SRBs increased with mother's age and decreased with mother's education. The SRB in women who were pregnant for the first time was 104.30. The SRB in primipara was normal (104.35), but it was extremely high in non-primipara, especially for women with three or more parities (141.76); only 5.26% of live births fell within this group. The SRBs increased significantly by the number of parities, especially in the rural areas of the central region. After adjustment for sociodemographic factors, women with three or more parities were 1.39 (95% CI 1.34, 1.43) times more likely to give birth to a boy compared with primiparae who were pregnant for the first time. Conclusion Our analysis suggests that the SRB was lower than what was reported officially but higher than normal. The government should keep strengthening supervision to prevent sex-selection, especially in the wake of the two-child policy implemented in 2015.	[Huang, Yan] Sichuan Univ, West China Univ Hosp 2, Dept Nursing, Chengdu, Sichuan, Peoples R China; [Tang, Wen; Mu, Yi; Li, Xiaohong; Liu, Zheng; Wang, Yanping; Li, Mingrong; Li, Qi; Dai, Li; Liang, Juan; Zhu, Jun] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Natl Off Maternal & Child Hlth Surveillance China, West China Univ Hosp 2,Minist Educ, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University	Liang, J; Zhu, J (corresponding author), Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Natl Off Maternal & Child Hlth Surveillance China, West China Univ Hosp 2,Minist Educ, Chengdu, Sichuan, Peoples R China.	liangjuan028@163.com; zhujun028@163.com		Li, Xiaohong/0000-0003-0336-7302	UNICEF; China Medical Board [11-065]; National "Twelfth Five-Year Plan for Science and Technology Support [2014BAI06B01]	UNICEF; China Medical Board; National "Twelfth Five-Year Plan for Science and Technology Support	The authors received support from the UNICEF, China Medical Board (11-065), and the National "Twelfth Five-Year Plan for Science and Technology Support (2014BAI06B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BHAT PNM, 2002, ECON POLIT WEEKLY, V51, P5105; Boklage CE, 2005, HUM REPROD, V20, P583, DOI 10.1093/humrep/deh662; Garenne M, 2008, HUM BIOL, V80, P473, DOI 10.3378/1534-6617-80.5.473; Gavalas V, 2015, J BIOSOC SCI, V47, P363, DOI 10.1017/S0021932014000182; Gong WG, 2013, REGIONAL VARIATIONS, V27, P32; Guilmoto CZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004624; He J, 2013, LIB RES, V43, P126; Health and Family Planning Commission of the People's Republic of China, CHIN OFF Q A NUM BIR; Health and Family Planning Commission of the People's Republic of China, CHIN SRB KEPT GOING; Health and Family Planning Commission of the People's Republic of China, NOT STRENGTH PREV ID; Hongyan Cui, 2013, POPULATION RES, V37, P10; Jia ZK, 2012, SOCIAL SCI, P22; Jiang QB, 2015, CHINESE J POPULATION, P60; Jiang QB, 2014, POPUL RES POLICY REV, V33, P189, DOI 10.1007/s11113-013-9283-8; Liu Haocheng, 2014, SHANGHAI MANAGEMENT, V36, P5; Liu LG, 2014, J CONTEMP CHINA, V23, P351, DOI 10.1080/10670564.2013.832541; Madhukar SD, 2013, NATURWISSENSCHAFTEN, V100, P559, DOI [10.1007/s00114-013-1052-3, DOI 10.1007/S00114-013-1052-3]; Ministry of Health China, NAT MAT NEAR MISS SU; Ministry of Human Resources and Social Security of the People's Republic of China, 2014, ANN REP DEV SOC INS; National Bureau of Statistics of China, CHIN EC REAL MOD STA; National Bureau of Statistics of China, STAT COMM PEOPL REP; Nie JB, 2011, BRIT MED BULL, V98, P7, DOI 10.1093/bmb/ldr015; PARK CB, 1995, POPUL DEV REV, V21, P59, DOI 10.2307/2137413; Pham BN, 2010, J BIOSOC SCI, V42, P757, DOI 10.1017/S0021932010000398; Research Team of National Strategy on Population Development, 2007, GEN REP CHIN NAT STR, P45; ROSTRON J, 1977, ANN HUM GENET, V41, P205, DOI 10.1111/j.1469-1809.1977.tb01916.x; Sun QR, 2013, POPULATION DEV, V19, P95; The Central People's Government of the People's Republic of China, NAT POP CENS REG; Wang G, 2016, SCI PROGRAMMING-NETH, V2016, DOI 10.1155/2016/3676149; Wang Pei'an, VIC MIN NAT HLTH FAM; Wang SA, 2009, HEBEI ACAD J, P174; Wang XF, 2015, MED SOC, V28, P34; Xu L, 2008, POPULATION RES, V32, P79; Yang JH, 2009, POPULATION DEV, V15, P37; Yu GJ, 2014, J XIANGTAN U PHILOS, P112; Yu p, 2007, GANSU SOCIAL SCI, P189; ZENG Y, 1993, POPUL DEV REV, V19, P283; Zhai ZW, 2011, J FUJIAN JIANGXIA U, V1, P4; Zhao XF, 2014, J ANHUI VOCATIONAL C, V13, P7; Zhou XD, 2011, SOC SCI MED, V73, P1422, DOI 10.1016/j.socscimed.2011.07.033; Zhu J, 2016, LANCET GLOB HEALTH, V4, pE109, DOI 10.1016/S2214-109X(15)00271-5; Zhu XJ, 2010, NW POPULATION, V31, P8	43	12	12	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167575	10.1371/journal.pone.0167575	http://dx.doi.org/10.1371/journal.pone.0167575			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27941978	Green Submitted, Green Published, gold			2022-12-27	WOS:000392745600022
J	Sankar, CP; Asharaf, S; Kumar, KS				Sankar, C. Prem; Asharaf, S.; Kumar, K. Satheesh			Learning from Bees: An Approach for Influence Maximization on Viral Campaigns	PLOS ONE			English	Article							ALGORITHM	Maximisation of influence propagation is a key ingredient to any viral marketing or sociopolitical campaigns. However, it is an NP-hard problem, and various approximate algorithms have been suggested to address the issue, though not largely successful. In this paper, we propose a bio-inspired approach to select the initial set of nodes which is significant in rapid convergence towards a sub-optimal solution in minimal runtime. The performance of the algorithm is evaluated using the re-tweet network of the hashtag #KissofLove on Twitter associated with the non-violent protest against the moral policing spread to many parts of India. Comparison with existing centrality based node ranking process the proposed method significant improvement on influence propagation. The proposed algorithm is one of the hardly few bio-inspired algorithms in network theory. We also report the results of the exploratory analysis of the network kiss of love campaign.	[Sankar, C. Prem; Kumar, K. Satheesh] Univ Kerala, Dept Futures Studies, Kariyavattom 695581, Kerala, India; [Asharaf, S.] IIITM K, Thiruvananthapuram 695581, Kerala, India	University of Kerala	Kumar, KS (corresponding author), Univ Kerala, Dept Futures Studies, Kariyavattom 695581, Kerala, India.	kskumar@keralauniversity.ac.in	c, Prem Sankar/N-6643-2014	KUMAR P, SATHEESH/0000-0003-3643-3644; C, Prem Sankar/0000-0002-7053-0651				Achananuparp P, 2012, ACM TRANS MANAG INF, V3, DOI 10.1145/2361256.2361258; Akay B, 2012, INFORM SCIENCES, V192, P120, DOI 10.1016/j.ins.2010.07.015; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bojic I., 2012, COMPUTATIONAL SOCIAL, P51, DOI [10.1007/978-1-4471-4054-2_3, DOI 10.1007/978-1-4471-4054-2_3]; Brajevic I, 2013, J INTELL MANUF, V24, P729, DOI 10.1007/s10845-011-0621-6; Cha M., 2010, ICWSM, P10, DOI DOI 10.1093/JSCR/2010.10.10; Dorigo M, 1999, ARTIF LIFE, V5, P137, DOI 10.1162/106454699568728; Gao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066732; Gonzalez-Bailon S, 2013, AM BEHAV SCI; Halim AH, 2014, NNGT J INT J INFORM, V1, P1; Jansen BJ, 2009, J AM SOC INF SCI TEC, V60, P2169, DOI 10.1002/asi.21149; Karaboga D., 2005, IDEA BASED HONEY BEE, DOI 10.1.1.714.4934; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Karaboga D, 2009, APPL MATH COMPUT, V214, P108, DOI 10.1016/j.amc.2009.03.090; Kempe D, 2005, LECT NOTES COMPUT SC, V3580, P1127, DOI 10.1007/11523468_91; Kempe D., 2015, THEORY COMPUT, V11, P105, DOI [DOI 10.4086/T0C.2015.V011A004, 10.4086/toc.2015.v011a004, DOI 10.4086/TOC.2015.V011A004]; Kempe D, 2003, P 9 ACM SIGKDD INT C, V2003, P137, DOI DOI 10.1145/956750.956769; Kennedy J., 1995, P ICNN 95 INT C NEUR, P1942; Lambiotte R., 2008, LAPLACIAN DYNAMICS M; Narayanam R, 2011, IEEE T AUTOM SCI ENG, V8, P130, DOI 10.1109/TASE.2010.2052042; Nikolaev A, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P225, DOI 10.1145/2939672.2939681; Omkar SN, 2011, APPL SOFT COMPUT, V11, P489, DOI 10.1016/j.asoc.2009.12.008; Pan QK, 2011, INFORM SCIENCES, V181, P2455, DOI 10.1016/j.ins.2009.12.025; Pei S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05547; Richardson M., 2002, P 8 ACM SIGKDD INT C, P61, DOI DOI 10.1145/775047.775057; Rivero J, 2012, APPL INTELL, V36, P899, DOI 10.1007/s10489-011-0304-1; Rogers EM, 2004, J HEALTH COMMUN, V9, P13, DOI 10.1080/10810730490271449; Singh A, 2009, APPL SOFT COMPUT, V9, P625, DOI 10.1016/j.asoc.2008.09.001; Teodorovic DA, 2003, TRANSPORT PLAN TECHN, V26, P289, DOI 10.1080/0308106032000154593; Weng J., 2010, P 3 ACM INT C WEB SE, P261, DOI [10.1145/1718487.1718520, DOI 10.1145/1718487.1718520]; Wu F, 2004, PHYSICA A, V337, P327, DOI 10.1016/j.physa.2004.01.030; Wu XJ, 2012, APPL MECH MATER, V102-102, P315, DOI 10.4028/www.scientific.net/AMM.101-102.315; Xu CF, 2010, AEROSP SCI TECHNOL, V14, P535, DOI 10.1016/j.ast.2010.04.008; Yang X.-S., 2013, BRIEF REV NATURE INS; Zhang B, 2013, INT J MODEL IDENTIF, V18, P349; Zhang XY, 2014, IEEE T MAGN, V50, DOI 10.1109/TMAG.2013.2285161; Zhu YQ, 2015, J COMB OPTIM, V30, P97, DOI 10.1007/s10878-013-9635-7	37	25	26	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168125	10.1371/journal.pone.0168125	http://dx.doi.org/10.1371/journal.pone.0168125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992472	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600037
J	Siebert, A; Goren, I; Pfeilschifter, J; Frank, S				Siebert, Anna; Goren, Itamar; Pfeilschifter, Josef; Frank, Stefan			Anti-Inflammatory Effects of Rosiglitazone in Obesity-Impaired Wound Healing Depend on Adipocyte Differentiation	PLOS ONE			English	Article							GROWTH-FACTOR EXPRESSION; ACTIVATED-RECEPTOR-GAMMA; DIABETIC OB/OB MICE; PPAR-GAMMA; NITRIC-OXIDE; CULTURED KERATINOCYTES; INSULIN-RESISTANCE; ADIPOSE-TISSUE; POTENTIAL ROLE; SKIN REPAIR	Combined diabetes-obesity syndromes severely impair regeneration of acute skin wounds in mouse models. This study assessed the contribution of subcutaneous adipose tissue to exacerbated wound inflammatory conditions. Genetically obese (ob/ob) mice showed an increased expression of positive transcriptional effectors of adipocyte differentiation such as Kruppel-like factor (KLF)-5 and peroxisome proliferator-activated receptor (PPAR)-gamma and an associated expression of leptin and fatty acid-binding protein (FABP)-4, but also CXCL2 in isolated subcutaneous fat. This observation in obese mice is in keeping with differentially elevated levels of KLF-5, PPAR-gamma, leptin, FABP-4 and CXCL2 in in vitro-differentiated 3T3-L1 adipocytes. Notably, CXCL2 expression restrictively appeared upon cytokine (IL-1 beta/TNF-alpha) stimulation only in mature, but not immature 3T3-L1 adipocytes. Of importance, the critical regulator of adipocyte maturation, PPAR-gamma, was merely expressed in the final phase of in-vitro induced adipocyte differentiation from 3T3-L1 pre-adipocytes. Consistently, the PPAR-gamma agonist rosiglitazone suppressed cytokine-induced CXCL2 release from mature adipocytes, but not from early 3T3-L1 adipocyte stages. The inhibitory effect of PPAR-gamma activation on CXCL2 release appeared to be a general anti-inflammatory effect in mature adipocytes, as cytokine-induced cyclooxygenase (Cox)-2 was simultaneously repressed by rosiglitazone. In accordance with these findings, oral administration of rosiglitazone to wounded obese mice significantly changed subcutaneous adipocyte morphology, reduced wound CXCL2 and Cox-2 expression and improved tissue regeneration. Thus, our data suggest that PPAR-gamma might provide a target to suppress inflammatory signals from mature adipocytes, which add to the prolonged wound inflammation observed in diabetes-obesity conditions.	[Siebert, Anna; Goren, Itamar; Pfeilschifter, Josef; Frank, Stefan] Klinikum Johann Wolfgang Goethe Univ, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Goren, I (corresponding author), Klinikum Johann Wolfgang Goethe Univ, Pharmazentrum Frankfurt ZAFES, Theodor Stern Kai 7, Frankfurt, Germany.	goren@chemie.uni-frankfurt.de			Deutsche Forschungsgemeinschaft (DFG) [GRK 1172]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Support was provided by Deutsche Forschungsgemeinschaft (DFG), GRK 1172, http://www.dfg.de/, to SF and JP.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; APELQVIST J, 1993, J INTERN MED, V233, P485, DOI 10.1111/j.1365-2796.1993.tb01003.x; Bost F, 2005, BIOCHIMIE, V87, P51, DOI 10.1016/j.biochi.2004.10.018; CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Carrington AL, 2001, DIABETES CARE, V24, P216, DOI 10.2337/diacare.24.2.216; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; deMora JF, 1997, MOL CELL BIOL, V17, P6068, DOI 10.1128/MCB.17.10.6068; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; Faglia E, 2001, DIABETES CARE, V24, P78, DOI 10.2337/diacare.24.1.78; Falanga V, 2005, LANCET, V366, P1736, DOI 10.1016/S0140-6736(05)67700-8; Frank S, 1999, FASEB J, V13, P2002, DOI 10.1096/fasebj.13.14.2002; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Frank S, 2000, J CLIN INVEST, V106, P501, DOI 10.1172/JCI9148; GELOEN A, 1989, AM J PHYSIOL, V257, pE547, DOI 10.1152/ajpendo.1989.257.4.E547; GOODSON WH, 1986, DIABETES, V35, P491, DOI 10.2337/diab.35.4.491; Goren I, 2006, AM J PATHOL, V168, P765, DOI 10.2353/ajpath.2006.050293; Goren I, 2003, DIABETES, V52, P2821, DOI 10.2337/diabetes.52.11.2821; Goren I, 2007, J INVEST DERMATOL, V127, P2259, DOI 10.1038/sj.jid.5700842; Goren I, 2009, J INVEST DERMATOL, V129, P752, DOI 10.1038/jid.2008.230; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Henry RR, 1997, ENDOCRIN METAB CLIN, V26, P553, DOI 10.1016/S0889-8529(05)70267-X; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Kampfer H, 2001, LAB INVEST, V81, P361, DOI 10.1038/labinvest.3780244; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kloting N, 2014, REV ENDOCR METAB DIS, V15, P277, DOI 10.1007/s11154-014-9301-0; Kralisch S, 2013, DIABETOLOGIA, V56, P10, DOI 10.1007/s00125-012-2737-4; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kumar A, 2015, FUTURE MED CHEM, V7, P2065, DOI 10.4155/fmc.15.132; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; LEIBOVICH SJ, 1975, AM J PATHOL, V78, P71; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Ptasinska A, 2007, FASEB J, V21, P950, DOI 10.1096/fj.06-6822com; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012; Reiber GE, 1998, AM J SURG, V176, p5S, DOI 10.1016/S0002-9610(98)00181-0; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Sakaue H, 2004, J BIOL CHEM, V279, P39951, DOI 10.1074/jbc.M407353200; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; Seitz O, 2010, EXP DIABETES RES, DOI 10.1155/2010/476969; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Siegmund B, 2002, GASTROENTEROLOGY, V122, P2011, DOI 10.1053/gast.2002.33631; SIMPSON DM, 1972, J CLIN INVEST, V51, P2009, DOI 10.1172/JCI107007; Stallmeyer B, 1999, J INVEST DERMATOL, V113, P1090, DOI 10.1046/j.1523-1747.1999.00784.x; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245; WAHL SM, 1974, AM J PATHOL, V75, P73; Walsh JW, 2015, DIAB MED; Wang SB, 2016, PHARMACOL RES, V111, P76, DOI 10.1016/j.phrs.2016.02.028; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; WERNER S, 1994, J INVEST DERMATOL, V103, P469, DOI 10.1111/1523-1747.ep12395564; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; WIDMER U, 1993, J IMMUNOL, V150, P4996; Wright MB, 2014, MOL ENDOCRINOL, V28, P1756, DOI 10.1210/me.2013-1427; Yaacob NS, 2009, J CLIN IMMUNOL, V29, P595, DOI 10.1007/s10875-009-9300-1; Zebisch K, 2012, ANAL BIOCHEM, V425, P88, DOI 10.1016/j.ab.2012.03.005; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)02129-8; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	70	11	12	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168562	10.1371/journal.pone.0168562	http://dx.doi.org/10.1371/journal.pone.0168562			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992530	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600076
J	Tellapragada, C; Kamthan, A; Shaw, T; Vandana, KE; Kumar, S; Bhat, V; Mukhopadhyay, C				Tellapragada, Chaitanya; Kamthan, Aayushi; Shaw, Tushar; Vandana, K. E.; Kumar, Subodh; Bhat, Vinod; Mukhopadhyay, Chiranjay			Unravelling the Molecular Epidemiology and Genetic Diversity among Burkholderia pseudomallei Isolates from South India Using Multi-Locus Sequence Typing	PLoS One			English	Article							MELIOIDOSIS	There is a slow but steady rise in the case detection rates of melioidosis from various parts of the Indian sub-continent in the past two decades. However, the epidemiology of the disease in India and the surrounding South Asian countries remains far from well elucidated. Multi-locus sequence typing (MLST) is a useful epidemiological tool to study the genetic relatedness of bacterial isolates both with-in and across the countries. With this background, we studied the molecular epidemiology of 32 Burkholderia pseudomallei isolates (31 clinical and 1 soil isolate) obtained during 2006-2015 from various parts of south India using multi-locus sequencing typing and analysis. Of the 32 isolates included in the analysis, 30 (93.7%) had novel allelic profiles that were not reported previously. Sequence type (ST) 1368 (n = 15, 46.8%) with allelic profile (1, 4, 6, 4, 1, 1, 3) was the most common genotype observed. We did not observe a genotypic association of STs with geographical location, type of infection and year of isolation in the present study. Measure of genetic differentiation (F-ST) between Indian and the rest of world isolates was 0.14413. Occurrence of the same ST across three adjacent states of south India suggest the dispersion of B.pseudomallei across the south western coastal part of India with limited geographical clustering. However, majority of the STs reported from the present study remained as "outliers" on the eBURST "Population snapshot", suggesting the genetic diversity of Indian isolates from the Australasian and Southeast Asian isolates.	[Tellapragada, Chaitanya; Shaw, Tushar; Vandana, K. E.; Mukhopadhyay, Chiranjay] Manipal Univ, Kasturba Med Coll, Dept Microbiol, Manipal, India; [Kamthan, Aayushi; Kumar, Subodh] Def Res & Dev Org, Div Microbiol, Gwalior, India; [Bhat, Vinod] Manipal Univ, Kasturba Med Coll, Dept Community Med, Manipal, India	Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Defence Research & Development Organisation (DRDO); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal	Mukhopadhyay, C (corresponding author), Manipal Univ, Kasturba Med Coll, Dept Microbiol, Manipal, India.	chiranjay.m@manipal.edu	Shaw, Tushar/AAP-7846-2020; Tellapragada, Chaitanya/AAS-1232-2021; Mukhopadhyay, Chiranjay/GLU-2887-2022	Mukhopadhyay, Chiranjay/0000-0003-0402-1143; Tellapragada, chaitanya/0000-0002-0117-5369; Kumar, Subodh/0000-0002-8764-3361	Indian Council of Medical Research [2012-0465]	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The study was funded by Indian Council of Medical Research (2012-0465). Part of the work was also carried out at Defense Research and Development Organization India where experiment and data analysis was carried. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuradha K, 2003, Indian J Med Microbiol, V21, P129; Corea EM, 2016, AM J TROP MED HYG, V94, P292, DOI 10.4269/ajtmh.15-0567; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; Godoy D, 2003, J CLIN MICROBIOL, V41, P2068, DOI 10.1128/JCM.41.5.2068-2079.2003; Gopalakrishnan R., 2013, Journal of the Association of Physicians of India, V61, P24; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; McCombie RL, 2006, J CLIN MICROBIOL, V44, P2951, DOI 10.1128/JCM.00725-06; Mukhopadhyay C, 2011, AM J TROP MED HYG, V85, P121, DOI 10.4269/ajtmh.2011.11-0166; Pearson T, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-78; Vandana K, 2010, MELIOIDOSIS SO INDIA	11	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168331	10.1371/journal.pone.0168331	http://dx.doi.org/10.1371/journal.pone.0168331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992477	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600049
J	Liu, RS; Wang, J; Shang, XK; Wang, YY; Su, ZX; Cai, Y				Liu, Risheng; Wang, Jing; Shang, Xiaoke; Wang, Yiyang; Su, Zhixun; Cai, Yu			Sparse Coding and Counting for Robust Visual Tracking	PLOS ONE			English	Article							OBJECT TRACKING; PURSUIT	In this paper, we propose a novel sparse coding and counting method under Bayesian framework for visual tracking. In contrast to existing methods, the proposed method employs the combination of L-0 and L-1 norm to regularize the linear coefficients of incrementally updated linear basis. The sparsity constraint enables the tracker to effectively handle difficult challenges, such as occlusion or image corruption. To achieve real-time processing, we propose a fast and efficient numerical algorithm for solving the proposed model. Although it is an NP-hard problem, the proposed accelerated proximal gradient (APG) approach is guaranteed to converge to a solution quickly. Besides, we provide a closed solution of combining L-0 and L-1 regularized representation to obtain better sparsity. Experimental results on challenging video sequences demonstrate that the proposed method achieves state-of-the-art results both in accuracy and speed.	[Liu, Risheng] Dalian Univ Technol, Sch Software Technol, Dalian, Liaoning Provin, Peoples R China; [Liu, Risheng] Key Lab Ubiquitous Network & Serv Software Liaoni, Dalian, Liaoning Provin, Peoples R China; [Wang, Jing; Wang, Yiyang; Su, Zhixun; Cai, Yu] Dalian Univ Technol, Sch Math Sci, Dalian, Liaoning Provin, Peoples R China; [Shang, Xiaoke] Luxun Acad Fine Arts, Dalian Campus, Dalian, Liaoning Provin, Peoples R China	Dalian University of Technology; Dalian University of Technology; Lu Xun Academy of Fine Arts	Liu, RS (corresponding author), Dalian Univ Technol, Sch Software Technol, Dalian, Liaoning Provin, Peoples R China.; Liu, RS (corresponding author), Key Lab Ubiquitous Network & Serv Software Liaoni, Dalian, Liaoning Provin, Peoples R China.	rsliu@dlut.edu.cn		Wang, Yiyang/0000-0002-8924-3468	National Natural Science Foundation of China [61672125, 61300086, 61432003]; Fundamental Research Funds for the Central Universities [DUT15QY15]; Hong Kong Scholar Program [XJ2015008]; National Science and Technology Major Project [2013ZX04005-021, 2014ZX001011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hong Kong Scholar Program; National Science and Technology Major Project	This work is partially supported by the National Natural Science Foundation of China (Nos. 61672125, 61300086, 61432003), the Fundamental Research Funds for the Central Universities (DUT15QY15), the Hong Kong Scholar Program (No. XJ2015008), and National Science and Technology Major Project (Nos. 2013ZX04005-021, 2014ZX001011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babenko B, 2009, PROC CVPR IEEE, P983, DOI 10.1109/CVPRW.2009.5206737; Bai QX, 2013, IEEE I CONF COMP VIS, P2040, DOI 10.1109/ICCV.2013.255; BAO CL, 2012, PROC CVPR IEEE, P1830, DOI DOI 10.1109/CVPR.2012.6247881; Hare S, 2011, IEEE I CONF COMP VIS, P263, DOI 10.1109/ICCV.2011.6126251; Jepson AD, 2003, IEEE T PATTERN ANAL, V25, P1296, DOI 10.1109/TPAMI.2003.1233903; Jia X, 2012, PROC CVPR IEEE, P1822, DOI 10.1109/CVPR.2012.6247880; Jin W, 2014, IEEE INT CON MULTI; Kalal Z, 2012, IEEE T PATTERN ANAL, V34, P1409, DOI 10.1109/TPAMI.2011.239; Levy A, 2000, IEEE T IMAGE PROCESS, V9, P1371, DOI 10.1109/83.855432; Lin Z., 2009, P COMP ADV MULT AD P; Liu BY, 2010, LECT NOTES COMPUT SC, V6314, P624; Liu RS, 2014, IEEE MULTIMEDIA, V21, P47, DOI 10.1109/MMUL.2014.49; Liu RS, 2014, NEUROCOMPUTING, V142, P529, DOI 10.1016/j.neucom.2014.03.046; Liu R, 2009, IEEE I CONF COMP VIS, P1459, DOI 10.1109/ICCV.2009.5459285; Lu XQ, 2013, IEEE T NEUR NET LEAR, V24, P929, DOI 10.1109/TNNLS.2013.2245914; Mei X, 2009, IEEE I CONF COMP VIS, P1436, DOI 10.1109/ICCV.2009.5459292; Pan J, 2013, BMVC; Ross DA, 2008, INT J COMPUT VISION, V77, P125, DOI 10.1007/s11263-007-0075-7; Tseng P., 2008, SIAM J OPTIMIZ UNPUB; Vojfr T., 2014, REGISTRATION RECOGNI, P113, DOI DOI 10.1007/978-3-642-44907-9_6; Wang D, 2013, PROC CVPR IEEE, P2371, DOI 10.1109/CVPR.2013.307; Wang D, 2013, IEEE T IMAGE PROCESS, V22, P314, DOI 10.1109/TIP.2012.2202677; Wu Y, 2013, PROC CVPR IEEE, P2411, DOI 10.1109/CVPR.2013.312; Zhang CC, 2014, NEUROCOMPUTING, V131, P237, DOI 10.1016/j.neucom.2013.10.020; Zhang L, 2013, PROC CVPR IEEE, P1838, DOI 10.1109/CVPR.2013.240; Zhang TZ, 2013, INT J COMPUT VISION, V101, P367, DOI 10.1007/s11263-012-0582-z; ZHANG TZ, 2015, PROC CVPR IEEE, P150, DOI DOI 10.1109/CVPR.2015.7298610; Zhong W, 2012, PROC CVPR IEEE, P1838, DOI 10.1109/CVPR.2012.6247882	28	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168093	10.1371/journal.pone.0168093	http://dx.doi.org/10.1371/journal.pone.0168093			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992474	gold, Green Published, Green Submitted			2022-12-27	WOS:000392758000027
J	Puigvehi, M; Hernandez, J; Broquetas, T; Coll, S; Garcia-Retortillo, M; Canete, N; Gimenez, MD; Garcia, M; Bory, F; Salvado, M; Sola, R; Carrion, JA				Puigvehi, Marc; Hernandez, Juanjo; Broquetas, Teresa; Coll, Susanna; Garcia-Retortillo, Montserrat; Canete, Nuria; Dolors Gimenez, Maria; Garcia, Mar; Bory, Felipe; Salvado, Margarita; Sola, Ricard; Carrion, Jose A.			Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF (R)) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years	PLOS ONE			English	Article							SIMPLE NONINVASIVE INDEX; LONG-TERM STORAGE; STABILITY; CIRRHOSIS; MARKERS; PREDICT	Introduction & Aims Cryopreservation of serum samples is a standard procedure for biomedical research in tertiary centers. However, studies evaluating the long-term biological stability of direct liver fibrosis markers using cryopreserved samples are scarce. Methods We compared the stability of hyaluronic acid (HA), tissue inhibitor of metalloproteinases (TIMP-1) and amino-terminal propeptide of type III procollagen (PIIINP) in 225 frozen serum samples of HCV-infected patients with a paired liver biopsy for up to 25 years (1990-2014). Moreover, we assessed the diagnostic accuracy (AUROC) of the Enhanced Liver Fibrosis (ELF (R)) score to identify significant fibrosis (F2-4) and its predictive capacity to identify clinical events during follow-up. Results Seventy-six patients (39,8%) had mild fibrosis (F0-1) and 115 (60,2%) significant fibrosis (F2-4). HA, PIIINP and TIMP-1 values remained stable during the period from 1995 to 2014 while those of 1990-94 were slightly higher. We did not find significant differences in the median ELF (R) values during the 20-year period from 1995-2014 in patients with mild (from 8,4 to 8,7) and significant fibrosis (from 9,9 to 10,9) (p = ns between periods and fibrosis stages). The AUROCs of ELF (R) to identify significant fibrosis were high in all the periods (from 0,85 to 0,91). The ELF (R) score showed a good predictive capability to identify clinical events during follow-up. Conclusions The biological stability of direct serum markers (HA, PIIINP and TIMP-1) using HCV-infected samples cryopreserved for 20 years is good. Therefore, the diagnostic accuracy of the ELF (R) score to identify significant fibrosis and clinical events during follow-up is very high.	[Puigvehi, Marc; Broquetas, Teresa; Coll, Susanna; Garcia-Retortillo, Montserrat; Canete, Nuria; Dolors Gimenez, Maria; Bory, Felipe; Sola, Ricard; Carrion, Jose A.] Univ Autonoma Barcelona, Hosp Mar, Dept Gastroenterol, Liver Sect, E-08193 Barcelona, Spain; [Puigvehi, Marc; Broquetas, Teresa; Coll, Susanna; Garcia-Retortillo, Montserrat; Canete, Nuria; Dolors Gimenez, Maria; Sola, Ricard; Carrion, Jose A.] IMIM Hosp Mar Med Res Inst, Barcelona, Spain; [Hernandez, Juanjo; Salvado, Margarita] Lab Referencia Catalunya, Barcelona, Spain; [Garcia, Mar] Hosp Mar, Dept Pathol, Barcelona, Spain	Autonomous University of Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar	Carrion, JA (corresponding author), Univ Autonoma Barcelona, Hosp Mar, Dept Gastroenterol, Liver Sect, E-08193 Barcelona, Spain.; Carrion, JA (corresponding author), IMIM Hosp Mar Med Res Inst, Barcelona, Spain.	95565@parcsalutmar.cat	Garcia, Mar/GOG-9086-2022; Carrion, Jose A/M-2086-2017; Carrión, Jose A. A/GPW-5566-2022	Garcia, Mar/0000-0003-2078-8205; Carrion, Jose A/0000-0001-7191-6081; Carrión, Jose A. A/0000-0001-7191-6081; BROQUETAS, TERESA/0000-0002-5935-3076; Nuria, Canete Hidalgo/0000-0001-9501-7590; Puigvehi, Marc/0000-0002-3694-3241; GARCIA-RETORTILLO, MONTSERRAT/0000-0001-6783-7604				Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Carrion JA, 2014, J VIRAL HEPAT; Castera L, 2011, LIVER INT, V31, P13, DOI 10.1111/j.1478-3231.2010.02380.x; Chou R, 2013, ANN INTERN MED, V158, P807, DOI 10.7326/0003-4819-158-11-201306040-00005; DIMAGNO EP, 1989, MAYO CLIN PROC, V64, P1226, DOI 10.1016/S0025-6196(12)61285-3; Forns X, 2002, HEPATOLOGY, V36, P986, DOI 10.1053/jhep.2002.36128; Gislefoss RE, 2009, CLIN CHEM LAB MED, V47, P596, DOI 10.1515/CCLM.2009.121; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Kisand K, 2011, CLIN CHEM LAB MED, V49, P229, DOI 10.1515/CCLM.2011.049; Lichtinghagen R, 2013, J HEPATOL, V59, P236, DOI 10.1016/j.jhep.2013.03.016; Parkes J, 2011, J VIRAL HEPATITIS, V18, P23, DOI 10.1111/j.1365-2893.2009.01263.x; Pawlotsky JM, 2014, J HEPATOL, V61, P373, DOI 10.1016/j.jhep.2014.05.001; Reed AB, 2008, J UROLOGY, V180, P534, DOI 10.1016/j.juro.2008.04.021; Rosenberg WMC, 2004, GASTROENTEROLOGY, V127, P1704, DOI 10.1053/j.gastro.2004.08.052; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Vergniol J, 2011, GASTROENTEROLOGY, V140, P1970, DOI 10.1053/j.gastro.2011.02.058; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Xie QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092772	18	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0164883	10.1371/journal.pone.0164883	http://dx.doi.org/10.1371/journal.pone.0164883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27984583	Green Published, gold			2022-12-27	WOS:000392758000001
J	Bing, R; Chow, V; Lau, JK; Thomas, L; Kritharides, L; Ng, ACC				Bing, Rong; Chow, Vincent; Lau, Jerrett K.; Thomas, Liza; Kritharides, Leonard; Ng, Austin Chin Chwan			Prevalence of Echocardiography Use in Patients Hospitalized with Confirmed Acute Pulmonary Embolism: A Real-World Observational Multicenter Study	PLOS ONE			English	Article							RIGHT-VENTRICULAR DYSFUNCTION; VENOUS THROMBOEMBOLISM; EUROPEAN-SOCIETY; SEVERITY INDEX; RIGHT HEART; MORTALITY; DIAGNOSIS; VALIDATION; MANAGEMENT; METAANALYSIS	Background Acute pulmonary embolism (PE) carries an increased risk of death. Using transthoracic echocardiography (TTE) to assist diagnosis and risk stratification is recommended in current guidelines. However, its utilization in real-world clinical practice is unknown. We conducted a retrospective observational study to delineate the prevalence of inpatient TTE use following confirmed acute PE, identify predictors for its use and its impact on patient's outcome. Methods Clinical details of consecutive patients (2000 to 2012) from two tertiary-referral hospitals were retrieved from dedicated PE databases. All-cause and cause-specific mortality was tracked from a state-wide death registry. Results In total, 2306 patients were admitted with confirmed PE, of whom 687 (29.8%) had inpatient TTE (39.3% vs 14.4% between sites, P< 0.001). Site to which patient presented, older age, cardiac failure, atrial fibrillation and diabetes were independent predictors for inpatient TTE use, while malignancy was a negative predictor. Overall mortality was 41.4% (mean followup 66.5 +/- 49.5months). Though inpatient TTE use was not an independent predictor for all-cause or cardiovascular mortality in multivariable analysis, in the inpatient TTE subgroup, right ventricle-right atrial pressure gradient (hazard ratio [HR] 1.02 per-1mmHg increase, 95% confidence interval [CI] 1.01-1.03) and moderate/severe aortic stenosis (HR 2.26, 95% CI 1.20-4.27) independently predicted all-cause mortality. Conclusions Inpatient TTE is used infrequently in real-world clinical settings following acute PE despite its usefulness in risk stratification, prognostication and assessing comorbid cardiac pathologies. Identifying patients that will benefit most from a TTE assessment following an acute PE episode and reducing barriers in accessing TTE should be explored.	[Bing, Rong; Chow, Vincent; Lau, Jerrett K.; Kritharides, Leonard; Ng, Austin Chin Chwan] Univ Sydney, Concord Hosp, Dept Cardiol, Concord, NSW, Australia; [Thomas, Liza] Univ New South Wales, Liverpool Hosp, Sydney South West Clin Sch, Dept Cardiol, Liverpool, Merseyside, Australia	Concord Repatriation General Hospital; University of Sydney; Liverpool Hospital; University of New South Wales Sydney	Ng, ACC (corresponding author), Univ Sydney, Concord Hosp, Dept Cardiol, Concord, NSW, Australia.	chin.ng@sydney.edu.au	Ng, Austin Chin Chwan/AAQ-3192-2021; Kritharides, Leonard/AAQ-2720-2020	Ng, Austin Chin Chwan/0000-0002-1317-876X	NHMRC [APP1037903]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Professor Leonard Kritharides is supported by NHMRC Program grant (APP1037903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becattini C, 2013, CHEST, V144, P1539, DOI 10.1378/chest.12-2938; Birkhahn RH, 2005, AM J EMERG MED, V23, P323, DOI 10.1016/j.ajem.2005.02.029; Chan CM, 2010, J THROMB HAEMOST, V8, P1509, DOI 10.1111/j.1538-7836.2010.03888.x; Chartier L, 1999, CIRCULATION, V99, P2779, DOI 10.1161/01.CIR.99.21.2779; Cho JH, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-64; Chow V, 2013, CARDIOVASC ULTRASOUN, V11, DOI 10.1186/1476-7120-11-17; den Exter PL, 2013, BLOOD REV, V27, P185, DOI 10.1016/j.blre.2013.06.003; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Gussoni G, 2013, THROMB RES, V131, P24, DOI 10.1016/j.thromres.2012.10.007; Hall WH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-94; Hee L, 2015, INT J CARDIOL, V199, P13, DOI 10.1016/j.ijcard.2015.06.169; Ho WK, 2008, MED J AUSTRALIA, V189, P144, DOI 10.5694/j.1326-5377.2008.tb01947.x; Jaff MR, 2011, CIRCULATION, V123, P1788, DOI 10.1161/CIR.0b013e318214914f; Jimenez D, 2010, ARCH INTERN MED, V170, P1383, DOI 10.1001/archinternmed.2010.199; Klok FA, 2010, AM J RESP CRIT CARE, V181, P501, DOI 10.1164/rccm.200907-1141OC; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Miniati M, 2001, AM J MED, V110, P528, DOI 10.1016/S0002-9343(01)00693-3; National Research Council, 2008, INSTR CLASS UND CAUS, P20001; Ng ACC, 2013, RESPIRATION, V85, P408, DOI 10.1159/000342024; Ng ACC, 2013, INT J CARDIOL, V165, P126, DOI 10.1016/j.ijcard.2011.07.107; Ng ACC, 2011, CIRC-CARDIOVASC QUAL, V4, P122, DOI 10.1161/CIRCOUTCOMES.110.958397; Peugh JL, 2004, REV EDUC RES, V74, P525, DOI 10.3102/00346543074004525; Roy PM, 2005, BMJ-BRIT MED J, V331, P259, DOI 10.1136/bmj.331.7511.259; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sanchez O, 2008, EUR HEART J, V29, P1569, DOI 10.1093/eurheartj/ehn208; Vieillard-Baron A, 2001, INTENS CARE MED, V27, P1481, DOI 10.1007/s001340101032	26	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168554	10.1371/journal.pone.0168554	http://dx.doi.org/10.1371/journal.pone.0168554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977781	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400117
J	Ibrahim, J; Eisen, JA; Jospin, G; Coil, DA; Khazen, G; Tokajian, S				Ibrahim, Joe; Eisen, Jonathan A.; Jospin, Guillaume; Coil, David A.; Khazen, Georges; Tokajian, Sima			Genome Analysis of Streptococcus pyogenes Associated with Pharyngitis and Skin Infections	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; SHOCK-LIKE SYNDROME; MOLECULAR CHARACTERIZATION; SIGMA-FACTOR; EMM TYPE; TETRACYCLINE RESISTANCE; ERYTHROMYCIN RESISTANCE; REDUCED SUSCEPTIBILITY; SUPERANTIGEN GENE; IMMUNE EVASION	Streptococcus pyogenes is a very important human pathogen, commonly associated with skin or throat infections but can also cause life-threatening situations including sepsis, streptococcal toxic shock syndrome, and necrotizing fasciitis. Various studies involving typing and molecular characterization of S. pyogenes have been published to date; however next-generation sequencing (NGS) studies provide a comprehensive collection of an organism's genetic variation. In this study, the genomes of nine S. pyogenes isolates associated with pharyngitis and skin infection were sequenced and studied for the presence of virulence genes, resistance elements, prophages, genomic recombination, and other genomic features. Additionally, a comparative phylogenetic analysis of the isolates with global clones highlighted their possible evolutionary lineage and their site of infection. The genomes were found to also house a multitude of features including gene regulation systems, virulence factors and antimicrobial resistance mechanisms.	[Ibrahim, Joe; Tokajian, Sima] Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Byblos, Lebanon; [Eisen, Jonathan A.; Jospin, Guillaume; Coil, David A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Khazen, Georges] Lebanese Amer Univ, Sch Arts & Sci, Dept Comp Sci & Math, Byblos, Lebanon	Lebanese American University; University of California System; University of California Davis; Lebanese American University	Tokajian, S (corresponding author), Lebanese Amer Univ, Sch Arts & Sci, Dept Nat Sci, Byblos, Lebanon.	stokajian@lau.edu.lb	Khazen, Georges/AAC-2923-2020; Tokajian, Sima T/G-9644-2018; Eisen, Jonathan A./H-2706-2019	Tokajian, Sima T/0000-0002-3653-8940; Eisen, Jonathan A./0000-0002-0159-2197; Khazen, Geroges/0000-0002-9244-2978; Jospin, Guillaume/0000-0002-8746-2632; Ibrahim, Joe/0000-0001-9728-5273				Agniswamy J, 2004, J BIOL CHEM, V279, P52789, DOI 10.1074/jbc.M410698200; Akesson P, 1996, J BIOL CHEM, V271, P1081, DOI 10.1074/jbc.271.2.1081; Albrich WC, 2004, EMERG INFECT DIS, V10, P514, DOI 10.3201/eid1003.030252; Ardanuy C, 2010, J ANTIMICROB CHEMOTH, V65, P634, DOI 10.1093/jac/dkq006; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Aziz RK, 2004, MOL MICROBIOL, V54, P184, DOI 10.1111/j.1365-2958.2004.04255.x; Bahnan W, 2011, J MED MICROBIOL, V60, P98, DOI 10.1099/jmm.0.023317-0; Banks DJ, 2004, J INFECT DIS, V190, P727, DOI 10.1086/422697; Banks DJ, 2003, J INFECT DIS, V188, P1898, DOI 10.1086/379897; Ben Zakour NL, 2012, J CLIN MICROBIOL, V50, P2224, DOI 10.1128/JCM.00675-12; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Bessen DE, 2002, INFECT IMMUN, V70, P1159, DOI 10.1128/IAI.70.3.1159-1167.2002; Bisno A.L., 1980, STREPTOCOCCAL DISEAS, P789; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Brenciani A, 2010, ANTIMICROB AGENTS CH, V54, P221, DOI 10.1128/AAC.00499-09; Canchaya C, 2004, MOL MICROBIOL, V53, P9, DOI 10.1111/j.1365-2958.2004.04113.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chan JCK, 2009, PATHOLOGY, V41, P681, DOI 10.3109/00313020903257723; CHEN CC, 1990, J BIOL CHEM, V265, P3161; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Christensen BB, 1999, J BACTERIOL, V181, P2683, DOI 10.1128/JB.181.9.2683-2688.1999; Coil D, 2015, BIOINFORMATICS, V31, P587, DOI 10.1093/bioinformatics/btu661; Commons R, 2008, J MED MICROBIOL, V57, P1238, DOI 10.1099/jmm.0.2008/001156-0; Commons RJ, 2014, TRENDS MOL MED, V20, P48, DOI 10.1016/j.molmed.2013.10.004; Cosentino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077302; CROOKE E, 1993, J MOL BIOL, V233, P16, DOI 10.1006/jmbi.1993.1481; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Darling AE, 2014, PEERJ, V2, DOI 10.7717/peerj.243; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davies MR, 2015, NAT GENET, V47, P84, DOI 10.1038/ng.3147; DeLasPenas A., 1997, J BACTERIOL, V179, P6862, DOI [10.1128/jb.179.21.6862-6864.1997, DOI 10.1128/JB.179.21.6862-6864.1997]; Enright MC, 2001, INFECT IMMUN, V69, P2416, DOI 10.1128/IAI.69.4.2416-2427.2001; Farmand S, 2012, EUR J CLIN MICROBIOL, V31, P707, DOI 10.1007/s10096-011-1362-3; Feklistov A, 2014, ANNU REV MICROBIOL, V68, P357, DOI 10.1146/annurev-micro-092412-155737; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fischetti VA, 2007, TRENDS MICROBIOL, V15, P297, DOI 10.1016/j.tim.2007.05.003; Fittipaldi N, 2012, AM J PATHOL, V180, P1522, DOI 10.1016/j.ajpath.2011.12.037; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gao F, 2013, NUCLEIC ACIDS RES, V41, pD90, DOI 10.1093/nar/gks990; Gase K, 1999, INFECT IMMUN, V67, P4725, DOI 10.1128/IAI.67.9.4725-4731.1999; Giovanetti E, 2012, ANTIMICROB AGENTS CH, V56, P591, DOI 10.1128/AAC.05352-11; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Hoe NP, 2001, J INFECT DIS, V183, P633, DOI 10.1086/318543; Holden MTG, 2007, J BACTERIOL, V189, P1473, DOI 10.1128/JB.01227-06; HOLLINGSHEAD SK, 1993, MOL MICROBIOL, V8, P707, DOI 10.1111/j.1365-2958.1993.tb01614.x; Homuth G, 1997, J BACTERIOL, V179, P1153, DOI 10.1128/jb.179.4.1153-1164.1997; Hondorp ER, 2007, MOL MICROBIOL, V66, P1056, DOI 10.1111/j.1365-2958.2007.06006.x; Hondorp ER, 2013, MOL MICROBIOL, V88, P1176, DOI 10.1111/mmi.12250; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ikebe T, 2002, INFECT IMMUN, V70, P3227, DOI 10.1128/IAI.70.6.3227-3233.2002; Imohl M, 2010, FEMS IMMUNOL MED MIC, V58, P389, DOI 10.1111/j.1574-695X.2010.00652.x; Inagaki Y, 2000, J INFECT DIS, V181, P975, DOI 10.1086/315299; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Karaky NM, 2014, J MED MICROBIOL, V63, P1197, DOI 10.1099/jmm.0.063412-0; Kratovac Z, 2007, J BACTERIOL, V189, P1299, DOI 10.1128/JB.01301-06; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Lei BF, 2001, NAT MED, V7, P1298, DOI 10.1038/nm1201-1298; Lewis T, 2010, J HOSP INFECT, V75, P37, DOI 10.1016/j.jhin.2010.01.012; Li W, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2470; Lizano S, 2007, J BACTERIOL, V189, P1426, DOI 10.1128/JB.01179-06; Luca-Harari B, 2008, J CLIN MICROBIOL, V46, P79, DOI 10.1128/JCM.01626-07; Luca-Harari B, 2009, J CLIN MICROBIOL, V47, P1155, DOI 10.1128/JCM.02155-08; Luo P, 2003, J BACTERIOL, V185, P349, DOI 10.1128/JB.185.1.349-358.2003; Malhotra-Kumar S, 2005, ANTIMICROB AGENTS CH, V49, P4798, DOI 10.1128/AAC.49.11.4798-4800.2005; McAleese F, 2005, ANTIMICROB AGENTS CH, V49, P1865, DOI 10.1128/AAC.49.5.1865-1871.2005; McCormick JK, 2001, INFECT IMMUN, V69, P1381, DOI 10.1128/IAI.69.3.1381-1388.2001; McGregor KF, 2004, J BACTERIOL, V186, P4285, DOI 10.1128/JB.186.13.4285-4294.2004; MCIVER KS, 1995, J BACTERIOL, V177, P6619, DOI 10.1128/jb.177.22.6619-6624.1995; Mihaila-Amrouche L, 2004, J CLIN MICROBIOL, V42, P3844, DOI 10.1128/JCM.42.8.3844-3846.2004; Miyoshi-Akiyama T, 2005, J INFECT DIS, V192, P107, DOI 10.1086/430617; Montes M, 2010, ANTIMICROB AGENTS CH, V54, P93, DOI 10.1128/AAC.00780-09; Musser JM, 2009, J CLIN INVEST, V119, P2455, DOI 10.1172/JCI38095; Musser JM, 2005, AM J PATHOL, V167, P1461, DOI 10.1016/S0002-9440(10)61232-1; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; OFEK I, 1972, INFECT IMMUN, V6, P459, DOI 10.1128/IAI.6.4.459-464.1972; Okumura CYM, 2013, MBIO, V4, DOI 10.1128/mBio.00499-13; Opdyke JA, 2001, MOL MICROBIOL, V42, P495, DOI 10.1046/j.1365-2958.2001.02657.x; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Perez-Trallero E, 2011, ANTIMICROB AGENTS CH, V55, P2406, DOI 10.1128/AAC.01665-10; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Pichichero ME, 2007, OTOLARYNG HEAD NECK, V137, P851, DOI 10.1016/j.otohns.2007.07.033; PLUMMER T H JR, 1991, Glycobiology, V1, P257, DOI 10.1093/glycob/1.3.257; PODBIELSKI A, 1994, MED MICROBIOL IMMUN, V183, P239, DOI 10.1007/BF00198458; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Proft T, 2000, J EXP MED, V191, P1765, DOI 10.1084/jem.191.10.1765; Rantala S, 2012, EUR J CLIN MICROBIOL, V31, P859, DOI 10.1007/s10096-011-1385-9; Ribardo DA, 2006, MOL MICROBIOL, V62, P491, DOI 10.1111/j.1365-2958.2006.05381.x; Richter S, 1998, MOL GEN GENET, V257, P534, DOI 10.1007/s004380050679; Robinson NP, 2005, FEBS J, V272, P3757, DOI 10.1111/j.1742-4658.2005.04768.x; Sanderson-Smith M, 2014, J INFECT DIS, V210, P1325, DOI 10.1093/infdis/jiu260; Schulze K, 2006, VACCINE, V24, P6088, DOI 10.1016/j.vaccine.2006.05.024; Seppala H, 1998, ANTIMICROB AGENTS CH, V42, P257; Sjogren J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-120; Sjogren J, 2013, BIOCHEM J, V455, P107, DOI 10.1042/BJ20130126; Spaulding AR, 2013, CLIN MICROBIOL REV, V26, P422, DOI 10.1128/CMR.00104-12; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; Stollerman GH, 1997, LANCET, V349, P935, DOI 10.1016/S0140-6736(96)06364-7; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Suzuki T, 2000, J APPL MICROBIOL, V88, P555, DOI 10.1046/j.1365-2672.2000.00840.x; Takaya A, 2004, INFECT IMMUN, V72, P1364, DOI 10.1128/IAI.72.3.1364-1373.2004; Timmer AM, 2009, J BIOL CHEM, V284, P862, DOI 10.1074/jbc.M804632200; Tokajian Sima, 2014, Genome Announc, V2, DOI 10.1128/genomeA.00358-14; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Tritt A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042304; Twisselmann B, 2000, EURO SURVEILL, V4; Van Heirstraeten L, 2012, J ANTIMICROB CHEMOTH, V67, P2602, DOI 10.1093/jac/dks281; Vojtek I, 2008, J INFECT DIS, V197, P225, DOI 10.1086/524687; Wajima T, 2008, J MED MICROBIOL, V57, P1383, DOI 10.1099/jmm.0.2008/002642-0; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Walker MJ, 2014, CLIN MICROBIOL REV, V27, P264, DOI 10.1128/CMR.00101-13; WANG H, 1995, MICROB PATHOGENESIS, V18, P153, DOI 10.1016/S0882-4010(95)90013-6; Wargo MJ, 2008, J BACTERIOL, V190, P2690, DOI 10.1128/JB.01393-07; Wong SSY, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.9; Wu DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077033; Yan SS, 2008, DIAGN MICR INFEC DIS, V62, P205, DOI 10.1016/j.diagmicrobio.2008.04.018; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zheng PX, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00149-12; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	124	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168177	10.1371/journal.pone.0168177	http://dx.doi.org/10.1371/journal.pone.0168177			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977735	gold, Green Published			2022-12-27	WOS:000391217400072
J	Kim, JW; Park, SY; You, YH; Ham, DS; Lee, SH; Yang, HK; Jeong, IK; Ko, SH; Yoon, KH				Kim, Ji-Won; Park, Shin-Young; You, Young-Hye; Ham, Dong-Sik; Lee, Seung-Hwan; Yang, Hae Kyung; Jeong, In-Kyung; Ko, Seung-Hyun; Yoon, Kun-Ho			Suppression of ROS Production by Exendin-4 in PSC Attenuates the High Glucose-Induced Islet Fibrosis	PLOS ONE			English	Article							PANCREATIC STELLATE CELLS; ACTIVATION; IDENTIFICATION; HYPERGLYCEMIA; DYSFUNCTION; TGF-BETA-1; TOLERANCE; GROWTH; RATS; MASS	Pancreatic stellate cells (PSCs) play a major role to fibrotic islet destruction observed in diabetic patients and animal model of diabetes. Exendin-4 (Ex-4) is a potent insulinotropic agent and has been approved for the treatment of type 2 diabetes. However, there have been no reports demonstrating the effects of Ex-4 on pancreatic islet fibrosis. In this study, Ex-4 treatment clearly attenuated fibrotic islet destruction and improved glucose tolerance and islet survival. GLP-1 receptor expression was upregulated during activation and proliferation of PSCs by hyperglycemia. The activation of PKA pathway by Ex-4 plays a role in ROS production and angiotensin II (Ang II) production. Exposure to high glucose stimulated ERK activation and Ang II-TGF-beta 1 production in PSCs. Interestingly, Ex-4 significantly reduced Ang II and TGF-beta 1 production by inhibition of ROS production but not ERK phosphorylation. Ex-4 may be useful not only as an anti-diabetic agent but also as an anti-fibrotic agent in type 2 diabetes due to its ability to inhibit PSC activation and proliferation and improve islet fibrosis in OLETF rats.	[Kim, Ji-Won; Park, Shin-Young; You, Young-Hye; Ham, Dong-Sik; Lee, Seung-Hwan; Yang, Hae Kyung; Ko, Seung-Hyun; Yoon, Kun-Ho] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea; [Kim, Ji-Won; You, Young-Hye; Ham, Dong-Sik; Lee, Seung-Hwan; Yang, Hae Kyung; Yoon, Kun-Ho] Catholic Univ Korea, Catholic Res Inst Med Sci, Convergent Res Consortium Immunol Dis, Seoul, South Korea; [Jeong, In-Kyung] Kyung Hee Univ, Sch Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Kyung Hee University	Yoon, KH (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Endocrinol & Metab, Seoul, South Korea.; Yoon, KH (corresponding author), Catholic Univ Korea, Catholic Res Inst Med Sci, Convergent Res Consortium Immunol Dis, Seoul, South Korea.	yoonk@catholic.ac.kr	Lee, Seung-Hwan/C-7568-2018; Lee, Seung-Hwan/AAG-1361-2019; Jeong, In-Kyung/AAI-6488-2020	Lee, Seung-Hwan/0000-0002-3964-3877; Lee, Seung-Hwan/0000-0002-3964-3877; Jeong, In-Kyung/0000-0001-7857-546X; Kim, Ji-Won/0000-0002-3806-4873	Korea Healthcare Technology R&D Project of the Ministry of Health, Welfare Family Affairs [HI14C3417]; Investigator Initiated Study Program of Merck; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0013729]	Korea Healthcare Technology R&D Project of the Ministry of Health, Welfare Family Affairs; Investigator Initiated Study Program of Merck; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology	This study was supported by a grant from the Korea Healthcare Technology R&D Project (HI14C3417) of the Ministry of Health, Welfare & Family Affairs and the Investigator Initiated Study Program of Merck. The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck. This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0013729).	Apte MV, 1999, GUT, V44, P534, DOI 10.1136/gut.44.4.534; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bonner-Weir S, 2001, DIABETES, V50, pS20, DOI 10.2337/diabetes.50.2007.S20; Chung LTK, 2009, BIOCHEM BIOPH RES CO, V390, P613, DOI 10.1016/j.bbrc.2009.10.015; Clark A, 2001, DIABETES, V50, pS169, DOI 10.2337/diabetes.50.2007.S169; Hama K, 2004, BIOCHEM BIOPH RES CO, V315, P905, DOI 10.1016/j.bbrc.2004.01.155; Hayden MR, 2007, ANTIOXID REDOX SIGN, V9, P891, DOI 10.1089/ars.2007.1610; Hirata K, 2009, BIOCHEM BIOPH RES CO, V380, P44, DOI 10.1016/j.bbrc.2009.01.003; Hong OK, 2007, J CELL BIOCHEM, V101, P665, DOI 10.1002/jcb.21222; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kim JW, 2008, FRONT BIOSCI-LANDMRK, V13, P6022, DOI 10.2741/3133; Ko SH, 2006, J CELL BIOCHEM, V98, P343, DOI 10.1002/jcb.20797; Ko SH, 2004, BIOCHEM BIOPH RES CO, V316, P114, DOI 10.1016/j.bbrc.2004.02.023; Kodera R, 2011, DIABETOLOGIA, V54, P965, DOI 10.1007/s00125-010-2028-x; Kruse ML, 2000, REGUL PEPTIDES, V90, P47, DOI 10.1016/S0167-0115(00)00104-X; Leahy JL, 2010, J CLIN ENDOCR METAB, V95, P4206, DOI 10.1210/jc.2010-0668; LEAHY JL, 1992, DIABETES CARE, V15, P442, DOI 10.2337/diacare.15.3.442; Li WB, 2012, CELL PHYSIOL BIOCHEM, V30, P749, DOI 10.1159/000341454; List JF, 2004, AM J PHYSIOL-ENDOC M, V286, pE875, DOI 10.1152/ajpendo.00007.2004; Mukai E, 2011, DIABETES, V60, P218, DOI 10.2337/db10-0021; Nielsen LL, 2004, REGUL PEPTIDES, V117, P77, DOI 10.1016/j.regpep.2003.10.028; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Ryu GR, 2013, BIOCHEM BIOPH RES CO, V439, P258, DOI 10.1016/j.bbrc.2013.08.046; Strauss A, 2008, TRANSPL P, V40, P533, DOI 10.1016/j.transproceed.2008.02.004; Weibel ER., 1978, PRACTICAL METHODS BI; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	29	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0163187	10.1371/journal.pone.0163187	http://dx.doi.org/10.1371/journal.pone.0163187			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977690	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400001
J	Wahn, B; Ferris, DP; Hairston, WD; Konig, P				Wahn, Basil; Ferris, Daniel P.; Hairston, W. David; Koenig, Peter			Pupil Sizes Scale with Attentional Load and Task Experience in a Multiple Object Tracking Task	PLOS ONE			English	Article							LOCUS-COERULEUS; DILATION; EYE; PERFORMANCE; RESPONSES; DIAMETER; REVEALS	Previous studies have related changes in attentional load to pupil size modulations. However, studies relating changes in attentional load and task experience on a finer scale to pupil size modulations are scarce. Here, we investigated how these changes affect pupil sizes. To manipulate attentional load, participants covertly tracked between zero and five objects among several randomly moving objects on a computer screen. To investigate effects of task experience, the experiment was conducted on three consecutive days. We found that pupil sizes increased with each increment in attentional load. Across days, we found systematic pupil size reductions. We compared the model fit for predicting pupil size modulations using attentional load, task experience, and task performance as predictors. We found that a model which included attentional load and task experience as predictors had the best model fit while adding performance as a predictor to this model reduced the overall model fit. Overall, results suggest that pupillometry provides a viable metric for precisely assessing attentional load and task experience in visuospatial tasks.	[Wahn, Basil; Koenig, Peter] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany; [Ferris, Daniel P.] Univ Michigan, Sch Kinesiol, Human Neuromech Lab, Ann Arbor, MI 48109 USA; [Hairston, W. David] US Army Res Lab, Human Res & Engn Directorate, Aberdeen, MD USA; [Koenig, Peter] Univ Med Ctr Hamburg Eppendorf, Ctr Med Expt, Dept Neurophysiol & Pathophysiol, Hamburg, Germany	University Osnabruck; University of Michigan System; University of Michigan; United States Department of Defense; United States Army; US Army Research, Development & Engineering Command (RDECOM); US Army Research Laboratory (ARL); University of Hamburg; University Medical Center Hamburg-Eppendorf	Wahn, B (corresponding author), Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany.	bwahn@uos.de	König, Peter/ABB-2380-2020; Ferris, Daniel P/A-9624-2008; Wahn, Basil/AAV-5770-2021; Ferris, Daniel P./N-6436-2019	König, Peter/0000-0003-3654-5267; Ferris, Daniel P/0000-0001-6373-6021; Ferris, Daniel P./0000-0001-6373-6021; Wahn, Basil/0000-0002-0318-7160	H2020 - H2020-FETPROACT [641321]; ERC-AdG [269716]; Cognition and Neuroergonomics Collaborative Technology Alliance [ARL W91 1NF-10-2-0022]	H2020 - H2020-FETPROACT; ERC-AdG; Cognition and Neuroergonomics Collaborative Technology Alliance	We gratefully acknowledge the support by H2020 - H2020-FETPROACT-2014 641321 - socSMCs (for BW), ERC-2010-AdG \#269716 - MULTISENSE (for PK), and the Cognition and Neuroergonomics Collaborative Technology Alliance ARL W91 1NF-10-2-0022 (for DPF and WDH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	AHERN S, 1979, SCIENCE, V205, P1289, DOI 10.1126/science.472746; Ahern S., 1981, INTELLIGENCE LEARNIN, P121, DOI DOI 10.1007/978-1-4684-1083-9_9; Alnaes D, 2014, J VISION, V14, DOI 10.1167/14.4.1; Arrighi R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00056; Attar N, 2016, MEM COGNITION, P1; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beatty J., 2000, HDB PSYCHOPHYSIOLOGY, P142; Binda P, 2015, TRENDS COGN SCI, V19, P1, DOI 10.1016/j.tics.2014.11.002; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Bradshaw J, 1967, PUPIL SIZE MEASURE A; Causse M, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00240; Cavanagh P, 2005, TRENDS COGN SCI, V9, P349, DOI 10.1016/j.tics.2005.05.009; de Gee JW, 2014, P NATL ACAD SCI USA, V111, pE618, DOI 10.1073/pnas.1317557111; Einhauser Wolfgang, 2010, Front Hum Neurosci, V4, P18, DOI 10.3389/fnhum.2010.00018; Geng JJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00435; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; Granholm E, 2004, INT J PSYCHOPHYSIOL, V52, P1, DOI 10.1016/j.ijpsycho.2003.12.001; Heinrich W., 1896, Z PSYCHOL PHYSL SINN, P342; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; HYONA J, 1995, Q J EXP PSYCHOL-A, V48, P598; Johnson EL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00218; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; Karatekin C, 2004, PSYCHOPHYSIOLOGY, V41, P175, DOI 10.1111/j.1469-8986.2004.00147.x; Kietzmann TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022614; Kloosterman NA, 2015, EUR J NEUROSCI, V41, P1068, DOI 10.1111/ejn.12859; Konstantopoulos P, 2010, ACCIDENT ANAL PREV, V42, P827, DOI 10.1016/j.aap.2009.09.022; Laeng Bruno, 2012, Proc Natl Acad Sci U S A, V109, P2162, DOI 10.1073/pnas.1118298109; Lisi M, 2015, BIOL PSYCHOL, V112, P39, DOI 10.1016/j.biopsycho.2015.10.002; LOEWENFELD I. E., 1958, DOCUMENTA OPHTHALMOL, V12, P185, DOI 10.1007/BF00913471; Mathot S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148805; Mathot S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078168; Murphy PR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003854; Naber M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00919; PAYNE DT, 1968, PERCEPT PSYCHOPHYS, V4, P139, DOI 10.3758/BF03210453; Porter G, 2007, Q J EXP PSYCHOL, V60, P211, DOI 10.1080/17470210600673818; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Privitera CM, 2010, J VISION, V10, DOI 10.1167/10.10.3; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Rajkowski J, 2004, J NEUROPHYSIOL, V92, P361, DOI 10.1152/jn.00673.2003; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Schneider KA, 2009, J NEUROSCI, V29, P1784, DOI 10.1523/JNEUROSCI.4452-08.2009; Sirois S, 2014, WIRES COGN SCI, V5, P679, DOI 10.1002/wcs.1323; Tsai YF, 2007, AVIAT SPACE ENVIR MD, V78, pB176; Twisk J. W. R., 2006, Applied multilevel analysis: a practical guide; Unsworth N, 2016, COGN AFFECT BEHAV NE, P1; van Rijn H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051134; Vanderhasselt MA, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00207; Wahn B., 2016, COGSCI, P2747; Wahn B, 2015, ERGONOMICS; Wahn B, 2016, FRONT INTEGR NEUROSC, V10, DOI 10.3389/fnint.2016.00013; Wahn B, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01084; Wahn B, 2015, MULTISENS RES, V28, P371, DOI 10.1163/22134808-00002482; Wang CA, 2015, CURR OPIN NEUROBIOL, V33, P134, DOI 10.1016/j.conb.2015.03.018; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Zylberberg A, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00316	56	45	45	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168087	10.1371/journal.pone.0168087	http://dx.doi.org/10.1371/journal.pone.0168087			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977762	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400056
J	Fairoozy, RH; White, J; Palmen, J; Kalea, AZ; Humphries, SE				Fairoozy, Roaa Hani; White, Jon; Palmen, Jutta; Kalea, Anastasia Z.; Humphries, Steve E.			Identification of the Functional Variant(s) that Explain the Low-Density Lipoprotein Receptor (LDLR) GWAS SNP rs6511720 Association with Lower LDL-C and Risk of CHD	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RNA-POLYMERASE-II; DNA-BINDING; FAMILIAL HYPERCHOLESTEROLEMIA; TRANSCRIPTIONAL ACTIVATION; COMMON POLYMORPHISM; SPLICING EFFICIENCY; PROMOTER; GENE; CHOLESTEROL	Background The Low-Density Lipoprotein Receptor (LDLR) SNP rs6511720 (G>T), located in intron-1 of the gene, has been identified in genome-wide association studies (GWAS) as being associated with lower plasma levels of LDL-C and a lower risk of coronary heart disease (CHD). Whether or not rs6511720 is itself functional or a marker for a functional variant elsewhere in the gene is not known. Methods The association of LDLR SNP rs6511720 with incidence of CHD and levels of LDL-C was determined by reference to CARDIoGRAM, C4D and Global lipids genetics consortium (GLGC) data. SNP annotation databases were used to identify possible SNP function and prioritization. Luciferase reporter assays in the liver cell line Huh7 were used to measure the effect of variant genotype on gene expression. Electrophoretic Mobility Shift Assays (EMSAs) were used to identify the Transcription Factors (TFs) involved in gene expression regulation. Results The phenotype-genotype analysis showed that the rs6511720 minor allele is associated with lower level of LDL-C [beta = -0.2209, p = 3.85 x10(-262)], and lower risk of CHD [log (OR) = 0.1155, p = 1.04 x 10(-7)]. Rs6511720 is in complete linkage. Rs6511720 is in complete linkage disequilibrium (LD) with three intron-1 SNPs (rs141787760, rs60173709, rs57217136). Luciferase reporter assays in Huh7 cells showed that the rare alleles of both rs6511720 and rs57217136 caused a significant increase in LDLR expression compared to the common alleles (+29% and +24%, respectively). Multiplex Competitor-EMSAs (MC-EMSA) identified that the transcription factor serum response element (SRE) binds to rs6511720, while retinoic acid receptor (RAR) and signal transducer and activator of transcription 1 (STAT1) bind to rs57217136. Conclusion Both LDLR rs6511720 and rs57217136 are functional variants. Both these minor alleles create enhancer-binding protein sites for TFs and may contribute to increased LDLR expression, which is consequently associated with reduced LDL-C levels and 12% lower CHD risk.	[Fairoozy, Roaa Hani; Palmen, Jutta; Kalea, Anastasia Z.; Humphries, Steve E.] UCL, Inst Cardiovasc Sci, BHF Labs, Ctr Cardiovasc Genet, London, England; [White, Jon] UCL, Genet Inst, Dept Genet Environm & Evolut, London, England	University of London; University College London; University of London; University College London	Fairoozy, RH (corresponding author), UCL, Inst Cardiovasc Sci, BHF Labs, Ctr Cardiovasc Genet, London, England.	roaa.fairoozy.12@ucl.ac.uk	Kalea, Anastasia Z./G-4053-2010	Kalea, Anastasia Z./0000-0001-5775-3984; Humphries, Stephen E/0000-0002-8221-6547	King Abdullah Medical city in Holly city (KAMC), the Ministry of Health, Saudi Arabia; National Institute for Health Research, University College London Hospitals, Biomedical Research Centre Cardiometabolic Programme [BRC105CMSH/5982]; BHF [BHFPG08/008]; National Institute for Health Research UCL Hospitals Biomedical Research Centre; British Heart Foundation [RG/08/008/25291] Funding Source: researchfish	King Abdullah Medical city in Holly city (KAMC), the Ministry of Health, Saudi Arabia; National Institute for Health Research, University College London Hospitals, Biomedical Research Centre Cardiometabolic Programme; BHF(British Heart Foundation); National Institute for Health Research UCL Hospitals Biomedical Research Centre; British Heart Foundation(British Heart Foundation)	RHF is funded by King Abdullah Medical city in Holly city (KAMC), the Ministry of Health, Saudi Arabia. AZK is funded by a National Institute for Health Research, University College London Hospitals, Biomedical Research Centre Cardiometabolic Programme (BRC105CMSH/5982). SEH is a British Heart Foundation (BHF) Professor and he and JP are funded by BHF grant (grant numbers BHFPG08/008) and by the National Institute for Health Research UCL Hospitals Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsellem S, 2002, HUM GENET, V111, P501, DOI 10.1007/s00439-002-0813-4; Anand SS, 2009, CIRC-CARDIOVASC GENE, V2, P16, DOI 10.1161/CIRCGENETICS.108.813709; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Boright AP, 1998, J HUM GENET, V43, P153, DOI 10.1007/s100380050060; Bradley DT, 2013, CIRC-CARDIOVASC GENE, V6, P498, DOI 10.1161/CIRCGENETICS.113.000165; BROWN MS, 1979, P NATL ACAD SCI USA, V76, P3330, DOI 10.1073/pnas.76.7.3330; Calhoun VC, 2002, P NATL ACAD SCI USA, V99, P9243, DOI 10.1073/pnas.142291299; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Castro-Oros I, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-17; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Donnelly P, 2008, NATURE, V456, P728, DOI 10.1038/nature07631; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gao F, 2013, HUM MOL GENET, V22, P1424, DOI 10.1093/hmg/dds559; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hobbs Helen H., 1992, Human Mutation, V1, P445, DOI 10.1002/humu.1380010602; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kadonaga JT, 2004, CELL, V116, P247, DOI 10.1016/S0092-8674(03)01078-X; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Khamis A, 2015, EUR J HUM GENET, V23, P790, DOI 10.1038/ejhg.2014.199; Lee JD, 2014, DNA CELL BIOL, V33, P869, DOI 10.1089/dna.2014.2577; Martinelli N, 2010, BLOOD, V116, P5688, DOI 10.1182/blood-2010-03-277079; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Mittal V, 1999, GENE DEV, V13, P1807, DOI 10.1101/gad.13.14.1807; Mozas P, 2002, J LIPID RES, V43, P13; MULLER HP, 1989, CELL, V58, P767, DOI 10.1016/0092-8674(89)90110-4; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pak YK, 1996, BIOCHEM MOL BIOL INT, V38, P31; Peden JF, 2011, NAT GENET, V43, P339, DOI 10.1038/ng.782; Planas AM, 1997, J NEUROCHEM, V68, P1345; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Qin JZ, 2001, J INVEST DERMATOL, V117, P583, DOI 10.1046/j.0022-202x.2001.01436.x; Rose AB, 2008, CURR TOP MICROBIOL, V326, P277; Sadowski CL, 1996, P NATL ACAD SCI USA, V93, P4289, DOI 10.1073/pnas.93.9.4289; SCHLEIF R, 1992, ANNU REV BIOCHEM, V61, P199, DOI 10.1146/annurev.bi.61.070192.001215; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Smith AJP, 2007, EUR J HUM GENET, V15, P1186, DOI 10.1038/sj.ejhg.5201897; Smith AJP, 2009, J MOL BIOL, V385, P714, DOI 10.1016/j.jmb.2008.11.035; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; Talmud PJ, 2013, LANCET, V381, P1293, DOI 10.1016/S0140-6736(12)62127-8; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Usifo E, 2012, ANN HUM GENET, V76, P387, DOI 10.1111/j.1469-1809.2012.00724.x; Ward LD, 2015, NUCL ACIDS RES; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Zhu H, 2007, HUM MOL GENET, V16, P1765, DOI 10.1093/hmg/ddm124; Zou FG, 2008, HUM MOL GENET, V17, P929, DOI 10.1093/hmg/ddm365; Zweig AS, 2008, GENOMICS, V92, P75, DOI 10.1016/j.ygeno.2008.02.003	59	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167676	10.1371/journal.pone.0167676	http://dx.doi.org/10.1371/journal.pone.0167676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973560	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300038
J	Serrao, F; Papacci, P; Costa, S; Giannantonio, C; Cota, F; Vento, G; Romagnoli, C				Serrao, Francesca; Papacci, Patrizia; Costa, Simonetta; Giannantonio, Carmen; Cota, Francesco; Vento, Giovanni; Romagnoli, Costantino			Effect of Early Expressed Human Milk on Insulin-Like Growth Factor 1 and Short-Term Outcomes in Preterm Infants	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; FACTOR-I; IGF-I; BINDING-PROTEINS; ABSORPTION; TRANSPORT; NUTRITION; MOTHERS	Aims Preterm breast milk contains high levels of bioactive components, including insulin-like growth factor 1 (IGF-1), that are reduced by Holder pasteurization. Animal studies have shown that milk-borne IGF-1 is likely absorbed intact in a bioactive form by the intestines. The aim of this study was to assess if early non-pasteurized expressed breast milk nutrition may affect IGF-1 plasma levels in premature infants. We also investigated the possible association between early expressed milk nutrition and short-term outcomes. Methods Fifty-two preterm infants with gestational age < 31 weeks were divided into two groups according to expressed breast milk intake (< or >= 50 mL/Kg/day) until 32 weeks of post-menstrual age when blood sampling for IGF-1 analysis was performed. Results In our population, early expressed breast milk does not affect IGF-1 plasma levels (p 0.48). An association was observed between early expressed milk nutrition and a lower incidence of bronchopulmonary dysplasia, sepsis, feeding intolerance, need for parenteral nutrition and length of hospitalization. Conclusions Contrary to the results in some animal studies, our results did not seem to show that early expressed breast milk can help to maintain postnatal IGF-1 near foetal levels in preterm infants. The observed protective effect of expressed breast milk on short-term outcomes can be the starting point for further study of the effects of non-pasteurized human milk in preterm infants.	[Serrao, Francesca; Papacci, Patrizia; Costa, Simonetta; Giannantonio, Carmen; Cota, Francesco; Vento, Giovanni; Romagnoli, Costantino] Univ Cattolica Sacro Cuore, Div Neonatol, Dept Pediat, Rome, Italy	Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Serrao, F (corresponding author), Univ Cattolica Sacro Cuore, Div Neonatol, Dept Pediat, Rome, Italy.	francesca.serrao@yahoo.it	Cota, Francesco/P-1371-2014; Costa, Simonetta/AAH-2792-2022; Giannantonio, Carmen/AFT-2148-2022; Costa, Simonetta/AFM-0456-2022	Cota, Francesco/0000-0002-9009-3997; COSTA, Simonetta/0000-0003-0980-5297; Vento, Giovanni/0000-0003-3121-9569				Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Bancalari E, 2001, BIOL NEONATE, V80, P7, DOI 10.1159/000047170; Bastian SEP, 1999, J ENDOCRINOL, V162, P361, DOI 10.1677/joe.0.1620361; BAUMRUCKER CR, 1994, J ANIM SCI, V72, P428, DOI 10.2527/1994.722428x; Bertino E, 2010, J PEDIATR GASTR NUTR, V51, P353, DOI 10.1097/MPG.0b013e3181da213e; Burrin DG, 1997, J NUTR, V127, pS975, DOI 10.1093/jn/127.5.975S; Corpeleijn WE, 2012, NEONATOLOGY, V102, P276, DOI 10.1159/000341335; Dritsakou K, 2015, J MATERN-FETAL NEO M, V24, P1; Elmlinger MW, 2007, HORM RES, V68, P124, DOI 10.1159/000100488; Engstrom E, 2005, PEDIATR RES, V57, P605, DOI 10.1203/01.PDR.0000155950.67503.BC; Ewaschuk JB, 2011, APPL PHYSIOL NUTR ME, V36, P175, DOI [10.1139/H11-008, 10.1139/h11-008]; Gartner LM, 2005, PEDIATRICS, V115, P496, DOI 10.1542/peds.2004-2491; Goelz R, 2009, PEDIATR RES, V65, P458, DOI 10.1203/PDR.0b013e3181991f18; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Hansen-Pupp I, 2011, PEDIATR RES, V69, P448, DOI 10.1203/PDR.0b013e3182115000; LASSARRE C, 1991, PEDIATR RES, V29, P219, DOI 10.1203/00006450-199103000-00001; Lee C.-Y., 1995, Asian-Australasian Journal of Animal Sciences, V8, P51; Lim WH, 2012, PEDIATR NEONATOL, V53, P228, DOI 10.1016/j.pedneo.2012.06.003; Philipps AF, 2002, J PEDIATR GASTR NUTR, V35, P539, DOI 10.1097/00005176-200210000-00015; Philipps AF, 2000, J PEDIATR GASTR NUTR, V31, P128, DOI 10.1097/00005176-200008000-00008; Silvestre D, 2008, ACTA PAEDIATR, V97, P1070, DOI 10.1111/j.1651-2227.2008.00870.x; WALSH MC, 1986, PEDIATR CLIN N AM, V33, P179, DOI 10.1016/s0031-3955(16)34975-6; Xu RJ, 1996, J PEDIATR GASTR NUTR, V23, P430, DOI 10.1097/00005176-199611000-00013	24	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168139	10.1371/journal.pone.0168139	http://dx.doi.org/10.1371/journal.pone.0168139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973552	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300059
J	Blanc, P; Dutronc, H; Peuchant, O; Dauchy, FA; Cazanave, C; Neau, D; Wirth, G; Pellegrin, JL; Morlat, P; Mercie, P; Tunon-de-Lara, JM; Doutre, MS; Pelissier, P; Dupon, M				Blanc, Peggy; Dutronc, Herve; Peuchant, Olivia; Dauchy, Frederic-Antoine; Cazanave, Charles; Neau, Didier; Wirth, Gaetane; Pellegrin, Jean-Luc; Morlat, Philippe; Mercie, Patrick; Tunon-de-Lara, Jose-Manuel; Doutre, Marie-Sylvie; Pelissier, Philippe; Dupon, Michel			Nontuberculous Mycobacterial Infections in a French Hospital: A 12-Year Retrospective Study	PLOS ONE			English	Article							HIV-NEGATIVE PATIENTS; COMPLEX LUNG-DISEASE; PULMONARY-DISEASE; AVIUM COMPLEX; CLINICAL-MANIFESTATIONS; PROGNOSTIC-FACTORS; RISK-FACTORS; MORTALITY; XENOPI	Background Nontuberculous mycobacteria (NTM) are environmental organisms associated with a range of infections. Reports of NTM epidemiology are mainly focused on pulmonary infections and isolations, and extrapulmonary infections are less frequently described. Methods We conducted a retrospective study of NTM infections at the Bordeaux University Hospital, France, between January 2002 and December 2013. We used the microbiologic component of the American Thoracic Society/Infectious Diseases Society of America's pulmonary NTM disease criteria to define cases of pulmonary NTM, and patients with isolates from a normally sterile site were classified as having extrapulmonary disease. Results In our setting, 170 patients were included. Pulmonary cases predominated (54.1%), followed by skin and soft tissue infections (22.9%), disseminated cases (10.6%), lymphadenitis (7.7%), bone and joint infections (2.9%) and the remaining 1.8% catheter-related infections. Overall, 16 NTM species were isolated. Mycobacterium avium (31.8%) and M. intracellulare (20%) were the most common species identified, followed by M. marinum (13.5%), M. kansasii (10.6%), M. xenopi (9.4%), rapidly growing mycobacteria (9.4%) and other slowly growing mycobacteria (5.3%). In general, NTM isolates were largely prevalent in people older than 50 (62.4%); patients aged 1-10 year-old exclusively yielded M. avium from lymph nodes, almost cases having being diagnosed after 2007. Among the 121 patients with complete follow-up, 78 (64.5%), 24 (19.8%), and 19 (15.7%) were cured, experienced relapse, or died, respectively. Conclusion In our study, extrapulmonary NTM infections represented almost half of cases, consisting mainly in skin and soft tissue infections. The increase lymphadenitis cases in children after 2007 could be linked to the cessation of mandatory BCG vaccination in France. We observed similar cure rates (64%) between pulmonary and extrapulmonary infections.	[Blanc, Peggy; Dutronc, Herve; Dauchy, Frederic-Antoine; Cazanave, Charles; Neau, Didier; Dupon, Michel] Ctr Hosp Univ Bordeaux, Serv Malad Infect & Trop, Bordeaux, France; [Peuchant, Olivia] Ctr Hosp Univ Bordeaux, Lab Bacteriol, Bordeaux, France; [Peuchant, Olivia] Univ Bordeaux, Infect Humaines Mycoplasmes & Chlamydiae, Bordeaux, France; [Peuchant, Olivia] INRA, Infect Humaines Mycoplasmes & Chlamydiae, Bordeaux, France; [Pellegrin, Jean-Luc; Morlat, Philippe; Mercie, Patrick] Ctr Hosp Univ Bordeaux, Med Interna Serv, Bordeaux, France; [Tunon-de-Lara, Jose-Manuel] Ctr Hosp Univ Bordeaux, Serv Pneumol, Bordeaux, France; [Doutre, Marie-Sylvie] Ctr Hosp Univ Bordeaux, Serv Dermatol, Bordeaux, France; [Pelissier, Philippe] Ctr Hosp Univ Bordeaux, Serv Chirurgie Plast Reconstruct & Esthet Brules, Bordeaux, France	CHU Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; INRAE; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux; CHU Bordeaux	Peuchant, O (corresponding author), Ctr Hosp Univ Bordeaux, Lab Bacteriol, Bordeaux, France.; Peuchant, O (corresponding author), Univ Bordeaux, Infect Humaines Mycoplasmes & Chlamydiae, Bordeaux, France.; Peuchant, O (corresponding author), INRA, Infect Humaines Mycoplasmes & Chlamydiae, Bordeaux, France.	olivia.peuchant@u-bordeaux.fr	Dauchy, Frédéric-Antoine/T-4652-2019; Cazanave, Charles/AHE-5492-2022					Andrejak C, 2009, THORAX, V64, P291, DOI 10.1136/thx.2008.096842; Andrejak C, 2010, AM J RESP CRIT CARE, V181, P514, DOI 10.1164/rccm.200905-0778OC; Atkins BL, 2014, CURR OPIN INFECT DIS, V27, P137, DOI 10.1097/QCO.0000000000000041; Aubry A, 2002, ARCH INTERN MED, V162, P1746, DOI 10.1001/archinte.162.15.1746; Carrillo MC, 2014, CAN ASSOC RADIOL J, V65, P207, DOI 10.1016/j.carj.2013.05.006; Cassidy PM, 2009, CLIN INFECT DIS, V49, pE124, DOI 10.1086/648443; Clinical and Laboratory Standards Institute, 2011, SUSC TEST MYC OTH AE; Dailloux M, 2006, EUR RESPIR J, V28, P1211, DOI 10.1183/09031936.00063806; Falkinham JO, 2002, CLIN CHEST MED, V23, P529, DOI 10.1016/S0272-5231(02)00014-X; Fleshner M, 2016, INT J TUBERC LUNG D, V20, P582, DOI 10.5588/ijtld.15.0807; Gommans EPAT, 2015, RESP MED, V109, P137, DOI 10.1016/j.rmed.2014.10.013; Gonzalez-Santiago TM, 2015, DERMATOL CLIN, V33, P563, DOI 10.1016/j.det.2015.03.017; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Guglielmetti L, 2015, FUTURE MICROBIOL, V10, P1467, DOI 10.2217/fmb.15.64; Hayashi M, 2012, AM J RESP CRIT CARE, V185, P575, DOI 10.1164/rccm.201107-1203OC; Hoefsloot W, 2013, EUR RESPIR J, V42, P1604, DOI 10.1183/09031936.00149212; Ide S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128304; Jenkins PA, 2003, RESP MED, V97, P439, DOI 10.1053/rmed.2002.1444; Jimenez-Montero B, 2014, PEDIATR INFECT DIS J, V33, P28, DOI 10.1097/INF.0000000000000007; Kang HK, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0823-1; Kotilainen H, 2015, EUR J CLIN MICROBIOL, V34, P1909, DOI 10.1007/s10096-015-2432-8; Lee BY, 2015, ANTIMICROB AGENTS CH, V59, P2972, DOI 10.1128/AAC.04577-14; Maugein J, 2005, EUR RESPIR J, V26, P1092, DOI 10.1183/09031936.05.00148604; Mirsaeidi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091879; Rindi L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1380-y; Shah NM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1521-3; Smith GS, 2016, J INFECTION, V72, P678, DOI 10.1016/j.jinf.2016.03.008; Stout JE, 2016, INT J INFECT DIS, V45, P123, DOI 10.1016/j.ijid.2016.03.006; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; Tortoli E, 2009, CLIN MICROBIOL INFEC, V15, P906, DOI 10.1111/j.1469-0691.2009.03014.x; Tortoli E, 2012, INT J MYCOBACT, V1, P165, DOI 10.1016/j.ijmyco.2012.10.008; van Ingen J, 2009, THORAX, V64, P502, DOI 10.1136/thx.2008.110957; Wallace RJ, 2014, J ANTIMICROB CHEMOTH, V69, P1945, DOI 10.1093/jac/dku062; Wassilew N, 2016, RESPIRATION, V91, P386, DOI 10.1159/000445906	34	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168290	10.1371/journal.pone.0168290	http://dx.doi.org/10.1371/journal.pone.0168290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959960	gold, Green Published, Green Submitted			2022-12-27	WOS:000392753900057
J	Carmeis, ACA; Crusciol, CAC; Guimaraes, TM; Calonego, JC; Mooney, SJ				Carmeis Filho, Antonio C. A.; Crusciol, Carlos A. C.; Guimaraes, Tiara M.; Calonego, Juliano C.; Mooney, Sacha J.			Impact of Amendments on the Physical Properties of Soil under Tropical Long-Term No Till Conditions	PLOS ONE			English	Article							CROP GRAIN PRODUCTION; PARTICULATE ORGANIC-MATTER; SURFACE APPLICATION; CARBON CONTENT; LIME; GYPSUM; MANAGEMENT; AGGREGATE; ACID; ROOT	Tropical regions have been considered the world's primary agricultural frontier; however, some physico-chemical deficiencies, such as low soil organic matter content, poor soil structure, high erodibility, soil acidity, and aluminum toxicity, have affected their productive capacity. Lime and gypsum are commonly used to improve soil chemical fertility, but no information exists about the long-term effects of these products on the physical attributes and C protection mechanisms of highly weathered Oxisols. A field trial was conducted in a sandy clay loam (kaolinitic, thermic Typic Haplorthox) under a no-tillage system for 12 years. The trial consisted of four treatments: a control with no soil amendment application, the application of 2.1 Mg ha (-1) phosphogypsum, the application of 2.0 Mg ha(-1) lime, and the application of lime + phosphogypsum (2.0 + 2.1 Mg ha(-1), respectively). Since the experiment was established in 2002, the rates have been applied three times (2002, 2004, and 2010). Surface liming effectively increased water-stable aggregates > 2.0 mm at a depth of up to 0.2 m; however, the association with phosphogypsum was considered a good strategy to improve the macroaggregate stability in subsoil layers (0.20 to 0.40 m). Consequently, both soil amendments applied together increased the mean weight diameter (MWD) and geometric mean diameter (GMD) in all soil layers, with increases of up to 118 and 89%, respectively, according to the soil layer. The formation and stabilization of larger aggregates contributed to a higher accumulation of total organic carbon (TOC) on these structures. In addition to TOC, the MWD and aggregate stability index were positively correlated with Ca2+ and Mg2+ levels and base saturation. Consequently, the increase observed in the aggregate size class resulted in a better organization of soil particles, increasing the macroporosity and reducing the soil bulk density and penetration resistance. Therefore, adequate soil chemical management plays a fundamental role in improving the soil's physical attributes in tropical areas under conservative management and highly affected by compaction caused by intensive farming.	[Carmeis Filho, Antonio C. A.; Crusciol, Carlos A. C.; Guimaraes, Tiara M.; Calonego, Juliano C.] Sao Paulo State Univ UNESP, Dept Crop Sci, Coll Agr Sci, Botucatu, SP, Brazil; [Mooney, Sacha J.] Univ Nottingham, Div Agr & Environm Sci, Nottingham, England	Universidade Estadual Paulista; University of Nottingham	Crusciol, CAC (corresponding author), Sao Paulo State Univ UNESP, Dept Crop Sci, Coll Agr Sci, Botucatu, SP, Brazil.	crusciol@fca.unesp.br	Calonego, Juliano/N-4011-2017; Calonego, Juliano C/AAD-9707-2020; Calonego, Juliano/AFS-1997-2022; Mooney, Sacha J/G-4020-2010	Calonego, Juliano C/0000-0002-8950-3231; Calonego, Juliano/0000-0002-8950-3231; /0000-0003-4673-1071	Sao Paulo Research Foundation (FAPESP) [2013/18462-0, 2014/16712-2]; National Council for Scientific and Technological Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank the Sao Paulo Research Foundation (FAPESP, Proc. 2013/18462-0 and 2014/16712-2) for the financial support and the National Council for Scientific and Technological Development (CNPq) for an award for excellence in research to the second and third authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Sao Paulo Research Foundation (FAPESP, Proc. 2013/18462-0 and 2014/16712-2) for the financial support and the National Council for Scientific and Technological Development (CNPq) for an award for excellence in research to the second and third authors.	Abiven S, 2005, BIOL FERT SOILS, V42, P119, DOI 10.1007/s00374-005-0006-0; Alcarde JA, 2003, TOPICOS CIENCIA SOLO, P291; Baldock D., 1994, NATURE FARMING LOW I; BLAKE G. R., 1986, METHODS SOIL ANAL PH, P363, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C13; Bongiovanni MD, 2006, GEODERMA, V136, P660, DOI 10.1016/j.geoderma.2006.05.002; Briedis C, 2012, GEODERMA, V170, P80, DOI 10.1016/j.geoderma.2011.10.011; Caires EF, 2008, EUR J AGRON, V28, P57, DOI 10.1016/j.eja.2007.05.002; Caires EF, 2015, EUR J AGRON, V66, P41, DOI 10.1016/j.eja.2015.02.008; Caires EF, 2011, AGRON J, V103, P1804, DOI 10.2134/agronj2011.0192; Caires EF, 2005, AGRON J, V97, P791, DOI 10.2134/agronj2004.0207; Cantarella H, 1998, COMMUN SOIL SCI PLAN, V29, P1691, DOI 10.1080/00103629809370060; Carvalho MCS, 1997, PLANT SOIL, V192, P37, DOI 10.1023/A:1004285113189; Castro Filho C., 2002, Soil and Tillage Research, V65, P45, DOI 10.1016/S0167-1987(01)00275-6; Castro GSA, 2013, GEODERMA, V195, P234, DOI 10.1016/j.geoderma.2012.12.006; Chevallier T, 2004, AGR ECOSYST ENVIRON, V103, P375, DOI 10.1016/j.agee.2003.12.009; Correa JC, 2009, REV BRAS CIENC SOLO, V33, P263, DOI 10.1590/S0100-06832009000200004; Crusciol CAC, 2016, CATENA, V137, P87, DOI 10.1016/j.catena.2015.09.009; Denef K, 2001, SOIL BIOL BIOCHEM, V33, P1599, DOI 10.1016/S0038-0717(01)00076-1; Dube F, 2009, FOREST ECOL MANAG, V257, P1695, DOI 10.1016/j.foreco.2009.01.044; EDWARDS AP, 1967, J SOIL SCI, V18, P64, DOI 10.1111/j.1365-2389.1967.tb01488.x; ELLIOTT ET, 1986, SOIL SCI SOC AM J, V50, P627, DOI 10.2136/sssaj1986.03615995005000030017x; Embrapa Brazilian Agricultural Research Corporation, 1997, MAN METH SOIL AN; Fageria NK, 2008, ADV AGRON, V99, P345, DOI 10.1016/S0065-2113(08)00407-0; Fageria NK, 2014, ADV AGRON, V128, P221, DOI 10.1016/B978-0-12-802139-2.00006-8; FARINA MPW, 1988, SOIL SCI SOC AM J, V52, P175, DOI 10.2136/sssaj1988.03615995005200010031x; Franzluebbers AJ, 1997, SOIL SCI SOC AM J, V61, P1382, DOI 10.2136/sssaj1997.03615995006100050014x; Garbuio FJ, 2011, SOIL SCI SOC AM J, V75, P1723, DOI 10.2136/sssaj2010.0291; Garcia RA, 2013, SOIL SCI SOC AM J, V77, P1724, DOI 10.2136/sssaj2012.0310; Hati KM, 2008, GEODERMA, V148, P173, DOI 10.1016/j.geoderma.2008.09.015; Haynes RJ, 1998, NUTR CYCL AGROECOSYS, V51, P123, DOI 10.1023/A:1009738307837; Kemper W.D., 1965, SIZE DISTRIBUTION 1, P499; Kiehl EJ, EDAPHOLOGY MANUAL SO; Klute A., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P687; Lal R, 2000, SOIL SCI, V165, P191, DOI 10.1097/00010694-200003000-00002; Lehmann J, 2007, BIOGEOCHEMISTRY, V85, P45, DOI 10.1007/s10533-007-9105-3; Leys A, 2010, J HYDROL, V390, P143, DOI 10.1016/j.jhydrol.2010.06.034; Manna MC, 2007, SOIL TILL RES, V94, P397, DOI 10.1016/j.still.2006.08.013; Marsili A, 1998, SOIL TILL RES, V49, P185, DOI 10.1016/S0167-1987(98)00169-X; Martins MR, 2013, SOIL BIOL BIOCHEM, V58, P153, DOI 10.1016/j.soilbio.2012.11.011; Mbagwu JSC, 1989, SOIL TECHNOL, V2, P49, DOI DOI 10.1016/S0933-3630(89)80006-6; McCallum MH, 2004, AUST J EXP AGR, V44, P299, DOI 10.1071/EA03076; Mitchell JP, 2000, AGR WATER MANAGE, V45, P55, DOI 10.1016/S0378-3774(99)00070-0; MUNEER M, 1989, AUST J SOIL RES, V27, P411, DOI 10.1071/SR9890411; OGNER G, 1971, CAN J CHEMISTRY, V49, P1053, DOI 10.1139/v71-175; Pagliai M, 2004, SOIL TILL RES, V79, P131, DOI 10.1016/j.still.2004.07.002; Reichert JM, 2009, SOIL TILL RES, V102, P242, DOI 10.1016/j.still.2008.07.002; ROTH CH, 1991, GEODERMA, V48, P351, DOI 10.1016/0016-7061(91)90053-V; Ruhlmann J, 2006, GEODERMA, V130, P272, DOI 10.1016/j.geoderma.2005.01.024; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Smith K.A., 1991, SOIL ANAL PHYS METHO; Soil Survey Staff, 1999, SOIL TAX BAS SYST SO, V2, P436, DOI DOI 10.1111/J.1475-2743.2001.TB00008.X; TISDALL JM, 1982, J SOIL SCI, V33, P141, DOI 10.1111/j.1365-2389.1982.tb01755.x; Tormena C. A., 1998, Revista Brasileira de Ciencia do Solo, V22, P573, DOI 10.1590/S0100-06831998000400002; Traore O, 2000, EUR J SOIL SCI, V51, P575, DOI 10.1111/j.1365-2389.2000.00348.x; Valzano FP, 2001, AUST J SOIL RES, V39, P1307, DOI 10.1071/SR99086; van Raij B., 2001, CHEM ANAL FERTILITY; van Raij B, 1997, RECOMMENDATIONS FERT	57	11	11	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167564	10.1371/journal.pone.0167564	http://dx.doi.org/10.1371/journal.pone.0167564			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959897	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900010
J	Marrone, A; Re, N; Storchi, L				Marrone, Alessandro; Re, Nazzareno; Storchi, Loriano			The Effects of Ca2+ Concentration and E200K Mutation on the Aggregation Propensity of PrPC : A Computational Study	PLOS ONE			English	Article							CELLULAR PRION PROTEIN; STRUCTURAL BASIS; SCRAPIE; BINDING; DISEASE; PROPAGATION; SIMILARITY; CONVERSION; MECHANISM; EPITOPE	The propensity of cellular prion protein to aggregation is reputed essential for the initiation of the amyloid cascade that ultimately lead to the accumulation of neurotoxic aggregates. In this paper, we extended and applied an already reported computational workflow [Proteins 2015; 83: 1751-1765] to elucidate in details the aggregation propensity of PrP protein systems including wild type, wild type treated at different [Ca2+] and E200K mutant. The application of the computational procedure to two segments of PrPC, i.e. 125-228 and 120-231, allowed to emphasize how the inclusion of complete C-terminus and last portion (120-126) of the neurotoxic segment 106-126 may be crucial to unveil significant and unexpected interaction properties. Indeed, the anchoring of N-terminus on H2 domain detected in the wild type resulted to be disrupted upon either E200K mutation or Ca2+ binding, and to unbury hydrophobic spots on the PrPC surface. A peculiar dinuclear Ca2+ binding motif formed by the C-terminus and the S2-H2 loop was detected for [Ca2+] > 5 mM and showed similarities with binding motifs retraced in other protein systems, thus suggesting a possible functional meaning for its formation. Therefore, we potentiated the computational procedure by including a tool that clusterize the minima of molecular interaction fields of a proteinand delimit the regions of space with higher hydrophobic or higher hydrophilic character, hence, more likely involved in the self-assembly process. Plausible models for the self-assembly of either the E200K mutated or Ca2+-bound PrPC were sketched and discussed. The present investigation provides for structure-based information and new prompts that may represent a startings point for future experimental or computational works on the PrPC aggregation.	[Marrone, Alessandro; Re, Nazzareno; Storchi, Loriano] Univ G dAnnunzio, Dept Pharm, Chieti, Italy; [Storchi, Loriano] Mol Discovery Ltd, London, England	G d'Annunzio University of Chieti-Pescara	Marrone, A (corresponding author), Univ G dAnnunzio, Dept Pharm, Chieti, Italy.	amarrone@unich.it	Storchi, Loriano/K-3557-2018	Storchi, Loriano/0000-0001-5021-7759; Marrone, Alessandro/0000-0002-8311-8172	Molecular Discovery Limited, Middlesex, London, United Kingdom	Molecular Discovery Limited, Middlesex, London, United Kingdom	The authors received no specific funding for this work. Concerning the affiliation of Loriano Storchi (LS) to the commercial company Molecular Discovery Limited, Middlesex, London, United Kingdom, we declare that this funder provided support in the form of salaries for one author [LS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.	Bieschke J, 2004, P NATL ACAD SCI USA, V101, P12207, DOI 10.1073/pnas.0404650101; CARBO R, 1980, INT J QUANTUM CHEM, V17, P1185, DOI 10.1002/qua.560170612; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chen W, 2014, BIOPHYS J, V106, P1152, DOI 10.1016/j.bpj.2013.12.053; Chiovitti K, 2007, J NEUROCHEM, V103, P2597, DOI 10.1111/j.1471-4159.2007.04965.x; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chon NL, 2015, BIOCHEMISTRY-US, V54, P5696, DOI 10.1021/acs.biochem.5b00422; Corsaro A, 2011, INT J BIOCHEM CELL B, V43, P372, DOI 10.1016/j.biocel.2010.11.007; Cross S, 2010, DRUG DISCOV TODAY, V15, P23, DOI 10.1016/j.drudis.2008.12.006; Damberger FF, 2011, P NATL ACAD SCI USA, V108, P17308, DOI 10.1073/pnas.1106325108; DeMarco ML, 2006, BIOCHEMISTRY-US, V45, P15573, DOI 10.1021/bi0612723; Florio T, 1998, J NEUROSCI RES, V54, P341, DOI 10.1002/(SICI)1097-4547(19981101)54:3<341::AID-JNR5>3.0.CO;2-G; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Grabarek Z, 2006, J MOL BIOL, V359, P509, DOI 10.1016/j.jmb.2006.03.066; HOLMES MA, 1982, J MOL BIOL, V160, P623, DOI 10.1016/0022-2836(82)90319-9; HUANG ZW, 1994, P NATL ACAD SCI USA, V91, P7139, DOI 10.1073/pnas.91.15.7139; Jones E., SCIPY OPEN SOURCE SC; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kanyo ZF, 1999, J MOL BIOL, V293, P855, DOI 10.1006/jmbi.1999.3193; Khan MQ, 2010, P NATL ACAD SCI USA, V107, P19808, DOI 10.1073/pnas.1005267107; Li L, 2009, PROTEIN ENG DES SEL, V22, P523, DOI 10.1093/protein/gzp038; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Nakano T, 2000, CHEM PHYS LETT, V318, P614, DOI 10.1016/S0009-2614(00)00070-1; NGUYEN JT, 1995, J MOL BIOL, V252, P412, DOI 10.1006/jmbi.1995.0507; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paulis D, 2011, NEUROCHEM INT, V59, P168, DOI 10.1016/j.neuint.2011.04.008; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Simon ES, 2000, ANN NEUROL, V47, P257, DOI 10.1002/1531-8249(200002)47:2<257::AID-ANA20>3.0.CO;2-U; Sorrentino S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038314; Storchi L, 2015, PROTEINS, V83, P1751, DOI 10.1002/prot.24836; Ueyama N, 1999, INORG CHEM, V38, P4028, DOI 10.1021/ic9811042; Van Rossum G., 1995, PYTHON TUTORIAL, V620; Voigtlander T, 2008, NEUROPATH APPL NEURO, V34, P435, DOI 10.1111/j.1365-2990.2007.00902.x; Wiseman F, 2005, BIOCHEM SOC T, V33, P1094, DOI 10.1042/BST20051094; Yagi H, 2015, J BIOL CHEM, V290, P25213, DOI 10.1074/jbc.M115.668384; Yamamoto N, 2014, J PHYS CHEM B, V118, P9826, DOI 10.1021/jp5034245; Yin SM, 2007, P NATL ACAD SCI USA, V104, P7546, DOI 10.1073/pnas.0610827104; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	43	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168039	10.1371/journal.pone.0168039	http://dx.doi.org/10.1371/journal.pone.0168039			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959938	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900035
J	Hogberg, A; Lombard, M				Hogberg, Anders; Lombard, Marlize			Still Bay Point-Production Strategies at Hollow Rock Shelter and Umhlatuzana Rock Shelter and Knowledge-Transfer Systems in Southern Africa at about 80-70 Thousand Years Ago	PLOS ONE			English	Article							MIDDLE STONE-AGE; HOWIESONS POORT; BLOMBOS CAVE; WESTERN CAPE; BEHAVIORAL MODERNITY; HEAT-TREATMENT; DIEPKLOOF; SEQUENCE; ARCHAEOLOGY; STRATIGRAPHY	It has been suggested that technological variations associated with Still Bay assemblages of southern Africa have not been addressed adequately. Here we present a study developed to explore regional and temporal variations in Still Bay point-production strategies. We applied our approach in a regional context to compare the Still Bay point assemblages from Hollow Rock Shelter (Western Cape) and Umhlatuzana Rock Shelter (KwaZulu-Natal). Our interpretation of the point-production strategies implies inter-regional point-production conventions, but also highlights variability and intra-regional knapping strategies used for the production of Still Bay points. These strategies probably reflect flexibility in the organisation of knowledge-transfer systems at work during the later stages of the Middle Stone Age between about 80 ka and 70 ka in South Africa.	[Hogberg, Anders] Linnaeus Univ, Fac Art & Humanities, Dept Cultural Sci, Archaeol, Kalmar, Sweden; [Hogberg, Anders; Lombard, Marlize] Univ Johannesburg, Dept Anthropol & Dev Studies, Auckland Pk, South Africa; [Hogberg, Anders; Lombard, Marlize] Univ Stellenbosch, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS, Stellenbosch, South Africa	Linnaeus University; University of Johannesburg; Stellenbosch University	Hogberg, A (corresponding author), Linnaeus Univ, Fac Art & Humanities, Dept Cultural Sci, Archaeol, Kalmar, Sweden.; Hogberg, A (corresponding author), Univ Johannesburg, Dept Anthropol & Dev Studies, Auckland Pk, South Africa.; Hogberg, A (corresponding author), Univ Stellenbosch, Wallenberg Res Ctr, Stellenbosch Inst Adv Study STIAS, Stellenbosch, South Africa.	anders.hogberg@lnu.se	Lombard, Marlize/O-2073-2019	Lombard, Marlize/0000-0002-0675-0414; Hogberg, Anders/0000-0002-8747-4131	National Research Foundation of South Africa; Swedish Research Council [721-2014-2100]	National Research Foundation of South Africa(National Research Foundation - South Africa); Swedish Research Council(Swedish Research CouncilEuropean Commission)	The research of Hogberg and Lombard is funded by an African Origins Platform Grant awarded to Lombard by the National Research Foundation of South Africa. http://www.nrf.ac.za. The research of Hogberg is also funded by the Swedish Research Council (Dnr 721-2014-2100) http://www.vr.se.	[Anonymous], 1988, AM ANTHROPOL; Apel J, 2001, KNOWLEDGE POWER SOCI, V3; Archer W, 2016, J HUM EVOL, V97, P58, DOI 10.1016/j.jhevol.2016.05.007; Archer W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132428; Argote L, 2000, ORGAN BEHAV HUM DEC, V82, P150, DOI 10.1006/obhd.2000.2893; Aubry T, 2008, WORLD ARCHAEOL, V40, P48, DOI 10.1080/00438240701843538; Barnard Alan, 2011, SOCIAL ANTHR HUMAN O; Barnard Alan., 2000, HIST THEORY ANTHR; Barrett HC, 2009, FOUNDATIONS IN EVOLUTIONARY COGNITIVE NEUROSCIENCE, P97, DOI 10.1017/CBO9780511626586.004; Bijker Wiebe E., 1997, BICYCLES BAKELITES B; Bleed P, 2001, J ARCHAEOL METHOD TH, V8, P101, DOI 10.1023/A:1009526016167; Byrne R., 1995, THINKING APE EVOLUTI; Charbonneau M, 2016, PHILOS TECHNOL; Conard NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130001; Crabtree D.E., 1973, TEBIWA J IDAHO STATE, V16, P10; d'Errico F, 2016, J HUM EVOL, V93, P91, DOI 10.1016/j.jhevol.2016.01.002; d'Errico F, 2015, CAMB ARCHAEOL J, V25, P859, DOI 10.1017/S0959774315000384; de la Pen~a P., 2013, S AFR ARCHAEOL BULL, V68, P119; Deacon Janette, 1990, HIST AFRICAN ARCHAEO, P39; DOMANSKI M, 1992, J ARCHAEOL SCI, V19, P601, DOI 10.1016/0305-4403(92)90031-W; Evans U., 1994, S AFR FIELD ARCHAEOL, V3, P63; Evans U, 1993, HOLLOW ROCK SHELTER; Feathers J, 2015, J ARCHAEOL SCI, V63, P164, DOI 10.1016/j.jas.2015.02.012; Gardenfors P, 2016, CURR ANTHR IN PRESS; Goodwin AJH, 1926, S AFRICAN MUSEUM HDB; Goodwin AJH., 1929, ANN SOUTH AFR MUS, V27, P1; Haidle MN, 2015, J ANTHROPOL SCI, V93, P43, DOI [10.4436/jass.93011, 10.4436/JASS.93011]; Henshilwood CS, 2012, J WORLD PREHIST, V25, P205, DOI 10.1007/s10963-012-9060-3; Heyes C, 2012, PHILOS T R SOC B, V367, P2181, DOI 10.1098/rstb.2012.0120; Hogberg A, 2014, S AFR ARCHAEOL BULL, V69, P142; Hogberg A, 2016, LITHIC ATTRIBUTE ANA; Hogberg A., 2009, BAR INT SERIES, V1932; Hogberg A, 2016, S AFR ARCHAEOL B; Hogberg A, 2008, J ARCHAEOL METHOD TH, V15, P112, DOI 10.1007/s10816-007-9050-4; Hogberg A, 2015, CAMB ARCHAEOL J, V25, P847, DOI 10.1017/S0959774315000402; Hogberg A, 2011, J HUM EVOL, V61, P133, DOI 10.1016/j.jhevol.2011.02.006; Holdaway S.J., 2004, RECORD STONE STUDY A; Inizan Marie -Louise, 1999, PRE HIST PIERRE TAIL; Jacobs Z, 2008, SCIENCE, V322, P733, DOI 10.1126/science.1162219; Jacobs Z, 2015, J ARCHAEOL SCI, V63, P175, DOI 10.1016/j.jas.2015.01.023; Julien CK, 1994, ANCIENT MIND ELEMENT, P152, DOI DOI 10.1017/CBO9780511598388.016; Kandel AW, 2016, J ARCHAEOL METHOD TH, V23, P623, DOI 10.1007/s10816-015-9254-y; Kaplan J, 1990, SOUTH AFR HUMANIT, P94; Kaplan JM., 1989, GOODWIN SERIES, V6, P7, DOI DOI 10.2307/3858128; Kelly Robert L, 2013, LIFEWAYS HUNTER GATH; Kline MA., 2015, BEHAV BRAIN SCI, V38, P1, DOI [10.1017/S0140525X14000090, DOI 10.1017/S0140525X14000090]; Larsson L., 2009, UNDERSTANDING PAPERS, P199; Lombard M., 2006, SOUTH AFR HUMANIT, V18, P27; Lombard M, 2007, S AFR ARCHAEOL BULL, V62, P62, DOI 10.2307/20474947; Lombard M, 2016, VERTEBR PALEOBIOL PA, P135, DOI 10.1007/978-94-017-7426-0_12; Lombard M, 2012, S AFR ARCHAEOL BULL, V67, P123; Lombard M, 2012, QUATERN INT, V270, P140, DOI 10.1016/j.quaint.2012.02.033; Lombard M, 2010, J ARCHAEOL SCI, V37, P1773, DOI 10.1016/j.jas.2010.02.015; Mackay A, 2014, J HUM EVOL, V72, P26, DOI 10.1016/j.jhevol.2014.03.003; McCall GS, 2009, AZANIA, V44, P311, DOI 10.1080/00672700903337519; Minichillo T., 2005, MIDDLE STONE AGE LIT; Mohapi M, 2013, SOUTH AFR HUMANIT, V25, P25; Morgan TJH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7029; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; Mucina L., 2006, VEGETATION S AFRICA; Patten R.J., 1978, LITHIC TECHNOLOGY, V7, P3, DOI [10.1080/01977261.1978.11754390, DOI 10.1080/01977261.1978.11754390]; Pelegrin J, 1990, ARCHAEOLOGICAL REV C, V9, P116; Porraz G., 2008, S AFRICAN ARCHAEOLOG, V10, P105; Porraz G, 2013, J ARCHAEOL SCI, V40, P3542, DOI 10.1016/j.jas.2013.02.024; Porraz G, 2013, J ARCHAEOL SCI, V40, P3376, DOI 10.1016/j.jas.2013.02.012; Riede F., 2006, ARCHAEOLOGICAL REV C, V21, P50; Roberts P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157408; Schmidt I., 2015, BAR INT SERIES, V2778; Schmidt P, 2013, J ARCHAEOL SCI, V40, P3519, DOI 10.1016/j.jas.2012.10.016; Shea JJ, 2011, CURR ANTHROPOL, V52, P1, DOI 10.1086/658067; Sorensen M, 2013, NOR ARCHAEOL REV, V46, P19, DOI 10.1080/00293652.2013.770416; Sorensens L, 2014, ACTA ARCHAEOLOGICA S, V8, pI; Soressi M., 2003, MULTIPLE APPROACHES; Soriano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131127; Texier PJ, 2010, P NATL ACAD SCI USA, V107, P6180, DOI 10.1073/pnas.0913047107; Tostevin GB., 2012, SEEING LITHICS MIDDL; Tribolo C, 2013, J ARCHAEOL SCI, V40, P3401, DOI 10.1016/j.jas.2012.12.001; Tribolo C, 2009, J ARCHAEOL SCI, V36, P730, DOI 10.1016/j.jas.2008.10.018; van Schaik CP, 2011, PHILOS T R SOC B, V366, P1008, DOI 10.1098/rstb.2010.0304; Villa P, 2010, J ARCHAEOL SCI, V37, P630, DOI 10.1016/j.jas.2009.10.028; Villa P, 2009, J ARCHAEOL SCI, V36, P441, DOI 10.1016/j.jas.2008.09.028; Vogelsang R, 2010, J AFR ARCHAEOL, V8, P185, DOI 10.3213/1612-1651-10170; Wadley L, 2007, J HUM EVOL, V52, P681, DOI 10.1016/j.jhevol.2007.01.002; Wadley L, 2015, AZANIA, V50, P155, DOI 10.1080/0067270X.2015.1039236; Whittaker J.C., 1994, FLINTKNAPPING MAKING; Wurz S, 2013, CURR ANTHROPOL, V54, pS305, DOI 10.1086/673283	86	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168012	10.1371/journal.pone.0168012	http://dx.doi.org/10.1371/journal.pone.0168012			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EI8HA	27942012	gold, Green Published			2022-12-27	WOS:000392745600046
J	Tarazanova, M; Beerthuyzen, M; Siezen, R; Fernandez-Gutierrez, MM; de Jong, A; van der Meulen, S; Kok, J; Bachmann, H				Tarazanova, Mariya; Beerthuyzen, Marke; Siezen, Roland; Fernandez-Gutierrez, Marcela M.; de Jong, Anne; van der Meulen, Sjoerd; Kok, Jan; Bachmann, Herwig			Plasmid Complement of Lactococcus lactis NCDO712 Reveals a Novel Pilus Gene Cluster	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; HIGH-FREQUENCY CONJUGATION; COMPLETE GENOME SEQUENCE; EXPRESSION SYSTEM NICE; CELL-AGGREGATION; PHAGE RESISTANCE; NISIN RESISTANCE; NATURAL ISOLATE; SSP CREMORIS; IDENTIFICATION	Lactococcus lactis MG1363 is an important gram-positive model organism. It is a plasmid-free and phage-cured derivative of strain NCDO712. Plasmid-cured strains facilitate studies on molecular biological aspects, but many properties which make L. lactis an important organism in the dairy industry are plasmid encoded. We sequenced the total DNA of strain NCDO712 and, contrary to earlier reports, revealed that the strain carries 6 rather than 5 plasmids. A new 50-kb plasmid, designated pNZ712, encodes functional nisin immunity (nisCIP) and copper resistance (lcoRSABC). The copper resistance could be used as a marker for the conjugation of pNZ712 to L. lactis MG1614. A genome comparison with the plasmid cured daughter strain MG1363 showed that the number of single nucleotide polymorphisms that accumulated in the laboratory since the strains diverted more than 30 years ago is limited to 11 of which only 5 lead to amino acid changes. The 16-kb plasmid pSH74 was found to contain a novel 8-kb pilus gene cluster spaCB-spaA-srtC1-srtC2, which is predicted to encode a pilin tip protein SpaC, a pilus basal subunit SpaB, and a pilus backbone protein SpaA. The sortases SrtC1/SrtC2 are most likely involved in pilus polymerization while the chromosomally encoded SrtA could act to anchor the pilus to peptidoglycan in the cell wall. Overexpression of the pilus gene cluster from a multi-copy plasmid in L. lactis MG1363 resulted in cell chaining, aggregation, rapid sedimentation and increased conjugation efficiency of the cells. Electron microscopy showed that the over-expression of the pilus gene cluster leads to appendices on the cell surfaces. A deletion of the gene encoding the putative basal protein spaB, by truncating spaCB, led to more pilus-like structures on the cell surface, but cell aggregation and cell chaining were no longer observed. This is consistent with the prediction that spaB is involved in the anchoring of the pili to the cell.	[Tarazanova, Mariya; Beerthuyzen, Marke; Bachmann, Herwig] NIZO Food Res BV, Ede, Netherlands; [Tarazanova, Mariya; Beerthuyzen, Marke; Siezen, Roland; Fernandez-Gutierrez, Marcela M.; de Jong, Anne; van der Meulen, Sjoerd; Kok, Jan; Bachmann, Herwig] TI Food & Nutr, Wageningen, Netherlands; [Tarazanova, Mariya; de Jong, Anne; van der Meulen, Sjoerd; Kok, Jan] Univ Groningen, Mol Genet, Groningen, Netherlands; [Siezen, Roland] Radboud UMC, Ctr Mol & Biomol Informat, Nijmegen, Netherlands; [Fernandez-Gutierrez, Marcela M.] Wageningen Univ, Host Microbe Interact Grp, Anim Sci, Wageningen, Netherlands	NIZO Food Research; Top Institute Food & Nutrition; University of Groningen; Radboud University Nijmegen; Wageningen University & Research	Bachmann, H (corresponding author), NIZO Food Res BV, Ede, Netherlands.; Bachmann, H (corresponding author), TI Food & Nutr, Wageningen, Netherlands.	Herwig.Bachmann@nizo.com	Bachmann, Herwig/ABE-6301-2021; Siezen, Roland J/P-5745-2015	Bachmann, Herwig/0000-0002-8224-0993; Fernandez-Gutierrez, Marcela M./0000-0001-5314-9659	Top Institute Food & Nutrition (TIFN, Wageningen, The Netherlands) [FF001]; TIFN	Top Institute Food & Nutrition (TIFN, Wageningen, The Netherlands); TIFN	This study was funded by the Top Institute Food & Nutrition (TIFN, Program FF001, Wageningen, The Netherlands). MB and HB are also employed by NIZO Food Research. TIFN provided support in the form of salaries for authors HB, MB, RS, AdJ, SvM, JK and HB. Neither NIZO food research nor TIFN had an additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth S, 2014, FEMS MICROBIOL REV, V38, P1066, DOI 10.1111/1574-6976.12074; Ainsworth S, 2014, APPL ENVIRON MICROB, V80, P4341, DOI 10.1128/AEM.01070-14; ANDERSON DG, 1984, J BACTERIOL, V158, P954, DOI 10.1128/JB.158.3.954-962.1984; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bachmann H, 2012, GENOME RES, V22, P115, DOI 10.1101/gr.121285.111; Barrick JE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1039; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; Campelo AB, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-77; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Clarke M, 2008, P NATL ACAD SCI USA, V105, P17978, DOI 10.1073/pnas.0806786105; Coakley M, 1997, APPL ENVIRON MICROB, V63, P1434, DOI 10.1128/AEM.63.4.1434-1440.1997; Cozzi R, 2012, FASEB J, V26, P2008, DOI 10.1096/fj.11-196378; Cui YH, 2015, INT J MOL SCI, V16, P13172, DOI 10.3390/ijms160613172; DAVIES FL, 1981, J APPL BACTERIOL, V51, P325, DOI 10.1111/j.1365-2672.1981.tb01249.x; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; DEVOS WM, 1987, FEMS MICROBIOL LETT, V46, P281, DOI 10.1111/j.1574-6968.1987.tb02466.x; Le DTL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079850; Douillard FP, 2014, J BIOL CHEM, V289, P15764, DOI 10.1074/jbc.M113.542332; Duan K, 1999, APPL MICROBIOL BIOT, V53, P36, DOI 10.1007/s002530051611; EFSTATHIOU JD, 1977, J BACTERIOL, V130, P257, DOI 10.1128/JB.130.1.257-265.1977; Fallico V, 2012, J DAIRY SCI, V95, P3593, DOI 10.3168/jds.2011-5255; Filloux A, 2010, J BACTERIOL, V192, P3243, DOI 10.1128/JB.00424-10; GASSON MJ, 1992, MOL MICROBIOL, V6, P3213, DOI 10.1111/j.1365-2958.1992.tb01776.x; GASSON MJ, 1980, J BACTERIOL, V143, P1260, DOI 10.1128/JB.143.3.1260-1264.1980; GASSON MJ, 1983, J BACTERIOL, V154, P1; Gevers D, 2003, FEMS MICROBIOL LETT, V225, P125, DOI 10.1016/S0378-1097(03)00505-6; GODON JJ, 1994, MOL MICROBIOL, V12, P655, DOI 10.1111/j.1365-2958.1994.tb01053.x; Gorecki RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022238; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Hendrickx APA, 2008, MICROBIOL-SGM, V154, P3212, DOI 10.1099/mic.0.2008/020891-0; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Ingham CJ, 2006, J MED MICROBIOL, V55, P1511, DOI 10.1099/jmm.0.46585-0; Kankainen M, 2009, P NATL ACAD SCI USA, V106, P17193, DOI 10.1073/pnas.0908876106; Kelly WJ, 1998, INT J FOOD MICROBIOL, V45, P85, DOI 10.1016/S0168-1605(98)00135-4; Khunajakr N, 1999, GENE, V229, P229, DOI 10.1016/S0378-1119(98)00395-3; KLAENHAMMER TR, 1985, J GEN MICROBIOL, V131, P1531; Kline KA, 2010, TRENDS MICROBIOL, V18, P224, DOI 10.1016/j.tim.2010.03.002; Kojic M, 2005, CAN J MICROBIOL, V51, P305, DOI [10.1139/w05-009, 10.1139/W05-009]; Kojic M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-265; KOK J, 1984, APPL ENVIRON MICROB, V48, P726, DOI 10.1128/AEM.48.4.726-731.1984; Kuipers OP, 1997, TRENDS BIOTECHNOL, V15, P135, DOI 10.1016/S0167-7799(97)01029-9; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Le Bourgeois P, 2000, J BACTERIOL, V182, P2481, DOI 10.1128/JB.182.9.2481-2491.2000; LEENHOUTS KJ, 1991, APPL ENVIRON MICROB, V57, P2562, DOI 10.1128/AEM.57.9.2562-2567.1991; Linares DM, 2010, J BACTERIOL, V192, P5806, DOI 10.1128/JB.00533-10; Liu CQ, 2002, GENE, V297, P241, DOI 10.1016/S0378-1119(02)00918-6; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mantovani HC, 2001, APPL ENVIRON MICROB, V67, P808, DOI 10.1128/AEM.67.2.808-813.2001; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; MCKAY LL, 1980, APPL ENVIRON MICROB, V40, P84, DOI 10.1128/AEM.40.1.84-91.1980; Meyrand M, 2013, MOL CELL PROTEOMICS, V12, P3935, DOI 10.1074/mcp.M113.029066; Mierau I, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-15; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Millen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051663; Mills S, 2006, FEMS MICROBIOL REV, V30, P243, DOI 10.1111/j.1574-6976.2005.00011.x; Montville TJ, 1998, APPL MICROBIOL BIOT, V50, P511, DOI 10.1007/s002530051328; O'Driscoll J, 2006, J BACTERIOL, V188, P6629, DOI 10.1128/JB.00672-06; Oxaran V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050989; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Rintahaka J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113922; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Siezen RJ, 2005, APPL ENVIRON MICROB, V71, P8371, DOI 10.1128/AEM.71.12.8371-8382.2005; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; SIMON D, 1988, BIOCHIMIE, V70, P559, DOI 10.1016/0300-9084(88)90093-4; SING WD, 1991, J DAIRY SCI, V74, P1133, DOI 10.3168/jds.S0022-0302(91)78265-9; STEELE JL, 1986, APPL ENVIRON MICROB, V51, P57, DOI 10.1128/AEM.51.1.57-64.1986; Stentz R, 2004, MICROBIOL-SGM, V150, P2503, DOI 10.1099/mic.0.27149-0; STERKENBURG A, 1988, BIOCHIMIE, V70, P451, DOI 10.1016/0300-9084(88)90220-9; Stone BJ, 1998, INFECT IMMUN, V66, P1768, DOI 10.1128/IAI.66.4.1768-1775.1998; Taguchi F, 2011, MOL PLANT MICROBE IN, V24, P1001, DOI 10.1094/MPMI-02-11-0026; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2004, BBA-MOL CELL RES, V1694, P269, DOI 10.1016/j.bbamcr.2004.04.014; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Tripathi P, 2012, MICRON, V43, P1323, DOI 10.1016/j.micron.2012.01.001; van der Meulen SB, 2016, RNA BIOL, V13, P353, DOI 10.1080/15476286.2016.1146855; VANBELKUM MJ, 1991, APPL ENVIRON MICROB, V57, P492, DOI 10.1128/AEM.57.2.492-498.1991; VANDERLELIE D, 1991, APPL ENVIRON MICROB, V57, P201, DOI 10.1128/AEM.57.1.201-206.1991; VANDERMEER JR, 1993, J BACTERIOL, V175, P2578, DOI 10.1128/JB.175.9.2578-2588.1993; Vlieg JETV, 2006, CURR OPIN BIOTECH, V17, P183, DOI 10.1016/j.copbio.2006.02.007; von Ossowski I, 2010, APPL ENVIRON MICROB, V76, P2049, DOI 10.1128/AEM.01958-09; WALSH PM, 1981, J BACTERIOL, V146, P937, DOI 10.1128/JB.146.3.937-944.1981; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wegmann U, 2012, MICROBIOL-SGM, V158, P2936, DOI 10.1099/mic.0.062554-0; WELLS JM, 1993, J APPL BACTERIOL, V74, P629, DOI 10.1111/j.1365-2672.1993.tb05195.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zerbino DR, 2010, CURR PROTOC BIOINFOR, V11, P11	91	27	27	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167970	10.1371/journal.pone.0167970	http://dx.doi.org/10.1371/journal.pone.0167970			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941999	Green Published, gold			2022-12-27	WOS:000392745600042
J	Svagan, AJ; Kusic, A; De Gobba, C; Larsen, FH; Sassene, P; Zhou, Q; van de Weert, M; Mullertz, A; Jorgensen, B; Ulvskov, P				Svagan, Anna J.; Kusic, Anja; De Gobba, Cristian; Larsen, Flemming H.; Sassene, Philip; Zhou, Qi; van de Weert, Marco; Mullertz, Anette; Jorgensen, Bodil; Ulvskov, Peter			Rhamnogalacturonan-I Based Microcapsules for Targeted Drug Release	PLOS ONE			English	Article							POLYSACCHARIDES; POLYURETHANE; DELIVERY; SOLUBILIZATION; DIISOCYANATE; SPECTROSCOPY; ABSORPTION; EXPRESSION; DIGESTION; CAPSULES	Drug targeting to the colon via the oral administration route for local treatment of e.g. inflammatory bowel disease and colonic cancer has several advantages such as needle-free administration and low infection risk. A new source for delivery is plant-polysaccharide based delivery platforms such as Rhamnogalacturonan-I (RG-I). In the gastro-intestinal tract the RG-I is only degraded by the action of the colonic microflora. For assessment of potential drug delivery properties, RG-I based microcapsules (similar to 1 mu m in diameter) were prepared by an interfacial poly-addition reaction. The cross-linked capsules were loaded with a fluorescent dye (model drug). The capsules showed negligible and very little in vitro release when subjected to media simulating gastric and intestinal fluids, respectively. However, upon exposure to a cocktail of commercial RG-I cleaving enzymes, similar to 9 times higher release was observed, demonstrating that the capsules can be opened by enzymatic degradation. The combined results suggest a potential platform for targeted drug delivery in the terminal gastro-intestinal tract.	[Svagan, Anna J.; Kusic, Anja; Sassene, Philip; van de Weert, Marco; Mullertz, Anette] Univ Copenhagen, Dept Pharm, Copenhagen, Denmark; [De Gobba, Cristian; Larsen, Flemming H.] Univ Copenhagen, Dept Food Sci, Copenhagen, Denmark; [Zhou, Qi] Royal Inst Technol KTH, Sch Biotechnol, Stockholm, Sweden; [Jorgensen, Bodil; Ulvskov, Peter] Univ Copenhagen, Dept Plant & Environm Sci, Copenhagen, Denmark; [Svagan, Anna J.] Royal Inst Technol KTH, Dept Fibre & Polymertechnol, Stockholm, Sweden	University of Copenhagen; University of Copenhagen; Royal Institute of Technology; University of Copenhagen; Royal Institute of Technology	Svagan, AJ (corresponding author), Univ Copenhagen, Dept Pharm, Copenhagen, Denmark.; Svagan, AJ (corresponding author), Royal Inst Technol KTH, Dept Fibre & Polymertechnol, Stockholm, Sweden.	svagan@kth.se	Zhou, Qi/B-9095-2013; Larsen, Flemming/A-5255-2015; De Gobba, Cristian/M-5178-2014; van de Weert, Marco/AGR-7726-2022; Ulvskov, Peter/I-1228-2014; Müllertz, Anette/ABF-6935-2021; Jorgensen, Bodil/F-6551-2014	Zhou, Qi/0000-0001-9832-027X; Larsen, Flemming/0000-0001-5180-6870; De Gobba, Cristian/0000-0002-2774-5876; Ulvskov, Peter/0000-0003-3776-818X; Müllertz, Anette/0000-0003-3020-8892; Jorgensen, Bodil/0000-0002-0453-1277; Svagan (Hanner), Anna J./0000-0002-4583-723X	Danish Council for Independent Research	Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Council for Independent Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lorenzo C, 2013, ADV DRUG DELIVER REV, V65, P1148, DOI 10.1016/j.addr.2013.04.016; Armand M, 1996, AM J PHYSIOL-GASTR L, V271, pG172, DOI 10.1152/ajpgi.1996.271.1.G172; Assifaoui A, 2013, ACTA BIOMATER, V9, P6218, DOI 10.1016/j.actbio.2012.11.031; Assifaoui A, 2011, CARBOHYD POLYM, V85, P388, DOI 10.1016/j.carbpol.2011.02.037; Baier G, 2010, BIOMACROMOLECULES, V11, P960, DOI 10.1021/bm901414k; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Bergstrom CAS, 2014, EUR J PHARM SCI, V57, P173, DOI 10.1016/j.ejps.2013.10.015; Berthelsen R, 2015, MOL PHARMACEUT, V12, P1062, DOI 10.1021/mp500545k; Boulet JC, 2007, CARBOHYD POLYM, V69, P79, DOI 10.1016/j.carbpol.2006.09.003; Buchanan BB, 2007, BIOCH MOL BIOL PLANT; Byg I, 2012, FOOD CHEM, V131, P1207, DOI 10.1016/j.foodchem.2011.09.106; CARRIERE F, 1993, GASTROENTEROLOGY, V105, P876, DOI 10.1016/0016-5085(93)90908-U; Desilets S, 1997, J POLYM SCI POL CHEM, V35, P2991, DOI 10.1002/(SICI)1099-0518(199710)35:14<2991::AID-POLA20>3.0.CO;2-D; Ei-Gibaly I, 2002, INT J PHARM, V232, P199, DOI 10.1016/S0378-5173(01)00903-6; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Humblet-Hua NPK, 2012, J AGR FOOD CHEM, V60, P9502, DOI 10.1021/jf3024529; Kwon OJ, 2007, J APPL POLYM SCI, V103, P1544, DOI 10.1002/app.25363; Li SS, 2015, CHINESE J POLYM SCI, V33, P1196, DOI 10.1007/s10118-015-1670-7; Manderson K, 2005, APPL ENVIRON MICROB, V71, P8383, DOI 10.1128/AEM.71.12.8383-8389.2005; Marquis M, 2015, CARBOHYD POLYM, V116, P189, DOI 10.1016/j.carbpol.2014.01.083; Maxwell EG, 2015, CARBOHYD POLYM, V132, P546, DOI 10.1016/j.carbpol.2015.06.082; METZ G, 1994, J MAGN RESON SER A, V110, P219, DOI 10.1006/jmra.1994.1208; Molgaard SL, 2014, CARBOHYD POLYM, V114, P179, DOI 10.1016/j.carbpol.2014.08.011; Munjeri O, 1997, J CONTROL RELEASE, V46, P273, DOI 10.1016/S0168-3659(96)01607-0; Natrajan VK, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/1/015401; Orfila C, 2012, PLANTA, V236, P185, DOI 10.1007/s00425-012-1596-z; Rueda L, 2011, COMPOS SCI TECHNOL, V71, P1953, DOI 10.1016/j.compscitech.2011.09.014; Sassene P, 2014, AAPS J, V16, P1344, DOI 10.1208/s12248-014-9672-x; SCHOLS HA, 1994, CARBOHYD RES, V256, P97, DOI 10.1016/0008-6215(94)84230-2; Svagan AJ, 2016, CARBOHYD POLYM, V136, P292, DOI 10.1016/j.carbpol.2015.09.040; Thomassen LV, 2011, ENZYME MICROB TECH, V49, P289, DOI 10.1016/j.enzmictec.2011.06.006; Vertzoni M, 2005, EUR J PHARM BIOPHARM, V60, P413, DOI 10.1016/j.ejpb.2005.03.002; Yiamsawas D, 2014, RSC ADV, V4, P11661, DOI 10.1039/c3ra47971d; Zangenberg NH, 2001, EUR J PHARM SCI, V14, P115, DOI 10.1016/S0928-0987(01)00169-5; Zhang ML, 2014, P NATL ACAD SCI USA, V111, pE3708, DOI 10.1073/pnas.1406156111	35	9	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168050	10.1371/journal.pone.0168050	http://dx.doi.org/10.1371/journal.pone.0168050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992455	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600030
J	Ho, YH; Tseng, CC; Wang, LS; Chen, YT; Ho, GJ; Lin, TY; Wang, LY; Chen, LK				Ho, Yu-Huai; Tseng, Chun-Chieh; Wang, Lih-Shinn; Chen, Yi-Ting; Ho, Guan-Jin; Lin, Teng-Yi; Wang, Ling-Yi; Chen, Li-Kuang			Application of Bacteriophage-containing Aerosol against Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii in an Intensive Care Unit	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; GENOMIC ANALYSIS; HOSPITAL ROOMS; SURFACES; THERAPY; COMPLEX; IMPACT	Background Carbapenem-resistant Acinetobacter baumannii (CRAB) is associated with nosocomial infections worldwide. Here, we used phage as a potential agent to evaluate the efficacy of daily cleaning practices combined with a bacteriophage-containing aerosol against CRAB. Methods A two-phase prospective intervention study was performed at a 945-bed public teaching hospital. From March to December 2013, we performed terminal cleaning using standard procedures plus an aerosol with active bacteriophage in the intensive care units to evaluate the impact on nosocomial incidence density, carbapenem-resistance rates and antimicrobial drug consumption amounts. Patients with culture proven CRAB infection were transferred to the isolation room when the phage aerosol cleaning had been completed. Results A total of 264 new acquisitions of CRAB were identified in the intensive care units (191 in the pre-intervention period and 73 in the intervention period). The rates of new acquisitions of CRAB in the intensive care units decreased from 8.57 per 1000 patient-days in the pre-intervention period to 5.11 per 1000 patient-days in the intervention period (p = 0.0029). The mean percentage of resistant isolates CRAB decreased from 87.76% to 46.07% in the intensive care units (p = 0.001). All of the antimicrobials showed a significant reduction in consumption except imipenem. Conclusions The bacteriophage was successful in decreasing the rates of infection caused by CRAB across intensive care units in a large teaching hospital.	[Ho, Yu-Huai; Wang, Lih-Shinn] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Div Infect Dis, Hualien, Taiwan; [Ho, Yu-Huai; Wang, Lih-Shinn; Chen, Yi-Ting; Ho, Guan-Jin] Tzu Chi Univ, Hualien, Taiwan; [Tseng, Chun-Chieh] Tzu Chi Univ, Dept & Grad Inst Publ Hlth, Hualien, Taiwan; [Chen, Yi-Ting] Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Med Intens Care Unit, Hualien, Taiwan; [Ho, Guan-Jin] Buddhist Tzu Chi Gen Hosp, Dept Surg Crit Care Unit, Hualien, Taiwan; [Lin, Teng-Yi] Buddhist Tzu Chi Gen Hosp, Dept Lab Med, Hualien, Taiwan; [Wang, Ling-Yi] Buddhist Tzu Chi Gen Hosp, Dept Med Res, Hualien, Taiwan; [Chen, Li-Kuang] Tzu Chi Univ, Coll Med, Inst Med Sci, Dept Lab Diagnost, Hualien, Taiwan; [Chen, Li-Kuang] Buddhist Tzu Chi Gen Hosp, Dept Lab Med, Clin Pathol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Chen, LK (corresponding author), Tzu Chi Univ, Coll Med, Inst Med Sci, Dept Lab Diagnost, Hualien, Taiwan.; Chen, LK (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Lab Med, Clin Pathol, Hualien, Taiwan.	likuangchen@gmail.com	Chen, Yi/HIR-2608-2022		Buddhist Tzu Chi General Hospital [TCRD-102-73]	Buddhist Tzu Chi General Hospital	This work was supported by grant TCRD-102-73 from Buddhist Tzu Chi General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze T, 2008, APPL ENVIRON MICROB, V74, P6230, DOI 10.1128/AEM.01465-08; Blot S, 2002, CLIN INFECT DIS, V34, P1600, DOI 10.1086/340616; Burrowes B, 2011, EXPERT REV ANTI-INFE, V9, P775, DOI [10.1586/ERI.11.90, 10.1586/eri.11.90]; Capparelli R, 2007, ANTIMICROB AGENTS CH, V51, P2765, DOI 10.1128/AAC.01513-06; Chang KC, 2011, GENOMICS, V97, P249, DOI 10.1016/j.ygeno.2011.01.002; Chen LK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-154; Cho OH, 2014, AM J INFECT CONTROL, V42, P976, DOI 10.1016/j.ajic.2014.05.027; Eaton MD, 1934, J AMER MED ASSOC, V103, P1847, DOI 10.1001/jama.1934.72750500003009; Ho YH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060576; Jawad A, 1998, J CLIN MICROBIOL, V36, P1938, DOI 10.1128/JCM.36.7.1938-1941.1998; Jeon J, 2016, J APPL MICROBIOLOGY; Karageorgopoulos DE, 2008, LANCET INFECT DIS, V8, P751, DOI 10.1016/S1473-3099(08)70279-2; Lai MJ, 2013, INT J ANTIMICROB AG, V42, P141, DOI 10.1016/j.ijantimicag.2013.04.022; Lai MJ, 2011, APPL MICROBIOL BIOT, V90, P529, DOI 10.1007/s00253-011-3104-y; Lee NY, 2007, INFECT CONT HOSP EP, V28, P713, DOI 10.1086/517954; Leverentz B, 2003, APPL ENVIRON MICROB, V69, P4519, DOI 10.1128/AEM.69.8.4519-4526.2003; Lin NT, 2010, RES MICROBIOL, V161, P308, DOI 10.1016/j.resmic.2010.03.007; Manian FA, 2013, AM J INFECT CONTROL, V41, P384, DOI 10.1016/j.ajic.2012.04.321; Manian FA, 2011, INFECT CONT HOSP EP, V32, P667, DOI 10.1086/660357; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Peng F, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-181; Sabour PM, 2010, BACTERIOPHAGES CONTR; Shen GH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046537; Sherlock O, 2009, J HOSP INFECT, V72, P140, DOI 10.1016/j.jhin.2009.02.013; Siegel JD, 2007, AM J INFECT CONTROL, V35, pS165, DOI 10.1016/j.ajic.2007.10.006; Sulakvelidze A, 2001, ANTIMICROB AGENTS CH, V45, P649, DOI 10.1128/AAC.45.3.649-659.2001; Tacconelli E, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12427; Taiwan Center for Disease Control, 2013, STAT COMM DIS SURV R; Taiwan Center for Disease Control, 2004, STAT COMM DIS SURV R; Thiel K, 2004, NAT BIOTECHNOL, V22, P31, DOI 10.1038/nbt0104-31; Tseng YC, 2007, DIAGN MICR INFEC DIS, V59, P181, DOI 10.1016/j.diagmicrobio.2007.04.024; Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205; Wilson SJ, 2004, AM J INFECT CONTROL, V32, P342, DOI 10.1016/j.ajic.2004.02.008	33	23	26	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168380	10.1371/journal.pone.0168380	http://dx.doi.org/10.1371/journal.pone.0168380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992494	Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000044
J	van der Kolk, BA; Hodgdon, H; Gapen, M; Musicaro, R; Suvak, MK; Hamlin, E; Spinazzola, J				van der Kolk, Bessel A.; Hodgdon, Hilary; Gapen, Mark; Musicaro, Regina; Suvak, Michael K.; Hamlin, Ed; Spinazzola, Joseph			A Randomized Controlled Study of Neurofeedback for Chronic PTSD	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; EEG-NEUROFEEDBACK; EFFECT SIZES; ATTENTION; ADHD; CHILDREN; EFFICACY; PSYCHOTHERAPY; BIOFEEDBACK; ACTIVATION	Introduction Brain/Computer Interaction (BCI) devices are designed to alter neural signals and, thereby, mental activity. This study was a randomized, waitlist (TAU) controlled trial of a BCI, EEG neurofeedback training (NF), in patients with chronic PTSD to explore the capacity of NF to reduce PTSD symptoms and increase affect regulation capacities. Study Design 52 individuals with chronic PTSD were randomized to either NF (n = 28) or waitlist (WL) (n = 24). They completed four evaluations, at baseline (T1), after week 6 (T2), at post-treatment (T3), and at one month follow up (T4). Assessment measures were: 1. Traumatic Events Screening Inventory (T1); 2. the Clinician Administered PTSD Scale (CAPS; T1, T3, T4); 3. the Davidson Trauma Scale (DTS; T1-T4) and 4. the Inventory of Altered Self-Capacities (IASC; T1-T4). NF training occurred two times per week for 12 weeks and involved a sequential placement with T4 as the active site, P4 as the reference site. Results Participants had experienced an average of 9.29 (SD = 2.90) different traumatic events. Post-treatment a significantly smaller proportion of NF (6/22, 27.3%) met criteria for PTSD than the WL condition (15/22, 68.2%), chi(2) (n = 44, df = 1) = 7.38, p =.007. There was a significant treatment condition x time interaction (b = -10.45, t = -5.10, p<.001). Measures of tension reduction activities, affect dysregulation, and affect instability exhibited a significant Time x Condition interaction. The effect sizes of NF (d = -2.33 within, d = -1.71 between groups) are comparable to those reported for the most effective evidence based treatments for PTSD. Discussion Compared with the control group NF produced significant PTSD symptom improvement in individuals with chronic PTSD, as well as in affect regulation capacities. NF deserves further investigation for its potential to ameliorate PTSD and to improve affect regulation, and to clarify its mechanisms of action.	[van der Kolk, Bessel A.; Hodgdon, Hilary; Gapen, Mark; Musicaro, Regina; Suvak, Michael K.; Spinazzola, Joseph] Justice Resource Inst JRI, Ctr Trauma, Brookline, MA 02446 USA; [van der Kolk, Bessel A.] Boston Univ, Sch Med, Boston, MA 02215 USA; [van der Kolk, Bessel A.; Hodgdon, Hilary; Spinazzola, Joseph] Natl Child Traumat Stress Network, Brookline, MA 02446 USA; [Musicaro, Regina; Suvak, Michael K.; Spinazzola, Joseph] Suffolk Univ, Dept Psychol, Boston, MA 02114 USA; [Hamlin, Ed] Univ N Carolina, Sch Med, Dept Psychiat, Chapel Hill, NC USA; [Hamlin, Ed] Western Carolina Univ, Dept Psychol, Cullowhee, NC 28723 USA	Boston University; Suffolk University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; Western Carolina University	van der Kolk, BA (corresponding author), Justice Resource Inst JRI, Ctr Trauma, Brookline, MA 02446 USA.; van der Kolk, BA (corresponding author), Boston Univ, Sch Med, Boston, MA 02215 USA.; van der Kolk, BA (corresponding author), Natl Child Traumat Stress Network, Brookline, MA 02446 USA.	besselvanderkolk@gmail.com						Arnold LE, 2013, J ATTEN DISORD, V17, P410, DOI 10.1177/1087054712446173; Arns M, 2009, CLIN EEG NEUROSCI, V40, P180, DOI 10.1177/155005940904000311; Beauregard M, 2006, APPL PSYCHOPHYS BIOF, V31, P3, DOI 10.1007/s10484-006-9001-y; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Briere J, 2002, ASSESSMENT, V9, P230, DOI 10.1177/1073191102009003002; BURSTEIN A, 1986, PSYCHOSOMATICS, V27, P37, DOI 10.1016/S0033-3182(86)72741-2; Cloitre M, 2009, J TRAUMA STRESS, V22, P399, DOI 10.1002/jts.20444; Davidson JRT, 2002, DEPRESS ANXIETY, V15, P75, DOI 10.1002/da.10021; Doud AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026322; Duncan NW, 2015, HUM BRAIN MAPP, V36, P4622, DOI 10.1002/hbm.22941; Edlinger G, 2011, SPRINGER HANDBOOK OF MEDICAL TECHNOLOGY, P1003; Egner T, 2004, CLIN NEUROPHYSIOL, V115, P131, DOI 10.1016/S1388-2457(03)00353-5; Egner T, 2001, NEUROREPORT, V12, P4155, DOI 10.1097/00001756-200112210-00058; Feingold A, 2009, PSYCHOL METHODS, V14, P43, DOI 10.1037/a0014699; Ford J. D., 2007, J PSYCHIAT INTENSIVE, V3, DOI [10.1017/s1742646407001094, DOI 10.1017/S1742646407001094]; Frewen P, 2016, HUMAN BRAIN IN PRESS; Frewen PA, 2012, PSYCHOL TRAUMA-US, V4, P152, DOI 10.1037/a0023114; Gapen M., 2016, APPL PSYCHOPHYS BIOF, P1; Georgopoulos AP, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016011; Gruzelier JH, 2014, NEUROSCI BIOBEHAV R, V44, P124, DOI 10.1016/j.neubiorev.2013.09.015; Harmon-Jones E, 2008, J PERS SOC PSYCHOL, V94, P1, DOI 10.1037/0022-3514.94.1.1; Hurt E, 2014, CHILD ADOL PSYCH CL, V23, P465, DOI 10.1016/j.chc.2014.02.001; Insel TR, 2015, WORLD PSYCHIATRY, V14, P151, DOI 10.1002/wps.20227; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jaycox LH, 1996, CLIN PSYCHOL PSYCHOT, V3, P176; Johnston S, 2011, COGN AFFECT BEHAV NE, V11, P44, DOI 10.3758/s13415-010-0010-1; Jokic-Begic N, 2003, NORD J PSYCHIAT, V57, P351, DOI 10.1080/08039480310002688; Keizer AW, 2010, NEUROIMAGE, V49, P3404, DOI 10.1016/j.neuroimage.2009.11.023; Klimesch W, 1997, INT J PSYCHOPHYSIOL, V26, P319, DOI 10.1016/S0167-8760(97)00773-3; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kluetsch RC, 2014, ACTA PSYCHIAT SCAND, V130, P123, DOI 10.1111/acps.12229; Kouijzer MEJ, 2009, RES AUTISM SPECT DIS, V3, P145, DOI 10.1016/j.rasd.2008.05.001; Kropotov JD, 2005, INT J PSYCHOPHYSIOL, V55, P23, DOI 10.1016/j.ijpsycho.2004.05.011; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Levine M, 2001, PHARMACOTHERAPY, V21, P405, DOI 10.1592/phco.21.5.405.34503; Linden DEJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038115; Muthen B., 2010, MPLUS USERS GUIDE; Muthen LK, 2002, STRUCT EQU MODELING, V9, P599, DOI 10.1207/S15328007SEM0904_8; Paquette V, 2009, PSYCHIAT RES-NEUROIM, V174, P231, DOI 10.1016/j.pscychresns.2009.06.002; Pascual-Marqui RD, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00448; Peniston E., 1991, MED PSYCHOTHER, V4, P47; Peugh J. L., 2005, EDUC PSYCHOL MEAS, V65, P714; PITMAN RK, 1991, J CLIN PSYCHIAT, V52, P17; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Ros T, 2014, BIOL PSYCHOL, V95, P54, DOI 10.1016/j.biopsycho.2013.04.013; Ros T, 2013, NEUROIMAGE, V65, P324, DOI 10.1016/j.neuroimage.2012.09.046; Sanei S., 2007, EEG SIGNAL PROCESSIN, P1; Shih JJ, 2012, MAYO CLIN PROC, V87, P268, DOI 10.1016/j.mayocp.2011.12.008; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Sokhadze TM, 2008, APPL PSYCHOPHYS BIOF, V33, P1, DOI 10.1007/s10484-007-9047-5; Steiner NJ, 2014, PEDIATRICS, V133, P483, DOI 10.1542/peds.2013-2059; Tesche CD, 2000, P NATL ACAD SCI USA, V97, P919, DOI 10.1073/pnas.97.2.919; Uhlhaas PJ, 2012, NEURON, V75, P963, DOI 10.1016/j.neuron.2012.09.004; Van Essen DC, 2015, WORLD PSYCHIATRY, V14, P154, DOI 10.1002/wps.20228; Van Etten ML, 1998, CLIN PSYCHOL PSYCHOT, V5, P126, DOI 10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.3.CO;2-8; Veltmeyer Melinda D., 2006, Journal of Integrative Neuroscience, V5, P123, DOI 10.1142/S0219635206001057; Wangler S, 2011, CLIN NEUROPHYSIOL, V122, P942, DOI 10.1016/j.clinph.2010.06.036; Zoefel B, 2011, NEUROIMAGE, V54, P1427, DOI 10.1016/j.neuroimage.2010.08.078	59	58	58	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0166752	10.1371/journal.pone.0166752	http://dx.doi.org/10.1371/journal.pone.0166752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992435	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000007
J	Anda, L; Bronnick, KS; Johnsen, E; Kroken, RA; Jorgensen, H; Loberg, EM				Anda, Liss; Bronnick, Kolbjorn S.; Johnsen, Erik; Kroken, Rune A.; Jorgensen, Hugo; Loberg, Else-Marie			The Course of Neurocognitive Changes in Acute Psychosis: Relation to Symptomatic Improvement	PLOS ONE			English	Article							NEGATIVE SYNDROME SCALE; 1ST-EPISODE SCHIZOPHRENIA; NEUROPSYCHOLOGICAL STATUS; COGNITIVE PERFORMANCE; REPEATABLE BATTERY; SUBACUTE PHASES; NORMATIVE DATA; 1ST EPISODE; HIGH-RISK; DEFICITS	Introduction Cognitive impairment is a core aspect of psychosis, but the course of cognitive functioning during acute psychosis remains poorly understood, as does the association between symptom change and neurocognitive change. Some studies have found cognitive improvement to be related to improvement in negative symptoms, but few have examined cognitive changes in the early acute phase, when clinical improvement mainly happens. This study's aim was to investigate the relation between cognitive and symptomatic change in clinically heterogeneous patients during the early acute phase of psychosis. Method Participants (n = 84), including both first-episode and previously ill patients, were recruited from consecutive admissions to the acute psychiatric emergency ward of Haukeland University Hospital, Bergen, Norway, as part of the Bergen Psychosis Project (BPP). The RBANS neurocognitive test battery was administered on admission and again at discharge from the acute ward (mean time 4.1 weeks, SD 1.86 weeks). Symptomatic change was measured by PANSS. Results The proportion of subjects with cognitive impairment (t < 35) was 28.6% in the acute phase and 13.1% at follow-up. A sequential multiple linear regression model with RBANS change as the dependent variable found PANSS negative symptoms change to significantly predict total RBANS performance improvement (beta = -. 307, p = .016). There was no significant difference between subjects with schizophrenia and those with other psychotic disorders in terms of cognitive change. Conclusion The proportion of subjects with mild to moderate impairment in cognitive test performance is reduced across the acute phase of psychosis, with improvement related to amelioration of negative symptoms.	[Anda, Liss; Bronnick, Kolbjorn S.] Stavanger Univ Hosp, Div Psychiat, TIPS, Stavanger, Norway; [Anda, Liss] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Bronnick, Kolbjorn S.] Univ Stavanger, Fac Social Sci, Inst Hlth, Stavanger, Norway; [Johnsen, Erik; Kroken, Rune A.; Loberg, Else-Marie] Haukeland Hosp, Div Psychiat, Bergen, Norway; [Johnsen, Erik; Kroken, Rune A.; Jorgensen, Hugo] Univ Bergen, Dept Clin Med, Bergen, Norway; [Loberg, Else-Marie] Univ Bergen, Dept Clin Psychol, Bergen, Norway; [Loberg, Else-Marie] Haukeland Hosp, Dept Addict Med, Bergen, Norway	Stavanger University Hospital; University of Bergen; Universitetet i Stavanger; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Anda, L (corresponding author), Stavanger Univ Hosp, Div Psychiat, TIPS, Stavanger, Norway.; Anda, L (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.	lissgoril@gmail.com	/AAQ-2163-2021	Anda, Liss/0000-0003-2431-4306; Kroken, Rune/0000-0002-0903-3840	Norwegian research council; Haukeland University Hospital	Norwegian research council(Research Council of NorwayEuropean Commission); Haukeland University Hospital	Funded by Norwegian research council (http://www.forskningsradet.no/en/Home_page/1177315753906) (EJ) and Haukeland University Hospital (http://www.helse-bergen.no/no/Sider/default.aspx) (EJ).	Bell MD, 2006, SCHIZOPHR RES, V81, P17, DOI 10.1016/j.schres.2005.09.016; Berge D, 2011, ACTA PSYCHIAT SCAND, V123, P431, DOI 10.1111/j.1600-0447.2010.01635.x; Bilder RM, 2006, J CLIN EXP NEUROPSYC, V28, P270, DOI 10.1080/13803390500360554; Bora E, 2014, SCHIZOPHRENIA BULL, V40, P744, DOI 10.1093/schbul/sbt085; Bozikas VP, 2011, AUST NZ J PSYCHIAT, V45, P93, DOI 10.3109/00048674.2010.541418; Cornblatt B, 2002, SCHIZOPHR RES, V54, P177, DOI 10.1016/S0920-9964(01)00365-6; Dickinson D, 2014, AM J PSYCHIAT, V171, P9, DOI 10.1176/appi.ajp.2013.13101303; Dominguez MD, 2009, PSYCHOL BULL, V135, P157, DOI 10.1037/a0014415; Foussias G, 2015, SCHIZOPHR RES, V166, P276, DOI 10.1016/j.schres.2015.05.019; Foussias G, 2010, SCHIZOPHRENIA BULL, V36, P359, DOI 10.1093/schbul/sbn094; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Gonzalez-Blanch C, 2010, PSYCHOL MED, V40, P935, DOI 10.1017/S0033291709991267; Gruner R, 2014, FRONTIERS PSYCHIAT, V5, P11, DOI [10.3389/fpsyt.2014.00011, DOI 10.3389/FPSYT.2014.00011]; HAGGER C, 1993, BIOL PSYCHIAT, V34, P702, DOI 10.1016/0006-3223(93)90043-D; Harvey PD, 2006, SCHIZOPHRENIA BULL, V32, P250, DOI 10.1093/schbul/sbj011; Harvey PD, 2014, AM J PSYCHIAT; Heaton RK, 1991, COMPREHENSIVE NORMS; IBM Corporation, 2013, IBM SPSS STAT WINDOW; Iverson GL, 2009, APPL NEUROPSYCHOL, V16, P31, DOI 10.1080/09084280802644128; Johnsen E, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-26; Kahn RS, 2013, JAMA PSYCHIAT, V70, P1107, DOI 10.1001/jamapsychiatry.2013.155; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Keane BP, 2013, J ABNORM PSYCHOL, V122, P506, DOI 10.1037/a0032110; Keefe Richard S E, 2012, Handb Exp Pharmacol, P11, DOI 10.1007/978-3-642-25758-2_2; Keefe RSE, 2004, AM J PSYCHIAT, V161, P985, DOI 10.1176/appi.ajp.161.6.985; Leeson VC, 2011, SCHIZOPHRENIA BULL, V37, P768, DOI 10.1093/schbul/sbp143; Loberg EM, 2006, REL VAL NORW TRANSL; McGrath J, 2001, ACTA PSYCHIAT SCAND, V103, P181, DOI 10.1034/j.1600-0447.2001.00114.x; McGrath J, 1997, SCHIZOPHR RES, V26, P127, DOI 10.1016/S0920-9964(97)00070-4; Meier MH, 2014, AM J PSYCHIAT; Mesholam-Gately RI, 2009, NEUROPSYCHOLOGY, V23, P315, DOI 10.1037/a0014708; Milev P, 2005, AM J PSYCHIAT, V162, P495, DOI 10.1176/appi.ajp.162.3.495; Morra LF, 2015, SCHIZOPHR RES, V162, P205, DOI 10.1016/j.schres.2014.12.033; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; O'Leary DS, 2000, J NEUROPSYCH CLIN N, V12, P4, DOI 10.1176/jnp.12.1.4; Olivier MR, 2015, PSYCHOL MED, V45, P2873, DOI 10.1017/S0033291715000860; Ortiz-Gil J, 2011, BRIT J PSYCHIAT, V199, P202, DOI 10.1192/bjp.bp.110.083600; Patel DD, 2010, PSYCHOL MED, V40, P921, DOI 10.1017/S0033291709991255; Pousa E, 2008, PSYCHIAT RES, V158, P1, DOI 10.1016/j.psychres.2006.05.018; Rajji TK, 2014, CAN J PSYCHIAT, V59, P13, DOI 10.1177/070674371405900104; Randolph C., 1998, RBANS MANUAL HEPEATA; Reichenberg A, 2010, AM J PSYCHIAT; Riedel M, 2010, HUM PSYCHOPHARM CLIN, V25, P116, DOI 10.1002/hup.1101; Rund BR, 2007, SCHIZOPHR RES, V91, P132, DOI 10.1016/j.schres.2006.11.030; Rund BR, 2015, SCHIZOPHRENIA B; Sanfilipo M, 2000, ARCH GEN PSYCHIAT, V57, P471, DOI 10.1001/archpsyc.57.5.471; Schaefer J, 2013, SCHIZOPHR RES, V150, P42, DOI 10.1016/j.schres.2013.07.009; Strauss GP, 2015, NEUROPSYCHOLOGY, V29, P282, DOI 10.1037/neu0000113; Trampush JW, 2015, SCHIZOPHRENIA B; Tyson PJ, 2004, PSYCHIAT RES, V129, P229, DOI 10.1016/j.psychres.2004.09.007; Ventura J, 2009, SCHIZOPHR RES, V113, P189, DOI 10.1016/j.schres.2009.03.035; Wallwork RS, 2012, SCHIZOPHR RES, V137, P246, DOI 10.1016/j.schres.2012.01.031; Waltz JA, 2009, NEUROPSYCHOPHARMACOL, V34, P1567, DOI 10.1038/npp.2008.214; Wilk CM, 2004, SCHIZOPHR RES, V70, P175, DOI 10.1016/j.schres.2003.10.009; World Health Organization, 2004, INT STAT CLASS DIS R; Zanelli J, 2010, AM J PSYCHIAT	56	15	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167390	10.1371/journal.pone.0167390	http://dx.doi.org/10.1371/journal.pone.0167390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977720	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400019
J	Jorger, AK; Liu, L; Fehlner, K; Weisser, T; Cheng, ZJ; Lu, M; Hochst, B; Bolzer, A; Wang, BC; Hartmann, D; Assfalg, V; Sunami, Y; Schlitter, AM; Friess, H; Huser, N; Laschinger, M				Joerger, Ann-Kathrin; Liu, Lei; Fehlner, Karin; Weisser, Tanja; Cheng, Zhangjun; Lu, Miao; Hoechst, Bastian; Bolzer, Andreas; Wang, Baocai; Hartmann, Daniel; Assfalg, Volker; Sunami, Yoshiaki; Schlitter, Anna Melissa; Friess, Helmut; Hueser, Norbert; Laschinger, Melanie			Impact of NKT Cells and LFA-1 on Liver Regeneration under Subseptic Conditions	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; FUNCTION-ASSOCIATED ANTIGEN-1; PARTIAL-HEPATECTOMY; T-CELLS; HEPATOCYTE REGENERATION; MICE; ACTIVATION; ENDOTOXIN; RECEPTOR; INJURY	Background Activation of the immune system in terms of subseptic conditions during liver regeneration is of paramount clinical importance. However, little is known about molecular mechanisms and their mediators that control hepatocyte proliferation. We sought to determine the functional role of immune cells, especially NKT cells, in response to partial hepatectomy (PH), and to uncover the impact of the integrin lymphocyte function-associated antigen-1 (LFA-1) on liver regeneration in a subseptic setting. Methods Wild-type (WT) and LFA-1(-/-) mice underwent a 2/3 PH and low-dose lipopolysaccharid (LPS) application. Hepatocyte proliferation, immune cell infiltration, and cytokine profile in the liver parenchyma were determined. Results Low-dose LPS application after PH results in a significant delay of liver regeneration between 48h and 72h, which is associated with a reduced number of CD3(+) cells within the regenerating liver. In absence of LFA-1, an impaired regenerative capacity was observed under low-dose LPS application. Analysis of different leukocyte subpopulations showed less CD3(+)NK1.1(+) NKT cells in the liver parenchyma of LFA-1(-/-) mice after PH and LPS application compared to WT controls, while CD3(-)NK1.1(+) NK cells markedly increased. Concordantly with this observation, lower levels of NKT cell related cytokines IL-12 and IL-23 were expressed in the regenerating liver of LFA-1(-/-) mice, while the expression of NK cell-associated CCL5 and IL-10 was increased compared to WT mice. Conclusion A subseptic situation negatively alters hepatocyte proliferation. Within this scenario, we suggest an important impact of NKT cells and postulate a critical function for LFA-1 during processes of liver regeneration.	[Joerger, Ann-Kathrin; Liu, Lei; Fehlner, Karin; Weisser, Tanja; Cheng, Zhangjun; Lu, Miao; Wang, Baocai; Hartmann, Daniel; Assfalg, Volker; Sunami, Yoshiaki; Friess, Helmut; Hueser, Norbert; Laschinger, Melanie] Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, Munich, Germany; [Hoechst, Bastian] Tech Univ Munich, Klinikum Rechts Isar, Inst Mol Immunol, Munich, Germany; [Bolzer, Andreas] ZEISS Grp, Carl Zeiss Microscopy, Munich, Germany; [Schlitter, Anna Melissa] Tech Univ Munich, Inst Pathol, Munich, Germany; [Liu, Lei; Cheng, Zhangjun] Southeast Univ, Affiliated Zhongda Hosp, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China	Technical University of Munich; Technical University of Munich; Technical University of Munich; Southeast University - China	Huser, N (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Surg, Munich, Germany.	norbert.hueser@tum.de	Sunami, Yoshiaki/G-5313-2012; Höchst, Bastian/ABG-2094-2020; Schlitter, Anna Melissa/AAX-3449-2021; Sunami, Yoshiaki/AAT-5931-2020	Sunami, Yoshiaki/0000-0002-1235-7512; Höchst, Bastian/0000-0002-5567-1173; Sunami, Yoshiaki/0000-0002-1235-7512	Deutsche Forschungsgemeinschaft DFG [SFB 914, A4]; Gesellschaft fur Gastroenterologie in Bayern e.V.; ZEISS	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Gesellschaft fur Gastroenterologie in Bayern e.V.; ZEISS	M.L. received a grant from the Deutsche Forschungsgemeinschaft DFG (SFB 914, project A4) D.H. and N.H. have received a grant from the Gesellschaft fur Gastroenterologie in Bayern e.V. Andreas Bolzer is employed by Carl Zeiss Microscopy, ZEISS group. Carl Zeiss Microscopy, ZEISS group provided support in the form of salary for author AB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section	Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Anders RA, 2005, J IMMUNOL, V175, P1295, DOI 10.4049/jimmunol.175.2.1295; Anderson CF, 2007, J EXP MED, V204, P285, DOI 10.1084/jem.20061886; BERGESE SD, 1994, TRANSPLANTATION, V57, P711, DOI 10.1097/00007890-199403150-00013; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; Bertolino P, 2005, HEPATOLOGY, V42, P1063, DOI 10.1002/hep.20885; CORNELL RP, 1985, AM J PHYSIOL, V249, pR551, DOI 10.1152/ajpregu.1985.249.5.R551; CORNELL RP, 1985, AM J PHYSIOL, V249, pR563, DOI 10.1152/ajpregu.1985.249.5.R563; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; DAHMEN U, 1995, TRANSPLANTATION, V60, P577, DOI 10.1097/00007890-199509270-00010; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; DeAngelis RA, 2012, J IMMUNOL, V188, P641, DOI 10.4049/jimmunol.1101925; Emoto M, 2000, EUR J IMMUNOL, V30, P3049, DOI 10.1002/1521-4141(200010)30:10<3049::AID-IMMU3049>3.0.CO;2-F; Emoto M, 1999, J IMMUNOL, V162, P5094; Emoto M, 2003, J IMMUNOL, V171, P584, DOI 10.4049/jimmunol.171.2.584; Fogler WE, 1996, J IMMUNOL, V156, P4707; Graubardt N, 2013, HEPATOLOGY, V57, P1969, DOI 10.1002/hep.26008; HEWETT JA, 1992, LAB INVEST, V66, P347; Higgins GM, 1931, ARCH PATHOL, V12, P186; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Hosoya S, 2013, AM J PHYSIOL-GASTR L, V304, pG293, DOI 10.1152/ajpgi.00083.2012; Iesalnieks I, 2000, VISZERALCHIRURGIE, V35, P392; Ito H, 2003, HEPATOLOGY, V38, P1116, DOI 10.1053/jhep.2003.50471; JAESCHKE H, 1991, AM J PHYSIOL, V261, pG1051, DOI 10.1152/ajpgi.1991.261.6.G1051; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Knolle PA, 2000, IMMUNOL REV, V174, P21, DOI 10.1034/j.1600-0528.2002.017408.x; Li MO, 2008, IMMUNITY, V28, P468, DOI 10.1016/j.immuni.2008.03.003; Li X, 2004, BRIT J PHARMACOL, V141, P709, DOI 10.1038/sj.bjp.0705634; Malato Y, 2012, GASTROENTEROLOGY, V143, P1597, DOI 10.1053/j.gastro.2012.08.030; Marcos A, 2000, TRANSPLANTATION, V69, P1375, DOI 10.1097/00007890-200004150-00028; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Matsuda JL, 2002, NAT IMMUNOL, V3, P966, DOI 10.1038/ni837; McNab G, 1996, GASTROENTEROLOGY, V110, P522, DOI 10.1053/gast.1996.v110.pm8566600; Minagawa M, 2000, HEPATOLOGY, V31, P907, DOI 10.1053/he.2000.5850; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; Morris MA, 2004, CURR MOL MED, V4, P431, DOI 10.2174/1566524043360609; Nakashima H, 2006, GASTROENTEROLOGY, V131, P1573, DOI 10.1053/j.gastro.2006.08.028; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Rachitskaya AV, 2008, J IMMUNOL, V180, P5167, DOI 10.4049/jimmunol.180.8.5167; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; Rudich N, 2009, LIVER INT, V29, P1273, DOI 10.1111/j.1478-3231.2009.02048.x; Selzner N, 2003, GASTROENTEROLOGY, V124, P692, DOI 10.1053/gast.2003.50098; Slotta JE, 2010, J SURG RES, V162, P184, DOI 10.1016/j.jss.2009.03.057; Su GL, 2004, DIGEST DIS SCI, V49, P843, DOI 10.1023/B:DDAS.0000030097.52476.aa; Sun R, 2004, GASTROENTEROLOGY, V127, P1525, DOI 10.1053/j.gastro.2004.08.055; Tumanov AV, 2009, GASTROENTEROLOGY, V136, P694, DOI 10.1053/j.gastro.2008.09.015; Vaquero J, 2011, HEPATOLOGY, V54, P597, DOI 10.1002/hep.24420; Yin S, 2011, AM J PATHOL, V178, P1614, DOI 10.1016/j.ajpath.2011.01.001; Zhai Y, 2008, TRANSPLANTATION, V85, P1016, DOI 10.1097/TP.0b013e3181684248	50	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168001	10.1371/journal.pone.0168001	http://dx.doi.org/10.1371/journal.pone.0168001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977747	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400048
J	Kirsch, W; Ullrich, B; Kunde, W				Kirsch, Wladimir; Ullrich, Benjamin; Kunde, Wilfried			Are Effects of Action on Perception Real? Evidence from Transformed Movements	PLOS ONE			English	Article							EL-GRECO FALLACY; SLANT PERCEPTION; TOOL USE; ABILITY; HUMANS; HILLS; SIZE	It has been argued that several reported non-visual influences on perception cannot be truly perceptual. If they were, they should affect the perception of target objects and reference objects used to express perceptual judgments, and thus cancel each other out. This reasoning presumes that non-visual manipulations impact target objects and comparison objects equally. In the present study we show that equalizing a body-related manipulation between target objects and reference objects essentially abolishes the impact of that manipulation so as it should do when that manipulation actually altered perception. Moreover, the manipulation has an impact on judgements when applied to only the target object but not to the reference object, and that impact reverses when only applied to the reference object but not to the target object. A perceptual explanation predicts this reversal, whereas explanations in terms of post-perceptual response biases or demand effects do not. Altogether these results suggest that body-related influences on perception cannot as a whole be attributed to extra-perceptual factors.	[Kirsch, Wladimir; Ullrich, Benjamin; Kunde, Wilfried] Univ Wurzburg, Dept Psychol, Wurzburg, Germany	University of Wurzburg	Kirsch, W (corresponding author), Univ Wurzburg, Dept Psychol, Wurzburg, Germany.	kirsch@psychologie.uni-wuerzburg.de		Kunde, Wilfried/0000-0001-6256-8011	German Research Council (DFG). [KI 1620/1-2]	German Research Council (DFG).(German Research Foundation (DFG))	This research was supported by grant KI 1620/1-2 awarded to W. Kirsch by the German Research Council (DFG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton-Erxleben K, 2007, J VISION, V7, DOI 10.1167/7.11.5; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Carrasco M, 2004, NAT NEUROSCI, V7, P308, DOI 10.1038/nn1194; Cooper AD, 2012, VISION RES, V62, P235, DOI 10.1016/j.visres.2012.04.009; Cousineau D, 2005, TUTORIALS QUANTITATI, V1, P75; de Grave DDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016697; Durgin FH, 2012, J EXP PSYCHOL HUMAN, V38, P1582, DOI 10.1037/a0027805; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Ernst MO, 2000, NAT NEUROSCI, V3, P69, DOI 10.1038/71140; Firestone C., BEHAV BRAIN IN PRESS; Firestone C, 2014, PSYCHOL SCI, V25, P38, DOI 10.1177/0956797613485092; Firestone C, 2013, PERSPECT PSYCHOL SCI, V8, P455, DOI 10.1177/1745691613489835; Girshick A. R., 2012, NAT NEUROSCI, V14, P926; Hofmann W, 2010, PSYCHOL BULL, V136, P390, DOI 10.1037/a0018916; Kirsch W., J EXPT PSYC IN PRESS; Kirsch W, 2016, ATTEN PERCEPT PSYCHO, V78, P133, DOI 10.3758/s13414-015-0997-z; Kirsch W, 2015, PSYCHON B REV, V22, P1235, DOI 10.3758/s13423-014-0792-1; Kirsch W, 2014, ATTEN PERCEPT PSYCHO, V76, P1752, DOI 10.3758/s13414-014-0685-4; Kirsch W, 2013, J EXP PSYCHOL HUMAN, V39, P1313, DOI 10.1037/a0031074; Knill D. C., 1996, PERCEPTION BAYESIAN, P1, DOI [DOI 10.1017/CBO9780511984037, 10.1017/cbo9780511984037, 10.1017/CBO9780511984037]; Linkenauger SA, 2015, NEUROPSYCHOLOGIA, V70, P393, DOI 10.1016/j.neuropsychologia.2014.10.034; Linkenauger SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068594; Linkenauger SA, 2011, J EXP PSYCHOL HUMAN, V37, P1432, DOI 10.1037/a0024248; Musseler J, 2008, EUR J COGN PSYCHOL, V20, P211, DOI 10.1080/09541440701275815; Philbeck JW, 2015, PSYCHOL BULL, V141, P1120, DOI 10.1037/a0039738; Proffitt DR, 2006, PERSPECT PSYCHOL SCI, V1, P110, DOI 10.1111/j.1745-6916.2006.00008.x; Proffitt DR, 2013, PERSPECT PSYCHOL SCI, V8, P474, DOI 10.1177/1745691613489837; Proffitt DR, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P171; Rand MK, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02056; Rand MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068471; Simunovic MP, 2014, JAMA OPHTHALMOL, V132, P491, DOI 10.1001/jamaophthalmol.2013.5684; Takahashi C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00109; Takahashi C, 2009, J VISION, V9, DOI 10.1167/9.6.3; Taylor J. E. T., 2010, J VISION, V10, P1017, DOI DOI 10.1167/10.7.1017; Wei XX, 2015, NAT NEUROSCI, V18, P1509, DOI 10.1038/nn.4105; Witt JK, 2011, CURR DIR PSYCHOL SCI, V20, P201, DOI 10.1177/0963721411408770; Witt JK, 2011, J EXP PSYCHOL HUMAN, V37, P1148, DOI 10.1037/a0021933; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880	39	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167993	10.1371/journal.pone.0167993	http://dx.doi.org/10.1371/journal.pone.0167993			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977726	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400046
J	Li, BB; Cheng, G; Zhang, DJ; Wei, DT; Qiao, L; Wang, XP; Che, XW				Li, Bingbing; Cheng, Gang; Zhang, Dajun; Wei, Dongtao; Qiao, Lei; Wang, Xiangpeng; Che, Xianwei			Regional Brain Responses Are Biased Toward Infant Facial Expressions Compared to Adult Facial Expressions in Nulliparous Women	PLOS ONE			English	Article							FUNCTIONAL-ANATOMY; MATERNAL-BEHAVIOR; SEX-DIFFERENCES; HUMAN AMYGDALA; ATTACHMENT; MOTHERS; EMPATHY; FACES; REPRESENTATIONS; RECOGNITION	Recent neuroimaging studies suggest that neutral infant faces compared to neutral adult faces elicit greater activity in brain areas associated with face processing, attention, empathic response, reward, and movement. However, whether infant facial expressions evoke larger brain responses than adult facial expressions remains unclear. Here, we performed event-related functional magnetic resonance imaging in nulliparous women while they were presented with images of matched unfamiliar infant and adult facial expressions (happy, neutral, and uncomfortable/sad) in a pseudo-randomized order. We found that the bilateral fusiform and right lingual gyrus were overall more activated during the presentation of infant facial expressions compared to adult facial expressions. Uncomfortable infant faces compared to sad adult faces evoked greater activation in the bilateral fusiform gyrus, precentral gyrus, postcentral gyrus, posterior cingulate cortex-thalamus, and precuneus. Neutral infant faces activated larger brain responses in the left fusiform gyrus compared to neutral adult faces. Happy infant faces compared to happy adult faces elicited larger responses in areas of the brain associated with emotion and reward processing using a more liberal threshold of p < 0.005 uncorrected. Furthermore, the level of the test subjects' Interest-In-Infants was positively associated with the intensity of right fusiform gyrus response to infant faces and uncomfortable infant faces compared to sad adult faces. In addition, the Perspective Taking subscale score on the Interpersonal Reactivity Index-Chinese was significantly correlated with precuneus activity during uncomfortable infant faces compared to sad adult faces. Our findings suggest that regional brain areas may bias cognitive and emotional responses to infant facial expressions compared to adult facial expressions among nulliparous women, and this bias may be modulated by individual differences in Interest-In-Infants and perspective taking ability.	[Li, Bingbing; Zhang, Dajun; Wei, Dongtao; Qiao, Lei; Wang, Xiangpeng] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Li, Bingbing; Zhang, Dajun] Southwest Univ, Ctr Mental Hlth Educ, Chongqing, Peoples R China; [Cheng, Gang] Guizhou Normal Univ, Sch Educ Sci, Guiyang, Peoples R China; [Wei, Dongtao; Qiao, Lei; Wang, Xiangpeng] Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; [Che, Xianwei] The Alfred, Monash Alfred Psychiat Res Ctr, Melbourne, Vic, Australia; [Che, Xianwei] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia	Southwest University - China; Southwest University - China; Guizhou Normal University; Monash University; Monash University	Zhang, DJ (corresponding author), Southwest Univ, Sch Psychol, Chongqing, Peoples R China.; Zhang, DJ (corresponding author), Southwest Univ, Ctr Mental Hlth Educ, Chongqing, Peoples R China.	Zhangdj@swu.edu.cn		Cheng, Gang/0000-0002-6903-6381; Che, Xianwei/0000-0002-0039-7306				Best D.L., 2001, HDB CULTURE PSYCHOL, P195; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Bowlby J, 1969, ATTACHMENT LOSS SEPA; Brett M, 2002, NEUROIMAGE, V16, pS497, DOI DOI 10.1016/S1053-8119(02)90010-8; Caria A, 2012, NEUROIMAGE, V60, P884, DOI 10.1016/j.neuroimage.2011.12.068; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cheng G, 2015, PERS INDIV DIFFER, V87, P39, DOI 10.1016/j.paid.2015.07.004; De Pisapia N, 2013, NEUROREPORT, V24, P142, DOI 10.1097/WNR.0b013e32835df4fa; Engen HG, 2013, CURR OPIN NEUROBIOL, V23, P275, DOI 10.1016/j.conb.2012.11.003; Farrow TFD, 2001, NEUROREPORT, V12, P2433, DOI 10.1097/00001756-200108080-00029; Fengfeng Z., 2010, CHIN J CLIN PSYCHOL, V18, P155; Freeman JB, 2016, TRENDS COGN SCI, V20, P362, DOI 10.1016/j.tics.2016.03.003; Gang C, 2015, CHINESE MENTAL HLTH, V29, P406; Glocker ML, 2009, P NATL ACAD SCI USA, V106, P9115, DOI 10.1073/pnas.0811620106; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; Harvey PO, 2013, SCHIZOPHRENIA BULL, V39, P617, DOI 10.1093/schbul/sbs042; Kranz F, 2006, CURR BIOL, V16, P63, DOI 10.1016/j.cub.2005.10.070; Kringelbach ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001664; Leibenluft E, 2004, BIOL PSYCHIAT, V56, P225, DOI 10.1016/j.biopsych.2004.05.017; Lenzi D, 2009, CEREB CORTEX, V19, P1124, DOI 10.1093/cercor/bhn153; Lenzi D, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01241; Lenzi D, 2013, HUM BRAIN MAPP, V34, P1399, DOI 10.1002/hbm.21520; Lorberbaum JP, 2002, BIOL PSYCHIAT, V51, P431, DOI 10.1016/S0006-3223(01)01284-7; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; MacLean P, 1990, TRIUNE BRAIN EVOLUTI; Maestripieri D, 1999, NEUROSCI BIOBEHAV R, V23, P411, DOI 10.1016/S0149-7634(98)00042-6; Maestripieri D, 2002, HUM NATURE-INT BIOS, V13, P327, DOI 10.1007/s12110-002-1018-1; Mesulam M, 2000, BRAIN COGNITION, V42, P4, DOI 10.1006/brcg.1999.1145; Minagawa-Kawai Y, 2009, CEREB CORTEX, V19, P284, DOI 10.1093/cercor/bhn081; Montoya JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036270; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; MURPHY MR, 1981, SCIENCE, V213, P459, DOI 10.1126/science.7244642; Nishitani S, 2011, NEUROSCI RES, V70, P183, DOI 10.1016/j.neures.2011.02.007; Nitschke JB, 2004, NEUROIMAGE, V21, P583, DOI 10.1016/j.neuroimage.2003.10.005; Noriuchi M, 2008, BIOL PSYCHIAT, V63, P415, DOI 10.1016/j.biopsych.2007.05.018; Parsons CE, 2010, PROG NEUROBIOL, V91, P220, DOI 10.1016/j.pneurobio.2010.03.001; Pechtel Pia, 2013, Transl Dev Psychiatry, V1, DOI 10.3402/tdp.v1i0.19673; Peltola MJ, 2014, EMOTION, V14, P469, DOI 10.1037/a0035959; Phillips ML, 1998, PSYCHIAT RES-NEUROIM, V83, P127, DOI 10.1016/S0925-4927(98)00036-5; Proverbio AM, 2006, NEUROPSYCHOLOGIA, V44, P2987, DOI 10.1016/j.neuropsychologia.2006.06.015; Proverbio AM, 2011, J COGNITIVE NEUROSCI, V23, P3197, DOI 10.1162/jocn_a_00041; Proverbio AM, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00169; Proverbio AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011242; Riem MME, 2012, ATTACH HUM DEV, V14, P533, DOI 10.1080/14616734.2012.727252; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Shamay-Tsoory SG, 2009, BRAIN, V132, P617, DOI 10.1093/brain/awn279; SLOTNICK BM, 1967, BEHAVIOUR, V29, P204, DOI 10.1163/156853967X00127; STAMM JS, 1955, J COMP PHYSIOL PSYCH, V48, P347, DOI 10.1037/h0042977; Stolier RM, 2016, NAT NEUROSCI; Strathearn L, 2008, PEDIATRICS, V122, P40, DOI 10.1542/peds.2007-1566; Strathearn L, 2009, NEUROPSYCHOPHARMACOL, V34, P2655, DOI 10.1038/npp.2009.103; Thompson-Booth C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109362; Thompson-Booth C, 2014, DEVELOPMENTAL SCI, V17, P35, DOI 10.1111/desc.12090; Willenbockel V, 2010, BEHAV RES METHODS, V42, P671, DOI 10.3758/BRM.42.3.671	55	4	5	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0166860	10.1371/journal.pone.0166860	http://dx.doi.org/10.1371/journal.pone.0166860			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977692	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400008
J	Marken, JP; Halleran, AD; Rahman, A; Odorizzi, L; LeFew, MC; Golino, CA; Kemper, P; Saha, MS				Marken, John P.; Halleran, Andrew D.; Rahman, Atiqur; Odorizzi, Laura; LeFew, Michael C.; Golino, Caroline A.; Kemper, Peter; Saha, Margaret S.			A Markovian Entropy Measure for the Analysis of Calcium Activity Time Series	PLOS ONE			English	Article							DIFFERENTIATION; DECONVOLUTION; XENOPUS; SCALE	Methods to analyze the dynamics of calcium activity often rely on visually distinguishable features in time series data such as spikes, waves, or oscillations. However, systems such as the developing nervous system display a complex, irregular type of calcium activity which makes the use of such methods less appropriate. Instead, for such systems there exists a class of methods (including information theoretic, power spectral, and fractal analysis approaches) which use more fundamental properties of the time series to analyze the observed calcium dynamics. We present a new analysis method in this class, the Markovian Entropy measure, which is an easily implementable calcium time series analysis method which represents the observed calcium activity as a realization of a Markov Process and describes its dynamics in terms of the level of predictability underlying the transitions between the states of the process. We applied our and other commonly used calcium analysis methods on a dataset from Xenopus laevis neural progenitors which displays irregular calcium activity and a dataset from murine synaptic neurons which displays activity time series that are well-described by visually-distinguishable features. We find that the Markovian Entropy measure is able to distinguish between biologically distinct populations in both datasets, and that it can separate biologically distinct populations to a greater extent than other methods in the dataset exhibiting irregular calcium activity. These results support the benefit of using the Markovian Entropy measure to analyze calcium dynamics, particularly for studies using time series data which do not exhibit easily distinguishable features.	[Marken, John P.; Halleran, Andrew D.; LeFew, Michael C.; Golino, Caroline A.] Coll William & Mary, Dept Math, Williamsburg, VA 23185 USA; [Halleran, Andrew D.; Odorizzi, Laura; LeFew, Michael C.; Golino, Caroline A.; Saha, Margaret S.] Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA; [Rahman, Atiqur; Kemper, Peter] Coll William & Mary, Dept Comp Sci, Williamsburg, VA 23185 USA; [Halleran, Andrew D.] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Odorizzi, Laura] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	William & Mary; William & Mary; William & Mary; California Institute of Technology; University of Texas System; University of Texas Health San Antonio	Saha, MS (corresponding author), Coll William & Mary, Dept Biol, Williamsburg, VA 23185 USA.	mssaha@wm.edu	Rahman, Md Atiqur/GSE-2794-2022	Saha, Margaret/0000-0003-0096-2667; Halleran, Andrew/0000-0001-8720-1451; Marken, John/0000-0001-9696-088X	National Institutes of Health [R15NS067566, 1R15HD077624-01]; National Science Foundation [1257895]; Howard Hughes Medical Institute [52006919]; Arnold and Mabel Beckman Foundation Beckman Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R15HD077624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS067566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Arnold and Mabel Beckman Foundation Beckman Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health grants R15NS067566 and 1R15HD077624-01 to MS, National Science Foundation grant 1257895 to MS, Howard Hughes Medical Institute grant 52006919 to the College of William and Mary, Arnold and Mabel Beckman Foundation Beckman Scholar Award to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bickenbach F, 2003, INT REGIONAL SCI REV, V26, P363, DOI 10.1177/0160017603253789; Cline HT, 2012, DEV NEUROBIOL, V72, P463, DOI 10.1002/dneu.22012; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cover T. M., 1991, Elements of information theory, DOI 10.1002/0471200611; Eilers PH, 2005, BASELINE CORRECTION, V1, P1, DOI DOI 10.1021/AC034173T; Freeman J, 2014, NAT METHODS, V11, P941, DOI [10.1038/NMETH.3041, 10.1038/nmeth.3041]; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; GU XN, 1994, J NEUROSCI, V14, P6325; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; HENNINGS H, 1980, CELL, V19, P245, DOI 10.1016/0092-8674(80)90406-7; Jenkins G., 1968, SPECTRAL ANAL ITS AP; Khodagholy D, 2015, NAT NEUROSCI, V18, P310, DOI 10.1038/nn.3905; LECHLEITER J, 1991, SCIENCE, V252, P123, DOI 10.1126/science.2011747; Marken J, MARKOVIAN ENTROPY ME; Michod D, 2012, NEURON, V74, P122, DOI 10.1016/j.neuron.2012.02.021; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nakano T, 2009, L N INST COMP SCI SO, V20, P29; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Onativia J, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046017; Pahle J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-139; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Prank K, 2000, BIOSYSTEMS, V55, P15, DOI 10.1016/S0303-2647(99)00078-7; Qian B., 2004, IASTED C FIN ENG APP, P203; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Root CM, 2008, J NEUROSCI, V28, P4777, DOI 10.1523/JNEUROSCI.4873-07.2008; Rosenbaum Sara, 2011, Issue Brief (Commonw Fund), V3, P1, DOI 10.1101/cshperspect.a004259; Ruffault PL, 2015, ELIFE, V4, DOI 10.7554/eLife.07051; Salles A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003245; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smaili SS, 2013, CURR MOL MED, V13, P252; SPITZER NC, 1995, J NEUROBIOL, V26, P316, DOI 10.1002/neu.480260304; Theis L., 2015, ARXIV PREPRINT ARXIV; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874	37	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168342	10.1371/journal.pone.0168342	http://dx.doi.org/10.1371/journal.pone.0168342			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977764	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400098
J	Yu, ZX; Mouillesseaux, KP; Kushner, EJ; Bautch, VL				Yu, Zhixian; Mouillesseaux, Kevin P.; Kushner, Erich J.; Bautch, Victoria L.			Tumor-Derived Factors and Reduced p53 Promote Endothelial Cell Centrosome Over-Duplication	PLOS ONE			English	Article							MORPHOGENETIC PROTEIN-RECEPTOR; HYPOXIA; GROWTH; CANCER; INTERLEUKIN-8; ANGIOGENESIS; INFLAMMATION; ACTIVATION; EXPRESSION; DELETION	Approximately 30% of tumor endothelial cells have over-duplicated (>2) centrosomes, which may contribute to abnormal vessel function and drug resistance. Elevated levels of vascular endothelial growth factor A induce excess centrosomes in endothelial cells, but how other features of the tumor environment affect centrosome over-duplication is not known. To test this, we treated endothelial cells with tumor-derived factors, hypoxia, or reduced p53, and assessed centrosome numbers. We found that hypoxia and elevated levels of bone morphogenetic protein 2, 6 and 7 induced excess centrosomes in endothelial cells through BMPR1A and likely via SMAD signaling. In contrast, inflammatory mediators IL-8 and lipopolysaccharide did not induce excess centrosomes. Finally, down-regulation in endothelial cells of p53, a critical regulator of DNA damage and proliferation, caused centrosome over-duplication. Our findings suggest that some tumor-derived factors and genetic changes in endothelial cells contribute to excess centrosomes in tumor endothelial cells.	[Yu, Zhixian; Bautch, Victoria L.] Univ North Carolina Chapel Hill, Curriculum Genet & Mol Biol, Chapel Hill, NC 27514 USA; [Mouillesseaux, Kevin P.; Kushner, Erich J.; Bautch, Victoria L.] Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27514 USA; [Bautch, Victoria L.] Univ North Carolina Chapel Hill, McAllister Heart Inst, Chapel Hill, NC 27514 USA; [Mouillesseaux, Kevin P.] StrideBio, Durham, NC USA; [Kushner, Erich J.] Univ Denver, Dept Biol Sci, Denver, CO 80208 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Denver	Bautch, VL (corresponding author), Univ North Carolina Chapel Hill, Curriculum Genet & Mol Biol, Chapel Hill, NC 27514 USA.; Bautch, VL (corresponding author), Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC 27514 USA.; Bautch, VL (corresponding author), Univ North Carolina Chapel Hill, McAllister Heart Inst, Chapel Hill, NC 27514 USA.	bautch@med.unc.edu			NIH-NHLBI [HL116719, HL43174]	NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH-NHLBI (HL116719 and HL43174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 2009, AM J PATHOL, V175, P2657, DOI 10.2353/ajpath.2009.090202; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Bobinac D, 2005, CROAT MED J, V46, P389; Brat DJ, 2005, NEURO-ONCOLOGY, V7, P122, DOI 10.1215/S1152851704001061; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; Dudley AC, 2008, BRIT J CANCER, V99, P118, DOI 10.1038/sj.bjc.6604465; Dudley AC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006536; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Gaussin V, 2005, CIRC RES, V97, P219, DOI 10.1161/01.RES.0000177862.85474.63; Gaussin V, 2002, P NATL ACAD SCI USA, V99, P2878, DOI 10.1073/pnas.042390499; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Kushner EJ, 2016, MOL BIOL CELL, V27, P1911, DOI 10.1091/mbc.E15-09-0645; Kushner EJ, 2014, J CELL BIOL, V206, P257, DOI 10.1083/jcb.201311013; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; MARTICH GD, 1993, IMMUNOBIOLOGY, V187, P403, DOI 10.1016/S0171-2985(11)80353-0; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Roberts DM, 2004, MOL CELL BIOL, V24, P10515, DOI 10.1128/MCB.24.24.10515-10528.2004; Taylor SM, 2010, BLOOD, V116, P3108, DOI 10.1182/blood-2010-01-266197; Upton PD, 2008, MOL PHARMACOL, V73, P539, DOI 10.1124/mol.107.041673; Vaupel P, 2004, ONCOLOGIST, V9, P4, DOI 10.1634/theoncologist.9-90005-4; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Yi SE, 2000, DEVELOPMENT, V127, P621; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200; Yuan A, 2005, FRONT BIOSCI-LANDMRK, V10, P853, DOI 10.2741/1579; Zhang XJ, 2010, FRONT BIOSCI-LANDMRK, V15, P151, DOI 10.2741/3612	35	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168334	10.1371/journal.pone.0168334	http://dx.doi.org/10.1371/journal.pone.0168334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977771	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400094
J	Casarrubia, S; Sapienza, S; Fritz, H; Daghino, S; Rosenkranz, M; Schnitzler, JP; Martin, F; Perotto, S; Martino, E				Casarrubia, Salvatore; Sapienza, Sara; Fritz, Hema; Daghino, Stefania; Rosenkranz, Maaria; Schnitzler, Joerg-Peter; Martin, Francis; Perotto, Silvia; Martino, Elena			Ecologically Different Fungi Affect Arabidopsis Development: Contribution of Soluble and Volatile Compounds	PLOS ONE			English	Article							ERICOID MYCORRHIZAL FUNGI; LATERAL ROOT-FORMATION; PLANT-GROWTH; AUXIN TRANSPORT; ECTOMYCORRHIZAL FUNGI; FUSARIUM-OXYSPORUM; MODEL SYSTEM; L-GLUTAMATE; THALIANA; PINUS	Plant growth and development can be influenced by mutualistic and non-mutualistic microorganisms. We investigated the ability of the ericoid endomycorrhizal fungus Oidiodendron maius to influence growth and development of the non-host plant Arabidopsis thaliana. Different experimental setups (non-compartmented and compartmented co-culture plates) were used to investigate the influence of both soluble and volatile fungal molecules on the plant phenotype. O. maius promoted growth of A. thaliana in all experimental setups. In addition, a peculiar clumped root phenotype, characterized by shortening of the primary root and by an increase of lateral root length and number, was observed in A. thaliana only in the non-compartmented plates, suggesting that soluble diffusible molecules are responsible for this root morphology. Fungal auxin does not seem to be involved in plant growth promotion and in the clumped root phenotype because co-cultivation with O. maius did not change auxin accumulation in plant tissues, as assessed in plants carrying the DR5::GUS reporter construct. In addition, no correlation between the amount of fungal auxin produced and the plant root phenotype was observed in an O. maius mutant unable to induce the clumped root phenotype in A. thaliana. Addition of active charcoal, a VOC absorbant, in the compartmented plates did not modify plant growth promotion, suggesting that VOCs are not involved in this phenomenon. The low VOCs emission measured for O. maius further corroborated this hypothesis. By contrast, the addition of CO2 traps in the compartmented plates drastically reduced plant growth, suggesting involvement of fungal CO2 in plant growth promotion. Other mycorrhizal fungi, as well as a saprotrophic and a pathogenic fungus, were also tested with the same experimental setups. In the non-compartmented plates, most fungi promoted A. thaliana growth and some could induce the clumped root phenotype. In the compartmented plate experiments, a general induction of plant growth was observed for most other fungi, especially those producing higher biomass, further strengthening the role of a nonspecific mechanism, such as CO2 emission.	[Casarrubia, Salvatore; Sapienza, Sara; Daghino, Stefania; Perotto, Silvia; Martino, Elena] Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy; [Fritz, Hema; Martin, Francis; Martino, Elena] INRA Nancy, Champenoux, France; [Fritz, Hema; Martin, Francis; Martino, Elena] Lorraine Univ, Lab Excellence ARBRE, UMR 1136, Champenoux, France; [Rosenkranz, Maaria; Schnitzler, Joerg-Peter] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Inst Biochem Plant Pathol, Res Unit Environm Simulat, Neuherberg, Germany	University of Turin; INRAE; Universite de Lorraine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Martino, E (corresponding author), Univ Turin, Dept Life Sci & Syst Biol, Turin, Italy.; Martino, E (corresponding author), INRA Nancy, Champenoux, France.; Martino, E (corresponding author), Lorraine Univ, Lab Excellence ARBRE, UMR 1136, Champenoux, France.	elena.martino@unito.it	Daghino, Stefania/AAO-7718-2021; Rosenkranz, Maaria/B-3338-2013; Schnitzler, Joerg-Peter/C-5268-2011	Rosenkranz, Maaria/0000-0002-1421-112X; Schnitzler, Joerg-Peter/0000-0002-9825-867X; DAGHINO, Stefania/0000-0001-5722-1558; PEROTTO, Silvia/0000-0003-0121-1806; Martino, Elena/0000-0003-3446-2994	Italian MIUR; University of Turin; Laboratory of Excellence ARBRE [ANR-11-LABX-0002-01]	Italian MIUR(Ministry of Education, Universities and Research (MIUR)); University of Turin; Laboratory of Excellence ARBRE	S.C. was supported by a PhD fellowship from the Italian MIUR. The authors acknowledge financial support from local funding of the University of Turin and from the Laboratory of Excellence ARBRE (ANR-11-LABX-0002-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba S, 2009, MOL PLANT MICROBE IN, V22, P1412, DOI 10.1094/MPMI-22-11-1412; Contreras-Cornejo HA, 2009, PLANT PHYSIOL, V149, P1579, DOI 10.1104/pp.108.130369; Bent E, 2006, MULTIGENIC AND INDUCED SYSTEMIC RESISTANCE IN PLANTS, P225, DOI 10.1007/0-387-23266-4_10; Berg G, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00148, 10.3389/fmicb.2014.00491]; Berg G, 2009, APPL MICROBIOL BIOT, V84, P11, DOI 10.1007/s00253-009-2092-7; Berta G, 1987, MYCORRHIZAE PHYSL GE, P673; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Cairney JWG, 2003, EUR J SOIL SCI, V54, P735, DOI 10.1046/j.1351-0754.2003.0555.x; Chambers SM, 2008, FEMS MICROBIOL ECOL, V65, P263, DOI 10.1111/j.1574-6941.2008.00481.x; Crookshanks M, 1998, J EXP BOT, V49, P593, DOI 10.1093/jexbot/49.320.593; Daghino S, 2016, MYCORRHIZA, V26, P263, DOI 10.1007/s00572-015-0675-y; Ditengou FA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7279; Dobbelaere S, 1999, PLANT SOIL, V212, P155, DOI 10.1023/A:1004658000815; Dovana F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143353; Felten J, 2009, PLANT PHYSIOL, V151, P1991, DOI 10.1104/pp.109.147231; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Forde BG, 2014, J EXP BOT, V65, P779, DOI 10.1093/jxb/ert335; Garnica-Vergara A, 2016, NEW PHYTOL, V209, P1496, DOI 10.1111/nph.13725; Gay G, 1986, N MYCORRHIZAE PHYSL; Glick BR, 2007, EUR J PLANT PATHOL, V119, P329, DOI 10.1007/s10658-007-9162-4; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Gougoulias C, 2014, J SCI FOOD AGR, V94, P2362, DOI 10.1002/jsfa.6577; Gutjahr C, 2009, NEW PHYTOL, V182, P829, DOI 10.1111/j.1469-8137.2009.02839.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; Heller G, 2012, MYCORRHIZA, V22, P271, DOI 10.1007/s00572-011-0402-2; Hung R, 2013, FUNGAL ECOL, V6, P19, DOI 10.1016/j.funeco.2012.09.005; KAGEYAMA S.A., 2008, MYCORRHIZA STATE ART, P29, DOI DOI 10.1007/978-3-540-78826-3_2; Kai M, 2009, FEBS LETT, V583, P3473, DOI 10.1016/j.febslet.2009.09.053; Kaldorf M, 2000, PHYSIOL PLANTARUM, V109, P58, DOI 10.1034/j.1399-3054.2000.100109.x; Karabaghli-Degron C, 1998, NEW PHYTOL, V140, P723, DOI 10.1046/j.1469-8137.1998.00307.x; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Liu YX, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0079417, 10.1371/journal.pone.0082678, 10.1371/journal.pone.0061031, 10.1371/journal.pone.0072930, 10.1371/journal.pone.0055221, 10.1371/journal.pone.0075318, 10.1371/journal.pone.0080097]; Lobet G, 2011, PLANT PHYSIOL, V157, P29, DOI 10.1104/pp.111.179895; Lopez-Bucio J, 2007, PLANT PHYSIOL, V145, P1703, DOI 10.1104/pp.107.107953; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Sanchez-Lopez AM, 2016, PLANT CELL ENVIRON, V39, P2592, DOI 10.1111/pce.12759; Martino E, 2000, MYCOL RES, V104, P338, DOI 10.1017/S0953756299001252; Martinuz A, 2015, PLANTA, V241, P1015, DOI 10.1007/s00425-014-2237-5; Minerdi D, 2011, FEMS MICROBIOL ECOL, V76, P342, DOI 10.1111/j.1574-6941.2011.01051.x; Muller A, 2013, FUNGAL GENET BIOL, V54, P25, DOI 10.1016/j.fgb.2013.02.005; Murali Amruthesh KN, 2012, SCREENING PLANT GROW, V4, P30; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Newsholme P, 2003, CELL BIOCHEM FUNCT, V21, P1, DOI 10.1002/cbf.1003; Niemi K, 2002, TREE PHYSIOL, V22, P1231, DOI 10.1093/treephys/22.17.1231; Orfanoudakis M, 2010, MYCORRHIZA, V20, P117, DOI 10.1007/s00572-009-0271-0; Ortiz-Castro R, 2011, P NATL ACAD SCI USA, V108, P7253, DOI 10.1073/pnas.1006740108; Perotto S, 2012, FUNGAL ASS, P255; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Piechulla B, 2016, TRENDS PLANT SCI, V21, P541, DOI 10.1016/j.tplants.2016.05.001; Rai Mahendra, 2005, Electron. J. Biotechnol., V8, P1; Rincon A, 2003, TREE PHYSIOL, V23, P785, DOI 10.1093/treephys/23.11.785; Rommert AK, 2002, 7 INT MYC C U OSL; Ryu CM, 2005, PLANT SOIL, V268, P285, DOI 10.1007/s11104-004-0301-9; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Salas-Marina MA, 2011, J MICROBIOL BIOTECHN, V21, P686, DOI 10.4014/jmb.1101.01012; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Sharples JM, 2000, NATURE, V404, P951, DOI 10.1038/35010193; Shi CL, 2010, MOL CELLS, V29, P251, DOI 10.1007/s10059-010-0032-0; Shi W-L, 2016, J EXP BOT; Sirrenberg A, 2007, PHYSIOL PLANTARUM, V131, P581, DOI 10.1111/j.1399-3054.2007.00983.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Splivallo R, 2009, PLANT PHYSIOL, V150, P2018, DOI 10.1104/pp.109.141325; Sukumar P, 2013, PLANT CELL ENVIRON, V36, P909, DOI 10.1111/pce.12036; Tranvan H, 2000, TREE PHYSIOL, V20, P123; Tsavkelova EA, 2006, APPL BIOCHEM MICRO+, V42, P229, DOI 10.1134/S000368380603001X; Turjaman M, 2006, MYCORRHIZA, V16, P459, DOI 10.1007/s00572-006-0059-4; Villarreal-Ruiz L, 2004, NEW PHYTOL, V164, P183, DOI 10.1111/j.1469-8137.2004.01167.x; Walch-Liu P, 2006, ANN BOT-LONDON, V97, P875, DOI 10.1093/aob/mcj601; Walch-Liu P, 2006, PLANT CELL PHYSIOL, V47, P1045, DOI 10.1093/pcp/pcj075; Walch-Liu P, 2007, PLANT SIGNAL BEHAV, V2, P284, DOI 10.4161/psb.2.4.4016; Weikl F, 2016, SCI REP-UK, V6, DOI 10.1038/srep22152; Zhang H, 2007, PLANTA, V226, P839, DOI 10.1007/s00425-007-0530-2	74	21	21	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168236	10.1371/journal.pone.0168236	http://dx.doi.org/10.1371/journal.pone.0168236			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973595	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300068
J	Li, B; Luo, XM; Li, T; Zheng, CY; Ji, SM; Ma, YY; Zhang, SS; Zhou, XD				Li, Bing; Luo, Xiumei; Li, Tao; Zheng, Changyue; Ji, Shunmei; Ma, Yuanyuan; Zhang, Shuangshuang; Zhou, Xiaodong			Effects of Constant Flickering Light on Refractive Status, 5-HT and 5-HT2A Receptor in Guinea Pigs	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; RETINAL DOPAMINE; DEPRIVATION MYOPIA; SEROTONIN 5-HT2A; RAT RETINA; CELLS; CHICKENS; NEURONS; ERRORS; EPINEPHRINE	Purpose To investigate the effects of constant flickering light on refractive development, the role of serotonin (i.e. 5-hydroxytryptamine, 5-HT) and 5-HT2A receptor in myopia induced by flickering light in guinea pigs. Methods Forty-five guinea pigs were randomly divided into three groups: control, form deprivation myopia (FDM) and flickering light induced myopia (FLM) groups(n = 15 for each group). The right eyes of the FDM group were covered with semitransparent hemispherical plastic shells serving as eye diffusers. Guinea pigs in FLM group were raised with illumination of a duty cycle of 50% at a flash frequency of 0.5Hz. The refractive status, axial length (AL), corneal radius of curvature(CRC) were measured by streak retinoscope, A-scan ultrasonography and keratometer, respectively. Ultramicroscopy images were taken by electron microscopy. The concentrations of 5-HTin the retina, vitreous body and retinal pigment epithelium (RPE) were assessed by high performance liquid chromatography, the retinal 5-HT2A receptor expression was evaluated by immunohistofluorescence and western blot. Results The refraction of FDM and FLM eyes became myopic from some time point (the 4th week and the 6th week, respectively) in the course of the experiment, which was indicated by significantly decreased refraction and longer AL when compared with the controls (p<0.05). The concentrations of 5-HT in the retina, vitreous body and RPE of FDM and FLM eyes were significantly increased in comparison with those of control eyes (both p<0.05). Similar to FDM eyes, the expression of retinal 5-HT2A receptor in FLM eyes was significantly upregulated compared to that of control eyes (both p<0.05). Western blot analysis showed that retinal 5-HT2A receptor level elevated less in the FLM eyes than that in the FDM eyes. Moreover, the levels of norepinephrine and epinephrine in FDM and FLM groups generally decreased when compared with control groups (all p<0.05). Conclusions Constant flickering light could cause progressive myopia in guinea pigs. 5-HT and 5-HT2A receptor increased both in form deprivation myopia and flickering light induced myopia, indicating that 5-HT possibly involved in myopic development via binding to5-HT2A receptor.	[Li, Bing] Fudan Univ, Jinshan Hosp, Cent Lab, Shanghai, Peoples R China; [Luo, Xiumei; Li, Tao; Zheng, Changyue; Ji, Shunmei; Zhou, Xiaodong] Fudan Univ, Jinshan Hosp, Dept Ophthalmol, Shanghai, Peoples R China; [Ma, Yuanyuan] Fudan Univ, Shanghai Med Coll, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai, Peoples R China; [Ma, Yuanyuan] Fudan Univ, Shanghai Med Coll, Collaborat Innovat Ctr Brain Sci, Shanghai, Peoples R China; [Zhang, Shuangshuang] Fudan Univ, Jinshan Hosp, Dept Dermatol, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University	Zhou, XD (corresponding author), Fudan Univ, Jinshan Hosp, Dept Ophthalmol, Shanghai, Peoples R China.	jinshantg@163.com	Zhang, Shuangshuang/GVS-0109-2022		Shanghai health and family planning committee funded projects of China [201640046]; Shanghai Municipal Natural Science Foundation of China [13ZR1405800]; Shanghai Municipality Health Bureau Youth Project [2013-121]	Shanghai health and family planning committee funded projects of China; Shanghai Municipal Natural Science Foundation of China; Shanghai Municipality Health Bureau Youth Project	This work was supported by Grants from the Shanghai health and family planning committee funded projects of China (No. 201640046), Shanghai Municipal Natural Science Foundation of China (13ZR1405800) and Shanghai Municipality Health Bureau Youth Project (2013-121). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex KD, 2007, PHARMACOL THERAPEUT, V113, P296, DOI 10.1016/j.pharmthera.2006.08.004; BARTMANN M, 1994, VISUAL NEUROSCI, V11, P199, DOI 10.1017/S0952523800001565; Bubar MJ, 2006, CURR TOP MED CHEM, V6, P1971, DOI 10.2174/156802606778522131; Chanut E, 2002, J NEUROCHEM, V83, P863, DOI 10.1046/j.1471-4159.2002.01194.x; Chidlow G, 1998, NEUROSCIENCE, V87, P675, DOI 10.1016/S0306-4522(98)00181-X; Cohen Y, 2008, VISION RES, V48, P2329, DOI 10.1016/j.visres.2008.07.010; Crewther SG, 2006, EXP EYE RES, V83, P322, DOI 10.1016/j.exer.2005.12.016; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; Di Giovanni G, 2016, PROGR NEUROBIOLOGY; Di Y, 2013, INT J OPHTHALMOL-CHI, V6, P115, DOI 10.3980/j.issn.2222-3959.2013.02.01; George A, 2005, EXP EYE RES, V81, P616, DOI 10.1016/j.exer.2005.03.021; Gervais J, 2000, SYNAPSE, V35, P281, DOI 10.1002/(SICI)1098-2396(20000315)35:4<281::AID-SYN6>3.0.CO;2-A; Grewal JS, 1999, AM J PHYSIOL-RENAL, V276, pF922, DOI 10.1152/ajprenal.1999.276.6.F922; GUO SS, 1995, CURR EYE RES, V14, P385, DOI 10.3109/02713689508999936; HADJICONSTANTINOU M, 1983, J NEUROCHEM, V41, P1440, DOI 10.1111/j.1471-4159.1983.tb00843.x; HAMMANG JP, 1992, J COMP NEUROL, V316, P383, DOI 10.1002/cne.903160309; Han L, 2007, BRAIN RES BULL, V73, P273, DOI 10.1016/j.brainresbull.2007.04.005; Hidaka S, 2009, J INTEGR NEUROSCI, V8, P299, DOI 10.1142/S0219635209002198; Howell LL, 2015, PHARMACOL REV, V67, P176, DOI 10.1124/pr.114.009514; KATO S, 1982, J NEUROCHEM, V39, P493, DOI 10.1111/j.1471-4159.1982.tb03971.x; KELLAND MD, 1993, BRAIN RES BULL, V31, P539, DOI 10.1016/0361-9230(93)90121-Q; Liu Yan, 2005, J PREV MED CHIN PLA, V5, P415; Nash M, 1999, OPHTHALMIC RES, V31, P1, DOI 10.1159/000055506; NORTON TT, 1992, VISION RES, V32, P833, DOI 10.1016/0042-6989(92)90026-F; Ohngemach S, 1997, VISUAL NEUROSCI, V14, P493, DOI 10.1017/S0952523800012153; OSBORNE NN, 1982, NEUROCHEM INT, V4, P175, DOI 10.1016/0197-0186(82)90012-2; OSBORNE NN, 1981, J NEUROCHEM, V36, P17, DOI 10.1111/j.1471-4159.1981.tb02372.x; OSBORNE NN, 1983, NEUROSCI LETT, V39, P33, DOI 10.1016/0304-3940(83)90161-1; Pootanakit K, 1999, VISUAL NEUROSCI, V16, P221, DOI 10.1017/S0952523899162035; SCHAEFFEL F, 1995, VISION RES, V35, P1247, DOI 10.1016/0042-6989(94)00221-7; Schwahn HN, 1997, VISION RES, V37, P2661, DOI 10.1016/S0042-6989(97)00114-4; STONE RA, 1989, P NATL ACAD SCI USA, V86, P704, DOI 10.1073/pnas.86.2.704; TSAI WH, 1987, NEUROSCIENCE, V22, P675, DOI 10.1016/0306-4522(87)90363-0; Wang F, 2011, CURR EYE RES, V36, P103, DOI 10.3109/02713683.2010.526750; Yang JW, 2010, INT J OPHTHALMOL-CHI, V3, P299, DOI 10.3980/j.issn.2222-3959.2010.04.05; Yu Y, 2011, OPHTHALMIC RES, V46, P80, DOI 10.1159/000323179; ZIFA E, 1992, PHARMACOL REV, V44, P401	37	11	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167902	10.1371/journal.pone.0167902	http://dx.doi.org/10.1371/journal.pone.0167902			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959948	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900022
J	Luft, N; Wozniak, PA; Aschinger, GC; Fondi, K; Bata, AM; Werkmeister, RM; Schmidl, D; Witkowska, KJ; Bolz, M; Garhofer, G; Schmetterer, L				Luft, Nikolaus; Wozniak, Piotr A.; Aschinger, Gerold C.; Fondi, Klemens; Bata, Ahmed M.; Werkmeister, Rene M.; Schmidl, Doreen; Witkowska, Katarzyna J.; Bolz, Matthias; Garhoefer, Gerhard; Schmetterer, Leopold			Ocular Blood Flow Measurements in Healthy White Subjects Using Laser Speckle Flowgraphy	PLOS ONE			English	Article							OPTIC-NERVE HEAD; WAVE-FORM ANALYSIS; CENTRAL SEROUS CHORIORETINOPATHY; NORMAL-TENSION GLAUCOMA; COHERENCE TOMOGRAPHY; HUMAN RETINA; VELOCITY; CIRCULATION; PULSE; MICROCIRCULATION	Purpose To assess the feasibility and reliability of Laser Speckle Flowgraphy (LSFG) to measure ocular perfusion in a sample of healthy white subjects and to elucidate the age-dependence of the parameters obtained. Methods This cross-sectional study included 80 eyes of 80 healthy, non-smoking white subjects of Western European descent between 19 and 79 years of age. A commercial LSFG instrument was applied to measure ocular blood flow at the optic nerve head (ONH) three successive times before and after pharmacological pupil dilation. The mean blur rate (MBR), a measure of relative blood flow velocity, was obtained for different regions of the ONH. Eight parameters of ocular perfusion derived from the pulse-waveform analysis of MBR including blowout time (BOT) and falling rate (FR) were also recorded. Results Artifact-free LSFG images meeting the quality criteria for automated image analysis were obtainable in 93.8% without pupil dilation and in 98.8% with pharmacological pupil dilation. Measurements of MBR showed excellent repeatability with intraclass correlation coefficients >= 0.937 and were barely affected by pupil dilation. The majority of pulse-waveform derived variables exhibited equally high repeatability. MBR-related blood flow indices exhibited significant age dependence (p<0.001). FR (r = 0.747, p<0.001) and BOT (r = -0.714, p<0.001) most strongly correlated with age. Conclusions LSFG represents a reliable method for the quantitative assessment of ocular blood flow in white subjects. Our data affirms that the LSFG-derived variables FR and BOT may be useful biomarkers for age-related changes in ocular perfusion.	[Luft, Nikolaus; Wozniak, Piotr A.; Fondi, Klemens; Bata, Ahmed M.; Schmidl, Doreen; Witkowska, Katarzyna J.; Garhoefer, Gerhard; Schmetterer, Leopold] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria; [Luft, Nikolaus; Bolz, Matthias] Kepler Univ Hosp, Dept Ophthalmol, Linz, Austria; [Luft, Nikolaus] Ludwig Maximilians Univ Munchen, Univ Eye Hosp, Munich, Germany; [Wozniak, Piotr A.] Med Univ Warsaw, Dept Ophthalmol, Warsaw, Poland; [Aschinger, Gerold C.; Werkmeister, Rene M.; Schmidl, Doreen; Schmetterer, Leopold] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria; [Aschinger, Gerold C.] Vienna Univ Technol, Inst Appl Phys, Vienna, Austria; [Schmetterer, Leopold] Singapore Eye Res Inst, Singapore, Singapore; [Schmetterer, Leopold] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore	Medical University of Vienna; Kepler University Hospital; University of Munich; Medical University of Warsaw; Medical University of Vienna; Technische Universitat Wien; National University of Singapore; Singapore National Eye Center; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Schmetterer, L (corresponding author), Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria.; Schmetterer, L (corresponding author), Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria.; Schmetterer, L (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.; Schmetterer, L (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.	leopold.schmetterer@meduniwien.ac.at	Bata, Ahmed/AAH-1735-2020; Wozniak, Piotr/AAT-7394-2020; Bolz, Matthias/HCI-0622-2022	Bata, Ahmed/0000-0001-5228-762X; Wozniak, Piotr/0000-0002-0944-0438; Schmetterer, Leopold/0000-0002-7189-1707; Schmidl, Doreen/0000-0001-5664-7768; Bolz, Matthias/0000-0001-8691-5276; Werkmeister, Rene/0000-0002-5147-5714	NIDEK Co. Ltd.	NIDEK Co. Ltd.	This study was supported by an unrestricted grant from NIDEK Co. Ltd. (https://www.nidek-intl.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa N, 2014, INVEST OPHTH VIS SCI, V55, P7991, DOI 10.1167/iovs.14-15373; Aizawa N, 2011, CLIN OPHTHALMOL, V5, P1171, DOI 10.2147/OPTH.S22093; Baumann B, 2011, BIOMED OPT EXPRESS, V2, P1539, DOI 10.1364/BOE.2.001539; BRIERS JD, 1982, INVEST OPHTH VIS SCI, V22, P255; Cherecheanu AP, 2013, CURR OPIN PHARMACOL, V13, P36, DOI 10.1016/j.coph.2012.09.003; Cull G, 2013, INVEST OPHTH VIS SCI, V54, P4271, DOI 10.1167/iovs.13-12013; Doblhoff-Dier V, 2014, BIOMED OPT EXPRESS, V5, P630, DOI 10.1364/BOE.5.000630; FRANK O, 1990, J MOL CELL CARDIOL, V22, P255, DOI 10.1016/0022-2828(90)91460-O; Garhofer G, 2004, CURR EYE RES, V28, P351, DOI 10.1076/ceyr.28.5.351.28680; Garhofer G, 2012, INVEST OPHTH VIS SCI, V53, P698, DOI 10.1167/iovs.11-8624; Himori N, 2016, GRAEF ARCH CLIN EXP, V254, P333, DOI 10.1007/s00417-015-3203-z; Hirose S, 2008, ACTA OPHTHALMOL, V86, P902, DOI 10.1111/j.1755-3768.2008.01384.x; Iwase T, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001256; Iwase T, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000519; KRAMER MS, 1981, CLIN PHARMACOL THER, V29, P111, DOI 10.1038/clpt.1981.18; Kuroda Y, 2016, GRAEF ARCH CLIN EXP, V254, P963, DOI 10.1007/s00417-015-3247-0; Matsumoto T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/693056; MULLER R, 1994, STAT MED, V13, P2465, DOI 10.1002/sim.4780132310; Murakami Y, 2015, ACTA OPHTHALMOL, V93, pE644, DOI 10.1111/aos.12693; Okamoto M, 2016, RETINA-J RET VIT DIS, V36, P805, DOI 10.1097/IAE.0000000000000800; Okuno T, 2002, JPN J OPHTHALMOL, V46, P170, DOI 10.1016/S0021-5155(01)00498-1; Pemp B, 2008, CAN J OPHTHALMOL, V43, P295, DOI 10.3129/i08-049; Rina M, 2015, GRAEF ARCH CLIN EXP, V253, P2285, DOI 10.1007/s00417-015-3123-y; RIVA CE, 1985, INVEST OPHTH VIS SCI, V26, P1124; Riva CE, 2010, ACTA OPHTHALMOL, V88, P622, DOI 10.1111/j.1755-3768.2009.01621.x; Saito M, 2015, INVEST OPHTH VIS SCI, V56, P6515, DOI 10.1167/iovs.15-17246; Saito M, 2014, CLIN EXP OPHTHALMOL, V42, P139, DOI 10.1111/ceo.12143; Saito M, 2013, BRIT J OPHTHALMOL, V97, P775, DOI 10.1136/bjophthalmol-2012-302349; Schmidl D, 2015, CURR EYE RES, V40, P201, DOI 10.3109/02713683.2014.906625; Shiba T, 2016, GRAEF ARCH CLIN EXP, V254, P1033, DOI 10.1007/s00417-015-3145-5; Shiba T, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/291687; Shiba T, 2012, J ATHEROSCLER THROMB, V19, P999, DOI 10.5551/jat.13631; Shiba T, 2012, GRAEF ARCH CLIN EXP, V250, P1275, DOI 10.1007/s00417-012-1952-5; Shiga Y, 2015, CURR EYE RES, V40, P1055, DOI 10.3109/02713683.2014.971934; Shiga Y, 2014, INVEST OPHTH VIS SCI, V55, P3899, DOI 10.1167/iovs.14-14116; Shiga Y, 2013, INVEST OPHTH VIS SCI, V54, P7699, DOI 10.1167/iovs.13-12930; Shiga Y, 2013, CURR EYE RES, V38, P691, DOI 10.3109/02713683.2012.758292; Sugiyama T, 1996, JPN J OPHTHALMOL, V40, P339; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Sugiyama T, 2009, ACTA OPHTHALMOL, V87, P797, DOI 10.1111/j.1755-3768.2008.01460.x; Takahashi H, 2013, EXP EYE RES, V108, P10, DOI 10.1016/j.exer.2012.12.003; Takayama J, 2009, EYE, V23, P827, DOI 10.1038/eye.2008.142; Tamaki Y, 1997, JPN J OPHTHALMOL, V41, P49, DOI 10.1016/S0021-5155(96)00008-1; TAMAKI Y, 1994, INVEST OPHTH VIS SCI, V35, P3825; Terai N, 2012, ACTA OPHTHALMOL, V90, pE524, DOI 10.1111/j.1755-3768.2012.02486.x; Tsuda S, 2014, CURR EYE RES, V39, P1207, DOI 10.3109/02713683.2014.905608; Wang L, 2014, INVEST OPHTH VIS SCI, V55, P873, DOI 10.1167/iovs.13-13716; Wang L, 2012, INVEST OPHTH VIS SCI, V53, P8303, DOI 10.1167/iovs.12-10911; Wang YM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2772871; Werkmeister RM, 2012, INVEST OPHTH VIS SCI, V53, P6062, DOI 10.1167/iovs.12-9514; Yanagida K, 2015, INVEST OPHTH VIS SCI, V56, P4880, DOI 10.1167/iovs.15-16567	51	54	54	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168190	10.1371/journal.pone.0168190	http://dx.doi.org/10.1371/journal.pone.0168190			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959905	gold, Green Published			2022-12-27	WOS:000392753900048
J	Mendonca, C; Mandelli, P; Pulkki, V				Mendonca, Catarina; Mandelli, Pietro; Pulkki, Ville			Modeling the Perception of Audiovisual Distance: Bayesian Causal Inference and Other Models	PLOS ONE			English	Article							AUDITORY-PERCEPTION; INTEGRATION; VENTRILOQUISM; CAPTURE; VISION; HUMANS; DEPTH	Studies of audiovisual perception of distance are rare. Here, visual and auditory cue interactions in distance are tested against several multisensory models, including a modified causal inference model. In this causal inference model predictions of estimate distributions are included. In our study, the audiovisual perception of distance was overall better explained by Bayesian causal inference than by other traditional models, such as sensory dominance and mandatory integration, and no interaction. Causal inference resolved with probability matching yielded the best fit to the data. Finally, we propose that sensory weights can also be estimated from causal inference. The analysis of the sensory weights allows us to obtain windows within which there is an interaction between the audiovisual stimuli. We find that the visual stimulus always contributes by more than 80% to the perception of visual distance. The visual stimulus also contributes by more than 50% to the perception of auditory distance, but only within a mobile window of interaction, which ranges from 1 to 4 m.	[Mendonca, Catarina; Pulkki, Ville] Aalto Univ, Dept Signal Proc & Acoust, Espoo, Finland; [Mandelli, Pietro] Polytech Univ Milan, Sch Ind & Informat Engn, Milan, Italy	Aalto University; Polytechnic University of Milan	Mendonca, C (corresponding author), Aalto Univ, Dept Signal Proc & Acoust, Espoo, Finland.	Catarina.Mendonca@aalto.fi	Pulkki, Ville/G-2394-2013; Mendonca, Catarina/L-8877-2013	Pulkki, Ville/0000-0003-3460-9677; Mendonca, Catarina/0000-0002-4333-898X	European Union [659114]; Academy of Finland [266239]	European Union(European Commission); Academy of Finland(Academy of Finland)	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant No 659114 and by the Academy of Finland, decision No 266239. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska Curie grant No 659114 and by the Academy of Finland, decision no 266239.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Alais D, 2005, P NATL ACAD SCI USA, V102, P2244, DOI 10.1073/pnas.0407034102; Andersen TS, 2005, NEUROSCI LETT, V380, P155, DOI 10.1016/j.neulet.2005.01.030; Anderson PW, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01097; Battaglia PW, 2003, J OPT SOC AM A, V20, P1391, DOI 10.1364/JOSAA.20.001391; Beierholm U, 2007, ADV NEURAL INFORM PR, P81; Bizley JK, 2016, TRENDS NEUROSCI, V39, P74, DOI 10.1016/j.tins.2015.12.007; Bronkhorst AW, 1999, NATURE, V397, P517, DOI 10.1038/17374; Calcagno ER, 2012, PERCEPTION, V41, P175, DOI 10.1068/p7153; CHONG SC, 1975, PERCEPT PSYCHOPHYS, V18, P55, DOI DOI 10.3758/BF03199367; COLAVITA FB, 1974, PERCEPT PSYCHOPHYS, V16, P409, DOI 10.3758/BF03203962; COLEMAN PD, 1963, PSYCHOL BULL, V60, P302, DOI 10.1037/h0045716; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Elliott MT, 2010, EUR J NEUROSCI, V31, P1828, DOI 10.1111/j.1460-9568.2010.07205.x; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; GARDNER MB, 1968, J ACOUST SOC AM, V43, P163, DOI 10.1121/1.1910747; GARDNER MB, 1969, J ACOUST SOC AM, V45, P47, DOI 10.1121/1.1911372; GILINSKY AS, 1951, PSYCHOL REV, V58, P460, DOI 10.1037/h0061505; Kim HY, 2001, APPL ACOUST, V62, P245, DOI 10.1016/S0003-682X(00)00023-2; KONRAD PK, 2007, PLOS ONE, V2, pE943, DOI DOI 10.1371/JOURNAL.PONE.0000943; Laitinen Mikko-Ville, 2009, 2009 IEEE Workshop on Applications of Signal Processing to Audio and Acoustics (WASPAA), P337, DOI 10.1109/ASPAA.2009.5346545; LITTLE AD, 1992, PERCEPTION, V21, P405, DOI 10.1068/p210405; Mendonca C, 2011, EXP BRAIN RES, V213, P185, DOI 10.1007/s00221-011-2620-4; MERSHON DH, 1989, PERCEPTION, V18, P403, DOI 10.1068/p180403; MERSHON DH, 1975, PERCEPT PSYCHOPHYS, V18, P409, DOI 10.3758/BF03204113; Mershon Donald H, 1980, J AUDITORY RES; Moore DR, 1999, CURR BIOL, V9, pR361, DOI 10.1016/S0960-9822(99)80227-9; Morein-Zamir S, 2003, COGNITIVE BRAIN RES, V17, P154, DOI 10.1016/S0926-6410(03)00089-2; Odegaard B, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004649; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Pulkki V, 2007, J AUDIO ENG SOC, V55, P503; Roach NW, 2006, P ROY SOC B-BIOL SCI, V273, P2159, DOI 10.1098/rspb.2006.3578; Sato Y, 2007, NEURAL COMPUT, V19, P3335, DOI 10.1162/neco.2007.19.12.3335; Shams L, 2005, NEUROREPORT, V16, P1923, DOI 10.1097/01.wnr.0000187634.68504.bb; Shams L, 2010, TRENDS COGN SCI, V14, P425, DOI 10.1016/j.tics.2010.07.001; Silva CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080096; Sugita Y, 2003, NATURE, V421, P911, DOI 10.1038/421911a; Van der Stoep N, 2016, EXP BRAIN RES, V234, P1175, DOI 10.1007/s00221-015-4248-2; Van der Stoep N, 2015, NEUROPSYCHOLOGIA, V70, P335, DOI 10.1016/j.neuropsychologia.2014.12.007; Vroomen J, 2004, J EXP PSYCHOL HUMAN, V30, P513, DOI 10.1037/0096-1523.30.3.513; WELCH RB, 1980, PSYCHOL BULL, V88, P638, DOI 10.1037/0033-2909.88.3.638; Wozny DR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000871; Zahorik P, 2002, J ACOUST SOC AM, V111, P1832, DOI 10.1121/1.1458027; Zahorik P, 2005, ACTA ACUST UNITED AC, V91, P409; Zahorik P, 2001, OPTOMETRY VISION SCI, V78, P270, DOI 10.1097/00006324-200105000-00009	45	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0165391	10.1371/journal.pone.0165391	http://dx.doi.org/10.1371/journal.pone.0165391			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	27959919	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900002
J	Sartor, F; Bonato, M; Papini, G; Bosio, A; Mohammed, RA; Bonomi, AG; Moore, JP; Merati, G; La Torre, A; Kubis, HP				Sartor, Francesco; Bonato, Matteo; Papini, Gabriele; Bosio, Andrea; Mohammed, Rahil A.; Bonomi, Alberto G.; Moore, Jonathan P.; Merati, Giampiero; La Torre, Antonio; Kubis, Hans-Peter			A 45-Second Self-Test for Cardiorespiratory Fitness: Heart Rate-Based Estimation in Healthy Individuals	PLOS ONE			English	Article							MAXIMAL OXYGEN-UPTAKE; EXERCISE; STATEMENT; CRITERIA	Cardio-respiratory fitness (CRF) is a widespread essential indicator in Sports Science as well as in Sports Medicine. This study aimed to develop and validate a prediction model for CRF based on a 45 second self-test, which can be conducted anywhere. Criterion validity, test re-test study was set up to accomplish our objectives. Data from 81 healthy volunteers (age: 29 +/- 8 years, BMI: 24.0 +/- 2.9), 18 of whom females, were used to validate this test against gold standard. Nineteen volunteers repeated this test twice in order to evaluate its repeatability. CRF estimation models were developed using heart rate (HR) features extracted from the resting, exercise, and the recovery phase. The most predictive HR feature was the intercept of the linear equation fitting the HR values during the recovery phase normalized for the height(2) (r(2) = 0.30). The Ruffier-Dickson Index (RDI), which was originally developed for this squat test, showed a negative significant correlation with CRF (r = -0.40), but explained only 15% of the variability in CRF. A multivariate model based on RDI and sex, age and height increased the explained variability up to 53% with a cross validation (CV) error of 0.532 L . min(-1) and substantial repeatability (ICC = 0.91). The best predictive multivariate model made use of the linear intercept of HR at the beginning of the recovery normalized for height 2 and age 2; this had an adjusted r(2) = 0. 59, a CV error of 0.495 L . min(-1) and substantial repeatability (ICC = 0.93). It also had a higher agreement in classifying CRF levels (kappa = 0.42) than RDI-based model (kappa = 0.29). In conclusion, this simple 45 s self-test can be used to estimate and classify CRF in healthy individuals with moderate accuracy and large repeatability when HR recovery features are included.	[Sartor, Francesco; Papini, Gabriele; Bonomi, Alberto G.] Philips Res, Personal Hlth, Eindhoven, Netherlands; [Bonato, Matteo; Merati, Giampiero; La Torre, Antonio] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy; [Papini, Gabriele] Univ Pisa, Dept Informat Engn, Pisa, Italy; [Papini, Gabriele] Eindhoven Univ Technol, Dept Elect Engn, Eindhoven, Netherlands; [Bosio, Andrea] Mapei Sport, Olgiate Olona, Varese, Italy; [Mohammed, Rahil A.; Moore, Jonathan P.; Kubis, Hans-Peter] Bangor Univ, Coll Hlth & Behav Sci, Bangor, Gwynedd, Wales; [Mohammed, Rahil A.] Univ Sulaimani, Sch Phys Educ, Sulaimani, Iraq	Philips; Philips Research; University of Milan; University of Pisa; Eindhoven University of Technology; Bangor University; University of Sulimanyah	Sartor, F (corresponding author), Philips Res, Personal Hlth, Eindhoven, Netherlands.	francesco.sartor@philips.com	Papini, Gabriele/AAA-8996-2019; Bonato, Matteo/R-1917-2019; Moore, Jonathan/W-8362-2019; Merati, Giampiero/AAT-3854-2021; Sartor, Francesco/I-4479-2019; Merati, Giampiero/J-9713-2018	Papini, Gabriele/0000-0002-5752-9226; Bonato, Matteo/0000-0002-5589-7957; Moore, Jonathan/0000-0002-4244-8220; Sartor, Francesco/0000-0003-2254-9187; Merati, Giampiero/0000-0002-1389-7596				American College of Sports Medicine (ACSM), 2009, ACSMS GUIDELINES EXE; ASTRAND I, 1960, Acta Physiol Scand Suppl, V49, P1; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; BLOMQVIST CG, 1981, CIRC RES, V48, P87; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Goran M, 2000, INT J OBESITY, V24, P841, DOI 10.1038/sj.ijo.0801241; GREIWE JS, 1995, MED SCI SPORT EXER, V27, P1315; Joussellin E., 2007, MED SPORT, V83, P33; Kaminsky LA, 2013, CIRCULATION, V127, P652, DOI 10.1161/CIR.0b013e31827ee100; Lloyd-Jones DM, 2013, CIRCULATION, V12, P12; MCARDLE WD, 1972, MED SCI SPORT EXER, V4, P182; Midgley AW, 2007, SPORTS MED, V37, P1019, DOI 10.2165/00007256-200737120-00002; NEVILL AM, 1992, EUR J APPL PHYSIOL, V65, P110, DOI 10.1007/BF00705066; Papini G, 45 2 SELF T IN PRESS; Piquet L, 2000, ULTRASOUND MED BIOL, V26, P1001, DOI 10.1016/S0301-5629(00)00222-2; Pober DM, 2002, CAN J APPL PHYSIOL, V27, P575, DOI 10.1139/h02-033; Poole DC, 2008, EUR J APPL PHYSIOL, V102, P403, DOI 10.1007/s00421-007-0596-3; Sartor F, 2013, SPORTS MED, V43, P865, DOI 10.1007/s40279-013-0068-3; Viera AJ, 2005, FAM MED, V37, P360	19	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168154	10.1371/journal.pone.0168154	http://dx.doi.org/10.1371/journal.pone.0168154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959935	Green Published, gold			2022-12-27	WOS:000392753900041
J	Wen, SX; Chen, XL; Xu, FZ; Sun, HL				Wen, Shuxiang; Chen, Xiaoling; Xu, Fuzhou; Sun, Huiling			Validation of Reference Genes for Real-Time Quantitative PCR (qPCR) Analysis of Avibacterium paragallinarum	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; 16S RIBOSOMAL-RNA; RT-PCR; HOUSEKEEPING GENES; INTERNAL CONTROL; EXPRESSION; NORMALIZATION; PASTEURELLA; TOOL; IDENTIFICATION	Real-time quantitative reverse transcription PCR (qRT-PCR) offers a robust method for measurement of gene expression levels. Selection of reliable reference gene(s) for gene expression study is conducive to reduce variations derived from different amounts of RNA and cDNA, the efficiency of the reverse transcriptase or polymerase enzymes. Until now reference genes identified for other members of the family Pasteurellaceae have not been validated for Avibacterium paragallinarum. The aim of this study was to validate nine reference genes of serovars A, B, and C strains of A. paragallinarum in different growth phase by qRT-PCR. Three of the most widely used statistical algorithms, geNorm, NormFinder and Delta CT method were used to evaluate the expression stability of reference genes. Data analyzed by overall rankings showed that in exponential and stationary phase of serovar A, the most stable reference genes were gyrA and atpD respectively; in exponential and stationary phase of serovar B, the most stable reference genes were atpD and recN respectively; in exponential and stationary phase of serovar C, the most stable reference genes were rpoB and recN respectively. This study provides recommendations for stable endogenous control genes for use in further studies involving measurement of gene expression levels.	[Wen, Shuxiang; Chen, Xiaoling; Xu, Fuzhou; Sun, Huiling] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, Beijing, Peoples R China	Beijing Academy of Agriculture & Forestry	Sun, HL (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing Key Lab Prevent & Control Infect Dis Live, Beijing, Peoples R China.	sunhuiling01@163.com			National Key Research and Development Program of China [2016YFD0500804]; National Natural Science Foundation of China [30871867]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant 2016YFD0500804 from National Key Research and Development Program of China, and grant 30871867 from National Natural Science Foundation of China. There was no additional external funding received for this study. The funders (funding bodies) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arvidsson S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-465; Blackall PJ, 2005, INT J SYST EVOL MICR, V55, P353, DOI 10.1099/ijs.0.63357-0; Blackall PJ, 1999, CLIN MICROBIOL REV, V12, P627, DOI 10.1128/CMR.12.4.627; Blackall PJ, 1997, DIS POULTRY, P179; Bujold Adina R, 2015, BMC Res Notes, V8, P86, DOI 10.1186/s13104-015-1045-8; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen DL, 2011, J CELL PHYSIOL, V226, P2469, DOI 10.1002/jcp.22725; Christensen H, 2004, INT J SYST EVOL MICR, V54, P1601, DOI 10.1099/ijs.0.03018-0; Christensen H, 2004, VET MICROBIOL, V99, P13, DOI 10.1016/j.vetmic.2003.12.002; Gautier AL, 2005, J CLIN MICROBIOL, V43, P2307, DOI 10.1128/JCM.43.5.2307-2314.2005; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Jacob TR, 2011, BIOTECHNOL LETT, V33, P1177, DOI 10.1007/s10529-011-0552-5; Jacobsen AV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115592; Jian B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-59; Kuhnert P, 2006, MICROBIOL-SGM, V152, P2537, DOI 10.1099/mic.0.28991-0; Labandeira-Rey M, 2009, INFECT IMMUN, V77, P3402, DOI 10.1128/IAI.00292-09; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Norskov-Lauritsen N, 2005, INT J SYST EVOL MICR, V55, P449, DOI 10.1099/ijs.0.63325-0; PAGE LA, 1962, AM J VET RES, V23, P85; Petersen KD, 2001, MICROBIOL-SGM, V147, P2739, DOI 10.1099/00221287-147-10-2739; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Reid KE, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-27; Richardson J, 2005, J MED MICROBIOL, V54, P497, DOI 10.1099/jmm.0.45949-0; Sihto HM, 2014, FEMS MICROBIOL LETT, V356, P134, DOI 10.1111/1574-6968.12491; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Vandecasteele SJ, 2001, J BACTERIOL, V183, P7094, DOI 10.1128/JB.183.24.7094-7101.2001; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	35	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167736	10.1371/journal.pone.0167736	http://dx.doi.org/10.1371/journal.pone.0167736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942007	gold, Green Published, Green Submitted			2022-12-27	WOS:000392745600028
J	Gous, N; Scott, L; Berrie, L; Stevens, W				Gous, Natasha; Scott, Lesley; Berrie, Leigh; Stevens, Wendy			Options to Expand HIV Viral Load Testing in South Africa: Evaluation of the GeneXpert (R) HIV-1 Viral Load Assay	PLOS ONE			English	Article							DRIED CULTURE SPOTS	Background Expansion of HIV viral load (VL) testing services are required to meet increased targets for monitoring patients on antiretroviral treatment. South Africa currently tests > 4million VLs per annum in 16 highly centralised, automated high-throughput laboratories. The Xpert HIV-1 VL assay (Cepheid) was evaluated against in-country predicates, the Roche Cobas Taqmanv2 and Abbott HIV-1RT, to investigate options for expanding VL testing using GeneXpert's random access, polyvalent capabilities and already established footprint in South Africa with the Xpert MTB/RIF assay (207 sites). Additionally, the performance of Xpert HIV-1VL on alternative, off-label specimen types, Dried Blood Spots (DBS) and whole blood, was investigated. Method Precision, accuracy (agreement) and clinical misclassification (1000cp/ml) of Xpert HIV-1VL plasma was compared to Taqmanv2 (n = 155) and Abbott HIV-1 RT (n = 145). Misclassification of Xpert HIV-1VL was further tested on DBS (n = 145) and whole blood (n = 147). Results Xpert HIV-1VL demonstrated 100% concordance with predicate platforms on a standardised frozen, plasma panel (n = 42) and low overall percentage similarity CV of 1.5% and 0.9% compared to Taqmanv2 and Abbott HIV-1 RT, respectively. On paired plasma clinical specimens, Xpert HIV-1VL had low bias (SD 0.32-0.37logcp/ml) and 3% misclassification at the 1000cp/ml threshold compared to Taqmanv2 (fresh) and Abbott HIV-1 RT (frozen), respectively. Xpert HIV-1VL on whole blood and DBS increased misclassification (upward) by up to 14% with increased invalid rate. All specimen testing was easy to perform and compatible with concurrent Xpert MTB/RIF Tuberculosis testing on the same instrument. Conclusion The Xpert HIV-1VL on plasma can be used interchangeably with existing predicate platforms in South Africa. Whole blood and DBS testing requires further investigation, but polyvalency of the GeneXpert offers a solution to extending VL testing services.	[Gous, Natasha; Scott, Lesley; Stevens, Wendy] Univ Witwatersrand, Sch Pathol, Dept Haematol & Mol Med, Fac Hlth Sci, Johannesburg, South Africa; [Gous, Natasha; Berrie, Leigh; Stevens, Wendy] Natl Hlth Lab Serv, Natl Prior Program, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service	Gous, N (corresponding author), Univ Witwatersrand, Sch Pathol, Dept Haematol & Mol Med, Fac Hlth Sci, Johannesburg, South Africa.; Gous, N (corresponding author), Natl Hlth Lab Serv, Natl Prior Program, Johannesburg, South Africa.	natasha.gous@gmail.com		Scott, Lesley/0000-0001-6573-9525	Grand Challenges Canada POC implementation grant [0007-02-01-01-01]	Grand Challenges Canada POC implementation grant	This publication was made possible by the generous financial support of the Grand Challenges Canada POC implementation grant (grant 0007-02-01-01-01). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilic-Zulle L, 2011, BIOCHEM MEDICA, V21, P49; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Ceffa S, 2016, J VIROL METHODS, V229, P35, DOI 10.1016/j.jviromet.2015.12.007; Cepheid, 2014, HIV 1 QUANT MAN REV; Cepheid, 2013, 5 ANN GLI PARTN M PE; Cvitkovic M, 2011, CRIT CARE NURS Q, V34, P116, DOI 10.1097/CNQ.0b013e31820f6f0a; Ferreyra C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049834; Glencross DK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114727; Gous N, 2013, J CLIN MICROBIOL, V51, P4018, DOI 10.1128/JCM.01715-13; Gueudin M, 2015, ABSTRACTS J CLIN VIR, V70, pS1; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014, AMB TREATM TARG HELP; Lin L., 2000, BIOMETRICS, V56, P324, DOI [10.1111/j.0006-341X.2000.00324.x, DOI 10.1111/J.0006-341X.2000.00324.X]; McBride GB, 2005, HAM2005062 NIWA; Mor O, 2015, J CLIN MICROBIOL, V53, P3458, DOI 10.1128/JCM.01806-15; Roche, 2015, COB 6800 8800 SYST E; Scott LE, 2011, J CLIN MICROBIOL, V49, P4356, DOI 10.1128/JCM.05167-11; Scott LE, 2003, CYTOM PART B-CLIN CY, V54B, P46, DOI 10.1002/cyto.b.10016; Scott LE, 2012, J CLIN MICROBIOL, V50, P4083, DOI 10.1128/JCM.01355-12; Scott LE, 2009, J CLIN MICROBIOL, V47, P2209, DOI 10.1128/JCM.01761-08; World Health Organization, 2014, 2013 CONS GUID US S; World Health Organization, 2014, TECHN OP CONS IMPL H	21	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168244	10.1371/journal.pone.0168244	http://dx.doi.org/10.1371/journal.pone.0168244			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992495	Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000033
J	Beyhun, NE; Kolayli, CC; Can, G; Topbas, M				Beyhun, Nazim Ercument; Kolayli, Cevriye Ceyda; Can, Gamze; Topbas, Murat			Turkish Final Year Medical Students' Exposure to and Attitudes Concerning Drug Company Interactions: A Perspective from a Minimally Regulated Environment for Medical Students	PLOS ONE			English	Article							PHARMACEUTICAL PROMOTION; POLICIES; REPRESENTATIVES; RESIDENTS; IMPACT	Interactions between drug companies and medical students may affect evidence-based medical practice and patient safety. The aim of this study was to assess drug company-medical student interactions in a medical faculty where limited specific national or institutional regulations apply between drug companies and medical students. The objectives of the study were to determine the exposure and attitudes of final year medical students in terms of drug company-medical student and physician interactions, to identify factors affecting those attitudes and to provide data for policymakers working on the regulation of interactions between drug companies and medical students. This anonymous questionnaire-based study of 154 medical final year medical students at the Karadeniz Technical University Medical Faculty, Trabzon, Turkey, in April and May 2015 attracted a response rate of 92.2% (n/N, 154/164). Exposure to interaction with a pharmaceutical representative was reported by 90.3% (139/ 154) of students, and 68.8% (106/154) reported experiencing such interaction alongside a resident. In addition, 83.7% (128/153) of students reported an interaction during internship. Furthermore, 69.9% (107/153) of students agreed that interactions influence physicians' prescription preferences, while 33.1% (51/154) thought that a medical student should never accept a gift from a drug company and 24.7% (38/154) agreed with the proposition that "drug companies should not hold activities in medical faculties". Students with rational prescription training expressed greater agreement with the statement "I am skeptical concerning the information provided by drug companies during interactions" than those who had not received such training, and this finding was supported by logistic regression [O.R.(C.I), p-3.7(1.2- 11.5), p = 0.022]. Acceptance of advertisement brochures was found to significantly reduce the level of agreement with the proposition that-A physician should not accept any gift from a drug company." (0.3[0.1-0.9], p = 0.030). In summary, exposure to drug companies was widespread among our final year medical students who, like students in both Western and non-Western societies, hold permissive attitudes concerning accepting gifts, and drug advertising brochures may relax those permissive attitudes still further. Rational prescription training was useful in generating rational attitudes. Policies concerning drug company-medical student relationships should be developed in Turkey as well as internationally.	[Beyhun, Nazim Ercument; Kolayli, Cevriye Ceyda; Can, Gamze; Topbas, Murat] Karadeniz Tech Univ, Fac Med, Dept Publ Hlth, Trabzon, Turkey	Karadeniz Technical University	Beyhun, NE (corresponding author), Karadeniz Tech Univ, Fac Med, Dept Publ Hlth, Trabzon, Turkey.	ebeyhun@yahoo.com	Beyhun, Nazim Ercument/AAO-3072-2021; Topbas, Murat/AAT-1095-2020	TOPBAS, MURAT/0000-0003-4047-4027				Alosaimi FD, 2014, E MEDITERR HEALTH J, V20, P812, DOI 10.26719/2014.20.12.812; Alssageer MA, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.132.2598; [Anonymous], 2007, PHARM EDUC, DOI DOI 10.1080/15602210701737897; Association of American Medical Colleges, 2009, IND FUND MED ED REP; Association of American Medical Colleges, 2008, IND FUND MED ED REP; Austad KE, 2013, J GEN INTERN MED, V28, P1115, DOI 10.1007/s11606-013-2524-Z; Austad KE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001037; Bellin M, 2004, ACAD MED, V79, P1041, DOI 10.1097/00001888-200411000-00005; BROTZMAN GL, 1993, J GEN INTERN MED, V8, P130, DOI 10.1007/BF02599757; De Ferrari A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100114; Epstein AJ, 2013, MED CARE, V51, P199, DOI 10.1097/MLR.0b013e318277eb19; Etain B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092858; Giri BR, 2005, PLOS MED, V2, P710, DOI 10.1371/journal.pmed.0020256; Gonul FF, 2001, J MARKETING, V65, P79, DOI 10.1509/jmkg.65.3.79.18329; Institute of Medicine, 2009, CONFL INT MED RES ED; Jahnke K, 2014, GMS Z MED AUSBILD, V31; Kamal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140457; Kaushal S, 2015, ANAESTH PAIN INTENSI, V19, P489; King M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f264; Mathieu G, 2012, BIOETHIQUE ONLINE, V1; McCormick BB, 2001, JAMA-J AM MED ASSOC, V286, P1994, DOI 10.1001/jama.286.16.1994; ORLOWSKI JP, 1992, CHEST, V102, P270, DOI 10.1378/chest.102.1.270; Prosser H, 2003, FAM PRACT, V20, P61, DOI 10.1093/fampra/20.1.61; Sarikaya O, 2009, ADV HEALTH SCI EDUC, V14, P713, DOI 10.1007/s10459-009-9153-7; Shnier A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068633; Siddiqui UT, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-36; Sierles FS, 2015, ACAD MED, V90, P1137, DOI 10.1097/ACM.0000000000000686; Sierles FS, 2005, JAMA-J AM MED ASSOC, V294, P1034, DOI 10.1001/jama.294.9.1034; Spingarn RW, 1996, ACAD MED, V71, P86, DOI 10.1097/00001888-199601000-00022; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; Vancelik S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-122; Villanueva P, 2003, LANCET, V361, P27, DOI 10.1016/S0140-6736(03)12118-6; Vinson D C, 1993, Fam Med, V25, P31; Zipkin DA, 2005, J GEN INTERN MED, V20, P777, DOI 10.1111/j.1525-1497.2005.0134.x	35	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168094	10.1371/journal.pone.0168094	http://dx.doi.org/10.1371/journal.pone.0168094			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977744	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400059
J	Krause, ET				Krause, E. Tobias			Colour Cues That Are Not Directly Attached to the Body of Males Do Not Influence the Mate Choice of Zebra Finches	PLOS ONE			English	Article							REPUTED BAND ATTRACTIVENESS; SEX-RATIO MANIPULATION; COURTSHIP DISPLAY; VIDEO IMAGES; PREFERENCES; SONG	Mate choice decisions of female zebra finches are generally thought to rely on the assessment of male quality, which includes the specific ornamentation of males. A commonly used paradigm to experimentally manipulate a male's attractiveness is to add a coloured leg ring to the bird. Some studies have shown that female zebra finches prefer or alter their investment in males that have an additional red leg ring compared with males with green leg rings. Whether the coloured artificial ornaments need to be attached to the male's body or whether environmental colouration could have a similar effect on male attractiveness remains unclear. Here, I investigated this novel context to determine whether female choice between males is affected by environmental colour cues that are not directly attached to the male's body in four experiments involving 220 zebra finches (Taeniopygia guttata). A first experiment revealed that females chose males with red colour cues in the environmental background over males with green cues in the background. Based on this finding, I conducted follow-up experiments to obtain a deeper understanding of how environmental colour cues affect mate choice. Therefore, I examined whether female choice behaviour or male behaviour was altered in two additional experiments. Both experiments failed to show any effects of environmental colour cues on female choice or on male behaviour. Therefore, I replicated the initial experiment in a fourth experiment. Again replication failed; thus, the initial results indicating that environmental colouration affects mate choice behaviour of female zebra finches were not supported by the three subsequent experiments; thus, the outcome of the first experiment seems to be a false positive. Taking my results together, I found no robust support for the idea that environmental colour cues that are not directly attached to the body of male zebra finches affect female mate choice decisions.	[Krause, E. Tobias] Univ Bielefeld, Dept Anim Behav, Konsequenz 45, Bielefeld, Germany; [Krause, E. Tobias] Friedrich Loeffler Inst, Inst Anim Welf & Anim Husb, Dornbergstr 25-27, Greifswald, Germany	University of Bielefeld; Friedrich Loeffler Institute	Krause, ET (corresponding author), Univ Bielefeld, Dept Anim Behav, Konsequenz 45, Bielefeld, Germany.; Krause, ET (corresponding author), Friedrich Loeffler Inst, Inst Anim Welf & Anim Husb, Dornbergstr 25-27, Greifswald, Germany.	tobias.krause@fli.de	Krause, E. Tobias/A-9900-2009	Krause, E. Tobias/0000-0002-8327-3711	Deutsche Forschungsgemeinschaft; Bielefeld University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bielefeld University	The author acknowledges support for the Article Processing Charge from the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adret P, 1997, J COMP PSYCHOL, V111, P115; BURLEY N, 1986, EVOLUTION, V40, P1191, DOI 10.1111/j.1558-5646.1986.tb05744.x; BURLEY N, 1981, SCIENCE, V211, P721, DOI 10.1126/science.211.4483.721; BURLEY N, 1987, ETHOLOGY, V76, P133; BURLEY N, 1982, ANIM BEHAV, V30, P444, DOI 10.1016/S0003-3472(82)80055-9; BURLEY N, 1986, ANIM BEHAV, V34, P1732, DOI 10.1016/S0003-3472(86)80260-3; BURLEY N, 1988, ANIM BEHAV, V36, P1235, DOI 10.1016/S0003-3472(88)80085-X; Caspers BA, 2015, BEHAV ECOL SOCIOBIOL, V69, P1827, DOI 10.1007/s00265-015-1995-9; COLLINS SA, 1994, BEHAV ECOL SOCIOBIOL, V35, P21, DOI 10.1007/s002650050065; DeKogel CH, 1996, ANIM BEHAV, V51, P699, DOI 10.1006/anbe.1996.0073; Fleishman L.J., 2000, Acta Ethologica, V3, P15, DOI 10.1007/s102110000025; Forstmeier W, 2004, ANIM BEHAV, V68, P1017, DOI 10.1016/j.anbehav.2004.02.007; Galoch Zdzislaw, 2006, Ornithological Science, V5, P57, DOI 10.2326/osj.5.57; Galoch Z, 2007, BEHAV PROCESS, V74, P21, DOI 10.1016/j.beproc.2006.09.002; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; Ikebuchi M, 1999, ZOOL SCI, V16, P63, DOI 10.2108/zsj.16.63; Immelmann K., 1959, Zool Jb (Abt Syst), V86, P437; IMMELMANN K, 1982, SCIENCE, V215, P422, DOI 10.1126/science.215.4531.422; Jennions MD, 1998, ANIM BEHAV, V55, P61, DOI 10.1006/anbe.1997.0579; Miazzi F., 2012, THESIS; Pariser EC, 2010, BEHAV ECOL, V21, P264, DOI 10.1093/beheco/arp185; Quinn GP, 2003, EXPT DESIGN DATA ANA; Riebel K, 2009, ADV STUD BEHAV, V40, P197, DOI 10.1016/S0065-3454(09)40006-8; Ritschard M, 2010, ANIM BEHAV, V79, P877, DOI 10.1016/j.anbehav.2009.12.038; Rutstein AN, 2007, ANIM BEHAV, V74, P1277, DOI 10.1016/j.anbehav.2007.02.022; Rutstein AN, 2004, ANIM BEHAV, V68, P1087, DOI 10.1016/j.anbehav.2004.02.011; Seguin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037785; SOMA M, 2015, FRONT ECOL EVOL, V3, DOI DOI 10.3389/FEV0.2015.00004; Specht R, 2010, AVISOTT SAS LAB PRO; Swaddle JP, 2006, ANIM BEHAV, V72, P161, DOI 10.1016/j.anbehav.2005.12.005; THISSEN D, 1982, SCIENCE, V215, P423, DOI 10.1126/science.215.4531.423; Witte K, 2003, ANIM BEHAV, V65, P195, DOI 10.1006/anbe.2002.2009; Witte K., 2004, PROXIMATE CONTRO AVI, P13; Witte K, 2006, BEHAVIOUR, V143, P969, DOI 10.1163/156853906778623626; Witte K, 2006, ETHOL ECOL EVOL, V18, P195, DOI 10.1080/08927014.2006.9522707; Zann RA., 1996, ZEBRA FINCH SYNTHESI; Zanollo V, 2013, ETHOLOGY, V119, P344, DOI 10.1111/eth.12071	38	0	0	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167674	10.1371/journal.pone.0167674	http://dx.doi.org/10.1371/journal.pone.0167674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977719	Green Submitted, gold, Green Published			2022-12-27	WOS:000391217400026
J	Lee, LM; Ji, M; Sinha, M; Dong, MB; Ren, X; Wang, YL; Lowell, CA; Ghosh, S; Locksley, RM; DeFranco, AL				Lee, Linda M.; Ji, Ming; Sinha, Meenal; Dong, Matthew B.; Ren, Xin; Wang, Yanli; Lowell, Clifford A.; Ghosh, Sankar; Locksley, Richard M.; DeFranco, Anthony L.			Determinants of Divergent Adaptive Immune Responses after Airway Sensitization with Ligands of Toll-Like Receptor 5 or Toll-Like Receptor 9	PLOS ONE			English	Article							HOUSE-DUST MITE; MEDIATED ALLERGIC INFLAMMATION; DENDRITIC CELLS; TYPE-2 IMMUNITY; STRUCTURAL CELLS; EPITHELIAL-CELLS; TH2 RESPONSES; REPORTER MICE; IN-VIVO; INNATE	Excessive type 2 helper T cell responses to environmental antigens can cause immunopathology such as asthma and allergy, but how such immune responses are induced remains unclear. We studied this process in the airways by immunizing mice intranasally with the antigen ovalbumin together with either of two Toll-like receptor (TLR) ligands. We found the TLR5 ligand flagellin promoted a type 2 helper T cell response, whereas, a TLR9 ligand CpG oligodeoxyribonucleotide (ODN) promoted a type 1 helper T cell response. CpG ODN induced mRNA encoding interleukin (IL)-12 p40, whereas, flagellin caused IL-33 secretion and induced mRNAs encoding IL-1 and thymic stromal lymphopoietin (TSLP). By using mice deficient in the TLR and IL-1R signaling molecule, myeloid differentiation primary response 88 (MyD88), in conventional dendritic cells (cDCs) and alveolar macrophages (AMs), and by cell sorting different lung populations after 2 hours of in vivo stimulation, we characterized the cell types that rapidly produced inflammatory cytokines in response to TLR stimulation. CpG ODN was likely recognized by TLR9 on cDCs and AMs, which made mRNA encoding IL-12. IL-12 was necessary for the subsequent innate and adaptive interferon-gamma production. In contrast, flagellin stimulated multiple cells of hematopoietic and non-hematopoietic origin, including AMs, DCs, monocytes, and lung epithelial cells. AMs were largely responsible for IL-1a, whereas lung epithelial cells made TSLP. Multiple hematopoietic cells, including AMs, DCs, and monocytes contributed to other cytokines, including IL-1 beta and TNF alpha. MyD88-dependent signals, likely through IL-1R and IL-33R, and MyD88-independent signals, likely from TSLP, were necessary in cDCs for promotion of the early IL-4 response by CD4 T cells in the draining lymph node. Thus, the cell types that responded to TLR ligands were a critical determinant of the innate cytokines produced and the character of the resulting adaptive immune response in the airways.	[Lee, Linda M.; Ji, Ming; Dong, Matthew B.; DeFranco, Anthony L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Lee, Linda M.; DeFranco, Anthony L.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Sinha, Meenal; Lowell, Clifford A.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Ren, Xin; Wang, Yanli; Locksley, Richard M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Ghosh, Sankar] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY USA; [Locksley, Richard M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	DeFranco, AL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; DeFranco, AL (corresponding author), Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA.	Anthony.DeFranco@ucsf.edu	Sinha, Meenal/B-7158-2016	Sinha, Meenal/0000-0002-4008-4080; Lee, Linda/0000-0002-8106-1360	National Institutes of Health [PO1AI078869, T32AI007334, P30 DK063720]; University of California San Francisco Graduate Student Research Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, R21AI117378] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California San Francisco Graduate Student Research Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was in part supported by National Institutes of Health grants: PO1AI078869 (CAL, RML, ALD), T32AI007334 (LML), and P30 DK063720 (Diabetes Research Center Grant). LML was in part supported by the University of California San Francisco Graduate Student Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Bartemes KR, 2012, CLIN IMMUNOL, V143, P222, DOI 10.1016/j.clim.2012.03.001; Besnard AG, 2011, EUR J IMMUNOL, V41, P1675, DOI 10.1002/eji.201041033; Bhattacharya M, 2014, J CLIN INVEST, V124, P4895, DOI 10.1172/JCI76658; Chen L, 2006, J IMMUNOL, V177, P2373, DOI 10.4049/jimmunol.177.4.2373; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cunningham AF, 2004, EUR J IMMUNOL, V34, P2986, DOI 10.1002/eji.200425403; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Fougeron D, 2015, VACCINE, P1; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hawn TR, 2007, J IMMUNOL, V179, P6981, DOI 10.4049/jimmunol.179.10.6981; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Herrick CA, 2000, J CLIN INVEST, V105, P765, DOI 10.1172/JCI8624; Honko AN, 2004, INFECT IMMUN, V72, P6676, DOI 10.1128/IAI.72.11.6676-6679.2004; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Janot L, 2009, EUR J IMMUNOL, V39, P1587, DOI 10.1002/eji.200838907; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Lambrecht BN, 2014, J ALLERGY CLIN IMMUN, V134, P499, DOI 10.1016/j.jaci.2014.06.036; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Liu YJ, 2007, J ALLERGY CLIN IMMUN, V120, P238, DOI 10.1016/j.jaci.2007.06.004; MacDonald A. S., 2008, EXP MED, V205, P13; Mathur R, 2012, CELL, V151, P590, DOI 10.1016/j.cell.2012.08.042; McAlees JW, 2014, MUCOSAL IMMUNOL; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; Nakano H, 2013, METHODS MOL BIOL, V1032, P19, DOI 10.1007/978-1-62703-496-8_2; O'Neill LAJ, 2008, IMMUNOL REV, P10, DOI [10.1111/j.1600-065X.2008.00701.x, DOI 10.1111/J.1600-065X.2008.00701.X]; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pesce I, 2010, J INNATE IMMUN, V2, P144, DOI 10.1159/000254948; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Price AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039750; Pulendran B, 2012, SCIENCE, V337, P431, DOI 10.1126/science.1221064; Rank MA, 2009, J ALLERGY CLIN IMMUN, V123, P1047, DOI 10.1016/j.jaci.2009.02.026; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Sanders CJ, 2008, J IMMUNOL, V180, P7184, DOI 10.4049/jimmunol.180.11.7184; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Schulke S, 2011, J ALLERGY CLIN IMMUN, V128, P1340, DOI 10.1016/j.jaci.2011.07.036; Schulke S, 2010, MOL IMMUNOL, V48, P341, DOI 10.1016/j.molimm.2010.07.006; Shim JU, 2016, J ALLERGY CLIN IMMUN, V137, P426, DOI 10.1016/j.jaci.2015.07.010; Sinha M, 2015, AM J RESP CELL MOL B, P1; Smith K.D., 2003, NAT IMMUNOL, V5, P451, DOI DOI 10.1038/NI1011; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; Suzuki K, 2005, AM J RESP CRIT CARE, V171, P707, DOI 10.1164/rccm.200408-1078OC; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Van Maele L, 2014, MUCOSAL IMMUNOL, V7, P489, DOI 10.1038/mi.2013.66; Voehringer D, 2004, IMMUNITY, V20, P267, DOI 10.1016/S1074-7613(04)00026-3; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691; Wilson RH, 2012, NAT MED, V18, P1705, DOI 10.1038/nm.2920; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	67	10	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167693	10.1371/journal.pone.0167693	http://dx.doi.org/10.1371/journal.pone.0167693			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977701	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400029
J	Liu, HY; Wang, G; Yang, LL; Qu, JJ; Yang, ZH; Zhou, XY				Liu, Hongying; Wang, Gang; Yang, Lili; Qu, Jianjun; Yang, Zhihui; Zhou, Xiangyu			Knockdown of Long Non-Coding RNA UCA1 Increases the Tamoxifen Sensitivity of Breast Cancer Cells through Inhibition of Wnt/beta-Catenin Pathway	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; DRUG-RESISTANCE; GROWTH	Acquired resistance to tamoxifen remains a major obstacle in breast cancer (BC) treatment, since the underlying mechanism has not been fully elucidated. The long non-coding RNA (lncRNA) urothelial carcinoma-associated 1 (UCA1) has been recently shown to be dysregulated and plays important roles in progression of breast cancer. In the present study, we aimed to investigate the biological role and clinical significance of UCA1 in BC drug resistance. Hence, we used quantitative PCR assay to evaluate the UCA1 expression in tissues from patients with BC as well as established tamoxifen-resistant BC cell lines in vitro. We tested the viability, invasive ability and apoptosis rate in MCF-7 and T47D cells using MTT assay, transwell assay and flow cytometry assay, respectively. The influence of UCA1 on tumorigenesis was monitored by in vivo mice xenograft model. The activation of Wnt/beta-catenin signaling pathway was evaluated by immunofluorescence assay, western blot assay and luciferase reporter assay, respectively. We found that the expression of UCA1 positively correlated with the pathological grade and mortality of breast cancer patients, moreover, expressions of UCA1 was increased significantly in the tamoxifen-resistant cell lines compared with the wild type parental cells. Ectopic expression of UCA1 promoted cell survival and resistance to tamoxifen treatment, whereas inhibition of UCA1 enhanced tamoxifen sensitivity of BC cells and induced more apoptotic cells. In addition, tamoxifen-resistant cells exhibited increased Wnt signaling activation as measured by the TOP/FOP Wnt luciferase reporter assay and beta-catenin protein level compared with parental MCF-7 and T47D cells, respectively. In line with these data, UCA1 depletion attenuated the activity of Wnt/beta-catenin pathway activation and the tumorigenicity of the tamoxifen-resistant BC cells. Taken together, our data highlights the pivotal role of UCA1-Wnt/beta-catenin signaling pathway in the tamoxifen resistance in breast cancer, which could be targeted to improve the effectiveness and efficacy of tamoxifen treatment in breast cancer.	[Liu, Hongying; Wang, Gang; Yang, Lili] Weifang Med Univ, Dept Genet, Weifang, Shandong, Peoples R China; [Qu, Jianjun] Weifang Peoples Hosp, Dept Surg Oncol, Weifang, Shandong, Peoples R China; [Yang, Zhihui] SouthWest Med Univ China, Dept Pathol, Luzhou, Sichuan, Peoples R China; [Zhou, Xiangyu] South Med Univ China, Dept Vasc & Thyroid Surg, Affiliated Hosp, Luzhou, Sichuan, Peoples R China	Weifang Medical University	Liu, HY (corresponding author), Weifang Med Univ, Dept Genet, Weifang, Shandong, Peoples R China.; Zhou, XY (corresponding author), South Med Univ China, Dept Vasc & Thyroid Surg, Affiliated Hosp, Luzhou, Sichuan, Peoples R China.	liuhongyingwf@163.com; xiangyuzhou971@126.com			Health and Family Planning Commission of Shandong Province Research Foundation [2015WSB27009]; Sichuan Provincial Science and Technology Foundation [2014JY0004]	Health and Family Planning Commission of Shandong Province Research Foundation; Sichuan Provincial Science and Technology Foundation	This work was supported by Health and Family Planning Commission of Shandong Province Research Foundation (2015WSB27009) and Sichuan Provincial Science and Technology Foundation (2014JY0004).	Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Cui JJ, 2012, CURR PHARM DESIGN, V18, P2464, DOI 10.2174/13816128112092464; Czerwinska Patrycja, 2015, Contemp Oncol (Pozn), V19, pA7, DOI 10.5114/wo.2014.47126; Deniz E, 2016, FUNCT INTEGR GENOMIC; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Fan Y, 2014, FEBS J, V281, P1750, DOI 10.1111/febs.12737; Fu X, 2016, ONCOTARGETS THER, V9, DOI 10.2147/OTT.S100633; Gao YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082436; Huang J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.541; Hurvitz SA, 2008, CANCER-AM CANCER SOC, V113, P2385, DOI 10.1002/cncr.23875; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Mahmoodzadeh S, 2006, FASEB J, V20, P926, DOI 10.1096/fj.05-5148com; McCrea E, 2016, PHARM RES; Ojo D, 2015, CURR MED CHEM, V22, P2360, DOI 10.2174/0929867322666150416095744; Raha P, 2011, EPIGENOMICS-UK, V3, P451, DOI [10.2217/epi.11.72, 10.2217/EPI.11.72]; Sang XB, 2016, ONCOLOGY REPORTS; Shooshtarizadeh T, 2016, PATHOLOGY RES PRACTI; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tuo YL, 2015, EUR REV MED PHARMACO, V19, P3403; Wang XS, 2006, CLIN CANCER RES, V12, P4851, DOI 10.1158/1078-0432.CCR-06-0134; Wang YY, 2015, CELL STEM CELL, V16, P413, DOI 10.1016/j.stem.2015.03.003; Wei ZT, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0842-9; Wilusz JE, 2016, BBA-GENE REGUL MECH, V1859, P128, DOI 10.1016/j.bbagrm.2015.06.003; Xia HP, 2014, CURR MED CHEM, V21, P3029, DOI 10.2174/0929867321666140414101939; Xue M, 2016, J CANCER RES CLIN, V142, P1407, DOI 10.1007/s00432-015-2042-y; Yin L, 2016, STEROIDS, V111, P95, DOI 10.1016/j.steroids.2016.01.019; Zhang ZY, 2016, CANCER LETT, V376, P62, DOI 10.1016/j.canlet.2016.03.022; Zhou Y, 2005, ENDOCR-RELAT CANCER, V12, pS37, DOI 10.1677/erc.1.00977	28	75	81	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168406	10.1371/journal.pone.0168406	http://dx.doi.org/10.1371/journal.pone.0168406			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977766	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400105
J	Sprague, S; Slobogean, GP; Spurr, H; McKay, P; Scott, T; Arseneau, E; Memon, M; Bhandari, M; Swaminathan, A				Sprague, Sheila; Slobogean, Gerard P.; Spurr, Hayley; McKay, Paula; Scott, Taryn; Arseneau, Erika; Memon, Muzammil; Bhandari, Mohit; Swaminathan, Aparna			A Scoping Review of Intimate Partner Violence Screening Programs for Health Care Professionals	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; DOMESTIC VIOLENCE; WOMEN; ABUSE; SETTINGS; INTERVENTION; EXPERIENCES; IMPLEMENTATION; QUESTIONNAIRE; INTERVIEW	Introduction Between 38 and 59 percent of women presenting to health care professionals have experienced intimate partner violence. Consequently, multiple intimate partner violence identification or screening programs within health care settings have been developed; however, substantial variations in program content and interpretation of program effectiveness has resulted in conflicting practice guidelines. The purpose of our scoping review is to broadly identify and synthesize the available literature evaluating intimate partner violence identification programs within health care settings to identify key areas for potential evidence-based recommendations and to focus research priorities in the field. Materials and Methods We conducted a search of MEDLINE, Embase, Cumulative Index of Nursing and Allied Health Literature, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, and psycINFO. We used broad eligibility criteria to identify studies that evaluated intimate partner violence identification programs in health care settings. We completed all screening and data extraction independently and in duplicate. We used descriptive statistics to summarize all data. Results We identified 59 eligible studies evaluating intimate partner violence identification programs within health care settings. The most commonly reported outcome themes were IPV disclosure (69%, n = 35), number of patients screened (39%, n = 20), HCP opinions towards screening (37%, n = 19), and patient opinions towards screening (29%, n = 15). The majority of studies (36 studies (70.6%)) reported positive program evaluation results. Discussion The majority of studies reported positive program evaluation results. This may suggest that many different intimate partner violence identification programs are beneficial for identifying victims of abuse, however, it remains unknown as to whether identification programs prevent future episodes of abuse. Additionally, the substantial heterogeneity of the intervention characteristics, study methodology, and outcome measures assessed limits the ability to make clear recommendations as to the optimal method(s) of screening.	[Sprague, Sheila; Memon, Muzammil; Bhandari, Mohit] McMaster Univ, Div Orthopaed Surg, Dept Surg, Hamilton, ON, Canada; [Sprague, Sheila; McKay, Paula; Scott, Taryn; Arseneau, Erika; Bhandari, Mohit] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Slobogean, Gerard P.] Univ Maryland, Sch Med, Dept Orthopaed, Baltimore, MD 21201 USA; [Spurr, Hayley] Royal Coll Surgeons Ireland, Grad Entry Med, Dublin, Ireland; [Swaminathan, Aparna] McMaster Univ, Dept Family Med, Hamilton, ON, Canada	McMaster University; McMaster University; University System of Maryland; University of Maryland Baltimore; Royal College of Surgeons - Ireland; McMaster University	Sprague, S (corresponding author), McMaster Univ, Div Orthopaed Surg, Dept Surg, Hamilton, ON, Canada.	sprags@mcmaster.ca	Bhandari, Mohit/AAQ-1675-2021; Sprague, Sheila/AAQ-4232-2021	Sprague, Sheila/0000-0003-1466-8063	Canadian Institutes of Health Research [KRS - 140988]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca) (KRS - 140988). Funding was received by SS, MB, GS, and AS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2009, ANN INTERN MED, V151, P93, DOI 10.7326/0003-4819-151-2-200907210-00124; American College of Obstetricians and Gynecologists, 2012, INTIMATE PARTNER VIO; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Bacchus L, 2002, BJOG-INT J OBSTET GY, V109, P9, DOI 10.1111/j.1471-0528.2002.00514.x; Bair-Merritt MH, 2006, ARCH PEDIAT ADOL MED, V160, P311, DOI 10.1001/archpedi.160.3.311; Baird K, 2013, MIDWIFERY, V29, P1003, DOI 10.1016/j.midw.2013.01.007; Canadian Institutes of Health Research, 2015, KNOWLEDGE TRANSLATIO; Canadian Orthopaedic Association, 2009, INTIMATE PARTNER VIO; Chang JC, 2012, PATIENT EDUC COUNS, V88, P443, DOI 10.1016/j.pec.2012.06.021; Chemlak D, 2005, J OBSTET GYNAECOL CA, V27, P365; Chen PH, 2007, ANN FAM MED, V5, P430, DOI 10.1370/afm.716; Coster WJ, 2013, AM J OCCUP THER, V67, P162, DOI 10.5014/ajot.2013.006015; Duncan MM, 2006, MATERN CHILD HLTH J, V10, P443, DOI 10.1007/s10995-006-0076-0; Feder GS, 2006, ARCH INTERN MED, V166, P22, DOI 10.1001/archinte.166.1.22; Fincher D, 2015, J INTERPERS VIOLENCE, V30, P818, DOI 10.1177/0886260514536280; Gass JD, 2010, SAMJ S AFR MED J, V100, P582, DOI 10.7196/SAMJ.4274; Grafton D, 2006, PUBLIC HEALTH NURS, V23, P535, DOI 10.1111/j.1525-1446.2006.00593.x; Griffin LK., 2010, J AGGRESS MALTREAT T, V19, P839, DOI DOI 10.1080/10926771.2010.522950; Halpern LR, 2009, J ORAL MAXIL SURG, V67, P1453, DOI 10.1016/j.joms.2009.03.003; Hawkins JW, 2009, PUBLIC HEALTH NURS, V26, P58, DOI 10.1111/j.1525-1446.2008.00754.x; Howard J, 2008, AUST J PRIM HEALTH, V14, P43, DOI 10.1071/PY08006; Hugl-Wajek JA, 2012, J EMERG MED, V43, P860, DOI 10.1016/j.jemermed.2009.07.031; Jack SM, 2008, CAN J NURS RES, V40, P150; Jones Carol, 2002, Aust J Midwifery, V15, P14, DOI 10.1016/S1445-4386(02)80018-0; Kataoka Y., 2004, JPN J NURS SCI, V1, P77, DOI [10.1111/j.1742-7924.2004.00017.x, DOI 10.1111/J.1742-7924.2004.00017.X]; Kataoka Y, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-84; Klevens J, 2012, JAMA-J AM MED ASSOC, V308, P681, DOI 10.1001/jama.2012.6434; Klevens J, 2012, WOMEN HEALTH ISS, V22, pE45, DOI 10.1016/j.whi.2011.06.008; Koziol-McLain J, 2008, J MIDWIFERY WOM HEAL, V53, P504, DOI 10.1016/j.jmwh.2008.06.002; Koziol-McLain J, 2010, ANN EMERG MED, V56, P413, DOI 10.1016/j.annemergmed.2010.05.001; Laisser RM, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.7288; MacMillan HL, 2006, JAMA-J AM MED ASSOC, V296, P530, DOI 10.1001/jama.296.5.530; MacMillan HL, 2009, JAMA-J AM MED ASSOC, V302, P493, DOI 10.1001/jama.2009.1089; McCosker-Howard H., 2005, BIRTH-ISS PERINAT C, V14, P49; McNulty Anna, 2006, Sex Health, V3, P179, DOI 10.1071/SH05056; Morrison LJ, 2000, J EMERG MED, V19, P117, DOI 10.1016/S0736-4679(00)00204-3; Morse DS, 2012, J AM BOARD FAM MED, V25, P333, DOI 10.3122/jabfm.2012.03.110193; Mott Helen., 2016, OPENDEMOCRACY B 1207; Moyer VA, 2013, ANN INTERN MED, V158, P478, DOI 10.7326/0003-4819-158-6-201303190-00588; National Institute for Health and Care Excellence, 2014, DOMESTIC VIOLENCE AN; Nelson HD, 2012, ANN INTERN MED, V156, P796, DOI 10.7326/0003-4819-156-11-201206050-00447; O'Campo P, 2011, SOC SCI MED, V72, P855, DOI 10.1016/j.socscimed.2010.12.019; O'Doherty L, 2015, COCHRANE DB SYST REV, V7, P1; O'Doherty LJ, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2913; O'Reilly R, 2010, TRAUMA VIOLENCE ABUS, V11, P190, DOI 10.1177/1524838010378298; Onifade R, 2010, J OBSTET GYNAECOL, V30, P550, DOI 10.3109/01443615.2010.494208; Owen-Smith A, 2008, ONCOL NURS FORUM, V35, P625, DOI 10.1188/08.ONF.625-633; Power C, 2011, AUST SOC WORK, V64, P537, DOI 10.1080/0312407X.2011.606909; Price S., 2007, EVIDENCE BASED MIDWI, V5, P100; Ramsay J, 2002, BRIT MED J, V325, P1; Ramsden C, 2002, Accid Emerg Nurs, V10, P31, DOI 10.1054/aaen.2001.0312; Ramsden C, 2002, AUSTR EMERGENCY NURS, V5, P15; Renker PR, 2008, J MIDWIFERY WOM HEAL, V53, P496, DOI 10.1016/j.jmwh.2008.07.017; Rhodes KV, 2006, ARCH INTERN MED, V166, P1107, DOI 10.1001/archinte.166.10.1107; Rivara FP, 2007, AM J PREV MED, V32, P89, DOI 10.1016/j.amepre.2006.10.001; Scholle SH, 2003, AM J PUBLIC HEALTH, V93, P1070, DOI 10.2105/AJPH.93.7.1070; Shattuck Susan R, 2002, J Community Health Nurs, V19, P121, DOI 10.1207/153276502760242323; Soglin LF, 2009, J INTERPERS VIOLENCE, V24, P338, DOI 10.1177/0886260508316481; Spangaro JM, 2010, WOMEN HEALTH, V50, P125, DOI 10.1080/03630241003705060; Spangaro J, 2011, VIOLENCE VICTIMS, V26, P130, DOI 10.1891/0886-6708.26.1.130; Spangaro Joanne M, 2007, N S W Public Health Bull, V18, P86, DOI 10.1071/NB07063; Sprague S, 2014, VIOLENCE AGAINST WOM, V20, P118, DOI 10.1177/1077801213520574; Stenson K, 2005, MIDWIFERY, V21, P311, DOI 10.1016/j.midw.2005.01.002; Svavarsdottir EK, 2010, SCAND J CARING SCI, V24, P224, DOI 10.1111/j.1471-6712.2009.00709.x; Svavarsdottir EK, 2009, J ADV NURS, V65, P779, DOI 10.1111/j.1365-2648.2008.04872.x; Trabold N, 2007, SOC WORK HEALTH CARE, V45, P1, DOI 10.1300/J010v45n01_01; Trautman DE, 2007, ANN EMERG MED, V49, P526, DOI 10.1016/j.annemergmed.2006.11.022; Ulbrich PM, 2002, WOMEN HEALTH, V35, P83, DOI 10.1300/J013v35n02_06; Usta J, 2012, ANN FAM MED, V10, P213, DOI 10.1370/afm.1336; Vanderburg S, 2010, PUBLIC HEALTH NURS, V27, P347, DOI 10.1111/j.1525-1446.2010.00865.x; Webster F, 2006, CAN J NURS RES, V38, P136; Webster J, 2001, MIDWIFERY, V17, P289, DOI 10.1054/midw.2001.0279; Weibe ER, 2001, WOMEN HEALTH ISS, V11, P436, DOI 10.1016/S1049-3867(01)00074-3; Wenzel John D., 2004, Journal of the American Osteopathic Association, V104, P233; World Health Organization, 2013, GLOBAL AND REGIONAL; World Health Organization, 2013, RESPONDING TO INTIMA	76	16	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168502	10.1371/journal.pone.0168502	http://dx.doi.org/10.1371/journal.pone.0168502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977769	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400113
J	Doughty, CE; Wolf, A				Doughty, Christopher E.; Wolf, Adam			Detecting 3D Vegetation Structure with the Galileo Space Probe: Can a Distant Probe Detect Vegetation Structure on Earth?	PLOS ONE			English	Article							DISK-AVERAGED SPECTRA; BIDIRECTIONAL REFLECTANCE; PLANETARY CHARACTERISTICS; EXTRASOLAR PLANETS; SIGNATURES; LIFE; PHOTOSYNTHESIS; DETECTABILITY; COEVOLUTION; ATMOSPHERE	Sagan et al. (1993) used the Galileo space probe data and first principles to find evidence of life on Earth. Here we ask whether Sagan et al. (1993) could also have detected whether life on Earth had three-dimensional structure, based on the Galileo space probe data. We reanalyse the data from this probe to see if structured vegetation could have been detected in regions with abundant photosynthetic pigments through the anisotropy of reflected short-wave radiation. We compare changing brightness of the Amazon forest (a region where Sagan et al. (1993) noted a red edge in the reflectance spectrum, indicative of photosynthesis) as the planet rotates to a common model of reflectance anisotropy and found measured increase of surface reflectance of 0.019 +/- 0.003 versus a 0.007 predicted from only anisotropic effects. We hypothesize the difference was due to minor cloud contamination. However, the Galileo dataset had only a small change in phase angle (sun-satellite position) which reduced the observed anisotropy signal and we demonstrate that theoretically if the probe had a variable phase angle between 0-20 degrees, there would have been a much larger predicted change in surface reflectance of 0.1 and under such a scenario three-dimensional vegetation structure on Earth could possibly have been detected. These results suggest that anisotropic effects may be useful to help determine whether exoplanets have three-dimensional vegetation structure in the future, but that further comparisons between empirical and theoretical results are first necessary.	[Doughty, Christopher E.] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA; [Wolf, Adam] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Northern Arizona University; Princeton University	Doughty, CE (corresponding author), No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA.	chris.doughty@nau.edu						Anglada-Escude A G, 2016, NATURE; [Anonymous], 1877, DIFFERENT FORMS FLOW; Arnold L, 2002, ASTRON ASTROPHYS, V392, P231, DOI 10.1051/0004-6361:20020933; Bacour C, 2005, REMOTE SENS ENVIRON, V98, P80, DOI 10.1016/j.rse.2005.06.008; BELTON MJS, 1992, SPACE SCI REV, V60, P413, DOI 10.1007/BF00216864; Bicheron P, 2000, J GEOPHYS RES-ATMOS, V105, P26669, DOI 10.1029/2000JD900380; Borucki WJ, 2013, SCIENCE, V340, P587, DOI 10.1126/science.1234702; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; Breon FM, 1997, IEEE T GEOSCI REMOTE, V35, P479, DOI 10.1109/36.563289; Breon FM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001094; Doughty CE, 2010, ASTROBIOLOGY, V10, P869, DOI 10.1089/ast.2010.0495; Ford EB, 2001, NATURE, V412, P885, DOI 10.1038/35091009; Fujii Y, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/2/184; Fujii Y, 2010, ASTROPHYS J, V715, P866, DOI 10.1088/0004-637X/715/2/866; Hall O, 2005, IEEE GEOSCI REMOTE S, V2, P177, DOI 10.1109/LGRS.2004.842447; Kenny R, 2001, GEOL SOC AM BULL, V113, P650, DOI 10.1130/0016-7606(2001)113<0650:SIVITN>2.0.CO;2; Kiang NY, 2007, ASTROBIOLOGY, V7, P486; Kiang NY, 2007, ASTROBIOLOGY, V7, P252, DOI 10.1089/ast.2006.0108; LI XW, 1992, IEEE T GEOSCI REMOTE, V30, P276, DOI 10.1109/36.134078; Lucht W, 2000, IEEE T GEOSCI REMOTE, V38, P977, DOI 10.1109/36.841980; Maignan F, 2004, REMOTE SENS ENVIRON, V90, P210, DOI 10.1016/j.rse.2003.12.006; Montanes-Rodriguez P, 2006, ASTROPHYS J, V651, P544, DOI 10.1086/507694; Morton DC, 2014, NATURE, V506, P221, DOI 10.1038/nature13006; Robinson TD, 2010, ASTROPHYS J LETT, V721, pL67, DOI 10.1088/2041-8205/721/1/L67; SAGAN C, 1993, NATURE, V365, P715, DOI 10.1038/365715a0; Schaepman-Strub G, 2006, REMOTE SENS ENVIRON, V103, P27, DOI 10.1016/j.rse.2006.03.002; Seager S, 2005, ASTROBIOLOGY, V5, P372, DOI 10.1089/ast.2005.5.372; Tenenbaum P, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/1/6; Tinetti G, 2006, ASTROBIOLOGY, V6, P34, DOI 10.1089/ast.2006.6.34; Tinetti G, 2006, ASTROBIOLOGY, V6, P881, DOI 10.1089/ast.2006.6.881; Wolf A, 2010, REMOTE SENSING ENV	31	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167188	10.1371/journal.pone.0167188	http://dx.doi.org/10.1371/journal.pone.0167188			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973530	Green Submitted, Green Published, gold			2022-12-27	WOS:000392754300019
J	Queliconi, BB; Kowaltowski, AJ; Gottlieb, RA				Queliconi, Bruno B.; Kowaltowski, Alicia J.; Gottlieb, Roberta A.			Bicarbonate Increases Ischemia-Reperfusion Damage by Inhibiting Mitophagy	PLOS ONE			English	Article							CORONARY ENDOTHELIAL-CELLS; MITOCHONDRIAL FRAGMENTATION; SUPEROXIDE-DISMUTASE; IN-VIVO; HEART; INJURY; PROTEASOME; APOPTOSIS; AUTOPHAGY; TRANSPORT	During an ischemic event, bicarbonate and CO2 concentration increase as a consequence of O-2 consumption and lack of blood flow. This event is important as bicarbonate/CO2 is determinant for several redox and enzymatic reactions, in addition to pH regulation. Until now, most work done on the role of bicarbonate in ischemia-reperfusion injury focused on pH changes; although reperfusion solutions have a fixed pH, cardiac resuscitation protocols commonly employ bicarbonate to correct the profound acidosis associated with respiratory arrest. However, we previously showed that bicarbonate can increase tissue damage and protein oxidative damage independent of pH. Here we show the molecular basis of bicarbonate- induced reperfusion damage: the presence of bicarbonate selectively impairs mitophagy, with no detectable effect on autophagy, proteasome activity, reactive oxygen species production or protein oxidation. We also show that inhibition of autophagy reproduces the effects of bicarbonate in reperfusion injury, providing additional evidence in support of this mechanism. This phenomenon is especially important because bicarbonate is widely used in resuscitation protocols after cardiac arrest, and while effective as a buffer, may also contribute to myocardial injury.	[Queliconi, Bruno B.; Kowaltowski, Alicia J.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil; [Queliconi, Bruno B.; Gottlieb, Roberta A.] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA	Universidade de Sao Paulo; Cedars Sinai Medical Center	Gottlieb, RA (corresponding author), Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA.	Roberta.Gottlieb@cshs.org	Kowaltowski, Alicia J/H-8698-2012	Queliconi, Bruno Barros/0000-0001-7361-5573	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/51906-1]; Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina [13/07937-8]; Nucleo de Pesquisa em Processos Redox em Biomedicina (NAP-Rexodoma); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); NIH [P01 HL112730]; FAPESP [2009/50168-0, 2013/07292-7]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL112730] Funding Source: NIH RePORTER	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina; Nucleo de Pesquisa em Processos Redox em Biomedicina (NAP-Rexodoma); Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 10/51906-1) (AJK), Centro de Pesquisa, Inovacao e Difusao de Processos Redox em Biomedicina (13/07937-8) (AJK), Nucleo de Pesquisa em Processos Redox em Biomedicina (NAP-Rexodoma) (AJK, BBQ), Instituto Nacional de Ciencia e Tecnologia de Processos Redox em Biomedicina (INCT Redoxoma) (AJK), and NIH P01 HL112730 (RAG). BBQ was a doctoral student supported by two FAPESP grants (2009/50168-0 and 2013/07292-7).	Alka K, 2014, IUBMB LIFE, V66, P596, DOI 10.1002/iub.1315; Andres AM, 2016, AM J PHYSIOL-HEART C, V311, pH219, DOI 10.1152/ajpheart.00041.2016; Andres AM, 2015, J MOL CELL CARDIOL, V78, P62, DOI 10.1016/j.yjmcc.2014.10.003; Andres AM, 2013, ANTIOXID REDOX SIGNA, V11; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Ch'en FT, 2008, BRIT J PHARMACOL, V153, P972, DOI 10.1038/sj.bjp.0707667; da Cunha FM, 2011, FREE RADICAL BIO MED, V51, P664, DOI 10.1016/j.freeradbiomed.2011.05.035; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Dorn GW, 2015, CIRC RES, V116, P225, DOI 10.1161/CIRCRESAHA.114.305672; Duda T, 2015, J BIOL CHEM, V290, P11052, DOI 10.1074/jbc.M115.650408; Dutta D, 2013, AUTOPHAGY, V9, P328, DOI 10.4161/auto.22971; Facundo HTF, 2006, FREE RADICAL BIO MED, V40, P469, DOI 10.1016/j.freeradbiomed.2005.08.041; Gottlieb RA, 2015, SCIENCE, V350, P1162, DOI 10.1126/science.aad8222; Gottlieb RA, 2011, AUTOPHAGY, V7, P1573, DOI 10.4161/auto.7.12.18175; Goudeau J, 2010, AGING CELL, V9, P991, DOI 10.1111/j.1474-9726.2010.00625.x; Heijnen BHM, 2002, J APPL PHYSIOL, V93, P319, DOI 10.1152/japplphysiol.01112.2001; Huang CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020975; Inserte J, 2008, CARDIOVASC RES, V77, P782, DOI 10.1093/cvr/cvm082; Johnson D, 2012, AM J PHYSIOL-CELL PH, V302, pC1045, DOI 10.1152/ajpcell.00411.2011; Johnson D, 2010, MOL BIOL CELL, V21, P2191, DOI 10.1091/mbc.E09-10-0874; Jung T, 2008, IUBMB LIFE, V60, P743, DOI 10.1002/iub.114; Kobayashi S, 2014, BIOCH BIOPHYS ACTA D; Kubli DA, 2013, J BIOL CHEM, V288, P915, DOI 10.1074/jbc.M112.411363; Kumar S, 2007, J CELL MOL MED, V11, P798, DOI 10.1111/j.1582-4934.2007.00053.x; Kumar S, 2011, CARDIOVASC RES, V89, P392, DOI 10.1093/cvr/cvq330; Lima ML, 2012, REV BRAS CIR CARDIOV, V27, P110, DOI 10.5935/1678-9741.20120016; Liochev SI, 2002, J BIOL CHEM, V277, P34674, DOI 10.1074/jbc.M204726200; Medinas DB, 2007, IUBMB LIFE, V59, P255, DOI 10.1080/15216540701230511; Meiltz A, 1998, J MOL CELL CARDIOL, V30, P327, DOI 10.1006/jmcc.1997.0595; Nozik-Grayck E, 2003, AM J PHYSIOL-HEART C, V285, pH2327, DOI 10.1152/ajpheart.00507.2003; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Perry CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016288; Pierce JD, 2016, J INFUS MURS, V39, P40, DOI 10.1097/NAN.0000000000000149; Queiroz RF, 2013, BIOCHEM J, V455, P37, DOI 10.1042/BJ20130180; Queliconi BB, 2013, FREE RADICAL BIO MED, V55, P46, DOI 10.1016/j.freeradbiomed.2012.11.007; Queliconi BB, 2011, BBA-MOL CELL RES, V1813, P1309, DOI 10.1016/j.bbamcr.2010.11.005; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shirihai OS, 2015, CIRC RES, V116, P1835, DOI 10.1161/CIRCRESAHA.116.306374; Song MS, 2015, CELL METAB, V21, P195, DOI 10.1016/j.cmet.2014.12.019; Soubannier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052830; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; VandenHoek TL, 1996, AM J PHYSIOL-HEART C, V270, pH1334, DOI 10.1152/ajpheart.1996.270.4.H1334; Vaughan-Jones RD, 2009, J MOL CELL CARDIOL, V46, P318, DOI 10.1016/j.yjmcc.2008.10.024; Vincow ES, 2013, P NATL ACAD SCI USA, V110, P6400, DOI 10.1073/pnas.1221132110; Yitzhaki S, 2009, BASIC RES CARDIOL, V104, P157, DOI 10.1007/s00395-009-0006-6; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Zhou MJ, 1997, ANAL BIOCHEM, V253, P162, DOI 10.1006/abio.1997.2391	48	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167678	10.1371/journal.pone.0167678	http://dx.doi.org/10.1371/journal.pone.0167678			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973540	Green Submitted, gold, Green Published			2022-12-27	WOS:000392754300039
J	Esapa, CT; Piret, SE; Nesbit, MA; Loh, NY; Thomas, G; Croucher, PI; Brown, MA; Brown, SDM; Cox, RD; Thakker, RV				Esapa, Christopher T.; Piret, Sian E.; Nesbit, M. Andrew; Loh, Nellie Y.; Thomas, Gethin; Croucher, Peter I.; Brown, Matthew A.; Brown, Steve D. M.; Cox, Roger D.; Thakker, Rajesh V.			Mice with an N-Ethyl-N-Nitrosourea (ENU) Induced Tyr209Asn Mutation in Natriuretic Peptide Receptor 3 (NPR3) Provide a Model for Kyphosis Associated with Activation of the MAPK Signaling Pathway	PLOS ONE			English	Article							MOUSE MODEL; VERTEBRAL SEGMENTATION; SCHEUERMANN-DISEASE; SKELETAL GROWTH; GENE; MUTAGENESIS; DYSPLASIA; ETIOLOGY; DWARFISM	Non-syndromic kyphosis is a common disorder that is associated with significant morbidity and has a strong genetic involvement; however, the causative genes remain to be identified, as such studies are hampered by genetic heterogeneity, small families and various modes of inheritance. To overcome these limitations, we investigated 12 week old progeny of mice treated with the chemical mutagen N-ethyl-N-nitrosourea (ENU) using phenotypic assessments including dysmorphology, radiography, and dual-energy X-ray absorptiometry. This identified a mouse with autosomal recessive kyphosis (KYLB). KYLB mice, when compared to unaffected littermates, had: thoraco-lumbar kyphosis, larger vertebrae, and increased body length and increased bone area. In addition, female KYLB mice had increases in bone mineral content and plasma alkaline phosphatase activity. Recombination mapping localized the Kylb locus to a 5.5Mb region on chromosome 15A1, which contained 51 genes, including the natriuretic peptide receptor 3 (Npr3) gene. DNA sequence analysis of Npr3 identified a missense mutation, Tyr209Asn, which introduced an N-linked glycosylation consensus sequence. Expression of wild-type NPR3 and the KYLB-associated Tyr209Asn NPR3 mutant in COS-7 cells demonstrated the mutant to be associated with abnormal N-linked glycosylation and retention in the endoplasmic reticulum that resulted in its absence from the plasma membrane. NPR3 is a decoy receptor for C-type natriuretic peptide (CNP), which also binds to NPR2 and stimulates mitogen-activated protein kinase (MAPK) signaling, thereby increasing the number and size of hypertrophic chondrocytes. Histomorphometric analysis of KYLB vertebrae and tibiae showed delayed endochondral ossification and expansion of the hypertrophic zones of the growth plates, and immunohistochemistry revealed increased p38 MAPK phosphorylation throughout the growth plates of KYLB vertebrae. Thus, we established a model of kyphosis due to a novel NPR3 mutation, in which loss of plasma membrane NPR3 expression results in increased MAPK pathway activation, causing elongation of the vertebrae and resulting in kyphosis.	[Esapa, Christopher T.; Piret, Sian E.; Nesbit, M. Andrew; Loh, Nellie Y.; Thakker, Rajesh V.] Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Esapa, Christopher T.; Brown, Steve D. M.; Cox, Roger D.] MRC Harwell, MRC Mammalian Genet Unit, Harwell, Berks, England; [Esapa, Christopher T.; Brown, Steve D. M.; Cox, Roger D.] MRC Harwell, Mary Lyon Ctr, Harwell, Berks, England; [Thomas, Gethin; Brown, Matthew A.] Queensland Univ Technol, Translat Res Inst, Princess Alexandra Hosp, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Croucher, Peter I.] Garvan Inst Med Res, Sydney, NSW, Australia; [Nesbit, M. Andrew] Univ Ulster, Biomed Sci Res Inst, Coleraine, Londonderry, North Ireland; [Thomas, Gethin] Charles Sturt Univ, Wagga Wagga, NSW, Australia	University of Oxford; MRC Harwell; MRC Harwell; Queensland University of Technology (QUT); Garvan Institute of Medical Research; Ulster University; Charles Sturt University	Thakker, RV (corresponding author), Univ Oxford, Radcliffe Dept Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	rajesh.thakker@ndm.ox.ac.uk	Brown, Matthew A/E-5749-2010	Brown, Matthew A/0000-0003-0538-8211; Cox, Roger/0000-0001-7170-5014; Piret, Sian/0000-0002-3586-7654; Thomas, Gethin/0000-0001-9081-3686; Croucher, Peter/0000-0002-7102-2413	Medical Research Council UK [G0600702, G9825289, G1000467]; European Union [Health-F2-2008-200800]; Medical Research Council [MC_U142661184, MC_U142684172, G0600702] Funding Source: researchfish; MRC [G0600702, MC_U142684172, MC_U142661184] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was funded by the Medical Research Council UK, http://www.mrc.ac.uk (Grant numbers G0600702, G9825289, G1000467) (CTE, SEP, MAN, NYL, SDMB, RDC, RVT) and the European Union Framework 7, https://ec.europa.eu/research/fp7/index_en.cfm (Grant number Health-F2-2008-200800) (CTE, MAN, NYL, RVT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Arozena A, 2008, ANNU REV GENOM HUM G, V9, P49, DOI 10.1146/annurev.genom.9.081307.164224; Agoston H, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-18; ANDERSEN J, 1991, J BONE JOINT SURG BR, V73, P859, DOI 10.1302/0301-620X.73B5.1894681; Axenovich TI, 2001, AM J MED GENET, V100, P275, DOI 10.1002/ajmg.1290; Barbaric I, 2008, PHYSIOL GENOMICS, V32, P311, DOI 10.1152/physiolgenomics.00116.2007; Bartels CF, 2004, AM J HUM GENET, V75, P27, DOI 10.1086/422013; CARR AJ, 1990, J BONE JOINT SURG BR, V72, P144, DOI 10.1302/0301-620X.72B1.2298775; Chusho H, 2001, P NATL ACAD SCI USA, V98, P4016, DOI 10.1073/pnas.071389098; Dauphinee SM, 2013, G3-GENES GENOM GENET, V3, P1753, DOI 10.1534/g3.113.007310; Esapa CT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122650; Esapa CT, 2012, J BONE MINER RES, V27, P413, DOI 10.1002/jbmr.547; Estrada K, 2009, HUM MOL GENET, V18, P3516, DOI 10.1093/hmg/ddp296; Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078; FINDLAY A, 1989, J MED GENET, V26, P400, DOI 10.1136/jmg.26.6.400; Giampietro PF, 2009, ANN NY ACAD SCI, V1151, P38, DOI 10.1111/j.1749-6632.2008.03452.x; Goldsworthy M, 2008, DIABETES, V57, P2234, DOI 10.2337/db07-0337; HAGIWARA H, 1994, J BIOL CHEM, V269, P10729; Hardisty RE, 2003, JARO-J ASSOC RES OTO, V4, P130, DOI 10.1007/s10162-002-3015-9; Hough TA, 2007, J BONE MINER RES, V22, P1397, DOI 10.1359/jbmr.070515; Jaubert J, 1999, P NATL ACAD SCI USA, V96, P10278, DOI 10.1073/pnas.96.18.10278; Kake T, 2009, AM J PHYSIOL-ENDOC M, V297, pE1339, DOI 10.1152/ajpendo.00272.2009; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; Kruger M, 2008, CELL, V134, P353, DOI 10.1016/j.cell.2008.05.033; MAACK T, 1987, SCIENCE, V238, P675, DOI 10.1126/science.2823385; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; MCKENZIE L, 1992, J MED GENET, V29, P41, DOI 10.1136/jmg.29.1.41; Pejchalova K, 2007, MOL GENET METAB, V92, P210, DOI 10.1016/j.ymgme.2007.06.014; Piret SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045217; Potter LR, 2006, ENDOCR REV, V27, P47, DOI 10.1210/er.2005-0014; Scheuermann H., 1920, UGESKRIFT LAEGER, V82, P385; Serin E, 2006, FIRAT TIP DERGISI, V11, P213; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Stanton LA, 2004, BIOCHEM J, V378, P53, DOI 10.1042/BJ20030874; Stricker SJ, 2002, INT PEDIAT, V17, P135; THEVENON A, 1987, SPINE, V12, P744, DOI 10.1097/00007632-198710000-00005; Toye AA, 2004, DIABETES, V53, P1577, DOI 10.2337/diabetes.53.6.1577; Tsuji T, 2005, J BIOL CHEM, V280, P14288, DOI 10.1074/jbc.C500024200; Xin D, 2011, P INT C COMP PROBL S, P1; Yasoda A, 2004, NAT MED, V10, P80, DOI 10.1038/nm971	39	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167916	10.1371/journal.pone.0167916	http://dx.doi.org/10.1371/journal.pone.0167916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959934	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900023
J	Qian, JY; Chopp, M; Liu, ZW				Qian, Jian-Yong; Chopp, Michael; Liu, Zhongwu			Mesenchymal Stromal Cells Promote Axonal Outgrowth Alone and Synergistically with Astrocytes via tPA	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN; MYELIN-ASSOCIATED GLYCOPROTEIN; FACTOR GENE-EXPRESSION; BONE-MARROW; PLASMINOGEN-ACTIVATOR; STEM-CELLS; ISCHEMIC-STROKE; GROWTH-FACTOR; FUNCTIONAL RECOVERY; IN-VITRO	We reported that mesenchymal stromal cells (MSCs) enhance neurological recovery from experimental stroke and increase tissue plasminogen activator (tPA) expression in astrocytes. Here, we investigate mechanisms by which tPA mediates MSC enhanced axonal outgrowth. Primary murine neurons and astrocytes were isolated from wild-type (WT) and tPA-knockout (KO) cortices of embryos. Mouse MSCs (WT) were purchased from Cognate Inc. Neurons (WT or KO) were seeded in soma side of Xona microfluidic chambers, and astrocytes (WT or KO) and/or MSCs in axon side. The chambers were cultured as usual (normoxia) or subjected to oxygen deprivation. Primary neurons (seeded in plates) were cocultured with astrocytes and/or MSCs (in inserts) for Western blot. In chambers, WT axons grew significantly longer than KO axons and exogenous tPA enhanced axonal outgrowth. MSCs increased WT axonal outgrowth alone and synergistically with WT astrocytes at both normoxia and oxygen deprivation conditions. The synergistic effect was inhibited by U0126, an ERK inhibitor, and receptor associated protein (RAP), a low density lipoprotein receptor related protein 1 (LRP1) ligand antagonist. However, MSCs exerted neither individual nor synergistic effects on KO axonal outgrowth. Western blot showed that MSCs promoted astrocytic tPA expression and increased neuronal tPA alone and synergistically with astrocytes. Also, MSCs activated neuronal ERK alone and synergistically with astrocytes, which was inhibited by RAP. We conclude: (1) MSCs promote axonal outgrowth via neuronal tPA and synergistically with astrocytic tPA; (2) neuronal tPA is critical to observe the synergistic effect of MSC and astrocytes on axonal outgrowth; and (3) tPA mediates MSC treatment-induced axonal outgrowth through the LRP1 receptor and ERK.	[Qian, Jian-Yong; Chopp, Michael; Liu, Zhongwu] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI 48063 USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Liu, ZW (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	zwliu@neuro.hfh.edu		Liu, Zhongwu/0000-0002-8571-8112	National Institutes of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health [R01NS066041, R01AG037506]; American Heart Association [15GRNT25560025]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health under award numbers R01NS066041 (ZL) and R01AG037506 (MC), and American Heart Association 15GRNT25560025 (ZL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts MJ, 2013, NEUROLOGY, V80, P514, DOI 10.1212/WNL.0b013e31827b1b7c; Alder J, 2012, DEV NEUROBIOL, V72, P755, DOI 10.1002/dneu.20980; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Barzilay R, 2013, EUR NEUROPSYCHOPHARM, V23, P1115, DOI 10.1016/j.euroneuro.2012.10.002; Bernd P, 2008, GENE EXPRESSION, V14, P241, DOI 10.3727/105221608786883799; Bhasin A, 2011, CEREBROVASC DIS EXTR, V1, P93, DOI 10.1159/000333381; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; BU GJ, 1994, J BIOL CHEM, V269, P18521; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2009, STROKE, V40, pS143, DOI 10.1161/STROKEAHA.108.533141; Cramer SC, 2010, PRESS, px; CRUTCHER KA, 1986, CRIT REV NEUROBIOL, V2, P297; Davies BJ, 1998, J BIOL CHEM, V273, P23004, DOI 10.1074/jbc.273.36.23004; Ding XS, 2013, J CEREBR BLOOD F MET, V33, P1015, DOI 10.1038/jcbfm.2013.50; Eckert MA, 2013, J CEREBR BLOOD F MET, V33, P1322, DOI 10.1038/jcbfm.2013.91; EDGAR D, 1985, J CELL SCI, P107; Fahnestock M, 2004, PROG BRAIN RES, V146, P101, DOI 10.1016/S0079-6123(03)46007-X; Fang MC, 2010, J HOSP MED, V5, P406, DOI 10.1002/jhm.689; Filous A.R., 2016, PROG NEUROBIOL; Fuentealba RA, 2009, J BIOL CHEM, V284, P34045, DOI 10.1074/jbc.M109.021030; Gao Q, 2005, NEUROSCIENCE, V136, P123, DOI 10.1016/j.neuroscience.2005.06.091; Gaultier A, 2008, BLOOD, V111, P5316, DOI 10.1182/blood-2007-12-127613; Goto JJ, 2002, J MOL NEUROSCI, V19, P37, DOI 10.1007/s12031-002-0008-4; Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159; Gutierrez-Fernandez M, 2015, EXPERT OPIN BIOL TH, V15, P873, DOI 10.1517/14712598.2015.1040386; Hermann DM, 2012, LANCET NEUROL, V11, P369, DOI 10.1016/S1474-4422(12)70039-X; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hinman JD, 2014, CURR OPIN NEUROL, V27, P615, DOI 10.1097/WCO.0000000000000149; Honmou O, 2012, TRENDS MOL MED, V18, P292, DOI 10.1016/j.molmed.2012.02.003; Hu SQ, 2015, CNS NEUROSCI THER, V21, P520, DOI 10.1111/cns.12401; Ibrahim F, 2016, J STROKE CEREBROVASC; Kurozumi K, 2005, MOL THER, V11, P96, DOI 10.1016/j.ymthe.2004.09.020; Lee HY, 2007, J NEUROCHEM, V101, P1236, DOI 10.1111/j.1471-4159.2007.04417.x; LEPRINCE P, 1991, J NEUROCHEM, V57, P665, DOI 10.1111/j.1471-4159.1991.tb03798.x; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Li Y, 2014, GLIA, V62, P1, DOI 10.1002/glia.22585; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu ZW, 2010, J CEREBR BLOOD F MET, V30, P1288, DOI 10.1038/jcbfm.2010.8; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Powell EM, 1997, CELL TISSUE RES, V290, P385, DOI 10.1007/s004410050945; Prasad JM, 2015, J BIOL CHEM, V290, P17262, DOI 10.1074/jbc.M115.660084; Qu RJ, 2007, NEUROPATHOLOGY, V27, P355, DOI 10.1111/j.1440-1789.2007.00792.x; SAPPINO AP, 1993, J CLIN INVEST, V92, P679, DOI 10.1172/JCI116637; Shen LH, 2011, STROKE, V42, P459, DOI 10.1161/STROKEAHA.110.593863; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Stiles TL, 2013, J CELL SCI, V126, P209, DOI 10.1242/jcs.113191; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Tabakman R, 2005, ANN NY ACAD SCI, V1053, P84, DOI 10.1196/annals.1344.008; Taylor Anne M., 2011, Critical Reviews in Biomedical Engineering, V39, P185, DOI 10.1615/CritRevBiomedEng.v39.i3.20; Vizard TN, 2015, NEUROSCI LETT, V603, P77, DOI 10.1016/j.neulet.2015.07.019; Wakabayashi K, 2010, J NEUROSCI RES, V88, P1017, DOI 10.1002/jnr.22279; Webb DJ, 2001, J CELL BIOL, V152, P741, DOI 10.1083/jcb.152.4.741; Wind T, 2002, BIOL CHEM, V383, P21, DOI 10.1515/BC.2002.003; WOLF BB, 1992, AM J PATHOL, V141, P37; Wozniak W, 1993, Folia Morphol (Warsz), V52, P173; Xin HQ, 2013, NEUROSCI LETT, V542, P81, DOI 10.1016/j.neulet.2013.02.046; Xin HQ, 2011, J CEREBR BLOOD F MET, V31, P2181, DOI 10.1038/jcbfm.2011.116; Xin HQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009027; Yepes M, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3339/fncel.2015.00304, 10.3389/fncel.2015.00304]; Yi L, 2005, GLIA, V49, P407, DOI 10.1002/glia.20126; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhang Y., 2016, MOL NEUROBIOL; Zhang Y, 2013, J NEUROSCI, V33, P6885, DOI 10.1523/JNEUROSCI.5180-12.2013; Zilberberg A, 2004, J BIOL CHEM, V279, P17535, DOI 10.1074/jbc.M311292200	70	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168345	10.1371/journal.pone.0168345	http://dx.doi.org/10.1371/journal.pone.0168345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959956	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900060
J	Schibille, N; Meek, A; Tobias, B; Entwistle, C; Avisseau-Broustet, M; Da Mota, H; Gratuze, B				Schibille, Nadine; Meek, Andrew; Tobias, Bendeguz; Entwistle, Chris; Avisseau-Broustet, Mathilde; Da Mota, Henrique; Gratuze, Bernard			Comprehensive Chemical Characterisation of Byzantine Glass Weights	PLOS ONE			English	Article							ARCHAEOLOGICAL REFERENCE GLASSES; ROMAN GLASS; LATE-ANTIQUE; ISLAMIC GLASS; SCIENTIFIC ANALYSIS; APOLLONIA-ARSUF; CRYPTA BALBI; RAW GLASS; EASTERN; NATRON	The understanding of the glass trade in the first millennium CE relies on the characterisation of well-dated compositional groups and the identification of their primary production sites. 275 Byzantine glass weights from the British Museum and the Bibliotheque nationale de France dating to the sixth and seventh century were analysed by LA-ICP-MS. Multivariate statistical and graphical data analysis discriminated between six main primary glass types. Primary glass sources were differentiated based on multi-dimensional comparison of silicaderived elements (MgO, Al2O3, CaO, TiO2, Fe2O3, ZrO2) and components associated with the alkali source (Li2O, B2O3). Along with Egyptian and Levantine origins of the glassmaking sands, variations in the natron source possibly point to the exploitation of two different natron deposits. Differences in strontium to calcium ratios revealed variations in the carbonate fractions in the sand. At least two cobalt sources were employed as colouring agents, one of which shows strong correlations with nickel, indicating a specific post-Roman cobalt source. Typological evidence identified chronological developments in the use of the different glass groups. Throughout the sixth century, Byzantine glass weights were predominately produced from two glasses that are probably of an Egyptian origin (Foy-2 and Foy-2 high Fe). Towards the second half of the sixth century a new but related plant-ash glass type emerged (Magby). Levantine I was likewise found among the late sixth-to early seventh-century samples. The use of different dies for the same batch testifies to large-scale, centralised production of the weights, while the same die used for different primary production groups demonstrates the co-existence of alternative sources of supply. Given the comprehensive design of our study, these results can be extrapolated to the wider early Byzantine glass industry and its changes at large.	[Schibille, Nadine; Da Mota, Henrique; Gratuze, Bernard] CNRS, IRAMAT CEB, UMR 5060, Orleans, France; [Meek, Andrew] British Museum, Dept Sci Res, London, England; [Tobias, Bendeguz] Univ Innsbruck, Inst Archaol Fachbereich Ur & Fruhgeschichte Sowi, Innsbruck, Austria; [Entwistle, Chris] British Museum, Dept Britain Europe & Prehist, London, England; [Avisseau-Broustet, Mathilde] Bibliotheque Natl France, Dept Monnaies Medailles & Ant, Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; Universite de Orleans; Universite de Technologie de Belfort-Montbeliard (UTBM); CNRS - Institute for Humanities & Social Sciences (INSHS); Natural History Museum London; University of Innsbruck; Natural History Museum London	Schibille, N (corresponding author), CNRS, IRAMAT CEB, UMR 5060, Orleans, France.	nadine.schibille@cnrs-orleans.fr	Tobias, Bendeguz/W-3183-2019; Gratuze, Bernard/P-4002-2019	Tobias, Bendeguz/0000-0001-6946-4397; Gratuze, Bernard/0000-0001-6136-8085; Meek, Andrew/0000-0001-7380-4278; Schibille, Nadine/0000-0001-9242-0392	European Research Council (ERC) under the European Union's Horizon research and innovation programme [647315]; Austrian Research Fund (FWF) [P 25514-G19]; Austrian Science Fund (FWF) [P 25514] Funding Source: researchfish	European Research Council (ERC) under the European Union's Horizon research and innovation programme(European Research Council (ERC)); Austrian Research Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No. 647315 to NS). Writing of this text was also supported by project P 25514-G19 (to BT) of the Austrian Research Fund (FWF). The funding organisations had no influence in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agady S., 2002, WHAT ATHENS HAS JERU, V1, P423; [Anonymous], 2008, COMPOSITION PRODUCTI; Balog P., 1958, POIDS MONETAIRES VER; Bayley Justine, 2015, GLASS ROMAN WORLD, P1; Bimson Marvis, 1987, ANN 10 C ASS INT HIS, P237; Brandes W., 2002, FINANZVERWALTUNG KRI; Brems D, 2014, ARCHAEOMETRY, V56, P116, DOI 10.1111/arcm.12063; Brill R.H., 1988, EXCAVATIONS JALAME S, P257; Ceglia A, 2015, J ARCHAEOL SCI, V61, P213, DOI 10.1016/j.jas.2015.06.009; Cholakova A, 2016, J ARCHAEOL SCI-REP, V7, P625, DOI 10.1016/j.jasrep.2015.08.009; Conte S, 2014, J ARCHAEOL SCI, V49, P6, DOI 10.1016/j.jas.2014.04.014; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Degryse P, 2006, J ARCHAEOL SCI, V33, P494, DOI 10.1016/j.jas.2005.09.003; Degryse P, 2014, GLASS MAKING GRECO R, DOI DOI 10.26530/OAPEN_513796; Degryse P, 2009, GEOL BELG, V12, P135; Delmaire R., 1989, PUBLICATIONS ECOLE F, V121; Devulder V, 2014, J ARCHAEOL SCI, V46, P107, DOI 10.1016/j.jas.2014.03.009; Drauschke J., 2010, RGZM TAGUNGEN, P25; Entwistle C., 2002, EC HIST BYZANTIUM 7, V2, P611; Entwistle C., 2015, TECHNICAL RES B, V9, P1; Foster HE, 2010, J ARCHAEOL SCI, V37, P3068, DOI 10.1016/j.jas.2010.07.007; Foster HE, 2009, J ARCHAEOL SCI, V36, P189, DOI 10.1016/j.jas.2008.08.008; Foy D., 2003, CHANGES COMMERCE VER, P41; Freestone I., 2003, P ANN 16E C S ASS IN, P153; Freestone I.C., 2000, MOM D, P65; Freestone I. C., 1994, EXCAVATIONS CARTHAGE, V4, P290; Freestone I.C., 2001, P HYAL VITR GLASS P, P167; Freestone IC, 2008, J GLASS STUD, V50, P67; Freestone IC, 2015, J GLASS STUD, V57, P29; Freestone IC, 2015, J ARCHAEOL SCI, V62, P45, DOI 10.1016/j.jas.2015.07.003; Freestone IC, 2003, ARCHAEOMETRY, V45, P19, DOI 10.1111/1475-4754.00094; Freestone IC, 2002, ARCHAEOMETRY, V44, P257, DOI 10.1111/1475-4754.t01-1-00058; Freestone IC, 2009, ANN 17 C ASS INT HIS, V17, P130; Freestone IC., 2015, GLASS ROMAN WORLD, P61; Fulghum M. M., 1998, AJN, V10, P105; Gallo F, 2015, J ARCHAEOL SCI, V62, P55, DOI 10.1016/j.jas.2015.07.004; Gallo F, 2014, J ARCHAEOL SCI, V41, P7, DOI 10.1016/j.jas.2013.07.028; Ganio M, 2012, GLASS TECHNOL-PART A, V53, P217; Gorin-Rosen Y., 2000, MOM D, V33, P49, DOI DOI 10.2307/41017108; GRATUZE B, 1990, ARCHAEOMETRY, V32, P155, DOI 10.1111/j.1475-4754.1990.tb00462.x; Gratuze B., 1996, REV ARCHEOMETRIE, V20, P77, DOI [10.3406/arsci.1996.939, DOI 10.3406/ARSCI.1996.939]; Gratuze B., 1988, THESIS; Gratuze B., 2000, ANNEXE ETUDE CHIMIQU, P291; Gratuze B, 2014, CIRCULATION MATERIAU, P259; Gratuze B., 2007, ANATOLIA ANTIQUA, V15, P247; Gratuze B., 1992, REV ARCHEOMETRIE, V16, P97, DOI DOI 10.3406/ARSCI.1992.895; Gratuze B, 2016, NAT SCI ARCHAEOL, P179, DOI 10.1007/978-3-662-49894-1_12; Grierson P., 1999, BYZANTINE COINAGE; Henderson J, 2004, ARCHAEOMETRY, V46, P439, DOI 10.1111/j.1475-4754.2004.00167.x; Henderson J., 2013, ANCIENT GLASS INTERD; Henderson J., 2000, SCI ARCHAEOLOGY MAT; Hendy M. F, 1985, STUDIES BYZANTINE MO; HOLLOCHER K, 1995, GEOSTANDARD NEWSLETT, V19, P27, DOI 10.1111/j.1751-908X.1995.tb00149.x; Izdebski A, 2016, QUATERNARY SCI REV, V136, P189, DOI 10.1016/j.quascirev.2015.07.022; Jackson, 1997, ANN 13 C ASS INT HIS, V13, P289; Jackson CM, 2016, ARCHAEOMETRY, V58, P68, DOI 10.1111/arcm.12158; Jackson C. M., 2009, ANN 17 C ASS INT HIS, P150; James L, 2006, BYZANTINE MOD GREEK, V30, P29; Jochum KP, 2011, GEOSTAND GEOANAL RES, V35, P397, DOI 10.1111/j.1751-908X.2011.00120.x; Jungfleisch M., 1948, B I EGYPTIEN; Jungfleisch M, 1932, DENERAUX ESTAMPILLES; Kamber BS, 2005, GEOCHIM COSMOCHIM AC, V69, P1041, DOI 10.1016/j.gca.2004.08.020; Khamis Elias, 2007, OBJECTS CONTEXT OBJE, V5, P439; Kondic V., 1984, CARCIN GRAD BASILIQU, P179; Leese MN, 2004, PR06102 BRIT MUS RES; Lilyquist C., 1993, STUDIES EARLY EGYPTI; Maltoni S, 2016, J ARCHAEOL SCI, V73, P1, DOI 10.1016/j.jas.2016.07.002; Matin M, 2015, IRAN, V53, P171, DOI 10.1080/05786967.2015.11834755; Matson FR, 1949, GLASS IND, V30, P548; Matson FR, 1948, EARLY ARABIC GLASS W, V11, P31; Matson FR, 1949, GLASS IND, V30, P487; Matson FR, 1949, GLASS IND, V30, P516; McCormick M, 2012, J INTERDISCIPL HIST, V43, P169, DOI 10.1162/JINH_a_00379; Mirti P, 2000, ARCHAEOMETRY, V42, P359, DOI 10.1111/j.1475-4754.2000.tb00887.x; Mirti P, 2001, ARCHAEOMETRY, V43, P491, DOI 10.1111/1475-4754.00032; MIRTI P, 1993, ARCHAEOMETRY, V35, P225, DOI 10.1111/j.1475-4754.1993.tb01037.x; Morrison Cecile, 2002, EC HIST BYZANTIUM 7, V3, P909; Nenna M.-D., 2007, FACTA, V1, P125; Nenna M.D., 2014, NEIGHBORS SUCCESSORS, P177; Nenna M-D, 2005, ANN 16 C ASS INT HIS, V16, P56; Noujaim-Le Garrec S., 2004, ESTAMPILLES DENERAUX; Nowicki K, 2008, EXCAVATION CRETAN RE; Paynter S, 2008, J GLASS STUD, V50, P271; Phelps M, 2016, J ARCHAEOL SCI, V75, P57, DOI 10.1016/j.jas.2016.08.006; Picon M, 2008, B ASS FRANCAISE ARCH, P36; Rehren T., 2010, INTERDISCIPINARY STU, V22-23, P81; Rosenow D, 2014, J ARCHAEOL SCI, V49, P170, DOI 10.1016/j.jas.2014.04.025; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schibille N, 2017, ARCHAEOL ANTHROP SCI, V9, P1223, DOI 10.1007/s12520-016-0316-1; Schibille N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018970; Schlumberger G., 1895, REG, V8, P59; Shortland A, 2006, J ARCHAEOL SCI, V33, P521, DOI 10.1016/j.jas.2005.09.011; Shortland AJ, 2004, ARCHAEOMETRY, V46, P497, DOI 10.1111/j.1475-4754.2004.00170.x; Silvestri A, 2008, J ARCHAEOL SCI, V35, P1489, DOI 10.1016/j.jas.2007.10.014; Spehar P., 2010, MAT KULTURA IZ RANOV; Tal O, 2004, J GLASS STUD, V46, P51; Tal O, 2008, J GLASS STUD, V50, P81; Telelis I. G., 2008, JB OSTERREICHISCHEN, V58, P167, DOI [10.1553/joeb58-167, DOI 10.1553/JOEB58-167, DOI 10.1553/JOEB58S167]; Tite MS, 2006, J ARCHAEOL SCI, V33, P1284, DOI 10.1016/j.jas.2006.01.004; Tite MS, 2016, ARCHAEOMETRY, V58, P57, DOI 10.1111/arcm.12156; Tobias B., 2016, TOPLUMSAL TARIH, V267, P36; Tobias B., SPATANTIKE IN PRESS; Vicenzi EP, 2002, J RES NATL INST STAN, V107, P719, DOI 10.6028/jres.107.058; Vichy M., 2007, B ASS FRANCAISE ARCH, P55; Wagner B, 2012, ANAL BIOANAL CHEM, V402, P1667, DOI 10.1007/s00216-011-5597-8; Weinberg G. D., 1975, J GLASS STUD, V17, P127; Wolfgang Hahn, 2009, MONEY INCIPIENT BYZA	107	38	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168289	10.1371/journal.pone.0168289	http://dx.doi.org/10.1371/journal.pone.0168289			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	EI8JY	27959963	gold, Green Published, Green Submitted			2022-12-27	WOS:000392753900056
J	Xiao, Q; Zhang, BH; Deng, X; Wu, J; Wang, H; Wang, YG; Wang, WX				Xiao, Qin; Zhang, Baihua; Deng, Xiang; Wu, Jie; Wang, Hui; Wang, Yonggang; Wang, Wenxiang			The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma	PLOS ONE			English	Article							PRETREATMENT NEUTROPHIL; SURVIVAL; CANCER; RECURRENCE; CHEMOKINES; OUTCOMES	Background The pretreatment neutrophil-to-lymphocyte ratio (NLR) is an independent predictor of prognosis in various malignancies, but its predictive capacity in basaloid squamous cell carcinoma of the esophagus (BSCCE) remains unclear. We aim to determine the value of the inflammation-related factors, including the NLR, neutrophil-to-monocyte ratio (NMR), and albumin levels, in predicting BSCCE prognosis. Methods We retrospectively analyzed the records of 121 patients with pathologically diagnosed BSCCE that underwent a curative esophagectomy from January 2007 to December 2014. Univariate and multivariate analyses were used to identify prognostic factors for overall survival (OS) and recurrence-free survival (RFS). Results The preoperative NLR was correlated with the tumor length and NMR. In OS univariate analyses, a high NLR (>1.77), high NMR (>12.31), and low albumin (<= 40.0 g/L) level were significantly associated with a poorer survival in BSCCE. The median OS was significantly greater in low NLR (<= 1.77) than in the high NLR (>1.77) patients (51.0 vs. 31.0 months; P = 0.008). In multivariate analyses, only the NLR was an independent prognostic factor for OS (hazard ratio (HR), 2.030; 95% confidence interval (CI), 1.262-3.264; P = 0.003). A high NLR was also an independent predictor of a poorer RFS in BSCCE (HR, 2.222; 95% CI, 1.407-3.508; P = 0.001); the median RFS for low (<= 1.77) and high (>1.77) NLR patients was 44.0 months and 14.0 months, respectively. NLR remained a strong prognostic indicator for OS in stage I/II patients and a preoperative NLR>1.77 was predictive of a poor RFS in both stage I/II and stage III patients. Conclusions We show that the preoperative NLR, a convenient and cost-effective biomarker, may serve as a prognostic indicator for BSCCE patients following curative surgery.	[Xiao, Qin; Wang, Hui] Cent S Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med,Dept Radiat Oncol,Key Lab Transla, Changsha, Hunan, Peoples R China; [Zhang, Baihua; Deng, Xiang; Wu, Jie; Wang, Wenxiang] Cent S Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med,Dept Thorac Surg 2, Changsha, Hunan, Peoples R China; [Wang, Yonggang] Chinese Acad Med Sci, Canc Hosp & Inst, Dept Thorac Surg, Beijing, Peoples R China; [Wang, Yonggang] Peking Union Med Coll, Beijing, Peoples R China	Central South University; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wang, H (corresponding author), Cent S Univ, Hunan Canc Hosp, Affiliated Canc Hosp, Xiangya Sch Med,Dept Radiat Oncol,Key Lab Transla, Changsha, Hunan, Peoples R China.	wanghui710327@163.com						Baba Y, 2015, ANN SURG ONCOL, V22, P3659, DOI 10.1245/s10434-015-4445-z; Cho KJ, 2000, HISTOPATHOLOGY, V36, P331; Duan H, 2015, WORLD J GASTROENTERO, V21, P5591, DOI 10.3748/wjg.v21.i18.5591; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Feng JF, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-58; Hamilton SR, 2000, WHO CLASSIFICATION T; Huang ZZ, 2001, CHINESE MED J-PEKING, V114, P1084; Imamhasan A, 2012, HUM PATHOL, V43, P2012, DOI 10.1016/j.humpath.2012.02.010; Ji WH, 2016, DIS ESOPHAGUS, V29, P403, DOI 10.1111/dote.12322; Kumagai Y, 2013, INT SURG, V98, P455, DOI 10.9738/CC195; Lam KY, 2001, J PATHOL, V195, P435, DOI 10.1002/path.984; Li TJ, 2004, ARCH PATHOL LAB MED, V128, P1124; Liu JY, 2015, BRIT J CANCER, V113, P747, DOI 10.1038/bjc.2015.290; Liu JY, 2015, ONCOTARGET, V6, P24978, DOI 10.18632/oncotarget.4617; Lv L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018219; Saito T, 2015, INT J CLIN EXP PATHO, V8, P2267; Saito T, 2014, VIRCHOWS ARCH, V464, P135, DOI 10.1007/s00428-014-1538-1; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Sato-Kuwabara Y, 2016, TUMOR BIOL, V37, P6691, DOI 10.1007/s13277-015-4551-3; Sharaiha RZ, 2011, ANN SURG ONCOL, V18, P3362, DOI 10.1245/s10434-011-1754-8; Toyokawa T, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2696-0; TSANG WYW, 1991, HISTOPATHOLOGY, V19, P35, DOI 10.1111/j.1365-2559.1991.tb00892.x; Tsubochi H, 2000, ANTICANCER RES, V20, P1205; WAIN SL, 1986, HUM PATHOL, V17, P1158, DOI 10.1016/S0046-8177(86)80422-1; Wang JB, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-7; Wang SC, 2016, ANN SURG, V263, P292, DOI 10.1097/SLA.0000000000001189; Yang X, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S77099; Yang YG, 2016, SPRINGER THESES-RECO, P1, DOI 10.1007/978-3-662-48676-4_1; Yodying H, 2016, ANN SURG ONCOL, V23, P646, DOI 10.1245/s10434-015-4869-5; Yuan DW, 2014, J SURG ONCOL, V110, P333, DOI 10.1002/jso.23651; Zhang BH, 2013, ASIAN PAC J CANCER P, V14, P1889, DOI 10.7314/APJCP.2013.14.3.1889; Zhao WW, 2016, SCI REP-UK, V6, DOI 10.1038/srep31394	32	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168299	10.1371/journal.pone.0168299	http://dx.doi.org/10.1371/journal.pone.0168299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959959	Green Submitted, gold, Green Published			2022-12-27	WOS:000392753900058
J	Chen, JC; Du, CL; Han, PC				Chen, Jinchao; Du, Chenglie; Han, Pengcheng			Scheduling Independent Partitions in Integrated Modular Avionics Systems	PLOS ONE			English	Article							SCHEDULABILITY ANALYSIS	Recently the integrated modular avionics (IMA) architecture has been widely adopted by the avionics industry due to its strong partition mechanism. Although the IMA architecture can achieve effective cost reduction and reliability enhancement in the development of avionics systems, it results in a complex allocation and scheduling problem. All partitions in an IMA system should be integrated together according to a proper schedule such that their deadlines will be met even under the worst case situations. In order to help provide a proper scheduling table for all partitions in IMA systems, we study the schedulability of independent partitions on a multiprocessor platform in this paper. We firstly present an exact formulation to calculate the maximum scaling factor and determine whether all partitions are schedulable on a limited number of processors. Then with a Game Theory analogy, we design an approximation algorithm to solve the scheduling problem of partitions, by allowing each partition to optimize its own schedule according to the allocations of the others. Finally, simulation experiments are conducted to show the efficiency and reliability of the approach proposed in terms of time consumption and acceptance ratio.	[Chen, Jinchao; Du, Chenglie; Han, Pengcheng] Northwestern Polytech Univ, Dept Comp Sci, Xian 710072, Peoples R China	Northwestern Polytechnical University	Chen, JC (corresponding author), Northwestern Polytech Univ, Dept Comp Sci, Xian 710072, Peoples R China.	keysnow@hotmail.com	Chen, Jinchao/R-7884-2019	Chen, Jinchao/0000-0001-6234-1001				Al Sheikh A, 2011, EUROMICRO, P228, DOI 10.1109/ECRTS.2011.29; Al Sheikh A, 2012, REAL-TIME SYST, V48, P359, DOI 10.1007/s11241-012-9148-y; Arslan Hasan, 2011, WILEY ENCY OPERATION, DOI [10.1002/9780470400531.eorms0524, 10.1002/9780470400531.eorms0273, DOI 10.1002/9780470400531.EORMS0273]; Baruah S. K., 2006, Proceedings. 20th International Parallel and Distributed Processing Symposium (IEEE Cat. No.06TH8860); Chen JC, 2015, PR IEEE I C PROGR IN, P521, DOI 10.1109/PIC.2015.7489902; Chen JC, 2016, REAL-TIME SYST, V52, P239, DOI 10.1007/s11241-015-9226-z; Davis RI, 2011, REAL-TIME SYST, V47, P1, DOI 10.1007/s11241-010-9106-5; Eisenbrand F, 2010, LECT NOTES COMPUT SC, V6346, P11, DOI 10.1007/978-3-642-15775-2_2; Eisenbrand F, 2010, LECT NOTES COMPUT SC, V6198, P299, DOI 10.1007/978-3-642-14165-2_26; Fudenberg D., 1991, GAME THEORY; Guan N, 2011, J SYST ARCHITECT, V57, P536, DOI 10.1016/j.sysarc.2010.08.003; Hosseinabadi AAR, 2015, ANN OPER RES, V229, P1; IBM, 2014, IBM ILOG CPLEX OPT; Javanmardi S, 2014, ADV INTELL SYST, V303, P43, DOI 10.1007/978-3-319-08156-4_5; JEFFAY K, 1991, PROCEEDING : TWELFTH REAL-TIME SYSTEMS SYMPOSIUM, P129, DOI 10.1109/REAL.1991.160366; Jeschke S., 2017, INTERNET IS U SHAPED; Kermia O, 2008, RTCSA 2008: 14TH IEEE INTERNATIONAL CONFERENCE ON EMBEDDED AND REAL-TIME COMPUTING SYSTEMS AND APPLICATIONS - PROCEEDINGS, P25, DOI 10.1109/RTCSA.2008.44; Kim D, 2003, J SYST SOFTWARE, V65, P71, DOI 10.1016/S0164-1212(02)00028-6; Kim JE, 2013, DES AUT TEST EUROPE, P970; KORST J, 1991, LECT NOTES COMPUT SC, V505, P166; Lehoczky J., 1989, Proceedings. Real Time Systems Symposium (Cat. No.89CH2803-5), P166, DOI 10.1109/REAL.1989.63567; Marouf M., 2011, EM TECHN FACT AUT ET, V47, P1; Pira Clement, 2013, Learning and Intelligent Optimization. 7th International Conference, LION 7. Revised Selected Papers: LNCS 7997, P281, DOI 10.1007/978-3-642-44973-4_30; Pira C, 2016, J SCHEDULING, V19, P227, DOI 10.1007/s10951-014-0389-6; Rani S, 2015, SENSORS-BASEL, V15, P28603, DOI 10.3390/s151128603; Ren L, 2017, INTELL DAT CENT SYST, P339, DOI 10.1016/B978-0-12-803801-7.00022-5; Shojafar M, 2015, CLUSTER COMPUT, V18, P829, DOI 10.1007/s10586-014-0420-x; Song H, 2016, INTELLIGENT DATA CEN; Watkins CB, 2007, DIGIT AVION SYST CON, P241; Zhou TR, 2012, CHINESE J AERONAUT, V25, P109, DOI 10.1016/S1000-9361(11)60368-3	30	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168064	10.1371/journal.pone.0168064	http://dx.doi.org/10.1371/journal.pone.0168064			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942013	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600050
J	Al-Samman, AM; Azmi, MH; Rahman, TA; Khan, I; Hindia, MN; Fattouh, A				Al-Samman, A. M.; Azmi, M. H.; Rahman, T. A.; Khan, I.; Hindia, M. N.; Fattouh, A.			Window-Based Channel Impulse Response Prediction for Time-Varying Ultra-Wideband Channels	PLOS ONE			English	Article							MODELS	This work proposes channel impulse response (CIR) prediction for time-varying ultra-wide-band (UWB) channels by exploiting the fast movement of channel taps within delay bins. Considering the sparsity of UWB channels, we introduce a window-based CIR (WB-CIR) to approximate the high temporal resolutions of UWB channels. A recursive least square (RLS) algorithm is adopted to predict the time evolution of the WB-CIR. For predicting the future WB-CIR tap of window w(k), three RLS filter coefficients are computed from the observed WB-CIRs of the left w(k-1), the current wk and the right w(k+1) windows. The filter coefficient with the lowest RLS error is used to predict the future WB-CIR tap. To evaluate our proposed prediction method, UWB CIRs are collected through measurement campaigns in outdoor environments considering line-of-sight (LOS) and non-line-of-sight (NLOS) scenarios. Under similar computational complexity, our proposed method provides an improvement in prediction errors of approximately 80% for LOS and 63% for NLOS scenarios compared with a conventional method.	[Al-Samman, A. M.; Azmi, M. H.; Rahman, T. A.; Hindia, M. N.] Univ Teknol Malaysia, Dept Wireless Commun Ctr, Fac Elect Engn, Johor Baharu 81310, Malaysia; [Khan, I.] Islamic Univ Madinah, Dept Elect Engn, Madinah, Saudi Arabia; [Fattouh, A.] KAU, Fac Comp & Informat Technol, Dept Comp Sci, Jeddah, Saudi Arabia	Universiti Teknologi Malaysia; Islamic University of Al Madinah; King Abdulaziz University	Al-Samman, AM (corresponding author), Univ Teknol Malaysia, Dept Wireless Commun Ctr, Fac Elect Engn, Johor Baharu 81310, Malaysia.	Ahmedsecure99@gmail.com	Khan, Imdad/F-4199-2015; Fattouh, Anas M/H-6697-2012; HINDIA, MHD NOUR/AAE-3805-2020; M. AL-SAMMAN, AHMED/S-5101-2017	Khan, Imdad/0000-0001-7430-9738; Fattouh, Anas M/0000-0001-5488-2799; M. AL-SAMMAN, AHMED/0000-0001-5183-7810	Tabung Pusat Kecemerlangan Pengajian Tinggi (HICOE) [A.J090601.5357.07085]; UTM [Q.J130000.2723.02K15]	Tabung Pusat Kecemerlangan Pengajian Tinggi (HICOE); UTM	The authors would like to acknowledge funding from the Tabung Pusat Kecemerlangan Pengajian Tinggi (HICOE) of grant number A.J090601.5357.07085. Pusat Komunikasi Wayarles (WCC) managed by the research management center, Universiti Teknologi Malaysia. Also, we would like to acknowledge the UTM grant number Q.J130000.2723.02K15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeogun RO, 2014, IEEE ICC, P4632, DOI 10.1109/ICC.2014.6884052; Akhtman J, 2007, IEEE T VEH TECHNOL, V56, P2767, DOI 10.1109/TVT.2007.900395; Al-Samman AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163034; Bello PA, 2007, IEEE T WIREL COMMUN, V6, P4145, DOI 10.1109/TWC.2007.060268; Chitra S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116326; Chong CC, 2005, IEEE T ANTENN PROPAG, V53, P2389, DOI 10.1109/TAP.2005.852505; Cramer JM, 2002, IEEE T ANTENN PROPAG, V50, P561, DOI 10.1109/TAP.2002.1011221; Duel-Hallen A, 2007, P IEEE, V95, P2299, DOI 10.1109/JPROC.2007.904443; Eyceoz T, 1998, IEEE COMMUN LETT, V2, P254, DOI 10.1109/4234.718494; HASHEMI H, 1994, IEEE T VEH TECHNOL, V43, P110, DOI 10.1109/25.282271; Hindia MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121901; Kalil M, 2015, IEEE T VEH TECHNOL, V64, P4551, DOI 10.1109/TVT.2014.2376038; Lee HC, 2013, IEEE T BROADCAST, V59, P648, DOI 10.1109/TBC.2013.2283097; Li HB, 2000, PROCEEDINGS OF THE TENTH IEEE WORKSHOP ON STATISTICAL SIGNAL AND ARRAY PROCESSING, P229, DOI 10.1109/SSAP.2000.870117; Mo YF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142775; Molisch A.F., 2011, WIRELESS COMMUNICATI, DOI [10.1002/9781119992806, DOI 10.1002/9781119992806.FMATTER, 10.1002/9781119992806.fmatter]; Molisch AF, 2014, IEICE T COMMUN, VE97B, P2022, DOI 10.1587/transcom.E97.B.2022; Morales CM, 2014, IEEE LAT AMER SYMP; Pham VH, 2011, IEEE COMMUN LETT, V15, P713, DOI 10.1109/LCOMM.2011.051011.101684; Rappaport TS, 2015, IEEE T COMMUN, V63, P3029, DOI 10.1109/TCOMM.2015.2434384; Santos T, 2010, IEEE T WIREL COMMUN, V9, P1987, DOI 10.1109/TWC.2010.06.090392; Sarkar TK, 2003, IEEE ANTENN PROPAG M, V45, P51, DOI 10.1109/MAP.2003.1232163; Schafhuber D, 2005, IEEE T WIREL COMMUN, V4, P593, DOI 10.1109/TWC.2004.843055; TIME DOMAIN, 2012, CHANN AN TOOL CAT US, P1; Tsao J, 2007, IEEE J-STSP, V1, P340, DOI 10.1109/JSTSP.2007.906662; Uthirajoo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101862; Wang Z, 2015, IEEE J SEL AREA COMM, V33, P382, DOI 10.1109/JSAC.2015.2391571	27	17	18	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0164944	10.1371/journal.pone.0164944	http://dx.doi.org/10.1371/journal.pone.0164944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992445	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600002
J	Chang, JC; Federle, MJ				Chang, Jennifer C.; Federle, Michael J.			PptAB Exports Rgg Quorum-Sensing Peptides in Streptococcus	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ABC TRANSPORTER; COMPETENCE; PYOGENES; PHEROMONE; IDENTIFICATION; TRANSFORMATION; EXPRESSION; PROTEINS; PATHWAY	A transposon mutagenesis screen designed to identify mutants that were defective in peptide- pheromone signaling of the Rgg2/Rgg3 pathway in Streptococcus pyogenes generated insertions in sixteen loci displaying diminished reporter activity. Fourteen unique transposon insertions were mapped to pptAB, an ABC-type transporter recently described to export sex pheromones of Enterococcus faecalis. Consistent with an idea that PptAB exports signaling peptides, the pheromones known as SHPs (short hydrophobic peptides) were no longer detected in cell-free culture supernatants in a generated deletion mutant of pptAB. PptAB exporters are conserved among the Firmicutes, but their function and substrates remain unclear. Therefore, we tested a pptAB mutant generated in Streptococcus mutans and found that while secretion of heterologously expressed SHP peptides required PptAB, secretion of the S. mutans endogenous pheromone XIP (sigX inducing peptide) was only partially disrupted, indicating that a secondary secretion pathway for XIP exists.	[Chang, Jennifer C.; Federle, Michael J.] Univ Illinois, Coll Pharm, Ctr Biomol Sci, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Federle, MJ (corresponding author), Univ Illinois, Coll Pharm, Ctr Biomol Sci, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA.	mfederle@uic.edu	Federle, Michael J./E-5522-2017	Chang, Jennifer/0000-0002-6175-1284	NIH NIAID [AI091779]; Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Dieseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091779] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Dieseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants from the NIH NIAID #AI091779 and the Burroughs Wellcome Fund Investigators in the Pathogenesis of Infectious Dieseases.	Aggarwal C, 2014, J BIOL CHEM, V289, P22427, DOI 10.1074/jbc.M114.583989; Chang JC, 2015, MOL MICROBIOL, V97, P1097, DOI 10.1111/mmi.13088; Chang JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002190; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; Cook LC, 2013, MBIO, V4, DOI 10.1128/mBio.00382-13; Degnan BA, 2000, INFECT IMMUN, V68, P2441, DOI 10.1128/IAI.68.5.2441-2448.2000; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Desai K, 2012, J BACTERIOL, V194, P3774, DOI 10.1128/JB.00337-12; Fontaine L, 2015, INFECT GENET EVOL, V33, P343, DOI 10.1016/j.meegid.2014.09.010; Gardan R, 2013, J BACTERIOL, V195, P1845, DOI 10.1128/JB.02196-12; Guo Q, 2014, J BACTERIOL, V196, P227, DOI 10.1128/JB.00995-13; Hale JDF, 2005, J BACTERIOL, V187, P5036, DOI 10.1128/JB.187.14.5036-5039.2005; Hidalgo-Grass C, 2002, MOL MICROBIOL, V46, P87, DOI 10.1046/j.1365-2958.2002.03127.x; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; Howell-Adams B, 2000, MOL MICROBIOL, V37, P1146, DOI 10.1046/j.1365-2958.2000.02067.x; Jonsson IM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014209; Khan R, 2012, J BACTERIOL, V194, P3781, DOI 10.1128/JB.00624-12; KONTINEN VP, 1988, J GEN MICROBIOL, V134, P2333; LaSarre B, 2013, J BACTERIOL, V195, P4310, DOI 10.1128/JB.00684-13; Leskela S, 1996, MICROBIOL-SGM, V142, P71, DOI 10.1099/13500872-142-1-71; Leskela S, 1999, MOL MICROBIOL, V31, P533, DOI 10.1046/j.1365-2958.1999.01194.x; Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263; Marks LR, 2014, J INFECT DIS, V210, P25, DOI 10.1093/infdis/jiu058; Mashburn-Warren L, 2012, J BACTERIOL, V194, P4589, DOI 10.1128/JB.00830-12; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; McIver KS, 2013, CURR PROTOC MICROBIO, V30; Perez-Pascual D, 2015, MBIO, V6, DOI 10.1128/mBio.02306-14; Shanker E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005979; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; Varahan S, 2014, MBIO, V5, DOI 10.1128/mBio.01726-14; Wenderska IB, 2012, FEMS MICROBIOL LETT, V336, P104, DOI 10.1111/j.1574-6968.2012.02660.x; Wilkening RV, 2016, MOL MICROBIOL, V99, P71, DOI 10.1111/mmi.13216	32	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168461	10.1371/journal.pone.0168461	http://dx.doi.org/10.1371/journal.pone.0168461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992504	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842600061
J	Ontweka, LN; Deng, LO; Rauzier, J; Debes, AK; Tadesse, F; Parker, LA; Wamala, JF; Bior, BK; Lasuba, M; But, AB; Grandesso, F; Jamet, C; Cohuet, S; Ciglenecki, I; Serafini, M; Sack, DA; Quilici, ML; Azman, AS; Luquero, FJ; Page, AL				Ontweka, Lameck N.; Deng, Lul O.; Rauzier, Jean; Debes, Amanda K.; Tadesse, Fisseha; Parker, Lucy A.; Wamala, Joseph F.; Bior, Bior K.; Lasuba, Michael; But, Abiem Bona; Grandesso, Francesco; Jamet, Christine; Cohuet, Sandra; Ciglenecki, Iza; Serafini, Micaela; Sack, David A.; Quilici, Marie-Laure; Azman, Andrew S.; Luquero, Francisco J.; Page, Anne-Laure			Cholera Rapid Test with Enrichment Step Has Diagnostic Performance Equivalent to Culture	PLOS ONE			English	Article							VIBRIO-CHOLERAE; DIPSTICK TEST; O1	Cholera rapid diagnostic tests (RDT) could play a central role in outbreak detection and surveillance in low -resource settings, but their modest performance has hindered their broad adoption. The addition of an enrichment step may improve test specificity. We describe the results of a prospective diagnostic evaluation of the Crystal VC RDT (Span Diagnostics, India) with enrichment step and of culture, each compared to polymerase chain reaction (PCR), during a cholera outbreak in South Sudan. RDTs were performed on alkaline peptone water inoculated with stool and incubated for 4-6 hours at ambient temperature. Cholera culture was performed from wet filter paper inoculated with stool. Molecular detection of Vibrio cholerae 01 by PCR was done from dry Whatman 903 filter papers inoculated with stool, and from wet filter paper supernatant. In August and September 2015, 101 consecutive suspected cholera cases were enrolled, of which 36 were confirmed by PCR. The enriched RDT had 86.1% (95% CI: 70.5-95.3) sensitivity and 100% (95% CI: 94.4-100) specificity compared to PCR as the reference standard. The sensitivity of culture versus PCR was 83.3% (95% CI: 67.2-93.6) for culture performed on site and 72.2% (95% CI: 54.8-85.8) at the international reference laboratory, where samples were tested after an average delay of two months after sample collection, and specificity was 98.5% (95% CI: 91.7-100) and 100% (95% CI: 94.5-100), respectively. The RDT with enrichment showed performance comparable to that of culture and could be a sustainable alternative to culture confirmation where laboratory capacity is limited.	[Ontweka, Lameck N.; Parker, Lucy A.; Jamet, Christine; Ciglenecki, Iza; Serafini, Micaela; Azman, Andrew S.] Medecins Sans Frontieres Operat Ctr Geneva, Geneva, Switzerland; [Ontweka, Lameck N.] Amref Hlth Africa Headquarters, Nairobi, Kenya; [Deng, Lul O.; Bior, Bior K.; Lasuba, Michael; But, Abiem Bona] Natl Publ Hlth Lab, Minist Hlth, Juba, South Sudan; [Rauzier, Jean; Quilici, Marie-Laure] Natl Reference Ctr Vibrios & Cholera, Inst Pasteur, Enter Bacterial Pathogens Unit, Paris, France; [Debes, Amanda K.; Sack, David A.; Luquero, Francisco J.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD USA; [Tadesse, Fisseha; Grandesso, Francesco; Cohuet, Sandra; Luquero, Francisco J.; Page, Anne-Laure] Epictr, Field Epidemiol, Paris, France; [Wamala, Joseph F.] World Hlth Org, Juba, South Sudan; [Azman, Andrew S.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA	African Medical & Research Foundation (AMREF); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Johns Hopkins University; World Health Organization; Johns Hopkins University	Page, AL (corresponding author), Epictr, Field Epidemiol, Paris, France.	anne-laure.page@epicentre.msf.org	Tadesse, Fisseha Shiferie/AAK-7579-2021; Parker, Lucy Anne/R-3622-2017	Tadesse, Fisseha Shiferie/0000-0003-1492-002X; Azman, Andrew/0000-0001-8662-9077; Parker, Lucy Anne/0000-0002-2362-4057	Medecins Sans Frontieres Operational Center Geneva	Medecins Sans Frontieres Operational Center Geneva	This study was funded by Medecins Sans Frontieres Operational Center Geneva. The funders had staff (co-authors of this manuscript) who played a role in study design, data collection and analysis, and preparation of the manuscript. The corresponding author had full access to all data and had final responsibility for the decision to submit for publication.	Alam M, 2010, J CLIN MICROBIOL, V48, P3918, DOI 10.1128/JCM.00616-10; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P517; Azman AS, LANCET GLOB HLTH, V4, pe856; Bhuiyan NA, 2003, J CLIN MICROBIOL, V41, P3939, DOI 10.1128/JCM.41.8.3939-3941.2003; Boncy J, 2013, DIAGN MICR INFEC DIS, V76, P521, DOI 10.1016/j.diagmicrobio.2013.03.010; Chun J, 1999, APPL ENVIRON MICROB, V65, P2202; Debes AK, 2016, AM J TROP MED HYG, V94, P537, DOI 10.4269/ajtmh.15-0496; Dick MH, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001845; Dodin A, DIAGNOSIS CHOLERA VI, P59; George CM, 2014, TROP MED INT HEALTH, V19, P301, DOI 10.1111/tmi.12252; Hasan N.A, 2011, BANGLADESH J MICROBI, V27, P46, DOI 10.3329/bjm.v27i2.9171; Hoshino K, 1988, FEMS IMMUNOL MED MIC, V20, P207; Kalluri P, 2006, TROP MED INT HEALTH, V11, P49, DOI 10.1111/j.1365-3156.2005.01539.x; Ley B, 2012, PLOS ONE, V7, P3; Martinez-Pino I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002366; Mukherjee P, 2010, JPN J INFECT DIS, V63, P234; Nandi B, 2000, J CLIN MICROBIOL, V38, P4145, DOI 10.1128/JCM.38.11.4145-4151.2000; Page AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037360; Sinha A, 2012, INDIAN J MED RES, V135, P523; Wang XY, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-17	21	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168257	10.1371/journal.pone.0168257	http://dx.doi.org/10.1371/journal.pone.0168257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992488	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600045
J	Szekely, A; Kotyuk, E; Bircher, J; Vereczkei, A; Balota, DA; Sasvari-Szekely, M; Ronai, Z				Szekely, Anna; Kotyuk, Eszter; Bircher, Julianna; Vereczkei, Andrea; Balota, David A.; Sasvari-Szekely, Maria; Ronai, Zsolt			Association between Age and the 7 Repeat Allele of the Dopamine D4 Receptor Gene	PLoS One			English	Article							DEFICIT HYPERACTIVITY DISORDER; GENOME-WIDE ASSOCIATION; HUMAN PERSONALITY; 4TH COMPONENT; DRD4 GENE; LONGEVITY; POPULATION; COMPLEMENT; ADHD; POLYMORPHISMS	Longevity is in part (25%) inherited, and genetic studies aim to uncover allelic variants that play an important role in prolonging life span. Results to date confirm only a few gene variants associated with longevity, while others show inconsistent results. However, GWAS studies concentrate on single nucleotide polymorphisms, and there are only a handful of studies investigating variable number of tandem repeat variations related to longevity. Recently, Grady and colleagues (2013) reported a remarkable (66%) accumulation of those carrying the 7 repeat allele of the dopamine D4 receptor gene in a large population of 90109 years old Californian centenarians, as compared to an ancestry-matched young population. In the present study we demonstrate the same association using continuous age groups in an 18-97 years old Caucasian sample (N = 1801, p = 0.007). We found a continuous pattern of increase from 18-75, however frequency of allele 7 carriers decreased in our oldest age groups. Possible role of gene-environment interaction effects driven by historical events are discussed. In accordance with previous findings, we observed association preferentially in females (p = 0.003). Our results underlie the importance of investigating non disease related genetic variants as inherited components of longevity, and confirm, that the 7-repeat allele of the dopamine D4 receptor gene is a longevity enabling genetic factor, accumulating in the elderly female population.	[Szekely, Anna; Kotyuk, Eszter; Bircher, Julianna] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Kotyuk, Eszter] Hungarian Acad Sci, Postdoctoral Res Program, Budapest, Hungary; [Bircher, Julianna] Eotvos Lorand Univ, Doctoral Sch Psychol, Budapest, Hungary; [Vereczkei, Andrea; Sasvari-Szekely, Maria; Ronai, Zsolt] Semmelweis Univ, Dept Med Chem Mol Biol & Pathobiochem, Budapest, Hungary; [Balota, David A.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA	Eotvos Lorand University; Hungarian Academy of Sciences; Eotvos Lorand University; Semmelweis University; Washington University (WUSTL)	Kotyuk, E (corresponding author), Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary.; Kotyuk, E (corresponding author), Hungarian Acad Sci, Postdoctoral Res Program, Budapest, Hungary.	kotyuk.eszter@ppk.elte.hu	Kotyuk, Eszter/K-3116-2018; Bircher, Julianna/Q-5759-2019	Kotyuk, Eszter/0000-0002-6630-087X; 	Hungarian Scientific Research Fund (OTKA) [K100845]; Molecule Foundation; Hungarian Academy of Sciences	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Molecule Foundation; Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Hungarian Scientific Research Fund (OTKA K100845) and we thank support of the Molecule Foundation and the postdoctoral scholarship awarded to Eszter Kotyuk by the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; [Anonymous], 1991, REGIO KISEBBSEGTUDOM, V2; Arason GJ, 2003, ANN NY ACAD SCI, V1010, P496, DOI 10.1196/annals.1299.091; Beekman M, 2010, P NATL ACAD SCI USA, V107, P18046, DOI 10.1073/pnas.1003540107; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Boor K, 2002, CURR MED CHEM, V9, P793, DOI 10.2174/0929867024606821; Brooks-Wilson AR, 2013, HUM GENET, V132, P1323, DOI 10.1007/s00439-013-1342-z; Chang FM, 1996, HUM GENET, V98, P91, DOI 10.1007/s004390050166; Chen CS, 1999, EVOL HUM BEHAV, V20, P309, DOI 10.1016/S1090-5138(99)00015-X; Ding YC, 2002, P NATL ACAD SCI USA, V99, P309, DOI 10.1073/pnas.012464099; Eaton NR, 2012, J GERONTOL A-BIOL, V67, P480, DOI 10.1093/gerona/gls090; Ebstein RP, 1996, NAT GENET, V12, P78, DOI 10.1038/ng0196-78; Ebstein RP, 2006, MOL PSYCHIATR, V11, P427, DOI 10.1038/sj.mp.4001814; Everitt B.S., 1992, ANAL CONTINGENCY TAB; Ewbank DC, 2004, J GERONTOL A-BIOL, V59, P16; Frank MJ, 2011, NEUROPSYCHOPHARMACOL, V36, P133, DOI 10.1038/npp.2010.96; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; Gierman HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112430; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Grady DL, 2013, J NEUROSCI, V33, P286, DOI 10.1523/JNEUROSCI.3515-12.2013; Grady DL, 2003, MOL PSYCHIATR, V8, P536, DOI 10.1038/sj.mp.4001350; Hablicsek L., 2007, STATISZTIKAI SZEMLE, V85, P172; Hardy GH, 1908, SCIENCE, V28, P49, DOI 10.1126/science.28.706.49; Kawas Claudia H., 2006, Current Alzheimer Research, V3, P411, DOI 10.2174/156720506779025233; Kotler M, 1997, MOL PSYCHIATR, V2, P251, DOI 10.1038/sj.mp.4000248; Kotyuk E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080613; KRAMER J, 1991, HUM GENET, V86, P595; Li DW, 2006, HUM MOL GENET, V15, P2276, DOI 10.1093/hmg/ddl152; McGeary J, 2009, PHARMACOL BIOCHEM BE, V93, P222, DOI 10.1016/j.pbb.2009.03.010; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Munafo MR, 2008, BIOL PSYCHIAT, V63, P197, DOI 10.1016/j.biopsych.2007.04.006; Murabito JM, 2012, J GERONTOL A-BIOL, V67, P470, DOI 10.1093/gerona/gls089; Nemoda Z, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-4; Paterson AD, 1999, NEUROPSYCHOPHARMACOL, V21, P3, DOI 10.1016/S0893-133X(98)00115-8; Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483; Perls T, 2003, EXP GERONTOL, V38, P725, DOI 10.1016/S0531-5565(03)00098-6; Ronai Z, 2000, ELECTROPHORESIS, V21, P2058, DOI 10.1002/1522-2683(20000601)21:10<2058::AID-ELPS2058>3.0.CO;2-1; Sebastiani P., 2010, SCIENCE, V2010; Sebastiani Paola, 2012, Frontiers in Genetics, V3, P277, DOI 10.3389/fgene.2012.00277; Seeman TE, 2004, SOC SCI MED, V58, P1985, DOI 10.1016/S0277-9536(03)00402-7; Swanson JM, 1998, MOL PSYCHIATR, V3, P38, DOI 10.1038/sj.mp.4000354; Szekely A, 2004, AM J MED GENET B, V126B, P106, DOI 10.1002/ajmg.b.20134; Szekely A, 2011, GENES BRAIN BEHAV, V10, P129, DOI 10.1111/j.1601-183X.2010.00645.x; Szilagyi A, 2008, CYTOGENET GENOME RES, V123, P118, DOI 10.1159/000184699; VANTOL HHM, 1992, NATURE, V358, P149; Varga G, 2012, AM J MED GENET B, V159B, P281, DOI 10.1002/ajmg.b.32025; Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124	48	4	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167753	10.1371/journal.pone.0167753	http://dx.doi.org/10.1371/journal.pone.0167753			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992450	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600022
J	Heslop, R; Bojang, AL; Jarju, S; Mendy, J; Mulwa, S; Secka, O; Mendy, FS; Owolabi, O; Kampmann, B; Sutherland, JS				Heslop, Rhiannon; Bojang, Adama L.; Jarju, Sheikh; Mendy, Joseph; Mulwa, Sarah; Secka, Ousman; Mendy, Francis S.; Owolabi, Olumuyiwa; Kampmann, Beate; Sutherland, Jayne S.			Changes in Host Cytokine Patterns of TB Patients with Different Bacterial Loads Detected Using S-16 rRNA Analysis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; SPUTUM; BIOMARKERS; RESPONSES; DISEASE	Background Tuberculosis (TB) has overtaken HIV as the biggest infectious disease killer, with the majority of deaths occurring in sub-Saharan Africa. However it is unknown how differences in bacterial load alter host immune profiles in the sputum and blood of TB patients. Methods S-16 ribosomal RNA analysis was used to determine bacterial load in sputum samples obtained from 173 patients with active TB (57 pre-treatment and 116 post-treatment). Host analyte concentrations in sputum and Mycobacterium tuberculosis (Mtb) antigen stimulated whole blood assay supernatants were analysed using multiplex cytokine arrays. Results Multiple logistic regression adjusting for age, sex and HIV status showed highly significant correlation of bacterial load with IL1 beta, IL2, IL1RA, IL4, IL6, IL8, IL9, IL15, IL17, EOTAX, FGF, IFN-gamma, GCSF, MCP1, M1P1 alpha, M1P1 beta, PDGF, TNF alpha, VEGF in sputum. With increasing time on treatment, FGF levels in sputum displayed the most significant inverse correlation with reduction in bacterial load. Conclusions We show that differences in bacterial load correlates with changes in several host biomarkers. These findings have implications for development of tests for TB diagnosis and treatment response.	[Heslop, Rhiannon; Bojang, Adama L.; Jarju, Sheikh; Mendy, Joseph; Mulwa, Sarah; Secka, Ousman; Mendy, Francis S.; Owolabi, Olumuyiwa; Kampmann, Beate; Sutherland, Jayne S.] Med Res Council MRC Unit, Vaccines & Immun Theme, Banjul, Gambia; [Heslop, Rhiannon] Univ Manchester, Manchester, Lancs, England	University of London; London School of Hygiene & Tropical Medicine; University of Manchester	Sutherland, JS (corresponding author), Med Res Council MRC Unit, Vaccines & Immun Theme, Banjul, Gambia.	jsutherland@mrc.gm		Heslop, Rhiannon/0000-0002-4332-4393; Sutherland, Jayne/0000-0002-7083-4997	United Kingdom (UK) Medical Research Council (MRC); UK Department for International Development (DFID) under MRC/DFID; MRC [MC_U190071468, MC_UP_A900_1122] Funding Source: UKRI; Medical Research Council [MC_UP_A900_1122, MC_U190071468] Funding Source: researchfish; National Institute for Health Research [SRF-2009-02-07] Funding Source: researchfish	United Kingdom (UK) Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID) under MRC/DFID; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was jointly supported by the United Kingdom (UK) Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; El-Sony A, 2002, INT J TUBERC LUNG D, V6, P91; Honeyborne I, 2014, J CLIN MICROBIOL, V52, P3064, DOI 10.1128/JCM.01128-14; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lohmann EM, 2012, INT J TUBERC LUNG D, V16, P1477, DOI 10.5588/ijtld.12.0129; Mihret A, 2013, J INFECTION, V66, P357, DOI 10.1016/j.jinf.2012.11.005; Ota MOC, 2014, EUR RESPIR J, V44, P254, DOI 10.1183/09031936.00209913; Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07; Sundaramurthy V, 2007, MICROBES INFECT, V9, P1671, DOI 10.1016/j.micinf.2007.09.007; Sutherland JS, HIGHLY ACCURATE DIAG; Theron G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037436; Tsao TCY, 2000, CHEST, V117, P103, DOI 10.1378/chest.117.1.103; Wallis RS, 2013, LANCET INFECT DIS, V13, P362, DOI 10.1016/S1473-3099(13)70034-3; Young JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011237	14	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168272	10.1371/journal.pone.0168272	http://dx.doi.org/10.1371/journal.pone.0168272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992487	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000392758000035
J	Siritongsuk, P; Hongsing, N; Thammawithan, S; Daduang, S; Klaynongsruang, S; Tuanyok, A; Patramanon, R				Siritongsuk, Pawinee; Hongsing, Nuttaya; Thammawithan, Saengrawee; Daduang, Sakda; Klaynongsruang, Sompong; Tuanyok, Apichai; Patramanon, Rina			Two-Phase Bactericidal Mechanism of Silver Nanoparticles against Burkholderia pseudomallei	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; BIOFILM FORMATION; WOUND DRESSINGS; MELIOIDOSIS; SUSCEPTIBILITY; RESISTANCE; RELEASE; NANOMATERIALS; VIABILITY	Silver nanoparticles (AgNPs) have a strong antimicrobial activity against a variety of pathogenic bacteria. The killing mechanism of AgNPs involves direct physical membrane destruction and subsequent molecular damage from both AgNPs and released Ag+. Burkholderia pseudomallei is the causative agent of melioidosis, an endemic infectious disease primarily found in northern Australia and Southeast Asia. B. pseudomallei is intrinsically resistant to most common antibiotics. In this study, the antimicrobial activity and mechanism of AgNPs (10-20 nm) against B. pseudomallei were investigated. The MIC and MBC for nine B. pseudomallei strains ranged from 32-48 mu g/mL and 96-128 mu g/mL, respectively. Concentrations of AgNPs less than 256 mu g/mL were not toxic to human red blood cells. AgNPs exhibited a two-phase mechanism: cell death induction and ROS induction. The first phase was a rapid killing step within 5 min, causing the direct damage of the cytoplasmic membrane of the bacterial cells, as observed by a time-kill assay and fluorescence microscopy. During the period of 5-30 min, the cell surface charge was rapidly neutralized from -8.73 and -7.74 to 2.85 and 2.94 mV in two isolates of B. pseudomallei, as revealed by zeta potential measurement. Energy-dispersive X-ray (EDX) spectroscopy showed the silver element deposited on the bacterial membrane, and TEM micrographs of the AgNP-treated B. pseudomallei cells showed severe membrane damage and cytosolic leakage at 1/5 MIC and cell bursting at MBC. During the killing effect the released Ag+ from AgNPs was only 3.9% from the starting AgNPs concentration as observed with ICP-OES experiment. In the second phase, the ROS induction occurred 1-4 hr after the AgNP treatment. Altogether, we provide direct kinetic evidence of the AgNPs killing mechanism, by which cell death is separable from the ROS induction and AgNPs mainly contributes in the killing action. AgNPs may be considered a potential candidate to develop a novel alternative agent for melioidosis treatment with fast action.	[Siritongsuk, Pawinee; Hongsing, Nuttaya; Thammawithan, Saengrawee; Klaynongsruang, Sompong; Patramanon, Rina] Khon Kaen Univ, Dept Biochem, Fac Sci, Khon Kaen, Thailand; [Siritongsuk, Pawinee; Hongsing, Nuttaya; Daduang, Sakda; Klaynongsruang, Sompong; Patramanon, Rina] Khon Kaen Univ, Prot & Prote Res Ctr Commercial & Ind Purposes, Khon Kaen, Thailand; [Daduang, Sakda] Khon Kaen Univ, Fac Pharmaceut Sci, Khon Kaen, Thailand; [Tuanyok, Apichai] Univ Florida, Coll Vet Med, Gainesville, FL USA; [Tuanyok, Apichai] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Khon Kaen University; Khon Kaen University; Khon Kaen University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Patramanon, R (corresponding author), Khon Kaen Univ, Dept Biochem, Fac Sci, Khon Kaen, Thailand.; Patramanon, R (corresponding author), Khon Kaen Univ, Prot & Prote Res Ctr Commercial & Ind Purposes, Khon Kaen, Thailand.	narin@kku.ac.th	Daduang, Sakda/L-5446-2019	Klaynongsruang, Sompong/0000-0003-2872-1291	Protein and Proteomics Research Center for Commercial and Industrial Purposes, Khon Kaen University; Research and Researchers for Industries (RRi) Grant, Thailand Research Fund	Protein and Proteomics Research Center for Commercial and Industrial Purposes, Khon Kaen University; Research and Researchers for Industries (RRi) Grant, Thailand Research Fund	This work was supported by scholarship from the Protein and Proteomics Research Center for Commercial and Industrial Purposes, Khon Kaen University and Research and Researchers for Industries (RRi) Grant, Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955; Anjum S, 2016, INT J NANOMED, V11, P1663, DOI 10.2147/IJN.S105532; Anutrakunchai C, 2015, TROP BIOMED, V32, P300; Cao HL, 2010, WIRES NANOMED NANOBI, V2, P670, DOI 10.1002/wnan.113; Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006; Cho KH, 2005, ELECTROCHIM ACTA, V51, P956, DOI 10.1016/j.electacta.2005.04.071; Crowe A, 2014, INT J ANTIMICROB AG, V44, P160, DOI 10.1016/j.ijantimicag.2014.04.012; Currie BJ, 2000, CLIN INFECT DIS, V31, P981, DOI 10.1086/318116; DeShazer D, 2004, J BACTERIOL, V186, P3938, DOI 10.1128/JB.186.12.3938-3950.2004; Dobias J, 2013, ENVIRON SCI TECHNOL, V47, P4140, DOI 10.1021/es304023p; Durairaj R, 2012, WORLD ACAD SCI ENG T, P210, DOI [10.12659/MSMBR.883835, DOI 10.12659/MSMBR.883835]; Dwyer DJ, 2012, MOL CELL, V46, P561, DOI 10.1016/j.molcel.2012.04.027; Fischer D, 2003, BIOMATERIALS, V24, P1121, DOI 10.1016/S0142-9612(02)00445-3; Gottschalk F, 2010, ENVIRON TOXICOL CHEM, V29, P1036, DOI 10.1002/etc.135; Grigor'eva A, 2013, BIOMETALS, V26, P479, DOI 10.1007/s10534-013-9633-3; Gupta A, 1998, NAT BIOTECHNOL, V16, P888, DOI 10.1038/nbt1098-888; Guzman M, 2012, NANOMED-NANOTECHNOL, V8, P37, DOI 10.1016/j.nano.2011.05.007; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Isshiki Y, 1998, CARBOHYD RES, V313, P21, DOI 10.1016/S0008-6215(98)00179-7; Kager LM, 2014, EXPERT REV ANTI-INFE, V12, P993, DOI 10.1586/14787210.2014.928198; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kanthawong S, 2012, INT J ANTIMICROB AG, V39, P39, DOI 10.1016/j.ijantimicag.2011.09.010; Kanthawong S, 2009, INT J ANTIMICROB AG, V34, P309, DOI 10.1016/j.ijantimicag.2009.05.012; Karlsson HL, 2013, TOXICOLOGY, V313, P59, DOI 10.1016/j.tox.2013.07.012; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kostenko V, 2010, ANTIMICROB AGENTS CH, V54, P5120, DOI 10.1128/AAC.00825-10; Lara HH, 2010, WORLD J MICROB BIOT, V26, P615, DOI 10.1007/s11274-009-0211-3; LEELARASAMEE A, 1989, REV INFECT DIS, V11, P413; Li QL, 2008, WATER RES, V42, P4591, DOI 10.1016/j.watres.2008.08.015; Li WR, 2010, APPL MICROBIOL BIOT, V85, P1115, DOI 10.1007/s00253-009-2159-5; Li XZ, 1997, J BACTERIOL, V179, P6127, DOI 10.1128/JB.179.19.6127-6132.1997; Limmathurotsakul D, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.8, 10.1038/nmicrobiol.2015.8]; Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079; Madhongsa K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002267; Maillard JY, 2013, CRIT REV MICROBIOL, V39, P373, DOI 10.3109/1040841X.2012.713323; Marcato PD, 2008, J NANOSCI NANOTECHNO, V8, P2216, DOI 10.1166/jnn.2008.274; Mei L, 2013, BIOMATERIALS, V34, P10328, DOI 10.1016/j.biomaterials.2013.09.045; Mirzajani F, 2011, RES MICROBIOL, V162, P542, DOI 10.1016/j.resmic.2011.04.009; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Novem V, 2009, CLIN VACCINE IMMUNOL, V16, P1420, DOI 10.1128/CVI.00472-08; Peacock SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001488; Percival Steven L, 2007, Int Wound J, V4, P186, DOI 10.1111/j.1742-481X.2007.00296.x; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Rai MK, 2012, J APPL MICROBIOL, V112, P841, DOI 10.1111/j.1365-2672.2012.05253.x; Reidy B, 2013, MATERIALS, V6, P2295, DOI 10.3390/ma6062295; Sarovich Derek S, 2012, Infect Drug Resist, V5, P129, DOI 10.2147/IDR.S35529; Schweizer HP, 2012, FUTURE MICROBIOL, V7, P1389, DOI [10.2217/fmb.12.116, 10.2217/FMB.12.116]; Silipo A, 2005, GLYCOBIOLOGY, V15, P561, DOI 10.1093/glycob/cwi029; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Silver S, 2006, J IND MICROBIOL BIOT, V33, P627, DOI 10.1007/s10295-006-0139-7; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Thomas R, 2014, BRAZ J MICROBIOL, V45, P1221, DOI 10.1590/S1517-83822014000400012; Thomas V, 2007, J COLLOID INTERF SCI, V315, P389, DOI 10.1016/j.jcis.2007.06.068; Tiede K, 2008, FOOD ADDIT CONTAM A, V25, P795, DOI 10.1080/02652030802007553; Tunpiboonsak S, 2010, J MICROBIOL, V48, P63, DOI 10.1007/s12275-010-9138-5; Wong KKY, 2010, MEDCHEMCOMM, V1, P125, DOI 10.1039/c0md00069h; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Xu HY, 2012, BIOMETALS, V25, P45, DOI 10.1007/s10534-011-9482-x; You CG, 2012, MOL BIOL REP, V39, P9193, DOI 10.1007/s11033-012-1792-8; Zhao GJ, 1998, BIOMETALS, V11, P27, DOI 10.1023/A:1009253223055	60	41	41	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168098	10.1371/journal.pone.0168098	http://dx.doi.org/10.1371/journal.pone.0168098			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977746	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400060
J	Slaker, M; Barnes, J; Sorg, BA; Grimm, JW				Slaker, Megan; Barnes, Jesse; Sorg, Barbara A.; Grimm, Jeffrey W.			Impact of Environmental Enrichment on Perineuronal Nets in the Prefrontal Cortex following Early and Late Abstinence from Sucrose Self-Administration in Rats	PLOS ONE			English	Article							CONDITIONED PLACE PREFERENCE; INDUCED REINSTATEMENT; SEEKING BEHAVIOR; DRUG-ADDICTION; VISUAL-CORTEX; COCAINE; PLASTICITY; AMPHETAMINE; PARVALBUMIN; BRAIN	Perineuronal nets (PNNs) are aggregates of extracellular matrix that form structures surrounding a subset of GABAergic interneurons. The staining intensity of PNNs appears to be related to plasticity. Environmental enrichment (EE) influences plasticity during adulthood: EE decreases the rewarding effects of drugs of abuse and diminishes both drug- and sucrose-seeking behavior. We determined the impact of EE on PNN intensity in the medial prefrontal cortex (mPFC) in rats trained to self-administer sucrose. We examined the number and intensity of PNNs within the prelimbic (PL), infralimbic (IL), and orbitofrontal (OF) regions of the mPFC of adult Long-Evans rats that were trained for sucrose self-administration followed by acute or chronic EE during abstinence and a cue-induced reinstatement test. Rats exposed to EE prior to a cue-induced reinstatement of sucrose seeking had an increase in PNN staining compared with rats in standard housing. Conversely, naive rats given 1 day of EE had a decrease in PNN intensity in the PL, no change in the IL, and an increase in the OF. Our findings demonstrate that EE increases PNN intensity in the mPFC after sucrose training, suggesting that training enhances the ability of EE to increase PNN intensity. We further demonstrate an interaction between time of abstinence, duration of EE exposure, and cue-induced reinstatement. Our results suggest that increased PNN intensity after EE may alter the excitatory/inhibitory balance of mPFC neurons such that rats are less responsive to a sucrose cue.	[Slaker, Megan; Sorg, Barbara A.] Washington State Univ, Dept Integrat Physiol & Neurosci, Vancouver, WA 98686 USA; [Slaker, Megan; Sorg, Barbara A.] Washington State Univ, Translat Addict Res Ctr, Vancouver, WA 98686 USA; [Barnes, Jesse] Washington State Univ, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA; [Barnes, Jesse; Grimm, Jeffrey W.] Western Washington Univ, Dept Psychol, Bellingham, WA 98225 USA; [Barnes, Jesse; Grimm, Jeffrey W.] Western Washington Univ, Behav Neurosci Program, Bellingham, WA 98225 USA	Washington State University; Washington State University; Washington State University; Western Washington University; Western Washington University	Sorg, BA (corresponding author), Washington State Univ, Dept Integrat Physiol & Neurosci, Vancouver, WA 98686 USA.; Sorg, BA (corresponding author), Washington State Univ, Translat Addict Res Ctr, Vancouver, WA 98686 USA.	sorg@vetmed.wsu.edu		Sorg, Barbara/0000-0002-4913-4910; Slaker, Megan/0000-0003-1757-5321	NIH [DA033404, DA016285]; NATIONAL INSTITUTE ON DRUG ABUSE [R15DA016285, R01DA033404] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by NIH Grant DA033404 (BAS) and NIH Grant DA016285 (JWG). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER BK, 1978, PSYCHOPHARMACOLOGY, V58, P175, DOI 10.1007/BF00426903; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Bardo MT, 2001, PSYCHOPHARMACOLOGY, V155, P278; BOWLING SL, 1993, NEUROPHARMACOLOGY, V32, P885, DOI 10.1016/0028-3908(93)90144-R; BRUCKNER G, 1994, BRAIN RES, V658, P67; BRUCKNER G, 1993, GLIA, V8, P183, DOI 10.1002/glia.440080306; Cass DK, 2013, BIOL PSYCHIAT, V74, P490, DOI 10.1016/j.biopsych.2013.02.021; Chauvet C, 2011, NEUROSCIENCE, V184, P88, DOI 10.1016/j.neuroscience.2011.03.068; Chauvet C, 2009, NEUROPSYCHOPHARMACOL, V34, P2767, DOI 10.1038/npp.2009.127; Donato F, 2013, NATURE, V504, P272, DOI 10.1038/nature12866; Foscarin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016666; Green TA, 2002, PSYCHOPHARMACOLOGY, V162, P373, DOI 10.1007/s00213-002-1134-y; Grimm JW, 2008, BEHAV PHARMACOL, V19, P777, DOI 10.1097/FBP.0b013e32831c3b18; Grimm JW, 2016, BRAIN STRUCT FUNCT, V221, P2817, DOI 10.1007/s00429-015-1074-z; Grimm JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054164; LALUMIERE RT, 2012, THE EUROPEAN JOURNAL, V35, P614, DOI DOI 10.1111/J.1460-9568.2012.07991.X; Madinier A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093121; McFarland K, 2003, J NEUROSCI, V23, P3531; Orsini CA, 2015, NEUROSCI BIOBEHAV R, V58, P147, DOI 10.1016/j.neubiorev.2015.04.009; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Salinas E, 2001, NAT REV NEUROSCI, V2, P539, DOI 10.1038/35086012; Scali M, 2012, EXP GERONTOL, V47, P337, DOI 10.1016/j.exger.2012.01.007; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Slaker M, 2015, J NEUROSCI, V35, P4190, DOI 10.1523/JNEUROSCI.3592-14.2015; Slaker ML, 2016, IBRO REP, V1, P54, DOI 10.1016/j.ibror.2016.10.001; Smith ACW, 2015, BRAIN RES, V1628, P29, DOI 10.1016/j.brainres.2015.03.027; Solbakk AK, 2014, SCAND J PSYCHOL, V55, P233, DOI 10.1111/sjop.12106; Solinas M, 2009, NEUROPSYCHOPHARMACOL, V34, P1102, DOI 10.1038/npp.2008.51; Solinas M, 2008, P NATL ACAD SCI USA, V105, P17145, DOI 10.1073/pnas.0806889105; Thiel KJ, 2011, PHARMACOL BIOCHEM BE, V97, P595, DOI 10.1016/j.pbb.2010.09.014; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wislowska-Stanek A, 2013, BEHAV BRAIN RES, V253, P337, DOI 10.1016/j.bbr.2013.07.042; Xue YX, 2014, J NEUROSCI, V34, P6647, DOI 10.1523/JNEUROSCI.5390-13.2014; Yamada J, 2014, EUROPEAN J NEUROSCIE; Zanca RM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00303	36	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168256	10.1371/journal.pone.0168256	http://dx.doi.org/10.1371/journal.pone.0168256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977779	gold, Green Submitted, Green Published			2022-12-27	WOS:000391217400083
J	Legramante, JM; Morciano, L; Lucaroni, F; Gilardi, F; Caredda, E; Pesaresi, A; Coscia, M; Orlando, S; Brandi, A; Giovagnoli, G; Di Lecce, VN; Visconti, G; Palombi, L				Legramante, Jacopo M.; Morciano, Laura; Lucaroni, Francesca; Gilardi, Francesco; Caredda, Emanuele; Pesaresi, Alessia; Coscia, Massimo; Orlando, Stefano; Brandi, Antonella; Giovagnoli, Germano; Di Lecce, Vito N.; Visconti, Giuseppe; Palombi, Leonardo			Frequent Use of Emergency Departments by the Elderly Population When Continuing Care Is Not Well Established	PLOS ONE			English	Article							OLDER-ADULTS; HOSPITAL ADMISSIONS; RISK; ACCESS; MODEL	Introduction The elderly, who suffer from multiple chronic diseases, represent a substantial proportion of Emergency Department (ED) frequent users, thus contributing to ED overcrowding, although they could benefit from other health care facilities, if those were available. The aim of this study was to evaluate and characterize hospital visits of older patients (age 65 or greater) to the ED of a university teaching hospital in Rome from the 1st of January to the 31st of December 2014, in order to identify clinical and social characteristics potentially associated with "elderly frequent users". Material and Methods A retrospective study was performed during the calendar year 2014 (1st January 2014-31st December 2014) analyzing all ED admissions to the University Hospital of Rome Tor Vergata. Variables collected included age, triage code, arrival data, discharge diagnosis, and visit outcome. We performed a risk analysis using univariate binary logistic regression models. Results A total number of 38,016 patients accessed the ED, generating 46,820 accesses during the study period, with an average of 1.23 accesses for patient. The elderly population represented a quarter of the total ED population and had an increased risk of frequent use (OR 1.5: CI 1.4-1.7) and hospitalization (OR 3.8: CI 3.7-4). Moreover, they showed a greater diagnostic complexity, as demonstrated by the higher incidence of yellow and red priority codes compared to other ED populations (OR 3.1: CI 2.9-3.2). Discussion Older patients presented clinical and social characteristics related to the definition of "elderly frail frequent users". The fact that a larger number of hospitalizations occurred in such patients is indirect evidence of frailty in this specific population, suggesting that hospital admissions may be an inappropriate response to frailty, especially when continued care is not established. Conclusion Enhancement of continuity of care, establishment of a tracking system for those who are at greater risk of visiting the ED and evaluating fragile individuals should be the highest priority in addressing ED frequent usage by the elderly.	[Legramante, Jacopo M.] Univ Roma Tor Vergata, Fdn Policlin Tor Vergata, Dept Med Syst, Rome, Italy; [Morciano, Laura; Lucaroni, Francesca; Gilardi, Francesco; Caredda, Emanuele; Pesaresi, Alessia; Coscia, Massimo; Orlando, Stefano; Palombi, Leonardo] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Visconti, Giuseppe] Fdn Policlin Tor Vergata, Sanit Director, Rome, Italy; [Brandi, Antonella; Giovagnoli, Germano; Di Lecce, Vito N.] Fdn Policlin Tor Vergata, Emergengy Dept, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata; University of Rome Tor Vergata	Palombi, L (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy.	Leonardo.palombi@gmail.com	Gilardi, Francesco/AAA-1999-2020; Orlando, Stefano/AAU-2937-2021; Caredda, Emanuele/AAB-5230-2020	Orlando, Stefano/0000-0001-9706-4075; Caredda, Emanuele/0000-0002-2828-6202; Gilardi, Francesco/0000-0002-4038-6003				Affleck A, 2013, CAN J EMERG MED, V15, P359; Aminzadeh F, 2002, ANN EMERG MED, V39, P238, DOI 10.1067/mem.2002.121523; Asplin BR, 2003, ANN EMERG MED, V42, P173, DOI 10.1067/mem.2003.302; Ciccone MM, 2013, CLIN AUDIT, V2013, P49; de Stampa M, 2014, ARCH GERONTOL GERIAT, V58, P350, DOI 10.1016/j.archger.2014.01.005; Deschodt M, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0055-7; Di Bari M, 2012, J GERONTOL A-BIOL, V67, P544, DOI 10.1093/gerona/glr209; Di Somma S, 2015, INTERN EMERG MED, V10, P171, DOI 10.1007/s11739-014-1154-8; Ellis G, 2014, CLIN INTERV AGING, V9, P2033, DOI 10.2147/CIA.S29662; Ercoli L, 2015, MINERVA PEDIATR, V67, P11; Franchi C, 2017, AGING CLIN EXP RES, V29, P319, DOI 10.1007/s40520-016-0550-5; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Fuda KK, 2006, ANN EMERG MED, V48, P9, DOI 10.1016/j.annemergmed.2006.03.001; Hastings SN, 2014, J AM GERIATR SOC, V62, P711, DOI 10.1111/jgs.12746; Hoot NR, 2008, ANN EMERG MED, V52, P126, DOI 10.1016/j.annemergmed.2008.03.014; Hunt KA, 2006, ANN EMERG MED, V48, P1, DOI 10.1016/j.annemergmed.2005.12.030; LaCalle E, 2010, ANN EMERG MED, V56, P42, DOI 10.1016/j.annemergmed.2010.01.032; LaCalle EJ, 2013, J EMERG MED, V44, P1167, DOI 10.1016/j.jemermed.2012.11.042; Latham LP, 2014, CAN GERIATR J, V17, P118, DOI 10.5770/cgj.17.108; Lowthian JA, 2012, MED J AUSTRALIA, V196, P128, DOI 10.5694/mja11.10955; Ondler C, 2014, AM J EMERG MED, V32, P1215, DOI 10.1016/j.ajem.2014.07.013; Oredsson S, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-43; Palmer E, 2014, CAN FAM PHYSICIAN, V60, pE223; Palombi Leonardo, 2013, Ig Sanita Pubbl, V69, P105; Pines JM, 2011, ACAD EMERG MED, V18, P1358, DOI 10.1111/j.1553-2712.2011.01235.x; Raven MC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-270; Salvi F, 2011, G GERONTOL, V59, P179; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015; Sona A, 2012, EUR J PUBLIC HEALTH, V22, P76, DOI 10.1093/eurpub/ckr008; Tricco AC, 2014, CAN MED ASSOC J, V186, pE568, DOI 10.1503/cmaj.140289; van der Linden MC, 2014, INT J EMERG MED, V7, DOI 10.1186/1865-1380-7-9; Vinton DT, 2014, EMERG MED J, V31, P526, DOI 10.1136/emermed-2013-202407; Wajnberg A, 2012, J EMERG MED, V43, P376, DOI 10.1016/j.jemermed.2011.06.056; Waldner A, 2014, REDEFINING FREQUENT; Yim VWT, 2009, INT J EMERG MED, V2, P19, DOI 10.1007/s12245-009-0087-x	35	50	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0165939	10.1371/journal.pone.0165939	http://dx.doi.org/10.1371/journal.pone.0165939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973563	Green Submitted, gold, Green Published			2022-12-27	WOS:000392754300006
J	Maguilla, E; Escudero, M				Maguilla, Enrique; Escudero, Marcial			Cryptic Species Due to Hybridization: A Combined Approach to Describe a New Species (Carex: Cyperaceae)	PLOS ONE			English	Article							DIVERSIFICATION RATES; DELIMITATION; PHYLOGENY; EVOLUTION; POPULATIONS; SYSTEMATICS; BOUNDARIES; SEQUENCES; RICHNESS; ZONES	Disappearance of diagnostic morphological characters due to hybridization is considered to be one of the causes of the complex taxonomy of the species-rich (ca. 2000 described species) genus Carex (Cyperaceae). Carex furva s.l. belongs to section Glareosae. It is an endemic species from the high mountains of the Iberian Peninsula (Spain and Portugal). Previous studies suggested the existence of two different, cryptic taxa within C. furva s.l. Intermediate morphologies found in the southern Iberian Peninsula precluded the description of a new taxa. We aimed to determine whether C. furva s.l. should be split into two different species based on the combination of morphological and molecular data. We sampled ten populations across its full range and performed a morphological study based on measurements on herbarium specimens and silica-dried inflorescences. Both morphological and phylogenetic data support the existence of two different species within C. furva s.l. Nevertheless, intermediate morphologies and sterile specimens were found in one of the southern populations (Sierra Nevada) of C. furva s.l., suggesting the presence of hybrid populations in areas where both supposed species coexist. Hybridization between these two putative species has blurred morphological and genetic limits among them in this hybrid zone. We have proved the utility of combining molecular and morphological data to discover a new cryptic species in a scenario of hybridization. We now recognize a new species, C. lucennoiberica, endemic to the Iberian Peninsula (Sierra Nevada, Central system and Cantabrian Mountains). On the other hand, C. furva s.s. is distributed only in Sierra Nevada, where it may be threatened by hybridization with C. lucennoiberica. The restricted distribution of both species and their specific habitat requirements are the main limiting factors for their conservation.	[Maguilla, Enrique] Univ Pablo Olavide, Dept Biol Mol & Ingn Bioquim, Seville, Spain; [Escudero, Marcial] Univ Seville, Dept Biol Vegetal & Ecol, Seville, Spain	Universidad Pablo de Olavide; University of Sevilla	Maguilla, E (corresponding author), Univ Pablo Olavide, Dept Biol Mol & Ingn Bioquim, Seville, Spain.	emagsal@gmail.com	Lirio, Antonio Marcial Escudero/H-2099-2015; Maguilla, Enrique/A-9738-2016	Lirio, Antonio Marcial Escudero/0000-0002-2541-5427; Maguilla, Enrique/0000-0002-8245-3024				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bauer AM, 2011, P ROY SOC B-BIOL SCI, V278, P490, DOI 10.1098/rspb.2010.1330; Brummitt R.K., 2001, WORLD GEOGRAPHIC SCH, V2; CAYOUETTE J, 1992, BOT REV, V58, P351, DOI 10.1007/BF02858773; Costedoat C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000357; Cracraft J., 1989, P28; Cronquist A., 1988, EVOLUTION CLASSIFICA; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Queiroz A, 2005, TRENDS ECOL EVOL, V20, P68, DOI 10.1016/j.tree.2004.11.006; Depraz A, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-171; Dobzhansky T., 1941, GENETICS ORIGIN SPEC; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edwards DL, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2765; Egorova T.V., 1999, SEDGES CAREX L RUSSI; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Escudero M, 2012, MOL PHYLOGENET EVOL, V63, P650, DOI 10.1016/j.ympev.2012.02.005; Escudero M, 2014, MOL PHYLOGENET EVOL, V79, P359, DOI 10.1016/j.ympev.2014.06.026; Escudero M, 2013, AM J BOT, V100, P2403, DOI 10.3732/ajb.1300162; Escudero M, 2009, PLANT SYST EVOL, V279, P163, DOI 10.1007/s00606-009-0156-x; Gay J, 1839, ANN SCI NAT BOT 2, V11, P179; Gopalan, 2015, PLOS ONE, V10, P1; Govaerts R, 2007, ROYAL BOT GARDENS; Jarvis A., 2008, CGIAR CSI SRTM 90 M, DOI DOI 10.1111/ecog.00774; Jimenez-Mejias P, 2016, SYST BOT, V41, P500, DOI 10.1600/036364416X692497; Jimenez-Mejias P, 2014, SYST BOT, V39, P117, DOI 10.1600/036364414X677973; Jimenez-Mejias P, 2012, SYST BOT, V37, P382, DOI 10.1600/036364412X635449; Jimenez-Mejias P, 2011, AM J BOT, V98, P1855, DOI 10.3732/ajb.1100120; Judd W. S., 2007, PLANT SYSTEMATICS PH; Kauserud H, 2007, MOL ECOL, V16, P389, DOI 10.1111/j.1365-294X.2006.03129.x; Kukenthal G., 1909, PFLANZENREICH 4, V20; KUKKONEN I, 1988, AQUAT BOT, V30, P5, DOI 10.1016/0304-3770(88)90003-4; Lamer JT, 2014, MOL ECOL RESOUR, V14, P79, DOI 10.1111/1755-0998.12152; Latch EK, 2006, J WILDLIFE MANAGE, V70, P485, DOI 10.2193/0022-541X(2006)70[485:AHIWPU]2.0.CO;2; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Lemmon EM, 2007, MOL PHYLOGENET EVOL, V44, P1068, DOI 10.1016/j.ympev.2007.04.010; Luceno M., 2008, FLORA IBERICA, P146; Luceno M., 1986, AN JARDIN BOT MADRID, V42, P427; Luceno Modesto, 2015, Acta Botanica Malacitana, V40, P217; Maguilla E, 2015, AM J BOT, V102, P1128, DOI 10.3732/ajb.1500169; Marino IAM, 2015, J HERED, V106, P123, DOI 10.1093/jhered/esu064; Martin-Bravo S, 2013, S AFR J BOT, V87, P85, DOI 10.1016/j.sajb.2013.03.014; Martin-Bravo S, 2009, FOLIA GEOBOT, V44, P399, DOI 10.1007/s12224-009-9052-y; MAYR E, 1969, Biological Journal of the Linnean Society, V1, P311, DOI 10.1111/j.1095-8312.1969.tb00123.x; Oliveira R, 2008, PHILOS T R SOC B, V363, P2953, DOI 10.1098/rstb.2008.0052; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Roalson EH, 2001, SYST BOT, V26, P318; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Thiers B., 2015, INDEX HERBARIORUM GL; TOIVONEN H, 1980, ANN BOT FENN, V17, P91; Toivonen H., 1981, ACTA BOT FENN, V116, P1; Toivonen H., 2002, FLORA N AM, P311; Valcarcel V, 2010, AM J BOT, V97, P1555, DOI 10.3732/ajb.1000115; Wang ZP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107101; Watanabe MT, 2015, PLOS ONE, V10, P1; Waterway MJ, 2015, BOT J LINN SOC, V179, P1, DOI 10.1111/boj.12298; Waterway MJ, 2009, BOT REV, V75, P138, DOI 10.1007/s12229-008-9024-6; Webb PB, 1838, ITER HISPANIENSE, V5; Yang HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136373; Yang RC, 2016, EXP PARASITOL, V163, P16, DOI 10.1016/j.exppara.2016.01.013	63	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166949	10.1371/journal.pone.0166949	http://dx.doi.org/10.1371/journal.pone.0166949			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973589	Green Published, gold			2022-12-27	WOS:000392754300017
J	Ning, DF; Liang, YC; Liu, ZD; Xiao, JF; Duan, AW				Ning, Dongfeng; Liang, Yongchao; Liu, Zhandong; Xiao, Junfu; Duan, Aiwang			Impacts of Steel-Slag-Based Silicate Fertilizer on Soil Acidity and Silicon Availability and Metals-Immobilization in a Paddy Soil	PLOS ONE			English	Article							IN-SITU REMEDIATION; POLLUTED SOILS; SEQUENTIAL EXTRACTION; HEAVY-METALS; RICE; CADMIUM; ACCUMULATION; MECHANISMS; AMENDMENTS; COMPONENTS	Slag-based silicate fertilizer has been widely used to improve soil silicon-availability and crop productivity. A consecutive early rice-late rice rotation experiment was conducted to test the impacts of steel slag on soil pH, silicon availability, rice growth and metals-immobilization in paddy soil. Our results show that application of slag at a rate above higher or equal to 1 600 mg plant-available SiO2 per kg soil increased soil pH, dry weight of rice straw and grain, plant-available Si concentration and Si concentration in rice shoots compared with the control treatment. No significant accumulation of total cadmium (Cd) and lead (Pb) was noted in soil; rather, the exchangeable fraction of Cd significantly decreased. The cadmium concentrations in rice grains decreased significantly compared with the control treatment. In conclusion, application of steel slag reduced soil acidity, increased plant-availability of silicon, promoted rice growth and inhibited Cd transport to rice grain in the soil-plant system.	[Ning, Dongfeng; Liu, Zhandong; Xiao, Junfu; Duan, Aiwang] Chinese Acad Agr Sci, Inst Farmland Irrigat Res, Minist Agr, Key Lab Crop Water Use & Regulat, Xinxiang, Peoples R China; [Liang, Yongchao] Zhejiang Univ, Coll Environm & Resource Sci, Minist Educ, Key Lab Environm Remediat & Ecol Hlth, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Agricultural Sciences; Farmland Irrigation Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Zhejiang University	Ning, DF (corresponding author), Chinese Acad Agr Sci, Inst Farmland Irrigat Res, Minist Agr, Key Lab Crop Water Use & Regulat, Xinxiang, Peoples R China.	smile_0808@163.com	Liang, Yongchao/S-9281-2019; Liang, Yongchao/D-5809-2012	Liang, Yongchao/0000-0002-0501-2823; Liang, Yongchao/0000-0002-0501-2823	National Natural Science Foundation of China [51509249]; 12th Five-year Key Programs, China [2013BAB03B02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12th Five-year Key Programs, China	The National Natural Science Foundation of China entitled "Immobilization of heavy metals in a contaminated paddy soil using nano-slag-based silicon fertilizer and ecological assessment" (Approved No. 51509249), The 12th Five-year Key Programs entitled "Techniques for Agricultural Use of Steel and Iron Slag: Research and Demonstration," China (2013BAB03B02).; This work was jointly supported by The National Natural Science Foundation of China entitled "Immobilization of heavy metals in a contaminated paddy soil using nano-slag-based silicon fertilizer and ecological assessment" (Approved No. 51509249), The 12 th Five-year Key Programs entitled "Techniques for Agricultural Use of Steel and Iron Slag: Research and Demonstration", China (2013BAB03B02)	Alvarez J, 2001, CROP PROT, V20, P43, DOI 10.1016/S0261-2194(00)00051-X; Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8; Bocharnikova E. A., 2010, Russian Agricultural Sciences, V36, P446, DOI 10.3103/S1068367410060157; Chen J, 2007, CATENA, V69, P1, DOI 10.1016/j.catena.2006.04.019; Cooke J, 2011, TRENDS PLANT SCI, V16, P61, DOI 10.1016/j.tplants.2010.10.003; Dai WeiMin, 2005, Chinese Journal of Rice Science, V19, P460; Dallagnol LJ, 2009, PHYTOPATHOLOGY, V99, P116, DOI 10.1094/PHYTO-99-1-0116; Datnoff LE, 1997, CROP PROT, V16, P525, DOI 10.1016/S0261-2194(97)00033-1; DEREN CW, 1994, CROP SCI, V34, P733, DOI 10.2135/cropsci1994.0011183X003400030024x; Duan JM, 2014, CHEM ENG J, V246, P160, DOI 10.1016/j.cej.2014.02.056; EPSTEIN E, 1994, P NATL ACAD SCI USA, V91, P11, DOI 10.1073/pnas.91.1.11; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Friesl W, 2003, J PLANT NUTR SOIL SC, V166, P191, DOI 10.1002/jpln.200390028; Fuentes A, 2004, J HAZARD MATER, V108, P161, DOI 10.1016/j.jhazmat.2004.02.014; Gray CW, 2006, ENVIRON POLLUT, V142, P530, DOI 10.1016/j.envpol.2005.10.017; Gu HH, 2011, CHEMOSPHERE, V83, P1234, DOI 10.1016/j.chemosphere.2011.03.014; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Gutierrez J, 2010, BIOL FERT SOILS, V46, P617, DOI 10.1007/s00374-010-0470-z; Hamon RE, 2002, ENVIRON SCI TECHNOL, V36, P3991, DOI 10.1021/es025558g; Haynes RJ, 2013, J PLANT NUTR SOIL SC, V176, P238, DOI 10.1002/jpln.201200372; Kaasalainen M, 2003, ENVIRON POLLUT, V126, P225, DOI 10.1016/S0269-7491(03)00191-X; Kato N, 1997, SOIL SCI PLANT NUTR, V43, P329, DOI 10.1080/00380768.1997.10414757; Kato N, 1997, SOIL SCI PLANT NUTR, V43, P351, DOI 10.1080/00380768.1997.10414759; Kirkham MB, 2006, GEODERMA, V137, P19, DOI 10.1016/j.geoderma.2006.08.024; Li P, 2008, J ENVIRON SCI, V20, P449, DOI 10.1016/S1001-0742(08)62078-1; Li ZY, 2014, SCI TOTAL ENVIRON, V468, P843, DOI 10.1016/j.scitotenv.2013.08.090; Liang YC, 2005, CHEMOSPHERE, V58, P475, DOI 10.1016/j.chemosphere.2004.09.034; LIANG YC, 1994, COMMUN SOIL SCI PLAN, V25, P2285, DOI 10.1080/00103629409369189; Liang YC, 2007, ENVIRON POLLUT, V147, P422, DOI 10.1016/j.envpol.2006.06.008; Lombi E, 2003, ENVIRON SCI TECHNOL, V37, P979, DOI 10.1021/es026083w; Lu R.K, 2000, ANAL METHOD SOIL AGR; Ma J.F., 2002, SOIL FERTILIZER PLAN; Ma JF, 2006, TRENDS PLANT SCI, V11, P392, DOI 10.1016/j.tplants.2006.06.007; Ma TS, 1994, SOIL, V26, P154; Maiz I, 2000, ENVIRON POLLUT, V110, P3, DOI 10.1016/S0269-7491(99)00287-0; Meena V. D., 2014, Proceedings of the Indian National Science Academy Part B Biological Sciences, V84, P505, DOI 10.1007/s40011-013-0270-y; Nanayakkara UN, 2008, PLANT DIS, V92, P870, DOI 10.1094/PDIS-92-6-0870; Ning DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102681; Pueyo M, 2008, ENVIRON POLLUT, V152, P330, DOI 10.1016/j.envpol.2007.06.020; Raven JA, 2003, NEW PHYTOL, V158, P419, DOI 10.1046/j.1469-8137.2003.00778.x; Rodrigues FA, 2001, PLANT DIS, V85, P827, DOI 10.1094/PDIS.2001.85.8.827; Sauve S, 1998, SOIL SCI SOC AM J, V62, P618, DOI 10.2136/sssaj1998.03615995006200030010x; Savant NK, 1997, ADV AGRON, V58, P151; Seebold KW, 2001, PHYTOPATHOLOGY, V91, P63, DOI 10.1094/PHYTO.2001.91.1.63; Song A, 2009, J HAZARD MATER, V172, P74, DOI 10.1016/j.jhazmat.2009.06.143; Tsakiridis PE, 2008, J HAZARD MATER, V152, P805, DOI 10.1016/j.jhazmat.2007.07.093; Wu SP, 2007, BUILD ENVIRON, V42, P2580, DOI 10.1016/j.buildenv.2006.06.008; Xu XH, 2014, ECOTOX ENVIRON SAFE, V108, P161, DOI 10.1016/j.ecoenv.2014.07.001; Xue YJ, 2009, J HAZARD MATER, V162, P973, DOI 10.1016/j.jhazmat.2008.05.131; Zhang CC, 2008, ENVIRON EXP BOT, V62, P300, DOI 10.1016/j.envexpbot.2007.10.024; Zhang XP, 1982, SOIL, V14, P185; Zhu GL, 2010, IRON STEEL SCRAP, V1, P12; Zhuo L, 2012, ENVIRON SCI POLLUT R, V19, P2842, DOI 10.1007/s11356-012-0790-7	53	52	55	10	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168163	10.1371/journal.pone.0168163	http://dx.doi.org/10.1371/journal.pone.0168163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973585	Green Submitted, Green Published, gold			2022-12-27	WOS:000392754300060
J	Strullu-Derrien, C; Goral, T; Longcore, JE; Olesen, J; Kenrick, P; Edgecombe, GD				Strullu-Derrien, Christine; Goral, Tomasz; Longcore, Joyce E.; Olesen, Jorgen; Kenrick, Paul; Edgecombe, Gregory D.			A New Chytridiomycete Fungus Intermixed with Crustacean Resting Eggs in a 407-Million-Year- Old Continental Freshwater Environment	PLOS ONE			English	Article							DEVONIAN RHYNIE CHERT; RHIZOPHYDIALES CHYTRIDIOMYCOTA; GREEN-ALGA; LAND PLANT; FOOD-WEB; SCOTLAND; ABERDEENSHIRE; EVOLUTION; HORNEOPHYTON; MICROFUNGUS	The 407-million-year-old Rhynie Chert (Scotland) contains the most intact fossilised remains of an early land-based ecosystem including plants, arthropods, fungi and other microorganisms. Although most studies have focused on the terrestrial component, fossilised freshwater environments provide critical insights into fungal-algal interactions and the earliest continental branchiopod crustaceans. Here we report interactions between an enigmatic organism and an exquisitely preserved fungus. The fungal reproductive structures are intermixed with exceptionally well-preserved globular spiny structures interpreted as branchiopod resting eggs. Confocal laser scanning microscopy enabled us to reconstruct the fungus and its possible mode of nutrition, the affinity of the resting eggs, and their spatial associations. The new fungus (Cultoraquaticus trewini gen. et sp. nov) is attributed to Chytridiomycota based on its size, consistent formation of papillae, and the presence of an internal rhizoidal system. It is the most pristine fossil Chytridiomycota known, especially in terms of rhizoidal development and closely resembles living species in the Rhizophydiales. The spiny resting eggs are attributed to the crustacean Lepidocaris rhyniensis, dating branchiopod adaptation to life in ephemeral pools to the Early Devonian. The new fungal interaction suggests that, as in modern freshwater environments, chytrids were important to the mobilisation of nutrients in early aquatic foodwebs.	[Strullu-Derrien, Christine; Kenrick, Paul; Edgecombe, Gregory D.] Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London, England; [Goral, Tomasz] Nat Hist Museum, Imaging & Anal Ctr, Cromwell Rd, London, England; [Longcore, Joyce E.] Univ Maine, Sch Biol & Ecol, 5722 Deering Hall, Orono, ME USA; [Olesen, Jorgen] Univ Copenhagen, Nat Hist Museum, Univ Pk, Copenhagen, Denmark	Natural History Museum London; Natural History Museum London; University of Maine System; University of Maine Orono; University of Copenhagen	Strullu-Derrien, C (corresponding author), Nat Hist Museum, Dept Earth Sci, Cromwell Rd, London, England.	c.strullu-derrien@nhm.ac.uk	Strullu-Derrien, Christine/P-4543-2019; Olesen, Jørgen/A-3353-2013	Strullu-Derrien, Christine/0000-0003-1131-9546; Olesen, Jørgen/0000-0001-9582-7083; Edgecombe, Gregory/0000-0002-9591-8011; Kenrick, Paul/0000-0002-3626-5460	Marie Curie Intra-European Fellowship for Career Development [SYMBIONTS GA-2011-298735]; FP7 SYNTHESYS grant of the European Commission [NL-TAF 3245]	Marie Curie Intra-European Fellowship for Career Development; FP7 SYNTHESYS grant of the European Commission	This work was supported by a Marie Curie Intra-European Fellowship for Career Development (SYMBIONTS GA-2011-298735) and a FP7 SYNTHESYS grant (NL-TAF 3245) of the European Commission to C.S.-D for data collection and analysis.	Anderson LI, 2003, PALAEONTOLOGY, V46, P467, DOI 10.1111/1475-4983.00308; BARR DJS, 1984, CAN J BOT, V62, P1171, DOI 10.1139/b84-161; Barr DJS, 2001, MYCOTA, V7, P93; Bruner E, 2013, HYDROBIOLOGIA, V705, P1, DOI 10.1007/s10750-012-1343-2; CANTER HILDA M., 1949, TRANS BRIT MYCOL SOC, V32, P69; Crous PW, 2004, STUD MYCOL, P19; Fayers SR, 2003, T ROY SOC EDIN-EARTH, V93, P355; FORSTER H, 1990, MYCOLOGIA, V82, P306, DOI 10.2307/3759901; FRYER G, 1985, Transactions of the Royal Society of Edinburgh Earth Sciences, V76, P103; Fryer G, 2009, ZOOL J LINN SOC-LOND, V155, P513, DOI 10.1111/j.1096-3642.2008.00455.x; Gueriau P, 2016, CURR BIOL, V26, P383, DOI 10.1016/j.cub.2015.12.039; Habgood KS, 2004, T ROY SOC EDIN-EARTH, V94, P371, DOI 10.1017/S0263593300000754; HASS H, 1994, AM J BOT, V81, P29, DOI 10.2307/2445559; Haug C, 2014, ATLAS OF CRUSTACEAN LARVAE, P36; Haug C, 2012, PALAEONTOL ELECTRON, V15; ILLMAN WI, 1984, MYCOLOGIA, V76, P545, DOI 10.2307/3793338; James TY, 2006, MYCOLOGIA, V98, P860, DOI 10.3852/mycologia.98.6.860; Kagami M, 2007, HYDROBIOLOGIA, V578, P113, DOI 10.1007/s10750-006-0438-z; Kagami M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00166; Karling John S., 1946, LLOYDIA [CINCINNATI], V9, P1; Karling JS, 1977, CHYTRIDIOMYCETARUM I; Krings M, 2007, NEW PHYTOL, V174, P648, DOI 10.1111/j.1469-8137.2007.02008.x; Krings M, 2014, NOVA HEDWIGIA, V99, P403, DOI 10.1127/0029-5035/2014/0205; Krings Michael, 2009, Zitteliana Reihe A, V48-49, P165; Letcher PM, 2008, MYCOL RES, V112, P759, DOI 10.1016/j.mycres.2008.01.025; Letcher PM, 2006, MYCOL RES, V110, P898, DOI 10.1016/j.mycres.2006.06.011; Letcher PM, 2012, TAXONOMIC SUMMARY RH; Mark DF, 2013, J GEOL SOC LONDON, V170, P701, DOI 10.1144/jgs2011-110; MARTIN JW, 1992, MICROSCOPIC ANATOMY, V9, P25; Olesen Jorgen, 2009, Arthropod Systematics & Phylogeny, V67, P3; POWELL MJ, 1993, MYCOLOGIA, V85, P1, DOI 10.2307/3760471; REMY W, 1994, AM J BOT, V81, P690, DOI 10.2307/2445647; REMY W, 1994, P NATL ACAD SCI USA, V91, P11841, DOI 10.1073/pnas.91.25.11841; Rice CM, 2002, J GEOL SOC LONDON, V159, P203, DOI 10.1144/0016-764900-181; Schopf JW, 2011, TOP GEOBIOL, V32, P457, DOI 10.1007/978-90-481-8643-3_13; Schopf JW, 2009, PRECAMBRIAN RES, V173, P39, DOI 10.1016/j.precamres.2009.02.007; Schram FR, 2001, EVOL DEV, V3, P343, DOI 10.1046/j.1525-142X.2001.01038.x; Scourfield DJ, 1926, PHILOS T R SOC LON B, V214, P153, DOI 10.1098/rstb.1926.0005; Scourfield DJ., 1940, ZOOLOGICAL J LINNEAN, V152, P290; Shi CS, 2013, AM J BOT, V100, P1626, DOI 10.3732/ajb.1300027; Sparrow F.K., 1960, AQUATIC PHYCOMYCETES; Stalpers J., MYCOBANK ENGINE RELA; Strullu-Derrien C, 2015, BOT J LINN SOC, V179, P201, DOI 10.1111/boj.12307; Strullu-Derrien C, 2014, NEW PHYTOL, V203, P964, DOI 10.1111/nph.12805; Talyor T.N., 2015, FOSSIL FUNGI; TAYLOR TN, 1994, NATURE, V367, P601, DOI 10.1038/367601a0; Taylor TN, 2004, T ROY SOC EDIN-EARTH, V94, P457, DOI 10.1017/S026359330000081X; TAYLOR TN, 1992, MYCOLOGIA, V84, P901, DOI 10.2307/3760288; TAYLOR TN, 1992, AM J BOT, V79, P1233, DOI 10.2307/2445050; TAYLOR TN, 1992, NATURE, V357, P493, DOI 10.1038/357493a0; Trewin NH, 2004, T R SOC EDINB EARTH, V94	51	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167301	10.1371/journal.pone.0167301	http://dx.doi.org/10.1371/journal.pone.0167301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973602	Green Published, gold			2022-12-27	WOS:000392754300023
J	Assadi, G; Vesterlund, L; Bonfiglio, F; Mazzurana, L; Cordeddu, L; Schepis, D; Mjosberg, J; Ruhrmann, S; Fabbri, A; Vukojevic, V; Percipalle, P; Salomons, FA; Laurencikiene, J; Torkvist, L; Halfvarson, J; D'Amato, M				Assadi, Ghazaleh; Vesterlund, Liselotte; Bonfiglio, Ferdinando; Mazzurana, Luca; Cordeddu, Lina; Schepis, Danika; Mjosberg, Jenny; Ruhrmann, Sabrina; Fabbri, Alessia; Vukojevic, Vladana; Percipalle, Piergiorgio; Salomons, Florian A.; Laurencikiene, Jurga; Torkvist, Leif; Halfvarson, Jonas; D'Amato, Mauro			Functional Analyses of the Crohn's Disease Risk Gene LACC1	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; SUSCEPTIBILITY; ASSOCIATION; EXPRESSION; LEPROSY; LOCI; MICE	Background Genetic variation in the Laccase (multicopper oxidoreductase) domain-containing 1 (LACC1) gene has been shown to affect the risk of Crohn's disease, leprosy and, more recently, ulcerative colitis and juvenile idiopathic arthritis. LACC1 function appears to promote fatty-acid oxidation, with concomitant inflammasome activation, reactive oxygen species production, and anti-bacterial responses in macrophages. We sought to contribute to elucidating LACC1 biological function by extensive characterization of its expression in human tissues and cells, and through preliminary analyses of the regulatory mechanisms driving such expression. Methods We implemented Western blot, quantitative real-time PCR, immunofluorescence microscopy, and flow cytometry analyses to investigate fatty acid metabolism-immune nexus (FAMIN; the LACC1 encoded protein) expression in subcellular compartments, cell lines and relevant human tissues. Gene-set enrichment analyses were performed to initially investigate modulatory mechanisms of LACC1 expression. A small-interference RNA knockdown in vitro model system was used to study the effect of FAMIN depletion on peroxisome function. Results FAMIN expression was detected in macrophage-differentiated THP-1 cells and several human tissues, being highest in neutrophils, monocytes/macrophages, myeloid and plasmacytoid dendritic cells among peripheral blood cells. Subcellular co-localization was exclusively confined to peroxisomes, with some additional positivity for organelle endomembrane structures. LACC1 co-expression signatures were enriched for genes involved in peroxisome proliferator-activated receptors (PPAR) signaling pathways, and PPAR ligands downregulated FAMIN expression in in vitro model systems. Conclusion FAMIN is a peroxisome-associated protein with primary role(s) in macrophages and other immune cells, where its metabolic functions may be modulated by PPAR signaling events. However, the precise molecular mechanisms through which FAMIN exerts its biological effects in immune cells remain to be elucidated.	[Assadi, Ghazaleh; Vesterlund, Liselotte; Bonfiglio, Ferdinando; Cordeddu, Lina; D'Amato, Mauro] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Mazzurana, Luca; Mjosberg, Jenny] Karolinska Inst, Ctr Infect Med, Dept Med Huddinge, Stockholm, Sweden; [Schepis, Danika] Karolinska Univ Hosp, Karolinska Inst, Dept Med Solna, Rheumatol Unit, Stockholm, Sweden; [Ruhrmann, Sabrina; Vukojevic, Vladana] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Fabbri, Alessia] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, Rome, Italy; [Percipalle, Piergiorgio] New York Univ Abu Dhabi, Biol Program, Abu Dhabi, U Arab Emirates; [Percipalle, Piergiorgio] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Salomons, Florian A.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Laurencikiene, Jurga] Karolinska Inst, Dept Med Huddinge, Lipid Lab, Stockholm, Sweden; [Torkvist, Leif] Karolinska Univ Hosp, Gastroctr, Stockholm, Sweden; [Halfvarson, Jonas] Univ Orebro, Fac Med & Hlth, Dept Gastroenterol, Orebro, Sweden; [D'Amato, Mauro] Basque Fdn Sci, BioDonostia Hlth Res Inst, San Sebastian & IKERBASQUE, Bilbao, Spain	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Istituto Superiore di Sanita (ISS); Stockholm University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Orebro University; Basque Foundation for Science; Instituto de Investigacion Sanitaria Biodonostia	Assadi, G (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	ghazaleh.assadi@ki.se	Vukojevic, Vladana B/AAY-3144-2021; D'Amato, Mauro/F-2450-2010; Bonfiglio, Ferdinando/ABE-5834-2021; RICE, GREGORY E/F-2412-2010; D'Amato, Mauro/B-5050-2019; Fabbri, Alessia/AAA-4594-2019; Halfvarson, Jonas/AAU-4687-2020; Bonfiglio, Ferdinando/AAP-4424-2020	D'Amato, Mauro/0000-0003-2743-5197; Bonfiglio, Ferdinando/0000-0003-2488-3867; RICE, GREGORY E/0000-0001-7177-0246; D'Amato, Mauro/0000-0003-2743-5197; Fabbri, Alessia/0000-0002-3075-3367; Bonfiglio, Ferdinando/0000-0003-2488-3867; , Jurga/0000-0002-7032-2924; Vesterlund, Liselotte/0000-0003-3547-9288; Vukojevic, Vladana/0000-0003-0873-5653; Mjosberg, Jenny/0000-0002-1119-0976	Swedish Research Council, Vetenskapsradet (VR); Karolinska Institutet KID PhD fellowship	Swedish Research Council, Vetenskapsradet (VR)(Swedish Research Council); Karolinska Institutet KID PhD fellowship	This study was supported by funds from the Swedish Research Council, Vetenskapsradet (VR; http://www.vr.se/) to MDA. GA is the recipient of a Karolinska Institutet KID PhD fellowship.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Assadi G, 2016, GENES IMMUN, V17, P261, DOI 10.1038/gene.2016.17; Bayley R, 2015, ANN RHEUM DIS, V74, P1588, DOI 10.1136/annrheumdis-2013-204796; Bertin B, 2010, CURR OPIN CLIN NUTR, V13, P574, DOI 10.1097/MCO.0b013e32833cf0f4; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Cable S, 1994, STUDIES PEROXISOMES, V39, P2177; Cader MZ, 2016, NAT IMMUNOL, V17, P1046, DOI 10.1038/ni.3532; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Goel A, 2014, GUT, V63, pA179, DOI 10.1136/gutjnl-2014-307263.385; Goncalves P, 2015, INFLAMM BOWEL DIS, V21, P453, DOI 10.1097/MIB.0000000000000209; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Grant AV, 2012, J INFECT DIS, V206, P1763, DOI 10.1093/infdis/jis588; Grygiel-Gorniak B, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-17; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hontecillas R, 2011, MUCOSAL IMMUNOL, V4, P304, DOI 10.1038/mi.2010.75; Hruz T, 2008, GENEVESTIGATOR, V2008; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Ning K, 2015, HUM MOL GENET, V24, P4147, DOI 10.1093/hmg/ddv142; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Rogovin VV, 2001, COMPOSITION NEUTROPH, V28, P396; Sales-Marques C, 2014, HUM GENET, V133, P1525, DOI 10.1007/s00439-014-1502-9; Skieceviciene J, 2013, INFLAMM BOWEL DIS, V19, P2349, DOI 10.1097/MIB.0b013e3182a3eaeb; Sugawara K, 2005, GASTROENTEROLOGY, V128, P351, DOI 10.1053/j.gastro.2004.11.001; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Wakil SM, 2015, ARTHRITIS RHEUMATOL, V67, P288, DOI 10.1002/art.38877; Xiong JH, 2016, INT J DERMATOL, V55, P65, DOI 10.1111/ijd.12981; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	35	20	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168276	10.1371/journal.pone.0168276	http://dx.doi.org/10.1371/journal.pone.0168276			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959965	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900054
J	Posod, A; Komazec, IO; Kager, K; Peglow, UP; Griesmaier, E; Schermer, E; Wurtinger, P; Baumgartner, D; Kiechl-Kohlendorfer, U				Posod, Anna; Komazec, Irena Odri; Kager, Katrin; Peglow, Ulrike Pupp; Griesmaier, Elke; Schermer, Elisabeth; Wuertinger, Philipp; Baumgartner, Daniela; Kiechl-Kohlendorfer, Ursula			Former Very Preterm Infants Show an Unfavorable Cardiovascular Risk Profile at a Preschool Age	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; LOW-BIRTH-WEIGHT; METABOLIC SYNDROME; CHILDREN; INSULIN; ADOLESCENTS; ADULTHOOD; MORTALITY; GROWTH; HEART	Cardiovascular disease is the leading cause of death worldwide. Evidence points towards an unfavorable cardiovascular risk profile of former preterm infants in adolescence and adulthood. The aim of this study was to determine whether cardiovascular risk predictors are detectable in former very preterm infants at a preschool age. Five-to seven-year-old children born at < 32 weeks' gestational age were included in the study. Same-aged children born at term served as controls. Basic data of study participants were collected by means of follow-up databases and standardized questionnaires. At study visit, anthropometric data, blood pressure readings and aortic intima-media thickness were assessed. Blood samples were obtained after an overnight fast. In comparison to children born at term, former preterm infants had higher systolic and diastolic blood pressure readings (odds ratio [95% confidence interval] per 1-SD higher blood pressure level 3.2 [2.0-5.0], p< 0.001 and 1.6 [1.1 - 1.2], p = 0.008), fasting glucose levels (OR [95% CI] 5.2 [2.7-10.1], p< 0.001), homeostasis model assessment index (OR [95% CI] 1.6 [1.0-2.6], p = 0.036), and cholesterol levels (OR [95% CI] 2.1 [1.3-3.4], p = 0.002). Systolic prehypertension (23.7% vs. 2.2%; OR [95% CI] 13.8 [3.1-60.9], p = 0.001), elevated glucose levels (28.6% vs. 5.9%; OR [95% CI] 6.4 [1.4 - 28.8], p = 0.016), and hypercholesterolemia (77.4% vs. 52.9%; OR [95% CI] 3.0 [1.3-7.1], p = 0.010) were significantly more prevalent in the preterm group. As former very preterm infants display an unfavorable cardiovascular risk profile already at a preschool age, implementation of routine cardiovascular follow-up programs might be warranted.	[Posod, Anna; Komazec, Irena Odri; Kager, Katrin; Peglow, Ulrike Pupp; Griesmaier, Elke; Kiechl-Kohlendorfer, Ursula] Med Univ Innsbruck, Dept Pediat Pediat Neonatol 2, Innsbruck, Austria; [Komazec, Irena Odri; Schermer, Elisabeth; Baumgartner, Daniela] Med Univ Innsbruck, Dept Pediat Pediat Pediat Cardiol Pulmonol Allerg, Innsbruck, Austria; [Wuertinger, Philipp] Univ Innsbruck Hosp, Cent Inst Med & Chem Lab Diag, Innsbruck, Austria; [Baumgartner, Daniela] Med Univ Graz, Dept Pediat Clin, Clin Div Cardiol, Graz, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Graz	Kiechl-Kohlendorfer, U (corresponding author), Med Univ Innsbruck, Dept Pediat Pediat Neonatol 2, Innsbruck, Austria.	ursula.kohlendorfer@i-med.ac.at	Posod, Anna/AAE-8951-2020	Baumgartner, Daniela/0000-0001-8141-2426; Kiechl-Kohlendorfer, Ursula/0000-0003-0433-6196	Anniversary Fund of the Austrian National Bank [14570]; Austrian Heart Foundation; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - BMVIT [843536]; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - BMWFW [843536]; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - Wirtschaftsagentur Wien [843536]; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - Standortagentur Tirol [843536]	Anniversary Fund of the Austrian National Bank; Austrian Heart Foundation; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - BMVIT; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - BMWFW; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - Wirtschaftsagentur Wien; excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" - Standortagentur Tirol	This study was supported by the Anniversary Fund of the Austrian National Bank (Project No. 14570) (UK-K) and the Austrian Heart Foundation (UK-K). UK-K is also supported by the excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: "Research Center of Excellence in Vascular Ageing - Tyrol, VASCage" (K-Project No. 843536) funded by BMVIT, BMWFW, Wirtschaftsagentur Wien and Standortagentur Tirol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abella V, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/343746; Bracewell MA, 2008, ARCH DIS CHILD-FETAL, V93, pF108, DOI 10.1136/adc.2007.118596; Breukhoven PE, 2012, J CLIN ENDOCR METAB, V97, P1294, DOI 10.1210/jc.2011-2621; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Darendeliler F, 2008, CLIN ENDOCRINOL, V68, P773, DOI 10.1111/j.1365-2265.2007.03119.x; de Jong F, 2012, HYPERTENSION, V59, P226, DOI 10.1161/HYPERTENSIONAHA.111.181784; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; Jarvisalo MJ, 2001, CIRCULATION, V104, P2943, DOI 10.1161/hc4901.100522; Kaijser M, 2009, DIABETES, V58, P523, DOI 10.2337/db08-0558; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lawlor DA, 2006, DIABETOLOGIA, V49, P2614, DOI 10.1007/s00125-006-0408-z; Lopez-Jaramillo P, 2014, HORM MOL BIOL CLIN I, V18, P37, DOI 10.1515/hmbci-2013-0053; Maric-Bilkan C, 2016, HYPERTENSION, V67, P802, DOI 10.1161/HYPERTENSIONAHA.115.06967; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Mathai S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081840; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Norman M, 2008, ACTA PAEDIATR, V97, P1165, DOI 10.1111/j.1651-2227.2008.00904.x; Parkinson JRC, 2013, PEDIATRICS, V131, pE1240, DOI 10.1542/peds.2012-2177; Peplies J, 2014, INT J OBESITY, V38, pS39, DOI 10.1038/ijo.2014.134; Piyasena C, 2014, ARCH DIS CHILD-FETAL, V99, pF29, DOI [10.1136/archdischild-2014-306742, 10.1136/archdischild-2013-304101]; Risnes KR, 2011, INT J EPIDEMIOL, V40, P647, DOI 10.1093/ije/dyq267; Saigal S, 2006, PEDIATR RES, V60, P751, DOI 10.1203/01.pdr.0000246201.93662.8e; Shimizu T, 2014, PEDIATR CARDIOL, V35, P121, DOI 10.1007/s00246-013-0750-0; Sipola-Leppanen M, 2015, CURR OPIN LIPIDOL, V26, P282, DOI 10.1097/MOL.0000000000000190; Sipola-Leppanen M, 2014, PEDIATRICS, V134, pE1072, DOI 10.1542/peds.2013-4186; Stoll BJ, 2015, JAMA-J AM MED ASSOC, V314, P1039, DOI 10.1001/jama.2015.10244; Thornburg KL, 2015, J DEV ORIG HLTH DIS, V6, P366, DOI 10.1017/S2040174415001300; Truthmann J, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-133; Wabitsch M, 2014, KONSENSBASIERTE S2 L	30	27	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168162	10.1371/journal.pone.0168162	http://dx.doi.org/10.1371/journal.pone.0168162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959909	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900043
J	Yamazaki, R; Nishiyama, O; Sano, H; Iwanaga, T; Higashimoto, Y; Kume, H; Tohda, Y				Yamazaki, Ryo; Nishiyama, Osamu; Sano, Hiroyuki; Iwanaga, Takashi; Higashimoto, Yuji; Kume, Hiroaki; Tohda, Yuji			Clinical Features and Outcomes of IPF Patients Hospitalized for Pulmonary Infection: A Japanese Cohort Study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; REQUIRING HOSPITALIZATION; ACUTE EXACERBATION; FIBROSIS; DIAGNOSIS; RISK; STANDARDIZATION; GUIDELINES; MANAGEMENT; CULTURE	Many patients with idiopathic pulmonary fibrosis (IPF) undergo hospitalizations due to pulmonary infections. We retrospectively investigated the characteristics of hospitalizations due to pulmonary infection in patients with IPF to elucidate causative pathogens and mortality. We reviewed patients with IPF who were admitted between January 2008 and December 2014 for pulmonary infections including pneumonia and bronchitis. The causative pathogen, the relationship between the site of pneumonia and existing IPF radiological patterns on high-resolution chest CT, and predictors of mortality were evaluated. Forty-eight IPF patients were hospitalized a totally of 81 times due to pulmonary infection during the study period. In the 48 first-time admissions after IPF diagnosis, causative pathogens were detected in 20 patients (41.6%). The most common pathogen was Haemophilus influenzae (14.5%) followed by Pseudomonas aeruginosa (4.1%), Staphylococcus aureus (4.1%), Branhamella catarrhalis (4.1%), and Klebsiella pneumoniae (4.1%). Among all 81 admissions, the most common pathogen was P. aeruginosa (12.3%), followed by H. influenzae (8.6%), S. aureus (6.1%) and Escherichia coli (4.9%). No relationship was observed between the detected pathogen and the site of pneumonia. The 30-day and hospital mortality rates were 14.5% and 18.7%, respectively. Pneumonia severity index on admission was significantly associated with both 30-day and hospital mortality. In conclusion, IPF patients hospitalized for pulmonary infections had high 30-day and hospital mortality. In contrast to community-acquired pneumonia, the causative pathogens mainly consisted of gram-negative bacteria. The PSI score may be a significant predictor of mortality. These results provide information for empiric antibiotic selection when treating IPF patients with pulmonary infections.	[Yamazaki, Ryo; Nishiyama, Osamu; Sano, Hiroyuki; Iwanaga, Takashi; Higashimoto, Yuji; Kume, Hiroaki; Tohda, Yuji] Kindai Univ, Fac Med, Dept Resp Med & Allergol, Osakasayama, Osaka, Japan		Nishiyama, O (corresponding author), Kindai Univ, Fac Med, Dept Resp Med & Allergol, Osakasayama, Osaka, Japan.	nishiyama_o@yahoo.co.jp	Higashimoto, Yuji/AAW-2703-2021	Nishiyama, Osamu/0000-0002-9163-9605				Andruska A, 2015, CHEST, V148, P103, DOI 10.1378/chest.14-2129; Arancibia F, 2002, ARCH INTERN MED, V162, P1849, DOI 10.1001/archinte.162.16.1849; Brown AW, 2015, CHEST, V147, P173, DOI 10.1378/chest.13-2424; Cilloniz C, 2011, THORAX, V66, P340, DOI 10.1136/thx.2010.143982; Collard HR, 2016, AM J RESP CRIT CARE, V194, P265, DOI 10.1164/rccm.201604-0801CI; Durheim MT, 2015, LANCET RESP MED, V3, P388, DOI 10.1016/S2213-2600(15)00093-4; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Garcia-Vazquez E, 2004, ARCH INTERN MED, V164, P1807, DOI 10.1001/archinte.164.16.1807; Han MK, 2014, LANCET RESP MED, V2, P548, DOI 10.1016/S2213-2600(14)70069-4; Hanamoto S, 1992, Nihon Kyobu Shikkan Gakkai Zasshi, V30, P2051; Hirama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024474; Ishida T, 1998, CHEST, V114, P1588, DOI 10.1378/chest.114.6.1588; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kubota M, 2014, RESPIR INVESTIG, V52, P242, DOI 10.1016/j.resinv.2014.03.003; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martinez FJ, 2005, ANN INTERN MED, V142, P963, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00005; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miyashita N, 2008, MED SCI MONITOR, V14, pCR171; Molyneaux PL, 2014, AM J RESP CRIT CARE, V190, P906, DOI 10.1164/rccm.201403-0541OC; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Zalacain R, 2003, EUR RESPIR J, V21, P294, DOI 10.1183/09031936.03.00064102	24	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168164	10.1371/journal.pone.0168164	http://dx.doi.org/10.1371/journal.pone.0168164			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959904	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900044
J	Kumar, S; Archak, S; Tyagi, RK; Kumar, J; Vikas, VK; Jacob, SR; Srinivasan, K; Radhamani, J; Parimalan, R; Sivaswamy, M; Tyagi, S; Yadav, M; Kumari, J; Deepali; Sharma, S; Bhagat, I; Meeta, M; Bains, NS; Chowdhury, AK; Saha, BC; Bhattacharya, PM; Kumari, J; Singh, MC; Gangwar, OP; Prasad, P; Bharadwaj, SC; Gogoi, R; Sharma, JB; Kumar, GMS; Saharan, MS; Bag, M; Roy, A; Prasad, TV; Sharma, RK; Dutta, M; Sharma, I; Bansal, KC				Kumar, Sundeep; Archak, Sunil; Tyagi, R. K.; Kumar, Jagdish; Vikas, V. K.; Jacob, Sherry R.; Srinivasan, Kalyani; Radhamani, J.; Parimalan, R.; Sivaswamy, M.; Tyagi, Sandhya; Yadav, Mamata; Kumari, Jyotisna; Deepali; Sharma, Sandeep; Bhagat, Indoo; Meeta, Madhu; Bains, N. S.; Chowdhury, A. K.; Saha, B. C.; Bhattacharya, P. M.; Kumari, Jyoti; Singh, M. C.; Gangwar, O. P.; Prasad, P.; Bharadwaj, S. C.; Gogoi, Robin; Sharma, J. B.; Kumar, Sandeep G. M.; Saharan, M. S.; Bag, Manas; Roy, Anirban; Prasad, T. V.; Sharma, R. K.; Dutta, M.; Sharma, Indu; Bansal, K. C.			Evaluation of 19,460 Wheat Accessions Conserved in the Indian National Genebank to Identify New Sources of Resistance to Rust and Spot Blotch Diseases	PLOS ONE			English	Article							ADULT-PLANT RESISTANCE; STEM-RUST; STRIPE-RUST; BIPOLARIS-SOROKINIANA; LEAF; GENES; MICROSATELLITE; REGION; UG99; IDENTIFICATION	A comprehensive germplasm evaluation study of wheat accessions conserved in the Indian National Genebank was conducted to identify sources of rust and spot blotch resistance. Genebank accessions comprising three species of wheat-Triticum aestivum, T. durum and T. dicoccum were screened sequentially at multiple disease hotspots, during the 2011-14 crop seasons, carrying only resistant accessions to the next step of evaluation. Wheat accessions which were found to be resistant in the field were then assayed for seedling resistance and profiled using molecular markers. In the primary evaluation, 19,460 accessions were screened at Wellington (Tamil Nadu), a hotspot for wheat rusts. We identified 4925 accessions to be resistant and these were further evaluated at Gurdaspur (Punjab), a hotspot for stripe rust and at Cooch Behar (West Bengal), a hotspot for spot blotch. The second round evaluation identified 498 accessions potentially resistant to multiple rusts and 868 accessions potentially resistant to spot blotch. Evaluation of rust resistant accessions for seedling resistance against seven virulent pathotypes of three rusts under artificial epiphytotic conditions identified 137 accessions potentially resistant to multiple rusts. Molecular analysis to identify different combinations of genetic loci imparting resistance to leaf rust, stem rust, stripe rust and spot blotch using linked molecular markers, identified 45 wheat accessions containing known resistance genes against all three rusts as well as a QTL for spot blotch resistance. The resistant germplasm accessions, particularly against stripe rust, identified in this study can be excellent potential candidates to be employed for breeding resistance into the background of high yielding wheat cultivars through conventional or molecular breeding approaches, and are expected to contribute toward food security at national and global levels.	[Kumar, Sundeep; Archak, Sunil; Tyagi, R. K.; Jacob, Sherry R.; Srinivasan, Kalyani; Radhamani, J.; Parimalan, R.; Tyagi, Sandhya; Yadav, Mamata; Kumari, Jyotisna; Deepali; Sharma, Sandeep; Kumari, Jyoti; Singh, M. C.; Bag, Manas; Roy, Anirban; Prasad, T. V.; Sharma, R. K.; Dutta, M.; Bansal, K. C.] Natl Bur Plant Genet Resources, ICAR, Pusa Campus, New Delhi, India; [Kumar, Jagdish; Vikas, V. K.; Sivaswamy, M.] Indian Agr Res Inst, Reg Stn, ICAR, Wellington, Tamil Nadu, India; [Bhagat, Indoo] Punjab Agr Univ, Reg Stn, Gurdaspur, Punjab, India; [Meeta, Madhu; Bains, N. S.] Punjab Agr Univ, Ludhiana, Punjab, India; [Chowdhury, A. K.; Saha, B. C.; Bhattacharya, P. M.] North Bengal Agr Univ, Cooch Behar, Cooch Behar, W Bengal, India; [Gangwar, O. P.; Prasad, P.; Bharadwaj, S. C.] Indian Inst Wheat & Barley Res, Reg Stn, ICAR, Flowerdale, Himachal Prades, India; [Gogoi, Robin; Sharma, J. B.] Indian Agr Res Inst, ICAR, New Delhi, India; [Kumar, Sandeep G. M.] Indian Agr Res Inst, Reg Stn, ICAR, Katrain, Himachal Prades, India; [Saharan, M. S.; Sharma, Indu] Indian Inst Wheat & Barley Res, ICAR, Karnal, Haryana, India; [Kumar, Jagdish] Natl Inst Biot Stress Management, ICAR, Raipur, Madhya Pradesh, India; [Bag, Manas] Cent Rice Res Inst, ICAR, Cuttack, Orissa, India; [Roy, Anirban] Indian Agr Res Inst, ICAR, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Punjab Agricultural University; Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Wheat & Barley Research; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Biotic Stresses Management; Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Bansal, KC (corresponding author), Natl Bur Plant Genet Resources, ICAR, Pusa Campus, New Delhi, India.	kailashbansal@hotmail.com	Gogoi, Robin/AAF-7155-2019; Saharan, Mahender/AAI-9831-2020; Bhardwaj, Subhash Chander/U-2644-2017; Bag, Manas Kumar/ABA-4776-2021; Gangwar, Om Prakash/ABA-5954-2021; Prasad, Pramod/M-4679-2017	Bhardwaj, Subhash Chander/0000-0002-4070-8412; Bag, Manas Kumar/0000-0002-5429-2497; Prasad, Pramod/0000-0003-4091-1119; SHARMA, SANDEEP/0000-0002-5795-8899; ARCHAK, SUNIL/0000-0002-9146-2993; TYAGI, SANDHYA/0000-0002-8168-017X	National Innovations on Climate Resilient Agriculture (NICRA)	National Innovations on Climate Resilient Agriculture (NICRA)	The work was funded by a sponsored research component of National Innovations on Climate Resilient Agriculture (NICRA) given to ICAR-NBPGR (http//www.nicra-icar.in/nicrarevised/index.php/spnsored-competative-grants/list-of-projects).	Bansal UK, 2008, WHEAT GENET S, V1, P188; Bonman JM, 2007, CROP SCI, V47, P1955, DOI 10.2135/cropsci2007.01.0028; BROWDER LE, 1973, PHYTOPATHOLOGY, V63, P524, DOI 10.1094/Phyto-63-524; Caldwell RM, 1968, P 3 INT WHEAT GEN S, P263; Chakraborty S, 2011, EUPHYTICA, V179, P19, DOI 10.1007/s10681-010-0324-7; Chand R, 2003, Z PFLANZENK PFLANZEN, V110, P27; Chaurasia S, 1999, GENET RESOUR CROP EV, V46, P469, DOI 10.1023/A:1008797232108; Chen X. M., 2013, American Journal of Plant Sciences, V4, P608; Chowdhury A.K., 2013, J WHEAT RES, V5, P1; CIMMYT, 2013, RES BATTL WHEAT SPOT; Curtis BC, 2002, MACPHERSON HG BREAD, P1; Daetwyler HD, 2014, THEOR APPL GENET, V127, P1795, DOI 10.1007/s00122-014-2341-8; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; DUBIN HJ, 1998, P INT WORKSH HELM DI, P182; Duveiller E., 1998, HELMINTHOSPORIUM BLI, P162; Duveiller E, 2007, EUPHYTICA, V157, P417, DOI 10.1007/s10681-007-9380-z; Duveiller E, 2012, CABI PLANT PROT SER, P120, DOI 10.1079/9781845938185.0120; Eisa M, 2013, EUR J PLANT PATHOL, V137, P805, DOI 10.1007/s10658-013-0290-8; Ellis JG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00641; Elouafi I, 2001, HEREDITAS, V135, P255, DOI 10.1111/j.1601-5223.2001.t01-1-00255.x; Eyal Z., 1987, SEPTORIA DIS WHEAT C; FAOSTAT, 2016, FAOSTAT AGR DAT, P1; Hadi Bux, 2012, Australian Journal of Crop Science, V6, P116; Helguera M, 2003, CROP SCI, V43, P1839, DOI 10.2135/cropsci2003.1839; Hiebert CW, 2007, THEOR APPL GENET, V115, P877, DOI 10.1007/s00122-007-0604-3; Hiebert CW, 2010, THEOR APPL GENET, V121, P1083, DOI 10.1007/s00122-010-1373-y; Hoisington D, 1999, P NATL ACAD SCI USA, V96, P5937, DOI 10.1073/pnas.96.11.5937; Iftikhar S, 2012, PAK J BOT, V44, P361; Jin Y, 2006, PLANT DIS, V90, P476, DOI 10.1094/PD-90-0476; Johnson R, 1998, BREEDING STRATEGIES, P63; Joshi AK, 2007, FIELD CROP RES, V103, P53, DOI 10.1016/j.fcr.2007.04.010; Joshi AK, 2011, EUPHYTICA, V179, P187, DOI 10.1007/s10681-010-0314-9; Joshi AK, 2004, PLANT BREEDING, V123, P213, DOI 10.1111/j.1439-0523.2004.00954.x; Kolmer JA, 2007, AUST J AGR RES, V58, P631, DOI 10.1071/AR07057; Kolmer JA, 2008, CROP SCI, V48, P1841, DOI 10.2135/cropsci2007.08.0474; Kumar J, 2014, INDIAN J AGR SCI, V84, P112; Kumar J, 2011, J WHEAT RES, V3, P8; Kumar U, 2010, MOL BREEDING, V26, P477, DOI 10.1007/s11032-009-9388-2; Kumar U, 2009, THEOR APPL GENET, V118, P783, DOI 10.1007/s00122-008-0938-5; Lagudah ES, 2006, THEOR APPL GENET, V114, P21, DOI 10.1007/s00122-006-0406-z; Mago R, 2005, THEOR APPL GENET, V111, P496, DOI 10.1007/s00122-005-2039-z; Mago R, 2011, THEOR APPL GENET, V122, P735, DOI 10.1007/s00122-010-1482-7; McIntosh R., 1995, WHEAT RUSTS ATLAS RU, DOI [10.1071/9780643101463, DOI 10.1071/9780643101463]; McIntosh R A, 2010, CATALOGUE GENE SYM S; Mikhailova L. A., 2004, Archives of Phytopathology and Plant Protection, V37, P161, DOI 10.1080/03235400310001631909; Nagarajan S., 1975, Cereal Rusts Bulletin, V3, P29; Nagarajan S, 1985, DIS DISTRIBUTION EPI, V2; Nagarajan S., 1998, PROC INT WORKSHOP HE, P52; Nazari K, 2009, PLANT DIS, V93, DOI 10.1094/PDIS-93-3-0317B; Pardey PG, 2013, SCIENCE, V340, P147, DOI 10.1126/science.122970; Parlevliet J. E., 1985, CEREAL RUSTS, V2, P501; Peng JH, 2000, GENETICA, V109, P199, DOI 10.1023/A:1017573726512; Periyannan S, 2013, SCIENCE, V341, P786, DOI 10.1126/science.1239028; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Roder MS, 1998, GENETICS, V149, P2007; Roelfs A.P., 1992, RUST DIS WHEAT CONCE, P34; Saari E.E., 1998, HELMINTHOSPORIUM BLI, P37; Saintenac C, 2013, SCIENCE, V341, P783, DOI 10.1126/science.1239022; Shiferaw B, 2013, FOOD SECUR, V5, P291, DOI 10.1007/s12571-013-0263-y; Simons K, 2011, THEOR APPL GENET, V122, P649, DOI 10.1007/s00122-010-1444-0; Singh R. P., 2000, Acta Phytopathologica et Entomologica Hungarica, V35, P133; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Singh RP, 2011, ANNU REV PHYTOPATHOL, V49, P465, DOI 10.1146/annurev-phyto-072910-095423; SINGH RP, 1992, PHYTOPATHOLOGY, V82, P835, DOI 10.1094/Phyto-82-835; Singh RP, 2002, WHEAT RUSTS BREAD WH, P227; Somers DJ, 2004, THEOR APPL GENET, V109, P1105, DOI 10.1007/s00122-004-1740-7; Stakman EC, 1962, USDA ARS E617, P1; Thomas J, 2010, CROP SCI, V50, P2310, DOI 10.2135/cropsci2010.02.0065; Tiwari V, 2012, CROP IMPROVEMENT, VI; Tomar SMS, 2014, INDIAN J GENET PL BR, V74, P129, DOI 10.5958/0975-6906.2014.00150.3; Tyagi S, 2014, MOL BREEDING, V34, P167, DOI 10.1007/s11032-014-0027-1; Uauy C, 2005, THEOR APPL GENET, V112, P97, DOI 10.1007/s00122-005-0109-x; Vanderplank JE., 1968, DIS RESISTANCE PLANT; Vikas VK, 2014, GENETIC RESOURCES CR, V61; William M, 2003, PHYTOPATHOLOGY, V93, P153, DOI 10.1094/PHYTO.2003.93.2.153; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	76	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167702	10.1371/journal.pone.0167702	http://dx.doi.org/10.1371/journal.pone.0167702			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942031	Green Submitted, Green Published, gold			2022-12-27	WOS:000392745600026
J	Long, LC; Rosen, SB; Brennan, A; Moyo, F; Sauls, C; Evans, D; Modi, SL; Sanne, I; Fox, MP				Long, Lawrence C.; Rosen, Sydney B.; Brennan, Alana; Moyo, Faith; Sauls, Celeste; Evans, Denise; Modi, Shookdev L.; Sanne, Ian; Fox, Matthew P.			Treatment Outcomes and Costs of Providing Antiretroviral Therapy at a Primary Health Clinic versus a Hospital-Based HIV Clinic in South Africa	PLOS ONE			English	Article							POSITIVE PATIENTS; CARE; JOHANNESBURG; DELIVERY; NURSES; ACCESS; MODEL	Background In 2010 South Africa revised its HIV treatment guidelines to allow the initiation and management of patients on antiretroviral therapy (ART) by nurses, rather than solely doctors, under a program called NIMART (Nurse Initiated and Managed Antiretroviral Therapy). We compared the outcomes and costs of NIMART between the two major public sector HIV treatment delivery models in use in South Africa today, primary health clinics and hospital-based HIV clinics. Methods and findings The study was conducted at one hospital-based outpatient HIV clinic and one primary health clinic (PHC) in Gauteng Province. A retrospective cohort of adult patients initiated on ART at the PHC was propensity-score matched to patients initiated at the hospital outpatient clinic. Each patient was assigned a 12-month outcome of alive and in care or died/lost to follow up. Costs were estimated from the provider perspective for the 12 months after ART initiation. The proportion of patients alive and in care at 12 months did not differ between the PHC (76.5%) and the hospital-based site (74.2%). The average annual cost per patient alive and in care at 12 months after ART initiation was significantly lower at the PHC (US$238) than at the hospital outpatient clinic (US$428). Conclusions Initiating and managing ART patients at PHCs under NIMART is producing equally good outcomes as hospital-based HIV clinic care at much lower cost. Evolution of hospital-based clinics into referral facilities that serve complicated patients, while investing most program expansion resources into PHCs, may be a preferred strategy for achieving treatment coverage targets.	[Long, Lawrence C.; Rosen, Sydney B.; Brennan, Alana; Moyo, Faith; Sauls, Celeste; Evans, Denise; Sanne, Ian; Fox, Matthew P.] Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Fac Hlth Sci, Johannesburg, South Africa; [Long, Lawrence C.; Evans, Denise; Sanne, Ian; Fox, Matthew P.] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Long, Lawrence C.; Rosen, Sydney B.; Moyo, Faith; Sauls, Celeste; Evans, Denise; Sanne, Ian; Fox, Matthew P.] Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa; [Rosen, Sydney B.; Brennan, Alana; Sanne, Ian; Fox, Matthew P.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Modi, Shookdev L.; Sanne, Ian] Right Care, Johannesburg, South Africa; [Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University of Witwatersrand; University of Witwatersrand; University of Witwatersrand; Boston University; Boston University	Long, LC (corresponding author), Univ Witwatersrand, Sch Clin Med, Dept Internal Med, Fac Hlth Sci, Johannesburg, South Africa.; Long, LC (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa.; Long, LC (corresponding author), Wits Hlth Consortium, Hlth Econ & Epidemiol Res Off, Johannesburg, South Africa.	llong@heroza.org	Fox, Matthew/K-2004-2019; Sanne, Ian/ABH-2231-2020	Rosen, Sydney/0000-0002-6560-2964; Brennan, Alana/0000-0002-7746-0668; Long, Lawrence/0000-0003-4986-4988	United States Agency for International Development (USAID) [674-A-00-09-00018-00, 674-A-12-00029]; USAID [674-A-12-00029, 674-A-12-00020]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID))	LL, MPF, AB, FM, CS, DE and SBR were funded for this work by United States Agency for International Development (USAID) through the following agreements: 674-A-00-09-00018-00 & 674-A-12-00029. IS was funded for this work by USAID through the following agreement: 674-A-12-00029. SLM was funded for this work by USAID through the following agreement: 674-A-12-00020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author's views expressed in this publication do not necessarily reflect the views of the United States Agency for International Development or the United States Government.	[Anonymous], 2004, NAT ANT TREATM GUID; Barton GR, 2013, TROP MED INT HEALTH, V18, P769, DOI 10.1111/tmi.12093; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bergstralh E, 2014, VMATCH SAS MACRO MAY; Brennan AT, 2011, AIDS, V25, P2027, DOI 10.1097/QAD.0b013e32834b6480; Cameron D, 2012, SAMJ S AFR MED J, V102, P98, DOI 10.7196/SAMJ.5195; Fairall L, 2012, LANCET, V380, P889, DOI 10.1016/S0140-6736(12)60730-2; Fatti G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012888; Grimsrud A, 2014, TROP MED INT HEALTH, V19, P1029, DOI 10.1111/tmi.12346; Kredo T, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007331.pub3; Long L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001055; Meyer-Rath G, 2015, S AFRICAS INVESTMENT; Mitchell M, 2012, INT J MED INFORM, V81, P166, DOI 10.1016/j.ijmedinf.2011.11.003; Monyatsi G., 2011, S AFR MED J, V102, P34; Moshabela Mosa, 2011, Afr J AIDS Res, V10, P393, DOI 10.2989/16085906.2011.646654; Motsoaledi A., 2010, HLTH BUDGET SPEECH; *NAT DEP HLTH SOUT, 2010, CLIN GUID MAN HIV AI; Nyasulu JCY, 2013, SAMJ S AFR MED J, V103, P232, DOI [10.7196/SAMJ.6380, 10.7196/samj.6380]; O'Connor C, 2011, JAIDS-J ACQ IMM DEF, V58, P429, DOI 10.1097/QAI.0b013e318230d507; Rosen S, 2008, TROP MED INT HEALTH, V13, P1005, DOI 10.1111/j.1365-3156.2008.02114.x; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sanne I, 2010, LANCET, V376, P33, DOI 10.1016/S0140-6736(10)60894-X; Selke HM, 2010, JAIDS-J ACQ IMM DEF, V55, P483, DOI 10.1097/QAI.0b013e3181eb5edb; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; Umar NA, 2011, J PUBLIC HLTH AFRICA, V2; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2014, THE GAP REP; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019	28	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168118	10.1371/journal.pone.0168118	http://dx.doi.org/10.1371/journal.pone.0168118			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942005	gold, Green Published, Green Submitted			2022-12-27	WOS:000392745600052
J	Sainton, P; Nicol, C; Cabri, J; Barthelemy-Montfort, J; Chavet, P				Sainton, Patrick; Nicol, Caroline; Cabri, Jan; Barthelemy-Montfort, Joelle; Chavet, Pascale			Kinetics and Muscle Activity Patterns during Unweighting and Reloading Transition Phases in Running	PLOS ONE			English	Article							GROUND LEG ADJUSTMENTS; NEUROMUSCULAR CONTROL; WEIGHT SUPPORT; EMG ACTIVITY; GRAVITY; ACTIVATION; MECHANICS; TREADMILL; FORCE	Amongst reduced gravity simulators, the lower body positive pressure (LBPP) treadmill is emerging as an innovative tool for both rehabilitation and fundamental research purposes as it allows running while experiencing reduced vertical ground reaction forces. The appropriate use of such a treadmill requires an improved understanding of the associated neuromechanical changes. This study concentrates on the runner's adjustments to LBPP-induced unweighting and reloading during running. Nine healthy males performed two running series of nine minutes at natural speed. Each series comprised three sequences of three minutes at: 100% bodyweight (BW), 60 or 80% BW, and 100% BW. The progressive unweighting and reloading transitions lasted 10 to 15 s. The LBPP-induced unweighting level, vertical ground reaction force and center of mass accelerations were analyzed together with surface electromyographic activity from 6 major lower limb muscles. The analyses of stride-to-stride adjustments during each transition established highly linear relationships between the LBPP-induced progressive changes of BW and most mechanical parameters. However, the impact peak force and the loading rate systematically presented an initial 10% increase with unweighting which could result from a passive mechanism of leg retraction. Another major insight lies in the distinct neural adjustments found amongst the recorded lower-limb muscles during the pre- and post-contact phases. The preactivation phase was characterized by an overall EMG stability, the braking phase by decreased quadriceps and soleus muscle activities, and the push-off phase by decreased activities of the shank muscles. These neural changes were mirrored during reloading. These neural adjustments can be attributed in part to the lack of visual cues on the foot touchdown. These findings highlight both the rapidity and the complexity of the neuromechanical changes associated with LBPP-induced unweighting and reloading during running. This in turn emphasizes the need for further investigation of the evolution over time of these neuromechanical changes.	[Sainton, Patrick; Nicol, Caroline; Barthelemy-Montfort, Joelle; Chavet, Pascale] Aix Marseille Univ, CNRS, ISM UMR 7287, Marseille, France; [Cabri, Jan] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway; [Cabri, Jan] LU NEX Univ, Fac Hlth Sci, Differdange, Luxembourg	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Norwegian School of Sport Sciences	Sainton, P (corresponding author), Aix Marseille Univ, CNRS, ISM UMR 7287, Marseille, France.	patrick.sainton@univ-amu.fr	sainton, patrick/J-3071-2016	Cabri, Jan/0000-0001-5539-4148				AVELA J, 1994, AVIAT SPACE ENVIR MD, V65, P301; Avela J, 1996, EUR J APPL PHYSIOL, V72, P553, DOI 10.1007/BF00242290; Biewener AA, 2007, J EXP BIOL, V210, P2949, DOI 10.1242/jeb.005801; Blickhan R, 2007, PHILOS T R SOC A, V365, P199, DOI 10.1098/rsta.2006.1911; Chang YH, 2000, J EXP BIOL, V203, P229; Cohen J.E., 1988, STAT POWER ANAL BEHA; Donelan JM, 2000, J EXP BIOL, V203, P2405; Ferris DP, 1998, P ROY SOC B-BIOL SCI, V265, P989, DOI 10.1098/rspb.1998.0388; GOLLHOFER A, 1991, INT J SPORTS MED, V12, P34, DOI 10.1055/s-2007-1024652; Grabowski AM, 2008, J APPL BIOMECH, V24, P288, DOI 10.1123/jab.24.3.288; Grimmer S, 2008, J EXP BIOL, V211, P2989, DOI 10.1242/jeb.014357; HE JP, 1991, J APPL PHYSIOL, V71, P863, DOI 10.1152/jappl.1991.71.3.863; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hunter I, 2014, J ELECTROMYOGR KINES, V24, P348, DOI 10.1016/j.jelekin.2014.01.009; Jensen BR, 2016, J APPL BIOMECH, V32, P335, DOI 10.1123/jab.2015-0075; KOMI PV, 1987, INT J SPORTS MED, V8, P196, DOI 10.1055/s-2008-1025655; Lamy JC, 2008, J PHYSIOL-LONDON, V586, P5931, DOI 10.1113/jphysiol.2008.160630; Landreneau LL, 2014, INT J SPORTS PHYS TH, V9, P888; Liebenberg J, 2011, J SPORT SCI, V29, P207, DOI 10.1080/02640414.2010.534806; Lowrey CR, 2014, J APPL PHYSIOL, V116, P683, DOI 10.1152/japplphysiol.01200.2013; MASSION J, 1995, J VESTIBUL RES-EQUIL, V5, P211, DOI 10.1016/0957-4271(94)00031-V; MEUNIER S, 1993, EXP BRAIN RES, V96, P534; Morio C, 2012, EUR J APPL PHYSIOL, V112, P2817, DOI 10.1007/s00421-011-2242-3; Muller R, 2015, J EXP BIOL, V218, P451, DOI 10.1242/jeb.113688; Muller R, 2010, HUM MOVEMENT SCI, V29, P578, DOI 10.1016/j.humov.2010.04.007; Muller R, 2010, HUM MOVEMENT SCI, V29, P299, DOI 10.1016/j.humov.2010.01.003; NEWMAN DJ, 1994, AVIAT SPACE ENVIR MD, V65, P815; Patil S, 2013, J ORTHOP RES, V31, P672, DOI 10.1002/jor.22272; Ritzmann R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128400; Roll R, 1998, EXP BRAIN RES, V122, P393, DOI 10.1007/s002210050527; Sainton P, 2015, EUR J APPL PHYSIOL, V115, P1135, DOI 10.1007/s00421-014-3095-3; Sano K, 2015, EUR J APPL PHYSIOL, V115, P849, DOI 10.1007/s00421-014-3067-7; Santello M, 1998, EXP PHYSIOL, V83, P857, DOI 10.1113/expphysiol.1998.sp004165; Schmidtbleicher D., 1982, LEISTUNGSSPORT, V12, P298; Suzuki T, 2014, HUM MOVEMENT SCI, V36, P35, DOI 10.1016/j.humov.2014.04.009; Sylos-Labini F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/547242; Tenforde AS, 2012, PM&R, V4, P629, DOI 10.1016/j.pmrj.2012.02.003; Zadpoor AA, 2011, CLIN BIOMECH, V26, P23, DOI 10.1016/j.clinbiomech.2010.08.005	38	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168545	10.1371/journal.pone.0168545	http://dx.doi.org/10.1371/journal.pone.0168545			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992539	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600074
J	Shiode, Y; Morizane, Y; Toshima, S; Kimura, S; Kumase, F; Hosokawa, M; Hirano, M; Doi, S; Takahashi, K; Hosogi, M; Fujiwara, A; Shiraga, F				Shiode, Yusuke; Morizane, Yuki; Toshima, Shinji; Kimura, Shuhei; Kumase, Fumiaki; Hosokawa, Mio; Hirano, Masayuki; Doi, Shinichiro; Takahashi, Kosuke; Hosogi, Mika; Fujiwara, Atsushi; Shiraga, Fumio			Surgical Outcome of Idiopathic Epiretinal Membranes with Intraretinal Cystic Spaces	PLoS One			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MICROCYSTIC MACULAR EDEMA; INNER NUCLEAR LAYER; VITRECTOMY; SURGERY; PUCKER; PATHOLOGY; GLIOSIS	Objective To investigate the occurrence ratio, localization, and surgical outcomes of intraretinal cystic spaces in idiopathic epiretinal membranes (ERMs). Methods We retrospectively reviewed the charts of 432 eyes of 398 consecutive patients with idiopathic ERM who underwent vitrectomy and ERM peeling from January 2012 to September 2015. We selected cases with intraretinal cystic space prior to surgery, detected by spectral- domain optical coherence tomography. We then evaluated the effects of ERM peeling on intraretinal cystic spaces, best corrected visual acuity, and central retinal thickness at 6 months after surgery. Results Twenty-four eyes (5.5%) showed intraretinal cystic spaces before surgery, present in the inner retinal layer (the inner group) in 9 eyes, in the outer retinal layer (the outer group) in 6 eyes, and in both the inner and the outer retinal layers (the combined group) in 9 eyes. Additionally, 30 eyes with ERM but without any presence of intraretinal cystic space were selected randomly and classified as the no cyst group. At 6 months after surgery, the disappearance rate of cystic spaces was significantly greater for the outer group than for the inner group (83.3% and 11.1%, respectively, P = 0.011). The mean best corrected visual acuity improved significantly after surgery in the inner group, the outer group, and the no cyst group (P < 0.05 for all three groups) but did not improve in the combined group (P = 0.58). The mean central retinal thickness decreased significantly after surgery in the inner group, the combined group, and the no cyst group (P < 0.05). Conclusions Intraretinal cystic spaces were observed in 5.5% of preoperative idiopathic ERM cases. Following surgery, the cystic spaces in the outer retinal layer disappeared at higher rates than those in the inner retinal layer, suggesting that the pathophysiologies of these cystic spaces are different.	[Shiode, Yusuke; Morizane, Yuki; Toshima, Shinji; Kimura, Shuhei; Kumase, Fumiaki; Hosokawa, Mio; Hirano, Masayuki; Doi, Shinichiro; Takahashi, Kosuke; Hosogi, Mika; Fujiwara, Atsushi; Shiraga, Fumio] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama, Okayama, Japan	Okayama University	Morizane, Y (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Ophthalmol, Okayama, Okayama, Japan.	moriza-y@okayama-u.ac.jp						[Anonymous], 1985, ARCH OPHTHALMOL-CHIC, V103, pe1095, DOI [10.1016/j.ophtha.2010.01.058, DOI 10.1016/J.OPHTHA.2010.01.058]; Barthelmes D, 2008, INVEST OPHTH VIS SCI, V49, P3529, DOI 10.1167/iovs.07-1320; Bu SC, 2014, RETINA-J RET VIT DIS, V34, P2317, DOI 10.1097/IAE.0000000000000349; Burggraaff MC, 2014, INVEST OPHTH VIS SCI, V55, P952, DOI 10.1167/iovs.13-12912; DEBUSTROS S, 1988, BRIT J OPHTHALMOL, V72, P692, DOI 10.1136/bjo.72.9.692; EGGER EGE, 1973, OPHTHALMOLOGICA, V167, P443, DOI 10.1159/000306992; Frisina R, 2015, GRAEF ARCH CLIN EXP, V253, P47, DOI 10.1007/s00417-014-2655-x; Fujiwara A, 2016, AM J OPHTHALMOL; Gelfand JM, 2012, BRAIN, V135, P1786, DOI 10.1093/brain/aws098; Kinoshita T, 2011, RETINA-J RET VIT DIS, V31, P1692, DOI 10.1097/IAE.0b013e31820f49d0; Massin P, 2000, AM J OPHTHALMOL, V130, P732, DOI 10.1016/S0002-9394(00)00574-2; Michalewski J, 2007, GRAEF ARCH CLIN EXP, V245, P1623, DOI 10.1007/s00417-007-0579-4; MICHELS RG, 1984, OPHTHALMOLOGY, V91, P1384; PEARLSTONE AD, 1985, ANN OPHTHALMOL, V17, P378; PESIN SR, 1991, OPHTHALMOLOGY, V98, P1109; Pournaras CJ, 2011, SEMIN OPHTHALMOL, V26, P42, DOI 10.3109/08820538.2010.544237; Rao P, 2016, EUR J OPHTHALMOL; Ritter M, 2011, EYE, V25, P1284, DOI 10.1038/eye.2011.190; Ritter M, 2014, BRIT J OPHTHALMOL, V98, P1629, DOI 10.1136/bjophthalmol-2014-305186; Rogers SL, 2010, OPHTHALMOLOGY, V117, P1094, DOI 10.1016/j.ophtha.2010.01.058; Scheerlinck LME, 2015, ACTA OPHTHALMOL, V93, P203, DOI 10.1111/aos.12537; SIDD RJ, 1982, AM J OPHTHALMOL, V94, P44, DOI 10.1016/0002-9394(82)90189-1; Sigler EJ, 2014, INVEST OPHTH VIS SCI, V55, P3282, DOI 10.1167/iovs.14-14056; Sigler EJ, 2013, GRAEF ARCH CLIN EXP, V251, P1679, DOI 10.1007/s00417-012-2253-8; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P5103, DOI 10.1167/iovs.08-2127; Sugiura Y, 2016, RELATIONSHIP METAMOR; TRESE MT, 1983, GRAEF ARCH CLIN EXP, V221, P12, DOI 10.1007/BF02171725; TSO MOM, 1982, OPHTHALMOLOGY, V89, P902; Verdaguer P, 2012, EUR J OPHTHALMOL, V22, P506, DOI 10.5301/ejo.5000034	29	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168555	10.1371/journal.pone.0168555	http://dx.doi.org/10.1371/journal.pone.0168555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992520	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600075
J	Elmas, A; Yang, THO; Wang, XD; Anastassiou, D				Elmas, Abdulkadir; Yang, Tai-Hsien Ou; Wang, Xiaodong; Anastassiou, Dimitris			Discovering Genome-Wide Tag SNPs Based on the Mutual Information of the Variants	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HAPLOTYPE STRUCTURE; SEQUENCE VARIATION; DNA-SEQUENCE; SELECTION; BLOCKS; MAP; LD	Exploring linkage disequilibrium (LD) patterns among the single nucleotide polymorphism (SNP) sites can improve the accuracy and cost-effectiveness of genomic association studies, whereby representative (tag) SNPs are identified to sufficiently represent the genomic diversity in populations. There has been considerable amount of effort in developing efficient algorithms to select tag SNPs from the growing large-scale data sets. Methods using the classical pairwise-LD and multi-locus LD measures have been proposed that aim to reduce the computational complexity and to increase the accuracy, respectively. The present work solves the tag SNP selection problem by efficiently balancing the computational complexity and accuracy, and improves the coverage in genomic diversity in a cost-effective manner. The employed algorithm makes use of mutual information to explore the multi-locus association between SNPs and can handle different data types and conditions. Experiments with benchmark HapMap data sets show comparable or better performance against the state-of-the-art algorithms. In particular, as a novel application, the genome-wide SNP tagging is performed in the 1000 Genomes Project data sets, and produced a well-annotated database of tagging variants that capture the common genotype diversity in 2,504 samples from 26 human populations. Compared to conventional methods, the algorithm requires as input only the genotype (or haplotype) sequences, can scale up to genome-wide analyses, and produces accurate solutions with more information-rich output, providing an improved platform for researchers towards the subsequent association studies.	[Elmas, Abdulkadir; Yang, Tai-Hsien Ou; Wang, Xiaodong; Anastassiou, Dimitris] Columbia Univ, Dept Elect Engn, New York, NY 10027 USA; [Yang, Tai-Hsien Ou; Anastassiou, Dimitris] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Elmas, Abdulkadir] Arizona State Univ, Biodesign Inst, Tempe, AZ USA	Columbia University; Columbia University; Arizona State University; Arizona State University-Tempe	Wang, XD; Anastassiou, D (corresponding author), Columbia Univ, Dept Elect Engn, New York, NY 10027 USA.; Anastassiou, D (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.	xw2008@columbia.edu; d.anastassiou@columbia.edu	Elmas, Abdulkadir/AAH-5958-2021	Elmas, Abdulkadir/0000-0002-7999-5770; Ou Yang, Tai-Hsien/0000-0001-9650-1253				Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; [Anonymous], 2014, MATLAB MACHINE LEARN; Avi-Itzhak Hadar I, 2003, Pac Symp Biocomput, P466; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Birney E, 2015, NATURE, V526, P52, DOI 10.1038/526052a; Bush WS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002822; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Cheng WY, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005974; Cheng WY, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002920; Cheng WY, ARXIV13062584; Collins FS, 1997, SCIENCE, V278, P1580, DOI 10.1126/science.278.5343.1580; Cover TM., 2006, WILEY SERIES TELECOM; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Daub CO, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-118; De Bakker Paul I W, 2006, Pac Symp Biocomput, P478, DOI 10.1142/9789812701626_0044; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Deng LB, 2008, HUM MUTAT, V29, P1209, DOI 10.1002/humu.20775; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Hampe J, 2003, HUM GENET, V114, P36, DOI 10.1007/s00439-003-1017-2; Hao K, 2007, BIOINFORMATICS, V23, P3178, DOI 10.1093/bioinformatics/btm496; He JW, 2007, IEEE T NANOBIOSCI, V6, P60, DOI 10.1109/TNB.2007.891901; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Judson R, 2002, PHARMACOGENOMICS, V3, P379, DOI 10.1517/14622416.3.3.379; Katanforoush A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-269; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; LEWONTIN RC, 1988, GENETICS, V120, P849; LI WT, 1994, PHYSICA D, V75, P392, DOI 10.1016/0167-2789(94)90294-1; Li X, 2013, IEEE ACM T COMPUT BI, V10, P688, DOI 10.1109/TCBB.2013.61; Liao B, 2015, IEEE ACM T COMPUT BI, V12, P113, DOI 10.1109/TCBB.2014.2351797; Liu GM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-66; Liu ZQ, 2005, GENET EPIDEMIOL, V29, P353, DOI 10.1002/gepi.20092; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Phuong Tu Minh, 2006, Journal of Bioinformatics and Computational Biology, V4, P241, DOI 10.1142/S0219720006001941; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Stram Daniel O., 2005, Human Genomics, V2, P144; Ting CK, 2010, BIOINFORMATICS, V26, P1446, DOI 10.1093/bioinformatics/btq158; Yang THO, 2014, CANCER EPIDEM BIOMAR, V23, P2850, DOI 10.1158/1055-9965.EPI-14-0399; Zhang K, 2004, GENOME RES, V14, P908, DOI 10.1101/gr.1837404	44	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167994	10.1371/journal.pone.0167994	http://dx.doi.org/10.1371/journal.pone.0167994			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992465	gold, Green Published, Green Submitted			2022-12-27	WOS:000392758000021
J	Meza-Rios, A; Garcia-Benavides, L; Garcia-Banuelos, J; Salazar-Montes, A; Armendariz-Borunda, J; Sandoval-Rodriguez, A				Meza-Rios, Alejandra; Garcia-Benavides, Leonel; Garcia-Banuelos, Jesus; Salazar-Montes, Adriana; Armendariz-Borunda, Juan; Sandoval-Rodriguez, Ana			Simultaneous Administration of ADSCs-Based Therapy and Gene Therapy Using Ad-huPA Reduces Experimental Liver Fibrosis	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ADENOVIRAL VECTORS; UROKINASE; EXPRESSION; CIRRHOSIS; CHEMOKINES	Background and Aims hADSCs transplantation in cirrhosis models improves liver function and reduces fibrosis. In addition, Ad-huPA gene therapy diminished fibrosis and increased hepatocyte regeneration. In this study, we evaluate the combination of these therapies in an advanced liver fibrosis experimental model. Methods hADSCs were expanded and characterized before transplantation. Ad-huPA was simultaneously administrated via the ileac vein. Animals were immunosuppressed by CsA 24 h before treatment and until sacrifice at 10 days post-treatment. huPA liver expression and hADSCs biodistribution were evaluated, as well as the percentage of fibrotic tissue, hepatic mRNA levels of Col-alpha I, TGF-beta 1, CTGF, alpha-SMA, PAI-I, MMP2 and serum levels of ALT, AST and albumin. Results hADSCs homed mainly in liver, whereas huPA expression was similar in Ad-huPA and hADSCs/Ad-huPA groups. hADSCs, Ad-huPA and hADSCs/Ad-huPA treatment improves albumin levels, reduces liver fibrosis and diminishes Collagen alpha 1, CTGF and alpha-SMA mRNA liver levels. ALT and AST serum levels showed a significant decrease exclusively in the hADSCs group. Conclusions These results showed that combinatorial effect of cell and gene-therapy does not improve the antifibrogenic effects of individual treatments, whereas hADSCs transplantation seems to reduce liver fibrosis in a greater proportion.	[Meza-Rios, Alejandra; Garcia-Banuelos, Jesus; Salazar-Montes, Adriana; Armendariz-Borunda, Juan; Sandoval-Rodriguez, Ana] Univ Guadalajara, Hlth Sci Univ Ctr, Inst Mol Biol Med, Dept Mol Biol & Genom, Guadalajara, Jalisco, Mexico; [Garcia-Benavides, Leonel] Univ Guadalajara, Hlth Sci Univ Ctr, Dept Physiol, Unit Cardiovasc Invest, Guadalajara, Jalisco, Mexico; [Armendariz-Borunda, Juan] INNOVARE, Guadalajara, Jalisco, Mexico	Universidad de Guadalajara; Universidad de Guadalajara	Armendariz-Borunda, J; Sandoval-Rodriguez, A (corresponding author), Univ Guadalajara, Hlth Sci Univ Ctr, Inst Mol Biol Med, Dept Mol Biol & Genom, Guadalajara, Jalisco, Mexico.; Armendariz-Borunda, J (corresponding author), INNOVARE, Guadalajara, Jalisco, Mexico.	armdbo@gmail.com; anasol44@hotmail.com	Armendáriz-Borunda, Juan/AAU-1471-2021; Garcia Benavides, Leonel/GPP-7463-2022; garcia, leonel/V-9040-2017; Meza-Rios, Alejandra/Q-6629-2019; Garcia-Banuelos, Jesus/W-2927-2019	Garcia Benavides, Leonel/0000-0001-8087-3597; garcia, leonel/0000-0001-8087-3597; Meza-Rios, Alejandra/0000-0002-1322-1684; Sandoval-Rodriguez, Ana/0000-0003-1708-1495	CONACYT [103772, 183039]; Innovare	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Innovare	The funders (CONACYT Grant 103772 to ASR and 183039 to JAB) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also, the funder (Innovare) provided support in the form of salaries for author JAB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Armendariz-Borunda J, 2011, J BIOSCI BIOENG, V112, P415, DOI 10.1016/j.jbiosc.2011.07.018; Baek SJ, 2011, EXP MOL MED, V43, P596, DOI 10.3858/emm.2011.43.10.069; Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bueno M, 2006, J GENE MED, V8, P1291, DOI 10.1002/jgm.961; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cui L, 2007, TISSUE ENG, V13, P1185, DOI 10.1089/ten.2006.0315; Fiore EJ, 2015, STEM CELLS DEV, V24, P791, DOI 10.1089/scd.2014.0174; Garcia-Banuelos J, 2002, GENE THER, V9, P127, DOI 10.1038/sj.gt.3301647; Harn HJ, 2012, CELL TRANSPLANT, V21, P2753, DOI 10.3727/096368912X652959; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Kamada Y, 2009, AM J PHYSIOL-GASTR L, V296, pG157, DOI 10.1152/ajpgi.90463.2008; LEE YG, 2008, J TISSUE ENG REGEN M, V5, P613; Li H, 2011, J HEPATOL, V54, P930, DOI 10.1016/j.jhep.2010.07.051; Lin HW, 2011, MATH PROBL ENG, V2011, DOI 10.1155/2011/402437; Lue J, 2010, LIVER INT, V30, P913, DOI 10.1111/j.1478-3231.2010.02231.x; Mohammadzadeh A, 2014, INT IMMUNOPHARMACOL, V20, P316, DOI 10.1016/j.intimp.2014.03.003; Muruve DA, 1999, HUM GENE THER, V10, P965, DOI 10.1089/10430349950018364; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; Parekkadan B, 2007, BIOCHEM BIOPH RES CO, V363, P247, DOI 10.1016/j.bbrc.2007.05.150; Salgado AJ, 2010, CURR STEM CELL RES T, V5, P103; Salgado S, 2000, MOL THER, V2, P545, DOI 10.1006/mthe.2000.0210; Wang Y, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-133; Yu Y, 2007, MOL THER, V15, P1382, DOI 10.1038/sj.mt.6300202; Zuk, 2013, ISRN STEM CELLS, DOI [10.1155/2013/713959, DOI 10.1155/2013/713959]	26	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0166849	10.1371/journal.pone.0166849	http://dx.doi.org/10.1371/journal.pone.0166849			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992438	Green Submitted, gold, Green Published			2022-12-27	WOS:000392758000009
J	Qin, F; Liu, DX; Sun, BD; Ruan, L; Ma, ZH; Wang, HG				Qin, Feng; Liu, Dongxia; Sun, Bingda; Ruan, Liu; Ma, Zhanhong; Wang, Haiguang			Identification of Alfalfa Leaf Diseases Using Image Recognition Technology	PLOS ONE			English	Article							FEATURES; MACHINE	Common leaf spot (caused by Pseudopeziza medicaginis), rust (caused by Uromyces striatus), Leptosphaerulina leaf spot (caused by Leptosphaerulina briosiana) and Cercospora leaf spot (caused by Cercospora medicaginis) are the four common types of alfalfa leaf diseases. Timely and accurate diagnoses of these diseases are critical for disease management, alfalfa quality control and the healthy development of the alfalfa industry. In this study, the identification and diagnosis of the four types of alfalfa leaf diseases were investigated using pattern recognition algorithms based on image-processing technology. A sub-image with one or multiple typical lesions was obtained by artificial cutting from each acquired digital disease image. Then the sub-images were segmented using twelve lesion segmentation methods integrated with clustering algorithms (including K_means clustering, fuzzy C-means clustering and K_median clustering) and supervised classification algorithms (including logistic regression analysis, Naive Bayes algorithm, classification and regression tree, and linear discriminant analysis). After a comprehensive comparison, the segmentation method integrating the K_median clustering algorithm and linear discriminant analysis was chosen to obtain lesion images. After the lesion segmentation using this method, a total of 129 texture, color and shape features were extracted from the lesion images. Based on the features selected using three methods (ReliefF, 1R and correlation-based feature selection), disease recognition models were built using three supervised learning methods, including the random forest, support vector machine (SVM) and K-nearest neighbor methods. A comparison of the recognition results of the models was conducted. The results showed that when the ReliefF method was used for feature selection, the SVM model built with the most important 45 features (selected from a total of 129 features) was the optimal model. For this SVM model, the recognition accuracies of the training set and the testing set were 97.64% and 94.74%, respectively. Semi-supervised models for disease recognition were built based on the 45 effective features that were used for building the optimal SVM model. For the optimal semi-supervised models built with three ratios of labeled to unlabeled samples in the training set, the recognition accuracies of the training set and the testing set were both approximately 80%. The results indicated that image recognition of the four alfalfa leaf diseases can be implemented with high accuracy. This study provides a feasible solution for lesion image segmentation and image recognition of alfalfa leaf disease.	[Qin, Feng; Ruan, Liu; Ma, Zhanhong; Wang, Haiguang] China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China; [Liu, Dongxia] Hebei North Univ, Coll Agr & Forestry Sci & Technol, Zhangjiakou, Hebei Province, Peoples R China; [Sun, Bingda] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	China Agricultural University; Hebei North University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Wang, HG (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing, Peoples R China.	wanghaiguang@cau.edu.cn	Ma, Zhanhong/AAY-4348-2021; Da Sun, Bing/AAT-7712-2020	Ma, Zhanhong/0000-0002-4910-5001	Special Fund for Agro-scientific Research in the Public Interest [201303057]	Special Fund for Agro-scientific Research in the Public Interest	HGW received Special Fund for Agro-scientific Research in the Public Interest (grant number 201303057). The URL of the funder's website is http://www.kjs.moa.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, orpreparation of the manuscript.	Aji Alham F., 2013, International Journal of Computer Theory and Engineering, V5, P528, DOI 10.7763/IJCTE.2013.V5.743; Barbedo JGA, 2016, BIOSYST ENG, V144, P52, DOI 10.1016/j.biosystemseng.2016.01.017; Barbedo JGA, 2014, PLANT DIS, V98, P1709, DOI 10.1094/PDIS-03-14-0290-RE; Atoum Y, 2016, PATTERN RECOGN, V53, P287, DOI 10.1016/j.patcog.2015.11.021; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Camargo A, 2009, BIOSYST ENG, V102, P9, DOI 10.1016/j.biosystemseng.2008.09.030; Camargo A, 2009, COMPUT ELECTRON AGR, V66, P121, DOI 10.1016/j.compag.2009.01.003; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Dubey Shiv Ram, 2014, International Journal of Computer Vision and Image Processing, V4, P52, DOI 10.4018/ijcvip.2014040104; Gonzalez R. C., 2007, DIGITAL IMAGE PROCES; Gonzalez R. C., 2005, DIGITAL IMAGE PROCES; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Kononenko I., 1994, EUR C MACH LEARN, V784, P171, DOI DOI 10.1007/3-540-57868-4_57; Leiva-Valenzuela GA, 2013, FOOD CONTROL, V33, P166, DOI 10.1016/j.foodcont.2013.02.025; Li GuanLin, 2012, Journal of China Agricultural University, V17, P72; Li YZ, 2015, METHODS DIAGNOSE INV; Liu AP, 2005, PESTS THEIR CONTROL; Liu Lu, 2008, Computer Engineering and Applications, V44, P32; Mao HanPing, 2008, Transactions of the Chinese Society of Agricultural Engineering, V24, P136; Mao HanPing, 2003, Nongye Jixie Xuebao = Transactions of the Chinese Society of Agricultural Machinery, V34, P73; Omrani E, 2014, MEASUREMENT, V55, P512, DOI 10.1016/j.measurement.2014.05.033; Patil JK, 2011, J ADV BIOINFORM APPL, V2, P135; Patil S. B., 2011, INT J ENG TECHNOLOGY, V3, P297, DOI 10.7763/IJET.2011.V3.241; Phadikar S, 2013, COMPUT ELECTRON AGR, V90, P76, DOI 10.1016/j.compag.2012.11.001; Powers D. M, 2011, ARXIV201016061; Pydipati R, 2006, COMPUT ELECTRON AGR, V52, P49, DOI 10.1016/j.compag.2006.01.004; [屈赟 Qu Yun], 2015, [河北农业大学学报, Journal of Agricultural University of Hebei], V38, P102; Rosenberg C, 2005, WACV 2005: SEVENTH IEEE WORKSHOP ON APPLICATIONS OF COMPUTER VISION, PROCEEDINGS, P29; Samac DA, 2014, COMPENDIUM ALFALFA D; Sankaran S, 2010, COMPUT ELECTRON AGR, V72, P1, DOI 10.1016/j.compag.2010.02.007; Schaad NW, 2002, CAN J PLANT PATHOL, V24, P250; Song Y, 2007, LECT NOTES ARTIF INT, V4702, P248; Story D, 2010, COMPUT ELECTRON AGR, V74, P238, DOI 10.1016/j.compag.2010.08.010; STRICKER M, 1995, P SOC PHOTO-OPT INS, V2410, P381, DOI 10.1117/12.205308; Tan W.X., 2015, T CSAM, V46, P20, DOI 10.6041/j.issn.1000-1298.2015.01.004; Tian YouWen, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P175; Torgo L., 2010, DATA MINING R LEARNI; Wang XY, 2012, NEURAL NETWORKS, V33, P148, DOI 10.1016/j.neunet.2012.04.012; Witten IH, 2014, DATA MINING PRACTICA; Xia YQ, 2014, J ZHENGZHOU U LIGHT, V29, P71; Xu GL, 2011, PATTERN RECOGN LETT, V32, P1584, DOI 10.1016/j.patrec.2011.04.020; [叶海建 Ye Haijian], 2016, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V47, P270; Zhang JianHua, 2012, Transactions of the Chinese Society of Agricultural Engineering, V28, P161; Zhang M, 2011, PATTERN RECOGN LETT, V32, P2036, DOI 10.1016/j.patrec.2011.08.003; Zhao YuXia, 2007, Scientia Agricultura Sinica, V40, P698; Zheng Jiao, 2015, Computer Engineering and Science, V37, P1366, DOI 10.3969/j.issn.1007-130X.2015.07.023; Zhou R, 2015, COMPUT ELECTRON AGR, V116, P65, DOI 10.1016/j.compag.2015.05.020	50	55	59	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168274	10.1371/journal.pone.0168274	http://dx.doi.org/10.1371/journal.pone.0168274			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977767	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400086
J	Wang, B; Russell, ML; Moss, L; Fonseca, K; Earn, DJD; Aoki, F; Horsman, G; Van Caeseele, P; Chokani, K; Vooght, M; Babiuk, L; Webby, R; Walter, SD; Loeb, M				Wang, Biao; Russell, Margaret L.; Moss, Lorraine; Fonseca, Kevin; Earn, David J. D.; Aoki, Fred; Horsman, Gregory; Van Caeseele, Paul; Chokani, Khami; Vooght, Mark; Babiuk, Lorne; Webby, Richard; Walter, Stephen D.; Loeb, Mark			Effect of Influenza Vaccination of Children on Infection Rate in Hutterite Communities: Follow-Up Study of a Randomized Trial	PLOS ONE			English	Article							UNITED-STATES; MORBIDITY; VACCINES; SCHOOLCHILDREN; METAANALYSIS; PROTECTION; EXPERIENCE; EFFICACY; CONTACTS; VIRUS	Background An earlier cluster randomized controlled trial (RCT) of Hutterite colonies had shown that if more than 80% of children and adolescents were immunized with influenza vaccine there was a statistically significant reduction in laboratory-confirmed influenza among all unimmunized community members. We assessed the impact of this intervention for two additional influenza seasonal periods. Methods Follow-up data for two influenza seasonal periods of a cluster randomized trial involving 1053 Canadian children and adolescents aged 36 months to 15 years in Season 2 and 1014 in Season 3 who received the study vaccine, and 2805 community members in Season 2 and 2840 in Season 3 who did not receive the study vaccine. Follow-up for Season 2 began November 18, 2009 and ended April 25, 2010 while Season 3 extended from December 6, 2010 and ended May 27, 2011. Children were randomly assigned in a blinded manner according to community membership to receive either inactivated trivalent influenza vaccine or hepatitis A. The primary outcome was confirmed influenza A and B infection using RT-PCR assay. Due to the outbreak of 2009 H1N1 pandemic, data in Season 2 were excluded for analysis. Results For an analysis of the combined Season 1 and Season 3 data, among non-recipients (i.e., participants who did not receive study vaccines), 66 of the 2794 (2.4%) participants in the influenza vaccine colonies and 121 of the 2301 (5.3%) participants in the hepatitis A colonies had influenza confirmed by RT-PCR, for a protective effectiveness of 60% (95% CI, 6% to 83%; P = 0.04); among all study participants (i.e., including both those who received study vaccine and those who did not), 125 of the 3806 (3.3%) in the influenza vaccine colonies and 239 of the 3243 (7.4%) in the hepatitis A colonies had influenza confirmed by RTPCR, for a protective effectiveness of 63% (95% CI, 5% to 85%; P = 0.04). Conclusion Immunizing children and adolescents with inactivated influenza vaccine can offer a protective effect among unimmunized community members for influenza A and B together when considered over multiple years of seasonal influenza.	[Wang, Biao; Moss, Lorraine; Loeb, Mark] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Russell, Margaret L.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Fonseca, Kevin; Walter, Stephen D.] Univ Calgary, Dept Microbiol & Infect Dis, Calgary, AB, Canada; [Fonseca, Kevin; Walter, Stephen D.] Univ Calgary, Prov Lab Publ Hlth, Calgary, AB, Canada; [Earn, David J. D.; Loeb, Mark] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Earn, David J. D.; Loeb, Mark] McMaster Univ, Michael G De Groote Inst Infect Dis Res, Hamilton, ON, Canada; [Earn, David J. D.] McMaster Univ, Dept Math & Stat, Hamilton, ON, Canada; [Aoki, Fred] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Aoki, Fred] Univ Manitoba, Dept Med Microbiol & Pharmacol, Winnipeg, MB, Canada; [Aoki, Fred] Univ Manitoba, Dept Therapeut, Winnipeg, MB, Canada; [Horsman, Gregory] Saskatchewan Dis Control Lab, Regina, SK, Canada; [Van Caeseele, Paul] Univ Manitoba, Cadham Prov Lab, Dept Med Microbiol, Winnipeg, MB, Canada; [Chokani, Khami] Saskatchewan Hlth, Prince Albert Parkland Hlth Reg, Prince Albert, SK, Canada; [Vooght, Mark] Saskatchewan Hlth, Hills Hlth Reg 5, Moose Jaw, SK, Canada; [Babiuk, Lorne] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Webby, Richard] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Webby, Richard] WHO Collaborating Ctr, Memphis, TN USA; [Loeb, Mark] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; University of Calgary; University of Calgary; University of Calgary; McMaster University; McMaster University; McMaster University; University of Manitoba; University of Manitoba; University of Manitoba; University of Manitoba; University of Alberta; St Jude Children's Research Hospital; World Health Organization; McMaster University	Loeb, M (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.; Loeb, M (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.; Loeb, M (corresponding author), McMaster Univ, Michael G De Groote Inst Infect Dis Res, Hamilton, ON, Canada.; Loeb, M (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.	loebm@mcmaster.ca	Walter, Stephen/AAB-5548-2022; Webby, Richard J/N-5657-2018	Walter, Stephen/0000-0003-4157-8928; Earn, David/0000-0002-7562-1341	Canadian Institutes for Health Research; National Institute for Allergy and Infectious Diseases	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Canadian Institutes for Health Research and the National Institute for Allergy and Infectious Diseases. Sanofi Pasteur donated vaccines used for the study but provided no funding for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CLOVER RD, 1991, J INFECT DIS, V163, P300, DOI 10.1093/infdis/163.2.300; Esposito S, 2003, VACCINE, V21, P3162, DOI 10.1016/S0264-410X(03)00253-6; Ghendon YZ, 2006, EPIDEMIOL INFECT, V134, P71, DOI 10.1017/S0950268805005650; Glezen WP, 2010, J INFECT DIS, V202, P1626, DOI 10.1086/657089; GRUBER WC, 1990, AM J DIS CHILD, V144, P595, DOI 10.1001/archpedi.1990.02150290089035; Hurwitz ES, 2000, JAMA-J AM MED ASSOC, V284, P1677, DOI 10.1001/jama.284.13.1677; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Immunization NACo, 2009, CAN COMMUN DIS REP, V35, P1; Immunization NACo, 2011, CAN COMMUN DIS REP, V37, P1; Immunization NACo, 2010, CAN COMMUN DIS REP, V36, P1; Jordan R, 2006, VACCINE, V24, P1047, DOI 10.1016/j.vaccine.2005.09.017; Lang PO, 2011, AGEING RES REV, V10, P389, DOI 10.1016/j.arr.2010.09.005; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Piedra PA, 2007, PEDIATRICS, V120, pE553, DOI 10.1542/peds.2006-2836; Principi N, 2003, PEDIATR INFECT DIS J, V22, pS207, DOI 10.1097/01.inf.0000092188.48726.e4; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; RUDENKO LG, 1993, J INFECT DIS, V168, P881, DOI 10.1093/infdis/168.4.881; Therneau T, 2012, COXME MIXED EFFECTS; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Wenzel RP, 2009, NEW ENGL J MED, V361, P1991, DOI 10.1056/NEJMe0909666; Wienke A., 2010, FRAILTY MODELS SURVI	27	13	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167281	10.1371/journal.pone.0167281	http://dx.doi.org/10.1371/journal.pone.0167281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977707	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400017
J	Wang, ZW; Huang, B; Dong, H; Zhao, QP; Zhu, SH; Xia, WL; Xu, SB; Xie, YX; Cui, XX; Tang, M; Men, QF; Yang, ZY; Li, C; Zhu, XL; Han, HY				Wang, Ziwen; Huang, Bing; Dong, Hui; Zhao, Qiping; Zhu, Shunhai; Xia, Weili; Xu, Shuaibin; Xie, Yuxiang; Cui, Xiaoxia; Tang, Min; Men, Qifei; Yang, Zhiyuang; Li, Cong; Zhu, Xuelong; Han, Hongyu			Molecular Characterization and Functional Analysis of a Novel Calcium-Dependent Protein Kinase 4 from Eimeria tenella	PLOS ONE			English	Article							STAGE-SPECIFIC EXPRESSION; PLASMODIUM-FALCIPARUM; PARASITOPHOROUS VACUOLE; SELECTIVE INHIBITORS; HOST-CELL; GONDII; IDENTIFICATION; PARASITE; CDPK; PURIFICATION	Eimeria tenella is an obligate intracellular parasite that actively invades cecal epithelial cells of chickens. The basis of cell invasion is not completely understood, but some key molecules of host cell invasion have been discovered. This paper investigated the characteristics of calcium-dependent protein kinase 4 (EtCDPK4), a critical molecule in E. tenella invasion of host cells. A full-length EtCDPK4 cDNA was identified from E. tenella using rapid amplification of cDNA ends. EtCDPK4 had an open reading frame of 1803 bp encoding a protein of 600 amino acids. Quantitative real-time PCR and western blotting were used to explore differences in EtCDPK4 transcription and translation in four developmental stages of E. tenella. EtCDPK4 was expressed at higher levels in sporozoites, but translation was higher in second-generation merozoites. In vitro invasion inhibition assays explored whether EtCDPK4 was involved in invasion of DF-1 cells by E. tenella sporozoites. Polyclonal antibodies against recombinant EtCDPK4 (rEtCDPK4) inhibited parasite invasion, decreasing it by approximately 52%. Indirect immunofluorescence assays explored EtCDPK4 distribution during parasite development after E. tenella sporozoite invasion of DF-1 cells in vitro. The results showed that EtCDPK4 might be important in sporozoite invasion and development. To analyze EtCDPK4 functional domains according to the structural characteristics of EtCDPK4 and study the kinase activity of rEtCDPK4, an in vitro phosphorylation system was established. We verified that rEtCDPK4 was a protein kinase that was completely dependent on Ca2+ for enzyme activity. Specific inhibitors of rEtCDPK4 activity were screened by kinase activity in vitro. Some specific inhibitors were applied to assays of DF-1 cell invasion by E. tenella sporozoites to confirm that the inhibitors functioned in vitro. W-7, H-7, H-89, and myristoylated peptide inhibited DF-1 invasion by E. tenella sporozoites. The experimental results showed that EtCDPK4 may be involved in E. tenella invasion of chicken cecal epithelial cells.	[Wang, Ziwen; Huang, Bing; Dong, Hui; Zhao, Qiping; Zhu, Shunhai; Xia, Weili; Xu, Shuaibin; Xie, Yuxiang; Cui, Xiaoxia; Tang, Min; Men, Qifei; Yang, Zhiyuang; Li, Cong; Zhu, Xuelong; Han, Hongyu] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China; [Huang, Bing] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Han, HY (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China.	hhysh@shvri.ac.cn			National Natural Science Foundation of China [31572266, 31272557]; Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses [2016JB10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses	This work was supported by the National Natural Science Foundation of China (Grant No. 31572266, No. 31272557) and Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses (No. 2016JB10).	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; Alcala-Canto Y, 2014, BRIT POULTRY SCI, V55, P44, DOI 10.1080/00071668.2013.872770; Allwood EG, 2002, PLANT MOL BIOL, V49, P533, DOI 10.1023/A:1015502117870; Azevedo MF, 2013, BIOCHEM J, V452, P433, DOI 10.1042/BJ20130124; Bansal A, 2013, J BIOL CHEM, V288, P1590, DOI 10.1074/jbc.M112.411934; Belli SL, 2005, PROTEOMICS, V5, P918, DOI 10.1002/pmic.200401161; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Dammann C, 2003, PLANT PHYSIOL, V132, P1840, DOI 10.1104/pp.103.020008; Daszak P, 1999, PARASITOL TODAY, V15, P67, DOI 10.1016/S0169-4758(98)01379-9; Donald RGK, 2006, MOL BIOCHEM PARASIT, V149, P86, DOI 10.1016/j.molbiopara.2006.05.003; Dunn PPJ, 1996, PARASITOLOGY, V113, P439, DOI 10.1017/S0031182000081506; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; EICHHOLTZ T, 1993, J BIOL CHEM, V268, P1982; Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009; Entzeroth R, 1998, INT J PARASITOL, V28, P1015, DOI 10.1016/S0020-7519(98)00079-4; Etzold M, 2014, PARASITOL RES, V113, P2525, DOI 10.1007/s00436-014-3902-0; Fetterer RH, 2007, J PARASITOL, V93, P333, DOI 10.1645/GE-824R1.1; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Han HY, 2013, PARASITOLOGY, V140, P746, DOI 10.1017/S0031182012002107; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HARPER JF, 1991, SCIENCE, V252, P951, DOI 10.1126/science.1852075; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; Hettenhausen C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18973; Hrabak EM, 1996, PLANT MOL BIOL, V31, P405, DOI 10.1007/BF00021802; Huang Y, 1999, ACTA BIOCH BIOPH SIN, V31, P572; Hui R, 2015, TRENDS PHARMACOL SCI, V36, P452, DOI 10.1016/j.tips.2015.04.011; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jahn D, 2009, PARASITOL RES, V105, P655, DOI 10.1007/s00436-009-1437-6; Jiang Lian-lian, 2011, Zhongguo Shouyi Kexue, V41, P551; Jiang LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041115; Jiang LL, 2012, PARASITOL RES, V110, P865, DOI 10.1007/s00436-011-2568-0; Kaminski T, 2004, DOMEST ANIM ENDOCRIN, V27, P379, DOI 10.1016/j.domaniend.2004.05.001; Katrib M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-685; Keyloun KR, 2014, PARASITOLOGY, V141, P1499, DOI 10.1017/S0031182014000857; Kieschnick H, 2001, J BIOL CHEM, V276, P12369, DOI 10.1074/jbc.M011045200; Kudla J, 2010, PLANT CELL, V22, P541, DOI 10.1105/tpc.109.072686; Kumar P, 2014, J BIOL CHEM, V289, P20386, DOI 10.1074/jbc.M114.561670; Labbe M, 2006, INT J PARASITOL, V36, P1443, DOI 10.1016/j.ijpara.2006.08.011; Leclercq J, 2005, J EXP BOT, V56, P25, DOI 10.1093/jxb/eri003; Li JL, 2000, BBA-GENE STRUCT EXPR, V1491, P341, DOI 10.1016/S0167-4781(00)00032-4; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Lourido S, 2010, NATURE, V465, P359, DOI 10.1038/nature09022; Matsubayashi M, 2012, PARASITOLOGY, V139, P1553, DOI 10.1017/S0031182012001072; Mccoy JM, 2013, PLOS PATHOG, V8, P155; MICHALSKI WP, 1992, INT J PARASITOL, V22, P1157, DOI 10.1016/0020-7519(92)90035-J; MIELKE D, 1991, Angewandte Parasitologie, V32, P39; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Morlon-Guyot J, 2014, CELL MICROBIOL, V16, P95, DOI 10.1111/cmi.12186; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Nemoto K, 2015, J BIOL CHEM, V290, P16665, DOI 10.1074/jbc.M114.617274; Ojo KK, 2010, NAT STRUCT MOL BIOL, V17, P602, DOI 10.1038/nsmb.1818; Osuna L, 2004, BIOCHEM BIOPH RES CO, V314, P428, DOI 10.1016/j.bbrc.2003.12.103; Peroval M, 2006, INT J PARASITOL, V36, P1205, DOI 10.1016/j.ijpara.2006.04.006; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Ranjan R, 2009, J BIOL CHEM, V284, P15267, DOI 10.1074/jbc.M900656200; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Salowe SP, 2002, BIOCHEMISTRY-US, V41, P4385, DOI 10.1021/bi0156658; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sasai K, 2008, J PARASITOL, V94, P1432, DOI 10.1645/GE-1558.1; Sebastian S, 2012, CELL HOST MICROBE, V12, P9, DOI 10.1016/j.chom.2012.05.014; Shirley MW, 2004, TRENDS PARASITOL, V20, P199, DOI 10.1016/j.pt.2004.02.005; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Tabares E, 2004, MOL BIOCHEM PARASIT, V135, P123, DOI 10.1016/j.molbiopara.2004.01.013; Tomley F, 1997, METHODS, V13, P171, DOI 10.1006/meth.1997.0509; Treeck M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004197; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; Wilson PAG, 2007, J EUKARYOT MICROBIOL, V8, P410; XIE MQ, 1990, PARASITOL RES, V76, P566, DOI 10.1007/BF00932562; Zhang TG, 2005, J PLANT PHYSIOL, V162, P1149, DOI 10.1016/j.jplph.2004.12.010; Zhang ZS, 2014, ACS MED CHEM LETT, V5, P40, DOI 10.1021/ml400315s; ZHAO Y, 1994, MOL BIOCHEM PARASIT, V66, P329, DOI 10.1016/0166-6851(94)90159-7; ZHAO Y, 1994, BIOCHEMISTRY-US, V33, P3714, DOI 10.1021/bi00178a031	77	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168132	10.1371/journal.pone.0168132	http://dx.doi.org/10.1371/journal.pone.0168132			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977727	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400065
J	Yamaguchi, M; Steeves, EA; Shipley, C; Hopkins, LC; Cheskin, LJ; Gittelsohn, J				Yamaguchi, Miwa; Steeves, Elizabeth Anderson; Shipley, Cara; Hopkins, Laura C.; Cheskin, Lawrence J.; Gittelsohn, Joel			Inconsistency between Self-Reported Energy Intake and Body Mass Index among Urban, African-American Children	PLOS ONE			English	Article							BASAL METABOLIC-RATE; LOW-INCOME; GOLDBERG CUTOFF; QUESTIONNAIRE; VALIDITY; OVERWEIGHT; OBESITY; RELIABILITY; CONSUMPTION; DESIGN	Background To prevent obesity, it is important to assess dietary habits through self-reported energy intake (EI) in children. We investigated how EI is associated with body mass index and which elements of dietary habits and status are associated with EI among African-American (AA) children. Methods We assessed and included data from 218 10-14-year-old AA children in Baltimore, MD, USA. EI was calculated using a food frequency questionnaire. The basal metabolic rate (BMR) was used as the predicted minimal rate of energy expenditure of children. A fully adjusted multiple logistic regression was used to determine the prevalence of obesity (>= 95th BMI-for-age percentile) among the quartiles of EI/BMR ratio using the third quartile for the reference. The differences in the age-adjusted mean EI/BMR among the categories of dietary habits, social support, and socio economic status were analyzed using a general linear model. Results Children with the lowest EI/BMR had significantly higher adjusted odds ratio (aOR) of obesity as compared to those in the third quartile of EI/BMR (boys aOR 4.3; 95% confidence interval 1.08, 20 and girls aOR 4.1; 1.02, 21). In girls, the adjusted mean EI/BMR in the group that prepared food less than the means (3.8 times/week) was significantly lower than the group that prepared food over the means (P = 0.03). Further, the group that reported eating breakfast under 4 times/week indicated an adjusted mean EI/BMR lower than the group that ate breakfast over 5 times/week in both sexes. Conclusions When EI was under-reported with reference to BMR, we may observe high prevalence of obesity. Further, food preparation by children and frequent consumption of breakfast may instill food cognition with usual dietary habits. Therefore, holistic assessments including dietary habits are required to examine self-reported food intake especially among overweight/obese children.	[Yamaguchi, Miwa] Natl Inst Biomed Innovat Hlth & Nutr, Natl Inst Hlth & Nutr, Dept Nutr Sci, Tokyo, Japan; [Steeves, Elizabeth Anderson; Shipley, Cara; Hopkins, Laura C.; Cheskin, Lawrence J.; Gittelsohn, Joel] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth Global Obes Prevent Johns Hopkins, Baltimore, MD USA	National Institute of Health & Nutrition - Japan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Yamaguchi, M (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Natl Inst Hlth & Nutr, Dept Nutr Sci, Tokyo, Japan.	miwayama@nih.go.jp	Cheskin, Lawrence/AAM-1094-2021	Cheskin, Lawrence/0000-0003-0262-1030	Global Obesity Prevention Center (GOPC) at Johns Hopkins; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); Office of the Director, National Institutes of Health (OD) [U54HD070725]	Global Obesity Prevention Center (GOPC) at Johns Hopkins; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Office of the Director, National Institutes of Health (OD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by the Global Obesity Prevention Center (GOPC) at Johns Hopkins, and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Office of the Director, National Institutes of Health (OD) under award number U54HD070725. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 1985, World Health Organ Tech Rep Ser, V724, P1; Bandini LG, 2003, AM J CLIN NUTR, V78, P480, DOI 10.1093/ajcn/78.3.480; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Black AE, 2000, EUR J CLIN NUTR, V54, P395, DOI 10.1038/sj.ejcn.1600971; BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416; Centers for Disease Control and Prevention. Baltimore MD, 2016, BALT MD HIGH SCH YOU, V5, P25; Champagne CM, 1998, J AM DIET ASSOC, V98, P426, DOI 10.1016/S0002-8223(98)00097-2; Crews DC, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-192; Croezen S, 2009, EUR J CLIN NUTR, V63, P405, DOI 10.1038/sj.ejcn.1602950; Cullen KW, 2008, J AM DIET ASSOC, V108, P862, DOI 10.1016/j.jada.2008.02.015; Dennisuk LA, 2011, AM J PREV MED, V40, P625, DOI 10.1016/j.amepre.2011.02.015; Field AE, 1999, PUBLIC HEALTH NUTR, V2, P293, DOI 10.1017/S1368980099000397; Garriguet Didier, 2008, Health Rep, V19, P37; Gittelsohn J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-942; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Hallstrom L, 2011, APPETITE, V56, P649, DOI 10.1016/j.appet.2011.02.019; Hare ME, 2012, CHILD OBES, V8, P551, DOI 10.1089/chi.2011.0117; Iannotti RJ, 2013, PEDIATRICS, V132, P606, DOI 10.1542/peds.2013-1488; Kolodziejczyk JK, 2012, J PEDIATR GASTR NUTR, V55, P4, DOI 10.1097/MPG.0b013e318251550e; Lanctot JQ, 2008, OBESITY, V16, P1407, DOI 10.1038/oby.2008.222; Lazarus R, 1996, AM J CLIN NUTR, V63, P500, DOI 10.1093/ajcn/63.4.500; Lin BH, 1996, DIETS AM CHILDREN IN, V746; Livingstone MBE, 2004, BRIT J NUTR, V92, pS213, DOI 10.1079/BJN20041169; Livingstone MBE, 2000, P NUTR SOC, V59, P279, DOI 10.1017/S0029665100000318; Marshall TA, 2008, J AM DIET ASSOC, V108, P465, DOI 10.1016/j.jada.2007.12.002; Moore GF, 2008, J AM DIET ASSOC, V108, P1865, DOI 10.1016/j.jada.2008.08.012; Moore L, 2005, EUR J CLIN NUTR, V59, P809, DOI 10.1038/sj.ejcn.1602146; National Center for Health Statistics, 2002, VITAL HLTH STAT, V11; NutritionQuest, 2016, BLOCK QUEST, V5, P25; Pannacciulli N, 2007, AM J CLIN NUTR, V86, P625; Rosenkranz RR, 2008, NUTR REV, V66, P123, DOI 10.1111/j.1753-4887.2008.00017.x; Steeves ETA, 2016, PUBLIC HEALTH NUTR, V19, P3406, DOI 10.1017/S1368980016001701; van der Horst K, 2014, APPETITE, V79, P18, DOI 10.1016/j.appet.2014.03.030; Vance VA, 2009, PUBLIC HEALTH NUTR, V12, P222, DOI 10.1017/S1368980008003108; Wang Y, 2002, EUR J CLIN NUTR, V56, P973, DOI 10.1038/sj.ejcn.1601415; Wong WW, 1996, J APPL PHYSIOL, V81, P2407, DOI 10.1152/jappl.1996.81.6.2407; Worsley A, 2002, ASIA PAC J CLIN NUTR, V11, pS579, DOI 10.1046/j.1440-6047.11.supp3.7.x	37	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168303	10.1371/journal.pone.0168303	http://dx.doi.org/10.1371/journal.pone.0168303			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977776	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400090
J	Yang, Y; Kelly, PJ; Bai, JF; Zhang, R; Wang, CM				Yang, Yi; Kelly, Patrick John; Bai, Jianfa; Zhang, Rong; Wang, Chengming			First Molecular Characterization of Bovine Leukemia Virus Infections in the Caribbean	PLOS ONE			English	Article							SOMATIC-CELL SCORE; ENV GENE; PHYLOGENETIC ANALYSIS; NATURAL TRANSMISSION; AMBLYOMMA-VARIEGATUM; ENVELOPE PROTEIN; DAIRY HERDS; CATTLE; MILK; GP51	Bovine leukemia virus (BLV) is a retrovirus that causes enzootic bovine leucosis. To investigate the presence and genetic variability of BLV in the Caribbean for the first time, we preformed fluorescence resonance energy transfer (FRET)-PCR for the pol of BLV on DNA from whole blood of cattle from Dominica, Montserrat, Nevis and St. Kitts. Standard PCRs with primers for the env were used for phylogenetic analysis of BLV in positive animals. We found FRET-PCR positive cattle (12.6%, 41/325) on Dominica (5.2%; 4/77) and St. Kitts (19.2%; 37/193) but not on Montserrat (0%, 0/12) or Nevis (0%, 0/43). Positive animals were cows on farms where animals were raised intensively. Phylogenetic analysis using the neighbor-joining (NJ) method on partial and full-length env sequences obtained for strains from Dominica (n = 2) and St. Kitts (n = 5) and those available in GenBank (n = 90) (genotypes 1-10) revealed the Caribbean strains belonged to genotype 1 (98-100% sequence homology). Ours is the first molecular characterization of BLV infections in the Caribbean and the first description of genotype 1 in the region.	[Yang, Yi; Zhang, Rong; Wang, Chengming] Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Yang, Yi; Bai, Jianfa] Kansas State Univ, Coll Vet Med, Dept Vet Diagnost Lab, Manhattan, KS 66506 USA; [Kelly, Patrick John] Ross Univ, Sch Vet Med, Basseterre, St Kitts & Nevi; [Wang, Chengming] Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA	Yangzhou University; Kansas State University; Auburn University System; Auburn University	Wang, CM (corresponding author), Yangzhou Univ, Coll Vet Med, Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.; Bai, JF (corresponding author), Kansas State Univ, Coll Vet Med, Dept Vet Diagnost Lab, Manhattan, KS 66506 USA.; Wang, CM (corresponding author), Auburn Univ, Coll Vet Med, Dept Pathobiol, Auburn, AL 36849 USA.	jbai@vet.ksu.edu; wangche@auburn.edu	Bai, Jianfa/M-7830-2019	Bai, Jianfa/0000-0002-0021-3036; Yang, Yi/0000-0002-5214-5856	National Natural Science Foundation of China [31272575]; Program granted for Scientific Innovation Research of College Graduate in Jiangsu province [KYZZ16_0496]; Priority Academic Program Development of Jiangsu Higher Education Institutions; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program granted for Scientific Innovation Research of College Graduate in Jiangsu province; Priority Academic Program Development of Jiangsu Higher Education Institutions; China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (31272575) to CW; Program granted for Scientific Innovation Research of College Graduate in Jiangsu province (KYZZ16_0496) to YY; The Priority Academic Program Development of Jiangsu Higher Education Institutions to CW; China Scholarship Council to YY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EA, 2016, J DAIRY SCI, V99, P2005, DOI 10.3168/jds.2015-9833; Balic D, 2012, ARCH VIROL, V157, P1281, DOI 10.1007/s00705-012-1300-4; Bartlett PC, 2013, J DAIRY SCI, V96, P1591, DOI 10.3168/jds.2012-5930; CALLEBAUT I, 1993, J VIROL, V67, P5321, DOI 10.1128/JVI.67.9.5321-5327.1993; Camargos MF, 2007, VIRUS GENES, V34, P343, DOI 10.1007/s11262-006-0011-x; Camargos MF, 2002, J VET MED B, V49, P325, DOI 10.1046/j.1439-0450.2002.00582.x; DA Y, 1993, P NATL ACAD SCI USA, V90, P6538, DOI 10.1073/pnas.90.14.6538; DIMMOCK CK, 1991, AUST VET J, V68, P230, DOI 10.1111/j.1751-0813.1991.tb03213.x; Felmer R, 2005, VET MICROBIOL, V108, P39, DOI 10.1016/j.vetmic.2005.04.005; FRENCH S, 1983, J MOL EVOL, V19, P171, DOI 10.1007/BF02300754; Hemmatzadeh F, 2007, VET RES COMMUN, V31, P783, DOI 10.1007/s11259-007-0012-9; Hopkins SG, 1997, VET CLIN N AM-FOOD A, V13, P107; Inabe K, 1999, J VIROL, V73, P1293, DOI 10.1128/JVI.73.2.1293-1301.1999; Johnston ER, 2000, J VIROL, V74, P2930, DOI 10.1128/JVI.74.6.2930-2935.2000; Kelly PJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-182; Kelly PJ, 2011, J MED ENTOMOL, V48, P485, DOI 10.1603/ME10172; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee E, 2016, INFECT GENET EVOL, V41, P245, DOI 10.1016/j.meegid.2016.04.010; Li J, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0560-0; Licursi M, 2003, VET MICROBIOL, V96, P17, DOI 10.1016/S0378-1135(03)00202-5; MAMOUN RZ, 1990, J VIROL, V64, P4180, DOI 10.1128/JVI.64.9.4180-4188.1990; Mekata H, 2015, VET REC, V176, P254, DOI 10.1136/vr.102464; MILLER JM, 1979, J NATL CANCER I, V62, P425; Monti G, 2005, ARCH VIROL, V150, P443, DOI 10.1007/s00705-004-0437-1; Moratorio G, 2010, ARCH VIROL, V155, P481, DOI 10.1007/s00705-010-0606-3; Ochirkhuu N, 2016, ARCH VIROL, V161, P985, DOI 10.1007/s00705-015-2676-8; Polat M, 2016, ARCH VIROL; Polat M, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0239-z; Polat M, 2015, ARCH VIROL, V160, P285, DOI 10.1007/s00705-014-2280-3; Rodriguez SM, 2009, J GEN VIROL, V90, P2788, DOI 10.1099/vir.0.011791-0; Rola-Luszczak M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058705; SAGATA N, 1984, EMBO J, V3, P3231, DOI 10.1002/j.1460-2075.1984.tb02283.x; Wang CM, 2010, J CLIN MICROBIOL, V48, P1667, DOI 10.1128/JCM.00227-10; Yang Y, 2016, J DAIRY SCI, V99, P3688, DOI 10.3168/jds.2015-10580; Zhao XR, 2007, VIROLOGY, V366, P150, DOI 10.1016/j.virol.2007.03.058	35	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168379	10.1371/journal.pone.0168379	http://dx.doi.org/10.1371/journal.pone.0168379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977761	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400104
J	Chaplinska, M; Gerritsma, S; Dini-Andreote, F; Salles, JF; Wertheim, B				Chaplinska, Mariia; Gerritsma, Sylvia; Dini-Andreote, Francisco; Salles, Joana Falcao; Wertheim, Bregje			Bacterial Communities Differ among Drosophila melanogaster Populations and Affect Host Resistance against Parasitoids	PLOS ONE			English	Article							GEOGRAPHICAL VARIATION; WOLBACHIA INFECTION; GUT MICROBIOTA; EVOLUTION; INCOMPATIBILITY; HOMEOSTASIS; DIVERSITY; HEMOCYTES; DEFENSE; CELLS	In Drosophila, diet is considered a prominent factor shaping the associated bacterial community. However, the host population background (e.g. genotype, geographical origin and founder effects) is a factor that may also exert a significant influence and is often overlooked. To test for population background effects, we characterized the bacterial communities in larvae of six genetically differentiated and geographically distant D. melanogaster lines collected from natural populations across Europe. The diet for these six lines had been identical for ca. 50 generations, thus any differences in the composition of the microbiome originates from the host populations. We also investigated whether induced shifts in the microbiome D in this case by controlled antibiotic administration D alters the hosts' resistance to parasitism. Our data revealed a clear signature of population background on the diversity and composition of D. melanogaster microbiome that differed across lines, even after hosts had been maintained at the same diet and laboratory conditions for over 4 years. In particular, the number of bacterial OTUs per line ranged from 8 to 39 OTUs. Each line harboured 2 to 28 unique OTUs, and OTUs that were highly abundant in some lines were entirely missing in others. Moreover, we found that the response to antibiotic treatment differed among the lines and significantly altered the host resistance to the parasitoid Asobara tabida in one of the six lines. Wolbachia, a widespread intracellular endosymbiont associated with parasitoid resistance, was lacking in this line, suggesting that other components of the Drosophila microbiome caused a change in host resistance. Collectively, our results revealed that lines that originate from different population backgrounds show significant differences in the established Drosophila microbiome, outpacing the long-term effect of diet. Perturbations on these naturally assembled microbiomes to some degree influenced the hosts' resistance against natural parasites.	[Chaplinska, Mariia; Gerritsma, Sylvia; Wertheim, Bregje] Univ Groningen, Groningen Inst Evolutionary Life Sci, Evolutionary Genet Dev & Behav, Groningen, Netherlands; [Dini-Andreote, Francisco; Salles, Joana Falcao] Univ Groningen, Groningen Inst Evolutionary Life Sci, Genom Res Ecol & Evolut Nat, Groningen, Netherlands	University of Groningen; University of Groningen	Wertheim, B (corresponding author), Univ Groningen, Groningen Inst Evolutionary Life Sci, Evolutionary Genet Dev & Behav, Groningen, Netherlands.	b.wertheim@rug.nl	Wertheim, Bregje/B-6436-2009; Salles, Joana Falcao/AAG-7070-2020; Dini-Andreote, Francisco/M-6176-2017; Falcao Salles, Joana/A-7313-2008	Wertheim, Bregje/0000-0001-8555-1925; Salles, Joana Falcao/0000-0003-4317-7263; Dini-Andreote, Francisco/0000-0002-6654-0769; Falcao Salles, Joana/0000-0003-4317-7263	VIDI grant from the Netherlands Organisation for Scientific Research [854.08.008]	VIDI grant from the Netherlands Organisation for Scientific Research	This work was supported by a VIDI grant to BW [grant number: 854.08.008] from the Netherlands Organisation for Scientific Research (URL: www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Begon M., 1982, GENET BIOL DROSOPHIL, P345; Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543; Bourtzis K, 1996, GENETICS, V144, P1063; Broderick NA, 2012, GUT MICROBES, V3, P307, DOI 10.4161/gmic.19896; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chou HH, 2001, BIOINFORMATICS, V17, P1093, DOI 10.1093/bioinformatics/17.12.1093; Corby-Harris V, 2008, J ANIM ECOL, V77, P768, DOI 10.1111/j.1365-2656.2008.01399.x; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Crawley M.J., 2007, R BOOK; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eslin P, 1998, J INSECT PHYSIOL, V44, P807, DOI 10.1016/S0022-1910(98)00013-4; Fast EM, 2011, SCIENCE, V334, P990, DOI 10.1126/science.1209609; Franzenburg S, 2013, P NATL ACAD SCI USA, V110, pE3730, DOI 10.1073/pnas.1304960110; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Fytrou A, 2006, P R SOC B, V273, P791, DOI 10.1098/rspb.2005.3383; Gerritsma S., 2015, THESIS; Gerritsma S, 2013, J INSECT PHYSIOL, V59, P148, DOI 10.1016/j.jinsphys.2012.09.017; Guyenot E, 1913, CR SOC BIOL, V74, P97; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; KRAAIJEVELD AR, 1995, EVOL ECOL, V9, P10, DOI 10.1007/BF01237692; Kraaijeveld AR, 1999, AM NAT, V153, pS61, DOI 10.1086/303212; Lazzaro BP, 2006, GENETICS, V174, P1539, DOI 10.1534/genetics.105.054593; Lee WJ, 2013, ANNU REV CELL DEV BI, V29, P571, DOI 10.1146/annurev-cellbio-101512-122333; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Lize A, 2014, ISME J, V8, P469, DOI 10.1038/ismej.2013.157; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ma WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060459; Markus R, 2015, J INNATE IMMUN, V7, P340, DOI 10.1159/000369618; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Ohtoko K, 2000, EXTREMOPHILES, V4, P343, DOI 10.1007/s007920070003; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Salazar-Jaramillo L, 2014, GENOME BIOL EVOL, V6, P273, DOI 10.1093/gbe/evu012; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; TANCREDE C, 1992, EUR J CLIN MICROBIOL, V11, P1012, DOI 10.1007/BF01967791; [Team RDC R Development Core Team R Team RDC], 2011, R LANG ENV STAT COMP, P409; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Weeks AR, 2002, TRENDS ECOL EVOL, V17, P257, DOI 10.1016/S0169-5347(02)02480-1; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Xie J, 2014, HEREDITY, V112, P399, DOI 10.1038/hdy.2013.118; Zilber-Rosenberg I, 2008, FEMS MICROBIOL REV, V32, P723, DOI 10.1111/j.1574-6976.2008.00123.x	59	18	18	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167726	10.1371/journal.pone.0167726	http://dx.doi.org/10.1371/journal.pone.0167726			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973604	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300043
J	Gao, JQ; Chen, T; Zhao, DQ; Zheng, JP; Liu, ZJ				Gao, Junqing; Chen, Tao; Zhao, Deqiang; Zheng, Jianpu; Liu, Zongjun			Ginkgolide B Exerts Cardioprotective Properties against Doxorubicin-Induced Cardiotoxicity by Regulating Reactive Oxygen Species, Akt and Calcium Signaling Pathways In Vitro and In Vivo	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL-ISCHEMIA; OXIDATIVE STRESS; CRYSTALLINE NANOPARTICLES; PROTECTIVE ROLE; BILOBA LEAVES; BREAST-CANCER; MELATONIN; DELIVERY; EXTRACT	The aim of this study was to evaluate the effect of Ginkgolide B (GB) on doxorubicin (DOX) induced cardiotoxicity in vitro and in vivo. Rat cardiomyocyte cell line H9c2 was pretreated with GB and subsequently subjected to doxorubicin treatment. Cell viability and cell apoptosis were assessed by MTT assay and Hoechst staining, respectively. Reactive oxygen species (ROS), Akt phosphorylation and intracellular calcium were equally determined in order to explore the underlying molecular mechanism. To verify the in vivo therapeutic effect of GB, we established a mouse model of cardiotoxicity and determined left ventricle ejection fraction (LVEF) and left ventricular mass (LVM). The in vitro experimental results indicated that pretreatment with GB significantly decreases the viability and apoptosis of H9c2 cells by decreasing ROS and intracellular calcium levels and activating Akt phosphorylation. In the in vivo study, we recorded an improved LVEF and a decreased LVM in the group of cardiotoxic rats treated with GB. Altogether, our findings anticipate that GB exerts a cardioprotective effect through possible regulation of the ROS, Akt and calcium pathways. The findings suggest that combination of GB with DOX in chemotherapy could help avoid the cardiotoxic side effects of GB.	[Gao, Junqing; Chen, Tao; Zhao, Deqiang; Zheng, Jianpu; Liu, Zongjun] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Cardiol, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine	Zheng, JP; Liu, ZJ (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Cardiol, Shanghai, Peoples R China.	liuzongjun028@sina.com; zhengjianpu_p@163.com	郜, 俊清/GXM-4013-2022	郜, 俊清/0000-0001-8795-885X	national natural science foundation of China [81303145]; science and technology committee foundation of Shanghai [124119b1600]	national natural science foundation of China(National Natural Science Foundation of China (NSFC)); science and technology committee foundation of Shanghai	This work was supported by the national natural science foundation of China (81303145); and science and technology committee foundation of Shanghai (124119b1600).	Asensio-Lopez MC, 2013, FREE RADICAL BIO MED, V57, P188, DOI 10.1016/j.freeradbiomed.2012.09.009; Baghbani F, 2016, INT J BIOL MACROMOL, V93, P512, DOI 10.1016/j.ijbiomac.2016.09.008; Baliutyte G, 2012, J CARDIOVASC PHARM, V59, P450, DOI 10.1097/FJC.0b013e318249171d; Cao Y, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/674219; Carvalho FS, 2014, MED RES REV, V34, P106, DOI 10.1002/med.21280; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; Chan BY, 2016, FASEB J S, V30, P742; Chen XR, 2014, J PINEAL RES, V57, P168, DOI 10.1111/jpi.12153; Chen YL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/970490; Dias QC, 2016, INT BRAZ J UROL, V42, P942, DOI 10.1590/S1677-5538.IBJU.2015.0381; Dong QH, 2014, BRIT J PHARMACOL, V171, P4440, DOI 10.1111/bph.12795; Durham K, 2014, ARTERIOSCL THROM VAS, V34; Escarcega-Gonzalez CE, 2016, BIOCH RES INT, V2016; Fernandes RS, 2016, BIOMED PHARMACOTHER, V84, P252, DOI 10.1016/j.biopha.2016.09.032; Ghibu S, 2012, BIOCHIMIE, V94, P932, DOI 10.1016/j.biochi.2011.02.015; Govender J, 2014, J PINEAL RES, V57, P367, DOI 10.1111/jpi.12176; Granados-Principal S, 2014, BIOCHEM PHARMACOL, V90, P25, DOI 10.1016/j.bcp.2014.04.001; Guenancia C, 2015, TOXICOL APPL PHARM, V284, P152, DOI 10.1016/j.taap.2015.02.015; Hao EK, 2015, MOL MED, V21, DOI 10.2119/molmed.2014.00261; He B, 2016, J PINEAL RES, V60, P313, DOI 10.1111/jpi.12312; Huang CH, 2013, PHYTOMEDICINE, V20, P303, DOI 10.1016/j.phymed.2012.11.004; Iqbal M, 2008, PHARMACOL REP, V60, P382; Jagetia G.C., 2014, J MOL BIOCH, V3, P34; Jay SM, 2013, CIRCULATION, V128, P152, DOI 10.1161/CIRCULATIONAHA.113.002203; Kaur N, 2015, J NEUROSCI RES, V93, P938, DOI 10.1002/jnr.23565; Khan MA, 2014, CURR CLIN PHARMACOL, V9, P288, DOI 10.2174/1574884709999140606162053; Kumar S, 2012, TEXAS HEART I J, V39; Lamberti M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/240642; Ludke A, 2012, MOL CELL BIOCHEM, V360, P215, DOI 10.1007/s11010-011-1059-z; Lv SX, 2013, ACTA BIOMATER, V9, P9330, DOI 10.1016/j.actbio.2013.08.015; Mahmoud F, 2000, JPN J PHARMACOL, V83, P241, DOI 10.1254/jjp.83.241; Nozaki N, 2004, CIRCULATION, V110, P2869, DOI 10.1161/01.CIR.0000146889.46519.27; Pallerla S, 2017, EUR J MED CHEM, V125, P914, DOI 10.1016/j.ejmech.2016.10.015; Parimoo HA, 2014, TOXICON, V81, P1, DOI 10.1016/j.toxicon.2014.01.013; Ponnusamy L, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-4571; Potemski P, 2006, PHARMACOL REP, V58, P966; Qi XY, 2004, ACTA PHARMACOL SIN, V25, P203; Sin TK, 2015, J PHYSIOL-LONDON, V593, P1887, DOI 10.1113/jphysiol.2014.270101; Spallarossa P, 2006, CARDIOVASC RES, V69, P736, DOI 10.1016/j.cardiores.2005.08.009; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064526; Swain SM, 2003, CANCER, V97, P2869, DOI 10.1002/cncr.11407; Swarnakar NK, 2014, NANOMED-NANOTECHNOL, V10, P1231, DOI 10.1016/j.nano.2014.03.003; Swarnakar NK, 2014, PHARM RES-DORDR, V31, P1219, DOI 10.1007/s11095-013-1244-8; Tahover E, 2015, ANTI-CANCER DRUG, V26, P241, DOI 10.1097/CAD.0000000000000182; Varshosaz J, 2016, INT J BIOL MACROMOL, V93, P1192, DOI 10.1016/j.ijbiomac.2016.07.025; Walsh K, 2006, CIRCULATION, V113, P2032, DOI 10.1161/CIRCULATIONAHA.106.615138; Wang JX, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.41; Wang Z, 2016, PHYTOMEDICINE, V23, P621, DOI 10.1016/j.phymed.2016.03.005; Xia SH, 2008, PANCREAS, V37, P170, DOI 10.1097/MPA.0b013e3181661b07; Xiang SL, 2015, J PINEAL RES, V59, P60, DOI 10.1111/jpi.12239; Xin ZL, 2015, J PINEAL RES, V58, P375, DOI 10.1111/jpi.12227; Xu CN, 2016, BIOMATER SCI-UK, V4, P1646, DOI 10.1039/c6bm00601a; Yang Y, 2004, GUT, V53, P877, DOI 10.1136/gut.2003.024893; Yang Y, 2014, J PINEAL RES, V57, P357, DOI 10.1111/jpi.12175; Yu LM, 2015, J PINEAL RES, V59, P420, DOI 10.1111/jpi.12272; Yu LM, 2015, J PINEAL RES, V59, P376, DOI 10.1111/jpi.12269; Yu XH, 2013, ACTA BIOCH BIOPH SIN, V45, P817, DOI 10.1093/abbs/gmt082; Yuan WL, 2009, ACTA BIOCH BIOPH SIN, V41, P625, DOI 10.1093/abbs/gmp050; Zhang S, 2012, NAT MED, V18, P1639, DOI 10.1038/nm.2919; Zhang Zhi-Xiong, 2003, Shengli Xuebao, V55, P24	60	26	30	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168219	10.1371/journal.pone.0168219	http://dx.doi.org/10.1371/journal.pone.0168219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973574	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300066
J	Enos, RT; Velazquez, KT; Carson, MS; McClellan, JL; Nagarkatti, P; Nagarkatti, M; Davis, JM; Murphy, EA				Enos, Reilly T.; Velazquez, Kandy T.; Carson, Meredith S.; McClellan, Jamie L.; Nagarkatti, Prakash; Nagarkatti, Mitzi; Davis, J. Mark; Murphy, E. Angela			A Low Dose of Dietary Quercetin Fails to Protect against the Development of an Obese Phenotype in Mice	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; FATTY-LIVER-DISEASE; BODY-MASS INDEX; INSULIN-RESISTANCE; METABOLIC SYNDROME; SATURATED FAT; C57BL/6J MICE; RATS; INFLAMMATION; CANCER	The purpose of this study was to examine the effect of a 40% high-fat diet (HFD) supplemented with a dietary attainable level of quercetin (0.02%) on body composition, adipose tissue (AT) inflammation, Non-Alcoholic Fatty-Liver Disease (NAFLD), and metabolic outcomes. Diets were administered for 16 weeks to C57BL/6J mice (n = 10/group) beginning at 4 weeks of age. Body composition and fasting blood glucose, insulin, and total cholesterol concentrations were examined intermittently. AT and liver mRNA expression (RT-PCR) of inflammatory mediators (F4/80, CD206 (AT only), CD11c (AT only) TLR-2 (AT only), TLR-4 (AT only), MCP-1, TNF-alpha, IL-6 (AT only), and IL-10 (AT only)) were measured along with activation of NF kappa B-p65, and JNK (western blot). Hepatic lipid accumulation, gene expression (RT-PCR) of hepatic metabolic markers (ACAC1, SREBP-1, PPAR-gamma), protein content of Endoplasmic Reticulum (ER) Stress markers (BiP, phosphorylated and total EIF2 alpha, phosphorylated and total IRE1 alpha, CHOP), and hepatic oxidative capacity were assessed (western blot). Quercetin administration had no effect at mitigating increases in visceral AT, AT inflammation, hepatic steatosis, ER Stress, decrements in hepatic oxidative capacity, or the development of insulin resistance and hypercholesterolemia. In conclusion, 0.02% quercetin supplementation is not an effective therapy for attenuating HFD-induced obesity development. It is likely that a higher dose of quercetin supplementation is needed to elicit favorable outcomes in obesity.	[Enos, Reilly T.; Velazquez, Kandy T.; Carson, Meredith S.; McClellan, Jamie L.; Nagarkatti, Prakash; Nagarkatti, Mitzi; Murphy, E. Angela] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA; [Davis, J. Mark] Univ South Carolina, Dept Exercise Sci, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Murphy, EA (corresponding author), Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Angela.Murphy@uscmed.sc.edu	Enos, Reilly/AFO-4814-2022; davis, j mark/AAD-9575-2021	Enos, Reilly/0000-0001-5571-4586; Nagarkatti, Prakash/0000-0003-2663-0759	NIH/NCI [R21CA175636]; NIH/NCCIH [K01AT007824]; NATIONAL CANCER INSTITUTE [R21CA175636] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K01AT007824, P01AT003961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103641] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCCIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants R21CA175636 (NIH/NCI) and K01AT007824 (NIH/NCCIH) to EAM. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ables GP, 2012, PPAR RES, V2012, DOI 10.1155/2012/912351; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Arias N, 2016, EUR J NUTR, V55, P341, DOI 10.1007/s00394-015-0854-9; Arias N, 2015, J PHYSIOL BIOCHEM, V71, P569, DOI 10.1007/s13105-015-0403-2; Carson JA, 2002, J APPL PHYSIOL, V93, P242, DOI 10.1152/japplphysiol.01212.2001; Chikka MR, 2013, J BIOL CHEM, V288, P4405, DOI 10.1074/jbc.M112.432344; Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008; Dong J, 2014, J LIPID RES, V55, P363, DOI 10.1194/jlr.M038786; Enos RT, 2015, NUTR RES, V35, P449, DOI 10.1016/j.nutres.2015.04.003; Enos RT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094897; Enos RT, 2014, J NUTR BIOCHEM, V25, P600, DOI 10.1016/j.jnutbio.2014.01.011; Enos RT, 2013, J LIPID RES, V54, P152, DOI 10.1194/jlr.M030700; FOLCH J, 1957, J BIOL CHEM, V226, P497; Grotto D, 2010, NUTR CLIN PRACT, V25, P603, DOI 10.1177/0884533610386234; Henagan TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089365; Hoek-van den Hil EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051588; Jung CH, 2012, PHYTOTHER RES; Jung CH, 2013, PHYTOTHER RES, V27, P139, DOI 10.1002/ptr.4687; Jung JY, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-18; Kim CS, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0030-5; Kobori M, 2016, MOL NUTR FOOD RES, V60, P300, DOI 10.1002/mnfr.201500595; Kobori M, 2011, MOL NUTR FOOD RES, V55, P530, DOI 10.1002/mnfr.201000392; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Murphy EA, 2011, NUTR CANCER, V63, P421, DOI 10.1080/01635581.2011.535954; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Pagliassotti MJ, 2012, ANNU REV NUTR, V32, P17, DOI 10.1146/annurev-nutr-071811-150644; Panchal SK, 2012, J NUTR, V142, P1026, DOI 10.3945/jn.111.157263; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rivera L, 2008, OBESITY, V16, P2081, DOI 10.1038/oby.2008.315; Russo M, 2012, BIOCHEM PHARMACOL, V83, P6, DOI 10.1016/j.bcp.2011.08.010; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Seo MJ, 2015, J NUTR BIOCHEM, V26, P1308, DOI 10.1016/j.jnutbio.2015.06.005; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Steiner JL, 2014, CANCER BIOL THER, V15, P1456, DOI 10.4161/15384047.2014.955444; Stewart LK, 2009, DIABETOLOGIA, V52, P514, DOI 10.1007/s00125-008-1252-0; Stewart LK, 2008, METABOLISM, V57, pS39, DOI 10.1016/j.metabol.2008.03.003; van Kruijsdijk RCM, 2009, CANCER EPIDEM BIOMAR, V18, P2569, DOI 10.1158/1055-9965.EPI-09-0372; Wein S, 2010, EUR J PHARM SCI, V41, P16, DOI 10.1016/j.ejps.2010.05.004; Wein SA, 2015, J NUTR BIOCHEM, V26, P1660, DOI 10.1016/j.jnutbio.2015.08.010; Wyatt SB, 2006, AM J MED SCI, V331, P166, DOI 10.1097/00000441-200604000-00002; Ying HZ, 2013, FOOD CHEM TOXICOL, V52, P53, DOI 10.1016/j.fct.2012.10.030; Ying HZ, 2012, FOOD CHEM TOXICOL; Zhang LF, 2010, J AGR FOOD CHEM, V58, P7252, DOI 10.1021/jf101192k; Zhang XQ, 2014, WORLD J GASTROENTERO, V20, P1768, DOI 10.3748/wjg.v20.i7.1768	47	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167979	10.1371/journal.pone.0167979	http://dx.doi.org/10.1371/journal.pone.0167979			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959936	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900029
J	Tian, X; Zhong, L; von Cramon-Taubadel, S; Tu, HK; Wang, H				Tian, Xu; Zhong, Li; von Cramon-Taubadel, Stephan; Tu, Huakang; Wang, Hui			Restaurants in the Neighborhood, Eating Away from Home and BMI in China	PLOS ONE			English	Article							BODY-MASS INDEX; FAST-FOOD RESTAURANT; OUT-OF-HOME; DIETARY CHANGE; CONSUMPTION; OBESITY; ASSOCIATION; WEIGHT; ADULTS; RISK	Background To investigate the association between environmental risk factors, eating away from home, and increasing BMI of Chinese adults. Methods Participants were selected from the recent four waves (2004, 2006, 2009, and 2011) of the China Health and Nutrition Survey (CHNS). 10633 participants, including 5084 men and 5549 women, were used in the analysis. 24-h dietary recall data for three consecutive days with information on the time and place of consumption were collected. Nearby restaurants were measured by the number of fast food outlets, indoor restaurants, and food stands in the neighborhood. Random effects multivariable regression was used to assess associations between these variables. Results People living in neighborhoods with large numbers of indoor restaurants are more likely to eat away from home (p<0.05). Higher frequency of eating away from home is positively associated with BMI, but this effect is only significant for men (p<0.05). Moreover, while eating dinner or breakfast away from home contributes to BMI increase for men (p<0.05), no such association is found for lunch. Conclusion Eating dinner and breakfast away from home is positively associated with BMI for Chinese men. Labeling energy and portion size for the dishes served in indoor restaurants is recommended in China.	[Tian, Xu; Zhong, Li] Nanjing Agr Univ, China Ctr Food Secur Studies, Coll Econ & Management, Nanjing, Peoples R China; [von Cramon-Taubadel, Stephan] Univ Gottingen, Dept Agr Econ & Rural Dev, Gottingen, Germany; [Tu, Huakang] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Wang, Hui] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; University of Gottingen; University of Texas System; UTMD Anderson Cancer Center; Nanjing Medical University	Wang, H (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.	huiwang@njmu.edu.cn			National Natural Science Foundation of China (NSFC) [71473123, 81402741]; Natural Science Foundation Jiangsu Province [BK20140904]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Institute of Nutrition and Food Safety, China Center for Disease Control and Prevention; Carolina Population Centre, University of North Carolina at Chapel Hill; National Institutes of Health (NIH) [R01-HD30880, DK056350, R01-HD38700]; Fogarty International Centre, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030880] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038700] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW009077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); National Institute of Nutrition and Food Safety, China Center for Disease Control and Prevention; Carolina Population Centre, University of North Carolina at Chapel Hill; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Centre, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was sponsored by the National Natural Science Foundation of China (NSFC) (Project ID: 71473123&81402741), and BK20140904 from Natural Science Foundation Jiangsu Province, as well as "A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)." We also thank the National Institute of Nutrition and Food Safety, China Center for Disease Control and Prevention; the Carolina Population Centre, University of North Carolina at Chapel Hill; the National Institutes of Health (NIH; R01-HD30880, DK056350, and R01-HD38700); and the Fogarty International Centre, NIH, for their financial contribution toward the CHNS data collection and analysis files since 1989. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JF, 2012, CHINA AGR ECON REV, V4, P18, DOI 10.1108/17561371211196757; Bai JF, 2010, CHINA ECON REV, V21, P432, DOI 10.1016/j.chieco.2010.04.003; Batis C, 2014, BR J NUTR, V111, P1441; Bezerra IN, 2009, PUBLIC HEALTH NUTR, V12, P2037, DOI 10.1017/S1368980009005710; Binkley JK, 2000, INT J OBESITY, V24, P1032, DOI 10.1038/sj.ijo.0801356; Burns C, 2002, PUBLIC HEALTH NUTR, V5, P441, DOI 10.1079/PHN2001316; Butzlaff Iris, 2016, UNDERSTANDING DRIVER; Dearth-Wesley T, 2008, EUR J CLIN NUTR, V62, P1302, DOI 10.1038/sj.ejcn.1602853; Dong XX, 2010, AGRIC AGRIC SCI PROC, V1, P271, DOI 10.1016/j.aaspro.2010.09.034; Du WW, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004528; Duffey KJ, 2007, AM J CLIN NUTR, V85, P201, DOI 10.1093/ajcn/85.1.201; French SA, 2001, INT J OBESITY, V25, P1823, DOI 10.1038/sj.ijo.0801820; French SA, 2000, INT J OBESITY, V24, P1353, DOI 10.1038/sj.ijo.0801429; Gordon-Larsen P, 2014, OBES REV, V15, P37, DOI 10.1111/obr.12121; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Insik M, 2004, CHINA ECON REV, V15, P457; Kant AK, 2015, INT J OBESITY, V39, P820, DOI 10.1038/ijo.2014.183; Kant AK, 2004, PREV MED, V38, P243, DOI 10.1016/j.ypmed.2003.10.004; Lachat C, 2012, OBES REV, V13, P329, DOI 10.1111/j.1467-789X.2011.00953.x; Liu HY, 2015, FOOD POLICY, V51, P97, DOI 10.1016/j.foodpol.2014.12.011; Liu J, 2014, FOOD POLICY, V49, P323, DOI 10.1016/j.foodpol.2014.09.007; Ma HY, 2006, CAN J AGR ECON, V54, P101, DOI 10.1111/j.1744-7976.2006.00040.x; Marin-Guerrero AC, 2008, BRIT J NUTR, V100, P1142, DOI 10.1017/S0007114508966137; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Naska A, 2011, INT J OBESITY, V35, P416, DOI 10.1038/ijo.2010.142; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Orfanos P, 2009, EUR J CLIN NUTR, V63, pS239, DOI 10.1038/ejcn.2009.84; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Popkin BM, 2008, HEALTH AFFAIR, V27, P1064, DOI 10.1377/hlthaff.27.4.1064; REDMAN BJ, 1980, AM J AGR ECON, V62, P234, DOI 10.2307/1239690; Schroder H, 2007, BRIT J NUTR, V98, P1274, DOI 10.1017/S0007114507781436; Tian X, 2015, FOOD POLICY, V53, P67, DOI 10.1016/j.foodpol.2015.04.006; Tian X, 2013, FRONT ECON CHINA, V8, P186, DOI 10.3868/s060-002-013-0009-9; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; WHO Consultation, 2000, WHO TECH REP SER, V894, P1; Wooldridge Jeffrey M., 2012, INTRO ECONOMETRICS M, VFifth; Wu Y, 2009, CVD PREVENTION CONTR, V1, P19, DOI DOI 10.1016/J.CVDPC.2008.11.003; Xu HW, 2013, J EPIDEMIOL COMMUN H, V67, P271, DOI 10.1136/jech-2012-201157; Zhang B, 2014, OBES REV, V15, P2, DOI 10.1111/obr.12119; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	41	21	25	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167721	10.1371/journal.pone.0167721	http://dx.doi.org/10.1371/journal.pone.0167721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	27959893	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900014
J	Baljin, B; Baldan, G; Chimeddorj, B; Tulgaa, K; Gunchin, B; Sandag, T; Pfeffer, K; MacKenzie, CR; Wendel, AF				Baljin, Bayaraa; Baldan, Ganbaatar; Chimeddorj, Battogtokh; Tulgaa, Khosbayar; Gunchin, Batbaatar; Sandag, Tsogtsaikhan; Pfeffer, Klaus; MacKenzie, Colin R.; Wendel, Andreas F.			Faecal Carriage of Gram-Negative Multidrug-Resistant Bacteria among Patients Hospitalized in Two Centres in Ulaanbaatar, Mongolia	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; SEQUENCE TYPING SCHEME; ESCHERICHIA-COLI; MOLECULAR CHARACTERIZATION; HIGH PREVALENCE; MULTIPLEX PCR; RISK-FACTORS; CTX-M; GENES; COMMUNITY	Gram-negative multidrug-resistant organisms (GN-MDRO) producing beta-lactamases (ESBL, plasmid-mediated AmpC beta-lactamases and carbapenemases) are increasingly reported throughout Asia. The aim of this surveillance study was to determine the rate of bacterial colonization in patients from two hospitals in the Mongolian capital Ulaanbaatar. Rectal swabs were obtained from patients referred to the National Traumatology and Orthopaedics Research Centre (NTORC) or the Burn Treatment Centre (BTC) between July and September 2014, on admission and again after 14 days. Bacteria growing on selective chromogenic media (CHROMagar ESBL/KPC) were identified by MALDI-ToF MS. We performed susceptibility testing by disk diffusion and PCR (bla(IMP-1), bla(VIM), bla(GES), bla(NDM), bla(KPC), bla(OXA-48), bla(GIM-1), bla(OXA-23), bla(OXA-24/40), bla(OXA-51), bla(OXA-58), bla(OXA-143), bla(OXA-235), bla(CTX-M), bla(SHV) bla(TEM) and plasmid-mediated bla(AmpC)). Carbapenemase-producing isolates were additionally genotyped by PFGE and MLST. During the study period 985 patients in the NTORC and 65 patients in the BTC were screened on admission. The prevalence of GN-MDRO-carriage was 42.4% and 69.2% respectively (p< 0.001). Due to the different medical specialities the two study populations differed significantly in age (p< 0.029) and gender (p< 0.001) with younger and more female patients in the burn centre (BTC). We did not observe a significant difference in colonization rate in the respective age groups in the total study population. In both centres most carriers were colonized with CTX-M-producing E. coli, followed by CTX-M-producing K. pneumoniae and CTX-M-producing E. cloacae. 158 patients from the NTORC were re-screened after 14 days of whom 99 had acquired a new GN-MDRO (p< 0.001). Carbapenemases were detected in both centres in four OXA-58-producing A. baumannii isolates (ST642) and six VIM-2-producing P. aeruginosa isolates (ST235). This study shows a high overall prevalence of GN-MDRO in the study population and highlights the importance of routine surveillance, appropriate infection control practice and antibiotic prescribing policies to prevent further spread especially of carbapenemases.	[Baljin, Bayaraa; Baldan, Ganbaatar; Chimeddorj, Battogtokh; Gunchin, Batbaatar; Sandag, Tsogtsaikhan] Mongolian Natl Univ Med Sci, Sch Biomed, Dept Microbiol & Immunol, Ulaanbaatar, Mongolia; [Tulgaa, Khosbayar] Mongolian Natl Univ Med Sci, Sch Biomed, Dept Mol Biol & Genet, Ulaanbaatar, Mongolia; [Pfeffer, Klaus; MacKenzie, Colin R.; Wendel, Andreas F.] Heinrich Heine Univ, Univ Hosp, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany	Mongolian National University of Medical Sciences; Mongolian National University of Medical Sciences; Heinrich Heine University Dusseldorf	Wendel, AF (corresponding author), Heinrich Heine Univ, Univ Hosp, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany.	Andreas.Wendel@med.uni-duesseldorf.de	MacKenzie, Colin R/E-9368-2011; San, Tsogt/AAX-6434-2020	MacKenzie, Colin R/0000-0001-7732-2698; San, Tsogt/0000-0003-4916-5108; Baljin, Bayaraa/0000-0002-2750-0588; Batbaatar, Gunchin/0000-0002-6678-7569; Tulgaa, Khosbayar/0000-0001-6288-9624	Medical Faculty of the Heinrich-Heine-University, Dusseldorf, Germany; ESCMID Study Group on Genomic and Molecular Diagnostics (ESGMD), Basel, Switzerland; DAAD-PAGEL program [54448058]	Medical Faculty of the Heinrich-Heine-University, Dusseldorf, Germany; ESCMID Study Group on Genomic and Molecular Diagnostics (ESGMD), Basel, Switzerland; DAAD-PAGEL program	This work was supported by the Medical Faculty of the Heinrich-Heine-University, Dusseldorf, Germany, in collaboration with the ESCMID Study Group on Genomic and Molecular Diagnostics (ESGMD), Basel, Switzerland. and by the DAAD-PAGEL program (54448058).	Azzopardi EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095042; Bartual SG, 2005, J CLIN MICROBIOL, V43, P4382, DOI 10.1128/JCM.43.9.4382-4390.2005; Bataar O, 2010, B WORLD HEALTH ORGAN, V88, P839, DOI 10.2471/BLT.10.077073; Castanheira M, 2004, ANTIMICROB AGENTS CH, V48, P4654, DOI 10.1128/AAC.48.12.4654-4661.2004; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; Dallenne C, 2010, J ANTIMICROB CHEMOTH, V65, P490, DOI 10.1093/jac/dkp498; Edelstein MV, 2013, LANCET INFECT DIS, V13, P867, DOI 10.1016/S1473-3099(13)70168-3; EUCAST, EUCAST GUID DET RES; Evans BA, 2008, CLIN MICROBIOL INFEC, V14, P268, DOI 10.1111/j.1469-0691.2007.01919.x; Higgins PG, 2013, ANTIMICROB AGENTS CH, V57, P2121, DOI 10.1128/AAC.02413-12; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Ider BE, 2010, J HOSP INFECT, V75, P209, DOI 10.1016/j.jhin.2010.02.022; Kao CY, 2016, J MICROBIOL IMMUNOL, V49, P692, DOI 10.1016/j.jmii.2015.05.009; Kao CY, 2014, INFECT GENET EVOL, V28, P313, DOI 10.1016/j.meegid.2014.10.024; Kao CY, 2014, INFECT GENET EVOL, V25, P66, DOI 10.1016/j.meegid.2014.04.012; Khandarmaa TO, 2012, BURNS, V38, P751, DOI 10.1016/j.burns.2011.11.006; Khorsandi M, 2015, ANN ROY COLL SURG, V97, P298, DOI 10.1308/003588415X14181254789169; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Molton JS, 2013, CLIN INFECT DIS, V56, P1310, DOI 10.1093/cid/cit020; Nakajima Rie, 2010, South Med Rev, V3, P19; Partridge SR, 2011, FEMS MICROBIOL REV, V35, P820, DOI 10.1111/j.1574-6976.2011.00277.x; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Schlesinger J, 2005, ANTIMICROB AGENTS CH, V49, P1150, DOI 10.1128/AAC.49.3.1150-1156.2005; Sun Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113121; Swayne RL, 2011, INT J ANTIMICROB AG, V38, P35, DOI 10.1016/j.ijantimicag.2011.03.010; Takehara K, 2016, MATERN CHILD HLTH J, V20, P1072, DOI 10.1007/s10995-015-1893-9; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Togoobaatar G, 2010, B WORLD HEALTH ORGAN, V88, P930, DOI 10.2471/BLT.10.079004; Valenza G, 2014, ANTIMICROB AGENTS CH, V58, P1228, DOI 10.1128/AAC.01993-13; Wendel AF, 2013, ANTIMICROB AGENTS CH, V57, P5162, DOI 10.1128/AAC.00118-13; Woerther PL, 2013, CLIN MICROBIOL REV, V26, P744, DOI 10.1128/CMR.00023-13; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; World Health Organization, 2014, ANT RES GLOB REP SUR; Zhang HN, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00239; Zhang J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0659-0	36	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168146	10.1371/journal.pone.0168146	http://dx.doi.org/10.1371/journal.pone.0168146			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942042	Green Published, Green Submitted, gold			2022-12-27	WOS:000392745600056
J	Embry, AE; Mohammadi, H; Niu, XY; Liu, LP; Moe, B; Miller-Little, WA; Lu, CY; Bruggeman, LA; McCulloch, CA; Janmey, PA; Miller, RT				Embry, Addie E.; Mohammadi, Hamid; Niu, Xinying; Liu, Liping; Moe, Borren; Miller-Little, William A.; Lu, Christopher Y.; Bruggeman, Leslie A.; McCulloch, Christopher A.; Janmey, Paul A.; Miller, R. Tyler			Biochemical and Cellular Determinants of Renal Glomerular Elasticity	PLOS ONE			English	Article							VIMENTIN INTERMEDIATE-FILAMENTS; ACTIN CYTOSKELETON; NEPHROTIC SYNDROME; CELLS; PODOCYTES; STRESS; MECHANISMS; MUTATIONS; DYNAMICS; ADHESION	The elastic properties of renal glomeruli and their capillaries permit them to maintain structural integrity in the presence of variable hemodynamic forces. Measured by micro-indentation, glomeruli have an elastic modulus (E, Young's modulus) of 2.1 kPa, and estimates from glomerular perfusion studies suggest that the E of glomeruli is between 2 and 4 kPa. F-actin depolymerization by latrunculin, inhibition of acto-myosin contractility by blebbistatin, reduction in ATP synthesis, and reduction of the affinity of adhesion proteins by EDTA reduced the glomerular E to 1.26, 1.7, 1.5, and 1.43 kPa, respectively. Actin filament stabilization with jasplakinolide and increasing integrin affinity with Mg2+ increased E to 2.65 and 2.87 kPa, respectively. Alterations in glomerular E are reflected in commensurate changes in F/G actin ratios. Disruption of vimentin intermediate filaments by withaferin A reduced E to 0.92 kPa. The E of decellularized glomeruli was 0.74 kPa, indicating that cellular components of glomeruli have dominant effects on their elasticity. The E of glomerular basement membranes measured by magnetic bead displacement was 2.4 kPa. Podocytes and mesangial cells grown on substrates with E values between 3 and 5 kPa had actin fibers and focal adhesions resembling those of podocytes in vivo. Renal ischemia and ischemia-reperfusion reduced the E of glomeruli to 1.58 kPa. These results show that the E of glomeruli is between 2 and 4 kPa. E of the GBM, 2.4 kPa, is consistent with this value, and is supported by the behavior of podocytes and mesangial cells grown on variable stiffness matrices. The podocyte cytoskeleton contributes the major component to the overall E of glomeruli, and a normal E requires ATP synthesis. The reduction in glomerular E following ischemia and in other diseases indicates that reduced glomerular E is a common feature of many forms of glomerular injury and indicative of an abnormal podocyte cytoskeleton.	[Embry, Addie E.; Niu, Xinying; Liu, Liping; Moe, Borren; Miller-Little, William A.; Lu, Christopher Y.; Miller, R. Tyler] UT Southwestern Med Sch, Nephrol & Med, Dallas, TX 75390 USA; [Mohammadi, Hamid; McCulloch, Christopher A.] Univ Toronto, Ctr Matrix Biol, Toronto, ON, Canada; [Bruggeman, Leslie A.] Case Western Reserve Univ, Metrohlth Med Ctr, Nephrol, Cleveland, OH USA; [Janmey, Paul A.] Univ Penn, Inst Med & Engn, Physiol & Biophys, Philadelphia, PA 19104 USA; [Miller, R. Tyler] Dallas VAMC, Med, Dallas, TX 75216 USA; [Moe, Borren] Univ Toronto, Engn, Toronto, ON, Canada; [Miller-Little, William A.] MSTP Case Western Reserve Univ, Cleveland, OH USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Toronto; Case Western Reserve University; MetroHealth System; University of Pennsylvania; Pennsylvania Medicine; University of Toronto; Case Western Reserve University	Miller, RT (corresponding author), UT Southwestern Med Sch, Nephrol & Med, Dallas, TX 75390 USA.; Miller, RT (corresponding author), Dallas VAMC, Med, Dallas, TX 75216 USA.	tyler.miller@utsouthwestern.edu	liu, li/HGC-0900-2022		National Institute of Health [RO1 DK083592, DK095832]; Charles and Jane Pak Foundation; Center for Mineral Metabolism and Clinical Research; U.T. Southwestern O'Brien Center for Kidney Disease; Veterans Affairs Administration; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083592, R01DK097836, R01DK095832] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles and Jane Pak Foundation; Center for Mineral Metabolism and Clinical Research; U.T. Southwestern O'Brien Center for Kidney Disease; Veterans Affairs Administration(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institute of Health grants RO1 DK083592 (RTM and PAJ), DK095832 (LAB) the Charles and Jane Pak Foundation and Center for Mineral Metabolism and Clinical Research, and the U.T. Southwestern O'Brien Center for Kidney Disease, and the Veterans Affairs Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Ashraf S, 2013, J CLIN INVEST, V123, P5179, DOI 10.1172/JCI69000; Atkinson SJ, 2004, J BIOL CHEM, V279, P5194, DOI 10.1074/jbc.M306973200; Bargana-Mohan P, 2015, PLOS ONE, V17; BRENNER BM, 1971, J CLIN INVEST, V50, P1776, DOI 10.1172/JCI106667; Brown Elizabeth J, 2010, Nat Genet, V42, P72, DOI 10.1038/ng.505; Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640; Byfield FJ, 2009, BIOPHYS J, V96, P5095, DOI 10.1016/j.bpj.2009.03.046; Chen YM, 2013, J AM SOC NEPHROL, V24, P1223, DOI 10.1681/ASN.2012121149; Correia I, 1999, J CELL BIOL, V146, P831, DOI 10.1083/jcb.146.4.831; Cortes P, 2000, KIDNEY INT, V58, P2452, DOI 10.1046/j.1523-1755.2000.00428.x; Cortes P, 1996, AM J PHYSIOL-RENAL, V270, pF356, DOI 10.1152/ajprenal.1996.270.2.F356; D'Addario M, 2002, J BIOL CHEM, V277, P47541, DOI 10.1074/jbc.M207681200; DANIELS BS, 1992, AM J PHYSIOL, V262, pF919, DOI 10.1152/ajprenal.1992.262.6.F919; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; DWORKIN LD, 1984, J CLIN INVEST, V73, P1448, DOI 10.1172/JCI111349; Endlich N, 2006, EUR J CELL BIOL, V85, P229, DOI 10.1016/j.ejcb.2005.09.006; Endlich N, 2012, SEMIN NEPHROL, V32, P327, DOI 10.1016/j.semnephrol.2012.06.004; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Esue O, 2006, J BIOL CHEM, V281, P30393, DOI 10.1074/jbc.M605452200; Ferrell N, 2015, AM J PHYSIOL-RENAL, V308, pF588, DOI 10.1152/ajprenal.00290.2014; Perez MF, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0146588, 10.1371/journal.pone.0165590]; Gladilin E, 2014, J BIOMECH, V47, P2598, DOI 10.1016/j.jbiomech.2014.05.020; GRANTHAM JJ, 1987, KIDNEY INT, V32, P187, DOI 10.1038/ki.1987.191; Greka A, 2012, ANNU REV PHYSIOL, V74, P299, DOI 10.1146/annurev-physiol-020911-153238; Grin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039065; Guo M, 2013, BIOPHYS J, V105, P1562, DOI 10.1016/j.bpj.2013.08.037; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Janmey PA, 2011, J CELL SCI, V124, P9, DOI 10.1242/jcs.071001; Kamgoue A, 2007, J BIOMECH ENG-T ASME, V129, P523, DOI 10.1115/1.2746374; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Kinnunen AI, 2011, J BIOL CHEM, V286, P7755, DOI 10.1074/jbc.M110.166132; KRIZ W, 1994, KIDNEY INT, V45, P369, DOI 10.1038/ki.1994.47; Levental I, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194120; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lu TC, 2008, J BIOL CHEM, V283, P8173, DOI 10.1074/jbc.M708920200; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miller RT, 2015, CURR OPIN NEPHROL HY, V24, P393, DOI 10.1097/MNH.0000000000000138; Miner JH, 2012, EXP CELL RES, V318, P973, DOI 10.1016/j.yexcr.2012.02.031; Mohammadi H, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1074; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; NAGATA M, 1992, KIDNEY INT, V42, P148, DOI 10.1038/ki.1992.272; O'Tool JF, 2007, JASN, V18, p136A; Perez-Liva M., 2016, 2016 Global Medical Engineering Physics Exchanges/Pan-American Health Care Exchanges (GMEPE/PAHCE), P1, DOI 10.1109/GMEPE-PAHCE.2016.7504651; RACUSEN LC, 1984, AM J PATHOL, V114, P157; Shankland SJ, 2014, SEMIN NEPHROL, V34, P418, DOI 10.1016/j.semnephrol.2014.06.008; Smithies O, 2003, P NATL ACAD SCI USA, V100, P4108, DOI 10.1073/pnas.0730776100; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Steenhard BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050745; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tandon R, 2007, AM J PHYSIOL-RENAL, V292, pF701, DOI 10.1152/ajprenal.00246.2006; Terzi F, 1997, J CLIN INVEST, V100, P1520, DOI 10.1172/JCI119675; Wagner MC, 2008, J BIOL CHEM, V283, P35579, DOI 10.1074/jbc.M805507200; Weins A, 2005, J AM SOC NEPHROL, V16, P3694, DOI 10.1681/ASN.2005070706; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Wyss HM, 2011, AM J PHYSIOL-CELL PH, V300, pC397, DOI 10.1152/ajpcell.00438.2010	56	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167924	10.1371/journal.pone.0167924	http://dx.doi.org/10.1371/journal.pone.0167924			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942003	Green Submitted, Green Published, gold			2022-12-27	WOS:000392745600038
J	Volpe, NL; Robinson, WD; Frey, SJK; Hadley, AS; Betts, MG				Volpe, Noelia L.; Robinson, W. Douglas; Frey, Sarah J. K.; Hadley, Adam S.; Betts, Matthew G.			Tropical Forest Fragmentation Limits Movements, but Not Occurrence of a Generalist Pollinator Species	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; MATRIX COMPOSITION; BIRD MOVEMENTS; HOME-RANGE; BEHAVIOR; DISPERSAL; LANDSCAPE; SONGBIRDS; NETWORKS; KEYSTONE	Habitat loss and fragmentation influence species distributions and therefore ecological processes that depend upon them. Pollination may be particularly susceptible to fragmentation, as it depends on frequent pollinator movement. Unfortunately, most pollinators are too small to track efficiently which has precluded testing the hypothesis that habitat fragmentation reduces or eliminates pollen flow by disrupting pollinator movement. We used radio-telemetry to examine space use of the green hermit hummingbird (Phaethornis guy), an important 'hub' pollinator of understory flowering plants across substantial portions of the neotropics and the primary pollinator of a keystone plant which shows reduced pollination success in fragmented landscapes. We found that green hermits strongly avoided crossing large stretches of non-forested matrix and preferred to move along stream corridors. Forest gaps as small as 50 m diminished the odds of movement by 50%. Green hermits occurred almost exclusively inside the forest, with the odds of occurrence being 8 times higher at points with >95% canopy cover compared with points having <5% canopy cover. Nevertheless, surprisingly. the species occurred in fragmented landscapes with low amounts of forest (similar to 30% within a 2 km radius). Our results indicate that although green hermits are present even in landscapes with low amounts of tropical forest, movement within these landscapes ends up strongly constrained by forest gaps. Restricted movement of pollinators may be an underappreciated mechanism for widespread declines in pollination and plant fitness in fragmented landscapes, even when in the presence of appropriate pollinators.	[Volpe, Noelia L.; Robinson, W. Douglas] Oregon State Univ, Dept Fisheries & Wildlife, 104 Nash Hall, Corvallis, OR 97331 USA; [Frey, Sarah J. K.; Hadley, Adam S.; Betts, Matthew G.] Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Betts, MG (corresponding author), Oregon State Univ, Dept Forest Ecosyst & Soc, Corvallis, OR 97331 USA.	matt.betts@oregonstate.edu	Frey, Sarah/AAZ-2404-2021; Frey, Sarah/D-5685-2013; Hadley, Adam/G-8391-2012; Betts, Matthew G/Q-2978-2019	Frey, Sarah/0000-0002-4343-0700; Hadley, Adam/0000-0002-8344-3354; Betts, Matthew G/0000-0002-7100-2551	National Science Foundation [DEB-1050954, DEB-1457837]; Bob and Phyllis Mace Professorship; Division Of Environmental Biology [1457837] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Bob and Phyllis Mace Professorship; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was partly funded by the National Science Foundation grants DEB-1050954 awarded to M.G.B. and W.D.R., and DEB-1457837 awarded to M.G.B. and A.S.H (http//www.nsf.gov), as well as the Bob and Phyllis Mace Professorship to W.D.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben J, 2012, ANIM CONSERV, V15, P658, DOI 10.1111/j.1469-1795.2012.00562.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bender DJ, 1998, ECOLOGY, V79, P517, DOI 10.2307/176950; Betts MG, 2006, ECOL APPL, V16, P1076, DOI 10.1890/1051-0761(2006)016[1076:IEOFOF]2.0.CO;2; Betts MG, 2015, P NATL ACAD SCI USA, V112, P3433, DOI 10.1073/pnas.1419522112; Beyer H. L, 2012, GEOSPATIAL MODELLING; Borgella R, 2001, BIOTROPICA, V33, P90, DOI 10.1111/j.1744-7429.2001.tb00160.x; Bosschieter L, 2010, ARDEA, V98, P383, DOI 10.5253/078.098.0312; Brosi BJ, 2008, CONSERV LETT, V1, P27, DOI 10.1111/j.1755-263X.2008.00004.x; Desrochers A, 2010, ECOGRAPHY, V33, P921, DOI 10.1111/j.1600-0587.2009.06061.x; Diekotter T, 2007, OIKOS, V116, P1588, DOI [10.1111/j.2007.0030-1299.15963.x, 10.1111/j.0030-1299.2007.15963.x]; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; Eckert CG, 2010, TRENDS ECOL EVOL, V25, P35, DOI 10.1016/j.tree.2009.06.013; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Farwig N, 2009, LANDSCAPE ECOL, V24, P919, DOI 10.1007/s10980-009-9376-2; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; Gillies CS, 2011, ECOL APPL, V21, P944, DOI 10.1890/09-2090.1; Gillies CS, 2010, J APPL ECOL, V47, P182, DOI 10.1111/j.1365-2664.2009.01756.x; Graham CH, 2001, CONSERV BIOL, V15, P1789, DOI 10.1046/j.1523-1739.2001.00070.x; GREENWOOD PJ, 1982, ANNU REV ECOL SYST, V13, P1, DOI 10.1146/annurev.es.13.110182.000245; Hadley AS, 2014, ECOLOGY, V95, P2202, DOI 10.1890/13-0929.1; Hadley AS, 2012, BIOL REV, V87, P526, DOI 10.1111/j.1469-185X.2011.00205.x; Hadley AS, 2009, BIOL LETTERS, V5, P207, DOI 10.1098/rsbl.2008.0691; Hadley AS., 2016, CURR LANDSC ECOL REP, V1, P55, DOI [10.1007/s40823-016-0007-8, DOI 10.1007/S40823-016-0007-8]; HEINRICH B, 1972, SCIENCE, V176, P597, DOI 10.1126/science.176.4035.597; Hole AR, 2007, STATA J, V7, P388, DOI 10.1177/1536867X0700700306; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Jennings SB, 1999, FORESTRY, V72, P59, DOI 10.1093/forestry/72.1.59; Kormann U, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2347; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Kucharick S, 2001, J ECOL RES, V3, P27; Lever JJ, 2014, ECOL LETT, V17, P350, DOI 10.1111/ele.12236; Lloyd H, 2011, RESTOR ECOL, V19, P74, DOI 10.1111/j.1526-100X.2009.00542.x; Magrach A, 2012, CONSERV BIOL, V26, P238, DOI 10.1111/j.1523-1739.2011.01818.x; Memmott J, 2004, P ROY SOC B-BIOL SCI, V271, P2605, DOI 10.1098/rspb.2004.2909; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Rettie WJ, 1999, CAN J ZOOL, V77, P1175, DOI 10.1139/cjz-77-8-1175; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Schuepp C, 2014, P R SOC LOND B, V281; Smith JNM, 2002, TRENDS ECOL EVOL, V17, P397, DOI 10.1016/S0169-5347(02)02576-4; Smith MJ, 2011, LANDSCAPE ECOL, V26, P709, DOI 10.1007/s10980-011-9595-1; SNOW BK, 1974, IBIS, V116, P278, DOI 10.1111/j.1474-919X.1974.tb00125.x; STILES FG, 1975, ECOLOGY, V56, P285, DOI 10.2307/1934961; Tittler R, 2009, ECOGRAPHY, V32, P1051, DOI 10.1111/j.1600-0587.2009.05680.x; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Van Dyck H, 2005, BASIC APPL ECOL, V6, P535, DOI 10.1016/j.baae.2005.03.005; Volpe NL, 2014, ECOL APPL, V24, P2122, DOI 10.1890/13-2168.1; Wilson RF, 2007, WILDLIFE RES, V34, P177, DOI 10.1071/WR06114; Zuur Alain F., 2009, P1	53	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167513	10.1371/journal.pone.0167513	http://dx.doi.org/10.1371/journal.pone.0167513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941984	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600020
J	Canepa, GE; Molina-Cruz, A; Barillas-Mury, C				Canepa, Gaspar E.; Molina-Cruz, Alvaro; Barillas-Mury, Carolina			Molecular Analysis of Pfs47-Mediated Plasmodium Evasion of Mosquito Immunity	PLoS One			English	Article							VECTOR ANOPHELES-GAMBIAE; FALCIPARUM; COMPLEMENT; SELECTION; SYSTEM	Malaria is a life-threatening disease caused by Plasmodium falciparum parasites that is transmitted through the bites of infected anopheline mosquitoes. P. falciparum dispersal from Africa, as a result of human migration, required adaptation of the parasite to several different indigenous anopheline species. The mosquito immune system can greatly limit infection and P. falciparum evolved a strategy to evade these responses that is mediated by the Pfs47 gene. Pfs47 is a polymorphic gene with signatures of diversifying selection and a strong geographic genetic structure at a continental level. Here, we investigated the role of single four amino acid differences between the Pfs47 gene from African (GB4 and NF54) and a New World (7G8) strains that differ drastically in their ability to evade the immune system of A. gambiae L35 refractory mosquitoes. Wild type NF54 and GB4 parasites can survive in this mosquito strain, while 7G8 parasites are eliminated. Our studies indicate that replacement in any of these four single amino acids in Pfs47 from the NF54 strain by those present in 7G8, completely disrupts the ability of NF54 parasites to hide from the mosquito immune system. One of these amino acid replacements had the opposite effect on A. albimanus mosquitoes, and enhanced infection. We conclude that malaria transmission involves a complex interplay between the genetic background of the parasite and the mosquito and that Pfs47 can be critical in this interaction as it mediates Plasmodium immune evasion through molecular interactions that need to be precise in some parasite/vector combinations.	[Canepa, Gaspar E.; Molina-Cruz, Alvaro; Barillas-Mury, Carolina] NINDS, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Barillas-Mury, C (corresponding author), NINDS, Lab Malaria & Vector Res, NIH, Rockville, MD 20892 USA.	cbarillas@niaid.nih.gov		Canepa, Gaspar/0000-0002-4195-8835	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjalley SH, 2010, METHODS MOL BIOL, V634, P87, DOI 10.1007/978-1-60761-652-8_6; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Caro F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-22; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Eldering M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20440; FELDMANN AM, 1989, MED VET ENTOMOL, V3, P41, DOI 10.1111/j.1365-2915.1989.tb00473.x; Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005; Garver LS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003622; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Molina-Cruz A, 2012, P NATL ACAD SCI US; Molina-Cruz A, 2015, P NATL ACAD SCI USA, V112, P15178, DOI 10.1073/pnas.1520426112; Molina-Cruz A, 2014, MEM I OSWALDO CRUZ, V109, P662, DOI 10.1590/0074-0276130553; Molina-Cruz A, 2013, SCIENCE, V340, P984, DOI 10.1126/science.1235264; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; Ramphul UN, 2015, P NATL ACAD SCI USA, V112, P1273, DOI 10.1073/pnas.1423586112; Sinka ME, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-69; World Health Organization, 2015, WORLD MAL REP 2015	20	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168279	10.1371/journal.pone.0168279	http://dx.doi.org/10.1371/journal.pone.0168279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992481	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600046
J	Gaines, TA; Barker, AL; Patterson, EL; Westra, P; Westra, EP; Wilson, RG; Jha, P; Kumar, V; Kniss, AR				Gaines, Todd A.; Barker, Abigail L.; Patterson, Eric L.; Westra, Philip; Westra, Eric P.; Wilson, Robert G.; Jha, Prashant; Kumar, Vipan; Kniss, Andrew R.			EPSPS Gene Copy Number and Whole-Plant Glyphosate Resistance Level in Kochia scoparia	PLOS ONE			English	Article							BETA-VULGARIS; SUGAR-BEET; AMPLIFICATION; SYNTHASE	Glyphosate-resistant (GR) Kochia scoparia has evolved in dryland chemical fallow systems throughout North America and the mechanism of resistance involves 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) gene duplication. Agricultural fields in four states were surveyed for K. scoparia in 2013 and tested for glyphosate-resistance level and EPSPS gene copy number. Glyphosate resistance was confirmed in K. scoparia populations collected from sugarbeet fields in Colorado, Wyoming, and Nebraska, and Montana. Glyphosate resistance was also confirmed in K. scoparia accessions collected from wheat-fallow fields in Montana. All GR samples had increased EPSPS gene copy number, with median population values up to 11 from sugarbeet fields and up to 13 in Montana wheat-fallow fields. The results indicate that glyphosate susceptibility can be accurately diagnosed using EPSPS gene copy number.	[Gaines, Todd A.; Barker, Abigail L.; Patterson, Eric L.; Westra, Philip; Westra, Eric P.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Wilson, Robert G.] Univ Nebraska, Dept Agron & Hort, Scottsbluff, NE USA; [Jha, Prashant; Kumar, Vipan] Montana State Univ, Southern Agr Res Ctr, Huntley, MT USA; [Kniss, Andrew R.] Univ Wyoming, Dept Plant Sci, Laramie, WY 82071 USA	Colorado State University; University of Nebraska System; Montana State University System; Montana State University Bozeman; University of Wyoming	Kniss, AR (corresponding author), Univ Wyoming, Dept Plant Sci, Laramie, WY 82071 USA.	akniss@uwyo.edu	Kumar, Vipan/N-1879-2019; Gaines, Todd/A-8998-2008; Kniss, Andrew/B-3247-2010	Kumar, Vipan/0000-0002-8301-5878; Gaines, Todd/0000-0003-1485-7665; Patterson, Eric/0000-0001-7111-6287; Kniss, Andrew/0000-0003-2551-4959	Western Sugar Cooperative Joint Grower Research Committee; USDA National Institute of Food and Agriculture [WYO-528-14, COL00719, MONB00658]; Montana Wheat and Barley Committee [4W6112]	Western Sugar Cooperative Joint Grower Research Committee; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Montana Wheat and Barley Committee	Research described in this manuscript was supported by the following funding sources: Western Sugar Cooperative Joint Grower Research Committee; USDA National Institute of Food and Agriculture, Hatch project WYO-528-14 to the Wyoming Agricultural Experiment Station, Hatch project COL00719 to the Colorado State University Agricultural Experiment Station, Hatch project MONB00658 to the Montana Agricultural Experiment Station; Montana Wheat and Barley Committee (grant #4W6112). Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the National Institute of Food and Agriculture (NIFA) or the United States Department of Agriculture (USDA). Western Sugar staff participated in the collection of plant material used in this research. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.	Beckie HJ, 2015, CAN J PLANT SCI, V95, P345, DOI [10.4141/CJPS-2014-328, 10.4141/cjps-2014-328]; Beckie HJ, 2013, WEED SCI, V61, P310, DOI 10.1614/WS-D-12-00140.1; Chahal P. S., 2015, Journal of Agricultural Science (Toronto), V7, P1; Coburn C, 2016, P W SOC WEED SCI, V69, P65; Forcella F., 1985, Weeds Today, V16, P4; Friesen LF, 2009, CAN J PLANT SCI, V89, P141, DOI 10.4141/CJPS08057; Gaines TA, 2015, P W SOC WEED SCI, V68, P127; Godar AS, 2015, WEED SCI, V63, P587, DOI 10.1614/WS-D-14-00145.1; Heap I., 2015, INT SURVEY HERBICIDE; Jugulam M, 2014, PLANT PHYSIOL, V166, P1200, DOI 10.1104/pp.114.242826; Khan M. F. R., 2010, Outlooks on Pest Management, V21, P38, DOI 10.1564/21feb10; Kniss A. R., 2010, Journal of Sugar Beet Research, V47, P127, DOI 10.5274/jsbr.47.3.127; Kniss AR, 2007, WEED SCI, V55, P572, DOI 10.1614/WS-07-002.1; Kniss AR, 2004, WEED TECHNOL, V18, P388, DOI 10.1614/WT-03-119R; Kumar V, 2015, WEED SCI, V63, P758, DOI 10.1614/WS-D-15-00021.1; Kumar V, 2014, WEED TECHNOL, V28, P122, DOI 10.1614/WT-D-13-00115.1; Mengistu LW, 2002, WEED SCI, V50, P498, DOI 10.1614/0043-1745(2002)050[0498:GDOK]2.0.CO;2; MESBAH A, 1994, WEED TECHNOL, V8, P754, DOI 10.1017/S0890037X00028645; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; STALLINGS GP, 1995, WEED SCI, V43, P95, DOI 10.1017/S0043174500080887; Varanasi VK, 2015, PEST MANAG SCI, V71, P1207, DOI 10.1002/ps.4034; Vila-Aiub MM, 2014, PLANTA, V239, P793, DOI 10.1007/s00425-013-2022-x; Waite J, 2013, WEED SCI, V61, P193, DOI 10.1614/WS-D-12-00101.1; Wiersma AT, 2015, PLANTA, V241, P463, DOI 10.1007/s00425-014-2197-9; Wilson RG, 2002, WEED TECHNOL, V16, P66, DOI 10.1614/0890-037X(2002)016[0066:IOGAGO]2.0.CO;2	26	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168295	10.1371/journal.pone.0168295	http://dx.doi.org/10.1371/journal.pone.0168295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992501	Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000036
J	Shen, ZR; Zhu, YN; Song, XH; Yan, J; Yao, K				Shen, Zeren; Zhu, Yanan; Song, Xiaohui; Yan, Jie; Yao, Ke			Dry Eye after Small Incision Lenticule Extraction (SMILE) versus Femtosecond Laser-Assisted in Situ Keratomileusis (FS-LASIK) for Myopia: A Meta-Analysis	PLOS ONE			English	Article							INDUCED NEUROTROPHIC EPITHELIOPATHY; CORNEAL SENSITIVITY; REFRACTIVE SURGERY; OCULAR SURFACE; OUTCOMES; PATHOPHYSIOLOGY; SENSATION	Purpose To compare dry eye after small incision lenticule extraction (SMILE) and femtosecond laser-assisted LASIK (FS-LASIK) for correcting myopia. Methods CENTRAL, Embase and PubMed were searched in November 2016. All randomized controlled trials (RCTs) and prospective cohorts that compared dry eye after SMILE with FS-LASIK were selected. Results Five cohorts and one RCT were identified for comparing dry eye after SMILE (291 eyes) and FS-LASIK (277 eyes). The pooled results revealed that the SMILE and FS-LASIK groups did not differ significantly in terms of Schirmer's I test (SIT) and tear film osmolarity (TFO) at any postoperative visits. By contrast, tear break up time (TBUT; p = 0.04 for one month, p < 0.001 for three months, and p = 0.02 for six months) and ocular surface disease index (OSDI; p < 0.001 for one month and three months, and p = 0.006 for six months) were significantly worse in the FS-LASIK group than in the SMILE group at follow-up. At six months postoperatively, TBUT and TFO values in both the SMILE and FS-LASIK groups and OSDI scores in the SMILE group returned to preoperative levels, but SIT values in both groups (p = 0.02 for the SMILE group and p < 0.001 for the FS-LASIK group) and OSDI in the FS-LASIK group (p < 0.001) were still statistically impaired. Conclusion Dry eye after both SMILE and FS-LASIK usually occurs transiently. SMILE does not show obvious superiority over FS-LASIK by exhibiting similar and acceptable objective parameters, and SMILE may have milder subjective symptoms.	[Shen, Zeren; Zhu, Yanan; Song, Xiaohui; Yan, Jie; Yao, Ke] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Eye, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Yao, K (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Ctr Eye, Hangzhou, Zhejiang, Peoples R China.	xlren@zju.edu.cn	Yao, Ke/AAM-6866-2021	Yao, Ke/0000-0002-6764-7365	National Natural Science Foundation [81570822]; Zhejiang Key Laboratory Fund of China [2011E10006]; Zhejiang Province Key Research and Development Program [2015C03042]; Zhejiang Provincial Natural Science Foundation of China [LQ15H120002]; National Natural Science Foundation of China [81500704]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Key Laboratory Fund of China; Zhejiang Province Key Research and Development Program; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Program of National Natural Science Foundation (No. 81570822), Zhejiang Key Laboratory Fund of China (No. 2011E10006) and Zhejiang Province Key Research and Development Program (2015C03042). KY is the recipient. This work was also supported by Zhejiang Provincial Natural Science Foundation of China (LQ15H120002) and Program of National Natural Science Foundation of China (No. 81500704). YZ is the recipient. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albietz JM, 2004, J CATARACT REFR SURG, V30, P675, DOI 10.1016/j.jcrs.2003.07.003; Ambrosio R, 2008, J REFRACT SURG, V24, P396, DOI 10.3928/1081597X-20080401-14; Battat L, 2001, OPHTHALMOLOGY, V108, P1230, DOI 10.1016/S0161-6420(01)00623-6; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Binder PS, 2004, J CATARACT REFR SURG, V30, P26, DOI 10.1016/S0886-3350(03)00578-9; Demirok A, 2013, OPTOMETRY VISION SCI, V90, P1040, DOI 10.1097/OPX.0b013e31829d9926; Denoyer A, 2015, OPHTHALMOLOGY, V122, P669, DOI 10.1016/j.ophtha.2014.10.004; Friedlaender Mitchell H., 2006, International Ophthalmology Clinics, V46, P145, DOI 10.1097/00004397-200604630-00013; Ganesh S, 2014, J REFRACT SURG, V30, P590, DOI 10.3928/1081597X-20140814-02; He M, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0129-5; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kezirian GM, 2004, J CATARACT REFR SURG, V30, P804, DOI 10.1016/j.jcrs.2003.10.026; Kobashi H, 2016, CORNEA, P1; Kumano Y, 2003, J CATARACT REFR SURG, V29, P757, DOI 10.1016/S0886-3350(02)01840-0; Levinson BA, 2008, J CATARACT REFR SURG, V34, P32, DOI 10.1016/j.jcrs.2007.08.028; Li MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077797; Nassaralla BA, 2003, OPHTHALMOLOGY, V110, P497, DOI 10.1016/S0161-6420(02)01897-3; Savini G, 2004, J REFRACT SURG, V20, P803; Shen ZR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158176; Stern ME, 2004, EXP EYE RES, V78, P409, DOI 10.1016/j.exer.2003.09.003; Sugar Alan, 2002, Curr Opin Ophthalmol, V13, P246, DOI 10.1097/00055735-200208000-00011; Toda I, 2001, AM J OPHTHALMOL, V132, P1, DOI 10.1016/S0002-9394(01)00959-X; Wang BJ, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/132417; Wells G.A., NEWCASTLE OTTAWA SCA; Wen D, 2015, CLIN EXPT OPHTHALMOL, V43, P523; Wilson SE, 2001, AM J OPHTHALMOL, V132, P405, DOI 10.1016/S0002-9394(01)00995-3; Xia L, 2016, CURR EYE RES, V1, P1; Xu YS, 2014, J REFRACT SURG, V30, P186, DOI 10.3928/1081597X-20140219-02; Zhang YJ, 2016, J REFRACT SURG, V32, P256, DOI 10.3928/1081597X-20151111-06	30	24	26	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168081	10.1371/journal.pone.0168081	http://dx.doi.org/10.1371/journal.pone.0168081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992482	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000026
J	Cantarutti, A; Merlino, L; Monzani, E; Giaquinto, C; Corrao, G				Cantarutti, Anna; Merlino, Luca; Monzani, Emiliano; Giaquinto, Carlo; Corrao, Giovanni			Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; MATERNAL DEPRESSION; IMPACT; METAANALYSIS; EXPOSURE; ESTRIOL; SMOKING; GROWTH; WOMEN	Background Untreated depression during pregnancy increases the risk of morbidity and mortality in the mother and child. Therefore, specific treatments are required for this population. Objective The study aimed to investigating the effect of antidepressant medication used during pregnancy with reference to the risk of preterm birth (PTB) and low birth weight (LBW). Methods A population-based study was carried out with data provided by the healthcare utilization database of Lombardy, an Italian region with about ten million inhabitants. The study included 384,673 births from 2005 to 2010. Maternal use of antidepressants before and during pregnancy was investigated. Log-binomial regression was used to estimate the association between the use of antidepressants during pregnancy, compared to the non-use or use just before pregnancy, and the prevalence ratio of PTB and LBW. Results Women who used antidepressants during pregnancy had a 20% (95% CI: 10-40%) increased prevalence of both PTB and LBW compared to those who never used antidepressants. There was no evidence that women who used antidepressants during pregnancy had a higher prevalence of the considered outcomes compared to women who used antidepressants before pregnancy, but stopped during pregnancy. Such findings were confirmed by considering separately the effects of SSRIs and other antidepressants together. Conclusions Our findings suggest that depression in itself, rather than antidepressant medication, might be implicated in the causal pathway of PTB and LBW.	[Cantarutti, Anna; Corrao, Giovanni] Univ Milano Bicocca, Div Biostat Epidemiol & Publ Hlth, Dept Stat & Quantitat Methods, Lab Healthcare Res & Pharmacoepidemiol, Milan, Italy; [Merlino, Luca] Operat Unit Terr Hlth Serv, Milan, Italy; [Monzani, Emiliano] Ca Granda Niguarda Hosp, Dept Mental Hlth, Milan, Italy; [Giaquinto, Carlo] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy	University of Milano-Bicocca; University of Padua	Cantarutti, A (corresponding author), Univ Milano Bicocca, Div Biostat Epidemiol & Publ Hlth, Dept Stat & Quantitat Methods, Lab Healthcare Res & Pharmacoepidemiol, Milan, Italy.	a.cantarutti@campus.unimib.it	Giaquinto, Carlo/AAB-5016-2020	MERLINO, Luca Giuseppe/0000-0001-9232-9994; GIAQUINTO, CARLO/0000-0001-9365-0413	Italian Ministry for University and Research "Fondo d'Ateneo per la Ricerca" [2014-ATE-0232]	Italian Ministry for University and Research "Fondo d'Ateneo per la Ricerca"	This study was funded by grants from the Italian Ministry for University and Research "Fondo d'Ateneo per la Ricerca" portion, year 2014. Grant number: 2014-ATE-0232.	Alwan S, 2011, J CLIN PHARMACOL, V51, P264, DOI 10.1177/0091270010373928; American Psychiatric Association (APA), 2010, PRACTICE GUIDELINE T, V3rd; Barker ED, 2012, BRIT J PSYCHIAT, V200, P124, DOI 10.1192/bjp.bp.111.092346; Cinciripini PM, 2010, J CONSULT CLIN PSYCH, V78, P44, DOI 10.1037/a0018168; Corrao G, 2015, HYPERTENSION, V65, P490, DOI 10.1161/HYPERTENSIONAHA.114.04858; Davis RL, 2007, PHARMACOEPIDEM DR S, V16, P1086, DOI 10.1002/pds.1462; de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007; El Marroun H, 2012, ARCH GEN PSYCHIAT, V69, P706, DOI 10.1001/archgenpsychiatry.2011.2333; Ferreira E, 2007, PEDIATRICS, V119, P52, DOI 10.1542/peds.2006-2133; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Huang H, 2014, GEN HOSP PSYCHIAT, V36, P13, DOI 10.1016/j.genhosppsych.2013.08.002; Jensen HM, 2013, PSYCHOPHARMACOLOGY, V228, P199, DOI 10.1007/s00213-013-3029-5; Kallen B, 2004, ARCH PEDIAT ADOL MED, V158, P312, DOI 10.1001/archpedi.158.4.312; Kallen K, 2001, EUR J PUBLIC HEALTH, V11, P329, DOI 10.1093/eurpub/11.3.329; Lattimore Keri A, 2005, J Perinatol, V25, P595; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S1; Lund N, 2009, ARCH PEDIAT ADOL MED, V163, P949, DOI 10.1001/archpediatrics.2009.164; Magnus MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116362; Maschi S, 2008, BJOG-INT J OBSTET GY, V115, P283, DOI 10.1111/j.1471-0528.2007.01518.x; MCGREGOR JA, 1995, AM J OBSTET GYNECOL, V173, P1337, DOI 10.1016/0002-9378(95)91383-1; Olivier JDA, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00073; Preti A, 2000, J AFFECT DISORDERS, V61, P101, DOI 10.1016/S0165-0327(99)00185-8; Ramos E, 2010, CAN J PSYCHIAT, V55, P643; Rampono J, 2009, PHARMACOPSYCHIATRY, V42, P95, DOI 10.1055/s-0028-1103296; Ross LE, 2013, JAMA PSYCHIAT, V70, P436, DOI 10.1001/jamapsychiatry.2013.684; Simon GE, 2002, AM J PSYCHIAT, V159, P2055, DOI 10.1176/appi.ajp.159.12.2055; Suri R, 2008, BIOL PSYCHIAT, V64, P533, DOI 10.1016/j.biopsych.2008.04.015; Tata LJ, 2005, HEART, V91, P465, DOI 10.1136/hrt.2004.037457; Udechuku A, 2010, AUST NZ J PSYCHIAT, V44, P978, DOI 10.3109/00048674.2010.507543; Verret-Chalifour J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117512; Wen SW, 2006, AM J OBSTET GYNECOL, V194, P961, DOI 10.1016/j.ajog.2006.02.019; Wisner KL, 2009, AM J PSYCHIAT, V166, P557, DOI 10.1176/appi.ajp.2008.08081170; Yonkers KA, 2012, EPIDEMIOLOGY, V23, P677, DOI 10.1097/EDE.0b013e31825838e9; Yonkers KA, 2011, OBSTET GYNECOL, V117, P961, DOI 10.1097/AOG.0b013e31821187a7	36	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168115	10.1371/journal.pone.0168115	http://dx.doi.org/10.1371/journal.pone.0168115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977749	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400063
J	Langness, S; Costantini, TW; Morishita, K; Eliceiri, BP; Coimbra, R				Langness, Simone; Costantini, Todd W.; Morishita, Koji; Eliceiri, Brian P.; Coimbra, Raul			Modulating the Biologic Activity of Mesenteric Lymph after Traumatic Shock Decreases Systemic Inflammation and End Organ Injury	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; NERVE-STIMULATION PROTECTS; RESPONSE SYNDROME SIRS; ACUTE LUNG INJURY; HEMORRHAGIC-SHOCK; DUCT LIGATION; VAGUS NERVE; BACTERIAL TRANSLOCATION; CIRCULATING NEUTROPHILS; INTRAVENOUS-INJECTION	Introduction Trauma/hemorrhagic shock (T/HS) causes the release of pro-inflammatory mediators into the mesenteric lymph (ML), triggering a systemic inflammatory response and acute lung injury (ALI). Direct and pharmacologic vagal nerve stimulation prevents gut barrier failure and alters the biologic activity of ML after injury. We hypothesize that treatment with a pharmacologic vagal agonist after T/HS would attenuate the biologic activity of ML and prevent ALI. Methods ML was collected from male Sprague-Dawley rats after T/HS, trauma-sham shock (T/SS) or T/HS with administration of the pharmacologic vagal agonist CPSI-121. ML samples from each experimental group were injected into naive mice to assess biologic activity. Blood samples were analyzed for changes in STAT3 phosphorylation (pSTAT3). Lung injury was characterized by histology, permeability and immune cell recruitment. Results T/HS lymph injected in naive mice caused a systemic inflammatory response characterized by hypotension and increased circulating monocyte pSTAT3 activity. Injection of T/HS lymph also resulted in ALI, confirmed by histology, lung permeability and increased recruitment of pulmonary macrophages and neutrophils to lung parenchyma. CPSI-121 attenuated T/HS lymph-induced systemic inflammatory response and ALI with stable hemodynamics and similar monocyte pSTAT3 levels, lung histology, lung permeability and lung immune cell recruitment compared to animals injected with lymph from T/SS. Conclusion Treatment with CPSI-121 after T/HS attenuated the biologic activity of the ML and decreased ALI. Given the superior clinical feasibility of utilizing a pharmacologic approach to vagal nerve stimulation, CPSI-121 is a potential treatment strategy to limit end organ dysfunction after injury.	[Langness, Simone; Costantini, Todd W.; Eliceiri, Brian P.; Coimbra, Raul] Univ Calif San Diego, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, San Diego, CA 92103 USA; [Morishita, Koji] Tokyo Med & Dent Univ, Div Acute Crit Care & Disaster Med, Tokyo, Japan	University of California System; University of California San Diego; Tokyo Medical & Dental University (TMDU)	Coimbra, R (corresponding author), Univ Calif San Diego, Dept Surg, Div Trauma Surg Crit Care Burns & Acute Care Surg, San Diego, CA 92103 USA.	rcoimbra@ucsd.edu	Coimbra, Raul/AAP-3019-2020	Coimbra, Raul/0000-0002-3759-6851; Eliceiri, Brian/0000-0003-1811-1916; Langness, Simone/0000-0001-7206-5186				Adams CA, 2002, SHOCK, V18, P513, DOI 10.1097/00024382-200212000-00005; Albertsmeier Markus, 2014, Viszeralmedizin, V30, P91, DOI 10.1159/000360149; Altshuler AE, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.109; BAKER JW, 1988, J TRAUMA, V28, P896, DOI 10.1097/00005373-198807000-00002; BEAL AL, 1994, JAMA-J AM MED ASSOC, V271, P226, DOI 10.1001/jama.271.3.226; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Condon M, 2011, J TRAUMA, V70, P489, DOI 10.1097/TA.0b013e31820329d8; Costantini TW, 2010, AM J PHYSIOL-GASTR L, V299, pG1308, DOI 10.1152/ajpgi.00156.2010; D'Alessandro A, 2014, SHOCK, V42, P509, DOI 10.1097/SHK.0000000000000259; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Deitch EA, 2006, SHOCK, V25, P460, DOI 10.1097/01.shk.0000209551.88215.1e; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Deitch EA, 2001, SHOCK, V16, P290, DOI 10.1097/00024382-200116040-00010; Deitch EA, 2001, SURGERY, V129, P39, DOI 10.1067/msy.2001.109119; Deitch EA, 2010, ANN NY ACAD SCI, V1207, pE103, DOI 10.1111/j.1749-6632.2010.05713.x; Deree J, 2007, J SURG RES, V143, P99, DOI 10.1016/j.jss.2007.03.083; Gaudilliere B, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009701; Goto-Inoue N, 2012, ANAL BIOANAL CHEM, V403, P1863, DOI 10.1007/s00216-012-5809-x; Kittel B, 2004, EXP TOXICOL PATHOL, V55, P413, DOI 10.1078/0940-2993-00349; Krzyzaniak M, 2012, J TRAUMA ACUTE CARE, V72, P355, DOI 10.1097/TA.0b013e31824484fe; Krzyzaniak M, 2011, J TRAUMA, V70, P1168, DOI 10.1097/TA.0b013e318216f754; Lagan AL, 2008, AM J PHYSIOL-LUNG C, V294, pL161, DOI 10.1152/ajplung.00169.2007; LAMY M, 1976, AM REV RESPIR DIS, V114, P267; Levy G, 2013, SHOCK, V39, P39, DOI 10.1097/SHK.0b013e31827b450d; LOKEN MR, 1990, CYTOMETRY, V11, P453, DOI 10.1002/cyto.990110402; Lopez NE, 2012, SHOCK, V38, P294, DOI 10.1097/SHK.0b013e31825f5fb2; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Magnotti LJ, 1999, ARCH SURG-CHICAGO, V134, P1333, DOI 10.1001/archsurg.134.12.1333; Matthay MA, 2005, AM J RESP CELL MOL, V33, P319, DOI 10.1165/rcmb.F305; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Minei JP, 2012, CRIT CARE MED, V40, P1129, DOI 10.1097/CCM.0b013e3182376e9f; MOORE EE, 1994, J TRAUMA, V37, P881, DOI 10.1097/00005373-199412000-00002; MOORE FA, 1991, J TRAUMA, V31, P629, DOI 10.1097/00005373-199105000-00006; Morishita K, 2015, AM J PHYSIOL-GASTR L, V309, pG202, DOI 10.1152/ajpgi.00097.2015; Morishita K, 2015, J TRAUMA ACUTE CARE, V78, P52, DOI 10.1097/TA.0000000000000489; Morishita K, 2014, J TRAUMA ACUTE CARE, V76, P610, DOI 10.1097/TA.0000000000000137; Morishita K, 2012, J TRAUMA ACUTE CARE, V72, P1541, DOI 10.1097/TA.0b013e318256df15; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Park JS, 2014, ARTHRITIS RHEUMATOL, V66, P918, DOI 10.1002/art.38305; Qin X, 2012, AM J PHYSIOL-GASTR L, V303, pG969, DOI 10.1152/ajpgi.00290.2012; Radu M, 2013, JOVE-J VIS EXP, DOI 10.3791/50062; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Reino DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014829; Reys LG, 2013, LIFE SCI, V92, P783, DOI 10.1016/j.lfs.2013.02.009; RUNCIMAN WB, 1984, ANAESTH INTENS CARE, V12, P193, DOI 10.1177/0310057X8401200302; Sambol JT, 2002, SHOCK, V18, P272, DOI 10.1097/00024382-200209000-00012; Sambol JT, 2009, J APPL PHYSIOL, V106, P57, DOI 10.1152/japplphysiol.90937.2008; Senthil M, 2007, ANN SURG, V246, P822, DOI 10.1097/SLA.0b013e3180caa3af; Senthil M, 2006, J TRAUMA, V60, P958, DOI 10.1097/01.ta.0000215500.00018.47; Simeone-Penney MC, 2007, J IMMUNOL, V178, P6191, DOI 10.4049/jimmunol.178.10.6191; Suliburk J, 2008, EUR SURG RES, V40, P184, DOI 10.1159/000110859; Ulloa L, 2005, NAT REV DRUG DISCOV, V4, P673, DOI 10.1038/nrd1797; Upperman JS, 1998, SHOCK, V10, P407, DOI 10.1097/00024382-199812000-00005; Varela JE, 2003, SHOCK, V20, P476, DOI 10.1097/01.SHK.0000094036.09886.9b; Vasamsetti SB, 2015, DIABETES, V64, P2028, DOI 10.2337/db14-1225; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu DZ, 2004, CRIT CARE MED, V32, P760, DOI 10.1097/01.CCM.0000114815.88622.9D; Zaets SB, 2003, J SURG RES, V109, P51, DOI 10.1016/S0022-4804(02)00024-0; Zallen G, 1999, J SURG RES, V83, P83, DOI 10.1006/jsre.1999.5569; ZIMMERMAN GA, 1984, AM REV RESPIR DIS, V129, P798, DOI 10.1164/arrd.1984.129.5.798	63	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168322	10.1371/journal.pone.0168322	http://dx.doi.org/10.1371/journal.pone.0168322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977787	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400093
J	Montesantos, S; Katz, I; Pichelin, M; Caillibotte, G				Montesantos, Spyridon; Katz, Ira; Pichelin, Marine; Caillibotte, Georges			The Creation and Statistical Evaluation of a Deterministic Model of the Human Bronchial Tree from HRCT Images	PLOS ONE			English	Article							RESOLUTION COMPUTED-TOMOGRAPHY; HUMAN-LUNG; AEROSOL DEPOSITION; AIRWAY DIMENSIONS; 3-DIMENSIONAL MODEL; COMPUTATIONAL MODEL; CONDUCTING AIRWAYS; WALL THICKNESS; MORPHOLOGY; CT	A quantitative description of the morphology of lung structure is essential prior to any form of predictive modeling of ventilation or aerosol deposition implemented within the lung. The human lung is a very complex organ, with airway structures that span two orders of magnitude and having a multitude of interfaces between air, tissue and blood. As such, current medical imaging protocols cannot provide medical practitioners and researchers with in-vivo knowledge of deeper lung structures. In this work a detailed algorithm for the generation of an individualized 3D deterministic model of the conducting part of the human tracheo-bronchial tree is described. Distinct initial conditions were obtained from the high-resolution computed tomography (HRCT) images of seven healthy volunteers. The algorithm developed is fractal in nature and is implemented as a self-similar space sub-division procedure. The expansion process utilizes physiologically realistic relationships and thresholds to produce an anatomically consistent human airway tree. The model was validated through extensive statistical analysis of the results and comparison of the most common morphological features with previously published morphometric studies and other equivalent models. The resulting trees were shown to be in good agreement with published human lung geometric characteristics and can be used to study, among other things, structure-function relationships in simulation studies.	[Montesantos, Spyridon; Katz, Ira; Pichelin, Marine; Caillibotte, Georges] Air Liquide Sante Int, Med R&D, Paris Saclay, France; [Katz, Ira] Lafayette Coll, Dept Mech Engn, Easton, PA 18042 USA	Air Liquide; UDICE-French Research Universities; Universite Paris Saclay; Lafayette College	Montesantos, S (corresponding author), Air Liquide Sante Int, Med R&D, Paris Saclay, France.	Spyridon.montesantos@airliquide.com			Medical R&D, Air Liquide Sante International, Paris Saclay, France	Medical R&D, Air Liquide Sante International, Paris Saclay, France	The study was conducted by member of the scientific team of Medical R&D, Air Liquide Sante International, Paris Saclay, France. The funder provided support in the form of salaries of authors Spyridon Montesantos (SM), Ira Katz (IK), Marine Pichelin (MP) and Georges Cailliobotte (GC) but did not have any additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; Aysola RS, 2008, CHEST, V134, P1183, DOI 10.1378/chest.07-2779; Bakker ME, 2012, RESP MED, V106, P677, DOI 10.1016/j.rmed.2011.11.013; Bordas R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144105; Boyden EA, 1955, SEGMENTAL ANATOMY LU; Brillet Pierre-Yves, 2008, Int J Chron Obstruct Pulmon Dis, V3, P97; Carroll JRD, 2006, EUR RESPIR J, V28, P712, DOI 10.1183/09031936.06.00012405; Conway J, 2012, J AEROSOL SCI, V52, P1, DOI 10.1016/j.jaerosci.2012.04.006; Darquenne C, 2011, J APPL PHYSIOL, V111, P48, DOI 10.1152/japplphysiol.00796.2010; Dubsky S, 2015, ADV DRUG DELIV REV; Escolar JD, 2007, HISTOL HISTOPATHOL, V22, P43, DOI 10.14670/HH-22.43; Farkas A, 2008, COMPUT BIOL MED, V38, P508, DOI 10.1016/j.compbiomed.2008.01.014; Fleming J, 2011, J AEROSOL MED PULM D, V24, P49, DOI 10.1089/jamp.2010.0843; Florens M, 1985, J APPL PHYSL BETHESD, V110, P756, DOI DOI 10.1152/JAPPLPHYSI0L; Gemci T, 2008, J BIOMECH, V41, P2047, DOI 10.1016/j.jbiomech.2007.12.019; Gupta S, 2014, J ALLERGY CLIN IMMUN, V133, P729, DOI 10.1016/j.jaci.2013.09.039; HAEFELIBLEUER B, 1988, ANAT RECORD, V220, P401, DOI 10.1002/ar.1092200410; HANSEN JE, 1975, J APPL PHYSIOL, V38, P990, DOI 10.1152/jappl.1975.38.6.990; Hasegawa M, 2006, AM J RESP CRIT CARE, V173, P1309, DOI 10.1164/rccm.200601-037OC; HORSFIELD K, 1967, B MATH BIOPHYS, V29, P245, DOI 10.1007/BF02476898; HORSFIELD K, 1987, THORAX, V42, P383, DOI 10.1136/thx.42.5.383; HORSFIELD K, 1981, B MATH BIOL, V43, P101, DOI 10.1016/S0092-8240(81)80010-9; HORSFIELD K, 1968, J APPL PHYSIOL, V24, P373, DOI 10.1152/jappl.1968.24.3.373; HORSFIELD K, 1976, B MATH BIOL, V38, P305, DOI 10.1007/BF02459562; KAMIYA A, 1974, B MATH BIOL, V36, P311, DOI 10.1007/BF02461331; Katz I, 2014, J AEROSOL MED PULM D, V27, P71, DOI 10.1089/jamp.2013.1072; Kim M, 2015, INT J NUMER METH BIO, V31, DOI 10.1002/cnm.2730; King GG, 2000, AM J RESP CRIT CARE, V161, P574, DOI 10.1164/ajrccm.161.2.9812073; Kitaoka H, 1999, J APPL PHYSIOL, V87, P2207, DOI 10.1152/jappl.1999.87.6.2207; KOBLINGER L, 1985, PHYS MED BIOL, V30, P541, DOI 10.1088/0031-9155/30/6/004; KOBLINGER L, 1990, J AEROSOL SCI, V21, P661, DOI 10.1016/0021-8502(90)90121-D; Kosciuch J, 2009, J PHYSIOL PHARMACOL, V60, P71; Litzlbauer HD, 2010, ANAT REC, V293, P1607, DOI 10.1002/ar.21161; Ma BS, 2009, J AEROSOL SCI, V40, P403, DOI 10.1016/j.jaerosci.2009.01.002; Majoral C, 2014, J AEROSOL MED PULM D, V27, P349, DOI 10.1089/jamp.2013.1065; Mandelbrot B.B., 1983, FRACTAL GEOMETRY NAT, V1; Martonen TB, 2007, J PHARM SCI-US, V96, P603, DOI 10.1002/jps.20707; MARTONEN TB, 1995, COMPUT BIOL MED, V25, P431, DOI 10.1016/0010-4825(95)00027-2; Matsuoka S, 2008, RADIOLOGY, V248, P1042, DOI 10.1148/radiol.2491071650; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; McDonough JE, 2015, J APPL PHYSIOL, V118, P1429, DOI 10.1152/japplphysiol.01017.2014; Mead-Hunter R, 2013, J AEROSOL SCI, V64, P48, DOI 10.1016/j.jaerosci.2013.05.006; Montaudon M, 2007, J ANAT, V211, P579, DOI 10.1111/j.1469-7580.2007.00811.x; Montaudon M, 2009, RADIOLOGY, V253, P844, DOI 10.1148/radiol.2533090303; Monteiro A, 2014, INT J MORPHOL, V32, P312, DOI 10.4067/s0717-95022014000100050; Montesantos S, 2013, ANAT REC, V296, P852, DOI 10.1002/ar.22695; Montesantos S, 2010, J AEROSOL MED PULM D, V23, P59, DOI 10.1089/jamp.2009.0765; Murray CD, 1926, P NATL ACAD SCI USA, V12, P299, DOI 10.1073/pnas.12.5.299; PHALEN RF, 1978, ANAT RECORD, V190, P167, DOI 10.1002/ar.1091900202; PHALEN RF, 1985, ANAT RECORD, V212, P368, DOI 10.1002/ar.1092120408; Phillips CG, 1997, RESP PHYSIOL, V107, P85, DOI 10.1016/S0034-5687(96)02506-6; Pichelin M, 2012, AEROSOL SCI TECH, V46, P70, DOI 10.1080/02786826.2011.605816; Sauret V, 1999, PHYS MED BIOL, V44, P1625, DOI 10.1088/0031-9155/44/7/304; Sauret V, 2002, J ANAT, V200, P123, DOI 10.1046/j.0021-8782.2001.00018.x; Schmidt A, 2004, COMPUT MED IMAG GRAP, V28, P203, DOI 10.1016/j.compmedimag.2004.01.001; SCHREIDER JP, 1981, AM J ANAT, V162, P221, DOI 10.1002/aja.1001620304; Schroeter JD, 2002, COMPUT MED IMAG GRAP, V26, P237, DOI 10.1016/S0895-6111(02)00014-9; Slomine B., 2021, APA 2021 CONVENTION; SOONG TT, 1979, RESP PHYSIOL, V37, P161, DOI 10.1016/0034-5687(79)90068-9; Strahler A.N., 1953, EOS T AM GEOPHYS UN, V34, P345; Swan AJ, 2012, J THEOR BIOL, V300, P222, DOI 10.1016/j.jtbi.2012.01.042; Tawhai MH, 2000, ANN BIOMED ENG, V28, P793, DOI 10.1114/1.1289457; Tawhai MH, 2004, J APPL PHYSIOL, V97, P2310, DOI 10.1152/japplphysiol.00520.2004; Tgavalekos NT, 2003, ANN BIOMED ENG, V31, P363, DOI 10.1114/1.1557972; THURLBECK A, 1980, RESP PHYSIOL, V41, P173, DOI 10.1016/0034-5687(80)90050-X; Tschirren J, 2005, IEEE T MED IMAGING, V24, P1529, DOI 10.1109/TMI.2005.857654; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; WANG CY, 1992, MATH COMPUT MODEL, V16, P91, DOI 10.1016/0895-7177(92)90050-U; Weibel ER, 1963, GEOMETRY DIMENSIONS, P110; YEH HC, 1980, B MATH BIOL, V42, P461, DOI 10.1007/BF02460796; Yin YB, 2013, J COMPUT PHYS, V244, P168, DOI 10.1016/j.jcp.2012.12.007	71	8	8	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168026	10.1371/journal.pone.0168026	http://dx.doi.org/10.1371/journal.pone.0168026			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977730	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400049
J	Otero-Muras, I; Banga, JR				Otero-Muras, Irene; Banga, Julio R.			Design Principles of Biological Oscillators through Optimization: Forward and Reverse Analysis	PLOS ONE			English	Article							MULTIOBJECTIVE OPTIMIZATION; CIRCADIAN-RHYTHMS; NETWORK; MOTIFS; ROBUST; ALGORITHM; DYNAMICS; NOISE; TIME	From cyanobacteria to human, sustained oscillations coordinate important biological functions. Although much has been learned concerning the sophisticated molecular mechanisms underlying biological oscillators, design principles linking structure and functional behavior are not yet fully understood. Here we explore design principles of biological oscillators from a multiobjective optimization perspective, taking into account the trade-offs between conflicting performance goals or demands. We develop a comprehensive tool for automated design of oscillators, based on multicriteria global optimization that allows two modes: (i) the automatic design (forward problem) and (ii) the inference of design principles (reverse analysis problem). From the perspective of synthetic biology, the forward mode allows the solution of design problems that mimic some of the desirable properties appearing in natural oscillators. The reverse analysis mode facilitates a systematic exploration of the design space based on Pareto optimality concepts. The method is illustrated with two case studies: the automatic design of synthetic oscillators from a library of biological parts, and the exploration of design principles in 3-gene oscillatory systems.	[Otero-Muras, Irene; Banga, Julio R.] Spanish Natl Res Council, CSIC, IIM, BioProc Engn Grp, Vigo, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM)	Otero-Muras, I (corresponding author), Spanish Natl Res Council, CSIC, IIM, BioProc Engn Grp, Vigo, Spain.	ireneotero@iim.csic.es	Banga, Julio R./A-8388-2008; Otero-Muras, Irene/K-3832-2014; Banga, Julio R./ABD-8629-2020	Banga, Julio R./0000-0002-4245-0320; Otero-Muras, Irene/0000-0003-2895-997X; Banga, Julio R./0000-0002-4245-0320	MINECO [DPI2014-55276-C5-2-R]	MINECO(Spanish Government)	This work was supported by MINECO (and the European Regional Development Fund) project SYNBIOFACTORY (grant number DPI2014-55276-C5-2-R).	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ananthasubramaniam B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104761; Ananthasubramaniam B, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003565; Angione C, 2015, SCI REP-UK, V5, DOI 10.1038/srep15147; Bandaru S, 2015, LECT NOTES COMPUT SC, V9018, P79, DOI 10.1007/978-3-319-15934-8_6; Barkai N, 2000, NATURE, V403, P267, DOI 10.1038/35002258; Cao YS, 2015, NAT PHYS, V11, P772, DOI 10.1038/NPHYS3412; d'Eysmond T, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/5/056005; de Hijas-Liste GM, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-1; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Egea JA, 2010, COMPUT OPER RES, V37, P315, DOI 10.1016/j.cor.2009.05.003; El Samad H, 2005, P 16 IFAC WORLD C PR; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Exler O, 2007, OPTIM LETT, V1, P269, DOI 10.1007/s11590-006-0026-1; Exler O, 2008, COMPUT CHEM ENG, V32, P1877, DOI 10.1016/j.compchemeng.2007.10.008; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gaspard P, 2002, J STAT PHYS, V106, P57, DOI 10.1023/A:1013167928166; Gaspard P, 2002, J CHEM PHYS, V117, P8905, DOI 10.1063/1.1513461; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Gonze D, 2002, J CHEM PHYS, V116, P10997, DOI 10.1063/1.1475765; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Gonze D, 2009, CELL SCI REV, V5; Granada AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059464; Handl J, 2007, IEEE ACM T COMPUT BI, V4, P279, DOI 10.1109/TCBB.2007.070203; Hasegawa Y, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1020; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Higuera C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041122; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kim JR, 2008, BIOPHYS J, V94, P359, DOI 10.1529/biophysj.107.105106; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; Loinger A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051917; Mantzaris NV, 2007, BIOPHYS J, V92, P4271, DOI 10.1529/biophysj.106.100271; Miettinen K, 2012, NONLINEAR MULTIOBJEC, V12; Min B, 2010, J KOREAN PHYS SOC, V56, P911, DOI 10.3938/jkps.56.911; MJOLSNESS E, 1991, J THEOR BIOL, V152, P429, DOI 10.1016/S0022-5193(05)80391-1; Munteanu A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05003; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Oh YG, 2009, BIOTECHNOL PROGR, V25, P999, DOI 10.1002/btpr.193; Otero-Muras I, 2016, BIOINFORMATICS, V32, P3360, DOI 10.1093/bioinformatics/btw415; Otero-Muras I, 2014, LECT NOTES COMPUT SC, V8859, P225, DOI 10.1007/978-3-319-12982-2_16; Otero-Muras I, 2014, BMC SYST BIOL, V8, DOI 10.1186/s12918-014-0113-3; Pedersen M, 2009, J R SOC INTERFACE, V6, DOI 10.1098/rsif.2008.0516.focus; Rand DA, 2004, J ROY SOC INTERFACE, V1, P119, DOI 10.1098/rsif.2004.0014; Rodrigo G, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr616; Rodrigo G, 2010, BIOCHIMIE, V92, P746, DOI 10.1016/j.biochi.2010.04.003; Rougemont J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100130; Schluter M, 2009, COMPUT OPER RES, V36, P2217, DOI 10.1016/j.cor.2008.08.015; Schuster P, 2012, COMPLEXITY, V18, P5, DOI 10.1002/cplx.21426; Sendin JOH, 2010, IET SYST BIOL, V4, P236, DOI 10.1049/iet-syb.2009.0045; Sendin JOH, 2006, IND ENG CHEM RES, V45, P8594, DOI 10.1021/ie0605433; Sendin JOH, 2009, ADV SOFT COMP, V49, P197; Sendin OH, 2006, MATH COMP MODEL DYN, V12, P469, DOI 10.1080/13873950600723442; Seoane LF, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032807; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Szekely P, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003163; Taneda A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0706-x; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Troein C, 2009, CURR BIOL, V19, P1961, DOI 10.1016/j.cub.2009.09.024; Tsai TYC, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001788; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; van Dorp M, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012722; Woods ML, 2016, ACS SYNTH BIOL, V5, P459, DOI 10.1021/acssynbio.5b00179	70	16	17	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0166867	10.1371/journal.pone.0166867	http://dx.doi.org/10.1371/journal.pone.0166867			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977695	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400009
J	Wang, Y; Wang, XH; Liu, FN; Jiang, XN; Xiao, Y; Dong, XH; Kong, XL; Yang, XM; Tian, DH; Qu, ZY				Wang, Yang; Wang, Xiaohua; Liu, Fangnan; Jiang, Xiaoning; Xiao, Yun; Dong, Xuehan; Kong, Xianglei; Yang, Xuemei; Tian, Donghua; Qu, Zhiyong			Negative Life Events and Antenatal Depression among Pregnant Women in Rural China: The Role of Negative Automatic Thoughts	PLOS ONE			English	Article							POSTNATAL DEPRESSION; POSTPARTUM DEPRESSION; PERINATAL DEPRESSION; RISK-FACTORS; SOCIAL SUPPORT; MENTAL-HEALTH; HELP-SEEKING; PREVALENCE; VALIDATION; EARTHQUAKE	Background Few studies have looked at the relationship between psychological and the mental health status of pregnant women in rural China. The current study aims to explore the potential mediating effect of negative automatic thoughts between negative life events and antenatal depression. Methods Data were collected in June 2012 and October 2012. 495 rural pregnant women were interviewed. Depressive symptoms were measured by the Edinburgh postnatal depression scale, stresses of pregnancy were measured by the pregnancy pressure scale, negative automatic thoughts were measured by the automatic thoughts questionnaire, and negative life events were measured by the life events scale for pregnant women. We used logistic regression and path analysis to test the mediating effect. Results The prevalence of antenatal depression was 13.7%. In the logistic regression, the only socio-demographic and health behavior factor significantly related to antenatal depression was sleep quality. Negative life events were not associated with depression in the fully adjusted model. Path analysis showed that the eventual direct and general effects of negative automatic thoughts were 0.39 and 0.51, which were larger than the effects of negative life events. Conclusions This study suggested that there was a potentially significant mediating effect of negative automatic thoughts. Pregnant women who had lower scores of negative automatic thoughts were more likely to suffer less from negative life events which might lead to antenatal depression.	[Wang, Yang] Univ Illinois, Sch Social Work, Champaign, IL USA; [Wang, Xiaohua; Tian, Donghua; Qu, Zhiyong] Beijing Normal Univ, China Inst Hlth, Sch Social Dev & Publ Policy, Beijing, Peoples R China; [Liu, Fangnan; Jiang, Xiaoning; Dong, Xuehan; Kong, Xianglei] Beijing Normal Univ, Sch Social Dev & Publ Policy, Beijing, Peoples R China; [Xiao, Yun] Maternal & Child Hlth Hosp Mianzhu Cty, Deyang, Sichuan, Peoples R China; [Yang, Xuemei] Sichuan Normal Univ, Teacher Educ Coll, Chengdu, Sichuan, Peoples R China	University of Illinois System; University of Illinois Urbana-Champaign; Beijing Normal University; Beijing Normal University; Sichuan Normal University	Qu, ZY (corresponding author), Beijing Normal Univ, China Inst Hlth, Sch Social Dev & Publ Policy, Beijing, Peoples R China.	qzy@bnu.edu.cn			Beijing Normal University Education Foundation	Beijing Normal University Education Foundation	The study was sponsored by the project of psychological services to children and adults affected by the earthquake in Sichuan Province of the Beijing Normal University Education Foundation.	AMATO PR, 1993, SOC PSYCHOL QUART, V56, P249, DOI 10.2307/2786662; Beck A, 1979, COGNITIVE THERAPY DE; Beck AT, 2011, ANNU REV MED, V62, P397, DOI 10.1146/annurev-med-052209-100032; Beck CT, 1998, ARCH PSYCHIAT NURS, V12, P12, DOI 10.1016/S0883-9417(98)80004-6; Beck CT, 1995, NURS RES, V44, P298, DOI 10.1097/00006199-199509000-00007; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Bilszta JLC, 2008, AUST NZ J PUBL HEAL, V32, P424, DOI 10.1111/j.1753-6405.2008.00274.x; Blaney NT, 2004, AIDS PATIENT CARE ST, V18, P405, DOI 10.1089/1087291041518201; Bowen Angela, 2006, Can Nurse, V102, P26; Chen Z, 1991, J MED SCI, V5, P505; Cho HJ, 2008, YONSEI MED J, V49, P553, DOI 10.3349/ymj.2008.49.4.553; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Dong XH, 2013, J AFFECT DISORDERS, V151, P566, DOI 10.1016/j.jad.2013.06.048; Du SN, 2011, CHINESE JOURNAL OF S, V28, P284; Evans EC, 2012, NURS HEALTH SCI, V14, P352, DOI 10.1111/j.1442-2018.2012.00700.x; Evans J, 2001, BRIT MED J, V323, P257, DOI 10.1136/bmj.323.7307.257; Flynn HA, 2004, GEN HOSP PSYCHIAT, V26, P316, DOI 10.1016/j.genhosppsych.2004.03.009; Fu F, 2004, J NURSING SCI, V19, P6; Goodman JH, 2004, J ADV NURS, V45, P26, DOI 10.1046/j.1365-2648.2003.02857.x; Han J., 1996, J CLIN PSYCHIAT, V6, P234; HARRELL TH, 1983, J CONSULT CLIN PSYCH, V51, P721, DOI 10.1037/0022-006X.51.5.721; Hartley M, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-9; Hewitt CE, 2009, METHOSDS IDENTIFY PO; HOLLON SD, 1980, COGNITIVE THER RES, V4, P383, DOI 10.1007/BF01178214; Huang M., 2007, ANHUI AGR SCI B, V13, P42; Huang ZHJ, 2007, MATERN CHILD HLTH J, V11, P257, DOI 10.1007/s10995-006-0168-x; KAPLAN A, 1986, PSYCHOTHER, V23, P234, DOI 10.1037/h0085603; Karacam Z, 2009, MIDWIFERY, V25, P344, DOI 10.1016/j.midw.2007.03.006; Kazdin A. E., 1990, PSYCHOL ASSESSMENT J, V2, P73, DOI DOI 10.1037/1040-3590.2.1.73; Kercher AJ, 2009, J ABNORM CHILD PSYCH, V37, P903, DOI 10.1007/s10802-009-9325-1; Klainin P, 2009, INT J NURS STUD, V46, P1355, DOI 10.1016/j.ijnurstu.2009.02.012; KWON SM, 1992, COGNITIVE THER RES, V16, P309, DOI 10.1007/BF01183284; Lancaster CA, 2010, AM J OBSTET GYNECOL, V202, P5, DOI 10.1016/j.ajog.2009.09.007; Lau Y, 2007, SOC SCI MED, V64, P1802, DOI 10.1016/j.socscimed.2007.01.001; Lau Y, 2011, ARCH PSYCHIAT NURS, V25, P206, DOI 10.1016/j.apnu.2010.07.009; Lau Y, 2011, JOGNN-J OBST GYN NEO, V40, P62, DOI 10.1111/j.1552-6909.2010.01208.x; Lau Y, 2010, ARCH WOMEN MENT HLTH, V13, P153, DOI 10.1007/s00737-009-0134-x; Lee DTS, 1998, BRIT J PSYCHIAT, V172, P433, DOI 10.1192/bjp.172.5.433; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Leung SSK, 2013, INT J NURS PRACT, V19, P28, DOI 10.1111/ijn.12021; Miranda J., 1998, COGNITIVE VULNERABIL; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; O'Mahen H, 2012, COGN BEHAV PRACT, V19, P359; Oei TPS, 2007, DEPRESS ANXIETY, V24, P112, DOI 10.1002/da.20225; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Price SK, 2009, J RURAL HEALTH, V25, P158, DOI 10.1111/j.1748-0361.2009.00212.x; [仇剑奎 QIU JianYin], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P469; Qu ZY, 2012, J AFFECT DISORDERS, V136, P117, DOI 10.1016/j.jad.2011.08.021; Rahman A, 2007, ARCH WOMEN MENT HLTH, V10, P211, DOI 10.1007/s00737-007-0193-9; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Raymond JE, 2009, MIDWIFERY, V25, P39, DOI 10.1016/j.midw.2007.01.005; Roomruangwong C, 2011, ASIAN BIOMED, V5, P179, DOI 10.5372/1905-7415.0502.024; Ross LE, 2011, ARCH WOMEN MENT HLTH, V14, P175, DOI 10.1007/s00737-011-0208-4; Rubertsson C, 2011, NORD J PSYCHIAT, V65, P414, DOI 10.3109/08039488.2011.590606; Schatz DB, 2012, PSYCHIAT INVEST, V9, P111, DOI 10.4306/pi.2012.9.2.111; [施慎逊 SHI ShenXun], 2007, [中国心理卫生杂志, Chinese Mental Health Journal], V21, P254; Simmons LA, 2007, AM J HEALTH BEHAV, V31, P657, DOI 10.5993/AJHB.31.6.10; STILES TC, 1989, COGNITIVE THER RES, V13, P161, DOI 10.1007/BF01173270; Su KP, 2007, GEN HOSP PSYCHIAT, V29, P436, DOI 10.1016/j.genhosppsych.2007.05.005; Tseng YF, 2008, J ADV NURS, V64, P495, DOI 10.1111/j.1365-2648.2008.04805.x; Wichers M, 2012, PSYCHOL MED, V42, P1801, DOI 10.1017/S003329171100300X; Wu H, 2010, J ZHEJIANG U, V40, P10; Yan Gao YY, 2005, BEHAV MED INVENTORY, P266; Zayas LH, 2002, WOMEN HEALTH ISS, V12, P16, DOI 10.1016/S1049-3867(01)00138-4	64	7	10	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167597	10.1371/journal.pone.0167597	http://dx.doi.org/10.1371/journal.pone.0167597			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977715	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400023
J	Malmberg, C; Yuen, PK; Spaak, J; Cars, O; Tangden, T; Lagerback, P				Malmberg, Christer; Yuen, Pikkei; Spaak, Johanna; Cars, Otto; Tangden, Thomas; Lagerback, Pernilla			A Novel Microfluidic Assay for Rapid Phenotypic Antibiotic Susceptibility Testing of Bacteria Detected in Clinical Blood Cultures	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; IN-VITRO; VANCOMYCIN	Background Appropriate antibiotic therapy is critical in the management of severe sepsis and septic shock to reduce mortality, morbidity and health costs. New methods for rapid antibiotic susceptibility testing are needed because of increasing resistance rates to standard treatment. Aims The purpose of this study was to evaluate the performance of a novel microfluidic method and the potential to directly apply this method on positive blood cultures. Methods Minimum inhibitory concentrations (MICs) of ciprofloxacin, ceftazidime, tigecycline and/or vancomycin for Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae and Staphylococcus aureus were determined using a linear antibiotic concentration gradient in a microfluidic assay. Bacterial growth along the antibiotic gradient was monitored using automated time-lapse photomicrography and growth inhibition was quantified by measuring greyscale intensity changes in the images. In addition to pure culture MICs, vancomycin MICs were determined for S. aureus from spiked and clinical blood cultures following a short centrifugation step. The MICs were compared with those obtained with the Etest and for S. aureus and vancomycin also with macrodilution. Results The MICs obtained with the microfluidic assay showed good agreement internally as well as with the Etest and macrodilution assays, although some minor differences were noted between the methods. The time to possible readout was within the range of 2 to 5 h. Conclusions The examined microfluidic assay has the potential to provide rapid and accurate MICs using samples from positive clinical blood cultures and will now be tested using other bacterial species and antibiotics.	[Malmberg, Christer; Yuen, Pikkei; Cars, Otto; Tangden, Thomas; Lagerback, Pernilla] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Malmberg, Christer; Spaak, Johanna] Gradientech AB, Uppsala, Sweden	Uppsala University	Malmberg, C; Yuen, PK (corresponding author), Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden.; Malmberg, C; Yuen, PK (corresponding author), Gradientech AB, Uppsala, Sweden.	christer.malmberg@medsci.uu.se; pikkei.yuen@medsci.uu.se		Wistrand-Yuen, Pikkei/0000-0002-2309-5394	AFA Insurance; Vinnova grant [2014-03512]	AFA Insurance; Vinnova grant(Vinnova)	This work was supported by AFA Insurance (PL OC) (https://www.afaforsakring.se/) and Vinnova grant 2014-03512 (OC TT) (http://www.vinnova.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Deresinski S, 2009, J INFECT DIS, V199, P605, DOI 10.1086/596630; Fraser A, 2006, COCHRANE DB SYST REV, DOI 10.1002/14561858.CD004785.pub3; Hegde SS, 2010, J ANTIMICROB CHEMOTH, V65, P725, DOI 10.1093/jac/dkq028; Hou ZN, 2014, LAB CHIP, V14, P3409, DOI 10.1039/c4lc00451e; Jones RN, 2006, CLIN INFECT DIS, V42, pS13, DOI 10.1086/491710; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; LaPlante KL, 2004, ANTIMICROB AGENTS CH, V48, P4665, DOI 10.1128/AAC.48.12.4665-4672.2004; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Prakash V, 2008, ANTIMICROB AGENTS CH, V52, P4528, DOI 10.1128/AAC.00904-08; Pulido MR, 2013, J ANTIMICROB CHEMOTH, V68, P2710, DOI 10.1093/jac/dkt253; Tenover FC, 2007, CLIN INFECT DIS, V44, P1208, DOI 10.1086/513203; Udekwu KI, 2009, J ANTIMICROB CHEMOTH; van Belkum A, 2013, J CLIN MICROBIOL, V51, P2018, DOI 10.1128/JCM.00313-13; van Hal SJ, 2011, ANTIMICROB AGENTS CH, V55, P405, DOI 10.1128/AAC.01133-10; YAGUPSKY P, 1990, CLIN MICROBIOL REV, V3, P269, DOI 10.1128/CMR.3.3.269-279.1990	16	25	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167356	10.1371/journal.pone.0167356	http://dx.doi.org/10.1371/journal.pone.0167356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27974860	gold, Green Published, Green Submitted			2022-12-27	WOS:000392754300025
J	Okkelman, IA; Dmitriev, RI; Foley, T; Papkovsky, DB				Okkelman, Irina A.; Dmitriev, Ruslan I.; Foley, Tara; Papkovsky, Dmitri B.			Use of Fluorescence Lifetime Imaging Microscopy (FLIM) as a Timer of Cell Cycle S Phase	PLOS ONE			English	Article							METFORMIN; PROBES	Incorporation of thymidine analogues in replicating DNA, coupled with antibody and fluorophore staining, allows analysis of cell proliferation, but is currently limited to monolayer cultures, fixed cells and end-point assays. We describe a simple microscopy imaging method for live real-time analysis of cell proliferation, S phase progression over several division cycles, effects of anti-proliferative drugs and other applications. It is based on the prominent (similar to 1.7-fold) quenching of fluorescence lifetime of a common cell-permeable nuclear stain, Hoechst 33342 upon the incorporation of 5-bromo-2'-deoxyuridine (BrdU) in genomic DNA and detection by fluorescence lifetime imaging microscopy (FLIM). We show that quantitative and accurate FLIM technique allows high-content, multi-parametric dynamic analyses, far superior to the intensity-based imaging. We demonstrate its uses with monolayer cell cultures, complex 3D tissue models of tumor cell spheroids and intestinal organoids, and in physiological study with metformin treatment.	[Okkelman, Irina A.; Dmitriev, Ruslan I.; Papkovsky, Dmitri B.] Univ Coll Cork, Sch Biochem & Cell Biol, ABCRF, Coll Rd, Cork, Ireland; [Foley, Tara] Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland	University College Cork; University College Cork	Dmitriev, RI (corresponding author), Univ Coll Cork, Sch Biochem & Cell Biol, ABCRF, Coll Rd, Cork, Ireland.	r.dmitriev@ucc.ie	Okkelman, Irina/AAV-6545-2020; Dmitriev, Ruslan/F-8741-2017	Papkovsky, Dmitri/0000-0003-1556-1145; Okkelman, Irina/0000-0002-7014-6887; Dmitriev, Ruslan/0000-0002-0347-8718	Science Foundation of Ireland (SFI) [13/SIRG/2144, 12/RC/2276]	Science Foundation of Ireland (SFI)(Science Foundation Ireland)	This work was supported by Science Foundation of Ireland (SFI) grants 13/SIRG/2144 (RID) and 12/RC/2276 (DBP, IAO), www.sfi.ie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner D, 2014, J MATER CHEM B, V2, P6792, DOI 10.1039/c4tb01006j; Appel AA, 2013, BIOMATERIALS, V34, P6615, DOI 10.1016/j.biomaterials.2013.05.033; Bailey CJ, 2008, DIABETOLOGIA, V51, P1552, DOI 10.1007/s00125-008-1053-5; Becker W, 2012, J MICROSC-OXFORD, V247, P119, DOI 10.1111/j.1365-2818.2012.03618.x; Becker W, 2015, ADV TIME CORRELATED, P65; Ben Sahra I, 2008, ONCOGENE, V27, P3576, DOI 10.1038/sj.onc.1211024; Ben Sahra I, 2011, CANCER RES, V71, P4366, DOI 10.1158/0008-5472.CAN-10-1769; Berezin MY, 2010, CHEM REV, V110, P2641, DOI 10.1021/cr900343z; Bradford JA, 2011, CURRENT PROTOCOLS CY; Buse JB, 2016, DIABETES CARE, V39, P198, DOI 10.2337/dc15-0488; Cappella P, 2008, CURRENT PROTOCOLS CY; CARRAWAY ER, 1991, ANAL CHEM, V63, P337, DOI 10.1021/ac00004a007; Cavanagh BL, 2011, MOLECULES, V16, P7980, DOI 10.3390/molecules16097980; Crissman HA, 2002, FLOW CYTOMETRIC FLUO; Dmitriev RI, 2015, ACS NANO, V9, P5275, DOI 10.1021/acsnano.5b00771; Dmitriev RI, 2015, PROC SPIE, V9328, DOI 10.1117/12.2079604; Dmitriev RI, 2014, BIOMATER SCI-UK, V2, P853, DOI 10.1039/c3bm60272a; Dmitriev RI, 2013, BIOMATERIALS, V34, P9307, DOI 10.1016/j.biomaterials.2013.08.065; DURAND RE, 1982, J HISTOCHEM CYTOCHEM, V30, P111, DOI 10.1177/30.2.7061816; Easwaran HP, 2005, CELL CYCLE, V4, P453, DOI 10.4161/cc.4.3.1525; Fujii M, 2015, NAT PROTOC, V10, P1474, DOI 10.1038/nprot.2015.088; Gallagher EJ, 2011, ANN NY ACAD SCI, V1243, P54, DOI 10.1111/j.1749-6632.2011.06285.x; HARD T, 1990, PHOTOCHEM PHOTOBIOL, V51, P77, DOI 10.1111/j.1751-1097.1990.tb01686.x; Jamieson LE, 2015, ANALYST, V140, P3910, DOI 10.1039/c5an00524h; Jenkins J, 2016, ANAL CHEM, V88, P10566, DOI 10.1021/acs.analchem.6b02675; Jenkins J, 2015, ACTA BIOMATER, V16, P126, DOI 10.1016/j.actbio.2015.01.032; KUBBIES M, 1983, CYTOMETRY, V3, P276, DOI 10.1002/cyto.990030408; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Lalau JD, 2010, DRUG SAFETY, V33, P727, DOI 10.2165/11536790-000000000-00000; Le Francois BG, 2007, BRIT J CANCER, V97, P1242, DOI 10.1038/sj.bjc.6604020; Leushacke M, 2014, GUT; Mozdziak PE, 2000, CYTOMETRY, V41, P89, DOI 10.1002/1097-0320(20001001)41:2<89::AID-CYTO2>3.0.CO;2-I; Niehorster T, 2016, NAT METHODS, V13, P257, DOI [10.1038/NMETH.3740, 10.1038/nmeth.3740]; Page H, 2013, CELL TISSUE RES, V352, P123, DOI 10.1007/s00441-012-1441-5; Purschke M, 2010, PHOTOCH PHOTOBIO SCI, V9, P1634, DOI 10.1039/c0pp00234h; Qu DZ, 2011, ANAL BIOCHEM, V417, P112, DOI 10.1016/j.ab.2011.05.037; RABINOVITCH PS, 1988, EXP CELL RES, V174, P309, DOI 10.1016/0014-4827(88)90302-3; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sarder P, 2015, BIOCONJUGATE CHEM, V26, P963, DOI 10.1021/acs.bioconjchem.5b00167; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Walenta S, 2000, J HISTOCHEM CYTOCHEM, V48, P509, DOI 10.1177/002215540004800409	42	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167385	10.1371/journal.pone.0167385	http://dx.doi.org/10.1371/journal.pone.0167385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973570	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300028
J	Stern, JA; Markova, S; Ueda, Y; Kim, JB; Pascoe, PJ; Evanchik, MJ; Green, EM; Harris, SP				Stern, Joshua A.; Markova, Svetlana; Ueda, Yu; Kim, Jae B.; Pascoe, Peter J.; Evanchik, Marc J.; Green, Eric M.; Harris, Samantha P.			A Small Molecule Inhibitor of Sarcomere Contractility Acutely Relieves Left Ventricular Outflow Tract Obstruction in Feline Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							SUBAORTIC STENOSIS; HUMAN-DISEASE; ANIMAL-MODEL; CATS; PREVALENCE; MUTATIONS; DYNAMICS; THERAPY	Hypertrophic cardiomyopathy (HCM) is an inherited disease of the heart muscle characterized by otherwise unexplained thickening of the left ventricle. Left ventricular outflow tract (LVOT) obstruction is present in approximately two-thirds of patients and substantially increases the risk of disease complications. Invasive treatment with septal myectomy or alcohol septal ablation can improve symptoms and functional status, but currently available drugs for reducing obstruction have pleiotropic effects and variable therapeutic responses. New medical treatments with more targeted pharmacology are needed, but the lack of preclinical animal models for HCM with LVOT obstruction has limited their development. HCM is a common cause of heart failure in cats, and a subset exhibit systolic anterior motion of the mitral valve leading to LVOT obstruction. MYK-461 is a recently-described, mechanistically novel small molecule that acts at the sarcomere to specifically inhibit contractility that has been proposed as a treatment for HCM. Here, we use MYK-461 to test whether direct reduction in contractility is sufficient to relieve LVOT obstruction in feline HCM. We evaluated mixed-breed cats in a research colony derived from a Maine Coon/mixed-breed founder with naturally-occurring HCM. By echocardiography, we identified five cats that developed systolic anterior motion of the mitral valve and LVOT obstruction both at rest and under anesthesia when provoked with an adrenergic agonist. An IV MYK-461 infusion and echocardiography protocol was developed to serially assess contractility and LVOT gradient at multiple MYK-461 concentrations. Treatment with MYK-461 reduced contractility, eliminated systolic anterior motion of the mitral valve and relieved LVOT pressure gradients in an exposure-dependent manner. Our findings provide proof of principle that acute reduction in contractility with MYK-461 is sufficient to relieve LVOT obstruction. Further, these studies suggest that feline HCM will be a valuable translational model for the study of disease pathology, particularly LVOT obstruction.	[Stern, Joshua A.; Ueda, Yu] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Markova, Svetlana; Kim, Jae B.; Evanchik, Marc J.; Green, Eric M.] MyoKardia Inc, San Francisco, CA 94080 USA; [Pascoe, Peter J.] Univ Calif Davis, Sch Vet Med, Dept Surg & Radiol Sci, Davis, CA 95616 USA; [Harris, Samantha P.] Univ Arizona, Coll Med, Dept Cellular & Mol Med, Tucson, AZ 85719 USA; [Kim, Jae B.] Alnylam Pharmaceut, Cambridge, MA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of Arizona	Green, EM (corresponding author), MyoKardia Inc, San Francisco, CA 94080 USA.; Harris, SP (corresponding author), Univ Arizona, Coll Med, Dept Cellular & Mol Med, Tucson, AZ 85719 USA.	egreen@myokardia.com; samharris@email.arizona.edu	Ueda, Yu/I-2694-2019	Pascoe, Peter/0000-0002-7401-2253; Stern, Joshua/0000-0001-5611-5745; Green, Eric/0000-0001-7874-9482	NIH [R21HL093603]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grant R21HL093603 to SPH and an unrestricted gift from MyoKardia, Inc (www.myokardia.com). Authors from MyoKardia were involved in study design, data collection and analysis and preparation of the manuscript.	Alfares AA, 2015, RESULTS CLIN GENETIC, P1; Boon J.A., 2011, VET ECHOCARDIOGRAPHY, V2nd ed.; BRAUNWALD E, 1964, CIRCULATION, V30, P3; FOX PR, 1995, CIRCULATION, V92, P2645, DOI 10.1161/01.CIR.92.9.2645; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Gersh BJ, 2011, J AM COLL CARDIOL, V58, pE212, DOI 10.1016/j.jacc.2011.06.011; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Ho CY, 2009, CIRC-CARDIOVASC GENE, V2, P314, DOI 10.1161/CIRCGENETICS.109.862128; Kim LK, 2016, JAMA CARDIOL, V1, P324, DOI 10.1001/jamacardio.2016.0252; Kittleson MD, 2015, J VET CARDIOL, V17, pS53, DOI 10.1016/j.jvc.2015.03.001; Kittleson MD, 1999, CIRCULATION, V99, P3172, DOI 10.1161/01.CIR.99.24.3172; Kooiker KB, 2016, ARCH BIOCH BIOPHYS; LELE SS, 1995, CIRCULATION, V92, P2886, DOI 10.1161/01.CIR.92.10.2886; Liebregts M, 2015, JACC-HEART FAIL, V3, P896, DOI 10.1016/j.jchf.2015.06.011; Maron BJ, 2015, J VET CARDIOL, V17, pS6, DOI 10.1016/j.jvc.2015.03.007; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron MS, 2006, CIRCULATION, V114, P2232, DOI 10.1161/CIRCULATIONAHA.106.644682; Maron MS, 2003, NEW ENGL J MED, V348, P295, DOI 10.1056/NEJMoa021332; Meurs KM, 2005, HUM MOL GENET, V14, P3587, DOI 10.1093/hmg/ddi386; Moore JR, 2012, CIRC RES, V111, P375, DOI 10.1161/CIRCRESAHA.110.223842; MORROW AG, 1965, AM J CARDIOL, V16, P540, DOI 10.1016/0002-9149(65)90031-7; NATHAN D, 1977, CHEST, V71, P746, DOI 10.1378/chest.71.6.746; Olivotto Iacopo, 2013, Glob Cardiol Sci Pract, V2013, P243, DOI 10.5339/gcsp.2013.31; Ommen SR, 2005, J AM COLL CARDIOL, V46, P470, DOI 10.1016/j.jacc.2005.02.090; Payne JR, 2015, J VET CARDIOL, V17, pS244, DOI 10.1016/j.jvc.2015.03.008; Ro R, 2014, J AM COLL CARDIOL, V64, P1984, DOI 10.1016/j.jacc.2014.04.090; Sedehi D, 2014, J CARDIOL; Sherrid MV, 2013, CIRC-HEART FAIL, V6, P694, DOI 10.1161/CIRCHEARTFAILURE.112.000122; Spoladore R, 2012, EUR HEART J, V33, P1724, DOI 10.1093/eurheartj/ehs150; STEWART S, 1968, CIRCULATION, V37, P8, DOI 10.1161/01.CIR.37.1.8; Veselka J, 2016, EUR HEART J, V37, P1517, DOI 10.1093/eurheartj/ehv693; WILSON WS, 1967, AM HEART J, V73, P4, DOI 10.1016/0002-8703(67)90303-1	34	55	60	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168407	10.1371/journal.pone.0168407	http://dx.doi.org/10.1371/journal.pone.0168407			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973580	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300081
J	You, I; Sharma, V; Atiquzzaman, M; Choo, KKR				You, Ilsun; Sharma, Vishal; Atiquzzaman, Mohammed; Choo, Kim-Kwang Raymond			GDTN: Genome-Based Delay Tolerant Network Formation in Heterogeneous 5G Using Inter-UA Collaboration	PLOS ONE			English	Article								With a more Internet-savvy and sophisticated user base, there are more demands for interactive applications and services. However, it is a challenge for existing radio access networks (e.g. 3G and 4G) to cope with the increasingly demanding requirements such as higher data rates and wider coverage area. One potential solution is the inter-collaborative deployment of multiple radio devices in a 5G setting designed to meet exacting user demands, and facilitate the high data rate requirements in the underlying networks. These heterogeneous 5G networks can readily resolve the data rate and coverage challenges. Networks established using the hybridization of existing networks have diverse military and civilian applications. However, there are inherent limitations in such networks such as irregular breakdown, node failures, and halts during speed transmissions. In recent years, there have been attempts to integrate heterogeneous 5G networks with existing ad hoc networks to provide a robust solution for delay-tolerant transmissions in the form of packet switched networks. However, continuous connectivity is still required in these networks, in order to efficiently regulate the flow to allow the formation of a robust network. Therefore, in this paper, we present a novel network formation consisting of nodes from different network maneuvered by Unmanned Aircraft (UA). The proposed model utilizes the features of a biological aspect of genomes and forms a delay tolerant network with existing network models. This allows us to provide continuous and robust connectivity. We then demonstrate that the proposed network model has an efficient data delivery, lower overheads and lesser delays with high convergence rate in comparison to existing approaches, based on evaluations in both real-time testbed and simulation environment.	[You, Ilsun] Soonchunhyang Univ, Dept Informat Secur Engn, Asan 31538, South Korea; [Sharma, Vishal] Thapar Univ, Dept Comp Sci & Engn, Patiala 147004, Punjab, India; [Atiquzzaman, Mohammed] Univ Oklahoma, Sch Comp Sci, Norman, OK 73019 USA; [Choo, Kim-Kwang Raymond] Univ Texas San Antonio, Dept Informat Syst & Cyber Secur, San Antonio, TX 78249 USA	Soonchunhyang University; Thapar Institute of Engineering & Technology; University of Oklahoma System; University of Oklahoma - Norman; University of Texas System; University of Texas at San Antonio (UTSA)	Sharma, V (corresponding author), Thapar Univ, Dept Comp Sci & Engn, Patiala 147004, Punjab, India.	vishal_sharma2012@hotmail.com	Atiquzzaman, Mohammed/G-4059-2017; Sharma, Vishal/E-5834-2017; Choo, Kim-Kwang Raymond/A-3634-2009; You, Ilsun/AAR-7793-2021	Atiquzzaman, Mohammed/0000-0001-9440-7669; Sharma, Vishal/0000-0001-7470-6506; Choo, Kim-Kwang Raymond/0000-0001-9208-5336; 	Ministry of Science, ICT and Future Planning, Korea; Soonchunhyang University Research Fund; Ministry of Science, ICT and Future Planning; Cross-Ministry Giga KOREA Project; Soonchunhyang University	Ministry of Science, ICT and Future Planning, Korea(Ministry of Science, ICT & Future Planning, Republic of Korea); Soonchunhyang University Research Fund; Ministry of Science, ICT and Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Cross-Ministry Giga KOREA Project(Giga Korea Co.); Soonchunhyang University	This work was supported by 'The Cross-Ministry Giga KOREA Project' grant from the Ministry of Science, ICT and Future Planning, Korea. In addition, it was partially supported by the Soonchunhyang University Research Fund. 1) Funder: the Ministry of Science, ICT and Future Planning (KR), Website of Funder: http://english.msip.go.kr/index.do, Grant Number: The Cross-Ministry Giga KOREA Project, Recipient: Ilsun You. 2) Funder: Soonchunhyang University (KR), Website of Funder: https://homepage.sch.ac.kr/english/, Grant Number: the Soonchunhyang University Research Fund, Recipient: Ilsun You. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerberg J., 2011, Proceedings of the 2011 9th IEEE International Conference on Industrial Informatics (INDIN 2011), P410, DOI 10.1109/INDIN.2011.6034912; [Anonymous], 2003, ACM SIGMOBILE, DOI DOI 10.1145/961268.961272; Bums B, 2008, AD HOC NETW, V6, P600, DOI 10.1016/j.adhoc.2007.05.002; Burgess J, 2006, IEEE INFOCOM SER, P1688, DOI 10.1109/infocom.2006.228; Chen JM, 2010, IEEE T IND ELECTRON, V57, P4219, DOI 10.1109/TIE.2010.2043038; Figueiras J, 2011, MOBILE POSITIONING T, DOI [10.1002/9780470663035, DOI 10.1002/9780470663035]; Gil-Castineira F, 2008, IEEE T IND ELECTRON, V55, P3307, DOI 10.1109/TIE.2008.927972; Han B, 2012, IEEE T MOBILE COMPUT, V11, P821, DOI 10.1109/TMC.2011.101; Hui P, 2011, IEEE T MOBILE COMPUT, V10, P1576, DOI 10.1109/TMC.2010.246; Jain R., 2008, ART COMPUTER SYSTEMS; Jones EPC, 2007, IEEE T MOBILE COMPUT, V6, P943, DOI 10.1109/TMC.2007.1016; Khanesar MA, 2015, IEEE T FUZZY SYST, V23, P205, DOI 10.1109/TFUZZ.2014.2362549; Ludwig A, 2010, GAUSS MARKOV LOSS P; Pereira PR, 2012, IEEE COMMUN SURV TUT, V14, P1166, DOI 10.1109/SURV.2011.081611.00102; Prasad A, 2015, 2015 IEEE 26TH ANNUAL INTERNATIONAL SYMPOSIUM ON PERSONAL, INDOOR, AND MOBILE RADIO COMMUNICATIONS (PIMRC), P1740, DOI 10.1109/PIMRC.2015.7343580; Ramasamy S, 2015, INT CONF UNMAN AIRCR, P765, DOI 10.1109/ICUAS.2015.7152360; Rao WX, 2015, IEEE T MOBILE COMPUT, V14, P755, DOI 10.1109/TMC.2014.2330296; Ridley M., 2000, GENOME; Rubinstein MG, 2009, IEEE COMMUN MAG, V47, P128, DOI 10.1109/MCOM.2009.5307476; Schoeneich RO, 2016, INT J DISTRIB SENS N, V12, DOI 10.1177/1550147716662755; Sharma V, 2014, IT CONVERGENCE PRACT, V2, P24; Sharma V, 2015, 2015 2ND INTERNATIONAL CONFERENCE ON ELECTRONICS AND COMMUNICATION SYSTEMS (ICECS), P1551, DOI 10.1109/ECS.2015.7124849; Sharma V, 2015, J INTELL ROBOT SYST, V77, P629, DOI 10.1007/s10846-014-0091-0; Shuai ZB, 2014, IEEE T VEH TECHNOL, V63, P591, DOI 10.1109/TVT.2013.2279843; Soares VNGJ, 2014, INFORM FUSION, V15, P102, DOI 10.1016/j.inffus.2011.11.003; Soares VNGJ, 2009, IEEE SYMP COMP COMMU, P122, DOI 10.1109/ISCC.2009.5202332; Spyropoulos T, 2008, IEEE ACM T NETWORK, V16, P63, DOI 10.1109/TNET.2007.897962; Stewart MF, 2016, 2016 INT C COMP NETW, P1; Tenne D, 2002, IEEE T AERO ELEC SYS, V38, P1072, DOI 10.1109/TAES.2002.1039425; Tian CP, 2014, 2014 IEEE 12TH INTERNATIONAL CONFERENCE ON DEPENDABLE, AUTONOMIC AND SECURE COMPUTING (DASC)/2014 IEEE 12TH INTERNATIONAL CONFERENCE ON EMBEDDED COMPUTING (EMBEDDEDCOM)/2014 IEEE 12TH INTERNATIONAL CONF ON PERVASIVE INTELLIGENCE AND COMPUTING (PICOM), P485, DOI 10.1109/DASC.2014.93; Vahdat A., 2000, EPIDEMIC ROUTING PAR; Yilmaz ONC, 2014, 2014 11TH INTERNATIONAL SYMPOSIUM ON WIRELESS COMMUNICATIONS SYSTEMS (ISWCS), P6, DOI 10.1109/ISWCS.2014.6933310; You L, 2015, AD HOC NETW, V24, P228, DOI 10.1016/j.adhoc.2014.09.004; Yu C, 2016, INT J COMMUN SYST, V29, P2416, DOI 10.1002/dac.3030	35	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167913	10.1371/journal.pone.0167913	http://dx.doi.org/10.1371/journal.pone.0167913			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973618	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300047
J	Waheeb, W; Ghazali, R; Herawan, T				Waheeb, Waddah; Ghazali, Rozaida; Herawan, Tutut			Ridge Polynomial Neural Network with Error Feedback for Time Series Forecasting	PLOS ONE			English	Article							LEARNING ALGORITHM; EXCHANGE-RATE; PREDICTION; FUZZY; HYBRID; NONSTATIONARY; MODEL	Time series forecasting has gained much attention due to its many practical applications. Higher-order neural network with recurrent feedback is a powerful technique that has been used successfully for time series forecasting. It maintains fast learning and the ability to learn the dynamics of the time series over time. Network output feedback is the most common recurrent feedback for many recurrent neural network models. However, not much attention has been paid to the use of network error feedback instead of network output feedback. In this study, we propose a novel model, called Ridge Polynomial Neural Network with Error Feedback (RPNN-EF) that incorporates higher order terms, recurrence and error feedback. To evaluate the performance of RPNN-EF, we used four univariate time series with different forecasting horizons, namely star brightness, monthly smoothed sunspot numbers, daily Euro/Dollar exchange rate, and Mackey-Glass time-delay differential equation. We compared the forecasting performance of RPNN-EF with the ordinary Ridge Polynomial Neural Network (RPNN) and the Dynamic Ridge Polynomial Neural Network (DRPNN). Simulation results showed an average 23.34% improvement in Root Mean Square Error (RMSE) with respect to RPNN and an average 10.74% improvement with respect to DRPNN. That means that using network errors during training helps enhance the overall forecasting performance for the network.	[Waheeb, Waddah; Ghazali, Rozaida] Univ Tun Hussein Onn Malaysia, Fac Comp Sci & Informat Technol, Batu Pahat, Johor, Malaysia; [Waheeb, Waddah] Hodeidah Univ, Dept Comp Sci, Hodeidah, Yemen; [Herawan, Tutut] Univ Malaya, Dept Informat Syst, Kuala Lumpur, Malaysia; [Herawan, Tutut] Univ Teknol Yogyakarta, Dept Comp Sci, Yogyakarta, Indonesia; [Herawan, Tutut] AMCS Res Ctr, Yogyakarta, Indonesia	University of Tun Hussein Onn Malaysia; Hodeidah University; Universiti Malaya	Waheeb, W (corresponding author), Univ Tun Hussein Onn Malaysia, Fac Comp Sci & Informat Technol, Batu Pahat, Johor, Malaysia.; Waheeb, W (corresponding author), Hodeidah Univ, Dept Comp Sci, Hodeidah, Yemen.	waddah.waheeb@gmail.com	Saeed, Waddah/E-9179-2015; Herawan, Tutut/AAB-6534-2021; Ghazali, Rozaida/D-3985-2013	Saeed, Waddah/0000-0002-2280-4427; Herawan, Tutut/0000-0001-9262-9137; Ghazali, Rozaida/0000-0003-0119-0873	Universitas Teknologi Yogyakarta Research Grant [07/UTY-R/SK/0/X/2013]	Universitas Teknologi Yogyakarta Research Grant	This work was supported by Universitas Teknologi Yogyakarta Research Grant 07/UTY-R/SK/0/X/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by Universitas Teknologi Yogyakarta Research Grant 07/UTY-R/SK/0/X/2013.	Abarbanel HDI., 1996, ANAL OBSERVED CHAOTI, DOI [10.1007/978-1-4612-0763-4, DOI 10.1007/978-1-4612-0763-4]; Aizenberg I, 2012, SOFT COMPUT, V16, P563, DOI 10.1007/s00500-011-0755-7; Al-Jumeily D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105766; Antweiler Werner, PACIFIC EXCHANGE RAT; Atiya AF., 1988, NEURAL INFORMATION P, P22; Behera NKS, 2014, 2014 INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATION CONTROL AND COMPUTING TECHNOLOGIES (ICACCCT), P1110, DOI 10.1109/ICACCCT.2014.7019270; Bouaziz S, 2013, NEUROCOMPUTING, V117, P107, DOI 10.1016/j.neucom.2013.01.024; Chatfield C., 2003, ANAL TIME SERIES INT, V6, DOI 10.4324/9780203491683; Cheng R, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/572592; CONNOR JT, 1994, IEEE T NEURAL NETWOR, V5, P240, DOI 10.1109/72.279188; Dash PK, 1997, IEEE T POWER SYST, V12, P675, DOI 10.1109/59.589648; Dhahri H, 2006, IEEE IJCNN, P2938; Dhahri H, 2008, STUD COMPUT INTELL, V129, P461; Diebold F. X., 2004, ELEMENTS FORECASTING; Dong YL, 2014, IEEE IJCNN, P157, DOI 10.1109/IJCNN.2014.6889431; Dunis C.L., 2002, TRADING REGULATION, P211, DOI DOI 10.1002/F0R.935; Feng GR, 2009, IEEE T NEURAL NETWOR, V20, P1352, DOI 10.1109/TNN.2009.2024147; Ghazali R, 2008, NEURAL COMPUT APPL, V17, P311, DOI 10.1007/s00521-007-0132-8; Ghazali R, 2011, EXPERT SYST APPL, V38, P3765, DOI 10.1016/j.eswa.2010.09.037; Ghazali R, 2009, NEUROCOMPUTING, V72, P2359, DOI 10.1016/j.neucom.2008.12.005; Ghosh J., 1993, International Journal of Neural Systems, V3, P323, DOI 10.1142/S0129065792000255; Gonzalez PA, 2005, ENERG BUILDINGS, V37, P595, DOI 10.1016/j.enbuild.2004.09.006; Graves D, 2009, NEUROCOMPUTING, V72, P1668, DOI 10.1016/j.neucom.2008.07.009; Haykin S., 2009, NEURAL NETWORKS LEAR; Hongwei Wang, 2012, 2012 Third International Conference on Intelligent Control and Information Processing (ICICIP 2012), P298, DOI 10.1109/ICICIP.2012.6391564; Huang SC, 2010, EXPERT SYST APPL, V37, P8590, DOI 10.1016/j.eswa.2010.06.001; Husaini NA, 2011, COMM COM INF SC, V151, P547; Hussain AJ, 2003, NEUROCOMPUTING, V55, P363, DOI 10.1016/S0925-2312(02)00629-X; KAWATO M, 1987, BIOL CYBERN, V57, P169, DOI 10.1007/BF00364149; Kitagawa G., 2010, INTRO TIME SERIES MO; Lanza PAG, 2002, ENG APPL ARTIF INTEL, V15, P459, DOI 10.1016/S0952-1976(02)00089-1; Leclercq E, 2005, NEUROCOMPUTING, V63, P25, DOI 10.1016/j.neucom.2004.04.007; Lin CJ, 2009, IEEE T SYST MAN CY C, V39, P55, DOI 10.1109/TSMCC.2008.2002333; Lin CM, 2015, IEEE T SYST MAN CY-S, V45, P1281, DOI 10.1109/TSMC.2015.2389752; Lohani AK, 2012, J HYDROL, V442, P23, DOI 10.1016/j.jhydrol.2012.03.031; Mahmud MS, 2015, SOFT COMPUT, P1; Makridakis S., 1998, FORECASTING METHODS; Nakanishi J, 2004, NEURAL NETWORKS, V17, P1453, DOI 10.1016/j.neunet.2004.05.003; Panda C, 2007, J POLICY MODEL, V29, P227, DOI 10.1016/j.jpolmod.2006.01.005; Parsapoor Mahboobeh, 2013, International Journal of Reasoning-based Intelligent Systems, V5, P113; Sabahi K, 2009, ENERG CONVERS MANAGE, V50, P938, DOI 10.1016/j.enconman.2008.12.028; Samarasinghe S., 2006, NEURAL NETWORKS APPL; Sermpinis G, 2012, DECIS SUPPORT SYST, V54, P316, DOI 10.1016/j.dss.2012.05.039; Sermpinis G, 2012, EXPERT SYST APPL, V39, P8865, DOI 10.1016/j.eswa.2012.02.022; SHIN Y, 1995, IEEE T NEURAL NETWOR, V6, P610, DOI 10.1109/72.377967; Shoorehdeli MA, 2009, APPL SOFT COMPUT, V9, P833, DOI 10.1016/j.asoc.2008.11.001; Tan JYB, 2012, ENG LET, V20, P203; Voutriaridis C, 2003, PROCEEDINGS EC-VIP-MC 2003, VOLS 1 AND 2, P519; Waheeb W, 2 INT C SOF IN PRESS; Wan DS, 2009, ICICTA: 2009 SECOND INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTATION TECHNOLOGY AND AUTOMATION, VOL I, PROCEEDINGS, P63, DOI 10.1109/ICICTA.2009.24; Wang HW, 2011, ASIAN J CONTROL, V13, P576, DOI 10.1002/asjc.355; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270; Wong WK, 2010, EUR J OPER RES, V207, P807, DOI 10.1016/j.ejor.2010.05.022; YABUTA T, 1991, 1991 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-3, P740, DOI 10.1109/ROBOT.1991.131673; Yu L, 2009, APPL SOFT COMPUT, V9, P563, DOI 10.1016/j.asoc.2008.08.001; Yu X, 2014, NEUROCOMPUTING, V129, P437, DOI 10.1016/j.neucom.2013.09.015; Yuanquan Wen, 2009, Proceedings of the 2009 Sixth International Conference on Fuzzy Systems and Knowledge Discovery (FSKD 2009), P458, DOI 10.1109/FSKD.2009.133; Zhang hui, 2012, 2012 9th International Conference on Fuzzy Systems and Knowledge Discovery, P93, DOI 10.1109/FSKD.2012.6233957	58	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							0167248	10.1371/journal.pone.0167248	http://dx.doi.org/10.1371/journal.pone.0167248			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959927	gold, Green Published, Green Submitted			2022-12-27	WOS:000392753900007
J	Choi, H; Shin, JH; Kim, ES; Park, SJ; Bae, IH; Jo, YK; Jeong, IY; Kim, HJ; Lee, Y; Park, HC; Jeon, HB; Kim, KW; Lee, TR; Cho, DH				Choi, Hyunjung; Shin, Ji Hyun; Kim, Eun Sung; Park, So Jung; Bae, Il-Hong; Jo, Yoon Kyung; Jeong, In Young; Kim, Hyoung-June; Lee, Youngjin; Park, Hea Chul; Jeon, Hong Bae; Kim, Ki Woo; Lee, Tae Ryong; Cho, Dong-Hyung			Primary Cilia Negatively Regulate Melanogenesis in Melanocytes and Pigmentation in a Human Skin Model	PLoS One			English	Article							SONIC HEDGEHOG; INTRAFLAGELLAR TRANSPORT; KIDNEY-DISEASE; MELANOMA-CELLS; PROTEIN; GLI2; DIFFERENTIATION; CILIOGENESIS; HAIR	The primary cilium is an organelle protruding from the cell body that senses external stimuli including chemical, mechanical, light, osmotic, fluid flow, and gravitational signals. Skin is always exposed to the external environment and responds to external stimuli. Therefore, it is possible that primary cilia have an important role in skin. Ciliogenesis was reported to be involved in developmental processes in skin, such as keratinocyte differentiation and hair formation. However, the relation between skin pigmentation and primary cilia is largely unknown. Here, we observed that increased melanogenesis in melanocytes treated with a melanogenic inducer was inhibited by a ciliogenesis inducer, cytochalasin D, and serumfree culture. However, these inhibitory effects disappeared in GLI2 knockdown cells. In addition, activation of sonic hedgehog (SHH)-smoothened (Smo) signaling pathway by a Smo agonist, SAG inhibited melanin synthesis in melanocytes and pigmentation in a human skin model. On the contrary, an inhibitor of primary cilium formation, ciliobrevin A1, activated melanogenesis in melanocytes. These results suggest that skin pigmentation may be regulated partly by the induction of ciliogenesis through Smo-GLI2 signaling.	[Choi, Hyunjung; Shin, Ji Hyun; Kim, Eun Sung; Park, So Jung; Jo, Yoon Kyung; Cho, Dong-Hyung] Kyung Hee Univ, Grad Sch East West Med Sci, Dept Gerontol, Yongin, Gyeonggi Do, South Korea; [Choi, Hyunjung; Bae, Il-Hong; Kim, Hyoung-June; Lee, Youngjin; Lee, Tae Ryong] AmorePacific Corp, R&D Unit, Yongin, Gyeonggi Do, South Korea; [Jeong, In Young; Park, Hea Chul] Korea Univ, Dept Med Sci, Ansan Hosp, Ansan, Gyeonggi Do, South Korea; [Jeon, Hong Bae] MEDIPOST Corp, Biomed Res Inst, Seongnam, Gyeonggi Do, South Korea; [Kim, Ki Woo] Yonsei Univ, Wonju Coll Med, Dept Pharmacol, Wonju, Gangwon Do, South Korea	Kyung Hee University; Korea University; Korea University Medicine (KU Medicine); MEDIPOST; Yonsei University	Cho, DH (corresponding author), Kyung Hee Univ, Grad Sch East West Med Sci, Dept Gerontol, Yongin, Gyeonggi Do, South Korea.; Lee, TR (corresponding author), AmorePacific Corp, R&D Unit, Yongin, Gyeonggi Do, South Korea.	trlee@amorepacific.com; dhcho@khu.ac.kr	Kim, Ki Woo Woo/AAW-9645-2021	Kim, Ki Woo Woo/0000-0002-7790-1515; Bae, Il-Hong/0000-0003-0535-8303	National Research Foundation, Ministry of Science, ICT and Future Planning, Republic of Korea [NRF-2013R1A1A1058361]; AmorePacific Corporation; MEDIPOST corporation	National Research Foundation, Ministry of Science, ICT and Future Planning, Republic of Korea; AmorePacific Corporation; MEDIPOST corporation	This study was supported by grants from the National Research Foundation (NRF-2013R1A1A1058361), Ministry of Science, ICT and Future Planning, Republic of Korea. All Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The AmorePacific Corporation (HC, IHB, HJK, YL, TRL) and MEDIPOST corporation (HBJ) provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balafa C, 2005, EXP DERMATOL, V14, P363, DOI 10.1111/j.0906-6705.2005.00287.x; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Chang H, 2012, PIGM CELL MELANOMA R, V25, P765, DOI 10.1111/pcmr.12002; Choi H, 2005, PIGM CELL RES, V18, P439, DOI 10.1111/j.1600-0749.2005.00266.x; Choi H, 2014, EXP DERMATOL, V23, P172, DOI 10.1111/exd.12343; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Ezratty EJ, 2011, CELL, V145, P1129, DOI 10.1016/j.cell.2011.05.030; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Gazea M, 2016, DEV BIOL, V409, P55, DOI 10.1016/j.ydbio.2015.10.033; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gerdes JM, 2008, CURR TOP DEV BIOL, V85, P175, DOI 10.1016/S0070-2153(08)00807-7; Han YG, 2010, CURR OPIN NEUROBIOL, V20, P58, DOI 10.1016/j.conb.2009.12.002; He M, 2014, NAT CELL BIOL, V16, P663, DOI 10.1038/ncb2988; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Javelaud D, 2011, PIGM CELL MELANOMA R, V24, P932, DOI 10.1111/j.1755-148X.2011.00893.x; Ji J, 2008, INT J CANCER, V122, P50, DOI 10.1002/ijc.23023; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kleene SJ, 2014, BIOSCIENCE, V64, P1092, DOI 10.1093/biosci/biu181; Lancaster MA, 2011, NAT CELL BIOL, V13, P700, DOI 10.1038/ncb2259; Lee CS, 2013, EXP DERMATOL, V22, P762, DOI 10.1111/exd.12248; Lehman JM, 2009, J INVEST DERMATOL, V129, P438, DOI 10.1038/jid.2008.279; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Seeger-Nukpezah T, 2012, CURR OPIN CELL BIOL, V24, P652, DOI 10.1016/j.ceb.2012.06.002; Snedecor ER, 2015, J INVEST DERMATOL, V135, P1456, DOI 10.1038/jid.2015.22; Tanaka Y, 2005, NATURE, V435, P172, DOI 10.1038/nature03494; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Yamaguchi Y, 2007, J BIOL CHEM, V282, P27557, DOI 10.1074/jbc.R700026200	34	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168025	10.1371/journal.pone.0168025	http://dx.doi.org/10.1371/journal.pone.0168025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941997	gold, Green Submitted, Green Published			2022-12-27	WOS:000392745600047
J	de Alvarenga, EC; Fonseca, MD; Carvalho, CC; Florentino, RM; Franca, A; Matias, E; Guimaraes, PB; Batista, C; Freire, V; Carmona, AK; Pesquero, JB; de Paula, AM; Foureaux, G; Leite, MD				de Alvarenga, Erika Costa; Fonseca, Matheus de Castro; Carvalho, Clarissa Coelho; Florentino, Rodrigo Machado; Franca, Andressa; Matias, Eveline; Guimaraes, Paola Bianchi; Batista, Carolina; Freire, Valder; Carmona, Adriana Karaoglanovic; Pesquero, Joao Bosco; de Paula, Ana Maria; Foureaux, Giselle; Leite, Maria de Fatima			Angiotensin Converting Enzyme Regulates Cell Proliferation and Migration	PLOS ONE			English	Article							NUCLEAR-LOCALIZATION; RECEPTOR BLOCKERS; SWISS 3T3-CELLS; CALCIUM SIGNALS; ACE-INHIBITORS; C-BETA; SYSTEM; ACTIVATION; MECHANISMS; CANCER	Background The angiotensin-I converting enzyme (ACE) plays a central role in the renin-angiotensin system, acting by converting the hormone angiotensin-I to the active peptide angiotensin-II (Ang-II). More recently, ACE was shown to act as a receptor for Ang-II, and its expression level was demonstrated to be higher in melanoma cells compared to their normal counterparts. However, the function that ACE plays as an Ang-II receptor in melanoma cells has not been defined yet. Aim Therefore, our aim was to examine the role of ACE in tumor cell proliferation and migration. Results We found that upon binding to ACE, Ang-II internalizes with a faster onset compared to the binding of Ang-II to its classical AT1 receptor. We also found that the complex Ang-II/ACE translocates to the nucleus, through a clathrin-mediated process, triggering a transient nuclear Ca2+ signal. In silico studies revealed a possible interaction site between ACE and phospholipase C (PLC), and experimental results in CHO cells, demonstrated that the beta 3 isoform of PLC is the one involved in the Ca2+ signals induced by Ang-II/ACE interaction. Further studies in melanoma cells (TM-5) showed that Ang-II induced cell proliferation through ACE activation, an event that could be inhibited either by ACE inhibitor (Lisinopril) or by the silencing of ACE. In addition, we found that stimulation of ACE by Ang-II caused the melanoma cells to migrate, at least in part due to decreased vinculin expression, a focal adhesion structural protein. Conclusion ACE activation regulates melanoma cell proliferation and migration.	[de Alvarenga, Erika Costa; Fonseca, Matheus de Castro; Carvalho, Clarissa Coelho; Florentino, Rodrigo Machado; Franca, Andressa; Foureaux, Giselle; Leite, Maria de Fatima] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil; [de Alvarenga, Erika Costa] Univ Fed Sao Joao del Rei, Dept Nat Sci, Sao Joao Del Rei, MG, Brazil; [Matias, Eveline; Freire, Valder] Univ Fed Ceara, Dept Phys, Fortaleza, CE, Brazil; [Guimaraes, Paola Bianchi; Batista, Carolina; Carmona, Adriana Karaoglanovic; Pesquero, Joao Bosco] Univ Fed Sao Paulo, Dept Biophys, Sao Paulo, SP, Brazil; [de Paula, Ana Maria] Univ Fed Minas Gerais, Dept Phys, Belo Horizonte, MG, Brazil; [Foureaux, Giselle] Univ Fed Minas Gerais, Dept Morphol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Sao Joao del-Rei; Universidade Federal do Ceara; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Leite, MD (corresponding author), Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil.	leitemd@ufmg.br	Freire, Valder Nogueira/GLV-3915-2022; de Fatima Leite, Maria/AAK-2555-2021; Carmona, Adriana K/D-2240-2012; Bezerra, Eveline Matias/M-3962-2014; De Paula, Alfredo Maurício Batista/K-3015-2012; Freire, Valder N/D-1136-2013; Alvarenga, Erika Costa/P-7596-2018; Fonseca, Matheus/GYU-2786-2022; de Paula, Ana Maria/D-2437-2010; Fonseca, Matheus C./L-8006-2017; Fonseca, Matheus C./O-9213-2019	Freire, Valder Nogueira/0000-0001-7867-3908; Carmona, Adriana K/0000-0003-3311-5456; Bezerra, Eveline Matias/0000-0002-2210-0526; De Paula, Alfredo Maurício Batista/0000-0002-8715-0030; Freire, Valder N/0000-0001-7867-3908; Alvarenga, Erika Costa/0000-0002-9480-9761; de Paula, Ana Maria/0000-0002-8551-5948; Fonseca, Matheus C./0000-0001-9048-9775; Fonseca, Matheus C./0000-0001-9048-9775	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); INCT Nanocarbono - UFMG (Brazil)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); INCT Nanocarbono - UFMG (Brazil)	This research was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and INCT Nanocarbono - UFMG (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya KR, 2003, NAT REV DRUG DISCOV, V2, P891, DOI 10.1038/nrd1227; Ahn SK, 2004, J BIOL CHEM, V279, P35518, DOI 10.1074/jbc.M405878200; Amaya MJ, 2014, HEPATOLOGY, V59, P274, DOI 10.1002/hep.26609; Andrade LM, 2012, J CANC SCI THER, V4, P131, DOI DOI 10.4172/1948-5956.1000127; Azizi M, 2000, J HYPERTENS, V18, P1139, DOI 10.1097/00004872-200018080-00020; Bhuiyan MA, 2010, J PHARMACOL SCI, V112, P459, DOI 10.1254/jphs.09343SC; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Christian JB, 2008, JNCI-J NATL CANCER I, V100, P1223, DOI 10.1093/jnci/djn262; COCCO L, 1988, BIOCHEM BIOPH RES CO, V154, P1266, DOI 10.1016/0006-291X(88)90276-8; Correa M, 2005, INT J CANCER, V114, P356, DOI 10.1002/ijc.20673; Damsky WE, 2014, ONCOGENE, V33, P2413, DOI 10.1038/onc.2013.194; De Groot-Besseling RRJ, 2004, INT J CANCER, V112, P329, DOI 10.1002/ijc.20400; Deshayes F, 2005, TRENDS ENDOCRIN MET, V16, P293, DOI 10.1016/j.tem.2005.07.009; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Egami K, 2003, J CLIN INVEST, V112, P67, DOI 10.1172/JCI200316645; FERRARIO CM, 1990, J CARDIOVASC PHARM, V15, pS1, DOI 10.1097/00005344-199000153-00001; Fleming I, 2006, CIRC RES, V98, P887, DOI 10.1161/01.RES.0000217340.40936.53; Fuchs S, 2008, HYPERTENSION, V51, P267, DOI 10.1161/HYPERTENSIONAHA.107.097865; Fyhrquist F, 2008, J INTERN MED, V264, P224, DOI 10.1111/j.1365-2796.2008.01981.x; George AJ, 2010, NAT REV CANCER, V10, P745, DOI 10.1038/nrc2945; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Gonzalez-Villalobos RA, 2013, J CLIN INVEST, V123, P2011, DOI 10.1172/JCI65460; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Guimaraes PB, 2001, HYPERTENSION, V57, P965; Hooper NM, 2003, NAT STRUCT BIOL, V10, P155, DOI 10.1038/nsb0303-155; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Inducible K, 2003, NATURE, V1429, P1427; Izaurralde E, 1998, RNA, V4, P351; JOHNSTON CI, 1993, KIDNEY INT, V44, pS59; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; Kapoor M, 2008, J CLIN INVEST, V118, P3279, DOI 10.1172/JCI35381; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; Klein CA, 2009, NAT REV CANCER, V9, P302, DOI 10.1038/nrc2627; Kohlstedt K, 2005, HYPERTENSION, V45, P126, DOI 10.1161/01.HYP.0000150159.48992.11; Kohlstedt K, 2004, CIRC RES, V94, P60, DOI 10.1161/01.RES.0000107195.13573.E4; Koss H, 2014, TRENDS BIOCHEM SCI, V39, P603, DOI 10.1016/j.tibs.2014.09.004; Kule CE, 2004, REGUL PEPTIDES, V120, P141, DOI 10.1016/j.regpep.2004.03.001; Ladeira MS, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/38/385101; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; LEITE MF, 1994, AM J PHYSIOL-HEART C, V267, pH2193, DOI 10.1152/ajpheart.1994.267.6.H2193; Lever AF, 1998, LANCET, V352, P179, DOI 10.1016/S0140-6736(98)03228-0; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lucero HA, 2010, J BIOL CHEM, V285, P5555, DOI 10.1074/jbc.M109.074740; MANZOLI L, 1995, CANCER RES, V55, P2978; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; Masuyer G, 2014, BIOL CHEM, V395, P1135, DOI 10.1515/hsz-2014-0157; Masuyer G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00717; MENARD J, 1991, HYPERTENSION, V18, P257, DOI 10.1161/01.HYP.18.3.257; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Oliveira AG, 2014, PHYSIOLOGY, V29, P361, DOI 10.1152/physiol.00056.2013; Petrel C, 2009, MOL CELL ENDOCRINOL, V302, P176, DOI 10.1016/j.mce.2008.10.049; Pierce BG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024657; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Ritter JM, 2011, BRIT J CLIN PHARMACO, V71, P313, DOI 10.1111/j.1365-2125.2011.03918.x; Rodrigues MA, 2009, BRAZ J MED BIOL RES, V42, P17, DOI 10.1590/S0100-879X2008005000050; Rodrigues MA, 2008, HEPATOLOGY, V48, P1621, DOI 10.1002/hep.22424; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; Rodrigues-Ferreira S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035667; Sabatini RA, 2007, ANAL BIOCHEM, V363, P255, DOI 10.1016/j.ab.2007.01.020; Sica Domenic A, 2007, J Clin Hypertens (Greenwich), V9, P78; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Stergiou GS, 2000, J CARDIOVASC PHARM, V35, P937, DOI 10.1097/00005344-200006000-00017; Taddei S, 2015, AM J CARDIOVASC DRUG, V15, P185, DOI 10.1007/s40256-015-0116-5; Thievessen I, 2015, FASEB J, V29, P4555, DOI 10.1096/fj.14-268235; THOMAS WG, 1995, J BIOL CHEM, V270, P22153, DOI 10.1074/jbc.270.38.22153; Touyz RM, 2000, PHARMACOL REV, V52, P639; van Esch JHM, 2005, HYPERTENSION, V45, P120, DOI 10.1161/01.HYP.0000151323.93372.f5; VANDENMEIRACKER AH, 1992, J HYPERTENS, V10, P803; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wang RF, 2012, EXP EYE RES, V94, P146, DOI 10.1016/j.exer.2011.11.019; Watermeyer J. M., 2009, CURRENT ENZYME INHIB, V5, P134, DOI DOI 10.2174/157340809789071155; Yasumatsu R, 2004, J CANCER RES CLIN, V130, P567, DOI 10.1007/s00432-004-0582-7; YORK JD, 1994, J BIOL CHEM, V269, P19992	77	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0165371	10.1371/journal.pone.0165371	http://dx.doi.org/10.1371/journal.pone.0165371			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992423	Green Published, gold			2022-12-27	WOS:000392842600004
J	Akinola, M; Fridman, I; Mor, S; Morris, MW; Crum, AJ				Akinola, Modupe; Fridman, Ilona; Mor, Shira; Morris, Michael W.; Crum, Alia J.			Adaptive Appraisals of Anxiety Moderate the Association between Cortisol Reactivity and Performance in Salary Negotiations	PLOS ONE			English	Article							DECISION-MAKING; GENDER-DIFFERENCES; STRESS; RESPONSES; EMOTION; BEHAVIOR; OUTCOMES; AROUSAL; THREAT; BRAIN	Prior research suggests that stress can be harmful in high-stakes contexts such as negotiations. However, few studies actually measure stress physiologically during negotiations, nor do studies offer interventions to combat the potential negative effects of heightened physiological responses in negotiation contexts. In the current research, we offer evidence that the negative effects of cortisol increases on negotiation performance can be reduced through a reappraisal of anxiety manipulation. We experimentally induced adaptive appraisals by randomly assigning 97 male and female participants to receive either instructions to appraise their anxiety as beneficial to the negotiation or no specific instructions on how to appraise the situation. We also measured participants' cortisol responses prior to and following the negotiation. Results revealed that cortisol increases were positively related to negotiation performance for participants who were told to view anxiety as beneficial, and not detrimental, for negotiation performance (appraisal condition). In contrast, cortisol increases were negatively related to negotiation performance for participants given no instructions on appraising their anxiety (control condition). These findings offer a means through which to combat the potentially deleterious effects of heightened cortisol reactivity on negotiation outcomes.	[Akinola, Modupe; Fridman, Ilona; Morris, Michael W.] Columbia Univ, Columbia Business Sch, New York, NY 10027 USA; [Mor, Shira] Tel Aviv Univ, Tel Aviv, Israel; [Crum, Alia J.] Stanford Univ, Dept Psychol, Stanford, CA USA	Columbia University; Tel Aviv University; Stanford University	Akinola, M (corresponding author), Columbia Univ, Columbia Business Sch, New York, NY 10027 USA.	makinola@columbia.edu		Akinola, Modupe/0000-0002-1219-2543				Akinola M, 2014, SOC PSYCHOL PERS SCI, V5, P43, DOI 10.1177/1948550613485604; Akinola M, 2012, BEHAV NEUROSCI, V126, P167, DOI 10.1037/a0026657; [Anonymous], 2011, GETTING YES NEGOTIAT; Babcock L., 2012, GENDER DIFFERENCES P, P239; Beltzer ML, 2014, EMOTION, V14, P761, DOI 10.1037/a0036326; Blascovich J., 2010, HDB SOCIAL PSYCHOL, V5th ed., P194, DOI DOI 10.1002/9780470561119.SOCPSY001006; Bos MGN, 2014, PSYCHONEUROENDOCRINO, V50, P72, DOI 10.1016/j.psyneuen.2014.07.030; Bowles HR, 2007, ORGAN BEHAV HUM DEC, V103, P84, DOI 10.1016/j.obhdp.2006.09.001; Brooks AW, 2011, ORGAN BEHAV HUM DEC, V115, P43, DOI 10.1016/j.obhdp.2011.01.008; Cahill L, 2003, LEARN MEMORY, V10, P270, DOI 10.1101/lm.62403; Crum AJ, 2013, J PERS SOC PSYCHOL, V104, P716, DOI 10.1037/a0031201; DALY JA, 1989, PERS INDIV DIFFER, V10, P903, DOI 10.1016/0191-8869(89)90025-1; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Galinsky AD, 2002, PERS SOC PSYCHOL B, V28, P271, DOI 10.1177/0146167202282012; Gross JJ, 2002, PSYCHOPHYSIOLOGY, V39, P281, DOI 10.1017/S0048577201393198; Hancock PA, 2005, THEOR ISS ERGON SCI, V6, P193, DOI 10.1080/14639220512331325747; Hayes A. F., 2013, INTRODUCTION TO MEDI; Jamieson JP, 2013, CURR DIR PSYCHOL SCI, V22, P51, DOI 10.1177/0963721412461500; Jamieson JP, 2010, J EXP SOC PSYCHOL, V46, P208, DOI 10.1016/j.jesp.2009.08.015; Josephs RA, 2006, J PERS SOC PSYCHOL, V90, P999, DOI 10.1037/0022-3514.90.6.999; Kassam KS, 2009, PSYCHOL SCI, V20, P1394, DOI 10.1111/j.1467-9280.2009.02455.x; Kray LJ, 2002, ORGAN BEHAV HUM DEC, V87, P386, DOI 10.1006/obhd.2001.2979; Lautenbach F, 2014, PSYCHONEUROENDOCRINO, V42, P218, DOI 10.1016/j.psyneuen.2014.01.011; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Mauss IB, 2005, EMOTION, V5, P175, DOI 10.1037/1528-3542.5.2.175; Mazei J, 2015, PSYCHOL BULL, V141, P85, DOI 10.1037/a0038184; McEwen BS, 2005, METABOLISM, V54, P20, DOI 10.1016/j.metabol.2005.01.008; Mendes WB, 2008, J PERS SOC PSYCHOL, V94, P278, DOI 10.1037/0022-3514.94.2.278; Mor S., 2014, IRON FIST VELVET GLO; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; O'Connor KM, 2010, J EXP SOC PSYCHOL, V46, P729, DOI 10.1016/j.jesp.2010.04.007; Page-Gould E, 2015, GROUP PROCESS INTERG, V18, P366, DOI 10.1177/1368430214556371; Radenbach C, 2015, PSYCHONEUROENDOCRINO, V53, P268, DOI 10.1016/j.psyneuen.2014.12.017; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Schaerer M, 2015, PSYCHOL SCI, V26, P170, DOI 10.1177/0956797614558718; Selye H, 1950, PHYSL PATHOLOGY EXPO; Senn S, 2006, STAT MED, V25, P4334, DOI 10.1002/sim.2682; Smyth N, 2013, SOC PERSONAL PSYCHOL, V7, P605, DOI 10.1111/spc3.12057; Starcke K, 2011, PSYCHONEUROENDOCRINO, V36, P210, DOI 10.1016/j.psyneuen.2010.07.010; Starcke K, 2008, BEHAV NEUROSCI, V122, P1352, DOI 10.1037/a0013281; Stuhlmacher AF, 2006, GENDER COMMUNICATION, P211; TOMAKA J, 1993, J PERS SOC PSYCHOL, V65, P248, DOI 10.1037/0022-3514.65.2.248; van den Bos R, 2009, PSYCHONEUROENDOCRINO, V34, P1449, DOI 10.1016/j.psyneuen.2009.04.016	43	13	13	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167977	10.1371/journal.pone.0167977	http://dx.doi.org/10.1371/journal.pone.0167977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992484	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000019
J	Feng, LP; Ransom, CE; Nazzal, MK; Allen, TK; Li, YJ; Truong, T; Potts, LC; Seed, PC; Murtha, AP				Feng, Liping; Ransom, Carla E.; Nazzal, Matthew K.; Allen, Terrence K.; Li, Yi-Ju; Truong, Tracy; Potts, Lauren C.; Seed, Patrick C.; Murtha, Amy P.			The Role of Progesterone and a Novel Progesterone Receptor, Progesterone Receptor Membrane Component 1, in the Inflammatory Response of Fetal Membranes to Ureaplasma parvum Infection	PLOS ONE			English	Article							PRETERM PREMATURE RUPTURE; AMNIOTIC-FLUID; INTRAUTERINE INFECTION; HUMAN-PLACENTA; UREALYTICUM; EXPRESSION; CHORIOAMNIONITIS; ASSOCIATION; CELLS; BIRTH	Ureaplasma parvum (U. parvum) is gaining recognition as an important pathogen for chorioamnionitis and preterm premature rupture of membranes. We aimed to investigate the roles of progesterone (P4) and a novel progesterone receptor, progesterone receptor membrane component 1 (PGRMC1), in the response of fetal membranes to U. parvum. Fetal membrane cells (amnion, chorion and decidua) were isolated and confirmed to be free of Mycoplasmataceae. Cells were treated with U. parvum (5x10(6) CFU), and adherence was quantified by qPCR. Amnion and chorion cells were transfected with scrambled siRNA or validated PGRMC1 siRNA for 72h. Cells were then treated with U. parvum for 4h with or without pretreatment with P4 (10(-7) M) or ethanol for 1h. Interleukin-8 (IL-8), matrix metalloproteinase 9 (MMP9) and cyclooxygenase (COX-2) mRNA expression were quantified by qRT-PCR. Culture medium was harvested and analyzed for IL-8 and prostaglandin (PGE2) secretion by ELISA and MMP9 activity by zymography. U. parvum had a mean adherence of 15.0+/-0.6%, 16.9+/-3.7% and 4.7+/-0.3% in cultured amnion, chorion and decidua cells, respectively. Exposure to U. parvum elicited significant inflammatory responses including induction of IL-8, COX-2, PGE2 and MMP9. A possible role of PGRMC1 was identified in the inhibition of U. parvum-stimulated COX-2 and MMP9 mRNA expression in chorion cells and MMP9 activity in amnion cells. On the other hand, it might enhance the U. parvum-stimulated IL-8 protein secretion in amnion cells. P4, mediated through PGRMC1, significantly inhibited U. Parvum-induced MMP9 mRNA and COX-2 mRNA expression in chorion cells. P4 appeared to attenuate U. parvum induced IL-8 mRNA expression in chorion cells, but this P4 effect might not mediated through PGRMC1. In summary, U. parvum preferentially adheres to and induces inflammatory responses in chorion and amnion cells. P4 and PGRMC1 appear to differentially modulate the inflammatory responses induced by U. parvum among amnion and chorion cells.	[Feng, Liping; Ransom, Carla E.; Nazzal, Matthew K.; Potts, Lauren C.; Murtha, Amy P.] Duke Univ, Dept Obstet & Gynecol, Durham, NC 27708 USA; [Allen, Terrence K.] Duke Univ, Dept Anesthesiol, Durham, NC USA; [Li, Yi-Ju; Truong, Tracy] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Seed, Patrick C.] Duke Univ, Dept Pediat, Durham, NC 27706 USA	Duke University; Duke University; Duke University; Duke University	Feng, LP (corresponding author), Duke Univ, Dept Obstet & Gynecol, Durham, NC 27708 USA.	feng0007@mc.duke.edu		Li, Yi-Ju/0000-0001-6996-4834	Charles Hammond Fund of the Department of Obstetrics and Gynecology, Duke University [564]; National Center for Advancing Translational Sciences of the National Institutes of Health [565, 566 KL2TR001115]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001115, UL1TR001117] Funding Source: NIH RePORTER	Charles Hammond Fund of the Department of Obstetrics and Gynecology, Duke University; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded by the Charles Hammond Fund of the Department of Obstetrics 564 and Gynecology, Duke University. This study was also supported by the National Center for 565 Advancing Translational Sciences of the National Institutes of Health under Award Number 566 KL2TR001115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TK, 2014, REPROD SCI, V21, P260, DOI 10.1177/1933719113493514; Allen TK, 2015, ANESTHESIA ANALGESIA; Breugelmans M, 2010, ACTA OBSTET GYN SCAN, V89, P256, DOI 10.3109/00016340903418769; Cahill MA, 2007, J STEROID BIOCHEM, V105, P16, DOI 10.1016/j.jsbmb.2007.02.002; Canzoneri BJ, 2013, REPROD SCI, V20, P1246, DOI 10.1177/1933719113483009; Casey ML, 1996, BIOL REPROD, V55, P1253, DOI 10.1095/biolreprod55.6.1253; CASSELL GH, 1993, CLIN MICROBIOL REV, V6, P69, DOI 10.1128/CMR.6.1.69-87.1993; CASSELL GH, 1988, PEDIATR INFECT DIS J, V7, P535; CHEROUNY PH, 1993, AM J OBSTET GYNECOL, V169, P1299, DOI 10.1016/0002-9378(93)90297-V; Cultrera R, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-166; DAXENBICHLER G, 1990, ANN NY ACAD SCI, V595, P440, DOI 10.1111/j.1749-6632.1990.tb34330.x; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001; ElMaradny E, 1996, AM J OBSTET GYNECOL, V174, P843, DOI 10.1016/S0002-9378(96)70311-3; Falkenstein E, 2000, EUR J CLIN INVEST, V30, P51, DOI 10.1046/j.1365-2362.2000.0300s3051.x; Feng L, 2014, PLACENTA, V35, P331, DOI 10.1016/j.placenta.2014.03.008; Ferrand PE, 2002, MOL HUM REPROD, V8, P494, DOI 10.1093/molehr/8.5.494; Flores-Espinosa P, 2014, AM J REPROD IMMUNOL, V71, P61, DOI 10.1111/aji.12163; Fortner KB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083338; Fortunato S, 2001, AM J OBSTET GYNECOL, V185, pS141, DOI 10.1016/S0002-9378(01)80252-0; Fortunato SJ, 2001, AM J OBSTET GYNECOL, V184, P1399, DOI 10.1067/mob.2001.115122; George RB, 2008, AM J PERINAT, V25, P29, DOI 10.1055/s-2007-1004828; Gerber S, 2003, J INFECT DIS, V187, P518, DOI 10.1086/368205; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Havelock OC, 2005, BIOL REPROD, V72, P707, DOI 10.1095/biolreprod.104.032979; Kasper DC, 2010, DIAGN MICR INFEC DIS, V67, P117, DOI 10.1016/j.diagmicrobio.2009.12.023; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Knox CL, 2010, BIOL REPROD, V83, P415, DOI 10.1095/biolreprod.109.083121; Knox CL, 1998, J CLIN MICROBIOL, V36, P3032, DOI 10.1128/JCM.36.10.3032-3039.1998; Kota Sunil K, 2013, Indian J Endocrinol Metab, V17, P50, DOI 10.4103/2230-8210.107841; Kumar D, 2006, BIOL REPROD, V74, P29, DOI 10.1095/biolreprod.105.045328; LAATIKAINEN T, 1981, J STEROID BIOCHEM, V14, P519, DOI 10.1016/0022-4731(81)90024-8; Li W, 2007, BIOL REPROD, V76, P654, DOI 10.1095/biolreprod.106.057034; Loudon JAZ, 2003, BIOL REPROD, V69, P331, DOI 10.1095/biolreprod.102.013698; MAZOR M, 1994, AM J OBSTET GYNECOL, V171, P231, DOI 10.1016/0002-9378(94)90474-X; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Meng Y, 2016, REPRODUCTIVE SCIENCE; Mercer BM, 2005, OBSTET GYN CLIN N AM, V32, P411, DOI 10.1016/j.ogc.2005.03.003; Merlino A, 2009, REPROD SCI, V16, P357, DOI 10.1177/1933719108328616; Meyer C, 1996, EUR J BIOCHEM, V239, P726, DOI 10.1111/j.1432-1033.1996.0726u.x; Mills AA, 2006, AM J OBSTET GYNECOL, V195, P998, DOI 10.1016/j.ajog.2006.06.040; Miura Y, 2014, ANTIMICROB AGENTS CH, V58, P5413, DOI 10.1128/AAC.03187-14; Mueck AO, 2014, J STEROID BIOCHEM, V142, P62, DOI 10.1016/j.jsbmb.2013.08.011; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Murtha A P, 2002, Infect Dis Obstet Gynecol, V10, P93, DOI 10.1155/S106474490200008X; Murtha AP, 2006, AM J OBSTET GYNECOL, V195, P1249, DOI 10.1016/j.ajog.2006.09.002; Namba F, 2010, PEDIATR RES, V67, P166, DOI 10.1203/PDR.0b013e3181c6e58e; Novy MJ, 2009, REPROD SCI, V16, P56, DOI 10.1177/1933719108325508; Oue S, 2009, ARCH DIS CHILD-FETAL, V94, pF17, DOI 10.1136/adc.2008.138321; Oyen ML, 2006, AM J OBSTET GYNECOL, V195, P510, DOI 10.1016/j.ajog.2006.02.010; Peltier MR, 2008, AM J REPROD IMMUNOL, V60, P346, DOI 10.1111/j.1600-0897.2008.00633.x; Peluso JJ, 2006, ENDOCRINOLOGY, V147, P3133, DOI 10.1210/en.2006-0114; Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050; Potts LC, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.137596; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; SAADA AB, 1991, INFECT IMMUN, V59, P467, DOI 10.1128/IAI.59.1.467-469.1991; Shimizu T, 2008, MICROBIOL-SGM, V154, P1318, DOI 10.1099/mic.0.2007/016212-0; SMITH DGE, 1994, MICROBIOL-UK, V140, P2893, DOI 10.1099/00221287-140-10-2893; Tarrant WP, 2009, J CLIN MICROBIOL, V47, P1965, DOI 10.1128/JCM.00352-09; Thomas P, 2008, FRONT NEUROENDOCRIN, V29, P292, DOI 10.1016/j.yfrne.2008.01.001; Torres-Morquecho A, 2010, AFR J MICROBIOL RES, V4, P480; Triantafilou M, 2013, PLOS ONE, V8, DOI [10.1371/annotation/1dc00176-e096-4621-9494-2d848dac8262, 10.1371/journal.pone.0061199]; Uchide N, 2005, MED SCI MONITOR, V11, pRA7; Viscardi RM, 2010, CLIN PERINATOL, V37, P393, DOI 10.1016/j.clp.2009.12.003; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waites KB, 2005, CLIN MICROBIOL REV, V18, P757, DOI 10.1128/CMR.18.4.757-789.2005; Wira CR, 2015, NAT REV IMMUNOL, V15, P217, DOI 10.1038/nri3819	69	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168102	10.1371/journal.pone.0168102	http://dx.doi.org/10.1371/journal.pone.0168102			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977732	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400061
J	Huang, XN; Chang, JJ; Feng, WW; Xu, YQ; Xu, T; Tang, H; Wang, HS; Pan, XP				Huang, Xiaona; Chang, Jenjen; Feng, Weiwei; Xu, Yiqun; Xu, Tao; Tang, He; Wang, Huishan; Pan, Xiaoping			Development of a New Growth Standard for Breastfed Chinese Infants: What Is the Difference from the WHO Growth Standards?	PLOS ONE			English	Article							BIRTH; CHILDREN; WEIGHT; HEIGHT	The objectives of this longitudinal study were to examine the trajectory of breastfed infants' growth in China to update growth standards for early childhood, and to compare these updated Chinese growth standards with the growth standards recommended by the World Health Organization (WHO) in 2006. This longitudinal cohort study enrolled 1,840 healthy breastfed infants living in an "optimal" environment favorable to growth and followed up until one year of age from 2007 to 2010. The study subjects were recruited from 60 communities in twelve cities in China. A participating infant's birth weight was measured within the first hour of the infant's life, and birth length and head circumference within 24 hours after birth. Repeated weekly and monthly anthropometric measurements were also taken. Multilevel (ML) modelling via MLwiN2.25 was fitted to estimate the growth curves of weight-for-age (WFA), length-for-age (LFA), and head circumference-for-age (HFA) for the study sample as a whole and by child sex, controlling for mode of delivery, the gravidity and parity of the mother, infant's physical measurements at birth, infant's daily food intaking frequency per day, infant's medical conditions, the season when the infant's physical measurement was taken, parents' ages, heights, and attained education, and family structure and income per month. During the first four weeks after birth, breastfed infants showed an increase in weight, length, and head circumference of 1110g, 4.9 cm, and 3.2 cm, respectively, among boys, and 980 g, 4.4 cm, and 2.8 cm, respectively, among girls. Throughout infancy, the total growth for these three was 6930 g, 26.4 cm, and 12.5 cm, respectively, among boys, and 6480 g, 25.5 cm, and 11.7 cm, respectively, among girls. As expected, there was a significant sex difference in growth during the first year. In comparison with the WHO growth standards, breastfed children in our study were heavier in weight, longer in length, and bigger in head circumference, with the exception of a few age points during the first two to four months on the upper two percentile curves. Our data suggested the growth curves for breastfed infants in China were significantly different in comparison with those based on the WHO standards. The adoption of the WHO infant growth standards among Chinese infants, as well as the methods used in the development of such growth standards in China, need careful and coordinated consideration.	[Huang, Xiaona; Feng, Weiwei; Xu, Yiqun; Xu, Tao; Tang, He; Wang, Huishan] Chinese Dis Prevent Control Ctr, Dept Children Hlth, Natl Ctr Women & Children Hlth, Beijing, Peoples R China; [Chang, Jenjen] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Epidemiol, St Louis, MO 63103 USA; [Pan, Xiaoping] Chinese Dis Prevent Control Ctr, Natl Ctr Women & Children Hlth, Dept Epidemiol, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for Women & Children's Health, Chinese Center for Disease Control & Prevention; Saint Louis University; Chinese Center for Disease Control & Prevention; National Center for Women & Children's Health, Chinese Center for Disease Control & Prevention	Wang, HS (corresponding author), Chinese Dis Prevent Control Ctr, Dept Children Hlth, Natl Ctr Women & Children Hlth, Beijing, Peoples R China.	wanghuishan@chinawch.org.cn			Ministry of Science and Technology of the People's Republic of China; Ministry of Health of the People's Republic of China	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Ministry of Health of the People's Republic of China	This study was funded by the Ministry of Science and Technology of the People's Republic of China for funding, and also supported by the the Ministry of Health of the Peoples Republic of China. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argnani L, 2008, COLLEGIUM ANTROPOL, V32, P807; Chen Chun-ming, 2006, Wei Sheng Yan Jiu, V35, P762; Coordinating Study Group of Nine Cities on Physical Growth and Development of Children, 2007, Zhonghua Er Ke Za Zhi, V45, P609; de Onis M, 2003, ACTA PAEDIATR, V92, P413, DOI 10.1111/j.1651-2227.2003.tb00570.x; de Onis M, 2006, ACTA PAEDIATR, V95, P16, DOI 10.1080/08035320500495423; Onis M, 2006, ACTA PAEDIATR, V95, P7, DOI 10.1080/08035320500495407; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; de Onis M, 2012, PUBLIC HEALTH NUTR, V15, P1603, DOI 10.1017/S136898001200105X; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Del-Rio-Navarro BE, 2007, EUR J CLIN NUTR, V61, P963, DOI 10.1038/sj.ejcn.1602612; Dewey KG, 2006, ACTA PAEDIATR, V95, P27, DOI 10.1080/08035320500495456; Ding ZY, 1996, CHIN J PEDIAT, V34, P93; Elmali F, 2012, PEDIATR NEUROL, V46, P307, DOI 10.1016/j.pediatrneurol.2012.02.016; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Garza Cutberto, 2004, Food Nutr Bull, V25, pS5; GOLDSTEIN H, 1986, ANN HUM BIOL, V13, P129, DOI 10.1080/03014468600008271; Hui LL, 2008, ARCH DIS CHILD, V93, P561, DOI 10.1136/adc.2007.119826; Iowne B, 2006, HUMAN GROWTH DEV, P103; Juliusson PB, 2011, ARCH DIS CHILD, V96, P916, DOI 10.1136/adc.2009.166157; Malkoc I, 2012, J CLIN RES PEDIATR E, V4, P14, DOI 10.4274/jcrpe.559; Marwaha RK, 2011, NATL MED J INDIA, V24, P269; Natale V, 2014, BMJ OPEN, V8, P4, DOI DOI 10.1136/BMJ0PEN-2013-003735; Roelants M, 2009, ANN HUM BIOL, V36, P680, DOI 10.3109/03014460903049074; Roelants M, 2010, ANN HUM BIOL, V37, P2, DOI 10.3109/03014460903458080; Rosario AS, 2011, ANN HUM BIOL, V38, P121, DOI 10.3109/03014460.2010.521193; Saari A, 2011, ANN MED, V43, P235, DOI 10.3109/07853890.2010.515603; The Division of Maternal and Child Health and Community Health Under Ministry of Health twgonccpds Capital Institute of Pediatrics, 2008, NAT GROWTH SURV CHIL; Victora CG, 1998, J NUTR, V128, P1134, DOI 10.1093/jn/128.7.1134; Victora CG, 2000, ACTA PAEDIATR, V89, P215, DOI 10.1080/080352500750028861; WHO, 2006, CHILD GROWTH STAND L; WHO Multicentre Growth Reference Study Group, 2007, WHO CHILD GROWTH STA; Wikland KA, 2002, ACTA PAEDIATR, V91, P739, DOI 10.1080/08035250213216; World Health Organization, 1997, WORLD HLTH REP 1996, P1; Wright C, 2008, ARCH DIS CHILD, V93, P566, DOI 10.1136/adc.2007.126854; Zong XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059569	35	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167816	10.1371/journal.pone.0167816	http://dx.doi.org/10.1371/journal.pone.0167816			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977706	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400035
J	Mejecase, C; Laurent-Coriat, C; Mayer, C; Poch, O; Mohand-Said, S; Prevot, C; Antonio, A; Boyard, F; Condroyer, C; Michiels, C; Blanchard, S; Letexier, M; Saraiva, JP; Sahel, JA; Audo, I; Zeitz, C				Mejecase, Cecile; Laurent-Coriat, Caroline; Mayer, Claudine; Poch, Olivier; Mohand-Said, Saddek; Prevot, Camille; Antonio, Aline; Boyard, Fiona; Condroyer, Christel; Michiels, Christelle; Blanchard, Steven; Letexier, Melanie; Saraiva, Jean-Paul; Sahel, Jose-Alain; Audo, Isabelle; Zeitz, Christina			Identification of a Novel Homozygous Nonsense Mutation Confirms the Implication of GNAT1 in Rod-Cone Dystrophy	PLOS ONE			English	Article							MESSENGER-RNA DECAY; ALPHA-SUBUNIT; TRANSDUCIN; RHODOPSIN; SITE; PHOTOTRANSDUCTION; MUTANT; STATE	GNAT1, encoding the transducin subunit G alpha, is an important element of the phototransduction cascade. Mutations in this gene have been associated with autosomal dominant and autosomal recessive congenital stationary night blindness. Recently, a homozygous truncating GNAT1 mutation was identified in a patient with late-onset rod-cone dystrophy. After exclusion of mutations in genes underlying progressive inherited retinal disorders, by targeted next generation sequencing, a 32 year-old male sporadic case with severe rod-cone dystrophy and his unaffected parents were investigated by whole exome sequencing. This led to the identification of a homozygous nonsense variant, c.963C>A p.(Cys321*) in GNAT1, which was confirmed by Sanger sequencing. The mother was heterozygous for this variant whereas the variant was absent in the father. c.963C>A p.(Cys321*) is predicted to produce a shorter protein that lacks critical sites for the phototransduction cascade. Our work confirms that the phenotype and the mode of inheritance associated with GNAT1 variants can vary from autosomal dominant, autosomal recessive congenital stationary night blindness to autosomal recessive rod-cone dystrophy.	[Mejecase, Cecile; Mohand-Said, Saddek; Antonio, Aline; Boyard, Fiona; Condroyer, Christel; Michiels, Christelle; Sahel, Jose-Alain; Audo, Isabelle; Zeitz, Christina] UPMC Univ Paris 06, Sorbonne Univ, INSERM, CNRS,Inst Vis, Paris, France; [Laurent-Coriat, Caroline; Mohand-Said, Saddek; Prevot, Camille; Antonio, Aline; Sahel, Jose-Alain; Audo, Isabelle] CHNO Quinze Vingts, DHU Sight Restore, INSERM, DHOS CIC1423, Paris, France; [Mayer, Claudine] Inst Pasteur, Paris, France; [Mayer, Claudine] CNRS, UMR 3528, Paris, France; [Mayer, Claudine] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Poch, Olivier] Univ Strasbourg, CNRS, Fac Med, Icube,UMR 7357,LBGI, Strasbourg, France; [Prevot, Camille; Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Blanchard, Steven; Letexier, Melanie; Saraiva, Jean-Paul] IntegraGen SA, Genopole, Paris, France; [Sahel, Jose-Alain; Audo, Isabelle] UCL, Inst Ophthalmol, London, England; [Sahel, Jose-Alain] Inst France, Acad Sci, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Fondation Adolphe de Rothschild; University of London; University College London	Audo, I; Zeitz, C (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, INSERM, CNRS,Inst Vis, Paris, France.; Audo, I (corresponding author), CHNO Quinze Vingts, DHU Sight Restore, INSERM, DHOS CIC1423, Paris, France.; Audo, I (corresponding author), UCL, Inst Ophthalmol, London, England.	Isabelle.audo@inserm.fr; Christina.zeitz@inserm.fr	Zeitz, Christina/F-2757-2017; Sahel, Jose-Alain/F-3172-2017; Méjécase, Cécile/AAG-2678-2021	Zeitz, Christina/0000-0002-3510-1712; Sahel, Jose-Alain/0000-0002-4831-1153; Méjécase, Cécile/0000-0003-2532-4004; Audo, Isabelle/0000-0003-0698-5309	Fondation Voir et Entendre; Prix Dalloz for "La recherche en ophtalmologie"; LABEX LIFESENSES by French state funds [ANR-10-LABX-65, ANR-11-IDEX-0004-0]; Foundation Fighting Blindness center grant [C-CMM-0907-0428-INSERM04]; Prix de la Fondation de l'OEil(IA); Ministere de l'Enseignement Superieur et de la Recherche (MESR); IntegraGen SA (Genopole, Campus, Evry, Paris, France)	Fondation Voir et Entendre; Prix Dalloz for "La recherche en ophtalmologie"; LABEX LIFESENSES by French state funds; Foundation Fighting Blindness center grant; Prix de la Fondation de l'OEil(IA); Ministere de l'Enseignement Superieur et de la Recherche (MESR)(Ministry of Research, France); IntegraGen SA (Genopole, Campus, Evry, Paris, France)	The study was supported by Fondation Voir et Entendre (http://www.fondave.org/) (CZ), Prix Dalloz for "La recherche en ophtalmologie" (CZ), LABEX LIFESENSES [reference ANR-10-LABX-65] supported by French state funds managed by the Agence Nationale de la Recherche within the Investissements d'Avenir program [ANR-11-IDEX-0004-0] (http://www.agencenationale-recherche.fr/investissements-d-avenir/), Foundation Fighting Blindness center grant [C-CMM-0907-0428-INSERM04](http://www.blindness.org/), Prix de la Fondation de l'OEil(IA), and doctoral funding from the Ministere de l'Enseignement Superieur et de la Recherche (MESR) (http://www.enseignementsup-recherche.gouv.fr/) (CM). IntegraGen SA (Genopole, Campus, Evry, Paris, France) provided support in the form of salaries for authors SB, ML and JPS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdulaev NG, 2006, BIOCHEMISTRY-US, V45, P12986, DOI 10.1021/bi061088h; ARTEMYEV NO, 1993, J BIOL CHEM, V268, P23611; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Audo I, 2011, HUM MUTAT, V32, pE2091, DOI 10.1002/humu.21460; Audo I, 2010, ARCH OPHTHALMOL-CHIC, V128, P1036, DOI 10.1001/archophthalmol.2010.162; BORNANCIN F, 1989, EUR J BIOCHEM, V184, P687, DOI 10.1111/j.1432-1033.1989.tb15068.x; Boulanger-Scemama E, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0300-3; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Carrigan M, 2016, BRIT J OPHTHALMOL, V100, P495, DOI 10.1136/bjophthalmol-2015-306939; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; El Shamieh S, 2014, AM J HUM GENET, V94, P625, DOI 10.1016/j.ajhg.2014.03.005; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kerov V, 2005, J BIOL CHEM, V280, P41069, DOI 10.1074/jbc.M508849200; Kurosaki T, 2016, J CELL SCI, V129, P461, DOI 10.1242/jcs.181008; Lykke-Andersen S, 2015, NAT REV MOL CELL BIO, V16, P665, DOI 10.1038/nrm4063; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; Moussaif M, 2006, J NEUROSCI, V26, P6863, DOI 10.1523/JNEUROSCI.1322-06.2006; Muradov KG, 2000, J BIOL CHEM, V275, P6969, DOI 10.1074/jbc.275.10.6969; Naeem MA, 2012, INVEST OPHTH VIS SCI, V53, P1353, DOI 10.1167/iovs.11-8026; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; Osawa S, 1995, J BIOL CHEM, V270, P31052, DOI 10.1074/jbc.270.52.31052; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Szabo V, 2007, HUM MUTAT, V28, P741, DOI 10.1002/humu.9499; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yao XQ, 2013, BIOPHYS J, V105, pL8, DOI [10.1016/j.bpj.2013.06.006, 10.1016/j.bpj.2013.06.00]; Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418; Zeitz C, 2015, PROG RETIN EYE RES, V45, P58, DOI 10.1016/j.preteyeres.2014.09.001; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	35	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168271	10.1371/journal.pone.0168271	http://dx.doi.org/10.1371/journal.pone.0168271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977773	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400085
J	Schmajuk, G; Tonner, C; Miao, YH; Yazdany, J; Gannon, J; Boscardin, WJ; Daikh, DI; Steinman, MA				Schmajuk, Gabriela; Tonner, Chris; Miao, Yinghui; Yazdany, Jinoos; Gannon, Jacqueline; Boscardin, W. John; Daikh, David I.; Steinman, Michael A.			Folic Acid Supplementation Is Suboptimal in a National Cohort of Older Veterans Receiving Low Dose Oral Methotrexate	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; MONOTHERAPY; ADHERENCE	Objectives Co-prescription of folic acid in patients receiving low dose oral methotrexate is recommended because it reduces adverse events and prolongs the use of methotrexate (MTX). However, little is known about how often new users of methotrexate are co-prescribed folic acid, and what factors are associated with its use. We aimed to determine the prevalence, predictors of, and persistence of folic acid use in a population-based cohort of MTX users with rheumatic diseases. Methods Using a national, administrative database of patients seen through the Veterans Health Administration (VHA) that included pharmacy and laboratory data, we performed an observational cohort study of veterans over 65 years old who were new users of MTX. We used log-binomial regression to identify independent predictors of folic acid use and Kaplan Meyer survival analysis to examine persistence of folic acid over time. Results We studied 2467 incident users of MTX. 27% of patients were not prescribed folic acid through the VHA pharmacy within 30 days of MTX initiation. Patients who did not see a rheumatologist were 23% less likely to receive folic acid compared to patients who did have a rheumatologist visit during the baseline period (RR (95% CI) 0.77 (0.72, 0.82). These results remained unchanged even after adjusting for demographic, clinical, and other factors (adjusted RR (95% CI) 0.78 (0.74, 0.85)). After 20 months, only 50% of patients continued to receive folic acid. Conclusions In a nationwide VHA cohort of new users of oral MTX, many patients did not receive folic acid or discontinued it over time. Rheumatologists were more likely to prescribe folic acid than other providers. These data highlight the need to improve patient safety for users of methotrexate by standardizing workflows for folic acid supplementation.	[Schmajuk, Gabriela; Tonner, Chris; Yazdany, Jinoos; Boscardin, W. John; Daikh, David I.; Steinman, Michael A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Schmajuk, Gabriela; Miao, Yinghui; Daikh, David I.; Steinman, Michael A.] Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA; [Gannon, Jacqueline] Yale Univ, Sch Publ Hlth, New Haven, CT USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Yale University	Schmajuk, G (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Schmajuk, G (corresponding author), Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA.	Gabriela.schmajuk@ucsf.edu		Gannon, Jacqueline/0000-0003-0318-3503	National Institutes of Health [K23AR063770, K24AG049057]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS024412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR063770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K24AG049057, P30AG044281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health K23AR063770 (GS) and K24AG049057 (MAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dabagh A, 2013, AM J CLIN DERMATOL, V14, P155, DOI 10.1007/s40257-013-0017-9; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; Asgari MM, 2013, PHARMACOEPIDEM DR S, V22, P842, DOI 10.1002/pds.3447; Barton JL, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4340; Borzecki AM, 2004, AM J MED QUAL, V19, P201, DOI 10.1177/106286060401900504; Cannon GW, 2011, ARTHRIT CARE RES, V63, P1680, DOI 10.1002/acr.20629; Cox E, 2009, VALUE HEALTH, V12, P1053, DOI 10.1111/j.1524-4733.2009.00601.x; Crowson CS, 2011, ARTHRITIS RHEUM-US, V63, P633, DOI 10.1002/art.30155; Curtis JR, 2010, ANN RHEUM DIS, V69, P43, DOI 10.1136/ard.2008.101378; Davis SA, 2013, J DRUGS DERMATOL, V12, P546; Desai SP, 2011, ARTHRITIS RHEUM-US, V63, P3649, DOI 10.1002/art.30605; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Hoadley JF, 2012, HEALTH AFFAIR, V31, P2266, DOI 10.1377/hlthaff.2012.0019; Johnson ES., 2012, AHRQ PUBLICATION; Kohler MJ, 2013, J GEN INTERN MED, V28, P825, DOI 10.1007/s11606-013-2360-1; Mendes FD, 2007, AM J GASTROENTEROL, V102, P344, DOI 10.1111/j.1572-0241.2006.00947.x; Nikiphorou E, 2014, CLIN RHEUMATOL, V33, P609, DOI 10.1007/s10067-014-2546-x; QUAM L, 1993, MED CARE, V31, P498, DOI 10.1097/00005650-199306000-00003; Salliot C, 2009, ANN RHEUM DIS, V68, P1100, DOI 10.1136/ard.2008.093690; Schmajuk G, 2007, ARTHRIT RHEUM-ARTHR, V57, P928, DOI 10.1002/art.22890; Schmajuk G, 2014, ARTHRIT CARE RES, V66, P1159, DOI 10.1002/acr.22294; Shea B, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000951.pub2; Singh JA, 2013, COCHRANE DB SYST REV, V7; Singh JA, 2012, ARTHRIT CARE RES, V64, P625, DOI 10.1002/acr.21641; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Sokka T, 2010, CLIN EXP RHEUMATOL, V28, pS13; Steinman MA, 2012, J AM GERIATR SOC, V60, P1872, DOI 10.1111/j.1532-5415.2012.04158.x; Yazdany J, 2014, ARTHRIT CARE RES, V66, P1447, DOI 10.1002/acr.22312; YOLA M, 1994, J CLIN EPIDEMIOL, V47, P731, DOI 10.1016/0895-4356(94)90170-8	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168369	10.1371/journal.pone.0168369	http://dx.doi.org/10.1371/journal.pone.0168369			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977768	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400102
J	Vyas, S; Srivastav, N; Spears, D				Vyas, Sangita; Srivastav, Nikhil; Spears, Dean			An Experiment with Air Purifiers in Delhi during Winter 2015-2016	PLOS ONE			English	Article							SIZE DISTRIBUTIONS; PARTICLE COUNTER; AEROSOL NUMBER; FILTERS; FINE; HEALTH; MASS; POLLUTION; PM2.5; REDUCTION	Particulate pollution has important consequences for human health, and is an issue of global concern. Outdoor air pollution has become a cause for alarm in India in particular because recent data suggest that ambient pollution levels in Indian cities are some of the highest in the world. We study the number of particles between 0.5 mu m and 2.5 mu m indoors while using affordable air purifiers in the highly polluted city of Delhi. Though substantial reductions in indoor number concentrations are observed during air purifier use, indoor air quality while using an air purifier is frequently worse than in cities with moderate pollution, and often worse than levels observed even in polluted cities. When outdoor pollution levels are higher, on average, indoor pollution levels while using an air purifier are also higher. Moreover, the ratio of indoor air quality during air purifier use to two comparison measures of air quality without an air purifier are also positively correlated with outdoor pollution levels, suggesting that as ambient air quality worsens there are diminishing returns to improvements in indoor air quality during air purifier use. The findings of this study indicate that although the most affordable air purifiers currently available are associated with significant improvements in the indoor environment, they are not a replacement for public action in regions like Delhi. Although private solutions may serve as a stopgap, reducing ambient air pollution must be a public health and policy priority in any region where air pollution is as high as Delhi's during the winter.	[Vyas, Sangita; Srivastav, Nikhil; Spears, Dean] Rice, New Delhi, India; [Spears, Dean] Indian Stat Inst, Econ & Planning Unit, New Delhi, India; [Spears, Dean] Univ Texas Austin, Dept Econ, Austin, TX 78712 USA	Indian Statistical Institute; Indian Statistical Institute Delhi; University of Texas System; University of Texas Austin	Vyas, S (corresponding author), Rice, New Delhi, India.	sangita@riceinstitute.org			Bill and Melinda Gates Foundation [OPP1125318]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Partial support for the authors' work was provided by a grant from the Bill and Melinda Gates Foundation (OPP1125318). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings, interpretations, and conclusions expressed in this paper are entirely those of the authors.	Allen RW, 2011, AM J RESP CRIT CARE, V183, P1222, DOI 10.1164/rccm.201010-1572OC; Batterman S, 2005, ENVIRON SCI TECHNOL, V39, P7260, DOI 10.1021/es048951q; Batterman S, 2012, INDOOR AIR, V22, P235, DOI 10.1111/j.1600-0668.2011.00761.x; Binnig J, 2007, J AEROSOL SCI, V38, P325, DOI 10.1016/j.jaerosci.2006.12.001; Brauner EV, 2008, AM J RESP CRIT CARE, V177, P419, DOI 10.1164/rccm.200704-632OC; Chay KY, 1999, W7442 NAT BUR EC RES; Committee on the Medical Effects of Air Pollutants, 2006, CARD DIS AIR POLL; DOCKERY DW, 1989, AM REV RESPIR DIS, V139, P587, DOI 10.1164/ajrccm/139.3.587; Du L, 2011, BUILD ENVIRON, V46, P2303, DOI 10.1016/j.buildenv.2011.05.012; Fisk WJ, 2013, INDOOR AIR, V23, P357, DOI 10.1111/ina.12036; Francis H, 2003, CLIN EXP ALLERGY, V33, P101, DOI 10.1046/j.1365-2222.2003.01570.x; Gao J, 2009, ATMOS ENVIRON, V43, P829, DOI 10.1016/j.atmosenv.2008.10.046; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Greenstone M, 2015, EC POLIT WKLY, V50, P41; Jovasevic-Stojanovic M, 2015, ENVIRON POLLUT, V206, P696, DOI 10.1016/j.envpol.2015.08.035; Krishnan V., 2015, HINDU; Laden F, 2006, AM J RESP CRIT CARE, V173, P667, DOI 10.1164/rccm.200503-443OC; Macintosh DL, 2008, J AIR WASTE MANAGE, V58, P1474, DOI 10.3155/1047-3289.58.11.1474; Monkkonen P, 2004, ATMOS ENVIRON, V38, P425, DOI 10.1016/j.atmosenv.2003.09.071; National Sample Survey Organization, 2013, NSS 68 ROUND; Nazaroff WW., 2000, EFFECTIVENESS AIR CL, P49; Northcross AL, 2013, ENVIRON SCI-PROC IMP, V15, P433, DOI 10.1039/c2em30568b; Pedroletti C, 2009, RESP MED, V103, P1313, DOI 10.1016/j.rmed.2009.03.020; Pitz M, 2001, ATMOS ENVIRON, V35, P4357, DOI 10.1016/S1352-2310(01)00229-1; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Pope CA, 2002, JAMA-J AM MED ASSOC, V287, P1132, DOI 10.1001/jama.287.9.1132; Ruuskanen J, 2001, ATMOS ENVIRON, V35, P3729, DOI 10.1016/S1352-2310(00)00373-3; Sarangi B, 2016, ATMOS MEAS TECH, V9, P859, DOI 10.5194/amt-9-859-2016; SHARMA VK, 1992, ATMOS ENVIRON B-URB, V26, P135, DOI 10.1016/0957-1272(92)90046-U; Shaughnessy RJ, 2006, J OCCUP ENVIRON HYG, V3, P169, DOI 10.1080/15459620600580129; Stanier CO, 2004, ATMOS ENVIRON, V38, P3275, DOI 10.1016/j.atmosenv.2004.03.020; Steinle S, 2015, SCI TOTAL ENVIRON, V508, P383, DOI 10.1016/j.scitotenv.2014.12.003; Sublett JL, 2011, CURR ALLERGY ASTHM R, V11, P395, DOI 10.1007/s11882-011-0208-5; Sulser C, 2009, INT ARCH ALLERGY IMM, V148, P23, DOI 10.1159/000151502; Tittarelli A, 2008, ATMOS ENVIRON, V42, P8543, DOI 10.1016/j.atmosenv.2008.07.056; US Embassy, 2016, AMB AIR QUAL DAT DAT; US Embassy, 2015, AMB AIR QUAL DAT DAT; vanderHeide S, 1997, EUR RESPIR J, V10, P1217, DOI 10.1183/09031936.97.10061217; Weichenthal S, 2013, INDOOR AIR, V23, P175, DOI 10.1111/ina.12019; WHO, 2014, AMB AIR POLL DAT; Wichmann H E, 2000, Res Rep Health Eff Inst, P5; Wittmaack K, 2002, J AEROSOL SCI, V33, P1009, DOI 10.1016/S0021-8502(02)00052-6	42	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167999	10.1371/journal.pone.0167999	http://dx.doi.org/10.1371/journal.pone.0167999			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978542	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400047
J	Chen, Y; Hora, B; DeMarco, T; Shah, SA; Ahmed, M; Sanchez, AM; Su, C; Carter, M; Stone, M; Hasan, R; Hasan, Z; Busch, MP; Denny, TN; Gao, F				Chen, Yue; Hora, Bhavna; DeMarco, Todd; Shah, Sharaf Ali; Ahmed, Manzoor; Sanchez, Ana M.; Su, Chang; Carter, Meredith; Stone, Mars; Hasan, Rumina; Hasan, Zahra; Busch, Michael P.; Denny, Thomas N.; Gao, Feng			Fast Dissemination of New HIV-1 CRF02/A1 Recombinants in Pakistan	PLOS ONE			English	Article							INJECTION-DRUG USERS; INFECTION; DYNAMICS; GENOMES	A number of HIV-1 subtypes are identified in Pakistan by characterization of partial viral gene sequences. Little is known whether new recombinants are generated and how they disseminate since whole genome sequences for these viruses have not been characterized. Near full-length genome (NFLG) sequences were obtained by amplifying two overlapping half genomes or next generation sequencing from 34 HIV-1-infected individuals in Pakistan. Phylogenetic tree analysis showed that the newly characterized sequences were 16 subtype As, one subtype C, and 17 A/G recombinants. Further analysis showed that all 16 subtype A1 sequences (47%), together with the vast majority of sequences from Pakistan from other studies, formed a tight subcluster (A1a) within the subtype A1 clade, suggesting that they were derived from a single introduction. More in-depth analysis of 17 A/G NFLG sequences showed that five shared similar recombination breakpoints as in CRF02 (15%) but were phylogenetically distinct from the prototype CRF02 by forming a tight subcluster (CRF02a) while 12 (38%) were new recombinants between CRF02a and A1a or a divergent A1b viruses. Unique recombination patterns among the majority of the newly characterized recombinants indicated ongoing recombination. Interestingly, recombination breakpoints in these CRF02/A1 recombinants were similar to those in prototype CRF02 viruses, indicating that recombination at these sites more likely generate variable recombinant viruses. The dominance and fast dissemination of new CRF02a/A1 recombinants over prototype CRF02 suggest that these recombinant have more adapted and may become major epidemic strains in Pakistan.	[Chen, Yue; Hora, Bhavna; DeMarco, Todd; Sanchez, Ana M.; Su, Chang; Carter, Meredith; Denny, Thomas N.; Gao, Feng] Duke Univ, Med Ctr, Dept Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Shah, Sharaf Ali; Ahmed, Manzoor] Bridge Consultants Fdn, Karachi, Pakistan; [Stone, Mars; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA; [Hasan, Rumina; Hasan, Zahra] Aga Khan Univ, Dept Pathol, Karachi, Pakistan; [Hasan, Rumina; Hasan, Zahra] Aga Khan Univ, Dept Microbiol, Karachi, Pakistan	Duke University; Vitalant; Vitalant Research Institute; Aga Khan University; Aga Khan University	Gao, F (corresponding author), Duke Univ, Med Ctr, Dept Med, Duke Human Vaccine Inst, Durham, NC 27710 USA.	fgao@duke.edu		Hasan, Zahra/0000-0001-7580-372X	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for External Quality Assurance Program Oversight Laboratory (EQAPOL) [HHSN272201000045C, HHSN272200800014C]	National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for External Quality Assurance Program Oversight Laboratory (EQAPOL)	This study was supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) for External Quality Assurance Program Oversight Laboratory (EQAPOL) (HHSN272201000045C and HHSN272200800014C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093415; Andrew Rambaut TTL, 2016, VIRUS EVOLUTION, V2, P1; [Anonymous], 2017, 2013 UNAIDS REP GLOB; Ansari AS, 2011, AIDS, V25, P1427, DOI 10.1097/QAD.0b013e32834800e7; Baqi S, 1999, INT J STD AIDS, V10, P300, DOI 10.1258/0956462991914159; Chen J, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026827, 10.1371/journal.pone.0025286]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Khanani MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022449; KHANANI RM, 1988, AIDS RES HUM RETROV, V4, P149, DOI 10.1089/aid.1988.4.149; Kijak GH, 2010, AIDS RES HUM RETROV, V26, P1317, DOI 10.1089/aid.2010.0127; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Konings FAJ, 2006, J MED VIROL, V78, P523, DOI 10.1002/jmv.20572; Liao HA, 2009, VIROLOGY, V391, P51, DOI 10.1016/j.virol.2009.05.023; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; National AIDS Control Program MoNHS, 2015, PAK GLOB AIDS RESP P; OU CY, 1993, LANCET, V341, P1171, DOI 10.1016/0140-6736(93)91001-3; Rai MA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-7; Rajabali A, 2008, LANCET INFECT DIS, V8, P511, DOI 10.1016/S1473-3099(08)70183-X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez AM, 2014, J IMMUNOL METHODS; Sanchez AM, 2014, J IMMUNOL METHODS, V409, P117, DOI 10.1016/j.jim.2014.01.004; Sanchez ana M., 2016, PLOS ONE; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Shah SA, 2004, INT J STD AIDS, V15, P209, DOI 10.1258/095646204322916713; Siddiqui AUR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000154; Simonyan V, 2014, GENES-BASEL, V5, P957, DOI 10.3390/genes5040957; Tee KK, 2008, J VIROL, V82, P9206, DOI 10.1128/JVI.00399-08; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; Yousaf MZ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-401	32	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167839	10.1371/journal.pone.0167839	http://dx.doi.org/10.1371/journal.pone.0167839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973597	gold, Green Published, Green Submitted			2022-12-27	WOS:000392754300045
J	Davis, SE; Maftei, M; Mallory, ML				Davis, Shanti E.; Maftei, Mark; Mallory, Mark L.			Migratory Connectivity at High Latitudes: Sabine's Gulls (Xema sabini) from a Colony in the Canadian High Arctic Migrate to Different Oceans	PLOS ONE			English	Article							RHODOSTETHIA-ROSEA; RADAR OBSERVATIONS; PAGOPHILA-EBURNEA; BIRD MIGRATION; EVOLUTION; TRACKING; ROUTES; GEOLOCATION; POPULATION; PHILOPATRY	The world's Arctic latitudes are some of the most recently colonized by birds, and an understanding of the migratory connectivity of circumpolar species offers insights into the mechanisms of range expansion and speciation. Migratory divides exist for many birds, however for many taxa it is unclear where such boundaries lie, and to what extent these affect the connectivity of species breeding across their ranges. Sabine's gulls (Xema sabini) have a patchy, circumpolar breeding distribution and overwinter in two ecologically similar areas in different ocean basins: the Humboldt Current off the coast of Peru in the Pacific, and the Benguela Current off the coasts of South Africa and Namibia in the Atlantic. We used geolocators to track Sabine's gulls breeding at a colony in the Canadian High Arctic to determine their migratory pathways and wintering sites. Our study provides evidence that birds from this breeding site disperse to both the Pacific and Atlantic oceans during the non-breeding season, which suggests that a migratory divide for this species exists in the Nearctic. Remarkably, members of one mated pair wintered in opposite oceans. Our results ultimately suggest that colonization of favorable breeding habitat may be one of the strongest drivers of range expansion in the High Arctic.	[Davis, Shanti E.; Maftei, Mark; Mallory, Mark L.] High Arctic Gull Res Grp, Victoria, BC, Canada; [Davis, Shanti E.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Mallory, Mark L.] Acadia Univ, Dept Biol, Wolfville, NS, Canada	Memorial University Newfoundland; Acadia University	Davis, SE (corresponding author), High Arctic Gull Res Grp, Victoria, BC, Canada.; Davis, SE (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	shanti.davis@gmail.com			Canadian Wildlife Federation; Natural Sciences and Engineering Research Council of Canada; Northern Scientific Training Program; Acadia University; Memorial University of Newfoundland	Canadian Wildlife Federation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Northern Scientific Training Program; Acadia University; Memorial University of Newfoundland	Financial support was received from Canadian Wildlife Federation (MM http://www.cwf-fcf.org); Natural Sciences and Engineering Research Council of Canada (MLM, SD, and I. Jones, http://www.nserc-crsng.gc.ca/); Northern Scientific Training Program (SD, MM https://nstp-pfsn.fluidreview.com/); Acadia University (MLM http://www2.acadiau.ca/); and Memorial University of Newfoundland (SD www.mun.ca). Logistical support was provided by Natural Resources Canada (Polar Continental Shelf Project, MLM, http://www.nrcan.gc.ca/the-north/polar-continental-shelf-program/polar-shelf/10003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 1999, P ROY SOC B-BIOL SCI, V266, P2499, DOI 10.1098/rspb.1999.0952; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; Alerstam T, 1999, ARCTIC, V52, P346; Alerstam T, 2011, J ORNITHOL, V152, P5, DOI 10.1007/s10336-011-0694-1; Alvarado AH, 2014, ECOL EVOL, V4, P3456, DOI 10.1002/ece3.1205; Bairlein F, 2012, BIOL LETTERS, V8, P505, DOI 10.1098/rsbl.2011.1223; Beyer HL, 2012, SPATIAL ECOLOGY LCC; BLOMQVIST S, 1981, ARCTIC, V34, P122; Bub H, 1991, BIRD TRAPPING BIRD B; CHAPMAN SE, 1969, IBIS, V111, P615, DOI 10.1111/j.1474-919X.1969.tb02576.x; Cramp S., 1980, BIRDS W PALEARCTIC, V2; Day Robert H., 2001, Birds of North America, V593, P1; Delmore KE, 2012, P ROY SOC B-BIOL SCI, V279, P4582, DOI 10.1098/rspb.2012.1229; Edwards Darryl B., 2011, Wader Study Group Bulletin, V118, P134; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Fifield DA, 2014, ORNITHOL MONOGR, P1; Fijn RC, 2013, E ANTARCTICA ARDEA, V101, P1; Freitas C., 2012, ARGOSFILTER ARGOS LO, P1; Gilg O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064614; Gilg O, 2010, J AVIAN BIOL, V41, P532, DOI 10.1111/j.1600-048X.2010.05125.x; Gilg O, 2010, SCIENCE, V327, P276, DOI 10.1126/science.1184964; Gratto-Trevor C, 2012, WATERBIRDS, V35, P83, DOI 10.1675/063.035.0109; Gudmundsson GA, 2002, ARCTIC, V55, P21; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hedenstrom A, 1998, ARCTIC, V51, P283; Henningsson SS, 2008, J BIOGEOGR, V35, P781, DOI 10.1111/j.1365-2699.2007.01845.x; Henningsson SS, 2005, P ROY SOC B-BIOL SCI, V272, P2251, DOI 10.1098/rspb.2005.3221; Hobson KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129340; Irwin Darren E., 2005, P27; Kerr KCR, 2013, ECOL EVOL, V3, P1915, DOI 10.1002/ece3.597; Kopp M, 2011, MAR ECOL PROG SER, V435, P263, DOI 10.3354/meps09229; Kraaijeveld K, 2000, ARDEA, V88, P193; Lambert K., 1972, CAN FIELD NAT, V87, P57; Lotek Wireless, 2010, LAT 2900 SER NAN LIG, P1; Macdonald C. A., 2013, Animal Migration, V1, P23, DOI 10.2478/ami-2012-0003; Maftei M, 2015, POLAR RES, V34, DOI 10.3402/polar.v34.25055; Mallory ML, 2012, POLAR BIOL, V35, P335, DOI 10.1007/s00300-011-1079-x; Marra P. P., 2011, ENVIROMENTAL LAW, V41, P317; Mehl KR, 2004, CONDOR, V106, P241, DOI 10.1650/7356; Morrison RIG, 2006, ARDEA, V94, P607; Mosbech A, 2006, ARDEA, V94, P651; Muller MS, 2015, ANIM BEHAV, V102, P267, DOI 10.1016/j.anbehav.2015.02.005; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; R Core Team, 2021, R LANGUAGE ENV STAT; Ramirez I, 2013, MAR ECOL PROG SER, V476, P269, DOI 10.3354/meps10083; Rogacheva E.V., 1987, P9; Shaffer SA, 2005, MAR BIOL, V147, P833, DOI 10.1007/s00227-005-1631-8; Stenhouse IJ, 2012, IBIS, V154, P42, DOI 10.1111/j.1474-919X.2011.01180.x; Stenhouse IJ, 2005, CONDOR, V107, P416, DOI 10.1650/7627; Stenhouse IJ, 2001, CONDOR, V103, P98, DOI 10.1650/0010-5422(2001)103[0098:RBOSSG]2.0.CO;2; Warnock N, 2010, J AVIAN BIOL, V41, P621, DOI 10.1111/j.1600-048X.2010.05155.x; Webster Michael S., 2005, P199; Yannic G, 2016, POLAR BIOL, V39, P221, DOI 10.1007/s00300-015-1775-z	56	16	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166043	10.1371/journal.pone.0166043	http://dx.doi.org/10.1371/journal.pone.0166043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973614	gold, Green Published, Green Submitted			2022-12-27	WOS:000392754300007
J	Goceroglu, A; Berden, AE; Fiocco, M; Flossmann, O; Westman, KW; Ferrario, F; Gaskin, G; Pusey, CD; Hagen, EC; Noel, LH; Rasmussen, N; Waldherr, R; Walsh, M; Bruijn, JA; Jayne, DRW; Bajema, IM				Goceroglu, Arda; Berden, Annelies E.; Fiocco, Marta; Flossmann, Oliver; Westman, Kerstin W.; Ferrario, Franco; Gaskin, Gill; Pusey, Charles D.; Hagen, E. Christiaan; Noel, Laure-Helene; Rasmussen, Niels; Waldherr, Ruediger; Walsh, Michael; Bruijn, Jan A.; Jayne, David R. W.; Bajema, Ingeborg M.		European Vasculitis Soc EUVAS	ANCA-Associated Glomerulonephritis: Risk Factors for Renal Relapse	PLOS ONE			English	Article							SMALL-VESSEL VASCULITIS; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; SYSTEMIC VASCULITIS; COMPETING RISKS; MICROSCOPIC POLYANGIITIS; WEGENERS-GRANULOMATOSIS; TREATMENT RESISTANCE; MULTISTATE MODELS; RANDOMIZED-TRIAL; PREDICTORS	Relapse in ANCA-associated vasculitis (AAV) has been studied previously, but there are few studies on renal relapse in particular. Identifying patients at high risk of renal relapse may aid in optimizing clinical management. We investigated which clinical and histological parameters are risk factors for renal relapse in ANCA-associated glomerulonephritis (AAGN). Patients (n = 174) were newly diagnosed and had mild-moderate or severe renal involvement. Data were derived from two trials of the European Vasculitis Society: MEPEX and CYCAZAREM. The Cox regression model was used to identify parameters increasing the instantaneous risk (= rate) of renal relapse (useful for instant clinical decisions). For identifying predictors of renal relapse during follow-up, we used Fine & Gray's regression model. Competing events were end-stage renal failure and death. The cumulative incidence of renal relapse at 5 years was 9.5% (95% CI: 4.8-14.3%). In the Cox model, sclerotic class AAGN increased the instantaneous risk of renal relapse. In Fine & Gray's model, the absence of interstitial infiltrates at diagnosis was predictive for renal relapse. In this study we used two different models to identify possible relationships between clinical and histopathological parameters at time of diagnosis of AAV with the risk of experiencing renal relapse. Sclerotic class AAGN increased the instantaneous risk of renal relapse. This association is most likely due to the high proportion of sclerosed glomeruli reducing the compensatory capacity. The absence of interstitial infiltrates increased the risk of renal relapse which is a warning sign that patients with a relatively benign onset of disease may also be prone to renal relapse. Renal relapses occurring in patients with sclerotic class AAGN and renal relapses occurring in patients without interstitial infiltrates were mutually exclusive, which may indicate that they are essentially different.	[Goceroglu, Arda; Berden, Annelies E.; Bruijn, Jan A.; Bajema, Ingeborg M.] Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands; [Fiocco, Marta] Leiden Univ, Med Ctr, Med Stat & Bioinformat, Leiden, Netherlands; [Fiocco, Marta] Leiden Univ, Inst Math, Leiden, Netherlands; [Flossmann, Oliver] Royal Berkshire Hosp, Renal Unit, Reading, Berks, England; [Westman, Kerstin W.] Malmo Univ Hosp, Dept Nephrol, Malmo, Sweden; [Ferrario, Franco] San Gerardo Hosp, Nephropathol Ctr, Monza, Italy; [Gaskin, Gill; Pusey, Charles D.] Hammersmith Hosp, Imperial Coll Healthcare NHS Trust, Dept Renal Med, London, England; [Hagen, E. Christiaan] Meander Med Ctr, Dept Nephrol, Amersfoort, Netherlands; [Noel, Laure-Helene] Univ Paris 05, Necker Hosp, Dept Pathol, Paris, France; [Rasmussen, Niels] Statens Seruminst, Dept Autoimmune Serol, Copenhagen, Denmark; [Waldherr, Ruediger] Heidelberg Univ, Dept Pathol, Heidelberg, Germany; [Walsh, Michael] McMaster Univ, St Josephs Hosp, Dept Med Nephrol, Hamilton, ON, Canada; [Walsh, Michael] McMaster Univ, St Josephs Hosp, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Jayne, David R. W.] Addenbrookes Hosp, Lupus & Vasculitis Clin, Cambridge, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Royal Berkshire Hospital; Lund University; Skane University Hospital; San Gerardo Hospital; Imperial College London; Meander Medisch Centrum; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Statens Serum Institut; Ruprecht Karls University Heidelberg; McGill University; McMaster University; McGill University; McMaster University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Goceroglu, A (corresponding author), Leiden Univ, Med Ctr, Dept Pathol, Leiden, Netherlands.	A.Goeceroglu@lumc.nl	Flossmann, Oliver/AAC-8719-2022; Dijkstra, Sander/F-2513-2017	Dijkstra, Sander/0000-0001-5368-757X; Westman, Kerstin/0000-0002-2930-998X; Jayne, David/0000-0002-1712-0637; Walsh, Michael/0000-0001-8292-2014; Stegeman, Coen/0000-0002-0224-0927	European Union [BMH1-CT93-1078, CIPD-CT94-0307, BMH4-CT97-2328, IC20-CT97-0019]; National Institute for Health Research [NF-SI-0611-10055] Funding Source: researchfish	European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The CYCAZAREM trial was supported by contracts (BMH1-CT93-1078, CIPD-CT94-0307, BMH4-CT97-2328, and IC20-CT97-0019) with the European Union; the MEPEX trial was designed and launched as part of the European Community Systemic Vasculitis Trial project (BMH1-CT93-1078 and CIPD-CT94-0307) and finished as part of the ANCA Associated Vasculitis European Randomized Trial project (BMH4-CT97-2328 and IC20-CT97-0019) funded by the European Union.	Andersen PK, 2012, INT J EPIDEMIOL, V41, P861, DOI 10.1093/ije/dyr213; Bajema IM, 1999, KIDNEY INT, V56, P1751, DOI 10.1046/j.1523-1755.1999.00758.x; Bajema IM, 1996, NEPHROL DIAL TRANSPL, V11, P1989, DOI 10.1093/oxfordjournals.ndt.a027086; Bajema IM, 1997, J LAB CLIN MED, V129, P17, DOI 10.1016/S0022-2143(97)90157-8; Berden AE, 2010, J AM SOC NEPHROL, V21, P1628, DOI 10.1681/ASN.2010050477; Booth AD, 2003, AM J KIDNEY DIS, V41, P776, DOI 10.1016/S0272-6386(03)00025-8; de Joode AAE, 2013, CLIN J AM SOC NEPHRO, V8, P1709, DOI 10.2215/CJN.01020113; de Wreede LC, 2011, J STAT SOFTW, V38, P1; de Wreede LC, 2010, COMPUT METH PROG BIO, V99, P261, DOI 10.1016/j.cmpb.2010.01.001; Falk RJ, 1997, J AM SOC NEPHROL, V8, P314; GORDON M, 1993, Q J MED, V86, P779; Hagen EC, 1998, KIDNEY INT, V53, P743, DOI 10.1046/j.1523-1755.1998.00807.x; Hauer HA, 2002, KIDNEY INT, V62, P1732, DOI 10.1046/j.1523-1755.2002.00605.x; Hogan SL, 2005, ANN INTERN MED, V143, P621, DOI 10.7326/0003-4819-143-9-200511010-00005; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; Jayne DRW, 2007, J AM SOC NEPHROL, V18, P2180, DOI 10.1681/ASN.2007010090; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Koldingsnes W, 2003, J RHEUMATOL, V30, P80; Koller MT, 2012, STAT MED, V31, P1089, DOI 10.1002/sim.4384; Kyndt X, 1999, AM J MED, V106, P527, DOI 10.1016/S0002-9343(99)00064-9; Lionaki S, 2012, ARTHRITIS RHEUM-US, V64, P3452, DOI 10.1002/art.34562; Little MA, 2010, ANN RHEUM DIS, V69, P1036, DOI 10.1136/ard.2009.109389; LUQMANI RA, 1994, Q J MED, V87, P671; Luqmani RA, 1997, BAILLIERE CLIN RHEUM, V11, P423, DOI 10.1016/S0950-3579(97)80052-0; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P1827, DOI 10.1136/ard.2008.101279; Nachman PH, 1996, J AM SOC NEPHROL, V7, P33; Pagnoux C, 2008, ARTHRITIS RHEUM-US, V58, P2908, DOI 10.1002/art.23800; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Slot MC, 2003, KIDNEY INT, V63, P670, DOI 10.1046/j.1523-1755.2003.00769.x; STEGEMAN CA, 1994, ANN INTERN MED, V120, P12, DOI 10.7326/0003-4819-120-1-199401010-00003; Wada T, 2012, J RHEUMATOL, V39, P545, DOI 10.3899/jrheum.110705; Walsh M, 2012, ARTHRITIS RHEUM-US, V64, P542, DOI 10.1002/art.33361; Westman KWA, 1998, J AM SOC NEPHROL, V9, P842	35	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0165402	10.1371/journal.pone.0165402	http://dx.doi.org/10.1371/journal.pone.0165402			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973575	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300003
J	von Byern, J; Dorrer, V; Merritt, DJ; Chandler, P; Stringer, I; Marchetti-Deschmann, M; McNaughton, A; Cyran, N; Thiel, K; Noeske, M; Grunwald, I				von Byern, Janek; Dorrer, Victoria; Merritt, David J.; Chandler, Peter; Stringer, Ian; Marchetti-Deschmann, Martina; McNaughton, Andrew; Cyran, Norbert; Thiel, Karsten; Noeske, Michael; Grunwald, Ingo			Characterization of the Fishing Lines in Titiwai (=Arachnocampa luminosa Skuse, 1890) from New Zealand and Australia	PLOS ONE			English	Article							ORB-WEAVING SPIDERS; VISCOUS CAPTURE THREADS; GLOW-WORM; CIRCADIAN BIOLUMINESCENCE; MALPIGHIAN TUBULES; GLYCOPROTEIN GLUE; INSECT SILK; EGG STALKS; DIPTERA; MYCETOPHILIDAE	Animals use adhesive secretions in a plethora of ways, either for attachment, egg anchorage, mating or as either active or passive defence. The most interesting function, however, is the use of adhesive threads to capture prey, as the bonding must be performed within milliseconds and under unsuitable conditions (movement of prey, variable environmental conditions, unfavourable attack angle, etc.) to be nonetheless successful. In the following study a detailed characterization of the prey capture system of the world-renowned glowworm group Arachnocampa from the macroscopic to the ultrastructural level is performed. The data reveal that the adhesive droplets consist mostly of water and display hygroscopic properties at varying humidity levels. The droplet core of Arachnocampa luminosa includes a certain amount of the elements sodium, sulphur and potassium (beside carbon, oxygen and nitrogen), while a different element composition is found in the two related species A. richardsae and A. tasmaniensis. Evidence for lipids, carbohydrates and proteins was negative on the histochemical level, however X-ray photoelectron spectroscopy confirm the presence of peptides within the droplet content. Different to earlier assumptions, the present study indicates that rather than oxalic acid, urea or uric acid are present in the adhesive droplets, presumably originating from the gut. Comparing the capture system in Arachnocampa with those of orb-spiders, large differences appear not only regarding the silky threads, but also, in the composition, hygroscopic properties and size of the mucous droplets.	[von Byern, Janek] Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria; [von Byern, Janek; Cyran, Norbert] Univ Vienna, Fac Life Sci, Core Facil Cell Imaging Ultrastruct Res, Vienna, Austria; [Dorrer, Victoria; Marchetti-Deschmann, Martina] Tech Univ Wien, Inst Chem Technol & Analyt, Vienna, Austria; [Merritt, David J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Chandler, Peter] Spellbound Cave, Waitomo, New Zealand; [Stringer, Ian] Dept Conservat, Wellington, New Zealand; [McNaughton, Andrew] Univ Otago, Otago Ctr Confocal Microscopy, Sch Med Sci, Dept Anat, Otago, New Zealand; [Thiel, Karsten; Noeske, Michael; Grunwald, Ingo] Fraunhofer Inst Mfg Technol & Adv Mat, Dept Adhes Bonding Technol & Surfaces, Bremen, Germany	Ludwig Boltzmann Institute; University of Vienna; Technische Universitat Wien; University of Queensland; University of Otago; Fraunhofer Gesellschaft	von Byern, J (corresponding author), Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.; von Byern, J (corresponding author), Univ Vienna, Fac Life Sci, Core Facil Cell Imaging Ultrastruct Res, Vienna, Austria.	vByern@freenet.de	Grunwald, Ingo/C-5662-2012; Noeske, Michael/AAB-9123-2020; Merritt, David J/D-2318-2010; Marchetti-Deschmann, Martina/AAO-9614-2020	Noeske, Michael/0000-0002-5417-6808; Merritt, David J/0000-0002-8573-7508; Marchetti-Deschmann, Martina/0000-0002-8060-7851; von Byern, Janek/0000-0001-7243-0438	Austrian Science Foundation FWF [AP 24531-B17]	Austrian Science Foundation FWF(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Foundation FWF (Project No. AP 24531-B17).	Baker C. H., 2003, Australian Entomologist, V30, P45; Baker CG., 2004, THESIS; Baker CH, 2002, WILDLIFE TOURISM RES, V21, P1; Baker CH, 2008, MEMOIRS QUEENSLAND M, V55, P11; Baker CH, 2008, MOL PHYLOGENET EVOL, V48, P506, DOI 10.1016/j.ympev.2008.04.037; Bauer F, 2012, BIOMACROMOLECULES, V13, P3730, DOI 10.1021/bm301199d; Bauer F, 2012, ANGEW CHEM INT EDIT, V51, P6521, DOI 10.1002/anie.201200591; Betz O, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P111, DOI 10.1007/978-3-7091-0286-2_8; Blackledge TA, 2006, J EXP BIOL, V209, P2452, DOI 10.1242/jeb.02275; BRADLEY TJ, 1985, COMPREHENSIVE INSECT, V4, P421; Broadley RA, 2012, NZ ENTOMOL, V35, P1, DOI 10.1080/00779962.2012.649689; Broadley R.A., 2009, BIOLUMINESCENCE FOCU, P325; Broadley RA, 2001, INVERTEBR BIOL, V120, P170, DOI 10.1111/j.1744-7410.2001.tb00121.x; Caballero-Herrera A, 2005, BIOPHYS J, V89, P842, DOI 10.1529/biophysj.105.061978; Choresh O, 2009, BIOMACROMOLECULES, V10, P2852, DOI 10.1021/bm900681w; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Craig CL, 1997, ANNU REV ENTOMOL, V42, P231, DOI 10.1146/annurev.ento.42.1.231; CRAIG R, 1960, ANNU REV ENTOMOL, V5, P53, DOI 10.1146/annurev.en.05.010160.000413; Doran B., 2004, THESIS; Edwards FW, 1933, P LINN SOC LONDON, P3; Edwards FW, 1924, J NAT HIST, V9, P175; Fu C, 2009, J CHEM SOC CHEM COMM, V43, P6515; FULTON B. B., 1941, ANN ENT SOC AMERICA, V34, P289; FULTON B. B., 1939, JOUR ELISHA MITCHELL SCI SOC, V55, P289; GATENBY J. BRONTE, 1960, TUATARA, V8, P86; GATENBY J. BRONTE, 1960, TRANS ROY SOC NEW ZEALAND, V88, P149; GATENBY J. BRONTE, 1959, TRANS ROY SOC NEW ZEALAND, V87, P291; GREEN LFB, 1979, TISSUE CELL, V11, P457, DOI 10.1016/0040-8166(79)90056-9; GREEN LFB, 1980, TISSUE CELL, V12, P141, DOI 10.1016/0040-8166(80)90057-9; GREEN LFB, 1979, TISSUE CELL, V11, P673, DOI 10.1016/0040-8166(79)90024-7; HARRISON RA, 1966, PAC INSECTS, V8, P877; HASTINGS JW, 1983, J MOL EVOL, V19, P309, DOI 10.1007/BF02101634; Hudson GV, 1891, T P NEW ZEAL I, V23, P43; Hudson GV, 1886, T P NZ I, V19, P62; Hudson GV., 1886, ENTOMOL MON MAG, V23, P99; Humphries T., 1889, APPENDICES J HOUSE R, VIII, pH; Hutton FW, 1901, T ROYAL SOC NZ, V34, P179; Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809; KENCHINGTON W, 1983, J INSECT PHYSIOL, V29, P355, DOI 10.1016/0022-1910(83)90037-9; Kermode L, 1974, NZ SPELEOL B, V5, P313; LEE J, 1976, PHOTOCHEM PHOTOBIOL, V24, P279, DOI 10.1111/j.1751-1097.1976.tb06823.x; MATILE L, 1981, ANN SOC ENTOMOL FR, V17, P99; May BM, 2013, NZ SPELEOLOGICAL B, V3, P169; Maynard AJ, 2013, INTEGR COMP BIOL, V53, P154, DOI 10.1093/icb/ict011; Merritt DJ, 2011, J BIOL RHYTHM, V26, P34, DOI 10.1177/0748730410391947; Merritt DJ, 2001, NEWCAVES CHRONICLES, V16, P42; Merritt DJ, 2009, BIOLUMINESCENCE FOCU, P291; Merritt DJ, 2005, WAITOMO CAVES MUSEUM, P1; Meyer-Rochow VB, 2007, LUMINESCENCE, V22, P251, DOI 10.1002/bio.955; Meyer-Rochow VB, 1990, NZ GLOWWORM; Meyrick E, 1886, ENTOMOLOGISTS MONTHL, V22, P266; Neuenfeldt M, 2015, INSECT MOL BIOL ECOL, P376; Opell BD, 2010, J EXP BIOL, V213, P339, DOI 10.1242/jeb.036947; Opell BD, 2007, J EXP BIOL, V210, P553, DOI 10.1242/jeb.02682; Opell BD, 2015, J ARACHNOL, V43, P152; Opell BD, 2013, J EXP BIOL, V216, P3023, DOI 10.1242/jeb.084822; Opell BD, 2011, J EXP BIOL, V214, P2988, DOI 10.1242/jeb.055996; Opell BD, 2009, J EXP BIOL, V212, P3026, DOI 10.1242/jeb.030064; Opell BD, 2009, ZOOLOGY, V112, P16, DOI 10.1016/j.zool.2008.04.002; Osten-Sacken CR, 1884, ENTOMOLOGISTS MONTHE, V23, P133; PANT R, 1978, BIOCHEM J, V174, P341, DOI 10.1042/bj1740341; Petrie E. M., 2007, HDB ADHESIVES SEALAN; Piper R., 2007, EXTRAORDINARY ANIMAL; PUGSLEY C, 1984, J ROY SOC NEW ZEAL, V14, P387, DOI 10.1080/03036758.1984.10421739; Pugsley C., 1982, U AUCKLAND NEWS, V12, P7; PUGSLEY CW, 1983, NEW ZEAL ENTOMOL, V7, P419; Pugsley CW, 1980, THESIS; Purchas AG., 1871, T N Z I, V4, P388; RAMSAY JA, 1958, J EXP BIOL, V35, P871; Rasines G, 2015, CARBON, V83, P262, DOI 10.1016/j.carbon.2014.11.015; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RICHARDS AOLA M., 1960, TRANS ROY SOC NEW ZEALAND, V88, P559; RICHARDS AOLA M., 1964, STUD SPELEOL, V1, P38; Rudall K. M., 1962, COMP BIOCH, P397; SCHILDKNECHT H, 1972, NATURWISSENSCHAFTEN, V59, P98, DOI 10.1007/BF00591781; Schulz S, 2001, LIPIDS, V36, P637, DOI 10.1007/s11745-001-0768-7; Skuse FAA, 1890, P LINNEAN SOC N S WA, V2, P677; Stellwagen SD, 2014, J EXP BIOL, V217, P1563, DOI 10.1242/jeb.097816; STRINGER I. A. N., 1967, TANE, V13, P107; Sutherland TD, 2010, ANNU REV ENTOMOL, V55, P171, DOI 10.1146/annurev-ento-112408-085401; Teuschl AH, 2014, TISSUE ENG PART C-ME, V20, P431, DOI [10.1089/ten.tec.2013.0278, 10.1089/ten.TEC.2013.0278]; Tillinghast EK, 1993, BIOMOLECULAR MAT, P9; Townley MA, 2006, J EXP BIOL, V209, P1463, DOI 10.1242/jeb.02147; Townley Mark A., 2013, P283; Viviani VR, 2002, PHOTOCHEM PHOTOBIOL, V75, P22, DOI 10.1562/0031-8655(2002)075<0022:TBDTNA>2.0.CO;2; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; von Byern J, 2015, ZOOLOGY, V118, P334, DOI 10.1016/j.zool.2015.04.003; Walker AA, 2015, COMP BIOCHEM PHYS B, V187, P78, DOI 10.1016/j.cbpb.2015.05.008; Walker AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030408; Willis RE, 2011, J COMP PHYSIOL B, V181, P477, DOI 10.1007/s00360-010-0533-3; Zahl P. A., 1971, National Geographic Mag, V140, P45	91	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0162687	10.1371/journal.pone.0162687	http://dx.doi.org/10.1371/journal.pone.0162687			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973586	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300002
J	Amaradasa, BS; Everhart, SE				Amaradasa, B. Sajeewa; Everhart, Sydney E.			Effects of Sublethal Fungicides on Mutation Rates and Genomic Variation in Fungal Plant Pathogen, Sclerotinia sclerotiorum	PLOS ONE			English	Article							UNDERSTANDING MOLECULAR-MECHANISMS; PHYTOPATHOGENIC FUNGI; R-PACKAGE; RESISTANCE; POPULATIONS; EVOLUTION; AFLP; MICROSATELLITES; ANTIBIOTICS; STROBILURIN	Pathogen exposure to sublethal doses of fungicides may result in mutations that may represent an important and largely overlooked mechanism of introducing new genetic variation into strictly clonal populations, including acquisition of fungicide resistance. We tested this hypothesis using the clonal plant pathogen, Sclerotinia sclerotiorum. Nine susceptible isolates were exposed independently to five commercial fungicides with different modes of action: boscalid (respiration inhibitor), iprodione (unclear mode of action), thiophanate methyl (inhibition of microtubulin synthesis) and azoxystrobin and pyraclostrobin (quinone outside inhibitors). Mycelium of each isolate was inoculated onto a fungicide gradient and sub-cultured from the 50-100% inhibition zone for 12 generations and experiment repeated. Mutational changes were assessed for all isolates at six neutral microsatellite (SSR) loci and for a subset of isolates using amplified fragment length polymorphisms (AFLPs). SSR analysis showed 12 of 85 fungicide-exposed isolates had a total of 127 stepwise mutations with 42 insertions and 85 deletions. Most stepwise deletions were in iprodione-and azoxystrobin- exposed isolates (n = 40/85 each). Estimated mutation rates were 1.7 to 60-fold higher for mutated loci compared to that expected under neutral conditions. AFLP genotyping of 33 isolates (16 non-exposed control and 17 fungicide exposed) generated 602 polymorphic alleles. Cluster analysis with principal coordinate analysis (PCoA) and discriminant analysis of principal components (DAPC) identified fungicide-exposed isolates as a distinct group from non-exposed control isolates (PhiPT = 0.15, P = 0.001). Dendrograms based on neighbor-joining also supported allelic variation associated with fungicide-exposure. Fungicide sensitivity of isolates measured throughout both experiments did not show consistent trends. For example, eight isolates exposed to boscalid had higher EC50 values at the end of the experiment, and when repeated, only one isolate had higher EC50 while most isolates showed no difference. Results of this support the hypothesis that sublethal fungicide stress increases mutation rates in a largely clonal plant pathogen under in vitro conditions. Collectively, this work will aid our understanding how non-lethal fungicide exposure may affect genomic variation, which may be an important mechanism of novel trait emergence, adaptation, and evolution for clonal organisms.	[Amaradasa, B. Sajeewa; Everhart, Sydney E.] Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA	University of Nebraska System; University of Nebraska Lincoln	Everhart, SE (corresponding author), Univ Nebraska, Dept Plant Pathol, Lincoln, NE 68583 USA.	everhart@unl.edu		Everhart, Sydney/0000-0002-5773-1280	North Central Soybean Research Program [639K623]; Layman Award [2446]; University of Nebraska-Lincoln	North Central Soybean Research Program; Layman Award; University of Nebraska-Lincoln	Funding for this research was provided by the North Central Soybean Research Program (#639K623) to SEE, a Layman Award (#2446) to SEE and start-up funds from the University of Nebraska-Lincoln to SEE.	Ajouz S, 2010, FUNGAL BIOL-UK, V114, P949, DOI 10.1016/j.funbio.2010.09.004; Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Andersson DI, 2014, NAT REV MICROBIOL, V12, P465, DOI 10.1038/nrmicro3270; Atallah ZK, 2004, PHYTOPATHOLOGY, V94, P737, DOI 10.1094/PHYTO.2004.94.7.737; Avenot HF, 2010, CROP PROT, V29, P643, DOI 10.1016/j.cropro.2010.02.019; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bartlett DW, 2002, PEST MANAG SCI, V58, P649, DOI 10.1002/ps.520; Beckerman JL, 2015, PEST MANAG SCI, V71, P331, DOI 10.1002/ps.3715; BOLAND GJ, 1994, CAN J PLANT PATHOL, V16, P93, DOI 10.1080/07060669409500766; Bolton MD, 2006, MOL PLANT PATHOL, V7, P1, DOI 10.1111/J.1364-3703.2005.00316.X; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; Mesa-Arango AC, 2014, ANTIMICROB AGENTS CH, V58, P6627, DOI 10.1128/AAC.03570-14; Chen FP, 2015, FUNGAL GENET BIOL, V85, P38, DOI 10.1016/j.fgb.2015.10.006; Cubeta MA, 1997, PHYTOPATHOLOGY, V87, P1000, DOI 10.1094/PHYTO.1997.87.10.1000; DAVIDSE LC, 1986, ANNU REV PHYTOPATHOL, V24, P43, DOI 10.1146/annurev.py.24.090186.000355; DEKKER J, 1976, ANNU REV PHYTOPATHOL, V14, P405, DOI 10.1146/annurev.py.14.090176.002201; Dettman JR, 2004, GENETICS, V168, P1231, DOI 10.1534/genetics.104.029322; Duan YB, 2012, PESTIC BIOCHEM PHYS, V103, P101, DOI 10.1016/j.pestbp.2012.04.004; Ekins MG, 2011, AUSTRALAS PLANT PATH, V40, P99, DOI 10.1007/s13313-010-0018-6; Everhart SE, 2016, ANN REP BEAN IMPROV, V59, P131; Fernandez-Ortuno D, 2008, INT MICROBIOL, V11, P1, DOI 10.2436/20.1501.01.38; Forster H, 2004, PHYTOPATHOLOGY, V94, P163, DOI 10.1094/PHYTO.2004.94.2.163; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Gressel J, 2011, PEST MANAG SCI, V67, P253, DOI 10.1002/ps.2071; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Kis-Papo T, 2003, P NATL ACAD SCI USA, V100, P14970, DOI 10.1073/pnas.2036284100; KOHLI Y, 1995, MOL ECOL, V4, P69, DOI 10.1111/j.1365-294X.1995.tb00193.x; Kohli Y, 1998, FUNGAL GENET BIOL, V23, P139, DOI 10.1006/fgbi.1997.1026; Kohn LM, 2008, FUNGAL GENET BIOL, V45, P613, DOI 10.1016/j.fgb.2007.09.013; Kokotovic B, 1999, J CLIN MICROBIOL, V37, P3300, DOI 10.1128/JCM.37.10.3300-3307.1999; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; MILGROOM MG, 1988, PHYTOPATHOLOGY, V78, P565, DOI 10.1094/Phyto-78-565; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petzoldt R., 1996, ANN REP BEAN IMPROV, V39, P142; Raffaele S, 2012, NAT REV MICROBIOL, V10, P417, DOI 10.1038/nrmicro2790; Rogers J. S., 1972, U TEXAS PUBL, V7213, P145; Schnabel G., 2014, Modern fungicides and antifungal compounds VII. Proceedings of the 17th International Reinhardsbrunn Symposium, April 21-25 2013, Friedrichroda, Germany, P263; Selmecki A, 2010, EUKARYOT CELL, V9, P991, DOI 10.1128/EC.00060-10; Selmecki AM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000705; Shapiro RS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004678; Sionov E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000848; Sirjusingh C, 2001, MOL ECOL NOTES, V1, P267, DOI 10.1046/j.1471-8278.2001.00102.x; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; STEADMAN JR, 1983, PLANT DIS, V67, P346, DOI 10.1094/PD-67-346; Sweet MJ, 2012, ADV APPL MICROBIOL, V81, P169, DOI 10.1016/B978-0-12-394382-8.00005-8; Troncoso-Rojas R., 2013, African Journal of Microbiology Research, V7, P838; van den Bosch F, 2011, PLANT PATHOL, V60, P597, DOI 10.1111/j.1365-3059.2011.02439.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Vuylsteke M, 2007, NAT PROTOC, V2, P1387, DOI 10.1038/nprot.2007.175; Wang Y, 2015, PLANT PATHOL, V64, P101, DOI 10.1111/ppa.12246; Wang Y., 2014, BIOMED RES INT, V2014; Wood PM, 2003, PEST MANAG SCI, V59, P499, DOI 10.1002/ps.655; Wright S, 1978, VARIABILITY NATURAL, V4; Zhao XL, 2014, CURR OPIN MICROBIOL, V21, P1, DOI 10.1016/j.mib.2014.06.008; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	61	13	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168079	10.1371/journal.pone.0168079	http://dx.doi.org/10.1371/journal.pone.0168079			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959950	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900037
J	Gao, B; Zhang, RH; Lou, XM				Gao, Bo; Zhang, Ronghui; Lou, Xiaoming			Modeling Day-to-day Flow Dynamics on Degradable Transport Network	PLOS ONE			English	Article							TRAFFIC ASSIGNMENT MODELS; ROUTE CHOICE; USER EQUILIBRIUM; STOCHASTIC EQUILIBRIUM; INFORMATION PROVISION; ADJUSTMENT PROCESS; PROSPECT-THEORY; STABILITY; EVOLUTION; SYSTEMS	Stochastic link capacity degradations are common phenomena in transport network which can cause travel time variations and further can affect travelers' daily route choice behaviors. This paper formulates a deterministic dynamic model, to capture the day-to-day (DTD) flow evolution process in the presence of degraded link capacity degradations. The aggregated network flow dynamics are driven by travelers' study of uncertain travel time and their choice of risky routes. This paper applies the exponential-smoothing filter to describe travelers' study of travel time variations, and meanwhile formulates risk attitude parameter updating equation to reflect travelers' endogenous risk attitude evolution schema. In addition, this paper conducts theoretical analyses to investigate several significant mathematical characteristics implied in the proposed DTD model, including fixed point existence, uniqueness, stability and irreversibility. Numerical experiments are used to demonstrate the effectiveness of the DTD model and verify some important dynamic system properties.	[Gao, Bo] Zhejiang Inst Commun, Hangzhou, Zhejiang, Peoples R China; [Zhang, Ronghui] Sun Yat Sen Univ, Res Ctr Intelligent Transportat Syst, Sch Engn, Guangzhou, Guangdong, Peoples R China; [Gao, Bo] Energy Conversat & Emiss Reduct Management Ctr, Zhejiang Prov Commun Dept, Hangzhou, Zhejiang, Peoples R China; [Lou, Xiaoming] Southeast Univ, Sch Transportat, Nanjing, Jiangsu, Peoples R China	Sun Yat Sen University; Southeast University - China	Zhang, RH (corresponding author), Sun Yat Sen Univ, Res Ctr Intelligent Transportat Syst, Sch Engn, Guangzhou, Guangdong, Peoples R China.	zrh1981819@126.com						Barkan R, 1999, PSYCHON B REV, V6, P547, DOI 10.3758/BF03212962; Bie J., 2008, THESIS; Bie J, 2010, TRANSPORT RES B-METH, V44, P90, DOI 10.1016/j.trb.2009.06.007; Cantarella GE, 2016, EURO J TRANSP LOGIST, V5, P69, DOI 10.1007/s13676-014-0073-1; Cantarella GE, 1995, TRANSPORT SCI, V29, P305, DOI 10.1287/trsc.29.4.305; Cantarella GE, 2015, NETW SPAT ECON, V15, P485, DOI 10.1007/s11067-013-9188-4; Cantarella GE, 2013, TRANSPORT RES C-EMER, V29, P117, DOI 10.1016/j.trc.2012.03.005; CASCETTA E, 1989, TRANSPORT RES B-METH, V23, P1, DOI 10.1016/0191-2615(89)90019-2; Chen R, 2004, TRANSPORT RES REC, P209, DOI 10.3141/1894-22; Chen R., 2009, EXPANDING SPHERE TRA; Cho HJ, 2005, IEEE T INTELL TRANSP, V6, P17, DOI 10.1109/TITS.2004.838184; Cho HJ, 2005, MATH COMPUT MODEL, V41, P501, DOI 10.1016/j.mcm.2004.03.005; Di X, 2015, NETW SPAT ECON, V15, P537, DOI 10.1007/s11067-014-9233-y; Du WB, 2016, TRANSPORT RES E-LOG, V89, P108, DOI 10.1016/j.tre.2016.03.009; EMMERINK RHM, 1995, TRANSPORTATION, V22, P21, DOI 10.1007/BF01151617; Engelson L, 2003, TRANSPORT RES C-EMER, V11, P161, DOI 10.1016/S0968-090X(03)00008-1; Friesz TL, 2011, TRANSPORT RES B-METH, V45, P176, DOI 10.1016/j.trb.2010.05.003; FRIESZ TL, 1994, OPER RES, V42, P1120, DOI 10.1287/opre.42.6.1120; Guimera R, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248701; Guo RY, 2015, TRANSPORT RES B-METH, V71, P248, DOI 10.1016/j.trb.2014.11.005; Guo RY, 2013, TRANSPORT RES C-EMER, V34, P121, DOI 10.1016/j.trc.2013.06.002; Guo XL, 2011, TRANSPORT RES B-METH, V45, P1606, DOI 10.1016/j.trb.2011.05.026; Hazelton ML, 2002, TRANSPORT RES B-METH, V36, P637, DOI 10.1016/S0191-2615(01)00032-7; He XZ, 2016, TRANSPORT RES B-METH, V84, P237, DOI 10.1016/j.trb.2015.12.003; He XZ, 2012, TRANSPORT RES B-METH, V46, P50, DOI 10.1016/j.trb.2011.07.012; He XZ, 2010, TRANSPORT RES B-METH, V44, P597, DOI 10.1016/j.trb.2009.10.001; HOROWITZ JL, 1984, TRANSPORT RES B-METH, V18, P13, DOI 10.1016/0191-2615(84)90003-1; Hu TY, 1997, TRANSPORT RES C-EMER, V5, P51, DOI 10.1016/S0968-090X(96)00026-5; Huang H. J., 2006, J ADV TRANSPORT, V42, P111; Iryo T, 2013, TRANSPORTMETRICA B, V1, P52, DOI 10.1080/21680566.2013.779793; Jha M, 1998, TRANSPORT RES C-EMER, V6, P189, DOI 10.1016/S0968-090X(98)00015-1; Jin WL, 2007, TRANSPORT RES B-METH, V41, P32, DOI 10.1016/j.trb.2006.02.010; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kumar A, 2015, TRANSPORT RES B-METH, V80, P235, DOI 10.1016/j.trb.2015.07.014; Lou XM, 2016, TRANSPORT RES REC, P27, DOI 10.3141/2565-04; Lou XM, 2016, TRANSPORTMETRI B MAR, P1; Meneguzzer C, 2012, J ADV TRANSPORT, V46, P351, DOI 10.1002/atr.1199; Parry K, 2016, EURO J TRANSP LOGIST, V5, P5, DOI 10.1007/s13676-013-0037-x; Peeta S, 2004, IEEE T SYST MAN CY A, V34, P243, DOI 10.1109/TSMCA.2003.822272; Smith M, 2014, TRANSPORTMETRICA A, V10, P647, DOI 10.1080/18128602.2012.751683; Smith M, 2011, TRANSPORT RES B-METH, V45, P1389, DOI 10.1016/j.trb.2011.05.013; SMITH MJ, 1984, TRANSPORT SCI, V18, P245, DOI 10.1287/trsc.18.3.245; Smith MJ, 1995, ANN OPER RES, V60, P59, DOI 10.1007/BF02031940; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Wang GC, 2013, TRANSPORT RES C-EMER, V35, P156, DOI 10.1016/j.trc.2013.06.019; Watling D, 1999, TRANSPORT RES B-METH, V33, P281, DOI 10.1016/S0191-2615(98)00033-2; Watling D, 2003, NETW SPAT ECON, V3, P349, DOI DOI 10.1023/A:1025398302560; Watling DP, 2015, NETW SPAT ECON, V15, P843, DOI 10.1007/s11067-013-9198-2; Watling DP, 2013, TRANSPORTMETRICA B, V1, P3, DOI 10.1080/21680566.2013.785372; Xu HL, 2014, TRANSPORTMETRICA B, V2, P20, DOI 10.1080/21680566.2013.859108; Xu HL, 2011, TRANSPORT RES B-METH, V45, P311, DOI 10.1016/j.trb.2010.09.003; Yan G, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046108; Yang F, 2009, TRANSPORT RES B-METH, V43, P119, DOI 10.1016/j.trb.2008.05.005; Zhang D, 2001, TRANSPORT RES B-METH, V35, P731, DOI 10.1016/S0191-2615(00)00020-5; Zhang D, 1996, TRANSPORT RES B-METH, V30, P245, DOI 10.1016/0191-2615(95)00034-8; Zhao L, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026125	56	10	11	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168241	10.1371/journal.pone.0168241	http://dx.doi.org/10.1371/journal.pone.0168241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	27959903	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900051
J	Guerrini, V; Subbian, S; Santucci, P; Canaan, S; Gennaro, ML; Pozzi, G				Guerrini, Valentina; Subbian, Selvakumar; Santucci, Pierre; Canaan, Stephane; Gennaro, Maria Laura; Pozzi, Gianni			Experimental Evolution of Mycobacterium tuberculosis in Human Macrophages Results in Low-Frequency Mutations Not Associated with Selective Advantage	PLOS ONE			English	Article							GROWTH; ALIGNMENT	Isolates of the human pathogen Mycobacterium tuberculosis recovered from clinical samples exhibit genetic heterogeneity. Such variation may result from the stressful environment encountered by the pathogen inside the macrophage, which is the host cell tubercle bacilli parasitize. To study the evolution of the M. tuberculosis genome during growth inside macrophages, we developed a model of intracellular culture in which bacteria were serially passaged in macrophage-like THP-1 cells for about 80 bacterial generations. Genome sequencing of single bacterial colonies isolated before and after the infection cycles revealed that M. tuberculosis developed mutations at a rate of about 5.7 x 10(-9) /bp/generation, consistent with mutation rates calculated during in vivo infection. Analysis of mutant growth in macrophages and in mice showed that the mutations identified after the cyclic infection conferred no advantage to the mutants relative to wild-type. Furthermore, activity testing of the recombinant protein harboring one of these mutations showed that the presence of the mutation did not affect the enzymatic activity. The serial infection protocol developed in this work to study M. tuberculosis genome microevolution can be applied to exposure to stressors to determine their effect on genome remodeling during intra-macrophage growth.	[Guerrini, Valentina; Subbian, Selvakumar; Gennaro, Maria Laura] Rutgers State Univ, Publ Hlth Res Inst, New Jersey Med Sch, Newark, NJ 07102 USA; [Guerrini, Valentina; Pozzi, Gianni] Univ Siena, Dept Med Biotechnol, Lab Mol Microbiol & Biotechnol, Siena, Italy; [Santucci, Pierre; Canaan, Stephane] Aix Marseille Univ, CNRS, Lab Enzymol Interfaciale & Physiol Lipolyse, Marseille, France	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Siena; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Gennaro, ML (corresponding author), Rutgers State Univ, Publ Hlth Res Inst, New Jersey Med Sch, Newark, NJ 07102 USA.	marila.gennaro@rutgers.edu	Pozzi, Gianni/Q-2713-2018	Pozzi, Gianni/0000-0002-9557-4714; SANTUCCI, Pierre/0000-0002-6291-3425; Subbian, Selvakumar/0000-0003-2021-8632; Gennaro, Maria Laura/0000-0003-4801-3567	NIH [HL106788, AI104615]; European Community's Seventh Framework Programme (FP7) [FP7-223681]; Ministere Francais de l'Enseignement Superieur et de la Recherche; Centre National de la Recherche Scientifique (CNRS)	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Community's Seventh Framework Programme (FP7); Ministere Francais de l'Enseignement Superieur et de la Recherche; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	The work was funded in part by NIH grants HL106788 and AI104615 to MLG and in part by European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement FP7-223681 (TB PAN-NET) to GP. PS's PhD fellowship was financed by the Ministere Francais de l'Enseignement Superieur et de la Recherche. We are also grateful for the support from the Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatt K, 2007, MICROBIOL-SGM, V153, P513, DOI 10.1099/mic.0.2006/003103-0; Boisvert S, 2010, J COMPUT BIOL, V17, P1519, DOI 10.1089/cmb.2009.0238; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Eldholm V, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0490-3; Ensminger AW, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002731; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; Ford CB, 2011, NAT GENET, V43, P482, DOI 10.1038/ng.811; Garcia de Viedma D, 2004, J CLIN MICROBIOL, V42, P3415, DOI 10.1128/JCM.42.8.3415-3418.2004; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Giovannini D, 2012, MICROB PATHOGENESIS, V53, P135, DOI 10.1016/j.micpath.2012.06.002; Guerrini V., 2016, NEW MICROBIOL, V39; Guerrini V, 2013, TUBERCULOSIS, V93, P405, DOI 10.1016/j.tube.2013.02.017; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; Lee WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090581; Martin A, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-73; McDonough JA, 2008, J BACTERIOL, V190, P6428, DOI 10.1128/JB.00749-08; Medie FM, 2011, PROTEIN EXPRES PURIF, V75, P172, DOI 10.1016/j.pep.2010.08.015; Michee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072459; Mitra A, 2008, TUBERCULOSIS, V88, P566, DOI 10.1016/j.tube.2008.06.004; N'Goma JCB, 2010, BBA-MOL CELL BIOL L, V1801, P1305, DOI 10.1016/j.bbalip.2010.08.007; Noens EE, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-27; O'Neill MB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005257; Perez-Lago L, 2014, J INFECT DIS, V209, P98, DOI 10.1093/infdis/jit439; REZAPOV BR, 1991, TERAPEVT ARKH, V63, P155; Russell DG, 2011, IMMUNOL REV, V240, P252, DOI 10.1111/j.1600-065X.2010.00984.x; Russell DG, 2010, CELL HOST MICROBE, V8, P68, DOI 10.1016/j.chom.2010.06.002; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Subbian S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110016; Sun G, 2012, J INFECT DIS, V206, P1724, DOI 10.1093/infdis/jis601; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Yang Y, 2014, CELL HOST MICROBE, V15, P153, DOI 10.1016/j.chom.2014.01.008; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375	34	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167989	10.1371/journal.pone.0167989	http://dx.doi.org/10.1371/journal.pone.0167989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959952	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900031
J	Martin, V; Perales, C; Fernandez-Algar, M; Dos Santos, HG; Garrido, P; Pernas, M; Parro, V; Moreno, M; Garcia-Perez, J; Alcami, J; Toran, JL; Abia, D; Domingo, E; Briones, C				Martin, Veronica; Perales, Celia; Fernandez-Algar, Maria; Dos Santos, Helena G.; Garrido, Patricia; Pernas, Maria; Parro, Victor; Moreno, Miguel; Garcia-perez, Javier; Alcami, Jose; Luis Toran, Jose; Abia, David; Domingo, Esteban; Briones, Carlos			An Efficient Microarray-Based Genotyping Platform for the Identification of Drug-Resistance Mutations in Majority and Minority Subpopulations of HIV-1 Quasispecies	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENERATION SEQUENCING DATA; REVERSE-TRANSCRIPTASE; VIROLOGICAL FAILURE; CLINICAL-IMPLICATIONS; DIPEPTIDE INSERTION; TREATMENT-NAIVE; MEMORY GENOMES; RNA VIRUSES; VARIANTS	The response of human immunodeficiency virus type 1 (HIV-1) quasispecies to antiretroviral therapy is influenced by the ensemble of mutants that composes the evolving population. Low-abundance subpopulations within HIV-1 quasispecies may determine the viral response to the administered drug combinations. However, routine sequencing assays available to clinical laboratories do not recognize HIV-1 minority variants representing less than 25% of the population. Although several alternative and more sensitive genotyping techniques have been developed, including next-generation sequencing (NGS) methods, they are usually very time consuming, expensive and require highly trained personnel, thus becoming unrealistic approaches in daily clinical practice. Here we describe the development and testing of a HIV-1 genotyping DNA microarray that detects and quantifies, in majority and minority viral subpopulations, relevant mutations and amino acid insertions in 42 codons of the pol gene associated with drug-and multidrug-resistance to protease (PR) and reverse transcriptase (RT) inhibitors. A customized bioinformatics protocol has been implemented to analyze the microarray hybridization data by including a new normalization procedure and a stepwise filtering algorithm, which resulted in the highly accurate (96.33%) detection of positive/negative signals. This microarray has been tested with 57 subtype B HIV-1 clinical samples extracted from multi-treated patients, showing an overall identification of 95.53% and 89.24% of the queried PR and RT codons, respectively, and enough sensitivity to detect minority subpopulations representing as low as 5-10% of the total quasispecies. The developed genotyping platform represents an efficient diagnostic and prognostic tool useful to personalize antiviral treatments in clinical practice.	[Martin, Veronica; Perales, Celia; Dos Santos, Helena G.; Abia, David; Domingo, Esteban] CSIC UAM, CBMSO, Campus Cantoblanco, Madrid, Spain; [Perales, Celia; Domingo, Esteban; Briones, Carlos] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain; [Perales, Celia] Univ Autonoma Barcelona, VHIR HUVH, Liver Unit, Internal Med,Lab Malalties Hepat, Barcelona, Spain; [Fernandez-Algar, Maria; Parro, Victor; Moreno, Miguel; Briones, Carlos] CSIC INTA, CAB, Dept Mol Evolut, Madrid, Spain; [Garrido, Patricia; Pernas, Maria; Luis Toran, Jose] SLU, Biotherapix, Parque Tecnol Madrid, Madrid, Spain; [Garcia-perez, Javier; Alcami, Jose] Inst Salud Carlos III, AIDS Immunopathogenesis Unit, Madrid, Spain; [Martin, Veronica] Inst Nacl Invest Tecnol Agr & Alimentaria, Ctr Invest Sanidad Anim CISA INIA, Madrid, Spain; [Dos Santos, Helena G.] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [Garrido, Patricia] Sygnis Biotech, Parque Cient Madrid,Campus Cantoblanco, Madrid, Spain; [Pernas, Maria] Inst Salud Carlos III, Madrid, Spain; [Luis Toran, Jose] CSIC, Spanish Natl Ctr Biotechnol CNB, Campus Cantoblanco, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Instituto de Salud Carlos III; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); State University System of Florida; Florida International University; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Briones, C (corresponding author), Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain.; Briones, C (corresponding author), CSIC INTA, CAB, Dept Mol Evolut, Madrid, Spain.	cbriones@cab.inta-csic.es	Briones, Carlos/G-3689-2016; Martin, Veronica/M-9641-2019; Martín, Verónica/H-2776-2015; Pernas, Maria/E-3998-2018; Moreno, Miguel/E-9552-2010; García-Pérez, Javier/F-9248-2019; Alcami, Pepe/T-2242-2018; Domingo, Esteban/K-3937-2014	Briones, Carlos/0000-0003-2213-8353; Martin, Veronica/0000-0003-1486-1656; Martín, Verónica/0000-0003-1486-1656; Pernas, Maria/0000-0003-2966-0160; Moreno, Miguel/0000-0002-6065-4095; García-Pérez, Javier/0000-0001-7551-7803; Alcami, Pepe/0000-0003-0023-7377; Perales Viejo, Celia Belen/0000-0003-1618-1937; Parro, Victor/0000-0003-3738-0724; Abia, David/0000-0003-0401-7590; Domingo, Esteban/0000-0002-0573-1676	Spanish Ministerio de Ciencia e Innovacion (MICINN) [BIO2010-20696]; Ministerio de Economia y Competitividad (MINECO) [BIO2013-47228-R, SAF2014-52400-R]; Comunidad Autanoma de Madrid (PLATESA) [52013/ABI-2906]; Biotherapix, S.L.U.; FEDER funds from the European Union; Institute de Salud Carlos III (ISCIII); MICINN [RyC2010-06516, AGL2015-64290-R]; Miguel Servet program of the ISCIII [CP14/00121]; European Regional Development Fund (ERDF); Spanish National Research Council (CSIC)	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Economia y Competitividad (MINECO)(Spanish Government); Comunidad Autanoma de Madrid (PLATESA); Biotherapix, S.L.U.; FEDER funds from the European Union(European Commission); Institute de Salud Carlos III (ISCIII); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Miguel Servet program of the ISCIII; European Regional Development Fund (ERDF)(European Commission); Spanish National Research Council (CSIC)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion (MICINN grant BIO2010-20696 to CB), Ministerio de Economia y Competitividad (MINECO grants BIO2013-47228-R to CB and SAF2014-52400-R to ED), Comunidad Autanoma de Madrid (PLATESA, grant 52013/ABI-2906 to ED), Biotherapix, S.L.U. and FEDER funds from the European Union. Work at CIBERehd is funded by the Institute de Salud Carlos III (ISCIII). MICINN provided funding for VM under grants RyC2010-06516 and AGL2015-64290-R. CP is supported by Miguel Servet program of the ISCIII (CP14/00121), co-financed by the European Regional Development Fund (ERDF). Funding for open access charge: Spanish National Research Council (CSIC). The funders provided support in the form of salaries and research materials for authors [MICINN and MINECO for VM, CP, MF-A, HGDS, VP, MM, DA, ED and CB; ISCIII for CP, JG-P and JA; Biotherapix, S.L.U. for PG, MP and JLT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baldwin C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-78; Barnett V., 1994, OUTLIERS STAT DATA; Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329; Bolsewicz K, 2015, AIDS CARE, V27, P1429, DOI 10.1080/09540121.2015.1114992; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Briones C, 2000, VIRUS RES, V66, P13, DOI 10.1016/S0168-1702(99)00120-3; Briones C, 2003, J MOL BIOL, V331, P213, DOI 10.1016/S0022-2836(03)00661-2; Briones C, 2008, AIDS REV, V10, P93; Briones C, 2006, GENE, V384, P129, DOI 10.1016/j.gene.2006.07.037; Capobianchi MR, 2013, CLIN MICROBIOL INFEC, V19, P15, DOI 10.1111/1469-0691.12056; Casadella M, 2015, J ANTIMICROB CHEMOTH, V70, P2885, DOI 10.1093/jac/dkv202; Cases-Gonzalez CE, 2007, J MOL BIOL, V365, P298, DOI 10.1016/j.jmb.2006.09.073; Chaix ML, 2009, AIDS, V23, P717, DOI 10.1097/QAD.0b013e328326ca77; Combe M, 2014, FUTURE VIROL, V9, P605, DOI 10.2217/FVL.14.41; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Eigen M, 1996, TRENDS MICROBIOL, V4, P216, DOI 10.1016/0966-842X(96)20011-3; Eshleman SH, 2005, J CLIN MICROBIOL, V43, P813, DOI 10.1128/JCM.43.2.813-817.2005; Fernandez N, 2011, NUCLEIC ACIDS RES, V39, P8572, DOI 10.1093/nar/gkr560; Fernandez N, 2011, VIROLOGY, V409, P251, DOI 10.1016/j.virol.2010.10.013; FORGY EW, 1965, BIOMETRICS, V21, P768; Frentz D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-407; Gega A, 2011, FUTURE VIROL, V6, P17, DOI 10.2217/FVL.10.77; Gibson RM, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0401-5; Goodman DD, 2011, AIDS, V25, P325, DOI 10.1097/QAD.0b013e3283427dcb; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Gupta S, 2014, VIRUSES-BASEL, V6, P3428, DOI 10.3390/v6093428; Halvas EK, 2010, J INFECT DIS, V201, P672, DOI 10.1086/650542; Hofstra LM, 2016, CLIN INFECT DIS, V62, P655, DOI 10.1093/cid/civ963; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Kozal MJ, 1996, NAT MED, V2, P753, DOI 10.1038/nm0796-753; Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005; Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079; Li JZ, 2013, CLIN INFECT DIS, V56, P1667, DOI 10.1093/cid/cit125; Li JZ, 2013, J INFECT DIS, V207, P893, DOI 10.1093/infdis/jis925; Li JZ, 2011, JAMA-J AM MED ASSOC, V305, P1327, DOI 10.1001/jama.2011.375; Mackay D. J., 2003, INFORM THEORY INFERE, P284, DOI [10.2277/0521642981, DOI 10.2277/0521642981]; Martell M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh088; Martin V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-117; Mas A, 2000, EMBO J, V19, P5752, DOI 10.1093/emboj/19.21.5752; Masimba P, 2014, TROP MED INT HEALTH, V19, P664, DOI 10.1111/tmi.12289; Matamoros T, 2008, J MOL BIOL, V375, P1234, DOI 10.1016/j.jmb.2007.11.021; Mayers D, 1998, J INFECT DIS, V177, P1730, DOI 10.1086/517433; Metzner KJ, 2013, J INFECT DIS, V208, P1102, DOI 10.1093/infdis/jit310; Metzner KJ, 2011, J CLIN VIROL, V50, P156, DOI 10.1016/j.jcv.2010.10.001; Metzner KJ, 2009, CLIN INFECT DIS, V48, P239, DOI 10.1086/595703; Mohamed S, 2014, AIDS, V28, P1315, DOI 10.1097/QAD.0000000000000267; Monge S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090710; Nishizawa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135941; Ojosnegros S, 2011, VIRUS RES, V162, P203, DOI 10.1016/j.virusres.2011.09.018; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Perales C, 2012, TRENDS MICROBIOL, V20, P595, DOI 10.1016/j.tim.2012.08.010; Peuchant O, 2008, AIDS, V22, P1417, DOI 10.1097/QAD.0b013e3283034953; Quan Y, 2009, J INFECT DIS, V200, P1479, DOI 10.1086/606117; Rhee SY, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001810; Romero-Lopez C, 2014, NUCLEIC ACIDS RES, V42, P567, DOI 10.1093/nar/gkt841; Romero-Lopez C, 2012, NUCLEIC ACIDS RES, V40, P11697, DOI 10.1093/nar/gks927; Ruiz-Jarabo CM, 2002, J MOL BIOL, V315, P285, DOI 10.1006/jmbi.2001.5232; Ruiz-Jarabo CM, 2000, J VIROL, V74, P3543, DOI 10.1128/JVI.74.8.3543-3547.2000; Samuel R, 2014, AIDS REV, V16, P187; Schanne M, 2008, ANAL BIOANAL CHEM, V391, P1661, DOI 10.1007/s00216-007-1775-0; Shao W, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-18; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Tang MW, 2012, DRUGS, V72, pE1, DOI 10.2165/11633630-000000000-00000; Vahey M, 1999, J CLIN MICROBIOL, V37, P2533, DOI 10.1128/JCM.37.8.2533-2537.1999; Vandamme AM, 2011, AIDS REV, V13, P77; Vandenhende MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086771; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wensing Annemarie M, 2015, Top Antivir Med, V23, P132; Wilson JW, 2000, J CLIN MICROBIOL, V38, P3022, DOI 10.1128/JCM.38.8.3022-3028.2000; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655; Zhang GQ, 2013, J CLIN MICROBIOL, V51, P3666, DOI 10.1128/JCM.01669-13; Zoufaly A, 2015, J ANTIMICROB CHEMOTH, V70, P922, DOI 10.1093/jac/dku470	76	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0166902	10.1371/journal.pone.0166902	http://dx.doi.org/10.1371/journal.pone.0166902			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959928	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900005
J	Radibratovic, M; Minic, S; Stanic-Vucinic, D; Nikolic, M; Milcic, M; Velickovic, TC				Radibratovic, Milica; Minic, Simeon; Stanic-Vucinic, Dragana; Nikolic, Milan; Milcic, Milos; Velickovic, Tanja Cirkovic			Stabilization of Human Serum Albumin by the Binding of Phycocyanobilin, a Bioactive Chromophore of Blue-Green Alga Spirulina: Molecular Dynamics and Experimental Study	PLOS ONE			English	Article							DRUG-BINDING; CONFORMATIONAL FLEXIBILITY; THERMAL-DENATURATION; CIRCULAR-DICHROISM; BILIRUBIN-BINDING; AQUEOUS-SOLUTION; PROTEINS; SIMULATIONS; STABILITY; CHEMISTRY	Phycocyanobilin (PCB) binds with high affinity (2.2 x 10 6 M-1 at 25 degrees C) to human serum albumin (HSA) at sites located in IB and IIA subdomains. The aim of this study was to examine effects of PCB binding on protein conformation and stability. Using 300 ns molecular dynamics (MD) simulations, UV-VIS spectrophotometry, CD, FT-IR, spectrofluorimetry, thermal denaturation and susceptibility to trypsin digestion, we studied the effects of PCB binding on the stability and rigidity of HSA, as well as the conformational changes in PCB itself upon binding to the protein. MD simulation results demonstrated that HSA with PCB bound at any of the two sites showed greater rigidity and lower overall and individual domain flexibility compared to free HSA. Experimental data demonstrated an increase in the a-helical content of the protein and thermal and proteolytic stability upon ligand binding. PCB bound to HSA undergoes a conformational change to a more elongated conformation in the binding pockets of HSA. PCB binding to HSA stabilizes the structure of this flexible transport protein, making it more thermostable and resistant to proteolysis. The results from this work explain at molecular level, conformational changes and stabilization of HSA structure upon ligand binding. The resultant increased thermal and proteolytic stability of HSA may provide greater longevity to HSA in plasma.	[Radibratovic, Milica] Univ Belgrade, Ctr Chem, Inst Chem Technol & Met, Belgrade, Serbia; [Minic, Simeon; Stanic-Vucinic, Dragana; Nikolic, Milan; Velickovic, Tanja Cirkovic] Univ Belgrade, Fac Chem, Ctr Excellence Mol Food Sci, Belgrade, Serbia; [Nikolic, Milan] Univ Belgrade, Fac Chem, Dept Biochem, Belgrade, Serbia; [Milcic, Milos] Univ Belgrade, Fac Chem, Dept Inorgan Chem, Belgrade, Serbia; [Milcic, Milos] Univ Belgrade, Fac Chem, Ctr Computat Chem & Bioinformat, Belgrade, Serbia; [Velickovic, Tanja Cirkovic] Ghent Univ Global Campus, Incheon, South Korea; [Velickovic, Tanja Cirkovic] Univ Ghent, Fac Biosci Engn, Ghent, Belgium	University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade; University of Belgrade; Ghent University; Ghent University	Velickovic, TC (corresponding author), Univ Belgrade, Fac Chem, Dept Inorgan Chem, Belgrade, Serbia.	mmilcic@chem.bg.ac.rs; tcirkov@chem.bg.ac.rs	Nikolić, Milan R/P-6923-2016; Radibratovic, Milica/ABG-6145-2021; Milcic, Milos/Q-8238-2016; Stanic-Vucinic, Dragana/J-7897-2016; Cirkovic Velickovic, Tanja/R-6751-2016	Nikolić, Milan R/0000-0003-0932-889X; Radibratovic, Milica/0000-0003-4708-6633; Milcic, Milos/0000-0002-0082-5278; Stanic-Vucinic, Dragana/0000-0003-2576-3074; Minic, Simeon/0000-0002-7053-1216; Cirkovic Velickovic, Tanja/0000-0003-2559-5234	Ministry of Education, Science and Technological Development of the Republic of Serbia [01172024]; FP7 RegPot project FCUB ERA [256716]	Ministry of Education, Science and Technological Development of the Republic of Serbia; FP7 RegPot project FCUB ERA	This work was supported by the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant No. 01172024) and FP7 RegPot project FCUB ERA GA No. 256716. The EC does not share responsibility for the content of the article.	Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375; Ascenzi P, 2006, MINI-REV MED CHEM, V6, P483, DOI 10.2174/138955706776361448; Barreca D, 2016, BIOCH BIOPHYS ACTA; Buono S, 2014, FOOD FUNCT, V5, P1669, DOI [10.1039/C4FO00125G, 10.1039/c4fo00125g]; CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153; Celej MS, 2003, PROTEIN SCI, V12, P1496, DOI 10.1110/ps.0240003; Chatterjee T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037468; Guizado TRC, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2450-y; Datta S, 2014, J PHYS CHEM B, V118, P6071, DOI 10.1021/jp501547r; Dong AC, 1997, ARCH BIOCHEM BIOPHYS, V347, P213, DOI 10.1006/abbi.1997.0349; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Frisch M. J., 2009, GAUSSIAN 16 REVISION; Goller AH, 2005, CHEMPHYSCHEM, V6, P1259, DOI 10.1002/cphc.200400667; Goller AH, 2001, CHEMPHYSCHEM, V2, P665, DOI 10.1002/1439-7641(20011119)2:11<665::AID-CPHC665>3.0.CO;2-O; Goncharova I, 2013, BIOPHYS CHEM, V180, P55, DOI 10.1016/j.bpc.2013.06.004; Gonzalez M, 1997, J BIOL CHEM, V272, P11288; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hou HN, 2008, J PHARMACEUT BIOMED, V47, P134, DOI 10.1016/j.jpba.2007.12.029; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kallubai M, 2015, MOL BIOSYST, V11, P1172, DOI 10.1039/c4mb00635f; Kulshreshtha A, 2008, CURR PHARM BIOTECHNO, V9, P400, DOI 10.2174/138920108785915111; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li JH, 2008, J MOL STRUCT, V885, P64, DOI 10.1016/j.molstruc.2007.10.020; LOHNER K, 1994, J PHARMACEUT BIOMED, V12, P1501, DOI 10.1016/0731-7085(94)00094-8; LOU J, 1973, Z NATURFORSCH C, VC 28, P511; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MARKUS G, 1967, J BIOL CHEM, V242, P4402; McCarty MF, 2007, J MED FOOD, V10, P566, DOI 10.1089/jmf.2007.621; Minic SL, 2015, RSC ADV, V5, P61787, DOI 10.1039/c5ra05534b; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SJODIN T, 1977, BIOCHIM BIOPHYS ACTA, V494, P61, DOI 10.1016/0005-2795(77)90135-0; SUDLOW G, 1975, MOL PHARMACOL, V11, P824; TERRY MJ, 1993, J BIOL CHEM, V268, P26099; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tu PH, 2009, J MOL STRUC-THEOCHEM, V894, P9, DOI 10.1016/j.theochem.2008.09.034; Yamamoto T, 2006, J MOL STRUCT, V782, P60, DOI 10.1016/j.molstruc.2005.01.024; Zaidi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071422; Zsila F, 2013, MOL PHARMACEUT, V10, P1668, DOI 10.1021/mp400027q; Zunszain PA, 2008, J MOL BIOL, V381, P394, DOI 10.1016/j.jmb.2008.06.016	39	23	23	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167973	10.1371/journal.pone.0167973	http://dx.doi.org/10.1371/journal.pone.0167973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959940	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900028
J	Zhang, ZY; Ravassa, S; Yang, WY; Petit, T; Pejchinovski, M; Zurbig, P; Lopez, B; Wei, FF; Pontillo, C; Thijs, L; Jacobs, L; Gonzalez, A; Koeck, T; Delles, C; Voigt, JU; Verhamme, P; Kuznetsova, T; Diez, J; Mischak, H; Staessen, JA				Zhang, Zhen-Yu; Ravassa, Susana; Yang, Wen-Yi; Petit, Thibault; Pejchinovski, Martin; Zuerbig, Petra; Lopez, Begona; Wei, Fang-Fei; Pontillo, Claudia; Thijs, Lutgarde; Jacobs, Lotte; Gonzalez, Arantxa; Koeck, Thomas; Delles, Christian; Voigt, Jens-Uwe; Verhamme, Peter; Kuznetsova, Tatiana; Diez, Javier; Mischak, Harald; Staessen, Jan A.			Diastolic Left Ventricular Function in Relation to Urinary and Serum Collagen Biomarkers in a General Population	PLOS ONE			English	Article							HEART-FAILURE; HYPERTENSIVE PATIENTS; DILATED CARDIOMYOPATHY; CROSS-LINKING; MYOCARDIAL FIBROSIS; FILLING PRESSURES; PROTEOME ANALYSIS; BLOOD-PRESSURE; DYSFUNCTION; ECHOCARDIOGRAPHY	Current knowledge on the pathogenesis of diastolic heart failure predominantly rests on case-control studies involving symptomatic patients with preserved ejection fraction and relying on invasive diagnostic procedures including endomyocardial biopsy. Our objective was to gain insight in serum and urinary biomarkers reflecting collagen turnover and associated with asymptomatic diastolic LV dysfunction. We randomly recruited 782 Flemish (51.3% women; 50.5 years). We assessed diastolic LV function from the early and late diastolic peak velocities of the transmitral blood flow and of the mitral annulus. By sequencing urinary peptides, we identified 70 urinary collagen fragments. In serum, we measured carboxyterminal propeptide of procollagen type 1 (PICP) as marker of collagen I synthesis and tissue inhibitor of matrix metalloproteinase type 1 (TIMP-1), an inhibitor of collagen-degrading enzymes. In multivariable-adjusted analyses with Bonferroni correction, we expressed effect sizes per 1-SD in urinary collagen I (uCI) or collagen III (uCIII) fragments. In relation to uCI fragments, e' decreased by 0.183 cm/s (95% confidence interval, 0.017 to 0.350; p = 0.025), whereas E/e' increased by 0.210 (0.067 to 0.353; p = 0.0012). E/e' decreased with uCIII by 0.168 (0.021 to 0.316; p = 0.018). Based on age-specific echocardiographic criteria, 182 participants (23.3%) had subclinical diastolic LV dysfunction. Partial least squares discriminant analysis contrasting normal vs. diastolic LV dysfunction confirmed the aforementioned associations with the uCI and uCIII fragments. PICP and TIMP-1 increased in relation to uCI (p<0.0001), whereas these serum markers decreased with uCIII (p <= 0.0006). Diastolic LV dysfunction was associated with higher levels of TIMP-1 (653 vs. 696 ng/mL; p = 0.013). In a general population, the non-invasively assessed diastolic LV function correlated inversely with uCI and serum markers of collagen I deposition, but positively with uCIII. These observations generalise previous studies in patients to randomly recruited people, in whom diastolic LV function ranged from normal to subclinical impairment, but did not encompass overt diastolic heart failure.	[Zhang, Zhen-Yu; Yang, Wen-Yi; Petit, Thibault; Wei, Fang-Fei; Thijs, Lutgarde; Jacobs, Lotte; Kuznetsova, Tatiana; Staessen, Jan A.] Univ Leuven, Dept Cardiovasc Dis, KU Leuven, Res Unit Hypertens & Cardiovasc Epidemiol,Studies, Leuven, Belgium; [Ravassa, Susana; Lopez, Begona; Gonzalez, Arantxa; Diez, Javier] Univ Navarra, Ctr Appl Med, Program Cardiovasc Dis, Pamplona, Spain; [Ravassa, Susana; Lopez, Begona; Gonzalez, Arantxa; Diez, Javier] Inst Invest Sanitaria Navarra, Pamplona, Spain; [Pejchinovski, Martin; Zuerbig, Petra; Pontillo, Claudia; Koeck, Thomas; Mischak, Harald] Mosa Diagnost & Therapeut AG, Hannover, Germany; [Delles, Christian] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Voigt, Jens-Uwe] Univ Leuven, KU Leuven, Dept Cardiovasc Dis, Res Unit Cardiol, Leuven, Belgium; [Verhamme, Peter] Univ Leuven, Dept Cardiovasc Dis, KU Leuven, Ctr Mol & Vasc Biol, Leuven, Belgium; [Diez, Javier] Univ Navarra, Univ Navarra Clin, Dept Cardiol & Cardiac Surg, Pamplona, Spain; [Staessen, Jan A.] Maastricht Univ, R&D Grp VitaK, Maastricht, Netherlands	KU Leuven; University of Navarra; University of Glasgow; KU Leuven; KU Leuven; University of Navarra; Maastricht University	Staessen, JA (corresponding author), Univ Leuven, Dept Cardiovasc Dis, KU Leuven, Res Unit Hypertens & Cardiovasc Epidemiol,Studies, Leuven, Belgium.; Staessen, JA (corresponding author), Maastricht Univ, R&D Grp VitaK, Maastricht, Netherlands.	jan.staessen@med.kuleuven.be	Díez, Javier/D-7014-2017; Kuznetsova, Tatiana/ABI-5662-2020; Ravassa, Susana/I-2567-2017; Yang, Wenyi/ABA-5526-2021; Staessen, Jan A/A-1065-2011; Zhang, Zhenyu/GZL-8479-2022; González, Arantxa/D-6860-2017	Díez, Javier/0000-0002-3414-6919; Kuznetsova, Tatiana/0000-0003-4293-4576; Ravassa, Susana/0000-0001-5926-5677; Staessen, Jan A/0000-0002-3026-1637; Zhang, Zhenyu/0000-0002-3785-7417; González, Arantxa/0000-0001-5986-6528; Lopez Salazar, Begona/0000-0001-8508-698X; Yang, Wen-Yi/0000-0003-1279-0866; Verhamme, Anne/0000-0002-2201-1865; Zurbig, Petra/0000-0003-3465-2173; Voigt, Jens-Uwe/0000-0002-0575-1888; Thijs, Lutgarde/0000-0002-8108-2356; Mischak, Harald/0000-0003-0323-0306; Pejchinovski, Martin/0000-0002-8029-5800	European Union [HEALTH-FP7-278249-EUMASCARA, HEALTH-F7-305507 HOMAGE]; European Research Council [2011-294713-EPLORE, 713601-uPROPHET]; Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium [G.0881.13, G.088013, 11Z0916N]	European Union(European Commission); European Research Council(European Research Council (ERC)European Commission); Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium(FWO)	The European Union (HEALTH-FP7-278249-EUMASCARA, HEALTH-F7-305507 HOMAGE) and the European Research Council (Advanced Researcher Grant 2011-294713-EPLORE and Proof-of-Concept Grant 713601-uPROPHET) and the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13, G.088013, and 11Z0916N) currently support the Studies Coordinating Centre in Leuven. The funders provide support in the form of salaries for authors (ZYZ, WYY, TP, FFW, LT, LJ), but did not have any additional role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	[Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; Aoki T, 2011, CIRC J, V75, P2605, DOI 10.1253/circj.CJ-11-0568; BISHOP JE, 1990, J MOL CELL CARDIOL, V22, P1157, DOI 10.1016/0022-2828(90)90079-H; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Cianciulli TF, 2010, WORLD J CARDIOL, V2, P163, DOI 10.4330/wjc.v2.i7.163; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gonzalez A, 2010, HYPERTENSION, V55, P1418, DOI 10.1161/HYPERTENSIONAHA.109.149112; Gottdiener JS, 2004, J AM SOC ECHOCARDIOG, V17, P1086, DOI 10.1016/j.echo.2004.07.013; Grammer JB, 2005, BASIC RES CARDIOL, V100, P288, DOI 10.1007/s00395-005-0515-x; HESS OM, 1981, CIRCULATION, V63, P360, DOI 10.1161/01.CIR.63.2.360; Izawa H, 2005, CIRCULATION, V112, P2940, DOI 10.1161/CIRCULATIONAHA.105.571653; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kasner M, 2011, J AM COLL CARDIOL, V57, P977, DOI 10.1016/j.jacc.2010.10.024; KLAPPACHER G, 1995, AM J CARDIOL, V75, P913, DOI 10.1016/S0002-9149(99)80686-9; Klein J, 2014, ELECTROPHORESIS, V35, P1060, DOI 10.1002/elps.201300327; Kloch-Badelek M, 2012, CARDIOVASC ULTRASOUN, V10, DOI 10.1186/1476-7120-10-10; Kuznetsova T, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002882; Kuznetsova T, 2012, EUR HEART J, V33, P2342, DOI 10.1093/eurheartj/ehs185; Kuznetsova T, 2010, AM J EPIDEMIOL, V172, P440, DOI 10.1093/aje/kwq142; Kuznetsova T, 2009, CIRC-HEART FAIL, V2, P105, DOI 10.1161/CIRCHEARTFAILURE.108.822627; LAPIERE C M, 1977, Connective Tissue Research, V5, P21; Lazar C, 2016, J PROTEOME RES, V15, P1116, DOI 10.1021/acs.jproteome.5b00981; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li Y, 2007, HYPERTENSION, V49, P1291, DOI 10.1161/HYPERTENSIONAHA.106.085498; Longobardo L, 2014, EUR HEART J-CARD IMG, V15, P1, DOI 10.1093/ehjci/jet116; Lopez B, 2001, CIRCULATION, V104, P286, DOI 10.1161/01.CIR.104.3.286; Lopez B, 2006, J AM COLL CARDIOL, V48, P89, DOI 10.1016/j.jacc.2006.01.077; Lopez B, 2016, J AM COLL CARDIOL, V67, P251, DOI 10.1016/j.jacc.2015.10.063; Lopez B, 2015, J AM COLL CARDIOL, V65, P2449, DOI 10.1016/j.jacc.2015.04.026; Lopez B, 2012, HYPERTENSION, V60, P677, DOI 10.1161/HYPERTENSIONAHA.112.196113; Meleth S, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-7; Mischak H, 2013, CLIN BIOCHEM, V46, P432, DOI 10.1016/j.clinbiochem.2012.09.025; Mischak H, 2010, PROTEOM CLIN APPL, V4, P464, DOI 10.1002/prca.200900189; O'Brien E, 2003, J HYPERTENS, V21, P821, DOI 10.1097/00004872-200305000-00001; Pauschinger M, 1999, CIRCULATION, V99, P2750, DOI 10.1161/01.CIR.99.21.2750; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Staessen JA, 2001, J HYPERTENS, V19, P1349, DOI 10.1097/00004872-200108000-00002; Velagaleti RS, 2012, ARTERIOSCLER THROMB, V30, P2283; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4; Wei FF, 2016, EBIOMEDICINE, V4, P162, DOI 10.1016/j.ebiom.2016.01.011; Wei S, 1999, J CARD FAIL, V5, P117, DOI 10.1016/S1071-9164(99)90034-9; Westermann D, 2011, CIRC-HEART FAIL, V4, P44, DOI 10.1161/CIRCHEARTFAILURE.109.931451; Yang WY, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0272-2; Zhang ZY, 2015, HYPERTENSION, V66, P52, DOI 10.1161/HYPERTENSIONAHA.115.05296; Zhang ZY, 2014, INT J CARDIOL, V176, P158, DOI 10.1016/j.ijcard.2014.07.014; Zile MR, 2015, CIRCULATION, V131, P1247, DOI 10.1161/CIRCULATIONAHA.114.013215; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	49	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167582	10.1371/journal.pone.0167582	http://dx.doi.org/10.1371/journal.pone.0167582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959898	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000392753900011
J	Kotter, T; Ritter, J; Katalinic, A; Voltmer, E				Koetter, Thomas; Ritter, Johanna; Katalinic, Alexander; Voltmer, Edgar			Predictors of Participation of Sophomore Medical Students in a Health-Promoting Intervention: An Observational Study	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; STRESS REDUCTION; DEPRESSION SCALE; HOSPITAL ANXIETY; CONTROLLED-TRIAL; BEHAVIOR; EXPERIENCES; RELAXATION; PATTERNS	Medical students and doctors have to be particularly stress-resilient, as both medical education and practice are considered very stressful. Specific stressors can lead to increased risks of developing, for example, depression, anxiety and burnout. Relaxation techniques have proven to be effective for the prevention of these outcomes in student populations. However, only a very few medical students practice relaxation techniques regularly early on in their studies. Furthermore, it is unclear which students make use of stress-management offers and hence whether vulnerable students are generally reachable. Therefore, the aim of our study was to explore predictors of participating in a voluntary stress management course for sophomore medical students. One cohort of freshmen at a German medical school was surveyed at the end of the freshman year [t1] and at the end of the sophomore year [t2]. In addition to sociodemographic information, we captured perceived study stress, self-rated general health and mental health and dimensions of study-related behaviour and experience as potential predictors of participation at t1. During the sophomore year, we offered the participants a progressive muscle relaxation (PMR) beginners' course. At t2, we registered participation status. We used binary logistic regression analyses in order to assess correlations between potential predictors and participation. About one third of the whole class took part in the course. The main reason for non-participation was "no time". Being female and higher levels of anxiety were the strongest predictors of course participation. Career ambition (the higher, the less likely to participate) and emotional distancing (the higher, the more likely to participate) were further significant predictors. Future interventions should be attractive to both male and female medical students. Ideally, for every hour of stress management teaching, the curriculum should be cut by at least the same amount of time.	[Koetter, Thomas; Ritter, Johanna; Katalinic, Alexander] Univ Lubeck, Inst Social Med & Epidemiol, Lubeck, Germany; [Voltmer, Edgar] Friedensau Adventist Univ, Dept Hlth Sci, Mockern, Germany	University of Lubeck	Kotter, T (corresponding author), Univ Lubeck, Inst Social Med & Epidemiol, Lubeck, Germany.	thomas.koetter@uksh.de	Katalinic, Alexander/D-2512-2010	Katalinic, Alexander/0000-0003-0490-1554	Lubeck Medical School [E18-2011]	Lubeck Medical School	This research was supported by a grant from Lubeck Medical School (bit.ly/1pcsaZk) received by TK (E18-2011).	Aster-Schenck I, 2010, GMS Z MED AUSBILD, V27, DOI DOI 10.3205/ZMA000698; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; CARLSON CR, 1993, J CONSULT CLIN PSYCH, V61, P1059, DOI 10.1037/0022-006X.61.6.1059; Chew-Graham CA, 2003, MED EDUC, V37, P873, DOI 10.1046/j.1365-2923.2003.01627.x; Dahlin Marie E, 2007, BMC Med Educ, V7, P6, DOI 10.1186/1472-6920-7-6; de Vibe M, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-107; Dehghan-nayeri N, 2011, COMPLEMENT THER MED, V19, P194, DOI 10.1016/j.ctim.2011.06.002; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; DeSalvo KB, 2006, QUAL LIFE RES, V15, P191, DOI 10.1007/s11136-005-0887-2; Dunn LB, 2008, ACAD PSYCHIATR, V32, P44, DOI 10.1176/appi.ap.32.1.44; Dyrbye LN, 2006, ACAD MED, V81, P354, DOI 10.1097/00001888-200604000-00009; GABBARD GO, 1985, JAMA-J AM MED ASSOC, V254, P2926, DOI 10.1001/jama.254.20.2926; General Medical Council, 2014, STAT MED ED PRACT UK; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Ishak W, 2013, CLIN TEACH, V10, P242, DOI 10.1111/tct.12014; Jordan S, 2013, BUNDESGESUNDHEITSBLA, V56, P878, DOI 10.1007/s00103-013-1664-y; Kjeldstadli Kari, 2006, BMC Med Educ, V6, P48, DOI 10.1186/1472-6920-6-48; Kotter T, 2015, PERSPECT MED EDUC, V4, P128, DOI 10.1007/s40037-015-0189-5; Kotter T, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-134; Kotter Thomas, 2013, GMS Z Med Ausbild, V30, pDoc22, DOI 10.3205/zma000865; Mata DA, 2015, JAMA-J AM MED ASSOC, V314, P2373, DOI 10.1001/jama.2015.15845; McGrady A, 2012, APPL PSYCHOPHYS BIOF, V37, P253, DOI 10.1007/s10484-012-9198-x; Moffat KJ, 2004, MED EDUC, V38, P482, DOI 10.1046/j.1365-2929.2004.01814.x; NOTMAN MT, 1984, COMPR PSYCHIAT, V25, P355, DOI 10.1016/0010-440X(84)90068-3; Quince TA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001519; Rosenzweig S, 2003, TEACH LEARN MED, V15, P88, DOI 10.1207/S15328015TLM1502_03; Schaarschmidt U., 2008, ARBEITSBEZOGENES VER; Shapiro SL, 1998, J BEHAV MED, V21, P581, DOI 10.1023/A:1018700829825; Snaith R, 2011, HOSP ANXIETY DEPRESS; Vaidya V, 2012, J WOMENS HEALTH, V21, P140, DOI 10.1089/jwh.2011.2876; van Dijk I, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0302-9; VITALIANO PP, 1984, J NERV MENT DIS, V172, P730, DOI 10.1097/00005053-198412000-00006; Voltmer E, 2012, MED TEACH, V34, P840, DOI 10.3109/0142159X.2012.706339; Voltmer E, 2010, MED TEACH, V32, pE422, DOI 10.3109/0142159X.2010.496008; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Warnecke E, 2011, MED EDUC, V45, P381, DOI 10.1111/j.1365-2923.2010.03877.x; Wild K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114967; Woolf Katherine, 2007, BMC Med Educ, V7, P50, DOI 10.1186/1472-6920-7-50; World Health Organization, HLTH INT SURV INT HA; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168104	10.1371/journal.pone.0168104	http://dx.doi.org/10.1371/journal.pone.0168104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27942029	Green Submitted, Green Published, gold			2022-12-27	WOS:000392745600051
J	Li, HY; Zheng, L; Mo, YQ; Gong, Q; Jiang, AH; Zhao, J				Li, Huanyin; Zheng, Lan; Mo, Yanqing; Gong, Qi; Jiang, Aihua; Zhao, Jing			Voltage-Dependent Anion Channel 1(VDAC1) Participates the Apoptosis of the Mitochondrial Dysfunction in Desminopathy	PLoS One			English	Article							ACTIVATING TRANSCRIPTION FACTOR-2; SUBCELLULAR-LOCALIZATION; BCL-XL; BOUND HEXOKINASE; CELL-DEATH; BAX; BCL-X(L); PROTEIN; VDAC; ATF2	Desminopathies caused by the mutation in the gene coding for desmin are genetically protein aggregation myopathies. Mitochondrial dysfunction is one of pathological changes in the desminopathies at the earliest stage. The molecular mechanisms of mitochondria dysfunction in desminopathies remain exclusive. VDAC1 regulates mitochondrial uptake across the outer membrane and mitochondrial outer membrane permeabilization (MOMP). Relationships between desminopathies and Voltage-dependent anion channel 1 (VDAC1) remain unclear. Here we successfully constructed the desminopathy rat model, evaluated with conventional stains, containing hematoxylin and eosin (HE), Gomori Trichrome (MGT), (PAS), red oil (ORO), NADH-TR, SDH staining and immunohistochemistry. Immunofluorescence results showed that VDAC1 was accumulated in the desmin highly stained area of muscle fibers of desminopathy patients or desminopathy rat model compared to the normal ones. Meanwhile apoptosis related proteins bax and ATF2 were involved in desminopathy patients and desminopathy rat model, but not bcl-2, bcl-xl or HK2. VDAC1 and desmin are closely relevant in the tissue splices of deminopathies patients and rats with desminopathy at protein lever. Moreover, apoptotic proteins are also involved in the desminopathies, like bax, ATF2, but not bcl-2, bcl-xl or HK2. This pathological analysis presents the correlation between VDAC1 and desmin, and apoptosis related proteins are correlated in the desminopathy. Furthermore, we provide a rat model of desminopathy for the investigation of desmin related myopathy.	[Li, Huanyin; Zheng, Lan; Mo, Yanqing; Gong, Qi; Jiang, Aihua; Zhao, Jing] Fudan Univ, Shanghai Minhang Hosp, Dept Internal Neurol, Cent Hosp Minhang Dist, Shanghai, Peoples R China	Fudan University	Zhao, J (corresponding author), Fudan Univ, Shanghai Minhang Hosp, Dept Internal Neurol, Cent Hosp Minhang Dist, Shanghai, Peoples R China.	zjmzx16f@126.com			Minhang District Natural Science Foundation Project, ShangHai, China [2016MHZ20]	Minhang District Natural Science Foundation Project, ShangHai, China	This work was supported by Minhang District Natural Science Foundation Project in 2016 (2016MHZ20), ShangHai, China.	Banerjee J, 2004, BIOCHEM BIOPH RES CO, V323, P310, DOI 10.1016/j.bbrc.2004.08.094; Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003; Berger AJ, 2003, CANCER RES, V63, P8103; Berman SB, 2009, J CELL BIOL, V184, P707, DOI 10.1083/jcb.200809060; Bhoumik A, 2008, P NATL ACAD SCI USA, V105, P1674, DOI 10.1073/pnas.0706057105; Breuer ME, 2012, J INHERIT METAB DIS, V35, P193, DOI 10.1007/s10545-011-9375-8; BUSTAMANTE E, 1981, J BIOL CHEM, V256, P8699; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Capetanaki Y, 2015, CURR OPIN CELL BIOL, V32, P113, DOI 10.1016/j.ceb.2015.01.004; Chami M, 2004, J BIOL CHEM, V279, P54581, DOI 10.1074/jbc.M409663200; Chen YB, 2011, J CELL BIOL, V195, P263, DOI 10.1083/jcb.201108059; Cheng QL, 2011, FEBS LETT, V585, P328, DOI 10.1016/j.febslet.2010.12.008; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; Dong Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158672; Ferrer Isidre, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000793; Goldfarb LG, 2008, ADV EXP MED BIOL, V642, P131; GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033; Hong D, 2011, NEUROPATH APPL NEURO, V37, P257, DOI 10.1111/j.1365-2990.2010.01112.x; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Joanne P, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-4; Kim JE, 2014, BIOCHEM BIOPH RES CO, V447, P184, DOI 10.1016/j.bbrc.2014.03.124; Kostareva A, 2008, J MUSCLE RES CELL M, V29, P25, DOI 10.1007/s10974-008-9139-8; Krasnov GS, 2013, EXPERT OPIN THER TAR, V17, P1221, DOI 10.1517/14728222.2013.833607; Lau E, 2012, CELL, V148, P543, DOI 10.1016/j.cell.2012.01.016; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; Liu ZY, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0188-y; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Monaco G, 2015, J BIOL CHEM, V290, P9150, DOI 10.1074/jbc.M114.622514; NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010; NAKASHIMA RA, 1988, CANCER RES, V48, P913; Nordigarden A, 2009, BLOOD, V113, P2302, DOI 10.1182/blood-2008-07-167023; Panickar KS, 2005, NEUROSCIENCE, V135, P73, DOI 10.1016/j.neuroscience.2005.02.052; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Schroder R, 2003, HUM MOL GENET, V12, P657, DOI 10.1093/hmg/ddg060; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Sugawara M, 2000, NEUROLOGY, V55, P986, DOI 10.1212/WNL.55.7.986; Szabadkai G, 2004, FEBS LETT, V567, P111, DOI 10.1016/j.febslet.2004.04.059; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Vela L, 2015, CURR OPIN PHARMACOL, V23, P74, DOI 10.1016/j.coph.2015.05.014; Vela L, 2013, J BIOL CHEM, V288, P4935, DOI 10.1074/jbc.M112.422204; Wang TF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090780; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Yi XL, 2003, J BIOL CHEM, V278, P16992, DOI 10.1074/jbc.M300039200; Yin W, 2006, NEUROBIOL DIS, V21, P358, DOI 10.1016/j.nbd.2005.07.015	49	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167908	10.1371/journal.pone.0167908	http://dx.doi.org/10.1371/journal.pone.0167908			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941998	Green Published, Green Submitted, gold			2022-12-27	WOS:000392745600037
J	Wang, XH; Liu, XY; Li, LY; Zhang, FM; Hu, M; Ren, FJ; Chi, LL; Linhardt, RJ				Wang, Xiaohua; Liu, Xinyue; Li, Lingyun; Zhang, Fuming; Hu, Min; Ren, Fuji; Chi, Lianli; Linhardt, Robert J.			GlycCompSoft: Software for Automated Comparison of Low Molecular Weight Heparins Using Top-Down LC/MS Data	PLoS One			English	Article							MASS-SPECTROMETRY	Low molecular weight heparins are complex polycomponent drugs that have recently become amenable to top-down analysis using liquid chromatography-mass spectrometry. Even using open source deconvolution software, DeconTools, and automatic structural assignment software, GlycReSoft, the comparison of two or more low molecular weight heparins is extremely time-consuming, taking about a week for an expert analyst and provides no guarantee of accuracy. Efficient data processing tools are required to improve analysis. This study uses the programming language of Microsoft Excel (TM) Visual Basic for Applications to extend its standard functionality for macro functions and specific mathematical modules for mass spectrometric data processing. The program developed enables the comparison of top-down analytical glycomics data on two or more low molecular weight heparins. The current study describes a new program, GlycCompSoft, which has a low error rate with good time efficiency in the automatic processing of large data sets. The experimental results based on three lots of Lovenox (R), Clexane (R) and three generic enoxaparin samples show that the run time of GlycCompSoft decreases from 11 to 2 seconds when the data processed decreases from 18000 to 1500 rows.	[Wang, Xiaohua; Hu, Min; Ren, Fuji] Hefei Univ Technol, Sch Comp & Informat, Anhui Prov Key Lab Affect Comp & Adv Intelligent, Hefei, Peoples R China; [Wang, Xiaohua; Liu, Xinyue; Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA; [Liu, Xinyue; Chi, Lianli] Shandong Univ, Natl Glycoengn Res Ctr, Jinan, Peoples R China; [Li, Lingyun] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Ren, Fuji] Univ Tokushima, Dept Informat Sci & Intelligent Syst, Tokushima, Japan	Hefei University of Technology; Rensselaer Polytechnic Institute; Shandong University; State University of New York (SUNY) System; Wadsworth Center; Tokushima University	Wang, XH (corresponding author), Hefei Univ Technol, Sch Comp & Informat, Anhui Prov Key Lab Affect Comp & Adv Intelligent, Hefei, Peoples R China.; Wang, XH; Linhardt, RJ (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA.	xh_wang@hfut.edu.cn; linhar@rpi.edu	wang, xiao/HGB-7081-2022; Liu, Xinyue/AAR-6887-2021; Chi, Lianli/B-9149-2015	wang, xiao/0000-0002-4088-3341; Liu, Xinyue/0000-0002-0934-4155; Chi, Lianli/0000-0003-1126-1022	National Institutes of Health [HL125371, GM38060, GM090127, HL096972, HL10172]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125371, R01HL096972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090127, R01GM038060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by Grants from the National Institutes of Health in the form of Grants HL125371, GM38060, GM090127, HL096972, and HL10172.	[Anonymous], 2015, DECONTOOLS DECON2LS, V11, P17; Apte A, 2010, METHODS MOL BIOL, V600, P269, DOI 10.1007/978-1-60761-454-8_19; Bennett L, 2015, 5 INVALUABLE TECHNIQ, V6, P30; Cai WX, 2016, EXPERT REV PROTEOMIC, V13, P717, DOI 10.1080/14789450.2016.1209414; Cox R, 2007, REGULAR EXPRESSION M, P1; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Kronewitter SR, 2012, PROTEOMICS, V12, P2523, DOI 10.1002/pmic.201100273; Li DY, 2014, CARBOHYD POLYM, V99, P339, DOI 10.1016/j.carbpol.2013.08.074; Li GY, 2014, ANAL CHEM, V86, P6626, DOI 10.1021/ac501301v; Li LY, 2012, ANAL CHEM, V84, P8822, DOI 10.1021/ac302232c; Linhardt RJ, 1999, SEMINARS THROMBOSIS; Linhardt RJ., 1991, CHEM IND; Maxwell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045474; Slysz G.W., 2010, P 58 ASMS C MASS SPE; Thaysen-Andersen M, 2014, BBA-PROTEINS PROTEOM, V1844, P1437, DOI 10.1016/j.bbapap.2014.05.002; Tu CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160160; Xiao ZP, 2011, J MED CHEM, V54, P603, DOI 10.1021/jm101381k; Xu XH, 2015, CARBOHYD RES, V407, P26, DOI 10.1016/j.carres.2015.01.016	18	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167727	10.1371/journal.pone.0167727	http://dx.doi.org/10.1371/journal.pone.0167727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942011	Green Published, gold			2022-12-27	WOS:000392745600027
J	Yang, CC; Su, FC; Yang, PC; Lin, HT; Guo, LY				Yang, Chia-Chi; Su, Fong-Chin; Yang, Po-Ching; Lin, Hwai-Ting; Guo, Lan-Yuen			Characteristics of the Motor Units during Sternocleidomastoid Isometric Flexion among Patients with Mechanical Neck Disorder and Asymptomatic Individuals	PLoS One			English	Article							SURFACE EMG SIGNALS; EXPERIMENTAL MUSCLE PAIN; UPPER TRAPEZIUS MUSCLE; VOLUNTARY CONTRACTIONS; CERVICAL-SPINE; FIRING RATE; RECRUITMENT THRESHOLD; DISCHARGE RATES; CEREBRAL-PALSY; SYNCHRONIZATION	Mechanical neck disorder is a widespread and non-neurological musculoskeletal condition resulting from modern lifestyles. Presently, the fundamental electrophysiological properties of the motor units of the sternocleidomastoid muscles and the characteristics of the short-term synchronization of the motor unit in patients with neck pain are ambiguous. This study therefore aims to clarify the fundamental electrophysiological properties of the motor units of the sternocleidomastoid muscles in patients with mechanical neck disorder and in asymptomatic individuals. We further investigated whether alterations in the degree of motor unit short-term synchronization occur. The surface electrophysiological signals of the bilateral sternal heads of the sternocleidomastoid muscles of twelve patients with mechanical neck disorder and asymptomatic individuals were detected at 25% of the maximum voluntary contraction during cervical isometric flexion and then decomposed into individual motor unit action potential trains. We found that the patients with mechanical neck disorder showed significantly higher initial and mean firing rates of the sternocleidomastoid muscles and displayed substantially lower motor unit short-term synchronization values compared with the asymptomatic subjects. Consequently, these convincing findings support the assertion that patients with mechanical neck disorder display altered neuromuscular control strategies, such as the reinforcement of motor unit recruitment firing rates in the sternocleidomastoid muscles. The motor units of these patients also revealed neural recruitment strategies with relatively poor efficiency when executing the required motor tasks.	[Yang, Chia-Chi; Su, Fong-Chin] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan, Taiwan; [Su, Fong-Chin] Natl Cheng Kung Univ, Med Device Innovat Ctr, Tainan, Taiwan; [Yang, Po-Ching; Lin, Hwai-Ting; Guo, Lan-Yuen] Kaohsiung Med Univ, Dept Sports Med, Coll Med, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University; Kaohsiung Medical University	Guo, LY (corresponding author), Kaohsiung Med Univ, Dept Sports Med, Coll Med, Kaohsiung, Taiwan.	yuen@kmu.edu.tw	, 郭藍遠/AAY-8243-2021; Lin, Hwai-Ting/D-5123-2009; Guo, Lan-Yuen/C-7439-2009; SU, FONG-CHIN/C-8094-2011	, 郭藍遠/0000-0002-6256-355X; Guo, Lan-Yuen/0000-0002-6256-355X; SU, FONG-CHIN/0000-0002-3870-4842	National Health Research Institutes, Taiwan [NHRI-EX103-10204EI]	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work is financially supported by National Health Research Institutes, Taiwan. (NHRI-EX103-10204EI, http//english.nhri.org.tw/NHRI_WEB/nhriw001Action.do) Grant Recipient: LYG.	Ariens GAM, 2001, AM J IND MED, V39, P180, DOI 10.1002/1097-0274(200102)39:2<180::AID-AJIM1005>3.0.CO;2-#; BELLEMARE F, 1983, J NEUROPHYSIOL, V50, P1380, DOI 10.1152/jn.1983.50.6.1380; Bernard B., 1997, MUSCULOSKELETAL DISO; Binder MD, 1990, SEGMENTAL MOTOR SYST; Borghouts JAJ, 1998, PAIN, V77, P1, DOI 10.1016/S0304-3959(98)00058-X; Chiu TTW, 2002, CLIN REHABIL, V16, P851, DOI 10.1191/0269215502cr550oa; DATTA AK, 1990, J PHYSIOL-LONDON, V422, P397, DOI 10.1113/jphysiol.1990.sp017991; DATTA AK, 1991, J PHYSIOL-LONDON, V432, P401, DOI 10.1113/jphysiol.1991.sp018391; De Luca CJ, 2012, J NEUROPHYSIOL, V107, P178, DOI 10.1152/jn.00961.2010; De Luca CJ, 2010, J NEUROPHYSIOL, V104, P1034, DOI 10.1152/jn.01018.2009; DE LUCA CJ, 1993, J NEUROPHYSIOL, V70, P2010, DOI 10.1152/jn.1993.70.5.2010; DE LUCA CJ, 1994, TRENDS NEUROSCI, V17, P299, DOI 10.1016/0166-2236(94)90064-7; Defreitas JM, 2014, MUSCLE NERVE, V49, P575, DOI 10.1002/mus.23978; Falla D, 2008, EXP BRAIN RES, V191, P363, DOI 10.1007/s00221-008-1530-6; Falla D, 2004, DISABIL REHABIL, V26, P712, DOI 10.1080/09638280410001704287; Falla D, 2003, CLIN NEUROPHYSIOL, V114, P488, DOI 10.1016/S1388-2457(02)00418-2; Falla D, 2004, SPINE, V29, P1436, DOI 10.1097/01.BRS.0000128759.02487.BF; Falla D, 2010, CLIN NEUROPHYSIOL, V121, P744, DOI 10.1016/j.clinph.2009.12.029; Falla DL, 2004, SPINE, V29, P2108, DOI 10.1097/01.brs.0000141170.89317.0e; Farina D, 2004, J NEUROPHYSIOL, V91, P1250, DOI 10.1152/jn.00620.2003; FARMER SF, 1990, J PHYSIOL-LONDON, V428, P467, DOI 10.1113/jphysiol.1990.sp018222; FARMER SF, 1993, J PHYSIOL-LONDON, V463, P83, DOI 10.1113/jphysiol.1993.sp019585; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Gazzoni M, 2004, J NEUROSCI METH, V136, P165, DOI 10.1016/j.jneumeth.2004.01.002; Gibbs J, 1999, DEV MED CHILD NEUROL, V41, P465, DOI 10.1017/S0012162299001012; GOGIA PP, 1991, SPINE, V16, P1135, DOI 10.1097/00007632-199110000-00001; Guo LY, 2012, J BACK MUSCULOSKELET, V25, P47, DOI 10.3233/BMR-2012-0309; Hagen KB, 1997, SPINE, V22, P1501, DOI 10.1097/00007632-199707010-00015; Hanten WP, 2000, ARCH PHYS MED REHAB, V81, P62, DOI 10.1053/apmr.2000.0810062; Holtermann A, 2005, J ELECTROMYOGR KINES, V15, P131, DOI 10.1016/j.jelekin.2004.09.003; Johnston V, 2008, SPINE, V33, P555, DOI 10.1097/BRS.0b013e3181657d0d; Jordan A, 1997, J MANIP PHYSIOL THER, V20, P468; Kallenberg LAC, 2006, EUR J APPL PHYSIOL, V96, P203, DOI 10.1007/s00421-004-1215-1; Kallenberg LAC, 2011, MUSCLE NERVE, V43, P112, DOI 10.1002/mus.21803; KIRKWOOD PA, 1982, J PHYSIOL-LONDON, V327, P105, DOI 10.1113/jphysiol.1982.sp014223; Kleine BU, 2008, J ELECTROMYOGR KINES, V18, P652, DOI 10.1016/j.jelekin.2007.01.010; Kleine BU, 2007, J ELECTROMYOGR KINES, V17, P535, DOI 10.1016/j.jelekin.2006.05.003; Kleine BU, 2000, MUSCLE NERVE, V23, P1005, DOI 10.1002/1097-4598(200007)23:7<1005::AID-MUS2>3.0.CO;2-2; Korhonen T, 2003, OCCUP ENVIRON MED, V60, P475, DOI 10.1136/oem.60.7.475; Lee HJ, 2004, SPINE, V29, P33, DOI 10.1097/01.BRS.0000103944.10408.BA; Lukacs M, 2005, CLIN NEUROPHYSIOL, V116, P1566, DOI 10.1016/j.clinph.2005.04.005; Madeleine P, 2006, CLIN NEUROPHYSIOL, V117, P2436, DOI 10.1016/j.clinph.2006.06.753; McNeil CJ, 2011, J PHYSIOL-LONDON, V589, P3533, DOI 10.1113/jphysiol.2011.207191; Nawab SH, 2010, CLIN NEUROPHYSIOL, V121, P1602, DOI 10.1016/j.clinph.2009.11.092; Palmer KT, 2007, SCAND J WORK ENV HEA, V33, P165, DOI 10.5271/sjweh.1134; Rau G, 1997, J ELECTROMYOGR KINES, V7, P233, DOI 10.1016/S1050-6411(97)00007-2; Rose J, 2005, DEV MED CHILD NEUROL, V47, P329, DOI 10.1017/S0012162205000629; Schmied A, 1999, CLIN NEUROPHYSIOL, V110, P960, DOI 10.1016/S1388-2457(99)00032-2; SCHMIED A, 1994, J PHYSIOL-LONDON, V480, P369, DOI 10.1113/jphysiol.1994.sp020367; SEARS TA, 1976, J PHYSIOL-LONDON, V263, P357, DOI 10.1113/jphysiol.1976.sp011635; Semmler JG, 2002, EXERC SPORT SCI REV, V30, P8, DOI 10.1097/00003677-200201000-00003; Sjolander Per, 2002, J Electromyogr Kinesiol, V12, P167, DOI 10.1016/S1050-6411(02)00017-2; Standring S., 2016, GRAYS ANATOMY ANATOM, V41; Stock MS, 2012, MUSCLE NERVE, V45, P100, DOI 10.1002/mus.22266; UHLIG Y, 1995, J ORTHOP RES, V13, P240, DOI 10.1002/jor.1100130212; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Yang CC, 2014, EUR SPINE J, V23, P1743, DOI 10.1007/s00586-014-3413-9; Yang CC, 2012, SENSORS-BASEL, V12, P17463, DOI 10.3390/s121217463; Zazula D, 2005, COMPUT METH PROG BIO, V80, pS51, DOI 10.1016/S0169-2607(05)80006-9	59	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167737	10.1371/journal.pone.0167737	http://dx.doi.org/10.1371/journal.pone.0167737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941995	gold, Green Submitted, Green Published			2022-12-27	WOS:000392745600029
J	Du, ZY; Guo, W; Yang, RL; Tang, XD; Ji, T; Li, DS				Du, Zhiye; Guo, Wei; Yang, Rongli; Tang, Xiaodong; Ji, Tao; Li, Dasen			What Is the Value of Surgical Intervention for Sacral Metastases?	PLOS ONE			English	Article							QUALITY-OF-LIFE; SPINAL-CORD COMPRESSION; TUMOR RESECTION; BLOOD-LOSS; RADIOTHERAPY; CANCER; SURGERY; MANAGEMENT; TOXICITY; ONCOLOGY	Objective To investigate the impact of surgery on local control and quality of life for patients with sacral metastases and to determine whether the complications of surgery were acceptable. Methods Curettage for metastatic lesions of the sacrum was performed in 154 patients with obvious sacral nerve compression symptoms between July 1997 and July 2014. Potential risk factors were evaluated in univariate analysis for associations with local control; multivariate conditional logistic regression was used to identify the combined effects. Complications were recorded. The pre-and postoperative visual analogue scale of pain, Eastern Cooperative Oncology Group (ECOG) scores, and quality of life scores were collected to evaluate the impact of surgery. Results The cumulative survival rates were 71.8%, 41.1%, and 22.5% and the local control rates were 95.4%, 90.9%, and 79.4% at 6, 12, and 24 months, respectively. Tumors with rapid growth, the lack of preoperative radiotherapy, and application of aortic balloon occlusion were significantly associated with good local control. There were 29 (18.8%) complications related to surgery. The mean pain scores were 7.04 preoperatively, 1.66 at 1 month postoperatively (p = 0.003), and 1.51 at 3 months postoperatively (p = 0.002). The mean ECOG scores were 2.82 preoperatively and 1.47 3 months postoperatively (p < 0.001). There were significant improvements from preoperatively to 3 months postoperatively in global health status (43.3 vs. 52.1), pain (62.0 vs. 33.2), and constipation (51.4 vs. 30.3) (p< 0.001). Conclusions Surgery for sacral metastasis is effective to palliate pain rapidly and improve constipation and quality of life and has a low rate of complications.	[Du, Zhiye] Peking Univ, Dept Musculoskeletal Tumor Ctr, Beijing 100871, Peoples R China; Peoples Hosp, Beijing, Peoples R China	Peking University	Guo, W (corresponding author), Peking Univ, Dept Musculoskeletal Tumor Ctr, Beijing 100871, Peoples R China.	bonetumor@163.com	Li, D/N-4549-2019; Ji, Tao/AAI-2685-2020	Ji, Tao/0000-0001-6876-7361; Guo, Wei/0000-0003-2471-5767				AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Cella D F, 1996, Oncology (Williston Park), V10, P233; Chang EL, 2007, J NEUROSURG-SPINE, V7, P151, DOI 10.3171/SPI-07/08/151; Cummings BJ, INT J RAD ONCOL BIOL, V9, P633; Du Zhi-Ye, 2010, Orthop Surg, V2, P241, DOI 10.1111/j.1757-7861.2010.00095.x; Falicov A, 2006, SPINE, V31, P2849, DOI 10.1097/01.brs.0000245838.37817.40; Feiz-Erfan I, 2012, J NEUROSURG-SPINE, V17, P285, DOI 10.3171/2012.7.SPINE09351; FELDENZER JA, 1989, NEUROSURGERY, V25, P884, DOI 10.1227/00006123-198912000-00006; Gerszten PC, 2007, SPINE, V32, P193, DOI 10.1097/01.brs.0000251863.76595.a2; GILINSKY NH, 1983, Q J MED, V52, P40; Guo W, 2009, SPINE, V34, P1025, DOI 10.1097/BRS.0b013e31819d4127; Janjan N, 2001, SEMIN ONCOL, V28, P28, DOI 10.1053/sonc.2001.25444; Ji T, 2011, J BONE JOINT SURG BR, V93B, P1104, DOI 10.1302/0301-620X.93B8.26155; JOSEPH DL, 1973, ARCH OTOLARYNGOL, V97, P381; KETCHAM AS, 1969, AM J SURG, V118, P691, DOI 10.1016/0002-9610(69)90214-1; Kollender Y, 2003, CANCER-AM CANCER SOC, V97, P2830, DOI 10.1002/cncr.11383; Lawrence Jr W, CANCER, V33, P318; Li DS, 2013, EUR SPINE J, V22, P2069, DOI 10.1007/s00586-013-2765-x; Loblaw DA, 1998, J CLIN ONCOL, V16, P1613, DOI 10.1200/JCO.1998.16.4.1613; MAAS JM, 1948, AM J OBSTET GYNECOL, V56, P249, DOI 10.1016/0002-9378(48)90267-1; Maranzano E, 2003, TUMORI, V89, P469, DOI 10.1177/030089160308900502; Mi C, 2005, SPINE, V30, pE614, DOI 10.1097/01.brs.0000182111.64825.0f; Mizumoto M, 2011, INT J RADIAT ONCOL, V79, P208, DOI 10.1016/j.ijrobp.2009.10.056; Nader R, 2004, NEUROSURG CLIN N AM, V15, P453, DOI 10.1016/j.nec.2004.04.009; OBrien PC, 1997, RADIOTHER ONCOL, V45, P117, DOI 10.1016/S0167-8140(97)00146-1; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ozdemir MH, 1999, EUR J SURG ONCOL, V25, P44, DOI 10.1053/ejso.1998.0598; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; Piccioli A, 2014, INJURY, V45, P412, DOI 10.1016/j.injury.2013.09.025; PILEPICH MV, 1984, INT J RADIAT ONCOL, V10, P1861, DOI 10.1016/0360-3016(84)90263-3; Quraishi NA, 2010, J BONE JOINT SURG BR, V92B, P1054, DOI 10.1302/0301-620X.92B8.22296; Quraishi NA, 2012, EUR SPINE J, V21, P1984, DOI 10.1007/s00586-012-2394-9; Rades D, 2005, RADIOTHER ONCOL, V75, P70, DOI 10.1016/j.radonc.2004.12.013; Raque GH, 2001, J SURG ONCOL, V76, P301, DOI 10.1002/jso.1050; SMIT WGJM, 1990, INT J RADIAT ONCOL, V18, P23, DOI 10.1016/0360-3016(90)90262-I; Tang XD, 2010, J BONE JOINT SURG AM, V92A, P1747, DOI 10.2106/JBJS.I.01333; Tang XD, 2009, CLIN ORTHOP RELAT R, V467, P1599, DOI 10.1007/s11999-008-0483-1; Tomita K, 2006, J ORTHOP SCI, V11, P3, DOI 10.1007/s00776-005-0964-y; Wu JA, 2010, CANCER-AM CANCER SOC, V116, P3875, DOI 10.1002/cncr.25126; XU RM, 1995, J SPINAL DISORD, V8, P352	40	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168313	10.1371/journal.pone.0168313	http://dx.doi.org/10.1371/journal.pone.0168313			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992502	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600048
J	Park, L				Park, Leeyoung			Evidence of Recent Intricate Adaptation in Human Populations	PLOS ONE			English	Article							CLASSIC SELECTIVE SWEEPS; ESTIMATING F-STATISTICS; NATURAL-SELECTION; HUMAN GENOME; POSITIVE SELECTION; PROTEIN FAMILIES; RARE VARIANTS; COPY NUMBER; GENE; DIFFERENTIATION	Recent human adaptations have shaped population differentiation in genomic regions containing putative functional variants, mostly located in predicted regulatory elements. However, their actual functionalities and the underlying mechanism of recent adaptation remain poorly understood. In the current study, regions of genes and repeats were investigated for functionality depending on the degree of population differentiation, F-ST or Delta DAF (a difference in derived allele frequency). The high FST in the 5 A or 3 A untranslated regions (UTRs), in particular, confirmed that population differences arose mainly from differences in regulation. Expression quantitative trait loci (eQTL) analyses using lymphoblastoid cell lines indicated that the majority of the highly population-specific regions represented cis-and/or trans-eQTL. However, groups having the highest Delta DAFs did not necessarily have higher proportions of eQTL variants; in these groups, the patterns were complex, indicating recent intricate adaptations. The results indicated that East Asian (EAS) and European populations (EUR) experienced mutual selection pressures. The mean derived allele frequency of the high Delta DAF groups suggested that EAS and EUR underwent strong adaptation; however, the African population in Africa (AFR) experienced slight, yet broad, adaptation. The DAF distributions of variants in the gene regions showed clear selective pressure in each population, which implies the existence of more recent regulatory adaptations in cells other than lymphoblastoid cell lines. In-depth analysis of population-differentiated regions indicated that the coding gene, RNF135, represented a trans-regulation hotspot via cis-regulation by the population-specific variants in the region of selective sweep. Together, the results provide strong evidence of actual intricate adaptation of human populations via regulatory manipulation.	[Park, Leeyoung] Yonsei Univ, Nat Sci Res Inst, Seoul, South Korea	Yonsei University	Park, L (corresponding author), Yonsei Univ, Nat Sci Res Inst, Seoul, South Korea.	lypark@yonsei.ac.kr			National Research Foundation of Korea (NRF) grants - Korean Government (MSIP) [2013R1A1A3006685, 2014K2A7A1044502, 2015R1D1A1A01059302]; Korea Institute of Science and Technology Information (KISTI) [KSC-2014-C2-019]	National Research Foundation of Korea (NRF) grants - Korean Government (MSIP); Korea Institute of Science and Technology Information (KISTI)(Korea Institute of Science & Technology Information (KISTI))	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean Government (MSIP) (2013R1A1A3006685, 2014K2A7A1044502, and 2015R1D1A1A01059302). The supercomputing resources were supported by the Korea Institute of Science and Technology Information (KISTI), with grant no. KSC-2014-C2-019.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Bhatia G, 2013, GENOME RES, V23, P1514, DOI 10.1101/gr.154831.113; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Colonna V, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r88; Coop G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000500; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Douglas J, 2007, NAT GENET, V39, P963, DOI 10.1038/ng2083; Duforet-Frebourg N, 2016, MOL BIOL EVOL, V33, P1082, DOI 10.1093/molbev/msv334; Fagny M, 2014, MOL BIOL EVOL, V31, P1850, DOI 10.1093/molbev/msu118; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Granka JM, 2012, GENETICS, V192, P1049, DOI 10.1534/genetics.112.144071; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Hernandez RD, 2011, SCIENCE, V331, P920, DOI 10.1126/science.1198878; HUDSON RR, 1992, GENETICS, V132, P583; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kudaravalli S, 2009, MOL BIOL EVOL, V26, P649, DOI 10.1093/molbev/msn289; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Liu XY, 2013, AM J HUM GENET, V92, P866, DOI 10.1016/j.ajhg.2013.04.021; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Nei M., 2000, MOL EVOLUTION PYLOGE; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Nielsen R, 2009, GENOME RES, V19, P838, DOI 10.1101/gr.088336.108; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Park L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128186; Park L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046603; Pertile MD, 2009, GENOME RES, V19, P2202, DOI 10.1101/gr.092080.109; Racimo F, 2014, MOL BIOL EVOL, V31, P3344, DOI 10.1093/molbev/msu255; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schwartz RS, 2001, NEW ENGL J MED, V344, P1392, DOI 10.1056/NEJM200105033441810; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Sudmant PH, 2015, NATURE, V526, P75, DOI 10.1038/nature15394; Tastet J, 2015, PSYCHIAT GENET, V25, P263, DOI 10.1097/YPG.0000000000000100; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thomsen H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154259; Tromer E, 2015, GENOME BIOL EVOL; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS, 2012, PHILOS SCI, V79, P637, DOI 10.1086/667904; Weir BS, 2002, ANNU REV GENET, V36, P721, DOI 10.1146/annurev.genet.36.050802.093940; Winnefeld M, 2012, J INVEST DERMATOL, V132, P466, DOI 10.1038/jid.2011.323; Xue YL, 2009, GENETICS, V183, P1065, DOI 10.1534/genetics.109.107722; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	54	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0165870	10.1371/journal.pone.0165870	http://dx.doi.org/10.1371/journal.pone.0165870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992444	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600007
J	Rossini, BC; Oliveira, CAM; de Melo, FAG; Bertaco, VD; de Astarloa, JMD; Rosso, JJ; Foresti, F; Oliveira, C				Rossini, Bruno Cesar; Miranda Oliveira, Carlos Alexandre; Goncalves de Melo, Filipe Augusto; Bertaco, Vinicius de Araujo; Diaz de Astarloa, Juan M.; Rosso, Juan J.; Foresti, Fausto; Oliveira, Claudio			Highlighting Astyanax Species Diversity through DNA Barcoding	PLOS ONE			English	Article							FRESH-WATER FISHES; RIO-PARANA SYSTEM; CHARACIFORMES CHARACIDAE; OSTARIOPHYSI CHARACIFORMES; TELEOSTEI CHARACIFORMES; BRAZIL OSTARIOPHYSI; DELIMITATION METHOD; REDESCRIPTION; BASIN; EIGENMANN	DNA barcoding has been used extensively to solve taxonomic questions and identify new species. Neotropical fishes are found in a wide variety of shapes and sizes, with a large number of species yet to be described, many of which are very difficult to identify. Characidae is the most species-rich family of the Characiformes, and many of its genera are affected by taxonomic uncertainties, including the widely-distributed, species-rich genus Astyanax. In this study, we present an extensive analysis of Astyanax covering almost its entire area of occurrence, based on DNA barcoding. The use of different approaches (ABGD, GMYC and BIN) to the clustering of the sequences revealed ample consistency in the results obtained by the initial cutoff value of 2% divergence for putative species in the Neighbor-Joining analysis using the Kimura-2-parameter model. The results indicate the existence of five Astyanax lineages. Some groups, such as that composed by the trans-Andean forms, are mostly composed of well-defined species, and in others a number of nominal species are clustered together, hampering the delimitation of species, which in many cases proved impossible. The results confirm the extreme complexity of the systematics of the genus Astyanax and show that DNA barcoding can be an useful tool to address these complexes questions.	[Rossini, Bruno Cesar; Foresti, Fausto; Oliveira, Claudio] UNESP Univ Estadual Paulista, Dept Morfol, Lab Biol & Genet Peixes, Botucatu, SP, Brazil; [Rossini, Bruno Cesar] UNESP Univ Estadual Paulista, Inst Biotecnol, Botucatu, SP, Brazil; [Miranda Oliveira, Carlos Alexandre] Univ Estadual Maringa, Programa Posgrad Ecol Ambientes Aquat Continental, Maringa, Parana, Brazil; [Goncalves de Melo, Filipe Augusto] Univ Estadual Piau, Campus Alexandre Alves Oliveira, Parnaiba, Piaui, Brazil; [Bertaco, Vinicius de Araujo] Museu Ciencias Nat, Fundacao Zoobot Rio Grande Sul, Porto Alegre, RS, Brazil; [Diaz de Astarloa, Juan M.; Rosso, Juan J.] Univ Nacl Mar Plata, CONICET, Inst Invest Marinas & Costeras, Grp Biotaxon Morfol & Mol Peces, Buenos Aires, DF, Argentina	Universidade Estadual Paulista; Universidade Estadual Paulista; Universidade Estadual de Maringa; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Mar del Plata	Rossini, BC (corresponding author), UNESP Univ Estadual Paulista, Dept Morfol, Lab Biol & Genet Peixes, Botucatu, SP, Brazil.; Rossini, BC (corresponding author), UNESP Univ Estadual Paulista, Inst Biotecnol, Botucatu, SP, Brazil.	bu_rossini@yahoo.com.br	Bertaco, Vinicius A./B-8899-2013; de Astarloa, Juan Diaz/F-5395-2012; Oliveira, Claudio/D-7713-2012; Rossini, Bruno C/M-4704-2014; Rossini, Bruno Cesar Cesar/AAX-6765-2021; Rosso, Juan Jose/ABC-5504-2020	Oliveira, Claudio/0000-0002-7010-8880; Rossini, Bruno Cesar Cesar/0000-0002-5685-9610; Rosso, Juan Jose/0000-0001-6730-9385	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [00264-2/2011, 2010/17009-2]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [D1009]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [303854/2009-0]; Coordenadoria de Aperfeicoamento do Ensino Superior	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenadoria de Aperfeicoamento do Ensino Superior	This investigation was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (www.fapesp.br; grant number 00264-2/2011 for BCR and 2010/17009-2 for CO), Consejo Nacional de Investigaciones Cientificas y Tecnicas (http://www.conicet.gov.ar/; grant number D1009 for JMDA), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/; grant number 303854/2009-0 for CO) and Coordenadoria de Aperfeicoamento do Ensino Superior (https://www.capes.gov.br/).	Albert JS, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P3; [Anonymous], 2014, TRACER V1 6; [Anonymous], CATALOG FISHES; Barley AJ, 2016, MOL ECOL, V25, P1944, DOI 10.1111/mec.13590; Bertaco VA, 2006, NEOTROP ICHTHYOL, V4, P53, DOI 10.1590/S1679-62252006000100004; Bertaco VA, 2010, NEOTROP ICHTHYOL, V8, P7, DOI 10.1590/S1679-62252010000100002; Bertaco Vinicius Araujo, 2001, Ichthyological Exploration of Freshwaters, V12, P221; Buckup PA, 2011, HISTORICAL BIOGEOGRAPHY OF NEOTROPICAL FRESHWATER FISHES, P203; Camelier P, 2014, J FISH BIOL, V84, P475, DOI 10.1111/jfb.12295; Casciotta Jorge R., 2003, Ichthyological Exploration of Freshwaters, V14, P329; Casciotta JR, 2005, REV SUISSE ZOOL, V112, P401, DOI 10.5962/bhl.part.80305; Castro RMC, 2004, P BIOL SOC WASH, V117, P330; Costa-Silva GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135075; Cuvier LB., 1819, MEMOIRS, V5, P352; Cuvier LB, 1848, MEMOIRS MUSEUM HIST, V22, P1; de Carvalho DC, 2011, MITOCHONDR DNA, V22, P80, DOI 10.3109/19401736.2011.588214; de Lucena CAS, 2013, NEOTROP ICHTHYOL, V11, P537, DOI 10.1590/S1679-62252013000300007; De Lucena CAS, 2016, ZOOTAXA, V4072, P101, DOI 10.11646/zootaxa.4072.1.5; de Melo FAG, 2006, NEOTROP ICHTHYOL, V4, P45, DOI 10.1590/S1679-62252006000100003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eigenmann C. H., 1914, Indiana University Studies Bloomington, V19; Eigenmann C.H., 1921, Memoirs Museum of Comparative Zoology Cambridge Mass, V43, P209; Eigenmann C.H., 1911, ANN CARNEGIE MUS, V8, P164; EIGENMANN CARL H., 1927, MEM MUS COMP ZOOL, V43, P311; Eigenmann CH, 1917, MEMOIRS MUSEUM COMP, V23, P1; Ezard T, 2009, PACKAGE SPLITS SPECI; Fernandes CA, 2004, HEREDITAS, V141, P328; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Garavello JC, 2010, BRAZ J BIOL, V70, P847, DOI 10.1590/S1519-69842010000400016; Garutti V., 1999, Revista Brasileira de Biologia, V59, P585; Garutti V, 1995, THESIS; Garutti V, 2000, SERIE ZOOLOGIA, V13, P65; Garutti V, 2009, NEOTROP ICHTHYOL, V7, P371, DOI 10.1590/S1679-62252009000300003; Garutti Valdener, 1997, Papeis Avulsos de Zoologia (Sao Paulo), V40, P217; Gery J., 1977, CHARACOIDS WORLD; Gross JB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-105; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J., 1982, J APPL PROB A, V19, P27, DOI DOI 10.2307/3213548; Kullander S.O., 2003, CHECK LIST FRESHWATE, P605; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Lara A, 2010, MOL ECOL RESOUR, V10, P421, DOI 10.1111/j.1755-0998.2009.02785.x; Lima F. C. T., 2003, CHECK LIST FRESHWATE, P106, DOI DOI 10.1590/S1679-62252003000100003; Mabragana E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028655; Mirande JM, 2010, NEOTROP ICHTHYOL, V8, P385, DOI 10.1590/S1679-62252010000300001; Marinho MMF, 2013, ZOOTAXA, V3652, P475, DOI 10.11646/zootaxa.3652.4.5; Medrado AS, 2008, GENET MOL BIOL, V31, P208, DOI 10.1590/S1415-47572008000200007; Melo BF, 2011, NEOTROP ICHTHYOL, V9, P49, DOI 10.1590/S1679-62252011000100002; MELO F. A. G., 2001, ARQ MUS NAC, V59, P1; Melo FAG, 2005, THESIS; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miquelarena AM, 2005, REV SUISSE ZOOL, V112, P661, DOI 10.5962/bhl.part.80319; Miya M, 2000, MOL PHYLOGENET EVOL, V17, P437, DOI 10.1006/mpev.2000.0839; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; MOREIRA O, 1991, REV BRAS GENET, V14, P331; Peres WAM, 2012, REV FISH BIOL FISHER, V22, P519, DOI 10.1007/s11160-011-9246-2; Oliveira C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-275; Ornelas-Garcia Claudia Patricia, 2008, BMC Evol Biol, V8, P340, DOI 10.1186/1471-2148-8-340; Pavanelli CS, 2009, NEOTROP ICHTHYOL, V7, P569, DOI 10.1590/S1679-62252009000400003; Pazza R, 2008, J FISH BIOL, V72, P2002, DOI 10.1111/j.1095-8649.2008.01837.x; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Pereira LHG, 2011, MITOCHONDR DNA, V22, P71, DOI 10.3109/19401736.2010.532213; Pie MR, 2009, J FISH BIOL, V75, P2357, DOI 10.1111/j.1095-8649.2009.02438.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Powell JR, 2012, METHODS ECOL EVOL, V3, P1, DOI 10.1111/j.2041-210X.2011.00122.x; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Rosso JJ, 2012, MOL ECOL RESOUR, V12, P999, DOI 10.1111/1755-0998.12010; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schultz Leonard P, 1944, PROC U S NATION MUS, V95, P235; Soneira P, 2010, NEOTROP ICHTHYOL, V8, P779; Tagliacollo Victor A., 2011, Zootaxa, V2749, P40; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Vari RP, 2007, COPEIA, P150, DOI 10.1643/0045-8511(2007)7[150:NSOAOC]2.0.CO;2; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zanata AM, 2009, NEOTROP ICHTHYOL, V7, P175, DOI 10.1590/S1679-62252009000200007; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zinger L, 2016, MOL ECOL, V25, P1908, DOI 10.1111/mec.13639	91	55	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167203	10.1371/journal.pone.0167203	http://dx.doi.org/10.1371/journal.pone.0167203			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992537	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600012
J	Marini, S; Limongelli, I; Rizzo, E; Malovini, A; Errichiello, E; Vetro, A; Da, T; Zuffardi, O; Bellazzi, R				Marini, Simone; Limongelli, Ivan; Rizzo, Ettore; Malovini, Alberto; Errichiello, Edoardo; Vetro, Annalisa; Da, Tan; Zuffardi, Orsetta; Bellazzi, Riccardo			A Data Fusion Approach to Enhance Association Study in Epilepsy	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RARE-VARIANT ASSOCIATION; RHEUMATOID-ARTHRITIS; MOLECULAR DIAGNOSIS; GENETIC-VARIATION; COMMON VARIANTS; SEQUENCE; RISK; MUTATIONS; RESOURCE	Among the scientific challenges posed by complex diseases with a strong genetic component, two stand out. One is unveiling the role of rare and common genetic variants; the other is the design of classification models to improve clinical diagnosis and predictive models for prognosis and personalized therapies. In this paper, we present a data fusion framework merging gene, domain, pathway and protein-protein interaction data related to a next generation sequencing epilepsy gene panel. Our method allows integrating association information from multiple genomic sources and aims at highlighting the set of common and rare variants that are capable to trigger the occurrence of a complex disease. When compared to other approaches, our method shows better performances in classifying patients affected by epilepsy.	[Marini, Simone] Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Kyoto, Japan; [Marini, Simone; Da, Tan; Bellazzi, Riccardo] Univ Pavia, Dept Elect Comp & Biomed Engn, Pavia, Italy; [Limongelli, Ivan; Vetro, Annalisa; Zuffardi, Orsetta] IRCCS Fdn San Matteo, Genom Core Ctr, Pavia, Italy; [Limongelli, Ivan; Rizzo, Ettore] EnGenome Srl, Via Ferrata 5, Pavia, Italy; [Limongelli, Ivan; Rizzo, Ettore; Bellazzi, Riccardo] Univ Pavia, Ctr Hlth Technol, Pavia, Italy; [Malovini, Alberto; Bellazzi, Riccardo] IRCCS Fdn S Maugeri, Pavia, Italy; [Errichiello, Edoardo; Vetro, Annalisa; Zuffardi, Orsetta] Univ Pavia, Dept Mol Med, Pavia, Italy	Kyoto University; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia	Marini, S (corresponding author), Kyoto Univ, Bioinformat Ctr, Inst Chem Res, Kyoto, Japan.; Marini, S (corresponding author), Univ Pavia, Dept Elect Comp & Biomed Engn, Pavia, Italy.	simone.marini@unipv.it	Errichiello, Edoardo/K-8360-2019; Vetro, Annalisa/J-8203-2018; Malovini, Alberto/I-8727-2018; Bellazzi, Riccardo/J-6432-2018	Vetro, Annalisa/0000-0003-2437-7526; Malovini, Alberto/0000-0003-2857-5773; Bellazzi, Riccardo/0000-0002-6974-9808; Marini, Simone/0000-0002-5704-3533; Errichiello, Edoardo/0000-0001-6346-1988	University of Pavia; Telethon Italy [GGP13060]; University of Pavia: "Centre for Health Technologies"	University of Pavia; Telethon Italy(Fondazione Telethon); University of Pavia: "Centre for Health Technologies"	AV benefits of a research position granted by the University of Pavia in the context of the strategic plan: "Towards a governance model for the international migration: an interdisciplinary and diachronic perspective; OZ was supported by Telethon Italy Grant GGP13060. SM is an International Research Fellow of the Japan Society for the Promotion of Science. The work was partly supported by the strategic plan of the University of Pavia: "Centre for Health Technologies". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1; Auer PL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0138-2; Baum L, 2014, HUM GENET, V133, P651, DOI 10.1007/s00439-013-1405-1; Beleites C, 2013, ANAL CHIM ACTA, V760, P25, DOI 10.1016/j.aca.2012.11.007; Biscarini F, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0197-5; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; Chiewthanakul P, 2015, EPILEPSY BEHAV, V49, P155, DOI 10.1016/j.yebeh.2015.04.061; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Clarke GM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003694; Curtis D, 2016, ANN HUM GENET, V80, P38, DOI 10.1111/ahg.12135; de Kovel CGF, 2010, EPILEPSY RES, V89, P286, DOI 10.1016/j.eplepsyres.2010.01.013; Della Mina E, 2015, EUR J HUM GENET, V23, P354, DOI 10.1038/ejhg.2014.92; Deprez L, 2008, EPILEPSIA, V49, P500, DOI 10.1111/j.1528-1167.2007.01415.x; Dering C, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00323; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Diogo D, 2013, AM J HUM GENET, V92, P15, DOI 10.1016/j.ajhg.2012.11.012; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; EpiPM Consortium, 2016, LANCET NEUROL, V15, P241, DOI 10.1016/S1474-4422(15)00199-4; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Heinzen EL, 2012, AM J HUM GENET, V91, P293, DOI 10.1016/j.ajhg.2012.06.016; Hesdorffer DC, 2011, NEUROLOGY, V76, P23, DOI 10.1212/WNL.0b013e318204a36a; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hormozdiari F, 2015, GENOME RES, V25, P142, DOI 10.1101/gr.178855.114; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Kasperaviciute D, 2010, BRAIN; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Klei L, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-9; Larsen J, 2015, EPILEPSIA, V56, pE203, DOI 10.1111/epi.13222; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Leu C, 2012, EPILEPSIA, V53, P308, DOI 10.1111/j.1528-1167.2011.03379.x; Limongelli I, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0554-8; Ma L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003321; Martin HC, 2014, HUM MOL GENET, V23, P3200, DOI 10.1093/hmg/ddu030; Meng H. B., 2015, J HARBIN ENG U, V36, P1, DOI DOI 10.1002/HUMU.22782; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller ML, 2015, CELL SYST, V1, P197, DOI 10.1016/j.cels.2015.08.014; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Moutsianas L, 2014, BRIEF FUNCT GENOMICS, V13, P362, DOI 10.1093/bfgp/elu012; Oliveira MS, 2010, BRAIN RES, V1348, P187, DOI 10.1016/j.brainres.2010.05.095; Pane M, 2013, NEUROMUSCULAR DISORD, V23, P313, DOI 10.1016/j.nmd.2013.01.011; Poduri A, 2011, CURR OPIN GENET DEV, V21, P325, DOI 10.1016/j.gde.2011.01.005; Rosenthal Robert, 1984, ESSENTIALS BEHAV RES; Russu A, 2012, J AM MED INFORM ASSN, V19, pE13, DOI 10.1136/amiajnl-2011-000741; Spillane J, 2016, J NEUROL NEUROSUR PS, V87, P37, DOI 10.1136/jnnp-2015-311233; Tatonetti NP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S9-S9; Urrutia E, 2015, STAT INTERFACE, V8, P495, DOI 10.4310/SII.2015.v8.n4.a8; Uusimaa J, 2013, EPILEPSIA, V54, P1002, DOI 10.1111/epi.12115; van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Wu GD, 2013, GENET EPIDEMIOL, V37, P478, DOI 10.1002/gepi.21728; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yu W, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-16; Zhao Q, 2015, BRIEF BIOINFORM, V16, P291, DOI 10.1093/bib/bbu003; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	60	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0164940	10.1371/journal.pone.0164940	http://dx.doi.org/10.1371/journal.pone.0164940			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27984588	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000002
J	Yang, J; Teng, YG; Song, LT; Zuo, R				Yang, Jie; Teng, Yanguo; Song, Liuting; Zuo, Rui			Tracing Sources and Contamination Assessments of Heavy Metals in Road and Foliar Dusts in a Typical Mining City, China	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; STREET DUST; SIZE-DISTRIBUTION; URBAN; POLLUTION; SPECIATION; SEDIMENTS; DENSITY; SOILS	Road and foliar dust samples from four land-use districts of Panzhihua City, a famous V-Ti magnetite production area of China, were collected to investigate the sources and distribution characteristics of 9 heavy metals (V, Pb, Cd, Cu, Zn, Ni, Cr, Fe, and Mn). The results suggest that foliar samples had smaller particle size and higher heavy metal contents than road dusts. The contamination assessments of heavy metals were as follows: Pb and V (significant enrichment) > Zn, Ni, Cr, Fe, and Mn (moderate enrichment) > Cd and Ni (minimal enrichment). Statistical analyses showed Pb, as the primary pollution element, originated from waste incineration and lead-fuel combustion. The sources of Zn, Ni, Cr, Fe, V, and Mn were fugitive dust and traffic activities. Potential origins of Cu were corrosion of alloys used in vehicle components, vehicle covers, or other metallic surfaces and materials. The sources of Cd were different from any other heavy metals. Traffic and industrial activities were the main anthropogenic origins of heavy metals in dusts of Panzhihua, and more attention should be paid to heavy metal pollution in agricultural area.	[Yang, Jie; Teng, Yanguo; Song, Liuting; Zuo, Rui] Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China; [Yang, Jie; Teng, Yanguo; Song, Liuting; Zuo, Rui] Minist Educ, Engn Res Ctr Groundwater Pollut Control & Remedia, Beijing, Peoples R China	Beijing Normal University	Yang, J (corresponding author), Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China.; Yang, J (corresponding author), Minist Educ, Engn Res Ctr Groundwater Pollut Control & Remedia, Beijing, Peoples R China.	yangjie@bnu.edu.cn			Major Science and Technology Program for Water Pollution Control and Treatment [2014ZX07201-010]; National Natural Science Foundation of China [41403085]	Major Science and Technology Program for Water Pollution Control and Treatment; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Major Science and Technology Program for Water Pollution Control and Treatment (No. 2014ZX07201-010), and the National Natural Science Foundation of China (No. 41403085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta JA, 2015, CHEMOSPHERE, V134, P328, DOI 10.1016/j.chemosphere.2015.04.038; Ahmed F, 2006, ATMOS ENVIRON, V40, P3835, DOI 10.1016/j.atmosenv.2006.03.004; [Anonymous], 1995, 11466 ISO; Cheng Y, 2015, PARTICUOLOGY, V18, P96, DOI 10.1016/j.partic.2013.10.003; Del Rio-Salas R, 2012, ATMOS ENVIRON, V60, P202, DOI 10.1016/j.atmosenv.2012.06.061; Deletic A, 2005, J ENVIRON ENG, V131, P49, DOI 10.1061/(ASCE)0733-9372(2005)131:1(49); Duong TTT, 2011, J ENVIRON MANAGE, V92, P554, DOI 10.1016/j.jenvman.2010.09.010; Ferreira-Baptista L, 2005, ATMOS ENVIRON, V39, P4501, DOI 10.1016/j.atmosenv.2005.03.026; FreerSmith PH, 1997, ENVIRON POLLUT, V95, P27, DOI 10.1016/S0269-7491(96)00119-4; Gowd SS, 2010, J HAZARD MATER, V174, P113, DOI 10.1016/j.jhazmat.2009.09.024; Grousset FE, 2005, CHEM GEOL, V222, P149, DOI 10.1016/j.chemgeo.2005.05.006; Gunawardana C, 2012, CHEMOSPHERE, V87, P163, DOI 10.1016/j.chemosphere.2011.12.012; Han YM, 2006, SCI TOTAL ENVIRON, V355, P176, DOI 10.1016/j.scitotenv.2005.02.026; Hyeong K, 2011, CHEM GEOL, V286, P240, DOI 10.1016/j.chemgeo.2011.05.009; JIRIES A, 2003, ENVIRONMENTALIST, V23, P205, DOI DOI 10.1023/B:ENVR.0000017390.93161.99; Kumar M, 2013, GEODERMA, V211, P8, DOI 10.1016/j.geoderma.2013.07.004; Lee PK, 2013, CHEMOSPHERE, V91, P1018, DOI 10.1016/j.chemosphere.2013.01.074; Li HY, 2015, J ENVIRON SCI-CHINA, V32, P228, DOI 10.1016/j.jes.2014.11.014; Li ZG, 2013, ENVIRON POLLUT, V182, P408, DOI 10.1016/j.envpol.2013.07.041; Lim JH, 2002, ATMOS ENVIRON, V40, P7810; Lu XW, 2009, J HAZARD MATER, V161, P1058, DOI 10.1016/j.jhazmat.2008.04.052; Manno E, 2006, ATMOS ENVIRON, V40, P5929, DOI 10.1016/j.atmosenv.2006.05.020; Murakami M, 2005, CHEMOSPHERE, V61, P783, DOI 10.1016/j.chemosphere.2005.04.003; Onder S, 2006, ATMOS ENVIRON, V40, P1122, DOI 10.1016/j.atmosenv.2005.11.006; Prichard HM, 2009, SCI TOTAL ENVIRON, V407, P1715, DOI 10.1016/j.scitotenv.2008.10.042; Qiu Y, 2009, CHEMOSPHERE, V75, P447, DOI 10.1016/j.chemosphere.2008.12.061; Saeedi M, 2012, J HAZARD MATER, V227, P9, DOI 10.1016/j.jhazmat.2012.04.047; Salonen VP, 2007, APPL GEOCHEM, V22, P906, DOI 10.1016/j.apgeochem.2007.02.003; Shi GT, 2008, ENVIRON POLLUT, V156, P251, DOI 10.1016/j.envpol.2008.02.027; Simon E, 2011, ENVIRON POLLUT, V159, P1229, DOI 10.1016/j.envpol.2011.01.034; Singh AK, 2011, ENVIRON EARTH SCI, V62, P1447, DOI 10.1007/s12665-010-0630-3; Sun YB, 2010, J HAZARD MATER, V174, P455, DOI 10.1016/j.jhazmat.2009.09.074; Teng YG, 2011, ENVIRON MONIT ASSESS, V176, P605, DOI 10.1007/s10661-010-1607-0; Thorpe A, 2008, SCI TOTAL ENVIRON, V400, P270, DOI 10.1016/j.scitotenv.2008.06.007; Tomasevic M, 2005, CHEMOSPHERE, V61, P753, DOI 10.1016/j.chemosphere.2005.03.077; Wang W, 2013, J HAZARD MATER, V263, P627, DOI 10.1016/j.jhazmat.2013.10.023; Wei BG, 2010, ENVIRON MONIT ASSESS, V160, P33, DOI 10.1007/s10661-008-0655-1; World Health Organization, 1988, VAN ENV HLTH CRIT; World Health Organization (WHO), 2001, VAN PENT OTH IN VAN; Yasir F, 2009, PAK MICROCHEM J, V92, P186; Zhang DY, 2014, J TAIWAN INST CHEM E, V45, P2447, DOI 10.1016/j.jtice.2014.04.018; Zhao HT, 2010, J HAZARD MATER, V183, P203, DOI 10.1016/j.jhazmat.2010.07.012; [赵勇 Zhao Yong], 2002, [华中农业大学学报, Journal of Huazhong Agricultural University], V21, P582	43	30	31	7	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168528	10.1371/journal.pone.0168528	http://dx.doi.org/10.1371/journal.pone.0168528			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992518	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000058
J	Seo, KH; Bartley, GE; Tam, C; Kim, HS; Kim, DH; Chon, JW; Kim, H; Yokoyama, W				Seo, Kun-Ho; Bartley, Glenn E.; Tam, Christina; Kim, Hong-Seok; Kim, Dong-Hyeon; Chon, Jung-Whan; Kim, Hyunsook; Yokoyama, Wallace			Chardonnay Grape Seed Flour Ameliorates Hepatic Steatosis and Insulin Resistance via Altered Hepatic Gene Expression for Oxidative Stress, Inflammation, and Lipid and Ceramide Synthesis in Diet-Induced Obese Mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ADIPOSE-TISSUE; HYDROXYPROPYL METHYLCELLULOSE; NONALCOHOLIC STEATOHEPATITIS; PLASMA-CHOLESTEROL; METABOLIC SYNDROME; DEFICIENT MICE; WEIGHT-LOSS; GREEN TEA; EXTRACT	To identify differentially expressed hepatic genes contributing to the improvement of high-fat (HF) diet-induced hepatic steatosis and insulin resistance following supplementation of partially defatted flavonoid-rich Chardonnay grape seed flour (ChrSd), diet-induced obese (DIO) mice were fed HF diets containing either ChrSd or microcrystalline cellulose (MCC, control) for 5 weeks. The 2-h insulin area under the curve was significantly lowered by ChrSd, indicating that ChrSd improved insulin sensitivity. ChrSd intake also significantly reduced body weight gain, liver and adipose tissue weight, hepatic lipid content, and plasma low-density lipoprotein (LDL)-cholesterol, despite a significant increase in food intake. Exon microarray analysis of hepatic gene expression revealed down-regulation of genes related to triglyceride and ceramide synthesis, immune response, oxidative stress, and inflammation and upregulation of genes related to fatty acid oxidation, cholesterol, and bile acid synthesis. In conclusion, the effects of ChrSd supplementation in a HF diet on weight gain, insulin resistance, and progression of hepatic steatosis in DIO mice were associated with modulation of hepatic genes related to oxidative stress, inflammation, ceramide synthesis, and lipid and cholesterol metabolism.	[Seo, Kun-Ho; Kim, Hong-Seok; Kim, Dong-Hyeon; Chon, Jung-Whan] Konkuk Univ, Coll Vet Med, Seoul, South Korea; [Bartley, Glenn E.; Tam, Christina; Yokoyama, Wallace] ARS, USDA, Albany, CA USA; [Kim, Hyunsook] Hanyang Univ, Dept Food & Nutr, Seoul, South Korea	Konkuk University; United States Department of Agriculture (USDA); Hanyang University	Kim, H (corresponding author), Hanyang Univ, Dept Food & Nutr, Seoul, South Korea.	hyunsk15@hanyang.ac.kr	Seo, Kun-Ho/AAQ-2666-2020	Kim, Hyunsook/0000-0001-7345-4167; Kim, Dong-Hyeon/0000-0003-0585-2432	National Research Foundation of Korea (NRF) - Korea government (MSIP) [2015R1A2A2A01005017]; National Institute of Food and Agriculture (NIFA) Small Business Innovation Research Program Phase I grant (NIFA/SBIR) [2013-00549]	National Research Foundation of Korea (NRF) - Korea government (MSIP); National Institute of Food and Agriculture (NIFA) Small Business Innovation Research Program Phase I grant (NIFA/SBIR)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (No.2015R1A2A2A01005017) and partly by a National Institute of Food and Agriculture (NIFA) Small Business Innovation Research Program Phase I grant (NIFA/SBIR 2013-00549).	Babenko NA, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-1; Bartley GE, 2010, J NUTR, V140, P1255, DOI 10.3945/jn.109.118349; Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677; Brabant G, 2005, FASEB J, V19, P1048, DOI 10.1096/fj.04-2846fje; Chagnon YC, 1997, MOL MED, V3, P663, DOI 10.1007/BF03401705; Charradi K, 2014, DIGEST DIS SCI, V59, P1768, DOI 10.1007/s10620-014-3128-0; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Choquet H, 2010, GENOME MED, V2, DOI 10.1186/gm157; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; De Ceuninck F, 2013, BRIT J PHARMACOL, V168, P339, DOI 10.1111/j.1476-5381.2012.02184.x; De Groote D, 2012, ANN NUTR METAB, V61, P15, DOI 10.1159/000338634; Decorde K, 2009, MOL NUTR FOOD RES, V53, P659, DOI 10.1002/mnfr.200800165; Fernandez-Iglesias A, 2014, MOL NUTR FOOD RES, V58, P727, DOI 10.1002/mnfr.201300455; Ferre T, 2003, DIABETOLOGIA, V46, P1662, DOI 10.1007/s00125-003-1244-z; German JB, 1996, NUTR RES, V16, P1239, DOI 10.1016/0271-5317(96)00127-3; Gonzalez-Gallego J, 2010, BRIT J NUTR, V104, pS15, DOI 10.1017/S0007114510003910; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Hogan S, 2010, J AGR FOOD CHEM, V58, P11250, DOI 10.1021/jf102759e; Hokayem M, 2013, DIABETES CARE, V36, P1454, DOI 10.2337/dc12-1652; Holers VM, 2000, IMMUNOPHARMACOLOGY, V49, P125, DOI 10.1016/S0162-3109(00)80298-2; HORTON JD, 1994, J CLIN INVEST, V93, P2084, DOI 10.1172/JCI117203; Ji C, 2011, HEPATOLOGY, V54, P229, DOI 10.1002/hep.24368; Joven J, 2012, BBA-GEN SUBJECTS, V1820, P894, DOI 10.1016/j.bbagen.2012.03.020; Kadowaki T, 2014, BIOCHEM BIOPH RES CO, V446, P212, DOI 10.1016/j.bbrc.2014.02.089; Kamba A, 2013, CURR MOL MED, V13, P1110; Kar P, 2009, DIABETIC MED, V26, P526, DOI 10.1111/j.1464-5491.2009.02727.x; Kempf T, 2012, EUR J ENDOCRINOL, V167, P671, DOI 10.1530/EJE-12-0466; Khoshbaten Manouchehr, 2010, Saudi J Gastroenterol, V16, P194, DOI 10.4103/1319-3767.65197; Kim H, 2015, J AGR FOOD CHEM, V63, P1460, DOI 10.1021/jf5026373; Kim H, 2014, J AGR FOOD CHEM, V62, P1919, DOI 10.1021/jf404832s; Kim H, 2013, J AGR FOOD CHEM, V61, P6404, DOI 10.1021/jf400545w; Kim SJ, 2012, J NUTR BIOCHEM, V23, P113, DOI 10.1016/j.jnutbio.2010.10.012; LAMUELARAVENTOS RM, 1994, AM J ENOL VITICULT, V45, P1; Lee YS, 2010, J BIOL CHEM, V285, P22174, DOI 10.1074/jbc.M109.085464; Liu ZH, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-32; Marcolin E, 2012, J NUTR, V142, P1821, DOI 10.3945/jn.112.165274; Masterjohn C, 2012, NUTR REV, V70, P41, DOI 10.1111/j.1753-4887.2011.00440.x; McArdle Maeve A, 2013, Front Endocrinol (Lausanne), V4, P52, DOI 10.3389/fendo.2013.00052; Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141; O'Doherty RM, 1999, DIABETES, V48, P2022, DOI 10.2337/diabetes.48.10.2022; Ohyama K, 2011, ANN NUTR METAB, V58, P250, DOI 10.1159/000330444; Park Su-Hui, 2008, Nutr Res Pract, V2, P227, DOI 10.4162/nrp.2008.2.4.227; Peter A, 2011, J CLIN ENDOCR METAB, V96, pE1126, DOI 10.1210/jc.2010-2017; Procaccini C, 2010, CURR PHARM DESIGN, V16, P1902, DOI 10.2174/138161210791208884; Radonjic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006646; Rahimi RS, 2013, NUTR CLIN PRACT, V28, P40, DOI 10.1177/0884533612470464; Ress C, 2010, EUR CYTOKINE NETW, V21, P65, DOI 10.1684/ecn.2009.0177; Rinella Mary E, 2014, Gastroenterol Hepatol (N Y), V10, P219; Savini I, 2013, INT J MOL SCI, V14, P10497, DOI 10.3390/ijms140510497; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023; Takaishi K, 2004, P NATL ACAD SCI USA, V101, P7106, DOI 10.1073/pnas.0401715101; Tomaru U, 2012, AM J PATHOL, V180, P963, DOI 10.1016/j.ajpath.2011.11.012; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Valenti L, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/145421; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Waller-Evans H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082825; Warne JP, 2011, CELL METAB, V14, P791, DOI 10.1016/j.cmet.2011.11.001; Xia EQ, 2010, INT J MOL SCI, V11, P622, DOI 10.3390/ijms11020622; Yamamoto M, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/240365; Yilmaz Y, 2004, J AGR FOOD CHEM, V52, P255, DOI 10.1021/jf030117h; Yogalakshmi B, 2013, J LIPIDS, V2013, DOI 10.1155/2013/153897; Yunoki K, 2008, J AGR FOOD CHEM, V56, P12052, DOI 10.1021/jf8026217	65	21	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167680	10.1371/journal.pone.0167680	http://dx.doi.org/10.1371/journal.pone.0167680			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977712	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400027
J	Shimotsuma, Y; Tanaka, M; Izawa, T; Yamate, J; Kuwamura, M				Shimotsuma, Yukako; Tanaka, Miyuu; Izawa, Takeshi; Yamate, Jyoji; Kuwamura, Mitsuru			Enhanced Expression of Trib3 during the Development of Myelin Breakdown in dmy Myelin Mutant Rats	PLOS ONE			English	Article							TRB3; MUTATION; STRESS; GENE; TRIBBLES; IDENTIFICATION; REMYELINATION; ACTIVATION; DELETION; CELLS	The demyelination (dmy) rat exhibits hind limb ataxia and severe myelin breakdown in the central nervous system. The causative gene of dmy rats is the MRS2 magnesium transporter gene. Tribbles homolog 3 (Trib3) is a pseudokinase molecule that modifies certain signal pathways, and its expression is increased in response to various stresses. Here we sought to clarify the mechanism of myelin breakdown by focusing Trib3, which is remarkably up-regulated in dmy rats. The expression of Trib3 mRNA was significantly increased at 4, 5, 6, 7 and 8 weeks of age in the dmy rats, prior to the prominent myelin breakdown between 7 and 10 weeks of age. The expression level of Trib3 was increased concurrently with the progression of the clinical and pathological conditions in the dmy rats. Double immunofluorescence demonstrated that TRIB3 was mainly expressed in neurons and oligodendrocytes and localized in the Golgi apparatus. Our findings indicate that Trib3 may be associated with the pathogenic mechanism of dmy rats.	[Shimotsuma, Yukako; Tanaka, Miyuu; Izawa, Takeshi; Yamate, Jyoji; Kuwamura, Mitsuru] Osaka Prefecture Univ, Lab Vet Pathol, Izumisano City, Osaka, Japan	Osaka Metropolitan University	Kuwamura, M (corresponding author), Osaka Prefecture Univ, Lab Vet Pathol, Izumisano City, Osaka, Japan.	kuwamura@vet.osakafu-u.ac.jp	Shimotsuma, Yasuhiko/AAF-6335-2021	Shimotsuma, Yasuhiko/0000-0003-0588-3167; Izawa, Takeshi/0000-0003-3236-6050	Japan Society for Promotion of Science (JSPS) [23380180, 15H04595]	Japan Society for Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for Promotion of Science (JSPS) (URL: https://www.jsps.go.jp/english/) grant numbers: JSPS; no. 23380180 and 15H04595 to MK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aime P, 2015, J NEUROSCI, V35, P10731, DOI 10.1523/JNEUROSCI.0614-15.2015; Bowers AJ, 2003, ONCOGENE, V22, P2823, DOI 10.1038/sj.onc.1206367; Bruck W, 2003, J NEUROL SCI, V206, P181, DOI 10.1016/s0022-510x(02)00191-0; Corcoran CA, 2005, CANCER BIOL THER, V4, P1063, DOI 10.4161/cbt.4.10.2205; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; DUNCAN ID, 1992, J NEUROCYTOL, V21, P870, DOI 10.1007/BF01191684; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Izawa T, 2010, BRAIN RES, V1349, P105, DOI 10.1016/j.brainres.2010.06.030; KIMURA M, 1985, J NEUROCHEM, V44, P692, DOI 10.1111/j.1471-4159.1985.tb12870.x; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Kuramoto T, 1996, MAMM GENOME, V7, P890, DOI 10.1007/s003359900263; Kuramoto T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001262; Kuwamura M, 2004, BRAIN RES, V1022, P110, DOI 10.1016/j.brainres.2004.07.007; Kuwamura M, 2002, LAB INVEST, V82, P1279, DOI 10.1097/01.LAB.0000032375.70196.26; Kuwamura M, 2011, BRAIN RES, V1389, P161, DOI 10.1016/j.brainres.2011.03.009; Lange PS, 2008, J EXP MED, V205, P1227, DOI 10.1084/jem.20071460; Lin WS, 2005, J CELL BIOL, V169, P603, DOI 10.1083/jcb.200502086; Lorente M, 2009, GLIA, V57, P1374, DOI 10.1002/glia.20856; Mayumi-Matsuda K, 1999, BIOCHEM BIOPH RES CO, V258, P260, DOI 10.1006/bbrc.1999.0576; Mc Guire C, 2010, J IMMUNOL, V185, P7646, DOI 10.4049/jimmunol.1000930; Morse E, 2010, AM J PHYSIOL-RENAL, V299, pF965, DOI 10.1152/ajprenal.00236.2010; Nakane Y, 2002, EXP ANIM TOKYO, V51, P149, DOI 10.1538/expanim.51.149; NAVE KA, 1987, J NEUROCHEM, V49, P1873, DOI 10.1111/j.1471-4159.1987.tb02449.x; O'Connor LT, 1999, J NEUROSCI, V19, P3404; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ord D, 2005, BIOCHEM BIOPH RES CO, V330, P210, DOI 10.1016/j.bbrc.2005.02.149; Park S, 2003, J ENDOCRINOL INVEST, V26, P132, DOI 10.1007/BF03345141; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Shimizu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042721; SIMONS R, 1990, ANN NY ACAD SCI, V605, P146, DOI 10.1111/j.1749-6632.1990.tb42389.x; Stahnke T, 2007, J MOL NEUROSCI, V32, P25, DOI 10.1007/s12031-007-0005-8; Tanaka M, 2014, GLIA, V62, P1530, DOI 10.1002/glia.22698; Tokuda S, 2004, EXP ANIM TOKYO, V53, P73, DOI 10.1538/expanim.53.73; Wasef SZY, 2006, AM J PHYSIOL-ENDOC M, V291, pE1274, DOI 10.1052/ajpendo.00117.2006	35	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168250	10.1371/journal.pone.0168250	http://dx.doi.org/10.1371/journal.pone.0168250			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977799	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400081
J	Bien, SA; Wojcik, GL; Zubair, N; Gignoux, CR; Martin, AR; Kocarnik, JM; Martin, LW; Buyske, S; Haessler, J; Walker, RW; Cheng, I; Graff, M; Xia, L; Franceschini, N; Matise, T; James, R; Hindorff, L; Le Marchand, L; North, KE; Haiman, CA; Peters, U; Loos, RJF; Kooperberg, CL; Bustamante, CD; Kenny, EE; Carlson, CS				Bien, Stephanie A.; Wojcik, Genevieve L.; Zubair, Niha; Gignoux, Christopher R.; Martin, Alicia R.; Kocarnik, Jonathan M.; Martin, Lisa W.; Buyske, Steven; Haessler, Jeffrey; Walker, Ryan W.; Cheng, Iona; Graff, Mariaelisa; Xia, Lucy; Franceschini, Nora; Matise, Tara; James, Regina; Hindorff, Lucia; Le Marchand, Loic; North, Kari E.; Haiman, Christopher A.; Peters, Ulrike; Loos, Ruth J. F.; Kooperberg, Charles L.; Bustamante, Carlos D.; Kenny, Eimear E.; Carlson, Christopher S.		PAGE Study	Strategies for Enriching Variant Coverage in Candidate Disease Loci on a Multiethnic Genotyping Array	PLOS ONE			English	Article							SPLICING EFFICIENCY; POLYMORPHISM; GENE; DESIGN; MDR1; SNP	Investigating genetic architecture of complex traits in ancestrally diverse populations is imperative to understand the etiology of disease. However, the current paucity of genetic research in people of African and Latin American ancestry, Hispanic and indigenous peoples in the United States is likely to exacerbate existing health disparities for many common diseases. The Population Architecture using Genomics and Epidemiology, Phase II (PAGE II), Study was initiated in 2013 by the National Human Genome Research Institute to expand our understanding of complex trait loci in ethnically diverse and well characterized study populations. To meet this goal, the Multi-Ethnic Genotyping Array (MEGA) was designed to substantially improve fine-mapping and functional discovery by increasing variant coverage across multiple ethnicities at known loci for metabolic, cardiovascular, renal, inflammatory, anthropometric, and a variety of lifestyle traits. Studying the frequency distribution of clinically relevant mutations, putative risk alleles, and known functional variants across multiple populations will provide important insight into the genetic architecture of complex diseases and facilitate the discovery of novel, sometimes population-specific, disease associations. DNA samples from 51,650 self-identified African ancestry (17,328), Hispanic/Latino (22,379), Asian/Pacific Islander (8,640), and American Indian (653) and an additional 2,650 participants of either South Asian or European ancestry, and other reference panels have been genotyped on MEGA by PAGE II. MEGA was designed as a new resource for studying ancestrally diverse populations. Here, we describe the methodology for selecting trait-specific content for use in multi-ethnic populations and how enriching MEGA for this content may contribute to deeper biological understanding of the genetic etiology of complex disease.	[Bien, Stephanie A.; Zubair, Niha; Kocarnik, Jonathan M.; Haessler, Jeffrey; Peters, Ulrike; Kooperberg, Charles L.; Carlson, Christopher S.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Wojcik, Genevieve L.; Gignoux, Christopher R.; Martin, Alicia R.; Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Martin, Lisa W.] George Washington Univ, Sch Med & Hlth Sci, Div Cardiol, Washington, DC 20052 USA; [Buyske, Steven; Matise, Tara] Rutgers State Univ, Dept Genet, Sch Arts & Sci, Piscataway, NJ USA; [Walker, Ryan W.; Loos, Ruth J. F.; Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Walker, Ryan W.; Loos, Ruth J. F.; Kenny, Eimear E.] Icahn Sch Med Mt Sinai, Dept Prevent Med, New York, NY 10029 USA; [Cheng, Iona] Canc Prevent Inst Calif, Fremont, CA USA; [Graff, Mariaelisa; Franceschini, Nora; North, Kari E.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Xia, Lucy; Haiman, Christopher A.] Univ Southern Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Dept Prevent Med, Los Angeles, CA USA; [James, Regina] NICHHD, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Hindorff, Lucia] NHGRI, Div Genom Med, NIH, Bethesda, MD 20892 USA; [Le Marchand, Loic] Univ Hawaii, Dept Epidemiol Program, Ctr Canc, Honolulu, HI 96822 USA; [Peters, Ulrike; Carlson, Christopher S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; Stanford University; George Washington University; Rutgers State University New Brunswick; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Cancer Prevention Institute of California; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cancer Research Center of Hawaii; University of Hawaii System; University of Washington; University of Washington Seattle	Carlson, CS (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	sbien@fredhutch.org; ccarlson@fredhutch.org	Loos, Ruth J F/Q-2862-2016; Loos, Ruth/GON-5877-2022	Loos, Ruth J F/0000-0002-8532-5087; Kocarnik, Jonathan/0000-0001-8084-1608; Bustamante, Carlos D./0000-0002-4187-7920; Bien, Stephanie/0000-0002-8713-4583; Buyske, Steven/0000-0001-8539-5416; Martin, Alicia/0000-0003-0241-3522	National Human Genome Research Institute (NHGRI); National Institutes of Health [U01HG004803, U01HG004802, U01HG004790, U01HG004801]; NHGRI PAGE II program [U01HG004802]; National Cancer Institute [R37CA54281, R01 CA63, P01CA33619, U01CA136792, U01CA98758]; NHGRI PAGE program [U01HG004803, U01HG004790]; National Heart, Lung, and Blood Institute (NHLBI); US Department of Health and Human Services [N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, 44221]; NHLBI [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022, N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, N01-HC-45205, N01-HC-85079]; National Institute of Neurological Disorders and Stroke; National Center for Research Resources [M01-RR00425]; National Institute of Diabetes and Digestive and Kidney Diseases [DK063491]; National Center on Minority Health and Health Disparities; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; Office of Dietary Supplements; Andrea and Charles Bronfman Philantropies;  [N01-HC-85086];  [N01-HC-35129];  [N01-HC-15103];  [N01 HC-55222];  [N01-HC-75150];  [N01-HC-45133];  [U01HL080295];  [R01 HL087652];  [N01-HC65233];  [N01-HC65234];  [N01-HC65235];  [N01-HC65236];  [N01-HC65237];  [U01 HL65520];  [U01 HL41642];  [U01 HL41652];  [U01 HL41654];  [U01 HL65521]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, T32HD049311] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA071789] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007397, U01HG007376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007790] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020069] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI PAGE II program; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI PAGE program; National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Health and Human Services; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Andrea and Charles Bronfman Philantropies; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Population Architecture using Genomics and Epidemiology (PAGE) Study is a collaboration between the Multi-Ethnic Cohort Study (MEC), the Women's Health Initiative (WHI), the Institute for Personalized Medicine at the Icahn School of Medicine at Mount Sinai (ISMMS) and the Genetic Epidemiology of Causal Variants Across the Life Course (CALiCo) consortium, which comprises the Atherosclerosis Risk in Communities (ARIC) Study, the Coronary Artery Risk Development in Young Adults (CARDIA) Study, the Cardiovascular Health Study (CHS), the Hispanic Community Health Study/Study of Latinos (HCHS/SOL), and the Strong Heart Study (SHS). A complete list of members of the PAGE consortium can be found at [http://www.pagestudy.org]. PAGE II is funded by the National Human Genome Research Institute (NHGRI) and is supported by National Institutes of Health grants U01HG004803 (CALiCo), U01HG004802 (MEC), U01HG004790 (WHI), and U01HG004801 (Coordinating Center). Characterization of epidemiological architecture in the Multiethnic Cohort Study is funded through the NHGRI PAGE II program (grant U01HG004802). The Multiethnic Cohort Study is funded by the National Cancer Institute (grants R37CA54281, R01 CA63, P01CA33619, U01CA136792, and U01CA98758). Funding for the study of the epidemiology of putative genetic variants in the WHI is provided through the NHGRI PAGE program (grant U01HG004790). The WHI is funded by the National Heart, Lung, and Blood Institute (NHLBI) and the US Department of Health and Human Services through contracts N01WH22110, 24152, 32100-2, 32105-6, 32108-9, 32111-13, 32115, 32118-32119, 32122, 42107-26, 42129-32, and 44221. (The authors thank the WHI investigators and staff for their dedication). A full listing of WHI investigators can be found at [http://www.whiscience.org/publications/WHI_investigators_shortlist.pdf]. Funding for the CALiCo consortium was provided through the NHGRI PAGE program (grant U01HG004803). The ARIC Study is carried out as a collaborative study supported by NHLBI contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022. The CARDIA Study is supported by the following NHLBI contracts: N01-HC-95095, N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-45134, N01-HC-05187, and N01-HC-45205. The Cardiovascular Health Study is supported by contracts N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01-HC-15103, N01 HC-55222, N01-HC-75150, and N01-HC-45133 and grants U01HL080295 and R01 HL087652 from the NHLBI, with an additional contribution from the National Institute of Neurological Disorders and Stroke. Genome-wide association study DNA handling and genotyping in the Cardiovascular Health Study was supported in part by National Center for Research Resources grant M01-RR00425 to the Cedars-Sinai General Clinical Research Center genotyping core and by National Institute of Diabetes and Digestive and Kidney Diseases grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The HCHS/SOL is supported by NHLBI contracts N01-HC65233, N01-HC65234, N01-HC65235, N01-HC65236, and N01-HC65237.; The following institutes/centers/offices contribute to the HCHS/SOL through a transfer of funds to the NHLBI: the National Center on Minority Health and Health Disparities, the National Institute on Deafness and Other Communication Disorders, the National Institute of Dental and Craniofacial Research, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Neurological Disorders and Stroke, and the Office of Dietary Supplements. The Strong Heart Study is supported by NHLBI grants U01 HL65520, U01 HL41642, U01 HL41652, U01 HL41654, and U01 HL65521. (The opinions expressed in this paper are those of the author(s) and do not necessarily reflect the views of the Indian Health Service). Funding for the BioMe Biobank program is supported by the Andrea and Charles Bronfman Philantropies. We thank the participants in the BioMe Biobank for their invaluable contribution to biomedical research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; Bruun GH, 2013, MOL GENET METAB, V110, P122, DOI 10.1016/j.ymgme.2013.06.005; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Campbell MC, 2008, ANNU REV GENOM HUM G, V9, P403, DOI 10.1146/annurev.genom.9.081307.164258; Carlson CS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001661; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Gignoux C. R., 2016, 65 ANN M AM SOC HUM; Griseri P, 2011, HUM MOL GENET, V20, P4556, DOI 10.1093/hmg/ddr390; Haeussler M, 2011, BIOINFORMATICS, V27, P980, DOI 10.1093/bioinformatics/btr043; HUGHES GH, 1987, CONTROL CLIN TRIALS, V8, pS68; Huo DZ, 2007, JAMA-J AM MED ASSOC, V298, P2910, DOI 10.1001/jama.298.24.2910; Johnston H. R., 2015, 65 ANN M AM SOC HUM; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Landrum MJ, 2015, NUCL ACIDS RES; Matise TC, 2011, AM J EPIDEMIOL, V174, P849, DOI 10.1093/aje/kwr160; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; Nielsen KB, 2007, AM J HUM GENET, V80, P416, DOI 10.1086/511992; Oh SS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001918; Ohtsuki T, 2008, SCHIZOPHR RES, V101, P9, DOI 10.1016/j.schres.2008.01.027; Papp AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031930; Rosenberg NA, 2010, NAT REV GENET, V11, P356, DOI 10.1038/nrg2760; Sorlie PD, 2010, ANN EPIDEMIOL, V20, P629, DOI 10.1016/j.annepidem.2010.03.015; Suhy A, 2014, BIOCHEM BIOPH RES CO, V443, P1270, DOI 10.1016/j.bbrc.2013.12.127; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wojcik G. L., 2015, TAG SNP SELECTION LO; Zhu H, 2007, HUM MOL GENET, V16, P1765, DOI 10.1093/hmg/ddm124	30	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167758	10.1371/journal.pone.0167758	http://dx.doi.org/10.1371/journal.pone.0167758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973554	Green Submitted, Green Published, gold			2022-12-27	WOS:000392754300044
J	Hjelmgren, O; Gellerman, K; Kjelldahl, J; Lindahl, P; Bergstrom, GML				Hjelmgren, Ola; Gellerman, Karl; Kjelldahl, Josefin; Lindahl, Per; Bergstrom, Goran M. L.			Increased Vascularization in the Vulnerable Upstream Regions of Both Early and Advanced Human Carotid Atherosclerosis	PLOS ONE			English	Article							CONTRAST-ENHANCED ULTRASOUND; PLAQUE NEOVASCULARIZATION; CELLULAR COMPOSITION; ANGIOGENESIS; HYPOXIA; MECHANISMS; EXPRESSION; DISORDERS; DIRECTION; ARTERIES	Background Vascularization of atherosclerotic plaques has been linked to plaque vulnerability. The aim of this study was to test if the vascularization was increased in upstream regions of early atherosclerotic carotid plaques and also to test if the same pattern of vascularization was seen in complicated, symptomatic plaques. Methods We enrolled 45 subjects with early atherosclerotic lesions for contrast enhanced ultrasound and evaluated the percentage of plaque area in a longitudinal ultrasound section which contained contrast agent. Contrast-agent uptake was evaluated in both the upstream and downstream regions of the plaque. We also collected carotid endarterectomy specimens from 56 subjects and upstream and downstream regions were localized using magnetic resonance angiography and analyzed using histopathology and immunohistochemistry. Results Vascularization was increased in the upstream regions of early carotid plaques compared with downstream regions (30% vs. 23%, p = 0.033). Vascularization was also increased in the upstream regions of advanced atherosclerotic lesions compared with downstream regions (4.6 vs. 1.4 vessels/mm(2), p = 0.001) and was associated with intra-plaque hemorrhage and inflammation. Conclusions Vascularization is increased in the upstream regions of both early and advanced plaques and is in advanced lesions mainly driven by inflammation.	[Hjelmgren, Ola; Gellerman, Karl; Kjelldahl, Josefin; Lindahl, Per; Bergstrom, Goran M. L.] Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Mol & Clin Med,Wallenberg Lab, Gothenburg, Sweden; [Hjelmgren, Ola; Bergstrom, Goran M. L.] Sahlgrens Univ Hosp, Dept Clin Physiol, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Hjelmgren, O (corresponding author), Univ Gothenburg, Inst Med, Sahlgrenska Acad, Dept Mol & Clin Med,Wallenberg Lab, Gothenburg, Sweden.; Hjelmgren, O (corresponding author), Sahlgrens Univ Hosp, Dept Clin Physiol, Gothenburg, Sweden.	ola.hjelmgren@wlab.gu.se		Bergstrom, Goran/0000-0003-4289-5722; Hjelmgren, Ola/0000-0002-8639-6928	Swedish Heart and Lung Foundation [20110350]; Sahlgrenska university hospital LUA/ALF [70370]	Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Sahlgrenska university hospital LUA/ALF	This work was supported by the Swedish Heart and Lung Foundation grant number: 20110350, Sahlgrenska university hospital LUA/ALF (agreement concerning research and education of doctors) number: 70370.	Bokemark L, 2002, DIABETIC MED, V19, P144, DOI 10.1046/j.1464-5491.2002.00664.x; Chen F, 2005, CORONARY ARTERY DIS, V16, P191, DOI 10.1097/00019501-200505000-00009; Cicha I, 2011, STROKE, V42, P3502, DOI 10.1161/STROKEAHA.111.627265; Coli S, 2008, J AM COLL CARDIOL, V52, P223, DOI 10.1016/j.jacc.2008.02.082; Dirksen MT, 1998, CIRCULATION, V98, P2000, DOI 10.1161/01.CIR.98.19.2000; Fagerberg B, 2010, J VASC RES, V47, P221, DOI 10.1159/000255965; Fukuda D, 2012, P NATL ACAD SCI USA, V109, pE1868, DOI 10.1073/pnas.1116889109; Giannoni MF, 2009, EUR J VASC ENDOVASC, V37, P722, DOI 10.1016/j.ejvs.2008.12.028; Helderman F, 2007, CURR OPIN LIPIDOL, V18, P527, DOI 10.1097/MOL.0b013e3282ef7716; Hjelmgren O, 2013, EUR J VASC ENDOVASC, V46, P21, DOI 10.1016/j.ejvs.2013.03.023; Hoogi A, 2011, AM J ROENTGENOL, V196, P431, DOI 10.2214/AJR.10.4522; Inoue M, 1998, CIRCULATION, V98, P2108, DOI 10.1161/01.CIR.98.20.2108; Jeziorska M, 1999, J PATHOL, V188, P189; Lovett JK, 2004, CIRCULATION, V110, P2190, DOI 10.1161/01.CIR.0000144307.82502.32; Lovett JK, 2003, CEREBROVASC DIS, V16, P369, DOI 10.1159/000072559; Luque A, 2008, FRONT BIOSCI, V13, P6483, DOI 10.2741/3168; Moreno PR, 2012, ANN NY ACAD SCI, V1254, P7, DOI 10.1111/j.1749-6632.2012.06497.x; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Quillard T, 2013, INT J MOL SCI, V14, P6863, DOI 10.3390/ijms14046863; Shah F, 2007, VASC MED, V12, P291, DOI 10.1177/1358863X07083363; Siekmann AF, 2013, EXP CELL RES, V319, P1255, DOI 10.1016/j.yexcr.2013.01.019; Sluimer JC, 2008, J AM COLL CARDIOL, V51, P1258, DOI 10.1016/j.jacc.2007.12.025; Sluimer JC, 2009, J PATHOL, V218, P7, DOI 10.1002/path.2518; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Stromberg S, 2015, EUR J VASC ENDOVASC, V49, P137, DOI 10.1016/j.ejvs.2014.11.004; Thomas JL, 2013, CELL MOL LIFE SCI, V70, P1779, DOI 10.1007/s00018-013-1312-6; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P; Xiong L, 2009, RADIOLOGY, V251, P583, DOI 10.1148/radiol.2512081829; Xue YJ, 2008, ACTA RADIOL, V49, P558, DOI 10.1080/02841850801918548; Yilmaz A, 2007, EXP MOL PATHOL, V82, P245, DOI 10.1016/j.yexmp.2006.10.008	30	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166918	10.1371/journal.pone.0166918	http://dx.doi.org/10.1371/journal.pone.0166918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973542	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300016
J	Jankowich, M; Elston, B; Evans, SK; Wu, WC; Choudhary, G				Jankowich, Matthew; Elston, Beth; Evans, Samuel K.; Wu, Wen-Chih; Choudhary, Gaurav			Relationship of Iron Deficiency and Serum Ferritin Levels with Pulmonary Hypertension: The Jackson Heart Study	PLOS ONE			English	Article							ARTERIAL-HYPERTENSION; PRESSURE; HYPOXIA	Purpose Iron deficiency is prevalent in idiopathic pulmonary arterial hypertension (IPAH), but whether iron deficiency or ferritin levels are associated with pulmonary hypertension (PH) in the general population is unknown. Methods We performed a cross-sectional analysis of data on iron deficiency (exposure), and PH (pulmonary artery systolic pressure>40mmHg on echocardiogram) (outcome) on subjects with complete data on exposures and outcomes as well as covariates (n = 2,800) enrolled in the Jackson Heart Study, a longitudinal prospective observational cohort study of heart disease in African-Americans from Jackson, Mississippi. Iron deficiency was defined as a serum ferritin level < 15ng/mL (females); < 30ng/mL (males). We determined crude prevalence ratios (PRs) for PH in iron deficient versus non-iron deficient groups using modified Poisson regression modeling. We also analyzed the prevalence of PH by sex-specific quartiles of ferritin (Females <= 47ng/mL; > 47ng/mL-95ng/mL; > 95ng/mL-171ng/mL; > 171ng/mL; Males <= 110ng/mL; > 110ng/mL > 182ng/mL; > 182ng/mL > 294ng/mL; > 294ng/mL), using the same modeling technique with the lowest quartile as the referent. Results Median pulmonary artery systolic pressure was 27mmHg (interquartile range 23-31mmHg) in the study cohort. 147 subjects (5.2%) had PH and 140 (5.0%) had iron deficiency. However, of the 147 subjects with PH, only 4 were also iron deficient. The crude PH PR was 0.5 (95% CI 0.2-1.4) in iron-deficiency compared to non-deficient. In analysis by quartiles of ferritin, adjusting for age and sex, there was no evidence of association with PH in quartiles 2 (PR 1.1, 95% CI 0.7-1.6), 3 (PR 0.8, 95% CI 0.5-1.3), or 4 (PR 0.8, 95% CI 0.5-1.2) compared with quartile 1 (referent group, PR 1). Further analyses of the relationship between PH and ferritin as a log-transformed continuous variable or by quartiles of serum iron showed similar results. Conclusions In the Jackson Heart Study, the prevalence of PH was similar in iron-deficient and non-iron deficient subjects. There was no evidence of association between ferritin (or serum iron) levels and PH.	[Jankowich, Matthew; Wu, Wen-Chih; Choudhary, Gaurav] Providence VA Med Ctr, Vasc Res Lab, Providence, RI 02908 USA; [Jankowich, Matthew; Evans, Samuel K.; Wu, Wen-Chih; Choudhary, Gaurav] Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA; [Elston, Beth] Brown Univ, Ctr Publ Hlth & Clin Epidemiol, Providence, RI 02912 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; Brown University	Jankowich, M (corresponding author), Providence VA Med Ctr, Vasc Res Lab, Providence, RI 02908 USA.; Jankowich, M (corresponding author), Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA.	matthew_jankowich@brown.edu	Choudhary, Gaurav/M-1643-2019	Choudhary, Gaurav/0000-0001-9343-5481	National Heart, Lung, and Blood Institute Grant [1R01HL128661]; Jackson State University [HHSN268201300049C, HHSN268201300050C]; Tougaloo College [HHSN268201300048C]; University of Mississippi Medical Center from the National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201300046C, HHSN268201300047C]; National Institute for Minority Health and Health Disparities (NIMHD)	National Heart, Lung, and Blood Institute Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Jackson State University; Tougaloo College; University of Mississippi Medical Center from the National Heart, Lung, and Blood Institute (NHLBI); National Institute for Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Dr. Choudhary reports that he is supported by National Heart, Lung, and Blood Institute Grant (1R01HL128661). The Jackson Heart Study is supported and conducted in collaboration with Jackson State University (HHSN268201300049C and HHSN268201300050C), Tougaloo College (HHSN268201300048C), and the University of Mississippi Medical Center (HHSN268201300046C and HHSN268201300047C) contracts from the National Heart, Lung, and Blood Institute (NHLBI) and the National Institute for Minority Health and Health Disparities (NIMHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This material is based on work supported by the Department of Veterans Affairs. The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the National Heart, Lung, and Blood Institute; the National Institutes of Health; the U.S. Department of Health and Human Services; the Department of Veterans Affairs; or the United States government. The authors also wish to thank the staffs and participants of the JHS.	Altintas A, 2007, LEUKEMIA LYMPHOMA, V48, P1981, DOI 10.1080/10428190701493928; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P897; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Choudhary G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084264; Cotroneo E, 2015, CIRC RES, V116, P1680, DOI 10.1161/CIRCRESAHA.116.305265; Decker I, 2011, CTS-CLIN TRANSL SCI, V4, P253, DOI 10.1111/j.1752-8062.2011.00301.x; Frise MC, 2016, J CLIN INVEST, V126, P2139, DOI 10.1172/JCI85715; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Lam CSP, 2009, CIRCULATION, V119, P2663, DOI 10.1161/CIRCULATIONAHA.108.838698; Li J, 2015, HUM MOL GENET, V24, P572, DOI 10.1093/hmg/ddu454; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Miller JL, 2013, COLD SPRING HARB PER, V3; Rhodes CJ, 2011, J AM COLL CARDIOL, V58, P300, DOI 10.1016/j.jacc.2011.02.057; Robinson JC, 2014, AM J RESP CELL MOL, V51, P721, DOI 10.1165/rcmb.2014-0021TR; Ruiter G, 2011, EUR RESPIR J, V37, P1386, DOI 10.1183/09031936.00100510; Ruiter G, 2015, PULM CIRC, V5, P466, DOI 10.1086/682217; Smith TG, 2009, JAMA-J AM MED ASSOC, V302, P1444, DOI 10.1001/jama.2009.1404; Smith TG, 2008, J PHYSIOL-LONDON, V586, P5999, DOI 10.1113/jphysiol.2008.160960; Soon E, 2011, THORAX, V66, P326, DOI 10.1136/thx.2010.147272; Taylor HA, 2005, ETHNIC DIS, V15, pS4; van Empel VPM, 2014, HEART LUNG CIRC, V23, P287, DOI 10.1016/j.hlc.2013.08.007; Xi QY, 2015, CARDIOVASC PATHOL, V24, P76, DOI 10.1016/j.carpath.2014.09.006	23	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167987	10.1371/journal.pone.0167987	http://dx.doi.org/10.1371/journal.pone.0167987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973582	Green Submitted, Green Published, gold			2022-12-27	WOS:000392754300054
J	Sun, XY; Qian, CL; Chen, ZQ; Wu, ZH; Luo, BY; Pan, G				Sun, Xuyun; Qian, Cunle; Chen, Zhongqin; Wu, Zhaohui; Luo, Benyan; Pan, Gang			Remembered or Forgotten?-An EEG-Based Computational Prediction Approach	PLOS ONE			English	Article							THETA ACTIVITY; MEMORY; IMAGERY; ERP	Prediction of memory performance (remembered or forgotten) has various potential applications not only for knowledge learning but also for disease diagnosis. Recently, subsequent memory effects (SMEs)-the statistical differences in electroencephalography (EEG) signals before or during learning between subsequently remembered and forgotten events D have been found. This finding indicates that EEG signals convey the information relevant to memory performance. In this paper, based on SMEs we propose a computational approach to predict memory performance of an event from EEG signals. We devise a convolutional neural network for EEG, called ConvEEGNN, to predict subsequently remembered and forgotten events from EEG recorded during memory process. With the ConvEEGNN, prediction of memory performance can be achieved by integrating two main stages: feature extraction and classification. To verify the proposed approach, we employ an auditory memory task to collect EEG signals from scalp electrodes. For ConvEEGNN, the average prediction accuracy was 72.07% by using EEG data from pre-stimulus and during-stimulus periods, outperforming other approaches. It was observed that signals from pre-stimulus period and those from during-stimulus period had comparable contributions to memory performance. Furthermore, the connection weights of ConvEEGNN network can reveal prominent channels, which are consistent with the distribution of SME studied previously.	[Sun, Xuyun; Qian, Cunle; Wu, Zhaohui; Pan, Gang] Zhejiang Univ, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Chen, Zhongqin; Luo, Benyan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Pan, G (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China.	luobenyan@zju.edu.cn; gpan@zju.edu.cn	Pan, Gang/B-5978-2013	Pan, Gang/0000-0002-4049-6181	National Key Basic Research Program of China [2013CB329504]; Zhejiang Provincial Natural Science Foundation of China [LR15F020001]; Program for New Century Excellent Talents in University [NCET-13-0521]	National Key Basic Research Program of China(National Basic Research Program of China); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work is supported by National Key Basic Research Program of China (2013CB329504) (http://www.973.gov.cn/English/Index.aspx), Zhejiang Provincial Natural Science Foundation of China (LR15F020001) (http://www.zjnsf.gov.cn/), and Program for New Century Excellent Talents in University (NCET-13-0521) (http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hamid O, 2012, INT CONF ACOUST SPEE, P4277, DOI 10.1109/ICASSP.2012.6288864; Addante RJ, 2011, P NATL ACAD SCI USA, V108, P10702, DOI 10.1073/pnas.1014528108; Agresti A, 2000, AM STAT, V54, P280, DOI 10.2307/2685779; [Anonymous], 2014, 2014 IEEE C COMP VIS, P580, DOI [10.1109/CVPR.2014.81, DOI 10.1109/CVPR.2014.81]; Brunner Clemens, 2008, INT J BIOELEKTROMAGN, V10, P52, DOI DOI 10.1.1.330.3349; Chadwick MJ, 2010, CURR BIOL, V20, P544, DOI 10.1016/j.cub.2010.01.053; Farabet C, 2013, IEEE T PATTERN ANAL, V35, P1915, DOI 10.1109/TPAMI.2012.231; Fell J, 2011, J NEUROSCI, V31, P5392, DOI 10.1523/JNEUROSCI.3668-10.2011; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; Fukushima K, 2013, NEURAL NETWORKS, V37, P103, DOI 10.1016/j.neunet.2012.09.016; Gruber MJ, 2013, NEUROIMAGE, V64, P68, DOI 10.1016/j.neuroimage.2012.07.064; Guderian S, 2009, P NATL ACAD SCI USA, V106, P5365, DOI 10.1073/pnas.0900289106; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Horikawa T, 2013, SCIENCE, V340, P639, DOI 10.1126/science.1234330; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Institute BL, 1986, WORDS FREQ DICT MOD; Japkowicz N., 2000, P 2000 INT C ART INT; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Johannesen Jason K, 2016, Neuropsychiatr Electrophysiol, V2, P3; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kohavi R., 1995, PROC 14 INT JOINT C, P1137; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kusy B, 2009, 2009 INTERNATIONAL CONFERENCE ON INFORMATION PROCESSING IN SENSOR NETWORKS (IPSN 2009), P109; LeCun Y, 1998, LECT NOTES COMPUT SC, V1524, P9, DOI 10.1007/3-540-49430-8_2; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Noh E, 2014, NEUROIMAGE, V84, P712, DOI 10.1016/j.neuroimage.2013.09.028; Otten LJ, 2010, J COGNITIVE NEUROSCI, V22, P1212, DOI 10.1162/jocn.2009.21298; Otten LJ, 2006, NAT NEUROSCI, V9, P489, DOI 10.1038/nn1663; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Park H, 2011, J COGNITIVE NEUROSCI, V23, P2533, DOI 10.1162/jocn.2011.21611; Qin L, 2004, J NEURAL ENG, V1, P135, DOI 10.1088/1741-2560/1/3/002; Razavian AS, 2014, IEEE COMPUT SOC CONF, P512, DOI 10.1109/CVPRW.2014.131; Rugg MD, 1997, PSYCHOPHYSIOLOGY, V34, P572, DOI 10.1111/j.1469-8986.1997.tb01744.x; Rumelhart D.E., 1985, LEARNING INTERNAL RE; SANQUIST TF, 1980, PSYCHOPHYSIOLOGY, V17, P568, DOI 10.1111/j.1469-8986.1980.tb02299.x; SCHACTER DL, 1977, BIOL PSYCHOL, V5, P47, DOI 10.1016/0301-0511(77)90028-X; Sermanet P, 2014, PROC ICLR; Smith EE, 2008, COGNITIVE PSYCHOL; Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P2, DOI 10.1136/jnnp.2005.069245; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Watanabe T, 2011, NEUROIMAGE, V54, P3085, DOI 10.1016/j.neuroimage.2010.10.066; Wu ZH, 2016, IEEE INTELL SYST, V31, P44, DOI 10.1109/MIS.2016.105; Wu ZH, 2013, IEEE INTELL SYST, V28, P28, DOI 10.1109/MIS.2013.137; Yang Z, 2014, NEUROIMAGE, V99, P80, DOI 10.1016/j.neuroimage.2014.05.034; Yu YP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147754; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53	49	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167497	10.1371/journal.pone.0167497	http://dx.doi.org/10.1371/journal.pone.0167497			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973531	Green Submitted, Green Published, gold			2022-12-27	WOS:000392754300032
J	Hammell, C; Chan, AYC				Hammell, Cecilia; Chan, Amy Y. C.			Improving Physical Task Performance with Counterfactual and Prefactual Thinking	PLoS One			English	Article							BEHAVIOR; THOUGHT; REGRET; IF	Counterfactual thinking (reflecting on "what might have been") has been shown to enhance future performance by translating information about past mistakes into plans for future action. Prefactual thinking (imagining "what might be if...") may serve a greater preparative function than counterfactual thinking as it is future-orientated and focuses on more controllable features, thus providing a practical script to prime future behaviour. However, whether or not this difference in hypothetical thought content may translate into a difference in actual task performance has been largely unexamined. In Experiment 1 (n = 42), participants performed trials of a computer-simulated physical task, in between which they engaged in either task-related hypothetical thinking (counterfactual or prefactual) or an unrelated filler task (control). As hypothesised, prefactuals contained more controllable features than counterfactuals. Moreover, participants who engaged in either form of hypothetical thinking improved significantly in task performance over trials compared to participants in the control group. The difference in thought content between counterfactuals and prefactuals, however, did not yield a significant difference in performance improvement. Experiment 2 (n = 42) replicated these findings in a dynamic balance task environment. Together, these findings provide further evidence for the preparatory function of counterfactuals, and demonstrate that prefactuals share this same functional characteristic.	[Hammell, Cecilia; Chan, Amy Y. C.] Univ Wollongong, Sch Psychol, North Wollongong, NSW, Australia	University of Wollongong	Hammell, C (corresponding author), Univ Wollongong, Sch Psychol, North Wollongong, NSW, Australia.	ceciliah@uow.edu.au						Byrne RMJ, 2016, ANNU REV PSYCHOL, V67, P135, DOI 10.1146/annurev-psych-122414-033249; Daniel TO, 2013, APPETITE, V71, P120, DOI 10.1016/j.appet.2013.07.010; Epstude K, 2008, PERS SOC PSYCHOL REV, V12, P168, DOI 10.1177/1088868308316091; Epstude K, 2016, REV GEN PSYCHOL, V20, P48, DOI 10.1037/gpr0000064; Ferrante D, 2014, P TRIEST S PERC COGN; Gollwitzer PM, 1999, AM PSYCHOL, V54, P493, DOI 10.1037//0003-066X.54.7.493; Gollwitzer PM, 2001, J PERS SOC PSYCHOL, V81, P946; Halpern J, 2008, J GEN INTERN MED, V23, P1708, DOI 10.1007/s11606-008-0719-5; Hua-Wei Z, 2009, ACTA PSYCHOL SINICA, V41, P649; McConnell AR, 2000, PSYCHOL MARKET, V17, P281, DOI 10.1002/(SICI)1520-6793(200004)17:4<281::AID-MAR2>3.3.CO;2-X; Morris MW, 2000, ADMIN SCI QUART, V45, P737, DOI 10.2307/2667018; Nasco SA, 1999, PERS SOC PSYCHOL B, V25, P556; Page CM, 2003, PSYCHOL MARKET, V20, P955, DOI 10.1002/mar.10104; ROESE NJ, 1994, J PERS SOC PSYCHOL, V66, P805, DOI 10.1037/0022-3514.66.5.805; Sanna LJ, 1998, COGNITION EMOTION, V12, P635, DOI 10.1080/026999398379484; Schacter DL, 2016, NEUROBIOLOGY LEARNIN, V117, P14; Scholl A, 2015, PERS SOC PSYCHOL B, V41, P159, DOI 10.1177/0146167214559720; Smallman R, 2013, J EXP SOC PSYCHOL, V49, P842, DOI 10.1016/j.jesp.2013.05.004; Smallman R, 2012, EUR J SOC PSYCHOL, V42, P383, DOI 10.1002/ejsp.1858; Smallman R, 2009, J EXP SOC PSYCHOL, V45, P845, DOI 10.1016/j.jesp.2009.03.002; Torrance EP., 1990, TORRANCE TEST CREATI; Tsiros M, 2000, J CONSUM RES, V26, P401, DOI 10.1086/209571; Walsh C, 2013, J EXPT PSYCHOL GEN, V142, P23; Wood SL, 2007, J CONSUM PSYCHOL, V17, P188, DOI 10.1016/S1057-7408(07)70028-1; Wulf G, 2012, PSYCHOL AGING, V27, P14, DOI 10.1037/a0025718	25	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168181	10.1371/journal.pone.0168181	http://dx.doi.org/10.1371/journal.pone.0168181			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27942041	gold, Green Published			2022-12-27	WOS:000392745600057
J	McCarrey, JR; Lehle, JD; Raju, SS; Wang, YF; Nilsson, EE; Skinner, MK				McCarrey, John R.; Lehle, Jake D.; Raju, Seetha S.; Wang, Yufeng; Nilsson, Eric E.; Skinner, Michael K.			Tertiary Epimutations - A Novel Aspect of Epigenetic Transgenerational Inheritance Promoting Genome Instability	PLOS ONE			English	Article							ENDOCRINE DISRUPTOR VINCLOZOLIN; GENETIC INTEGRITY; CHROMATIN-STRUCTURE; MUTATION FREQUENCY; TRANSGENIC MICE; METHYLATION; EPIGENOME; DISEASE; INTERVALS; HEALTH	Exposure to environmental factors can induce the epigenetic transgenerational inheritance of disease. Alterations to the epigenome termed "epimutations" include "primary epimutations" which are epigenetic alterations in the absence of genetic change and "secondary epimutations" which form following an initial genetic change. To determine if secondary epimutations contribute to transgenerational transmission of disease following in utero exposure to the endocrine disruptor vinclozolin, we exposed pregnant female rats carrying the lad mutation-reporter transgene to vinclozolin and assessed the frequency of mutations in kidney tissue and sperm recovered from F1 and F3 generation progeny. Our results confirm that vinclozolin induces primary epimutations rather than secondary epimutations, but also suggest that some primary epimutations can predispose a subsequent accelerated accumulation of genetic mutations in F3 generation descendants that have the potential to contribute to transgenerational phenotypes. We therefore propose the existence of "tertiary epimutations" which are initial primary epimutations that promote genome instability leading to an accelerated accumulation of genetic mutations.	[McCarrey, John R.; Lehle, Jake D.; Raju, Seetha S.; Wang, Yufeng] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA; [Nilsson, Eric E.; Skinner, Michael K.] Washington State Univ, Ctr Reprod Biol, Sch Biol Sci, Pullman, WA USA	University of Texas System; University of Texas at San Antonio (UTSA); Washington State University	McCarrey, JR (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	John.McCarrey@utsa.edu	Nilsson, Eric/AAR-5021-2020	Wang, Yufeng/0000-0002-9959-4149	Kleberg Foundation; NIH/NIEHS; John Templeton Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC1GM100806] Funding Source: NIH RePORTER	Kleberg Foundation; NIH/NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); John Templeton Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Kleberg Foundation grant to JRM (http://www.klebergfoundation.org), NIH/NIEHS grant to MKS (http://www.niehs.nih.gov), and John Templeton Foundation grant to MKS and JRM (https://www.templeton.org).	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Almal SH, 2012, J HUM GENET, V57, P6, DOI 10.1038/jhg.2011.108; Anway MD, 2006, ENDOCRINOLOGY, V147, P5515, DOI 10.1210/en.2006-0640; Anway MD, 2005, SCIENCE, V308, P1466, DOI 10.1126/science.1108190; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bhandari RK, 2015, GEN COMP ENDOCR, V214, P195, DOI 10.1016/j.ygcen.2014.09.014; Blaze J, 2015, SEMIN CELL DEV BIOL, V43, P76, DOI 10.1016/j.semcdb.2015.04.004; Braunschweig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030583; Brun JM, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0303-z; Caperton L, 2007, P NATL ACAD SCI USA, V104, P5085, DOI 10.1073/pnas.0611642104; Chen IC, 2016, STEM CELLS DEV, V25, P1698, DOI 10.1089/scd.2016.0221; COLLINS DW, 1994, GENOMICS, V20, P386, DOI 10.1006/geno.1994.1192; Cooper DJ, 2014, STEM CELL RES, V13, P508, DOI 10.1016/j.scr.2014.09.006; de Waal E, 2012, P NATL ACAD SCI USA, V109, P4163, DOI 10.1073/pnas.1201990109; DYCAICO MJ, 1994, MUTAT RES, V307, P461, DOI 10.1016/0027-5107(94)90257-7; Fay MP, 2010, R J, V2, P53; Feinberg AP, 2004, SEMIN CANCER BIOL, V14, P427, DOI 10.1016/j.semcancer.2004.06.005; Friedberg EC, DNA REPAIR MUTAGENES, V2nd; Guerrero-Bosagna C, 2014, PLOS ONE; Guerrero-Bosagna C, 2012, REPROD TOXICOL, V34, P694, DOI 10.1016/j.reprotox.2012.09.005; Haque MM, 2015, PLOS ONE; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Hirji K., 2006, EXACT ANAL DISCRETE; Hrelia P, 1996, MUTAGENESIS, V11, P445, DOI 10.1093/mutage/11.5.445; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kelly WG, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-6; KOHLER SW, 1991, ENVIRON MOL MUTAGEN, V18, P316, DOI 10.1002/em.2850180421; KOHLER SW, 1991, P NATL ACAD SCI USA, V88, P7958, DOI 10.1073/pnas.88.18.7958; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Lutsenko E, 1999, MUTAT RES-REV MUTAT, V437, P11, DOI 10.1016/S1383-5742(99)00065-4; Ma J, 2015, TOXICOL APPL PHARM, V289, P193, DOI 10.1016/j.taap.2015.09.024; Macia A, 2011, MOL CELL BIOL, V31, P300, DOI 10.1128/MCB.00561-10; Manikkam M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031901; McCarrey JR, 2015, SCIENCE, V350, P634, DOI 10.1126/science.aad5138; McCarrey JR, 2014, MOL CELL ENDOCRINOL, V398, P13, DOI 10.1016/j.mce.2014.07.016; McCarrey JR, 2012, MOL CELL ENDOCRINOL, V354, P9, DOI 10.1016/j.mce.2011.09.014; Miyake K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066729; Muller-Hill B, 1975, Prog Biophys Mol Biol, V30, P227; Murphey P, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103481; Murphey P, 2009, P NATL ACAD SCI USA, V106, P4731, DOI 10.1073/pnas.0900687106; Nilsson EE, 2008, REPRODUCTION, V135, P713, DOI 10.1530/REP-07-0542; Nilsson EE, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.134817; Peters AHFM, 2005, CURR OPIN CELL BIOL, V17, P230, DOI 10.1016/j.ceb.2005.02.006; PROVOST GS, 1993, MUTAT RES, V288, P133; Rando OJ, 2016, COLD SPRING HARB PER; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schuster A, 2016, ENV EPIGENETICS; Siklenka K, 2015, SCIENCE, V350, DOI 10.1126/science.aab2006; Skinner MK, 2008, REPROD TOXICOL, V25, P2, DOI 10.1016/j.reprotox.2007.09.001; Skinner MK, 2016, NAT REV ENDOCRINOL, V12, P68, DOI 10.1038/nrendo.2015.206; Skinner MK, 2015, EPIGENETICS-US, V10, P762, DOI 10.1080/15592294.2015.1062207; Skinner MK, 2014, MOL CELL ENDOCRINOL, V398, P4, DOI 10.1016/j.mce.2014.07.019; Skinner MK, 2010, TRENDS ENDOCRIN MET, V21, P214, DOI 10.1016/j.tem.2009.12.007; SKINNER MK, 2014, BMC GENOMICS, V15; Smerdon MJ, 1991, CURR OPIN CELL BIOL, V3, P422, DOI 10.1016/0955-0674(91)90069-B; SVED J, 1990, P NATL ACAD SCI USA, V87, P4692, DOI 10.1073/pnas.87.12.4692; Tang MHE, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00197; Valentine CR, 2010, MUTAT RES-REV MUTAT, V705, P205, DOI 10.1016/j.mrrev.2010.07.001; Walter CA, 1998, P NATL ACAD SCI USA, V95, P10015, DOI 10.1073/pnas.95.17.10015; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Wu JT, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-305; Xing YL, 2007, PLOS GENET, V3, P1598, DOI 10.1371/journal.pgen.0030151; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; Youngson NA, 2015, ASIAN J ANDROL	65	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168038	10.1371/journal.pone.0168038	http://dx.doi.org/10.1371/journal.pone.0168038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992467	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600028
J	Rossi, R; Assaad, R; Rebeschini, A; Hamadeh, R				Rossi, Rodolfo; Assaad, Ramia; Rebeschini, Arianna; Hamadeh, Randa			Vaccination Coverage Cluster Surveys in Middle Dreib - Akkar, Lebanon: Comparison of Vaccination Coverage in Children Aged 12-59 Months Pre- and Post-Vaccination Campaign	PLoS One			English	Article							ROUTINE IMMUNIZATION SERVICES; IMPACT; POLIO	Introduction With the high proportion of refugee population throughout Lebanon and continuous population movement, it is sensible to believe that, in particular vulnerable areas, vaccination coverage may not be at an optimal level. Therefore, we assessed the vaccination coverage in children under 5 in a district of the Akkar governorate before and after a vaccination campaign. During the vaccination campaign, conducted in August 2015, 2,509 children were vaccinated. Materials and Methods We conducted a pre- and post-vaccination campaign coverage surveys adapting the WHO EPI cluster survey to the Lebanese MoPH vaccination calendar. Percentages of coverage for each dose of each vaccine were calculated for both surveys. Factors associated with complete vaccination were explored. Results Comparing the pre- with the post-campaign surveys, coverage for polio vaccine increased from 51.9% to 84.3%, for Pentavalent from 49.0% to 71.9%, for MMR from 36.2% to 61.0%, while the percentage of children with fully updated vaccination calendar increased from 32.9% to 53.8%. While Lebanese children were found to be better covered for some antigens compared to Syrians at the first survey, this difference disappeared at the post-campaign survey. Awareness and logistic obstacles were the primary reported causes of not complete vaccination in both surveys. Discussion Vaccination campaigns remain a quick and effective approach to increase vaccination coverage in crisis-affected areas. However, campaigns cannot be considered as a replacement of routine vaccination services to maintain a good level of coverage.	[Rossi, Rodolfo; Rebeschini, Arianna] Int Comm Red Cross, Dept Hlth, Beirut, Lebanon; [Assaad, Ramia] Minist Publ Hlth, Primary Hlth Care Serv, Halba, Lebanon; [Hamadeh, Randa] Minist Publ Hlth, Social Hlth Serv, Beirut, Lebanon; [Hamadeh, Randa] Dept Primary Hlth Care, Immunizat & Essential Drugs Program, Beirut, Lebanon		Rossi, R (corresponding author), Int Comm Red Cross, Dept Hlth, Beirut, Lebanon.	rrossi@icrc.org						Bishai DM, 2008, LANCET, V372, P2004, DOI 10.1016/S0140-6736(08)61853-X; Bonu S, 2003, SOC SCI MED, V57, P1807, DOI 10.1016/S0277-9536(03)00056-X; Clark A, 2009, LANCET, V373, P1543, DOI 10.1016/S0140-6736(09)60317-2; Helleringer S, 2016, VACCINE, V34, P3817, DOI 10.1016/j.vaccine.2016.05.037; Lebanese Information Center, 2013, LEB DEM REAL; Lim SS, 2008, LANCET, V372, P2031, DOI 10.1016/S0140-6736(08)61869-3; Luman ET, 2007, INT J EPIDEMIOL, V36, P633, DOI 10.1093/ije/dym025; OCHA, 2015, LEB AKK AR PROF 10 0; Rebeschini A, FACTSHEET VACCINATIO; REF UNHCR, 2016, SYR REG REF RESP; Rehn M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149857; Republic of Lebanon-Ministry of Public Health, 2015, PRIM HLTH CAR ANN RE; Rossi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132357; Uddin MJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1758-x; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI DOI 10.1038/NRMICRO1845; WHO and Ministry of Public Health Lebanon, 2015, EP MON UPD REV, V2; WHO/UNICEF, 2014, GLOB REG IMM PROF WH	18	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168145	10.1371/journal.pone.0168145	http://dx.doi.org/10.1371/journal.pone.0168145			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992470	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600038
J	Todorov, T; Balakrishnan, P; Savov, A; Socha, P; Schmidt, HHJ				Todorov, Theodor; Balakrishnan, Prahlad; Savov, Alexey; Socha, Piotr; Schmidt, Hartmut H. J.			Intragenic Deletions in ATP7B as an Unusual Molecular Genetics Mechanism of Wilson's Disease Pathogenesis	PLoS One			English	Article							HOMOZYGOSITY; MUTATIONS; SEQUENCES; DIAGNOSIS; ELEMENTS; DATABASE; PATIENT; DNA	Wilson's disease (WD) is an autosomal recessive disorder caused by mutations in the ATP7B resulting in copper overload in the liver and brain. Direct sequencing is routinely used to confirm WD diagnosis; however, partial and whole gene deletions in the heterozygous state cannot be detected by exon amplification since the normal allele will mask its presence. The aim of the present work was to search for unusual mutational events in the unexplained WD cases and to provide insight into the mechanisms. Out of 1420 clinically and biochemically confirmed WD samples received between 2000 and 2014 for routine mutation analysis, we were unable to detect mutant alleles in 142 samples, after extensive sequencing analysis. We used selective amplification and MLPA to identify the partial gene deletions and identified three different partial gene deletions in seven different families. All three deletions were fully characterized at the DNA sequence level. We report the first hemizygous case with WD due to intragenic deletion in the ATP7B (c.3134_3556+689de1). This novel deletion resulted from an excision event mediated by consensus sequences in an AluSq2 repeat element and could be traced to micro homologous end joining (MMEJ). Finally, we determined the prevalence of the three deletions in DNA samples from a multinational group of WD patients. Our results emphasize the need for searching mutant alleles beyond routine methods and highlight that large ATP7B deletions are rare, but account for a detectable proportion in some WD patients. Screening for gene aberrations will further improve mutation detection in patients with unidentified ATP7B mutations presenting with clinical manifestations of WD.	[Todorov, Theodor; Schmidt, Hartmut H. J.] Univ Munster, Dept Transplantat Med, Munster, Germany; [Balakrishnan, Prahlad] Sir Ganga Ram Hosp, Inst Med Genet & Genom, New Delhi, India; [Savov, Alexey] NGL, Sofia, Bulgaria; [Socha, Piotr] Childrens Mem Hlth Inst, Dept Gastroenterol Hepatol & Immunol, Warsaw, Poland; [Balakrishnan, Prahlad] Med Sci & Res Ctr, Dept Paediat Genet, Amrita Inst, Ponekkara PO, Kochi, Kerala, India	University of Munster; Children's Memorial Health Institute; Amrita Vishwa Vidyapeetham	Balakrishnan, P (corresponding author), Sir Ganga Ram Hosp, Inst Med Genet & Genom, New Delhi, India.; Balakrishnan, P (corresponding author), Med Sci & Res Ctr, Dept Paediat Genet, Amrita Inst, Ponekkara PO, Kochi, Kerala, India.	bprahlad@gmail.com	Todorov, Theodor/K-9672-2018; Todorov, Theodor/GWC-6426-2022; Balakrishnan, Prahald/AAX-5341-2020	Todorov, Theodor/0000-0002-0548-5487; Balakrishnan, Prahald/0000-0003-0740-5476; Socha, Piotr/0000-0002-1621-464X; Schmidt, Hartmut/0000-0002-2402-7764	European Commission (WilsonIndia project) [247506]; Eurowilson Project [LSHM-CT2004 503430]	European Commission (WilsonIndia project); Eurowilson Project	PB was partly funded by European Commission (WilsonIndia project 247506). In addition to funding from WilsonIndia project 247506, Professor Hartmut HJ Schmidt, also received grant from Eurowilson Project (www.eurowilson.org): LSHM-CT2004 503430. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bost M, 2012, J TRACE ELEM MED BIO, V26, P97, DOI 10.1016/j.jtemb.2012.04.024; Chen JM, 2010, SEMIN CANCER BIOL, V20, P222, DOI 10.1016/j.semcancer.2010.05.007; Coffey AJ, 2013, BRAIN, V136, P1476, DOI 10.1093/brain/awt035; Ferenci P, 2003, LIVER INT, V23, P139, DOI 10.1034/j.1600-0676.2003.00824.x; Ferenci P, 2006, HUM GENET, V120, P151, DOI 10.1007/s00439-006-0202-5; Hoste C, 2010, HUM MUTAT, V31, pE1304, DOI 10.1002/humu.21227; Incollu S, 2011, MOL CELL PROBE, V25, P195, DOI 10.1016/j.mcp.2011.07.003; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; KRAWCZAK M, 1991, HUM GENET, V86, P425; Mameli E, 2015, GENE, V569, P276, DOI 10.1016/j.gene.2015.05.067; McVey M, 2008, TRENDS GENET, V24, P529, DOI 10.1016/j.tig.2008.08.007; Moller LB, 2005, AM J MED GENET A, V138A, P340, DOI 10.1002/ajmg.a.30977; Moller LB, 2011, EUR J HUM GENET, V19, P935, DOI 10.1038/ejhg.2011.80; Moller LB, 2009, BIOCHIMIE, V91, P1273, DOI 10.1016/j.biochi.2009.05.011; Riley D, 2001, NEUROLOGY, V57, P141, DOI 10.1212/WNL.57.1.141; Smit A, 1996, REPEATMASKER OPEN 30; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; van Zelm MC, 2008, AM J HUM GENET, V82, P320, DOI 10.1016/j.ajhg.2007.10.011; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031	19	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168372	10.1371/journal.pone.0168372	http://dx.doi.org/10.1371/journal.pone.0168372			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992490	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600052
J	Xing, SH; Meng, XX; Zhou, LH; Mujahid, H; Zhao, CF; Zhang, YD; Wang, CL; Peng, ZH				Xing, Shihai; Meng, Xiaoxi; Zhou, Lihui; Mujahid, Hana; Zhao, Chunfang; Zhang, Yadong; Wang, Cailin; Peng, Zhaohua			Proteome Profile of Starch Granules Purified from Rice (Oryza sativa) Endosperm	PLoS One			English	Article							BIOSYNTHETIC-ENZYMES; LYSINE ACETYLATION; GENE-EXPRESSION; ADP-GLUCOSE; SYNTHASE-I; MAIZE; PROTEINS; METABOLISM; EVOLUTION; PATHWAY	Starch is the most important food energy source in cereals. Many of the known enzymes involved in starch biosynthesis are partially or entirely granule-associated in the endosperm. Studying the proteome of rice starch granules is critical for us to further understand the mechanisms underlying starch biosynthesis and packaging of starch granules in rice amyloplasts, consequently for the improvement of rice grain quality. In this article, we developed a protocol to purify starch granules from mature rice endosperm and verified the quality of purified starch granules by microscopy observations, I-2 staining, and Western blot analyses. In addition, we found the phenol extraction method was superior to Tris-HCl buffer extraction method with respect to the efficiency in recovery of starch granule associated proteins. LCMS/MS analysis showed identification of already known starch granule associated proteins with high confidence. Several proteins reported to be involved in starch synthesis in prior genetic studies in plants were also shown to be enriched with starch granules, either directly or indirectly, in our studies. In addition, our results suggested that a few additional candidate proteins may also be involved in starch synthesis. Furthermore, our results indicated that some starch synthesis pathway proteins are subject to protein acetylation modification. GO analysis and KEGG pathway enrichment analysis showed that the identified proteins were mainly located in plastids and involved in carbohydrate metabolism. This study substantially advances the understanding of the starch granule associated proteome in rice and post translational regulation of some starch granule associated proteins.	[Xing, Shihai; Zhou, Lihui; Zhao, Chunfang; Zhang, Yadong; Wang, Cailin; Peng, Zhaohua] Jiangsu Acad Agr Sci, Jiangsu High Qual Rice Res & Dev Ctr, Inst Food Crops, Nanjing Branch China Natl Ctr Rice Improvement, Nanjing, Jiangsu, Peoples R China; [Xing, Shihai; Meng, Xiaoxi; Mujahid, Hana; Zhang, Yadong; Peng, Zhaohua] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Starkville, MS 39762 USA	Jiangsu Academy of Agricultural Sciences; Mississippi State University	Wang, CL (corresponding author), Jiangsu Acad Agr Sci, Jiangsu High Qual Rice Res & Dev Ctr, Inst Food Crops, Nanjing Branch China Natl Ctr Rice Improvement, Nanjing, Jiangsu, Peoples R China.; Peng, ZH (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Starkville, MS 39762 USA.	clwang@jaas.ac.cn; zp7@BCH.msstate.edu	Meng, Xiaoxi/AAR-9754-2020	Meng, Xiaoxi/0000-0001-7217-2037	Agriculture and Food Research Initiative competitive grant of the USDA National Institute of Food and Agriculture [2011-67013-30125]; National Natural Science Foundation of China [31271678]; Jiangsu Agricultural Scientific Self-Innovation Fund [CX[11]4023]; Jiangsu Province Postdoctoral Science Foundation [1402003A]; Fundamental Research Funds for JARS [ZX(15)4003]	Agriculture and Food Research Initiative competitive grant of the USDA National Institute of Food and Agriculture; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Agricultural Scientific Self-Innovation Fund; Jiangsu Province Postdoctoral Science Foundation; Fundamental Research Funds for JARS	This research is supported by the Agriculture and Food Research Initiative competitive grant (2011-67013-30125) of the USDA National Institute of Food and Agriculture to Zhaohua Peng, the National Natural Science Foundation of China (No. 31271678) and Jiangsu Agricultural Scientific Self-Innovation Fund (Grant No. CX[11]4023) to Cailin Wang, Jiangsu Province Postdoctoral Science Foundation (1402003A) to Shihai Xing, and the Fundamental Research Funds for JARS (ZX(15)4003) to Lihui Zhou.	Ahmed Z, 2015, PLANT SCI, V233, P95, DOI 10.1016/j.plantsci.2014.12.016; Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; Ball SG, 2003, ANNU REV PLANT BIOL, V54, P207, DOI 10.1146/annurev.arplant.54.031902.134927; Balmer Y, 2006, P NATL ACAD SCI USA, V103, P2988, DOI 10.1073/pnas.0511040103; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Baunsgaard L, 2005, PLANT J, V41, P595, DOI 10.1111/j.1365-313X.2004.02322.x; Bergeron JJ, 2007, NAT BIOTECHNOL, V25, P61, DOI 10.1038/nbt0107-61; Biselli C, 2014, RICE, V7, DOI 10.1186/1939-8433-7-1; Butler CA, 2015, J PROTEOMICS, V128, P352, DOI 10.1016/j.jprot.2015.08.015; CAO HP, 1995, PHYSIOL PLANTARUM, V95, P176, DOI 10.1111/j.1399-3054.1995.tb00825.x; Cao H, 2015, J PROTEOMICS, V112, P95, DOI 10.1016/j.jprot.2014.08.002; Chen GX, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0198-2; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Comparot-Moss S, 2009, J EXP BOT, V60, P2481, DOI 10.1093/jxb/erp141; Dian WM, 2005, J EXP BOT, V56, P623, DOI 10.1093/jxb/eri065; Dian WM, 2003, PLANTA, V218, P261, DOI 10.1007/s00425-003-1101-9; Duan MJ, 2005, PLANT MOL BIOL, V59, P165, DOI 10.1007/s11103-004-7507-3; EVANS HJ, 1968, P NATL ACAD SCI USA, V61, P1448, DOI 10.1073/pnas.61.4.1448; Fitzgerald MA, 2009, TRENDS PLANT SCI, V14, P133, DOI 10.1016/j.tplants.2008.12.004; Friso G, 2015, PLANT PHYSIOL, V169, P1469, DOI 10.1104/pp.15.01378; Fujita N, 2009, J EXP BOT, V60, P1009, DOI 10.1093/jxb/ern349; Grimaud F, 2008, J EXP BOT, V59, P3395, DOI 10.1093/jxb/ern198; Hanashiro I, 2008, PLANT CELL PHYSIOL, V49, P925, DOI 10.1093/pcp/pcn066; Hennen-Bierwagen TA, 2009, PLANT PHYSIOL, V149, P1541, DOI 10.1104/pp.109.135293; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; Kang K, 2009, PLANT PHYSIOL, V150, P1380, DOI 10.1104/pp.109.138552; Koziol AG, 2012, J PROTEOMICS, V75, P993, DOI 10.1016/j.jprot.2011.10.019; KUIPERS AGJ, 1994, PLANT CELL, V6, P43, DOI 10.1105/tpc.6.1.43; Li GS, 2008, ELECTROPHORESIS, V29, P604, DOI 10.1002/elps.200700412; MuForster C, 1996, PLANT PHYSIOL, V111, P821, DOI 10.1104/pp.111.3.821; Nagai YS, 2009, PLANT CELL PHYSIOL, V50, P635, DOI 10.1093/pcp/pcp021; Nakamura Y, 2002, PLANT CELL PHYSIOL, V43, P718, DOI 10.1093/pcp/pcf091; NAKAMURA Y, 1989, PLANT CELL PHYSIOL, V30, P833, DOI 10.1093/oxfordjournals.pcp.a077813; Nallamilli BRR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089283; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Pilling E, 2003, PLANT PHYSIOL, V132, P365, DOI 10.1104/pp.102.018044; Pinheiro C, 2013, J PROTEOME RES, V12, P3152, DOI 10.1021/pr400012t; Quandt A., 2014, EUPA OPEN PROTEOMICS, V5, P21; Sabelli PA, 2009, PLANT PHYSIOL, V149, P14, DOI 10.1104/pp.108.129437; Satoh H, 2008, PLANT CELL, V20, P1833, DOI 10.1105/tpc.107.054007; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; Shannon JC, 1998, PLANT PHYSIOL, V117, P1235, DOI 10.1104/pp.117.4.1235; She KC, 2010, PLANT CELL, V22, P3280, DOI 10.1105/tpc.109.070821; Sikka VK, 2001, PLANT SCI, V161, P461, DOI 10.1016/S0168-9452(01)00431-9; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; STAMOVA BS, 2009, INT J PLANT GENOMICS; Sun MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018385; Tan F, 2011, J PROTEOME RES, V10, P551, DOI 10.1021/pr100748e; Tanaka N, 2004, PLANT BIOTECHNOL J, V2, P507, DOI 10.1111/j.1467-7652.2004.00097.x; Tian ZX, 2009, P NATL ACAD SCI USA, V106, P21760, DOI 10.1073/pnas.0912396106; TSAI CY, 1974, PHYTOCHEMISTRY, V13, P885, DOI 10.1016/S0031-9422(00)91418-3; Tuli Leepika, 2009, J Proteomics Bioinform, V2, P416; Umemoto T, 2005, FUNCT PLANT BIOL, V32, P763, DOI 10.1071/FP04214; Wang SJ, 2013, STARCH-STARKE, V65, P186, DOI 10.1002/star.201200093; Wang Z, 2002, MOL PLANT BREEDING, V1, P231; Wani AA, 2012, COMPR REV FOOD SCI F, V11, P417, DOI 10.1111/j.1541-4337.2012.00193.x; Xiong Y, 2012, J CELL BIOL, V198, P155, DOI 10.1083/jcb.201202056; Yang YH, 2013, GENET MOL BIOL, V36, P87, DOI 10.1590/S1415-47572013000100012; Yu GQ, 2011, MOL BIOL EVOL, V28, P659, DOI 10.1093/molbev/msq243; Yu Y, 1998, PLANT PHYSIOL, V116, P1451, DOI 10.1104/pp.116.4.1451; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhang XL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-96; Zhou SR, 2013, CURR OPIN PLANT BIOL, V16, P236, DOI 10.1016/j.pbi.2013.03.001	65	25	25	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168467	10.1371/journal.pone.0168467	http://dx.doi.org/10.1371/journal.pone.0168467			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992503	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600062
J	Nadian-Ghomsheh, A; Hassanian, Y; Navi, K				Nadian-Ghomsheh, Ali; Hassanian, Yassin; Navi, Keyvan			Intrinsic Image Decomposition via Structure-Preserving Image Smoothing and Material Recognition	PLOS ONE			English	Article							LIGHTNESS	Decoupling shading and reflectance from complex scene-images is a long-standing problem in computer vision. We introduce a framework for decomposing an image into the product of an illumination component and a reflectance component. Due to the ill-posed nature of the problem, prior information on shading and reflectance is mandatory. The proposed method adopts the premise that pixels in a region with similar chromaticity values should have the same reflectance. This assumption was used to minimize the l(2) norm of the local per-pixel reflectance gradients to extract the shading and reflectance components. To obtain smooth chromatic regions, texture was treated in a new style. Texture was removed in the first step of the algorithm and the smooth image was processed for intrinsic decomposition. In the final step, texture details were added to the intrinsic components based on the material of each pixel. In addition, user-assistance was used to further refine the results. The qualitative and quantitative evaluation on the MIT intrinsic dataset indicated that the quality of intrinsic image decomposition was improved in comparison with previous methods.	[Nadian-Ghomsheh, Ali] Shahid Beheshti Univ, Cyber Space Res Inst, Tehran, Iran; [Hassanian, Yassin; Navi, Keyvan] Shahid Beheshti Univ, Dept Comp Sci & Engn, Tehran, Iran	Shahid Beheshti University; Shahid Beheshti University	Nadian-Ghomsheh, A (corresponding author), Shahid Beheshti Univ, Cyber Space Res Inst, Tehran, Iran.	a_nadian@sbu.ac.ir						[Anonymous], 2011, P 24 INT C NEUR INF; Barron JT, 2015, IEEE T PATTERN ANAL, V37, P1670, DOI 10.1109/TPAMI.2014.2377712; Beigpour S, 2011, IEEE I CONF COMP VIS, P327, DOI 10.1109/ICCV.2011.6126259; Bell S, 2015, PROC CVPR IEEE, P3479, DOI 10.1109/CVPR.2015.7298970; Bell S, 2014, ACM T GRAPHIC, V33, DOI 10.1145/2601097.2601206; Berglund J, 2010, MAGN RESON MED, V63, P1659, DOI 10.1002/mrm.22385; BI S, 2015, ACM T GRAPHICS SIGGR, V34; BLAKE A, 1985, COMPUT VISION GRAPH, V32, P314, DOI 10.1016/0734-189X(85)90054-4; Bonneel N, 2014, ACM T GRAPHIC, V33, DOI 10.1145/2661229.2661253; Bousseau A, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1618452.1618476; Fang H, 2004, ACM T GRAPHIC, V23, P354, DOI 10.1145/1015706.1015728; Finlayson GD, 2006, IEEE T PATTERN ANAL, V28, P59, DOI 10.1109/TPAMI.2006.18; Finlayson GD, 2004, LECT NOTES COMPUT SC, V3023, P582; FUNT BV, 1992, LECT NOTES COMPUT SC, V588, P124; Garces E, 2012, COMPUT GRAPH FORUM, V31, P1415, DOI 10.1111/j.1467-8659.2012.03137.x; Grosse R, 2009, IEEE I CONF COMP VIS, P2335, DOI 10.1109/ICCV.2009.5459428; Hallett AH, 1982, J COMPUT APPL MATH, V8, P35; Karacan L, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2508363.2508403; Laffont PY, 2013, IEEE T VIS COMPUT GR, V19, P210, DOI 10.1109/TVCG.2012.112; Laffont Pierre-Yves, 2012, ACM T GRAPHIC, V31, P1; LAND EH, 1971, J OPT SOC AM, V61, P1, DOI 10.1364/JOSA.61.000001; Lee KJ, 2012, LECT NOTES COMPUT SC, V7577, P327, DOI 10.1007/978-3-642-33783-3_24; Levin A, 2004, ACM T GRAPHIC, V23, P689, DOI 10.1145/1015706.1015780; Liu XP, 2008, ACM T GRAPHIC, V27, DOI 10.1145/1409060.1409105; Matsushita Y, 2004, IEEE T PATTERN ANAL, V26, P1336, DOI 10.1109/TPAMI.2004.86; Meka A, 2016, ACM T GRAPHIC, V35, DOI 10.1145/2897824.2925907; Omer I, 2004, PROC CVPR IEEE, P946; Shen JB, 2014, INFORM SCIENCES, V281, P726, DOI 10.1016/j.ins.2014.02.134; Shen JB, 2013, IEEE T CYBERNETICS, V43, P425, DOI 10.1109/TSMCB.2012.2208744; Shen L, 2013, IEEE T PATTERN ANAL, V35, P2904, DOI 10.1109/TPAMI.2013.136; Shouhong Ding, 2017, Visual Computer, V33, P355, DOI 10.1007/s00371-015-1205-9; Tao WB, 2007, IEEE T SYST MAN CY B, V37, P1382, DOI 10.1109/TSMCB.2007.902249; Tappen MF, 2005, IEEE T PATTERN ANAL, V27, P1459, DOI 10.1109/TPAMI.2005.185; Tuzel O, 2006, LECT NOTES COMPUT SC, V3952, P589; Wang B, 2010, IEEE T SYST MAN CY B, V40, P857, DOI 10.1109/TSMCB.2009.2031090; Weiss Y, 2001, 8 INT C COMP VIS; Xie XH, 2016, COMPUT VIS IMAGE UND, V143, P183, DOI 10.1016/j.cviu.2015.11.018; Xing Yan, 2010, Proceedings 2010 International Conference on Digital Image Computing: Techniques and Applications (DICTA 2010), P486, DOI 10.1109/DICTA.2010.88; Yang LX, 2016, NEUROCOMPUTING, V173, P1646, DOI 10.1016/j.neucom.2015.09.037	39	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0166772	10.1371/journal.pone.0166772	http://dx.doi.org/10.1371/journal.pone.0166772			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992431	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000008
J	O'Brien, P; Corpe, CP				O'Brien, Patrick; Corpe, Christopher Peter			Acute Effects of Sugars and Artificial Sweeteners on Small Intestinal Sugar Transport: A Study Using CaCo-2 Cells As an In Vitro Model of the Human Enterocyte	PLOS ONE			English	Article							RAT SMALL-INTESTINE; GLUCOSE-ABSORPTION; TASTE RECEPTORS; NONNUTRITIVE SWEETENERS; DIFFERENTIAL EXPRESSION; HEALTHY-SUBJECTS; GLUT2; FRUCTOSE; T1R3; SECRETION	Background The gastrointestinal tract is responsible for the assimilation of nutrients and plays a key role in the regulation of nutrient metabolism and energy balance. The molecular mechanisms by which intestinal sugar transport are regulated are controversial. Based on rodent studies, two models currently exist that involve activation of the sweet-taste receptor, T1R2/3: an indirect model, whereby luminal carbohydrates activate T1R2/3 expressed on enteroendo-crine cells, resulting in the release of gut peptides which in turn regulate enterocyte sugar transport capacity; and a direct model, whereby T1R2/3 expressed on the enterocyte regulates enterocyte function. Aims To study the direct model of intestinal sugar transport using CaCo-2 cells, a well-established in vitro model of the human enterocyte. Methods Uptake of 10mM C-14 D-Glucose and D-Fructose into confluent CaCo-2/TC7 cells was assessed following 3hr preincubation with sugars and artificial sweeteners in the presence and absence of the sweet taste receptor inhibitor, lactisole. Expression of the intestinal sugar transporters and sweet-taste receptors were also determined by RT-PCR. Results In response to short term changes in extracellular glucose and glucose/fructose concentrations (2.5mM to 75mM) carrier-mediated sugar uptake mediated by SGLT1 and/or the facilitative hexose transporters (GLUT1,2,3 and 5) was increased. Lactisole and artificial sweeteners had no effect on sugar transport regulated by glucose alone; however, lactisole increased glucose transport in cells exposed to glucose/fructose. RT-PCR revealed Tas1r3 and SGLT3 gene expression in CaCo-2/TC7 cells, but not Tas1r2. Conclusions In the short term, enterocyte sugar transport activities respond directly to extracellular glucose levels, but not fructose or artificial sweeteners. We found no evidence of a functional heterodimeric sweet taste receptor, T1R2/3 in CaCo-2 cells. However, when glucose/fructose is administered together there is an inhibitory effect on glucose transport possibly mediated by T1R3.	[O'Brien, Patrick; Corpe, Christopher Peter] Kings Coll London, Diabet & Nutr Sci Div, Diet & Cardiovasc Hlth Grp, London, England	University of London; King's College London	Corpe, CP (corresponding author), Kings Coll London, Diabet & Nutr Sci Div, Diet & Cardiovasc Hlth Grp, London, England.	christopher.corpe@kcl.ac.uk		corpe, christopher/0000-0003-1994-8312	King's College London PhD studentship; King's College London	King's College London PhD studentship; King's College London	This work was supported by King's College London PhD studentship. Open access for this article was funded by King's College London.	BLAIS A, 1987, J MEMBRANE BIOL, V99, P113, DOI 10.1007/BF01871231; Bryant CE, 2014, EUR J CLIN NUTR, V68, P629, DOI 10.1038/ejcn.2014.19; BURANT CF, 1994, AM J PHYSIOL, V267, pG71, DOI 10.1152/ajpgi.1994.267.1.G71; CHANTRET I, 1994, J CELL SCI, V107, P213; Corpe CP, 1996, AM J PHYSIOL-GASTR L, V271, pG211, DOI 10.1152/ajpgi.1996.271.1.G211; Corpe CP, 1998, BBA-MOL CELL RES, V1402, P229, DOI 10.1016/S0167-4889(97)00155-9; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Ferraris RP, 2001, BIOCHEM J, V360, P265, DOI 10.1042/0264-6021:3600265; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Groen J, 1937, J CLIN INVEST, V16, P245, DOI 10.1172/JCI100854; Hamano K, 2015, J ENDOCRINOL, V226, P57, DOI 10.1530/JOE-15-0102; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Kellett GL, 2008, ANNU REV NUTR, V28, P35, DOI 10.1146/annurev.nutr.28.061807.155518; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Le Gall M, 2007, J CELL PHYSIOL, V213, P834, DOI 10.1002/jcp.21245; LEVIN RJ, 1994, AM J CLIN NUTR, V59, p690S, DOI 10.1093/ajcn/59.3.690S; Mace OJ, 2007, J PHYSIOL-LONDON, V582, P379, DOI 10.1113/jphysiol.2007.130906; MAHRAOUI L, 1994, BIOCHEM J, V298, P629, DOI 10.1042/bj2980629; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; Pepino MY, 2015, PHYSIOL BEHAV, V152, P450, DOI 10.1016/j.physbeh.2015.06.024; Pepino MY, 2013, DIABETES CARE, V36, P2530, DOI 10.2337/dc12-2221; Phillips LK, 2011, ANN NY ACAD SCI, V1243, P1, DOI 10.1111/j.1749-6632.2012.06491.x; Renwick AG, 2010, BRIT J NUTR, V104, P1415, DOI 10.1017/S0007114510002540; Stumpel F, 2001, P NATL ACAD SCI USA, V98, P11330, DOI 10.1073/pnas.211357698; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Temizkan S, 2015, EUR J CLIN NUTR, V69, P162, DOI 10.1038/ejcn.2014.208; Thomson ABR, 1997, DIGEST DIS SCI, V42, P470, DOI 10.1023/A:1018874404762; TRUSWELL AS, 1988, AM J CLIN NUTR, V48, P1424, DOI 10.1093/ajcn/48.6.1424; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zheng Y, 2012, SURGERY, V151, P13, DOI 10.1016/j.surg.2011.07.010; Zukerman S, 2009, AM J PHYSIOL-REG I, V296, pR866, DOI 10.1152/ajpregu.90870.2008	31	17	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167785	10.1371/journal.pone.0167785	http://dx.doi.org/10.1371/journal.pone.0167785			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992462	Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000016
J	Della Corte, C; Carpino, G; De Vito, R; De Stefanis, C; Alisi, A; Cianfarani, S; Overi, D; Mosca, A; Stronati, L; Cucchiara, S; Raponi, M; Gaudio, E; Byrne, CD; Nobili, V				Della Corte, Claudia; Carpino, Guido; De Vito, Rita; De Stefanis, Cristiano; Alisi, Anna; Cianfarani, Stefano; Overi, Diletta; Mosca, Antonella; Stronati, Laura; Cucchiara, Salvatore; Raponi, Massimiliano; Gaudio, Eugenio; Byrne, Christopher D.; Nobili, Valerio			Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; HEPATIC STELLATE CELLS; ESPGHAN HEPATOLOGY COMMITTEE; OBESE CHILDREN; POSITION STATEMENT; INSULIN-RESISTANCE; LIFE-STYLE; DISEASE; ADOLESCENTS; FIBROSIS	Background There are no licensed treatments for non alcoholic fatty liver disease (NAFLD) in adults or children. In NAFLD, several studies have shown a benefit of omega-3 fatty acid treatment on lipid profile, insulin-sensitivity and hepatic steatosis and it has also been suggested that Vitamin D treatment has potential antifibrotic properties in liver disease. Trial Design To date, however, there are no studies that have tested the combination of Docosahexanoic acid (DHA) and vitamin D treatment which may benefit the whole spectrum of disease in NAFLD. Our aim therefore, was to test the effect of daily DHA (500 mg) plus vitamin D (800 IU) treatment, in obese children with biopsy-proven NAFLD and vitamin D deficiency, in a randomized, double-blind placebo-controlled trial. Methods The 41/43 patients completed the study (18-treatment, 23-placebo). At 12 months: i) the main outcome was liver histology improvement, defined by NAS; ii) the secondary outcome was amelioration of metabolic parameters. Results DHA plus vitamin D treatment reduced the NAFLD Activity Score (NAS), in the treatment group (5.4 v1.92; p<0.001 for baseline versus end of study). There was no change in fibrosis score, but a reduction of the activation of hepatic stellate cells (HSC) and fibrillar collagen content was noted (3.51 +/- 1.66 v. 1.59 +/- 1.37; p = 0.003) in treatment group. Moreover, the triglycerides (174.5 vs. 102.15 mg/dl), ALT (40.25 vs. 24.5 UI/l) and HOMA-IR (4.59 vs. 3.42) were all decreased with treatment. Conclusion DHA plus vitamin D treatment improved insulin-resistance, lipid profile, ALT and NAS. There was also decreased HSC activation and collagen content with treatment.	[Della Corte, Claudia; Mosca, Antonella; Nobili, Valerio] Bambino Gesu Pediat Hosp, IRCCS Rome, Hepatometab Dept, Rome, Italy; [Carpino, Guido] Univ Rome Foro Italico, Div Hlth Sci, Dept Movement Human & Hlth Sci, Rome, Italy; [De Vito, Rita] Bambino Gesu Pediat Hosp, IRCCS Rome, Histopathol Unit, Rome, Italy; [De Stefanis, Cristiano; Alisi, Anna; Nobili, Valerio] Bambino Gesu Pediat Hosp, IRCCS Rome, Liver Res Unit, Rome, Italy; [Cianfarani, Stefano] Bambino Gesu Pediat Hosp, IRCCS Rome, Endocrinol & Diabet Unit, Rome, Italy; [Overi, Diletta; Gaudio, Eugenio] Sapienza Univ Rome, Dept Anat Histol Forens Med & Orthoped Sci, Rome, Italy; [Stronati, Laura] Sapienza Univ Hosp Umberto I, Dept Cellular Biotechnol & Hematol, Rome, Italy; [Cucchiara, Salvatore] Sapienza Univ Hosp Umberto I, Dept Pediat, Pediat Gastroenterol & Liver Unit, Rome, Italy; [Raponi, Massimiliano] Bambino Gesu Pediat Hosp, IRCCS Rome, Med Directorate, Rome, Italy; [Byrne, Christopher D.] Univ Southampton, Fac Med, Human Dev & Hlth Acad Unit, Southampton, Hants, England; [Byrne, Christopher D.] Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Byrne, Christopher D.] Univ Southampton, Southampton, Hants, England	IRCCS Bambino Gesu; Foro Italico University of Rome; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; Sapienza University Rome; Sapienza University Rome; University Hospital Sapienza Rome; Sapienza University Rome; University Hospital Sapienza Rome; IRCCS Bambino Gesu; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton	Nobili, V (corresponding author), Bambino Gesu Pediat Hosp, IRCCS Rome, Hepatometab Dept, Rome, Italy.; Nobili, V (corresponding author), Bambino Gesu Pediat Hosp, IRCCS Rome, Liver Res Unit, Rome, Italy.	nobili66@yahoo.it	Carpino, Guido/AAB-9692-2019; Mosca, Antonella/L-2523-2018; Alisi, Anna/A-6469-2010; De Stefanis, Cristiano/AAA-1524-2020; Nobili, Valerio/K-8670-2018; Overi, Diletta/AAP-3632-2021; Della Corte, Claudia/AAA-7478-2020; Geremia, Caterina/AAA-9380-2020; De Stefanis, Cristiano/K-8592-2018; cianfarani, stefano/K-2079-2016	Mosca, Antonella/0000-0001-9646-7462; Alisi, Anna/0000-0001-7241-6329; De Stefanis, Cristiano/0000-0001-5898-9518; Della Corte, Claudia/0000-0003-4755-5428; De Stefanis, Cristiano/0000-0001-5898-9518; cianfarani, stefano/0000-0002-2580-8781; Byrne, Christopher D/0000-0001-6322-7753; De Vito, rita/0000-0002-7450-8398; Overi, Diletta/0000-0003-3561-8903	Italian Ministry of Health funds (Fondi di Ricerca Corrente)	Italian Ministry of Health funds (Fondi di Ricerca Corrente)	VN is supported by the Italian Ministry of Health funds (Fondi di Ricerca Corrente 2016).	Abramovitch S, 2015, AM J PHYSIOL-GASTR L, V308, pG112, DOI 10.1152/ajpgi.00132.2013; Abramovitch S, 2011, GUT, V60, P1728, DOI 10.1136/gut.2010.234666; Adam John M F, 2004, Acta Med Indones, V36, P3; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Beilfuss A, 2015, GUT, V64, P791, DOI 10.1136/gutjnl-2014-307024; Black LJ, 2014, J GASTROEN HEPATOL, V29, P1215, DOI 10.1111/jgh.12541; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Carpino G, 2005, DIGEST LIVER DIS, V37, P349, DOI 10.1016/j.dld.2004.11.009; Carpino G, 2014, J HEPATOL, V60, P1194, DOI 10.1016/j.jhep.2014.01.026; Chung GE, 2016, CLIN MOL HEPATOL, V22, P146, DOI 10.3350/cmh.2016.22.1.146; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Conwell LS, 2004, DIABETES CARE, V27, P314, DOI 10.2337/diacare.27.2.314; Ding C, 2012, BRIT J NUTR, V108, P1915, DOI 10.1017/S0007114512003285; Eliades M, 2013, ALIMENT PHARM THER, V38, P246, DOI 10.1111/apt.12377; Gressner AM, 1998, CELL TISSUE RES, V292, P447, DOI 10.1007/s004410051073; Hannah WN, 2016, DIGEST DIS SCI, V61, P1365, DOI 10.1007/s10620-016-4153-y; Janczyk W, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-85; Luger M, 2016, OBES SURG; Manco M, 2010, HEPATOLOGY, V51, P2229, DOI 10.1002/hep.23724; Nader NS, 2014, HORM RES PAEDIAT, V82, P107, DOI 10.1159/000362449; Nelson JE, 2016, AM J GASTROENTEROL; Nobili V, 2008, HEPATOLOGY, V48, P119, DOI 10.1002/hep.22336; Nobili V, 2016, CRIT REV CL LAB SCI, V53, P106, DOI 10.3109/10408363.2015.1092106; Nobili V, 2015, J PEDIATR GASTR NUTR, V60, P550, DOI 10.1097/MPG.0000000000000715; Nobili V, 2015, JAMA PEDIATR, V169, P170, DOI 10.1001/jamapediatrics.2014.2702; Nobili V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088005; Nobili V, 2014, EUR J ENDOCRINOL, V170, P547, DOI 10.1530/EJE-13-0609; Nobili V, 2011, ARCH DIS CHILD, V96, P350, DOI 10.1136/adc.2010.192401; Noureddin M, 2016, ALIMENT PHARM THER, V43, P1109, DOI 10.1111/apt.13620; Orci LA, 2016, CLIN GASTROENTEROL S, VS1542-3565; Saggese G, 2015, EUR J PEDIATR, V174, P565, DOI 10.1007/s00431-015-2524-6; Santiago-Rolon A, 2015, P R HEALTH SCI J, V34, P189; Schwimmer JB, 2006, PEDIATRICS, V118, P1388, DOI 10.1542/peds.2006-1212; Scorletti E, 2014, HEPATOLOGY, V60, P1211, DOI 10.1002/hep.27289; Singh S, 2015, CLIN GASTROENTEROL H, V13, P643, DOI 10.1016/j.cgh.2014.04.014; Slomski A, 2011, JAMA-J AM MED ASSOC, V305, P453, DOI 10.1001/jama.2011.50; Smotkin-Tangorra M, 2007, J PEDIATR ENDOCR MET, V20, P817; Targher G, 2007, NUTR METAB CARDIOVAS, V17, P517, DOI 10.1016/j.numecd.2006.04.002; Vajro P, 2012, J PEDIATR GASTR NUTR, V54, P700, DOI 10.1097/MPG.0b013e318252a13f; Vespasiani-Gentilucci U, 2012, MODERN PATHOL, V25, P576, DOI 10.1038/modpathol.2011.197; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268; Zhu LD, 2015, CAN J PHYSIOL PHARM, V93, P385, DOI 10.1139/cjpp-2014-0275	42	70	71	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168216	10.1371/journal.pone.0168216	http://dx.doi.org/10.1371/journal.pone.0168216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977757	Green Published, Green Accepted, gold			2022-12-27	WOS:000391217400077
J	Hou, Q; Zhou, LL; Tang, JJ; Ma, N; Xu, AC; Tang, J; Zheng, DD; Chen, XG; Chen, F; Dong, XD; Tu, LL				Hou, Qiang; Zhou, Linglin; Tang, Jiajia; Ma, Nan; Xu, Ancong; Tang, Jiang; Zheng, Dandan; Chen, Xiaogang; Chen, Feng; Dong, Xiang Da; Tu, LiLi			LGR4 Is a Direct Target of MicroRNA-34a and Modulates the Proliferation and Migration of Retinal Pigment Epithelial ARPE-19 Cells	PLOS ONE			English	Article							DOWN-REGULATION; GPR48; GENE; CANCER; EXPRESSION; EGFR	The pathology of proliferative vitreoretinopathy and proliferative diabetic retinopathy is linked to proliferation, migration, and adhesion of the retinal pigment epithelium. MicroRNA-34a (miR-34a) expression modulates changes in proliferation and migration of retinal pigment epithelial cell line ARPE-19. In this study, we determined that miR-34a interacts with LGR4, identified by bioinformatics using TargetScan Human 5.0, to affect these changes. Double luciferase gene reporter assay confirmed miR-34a involvement in mediating control. miR-34a mimic transfection decreased LGR4 expression. Western blot analysis documented corresponding protein expression inhibition. MTS, Ki67 immunostaining, scratch and transwell testing, along with attachment assay showed that miR-34a upregulation inhibited ARPE-19 cell proliferation, migration and attachment partly through downregulation of LGR4 protein expression. Western blot analysis revealed that both miR-34a upregulation and LGR4 downregulation induced declines in E2F1, p-CDC2, CDK2, CDK4 and CDK6 protein expression. Taken together, miR-34a gene expression upregulation inhibits ARPE-19 cell proliferation, migration and adhesion partly by suppressing LGR4 expression. These results substantiate earlier indications that both miR-34a and LGR4 are potential drug targets to prevent fibrosis in a clinical setting.	[Hou, Qiang; Zhou, Linglin; Tang, Jiajia; Ma, Nan; Xu, Ancong; Tang, Jiang; Zheng, Dandan; Chen, Xiaogang; Chen, Feng; Tu, LiLi] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Hosp Eye, Wenzhou, Zhejiang, Peoples R China; [Hou, Qiang; Zhou, Linglin; Tang, Jiajia; Ma, Nan; Xu, Ancong; Tang, Jiang; Zheng, Dandan; Chen, Xiaogang; Chen, Feng; Tu, LiLi] Minist Hlth Peoples Republ China, State Key Lab, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Hou, Qiang; Zhou, Linglin; Tang, Jiajia; Ma, Nan; Xu, Ancong; Tang, Jiang; Zheng, Dandan; Chen, Xiaogang; Chen, Feng; Tu, LiLi] Minist Hlth Peoples Republ China, Key Lab Vis Sci, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Dong, Xiang Da] Westchester Med Ctr, Dept Surg, Valhalla, NY USA	Wenzhou Medical University; Westchester Medical Center	Tu, LL (corresponding author), Wenzhou Med Univ, Sch Ophthalmol & Optometry, Hosp Eye, Wenzhou, Zhejiang, Peoples R China.; Tu, LL (corresponding author), Minist Hlth Peoples Republ China, State Key Lab, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.; Tu, LL (corresponding author), Minist Hlth Peoples Republ China, Key Lab Vis Sci, Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China.	tulili@mail.eye.ac.cn	ma, nan/AAF-6968-2020	ma, nan/0000-0003-4006-1003	National Natural Science Foundation of China [81100671]; Zhejiang Provincial Natural Science Foundation of China [LY16H120009, Y2110609]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	National Natural Science Foundation of China Grant 81100671, Zhejiang Provincial Natural Science Foundation of China Grant LY16H120009 and Y2110609 for Q.Hou.	Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Gao Y, 2006, CANCER RES, V66, P11623, DOI 10.1158/0008-5472.CAN-06-2629; He SK, 2010, INVEST OPHTH VIS SCI, V51, P543, DOI 10.1167/iovs.09-3475; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hou Q, 2013, INVEST OPHTH VIS SCI, V54, P6481, DOI 10.1167/iovs.13-11873; Hsu PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106804; Jin C, 2008, INVEST OPHTH VIS SCI, V49, P4245, DOI 10.1167/iovs.08-1860; Jun JH, 2016, INVEST OPHTH VIS SCI, V57, P12, DOI 10.1167/iovs.15-17111; Kuznetsova AV, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/801787; Li MY, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.10; Liang F, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0486-1; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lodygin D, 2008, CELL CYCLE, V7, P2591, DOI 10.4161/cc.7.16.6533; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mohri Y, 2011, DEV DYNAM, V240, P1626, DOI 10.1002/dvdy.22651; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Styrkarsdottir U, 2013, NATURE, V497, P517, DOI 10.1038/nature12124; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Wang ZL, 2010, FEBS LETT, V584, P4057, DOI 10.1016/j.febslet.2010.08.028; Weng JS, 2008, P NATL ACAD SCI USA, V105, P6081, DOI 10.1073/pnas.0708257105; Wu JH, 2013, CARCINOGENESIS, V34, P2861, DOI 10.1093/carcin/bgt229; Zebisch M, 2015, J STRUCT BIOL, V191, P149, DOI 10.1016/j.jsb.2015.05.008; Zhu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119599; Zhu YB, 2013, ASIAN PAC J CANCER P, V14, P4775, DOI 10.7314/APJCP.2013.14.8.4775	28	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168320	10.1371/journal.pone.0168320	http://dx.doi.org/10.1371/journal.pone.0168320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977785	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400092
J	Kang, EJ; Seo, JH; Kim, LY; Park, GU; Oh, MJ; Park, PJ; Cho, GJ				Kang, Eun Joo; Seo, Jae Hong; Kim, Log Young; Park, Geun U.; Oh, Min-Jeong; Park, Pyoung-Jae; Cho, Geum Joon			Pregnancy-Associated Risk Factors of Postpartum Breast Cancer in Korea: A Nationwide Health Insurance Database Study	PLOS ONE			English	Article							TRANSIENT INCREASE; OXYTOCIN; PROLIFERATION; PROGNOSIS; CELLS; METASTASIS; INVOLUTION; DIAGNOSIS; SURVIVAL; FEATURES	Patients with postpartum breast cancer have been reported to have a poor prognosis. The present study aimed to evaluate the pregnancy-related risk factors of postpartum breast cancer in Korea. We collected patient data from the Korea National Health Insurance (KNHI) Claims Database of the Health Insurance Review and Assessment Service (HIRA) for the 2009-2013 period. We evaluated the pregnancy-related risk factors for postpartum breast cancer in two population groups. For Group 1 (women who had given birth during the 2010-2012 period), data on those who were diagnosed with breast cancer from childbirth to 1-year postpartum were extracted. For Group 2, we extracted the data of women who gave birth in 2010 and traced them until December 31, 2013. In Group 1, 1,384,551 deliveries and 317 postpartum breast cancer patients were recorded in Korea between January 1, 2010, and December 31, 2012. Women aged >= 35 years (Odds Ratio [OR], 2.003; 95% Confidence Interval [CI], 1.567-2.560) and those who gave birth via cesarean delivery (OR, 1.237; 95% CI, 0.986-1.553) were considered to be at a higher risk for breast cancer. Lower risk was noted in primiparous women (OR, 0.737; 95% CI, 0.585-0.928). In Group 2, the data of 457,924 women who gave birth in 2010 were traced until December 31, 2013. Among them, 655 patients were diagnosed with breast cancer, and age >= 35 years and cesarean delivery were associated with an higher risk of breast cancer, whereas primiparous status was associated with a lower risk of breast cancer. In conclusion, older age (>= 35 years) and cesarean delivery are significant risk factors for postpartum breast cancer, and primiparous women have a lower risk of developing postpartum breast cancer.	[Kang, Eun Joo; Seo, Jae Hong] Korea Univ, Coll Med, Guro Hosp, Div Hematooncol,Dept Internal Med, Seoul, South Korea; [Kim, Log Young] Hlth Insurance Review & Assessment Serv Korea, Seoul, South Korea; [Park, Geun U.] Chung Ang Univ, Dept Appl Stat, Seoul, South Korea; [Oh, Min-Jeong; Cho, Geum Joon] Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea; [Park, Pyoung-Jae] Korea Univ, Coll Med, Div Transplant & Vasc Surg, Dept Surg,Guro Hosp, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Chung Ang University; Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Cho, GJ (corresponding author), Korea Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.; Park, PJ (corresponding author), Korea Univ, Coll Med, Div Transplant & Vasc Surg, Dept Surg,Guro Hosp, Seoul, South Korea.	pyoungjaepark@gmail.com; md_cho@hanmail.net		Kang, Eun Joo/0000-0003-0702-3400				Albrektsen G, 2005, BRIT J CANCER, V92, P167, DOI 10.1038/sj.bjc.6602302; Anderson WF, 2007, CANCER CAUSE CONTROL, V18, P439, DOI 10.1007/s10552-006-0092-9; Andersson TML, 2015, CANCER-AM CANCER SOC, V121, P2072, DOI 10.1002/cncr.29325; Andersson TML, 2009, OBSTET GYNECOL, V114, P568, DOI 10.1097/AOG.0b013e3181b19154; Asgeirsson KS, 2011, ACTA OBSTET GYN SCAN, V90, P158, DOI 10.1111/j.1600-0412.2010.01035.x; Azim HA, 2012, CANCER TREAT REV, V38, P834, DOI 10.1016/j.ctrv.2012.06.004; Azim HA, 2012, ACTA ONCOL, V51, P653, DOI 10.3109/0284186X.2011.636069; Callihan EB, 2013, BREAST CANCER RES TR, V138, P549, DOI 10.1007/s10549-013-2437-x; Cassoni P, 2002, INT J ONCOL, V21, P375; Cassoni P, 1997, INT J CANCER, V72, P340, DOI 10.1002/(SICI)1097-0215(19970717)72:2<340::AID-IJC23>3.0.CO;2-I; CASSONI P, 1994, VIRCHOWS ARCH, V425, P467; Cassoni P, 2006, MOL CANCER RES, V4, P351, DOI 10.1158/1541-7786.MCR-06-0024; DEGEEST K, 1985, J PERINAT MED, V13, P3, DOI 10.1515/jpme.1985.13.1.3; Dimitrakakis C, 2013, BREAST CARE, V8, P203, DOI 10.1159/000352093; Genin AS, 2012, BREAST, V21, P550, DOI 10.1016/j.breast.2012.05.002; Gudjonsson T, 2005, J MAMMARY GLAND BIOL, V10, P261, DOI 10.1007/s10911-005-9586-4; Hou NQ, 2013, BREAST CANCER RES TR, V138, P633, DOI 10.1007/s10549-013-2434-0; Imanieh MH, 2014, EUR J PHARMACOL, V741, P112, DOI 10.1016/j.ejphar.2014.07.053; Jesmin E, 2015, Mymensingh Med J, V24, P750; Jinda S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3633; Jung KW, 2016, CANCER RES TREAT, V48, P451, DOI 10.4143/crt.2016.092; Kalan I, 2010, BREAST, V19, P67, DOI 10.1016/j.breast.2009.10.010; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kim M, 2013, J NANOMATER, V2013, DOI 10.1155/2013/138083; KUWABARA Y, 1987, ARCH GYNECOL OBSTET, V241, P13, DOI 10.1007/BF00931436; Lambe M, 1995, BRIT MED J, V311, P1607, DOI 10.1136/bmj.311.7020.1607; LAMBE M, 1994, NEW ENGL J MED, V331, P5, DOI 10.1056/NEJM199407073310102; Largent JA, 2005, BREAST CANCER RES, V7, pR541, DOI 10.1186/bcr1198; Lau Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0142861, 10.1371/journal.pone.0138694]; Lee YY, 2012, BJOG-INT J OBSTET GY, V119, P1572, DOI 10.1111/j.1471-0528.2012.03475.x; Liu Q, 2002, CANCER CAUSE CONTROL, V13, P299, DOI 10.1023/A:1015287208222; Lyons TR, 2014, J CLIN INVEST, V124, P3901, DOI 10.1172/JCI73777; Lyons TR, 2009, J MAMMARY GLAND BIOL, V14, P87, DOI 10.1007/s10911-009-9119-7; Martinson HA, 2015, INT J CANCER, V136, P1803, DOI 10.1002/ijc.29181; Murphy CG, 2012, CANCER-AM CANCER SOC, V118, P3254, DOI 10.1002/cncr.26654; MURRELL TGC, 1995, BREAST CANCER RES TR, V35, P225, DOI 10.1007/BF00668213; Pavlidis N, 2005, CANCER TREAT REV, V31, P439, DOI 10.1016/j.ctrv.2005.04.010; Pollan M, 2010, BREAST CANCER RES TR, V123, P3, DOI 10.1007/s10549-010-1098-2; Pollan M, 2009, JNCI-J NATL CANCER I, V101, P1584, DOI 10.1093/jnci/djp358; Rodriguez AO, 2008, OBSTET GYNECOL, V112, P71, DOI 10.1097/AOG.0b013e31817c4ebc; Smith LH, 2003, AM J OBSTET GYNECOL, V189, P1128, DOI 10.1067/S0002-9378(03)00537-4; Wang P, 2015, J NEUROIMMUNOL, V289, P152, DOI 10.1016/j.jneuroim.2015.11.001; Yankaskas Bonnie C, 2005, Breast Dis, V23, P3	43	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168469	10.1371/journal.pone.0168469	http://dx.doi.org/10.1371/journal.pone.0168469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977789	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400110
J	Khairy, H; Meinert, C; Wubbeler, JH; Poehlein, A; Daniel, R; Voigt, B; Riedel, K; Steinbuchel, A				Khairy, Heba; Meinert, Christina; Wuebbeler, Jan Hendrik; Poehlein, Anja; Daniel, Rolf; Voigt, Birgit; Riedel, Katharina; Steinbuechel, Alexander			Genome and Proteome Analysis of Rhodococcus erythropolis MI2: Elucidation of the 4,4 '- Dithiodibutyric Acid Catabolism	PLOS ONE			English	Article							COMPARATIVE-ANALYSIS SYSTEM; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-OLEOVORANS; SIGNAL PEPTIDES; RESISTANCE; RHODANESE; VIRULENCE	Rhodococcus erythropolis MI2 has the extraordinary ability to utilize the xenobiotic 4,4'-dithiodibutyric acid (DTDB). Cleavage of DTDB by the disulfide-reductase Nox, which is the only verified enzyme involved in DTDB-degradation, raised 4-mercaptobutyric acid (4MB). 4MB could act as building block of a novel polythioester with unknown properties. To completely unravel the catabolism of DTDB, the genome of R. erythropolis MI2 was sequenced, and subsequently the proteome was analyzed. The draft genome sequence consists of approximately 7.2 Mbp with an overall G+C content of 62.25% and 6,859 predicted protein-encoding genes. The genome of strain MI2 is composed of three replicons: one chromosome and two megaplasmids with sizes of 6.45, 0.4 and 0.35 Mbp, respectively. When cells of strain MI2 were cultivated with DTDB as sole carbon source and compared to cells grown with succinate, several interesting proteins with significantly higher expression levels were identified using 2D-PAGE and MALDI-TOF mass spectrometry. A putative luciferase-like monooxygenase-class F420-dependent oxidoreductase (RERY_05640), which is encoded by one of the 126 monooxygenase-encoding genes of the MI2-genome, showed a 3-fold increased expression level. This monooxygenase could oxidize the intermediate 4MB into 4-oxo-4-sulfanylbutyric acid. Next, a desulfurization step, which forms succinic acid and volatile hydrogen sulfide, is proposed. One gene coding for a putative desulfhydrase (RERY_06500) was identified in the genome of strain MI2. However, the gene product was not recognized in the proteome analyses. But, a significant expression level with a ratio of up to 7.3 was determined for a putative sulfide: quinone oxidoreductase (RERY_02710), which could also be involved in the abstraction of the sulfur group. As response to the toxicity of the intermediates, several stress response proteins were strongly expressed, including a superoxide dismutase (RERY_05600) and an osmotically induced protein (RERY_02670). Accordingly, novel insights in the catabolic pathway of DTDB were gained.	[Khairy, Heba; Meinert, Christina; Wuebbeler, Jan Hendrik; Steinbuechel, Alexander] Westfalische Wilhelms Univ Munster, Inst Mol Mikrobiol & Biotechnol, Munster, Germany; [Khairy, Heba] Univ Alexandria, Fac Sci, Dept Bot & Microbiol, Alexandria, Egypt; [Poehlein, Anja; Daniel, Rolf] Georg August Univ Gottingen, Inst Mikrobiol & Genet, Dept Genom & Appl Microbiol, Gottingen, Germany; [Poehlein, Anja; Daniel, Rolf] Georg August Univ Gottingen, Inst Mikrobiol & Genet, Gottingen Genom Lab, Gottingen, Germany; [Voigt, Birgit; Riedel, Katharina] Ernst Moritz Arndt Univ Greifswald, Inst Mikrobiol, Greifswald, Germany; [Steinbuechel, Alexander] King Abdulaziz Univ, Fac Environm Sci, Jeddah, Saudi Arabia	University of Munster; Egyptian Knowledge Bank (EKB); Alexandria University; University of Gottingen; University of Gottingen; Ernst Moritz Arndt Universitat Greifswald; King Abdulaziz University	Steinbuchel, A (corresponding author), Westfalische Wilhelms Univ Munster, Inst Mol Mikrobiol & Biotechnol, Munster, Germany.; Steinbuchel, A (corresponding author), King Abdulaziz Univ, Fac Environm Sci, Jeddah, Saudi Arabia.	steinbu@uni-muenster.de	Daniel, Rolf/AAQ-5933-2021	Daniel, Rolf/0000-0002-8646-7925; Poehlein, Anja/0000-0002-2473-6202; Khairy, Heba/0000-0001-6072-8202; Riedel, Katharina/0000-0002-4629-3019				Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bartels A, 2007, PLANT PHYSIOL BIOCH, V45, P178, DOI 10.1016/j.plaphy.2007.02.005; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; BERNI R, 1991, FREE RADICAL RES COM, V15, P203, DOI 10.3109/10715769109049142; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bordo D, 2002, EMBO REP, V3, P741, DOI 10.1093/embo-reports/kvf150; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDL H, 1988, APPL ENVIRON MICROB, V54, P1977, DOI 10.1128/AEM.54.8.1977-1982.1988; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Chan LK, 2009, J BACTERIOL, V191, P1026, DOI 10.1128/JB.01154-08; Cussiol JRR, 2010, J BIOL CHEM, V285, P21943, DOI 10.1074/jbc.M110.117283; de Carvalho CCCR, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00290; de Carvalho CCCR, 2012, RES MICROBIOL, V163, P125, DOI 10.1016/j.resmic.2011.11.003; de Carvalho CCCR, 2005, FEMS MICROBIOL ECOL, V51, P389, DOI 10.1016/j.femsec.2004.09.010; Elbanna K, 2004, ARCH MICROBIOL, V182, P212, DOI 10.1007/s00203-004-0715-z; Falkenby LG, 2011, FEMS MICROBIOL LETT, V323, P142, DOI 10.1111/j.1574-6968.2011.02370.x; Felce J, 2004, J MOL MICROB BIOTECH, V8, P169, DOI 10.1159/000085789; Fisher AJ, 1996, J BIOL CHEM, V271, P21956, DOI 10.1074/jbc.271.36.21956; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Goodfellow M, 1998, ANTON LEEUW INT J G, V74, P3, DOI 10.1023/A:1001730725003; GOODFELLOW M, 1977, J GEN MICROBIOL, V100, P99, DOI 10.1099/00221287-100-1-99; Griesbeck C., 2000, RECENT RES DEV MICRO, VVolume 4, P129; GUTIERREZ C, 1991, J MOL BIOL, V220, P959, DOI 10.1016/0022-2836(91)90366-E; Hara H, 2010, APPL ENVIRON MICROB, V76, P1516, DOI 10.1128/AEM.02621-09; HELD KD, 1994, RADIAT RES, V139, P15, DOI 10.2307/3578727; Imbernon L, 2015, POLYM CHEM-UK, V6, P4271, DOI 10.1039/c5py00459d; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jang LS, 2006, SENSOR MATER, V18, P367; Kanayama N, 2000, LANGMUIR, V16, P577, DOI 10.1021/la990182e; Kato M, 2005, BIOMACROMOLECULES, V6, P2275, DOI 10.1021/bm050168i; Kawada J, 2003, BIOMACROMOLECULES, V4, P1698, DOI 10.1021/bm0341327; Khairy H, NADH FLAVIN IN PRESS; Khairy H, 2015, APPL ENVIRON MICROB, V81, P8294, DOI 10.1128/AEM.02059-15; Kim DY, 2005, BIOMACROMOLECULES, V6, P897, DOI 10.1021/bm049334x; Kim IS, 2002, BIOTECHNOL BIOENG, V80, P650, DOI 10.1002/bit.10421; Komaki H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-323; Kriszt B, 2012, J BACTERIOL, V194, P1247, DOI 10.1128/JB.06603-11; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larkin MJ, 2005, CURR OPIN BIOTECH, V16, P282, DOI 10.1016/j.copbio.2005.04.007; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Lesniak J, 2002, EMBO J, V21, P6649, DOI 10.1093/emboj/cdf670; Letek M, 2008, J BACTERIOL, V190, P5797, DOI 10.1128/JB.00468-08; Letek M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001145; Luo GX, 1994, J BIOL CHEM, V269, P399; Maier S, 2015, CHEMBIOCHEM, V16, P1175, DOI 10.1002/cbic.201500048; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD560, DOI 10.1093/nar/gkt963; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Matthies A, 2005, BIOCHEMISTRY-US, V44, P7912, DOI 10.1021/bi0503448; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nandi DL, 2000, INT J BIOCHEM CELL B, V32, P465, DOI 10.1016/S1357-2725(99)00035-7; Nikaido H, 2012, FEMS MICROBIOL REV, V36, P340, DOI 10.1111/j.1574-6976.2011.00290.x; Oh-oka H., 2004, ENCY BIOL CHEM, P321; Onwueme KC, 2005, J BACTERIOL, V187, P4760, DOI 10.1128/JB.187.14.4760-4766.2005; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Prat L, 2012, FEBS J, V279, P2754, DOI 10.1111/j.1742-4658.2012.08660.x; Raberg M, 2008, APPL ENVIRON MICROB, V74, P4477, DOI 10.1128/AEM.00440-08; Rabilloud T, 1999, ELECTROPHORESIS, V20, P3603, DOI 10.1002/(SICI)1522-2683(19991201)20:18&lt;3603::AID-ELPS3603&gt;3.0.CO;2-V; Renato J, 2003, J BIOL CHEM, V278, P11570, DOI 10.1074/jbc.M300252200; Riemenschneider A, 2005, FEBS J, V272, P1291, DOI 10.1111/j.1742-4658.2005.04567.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sambrook J., 2001, MOL CLONING LAB MANU; SCHLEGEL HG, 1961, NATURE, V191, P463, DOI 10.1038/191463a0; SCHLEGEL HG, 1961, ARCH MIKROBIOL, V38, P209, DOI 10.1007/BF00422356; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Segura A, 2012, CURR OPIN BIOTECH, V23, P415, DOI 10.1016/j.copbio.2011.11.015; Sekine M, 2006, ENVIRON MICROBIOL, V8, P334, DOI 10.1111/j.1462-2920.2005.00899.x; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Simeone R, 2007, FEBS J, V274, P1957, DOI 10.1111/j.1742-4658.2007.05740.x; Steeves CH, 2011, PROTEOMICS, V11, P2027, DOI 10.1002/pmic.201000631; Theissen U, 2003, MOL BIOL EVOL, V20, P1564, DOI 10.1093/molbev/msg174; TIMM A, 1990, APPL MICROBIOL BIOT, V33, P296, DOI 10.1007/BF00164525; Torres S, 2011, BIOTECHNOL ADV, V29, P442, DOI 10.1016/j.biotechadv.2011.04.002; van der Geize R, 2004, CURR OPIN MICROBIOL, V7, P255, DOI 10.1016/j.mib.2004.04.001; Wang ZL, 2011, WORLD J MICROB BIOT, V27, P1965, DOI 10.1007/s11274-011-0656-z; WESTLEY J, 1983, FUND APPL TOXICOL, V3, P377, DOI 10.1016/S0272-0590(83)80008-6; Wolf C, 2008, PROTEOMICS, V8, P3139, DOI 10.1002/pmic.200701062; Wubbeler JH, 2014, CURR OPIN BIOTECH, V29, P85, DOI 10.1016/j.copbio.2014.02.017; Wubbeler JH, 2010, MICROBIOL-SGM, V156, P1221, DOI 10.1099/mic.0.036178-0; Yang JC, 2007, PLASMID, V57, P55, DOI 10.1016/j.plasmid.2006.08.002	87	7	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167539	10.1371/journal.pone.0167539	http://dx.doi.org/10.1371/journal.pone.0167539			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977722	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400022
J	Saxe, F; Weichold, S; Reinecke, A; Lisec, J; Doring, A; Neumetzler, L; Burgert, I; Eder, M				Saxe, Friederike; Weichold, Susann; Reinecke, Antje; Lisec, Jan; Doering, Anett; Neumetzler, Lutz; Burgert, Ingo; Eder, Michaela			Age Effects on Hypocotyl Mechanics	PLOS ONE			English	Article							PLANT-CELL WALLS; ARABIDOPSIS; GROWTH; NANOINDENTATION; ELONGATION; CELLULOSE	Numerous studies deal with composition and molecular processes involved in primary cell wall formation and alteration in Arabidopsis. However, it still remains difficult to assess the relation between physiological properties and mechanical function at the cell wall level. The thin and fragile structure of primary cell walls and their large biological variability, partly related to structural changes during growth, make mechanical experiments challenging. Since, to the best of our knowledge, there is no reliable data in the literature about how the properties of the fully elongated zone of hypocotyls change with age. We studied in a series of experiments on two different seed batches the tensile properties the region below the growth zone of 4 to 7 day old etiolated Arabidopsis hypocotyls. Additionally, we analysed geometrical parameters, hypocotyl density and cellulose content as individual traits and their relation to tissue mechanics. No significant differences of the mechanical parameters of the non-growing region between 5-7 day old plants could be found whereas in 4 day old plants both tensile stiffness and ultimate tensile stress were significantly lower than in the older plants. Furthermore hypocotyl diameters and densities remain almost the same for 5, 6 and 7 day old seedlings. Naturally, hypocotyl lengths increase with age. The evaluation whether the choice-age or length D influences the mechanical properties showed that both are equally applicable sampling parameters. Additionally, our detailed study allows for the estimation of biological variability, connections between mechanics and hypocotyl age could be established and complement the knowledge on biochemistry and genetics affecting primary plant cell wall growth. The application of two different micromechanical devices for testing living Arabidopsis hypocotyls allows for emphasizing and discussing experimental limitations and for presenting a wide range of possibilities to address current and future questions related to plant cell wall mechanics, synthesis and growth in combination with molecular biology methodologies.	[Saxe, Friederike; Weichold, Susann; Reinecke, Antje; Burgert, Ingo; Eder, Michaela] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Saxe, Friederike] Humboldt Univ, Cluster Excellence Image Knowledge Gestaltung, Berlin, Germany; [Lisec, Jan; Doering, Anett; Neumetzler, Lutz] Max Planck Inst Mol Plant Physiol, Plant Cell Wall Grp, Potsdam, Germany; [Lisec, Jan] Charite, Mol Krebsforschungszentrum MKFZ, Berlin, Germany; [Doering, Anett] Targenomix GmbH, Potsdam, Germany; [Burgert, Ingo] Fed Inst Technol, Inst Bldg Mat, Zurich, Switzerland; [Burgert, Ingo] Swiss Fed Labs Mat Sci & Technol, Appl Wood Mat Lab, Dubendorf, Switzerland	Max Planck Society; Humboldt University of Berlin; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Saxe, F; Eder, M (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany.; Saxe, F (corresponding author), Humboldt Univ, Cluster Excellence Image Knowledge Gestaltung, Berlin, Germany.	friederike.saxe@mpikg.mpg.de; michaela.eder@mpikg.mpg.de		Lisec, Jan/0000-0003-1220-2286; Eder, Michaela/0000-0002-1461-1668				Abasolo W, 2009, MOL PLANT, V2, P990, DOI 10.1093/mp/ssp065; Burgert I, 2003, HOLZFORSCHUNG, V57, P661, DOI 10.1515/HF.2003.099; Burgert I., 2006, CHARACT CELLUL CELL, V30, P7; Burgert I, 2009, INTEGR COMP BIOL, V49, P69, DOI 10.1093/icb/icp026; CARPITA NC, 1993, PLANT J, V3, P1, DOI 10.1111/j.1365-313X.1993.tb00007.x; Cosgrove DJ, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00204; Cosgrove DJ, 2011, METHODS MOL BIOL, V715, P291, DOI 10.1007/978-1-61779-008-9_20; Cosgrove DJ, 1997, ANNU REV CELL DEV BI, V13, P171, DOI 10.1146/annurev.cellbio.13.1.171; Derbyshire P, 2007, J EXP BOT, V58, P2079, DOI 10.1093/jxb/erm074; Fratzl P., 2007, THE EXPANDING CELL, P191; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gindl W, 2004, APPL PHYS A-MATER, V79, P2069, DOI 10.1007/s00339-004-2864-y; Kohler L, 2002, PLANTA, V215, P33, DOI 10.1007/s00425-001-0718-9; Park YB, 2012, PLANT PHYSIOL, V158, P1933, DOI 10.1104/pp.111.192880; PRESTON RD, 1982, PLANTA, V155, P356, DOI 10.1007/BF00429465; Refregier G, 2004, PLANT PHYSIOL, V135, P959, DOI 10.1104/pp.104.038711; REITER WD, 1993, SCIENCE, V261, P1032, DOI 10.1126/science.261.5124.1032; Ryden P, 2003, PLANT PHYSIOL, V132, P1033, DOI 10.1104/pp.103.021873; Saxe F, 2015, METHODS MOL BIOL, V1242, P211, DOI 10.1007/978-1-4939-1902-4_18; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Vandenbussche F, 2005, BIOESSAYS, V27, P275, DOI 10.1002/bies.20199; Wimmer R, 1997, WOOD SCI TECHNOL, V31, P131, DOI 10.1007/s002260050022; Yakubov GE, 2016, J EXP BOT, V67, P2799, DOI 10.1093/jxb/erw117; Yuan S, 2001, PLANT PHYSIOL, V127, P324, DOI 10.1104/pp.127.1.324	24	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167808	10.1371/journal.pone.0167808	http://dx.doi.org/10.1371/journal.pone.0167808			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977698	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400033
J	Tokunaga, E; Yamashita, N; Tanaka, K; Inoue, Y; Akiyoshi, S; Saeki, H; Oki, E; Kitao, H; Maehara, Y				Tokunaga, Eriko; Yamashita, Nami; Tanaka, Kimihiro; Inoue, Yuka; Akiyoshi, Sayuri; Saeki, Hiroshi; Oki, Eiji; Kitao, Hiroyuki; Maehara, Yoshihiko			Expression of APOBEC3B mRNA in Primary Breast Cancer of Japanese Women	PLOS ONE			English	Article							DELETION POLYMORPHISM; RESTRICTION FACTORS; GENES; MUTAGENESIS; MUTATIONS; TP53; RISK; ASSOCIATION; PROGNOSIS; IMPACT	Recent studies have identified the apolipoprotein B mRNA-editing enzyme catalytic poly-peptide-like 3B (APOBEC3B) as a source of mutations in various malignancies. APOBEC3B is overexpressed in several human cancer types, including breast cancer. In this study, we analyzed APOBEC3B mRNA expression in 305 primary breast cancers of Japanese women using quantitative reverse transcription-PCR, and investigated the relationships between the APOBEC3B mRNA expression and clinicopathological characteristics, prognosis, and TP53 mutations. The expression of APOBEC3B mRNA was detected in 277 tumors and not detected in 28 tumors. High APOBEC3B mRNA expression was significantly correlated with ER-and PR-negativity, high grade and high Ki67 index. The APOBEC3B mRNA expression was highest in the triple-negative and lowest in the hormone receptorpositive/ HER2-negative subtypes. The TP53 gene was more frequently mutated in the tumors with high APOBEC3B mRNA expression. High APOBEC3B mRNA expression was significantly associated with poor recurrence-free survival in all cases and the ER-positive cases. These findings were almost consistent with the previous reports from the Western countries. In conclusion, high APOBEC3B mRNA expression was related to the aggressive phenotypes of breast cancer, high frequency of TP53 mutation and poor prognosis, especially in ER-positive tumors.	[Tokunaga, Eriko; Yamashita, Nami; Tanaka, Kimihiro; Inoue, Yuka; Akiyoshi, Sayuri; Saeki, Hiroshi; Oki, Eiji; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka, Japan; [Kitao, Hiroyuki] Kyushu Univ, Grad Sch Med Sci, Dept Mol Oncol, Higashi Ku, Fukuoka, Japan; [Tokunaga, Eriko; Akiyoshi, Sayuri] Natl Hosp Org, Kyushu Canc Ctr, Dept Breast Oncol, Minami Ku, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu Cancer Center	Tokunaga, E (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Higashi Ku, Fukuoka, Japan.; Tokunaga, E (corresponding author), Natl Hosp Org, Kyushu Canc Ctr, Dept Breast Oncol, Minami Ku, Fukuoka, Japan.	eriko@surg2.med.kyuhsu-u.ac.jp; tokunaga.e@nk-cc.go.jp			JSPS KAKENHI [23591896]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 23591896.	Borresen-Dale AL, 2003, HUM MUTAT, V21, P292, DOI 10.1002/humu.10174; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Cescon DW, 2015, P NATL ACAD SCI USA, V112, P2841, DOI 10.1073/pnas.1424869112; Harris RS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0498-3; Henderson S, 2015, TRENDS MOL MED, V21, P274, DOI 10.1016/j.molmed.2015.02.007; Hisamatsu Y, 2012, ANN SURG ONCOL, V19, P1145, DOI 10.1245/s10434-011-2094-4; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuong KJ, 2013, NAT GENET, V45, P964, DOI 10.1038/ng.2736; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Leonard B, 2013, CANCER RES, V73, P7222, DOI 10.1158/0008-5472.CAN-13-1753; Long JR, 2013, JNCI-J NATL CANCER I, V105, P573, DOI 10.1093/jnci/djt018; Middlebrooks CD, 2016, NAT GENET, V48, P1330, DOI 10.1038/ng.3670; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Okada S, 2012, ANN SURG ONCOL, V19, P1499, DOI 10.1245/s10434-011-2166-5; Olivier M, 2006, CLIN CANCER RES, V12, P1157, DOI 10.1158/1078-0432.CCR-05-1029; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Refsland EW, 2013, CURR TOP MICROBIOL, V371, P1, DOI 10.1007/978-3-642-37765-5_1; Saeki H, 2011, CLIN CANCER RES, V17, P1731, DOI 10.1158/1078-0432.CCR-10-1996; Sieuwerts AM, 2014, HORM CANCER-US, V5, P405, DOI 10.1007/s12672-014-0196-8; Silwal-Pandit L, 2014, CLIN CANCER RES, V20, P3569, DOI 10.1158/1078-0432.CCR-13-2943; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Taylor BJM, 2013, ELIFE, V2, DOI 10.7554/eLife.00534; Tsuboi M, 2015, BREAST CANC; Xuan D, 2013, CARCINOGENESIS, V34, P2240, DOI 10.1093/carcin/bgt185	26	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168090	10.1371/journal.pone.0168090	http://dx.doi.org/10.1371/journal.pone.0168090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977754	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400057
J	Soltau, I; Mudersbach, E; Geissen, M; Schwedhelm, E; Winkler, MS; Geffken, M; Peine, S; Schoen, G; Debus, ES; Larena-Avellaneda, A; Daum, G				Soltau, Irina; Mudersbach, Eileen; Geissen, Markus; Schwedhelm, Edzard; Winkler, Martin S.; Geffken, Maria; Peine, Sven; Schoen, Gerhard; Debus, E. Sebastian; Larena-Avellaneda, Axel; Daum, Guenter			Serum-Sphingosine-1-Phosphate Concentrations Are Inversely Associated with Atherosclerotic Diseases in Humans	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; SPHINGOSINE 1-PHOSPHATE; SERUM SPHINGOSINE-1-PHOSPHATE; LYMPHOCYTE EGRESS; HUMAN PLATELETS; PLASMA; HDL; RELEASE; INFLAMMATION; SEPSIS	Background and Objectives Atherosclerotic changes of arteries are the leading cause for deaths in cardiovascular disease and greatly impair patient's quality of life. Sphingosine-1-phosphate (S1P) is a signaling sphingolipid that regulates potentially pro-as well as anti-atherogenic processes. Here, we investigate whether serum-S1P concentrations are associated with peripheral artery disease (PAD) and carotid stenosis (CS). Methods and Results Serum was sampled from blood donors (controls, N = 174) and from atherosclerotic patients (N = 132) who presented to the hospital with either clinically relevant PAD (N = 102) or CS (N = 30). From all subjects, serum-S1P was measured by mass spectrometry and blood parameters were determined by routine laboratory assays. When compared to controls, atherosclerotic patients before invasive treatment to restore blood flow showed significantly lower serum-S1P levels. This difference cannot be explained by risk factors for atherosclerosis (old age, male gender, hypertension, hypercholesteremia, obesity, diabetes or smoking) or comorbidities (Chronic obstructive pulmonary disease, kidney insufficiency or arrhythmia). Receiver operating characteristic curves suggest that S1P has more power to indicate atherosclerosis (PAD and CS) than high density lipoprotein-cholesterol (HDL-C). In 35 patients, serum-S1P was measured again between one and six months after treatment. In this group, serum-S1P concentrations rose after treatment independent of whether patients had PAD or CS, or whether they underwent open or endovascular surgery. Post-treatment S1P levels were highly associated to platelet numbers measured pre-treatment. Conclusions Our study shows that PAD and CS in humans is associated with decreased serum-S1P concentrations and that S1P may possess higher accuracy to indicate these diseases than HDL-C.	[Soltau, Irina; Geissen, Markus; Debus, E. Sebastian; Larena-Avellaneda, Axel; Daum, Guenter] Univ Med Ctr Hamburg Eppendorf, Univ Heart Ctr, Clin & Polyclin Vasc Med, Hamburg, Germany; [Mudersbach, Eileen; Schwedhelm, Edzard] Univ Med Ctr Hamburg Eppendorf, Inst Clin Pharmacol & Toxicol, Hamburg, Germany; [Winkler, Martin S.] Univ Med Ctr Hamburg Eppendorf, Ctr Anesthesiol & Intens Care Med, Hamburg, Germany; [Geffken, Maria; Peine, Sven] Univ Med Ctr Hamburg Eppendorf, Inst Transfus Med, Hamburg, Germany; [Schoen, Gerhard] Univ Med Ctr Hamburg Eppendorf, Inst Med Biometry & Epidemiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Geissen, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Univ Heart Ctr, Clin & Polyclin Vasc Med, Hamburg, Germany.	m.geissen@uke.de	Winkler, Martin Sebastian/AGZ-1086-2022		Forderverein des Universitaren Herzzentrums Hamburg e.V.; Dorit & Alexander Otto foundation	Forderverein des Universitaren Herzzentrums Hamburg e.V.; Dorit & Alexander Otto foundation	We thank the Forderverein des Universitaren Herzzentrums Hamburg e.V. and the Dorit & Alexander Otto foundation for their generous laboratory equipment funds. We thank Astrid Becker and Sina Noorzad for technical and organizational help.	Badimon L, 2014, J INTERN MED, V276, P618, DOI 10.1111/joim.12296; Brown Todd M, 2008, Curr Cardiol Rep, V10, P497, DOI 10.1007/s11886-008-0078-1; Bundes_aerztekammer, 2010, RICHTL GEW BLUT BLUT; Coldewey SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27594; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Daum G, 2009, ARTERIOSCL THROM VAS, V29, P1439, DOI 10.1161/ATVBAHA.108.175240; Deutschman DH, 2003, AM HEART J, V146, P62, DOI 10.1016/S0002-8703(03)00118-2; Frej C, 2016, J CELL MOL MED; Fujii K, 2013, CIRC J, V77, P588, DOI 10.1253/circj.CJ-12-1599; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Gomes L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113394; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Halcox JPJ, 2009, CIRCULATION, V119, P1005, DOI 10.1161/CIRCULATIONAHA.108.765701; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hovingh GK, 2015, CURR OPIN LIPIDOL, V26, P127, DOI 10.1097/MOL.0000000000000161; Ibrahimi P, 2013, ATHEROSCLEROSIS, V231, P323, DOI 10.1016/j.atherosclerosis.2013.09.035; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kingwell BA, 2014, NAT REV DRUG DISCOV, V13, P445, DOI 10.1038/nrd4279; Libby P, 2012, ARTERIOSCL THROM VAS, V32, P2045, DOI 10.1161/ATVBAHA.108.179705; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Magnoni M, 2015, J CARDIOL, V65, P261, DOI 10.1016/j.jjcc.2015.01.004; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Olivera A, 2013, BBA-MOL CELL BIOL L, V1831, P193, DOI 10.1016/j.bbalip.2012.06.007; Ono Y, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-20; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; RCore Team, 2016, R LANG ENV STAT COMP; Rosen H, 2013, ANNU REV BIOCHEM, V82, P637, DOI 10.1146/annurev-biochem-062411-130916; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sattler K, 2009, CARDIOVASC RES, V82, P201, DOI 10.1093/cvr/cvp070; Sattler KJE, 2010, BASIC RES CARDIOL, V105, P821, DOI 10.1007/s00395-010-0112-5; Shimizu T, 2007, CIRC RES, V101, P995, DOI 10.1161/CIRCRESAHA.107.159228; Spagnoli LG, 2007, J NUCL MED, V48, P1800, DOI 10.2967/jnumed.107.038661; Sugiura T, 2012, CORONARY ARTERY DIS, V23, P234, DOI 10.1097/MCA.0b013e328351ab0a; Ulrych T, 2011, J THROMB HAEMOST, V9, P790, DOI 10.1111/j.1538-7836.2011.04194.x; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Winkler MS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1089-0; Yatomi Y, 1997, J BIOCHEM, V121, P969; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193	39	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168302	10.1371/journal.pone.0168302	http://dx.doi.org/10.1371/journal.pone.0168302			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973607	Green Submitted, gold, Green Published			2022-12-27	WOS:000392754300075
J	Yasuda, T; Ura, T; Taniguchi, M; Yoshida, H				Yasuda, Takuwa; Ura, Takehiro; Taniguchi, Masaru; Yoshida, Hisahiro			Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy	PLOS ONE			English	Article							TRANSDERMAL DRUG-DELIVERY; DERMAL DENDRITIC CELLS; INFLUENZA VACCINE; EPICUTANEOUS IMMUNOTHERAPY; MICRONEEDLE ARRAYS; ATOPIC-DERMATITIS; IMMUNE-RESPONSES; BARRIER FUNCTION; STRATUM-CORNEUM; LYMPH-NODE	Skin is protected by a tough but flexible multilayered barrier and is a front line for immune responses against invading particles. For many years now, skin has been a tissue where certain vaccines are injected for the prevention of infectious disease, however, the detailed mechanisms of the skin immune response are not yet well understood. Using thin and small injection needles, we carefully injected OVA into a restricted region of mouse skin, i.e., intradermal (ID), and examined the antibody response in comparison with subcutaneous (SC) injection or epicutaneous patch administration of OVA. Epicutaneous patches induced a high IgE response against OVA, but IgG production was low. High IgG production was induced by both ID and SC injection, moreover, ID injection induced higher IgG production without any adjutants. Furthermore, OVA-specific IgE production was diminished by ID injection. We found that ID injection could efficiently stimulate skin resident DCs, drive Th1-biased conditions and diminish IgE production. The ID injection response was regulated by Langerin(+) dermal DCs, because OVA was taken up mainly by these cells and, after transiently deleting them, the IgE response was no longer diminished and IgG1 production was enhanced. We also tested whether ID injection might be an effective allergy treatment by attempting to inhibit ongoing IgE production in mice with experimentally induced high serum IgE levels. Multiple ID injections of OVA were shown to prevent elevation of serum OVA-specific IgE after repeated allergen challenge. In contrast, SC OVA injection could only transiently inhibit the OVA-specific IgE production. These findings indicated that ID injection results in higher induction of antigen-specific IgG, and thus may be useful for vaccine delivery with little or no adjuvant components. Moreover, the observed diminishment of IgE and induction of Th1-biased immune responses suggest that ID may be a useful injection route for allergy immunotherapy.	[Yasuda, Takuwa; Yoshida, Hisahiro] RIKEN Res Ctr Integrat Med Sci IMS, Immunogenet Lab, Yokohama, Kanagawa, Japan; [Ura, Takehiro] Terumo Co Ltd, Hosp Co R&D Dept, Nakai, Kanagawa, Japan; [Taniguchi, Masaru] RIKEN Res Ctr Integrat Med Sci IMS, Lab Immune Regulat, Yokohama, Kanagawa, Japan	RIKEN; Terumo Corporation; RIKEN	Yasuda, T (corresponding author), RIKEN Res Ctr Integrat Med Sci IMS, Immunogenet Lab, Yokohama, Kanagawa, Japan.	takuwa@riken.jp			Terumo Corporation	Terumo Corporation	One of the authors (TU) is employee of Terumo Corporation. About the Funding Statement, Terumo Corporation provided support in the form of salary for author [TU] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.	Alvarez-Roman R, 2004, J CONTROL RELEASE, V99, P53, DOI 10.1016/j.jconrel.2004.06.015; Anaya JM, 2015, CLIN EXP RHEUMATOL, V33, P545; Ansaldi F, 2011, EXPERT OPIN BIOL TH, V11, P415, DOI 10.1517/14712598.2011.557658; Arakane R, 2015, VACCINE, V33, P6650, DOI 10.1016/j.vaccine.2015.10.088; Arakane R, 2015, VACCINE, V33, P6340, DOI 10.1016/j.vaccine.2015.09.010; Batard T, 2015, ALLERGY; Beyer K, 2012, J ALLERGY CLIN IMMUN, V129, P1179, DOI 10.1016/j.jaci.2012.03.037; Dioszeghy V, 2011, J IMMUNOL, V186, P5629, DOI 10.4049/jimmunol.1003134; Dupont C, 2010, J ALLERGY CLIN IMMUN, V125, P1165, DOI 10.1016/j.jaci.2010.02.029; Ferrari L, 2011, RES VET SCI, V90, P64, DOI 10.1016/j.rvsc.2010.04.026; Flacher V, 2012, J IMMUNOL, V188, P2146, DOI 10.4049/jimmunol.1004120; Gorse GJ, 2013, VACCINE, V31, P2358, DOI 10.1016/j.vaccine.2013.03.008; Grunewald SM, 2001, INT ARCH ALLERGY IMM, V125, P322, DOI 10.1159/000053833; Guimaraes LE, 2015, PHARMACOL RES, V100, P190, DOI 10.1016/j.phrs.2015.08.003; Herz U, 1998, CLIN EXP ALLERGY, V28, P625; Jakasa I, 2011, J INVEST DERMATOL, V131, P540, DOI 10.1038/jid.2010.307; Jin GH, 2012, J DERMATOL SCI, V67, P181, DOI 10.1016/j.jdermsci.2012.06.005; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Matsui T, 2015, INT IMMUNOL, V27, P269, DOI 10.1093/intimm/dxv013; Matsushima H, 2003, J DERMATOL SCI, V32, P223, DOI 10.1016/S0923-1811(03)00106-3; Murakami R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073270; Naito S, 2012, VACCINE, V30, P1191, DOI 10.1016/j.vaccine.2011.11.111; Nishifuji K, 2013, VET DERMATOL, V24, P60, DOI 10.1111/j.1365-3164.2012.01090.x; Okubo Kimihiro, 2010, Journal of Nippon Medical School, V77, P285, DOI 10.1272/jnms.77.285; Pauli G, 2008, J ALLERGY CLIN IMMUN, V122, P951, DOI 10.1016/j.jaci.2008.09.017; Ptak W, 2002, INT ARCH ALLERGY IMM, V128, P8, DOI 10.1159/000057998; Romani N, 2012, CURR TOP MICROBIOL, V351, P113, DOI 10.1007/82_2010_118; Rotiroti G, 2012, J ALLERGY CLIN IMMUN, V130, P918, DOI 10.1016/j.jaci.2012.06.052; Rutkowski K, 2012, POSTGRAD MED J, V88, P458, DOI 10.1136/postgradmedj-2011-130634; Saad Abdel Hakim, 2006, Journal of the Egyptian Society of Parasitology, V36, P867; Schafer B, 2013, J ALLERGY CLIN IMMUN, V131, P541, DOI 10.1016/j.jaci.2012.05.009; Simon L, 2009, J PHARM SCI-US, V98, P187, DOI 10.1002/jps.21408; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Skobe M, 2000, J INVEST DERM SYMP P, V5, P14, DOI 10.1046/j.1087-0024.2000.00001.x; Suzuki Yusuke, 2011, Allergology International, V60, P11, DOI 10.2332/allergolint.10-RAI-0281; Tanizaki H, 2015, J DERMATOL SCI, V79, P310, DOI 10.1016/j.jdermsci.2015.06.010; Tarnow K, 2004, APPL NURS RES, V17, P275, DOI 10.1016/S0897-1897(04)00079-5; Tozuka M, 2016, J DERMATOL SCI, V82, P38, DOI 10.1016/j.jdermsci.2015.11.008; Tsang P, 2014, VACCINE, V32, P2507, DOI 10.1016/j.vaccine.2013.09.074; Tuan-Mahmood TM, 2013, EUR J PHARM SCI, V50, P623, DOI 10.1016/j.ejps.2013.05.005; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Wang G, 2007, CLIN EXP ALLERGY, V37, P151, DOI 10.1111/j.1365-2222.2006.02621.x; Wong SS, 2013, CLIN MICROBIOL REV, V26, P476, DOI 10.1128/CMR.00097-12; Yan GA, 2010, INT J PHARMACEUT, V391, P7, DOI 10.1016/j.ijpharm.2010.02.007; Zaric M, 2013, ACS NANO, V7, P2042, DOI 10.1021/nn304235j	47	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167952	10.1371/journal.pone.0167952	http://dx.doi.org/10.1371/journal.pone.0167952			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973543	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300050
J	Liao, NB; Zhong, JJ; Zhang, RH; Ye, XQ; Zhang, YJ; Wang, WJ; Wang, YX; Chen, SG; Liu, DH; Liu, RH				Liao, Ningbo; Zhong, Jianjun; Zhang, Ronghua; Ye, Xingqian; Zhang, Yanjun; Wang, Wenjun; Wang, Yuexia; Chen, Shiguo; Liu, Donghong; Liu, Ruihai			Protein-Bound Polysaccharide from Corbicula fluminea Inhibits Cell Growth in MCF-7 and MDA-MB-231 Human Breast Cancer Cells	PLOS ONE			English	Article							FRESH-WATER CLAM; AQUEOUS EXTRACT; EDIBLE MUSHROOM; APOPTOSIS; ANTIOXIDANT; LINES; PROLIFERATION; COMPONENTS; SULFATE; RATS	A novel protein-bound polysaccharide, CFPS-1, isolated from Corbicula fluminea, is composed predominantly of mannose (Man) and glucose (Glc) in a molar ratio of 3.1: 12.7. The polysaccharide, with an average molecular weight of about 283 kDa, also contains 10.8% protein. Atomic force microscopy, high-performance liquid chromatography, Fourier transform infrared spectroscopy, gas chromatography/mass spectrometry, and nuclear magnetic resonance spectroscopy analyses revealed that CFPS-1 has a backbone of 1,6-linked and 1,4,6-linked-alpha-D-Glc, which is terminated with a 1-linked-alpha-D-Man residue at the O-4 position of 1,4,6-linked-alpha-D-Glc, in a molar ratio of 3: 1: 1. Preliminary in vitro bioactivity tests revealed that CFPS-1 effectively and dose-dependently inhibits human breast cancer MCF7 and MDA-MB-231 cell growth, with an IC50 of 243 +/- 6.79 and 1142 +/- 14.84 mu g/mL, respectively. In MCF-7, CFPS-1 produced a significant up-regulation of p53, p21, Bax and cleaved caspase-7 and down-regulation of Cdk4, cyclin D1, Bcl-2 and caspase-7. These effects resulted in cell cycle blockade at the S-phase and apoptosis induction. In contrast, in MDA-MB-231, with limited degree of change in cell cycle distribution, CFPS-1 increases the proportion of cells in apoptotic sub-G1 phase executed by down-regulation of Bcl-2 and caspase-7 and up-regulation of Bax and cleaved caspase-7. This study extends our understanding of the anticancer mechanism of C. fluminea protein-bound polysaccharide.	[Liao, Ningbo; Zhang, Ronghua; Zhang, Yanjun] Zhejiang Prov Ctr Dis Control & Prevent, Dept Nutr & Food Safety, Hangzhou, Zhejiang, Peoples R China; [Zhong, Jianjun; Ye, Xingqian; Wang, Wenjun; Chen, Shiguo; Liu, Donghong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China; [Wang, Yuexia] Zhejiang Acad Sci & Technol Inspect & Quarantine, Hangzhou, Zhejiang, Peoples R China; [Liu, Donghong] Zhejiang Univ, Fuli Inst Food Sci, Hangzhou, Zhejiang, Peoples R China; [Liu, Ruihai] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA	Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang University; Zhejiang University; Cornell University	Liu, DH (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou, Zhejiang, Peoples R China.; Liu, DH (corresponding author), Zhejiang Univ, Fuli Inst Food Sci, Hangzhou, Zhejiang, Peoples R China.; Liu, RH (corresponding author), Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA.	dhliu@zju.edu.cn; rl23@cornell.edu	CHEN, SHIGUO/AGP-0850-2022; Liu, Rui Hai/AAE-4865-2019; Liao, Ningbo/ACM-4512-2022	Liu, Rui Hai/0000-0002-7018-7929; Zhong, Jian-Jun/0000-0002-0693-255X; CHEN, SHIGUO/0000-0001-8470-7983	National Natural Science Foundation of China [31371872]; Public Projects of Zhejiang Province [2015C32017]; Program of Health and Medicine Science in Zhejiang Province [2015RCA003]; Major Science and Technology Special Projects of Zhejiang, China [2013C03045-1]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Projects of Zhejiang Province; Program of Health and Medicine Science in Zhejiang Province; Major Science and Technology Special Projects of Zhejiang, China; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	This research was sponsored by the National Natural Science Foundation of China (NO. 31371872), http://fund.sciencenet.cn/index.php/ item/view/207237/, the Public Projects of Zhejiang Province (NO. 2015C32017), http://www.zjkjt.gov.cn/news/node01/detail0101/2015/0101_61846. htm, the Program of Health and Medicine Science in Zhejiang Province (NO. 2015RCA003), http://www.doc88.com/p-6572488490711.html, Major Science and Technology Special Projects of Zhejiang, China (NO. 2013C03045-1) and Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents, http://www.decmin.com/zj_view.asp?id=919. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armenta JM, 2010, ANAL CHEM, V82, P548, DOI 10.1021/ac901790q; Bohn JA, 1995, CARBOHYD POLYM, V28, P3, DOI 10.1016/0144-8617(95)00076-3; Chakraborty I, 2004, CARBOHYD RES, V339, P2249, DOI 10.1016/j.carres.2004.07.013; Chijimatsu T, 2008, BIOSCI BIOTECH BIOCH, V72, P2566, DOI 10.1271/bbb.80257; Chresta CM, 1996, CANCER RES, V56, P1834; Corbex M, 2014, EUR J CANCER, V50, P1808, DOI 10.1016/j.ejca.2014.03.016; Dalonso N, 2012, FOOD CHEM, V134, P1804, DOI 10.1016/j.foodchem.2012.03.088; Darby SC, 2013, NEW ENGL J MED, V15, P425; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Gonzaga MLC, 2005, CARBOHYD POLYM, V60, P43, DOI 10.1016/j.carbpol.2004.11.022; Han Peng, 2009, Xiamen Daxue Xuebao (Ziran Kexue Ban), V48, P576; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; Hsu CL, 2010, AM J CHINESE MED, V38, P881, DOI 10.1142/S0192415X10008329; Huang YT, 2006, FOOD CHEM TOXICOL, V44, P1261, DOI 10.1016/j.fct.2006.02.001; Kidd P M, 2000, Altern Med Rev, V5, P4; Kuwata H, 1998, BBA-PROTEIN STRUCT M, V1429, P129, DOI 10.1016/S0167-4838(98)00224-6; Li CI, 2013, BREAST CANCER RES TR, V137, P579, DOI 10.1007/s10549-012-2365-1; Liao NB, 2013, FOOD FUNCT, V4, P539, DOI 10.1039/c2fo30178d; Martin-Algarra S, 2009, EUR J CANCER, V45, P732, DOI 10.1016/j.ejca.2008.12.005; Miranda CL, 1999, FOOD CHEM TOXICOL, V37, P271, DOI 10.1016/S0278-6915(99)00019-8; Ohira SI, 2006, J CHROMATOGR A, V1121, P280, DOI 10.1016/j.chroma.2006.05.074; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Pang XB, 2007, CARBOHYD POLYM, V70, P291, DOI 10.1016/j.carbpol.2007.04.010; Pramanik M, 2005, CARBOHYD RES, V340, P629, DOI 10.1016/j.carres.2004.12.032; Qiao DL, 2010, CARBOHYD POLYM, V82, P1184, DOI 10.1016/j.carbpol.2010.06.048; Qiu Ping-ping, 2009, Xiamen Daxue Xuebao (Ziran Kexue Ban), V48, P406; Rout D, 2004, MED CHEM RES, V13, P509, DOI 10.1007/s00044-004-0050-6; SCHMITZ U, 1990, BIOCHEMISTRY-US, V29, P2357, DOI 10.1021/bi00461a021; Senaratne SG, 2000, BRIT J CANCER, V82, P1459, DOI 10.1054/bjoc.1999.1131; Servaty R, 2001, INT J BIOL MACROMOL, V28, P121, DOI 10.1016/S0141-8130(00)00161-6; Shen Y, 2001, ADV CANCER RES, V82, P55, DOI 10.1016/S0065-230X(01)82002-9; Tsai JS, 2006, PROCESS BIOCHEM, V41, P2276, DOI 10.1016/j.procbio.2006.05.023; Vaculova A, 2008, METHOD ENZYMOL, V442, P157, DOI 10.1016/S0076-6879(08)01408-0; Xiao J, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.22; Yanez J, 2004, NUTR CANCER, V49, P191, DOI 10.1207/s15327914nc4902_11; Yang XB, 2005, ANAL SCI, V21, P1177, DOI 10.2116/analsci.21.1177; You LJ, 2010, FOOD CHEM, V120, P810, DOI 10.1016/j.foodchem.2009.11.018; Yu XL, 2013, CARBOHYD POLYM, V92, P269, DOI 10.1016/j.carbpol.2012.09.045; Zhang N, 2010, CANCER SCI, V101, P2375, DOI 10.1111/j.1349-7006.2010.01680.x; Zhu Wen, 2004, Journal of Fishery Sciences of China, V11, P349; Zong AZ, 2012, CARBOHYD POLYM, V90, P1395, DOI 10.1016/j.carbpol.2012.07.026; Zordoky BNM, 2014, BBA-GEN SUBJECTS, V1840, P1943, DOI 10.1016/j.bbagen.2014.01.023	44	17	18	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167889	10.1371/journal.pone.0167889	http://dx.doi.org/10.1371/journal.pone.0167889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959954	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900021
J	Pecchinenda, A; Petrucci, M				Pecchinenda, Anna; Petrucci, Manuel			Emotion Unchained: Facial Expression Modulates Gaze Cueing under Cognitive Load	PLOS ONE			English	Article							WORKING-MEMORY LOAD; EYE GAZE; SELECTIVE ATTENTION; SPATIAL ATTENTION; SOCIAL ATTENTION; FACES; DIRECTION; PERCEPTION; FEARFUL; ANXIETY	Direction of eye gaze cues spatial attention, and typically this cueing effect is not modulated by the expression of a face unless top-down processes are explicitly or implicitly involved. To investigate the role of cognitive control on gaze cueing by emotional faces, participants performed a gaze cueing task with happy, angry, or neutral faces under high (i.e., counting backward by 7) or low cognitive load (i.e., counting forward by 2). Results show that high cognitive load enhances gaze cueing effects for angry facial expressions. In addition, cognitive load reduces gaze cueing for neutral faces, whereas happy facial expressions and gaze affected object preferences regardless of load. This evidence clearly indicates a differential role of cognitive control in processing gaze direction and facial expression, suggesting that under typical conditions, when we shift attention based on social cues from another person, cognitive control processes are used to reduce interference from emotional information.	[Pecchinenda, Anna; Petrucci, Manuel] Sapienza Univ Rome, Dept Psychol, Rome, Italy	Sapienza University Rome	Pecchinenda, A (corresponding author), Sapienza Univ Rome, Dept Psychol, Rome, Italy.	anna.pecchinenda@uniroma1.it		Pecchinenda, Anna/0000-0001-9139-5295	Sapienza University [C26A14JFTP, C26A15H5KA]	Sapienza University	AP was funded by Sapienza University grant C26A14JFTP and grant C26A15H5KA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2012, TRENDS COGN SCI, V16, P437, DOI 10.1016/j.tics.2012.06.010; Baddeley AD, 2009, J MEM LANG, V61, P438, DOI 10.1016/j.jml.2009.05.004; Bayless SJ, 2011, VIS COGN, V19, P483, DOI 10.1080/13506285.2011.552895; Bayliss AP, 2007, COGNITION, V104, P644, DOI 10.1016/j.cognition.2006.07.012; Bayliss AP, 2010, VIS COGN, V18, P1214, DOI 10.1080/13506285.2010.484657; Belopolsky AV, 2011, VIS COGN, V19, P27, DOI 10.1080/13506285.2010.536186; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Bobak AK, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01258; Brosch T, 2011, NEUROPSYCHOLOGIA, V49, P1779, DOI 10.1016/j.neuropsychologia.2011.02.056; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Chica AB, 2014, NEUROSCI BIOBEHAV R, V40, P35, DOI 10.1016/j.neubiorev.2014.01.002; Cohen N, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00033; Dawel A, 2015, DEVELOPMENTAL SCI, V18, P219, DOI 10.1111/desc.12203; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Duckworth KL, 2002, PSYCHOL SCI, V13, P513, DOI 10.1111/1467-9280.00490; Fichtenholtz HM, 2009, SOC NEUROSCI-UK, V4, P317, DOI 10.1080/17470910902809487; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Fox E, 2007, EMOTION, V7, P478, DOI 10.1037/1528-3542.7.3.478; Friesen CK, 2011, COGNITION EMOTION, V25, P73, DOI 10.1080/02699931003672381; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Galfano G, 2011, SOC NEUROSCI-UK, V6, P257, DOI 10.1080/17470919.2010.515722; Graham R, 2010, VIS COGN, V18, P331, DOI 10.1080/13506280802689281; Harding IH, 2016, CEREB CORTEX, V26, P557, DOI 10.1093/cercor/bhu208; Hayward DA, 2013, EXP BRAIN RES, V231, P405, DOI 10.1007/s00221-013-3705-z; Hietanen JK, 2003, J EXP PSYCHOL HUMAN, V29, P1228, DOI 10.1037/0096-1523.29.6.1228; Holmes A, 2006, BRAIN COGNITION, V60, P282, DOI 10.1016/j.bandc.2005.05.002; Holmes A, 2014, COGN AFFECT BEHAV NE, V14, P827, DOI 10.3758/s13415-013-0212-4; Holmes A, 2010, SOC NEUROSCI-UK, V5, P285, DOI 10.1080/17470910903422819; Hori E, 2005, PHYSIOL BEHAV, V84, P397, DOI 10.1016/j.physbeh.2005.01.002; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Jellema T, 2011, VIS COGN, V19, P616, DOI 10.1080/13506285.2011.569775; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Kanske P, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00042; Koster EHW, 2005, EMOTION, V5, P446, DOI 10.1037/1528-3542.5.4.446; Kuhn G, 2011, PSYCHON B REV, V18, P89, DOI 10.3758/s13423-010-0033-1; Lachat F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050499; Langton SRH, 1999, VIS COGN, V6, P541, DOI 10.1080/135062899394939; Lassalle A, 2013, SOC NEUROSCI-UK, V8, P583, DOI 10.1080/17470919.2013.835750; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Law AS, 2010, VIS COGN, V18, P1420, DOI 10.1080/13506285.2010.496579; Love J., 2015, JASP VERSION 0 7; Lundqvist D., 1998, KAROLINSKA DIRECTED; Mathews A, 2003, VIS COGN, V10, P823, DOI 10.1080/13506280344000095; Morey RD, 2011, PSYCHOL METHODS, V16, P406, DOI 10.1037/a0024377; Ohlsen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059471; Okon-Singer H, 2007, EMOTION, V7, P147, DOI 10.1037/1528-3542.7.1.147; Pecchinenda A., 2013, ABSTRACTS PSYCHONOMI, V18; Pecchinenda A, 2008, EMOTION, V8, P628, DOI 10.1037/a0013437; Pecchinenda A, 2007, EUR J COGN PSYCHOL, V19, P898, DOI 10.1080/09541440601095388; Pecchinenda A, 2015, NEUROPSYCHOLOGIA, V68, P1, DOI 10.1016/j.neuropsychologia.2014.12.023; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Petrucci M., 2016, COGNITION EMOTION; Picardo R, 2016, PLOSONE; Putman P, 2006, EMOTION, V6, P94, DOI 10.1037/1528-3542.6.1.94; Ramon M, 2010, NEUROPSYCHOLOGIA, V48, P933, DOI 10.1016/j.neuropsychologia.2009.11.014; Rao KV, 2013, Q J EXP PSYCHOL, V66, P1881, DOI 10.1080/17470218.2013.828314; Rhodes G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049317; Rigato S, 2013, INT J BEHAV DEV, V37, P154, DOI 10.1177/0165025412472410; Ristic J, 2002, PSYCHON B REV, V9, P507, DOI 10.3758/BF03196306; Rouder JN, 2012, J MATH PSYCHOL, V56, P356, DOI 10.1016/j.jmp.2012.08.001; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Schneider W., 2002, E PRIME USERS GUIDE; Tipples J, 2006, COGNITION EMOTION, V20, P309, DOI 10.1080/02699930500405550; Tipples J, 2005, J EXP PSYCHOL HUMAN, V31, P843, DOI 10.1037/0096-1523.31.5.843; Tipples J, 2002, PSYCHON B REV, V9, P314, DOI 10.3758/BF03196287	68	24	24	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168111	10.1371/journal.pone.0168111	http://dx.doi.org/10.1371/journal.pone.0168111			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	27959925	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900038
J	Tian, C; Harris, BS; Johnson, KR				Tian, Cong; Harris, Belinda S.; Johnson, Kenneth R.			Ectopic Mineralization and Conductive Hearing Loss in Enpp1(asj) Mutant Mice, a New Model for Otitis Media and Tympanosclerosis	PLOS ONE			English	Article							GENERALIZED ARTERIAL CALCIFICATION; VASCULAR CALCIFICATION; KNOCKOUT MOUSE; MIDDLE-EAR; USH1C GENE; MUTATION; DEAFNESS; OSTEOMALACIA; DISEASE; INFANCY	Otitis media (OM), inflammation of the middle ear, is a common cause of hearing loss in children and in patients with many different syndromic diseases. Studies of the human population and mouse models have revealed that OM is a multifactorial disease with many environmental and genetic contributing factors. Here, we report on otitis media-related hearing loss in asj (ages with stiffened joints) mutant mice, which bear a point mutation in the Enpp1 gene. Auditory-evoked brainstem response (ABR) measurements revealed that around 90% of the mutant mice (Enpp1(asj/asj)) tested had moderate to severe hearing impairment in at least one ear. The ABR thresholds were variable and generally elevated with age. We found otitis media with effusion (OME) in all of the hearing-impaired Enpp1(asj/asj) mice by anatomic and histological examinations. The volume and inflammatory cell content of the effusion varied among the asj mutant mice, but all mutants exhibited a thickened middle ear epithelium with fibrous polyps and more mucin-secreting goblet cells than controls. Other abnormalities observed in the Enpp1 mutant mice include over-ossification at the round window ridge, thickened and over-calcified stapedial artery, fusion of malleus and incus, and white patches on the inside of tympanic membrane, some of which are typical symptoms of tympanosclerosis. An excessive yellow discharge was detected in the outer ear canal of older asj mutant mice, with 100% penetrance by 5 months of age, and contributes to the progressive nature of the hearing loss. This is the first report of hearing loss and ear pathology associated with an Enpp1 mutation in mice. The Enpp1 asj mutant mouse provides a new animal model for studying tympanosclerotic otitis and otitis media with effusion, and also provides a specific model for the hearing loss recently reported to be associated with human ENPP1 mutations causing generalized arterial calcification of infancy and hypophosphatemic rickets.	[Tian, Cong; Harris, Belinda S.; Johnson, Kenneth R.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Tian, Cong] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA	Jackson Laboratory; University of Maine System; University of Maine Orono	Tian, C (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	cong.tian@maine.edu	Tian, Cong/E-6300-2012		National Institutes of Health [R01 DC004301, P40 OD010972, P30 CA034196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004301] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R01 DC004301 (KRJ), P40 OD010972 (The Jackson Laboratory Mouse Mutant Resource), and P30 CA034196 (The Jackson Laboratory Shared Services).	Babij P, 2009, J BONE MINER RES, V24, P1552, DOI [10.1359/JBMR.090417, 10.1359/jbmr.090417]; Bowman MAH, 2012, TRENDS CARDIOVAS MED, V22, P93, DOI 10.1016/j.tcm.2012.07.002; Brachet C, 2014, HORM RES PAEDIAT, V81, P63, DOI 10.1159/000354661; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058156; DAVIES M, 1984, ANN INTERN MED, V100, P230, DOI 10.7326/0003-4819-100-2-230; DIAMOND MK, 1989, J MORPHOL, V200, P71, DOI 10.1002/jmor.1052000109; Goycoolea MV, 1997, MICROSC RES TECHNIQ, V36, P201, DOI 10.1002/(SICI)1097-0029(19970201)36:3<201::AID-JEMT8>3.0.CO;2-R; Gurley KA, 2006, AM J HUM GENET, V79, P1017, DOI 10.1086/509881; Han FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043010; Han FC, 2009, INT J EXP PATHOL, V90, P480, DOI 10.1111/j.1365-2613.2009.00677.x; Harris BS WJ, 2012, AGES STIFF ENED JOIN; Hilton JM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r90; Johnson KR, 2003, HUM MOL GENET, V12, P3075, DOI 10.1093/hmg/ddg332; Kerschner JE, 2013, INT J PEDIATR OTORHI, V77, P79, DOI 10.1016/j.ijporl.2012.09.037; Li Q, 2014, ELECTRON J DIFFER EQ; Li QL, 2013, DIS MODEL MECH, V6, P1227, DOI 10.1242/dmm.012765; Lin Jizhen, 2012, Int J Otolaryngol, V2012, P745325, DOI 10.1155/2012/745325; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Lorenz-Depiereux B, 2004, MAMM GENOME, V15, P151, DOI 10.1007/s00335-003-2310-z; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Lysaght AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107681; Mackenzie NCW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032177; Mata M, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0420-1; Morava E, 2011, J CLIN ENDOCR METAB, V96, pE189, DOI 10.1210/jc.2010-1539; Nitschke Y, 2012, AM J HUM GENET, V90, P25, DOI 10.1016/j.ajhg.2011.11.020; Noben-Trauth K, 2011, J BIOL CHEM, V286, P3079, DOI 10.1074/jbc.M110.184598; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; OMALLEY SP, 1988, CLIN RADIOL, V39, P528, DOI 10.1016/S0009-9260(88)80224-1; Rye MS, 2011, MAMM GENOME, V22, P66, DOI 10.1007/s00335-010-9295-1; Tateossian H, 2013, HUM MOL GENET, V22, P2553, DOI 10.1093/hmg/ddt103; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Thys M, 2009, OTOL NEUROTOL, V30, P1021, DOI 10.1097/MAO.0b013e3181a86509; Tian C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034944; Tian C, 2010, BRAIN RES, V1328, P57, DOI 10.1016/j.brainres.2010.02.079; WEIR N, 1977, J LARYNGOL OTOL, V91, P717, DOI 10.1017/S0022215100084255; Yamada S, 2014, AM J PHYSIOL-RENAL, V306, pF1418, DOI 10.1152/ajprenal.00633.2013; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022622; Zhang Y, 2012, AM J PATHOL, V181, P761, DOI 10.1016/j.ajpath.2012.05.031; Zheng QY, 2006, BRAIN RES, V1091, P9, DOI 10.1016/j.brainres.2006.01.046; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	40	16	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168159	10.1371/journal.pone.0168159	http://dx.doi.org/10.1371/journal.pone.0168159			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959908	gold, Green Published, Green Submitted			2022-12-27	WOS:000392753900042
J	Arbogast, P; Flamant, F; Godement, P; Glosmann, M; Peichl, L				Arbogast, Patrick; Flamant, Frederic; Godement, Pierre; Gloesmann, Martin; Peichl, Leo			Thyroid Hormone Signaling in the Mouse Retina	PLOS ONE			English	Article							CONE OPSIN EXPRESSION; DEVELOPMENTAL EXPRESSION; TYPE-3 DEIODINASE; RECEPTOR-ALPHA; PHOTORECEPTOR; HYPOTHYROIDISM; CELLS; KNOCKOUT; PIGMENTS	Thyroid hormone is a crucial regulator of gene expression in the developing and adult retina. Here we sought to map sites of thyroid hormone signaling at the cellular level using the transgenic FINDT3 reporter mouse model in which neurons express beta-galactosidase (beta-gal) under the control of a hybrid Gal4-TR alpha receptor when triiodothyronine (T3) and cofactors of thyroid receptor signaling are present. In the adult retina, nearly all neurons of the ganglion cell layer (GCL, ganglion cells and displaced amacrine cells) showed strong beta-gal labeling. In the inner nuclear layer (INL), a minority of glycineric and GABAergic amacrine cells showed beta-gal labeling, whereas the majority of amacrine cells were unlabeled. At the level of amacrine types, beta-gal labeling was found in a large proportion of the glycinergic AII amacrines, but only in a small proportion of the cholinergic/GABAergic 'starburst' amacrines. At postnatal day 10, there also was a high density of strongly beta-gal-labeled neurons in the GCL, but only few amacrine cells were labeled in the INL. There was no labeling of bipolar cells, horizontal cells and Muller glia cells at both stages. Most surprisingly, the photoreceptor somata in the outer nuclear layer also showed no beta-gal label, although thyroid hormone is known to control cone opsin expression. This is the first record of thyroid hormone signaling in the inner retina of an adult mammal. We hypothesize that T3 levels in photoreceptors are below the detection threshold of the reporter system. The topographical distribution of beta-gal-positive cells in the GCL follows the overall neuron distribution in that layer, with more T3-signaling cells in the ventral than the dorsal half-retina.	[Arbogast, Patrick; Peichl, Leo] Max Planck Inst Brain Res, Max von Laue Str, Frankfurt, Germany; [Flamant, Frederic; Godement, Pierre] Ecole Normale Super Lyon, Inst Genom Fonct Lyon, 46 Allee Italie, Lyon 07, France; [Gloesmann, Martin] Univ Vet Med, VetCore Imaging, Vet Pl 1, Vienna, Austria; [Peichl, Leo] Ernst Strungmann Inst Neurosci, Deutschordenstr, Frankfurt, Germany	Max Planck Society; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); University of Veterinary Medicine Vienna	Peichl, L (corresponding author), Max Planck Inst Brain Res, Max von Laue Str, Frankfurt, Germany.; Peichl, L (corresponding author), Ernst Strungmann Inst Neurosci, Deutschordenstr, Frankfurt, Germany.	leo.peichl@brain.mpg.de	Glösmann, Martin/F-9349-2019	Glösmann, Martin/0000-0002-2094-3247; Peichl, Leo/0000-0002-8141-0911	Deutsche Forschungsgemeinschaft [PE 38/16-2]; Agence Nationale de la Recherche [ANR15 CE14-0011-01]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was funded by Deutsche Forschungsgemeinschaft (http://www.dfg.de) grant PE 38/16-2 to LP, and by Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr) grant Thyromut2 (ANR15 CE14-0011-01) to FF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Applebury ML, 2007, DEV DYNAM, V236, P1203, DOI 10.1002/dvdy.21155; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Cheng CL, 2009, INVEST OPHTH VIS SCI, V50, P3024, DOI 10.1167/iovs.08-2713; Demb JB, 2012, VISUAL NEUROSCI, V29, P51, DOI 10.1017/S0952523811000368; DRAGER UC, 1981, INVEST OPHTH VIS SCI, V20, P285; Flamant F, 2003, TRENDS ENDOCRIN MET, V14, P85, DOI 10.1016/S1043-2760(02)00043-7; Flamant F, 1998, DEV BIOL, V197, P1, DOI 10.1006/dbio.1998.8872; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Fujieda H, 2009, J NEUROCHEM, V108, P91, DOI 10.1111/j.1471-4159.2008.05739.x; Gamborino MJ, 2001, OPHTHALMIC RES, V33, P283, DOI 10.1159/000055682; Gereben B, 2008, CELL MOL LIFE SCI, V65, P570, DOI 10.1007/s00018-007-7396-0; Glaschke A, 2011, J NEUROSCI, V31, P4844, DOI 10.1523/JNEUROSCI.6181-10.2011; Glaschke A, 2010, INVEST OPHTH VIS SCI, V51, P1719, DOI 10.1167/iovs.09-3592; Harpavat S, 2003, THYROID, V13, P1013, DOI 10.1089/105072503770867183; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hernandez A, 2010, ENDOCRINOLOGY, V151, P5550, DOI 10.1210/en.2010-0450; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Lu AL, 2009, ENDOCRINOLOGY, V150, P1536, DOI 10.1210/en.2008-1092; Ma HW, 2014, P NATL ACAD SCI USA, V111, P3602, DOI 10.1073/pnas.1317041111; Ma WB, 2002, J HISTOCHEM CYTOCHEM, V50, P1421, DOI 10.1177/002215540205001015; Mader M, 2006, MOL VIS, V12, P915; Navegantes LCC, 1996, BRAZ J MED BIOL RES, V29, P665; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2011, J NEUROSCI, V31, P11118, DOI 10.1523/JNEUROSCI.1709-11.2011; Ng L, 2010, J NEUROSCI, V30, P3347, DOI 10.1523/JNEUROSCI.5267-09.2010; Ng L, 2009, NEUROREPORT, V20, P627, DOI 10.1097/WNR.0b013e32832a2c63; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peichl L, 2004, EUR J NEUROSCI, V19, P1545, DOI 10.1111/j.1460-9568.2004.03263.x; Peichl L, 2000, VISUAL NEUROSCI, V17, P937, DOI 10.1017/S0952523800176138; Pessoa CN, 2008, INVEST OPHTH VIS SCI, V49, P2039, DOI 10.1167/iovs.07-0908; Pinazo-Duran MD, 2005, OPHTHALMIC RES, V37, P225, DOI 10.1159/000086863; Quignodon L, 2004, J MOL ENDOCRINOL, V33, P467, DOI 10.1677/jme.1.01570; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Sevilla-Romero E, 2002, OPHTHALMIC RES, V34, P181, DOI 10.1159/000063885; SJOBERG M, 1992, DEVELOPMENT, V114, P39; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; Swaroop A, 2010, NAT REV NEUROSCI, V11, P563, DOI 10.1038/nrn2880; SZEL A, 1993, J COMP NEUROL, V331, P564, DOI 10.1002/cne.903310411; Thut CJ, 2001, DEV BIOL, V231, P63, DOI 10.1006/dbio.2000.0140; Trimarchi JM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-101; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wei W, 2011, TRENDS NEUROSCI, V34, P638, DOI 10.1016/j.tins.2011.08.002; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	51	4	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168003	10.1371/journal.pone.0168003	http://dx.doi.org/10.1371/journal.pone.0168003			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942035	Green Published, gold			2022-12-27	WOS:000392745600045
J	Carter, HE; Schofield, DJ; Shrestha, R				Carter, Hannah E.; Schofield, Deborah J.; Shrestha, Rupendra			The Productivity Costs of Premature Mortality Due to Cancer in Australia: Evidence from a Microsimulation Model	PLOS ONE			English	Article							ECONOMIC BURDEN	Aim To estimate the productivity costs of premature mortality due to cancer in Australia, in aggregate and for the 26 most prevalent cancer sites. Methods A human capital approach was adopted to estimate the long term impacts of Australian cancer deaths in 2003. Using population mortality data, the labour force participation and the present value of lifetime income (PVLI) forgone due to premature mortality was estimated based on individual characteristics at the time of death including age, sex and socioeconomic status. Outcomes were modelled to the year 2030 using economic data from a national microsimulation model. A discount rate of 3% was applied and costs were reported in 2016 Australian dollars. Results Premature deaths from cancer in 2003 resulted in 88,000 working years lost and a cost of $4.2 billion in the PVLI forgone. Costs were close to three times higher in males than females due to the higher number of premature deaths in men, combined with higher levels of workforce participation and income. Lung, colorectal and brain cancers accounted for the highest proportion of costs, while testicular cancer was the most costly cancer site per death. Conclusions The productivity costs of premature mortality due to cancer are significant. These results provide an economic measure of the cancer burden which may assist decision makers in allocating scare resources amongst competing priorities.	[Carter, Hannah E.; Schofield, Deborah J.; Shrestha, Rupendra] Univ Sydney, Fac Pharm, Sydney, NSW, Australia	University of Sydney	Carter, HE (corresponding author), Univ Sydney, Fac Pharm, Sydney, NSW, Australia.	hannah.carter@qut.edu.au		Carter, Hannah/0000-0002-0046-4126; Shrestha, Rupendra/0000-0001-5455-0735; Schofield, Deborah/0000-0002-1658-494X	Australian Research Council; Australian Research Council (ARC)/Linkage Projects (LP) [100100158]	Australian Research Council(Australian Research Council); Australian Research Council (ARC)/Linkage Projects (LP)(Australian Research Council)	Work associated with this manuscript was funded by an Australian Research Council grant: Long term economic impacts of disease on older workers to 2030: Costs to government and individuals and opportunities for intervention; Schofield D, Vos E, Grobler M, Percival R, Kelly S, Passey M, Kelly S, Vos E, Percival R; Australian Research Council (ARC)/Linkage Projects (LP) 100100158 (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHW, 2013, PROST CANC AUSTR; [Anonymous], 2015, AUSTR BURD DIS STUD; Australian Bureau of Statistics, 2015, AV WEEKL EARN; Australian Bureau of Statistics, 2003, DEATHS; Australian Bureau of Statistics, 2015, WAG PRIC IND; Australian Bureau of Statistics, 2015, CONS PRIC IND; Australian Bureau of Statistics, 2016, LAB FORC; Begg S., 2007, BURDEN DIS INJURY AU; Bradley CJ, 2008, JNCI-J NATL CANCER I, V100, P1763, DOI 10.1093/jnci/djn384; Branton PE, 2008, LANCET ONCOL, V9, P82, DOI 10.1016/S1470-2045(08)70007-X; Brown ML, 2001, ANNU REV PUBL HEALTH, V22, P91, DOI 10.1146/annurev.publhealth.22.1.91; Burnet NG, 2005, BRIT J CANCER, V92, P241, DOI 10.1038/sj.bjc.6602321; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; Carter AJR, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-526; Carter HE, 2014, INT J MOCROSIMULATIO, V7, P33; Carter HE, 2016, AUSTR NZ J IN PRESS; Cobb-Clark D., 2001, AUSTR EC REV, V34, P467; Dear RF, 2011, MED J AUSTRALIA, V194, P387, DOI 10.5694/j.1326-5377.2011.tb03027.x; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Hanly P, 2015, INT J CANCER, V136, pE136, DOI 10.1002/ijc.29105; Hanly P, 2014, EXPERT REV PHARM OUT, V14, P355, DOI 10.1586/14737167.2014.909287; Hanly Paul A, 2014, BMC Cancer, V14, P224, DOI 10.1186/1471-2407-14-224; International Statistical Classification of Diseases and Related Health Problems, 2003, 10 REV VERS 2003; Keegan M., 2007, HILDA SURV RES C MEL; Kelly S., 2007, APPSIM SELECTION MAI; Kim SG, 2008, EUR J CANCER CARE, V17, P136, DOI 10.1111/j.1365-2354.2007.00818.x; Koopmanschap MA, 1996, MED CARE, V34, pDS59; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Max W, 2003, GYNECOL ONCOL, V88, P96, DOI 10.1016/S0090-8258(02)00101-4; Max W, 2009, BREAST CANCER RES TR, V116, P201, DOI 10.1007/s10549-008-0149-4; Olsen JA, 2001, HEALTH ECON, V10, P39, DOI 10.1002/1099-1050(200101)10:1<39::AID-HEC563>3.0.CO;2-E; Ortiz-Ortiz KJ, 2010, P R HEALTH SCI J, V29, P241; Pennec S, 2007, 5 U CANB NAT CTR SOC; Rice DP, 1966, ESTIMATING COST OF I; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; WOODEN M, 2002, MERCER MELBOURNE I Q, V0003; Zhang W, 2011, SOC SCI MED, V72, P185, DOI 10.1016/j.socscimed.2010.10.026	37	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167521	10.1371/journal.pone.0167521	http://dx.doi.org/10.1371/journal.pone.0167521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942032	gold, Green Published, Green Submitted			2022-12-27	WOS:000392745600021
J	Gebremedhin, TA; Mohanty, I				Gebremedhin, Tesfaye Alemayehu; Mohanty, Itismita			Child Schooling in Ethiopia: The Role of Maternal Autonomy	PLoS One			English	Article							INTRAHOUSEHOLD ALLOCATION; WOMENS AUTONOMY; RURAL ETHIOPIA; COUNT DATA; DECISION-MAKING; FEMALE AUTONOMY; INDIA; HEALTH; EDUCATION; GENDER	This paper examines the effects of maternal autonomy on child schooling outcomes in Ethiopia using a nationally representative Ethiopian Demographic and Health survey for 2011. The empirical strategy uses a Hurdle Negative Binomial Regression model to estimate years of schooling. An ordered probit model is also estimated to examine age grade distortion using a trichotomous dependent variable that captures three states of child schooling. The large sample size and the range of questions available in this dataset allow us to explore the influence of individual and household level social, economic and cultural factors on child schooling. The analysis finds statistically significant effects of maternal autonomy variables on child schooling in Ethiopia. The roles of maternal autonomy and other household-level factors on child schooling are important issues in Ethiopia, where health and education outcomes are poor for large segments of the population.	[Gebremedhin, Tesfaye Alemayehu] Univ Canberra, Fac Business Govt & Law, Canberra, ACT, Australia; [Mohanty, Itismita] Univ Canberra, Hlth Res Inst, Ctr Res & Act Publ Hlth, Canberra, ACT, Australia	University of Canberra; University of Canberra	Gebremedhin, TA (corresponding author), Univ Canberra, Fac Business Govt & Law, Canberra, ACT, Australia.	tesfaye.gebremedhin@canberra.edu.au		Gebremedhin, Tesfaye/0000-0003-1476-4514; MOHANTY, ITISMITA/0000-0002-9013-1068				Abadian S, 1996, WORLD DEV, V24, P1793, DOI 10.1016/S0305-750X(96)00075-7; Allendorf K, 2007, WORLD DEV, V35, P1975, DOI 10.1016/j.worlddev.2006.12.005; Allison P. D., 1999, LOGISTIC REGRESSION; Anderson S, 2009, J DEV ECON, V90, P179, DOI 10.1016/j.jdeveco.2008.10.004; Azam M, 2013, WORLD DEV, V42, P143, DOI 10.1016/j.worlddev.2012.09.003; Bass L., 2004, CHILD LABOR SUBSAHAR; Basu A.M., 1992, CULTURE STATUS WOMEN; Basu AM, 2005, SOCIAL SCI MED, V60; Bilgic A, 2007, J ENVIRON MANAGE, V83, P478, DOI 10.1016/j.jenvman.2006.10.009; Black SE, 2011, HDB LABOR EC 4B; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Buchmann C, 2001, ANNU REV SOCIOL, V27, P77, DOI 10.1146/annurev.soc.27.1.77; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Cockburn J, 2007, J AFR ECON, V16, P519, DOI 10.1093/jae/ejl045; Dancer D, 2009, INDIAN GROWTH DEV RE, V2, P18, DOI 10.1108/17538250910953444; Dasgupta U, 2015, WORLD DEV, V67, P363, DOI 10.1016/j.worlddev.2014.10.021; Dendir S., 2013, 86 UNUWIDER; Dercon S, 2000, J POLIT ECON, V108, P688, DOI 10.1086/316098; Dommaraju P, 2009, J POPUL RES, V26, P249, DOI 10.1007/s12546-009-9014-5; Dostie B, 2006, ECON DEV CULT CHANGE, V54, P405, DOI 10.1086/497006; Dreze J., 2001, REV DEV ECON, V5, P1, DOI [10.1111/1467-9361.00103, DOI 10.1111/1467-9361.00103]; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Ebot JO, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0028-7; ESPS (Ethiopian Society of Population Studies), 2008, GEND EQ WOM EMP DEEP; Fafchamps M, 2002, J DEV STUD, V38, P47, DOI 10.1080/00220380412331322581; Fafchamps M, 2009, OXFORD B ECON STAT, V71, P567, DOI 10.1111/j.1468-0084.2009.00553.x; Federal Ministry of Education, 2010, ED SECT DEV PROGR 4; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Filmer D., 2000, 2268 WORLD BANK POL; Glewwe P, 1999, J HUM RESOUR, V34, P124, DOI 10.2307/146305; Glewwe P, 2004, J DEV ECON, V74, P33, DOI 10.1016/j.jdeveco.2003.12.003; Government of Ethiopia, 1994, CONST FED DEM REP ET; Green W.H., 2003, ECONOMETRIC ANAL, V6th ed.; Heath R, 2014, INTRAHOUSEHOLD BARGA; Hilbe J. M., 2008, BRIEF OVERVIEW INTER; Hudson G., 2012, AETHIOPICA, V15, p204 ; KABEER N., 2013, FEMINIST EC, V20, P138; Kinfu Y., 2005, WORKING PAPERS DEMOG; King E. M., 1987, ECON EDUC REV, V6, p167?181, DOI [10.1016/0272-7757(87)90050-1, DOI 10.1016/0272-7757(87)90050-1]; King EM, 1983, RAND PUBLICATIONS SE; Kingdon GG, 2005, ECON DEV CULT CHANGE, V53, P409, DOI 10.1086/425379; Kishor S., 2005, FOCUS GENDER COLLECT; Lepine A, 2013, WORLD DEV, V45, P17, DOI 10.1016/j.worlddev.2012.12.018; Lloyd CB, 1996, POPUL DEV REV, V22, P265, DOI 10.2307/2137435; Long J. S., 2003, REGRESSION MODELS CA; Luz L, 2015, DEMOGR RES, V32, P775, DOI 10.4054/DemRes.2015.32.25; Mabsout R, 2010, WORLD DEV, V38, P783, DOI 10.1016/j.worlddev.2009.11.011; Malhotra A., 2002, PAPER PREPARED WORLD; Mani S, 2013, J AFR ECON, V22, P693, DOI 10.1093/jae/ejt007; Mason K., 1997, CONTINUING DEMOGRAPH; Mason K. O., 2003, WOMENS EMPOWERMENT S; Mohanty I., 2012, GENDER ISSUES EMPOWE; Mohanty I, 2015, INDIAN GROWTH DEV RE, V8, P93, DOI 10.1108/IGDR-03-2014-0008; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; Osamor PE, 2016, INT J WOMENS HEALTH, V8, P191, DOI 10.2147/IJWH.S105483; Patrinos HA, 1997, J POPUL ECON, V10, P387, DOI 10.1007/s001480050050; Pazvakawambwa L., 2014, J MATH SYSTEM SCI, V4, P498; Rangel MA, 2006, ECON J, V116, P627, DOI 10.1111/j.1468-0297.2006.01104.x; Saffari SE, 2012, SORT-STAT OPER RES T, V36, P181; Schultz TP, 2004, J DEV ECON, V74, P199, DOI 10.1016/j.jdeveco.2003.12.009; Shroff M, 2009, MATERN CHILD NUTR, V5, P64, DOI 10.1111/j.1740-8709.2008.00161.x; STRAUSS J, 1990, ECON DEV CULT CHANGE, V38, P231, DOI 10.1086/451791; Sundaram A, 2008, WORLD DEV, V36, P128, DOI 10.1016/j.worlddev.2007.02.017; Tansel A, 1997, ECON DEV CULT CHANGE, V45, P825, DOI 10.1086/452309; THOMAS D, 1994, J HUM RESOUR, V29, P950, DOI 10.2307/146131; THOMAS D, 1990, J HUM RESOUR, V25, P635, DOI 10.2307/145670; Thomas D, 1997, J ECONOMETRICS, V77, P159, DOI 10.1016/S0304-4076(96)01811-8; United Nations Development Programme (UNDP), 2014, HUM DEV REP 2013 RIS; Williams L.B., 1990, DEV DEMOGRAPHY FAMIL; Winkelmann R., 2015, IZA WORLD OF LABOR, P148; Winkelmann R., 1995, J ECON SURV, V9, P1, DOI [10.1111/j.1467-6419.1995.tb00108.x, DOI 10.1111/J.1467-6419.1995.TB00108.X]; Winkelmann R, 2008, ECONOMETRIC ANAL COU; World Bank, WORLD BANK DAT; World Bank, 1998, 17739 WORLD BANK; World Bank, 2005, 28037 WORLD BANK; Yirga WS, 2012, INT J WOMENS HEALTH, V4, P45, DOI 10.2147/IJWH.S28805; Zimmermann L., 2011, 5687 IZA	77	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167639	10.1371/journal.pone.0167639	http://dx.doi.org/10.1371/journal.pone.0167639			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27942039	Green Submitted, gold, Green Published			2022-12-27	WOS:000392745600024
J	Jamalabadi, MYA; Bidokhti, AAA; Rah, HK; Vaezi, S; Hooshmand, P				Jamalabadi, M. Y. Abdollahzadeh; Bidokhti, Amin Ali Akbari; Rah, Hamid Khak; Vaezi, Siavash; Hooshmand, Payam			Numerical Investigation of Oxygenated and Deoxygenated Blood Flow through a Tapered Stenosed Arteries in Magnetic Field	PLoS One			English	Article							NON-NEWTONIAN BLOOD; ENTROPY GENERATION ANALYSIS; STENOTIC CONDITIONS; FLUID MODEL; NANOPARTICLES; SUSPENSION; SIMULATION; NANOFLUID; WATER; TUBE	Current paper is focused on transient modeling of blood flow through a tapered stenosed arteries surrounded a by solenoid under the presence of heat transfer. The oxygenated and deoxygenated blood are considered here by the Newtonian and Non-Newtonian fluid (power law and Carreau-Yasuda) models. The governing equations of bio magnetic fluid flow for an incompressible, laminar, homogeneous, non-Newtonian are solved by finite volume method with SIMPLE algorithm for structured grid. Both magnetization and electric current source terms are well thought-out in momentum and energy equations. The effects of fluid viscosity model, Hartmann number, and magnetic number on wall shear stress, shearing stress at the stenosis throat and maximum temperature of the system are investigated and are optimized. The current study results are in agreement with some of the existing findings in the literature and are useful in thermal and mechanical design of spatially varying magnets to control the drug delivery and biomagnetic fluid flows through tapered arteries.	[Jamalabadi, M. Y. Abdollahzadeh] Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul, South Korea; [Bidokhti, Amin Ali Akbari; Vaezi, Siavash] Sharif Univ Technol, Dept Mech Engn, Azadi St, Tehran, Iran; [Rah, Hamid Khak] Islamic Azad Univ, Shiraz Branch, Dept Mech Engn, Shiraz, Iran; [Hooshmand, Payam] Islamic Azad Univ, Sanandaj Branch, Dept Mech Engn, Sanandaj, Iran	Dongguk University; Sharif University of Technology; Islamic Azad University; Islamic Azad University	Jamalabadi, MYA (corresponding author), Dongguk Univ, Dept Mech Robot & Energy Engn, Seoul, South Korea.	abdollahzadeh@dongguk.edu	Jamalabadi, Mohammad Yaghoub Abdollahzadeh/M-5838-2015	Jamalabadi, Mohammad Yaghoub Abdollahzadeh/0000-0002-4423-1025				a-Medvidova M, INT J NUMERICAL METH, V56, P1409; Abdollahzadeh Jamalabadi M. Y., 2014, INT J SCI BASIC APPL, V14, P18; Abdollahzadeh Jamalabadi M Y, 2015, J CHEM PHARM RES, V7, P788; Abdollahzadeh Jamalabadi M Y, 2016, J HYDRODYNAMICS B, V2, P850; Abdollahzadeh Jamalabadi M Y, NUMERICAL INVESTIGAT, V18, P203; Abdollahzadeh Jamalabadi M Y, 2016, J CHEM PHARM RES, V8, P428; Akbar N.S., 2016, J APPL FLUID MECH, V9; Akbar NS, 2016, COMPUT METH PROG BIO, V132, P45, DOI 10.1016/j.cmpb.2016.04.022; Akbar NS, 2016, COMPUT METH PROG BIO, V130, P22, DOI 10.1016/j.cmpb.2016.03.003; Akbar NS, 2016, INT J EXERGY, V19, P41, DOI 10.1504/IJEX.2016.074266; Akbar NS, 2016, INT J BIOMATH, V9, DOI 10.1142/S1793524516500029; Akbar NS, 2015, PHYSICA E, V72, P70, DOI 10.1016/j.physe.2015.04.017; Akbar NS, 2015, ENTROPY-SWITZ, V17, P1411, DOI 10.3390/e17031411; Akbar NS, 2014, INT J BIOMATH, V7, DOI 10.1142/S1793524514500041; Berger SA, 2000, ANNU REV FLUID MECH, V32, P347, DOI 10.1146/annurev.fluid.32.1.347; Chakravarty S, 2000, INT J NONLIN MECH, V35, P779, DOI 10.1016/S0020-7462(99)00059-1; Edmund Eand Callaghan S H, 1960, D465 NAT AER SPAC AD; El-Dabe N.T., 2015, J APPL MATH PHYS, V3, P649, DOI [10.4236/jamp.2015.36078, DOI 10.4236/JAMP.2015.36078]; Ellahi R, 2014, APPL MATH INFORM SCI, V8, P1567, DOI 10.12785/amis/080410; HALDAR K, 1985, B MATH BIOL, V47, P545, DOI 10.1007/BF02460013; HIGASHI T, 1993, BLOOD, V82, P1328; Husain I, 2014, LECT NOTES ELECTR EN, V307, P55, DOI 10.1007/978-3-319-03967-1_5; Ikbal MA, 2009, J COMPUT APPL MATH, V230, P243, DOI 10.1016/j.cam.2008.11.010; Ishikawa T, 1998, FLUID DYN RES, V22, P251, DOI 10.1016/S0169-5983(97)00041-5; Jamalabadi MYA, 2016, ENTOMOL APPL SCI LET, V3, P52; Jamalabadi MYA, 2015, CHEM ENG RES DES, V102, P407, DOI 10.1016/j.cherd.2015.07.015; Johnston BM, 2006, J BIOMECH, V39, P1116, DOI 10.1016/j.jbiomech.2005.01.034; Ku DN, 1997, ANNU REV FLUID MECH, V29, P399, DOI 10.1146/annurev.fluid.29.1.399; Kumar Mandal P, 2007, INT J COMPUT MATH, V84, P1059; LOU Z, 1993, J BIOMECH, V26, P37, DOI 10.1016/0021-9290(93)90611-H; Mandal PK, 2005, INT J NONLIN MECH, V40, P151, DOI 10.1016/j.ijnonlinmec.2004.07.007; Mann FC, 1938, SURGERY, V4, P249; Mathur P., 2013, ADV APPL MATH BIOSCI, V4, P1; Medhavi A, 2015, 2 PHASE ARTERIAL BLO; MISRA JC, 1993, J BIOMECH, V26, P1129, DOI 10.1016/S0021-9290(05)80011-9; Mosayebidorcheh S, 2015, J BRAZILIAN SOC 0826; Pontrelli G, 2001, P I MECH ENG H, V215, P1, DOI 10.1243/0954411011533445; Prakash O, 2015, INT J BIOMATH, V8, DOI 10.1142/S1793524515500102; Sankar A R, 2013, INT J APPL INNOVATIO, V2, P30; Sankar DS, 2011, J MECH SCI TECHNOL, V25, P2573, DOI 10.1007/s12206-011-0728-x; Sarifuddin, 2008, Journal of Medical Engineering & Technology, V32, P385, DOI 10.1080/03091900601164820; Shahidian A, 2009, IEEE T MAGN, V45, P2667, DOI 10.1109/TMAG.2009.2018954; SHUKLA JB, 1980, B MATH BIOL, V42, P283, DOI 10.1007/BF02460787; Siauw W, MED ENG PHYS, V22, P265; Srivastava V, 2015, RESPONSE COMPOSITE S; Srivastava V.P., 2015, J SCI TECHNOL, V4, P5; SRIVASTAVA VP, 1995, RHEOL ACTA, V34, P406, DOI 10.1007/BF00367155; Tanwar V K, 2012, APPL MATH SCI, V6, P5959; Tzirtzilakis EE, 2008, PHYSICA D, V237, P66, DOI 10.1016/j.physd.2007.08.006; Tzirtzilakis EE, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1978807; Varshney G, 2010, INT J ENG SCI TECHNO, V2; Walker AM, 2014, ANN BIOMED ENG, V42, P97, DOI 10.1007/s10439-013-0893-4; Wang DN, 2009, COMPUT MATH APPL, V58, P1030, DOI 10.1016/j.camwa.2009.02.020; Xenos M., 2013, ADV DYN SYST APPL, V8, P427; Zaman A, 2015, AIP ADV, V5, DOI 10.1063/1.4916043	55	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167393	10.1371/journal.pone.0167393	http://dx.doi.org/10.1371/journal.pone.0167393			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941986	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600014
J	Kuuliala, K; Kuuliala, A; Koivuniemi, R; Kautiainen, H; Repo, H; Leirisalo-Repo, M				Kuuliala, Krista; Kuuliala, Antti; Koivuniemi, Riitta; Kautiainen, Hannu; Repo, Heikki; Leirisalo-Repo, Marjatta			STAT6 and STAT1 Pathway Activation in Circulating Lymphocytes and Monocytes as Predictor of Treatment Response in Rheumatoid Arthritis	PLOS ONE			English	Article							CITRULLINATED PROTEIN ANTIBODIES; TUMOR-NECROSIS-FACTOR; IFN-GAMMA; DISEASE-ACTIVITY; CLINICAL-RESPONSE; INTERFERON-GAMMA; FACTOR-ALPHA; EXPRESSION; THERAPY; IL-4	Objective To find novel predictors of treatment response to disease-modifying antirheumatic drugs (DMARDs), we studied activation of STAT (signal transducers and activators of transcription) 6 and 1 in circulating leukocytes of patients with rheumatoid arthritis (RA). Methods 19 patients with untreated recent-onset RA, 16 patients with chronic RA irresponsive to synthetic DMARDs and 37 healthy volunteers provided blood samples for whole blood flow cytometric determination of intracellular STAT6 and STAT1 phosphorylation, expressed as relative fluorescence units, in response to IL-4 and IFN-gamma, respectively. Phosphorylation was restudied and treatment response (according to European League Against Rheumatism) determined after 1-year treatment with synthetic DMARDs in recent-onset RA and with biological DMARD in synthetic DMARD-irresponsive RA. Estimation-based exact logistic regression was used to investigate relation of baseline variables to treatment response. 95% confidence intervals of means were estimated by bias-corrected bootstrapping and the significance between baseline and follow-up values was calculated by permutation test. Results At baseline, levels of phosphorylated STAT6 (pSTAT6) induced by IL-4 in monocytes were higher in those who achieved good treatment response to synthetic DMARDs than in those who did not among patients with untreated RA (OR 2.74, 95% CI 1.05 to 9.47), and IFN-gamma-stimulated lymphocyte pSTAT1 levels were higher in those who achieved good treatment response to a biological drug than in those who did not among patients with chronic RA (OR 3.91, 95% CI 1.12 to 20.68). During follow-up, in recent-onset RA patients with good treatment response to synthetic DMARDS, the lymphocyte pSTAT6 levels decreased (p = 0.011), and, consequently, the ratio of pSTAT1/pSTAT6 in lymphocytes increased (p = 0.042). Conclusion Cytokine-stimulated STAT6 and STAT1 phosphorylation in circulating leukocytes was associated with treatment response to DMARDs in this pilot study. The result, if confirmed in larger studies, may aid in developing personalized medicine in RA.	[Kuuliala, Krista; Kuuliala, Antti; Repo, Heikki] Helsinki Univ Hosp, Bacteriol & Immunol, Helsinki, Finland; [Kuuliala, Krista; Kuuliala, Antti; Koivuniemi, Riitta; Kautiainen, Hannu; Repo, Heikki; Leirisalo-Repo, Marjatta] Univ Helsinki, Helsinki, Finland; [Koivuniemi, Riitta; Leirisalo-Repo, Marjatta] Helsinki Univ Hosp, Rheumatol, Helsinki, Finland; [Kautiainen, Hannu] Helsinki Univ Hosp, Primary Hlth Care, Helsinki, Finland; [Kautiainen, Hannu] Helsinki Univ Hosp, Gen Practice, Helsinki, Finland; [Kautiainen, Hannu] Kuopio Univ Hosp, Unit Primary Hlth Care, Kuopio, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland	Kuuliala, K (corresponding author), Helsinki Univ Hosp, Bacteriol & Immunol, Helsinki, Finland.; Kuuliala, K (corresponding author), Univ Helsinki, Helsinki, Finland.	krista.kuuliala@gmail.com		Kuuliala, Antti/0000-0002-3190-207X	Paulo Foundation; Finnish Cultural Foundation; Helsinki University Central Hospital Research Funds; Finska Lakaresallskapet	Paulo Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Helsinki University Central Hospital Research Funds; Finska Lakaresallskapet	This work was supported by Paulo Foundation and Finnish Cultural Foundation (to KK); Helsinki University Central Hospital Research Funds (to MLR and HR); and Finska Lakaresallskapet (to MLR and HR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Ally MMTM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/183653; Bobbio-Pallavicini F, 2007, ANN RHEUM DIS, V66, P302, DOI 10.1136/ard.2006.060608; Braun-Moscovici Y, 2006, J RHEUMATOL, V33, P497; Cooper DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028918; Couderc M, 2013, ARTHRIT CARE RES, V65, P648, DOI 10.1002/acr.21865; Dickensheets HL, 1999, P NATL ACAD SCI USA, V96, P10800, DOI 10.1073/pnas.96.19.10800; Ermann J, 2015, NAT REV RHEUMATOL, V11, P541, DOI 10.1038/nrrheum.2015.71; Fabris M, 2012, AUTOIMMUN REV, V11, P315, DOI 10.1016/j.autrev.2010.06.012; Finnegan A, 2002, J IMMUNOL, V169, P3345, DOI 10.4049/jimmunol.169.6.3345; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Gonzalez-Alvaro I, 2015, CURR PHARM DESIGN, V21, P170; Gremese E, 2012, J RHEUMATOL, V39, P2276, DOI 10.3899/jrheum.120153; Hakala Markku, 2009, Duodecim, V125, P2131; Ho HH, 2008, J IMMUNOL, V181, P5089, DOI 10.4049/jimmunol.181.7.5089; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Hu Y, 2008, J IMMUNOL, V180, P8057, DOI 10.4049/jimmunol.180.12.8057; Huang Z, 2005, J IMMUNOL, V174, P1332, DOI 10.4049/jimmunol.174.3.1332; Isomaki P, 2007, RHEUMATOLOGY, V46, P1538, DOI 10.1093/rheumatology/kem198; Kasperkovitz PV, 2004, ANN RHEUM DIS, V63, P233, DOI 10.1136/ard.2003.013276; Kawashima M, 2005, ANN RHEUM DIS, V64, P415, DOI 10.1136/ard.2004.022731; Klaasen R, 2011, RHEUMATOLOGY, V50, P1487, DOI 10.1093/rheumatology/ker010; Klimiuk PA, 2005, J RHEUMATOL, V32, P1666; Knudsen LS, 2008, J RHEUMATOL, V35, P1277; Kuuliala K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137385; Maecker HT, 2006, CYTOM PART A, V69A, P1037, DOI 10.1002/cyto.a.20333; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; Muller-Ladner U, 2000, J IMMUNOL, V164, P3894, DOI 10.4049/jimmunol.164.7.3894; Nandakumar KS, 2006, EUR J IMMUNOL, V36, P1608, DOI 10.1002/eji.200535633; Nissinen R, 2004, ANN RHEUM DIS, V63, P681, DOI 10.1136/ard.2003.008599; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Oberprieler NG, 2011, CELL SIGNAL, V23, P14, DOI 10.1016/j.cellsig.2010.07.009; Oiva J, 2010, CRIT CARE, V14, DOI 10.1186/cc9329; Ortiz MA, 2015, CLIN IMMUNOL, V158, P174, DOI 10.1016/j.clim.2015.03.025; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Puolakka K, 2005, ARTHRITIS RHEUM, V52, P36, DOI 10.1002/art.20716; Romao VC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-17; Rudwaleit M, 2000, ANN RHEUM DIS, V59, P311, DOI 10.1136/ard.59.4.311; Sanchez-Guajardo V, J IMMUNOL; Scarsi M, 2011, J RHEUMATOL, V38, P2105, DOI 10.3899/jrheum.110386; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Seki Y, 2002, P NATL ACAD SCI USA, V99, P13003, DOI 10.1073/pnas.202477099; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Szalay B, 2014, CLIN RHEUMATOL, V33, P175, DOI 10.1007/s10067-013-2352-x; van den Broek M, 2013, CURR OPIN PHARMACOL, V13, P463, DOI 10.1016/j.coph.2013.03.006; van Lent PLEM, 2002, OSTEOARTHR CARTILAGE, V10, P234, DOI 10.1053/joca.2001.0501; Walker JG, 2006, ANN RHEUM DIS, V65, P1558, DOI 10.1136/ard.2005.050385; Wermeling F, 2013, P NATL ACAD SCI USA, V110, P13487, DOI 10.1073/pnas.1312525110; Yeh WI, 2014, J NEUROIMMUNOL, V267, P20, DOI 10.1016/j.jneuroim.2013.12.001; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	52	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167975	10.1371/journal.pone.0167975	http://dx.doi.org/10.1371/journal.pone.0167975			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942004	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600043
J	Bennouna, C; Feldman, B; Usman, R; Adiputra, R; Kusumaningrum, S; Stark, L				Bennouna, Cyril; Feldman, Brooke; Usman, Rahmadi; Adiputra, Rama; Kusumaningrum, Santi; Stark, Lindsay			Using the Three Delays Model to Examine Civil Registration Barriers in Indonesia	PLoS One			English	Article							MATERNAL MORTALITY; FRAMEWORK	The Three Delays Model has proven a useful framework for examining barriers to seeking obstetric care and preventing maternal and child mortality. This article demonstrates the applicability of the Three Delays Model to the case of civil registration in rural Indonesia and examines ways that efforts to strengthen civil registration services can draw on lessons from maternal and child health programming. Twenty focus group discussions were conducted using a participatory ranking exercise in four Indonesian districts. Focus groups were stratified into four groups: (1) government officials involved in civil registration, (2) civil society organization members that assist communities in civil registration, and (3) female and (4) male community members. Transcripts were analyzed using constant comparative method and thematic analysis, revealing barriers that communities commonly faced in accessing civil registration services. In examining the categories and themes related to these barriers, the research team found a significant overlap with the factors and phases of the Three Delays Model. Participants were delayed from seeking registration services by a range of sociocultural factors and by the perceived inaccessibility and poor quality of services. Once they decided to seek care, long distances to services and poor transportation options delayed their access to registration offices. Finally, a series of bottlenecks in service provision created extended delays once applicants reached registration offices. Ownership of civil registration documents in Indonesia remains exceptionally low, with just over half of children and youth possessing a birth certificate. To strengthen civil registration and health systems more generally, it is important to understand the factors that enable and constrain civil registration, how these factors relate to one another, and how they change over a child's life.	[Bennouna, Cyril; Usman, Rahmadi; Adiputra, Rama; Kusumaningrum, Santi] Univ Indonesia PUSKAPA, Ctr Child Protect & Wellbeing, Sch Social & Polit Sci, Depok, Indonesia; [Feldman, Brooke; Stark, Lindsay] Columbia Univ, Mailman Sch Publ Hlth, PFMH, New York, NY USA	University of Indonesia; Columbia University	Stark, L (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, PFMH, New York, NY USA.	ls2302@cumc.columbia.edu	Kusumaningrum, Santi/AAD-6223-2022	Kusumaningrum, Santi/0000-0001-9156-0166; Bennouna, Cyril/0000-0002-8449-0283	Australian Government's Australia-Indonesia Partnership for Justice (AIPJ) [AC43600/AIPJ/PUSKAPA/SL-18-05-14]	Australian Government's Australia-Indonesia Partnership for Justice (AIPJ)	This research was supported by the Australian Government's Australia-Indonesia Partnership for Justice (AIPJ) [grant number AC43600/AIPJ/PUSKAPA/SL-18-05-14]. The URL is http://www.aipj.or.id/en/main. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouzahr C, 2014, ASIA PAC POPUL J, V29, P2014; AbouZahr C, 2007, LANCET, V370, P1791, DOI 10.1016/S0140-6736(07)61310-5; AbouZahr C, 2015, LANCET, V386, P1373, DOI 10.1016/S0140-6736(15)60173-8; Ager A., 2011, RAPID APPRAISAL HUMA; [Anonymous], 2014, BIR BAI DIL RS DIUR; Badan Pusat Statistik [Central Statistics Agency], 2015, SURV SOS EK NA UNPUB; Badan Pusat Statistik National Population and Family Planning Board Kementerian Kesehatan ICF International, 2013, IND DEM HLTH SURV 20; Barnes-Josiah D, 1998, SOC SCI MED, V46, P981, DOI 10.1016/S0277-9536(97)10018-1; Belton S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-39; Duff P, 2016, LANCET GLOB HEALTH, V4, pE234, DOI 10.1016/S2214-109X(15)00321-6; Ellis C, 2011, INT J CHILDBIRTH, V1, P218, DOI 10.1891/2156-5287.1.4.218; Jackson Michelle, 2014, BMC Int Health Hum Rights, V14, P306, DOI 10.1186/s12914-014-0038-3; Kusumaningrum S., 2016, BACK WHAT COUNTS BIR; Mbaruku G, 2009, INT J GYNECOL OBSTET, V106, P85, DOI 10.1016/j.ijgo.2009.04.008; Muzzi Mariana, 2010, UNICEF GOOD PRACTICE; Pacagnella RC, 2012, REPROD HEALTH MATTER, V20, P155, DOI 10.1016/S0968-8080(12)39601-8; Peters BG, 2015, WP201505 UNICEF; Phillips DE, 2015, LANCET, V386, P1386, DOI 10.1016/S0140-6736(15)60172-6; QSR International Pty Ltd, 2014, NVIVO; Shankar A, 2008, LANCET, V371, P1226, DOI 10.1016/S0140-6736(08)60538-3; Sumner C, 2015, 064 CGD; Sumner C, 2013, AIPJ BASELINE STUDY; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Thorsen VC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052090; United Nations Children's Fund, 2013, EV CHILDS BIRTH RIGH; Upadhyay Ravi Prakash, 2012, ISRN Pediatr, V2012, P968921, DOI 10.5402/2012/968921; Van de Poel E, 2014, B WORLD HEALTH ORGAN, V92, P331, DOI 10.2471/BLT.13.129122; Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x; Yaya Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119321	29	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168405	10.1371/journal.pone.0168405	http://dx.doi.org/10.1371/journal.pone.0168405			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992515	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600056
J	Chaphalkar, AR; Jain, K; Gangan, MS; Athale, CA				Chaphalkar, Anushree R.; Jain, Kunalika; Gangan, Manasi S.; Athale, Chaitanya A.			Automated Multi-Peak Tracking Kymography (AMTraK): A Tool to Quantify Sub-Cellular Dynamics with Sub-Pixel Accuracy	PLoS One			English	Article							EXCESS MEMBRANE RESERVOIR; TUG-OF-WAR; ESCHERICHIA-COLI; QUANTITATIVE-ANALYSIS; SUPPORTED BILAYERS; VESICLE TRANSPORT; MOTILITY ASSAYS; EDGE-DETECTION; KINESIN; FILAMENTS	Kymographs or space-time plots are widely used in cell biology to reduce the dimensions of a time-series in microscopy for both qualitative and quantitative insight into spatio-temporal dynamics. While multiple tools for image kymography have been described before, quantification remains largely manual. Here, we describe a novel software tool for automated multi-peak tracking kymography (AMTraK), which uses peak information and distance minimization to track and automatically quantify kymographs, integrated in a GUI. The program takes fluorescence time-series data as an input and tracks contours in the kymographs based on intensity and gradient peaks. By integrating a branch-point detection method, it can be used to identify merging and splitting events of tracks, important in separation and coalescence events. In tests with synthetic images, we demonstrate sub-pixel positional accuracy of the program. We test the program by quantifying sub-cellular dynamics in rod-shaped bacteria, microtubule (MT) transport and vesicle dynamics. A time-series of E. coli cell division with labeled nucleoid DNA is used to identify the time-point and rate at which the nucleoid segregates. The mean velocity of microtubule (MT) gliding motility due to a recombinant kinesin motor is estimated as 0.5 mu m/s, in agreement with published values, and comparable to estimates using software for nanometer precision filament-tracking. We proceed to employ AMTraK to analyze previously published time-series microscopy data where kymographs had been manually quantified: clathrin polymerization kinetics during vesicle formation and anterograde and retrograde transport in axons. AMTraK analysis not only reproduces the reported parameters, it also provides an objective and automated method for reproducible analysis of kymographs from in vitro and in vivo fluorescence microscopy time-series of sub-cellular dynamics.	[Chaphalkar, Anushree R.; Jain, Kunalika; Gangan, Manasi S.; Athale, Chaitanya A.] IISER Pune, Div Biol, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Athale, CA (corresponding author), IISER Pune, Div Biol, Pune, Maharashtra, India.	cathale@iiserpune.ac.in	; Athale, Chaitanya A./G-8883-2011	Jain, Kunalika/0000-0002-4555-4627; Athale, Chaitanya A./0000-0002-9506-2153	Department of Biotechnology (DBT), Govt. of India [BT/PR1595/BRB/10/1043/2012]; University Grants Commission [F.2-14/2011 (SA-1)]; Department of Science and Technology, Ministry of Science and Technology [INSPIRE IF130394]; Indian Council of Medical Research [3/13/WLC/JRF-2011/HRD-156 (51550)]	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India); University Grants Commission(University Grants Commission, India); Department of Science and Technology, Ministry of Science and Technology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This research was supported by The Department of Biotechnology (DBT), Govt. of India (BT/PR1595/BRB/10/1043/2012), University Grants Commission (F.2-14/2011 (SA-1)), Department of Science and Technology, Ministry of Science and Technology (INSPIRE IF130394), and Indian Council of Medical Research (3/13/WLC/JRF-2011/HRD-156 (51550)).	ALLAN VJ, 1991, J CELL BIOL, V113, P347, DOI 10.1083/jcb.113.2.347; Athale CA, 2011, BIOINFORMATICS, V27, P2944, DOI 10.1093/bioinformatics/btr501; Avinoam O, 2015, SCIENCE, V348, P1369, DOI 10.1126/science.aaa9555; Bicek AD, 2009, MOL BIOL CELL, V20, P2943, DOI 10.1091/mbc.E08-09-0909; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; Brookes Mike, 2005, VOICEBOX; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Chenouard N, 2010, IEEE INT C IM PROC I; Chetta J, 2011, J NEUROSCI METH, V199, P230, DOI 10.1016/j.jneumeth.2011.05.013; Chiba K, 2014, TRAFFIC, V15, P1, DOI 10.1111/tra.12127; Cytoskeleton, 2005, KIN MOT ASS BIOCH KI; Das M, 2012, SCIENCE, V337, P239, DOI 10.1126/science.1218377; Ducret A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.77, 10.1038/nmicrobiol.2016.77]; Fisher JK, 2013, CELL, V153, P882, DOI 10.1016/j.cell.2013.04.006; Foster PJ, 2015, ELIFE, V4, DOI 10.7554/eLife.10837; Gibbons F, 2001, BIOPHYS J, V80, P2515, DOI 10.1016/S0006-3495(01)76223-6; Guberman JM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000233; Hallman S, 2007, MAKE KYMOGRAPH PLUGI; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hill DB, 2004, EUR BIOPHYS J BIOPHY, V33, P623, DOI 10.1007/s00249-004-0403-6; Holkar SS, 2015, J BIOL CHEM, V290, P14267, DOI 10.1074/jbc.M115.653394; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; Howard J., 2001, MECH MOTOR PROTEINS; Howard J, 2014, MOL BIOL CELL, V25, P3438, DOI 10.1091/mbc.E14-02-0715; Ikuta J, 2014, SCI REP-UK, V4, DOI 10.1038/srep05281; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Maeder CI, 2014, TRAFFIC, V15, P273, DOI 10.1111/tra.12142; Mangeol P, 2016, MOL BIOL CELL, V27, P1948, DOI 10.1091/mbc.E15-06-0404; Martin DS, 2013, METHOD CELL BIOL, V115, P13, DOI 10.1016/B978-0-12-407757-7.00002-5; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Miura K, 2005, ADV BIOCHEM ENG BIOT, P267; Mondal S, 2011, TRAFFIC, V12, P372, DOI 10.1111/j.1600-0854.2010.01157.x; Neumann S, 2013, NAT PROTOC, V8, P213, DOI 10.1038/nprot.2012.152; Nielsen HJ, 2006, MOL MICROBIOL, V62, P331, DOI 10.1111/j.1365-2958.2006.05346.x; Nitzsche B, 2010, METHOD CELL BIOL, V95, P247, DOI 10.1016/S0091-679X(10)95014-0; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pereira AJ, 2010, METHODS, V51, P214, DOI 10.1016/j.ymeth.2010.01.016; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Pucadyil TJ, 2010, BIOPHYS J, V99, P517, DOI 10.1016/j.bpj.2010.04.036; Rietdorf J., 2008, KYMOGRAPH TIME SPACE; Rietdorf J, 2008, MULTIKVMOGRAPH; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Sachs CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163453; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shekhara S, 2014, MOL BIOL CELL, V25, P3482, DOI 10.1091/mbc.E14-08-1286; Siebrasse JP, 2012, P NATL ACAD SCI USA, V109, P9426, DOI 10.1073/pnas.1201781109; SKARSTAD K, 1985, J BACTERIOL, V163, P661, DOI 10.1128/JB.163.2.661-668.1985; Skruzny M, 2015, DEV CELL, V33, P150, DOI 10.1016/j.devcel.2015.02.023; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Spahn C, 2014, J STRUCT BIOL, V185, P243, DOI 10.1016/j.jsb.2014.01.007; STEWART RJ, 1993, P NATL ACAD SCI USA, V90, P5209, DOI 10.1073/pnas.90.11.5209; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; TOYOSHIMA YY, 1987, NATURE, V328, P536, DOI 10.1038/328536a0; UNGEWICKELL E, 1981, NATURE, V289, P420, DOI 10.1038/289420a0; Welzel O, 2011, EUR BIOPHYS J BIOPHY, V40, P1061, DOI 10.1007/s00249-011-0722-3; Welzel O, 2009, EUR BIOPHYS J BIOPHY, V38, P883, DOI 10.1007/s00249-009-0458-5; Wery M, 2001, BIOCHIMIE, V83, P193, DOI 10.1016/S0300-9084(01)01254-8; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005	59	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167620	10.1371/journal.pone.0167620	http://dx.doi.org/10.1371/journal.pone.0167620			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992448	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600017
J	Sugiyama-Nakagiri, Y; Fujimura, T; Moriwaki, S				Sugiyama-Nakagiri, Yoriko; Fujimura, Tsutomu; Moriwaki, Shigeru			Induction of Skin-Derived Precursor Cells from Human Induced Pluripotent Stem Cells	PLoS One			English	Article							LABEL-RETAINING CELLS; FOLLICLE DERMAL CELLS; NICHE; GROWTH	The generation of full thickness human skin from dissociated cells is an attractive approach not only for treating skin diseases, but also for treating many systemic disorders. However, it is currently not possible to obtain an unlimited number of skin dermal cells. The goal of this study was to develop a procedure to produce skin dermal stem cells from induced pluripotent stem cells (iPSCs). Skin-derived precursor cells (SKPs) were isolated as adult dermal precursors that could differentiate into both neural and mesodermal progenies and could reconstitute the dermis. Thus, we attempted to generate SKPs from iPSCs that could reconstitute the skin dermis. Human iPSCs were initially cultured with recombinant noggin and SB431542, an inhibitor of activin/nodal and TGF beta signaling, to induce neural crest progenitor cells. Those cells were then treated with SKP medium that included CHIR99021, a WNT signal activator. The induction efficacy from neural crest progenitor cells to SKPs was more than 97%. No other modifiers tested were able to induce those cells. Those human iPSC-derived SKPs (hiPSC-SKPs) showed a similar gene expression signature to SKPs isolated from human skin dermis. Human iPSC-SKPs differentiated into neural and mesodermal progenies, including adipocytes, skeletogenic cell types and Schwann cells. Moreover, they could be induced to follicular type keratinization when co-cultured with human epidermal keratinocytes. We here provide a new efficient protocol to create human skin dermal stem cells from hiPSCs that could contribute to the treatment of various skin disorders.	[Sugiyama-Nakagiri, Yoriko; Fujimura, Tsutomu; Moriwaki, Shigeru] Kao Corp, Akabane Ichikai Machi, Tokyo, Tochigi, Japan	KAO Corporation	Sugiyama-Nakagiri, Y (corresponding author), Kao Corp, Akabane Ichikai Machi, Tokyo, Tochigi, Japan.	nakagiri.yoriko@kao.co.jp			Kao Corporation	Kao Corporation	This work was supported by Kao Corporation. The Funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Author Contributions' section.	Biemaskie J., 2009, CELL STEM CELL, V5, P610, DOI DOI 10.1016/J.STEM.2009.10.019; COHEN J, 1961, J EMBRYOL EXP MORPH, V9, P117; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Higgins CA, 2013, P NATL ACAD SCI USA, V110, P19679, DOI 10.1073/pnas.1309970110; Hill RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050742; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Itoh M, 2011, P NATL ACAD SCI USA, V108, P8797, DOI 10.1073/pnas.1100332108; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Morizane A, 2011, J NEUROSCI RES, V89, P117, DOI 10.1002/jnr.22547; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Mukherjee A, 2007, GROWTH HORM IGF RES, V17, P179, DOI 10.1016/j.ghir.2007.01.005; Ohyama M, 2012, J CELL SCI, V125, P4114, DOI 10.1242/jcs.105700; Ohyama M, 2010, EXP DERMATOL, V19, P89, DOI 10.1111/j.1600-0625.2009.00935.x; Oliver RF, 1970, J EMBRYOL EXP MORPHO, V23, P219; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Sabapathy V, 2016, J CELL MOL MED, V20, P1571, DOI 10.1111/jcmm.12839; Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823; Soma T, 2012, EXP DERMATOL, V21, P299; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tolar J, 2011, J INVEST DERMATOL, V131, P848, DOI 10.1038/jid.2010.346; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Veraitch O, 2013, J INVEST DERMATOL, V133, P1479, DOI 10.1038/jid.2013.7; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Yang RF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4071	32	14	14	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168451	10.1371/journal.pone.0168451	http://dx.doi.org/10.1371/journal.pone.0168451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992514	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600060
J	Hung, CI; Liu, CY; Yang, CH				Hung, Ching-I; Liu, Chia-Yih; Yang, Ching-Hui			Unintentional Injuries among Psychiatric Outpatients with Major Depressive Disorder	PLOS ONE			English	Article							SLEEP QUALITY INDEX; PSYCHOLOGICAL DISTRESS; SYMPTOMS; RISK; ASSOCIATION; ADOLESCENTS; OBESITY	Background No study has investigated the percentages of and factors related to unintentional injuries among psychiatric outpatients with major depressive disorder (MDD). This study aimed to investigate these issues. Methods One-hundred and forty-one outpatients with MDD at baseline were enrolled from psychiatric outpatients by systematic sampling, and 119 subjects attended a one-year follow-up. Self-reported unintentional injuries in the past one year were recorded. Psychiatric disorders were diagnosed using the Structured Clinical Interview for DSM-IV-TR. The severity of depression was evaluated by the Hamilton Depression Rating Scale. Other data, including body weight and height, cigarette smoking, headaches, and medications, were collected. Generalized Estimating Equations were used to investigate independent factors related to unintentional injuries. Results At baseline and follow-up, 40.4% and 27.7% of subjects had experienced at least one unintentional injury in the past one year, respectively. About half of subjects with unintentional injuries needed medical treatment for injuries and had functional impairment due to injuries. A greater severity of depression, cigarette smoking, a higher body mass index, and an older age were independent risk factors related to unintentional injuries. Conclusion Unintentional injuries that increased the medical burden and functional impairment were common among outpatients with MDD and should not be neglected. Treatment of depression, control of body weight, and quitting cigarettes might be helpful to prevent unintentional injuries.	[Hung, Ching-I; Liu, Chia-Yih] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan; [Hung, Ching-I; Liu, Chia-Yih] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Yang, Ching-Hui] Chang Gung Inst Technol, Dept Nursing, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University of Science & Technology	Hung, CI (corresponding author), Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan.; Hung, CI (corresponding author), Chang Gung Univ, Sch Med, Taoyuan, Taiwan.	a36250@cgmh.org.tw			National Science Council of Taiwan [NSC 97-2314-B-182A-017-MY2]; Chang Gung Memorial Hospital Research Program [CLRPG3D0043]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital Research Program(Chang Gung Memorial Hospital)	This study was supported in part by grants from the National Science Council of Taiwan (NSC 97-2314-B-182A-017-MY2) and Chang Gung Memorial Hospital Research Program (CLRPG3D0043). The funding sources had no role in the design and conduct of the study; collection, analysis, and interpretation of the data; and preparation, review or approval of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Bouchard DR, 2010, OBESITY FACTS, V3, P363, DOI 10.1159/000322873; Buysse D J, 1989, Psychiatry Res, V28, P193; Chen G, 2005, J ADOLESCENT HEALTH, V37, P460, DOI 10.1016/j.jadohealth.2004.09.005; Chen GM, 2008, INT J INJ CONTROL SA, V15, P157, DOI 10.1080/17457300802207833; de Ramirez SS, 2012, ANNU REV PUBL HEALTH, V33, P175, DOI 10.1146/annurev-publhealth-031811-124558; First MB, 2002, STRUCTURED CLIN INTE; Fragar L, 2013, J RURAL HEALTH, V29, P12, DOI 10.1111/j.1748-0361.2012.00423.x; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Hausdorff JM, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-39; Isometsa E, 2014, CAN J PSYCHIAT, V59, P120, DOI 10.1177/070674371405900303; Kim Yeon-Yong, 2014, J Prev Med Public Health, V47, P150, DOI 10.3961/jpmph.2014.47.3.150; Korniloff K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-516; Lavsa SM, 2010, AM J HEALTH-SYST PH, V67, P1274, DOI 10.2146/ajhp090611; Leistikow B N, 2000, Inj Prev, V6, P277, DOI 10.1136/ip.6.4.277; Martins IP, 2012, HEADACHE, V52, P1471, DOI 10.1111/j.1526-4610.2012.02218.x; McAninch J, 2014, INJURY PREV, V20, P258, DOI 10.1136/injuryprev-2013-040958; McDonald CC, 2014, INJURY PREV, V20, P365, DOI 10.1136/injuryprev-2014-041150; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; SACKS JJ, 1994, PREV MED, V23, P515, DOI 10.1006/pmed.1994.1070; Schwebel DC, 2008, J PEDIATR PSYCHOL, V33, P323, DOI 10.1093/jpepsy/jsm109; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Tiesman HM, 2006, INJURY PREV, V12, P172, DOI 10.1136/ip.2006.011544; Tsai PS, 2005, QUAL LIFE RES, V14, P1943, DOI 10.1007/s11136-005-4346-x; van der Westhuizen C, 2014, J NERV MENT DIS, V202, P638, DOI 10.1097/NMD.0000000000000176; Wright SL, 2011, J GERIATR PSYCH NEUR, V24, P142, DOI 10.1177/0891988711409408; Xiang H, 2005, AM J PREV MED, V29, P41, DOI 10.1016/j.amepre.2005.03.013	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168202	10.1371/journal.pone.0168202	http://dx.doi.org/10.1371/journal.pone.0168202			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992483	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000030
J	Al Ali, L; Hartman, MT; Lexis, CPH; Hummel, YM; Lipsic, E; van Melle, JP; van Veldhuisen, DJ; Voors, AA; van der Horst, ICC; van der Harst, P				Al Ali, Lawien; Hartman, Minke T.; Lexis, Chris P. H.; Hummel, Yoran M.; Lipsic, Erik; van Melle, Joost P.; van Veldhuisen, Dirk J.; Voors, Adriaan A.; van der Horst, Iwan C. C.; van der Harst, Pim			The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction	PLOS ONE			English	Article							LEFT-VENTRICULAR FUNCTION; LEFT ATRIAL VOLUME; HEART-FAILURE; TISSUE DOPPLER; DIABETIC-PATIENTS; EJECTION FRACTION; EUROPEAN-SOCIETY; CARDIAC-FUNCTION; FILLING PATTERN; YOUNG-ADULTS	Introduction Diastolic dysfunction is an important predictor of poor outcome after myocardial infarction. Metformin treatment improved diastolic function in animal models and patients with diabetes. Whether metformin improves diastolic function in patients presenting with ST-segment elevation myocardial infarction (STEMI) is unknown. Methods The GIPS-III trial randomized STEMI patients, without known diabetes, to metformin or placebo initiated directly after PCI. The previously reported primary endpoint was left ventricular ejection fraction at 4 months, which was unaffected by metformin treatment. This is a predefined substudy to determine an effect of metformin on diastolic function. For this substudy trans-thoracic echocardiography was performed during hospitalization and after 4 months. Diastolic dysfunction was defined as having the combination of a functional alteration (i.e. decreased tissue velocity: mean of septal e' and lateral e') and a structural alteration (i.e. increased left atrial volume index (LAVI)). In addition, left ventricular mass index and transmitral flow velocity (E) to mean e' ratio (E/e') were measured to determine an effect of metformin on individual echocardiographic markers of diastolic function. Results In 237 (63%) patients included in the GIPS-III trial diastolic function was measured during hospitalization as well as at 4 months. Diastolic dysfunction was present in 11 (9%) of patients on metformin and 11 (9%) patients on placebo treatment (P = 0.98) during hospitalization. After 4 months 22 (19%) of patients with metformin and 18 (15%) patients with placebo (P = 0.47) had diastolic dysfunction. In addition, metformin did not improve any of the individual echocardiographic markers of diastolic function. Conclusions In contrast to experimental and observational data, our randomized placebo controlled trial did not suggest a beneficial effect of short-term metformin treatment on diastolic function in STEMI patients.	[Al Ali, Lawien; Hartman, Minke T.; Lexis, Chris P. H.; Hummel, Yoran M.; Lipsic, Erik; van Melle, Joost P.; van Veldhuisen, Dirk J.; Voors, Adriaan A.; van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [van der Horst, Iwan C. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Crit Care, Groningen, Netherlands	University of Groningen; University of Groningen	van der Harst, P (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	p.van.der.harst@umcg.nl	Voors, Adriaan/ABE-6784-2020	Hartman, Minke H.T./0000-0002-6965-3259	Netherlands Organization for Health Research and Development (ZonMw)The Hague, the Netherlands [95103007]	Netherlands Organization for Health Research and Development (ZonMw)The Hague, the Netherlands(Netherlands Organization for Health Research and DevelopmentNetherlands Government)	The GIPS-III trial was supported by grant 95103007 from the Netherlands Organization for Health Research and Development (ZonMw; http://www.zonmw.nl), The Hague, the Netherlands.	Andersson C, 2010, EUR J ENDOCRINOL, V163, P593, DOI 10.1530/EJE-10-0624; Aronson D, 2010, CIRC-HEART FAIL, V3, P125, DOI 10.1161/CIRCHEARTFAILURE.109.877340; Azevedo PS, 2012, MED SCI MONITOR, V18, pBR253, DOI 10.12659/MSM.883202; Beinart R, 2004, J AM COLL CARDIOL, V44, P327, DOI 10.1016/j.jacc.2004.03.062; Beitnes JO, 2011, EUR J ECHOCARDIOGR, V12, DOI 10.1093/ejechocard/jeq116; Cerisano G, 2001, J AM COLL CARDIOL, V37, P793, DOI 10.1016/S0735-1097(00)01203-1; Ceyhan K, 2012, J AM SOC ECHOCARDIOG, V25, P349, DOI 10.1016/j.echo.2011.11.018; De Marco M, 2011, DIABETES CARE, V34, P2300, DOI 10.2337/dc11-0191; Desai CS, 2013, AM J EPIDEMIOL, V177, P20, DOI 10.1093/aje/kws224; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; DUBOIS D, 1989, NUTRITION, V5, P303; Fujimoto N, 2013, J HYPERTENS, V31, P2282, DOI 10.1097/HJH.0b013e3283649730; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Gotte MJW, 2006, J AM COLL CARDIOL, V48, P2002, DOI 10.1016/j.jacc.2006.07.048; Hillis GS, 2004, J AM COLL CARDIOL, V43, P360, DOI 10.1016/j.jacc.2003.07.044; Hummel YM, 2010, CLIN RES CARDIOL, V99, P453, DOI 10.1007/s00392-010-0141-y; Jarnert C, 2009, EUR J HEART FAIL, V11, P39, DOI 10.1093/eurjhf/hfn018; Jons C, 2010, EUR J ECHOCARDIOGR, V11, P602, DOI 10.1093/ejechocard/jeq024; Kao J, 2004, AM J CARDIOL, V93, P1347, DOI 10.1016/j.amjcard.2004.02.028; Ladeiras-Lopes R, 2014, CARDIOVASC DRUG THER, V28, P191, DOI 10.1007/s10557-014-6512-2; Lamblin N, 2012, J CARDIOVASC MED, V13, P353, DOI 10.2459/JCM.0b013e328353694b; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Lester SJ, 2008, J AM COLL CARDIOL, V51, P679, DOI 10.1016/j.jacc.2007.09.061; Leung M, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.003643; Lexis CPH, 2014, JAMA-J AM MED ASSOC, V311, P1526, DOI 10.1001/jama.2014.3315; Lexis CPH, 2014, CARDIOVASC DRUG THER, V28, P163, DOI 10.1007/s10557-013-6504-7; Lexis CPH, 2012, CARDIOVASC DRUG THER, V26, P417, DOI 10.1007/s10557-012-6413-1; McMurray JJV, 2012, EUR J HEART FAIL, V14, P803, DOI 10.1093/eurjhf/hfs105; Mellbin LG, 2011, DIABETOLOGIA, V54, P1308, DOI 10.1007/s00125-011-2084-x; Mellbin LG, 2008, EUR HEART J, V29, P166, DOI 10.1093/eurheartj/ehm518; Moller JE, 2008, CIRCULATION, V117, P2591, DOI 10.1161/CIRCULATIONAHA.107.738625; Moller JE, 2000, J AM COLL CARDIOL, V36, P1841, DOI 10.1016/S0735-1097(00)00965-7; Moller JE, 2006, AM HEART J, V151, P419, DOI 10.1016/j.ahj.2005.03.042; Moller JE, 2003, CIRCULATION, V107, P2207, DOI 10.1161/01.CIR.0000066318.21784.43; Nagueh SF, 2016, EUR HEART J CARDIOVA; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Naka KK, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-57; Namdar M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079152; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Ponikowski P, 2016, EUR J HEART FAIL; Prasad SB, 2011, AM J CARDIOL, V108, P348, DOI 10.1016/j.amjcard.2011.03.051; Roussel R, 2010, ARCH INTERN MED, V170, P1892, DOI 10.1001/archinternmed.2010.409; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; Scantlebury DC, 2011, CURR OPIN CARDIOL, V26, P562, DOI 10.1097/HCO.0b013e32834b7faf; Stahrenberg R, 2010, DIABETOLOGIA, V53, P1331, DOI 10.1007/s00125-010-1718-8; Temporelli PL, 2004, J AM COLL CARDIOL, V43, P1646, DOI 10.1016/j.jacc.2003.12.036; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Whalley GA, 2006, HEART, V92, P1588, DOI 10.1136/hrt.2005.083055; Whalley GA, 2007, INT J CARDIOL, V122, P207, DOI 10.1016/j.ijcard.2006.11.080; Yin MM, 2011, AM J PHYSIOL-HEART C, V301, pH459, DOI 10.1152/ajpheart.00054.2011	50	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168340	10.1371/journal.pone.0168340	http://dx.doi.org/10.1371/journal.pone.0168340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977774	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400096
J	Cary, DC; Fujinaga, K; Peterlin, BM				Cary, Daniele C.; Fujinaga, Koh; Peterlin, B. Matija			Euphorbia Kansui Reactivates Latent HIV	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HISTONE DEACETYLASE INHIBITORS; B P-TEFB; POSITIVE TRANSCRIPTION; MOLECULAR-MECHANISMS; IN-VITRO; CD4(+) T; REPLICATION; ELONGATION; RESERVOIR	While highly active anti-retroviral therapy has greatly improved the lives of HIV infected individuals, these treatments are unable to eradicate the virus. Current approaches to reactivate the virus have been limited by toxicity, lack of an orally available therapy, and limited responses in primary CD4+ T cells and in clinical trials. The PKC agonist ingenol, purified from Euphorbia plants, is a potent T cell activator and reactivates latent HIV. Euphorbia kansui itself has been used for centuries in traditional Chinese medicine to treat ascites, fluid retention, and cancer. We demonstrate that an extract of this plant, Euphorbia kansui, is capable of recapitulating T cell activation induced by the purified ingenol. Indeed, Euphorbia kansui induced expression of the early T cell activation marker CD69 and P-TEFb in a dosedependent manner. Furthermore, Euphorbia kansui reactivated latent HIV in a CD4+ T cell model of latency and in HIV+ HAART suppressed PBMC. When combined with the other latency reversing agents, the effective dose of Euphorbia kansui required to reactive HIV was reduced 10-fold and resulted in synergistic reactivation of latent HIV. We conclude that Euphorbia Euphorbia kansui reactivates latent HIV and activates CD4+ T cells. When used in combination with a latency reversing agent, the effective dose of Euphorbia kansui is reduced; which suggests its application as a combination strategy to reactivate latent HIV while limiting the toxicity due to global T cell activation. As a natural product, which has been used in traditional medicine for thousands of years, Euphorbia kansui is attractive as a potential treatment strategy, particularly in resource poor countries with limited treatment options. Further clinical testing will be required to determine its safety with current anti-retroviral therapies.	[Cary, Daniele C.; Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Cary, Daniele C.; Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA; [Cary, Daniele C.; Fujinaga, Koh; Peterlin, B. Matija] Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Cary, DC (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Cary, DC (corresponding author), Univ Calif San Francisco, Dept Microbiol, San Francisco, CA 94143 USA.; Cary, DC (corresponding author), Univ Calif San Francisco, Dept Immunol, San Francisco, CA 94143 USA.	Daniele.Cary@ucsf.edu			amfAR (Foundation for AIDS Research) Institute for HIV Cure Research; National Institute of Health [U19 AI096113, R01 AI49104, P50 GM082250]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI125104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082250] Funding Source: NIH RePORTER	amfAR (Foundation for AIDS Research) Institute for HIV Cure Research; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the amfAR (Foundation for AIDS Research) Institute for HIV Cure Research and by the National Institute of Health through grants U19 AI096113 and R01 AI49104 to BMP and grant P50 GM082250. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097257; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Anderson L, 2009, J AM ACAD DERMATOL, V60, P934, DOI 10.1016/j.jaad.2009.01.008; Archin NM, 2014, CURR OPIN INFECT DIS, V27, P29, DOI 10.1097/QCO.0000000000000026; Bartholomeeusen K, 2013, J BIOL CHEM, V288, P14400, DOI 10.1074/jbc.M113.464834; Bartholomeeusen K, 2012, J BIOL CHEM, V287, P36609, DOI 10.1074/jbc.M112.410746; Beans EJ, 2013, P NATL ACAD SCI USA, V110, P11698, DOI 10.1073/pnas.1302634110; Bensky D, 2004, CHINESE HERBAL MED M, V3rd; Blazkova J, 2012, J INFECT DIS, V206, P765, DOI 10.1093/infdis/jis412; Boehm D, 2013, CELL CYCLE, V12, P452, DOI 10.4161/cc.23309; Bullen CK, 2014, NAT MED, V20, P425, DOI 10.1038/nm.3489; Cary DC, 2016, J CLIN INVEST, V126, P448, DOI 10.1172/JCI80565; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Contreras X, 2009, J BIOL CHEM, V284, P6782, DOI 10.1074/jbc.M807898200; Darcis G, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005063; DeChristopher BA, 2012, NAT CHEM, V4, P705, DOI [10.1038/nchem.1395, 10.1038/NCHEM.1395]; Dutra RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027122; Fabricant DS, 2001, ENVIRON HEALTH PERSP, V109, P69, DOI 10.2307/3434847; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fujinaga K, 2012, NUCLEIC ACIDS RES, V40, P9160, DOI 10.1093/nar/gks682; Gama L, 2016, AIDS; Gu XD, 2007, CHIN J INTEGR MED, V13, P235, DOI 10.1007/s11655-007-0235-1; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; He NH, 2006, MOL CELL BIOL, V26, P7068, DOI 10.1128/MCB.00778-06; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hon T, 2015, BIOCHEM BIOPH RES CO, V459, P288, DOI 10.1016/j.bbrc.2015.02.102; Hou JJ, 2014, J PHARMACEUT BIOMED, V88, P321, DOI 10.1016/j.jpba.2013.08.049; Jablonski JA, 2009, J VIROL, V83, P981, DOI 10.1128/JVI.01801-08; Jiang GC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005066; Jiang GC, 2014, AIDS, V28, P1555, DOI 10.1097/QAD.0000000000000289; Jose DP, 2014, VIROLOGY, V462, P328, DOI 10.1016/j.virol.2014.05.033; Kim YK, 2011, J MOL BIOL, V410, P896, DOI 10.1016/j.jmb.2011.03.054; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; KUPCHAN SM, 1976, SCIENCE, V191, P571, DOI 10.1126/science.1251193; Laird GM, 2015, J CLIN INVEST, V125, P1901, DOI 10.1172/JCI80142; Liu PY, 2014, J BIOL CHEM, V289, P9918, DOI 10.1074/jbc.M113.539015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Massanella M, 2016, J CLIN INVEST, V126, P464, DOI 10.1172/JCI80567; Passos GF, 2013, EUR J PHARMACOL, V698, P413, DOI 10.1016/j.ejphar.2012.10.019; Raskin I, 2002, TRENDS BIOTECHNOL, V20, P522, DOI 10.1016/S0167-7799(02)02080-2; Rasmussen TA, 2013, HUM VACC IMMUNOTHER, V9, P993, DOI 10.4161/hv.23800; Routy JP, 2012, HIV MED, V13, P291, DOI 10.1111/j.1468-1293.2011.00975.x; SCHAUFELBERGER DE, 1991, J NAT PROD, V54, P1265, DOI 10.1021/np50077a004; Sedore SC, 2007, NUCLEIC ACIDS RES, V35, P4347, DOI 10.1093/nar/gkm443; Shi QW, 2008, CHEM REV, V108, P4295, DOI 10.1021/cr078350s; Spina CA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003834; Spivak AM, 2015, ANTIMICROB AGENTS CH; Taube R, 2013, VIRUSES-BASEL, V5, P902, DOI 10.3390/v5030902; Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471; UNAIDS, 2015, AIDS NUMB 2015; Wang C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142739; Wang LY, 2002, J NAT PROD, V65, P1246, DOI 10.1021/np0200921; Wei DG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004071; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xing F, 2012, J ETHNOPHARMACOL, V139, P343, DOI 10.1016/j.jep.2011.10.040; Yu WD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003146	59	29	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168027	10.1371/journal.pone.0168027	http://dx.doi.org/10.1371/journal.pone.0168027			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977742	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400050
J	Kouser, K; Lavanya, PG; Rangarajan, L; Kshitish, KA				Kouser, K.; Lavanya, P. G.; Rangarajan, Lalitha; Kshitish, Acharya K.			Effective Feature Selection for Classification of Promoter Sequences	PLOS ONE			English	Article							GENE-EXPRESSION; DNA; PREDICTION; MODES	Exploring novel computational methods in making sense of biological data has not only been a necessity, but also productive. A part of this trend is the search for more efficient in silico methods/tools for analysis of promoters, which are parts of DNA sequences that are involved in regulation of expression of genes into other functional molecules. Promoter regions vary greatly in their function based on the sequence of nucleotides and the arrangement of protein-binding short-regions called motifs. In fact, the regulatory nature of the promoters seems to be largely driven by the selective presence and/or the arrangement of these motifs. Here, we explore computational classification of promoter sequences based on the pattern of motif distributions, as such classification can pave a new way of functional analysis of promoters and to discover the functionally crucial motifs. We make use of Position Specific Motif Matrix (PSMM) features for exploring the possibility of accurately classifying promoter sequences using some of the popular classification techniques. The classification results on the complete feature set are low, perhaps due to the huge number of features. We propose two ways of reducing features. Our test results show improvement in the classification output after the reduction of features. The results also show that decision trees outperform SVM (Support Vector Machine), KNN (K Nearest Neighbor) and ensemble classifier LibD3C, particularly with reduced features. The proposed feature selection methods outperform some of the popular feature transformation methods such as PCA and SVD. Also, the methods proposed are as accurate as MRMR (feature selection method) but much faster than MRMR. Such methods could be useful to categorize new promoters and explore regulatory mechanisms of gene expressions in complex eukaryotic species.	[Kouser, K.; Lavanya, P. G.; Rangarajan, Lalitha] DoS Comp Sci, Mysore, Karnataka, India; [Kshitish, Acharya K.] IBAB, Biotech Pk, Bangalore, Karnataka, India; [Kshitish, Acharya K.] Shodhaka Life Sci Pvt Ltd, IBAB, Biotech Pk, Bangalore, Karnataka, India		Rangarajan, L (corresponding author), DoS Comp Sci, Mysore, Karnataka, India.	lalithar@compsci.uni-mysore.ac.in			private company Shodhaka Life Sciences Pvt. Ltd.	private company Shodhaka Life Sciences Pvt. Ltd.	This work/authors received no specific funding. The private company Shodhaka Life Sciences Pvt. Ltd. provided support in the form of assistance to one of the authors [AKK] in extracting and compiling some of the data, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This commercial affiliation also does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ALEXANDROV NN, 1990, NUCLEIC ACIDS RES, V18, P1847, DOI 10.1093/nar/18.7.1847; Bercher JF, 2006, AIP CONF PROC, V872, P235; Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902; Brieman L., 1998, CLASSIFICATION REGRE; Chan TM, 2010, IEEE C EVOL COMPUTAT; Chang CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022859; Deshpande M., 2002, Advances in Knowledge Discovery and Data Mining. 6th Pacific-Asia Conference, PAKDD 2002. Proceedings (Lecture Notes in Artificial Intelligence Vol.2336), P417; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Dong X, 2004, BIBE 2004: FOURTH IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, PROCEEDINGS, P483, DOI 10.1109/BIBE.2004.1317381; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, Journal of Machine Learning Research, V3, P1157, DOI 10.1162/153244303322753616; Hu QH, 2011, EXPERT SYST APPL, V38, P10737, DOI 10.1016/j.eswa.2011.01.023; Huang AC, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-20; Huang JP, 2010, COMPUT BIOL MED, V40, P698, DOI 10.1016/j.compbiomed.2010.06.004; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Kamath U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099982; Kingsford C, 2008, NAT BIOTECHNOL, V26, P1011, DOI 10.1038/nbt0908-1011; Kouser, 2015, PROCEDIA COMPUT SCI, V58, P356, DOI 10.1016/j.procs.2015.08.031; Kouser, 2015, LECT N BIOINFORMAT, V9044, P183, DOI 10.1007/978-3-319-16480-9_19; Kouser K, 2014, P 2014 INT C INT ADV, P37; Lazarevic A., 2001, NEUR NETW 2001 P IJC, V2, P796; LESLIE C, 2002, P PSB, V7, P566; Leung HCM, 2006, BIBE 2006: SIXTH IEEE SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, PROCEEDINGS, P70; Liang KC, 2007, IEEE ACM T COMPUT BI, V4, P430, DOI 10.1109/TCBB.2007.1027; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Liu B, 2016, MOL GENET GENOMICS, V291, P473, DOI 10.1007/s00438-015-1078-7; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, BIOINFORMATICS, V31, P1307, DOI 10.1093/bioinformatics/btu820; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Mathelier A, 2013, NUCLEIC ACIDS RES; Meera A., THESIS; Mitchell T.M, 2003, MACH LEARN; Murakami K, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-112; Pan F, 2004, J BIOMED INFORM, V37, P240, DOI 10.1016/j.jbi.2004.07.003; Pavlidis P, 2001, Pac Symp Biocomput, P151; PRESTRIDGE DS, 1995, J MOL BIOL, V249, P923, DOI 10.1006/jmbi.1995.0349; Qin YM, 2015, BIG DATA RES, V2, P12, DOI 10.1016/j.bdr.2015.02.005; Quinlan JR, 1993, C4 5 PROGRAMMING MAC, P38; Ratsch G, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S9; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Simon R, 2003, BRIT J CANCER, V89, P1599, DOI 10.1038/sj.bjc.6601326; Weston J, 2005, BIOINFORMATICS, V21, P3241, DOI 10.1093/bioinformatics/bti497; Wu SH, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041908; Xing Z., 2010, ACM SIGKDD EXPLOR NE, V12, P40, DOI DOI 10.1145/1882471.1882478; Yang JY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S3; Yang YH, 2005, BIOINFORMATICS, V21, P1084, DOI 10.1093/bioinformatics/bti108; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319	50	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167165	10.1371/journal.pone.0167165	http://dx.doi.org/10.1371/journal.pone.0167165			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978541	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400014
J	Mori, H; Kubo, M; Nishimura, R; Osako, T; Arima, N; Okumura, Y; Okido, M; Yamada, M; Kai, M; Kishimoto, J; Miyazaki, T; Oda, Y; Otsuka, T; Nakamura, M				Mori, Hitomi; Kubo, Makoto; Nishimura, Reiki; Osako, Tomofumi; Arima, Nobuyuki; Okumura, Yasuhiro; Okido, Masayuki; Yamada, Mai; Kai, Masaya; Kishimoto, Junji; Miyazaki, Tetsuyuki; Oda, Yoshinao; Otsuka, Takao; Nakamura, Masafumi			BRCAness as a Biomarker for Predicting Prognosis and Response to Anthracycline-Based Adjuvant Chemotherapy for Patients with Triple-Negative Breast Cancer	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; DEPENDENT PROBE AMPLIFICATION; PRIMARY THERAPY; NEOADJUVANT CHEMOTHERAPY; CLINICAL-FEATURES; AMERICAN-SOCIETY; BASAL-LIKE; PHASE-II; HIGHLIGHTS; SUBTYPES	Background Triple-negative breast cancer (TNBC) is a heterogeneous tumor that encompasses many different subclasses of the disease. In this study, we assessed BRCAness, defined as the shared characteristics between sporadic and BRCA1-mutated tumors, in a large cohort of TNBC cases. Methods The BRCAness of 262 patients with primary TNBCs resected between January 2004 and December 2014 was determined through the isolation of DNA from tumor tissue. Classification of BRCAness was performed using multiple ligation-dependent probe amplification (MLPA). The tumor subtypes were determined immunohistochemically using resected specimens. Results Of the 262 TNBCs, the results of the MLPA assays showed that 174 (66.4%) tumors had BRCAness. Patients with BRCAness tumors were younger than patients with non-BRCAness tumors (P = 0.003). There was no significant difference between the two groups regarding their pathological stages. The BRCAness group had a significantly shorter recurrence- free survival (RFS) compared with the non-BRCAness group (P = 0.04) and had a shorter overall survival (OS) although this did not reach statistical significance. Adjuvant treatments with anthracycline-based regimens provided significantly greater benefits to the BRCAness group (P = 0.003 for RFS, and P = 0.03 for OS). Multivariate Cox proportional hazard model analysis showed that BRCAness was an independent negative prognostic factor, and the anthracycline-based adjuvant chemotherapy was an independent positive prognostic factor for both RFS and OS in TNBC. Conclusions The 66.4% patients of TNBCs showed BRCAness. BRCAness is essential as a biomarker in the subclassification of TNBCs and might be of use for predicting their prognosis. Furthermore, this biomarker might be a predictive factor for the effectiveness of anthracycline-based adjuvant chemotherapy for patients with TNBCs.	[Mori, Hitomi; Kubo, Makoto; Yamada, Mai; Kai, Masaya; Otsuka, Takao; Nakamura, Masafumi] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka, Japan; [Nishimura, Reiki; Osako, Tomofumi] Kumamoto Shinto Gen Hosp, Breast Ctr, Kumamoto, Japan; [Arima, Nobuyuki] Kumamoto Shinto Gen Hosp, Dept Pathol, Kumamoto, Japan; [Okumura, Yasuhiro] Kumamoto City Hosp, Dept Breast & Endocrine Surg, Kumamoto, Japan; [Okido, Masayuki] Hamanomachi Hosp, Dept Surg, Fukuoka, Japan; [Kishimoto, Junji] Kyushu Univ, Dept Res & Dev Next Generat Med, Fac Med Sci, Fukuoka, Japan; [Miyazaki, Tetsuyuki; Oda, Yoshinao] Kyushu Univ, Dept Anat Pathol, Grad Sch Med Sci, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University	Kubo, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Oncol, Fukuoka, Japan.	mkubo@tumor.med.kyushu-u.ac.jp		Mori, Hitomi/0000-0002-5416-5869	Japan Society for the Promotion of Science, KAKENHI; Ministry of Education, Culture, Sports, Science and Technology, Japan [20591550]; World premier COE	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); World premier COE	This work was supported by the Japan Society for the Promotion of Science, KAKENHI, and by the budget demand from Ministry of Education, Culture, Sports, Science and Technology, Japan, Grant number 20591550, https://www.jsps.go.jp/j-grantsinaid/ to Makoto Kubo, and by World premier COE (core of excellence) formation for the treatment and research of pancreatic cancer (there is no grant number), http://www.mext.go.jp/en/ to Takao Otsuka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkevich V, 2012, BRIT J CANCER, V107, P1776, DOI 10.1038/bjc.2012.451; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Byrski T, 2009, BREAST CANCER RES TR, V115, P359, DOI 10.1007/s10549-008-0128-9; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Conforti R, 2007, ANN ONCOL, V18, P1477, DOI 10.1093/annonc/mdm209; Crown J, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds196; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Fostira F, 2012, BREAST CANCER RES TR, V134, P353, DOI 10.1007/s10549-012-2021-9; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gerratana L, 2016, CANCER TREAT REV, V48, P34, DOI 10.1016/j.ctrv.2016.06.004; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Isakoff SJ, 2015, J CLIN ONCOL, V33, P1902, DOI 10.1200/JCO.2014.57.6660; Joosse SA, 2009, BREAST CANCER RES TR, V116, P479, DOI 10.1007/s10549-008-0117-z; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lips EH, 2013, BRIT J CANCER, V108, P2172, DOI 10.1038/bjc.2013.144; Lips EH, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3049; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Miyoshi Y, 2010, BREAST CANCER-TOKYO, V17, P103, DOI 10.1007/s12282-009-0152-6; Oonk AMM, 2012, ANN ONCOL, V23, P2301, DOI 10.1093/annonc/mdr621; Petrelli F, 2014, BREAST CANCER RES TR, V144, P223, DOI 10.1007/s10549-014-2876-z; Prat A, 2014, BRIT J CANCER, V111, P1532, DOI 10.1038/bjc.2014.444; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Rakha EA, 2008, HUM PATHOL, V39, P857, DOI 10.1016/j.humpath.2007.10.011; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Silver DP, 2012, CANCER DISCOV, V2, P679, DOI 10.1158/2159-8290.CD-12-0221; Silver DP, 2010, J CLIN ONCOL, V28, P1145, DOI 10.1200/JCO.2009.22.4725; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Telli ML, 2016, CLIN CANCER RES, V22, P3764, DOI 10.1158/1078-0432.CCR-15-2477; Telli ML, 2015, J CLIN ONCOL, V33, P1895, DOI 10.1200/JCO.2014.57.0085; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vollebergh MA, 2011, ANN ONCOL, V22, P1561, DOI 10.1093/annonc/mdq624; Vollebergh MA, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3655; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984	42	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167016	10.1371/journal.pone.0167016	http://dx.doi.org/10.1371/journal.pone.0167016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977696	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400011
J	Nunez, D; Arias, VB; Campos, S				Nunez, D.; Arias, V. B.; Campos, S.			The Reliability and Validity of Liu's Self-Report Questionnaire for Screening Putative Pre-Psychotic States (BQSPS) in Adolescents	PLOS ONE			English	Article							OF-FIT INDEXES; HIGH-RISK; SUICIDAL IDEATION; COMMUNITY SAMPLE; ATTENUATED PSYCHOSIS; MENTAL-DISORDERS; EXPERIENCES; POPULATION; SYMPTOMS; SCHIZOPHRENIA	The usage of rigorous analyses based on contemporary methods to enhance psychometric properties of screening questionnaires aimed to address psychotic-like experiences (PLE) is currently being encouraged. The Brief Self-Report Questionnaire for Screening Putative Pre-psychotic States (BQSPS) is a recently created tool addressing PLE beyond attenuated positive symptoms (APS). Its psychometric properties as a screening tool for first step assessment seems to be adequate, but further research is needed to evaluate certain validity aspects, particularly its dimensionality, internal structure, and psychometric properties in different populations. We assessed the reliability, construct validity, and criterion validity of BQSPS in two samples: 727 adolescents aged 13-18 years, and 245 young adults aged 18-33 years. We used exploratory structural equation modeling (ESEM), confirmatory factor analysis (CFA), and Structural Equation Modeling (SEM). The original four-factor structure was not replicated. The best fit in adolescents was obtained by a structure of three-correlated factors: social anxiety (SA), negative symptoms (NS), and positive symptoms (PS). This structure was confirmed in young adult subjects. The three-factor model reached a predictive capability with suicidality as external criterion. PLE are represented by a three-factor structure, which is highly stable between adolescent and young-adult samples. Although the BQSPS seems to be a valid tool for screening PLE, its psychometric properties should be improved to obtain a more accurate measurement.	[Nunez, D.; Arias, V. B.; Campos, S.] Univ Talca, Fac Psychol, Talca, Chile	Universidad de Talca	Nunez, D (corresponding author), Univ Talca, Fac Psychol, Talca, Chile.	dnunez@utalca.cl	Arias, Victor B/R-6964-2018	Arias, Victor B/0000-0002-1260-7948; Nunez, Daniel/0000-0001-7091-2249				Addington J, 2015, EARLY INTERV PSYCHIA, V9, P345, DOI 10.1111/eip.12193; Armando M, 2010, SCHIZOPHR RES, V119, P258, DOI 10.1016/j.schres.2010.03.001; Barragan M, 2011, EUR PSYCHIAT, V26, P396, DOI 10.1016/j.eurpsy.2010.12.007; Capra C, 2015, PSYCHIAT RES, V228, P894, DOI 10.1016/j.psychres.2015.05.002; Capra C, 2013, SCHIZOPHR RES, V149, P104, DOI 10.1016/j.schres.2013.05.020; Chapman CL, 2015, ACTA PSYCHIAT SCAND, V131, P162, DOI 10.1111/acps.12359; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cicero DC, 2014, PSYCHOL ASSESSMENT, V26, P901, DOI 10.1037/a0036432; Daneault J, 2013, FRONTIERS PSYCHIAT, V4; Demmin D, 2015, EARLY INTERVENTION P; DeShong HL, 2015, PSYCHIAT RES, V226, P217, DOI 10.1016/j.psychres.2015.01.002; DeVylder JE, 2015, SOC PSYCH PSYCH EPID, V50, P1819, DOI 10.1007/s00127-015-1139-6; DeVylder JE, 2015, HEALTH SOC WORK, V40, P175, DOI 10.1093/hsw/hlv037; DeVylder JE, 2015, PSYCHIAT RES, V226, P489, DOI 10.1016/j.psychres.2015.02.007; DeVylder JE, 2015, JAMA PSYCHIAT, V72, P219, DOI 10.1001/jamapsychiatry.2014.2663; Fujita J, 2015, SCHIZOPHR RES, V168, P209, DOI 10.1016/j.schres.2015.07.028; Fusar-Poli P, 2015, WORLD PSYCHIATRY, V14, P322, DOI 10.1002/wps.20250; Fusar-Poli P, 2014, SCHIZOPHRENIA BULL, V40, P120, DOI 10.1093/schbul/sbs136; Fusar-Poli P, 2013, JAMA PSYCHIAT, V70, P107, DOI 10.1001/jamapsychiatry.2013.269; Grano N, 2015, PSYCHIAT RES, V225, P263, DOI 10.1016/j.psychres.2014.12.031; Honings S, 2016, PSYCHOL MED, V46, P237, DOI 10.1017/S0033291715001841; International Test Commission, 2006, INT J TESTING, V1, P93; Kelleher I, 2014, PSYCHOL MED, V44, P1615, DOI 10.1017/S0033291713002122; Kelleher I, 2012, PSYCHOL MED, V42, P1857, DOI 10.1017/S0033291711002960; Kelleher I, 2012, BRIT J PSYCHIAT, V201, P26, DOI 10.1192/bjp.bp.111.101543; Kelleher I, 2015, SCHIZOPHR RES, V165, P9, DOI 10.1016/j.schres.2015.03.020; Kelleher I, 2013, JAMA PSYCHIAT, V70, P940, DOI 10.1001/jamapsychiatry.2013.140; Keshavan MS, 2011, SCHIZOPHR RES, V126, P1, DOI 10.1016/j.schres.2010.10.006; Kline E, 2014, SCHIZOPHR RES, V158, P11, DOI 10.1016/j.schres.2014.06.036; Kline E, 2014, SCHIZOPHR RES, V152, P498, DOI 10.1016/j.schres.2013.12.012; Kline E, 2012, SCHIZOPHR RES, V134, P49, DOI 10.1016/j.schres.2011.10.001; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Koyanagi A, 2015, SCHIZOPHR RES, V168, P62, DOI 10.1016/j.schres.2015.07.041; Laurens KR, 2012, PSYCHOL MED, V42, P1495, DOI 10.1017/S0033291711002108; Liu CC, 2013, SCHIZOPHR RES, V143, P32, DOI 10.1016/j.schres.2012.10.042; Lorenzo-Seva U., 2006, METHODOLOGY, V2, P57, DOI [10.1027/1614-2241.2.2.57, DOI 10.1027/1614-2241.2.2.57]; Mark W, 2015, REV METAANALYSES SCH; Muniz J, 2013, PSICOTHEMA, V25, P151, DOI 10.7334/psicothema2013.24; Muthen L. K., 2014, MPLUS USERS GUIDE; Nishida A, 2014, SCHIZOPHR RES, V159, P257, DOI 10.1016/j.schres.2014.09.030; Nock MK, 2010, MOL PSYCHIATR, V15, P868, DOI 10.1038/mp.2009.29; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Nunez D, 2015, SCHIZOPHR RES, V165, P236, DOI 10.1016/j.schres.2015.04.018; OKASHA A, 1981, ACTA PSYCHIAT SCAND, V63, P409, DOI 10.1111/j.1600-0447.1981.tb00690.x; Owens DGC, 2006, PSYCHOL MED, V36, P1501; Owens DC, 2010, BRIT J PSYCHIAT, V196, P296, DOI 10.1192/bjp.bp.109.067694; Reininghaus U, 2013, SCHIZOPHRENIA BULL, V39, P884, DOI 10.1093/schbul/sbr182; Salvo GL, 2009, REV CHIL NEURO-PSIQU, V47, P16, DOI DOI 10.4067/S0717-92272009000100003; Seidman L, 2015, SCHIZOPHRENIA B, V41, P1; Stefanis N, 2002, EUROPEAN PSYCHIAT, V17, P61; Tandon N, 2012, NEUROPSYCHIATRY-LOND, V2, P345, DOI 10.2217/NPY.12.36; Therman S, 2016, PSYCHIAT RES, V235, P197, DOI 10.1016/j.psychres.2015.12.023; Thompson A, 2013, AUST NZ J PSYCHIAT, V47, P380, DOI 10.1177/0004867413476753; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P565, DOI 10.1093/oxfordjournals.schbul.a033478; Werbeloff N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119852; Werbeloff N, 2012, ARCH GEN PSYCHIAT, V69, P467, DOI 10.1001/archgenpsychiatry.2011.1580; Wigman JTW, 2012, SCHIZOPHRENIA BULL, V38, P247, DOI 10.1093/schbul/sbr196; Wigman JTW, 2011, SCHIZOPHRENIA BULL, V37, P850, DOI 10.1093/schbul/sbp154; Yung AR, 2009, AUST NZ J PSYCHIAT, V43, P118, DOI 10.1080/00048670802607188	60	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167982	10.1371/journal.pone.0167982	http://dx.doi.org/10.1371/journal.pone.0167982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973533	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300053
J	Lesieur, V; Martin, JF; Weaver, DK; Hoelmer, KA; Smith, DR; Morrill, WL; Kadiri, N; Peairs, FB; Cockrell, DM; Randolph, TL; Waters, DK; Bon, MC				Lesieur, Vincent; Martin, Jean-Francois; Weaver, David K.; Hoelmer, Kim A.; Smith, David R.; Morrill, Wendell L.; Kadiri, Nassera; Peairs, Frank B.; Cockrell, Darren M.; Randolph, Terri L.; Waters, Debra K.; Bon, Marie-Claude			Phylogeography of the Wheat Stem Sawfly, Cephus cinctus Norton (Hymenoptera: Cephidae): Implications for Pest Management	PLOS ONE			English	Article							COMPLETE MITOGENOMES; POPULATION-STRUCTURE; BIOLOGICAL-CONTROL; PYGMEUS L.; EVOLUTION; SOFTWARE; RESISTANCE; INFERENCE; GENETICS; CLUSTERS	The wheat stem sawfly, Cephus cinctus Norton (Hymenoptera: Cephidae), is a key pest of wheat in the northern Great Plains of North America, and damage resulting from this species has recently expanded southward. Current pest management practices are inadequate and uncertainty regarding geographic origin, as well as limited data on population structure and dynamics across North America impede progress towards more informed management. We examined the genetic divergence between samples collected in North America and northeastern Asia, the assumed native range of C. cinctus using two mitochondrial regions (COI and 16S). Subsequently, we characterized the structure of genetic diversity in the main wheat producing areas in North America using a combination of mtDNA marker and microsatellites in samples collected both in wheat fields and in grasses in wildlands. The strong genetic divergence observed between North American samples and Asian congeners, in particular the synonimized C. hyalinatus, did not support the hypothesis of a recent American colonization by C. cinctus. Furthermore, the relatively high genetic diversity both with mtDNA and microsatellite markers offered additional evidence in favor of the native American origin of this pest. The genetic diversity of North American populations is structured into three genetic clusters and these are highly correlated with geography. Regarding the recent southern outbreaks in North America, the results tend to exclude the hypothesis of recent movement of damaging wheat stem sawfly populations from the northern area. The shift in host plant use by local populations appears to be the most likely scenario. Finally, the significance of these findings is discussed in the context of pest management.	[Lesieur, Vincent; Bon, Marie-Claude] USDA ARS, European Biol Control Lab, 810 Ave Campus Agropolis, Montferrier Sur Lez, France; [Lesieur, Vincent; Martin, Jean-Francois] Montpellier SupAgro, UMR CBGP, 755 Ave Campus Agropolis, Montferrier Sur Lez, France; [Weaver, David K.; Morrill, Wendell L.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Hoelmer, Kim A.] USDA ARS, Beneficial Insects Introduct Res Unit, Newark, DE USA; [Smith, David R.] Smithsonian Inst, Systemat Entomol Lab, USDA ARS, Natl Museum Nat Hist, Washington, DC 20560 USA; [Kadiri, Nassera] Univ Paul Valery Montpellier 3, UMR CEFE 5175, Lab Zoogeog, Dept Biol Ecol Environm, Route Mende, Montpellier 5, France; [Peairs, Frank B.; Cockrell, Darren M.; Randolph, Terri L.] Colorado State Univ, Dept Bioagr Sci & Pest Management, Ft Collins, CO 80523 USA; [Waters, Debra K.] USDA ARS, Northern Plains Agr Res Lab, Sidney, MT USA	Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Montana State University System; Montana State University Bozeman; United States Department of Agriculture (USDA); Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; Colorado State University; United States Department of Agriculture (USDA)	Lesieur, V (corresponding author), USDA ARS, European Biol Control Lab, 810 Ave Campus Agropolis, Montferrier Sur Lez, France.; Lesieur, V (corresponding author), Montpellier SupAgro, UMR CBGP, 755 Ave Campus Agropolis, Montferrier Sur Lez, France.	vincent.lesieur@supagro.fr	Martin, Jean-Francois/M-9426-2017; Peairs, Frank B./R-5493-2018; Martin, Jean-Francois/AAD-3883-2019	Martin, Jean-Francois/0000-0001-9176-4476; Peairs, Frank B./0000-0002-6591-7958; Martin, Jean-Francois/0000-0001-9176-4476				Beauzay, 2010, INTEGRATED PEST MANA; Benson RB, 1950, T ACTIONS SOC BRIT E; Beres BL, 2011, CAN ENTOMOL, V143, P105, DOI 10.4039/n10-056; Bertheau C, 2013, MOL ECOL, V22, P3318, DOI 10.1111/mec.12296; Bon M-C, 2015, ANN ENTOMOLOGICAL SO; Budak M, 2011, ZOOKEYS, P363, DOI 10.3897/zookeys.130.1466; Castel G, 2014, VIRUSES-BASEL, V6, P1112, DOI 10.3390/v6031112; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chen S, 2004, J AGR URBAN ENTOMOLO, V2, P1; Criddle N., 1922, W WHEAT STEM SAWFLY, P1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DAVIS E. G., 1955, Bi-Monthly Bulletin. North Dakota Agricultural Experiment Station, V18, P63; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Duan Y, 2013, PLOS ONE, V8; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flagel LE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-195; Fletcher J., 1896, W WHEAT STEM SAWFLY, P147; Fresia P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076168; Fu YX, 1997, GENETICS, V147, P915; GOUDET J., 2001, FSTAT VERSION 2 9 3; Hartel KD, 2003, MOL ECOL NOTES, V3, P85, DOI 10.1046/j.1471-8286.2003.00359.x; Hitchcock AS, 1971, MANUAL GRASSES US; Hoddle MS, 2015, INSECTS, V6, P13, DOI 10.3390/insects6010013; Hoelmer KA, 2004, J AGR URBAN ENTOMOL, V21, P223; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Irell B, 2011, WHEAT STEM SAWFLY NE; Ivie MA, 1996, CAN ENTOMOL, V128, P347, DOI 10.4039/Ent128347-2; Ivie Michael A., 2001, American Entomologist, V47, P84; Johnson JR, 2007, GRASSLAND PLANTS S D; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kergoat GJ, 2015, ZOOL J LINN SOC-LOND, V175, P244, DOI 10.1111/zoj.12275; Kirk H, 2013, EVOL APPL, V6, P842, DOI 10.1111/eva.12071; Korkmaz EM, 2016, GENE, V576, P404, DOI 10.1016/j.gene.2015.10.050; Korkmaz EM, 2015, GENE, V558, P254, DOI 10.1016/j.gene.2014.12.069; Korkmaz EM, 2011, TURK J BIOL, V35, P713, DOI 10.3906/biy-1003-65; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Langella O., 1999, POPULATIONS 1 2 32; Leasi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104385; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lou KF, 1998, J HERED, V89, P329, DOI 10.1093/jhered/89.4.329; MACKAY MARGARET ROWLATT, 1955, CANADIAN JOUR ZOOL, V33, P161, DOI 10.1139/z55-011; McCullough C., 2016, DISPERSAL SAMPLING W; Michaud JP, 2013, WHEAT STEM SAWFLY; Middlekauff W. W., 1969, Bull. Calif. Insect. Surv., V11, P1; Modica MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102160; Norton E, 1872, T AM ENTOMOL SOC, V4, P77, DOI DOI 10.2307/25076265; Peairs FB, 2014, TR1407 COL AGR EXP S; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Mendoza J, 2006, ENVIRON ENTOMOL, V35, P1222, DOI 10.1603/0046-225X(2006)35[1222:TARHEO]2.0.CO;2; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Porretta D, 2007, J APPL ECOL, V44, P682, DOI 10.1111/j.1365-2664.2007.01301.x; Pritchard JK, 2000, GENETICS, V155, P945; Rand TA, 2015, CAN ENTOMOL, P1; Rand TA, 2016, BIOCONTROL SCI TECHN, V26, P61, DOI 10.1080/09583157.2015.1076377; Rand TA, 2014, AGR ECOSYST ENVIRON, V186, P135, DOI 10.1016/j.agee.2014.01.022; Rombaut A., 2012, FIGTREE V1 4 TREE FI; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Seamans, 1928, VALUE TRAP CROPS CON, P59; Shanower TG, 2004, J AGR URBAN ENTOMOL, V21, P197; Silva TL, 2015, MOL ECOL RESOUR, V15, P652, DOI 10.1111/1755-0998.12335; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smith DR, 2005, P ENTOMOL SOC WASH, V107, P864; Smith DR, 2002, P ENTOMOL SOC WASH, V104, P479; Smith DR., 1979, PRESS, V1, P1198; Steinfeld D., 2011, NATIV PLANTS J, V12, P269, DOI [10.3368/npj.12.3.269, DOI 10.3368/NPJ.12.3.269]; TAJIMA F, 1989, GENETICS, V123, P585; Talbert LE, 2014, PLANT BREEDING, V133, P427, DOI 10.1111/pbr.12184; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Varella AC, 2015, CROP SCI, V55, P2046, DOI 10.2135/cropsci2014.12.0852; Wallace L.E., 1966, STEM SAWFLIES EC IMP; Wares JP, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P229; Whitfield JB, 1998, MOL BIOL EVOL, V15, P1728, DOI 10.1093/oxfordjournals.molbev.a025899; Wilkinson K. M., 2008, Native Plants Journal, V9, P267, DOI 10.2979/NPJ.2008.9.3.267; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	82	31	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168370	10.1371/journal.pone.0168370	http://dx.doi.org/10.1371/journal.pone.0168370			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959958	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900061
J	de Oliveira, LH; Camacho, LAB; Coutinho, ESF; Martinez-Silveira, MS; Carvalho, AF; Ruiz-Matus, C; Toscano, CM				de Oliveira, Lucia Helena; Camacho, Luiz Antonio B.; Coutinho, Evandro S. F.; Martinez-Silveira, Martha S.; Carvalho, Ana Flavia; Ruiz-Matus, Cuauhtemoc; Toscano, Cristiana M.			Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review	PLOS ONE			English	Review							CHILDHOOD PNEUMONIA HOSPITALIZATIONS; STREPTOCOCCUS-PNEUMONIAE; DISEASE; 10-VALENT; BURDEN; BRAZIL; VACCINATION; MENINGITIS; EFFICACY; YOUNGER	Background Several Latin American and Caribbean (LAC) countries have introduced pneumococcal conjugate vaccine (PCV-10 or PCV-13) in their routine national immunization programs. Objectives We aimed to summarize the evidence of PCV impact and effectiveness in children under 5 years old in the LAC Region. Methods We conducted a systematic review of the literature on impact or effectiveness of PCVs on deaths or hospitalizations due to invasive pneumococcal disease (IPD), pneumonia, meningitis and sepsis. We searched Medline, WoS, Lilacs, Scopus, Central and gray literature published in any language from 2009 to January 2016. We included studies addressing the outcomes of interest in children in the target age group, and with the following designs: randomized trials, cohort or case-control, interrupted time series with at least three data points before and after the intervention, and before-after studies. Screening of citations, data extraction, and risk of bias assessment were conducted in duplicate by independent reviewers, according to the study protocol registered on PROSPERO. Descriptive analysis of the effectiveness measurements and sensitivity analysis were conducted. Effectiveness is reported as 1-OR or 1-RR for case control or cohort/clinical trials, and as percent change of disease incidence rates for before-after studies. Results We identified 1,085 citations, 892 from databases and 193 from other sources. Of these, 22 were further analyzed. Studies were from Brazil, Chile, Uruguay, Argentina, Peru and Nicaragua. Effectiveness ranged from 8.8-37.8% for hospitalizations due to X-ray confirmed pneumonia, 7.4-20.6% for clinical pneumonia, and 13.3-87.7% for meningitis hospitalizations, and 56-83.3% for IPD hospitalization, varying by age, outcome definition, type of vaccine and study design. Conclusions Available evidence to date indicates significant impact of both PCV-10 and PCV-13 in the outcomes studied, with no evidence of the superiority of one vaccine over the other on pneumonia, IPD or meningitis hospitalization reduction in children under 5 years old.	[de Oliveira, Lucia Helena; Ruiz-Matus, Cuauhtemoc] World Hlth Org PAHO, Pan Amer Hlth Org, Immunizat Unit FGL, Washington, DC 20037 USA; [Camacho, Luiz Antonio B.; Coutinho, Evandro S. F.] Oswaldo Cruz Fdn Fiocruz, Natl Publ Hlth Sch ENSP, Dept Epidemiol & Quantitat Methods Hlth, Rio De Janeiro, Brazil; [Martinez-Silveira, Martha S.] Oswaldo Cruz Fdn Fiocruz, Goncalo Moniz Inst, Salvador, BA, Brazil; [Carvalho, Ana Flavia] Sabin Vaccine Inst, Vaccine Advocacy & Educ, Washington, DC USA; [Toscano, Cristiana M.] Fed Univ Goias UFG, Inst Trop Pathol & Publ Hlth IPTSP, Goiania, Go, Brazil	Pan American Health Organization; World Health Organization; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Goias	de Oliveira, LH (corresponding author), World Hlth Org PAHO, Pan Amer Hlth Org, Immunizat Unit FGL, Washington, DC 20037 USA.	oliveirl@paho.org	Martinez-Silveira, Martha Silvia/O-7270-2014	Martinez-Silveira, Martha Silvia/0000-0002-1004-1784; TOSCANO, CRISTIANA/0000-0002-9453-2643; Coutinho, Evandro/0000-0002-4649-7353	Pan American Health Organization; Sabin Vaccine Institute	Pan American Health Organization; Sabin Vaccine Institute	The study was funded by the Pan American Health Organization and the Sabin Vaccine Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso ET, 2013, EMERG INFECT DIS, V19, P589, DOI 10.3201/eid1904.121198; Andrade AL, 2015, 33 ANN EUR SOC PAED, P1101; Andrade AL, 2015, 33 ANN EUR SOC PAED, P250; Andrade AL, 2016, HUM VACC IMMUNOTHER, V12, P285, DOI 10.1080/21645515.2015.1117713; Andrade AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098128; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P129; Azevedo J, 2015, 115 ANN M AM SOC MIC; Becker-Dreps S, 2013, PNEUM VACC CHILDR AD, P319; Becker-Dreps S, 2014, PEDIATR INFECT DIS J, V33, P637, DOI 10.1097/INF.0000000000000269; Berglund A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112211; Bonner K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135270; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; de Oliveira LH, 2016, EXPERT REV VACCINES, V30, P1; de Oliveira LH, 2013, VACCINE, V31, pC114, DOI 10.1016/j.vaccine.2013.05.032; Deceuninck G, 2015, VACCINE, V33, P2684, DOI 10.1016/j.vaccine.2015.04.005; Diaz J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153141; Domingues CMAS, 2014, LANCET RESP MED, V2, P464, DOI 10.1016/S2213-2600(14)70060-8; Domingues CMA., 2014, PNEUMONIA, V3, P145; Gabarrot GG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112337; Gentile A, 2015, PED BACT INF IDWEEK, P1234; Gentile A J., 2014, CONTR PNEUM DIS GLOB, V3, P168; Gentile A, 2015, ARCH ARGENT PEDIATR, V113, P502, DOI [10.5546/aap.2015.eng.502, 10.5546/aap.2015.502]; Gladstone RA, 2011, J MED MICROBIOL, V60, P1, DOI 10.1099/jmm.0.020016-0; Grando IM, 2015, CAD SAUDE PUBLICA, V31, P276, DOI 10.1590/0102-311X00169913; Greenberg D, 2015, VACCINE, V33, P4623, DOI 10.1016/j.vaccine.2015.06.062; Guevara M, 2016, EURO SURVEILL, V21; Hanquet G, 2013, VACCINE, V31, P5634, DOI 10.1016/j.vaccine.2013.07.006; Hirose TE, 2015, J PEDIAT-BRAZIL, V91, P130, DOI 10.1016/j.jped.2014.07.002; Hortal M, 2014, 9 INT S PNEUM PNEUM, V3, P142; Hortal M, 2015, WORLD J VACCINES, V5, P37, DOI [10.4236/wjv.2015.51005, DOI 10.4236/WJV.2015.51005]; Hortal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098567; Instituto de Salud Pu A blica de Chile, 2015, B I SALUD PUBICA CHI, V5, P1; Johns Hopkins Bloomberg School of Public Health International Vaccine Access Center, 2016, STAT PCV US IMP EV S; Lawley CM, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-8; Liphaus B, 2012, 8 INT S PNEUM PNEUM, P619; Loo JD, 2014, PEDIATR INFECT DIS J, V33, pS140, DOI 10.1097/INF.0000000000000082; Lucero MG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004977.pub2; Minamisava R, 2014, PNEUMONIA, V3, P248; Moreira M, 2016, VACCINE, V34, P2766, DOI 10.1016/j.vaccine.2016.04.006; National Institutes of Health, 2014, QUAL ASS TOOL PREP S; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Palmu AA, 2015, PEDIATRICS, V136, pE22, DOI 10.1542/peds.2015-0458; Pan American Health Organization, 2015, 23 TAG M 2015 1 3 JU; Pan American Health Organization, 2011, 19 TAG M 2011 JUL 6; Pinto L, 2013, PED RESP EP 23 ANN C; Principi N, 2015, EXPERT REV VACCINES, V14, P1359, DOI 10.1586/14760584.2015.1075884; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Rearte A, 2015, 9 WORLD C WORLD SOC, P73; Rodrigues LC, 1999, EPIDEMIOL REV, V21, P56, DOI 10.1093/oxfordjournals.epirev.a017988; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Russell F, 2012, 8 INT S PNEUM PNEUM, P352; Sagradini S, 2013, REV ARGENT SALUD PUB, V4, P45; Sanderson S, 2007, INT J EPIDEMIOL, V36, P666, DOI 10.1093/ije/dym018; Sartori AM, 2015, REV SAUDE PUBLICA, V49; Scotta MC, 2014, VACCINE, V32, P4495, DOI 10.1016/j.vaccine.2014.06.042; Sgambatti S, 2014, 32 ANN EUR SOC PAED; Sgambatti S, 2016, VACCINE, V34, P663, DOI 10.1016/j.vaccine.2015.12.007; Sinha A, 2008, REV PANAM SALUD PUBL, V24, P304, DOI 10.1590/S1020-49892008001100002; Sterne J.A., 2008, COCHRANE HDB SYSTEMA, DOI [10.1002/9780470712184.ch10, DOI 10.1002/9780470712184.CH10]; Suarez V, 2016, VACCINE, V34, P4738, DOI 10.1016/j.vaccine.2016.07.027; Valenzuela MT, 2009, REV PANAM SALUD PUBL, V25, P270, DOI 10.1590/S1020-49892009000300011; Valenzuela MT, 2014, REV CHIL INFECTOL, V31, P651, DOI 10.4067/S0716-10182014000600002; Verani JR, 2015, VACCINE; Vizzotti C, 2014, GLOB PNEUM DIS POL C, V3, P244; Vizzotti C, 2014, GLOB PNEUM DIS POL C, V3, P243; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Wells GA, 2014, NEWCASTLEOTTAWA SCAL; Zhou FJ, 2007, ARCH PEDIAT ADOL MED, V161, P1162, DOI 10.1001/archpedi.161.12.1162	69	82	83	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0166736	10.1371/journal.pone.0166736	http://dx.doi.org/10.1371/journal.pone.0166736			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941979	gold, Green Submitted, Green Published			2022-12-27	WOS:000392745600005
J	Lukhele, BW; Techasrivichien, T; Suguimoto, SP; Musumari, PM; El-saaidi, C; Haumba, S; Tagutanazvo, OB; Ono-Kihara, M; Kihara, M				Lukhele, Bhekumusa Wellington; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Musumari, Patou Masika; El-saaidi, Christina; Haumba, Samson; Tagutanazvo, Oslinah Buru; Ono-Kihara, Masako; Kihara, Masahiro			Structural and Behavioral Correlates of HIV Infection among Pregnant Women in a Country with a Highly Generalized HIV Epidemic: A Cross-Sectional Study with a Probability Sample of Antenatal Care Facilities in Swaziland	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SEXUAL RISK; REPRODUCTIVE HEALTH; POVERTY; FAMILY; MEN; COMMUNICATION; DETERMINANTS; PARTNERSHIPS; ASSOCIATION	Introduction HIV disproportionately affects women in Sub-Saharan Africa. Swaziland bears the highest HIV prevalence of 41% among pregnant women in this region. This heightened HIV-epidemic reflects the importance of context-specific interventions. Apart from routine HIV surveillance, studies that examine structural and behavioral factors associated with HIV infection among women may facilitate the revitalization of existing programs and provide insights to inform context-specific HIV prevention interventions. Methods and Findings This cross-sectional study employed a two-stage random cluster sampling in ten antenatal health care facilities in the Hhohho region of Swaziland in August and September 2015. Participants were eligible for the study if they were 18 years or older and had tested for HIV. Self-administered tablet-based questionnaires were used to assess HIV risk factors. Of all eligible pregnant women, 827 (92.4%) participated, out of which 297 (35.9%) were self-reportedly HIV positive. Among structural factors, family function was not significantly associated with self-reported HIV positive status, while lower than high school educational attainment (AOR, 1.65; CI, 1.14-3.38; P = 0.008), and income below minimum wage (AOR, 1.81; CI, 1.09-3.01; P = 0.021) were significantly associated with self-reported HIV positive status. Behavioral factors significantly associated with reporting a positive HIV status included; >= 2 lifetime sexual partners (AOR, 3.16; CI, 2.00-5.00; P< 0.001), and ever cohabited (AOR, 2.39; CI, 1.66-3.43; P = 0.00). The most cited reason for having multiple sexual partners was financial gain. HIV/AIDS-related knowledge level was high but not associated to self-reported HIV status (P = 0.319). Conclusions Structural and behavioral factors showed significant association with self-reported HIV infection among pregnant women in Swaziland while HIV/AIDS-related knowledge and family function did not. This suggests that HIV interventions should be reinforced taking into consideration these findings. The findings also suggest the importance of future research sensitive to the Swazi and African sociocultural contexts, especially research for family function.	[Lukhele, Bhekumusa Wellington; Techasrivichien, Teeranee; Suguimoto, S. Pilar; Musumari, Patou Masika; El-saaidi, Christina; Ono-Kihara, Masako; Kihara, Masahiro] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan; [Suguimoto, S. Pilar] Kyoto Univ, Grad Sch Med, Ctr Med Educ, Kyoto, Japan; [Haumba, Samson] Univ Res Co LLC, Ctr Human Serv, Mbabane, Eswatini; [Tagutanazvo, Oslinah Buru] Univ Swaziland, Dept Midwifery Sci, Fac Hlth Sci, Mbabane, Eswatini	Kyoto University; Kyoto University	Lukhele, BW (corresponding author), Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Global Hlth & Socioepidemiol, Kyoto, Japan.	bhekie.l@gmail.com	el-saaidi, christina/AGS-1983-2022	Suguimoto, S. Pilar/0000-0002-8447-9172; Lukhele, Bhekumusa Wellington/0000-0001-6429-638X				Ahmed S, 2001, AIDS, V15, P2171, DOI 10.1097/00002030-200111090-00013; [Anonymous], 2005, GLOB COAL WOM AIDS E, P4; Armistead L, 2014, HEALTH PSYCHOL, V33, P668, DOI 10.1037/hea0000067; Bell CC, 2008, J NATL MED ASSOC, V100, P936, DOI 10.1016/S0027-9684(15)31408-5; Bicego GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077101; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; Central Intelligence Agency, 2011, WORLD FACTB COUNTR C; Central Statistical Office, 2015, SWAZ MULT IND CLUST; Central Statistical Office (CSO) [Swaziland] and Macro Internationa Inc, 2007, SWAZ DEM HLTH SURV 2; Central Statistical Office UNICEF., 2011, SWAZ MULT IND CLUST; Chersich MF, 2008, AIDS, V22, pS27, DOI 10.1097/01.aids.0000341775.94123.75; Cluver LD, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20646; Creswell J, 2003, HDB MIXED METHODS DE, P209; Crosby RA, 2003, ARCH PEDIAT ADOL MED, V157, P169, DOI 10.1001/archpedi.157.2.169; DiClemente RJ, 2001, PEDIATRICS, V107, P1363, DOI 10.1542/peds.107.6.1363; Dunkle KL, 2008, LANCET, V371, P2183, DOI 10.1016/S0140-6736(08)60953-8; FHI/Impact Behavioural Surveillance Surveys (BSS), 2000, GUID REP BEH SURV PO; Fielding-Miller R, 2016, SOC SCI MED, V148, P25, DOI 10.1016/j.socscimed.2015.11.024; Fielding-Miller R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-79; Fox AM, 2010, PUBLIC HEALTH REP, V125, P16, DOI 10.1177/00333549101250S405; Fox J, 2010, ANTIVIR RES, V85, P276, DOI 10.1016/j.antiviral.2009.10.012; Fry K., 2014, MEASURING EQUITY NAT; Hammond RJ, 2010, SOCIOLOGY FAMILY; Handa S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085473; Hardee K, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18619; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Heywood W, 2015, ARCH SEX BEHAV, V44, P531, DOI 10.1007/s10508-014-0374-3; Huebner AJ, 2003, J ADOLESCENT HEALTH, V33, P71, DOI 10.1016/S1054-139X(03)00141-1; International Labour Office, 2005, BRIEF OCTOBER 2005 H; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2012, WOM OUT LOUD WOM LIV, P1; Kalichman SC, 2007, PREV SCI, V8, P141, DOI 10.1007/s11121-006-0061-2; Kish L, 1965, SURVEY SAMPLING; Lama TT, 2016, PREV SCI, V17, P227, DOI 10.1007/s11121-015-0607-2; Ma QQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-111; Magadi MA, 2013, AIDS BEHAV, V17, P1645, DOI 10.1007/s10461-012-0217-y; Markham CM, 2010, J ADOLESCENT HEALTH, V46, pS23, DOI 10.1016/j.jadohealth.2009.11.214; Masanjala W, 2007, SOC SCI MED, V64, P1032, DOI 10.1016/j.socscimed.2006.10.009; Mbirimtengerenji ND, 2007, CROAT MED J, V48, P605; Mercer CH, 2013, AM J EPIDEMIOL, V178, P249, DOI 10.1093/aje/kws467; Michael Kohn S, 2015, SAMPLE SIZE CALCULAT; Ministry of Health, 2013, SERV AV MAPP REP 201; Ministry of Health Swaziland, 2011, 12 NAT HIV SER WOM A; Mngadi S, 2009, SWAZILAND HIV PREVEN; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; National AIDS Control Council, 2014, KEN AIDS STRAT FRAM, P1; National Emergency Response Council on HIV/AIDS, 2011, SWAZ HEARS ETHN STUD; NERCHA, 2014, EXT NAT MULT HIV AID; Nkhambule M, 2008, HIV PREVENTION MULTI; Olson DH, 2004, FAMILY ADAPTABILITY; Parkhurst JO, 2010, B WORLD HEALTH ORGAN, V88, P519, DOI 10.2471/BLT.09.070185; Paul S., 2008, SAMPLING POPULATIONS; Pequegnat W, 2012, FAMILY AND HIV/AIDS: CULTURAL AND CONTEXTUAL ISSUES IN PREVENTION AND TREATMENT, P1, DOI 10.1007/978-1-4614-0439-2; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Pettifor A, 2009, INT PERSPECT SEX R H, V35, P82, DOI [10.1363/3508209, 10.1363/ifpp.35.082.09]; Piot P, 2015, LANCET, V386, P171, DOI 10.1016/S0140-6736(15)60658-4; Ramjee G, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-30; Republic of Namibia Ministry of Health and Social Services, 2015, NAM AIDS RESP PROGR; Risher K, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18715; Ruark A, 2014, AJAR-AFR J AIDS RES, V13, P133, DOI 10.2989/16085906.2014.927781; Sacolo HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067289; Sawers L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17431; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Statistics South Africa, 2015, S AFR MID POP EST 20; Stephen B. H., 2007, DESIGNING CLIN RES; Sullivan PS, 2005, PUBLIC HEALTH REP, V120, P230, DOI 10.1177/003335490512000304; Techasrivichien T, 2016, ARCH SEX BEHAV, V45, P367, DOI 10.1007/s10508-014-0429-5; The World Bank, HIV AIDS ED; Thoma BC, 2014, AIDS BEHAV, V18, P1604, DOI 10.1007/s10461-014-0717-z; UNAIDS, 2014, AIDS EPIDEMIOLOGY, P1; UNAIDS, 2013, ACC ANT THER AFR 201, P1; UNDP Swaziland, 2007, SWAZ HUM DEV REP HIV; UNICEF, 2013, STATISTICS; Voisin DR, 2002, AM J ORTHOPSYCHIAT, V72, P294, DOI 10.1037/0002-9432.722.294; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wamoyi J, 2015, CULT HEALTH SEX, V17, P718, DOI 10.1080/13691058.2014.992044; Wamoyi J, 2014, AJAR-AFR J AIDS RES, V13, P169, DOI 10.2989/16085906.2014.945387; Wamoyi J, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-6; Whiteside A, 2003, WHAT IS DRIVING HIV; World Health Organization, 2014, World Health Organ Tech Rep Ser, P1	79	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168140	10.1371/journal.pone.0168140	http://dx.doi.org/10.1371/journal.pone.0168140			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27942014	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600054
J	Kitagori, K; Yoshifuji, H; Oku, T; Sasaki, C; Miyata, H; Mori, KP; Nakajima, T; Ohmura, K; Kawabata, D; Yukawa, N; Imura, Y; Murakami, K; Nakashima, R; Usui, T; Fujii, T; Sakai, K; Yanagita, M; Hirayama, Y; Mimori, T				Kitagori, Koji; Yoshifuji, Hajime; Oku, Takuma; Sasaki, Chiyomi; Miyata, Hitomi; Mori, Keita P.; Nakajima, Toshiki; Ohmura, Koichiro; Kawabata, Daisuke; Yukawa, Naoichiro; Imura, Yoshitaka; Murakami, Kosaku; Nakashima, Ran; Usui, Takashi; Fujii, Takao; Sakai, Kaoru; Yanagita, Motoko; Hirayama, Yoshitaka; Mimori, Tsuneyo			Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis	PLoS One			English	Article							NEPHROTIC SYNDROME; REVISED CRITERIA; IN-VITRO; ERYTHEMATOSUS; GLOMERULONEPHRITIS; CLASSIFICATION; EXPRESSION; PATHOGENESIS; NEPHROPATHY; PROGRESSION	We assessed the utility of two forms of osteopontin (OPN), OPN full and its cleaved form (OPN N-half), in plasma and urine as markers of disease activity in lupus nephritis (LN). Samples were collected from patients with systemic lupus erythematosus (SLE) (LN: N = 29, non-LN: N = 27), IgA nephropathy (IgAN) (N = 14), minimal change nephrotic syndrome (MCNS) (N = 5), diabetic nephropathy (DN) (N = 14) and healthy volunteers (HC) (N = 17). While there was no significant difference in urine OPN full concentration between groups, urine OPN N-half concentration was significantly higher in patients with LN than HC (p < 0.05). Moreover, urine OPN N-half was higher in LN patients with overt proteinuria (urine protein/creatinine ratio: P/C > 0.5) than LN patients with minimal proteinuria (P/C < 0.5, p < 0.0001), and also higher than in DN patients with overt proteinuria (P/C > 0.5, p < 0.01). Urine thrombin activity correlated with urine OPN N-half concentration (p < 0.0001), but not with urine OPN full concentration. These results suggest that urine OPN N-half concentration reflects renal inflammation. Thus, urine OPN N-half may be a novel disease activity marker for LN.	[Kitagori, Koji; Yoshifuji, Hajime; Nakajima, Toshiki; Ohmura, Koichiro; Kawabata, Daisuke; Imura, Yoshitaka; Murakami, Kosaku; Nakashima, Ran; Usui, Takashi; Fujii, Takao; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Oku, Takuma; Sasaki, Chiyomi; Hirayama, Yoshitaka] Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Grad Sch Med, Kyoto, Japan; [Oku, Takuma; Sasaki, Chiyomi; Hirayama, Yoshitaka] Astellas Pharma Inc, Res Portfolio & Sci, Tokyo, Japan; [Miyata, Hitomi; Mori, Keita P.; Sakai, Kaoru; Yanagita, Motoko] Kyoto Univ, Grad Sch Med, Dept Nephrol, Kyoto, Japan; [Yukawa, Naoichiro; Fujii, Takao] Wakayama Med Univ, Dept Rheumatol & Clin Immunol, Wakayama, Japan	Kyoto University; Kyoto University; Astellas Pharmaceuticals; Kyoto University; Wakayama Medical University	Yoshifuji, H (corresponding author), Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan.	yossii@kuhp.kyoto-u.ac.jp	Yanagita, Motoko/AAJ-7731-2021; Yoshifuji, Hajime/AAZ-1657-2020; Kosaku, Murakami/T-8806-2019; Sakai, Kaoru/HGE-2792-2022	Yanagita, Motoko/0000-0002-0339-9008	Special Coordination Funds for Promoting Science and Technology of the Japanese Government; Astellas Pharma Inc. in the Formation of Innovation Center for Fusion of Advanced Technologies Program	Special Coordination Funds for Promoting Science and Technology of the Japanese Government; Astellas Pharma Inc. in the Formation of Innovation Center for Fusion of Advanced Technologies Program	This work was supported in part by the Special Coordination Funds for Promoting Science and Technology of the Japanese Government and in part by Astellas Pharma Inc. in the Formation of Innovation Center for Fusion of Advanced Technologies Program. Publication of this article was approved by an intellectual property committee composed of representatives from Kyoto University and Astellas Pharma Inc. TO, CS and YH are employees of Astellas Pharma Inc. The funder provided support in the form of salaries for authors (see above), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Cornell LD., 2011, DIAGNOSTIC PATHOLOGY, P142; Daniel V, 1997, CLIN NEPHROL, V47, P289; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Gang X, 2001, AM J KIDNEY DIS, V37, P374, DOI 10.1053/ajkd.2001.21316; Hertig A, 2004, J AM SOC NEPHROL, V15, P844, DOI 10.1097/01.ASN.0000115400.52705.83; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Ihara H, 2001, J BIOL CHEM, V276, P13065, DOI 10.1074/jbc.M010938200; Ikeuchi H, 2016, MOD RHEUMATOL, P1; Kitamoto Y, 2004, ANN CLIN BIOCHEM, V41, P133, DOI 10.1258/000456304322880023; Kon S, 2008, J EXP MED, V205, P25, DOI 10.1084/jem.20071324; Naito T, 2000, J AM SOC NEPHROL, V11, P2243, DOI 10.1681/ASN.V11122243; O'Regan AW, 1999, J IMMUNOL, V162, P1024; Okada H, 2000, AM J KIDNEY DIS, V36, P498, DOI 10.1053/ajkd.2000.9790; PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145; Qiong L, 2010, CHIN J DERMATOL, V43; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Rullo OJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4150; Sahali D, 2002, J AM SOC NEPHROL, V13, P1238, DOI 10.1681/ASN.V1351238; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Tahir S, 2015, J IMMUNOL, V194, P5725, DOI 10.4049/jimmunol.1500319; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558; Yamaguchi H, 2004, ENDOCR J, V51, P499, DOI 10.1507/endocrj.51.499; YAMAMOTO S, 1995, ANN NY ACAD SCI, V760, P378, DOI 10.1111/j.1749-6632.1995.tb44662.x	29	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167141	10.1371/journal.pone.0167141	http://dx.doi.org/10.1371/journal.pone.0167141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992535	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600011
J	Marmerola, GD; Oikawa, MA; Dias, Z; Goldenstein, S; Rocha, A				Marmerola, Guilherme D.; Oikawa, Marina A.; Dias, Zanoni; Goldenstein, Siome; Rocha, Anderson			On the Reconstruction of Text Phylogeny Trees: Evaluation and Analysis of Textual Relationships	PLOS ONE			English	Article							FORESTS	Over the history of mankind, textual records change. Sometimes due to mistakes during transcription, sometimes on purpose, as a way to rewrite facts and reinterpret history. There are several classical cases, such as the logarithmic tables, and the transmission of antique and medieval scholarship. Today, text documents are largely edited and redistributed on the Web. Articles on news portals and collaborative platforms (such as Wikipedia), source code, posts on social networks, and even scientific publications or literary works are some examples in which textual content can be subject to changes in an evolutionary process. In this scenario, given a set of near-duplicate documents, it is worthwhile to find which one is the original and the history of changes that created the whole set. Such functionality would have immediate applications on news tracking services, detection of plagiarism, textual criticism, and copyright enforcement, for instance. However, this is not an easy task, as textual features pointing to the documents' evolutionary direction may not be evident and are often dataset dependent. Moreover, side information, such as time stamps, are neither always available nor reliable. In this paper, we propose a framework for reliably reconstructing text phylogeny trees, and seamlessly exploring new approaches on a wide range of scenarios of text reusage. We employ and evaluate distinct combinations of dissimilarity measures and reconstruction strategies within the proposed framework, and evaluate each approach with extensive experiments, including a set of artificial near-duplicate documents with known phylogeny, and from documents collected from Wikipedia, whose modifications were made by Internet users. We also present results from qualitative experiments in two different applications: text plagiarism and reconstruction of evolutionary trees for manuscripts (stemmatology).	[Marmerola, Guilherme D.; Oikawa, Marina A.; Dias, Zanoni; Goldenstein, Siome; Rocha, Anderson] Univ Estadual Campinas, Inst Comp, Campinas, SP, Brazil	Universidade Estadual de Campinas	Rocha, A (corresponding author), Univ Estadual Campinas, Inst Comp, Campinas, SP, Brazil.	anderson.rocha@ic.unicamp.br	UNICAMP, CCES -/J-7787-2015		Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPQ - National Counsel of Technological and Scientific Development, CNPq [483370/2013-4, 304472/2015-8]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2014/19401-8, 2013/08293-7, 2014/13433-5, 2014/03535-5, 2015/19222-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior / COFECUB Program [831/15]; Air Force Research Laboratory (AFRL) [FA8750-16-2-0173]; DARPA	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPQ - National Counsel of Technological and Scientific Development, CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior / COFECUB Program; Air Force Research Laboratory (AFRL)(United States Department of DefenseUS Air Force Research Laboratory); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The authors received funding from: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPQ - National Counsel of Technological and Scientific Development (http://cnpq.br/), CNPq #483370/2013-4 ZD, CNPq #304472/2015-8 AR; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (http://www.fapesp.br/en/), #2014/19401-8 ZD, #2013/08293-7 ZD, #2014/13433-5 GM, #2014/03535-5 MO, #2015/19222-9 AR; and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (http://www.capes.gov.br) / COFECUB Program, #831/15 ZD, #Deep Eyes Project AR. In addition, part of this material is based on research sponsored by DARPA and Air Force Research Laboratory (AFRL) under agreement number FA8750-16-2-0173. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews Nicholas, 2012, P 2012 JOINT C EMP M, P344; Babbage C., 1827, MEMOIRS ASTRONOMICAL, V3, P65; Baugh Wesley, WIKIPEDIA EXTRACTOR; Bosch A, 2007, IEEE I CONF COMP VIS, P1863; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cebrian M, 2005, COMMUN INF SYST, V5, P367; Cilibrasi R, 2005, IEEE T INFORM THEORY, V51, P1523, DOI 10.1109/TIT.2005.844059; Clough P, 2011, LANG RESOUR EVAL, V45, P5, DOI 10.1007/s10579-009-9112-1; Costa F, 2015, P INT C IM IN PRESS; Costa FD, 2014, IEEE T INF FOREN SEC, V9, P1533, DOI 10.1109/TIFS.2014.2340017; Cuadros AM, 2007, IEEE CONF VIS ANAL, P99, DOI 10.1109/VAST.2007.4389002; Davies M., 2008, N GRAMS DATA CORPUS; Dias Z., 2010, IEEE INT WORKSH INF, P1; Dias Z, 2010, IEEE INT WORKS INFOR; Dias Z, 2013, J VIS COMMUN IMAGE R, V24, P1124, DOI 10.1016/j.jvcir.2013.07.011; Dias Z, 2013, FORENSIC SCI INT, V231, P178, DOI 10.1016/j.forsciint.2013.05.002; Dias Z, 2012, IEEE T INF FOREN SEC, V7, P774, DOI 10.1109/TIFS.2011.2169959; Dolan William B, 2005, P INT WORKSH PAR; Dumitras T, 2011, P 4 C CYB SEC EXP TE, P1; Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133; Gislason PO, 2006, PATTERN RECOGN LETT, V27, P294, DOI 10.1016/j.patrec.2005.08.011; Goldberg LA, 1998, J ALGORITHM, V26, P188, DOI 10.1006/jagm.1997.0897; Grozea C, 2010, LECT NOTES COMPUT SC, V6008, P700, DOI 10.1007/978-3-642-12116-6_59; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Howe CJ, 2001, TRENDS GENET, V17, P147, DOI 10.1016/S0168-9525(00)02210-1; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Ji JH, 2008, INT J CONTROL AUTOM, V6, P809; Ji JH, 2007, P 2 INT C DIG INF MA, P98; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Joly A, 2007, IEEE T MULTIMEDIA, V9, P293, DOI 10.1109/TMM.2006.886278; Karim ME, 2005, J COMPUT VIROL HACKI, V1, P13, DOI 10.1007/s11416-005-0002-9; Kruskal J.B., 1956, P AM MATH SOC, V7, P48, DOI [10.1090/S0002-9939-1956-0078686-7, DOI 10.1090/S0002-9939-1956-0078686-7, 10.2307/2033241]; Lai PH, 2010, IEEE INT SYMP INFO, P1403, DOI 10.1109/ISIT.2010.5513627; Leskovec J, 2014, MINING OF MASSIVE DATASETS, 2ND EDITION, P1; Liu Z, 2013, REUTER 50 50 DATA SE; Loper, 2009, NATURAL LANGUAGE PRO; Manning CD, 2008, INTRO INFORM RETRIEV; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mitton R., 1985, CORPORA MISSPELLINGS; Nawab Rao Muhammad Adeel, 2012, Advances in Information Retrieval. Proceedings of the 34th European Conference on IR Research (ECIR 2012), P207, DOI 10.1007/978-3-642-28997-2_18; Nucci M, 2013, IEEE INT WORKSH MULT, P99, DOI 10.1109/MMSP.2013.6659271; O'Brien MJ, 2002, EVOL ANTHROPOL, V11, P26, DOI 10.1002/evan.10007; Oliveira A, 2014, IEEE IMAGE PROC, P5347, DOI 10.1109/ICIP.2014.7026082; OSUNA E, 1997, PROC CVPR IEEE, P130, DOI DOI 10.1109/CVPR.1997.609310; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Reeds J., 2006, J DEE INTERDISCIPLIN, DOI [10.1007/1-4020-4246-9, DOI 10.1007/1-4020-4246-9]; Roos T, 2008, COMPUTER ASSISTED ST; Roos T, 2009, LIT LINGUIST COMPUT, V24, P417, DOI 10.1093/llc/fqp002; Ryu CK, 2008, 2008 IEEE 8TH INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION TECHNOLOGY, VOLS 1 AND 2, P119, DOI 10.1109/CIT.2008.4594660; Ryu CK, 2009, ACM S APPL COMPUTING, P863; Scheirer W, 2014, SENSE CONNE IN PRESS; Shrestha P, 2015, LECT NOTES COMPUT SC, V9042, P643, DOI 10.1007/978-3-319-18117-2_48; Spencer M., 2003, Literary & Linguistic Computing, V18, P407, DOI 10.1093/llc/18.4.407; Spencer M, 2004, J THEOR BIOL, V227, P503, DOI 10.1016/j.jtbi.2003.11.022; Sumi R., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P724, DOI 10.1109/PASSAT/SocialCom.2011.47; Tehrani J, 2002, J ANTHROPOL ARCHAEOL, V21, P443, DOI 10.1016/S0278-4165(02)00002-8; van Mulken M, 2004, STUDIES STEMMATOLOGY, VII; Viegas F., 2004, P 2004 C HUMAN FACTO, P575, DOI DOI 10.1145/985692.985765; Wattel E, 1996, STUDIES STEMMATOLOGY, P105; WU S, 1990, INFORM PROCESS LETT, V35, P317, DOI 10.1016/0020-0190(90)90035-V	60	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167822	10.1371/journal.pone.0167822	http://dx.doi.org/10.1371/journal.pone.0167822			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992446	Green Submitted, gold, Green Published			2022-12-27	WOS:000392842600023
J	Qi, QQ; Guo, CG; Ji, R; Li, Z; Zuo, XL; Li, YQ				Qi, Qingqing; Guo, Chuanguo; Ji, Rui; Li, Zhen; Zuo, Xiuli; Li, Yanqing			Diagnostic Performance of Magnifying Endoscopy for Helicobacter pylori Infection: A Meta-Analysis	PLOS ONE			English	Article							GASTRIC-MUCOSA; HISTOLOGIC GASTRITIS; CLASSIFICATION; PATTERNS; FEATURES; STOMACH; RISK; TOOL	Background Diagnosis of Helicobacter pylori (H. pylori) infection using magnifying endoscopy offers advantages over conventional invasive and noninvasive tests. Objective This meta-analysis aimed to assess the diagnostic performance of magnifying endoscopy in the prediction of H. pylori infection. Methods A literature search of the PubMed, Medline, EMBASE, Science Direct and the Cochrane Library databases was performed. A random-effects model was used to calculate the diagnostic efficiency of magnifying endoscopy for H. pylori infection. A summary receiver operator characteristic curve was plotted, and the area under the curve (AUC) was calculated. Results A total of 18 studies involving 1897 patients were included. The pooled sensitivity and specificity of magnifying endoscopy to predict H. pylori infection were 0.89 [95% confidence interval (CI) 0.87-0.91] and 0.82 (95%CI10.79-0.85), respectively, with an AUC of 0.9461. When targeting the gastric antrum, the pooled sensitivity and specificity were 0.82 (95%CI10.780.86) and 0.72 (95%CI10.66-0.78), respectively. When targeting the gastric corpus, the pooled sensitivity and specificity were 0.92 (95%CI10.90-0.94) and 0.86 (95%CI10.82-0.88), respectively. The pooled sensitivity and specificity using magnifying white light endoscopy were 0.90 (95%CI10.87-0.91) and 0.81 (95%CI10.77-0.84), respectively. The pooled sensitivity and specificity using magnifying chromoendoscopy were 0.87 (95%CI10.83-0.91) and 0.85 (95%Cl 0.80-0.88), respectively. The "pit plus vascular pattern" classification in the gastric corpus observed by magnifying endoscopy was able to accurately predict the status of H. pylori infection, as indicated by a pooled sensitivity and specificity of 0.96 (95%CI1 0.94-0.97) and 0.91 (95%CI10.87-0.93), respectively, with an AUC of 0.9872. Conclusions Magnifying endoscopy was able to accurately predict the status of H. pylori infection, either in magnifying white light endoscopy or magnifying chromoendoscopy mode. The "pit plus vascular pattern" classification in the gastric corpus is an optimum diagnostic criterion.	[Qi, Qingqing; Guo, Chuanguo; Ji, Rui; Li, Zhen; Zuo, Xiuli; Li, Yanqing] Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Shandong, Peoples R China	Shandong University	Li, YQ (corresponding author), Shandong Univ, Qilu Hosp, Dept Gastroenterol, Jinan, Shandong, Peoples R China.	liyanqing@sdu.edu.cn	Li, Zhen/HHM-3328-2022; Guo, Chuanguo/GWU-8356-2022; Li, Zhen/AAH-2515-2022; Li, Zhen/AFK-5293-2022	Li, Zhen/0000-0002-9783-169X; 	National Natural Science Foundation of China [81330012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study is supported by National Natural Science Foundation of China (Grant No. 81330012). URL: www.nsfc.gov.cn/publish/portal1/. The author YQL received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostopoulos GK, 2007, ENDOSCOPY, V39, P202, DOI 10.1055/s-2006-945056; BAH A, 1995, ENDOSCOPY, V27, P593, DOI 10.1055/s-2007-1005764; Bansal A, 2008, GASTROINTEST ENDOSC, V67, P210, DOI 10.1016/j.gie.2007.06.009; Chen XY, 1999, J CLIN PATHOL, V52, P612, DOI 10.1136/jcp.52.8.612; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Cirak MY, 2007, HELICOBACTER, V12, P4, DOI 10.1111/j.1523-5378.2007.00542.x; Egi Y, 2006, DIGEST DIS SCI, V51, P1582, DOI 10.1007/s10620-005-9046-4; Gonen C, 2009, HELICOBACTER, V14, P12, DOI 10.1111/j.1523-5378.2009.00650.x; Higashi R, 2010, GASTROINTEST ENDOSC, V72, P127, DOI 10.1016/j.gie.2010.01.054; Kawamura M, 2013, WORLD J GASTROENTERO, V19, P9392, DOI 10.3748/wjg.v19.i48.9392; KHAKOO SI, 1994, GUT, V35, P1172, DOI 10.1136/gut.35.9.1172; Kim S, 2004, DIGEST LIVER DIS, V36, P286, DOI 10.1016/j.dld.2003.09.021; Kim S, 2006, J GASTROEN HEPATOL, V21, P837, DOI 10.1111/j.1440-1746.2006.04193.x; LAINE L, 1995, GASTROINTEST ENDOSC, V42, P420, DOI 10.1016/S0016-5107(95)70043-9; Liu H, 2014, DIGEST DIS SCI, V59, P1513, DOI 10.1007/s10620-014-3027-4; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nakagawa S, 2003, GASTROINTEST ENDOSC, V58, P71, DOI 10.1067/mge.2003.316; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Patel SK, 2014, WORLD J GASTROENTERO, V20, P12847, DOI 10.3748/wjg.v20.i36.12847; Pohl J, 2007, ENDOSCOPY, V39, P80, DOI 10.1055/s-2006-945045; Qi QQ, 2013, J DIGEST DIS, V14, P579, DOI 10.1111/1751-2980.12086; Redeen S, 2003, ENDOSCOPY, V35, P946, DOI 10.1055/s-2003-43479; Tahara T, 2009, GASTROINTEST ENDOSC, V70, P246, DOI 10.1016/j.gie.2008.11.046; Uedo N, 2006, ENDOSCOPY, V38, P819, DOI 10.1055/s-2006-944632; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Yagi K, 2005, ENDOSCOPY, V37, P660, DOI 10.1055/s-2005-861423; Yagi K, 2002, J GASTROEN HEPATOL, V17, P39, DOI 10.1046/j.1440-1746.2002.02665.x; Yagi K, 2002, ENDOSCOPY, V34, P376, DOI 10.1055/s-2002-25281; Yagi K, 2014, HELICOBACTER, V19, P111, DOI 10.1111/hel.12104; YAMADA T, 1994, JAMA-J AM MED ASSOC, V272, P65, DOI 10.1001/jama.272.1.65; Yang JM, 2003, WORLD J GASTROENTERO, V9, P2552; Zhang JN, 2008, GASTROINTEST ENDOSC, V67, P843, DOI 10.1016/j.gie.2008.01.036	33	11	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168201	10.1371/journal.pone.0168201	http://dx.doi.org/10.1371/journal.pone.0168201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992489	Green Submitted, gold, Green Published			2022-12-27	WOS:000392842600041
J	Cao, LX; Weetall, M; Bombard, J; Qi, HY; Arasu, T; Lennox, W; Hedrick, J; Sheedy, J; Risher, N; Brooks, PC; Trifillis, P; Trotta, C; Moon, YC; Babiak, J; Almstead, NG; Colacino, JM; Davis, TW; Peltz, SW				Cao, Liangxian; Weetall, Marla; Bombard, Jenelle; Qi, Hongyan; Arasu, Tamil; Lennox, William; Hedrick, Jean; Sheedy, Josephine; Risher, Nicole; Brooks, Peter C.; Trifillis, Panayiota; Trotta, Christopher; Moon, Young-Choon; Babiak, John; Almstead, Neil G.; Colacino, Joseph M.; Davis, Thomas W.; Peltz, Stuart W.			Discovery of Novel Small Molecule Inhibitors of VEGF Expression in Tumor Cells Using a Cell-Based High Throughput Screening Platform	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INTERNAL RIBOSOME ENTRY; FACTOR MESSENGER-RNA; TRANSLATION INITIATION COMPLEX; URIDINE-RICH ELEMENTS; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; CANCER-THERAPY; IN-VIVO; HYPOXIA	Current anti-VEGF (Vascular Endothelial Growth Factor A) therapies to treat various cancers indiscriminately block VEGF function in the patient resulting in the global loss of VEGF signaling which has been linked to dose-limiting toxicities as well as treatment failures due to acquired resistance. Accumulating evidence suggests that this resistance is at least partially due to increased production of compensatory tumor angiogenic factors/cytokines. VEGF protein production is differentially controlled depending on whether cells are in the normal "homeostatic" state or in a stressed state, such as hypoxia, by post-transcriptional regulation imparted by elements in the 5' and 3' untranslated regions (UTR) of the VEGF mRNA. Using the Gene Expression Modulation by Small molecules (GEMS (TM)) phenotypic assay system, we performed a high throughput screen to identify low molecular weight compounds that target the VEGF mRNA UTR-mediated regulation of stress-induced VEGF production in tumor cells. We identified a number of compounds that potently and selectively reduce endogenous VEGF production under hypoxia in HeLa cells. Medicinal chemistry efforts improved the potency and pharmaceutical properties of one series of compounds resulting in the discovery of PTC-510 which inhibits hypoxia-induced VEGF expression in HeLa cells at low nanomolar concentration. In mouse xenograft studies, oral administration of PTC-510 results in marked reduction of intratumor VEGF production and single agent control of tumor growth without any evident toxicity. Here, we show that selective suppression of stress-induced VEGF production within tumor cells effectively controls tumor growth. Therefore, this approach may minimize the liabilities of current global anti-VEGF therapies.	[Cao, Liangxian; Weetall, Marla; Bombard, Jenelle; Qi, Hongyan; Arasu, Tamil; Lennox, William; Hedrick, Jean; Sheedy, Josephine; Risher, Nicole; Trifillis, Panayiota; Trotta, Christopher; Moon, Young-Choon; Babiak, John; Almstead, Neil G.; Colacino, Joseph M.; Davis, Thomas W.; Peltz, Stuart W.] PTC Therapeut Inc, South Plainfield, NJ 07080 USA; [Brooks, Peter C.] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA; [Arasu, Tamil] US FDA, Parsippany, NJ USA; [Davis, Thomas W.] PMV Pharmaceut Inc, Cedar Brook Corp Ctr, Cranbury Township, NJ USA	Maine Medical Center; US Food & Drug Administration (FDA)	Cao, LX (corresponding author), PTC Therapeut Inc, South Plainfield, NJ 07080 USA.	lcao@ptcbio.com			NIH [2 R44 CA108330-02]; PTC Therapeutics, Inc.	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PTC Therapeutics, Inc.	This program was partially supported by funding from NIH to JMC and LXC (2 R44 CA108330-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors [LC, MW, WL, JH, JS, NR, PT, CT, YM, JBabiak, NA, JMC, TD and SP], have received funding support for the conduct of this study and have also received salary compensation for time, effort, and reimbursed travel expenses related to data discussions and presentations from PTC Therapeutics, Inc. The specific roles of these authors are articulated in the 'author contributions' section.	Akiri G, 1998, ONCOGENE, V17, P227, DOI 10.1038/sj.onc.1202019; Arcondeguy T, 2013, NUCLEIC ACIDS RES, V41, P7997, DOI 10.1093/nar/gkt539; Bhattacharyya A, 2007, DRUG DISCOV TODAY, V12, P553, DOI 10.1016/j.drudis.2007.05.009; Bornes S, 2004, J BIOL CHEM, V279, P18717, DOI 10.1074/jbc.M308410200; Braunstein S, 2009, MOL CELL BIOL, V29, P5645, DOI 10.1128/MCB.00711-09; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Brooks PC, 1999, METH MOL B, V129, P257; Cammas A, 2015, RNA BIOL, V12, P320, DOI 10.1080/15476286.2015.1017236; Duda DG, 2007, TRENDS MOL MED, V13, P223, DOI 10.1016/j.molmed.2007.04.001; ERNST TJ, 1989, LEUKEMIA, V3, P620; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, ONCOLOGY-BASEL, V69, P11, DOI 10.1159/000088479; GOLDBERG MA, 1991, BLOOD, V77, P271; Houzet L, 2001, BLOOD, V98, P1281, DOI 10.1182/blood.V98.5.1281; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Huez I, 2001, MOL ENDOCRINOL, V15, P2197, DOI 10.1210/me.15.12.2197; Ilouga PE, 2012, J BIOMOL SCREEN, V17, P705, DOI 10.1177/1087057112441623; Kadenhe-Chiweshe A, 2008, MOL CANCER RES, V6, P1, DOI 10.1158/1541-7786.MCR-07-0101; Kasprzak A, 2013, INT J ONCOL, V42, P305, DOI 10.3892/ijo.2012.1706; Kawai M, 2010, ENDOCRINOLOGY, V151, P4861, DOI 10.1210/en.2010-0407; Khatri NI, 2012, CRIT REV THER DRUG, V29, P487, DOI 10.1615/CritRevTherDrugCarrierSyst.v29.i6.20; Konicek BW, 2008, CELL CYCLE, V7, P2466, DOI 10.4161/cc.7.16.6464; Levy AP, 1996, J BIOL CHEM, V271, P2746, DOI 10.1074/jbc.271.5.2746; Levy NS, 1997, BBA-GENE STRUCT EXPR, V1352, P167, DOI 10.1016/S0167-4781(97)00052-3; Lu Kan V, 2013, CNS Oncol, V2, P49; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; Meadows KL, 2012, PERSPECT MED, V2; Miller DL, 1998, FEBS LETT, V434, P417, DOI 10.1016/S0014-5793(98)01025-4; Mullard A, 2015, NAT REV DRUG DISCOV, V14, P807, DOI 10.1038/nrd4783; Nabors LB, 2001, CANCER RES, V61, P2154; Packer RJ, 2015, J NEURO-ONCOL, V121, P217, DOI 10.1007/s11060-014-1665-1; Pelletier J, 2015, CANCER RES, V75, P250, DOI 10.1158/0008-5472.CAN-14-2789; Rapisarda A, 2012, ADV CANCER RES, V114, P237, DOI 10.1016/B978-0-12-386503-8.00006-5; Ribatti D., 2016, ONCOTARGET; Richards Lisa, 2011, Nat Rev Clin Oncol, V8, P194, DOI 10.1038/nrclinonc.2011.28; Roodhart JM, 2008, CURR CLIN PHARMACOL, V3, P132, DOI 10.2174/157488408784293705; Sambrook J., 2001, MOL CLONING LAB MANU; Scandurro AB, 1998, BIOCHEM BIOPH RES CO, V246, P436, DOI 10.1006/bbrc.1998.8639; Shim MS, 2010, FEBS J, V277, P4814, DOI 10.1111/j.1742-4658.2010.07904.x; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Story MT, 1996, PROSTATE, V28, P219; Tandle Anita, 2003, Clin Adv Hematol Oncol, V1, P41; Tang XR, 2013, J CELL MOL MED, V17, P386, DOI 10.1111/jcmm.12020; Villar HO, 2009, EXPERT OPIN DRUG DIS, V4, P1215, DOI 10.1517/17460440903397368; Walters B, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00128; Wang EH, 1997, CANCER RES, V57, P5426; Weetall M, 2016, CLIN PHARM DRUG DEV, V5, P296, DOI 10.1002/cpdd.240; Yao P, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001635; Zheng W, 2013, DRUG DISCOV TODAY, V18, P1067, DOI 10.1016/j.drudis.2013.07.001	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168366	10.1371/journal.pone.0168366	http://dx.doi.org/10.1371/journal.pone.0168366			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992500	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000042
J	Dovom, MR; Tehrani, FR; Djalalinia, S; Cheraghi, L; Gandavani, SB; Azizi, F				Dovom, Marzieh Rostami; Tehrani, Fahimeh Ramezani; Djalalinia, Shirin; Cheraghi, Leila; Gandavani, Samira Behboudi; Azizi, Fereidoun			Menstrual Cycle Irregularity and Metabolic Disorders: A Population-Based Prospective Study	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; CORONARY-HEART-DISEASE; IMPAIRED GLUCOSE-TOLERANCE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; INCREASED RISK; WOMEN; ENDOCRINE; WEIGHT; ASSOCIATION	The regularity of menstrual cycles is considered an indicator of women's reproductive health. Previous studies with a cross-sectional design have documented the relationship between menstrual cycle irregularities, insulin-resistance and the future risks for metabolic disorders. Limited data documented by prospective studies can lead to premature conclusions regarding the relationship between menstrual cycle irregularities and other conditions influencing women's health. The present study therefore, using a prospective design aimed to assess the risk of metabolic disorders in women with a history of irregular menstrual cycles, was based on the data gathered from the Tehran Lipid and Glucose study (TLGS) an ongoing prospective cohort study initiated in 1999. Participants of the current study were 2128 women, aged between 18-49 years, followed for 15 years. Based on their menstrual cycles, the women were divided into two groups: (i) women with regular menstrual cycles (n = 1749), and (ii) those with irregular menstrual cycles (n = 379). The proportional COX regression model was used to compare hazard ratios (HRs) between the groups for the proposed events, including diabetes mellitus (DM), pre-diabetes (pre-DM), hypertension (HTN), pre-hypertension (pre-HTN) and dyslipidemia. It was found that during a 15-year follow up, there were 123 cases of DM, 456 cases of pre-DM, 290 cases of HTN, 481 cases of pre-HTN, and 402 cases of dyslipidemia. Compared to those with regular cycles, women with irregular menstrual cycles were found to have an increased risk for DM2 (age adjusted Hazard Ratios (HRs), 2.01; 95% confidence intervals (CI: 1.59-3.50), the increased risk for DM, associated with irregular cycles remained significant after the adjustment for Body Mass Index (BMI), fasting blood sugar (FBS), family history of diabetes, and parity (HRS, 1.73; 95% CI: 1.14-2.64). There was no significant difference in the increased risk for pre-DM between the groups (age adjusted HRs, 1.33, 95% CI: 1.05-1.69). However, after the adjustment of BMI, FBS and family history of pre-DM, compared to those with regular menstrual cycles, irregular menstrual cycles showed an increased risk for pre-DM (HRs, 1.33; 95% CI: 1.05-1.69). No statistically significant difference was found in the increasing risk for other proposed events between the groups demonstrating that menstrual cycle irregularities could be considered a marker of metabolic disorders and a predisposing factor of the increased risk for diabetes mellitus and pre-diabetes in women with irregular menstrual cycles.	[Dovom, Marzieh Rostami; Tehrani, Fahimeh Ramezani; Gandavani, Samira Behboudi] Shahid Beheshti Univ Med Sci, Reprod Endocrinol Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Djalalinia, Shirin] Univ Tehran Med Sci, Noncommunicable Dis Res Ctr, Endocrinol & Metab Res Inst, Tehran, Iran; [Djalalinia, Shirin] Dev Res Technol Ctr, Deputy Res & Technol, Minist Hlth & Med Educ, Tehran, Iran; [Cheraghi, Leila] Shahid Beheshti Univ Med Sci, Res Inst Endocrine Sci, Dept Biostatist & Epidemiol, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran	Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Ministry of Health & Medical Education (MOHME); Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Tehrani, FR (corresponding author), Shahid Beheshti Univ Med Sci, Reprod Endocrinol Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.	ramezani@endocrine.ac.ir	Tehrani, Fahimeh Ramezani/H-6133-2017; Azizi, Fereidoun/ABD-4136-2021; Dovom, Marzieh Rostami/AAD-7225-2020	Tehrani, Fahimeh Ramezani/0000-0002-4609-065X; Azizi, Fereidoun/0000-0002-6470-2517; Behboudi-Gandevani, Samira/0000-0003-3526-640X				Amato MC, 2015, J ENDOCRINOL INVEST, V38, P1319, DOI 10.1007/s40618-015-0372-x; American Diabetes Association, 2016, DIABETES CARE S1, V39; Azizi F, 2002, SOZ PRAVENTIV MED, V47, P408, DOI 10.1007/s000380200008; Beckers NGM, 2002, FERTIL STERIL, V78, P291, DOI 10.1016/S0015-0282(02)03227-2; Bozorgmanesh M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-100; Buccola JM, 2003, PRIMARY CARE, V30, P697, DOI 10.1016/S0095-4543(03)00089-7; Carmina E, 2013, HUM REPROD, V28, P2245, DOI 10.1093/humrep/det119; Carter AN, 2016, AM J CARDIOVASC DIS, V6, P129; Cibula D, 2000, HUM REPROD, V15, P785, DOI 10.1093/humrep/15.4.785; Committee on Practice BulletinsGynecology, 2012, Obstet Gynecol, V120, P197, DOI 10.1097/AOG.0b013e318262e320; Cupisti S, 2008, EUR J ENDOCRINOL, V158, P711, DOI 10.1530/EJE-07-0515; Du DF, 2013, INT J CLIN EXP MED, V6, P880; DUNAIF A, 1987, J CLIN ENDOCR METAB, V65, P499, DOI 10.1210/jcem-65-3-499; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gast GCM, 2010, FERTIL STERIL, V94, P2379, DOI 10.1016/j.fertnstert.2010.03.044; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hadaegh F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149780; Hosseinpanah F, 2011, CLIN ENDOCRINOL, V75, P692, DOI 10.1111/j.1365-2265.2011.04113.x; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Lo JC, 2006, J CLIN ENDOCR METAB, V91, P1357, DOI 10.1210/jc.2005-2430; Momenan AA, 2011, INT J PREVENTIVE MED, V2, P243; Mueller NT, 2013, BJOG-INT J OBSTET GY, V120, P1483, DOI 10.1111/1471-0528.12364; Nejat A, 2014, CLIN BIOCHEM, V47, P1239, DOI 10.1016/j.clinbiochem.2014.03.004; Nicholson WK, 2006, DIABETES CARE, V29, P2349, DOI 10.2337/dc06-0825; Panidis D, 2013, EUR J ENDOCRINOL, V168, P145, DOI 10.1530/EJE-12-0655; Pannacciulli N, 2003, DIABETES CARE, V26, P1230, DOI 10.2337/diacare.26.4.1230; Pereira M A, 1997, Med Sci Sports Exerc, V29, pS1; Rao SS, 2004, AM FAM PHYSICIAN, V69, P1961; ROBINSON S, 1993, CLIN ENDOCRINOL, V39, P351, DOI 10.1111/j.1365-2265.1993.tb02376.x; Roney JR, 2013, HORM BEHAV, V63, P636, DOI 10.1016/j.yhbeh.2013.02.013; Salagre S B, 2016, J Assoc Physicians India, V64, P22; Silverthorn DU, 2013, HUMAN PHYSL INTEGRAT, V6a; Solomon CG, 2002, J CLIN ENDOCR METAB, V87, P2013, DOI 10.1210/jc.87.5.2013; Solomon CG, 2001, JAMA-J AM MED ASSOC, V286, P2421, DOI 10.1001/jama.286.19.2421; Strowitzki T, 2010, EUR J OBSTET GYN R B, V149, P178, DOI 10.1016/j.ejogrb.2009.12.024; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Talbott E, 1998, J CLIN EPIDEMIOL, V51, P415, DOI 10.1016/S0895-4356(98)00010-9; Tehrani FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137609; Tehrani FR, 2014, HUM REPROD, V29, P2522, DOI 10.1093/humrep/deu249; Vrbikova J, 2005, HUM REPROD, V20, P3328, DOI 10.1093/humrep/dei221; Wang ET, 2011, J CLIN ENDOCR METAB, V96, pE114, DOI 10.1210/jc.2010-1709; Welt CK, 2006, J CLIN ENDOCR METAB, V91, P4842, DOI 10.1210/jc.2006-1327; WILD RA, 1988, AM J OBSTET GYNECOL, V159, P423, DOI 10.1016/S0002-9378(88)80099-1; Wild S, 2000, CLIN ENDOCRINOL, V52, P595, DOI 10.1046/j.1365-2265.2000.01000.x; World Health Organization (WHO), 2009, GLOB PHYS ACT SURV; Zadeh-Vakili A, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-18	48	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168402	10.1371/journal.pone.0168402	http://dx.doi.org/10.1371/journal.pone.0168402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992506	gold, Green Published, Green Submitted			2022-12-27	WOS:000392758000047
J	Beaudoin, G; Rafanoharana, S; Boissiere, M; Wijaya, A; Wardhana, W				Beaudoin, Guillaume; Rafanoharana, Serge; Boissiere, Manuel; Wijaya, Arief; Wardhana, Wahyu			Completing the Picture: Importance of Considering Participatory Mapping for REDD plus Measurement, Reporting and Verification (MRV)	PLOS ONE			English	Article							LAND-COVER; FOREST; GIS; ACCURACY; BENEFITS	Remote sensing has been widely used for mapping land cover and is considered key to monitoring changes in forest areas in the REDD+ Measurement, Reporting and Verification (MRV) system. But Remote Sensing as a desk study cannot capture the whole picture; it also requires ground checking. Therefore, complementing remote sensing analysis using participatory mapping can help provide information for an initial forest cover assessment, gain better understanding of how local land use might affect changes, and provide a way to engage local communities in REDD+. Our study looked at the potential of participatory mapping in providing complementary information for remotely sensed maps. The research sites were located in different ecological and socio-economic contexts in the provinces of Papua, West Kalimantan and Central Java, Indonesia. Twenty-one maps of land cover and land use were drawn with local community participation during focus group discussions in seven villages. These maps, covering a total of 270,000ha, were used to add information to maps developed using remote sensing, adding 39 land covers to the eight from our initial desk assessment. They also provided additional information on drivers of land use and land cover change, resource areas, territory claims and land status, which we were able to correlate to understand changes in forest cover. Incorporating participatory mapping in the REDD+ MRV protocol would help with initial remotely sensed land classifications, stratify an area for ground checks and measurement plots, and add other valuable social data not visible at the RS scale. Ultimately, it would provide a forum for local communities to discuss REDD+ activities and develop a better understanding of REDD+.	[Beaudoin, Guillaume; Rafanoharana, Serge; Boissiere, Manuel; Wijaya, Arief] Ctr Int Forestry Res CIFOR, Jl CIFOR, Bogor, Indonesia; [Boissiere, Manuel] Ctr Cooperat Int Rech Agron Dev CIRAD, Campus Baillarguet, Montpellier 6, France; [Wardhana, Wahyu] GadjahMada Univ UGM, Fac Forestry, Jl Agro Bulaksumur 1, Sleman Yogyakarta, Indonesia	CGIAR; Center for International Forestry Research (CIFOR); CIRAD	Boissiere, M (corresponding author), Ctr Int Forestry Res CIFOR, Jl CIFOR, Bogor, Indonesia.; Boissiere, M (corresponding author), Ctr Cooperat Int Rech Agron Dev CIRAD, Campus Baillarguet, Montpellier 6, France.	m.boissiere@cgiar.org	; Wijaya, Arief/L-8405-2015	BOISSIERE, Manuel/0000-0002-2552-7664; Wijaya, Arief/0000-0001-6165-0144	U.S. Agency for International Development (USAID) [MTO069018]; Norwegian Agency for Development (NORAD) [GLO-3945, QZA 12/0882]	U.S. Agency for International Development (USAID)(United States Agency for International Development (USAID)); Norwegian Agency for Development (NORAD)(CGIAR)	The authors acknowledge the U.S. Agency for International Development (USAID) grant number MTO069018 and the Norwegian Agency for Development (NORAD) grant number GLO-3945, QZA 12/0882 for their financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulharis R., 2014, FIG C 2014 ENG CHALL; [Anonymous], 2011, USITC PUBL; [Anonymous], 2013, GOFC GOLD SOURC METH; Asner G, 2014, HIGH RESOLUTION CARB; Torres AB, 2014, FORESTS, V5, P1815, DOI 10.3390/f5081815; Balram S, 2004, BIODIVERS CONSERV, V13, P1195, DOI 10.1023/B:BIOC.0000018152.11643.9c; Boissiere M, 2014, FORESTS, V5, P1855, DOI 10.3390/f5081855; Brofeldt S, 2014, FORESTS, V5, P1834, DOI 10.3390/f5081834; Brown G, 2014, LANDSCAPE URBAN PLAN, V122, P196, DOI 10.1016/j.landurbplan.2013.11.007; Burgess ND, 2010, ORYX, V44, P339, DOI 10.1017/S0030605310000554; Byron N, 1999, WORLD DEV, V27, P789, DOI 10.1016/S0305-750X(99)00025-X; Chambers R, 2006, ELECTR J INF SYS DEV, V25; Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025; Chhatre A, 2012, CURR OPIN ENV SUST, V4, P654, DOI 10.1016/j.cosust.2012.08.006; Chhatre A, 2009, P NATL ACAD SCI USA, V106, P17667, DOI 10.1073/pnas.0905308106; Danielsen F, 2009, CONSERV BIOL, V23, P31, DOI 10.1111/j.1523-1739.2008.01063.x; Danielsen F, 2013, ECOL SOC, V18, DOI 10.5751/ES-05464-180341; DeFries R, 2007, ENVIRON SCI POLICY, V10, P385, DOI 10.1016/j.envsci.2007.01.010; Dharmadi Hawthorne S., 2014, LIT REV PARTICIPATOR; Fry B, 2011, ENVIRON SCI POLICY, V14, P181, DOI 10.1016/j.envsci.2010.12.004; Gaillard JC, 2013, APPL GEOGR, V45, P158, DOI 10.1016/j.apgeog.2013.09.009; Graham K., 2009, CARBON CLIMATE LAW R, V3, P303; Hansen M C, 2013, SCIENCE, V342, P2011; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; Hossain M S, 2007, J SOCIAL SCI HUMANIT, V13, P413; Joseph S., 2013, ENVIRON RES LETT, V8, P34; Kauffman JB, 2010, WETLANDS, V30, P1077, DOI 10.1007/s13157-010-0114-y; Knowles T., 2010, CTR PATHWAYS IMPLEME, P141; Larrazabal A, 2012, CURR OPIN ENV SUST, V4, P707, DOI 10.1016/j.cosust.2012.10.008; Mapedza E, 2003, APPL GEOGR, V23, P1, DOI 10.1016/S0143-6228(02)00070-X; MATHER AS, 1992, AREA, V24, P367; Meta P., 2005, MAPPING COMMUNITIES, P29; Minang P. A., 2014, CLIM POLICY, P1; [Ministry of Forestry Direction general of Forestry Planning Kemetrian Kehutanan Direktorat Jenderal Planologi Kehutanan], 2012, KEM KEH DIR JEND PLA; Minter T., 2014, HUMAN ECOLOGY; Naidoo G, 2010, TREES-STRUCT FUNCT, V24, P667, DOI 10.1007/s00468-010-0436-7; NGENDAKUMANA S, 2013, ISRN FORESTRY, V2013; Padmanaba M., 2012, PROJECT REPORT; Pratihast AK, 2013, CARBON MANAG, V4, P91, DOI [10.4155/cmt.12.75, 10.4155/CMT.12.75]; Rambaldi G., 2006, PARTICIPATORY LEARNI, V54, P106; Resosudarmo IAP, 2014, WORLD DEV, V55, P68, DOI 10.1016/j.worlddev.2013.01.015; Richards J.A., 1999, REMOTE SENSING DIGIT, DOI [DOI 10.1007/978-3-642-30062-2, 10.1007/978-3-662-03978-6, DOI 10.1007/978-3-662-03978-6]; Richards S. J., 2002, RAP B BILOIGICAL ASS, V25; Rindfuss R.R., 1998, PEOPLE PIXELS LINKIN, P1, DOI [10.17226/5963, DOI 10.17226/5963]; Rindfuss RR, 2004, REMOTE SENSING IMAGE, V6, P379; Romijn E, 2012, ENVIRON SCI POLICY, V19-20, P33, DOI 10.1016/j.envsci.2012.01.005; Rouse J.W., 1973, EARTH RES TECHN SAT, P309; Salvini G, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074004; Sheil D, 2002, EXPLORING BIOL DIVER, P1, DOI [10.17528/cifor/001021, DOI 10.17528/CIFOR/001021]; Sheil D, 2015, ECOL SOC, V20, DOI 10.5751/ES-07625-200239; UNFCCC, 2010, OUTC WORK HOC WORK G; Vergara-Asenjo G, 2015, CONSERV LETT, V8, P432, DOI 10.1111/conl.12161; Wertz-Kanounnikoff S., 2009, REALISING REDD NATL, P13; World Agroforestry Centre, 2011, WORLD AGR CTR ACC LO; Zhang ZM, 2013, J NAT CONSERV, V21, P225, DOI 10.1016/j.jnc.2012.12.006	55	10	11	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0166592	10.1371/journal.pone.0166592	http://dx.doi.org/10.1371/journal.pone.0166592			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977685	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400004
J	Lohberger, B; Steinecker-Frohnwieser, B; Stuendl, N; Kaltenegger, H; Leithner, A; Rinner, B				Lohberger, Birgit; Steinecker-Frohnwieser, Bibiane; Stuendl, Nicole; Kaltenegger, Heike; Leithner, Andreas; Rinner, Beate			The Proteasome Inhibitor Bortezomib Affects Chondrosarcoma Cells via the Mitochondria-Caspase Dependent Pathway and Enhances Death Receptor Expression and Autophagy	PLOS ONE			English	Article							PHASE-I TRIAL; APOPTOSIS; COMBINATION; CHEMOTHERAPY; RADIATION; THERAPY; TARGET	High grade chondrosarcoma is characterized by its lack of response to conventional cytotoxic chemotherapy, the tendency to develop lung metastases, and low survival rates. Research within the field prioritizes the development and expansion of new treatment options for dealing with unresectable or metastatic diseases. Numerous clinical trials using the proteasome inhibitor bortezomib have shown specific efficacy as an active antitumor agent for treating a variety of solid tumors. However, as of yet the effect of bortezomib on chondrosarcoma has not been investigated. In our study, bortezomib decreased cell viability and proliferation in two different chondrosarcoma cell lines in a time-and dose dependent manner. FACS analysis, mRNA-and protein expression studies illustrated that induction of apoptosis developed through the intrinsic mitochondria-caspase dependent pathway. Furthermore, bortezomib treatment significantly increased expression of the death receptors TRAILR-1 and TRAILR-2 in chondrosarcoma cells. An increased expression of the autophagy markers Atg5/12, Beclin, and LC3BI-II supports the interpretation that bortezomib functions as a trigger for autophagy. Our results demonstrated for the first time that bortezomib reduced viability and proliferation of chondrosarcoma cells, induced apoptosis via the mitochondria-caspase dependent pathway and enhanced death receptor expression and autophagy.	[Lohberger, Birgit; Stuendl, Nicole; Kaltenegger, Heike; Leithner, Andreas] Med Univ Graz, Dept Orthoped Surg, Graz, Austria; [Steinecker-Frohnwieser, Bibiane] Ludwig Boltzmann Inst Rehabil Internal Dis, Ludwig Boltzmann Cluster Rheumatol Balneol & Reha, Saalfelden, Austria; [Steinecker-Frohnwieser, Bibiane] Med Univ Graz, Inst Biophys, Graz, Austria; [Rinner, Beate] Med Univ Graz, Div Biomed Res, Graz, Austria	Medical University of Graz; Ludwig Boltzmann Institute; Medical University of Graz; Medical University of Graz	Lohberger, B (corresponding author), Med Univ Graz, Dept Orthoped Surg, Graz, Austria.	birgit.lohberger@medunigraz.at		Steinecker-Frohnwieser, Bibiane/0000-0001-6852-4466; Rinner, Beate/0000-0002-6340-4905				Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; [Anonymous], 2013, WHO CLASSIFICATION T; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Besse B, 2012, LUNG CANCER, V76, P78, DOI 10.1016/j.lungcan.2011.09.006; Blaney SM, 2004, J CLIN ONCOL, V22, P4804, DOI 10.1200/JCO.2004.12.185; Cacan E, 2015, INT J MOL SCI, V16, P30405, DOI 10.3390/ijms161226238; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Dalby KN, 2010, AUTOPHAGY, V6, P322, DOI 10.4161/auto.6.3.11625; Damron TA, 2007, CLIN ORTHOP RELAT R, P40, DOI 10.1097/BLO.0b013e318059b8c9; El-Khattouti Abdelouahid, 2013, J Cell Death, V6, P37, DOI 10.4137/JCD.S11034; Fenichel MP, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv165; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; Geng JF, 2008, AUTOPHAGY, V4, P955, DOI 10.4161/auto.6791; Giuffrida AY, 2009, J BONE JOINT SURG AM, V91A, P1063, DOI 10.2106/JBJS.H.00416; Hu YM, 2015, TOXICOL APPL PHARM, V283, P1, DOI 10.1016/j.taap.2014.12.015; Kamada M, 2007, MOL CANCER THER, V6, P299, DOI 10.1158/1535-7163.MCT-06-0417; Kao C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.468; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Long JS, 2012, ONCOGENE, V31, P5045, DOI 10.1038/onc.2012.7; Ludwig H, 2005, CANCER-AM CANCER SOC, V104, P1794, DOI 10.1002/cncr.21414; Luster TA, 2009, MOL CANCER THER, V8, P292, DOI 10.1158/1535-7163.MCT-08-0918; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Messersmith WA, 2006, CLIN CANCER RES, V12, P1270, DOI 10.1158/1078-0432.CCR-05-1942; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Munoz-Galvan S, 2015, MOL CANCER THER, V14, P1454, DOI 10.1158/1535-7163.MCT-14-1053; Piperdi B, 2012, J THORAC ONCOL, V7, P1032, DOI 10.1097/JTO.0b013e31824de2fa; Poklepovic A, 2013, INVEST NEW DRUG, V31, P937, DOI 10.1007/s10637-012-9913-8; Pryczynicz A, 2010, FOLIA HISTOCHEM CYTO, V48, P425, DOI 10.2478/v10042-010-0058-3; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Ridzewski R, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00130; Rouschop KMA, 2009, CURR MOL MED, V9, P417, DOI 10.2174/156652409788167131; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350; van Maldegem AM, 2014, CANCER-AM CANCER SOC, V120, P3159, DOI 10.1002/cncr.28845; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wong PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9048	40	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168193	10.1371/journal.pone.0168193	http://dx.doi.org/10.1371/journal.pone.0168193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978543	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400074
J	Vicente, RL; Gullon, S; Marin, S; Mellado, RP				Vicente, Rebeca L.; Gullon, Sonia; Marin, Silvia; Mellado, Rafael P.			The Three Streptomyces lividans HtrA-Like Proteases Involved in the Secretion Stress Response Act in a Cooperative Manner	PLOS ONE			English	Article							METAL AFFINITY-CHROMATOGRAPHY; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; EXTRACELLULAR PROTEOME; CONJUGAL TRANSFER; SERINE PROTEASES; CLONING VECTORS; PROTEINS; CHAPERONE; STRAINS	Overproduction of Sec-proteins in S. lividans accumulates misfolded proteins outside of the cytoplasmic membrane where the accumulated proteins interfere with the correct functioning of the secretion machinery and with the correct cell functionality, triggering the expression in S. lividans of a CssRS two-component system which regulates the degradation of the accumulated protein, the so-called secretion stress response. Optimization of secretory protein production via the Sec route requires the identification and characterisation of quality factors involved in this process. The phosphorylated regulator (CssR) interacts with the regulatory regions of three genes encoding three different HtrA-like proteases. Individual mutations in each of these genes render degradation of the misfolded protein inoperative, and propagation in high copy number of any of the three proteases encoding genes results on indiscriminate alpha-amylase degradation. None of the proteases could complement the other two deficiencies and only propagation of each single copy protease gene can restore its own deficiency. The obtained results strongly suggest that the synthesis of the three HtrA-like proteases needs to be properly balanced to ensure the effective degradation of misfolded overproduced secretory proteins and, at the same time, avoid negative effects in the secreted proteins and the secretion machinery. This is particularly relevant when considering the optimisation of Streptomyces strains for the overproduction of homologous or heterologous secretory proteins of industrial application.	[Vicente, Rebeca L.; Gullon, Sonia; Marin, Silvia; Mellado, Rafael P.] CNB CSIC, Dept Biotecnol Microbiana, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Mellado, RP (corresponding author), CNB CSIC, Dept Biotecnol Microbiana, Madrid, Spain.	rpmellado@cnb.csic.es	Gullón, Sonia/P-7460-2018; Mellado, Rafael P/D-2680-2009		MINECO/FEDER [BIO201571504-R]	MINECO/FEDER	This work was supported by MINECO/FEDER grant BIO201571504-R.	Anne J, 2012, J BIOTECHNOL, V158, P159, DOI 10.1016/j.jbiotec.2011.06.028; Antelmann H, 2003, MOL MICROBIOL, V49, P143, DOI 10.1046/j.1365-2958.2003.03565.x; Ausubel F., 1995, SHORT PROTOCOLS MOL, P2; Bernfeld P, 1955, METHOD ENZYMOL, P140; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Bolanos-Garcia VM, 2006, BBA-GEN SUBJECTS, V1760, P1304, DOI 10.1016/j.bbagen.2006.03.027; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Darmon E, 2002, J BACTERIOL, V184, P5661, DOI 10.1128/JB.184.20.5661-5671.2002; De Wulf P, 1999, J BACTERIOL, V181, P6772, DOI 10.1128/JB.181.21.6772-6778.1999; DENIS F, 1992, GENE, V111, P115, DOI 10.1016/0378-1119(92)90611-R; Escutia MR, 2006, PROTEOMICS, V6, P4137, DOI 10.1002/pmic.200500927; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Gullon S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048987; Hopwood D. A., 1985, GENETIC MANIPULATION; Hyyrylainen HL, 2001, MOL MICROBIOL, V41, P1159, DOI 10.1046/j.1365-2958.2001.02576.x; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Lulko AT, 2007, APPL ENVIRON MICROB, V73, P5354, DOI 10.1128/AEM.00472-07; Noone D, 2001, J BACTERIOL, V183, P654, DOI 10.1128/JB.183.2.654-663.2001; Nybo SE, 2010, CURR PROTOC MICROBIO; Palacin A, 2002, J BACTERIOL, V184, P4875, DOI 10.1128/JB.184.17.4875-4880.2002; Pallen MJ, 1997, MOL MICROBIOL, V26, P209, DOI 10.1046/j.1365-2958.1997.5601928.x; Palomino C, 2008, INT MICROBIOL, V11, P25, DOI 10.2436/20.1501.01.41; Raivio TL, 1999, J BACTERIOL, V181, P5263, DOI 10.1128/JB.181.17.5263-5272.1999; Raju RM, 2012, NAT REV DRUG DISCOV, V11, P777, DOI 10.1038/nrd3846; Robichon C, 2011, APPL ENVIRON MICROB, V77, P4634, DOI 10.1128/AEM.00119-11; Ruckert C, 2015, J BIOTECHNOL, V199, P21, DOI 10.1016/j.jbiotec.2015.02.004; Sarvas M, 2004, BBA-MOL CELL RES, V1694, P311, DOI 10.1016/j.bbamcr.2004.04.009; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STRUMEYE.DH, 1967, ANAL BIOCHEM, V19, P61, DOI 10.1016/0003-2697(67)90134-0; TIMMONS TM, 1990, METHOD ENZYMOL, V182, P679; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; WARD JM, 1986, MOL GEN GENET, V203, P468, DOI 10.1007/BF00422072; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168112	10.1371/journal.pone.0168112	http://dx.doi.org/10.1371/journal.pone.0168112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977736	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400062
J	Graham, JB; Muir, D				Graham, James B.; Muir, David			Chondroitinase C Selectively Degrades Chondroitin Sulfate Glycosaminoglycans that Inhibit Axonal Growth within the Endoneurium of Peripheral Nerve	PLOS ONE			English	Article							SPINAL-CORD-INJURY; NEURITE OUTGROWTH; BASEMENT-MEMBRANE; MONOCLONAL-ANTIBODIES; EXTRACELLULAR-MATRIX; DEGENERATED NERVE; REGENERATION; PROTEOGLYCAN; GRAFTS; ABC	The success of peripheral nerve regeneration is highly dependent on the regrowth of axons within the endoneurial basal lamina tubes that promote target-oriented pathfinding and appropriate reinnervation. Restoration of nerve continuity at this structural level after nerve transection injury by direct repair and nerve grafting remains a major surgical challenge. Recently, biological approaches that alter the balance of growth inhibitors and promoters in nerve have shown promise to improve appropriate axonal regeneration and recovery of peripheral nerve function. Chondroitin sulfate proteoglycans (CSPGs) are known inhibitors of axonal growth. This growth inhibition is mainly associated with a CSPG's glycosaminoglycan chains. Enzymatic degradation of these chains with chondroitinase eliminates this inhibitory activity and, when applied in vivo, can improve the outcome of nerve repair. To date, these encouraging findings were obtained with chondroitinase ABC (a pan-specific chondroitinase). The aim of this study was to examine the distribution of CSPG subtypes in rodent, rabbit, and human peripheral nerve and to test more selective biological enzymatic approaches to improve appropriate axonal growth within the endoneurium and minimize aberrant growth. Here we provide evidence that the endoneurium, but not the surrounding epineurium, is rich in CSPGs that have glycosaminoglycan chains readily degraded by chondroitinase C. Biochemical studies indicate that chondroitinase C has degradation specificity for 6-sulfated glycosaminoglycans found in peripheral nerve. We found that chondroitinase C degrades and inactivates inhibitory CSPGs within the endoneurium but not so much in the surrounding nerve compartments. Cryoculture bioassays (neurons grown on tissue sections) show that chondroitinase C selectively and significantly enhanced neuritic growth associated with the endoneurial basal laminae without changing growth-inhibiting properties of the surrounding epineurium. Interestingly, chondroitinase ABC treatment increased greatly the growth-promoting properties of the epineurial tissue whereas chondroitinase C had little effect. Our evidence indicates that chondroitinase C effectively degrades and inactivates inhibitory CSPGs present in the endoneurial Schwann cell basal lamina and does so more specifically than chondroitinase ABC. These findings are discussed in the context of improving nerve repair and regeneration and the growth-promoting properties of processed nerve allografts.	[Graham, James B.; Muir, David] Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Graham, JB (corresponding author), Univ Florida, Coll Med, Dept Pediat, Gainesville, FL 32611 USA.	jbgraham@ufl.edu			United States Department of Defense Medical Research and Development Program Applied Research and Technology Development Award [DM090175]; National Institutes of Health; National Center for Research Resources Clinical and Translational Science Award [TL1 TR000066]	United States Department of Defense Medical Research and Development Program Applied Research and Technology Development Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by: United States Department of Defense Medical Research and Development Program Applied Research and Technology Development Award DM090175 (DM) and National Institutes of Health and National Center for Research Resources Clinical and Translational Science Award TL1 TR000066 (JBG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius E, 1998, J NEUROSCI, V18, P328; ASHER R, 1991, J NEUROSCI RES, V28, P410, DOI 10.1002/jnr.490280314; AVNUR Z, 1984, CELL, V38, P811, DOI 10.1016/0092-8674(84)90276-9; BEDI KS, 1992, EUR J NEUROSCI, V4, P193, DOI 10.1111/j.1460-9568.1992.tb00867.x; Bianchetti L, 2012, J CELL MOL MED, V16, P483, DOI 10.1111/j.1582-4934.2011.01344.x; BLAKESLEY RW, 1977, ANAL BIOCHEM, V82, P580, DOI 10.1016/0003-2697(77)90197-X; BRAUNEWELL KH, 1995, EUR J NEUROSCI, V7, P805, DOI 10.1111/j.1460-9568.1995.tb00683.x; CARBONETTO S, 1987, J NEUROSCI, V7, P610; Clement AM, 1998, J BIOL CHEM, V273, P28444, DOI 10.1074/jbc.273.43.28444; DANIELSEN N, 1994, BRAIN RES, V666, P250, DOI 10.1016/0006-8993(94)90779-X; English AW, 2005, J COMP NEUROL, V490, P427, DOI 10.1002/cne.20678; ENGVALL E, 1986, J CELL BIOL, V103, P2457, DOI 10.1083/jcb.103.6.2457; EVANS PJ, 1995, MUSCLE NERVE, V18, P1128, DOI 10.1002/mus.880181009; Evans PJ, 1998, MUSCLE NERVE, V21, P1507, DOI 10.1002/(SICI)1097-4598(199811)21:11<1507::AID-MUS21>3.0.CO;2-W; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; Ferguson TA, 2000, MOL CELL NEUROSCI, V16, P157, DOI 10.1006/mcne.2000.0859; Graham JB, 2007, EXP NEUROL, V203, P185, DOI 10.1016/j.expneurol.2006.08.004; Groves ML, 2005, EXP NEUROL, V195, P278, DOI 10.1016/j.expneurol.2005.04.007; Hamai A, 1997, J BIOL CHEM, V272, P9123; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; Huang WC, 2006, BIOCHEM BIOPH RES CO, V349, P963, DOI 10.1016/j.bbrc.2006.08.136; Hudson TW, 2004, TISSUE ENG, V10, P1641, DOI 10.1089/ten.2004.10.1641; Ito Y, 2005, GLYCOBIOLOGY, V15, P593, DOI 10.1093/glycob/cwi036; Izumikawa T, 2011, BIOCHEM J, V434, P321, DOI 10.1042/BJ20101456; Krekoski CA, 2001, J NEUROSCI, V21, P6206, DOI 10.1523/JNEUROSCI.21-16-06206.2001; LEIVO I, 1988, P NATL ACAD SCI USA, V85, P1544, DOI 10.1073/pnas.85.5.1544; MICHELACCI YM, 1976, J BIOL CHEM, V251, P1154; Muir D, 2010, EXP NEUROL, V223, P102, DOI 10.1016/j.expneurol.2009.05.038; Nadanaka S, 1998, J BIOL CHEM, V273, P3296, DOI 10.1074/jbc.273.6.3296; Neubauer D, 2007, EXP NEUROL, V207, P163, DOI 10.1016/j.expneurol.2007.06.006; Pomin VH, 2012, GLYCOBIOLOGY, V22, P826, DOI 10.1093/glycob/cws055; POOLE CA, 1991, J HISTOCHEM CYTOCHEM, V39, P1175, DOI 10.1177/39.9.1717545; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Sattelle BM, 2015, BIOMACROMOLECULES; SCOTT JE, 1972, HISTOCHEMISTRY, V32, P191, DOI 10.1007/BF00306028; Shields LBE, 2008, SURG NEUROL, V69, P568, DOI 10.1016/j.surneu.2008.02.009; SKENE JHP, 1981, J CELL BIOL, V89, P86, DOI 10.1083/jcb.89.1.86; SUGAHARA K, 1994, CARBOHYD RES, V255, P145, DOI 10.1016/S0008-6215(00)90976-5; Szynkaruk M, 2013, TISSUE ENG PART B-RE, V19, P83, DOI [10.1089/ten.TEB.2012.0275, 10.1089/ten.teb.2012.0275]; Tsuda H, 1999, EUR J BIOCHEM, V262, P127, DOI 10.1046/j.1432-1327.1999.00348.x; Wang H, 2008, J CELL SCI, V121, P3083, DOI 10.1242/jcs.032649; Yi JH, 2012, J COMP NEUROL, V520, P3295, DOI 10.1002/cne.23156; Yurchenco PD, 2009, CURR PHARM DESIGN, V15, P1277, DOI 10.2174/138161209787846766; Zuo J, 2002, EXP NEUROL, V176, P221, DOI 10.1006/exnr.2002.7922; Zuo J, 1998, J NEUROBIOL, V34, P41, DOI 10.1002/(SICI)1097-4695(199801)34:1<41::AID-NEU4>3.3.CO;2-4	45	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167682	10.1371/journal.pone.0167682	http://dx.doi.org/10.1371/journal.pone.0167682			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973564	gold, Green Published, Green Submitted			2022-12-27	WOS:000392754300040
J	Kinoshita, T; Mori, J; Okuda, N; Imaizumi, H; Iwasaki, M; Shimizu, M; Miyamoto, H; Akalwa, K; Semba, K; Sonoda, S; Sakamoto, T; Mitamura, Y				Kinoshita, Takamasa; Mori, Junya; Okuda, Natsuki; Imaizumi, Hiroko; Iwasaki, Masanori; Shimizu, Miho; Miyamoto, Hirotomo; Akalwa, Kei; Semba, Kentaro; Sonoda, Shozo; Sakamoto, Taiji; Mitamura, Yoshinori			Effects of Exercise on the Structure and Circulation of Choroid in Normal Eyes	PLOS ONE			English	Article							BLOOD-FLOW REGULATION; OPTIC-NERVE HEAD; LASER SPECKLE; INTRAOCULAR-PRESSURE; COHERENCE TOMOGRAPHY; ISOMETRIC-EXERCISE; DYNAMIC EXERCISE; STROMAL AREAS; AXIAL LENGTH; THICKNESS	Aims To determine the effects of dynamic exercise on the circulation and the luminal and stromal areas of the choroid in normal eyes. Methods This was a prospective interventional study of 38 eyes of 38 normal subjects enrolled by invitation. The systolic and diastolic blood pressures, heart rate, intraocularpressure, mean ocular perfusion pressure (MOPP), choroidal blood velocity, and enhanced depth imaging optical coherence tomographic (EDI-OCT) images were recorded before, and immediately after mild dynamic exercise. The same measurements were recorded after 10 min of rest. The choroidal blood velocity was measured bylaser speckle flowgraphy, and the mean blur rate was used for the evaluations. The horizontal EDI-OCT images of the subfoveal choroid were converted to binary images. The central choroidal thickness (CCT), total cross sectional choroidal area, luminal areas, stromal areas, and the ratio of luminal area to total choroidal area (L/C ratio) were determined from these images. Results The systolic and diastolic blood pressures, heart rate, MOPP, and the mean blur rate were significantly increased immediately after the exercise and significantly decreased 10 minutes after the exercise. There wereno significant changes in the mean CCT, the mean total choroidal area, the mean luminal and stromal areas, and the mean L/C ratio after the exercise. Conclusions Our results suggest that a rest period is needed before measurements of blood flow velocity but not necessary for the EDI-OCT imaging to determine the choroidal thickness and area.	[Kinoshita, Takamasa; Akalwa, Kei; Semba, Kentaro; Mitamura, Yoshinori] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Ophthalmol, Tokushima, Japan; [Kinoshita, Takamasa; Mori, Junya; Okuda, Natsuki; Imaizumi, Hiroko; Iwasaki, Masanori; Shimizu, Miho; Miyamoto, Hirotomo] Sapporo City Gen Hosp, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Sonoda, Shozo; Sakamoto, Taiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima, Japan	Tokushima University; Sapporo City General Hospital; Kagoshima University	Kinoshita, T (corresponding author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Ophthalmol, Tokushima, Japan.	knst129@gmail.com	Kinoshita, Takamasa/S-9174-2019; Iwasaki, Masanori/GQH-9944-2022	Kinoshita, Takamasa/0000-0002-0465-2140; 	Ministry of Education, Culture, Sports, Science and Technology, Japan [16K11288]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grant-in-aid 16K11288 (to YM) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. URL: http://www.mext.go.ip/ english/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwassia AA, 2013, RETINA-J RET VIT DIS, V33, P160, DOI 10.1097/IAE.0b013e3182618c22; ASHKENAZI I, 1992, INVEST OPHTH VIS SCI, V33, P2874; BILL A, 1990, EYE, V4, P319, DOI 10.1038/eye.1990.43; Chakraborty R, 2011, INVEST OPHTH VIS SCI, V52, P5121, DOI 10.1167/iovs.11-7364; CHRISTENSEN NJ, 1983, ANNU REV PHYSIOL, V45, P139, DOI 10.1146/annurev.ph.45.030183.001035; Cicek A, 2016, INT OPHTHALMOL; Egawa M, 2016, BRIT J OPHTHALMOL, V100, P1646, DOI 10.1136/bjophthalmol-2015-307734; Egawa M, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0127-7; Fuchsjager-Mayrl G, 2003, INVEST OPHTH VIS SCI, V44, P728, DOI 10.1167/iovs.02-0372; FUJII H, 1994, MED BIOL ENG COMPUT, V32, P302, DOI 10.1007/BF02512526; Harris A, 1996, GRAEF ARCH CLIN EXP, V234, P440, DOI 10.1007/BF02539410; HAYREH SS, 1990, EYE, V4, P273, DOI 10.1038/eye.1990.39; HONG J, 2014, PLOS GENET, V10, DOI DOI 10.1371/JOURNAL.PONE.0104294; Isono H, 2003, ARCH OPHTHALMOL-CHIC, V121, P225; Iwata A, 2015, BMC OPHTHALMOL, V15, DOI 10.1186/s12886-015-0014-2; Jablonski MM, 2007, INVEST OPHTH VIS SCI, V48, P479, DOI 10.1167/iovs.06-0972; Jones H, 2006, HYPERTENSION, V47, P778, DOI 10.1161/01.HYP.0000206421.09642.b5; Kawano H, 2016, GRAEF ARCH CLIN EXP, V254, P421, DOI 10.1007/s00417-016-3283-4; Kinoshita T, 2017, BRIT J OPHTHALMOL, V101, P360, DOI 10.1136/bjophthalmol-2016-308594; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; LEIGHTON DA, 1970, BRIT J OPHTHALMOL, V54, P599, DOI 10.1136/bjo.54.9.599; LI X, 2016, INVEST OPHTH VIS SCI, V57, pCT189, DOI DOI 10.1167/IOVS.15-18449; Lovasik JV, 2003, INVEST OPHTH VIS SCI, V44, P2126, DOI 10.1167/iovs.02-0825; Luksch A, 2003, INVEST OPHTH VIS SCI, V44, P734, DOI 10.1167/iovs.02-0177; Lutjen-Drecoll E, 2006, EXP EYE RES, V82, P357, DOI 10.1016/j.exer.2005.09.015; MacDonald JR, 2002, J HUM HYPERTENS, V16, P225, DOI 10.1038/sj.jhh.1001377; MASTER AM, 1968, AM HEART J, V75, P809, DOI 10.1016/0002-8703(68)90042-2; Nemeth J, 2002, GRAEF ARCH CLIN EXP, V240, P835, DOI 10.1007/s00417-002-0552-1; Okuno T, 2006, EYE, V20, P796, DOI 10.1038/sj.eye.6702004; PALATINI P, 1994, CLIN SCI, V87, P275, DOI 10.1042/cs0870275; Polska E, 2007, INVEST OPHTH VIS SCI, V48, P3768, DOI 10.1167/iovs.07-0307; Portmann N, INVEST OPHTHALMOL VI, V53, P7068; Read SA, 2011, EYE, V25, P767, DOI 10.1038/eye.2011.54; Sayin N, 2015, INDIAN J OPHTHALMOL, V63, P445, DOI 10.4103/0301-4738.159884; Sonoda S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157190; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Sonoda S, 2014, INVEST OPHTH VIS SCI, V55, P3893, DOI 10.1167/iovs.14-14447; Sugiyama T, 1996, JPN J OPHTHALMOL, V40, P339; Sugiyama T, 2010, ACTA OPHTHALMOL, V88, P723, DOI 10.1111/j.1755-3768.2009.01586.x; Suzuki T, 2003, AM J OPHTHALMOL, V136, P62, DOI 10.1016/S0002-9394(03)00149-1; Tamaki Y, 1997, JPN J OPHTHALMOL, V41, P49, DOI 10.1016/S0021-5155(96)00008-1; TAMAKI Y, 1995, EXP EYE RES, V60, P373, DOI 10.1016/S0014-4835(05)80094-6; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Usui S, 2012, INVEST OPHTH VIS SCI, V53, P2300, DOI 10.1167/iovs.11-8383; WENER J, 1953, CAN MED ASSOC J, V68, P368	45	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168336	10.1371/journal.pone.0168336	http://dx.doi.org/10.1371/journal.pone.0168336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973598	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300077
J	Seth, C; Mas, C; Conod, A; Mueller, J; Siems, K; Kuciak, M; Borges, I; Altaba, ARI				Seth, Chandan; Mas, Christophe; Conod, Arwen; Mueller, Jens; Siems, Karsten; Kuciak, Monika; Borges, Isabel; Altaba, Ariel Ruiz I.			Long-Lasting WNT-TCF Response Blocking and Epigenetic Modifying Activities of Withanolide F in Human Cancer Cells	PLOS ONE			English	Article							WNT/BETA-CATENIN PATHWAY; STEM-CELLS; INHIBITION; GROWTH; ACTIVATION; EXPRESSION; WITHAFERIN; PROMOTES; BINDING; ARREST	The WNT-TCF signaling pathway participates in adult tissue homeostasis and repair, and is hyperactive in a number of human diseases including cancers of the colon. Whereas to date there are no antagonists approved for patient use, a potential problem for their sustained use is the blockade of WNT signaling in healthy tissues, thus provoking potentially serious co-lateral damage. Here we have screened a library of plant and microorganism small molecules for novel WNT signaling antagonists and describe withanolide F as a potent WNT-TCF response blocker. This steroidal lactone inhibits TCF-dependent colon cancer xenograft growth and mimics the effects of genetic blockade of TCF and of ivermectin, a previously reported WNT-TCF blocker. However, withanolide F is unique in that it imposes a long-lasting repression of tumor growth, WNT-TCF targets and cancer stem cell clonogenicity after drug treatment. These findings are paralleled by its modulation of chromatin regulators and its alteration of overall H3K4me1 levels. Our results open up the possibility to permanently repress essential signaling responses in cancer cells through limited treatments with small molecules.	[Seth, Chandan; Mas, Christophe; Conod, Arwen; Kuciak, Monika; Borges, Isabel; Altaba, Ariel Ruiz I.] CMU, Dept Med Genet & Dev, 1 Rue Michel Servet, Geneva, Switzerland; [Mueller, Jens; Siems, Karsten] Analyticon Discovery, Biotech Campus Potsdam Hermannswerder, Potsdam, Germany	University of Geneva	Altaba, ARI (corresponding author), CMU, Dept Med Genet & Dev, 1 Rue Michel Servet, Geneva, Switzerland.	Ariel.RuizAltaba@unige.ch		Seth Nanda, Chandan/0000-0002-3955-8808; Mas, Christophe/0000-0002-7585-1091; Ruiz i Altaba, Ariel/0000-0003-2292-3933	European Union; Analyticon Discovery; Swiss Cancer League; National Swiss Science Foundation; Departement d'Instruction Publique de Geneve; Analyticon Discovery Gmbh	European Union(European Commission); Analyticon Discovery; Swiss Cancer League; National Swiss Science Foundation(Swiss National Science Foundation (SNSF)); Departement d'Instruction Publique de Geneve; Analyticon Discovery Gmbh	This work was funded by European Union ITN grants CAPPELLA and HEALING to ARA (Universite de Geneve) and Analyticon Discovery, and by the Swiss Cancer League, National Swiss Science Foundation and the Departement d'Instruction Publique de Geneve to ARA. Analyticon Discovery Gmbh provided support in the form of funds for small molecule sample preparation and analyses and salaries for authors JM and KS. Analyticon was in charge of providing extracts and small molecules and the discussion of the initial screen and project, as well as ongoing discussion on small molecules and their effects. As a company, it did not have additional roles in data collection and analysis, decision to publish, or preparation of the manuscript other than JM and KS providing insight and comments on the ms. The specific roles of these authors are articulated in the 'author contributions' section.	Abdeljebbar LH, 2007, HELV CHIM ACTA, V90, P346, DOI 10.1002/hlca.200790041; Amin H, 2016, MOL CARCINOGEN, V55, P864, DOI 10.1002/mc.22328; Antony ML, 2014, J BIOL CHEM, V289, P1852, DOI 10.1074/jbc.M113.496844; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Beg M, 2014, PHYTOMEDICINE, V21, P406, DOI 10.1016/j.phymed.2013.10.009; Cao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4127; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chevillard-Briet M, 2014, HUM MOL GENET, V23, P2120, DOI 10.1093/hmg/ddt604; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Duquet A, 2014, EMBO MOL MED, V6, P882, DOI 10.15252/emmm.201303799; Falsey RR, 2006, NAT CHEM BIOL, V2, P33, DOI 10.1038/nchembio755; Fernandez AF, 2015, GENOME RES, V25, P27, DOI 10.1101/gr.169011.113; Fu Y, 2013, EMBO MOL MED, V5, P737, DOI 10.1002/emmm.201202218; Fuentes RG, 2015, NAT PROD REP, V32, P1622, DOI 10.1039/c5np00074b; Gong FD, 2015, GENE DEV, V29, P197, DOI 10.1101/gad.252189.114; Gu MC, 2014, INVEST NEW DRUG, V32, P68, DOI 10.1007/s10637-013-9987-y; Abdeljebbar LH, 2009, THERAPIE, V64, P121, DOI 10.2515/therapie/2009015; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ihsan-ul-Haq, 2013, J NAT PROD, V76, P22, DOI 10.1021/np300534x; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kwon M, 2014, INT J CANCER, V135, P48, DOI 10.1002/ijc.28662; Lasorella A, 2014, NAT REV CANCER, V14, P77, DOI 10.1038/nrc3638; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Lorente-Trigos A, 2010, J MOL CELL BIOL, V2, P318, DOI 10.1093/jmcb/mjq035; Melotti A, 2014, EMBO MOL MED, V6, P1263, DOI 10.15252/emmm.201404084; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034277; Mondal S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-239; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nakamura Y, 2016, DEVELOPMENT, V143, P1914, DOI 10.1242/dev.131664; Panagopoulos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063663; Parody JP, 2010, GROWTH FACTORS, V28, P166, DOI 10.3109/08977190903547863; Rydziel S, 2007, J BIOL CHEM, V282, P19762, DOI 10.1074/jbc.M700212200; Sarkar S, 2014, ENDOCR-RELAT CANCER, V21, P113, DOI 10.1530/ERC-13-0315; Shen B, 2015, CELL, V163, P1297, DOI 10.1016/j.cell.2015.11.031; Singh N, 2011, AFR J TRADIT COMPLEM, V8, P208, DOI 10.4314/ajtcam.v8i5S.9; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Vanden Berghe W, 2012, BIOCHEM PHARMACOL, V84, P1282, DOI 10.1016/j.bcp.2012.08.027; Varnat F, 2010, EMBO MOL MED, V2, P440, DOI 10.1002/emmm.201000098; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048	45	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168170	10.1371/journal.pone.0168170	http://dx.doi.org/10.1371/journal.pone.0168170			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973612	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300062
J	Zhang, YL; Liao, ZT; Wei, QJ; Pan, YF; Wang, XW; Cao, SY; Guo, ZS; Wu, YQ; Rong, J; Jin, O; Xu, ML; Lin, ZM; Gu, JR				Zhang, Yanli; Liao, Zetao; Wei, Qiujing; Pan, Yunfeng; Wang, Xinwei; Cao, Shuangyan; Guo, Zishi; Wu, Yuqiong; Rong, Ju; Jin, Ou; Xu, Manlong; Lin, Zhiming; Gu, Jieruo			A Genome-Wide SNP Linkage Analysis Suggests a Susceptibility Locus on 6p21 for Ankylosing Spondylitis and Inflammatory Back Pain Trait	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; GENETIC-SUSCEPTIBILITY; MHC; ASSOCIATION; HLA-B27; ERAP1; MAPS	Objectives To screen susceptibility loci for ankylosing spondylitis (AS) using an affected-only linkage analysis based on high-density single nucleotide polymorphisms (SNPs) in a genome-wide manner. Patients and Methods AS patients from ten families with Cantonese origin of China were enrolled in the study. Blood samples were genotyped using genomic DNA derived from peripheral blood leukocytes by Illumina HumanHap 610-Quad SNP Chip. Genotype data were generated using the Illumina BeadStudio 3.2 software. PLINK package was used to remove non-autosomal SNPs and to further eliminate markers of typing errors. An affected-only linkage analysis was carried out using both non-parametric and parametric linkage analyses, as implemented in MERLIN. Result Seventy-eight AS patients (48 males and 30 females, mean age: 39 +/- 6 years) were enrolled in the study. The mean age of onset was 23 +/- 10 years and mean duration of disease was 16.7 +/- 12.2 years. Iritis (2/76, 2.86%), dactylitis (5/78, 6.41%), hip joint involvement (9/78, 11.54%), peripheral arthritis (22/78, 28.21%), inflammatory back pain (IBP) (69/78, 88.46%) and HLA-B27 positivity (70/78, 89.74%) were observed in these patients. Using non-parameter linkage analysis, we found one susceptibility locus for AS, IBP and HLA-B27 in 6p21 respectively, spanning about 13.5Mb, 20.9Mb and 21.2Mb, respectively No significant results were found in the other clinical trait groups including dactylitis, hip involved and arthritis. The identical susceptibility locus region spanning above 9.44Mb was detected in AS IBP and HLA-B27 by the parametric linkage analysis. Conclusion Our genome-wide SNP linkage analysis in ten families with ankylosing spondylitis suggests a susceptibility locus on 6p21 in AS, which is a risk locus for IBP in AS patients.	[Zhang, Yanli; Liao, Zetao; Wei, Qiujing; Pan, Yunfeng; Wang, Xinwei; Cao, Shuangyan; Guo, Zishi; Wu, Yuqiong; Rong, Ju; Jin, Ou; Xu, Manlong; Lin, Zhiming; Gu, Jieruo] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol & Immunol, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Lin, ZM; Gu, JR (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Rheumatol & Immunol, Guangzhou, Guangdong, Peoples R China.	lzm-zj99@163.com; gujieruo@163.com			Sun Yat-Sen University [5010]; National Natural Science Foundation for the youth NSFY of China [81302583]; Guangdong Natural Science Funds for Distinguished Young Scholar [2014A030306039]; High-level personnel of special support program for Technology Innovative Talents; Top Young of Guangdong Province [2015TQ01R516]; Fundamental Research Funds for the Central Universities [16ykzd05]; Distinguished Young Scholar Candidates Programme for The Third Affiliated Hospital of Sun Yat-Sen University; Pearl River Nova Program of Guangzhou [201610010005]	Sun Yat-Sen University; National Natural Science Foundation for the youth NSFY of China; Guangdong Natural Science Funds for Distinguished Young Scholar; High-level personnel of special support program for Technology Innovative Talents; Top Young of Guangdong Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Distinguished Young Scholar Candidates Programme for The Third Affiliated Hospital of Sun Yat-Sen University; Pearl River Nova Program of Guangzhou	This study was supported by 5010 Subject (2007) of Sun Yat-Sen University, National Natural Science Foundation for the youth NSFY of China (Grant No. 81302583), Guangdong Natural Science Funds for Distinguished Young Scholar (Grant No. 2014A030306039), High-level personnel of special support program for Technology Innovative Talents and the Top Young of Guangdong Province (Grant No. 2015TQ01R516), The Fundamental Research Funds for the Central Universities (16ykzd05), Distinguished Young Scholar Candidates Programme for The Third Affiliated Hospital of Sun Yat-Sen University and Pearl River Nova Program of Guangzhou (Grant No.201610010005).; We thank Prof. David Tak Yan Yu, Rheumatology Division, University of California at Los Angeles, for assistance and comments on our study. This study was supported by 5010 Subject (2007) of Sun Yat-Sen University, National Natural Science Foundation for the youth NSFY of China (Grant No.81302583), Guangdong Natural Science Funds for Distinguished Young Scholar (Grant No.2014A030306039), High-level personnel of special support program for Technology Innovative Talents and the Top Young of Guangdong Province (Grant No.2015TQ01R516), The Fundamental Research Funds for the Central Universities (16ykzd05), Distinguished Young Scholar Candidates Programme for The Third Affiliated Hospital of Sun Yat-Sen University and Pearl River Nova Program of Guangzhou (Grant No. 201610010005). (Si File)	Abecasis Goncalo, 2007, Nat Genet, V39, P153, DOI 10.1038/ng0207-153; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Braun J, 1998, ARTHRITIS RHEUM-US, V41, P58, DOI 10.1002/1529-0131(199801)41:1<58::AID-ART8>3.0.CO;2-G; BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499, DOI 10.1002/art.1780380407; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Breban M, 2006, JOINT BONE SPINE, V73, P355, DOI 10.1016/j.jbspin.2005.11.010; Brionez TF, 2008, CURR OPIN RHEUMATOL, V20, P384, DOI 10.1097/BOR.0b013e32830460fe; Brown MA, 2008, RHEUMATOLOGY, V47, P132, DOI 10.1093/rheumatology/kem269; Brown MA, 2000, ANN RHEUM DIS, V59, P883, DOI 10.1136/ard.59.11.883; Brown MA, 1997, ARTHRITIS RHEUM, V40, P1823, DOI 10.1002/art.1780401015; Brown MA, 2016, NAT REV RHEUMATOL, V12, P81, DOI 10.1038/nrrheum.2015.133; Cortes A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8146; Cozen W, 2012, BLOOD, V119, P469, DOI 10.1182/blood-2011-03-343921; Dick KJ, 2008, NEUROLOGY, V71, P248, DOI 10.1212/01.wnl.0000319610.29522.8a; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Gu J, 2009, J MED GENET, V46, P657, DOI 10.1136/jmg.2009.066456; Keith Michael P, 2012, Am J Orthop (Belle Mead NJ), V41, pE166; Laval SH, 2001, AM J HUM GENET, V68, P918, DOI 10.1086/319509; Lin ZM, 2012, NAT GENET, V44, P73, DOI 10.1038/ng.1005; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Peretz A, 2007, Rev Med Brux, V28, P290; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reveille JD, 2006, BEST PRACT RES CL RH, V20, P601, DOI 10.1016/j.berh.2006.03.004; Reveille JD, 2012, NAT REV RHEUMATOL, V8, P296, DOI 10.1038/nrrheum.2012.41; Reveille JD, 2010, J RHEUMATOL, V37, P2624, DOI 10.3899/jrheum.100891; Reveille JD, 2010, NAT GENET, V42, P123, DOI 10.1038/ng.513; Slager SL, 2011, BLOOD, V117, P1911, DOI 10.1182/blood-2010-09-308205; Smedby KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001378; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Zhang G, 2004, ARTHRITIS RHEUM-US, V50, P2246, DOI 10.1002/art.20308	30	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166888	10.1371/journal.pone.0166888	http://dx.doi.org/10.1371/journal.pone.0166888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973620	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300014
J	Boczkowska, M; Lapinski, B; Kordulasinska, I; Dostatny, DF; Czembor, JH				Boczkowska, Maja; Lapinski, Boguslaw; Kordulasinska, Izabela; Dostatny, Denise F.; Czembor, Jerzy H.			Promoting the Use of Common Oat Genetic Resources through Diversity Analysis and Core Collection Construction	PLOS ONE			English	Article							AVENA-SATIVA L.; POPULATION-STRUCTURE; POWDERY MILDEW; GRAIN-YIELD; DNA POLYMORPHISM; AFLP MARKERS; TEST WEIGHT; CROWN RUST; RESISTANCE; CULTIVARS	The assessment of diversity and population structure and construction of a core collection is beneficial for the efficient use and management of germplasm. A unique collection of common oat landraces, cultivated in the temperate climate of central Europe until the end of the twentieth century, is preserved in the Polish gene bank. It consists of 91 accessions that have never been used in breeding programs. In order to optimise the use of this genetic resource, we aimed to: (1) determine genetic and agro-morphological diversity, (2) identify internal genetic variation of the tested accessions, (3) form a core collection and (4) recognise the accessions useful for breeding programs or re-release for cultivation. The collection was screened using ISSR markers (1520 loci) and eight agro-morphological traits. Uniquely, we performed molecular studies based on 24 individuals of every accession instead of bulk samples. Therefore, assessment of the degree of diversity within each population and the identification of overlapping gene pools were possible. The observed internal diversity (Nei unbiased coefficient) was in the range of 0.17-0.31. Based on combined genetic and agromorphological data, we established the core collection composed of 21 landraces. Due to valuable compositions of important traits, some accessions were also identified as useful for breeding programs. The population structure and principal coordinate analysis revealed two major clusters. Based on the previous results, the accessions classified within the smaller one were identified as obsolete varieties instead of landraces. Our results show that the oat landraces are, in general, resistant to local races of diseases, well adapted to local conditions and, in some cases, yielding at the level of modern varieties. Therefore, in situ conservation of the landraces in the near future may be satisfactory for both farmers and researchers in terms of the genetic resources preservation.	[Boczkowska, Maja; Lapinski, Boguslaw; Kordulasinska, Izabela; Dostatny, Denise F.; Czembor, Jerzy H.] Natl Ctr Plant Genet Resources, Plant Breeding & Acclimatizat Inst IHAR, Natl Res Inst, Radzikow, Poland	Institute of Plant Breeding & Acclimatization	Boczkowska, M (corresponding author), Natl Ctr Plant Genet Resources, Plant Breeding & Acclimatizat Inst IHAR, Natl Res Inst, Radzikow, Poland.	m.boczkowska@ihar.edu.pl	Czembor, Jerzy H./I-8188-2015; Boczkowska, Maja/J-3654-2019; Dostatny, Denise/AAG-6582-2021	Boczkowska, Maja/0000-0001-8691-410X; Dostatny, Denise/0000-0002-6544-1531; Czembor, Jerzy H./0000-0002-3997-3868	Ministry of Agriculture and Rural Development of Poland [3-1-02-0-08, 3-1-02-0-13, PW 1.2, 3-1-03-0-08, 3-1-03-0-23]	Ministry of Agriculture and Rural Development of Poland	This work was supported by the Ministry of Agriculture and Rural Development of Poland in the form of the Multi-annual programs: 2015-2020:Creation of scientific basis for biological improvement and plant genetic resources protection as source of innovation and support of sustainable agriculture and national food security (Project No. 3-1-02-0-08; 3-1-02-0-13, PW 1.2); 2008-2013:Improving Plants for Sustainable agro-ecosystems, High quality food and crop production for non-food purposes (Project No. 3-1-03-0-08; 3-1-03-0-23).	Achleitner A, 2008, THEOR APPL GENET, V117, P1041, DOI 10.1007/s00122-008-0843-y; Adhikari TB, 2003, PHYTOPATHOLOGY, V93, P1158, DOI 10.1094/PHYTO.2003.93.9.1158; Baohong G, 2003, CEREAL RES COMMUN, V31, P339; Boczkowska M, 2016, ANN APPL BIOL, V169, P155, DOI 10.1111/aab.12289; Boczkowska M, 2014, GENET RESOUR CROP EV, V61, P927, DOI 10.1007/s10722-014-0087-4; Boczkowska M, 2013, GENET RESOUR CROP EV, V60, P2157, DOI 10.1007/s10722-013-9984-1; Boczkowska M, 2015, CEREAL RES COMMUN; Breseghello F, 2013, J AGR FOOD CHEM, V61, P8277, DOI 10.1021/jf305531j; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; EGISET, 2015, DAT NAT CTR PLANT GE; Ersts PJ, 2016, GEOGRAPHIC DISTANCE; EXCOFFIER L, 1992, GENETICS, V131, P479; FAO, 2010, 2 FAO; Fernandez ME, 2002, THEOR APPL GENET, V104, P845, DOI 10.1007/s00122-001-0848-2; Frey K. J., 1982, Plant improvement and somatic cell genetics, P43; Fu YB, 2004, CAN J PLANT SCI, V84, P23; Fu YB, 2003, CROP SCI, V43, P1989, DOI 10.2135/cropsci2003.1989; Gollin D, 2000, AM J AGR ECON, V82, P812, DOI 10.1111/0002-9092.00083; Gorny A., 2005, OUTLINE CERALS GENET; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Gregova E, 1999, GENET RESOUR CROP EV, V46, P521, DOI 10.1023/A:1008751815445; Hagenblad J, 2012, GENET RESOUR CROP EV, V59, P1185, DOI 10.1007/s10722-011-9754-x; Hammami R, 2014, PLANT SYST EVOL, V300, P2029, DOI 10.1007/s00606-014-1021-0; Herrmann M, 1996, EUPHYTICA, V89, P405; Holland JB, 2002, THEOR APPL GENET, V105, P113, DOI 10.1007/s00122-001-0845-5; Holland JB, 2001, CROP SCI, V41, P1041, DOI 10.2135/cropsci2001.4141041x; Hsam SLK, 2014, J APPL GENET, V55, P155, DOI 10.1007/s13353-014-0196-y; Hu J, 2000, THEOR APPL GENET, V101, P264, DOI 10.1007/s001220051478; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JONES IT, 1987, ANN APPL BIOL, V110, P591, DOI 10.1111/j.1744-7348.1987.tb04178.x; Karp A, 1997, MOL TOOLS SCREENING; Khan MK, 2014, GENET RESOUR CROP EV, V61, P1001, DOI 10.1007/s10722-014-0114-5; Kim KW, 2007, BIOINFORMATICS, V23, P2155, DOI 10.1093/bioinformatics/btm313; KOLB FL, 1990, CROP SCI, V30, P1023, DOI 10.2135/cropsci1990.0011183X003000050014x; LAWES DA, 1965, PLANT PATHOL, V14, P125, DOI 10.1111/j.1365-3059.1965.tb00295.x; LEATH S, 1991, PLANT DIS, V75, P807, DOI 10.1094/PD-75-0807; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Loskutov IG, 2001, RUSS J GENET+, V37, P467, DOI 10.1023/A:1016697812009; MANTEL N, 1967, CANCER RES, V27, P209; Montilla-Bascon G, 2013, PLANT MOL BIOL REP, V31, P1305, DOI 10.1007/s11105-013-0598-8; MUEHLBAU.FJ, 1971, CROP SCI, V11, P375, DOI 10.2135/cropsci1971.0011183X001100030019x; Newton AC, 2010, AGRON SUSTAIN DEV, V30, P237, DOI 10.1051/agro/2009032; Nikoloudakis N, 2008, THEOR APPL GENET, V117, P273, DOI 10.1007/s00122-008-0772-9; Nowosielska Dorota, 2008, Plant Breeding and Seed Science, V58, P11; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Olsen KM, 2001, AM J BOT, V88, P131, DOI 10.2307/2657133; Pawlisch PE, 1962, CROP SCI, P231; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PETR FC, 1966, CROP SCI, V6, P259, DOI 10.2135/cropsci1966.0011183X000600030013x; PIXLEY KV, 1991, CROP SCI, V31, P36, DOI 10.2135/cropsci1991.0011183X003100010008x; Roldan-Ruiz I, 2000, MOL BREEDING, V6, P125, DOI 10.1023/A:1009680614564; Schwarzbach E., 1988, EUROPEAN HDB PLANT D; Siripoonwiwat W, 1996, J QUANTITATIVE TRAIT, P2; Sucher Nikolaus J, 2012, Methods Mol Biol, V862, P13, DOI 10.1007/978-1-61779-609-8_2; TAKEDA K, 1977, EUPHYTICA, V26, P309, DOI 10.1007/BF00026992; ULLSTRUP AJ, 1972, ANNU REV PHYTOPATHOL, V10, P37, DOI 10.1146/annurev.py.10.090172.000345; UPOV, 1994, INT CONV PROT NEW VA; Villa Tania Carolina Camacho, 2005, Plant Genetic Resources Characterization and Utilization, V3, P373, DOI 10.1079/PGR200591; Wang HF, 2012, THEOR APPL GENET, V124, P789, DOI 10.1007/s00122-011-1750-1; Winkler LR, 2016, FRONT PLANT SCI, P7; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Zhu S, 2003, CROP SCI, V43, P358, DOI 10.2135/cropsci2003.0358; ZIETKIEWICZ E, 1994, GENOMICS, V20, P176, DOI 10.1006/geno.1994.1151	67	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167855	10.1371/journal.pone.0167855	http://dx.doi.org/10.1371/journal.pone.0167855			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959891	Green Submitted, gold, Green Published			2022-12-27	WOS:000392753900019
J	Yadav, KK; Datta, S; Naglot, A; Bora, A; Hmuaka, V; Bhagyawant, S; Gogoi, HK; Veer, V; Raju, PS				Yadav, Kamlesh K.; Datta, Sibnarayan; Naglot, Ashok; Bora, Ajitabh; Hmuaka, Vanlal; Bhagyawant, Sameer; Gogoi, Hemanta K.; Veer, Vijay; Raju, P. Srinivas			Diversity of Cultivable Midgut Microbiota at Different Stages of the Asian Tiger Mosquito, Aedes albopictus from Tezpur, India	PLOS ONE			English	Article							ANOPHELES-GAMBIAE; SP NOV.; GUT MICROBIOTA; POPULATION-DYNAMICS; BACTERIAL DIVERSITY; SYMBIOTIC BACTERIA; VECTOR; CHIKUNGUNYA; DIPTERA; MALARIA	Aedes aegypti and Ae. albopictus are among the most important vectors of arboviral diseases, worldwide. Recent studies indicate that diverse midgut microbiota of mosquitoes significantly affect development, digestion, metabolism, and immunity of their hosts. Midgut microbiota has also been suggested to modulate the competency of mosquitoes to transmit arboviruses, malaria parasites etc. Interestingly, the midgut microbial flora is dynamic and the diversity changes with the development of vectors, in addition to other factors such as species, sex, life-stage, feeding behavior and geographical origin. The aim of the present study was to investigate the midgut bacterial diversity among larva, adult male, sugar fed female and blood fed female Ae. albopictus collected from Tezpur, Northeastern India. Based on colony morphological characteristics, we selected 113 cultivable bacterial isolates for 16S rRNA gene sequence based molecular identification. Of the 113 isolates, we could identify 35 bacterial species belonging to 18 distinct genera under four major phyla, namely Proteobacteria, Firmicutes, Actinobacteria and Bacteroidetes. Phyla Proteobacteria and Firmicutes accounted for majority (80%) of the species, while phylum Actinobacteria constituted 17% of the species. Bacteroidetes was the least represented phylum, characterized by a single species-Chryseobacterium rhizoplanae, isolated from blood fed individuals. Dissection of midgut microbiota diversity at different developmental stages of Ae. albopictus will be helpful in better understanding mosquito-borne diseases, and for designing effective strategies to manage mosquito-borne diseases.	[Yadav, Kamlesh K.; Datta, Sibnarayan; Naglot, Ashok; Bora, Ajitabh; Hmuaka, Vanlal; Gogoi, Hemanta K.; Veer, Vijay; Raju, P. Srinivas] DRDO, Def Res Lab, Div Biotechnol, Tezpur, India; [Bhagyawant, Sameer] Jiwaji Univ, Sch Studies Biotechnol, Gwalior, India	Defence Research & Development Organisation (DRDO); Defence Research Laboratory (DRL); Jiwaji University Gwalior	Yadav, KK (corresponding author), DRDO, Def Res Lab, Div Biotechnol, Tezpur, India.	kamalbiotech.yadav@gmail.com	Datta, S./E-7036-2010; Yadav, Kamlesh/O-2071-2017	Datta, S./0000-0001-6953-1510; Yadav, Kamlesh/0000-0003-3871-9937; DHANGRAH, VINOD KUMAR/0000-0002-7954-6326				Abdul-Ghani R, 2012, ACTA TROP, V121, P71, DOI 10.1016/j.actatropica.2011.11.001; Alam SI, 2006, INT J SYST EVOL MICR, V56, P715, DOI 10.1099/ijs.0.63808-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apte-Deshpande A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040401; Apte-Deshpande AD, 2014, INDIAN J MED RES, V139, P762; Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011; Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0; Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742; Buck M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22806; CDC, SURV CONTR AED AEG A; Chandel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080453; CHAO JOWETT, 1959, JOUR INSECT PATHOL, V1, P311; Chavshin AR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-419; Chavshin AR, 2013, SYMBIOSIS, V60, P17, DOI 10.1007/s13199-013-0231-5; Chouaia B, 2010, APPL ENVIRON MICROB, V76, P7444, DOI 10.1128/AEM.01747-10; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Clarke K. R., 2001, CHANGES MARINE COMMU; Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771; Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003; DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219; Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004; Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223; Diaz-Nieto LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153133; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; FERGUSON MJ, 1961, J INSECT PATHOL, V3, P112; Finney CAM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004646; Foster WA, 2004, B ENTOMOL RES, V94, P145, DOI 10.1079/BER2003288; Fouda M. A., 2001, Journal of the Egyptian Society of Parasitology, V31, P767; Gaio Analiz de O, 2011, Parasit Vectors, V4, P105, DOI 10.1186/1756-3305-4-105; Gary RE, 2004, MED VET ENTOMOL, V18, P102, DOI 10.1111/j.0269-283X.2004.00483.x; Gneiding K, 2008, J CLIN MICROBIOL, V46, P3646, DOI 10.1128/JCM.01202-08; Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011; HaraKudo Y, 1997, MICROB PATHOGENESIS, V22, P31, DOI 10.1006/mpat.1996.0088; Hurwitz I, 2011, INT J BIOL SCI, V7, P1334, DOI 10.7150/ijbs.7.1334; Impoinvil DE, 2004, MED VET ENTOMOL, V18, P108, DOI 10.1111/j.0269-283X.2004.00484.x; Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5; Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002; Kampfer P, 2015, ANTON LEEUW INT J G, V107, P533, DOI 10.1007/s10482-014-0349-3; Kim HJ, 2011, J MICROBIOL, V49, P1044, DOI 10.1007/s12275-011-1548-5; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Laffineur K, 2003, J CLIN MICROBIOL, V41, P2242, DOI 10.1128/JCM.41.5.2242-2246.2003; Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Manda H, 2007, MED VET ENTOMOL, V21, P103, DOI 10.1111/j.1365-2915.2007.00672.x; Metchnikoff E, 1908, CR HEBD ACAD SCI, V147, P579; Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146; Moro CV, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-70; Mourya D. T., 2002, Dengue Bulletin, V26, P190; Oakeson KF, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00392-16; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597; Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214; Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96; Reinert JF, 2009, ZOOL J LINN SOC-LOND, V157, P700, DOI 10.1111/j.1096-3642.2009.00570.x; Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X; Ricci I, 2012, PATHOG GLOB HEALTH, V106, P380, DOI 10.1179/2047773212Y.0000000051; Rueda LM, 2004, PICRORIAL KEYS IDENT; Sambrook J., 2001, MOL CLONING LAB MANU; Shivaji S, 2009, INT J SYST EVOL MICR, V59, P2977, DOI 10.1099/ijs.0.002527-0; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith TW, 1998, J AM MOSQUITO CONTR, V14, P72; Sorensen T., 1948, K DAN VIDENSK SELSK, V5, P1; Soto-Rodriguez SA, 2013, J APPL MICROBIOL, V115, P654, DOI 10.1111/jam.12280; Straif SC, 1998, J MED ENTOMOL, V35, P222, DOI 10.1093/jmedent/35.3.222; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terenius O, 2012, FEMS MICROBIOL ECOL, V80, P556, DOI 10.1111/j.1574-6941.2012.01317.x; Wang SB, 2012, P NATL ACAD SCI USA, V109, P12734, DOI 10.1073/pnas.1204158109; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; World Health Organization, 2016, ZIK SIT REP NEUR SYN; Yadav KK, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1252-0; Yadav KK, 2015, INT J MICROBIOL RES, V2; Zhu DC, 2016, INT J SYST EVOL MICR, V66, P1857, DOI 10.1099/ijsem.0.000957; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x	82	30	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167409	10.1371/journal.pone.0167409	http://dx.doi.org/10.1371/journal.pone.0167409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941985	Green Published, Green Submitted, gold			2022-12-27	WOS:000392745600015
J	Tsukuda, K; Mogi, M; Iwanami, J; Kanno, H; Nakaoka, H; Wang, XL; Bai, HY; Shan, BS; Kukida, M; Higaki, A; Yamauchi, T; Min, LJ; Horiuchi, M				Tsukuda, Kana; Mogi, Masaki; Iwanami, Jun; Kanno, Harumi; Nakaoka, Hirotomo; Wang, Xiao-Li; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Higaki, Akinori; Yamauchi, Toshifumi; Min, Li-Juan; Horiuchi, Masatsugu			Enhancement of Adipocyte Browning by Angiotensin II Type 1 Receptor Blockade	PLoS One			English	Article							1A RECEPTOR; PPAR-GAMMA; EXPRESSION; DIFFERENTIATION; SYSTEM; MICE; CONVERSION; MOUSE; WHITE	Browning of white adipose tissue (WAT) has been highlighted as a new possible therapeutic target for obesity, diabetes and lipid metabolic disorders, because WAT browning could increase energy expenditure and reduce adiposity. The new clusters of adipocytes that emerge with WAT browning have been named 'beige' or 'brite' adipocytes. Recent reports have indicated that the renin-angiotensin system (RAS) plays a role in various aspects of adipose tissue physiology and dysfunction. The biological effects of angiotensin II, a major component of RAS, are mediated by two receptor subtypes, angiotensin II type 1 receptor (AT(1)R) and type 2 receptor (AT(2)R). However, the functional roles of angiotensin II receptor subtypes in WAT browning have not been defined. Therefore, we examined whether deletion of angiotensin II receptor subtypes (AT(1a)R and AT(2)R) may affect white-to-beige fat conversion in vivo. AT(1a) receptor knockout (AT(1a)KO) mice exhibited increased appearance of multilocular lipid droplets and upregulation of thermogenic gene expression in inguinal white adipose tissue (iWAT) compared to wild-type (WT) mice. AT(2) receptor-deleted mice did not show miniaturization of lipid droplets or alteration of thermogenic gene expression levels in iWAT. An in vitro experiment using adipose tissue-derived stem cells showed that deletion of the AT(1a) receptor resulted in suppression of adipocyte differentiation, with reduction in expression of thermogenic genes. These results indicate that deletion of the AT(1a) receptor might have some effects on the process of browning of WAT and that blockade of the AT(1) receptor could be a therapeutic target for the treatment of metabolic disorders.	[Tsukuda, Kana; Mogi, Masaki; Iwanami, Jun; Kanno, Harumi; Nakaoka, Hirotomo; Wang, Xiao-Li; Bai, Hui-Yu; Shan, Bao-Shuai; Kukida, Masayoshi; Higaki, Akinori; Yamauchi, Toshifumi; Min, Li-Juan; Horiuchi, Masatsugu] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan; [Kukida, Masayoshi; Higaki, Akinori] Ehime Univ, Grad Sch Med, Dept Cardiol Pulmonol Hypertens & Nephrol, Tohon, Ehime, Japan; [Yamauchi, Toshifumi] Ehime Univ, Grad Sch Med, Dept Pediat, Tohon, Ehime, Japan	Ehime University; Ehime University; Ehime University	Horiuchi, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan.	horiuchi@m.ehime-u.ac.jp	Higaki, Akinori/AAA-2551-2019	Higaki, Akinori/0000-0002-0827-874X	JSPS KAKENHI [25293310, 25462220, 15K19974, 26860567]; Ajinomoto Pharmaceuticals Co. Ltd.; Astellas Pharma Inc.; Bayer Yakuhin Ltd.; Daiichi-Sankyo Pharmaceutical Co. Ltd.; Nippon Boehringer Ingelheim Co. Ltd.; Novartis Pharma K.K.; Shionogi Co. Ltd.; Takeda Pharmaceutical Co. Ltd.	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ajinomoto Pharmaceuticals Co. Ltd.; Astellas Pharma Inc.(Astellas Pharmaceuticals); Bayer Yakuhin Ltd.; Daiichi-Sankyo Pharmaceutical Co. Ltd.; Nippon Boehringer Ingelheim Co. Ltd.(Boehringer Ingelheim); Novartis Pharma K.K.(Novartis); Shionogi Co. Ltd.; Takeda Pharmaceutical Co. Ltd.(Takeda Pharmaceutical Company Ltd)	This study was supported by JSPS KAKENHI [Grant Number 25293310 to MH, 25462220 to MM, 15K19974 to JI, and 26860567 to LJM] and research grants from pharmaceutical companies: Ajinomoto Pharmaceuticals Co. Ltd., Astellas Pharma Inc., Bayer Yakuhin Ltd., Daiichi-Sankyo Pharmaceutical Co. Ltd., Nippon Boehringer Ingelheim Co. Ltd., Novartis Pharma K.K., Shionogi & Co. Ltd., and Takeda Pharmaceutical Co. Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURSON JM, 1994, AM J PHYSIOL, V267, pE260, DOI 10.1152/ajpendo.1994.267.2.E260; de Kloet AD, 2014, PHYSIOL BEHAV, V136, P31, DOI 10.1016/j.physbeh.2014.01.016; de Kloet AD, 2013, J NEUROSCI, V33, P4825, DOI 10.1523/JNEUROSCI.3806-12.2013; Fujimoto M, 2004, FEBS LETT, V576, P492, DOI 10.1016/j.febslet.2004.09.027; Furuhashi M, 2004, J HYPERTENS, V22, P1977, DOI 10.1097/00004872-200410000-00021; Garcia-Alonso V, 2013, J BIOL CHEM, V288, P28230, DOI 10.1074/jbc.M113.468603; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Head GA, 2001, ANN NY ACAD SCI, V940, P361; Iwai M, 2005, CIRCULATION, V112, P1636, DOI 10.1161/CIRCULATIONAHA.104.525550; Iwai M, 2009, AM J HYPERTENS, V22, P784, DOI 10.1038/ajh.2009.85; Jing F, 2013, MOL CELL ENDOCRINOL, V378, P23, DOI 10.1016/j.mce.2012.03.005; Kouyama R, 2005, ENDOCRINOLOGY, V146, P3481, DOI 10.1210/en.2005-0003; LLORENSCORTES C, 1994, HYPERTENSION, V24, P538, DOI 10.1161/01.HYP.24.5.538; Lob HE, 2010, HYPERTENSION, V55, P277, DOI 10.1161/HYPERTENSIONAHA.109.142646; Marcus Y, 2013, DIABETES, V62, P1121, DOI 10.2337/db12-0792; Matsushita K, 2006, HYPERTENSION, V48, P1095, DOI 10.1161/01.HYP.0000248211.82232.a7; Mogi M, 2006, HYPERTENSION, V48, P1020, DOI 10.1161/01.HYP.0000248196.14826.31; Ohshima K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048387; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; SASAMURA H, 1992, BIOCHEM BIOPH RES CO, V185, P253, DOI 10.1016/S0006-291X(05)80983-0; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Tham DM, 2002, PHYSIOL GENOMICS, V11, P21, DOI 10.1152/physiolgenomics.00062.2002; Tiyerili V, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-30; Tomono Y, 2008, AM J HYPERTENS, V21, P206, DOI 10.1038/ajh.2007.50; Wang Chih-Hong, 2010, Open Hypertens J, V3, P1	27	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167704	10.1371/journal.pone.0167704	http://dx.doi.org/10.1371/journal.pone.0167704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992452	Green Submitted, gold, Green Published			2022-12-27	WOS:000392842600018
J	Kirzinger, L; Boy, S; Marienhagen, J; Schuierer, G; Neu, R; Ried, M; Hofmann, HS; Wiebe, K; Strobel, P; May, C; Kleylein-Sohn, J; Baierlein, C; Bogdahn, U; Marx, A; Schalke, B				Kirzinger, Lukas; Boy, Sandra; Marienhagen, Joerg; Schuierer, Gerhard; Neu, Reiner; Ried, Michael; Hofmann, Hans-Stefan; Wiebe, Karsten; Stroebel, Philipp; May, Christoph; Kleylein-Sohn, Julia; Baierlein, Claudia; Bogdahn, Ulrich; Marx, Alexander; Schalke, Berthold			Octreotide LAR and Prednisone as Neoadjuvant Treatment in Patients with Primary or Locally Recurrent Unresectable Thymic Tumors: A Phase II Study	PLOS ONE			English	Article							SOMATOSTATIN RECEPTOR SCINTIGRAPHY; COOPERATIVE-ONCOLOGY-GROUP; MALIGNANT THYMOMA; MYASTHENIA-GRAVIS; EPITHELIAL TUMORS; LONG-TERM; MANAGEMENT; PROGNOSIS; CARCINOMA; CRITERIA	Therapeutic options to cure advanced, recurrent, and unresectable thymomas are limited. The most important factor for long-term survival of thymoma patients is complete resection (R0) of the tumor. We therefore evaluated the response to and the induction of resectability of primarily or locally recurrent unresectable thymomas and thymic carcinomas by octreotide Long-Acting Release (LAR) plus prednisone therapy in patients with positive octreotide scans. In this open label, single-arm phase II study, 17 patients with thymomas considered unresectable or locally recurrent thymoma (n = 15) and thymic carcinoma (n = 2) at Masaoka stage III were enrolled. Octreotide LAR (30 mg once every 2 weeks) was administered in combination with prednisone (0.6 mg/kg per day) for a maximum of 24 weeks (study design according to Fleming's one sample multiple testing procedure for phase II clinical trials). Tumor size was evaluated by volumetric CT measurements, and a decrease in tumor volume of at least 20% at week 12 compared to baseline was considered as a response. We found that octreotide LAR plus prednisone elicited response in 15 of 17 patients (88%). Median reduction of tumor volume after 12 weeks of treatment was 51% (range 20%-86%). Subsequently, complete surgical resection was achieved in five (29%) and four patients (23%) after 12 and 24 weeks, respectively. Octreotide LAR plus prednisone treatment was discontinued in two patients before week 12 due to unsatisfactory therapeutic effects or adverse events. The most frequent adverse events were gastrointestinal (71%), infectious (65%), and hematological (41%) complications. In conclusion, octreotide LAR plus prednisone is efficacious in patients with primary or recurrent unresectable thymoma with respect to tumor regression. Octreotide LAR plus prednisone was well tolerated and adverse events were in line with the known safety profile of both agents.	[Kirzinger, Lukas; Boy, Sandra; Bogdahn, Ulrich; Schalke, Berthold] Univ Regensburg, Dept Neurol, Regensburg, Germany; [Marienhagen, Joerg] Univ Regensburg, Dept Nucl Med, Regensburg, Germany; [Schuierer, Gerhard] BKR, Inst Neuroradiol, Regensburg, Germany; [Neu, Reiner; Ried, Michael; Hofmann, Hans-Stefan] Univ Regensburg, Dept Thorac Surg, Regensburg, Germany; [Wiebe, Karsten] Univ Munster, Dept Cardiac & Thorac Surg, Munster, Germany; [Stroebel, Philipp] Univ Goettingen, Inst Pathol, Gottingen, Germany; [May, Christoph; Kleylein-Sohn, Julia; Baierlein, Claudia] Novartis Pharma GmbH, Nurnberg, Germany; [Marx, Alexander] Heidelberg Univ, Univ Med Ctr Mannheim, Inst Pathol, Mannheim, Germany; [Boy, Sandra] Asklepios Clin, Bad Toelz, Germany	University of Regensburg; University of Regensburg; University of Regensburg; University of Munster; University of Gottingen; Novartis; Ruprecht Karls University Heidelberg	Kirzinger, L (corresponding author), Univ Regensburg, Dept Neurol, Regensburg, Germany.	lukas.kirzinger@medbo.de	Ried, Michael/AAC-4518-2022	Ried, Michael/0000-0002-2365-4803	Novartis (Novartis Pharma GmbH, Nuremberg, Germany)	Novartis (Novartis Pharma GmbH, Nuremberg, Germany)	Novartis (Novartis Pharma GmbH, Nuremberg, Germany) funded the study, participated in the development of the study design, provided statistical support and the octreotide LAR medication, but did not participate in the collection and interpretation of the data. Novartis participated in the editorial writing and review of the manuscript. The author Dr. Boy became an employee of Asclepios clinic in 2015. Asclepios clinic was not a funder and did not play a role in this study.	Ahmad U, 2015, J THORAC CARDIOV SUR, V149, P95, DOI 10.1016/j.jtcvs.2014.09.124; Barratt S, 2007, EUR J CARDIO-THORAC, V31, P1142, DOI 10.1016/j.ejcts.2007.02.032; Benveniste MF, 2014, J THORAC ONCOL, V9, pS119, DOI 10.1097/JTO.0000000000000296; BESINGER UA, 1983, NEUROLOGY, V33, P1316, DOI 10.1212/WNL.33.10.1316; Bretti S, 2004, LUNG CANCER, V44, P69, DOI 10.1016/j.lungcan.2003.09.022; Caplin ME, 2014, NEW ENGL J MED, V371, P224, DOI 10.1056/NEJMoa1316158; Chen G, 2002, CANCER, V95, P420, DOI 10.1002/cncr.10665; DARDENNE M, 1986, CELL IMMUNOL, V100, P112, DOI 10.1016/0008-8749(86)90011-0; Detterbeck FC, 2004, ANN THORAC SURG, V77, P1860, DOI 10.1016/j.athoracsur.2003.10.001; Detterbeck FC, 2011, J THORAC ONCOL, V6, pS1710, DOI 10.1097/JTO.0b013e31821e8cff; Detterbeck FC, 2011, THORAC SURG CLIN, V21, P59, DOI 10.1016/j.thorsurg.2010.08.001; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Engels EA, 2003, INT J CANCER, V105, P546, DOI 10.1002/ijc.11099; FLEMING TR, 1982, BIOMETRICS, V38, P143, DOI 10.2307/2530297; FULLER PJ, 1989, J IMMUNOL, V143, P1015; Geffen DB, 2001, AM J CLIN ONCOL-CANC, V24, P566, DOI 10.1097/00000421-200112000-00007; Giustina A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036411; Harnath T, 2012, J THORAC ONCOL, V7, P1867, DOI 10.1097/JTO.0b013e3182745f73; Holbro A, 2012, HUM IMMUNOL, V73, P287, DOI 10.1016/j.humimm.2011.12.022; HU E, 1986, CANCER, V57, P1101, DOI 10.1002/1097-0142(19860315)57:6<1101::AID-CNCR2820570606>3.0.CO;2-A; Kelly RJ, 2011, J CLIN ONCOL, V29, P4820, DOI 10.1200/JCO.2011.36.0487; Kobayashi Y, 2006, CANCER-AM CANCER SOC, V106, P1901, DOI 10.1002/cncr.21875; Korst RJ, 2014, J THORAC CARDIOV SUR, V147, P36, DOI 10.1016/j.jtcvs.2013.08.061; Lastoria S, 1998, J NUCL MED, V39, P634; Lin K, 1999, CLIN NUCL MED, V24, P24, DOI 10.1097/00003072-199901000-00006; LOEHRER PJ, 1994, J CLIN ONCOL, V12, P1164, DOI 10.1200/JCO.1994.12.6.1164; Loehrer PJ, 2004, J CLIN ONCOL, V22, P293, DOI 10.1200/JCO.2004.02.047; Marienhagen J, 1999, PATHOL RES PRACT, V195, P575, DOI 10.1016/S0344-0338(99)80008-9; Marx A, 2010, AUTOIMMUNITY, V43, P413, DOI 10.3109/08916930903555935; MASAOKA A, 1981, CANCER, V48, P2485, DOI 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R; Muller-Hermelink HK., 2004, WHO CLASSIFICATION T, P196; Nicholson, 2015, WHO CLASSIFICATION T, P184; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Palmieri G, 1997, NEW ENGL J MED, V336, P263, DOI 10.1056/NEJM199701233360405; Palmieri G, 2002, CANCER-AM CANCER SOC, V94, P1414, DOI 10.1002/cncr.10374; REUBI JC, 1994, CANCER RES, V54, P3455; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Rosai J., 1999, HISTOLOGICAL TYPING, P5; Scorsetti M, 2016, CRIT REV ONCOL HEMAT, V99, P332, DOI 10.1016/j.critrevonc.2016.01.012; SOFFER LJ, 1952, J CLIN ENDOCR METAB, V12, P690, DOI 10.1210/jcem-12-6-690; Strobel P, 2004, J CLIN ONCOL, V22, P1501, DOI 10.1200/JCO.2004.10.113; Stroebel P, 2010, J THORAC ONCOL, V5, pS286, DOI 10.1097/JTO.0b013e3181f209a8; Weckbecker G, 2003, NAT REV DRUG DISCOV, V2, P999, DOI 10.1038/nrd1255; WECKBECKER G, 1993, PHARMACOL THERAPEUT, V60, P245, DOI 10.1016/0163-7258(93)90009-3; Weis CA, 2015, J THORAC ONCOL, V10, P367, DOI 10.1097/JTO.0000000000000393; WILLCOX N, 1987, AM J PATHOL, V127, P447; Woltering EA, 1997, INVEST NEW DRUG, V15, P77, DOI 10.1023/A:1005774713202	47	5	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168215	10.1371/journal.pone.0168215	http://dx.doi.org/10.1371/journal.pone.0168215			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992479	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000032
J	Mizuyama, R; Soma, S; Suemastu, N; Shimegi, S				Mizuyama, Ryo; Soma, Shogo; Suemastu, Naofumi; Shimegi, Satoshi			Noradrenaline Improves Behavioral Contrast Sensitivity via the beta-Adrenergic Receptor	PLOS ONE			English	Article							RAT VISUAL-CORTEX; LOCUS-COERULEUS; NEURONS; NOREPINEPHRINE; SEROTONIN; MONKEY	Noradrenaline (NA) is released from the locus coeruleus in the brainstem to almost the whole brain depending on the physiological state or behavioral context. NA modulates various brain functions including vision, but many questions about the functional role of its effects and mechanisms remain unclear. To explore these matters, we focused on three questions, 1) whether NA improves detectability of a behavior-relevant visual stimulus, 2) which receptor subtypes contribute to the NA effects, and 3) whether the NA effects are specific for visual features such as spatial frequency (SF). We measured contrast sensitivity in rats by a two-alternative forced choice visual detection task and tested the effects of NA receptor blockers in three SF conditions. Propranolol, a beta-adrenergic receptor inhibitor, significantly decreased contrast sensitivity, but neither prazosin nor idazoxan, alpha(1)- and alpha(2)-adrenergic receptor inhibitors, respectively, had an effect. This beta blocker effect was observed only at optimal SF. These results indicate that endogenous NA enhances visual detectability depending on stimulus spatial properties via mainly beta-adrenergic receptors.	[Mizuyama, Ryo; Shimegi, Satoshi] Osaka Univ, Lab Cognit & Behav Neurosci, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Soma, Shogo; Suemastu, Naofumi; Shimegi, Satoshi] Osaka Univ, Lab Cognit & Behav Neurosci, Grad Sch Med, Toyonaka, Osaka, Japan; [Soma, Shogo] Tamagawa Univ, Brain Sci Inst, Tokyo, Japan; [Suemastu, Naofumi] Osaka Univ, Grad Sch Engn, Suita, Osaka, Japan	Osaka University; Osaka University; Osaka University	Shimegi, S (corresponding author), Osaka Univ, Lab Cognit & Behav Neurosci, Grad Sch Frontier Biosci, Suita, Osaka, Japan.; Shimegi, S (corresponding author), Osaka Univ, Lab Cognit & Behav Neurosci, Grad Sch Med, Toyonaka, Osaka, Japan.	shimegi@vision.hss.osaka-u.ac.jp		Soma, Shogo/0000-0002-7381-9477	KAKENHI [22500573, 25282216, 25560302, 16H01869]; Grants-in-Aid for Scientific Research [16H01869] Funding Source: KAKEN	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by KAKENHI (http://www.mext.go.jp/english/), 22500573, 25282216, 25560302, and 16H01869 to S. Shimegi.	ARENA/OLAW, 2002, I AN CAR US COMM GUI, V2nd; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Bakshi VP, 1999, NEUROSCIENCE, V92, P113, DOI 10.1016/S0306-4522(98)00752-0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; DEVAUGES V, 1990, BEHAV BRAIN RES, V39, P19, DOI 10.1016/0166-4328(90)90118-X; Edeline JM, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00045; Histed MH, 2012, J NEUROPHYSIOL, V107, P758, DOI 10.1152/jn.00609.2011; JONES BE, 1977, BRAIN RES, V127, P1, DOI 10.1016/0006-8993(77)90377-8; Khalifa AE, 2001, J ETHNOPHARMACOL, V76, P49, DOI 10.1016/S0378-8741(01)00210-0; KOLTA A, 1989, CAN J PHYSIOL PHARM, V67, P615, DOI 10.1139/y89-098; KOLTA A, 1987, LIFE SCI, V41, P281, DOI 10.1016/0024-3205(87)90150-0; Lee S. B., 2012, INT J TOUR RES, V15, P209, DOI DOI 10.1016/J.NEUR0N.2012.09.012; Manunta Y, 1997, EUR J NEUROSCI, V9, P833, DOI 10.1111/j.1460-9568.1997.tb01433.x; OHRSTROM A, 1980, ARCH OPHTHALMOL-CHIC, V98, P2182; OLPE HR, 1980, BRAIN RES, V186, P9, DOI 10.1016/0006-8993(80)90251-6; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; RAJKOWSKI J, 1994, BRAIN RES BULL, V35, P607, DOI 10.1016/0361-9230(94)90175-9; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; READER TA, 1978, EXPERIENTIA, V34, P1586, DOI 10.1007/BF02034690; SATO H, 1989, J NEUROPHYSIOL, V62, P946, DOI 10.1152/jn.1989.62.4.946; Soma S, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12060; Soma S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00063; Soma S, 2013, BEHAV BRAIN RES, V256, P362, DOI 10.1016/j.bbr.2013.08.022; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; VIDEEN TO, 1984, J NEUROSCI, V4, P1607; WATERHOUSE BD, 1990, BRAIN RES, V514, P276, DOI 10.1016/0006-8993(90)91422-D	26	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168455	10.1371/journal.pone.0168455	http://dx.doi.org/10.1371/journal.pone.0168455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992510	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000051
J	Arif, R; Farag, M; Zaradzki, M; Reissfelder, C; Pianka, F; Bruckner, T; Kremer, J; Franz, M; Ruhparwar, A; Szabo, G; Beller, CJ; Karck, M; Kallenbach, K; Weymann, A				Arif, Rawa; Farag, Mina; Zaradzki, Marcin; Reissfelder, Christoph; Pianka, Frank; Bruckner, Thomas; Kremer, Jamila; Franz, Maximilian; Ruhparwar, Arjang; Szabo, Gabor; Beller, Carsten J.; Karck, Matthias; Kallenbach, Klaus; Weymann, Alexander			Ischemic Colitis after Cardiac Surgery: Can We Foresee the Threat?	PLOS ONE			English	Article							NONOCCLUSIVE MESENTERIC ISCHEMIA; OPEN-HEART-SURGERY; CARDIOPULMONARY-BYPASS; GASTROINTESTINAL COMPLICATIONS; RISK-FACTORS; SURGICAL-PATIENTS; MUCOSAL ISCHEMIA; DYSFUNCTION; DIAGNOSIS; GUT	Introduction Ischemic colitis (IC) remains a great threat after cardiac surgery with use of extracorporeal circulation. We aimed to identify predictive risk factors and influence of early catecholamine therapy for this disease. Methods We prospectively collected and analyzed data of 224 patients, who underwent laparotomy due to IC after initial cardiac surgery with use of extracorporeal circulation during 2002 and 2014. For further comparability 58 patients were identified, who underwent bypass surgery, aortic valve replacement or combination of both. Age +/-5 years, sex, BMI +/- 5, left ventricular function, peripheral arterial disease, diabetes and urgency status were used for match-pair analysis (1: 1) to compare outcome and detect predictive risk factors. Highest catecholamine doses during 1 POD were compared for possible predictive potential. Results Patients' baseline characteristics showed no significant differences. In-hospital mortality of the IC group with a mean age of 71 years (14% female) was significantly higher than the control group with a mean age of 70 (14% female) (67% vs. 16%, p < 0.001). Despite significantly longer bypass time in the IC group (133 +/- 68 vs. 101 +/- 42, p = 0.003), cross-clamp time remained comparable (64 +/- 33 vs. 56 +/- 25 p = 0.150). The majority of the IC group suffered low-output syndrome (71% vs. 14%, p < 0.001) leading to significant higher lactate values within first 24h after operation (55 +/- 46 mg/dl vs. 31 +/- 30 mg/dl, p = 0.002). Logistic regression revealed elevated lactate values to be significant predictor for colectomy during the postoperative course (HR 1.008, CI 95% 1.003 +/- 1.014, p = 0.003). However, Receiver Operating Characteristic Curve calculates a cut-off value for lactate of 22.5 mg/dl (sensitivity 73% and specificity 57%). Furthermore, multivariate analysis showed low-output syndrome (HR 4.301, CI 95% 2.108-8.776, p < 0.001) and vasopressin therapy (HR 1.108, CI 95% 1.012-1.213, p = 0.027) significantly influencing necessity of laparotomy. Conclusion Patients who undergo laparotomy for IC after initial cardiac surgery have a substantial inhospital mortality risk. Early postoperative catecholamine levels do not influence the development of an IC except vasopressin. Elevated lactate remains merely a vague predictive risk factor.	[Arif, Rawa; Farag, Mina; Zaradzki, Marcin; Kremer, Jamila; Franz, Maximilian; Ruhparwar, Arjang; Szabo, Gabor; Beller, Carsten J.; Karck, Matthias; Weymann, Alexander] Heidelberg Univ, Heart & Marfan Ctr, Dept Cardiac Surg, Heidelberg, Germany; [Reissfelder, Christoph] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Visceral Thorac & Vasc Surg, Fetscherstr, Dresden, Germany; [Pianka, Frank] Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany; [Bruckner, Thomas] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Kallenbach, Klaus] HaerzZenter INCCI, Dept Cardiac Surg, Rue Ernest Barble, Luxembourg, Luxembourg	Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Arif, R (corresponding author), Heidelberg Univ, Heart & Marfan Ctr, Dept Cardiac Surg, Heidelberg, Germany.	rawa.arif@med.uni-heidelberg.de	Weymann, Alexander/AAQ-5115-2021	Szabo, Gabor/0000-0001-6038-9968				Abboud B, 2008, WORLD J GASTROENTERO, V14, P5361, DOI 10.3748/wjg.14.5361; Acosta S, 2006, J INTERN MED, V259, P305, DOI 10.1111/j.1365-2796.2006.01613.x; ALLEN KB, 1992, J VASC SURG, V16, P391, DOI 10.1016/0741-5214(92)90372-F; BAILEY RW, 1986, ANN SURG, V203, P590, DOI 10.1097/00000658-198606000-00002; BAUE AE, 1993, ANN THORAC SURG, V55, P822, DOI 10.1016/0003-4975(93)90098-3; Bolcal C, 2005, CAN J GASTROENTEROL, V19, P613, DOI 10.1155/2005/975612; Bomberg H, 2016, ANN THORAC SURG; Bomberg H, 2015, EUR SURG RES, V54, P75, DOI 10.1159/000368355; Chang RW, 2006, WORLD J GASTROENTERO, V12, P3243, DOI 10.3748/wjg.v12.i20.3243; Demir IE, 2012, DIGEST SURG, V29, P226, DOI 10.1159/000338086; Demir M, 2014, MED PRIN PRACT, V23, P140, DOI 10.1159/000356860; Ghosh S, 2002, EUR J CARDIO-THORAC, V21, P411, DOI 10.1016/S1010-7940(02)00015-5; Groesdonk HV, 2013, J THORAC CARDIOV SUR, V145, P1603, DOI 10.1016/j.jtcvs.2012.11.022; Hasan S, 2004, Interact Cardiovasc Thorac Surg, V3, P475, DOI 10.1016/j.icvts.2004.04.003; Klotz S, 2001, ANN THORAC SURG, V72, P1583, DOI 10.1016/S0003-4975(01)03179-4; Mangi AA, 2005, ANN SURG, V241, P895, DOI 10.1097/01.sla.0000164173.05762.32; Reissfelder C, 2011, SURGERY, V149, P585, DOI 10.1016/j.surg.2010.11.008; Ritz JP, 2005, ANN VASC SURG, V19, P328, DOI 10.1007/s10016-005-0005-5; Schutz A, 1998, ANGIOLOGY, V49, P267, DOI 10.1177/000331979804900404; TAO WK, 1995, J THORAC CARDIOV SUR, V110, P819, DOI 10.1016/S0022-5223(95)70116-8; Tofukuji M, 2000, ANN THORAC SURG, V69, P799, DOI 10.1016/S0003-4975(99)01408-3; Trompeter M, 2002, EUR RADIOL, V12, P1179, DOI 10.1007/s00330-001-1220-2; Vassiliou I, 2008, CARDIOLOGY, V111, P94, DOI 10.1159/000119696; Venkateswaran RV, 2002, EUR J CARDIO-THORAC, V22, P534, DOI 10.1016/S1010-7940(02)00373-1; Zacharias A, 2000, TEX HEART I J, V27, P93	25	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167601	10.1371/journal.pone.0167601	http://dx.doi.org/10.1371/journal.pone.0167601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977704	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400024
J	Canela-Xandri, O; Rawlik, K; Woolliams, JA; Tenesa, A				Canela-Xandri, Oriol; Rawlik, Konrad; Woolliams, John A.; Tenesa, Albert			Improved Genetic Profiling of Anthropometric Traits Using a Big Data Approach	PLOS ONE			English	Article							COMPLEX TRAITS; PREDICTION; ASSOCIATION	Genome-wide association studies (GWAS) promised to translate their findings into clinically beneficial improvements of patient management by tailoring disease management to the individual through the prediction of disease risk. However, the ability to translate genetic findings from GWAS into predictive tools that are of clinical utility and which may inform clinical practice has, so far, been encouraging but limited. Here we propose to use a more powerful statistical approach, the use of which has traditionally been limited due to computational requirements and lack of sufficiently large individual level genotyped cohorts, but which improve the prediction of multiple medically relevant phenotypes using the same panel of SNPs. As a proof of principle, we used a shared panel of 319,038 common SNPs with MAF > 0.05 to train the prediction models in 114,264 unrelated White-British individuals for height and four obesity related traits (body mass index, basal metabolic rate, body fat percentage, and waist-to-hip ratio). We obtained prediction accuracies that ranged between 46% and 75% of the maximum achievable given the captured heritable component. For height, this represents an improvement in prediction accuracy of up to 68% (184% more phenotypic variance explained) over SNPs reported to be robustly associated with height in a previous GWAS meta-analysis of similar size. Across-population predictions in White non-British individuals were similar to those in White-British whilst those in Asian and Black individuals were informative but less accurate. We estimate that the genotyping of circa 500,000 unrelated individuals will yield predictions between 66% and 82% of the SNP-heritability captured by common variants in our array. Prediction accuracies did not improve when including rarer SNPs or when fitting multiple traits jointly in multivariate models.	[Canela-Xandri, Oriol; Rawlik, Konrad; Woolliams, John A.; Tenesa, Albert] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Easter Bush Campus, Edinburgh, Midlothian, Scotland; [Tenesa, Albert] Univ Edinburgh, Western Gen Hosp, MRC IGMM, MRC HGU, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Tenesa, A (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Easter Bush Campus, Edinburgh, Midlothian, Scotland.; Tenesa, A (corresponding author), Univ Edinburgh, Western Gen Hosp, MRC IGMM, MRC HGU, Edinburgh, Midlothian, Scotland.	Albert.Tenesa@ed.ac.uk	PAN, ZEQIANG/X-6341-2018	Tenesa, Albert/0000-0003-4884-4475	Medical Research Council [MR/K014781/1, MR/N003179/1]; BBSRC; Medical Research Council Human Genetics Unit; BBSRC [BBS/E/D/20211554, BBS/E/R/00001618, BBS/E/R/00001610, BBS/E/D/20211553] Funding Source: UKRI; MRC [MR/K014781/1, MR/N003179/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211554, BBS/E/R/00001610, BBS/B/05710, BBS/E/R/00000673, BBS/E/D/20211553, BBS/E/R/00001618] Funding Source: researchfish; Medical Research Council [MC_qA137853] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council Human Genetics Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was mainly supported by the Medical Research Council (http://www.mrc.ac.uk/) [grant numbers MR/K014781/1 and MR/N003179/1] and The Roslin Institute Strategic Grant funding from the BBSRC (http://www.bbsrc.ac.uk/). AT also acknowledges funding from the Medical Research Council Human Genetics Unit (https://www.hgu.mrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Biesecker BB, 1999, NAT GENET, V22, P133, DOI 10.1038/9641; Canela-Xandri O, 2015, NAT COMMUN IN PRESS; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2015, NAT GENET, V47, P284, DOI 10.1038/ng.3190; Meuwissen THE, 2001, GENETICS, V157, P1819; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schrodi SJ, 2014, FRONT GENET, V5, DOI [10.3389/fgene.2014.00162, 10.3389/fmicb.2014.00144]; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wray NR, 2013, NAT REV GENET, V14, P507, DOI 10.1038/nrg3457; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	18	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0166755	10.1371/journal.pone.0166755	http://dx.doi.org/10.1371/journal.pone.0166755			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977676	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400006
J	Hillier, A; Kelly, RP; Klinger, T				Hillier, Ann; Kelly, Ryan P.; Klinger, Terrie			Narrative Style Influences Citation Frequency in Climate Change Science	PLOS ONE			English	Article							PERSPECTIVE-TAKING; COMPREHENSION; STORIES	Peer-reviewed publications focusing on climate change are growing exponentially with the consequence that the uptake and influence of individual papers varies greatly. Here, we derive metrics of narrativity from psychology and literary theory, and use these metrics to test the hypothesis that more narrative climate change writing is more likely to be influential, using citation frequency as a proxy for influence. From a sample of 732 scientific abstracts drawn from the climate change literature, we find that articles with more narrative abstracts are cited more often. This effect is closely associated with journal identity: higher-impact journals tend to feature more narrative articles, and these articles tend to be cited more often. These results suggest that writing in a more narrative style increases the uptake and influence of articles in climate literature, and perhaps in scientific literature more broadly.	[Hillier, Ann; Kelly, Ryan P.; Klinger, Terrie] Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kelly, RP (corresponding author), Univ Washington, Sch Marine & Environm Affairs, Seattle, WA 98195 USA.	rpkelly@uw.edu						Abbott H.P., 2002, CAMBRIDGE INTRO NARR; Andrade Chittaranjan, 2011, Indian J Psychiatry, V53, P172, DOI 10.4103/0019-5545.82558; Andrews M., 2013, DOING NARRATIVE RES; [Anonymous], 2014, R LANG ENV STAT COMP; Behrend TS, 2011, BEHAV RES METHODS, V43, P800, DOI 10.3758/s13428-011-0081-0; Bilandzic H, 2014, EXEMPLARS ANECDOTES; BOWER GH, 1969, PSYCHON SCI, V14, P181, DOI 10.3758/BF03332778; Bruner J. S., 1986, ACTUAL MINDS POSSIBL, DOI DOI 10.4159/9780674029019; Brunye TT, 2009, PSYCHOL SCI, V20, P27, DOI 10.1111/j.1467-9280.2008.02249.x; Dahlstrom MF, 2015, COMMUN RES, V42, P779, DOI 10.1177/0093650213487374; Dahlstrom MF, 2014, P NATL ACAD SCI USA, V111, P13614, DOI 10.1073/pnas.1320645111; De Clercq O, 2014, NAT LANG ENG, V1, P59; Fisher WR., 1994, ARGUMENTATION, V8, P21, DOI [10.1007/BF00710701, DOI 10.1007/BF00710701]; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Graesser A.C., 2002, DOES MIND CONSTRUCT, P229; Gross A.G., 2002, COMMUNICATING SCI SC; Haunschild R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160393; Herman D., 2005, ROUTLEDGE ENCY NARRA; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Holstein J.A., 2012, VARIETIES NARRATIVE; Hurley LA, 2013, P ASIST ANN M, V50; Jones MD, 2014, SOC SCI QUART, V95, P1, DOI 10.1111/ssqu.12043; Kelly RP, 2014, AMBIO, V43, P592, DOI 10.1007/s13280-013-0442-2; LAWANI SM, 1983, J AM SOC INFORM SCI, V34, P59, DOI 10.1002/asi.4630340109; Lejano R, 2013, AM COMP ENVIRON POLI, P1; Mano Y, 2009, NEUROPSYCHOLOGIA, V47, P813, DOI 10.1016/j.neuropsychologia.2008.12.011; McBeth MK, 2010, POLICY SCI, V43, P391, DOI 10.1007/s11077-010-9114-2; Muurlink O, 2015, JCOM-J SCI COMMUN, V14; Norris SP, 2005, SCI EDUC, V89, P535, DOI 10.1002/sce.20063; Paschen JA, 2014, RES POLICY, V43, P1083, DOI 10.1016/j.respol.2013.12.006; Peterson EE, 2006, NARRAT INQ, V16, P173, DOI 10.1075/ni.16.1.22pet; Spoel P, 2008, TECH COMMUN Q, V18, P49, DOI 10.1080/10572250802437382; Stewart A.J., 2004, NARRATIVE ANAL STUDY, P223; Sydserff R., 1999, ACCOUNT AUDIT ACCOUN, V12, P459, DOI [10.1108/09513579910283503, DOI 10.1108/09513579910283503]; Tijssen RJW, 1990, SCIENCE, V41, P298; Wechsler D, 2014, FUTURES, V60, P14, DOI 10.1016/j.futures.2014.02.005; Weinberger CJ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004205	37	22	22	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167983	10.1371/journal.pone.0167983	http://dx.doi.org/10.1371/journal.pone.0167983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27978538	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400045
J	Hirasawa, K; Moriya, S; Miyahara, K; Kazama, H; Hirota, A; Takemura, J; Abe, A; Inazu, M; Hiramoto, M; Tsukahara, K; Miyazawa, K				Hirasawa, Kazuhiro; Moriya, Shota; Miyahara, Kana; Kazama, Hiromi; Hirota, Ayako; Takemura, Jun; Abe, Akihisa; Inazu, Masato; Hiramoto, Masaki; Tsukahara, Kiyoaki; Miyazawa, Keisuke			Macrolide Antibiotics Exhibit Cytotoxic Effect under Amino Acid-Depleted Culture Condition by Blocking Autophagy Flux in Head and Neck Squamous Cell Carcinoma Cell Lines	PLOS ONE			English	Article							PROTEIN VCP; STRESS; CANCER; EXPRESSION; APOPTOSIS; DEATH; TUMOR; CLARITHROMYCIN; BEVACIZUMAB; TRANSPORTER	Autophagy, a self-digestive system for cytoplasmic components, is required to maintain the amino acid pool for cellular homeostasis. We previously reported that the macrolide antibiotics azithromycin (AZM) and clarithromycin (CAM) have an inhibitory effect on autophagy flux, and they potently enhance the cytocidal effect of various anticancer reagents in vitro. This suggests that macrolide antibiotics can be used as an adjuvant for cancer chemotherapy. Since cancer cells require a larger metabolic demand than normal cells because of their exuberant growth, upregulated autophagy in tumor cells has now become the target for cancer therapy. In the present study, we examined whether macrolides exhibit cytotoxic effect under an amino acid-starving condition in head and neck squamous cancer cell lines such as CAL 27 and Detroit 562 as models of solid tumors with an upregulated autophagy in the central region owing to hypovascularity. AZM and CAM induced cell death under the amino acid-depleted (AAD) culture condition in these cell lines along with CHOP upregulation, although they showed no cytotoxicity under the complete culture medium. CHOP knockdown by siRNA in the CAL 27 cells significantly suppressed macrolide-induced cell death under the AAD culture condition. CHOP-/- murine embryonic fibroblast (MEF) cell lines also attenuated AZM-induced cell death compared with CHOP+/+ MEF cell lines. Using a tet-off atg5 MEF cell line, knockout of atg5, an essential gene for autophagy, also induced cell death and CHOP in the AAD culture medium but not in the complete culture medium. This suggest that macrolide-induced cell death via CHOP induction is dependent on autophagy inhibition. The cytotoxicity of macrolide with CHOP induction was completely cancelled by the addition of amino acids in the culture medium, indicating that the cytotoxicity is due to the insufficient amino acid pool. These data suggest the possibility of using macrolides for "tumor-starving therapy	[Hirasawa, Kazuhiro; Tsukahara, Kiyoaki] Tokyo Med Univ, Dept Otolaryngol Head & Neck Surg, Tokyo, Japan; [Moriya, Shota; Kazama, Hiromi; Hirota, Ayako; Takemura, Jun; Abe, Akihisa; Hiramoto, Masaki; Miyazawa, Keisuke] Tokyo Med Univ, Dept Biochem, Tokyo, Japan; [Miyahara, Kana] Tokyo Med Univ, Dept Breast Surg, Tokyo, Japan; [Inazu, Masato] Tokyo Med Univ, Inst Med Sci, Tokyo, Japan	Tokyo Medical University; Tokyo Medical University; Tokyo Medical University; Tokyo Medical University	Miyazawa, K (corresponding author), Tokyo Med Univ, Dept Biochem, Tokyo, Japan.	miyazawa@tokyo-med.ac.jp			Ministry of Education, Culture, Sports, Science and Technology [26460478]; Ministry of Education, Culture, Sports, Science and Technology of Japan [25860398]; Tokyo Medical University	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Medical University	This study was supported by funds provided through a MEXT-supported program of the Strategic Research Foundation at Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grants-in-Aid for Scientific Research (C) from The Ministry of Education, Culture, Sports, Science and Technology (no. 26460478, http://www.mext.go.jp/), and a Grant-in-Aid for Young Scientist (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (no. 25860398, http://www.mext.go.jp/) and a Research Grant from Tokyo Medical University to SM.	Carriere A, 2004, J BIOL CHEM, V279, P40462, DOI 10.1074/jbc.M407258200; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Cho H, 2015, AURIS NASUS LARYNX, V42, P396, DOI 10.1016/j.anl.2015.02.009; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Goodsell DS, 2003, STEM CELLS, V21, P118, DOI 10.1634/stemcells.21-1-118; Guo XL, 2013, J MOL MED, V91, P473, DOI 10.1007/s00109-012-0966-0; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Herberman RB, 2002, SEMIN ONCOL, V29, P27, DOI 10.1053/sonc.2002.33079; Hosokawa N, 2007, FEBS LETT, V581, P2623, DOI 10.1016/j.febslet.2006.04.008; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Komatsu S, 2012, INT J ONCOL, V40, P1029, DOI 10.3892/ijo.2011.1317; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maltese WA, 2014, AM J PATHOL, V184, P1630, DOI 10.1016/j.ajpath.2014.02.028; Maytin EV, 2001, EXP CELL RES, V267, P193, DOI 10.1006/excr.2001.5248; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moriya S, 2013, INT J ONCOL, V42, P1541, DOI 10.3892/ijo.2013.1870; Mukai S, 2016, INT J ONCOL, V48, P45, DOI 10.3892/ijo.2015.3237; Nujic K, 2012, EUR J PHARMACOL, V677, P163, DOI 10.1016/j.ejphar.2011.12.022; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sassa K, 1999, ANTIMICROB AGENTS CH, V43, P67, DOI 10.1128/AAC.43.1.67; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Scherz-Shouval R, 2011, TRENDS BIOCHEM SCI, V36, P30, DOI 10.1016/j.tibs.2010.07.007; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sperandio S, 2000, P NATL ACAD SCI USA, V97, P14376, DOI 10.1073/pnas.97.26.14376; Suraweera A, 2012, MOL CELL, V48, P242, DOI 10.1016/j.molcel.2012.08.003; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; van Nuffel AMT, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.513; Wang ZY, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju215; Wasik AM, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.106; Weerasinghe P, 2012, EXP MOL PATHOL, V93, P302, DOI 10.1016/j.yexmp.2012.09.018; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yatsunami J, 1997, RES EXP MED, V197, P189, DOI 10.1007/s004330050068; Yokoyama T, 2008, AUTOPHAGY, V4, P629, DOI 10.4161/auto.5941; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	49	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0164529	10.1371/journal.pone.0164529	http://dx.doi.org/10.1371/journal.pone.0164529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977675	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400002
J	Kar, S; Smith, DW; Gardiner, BS; Grodzinsky, AJ				Kar, Saptarshi; Smith, David W.; Gardiner, Bruce S.; Grodzinsky, Alan J.			Systems Based Study of the Therapeutic Potential of Small Charged Molecules for the Inhibition of IL-1 Mediated Cartilage Degradation	PLOS ONE			English	Article							CALCIUM PENTOSAN POLYSULFATE; GROWTH-FACTOR-I; ARTICULAR-CARTILAGE; SYNOVIAL-FLUID; INTRAARTICULAR INJECTION; GLUCOSAMINE SULFATE; CHONDROITIN SULFATE; SWELLING PRESSURE; GENE-EXPRESSION; DOUBLE-BLIND	Inflammatory cytokines are key drivers of cartilage degradation in post-traumatic osteoarthritis. Cartilage degradation mediated by these inflammatory cytokines has been extensively investigated using in vitro experimental systems. Based on one such study, we have developed a computational model to quantitatively assess the impact of charged small molecules intended to inhibit IL-1 mediated cartilage degradation. We primarily focus on the simplest possible computational model of small molecular interaction with the IL-1 system-direct binding of the small molecule to the active site on the IL-1 molecule itself. We first use the model to explore the uptake and release kinetics of the small molecule inhibitor by cartilage tissue. Our results show that negatively charged small molecules are excluded from the negatively charged cartilage tissue and have uptake kinetics in the order of hours. In contrast, the positively charged small molecules are drawn into the cartilage with uptake and release timescales ranging from hours to days. Using our calibrated computational model, we subsequently explore the effect of small molecule charge and binding constant on the rate of cartilage degradation. The results from this analysis indicate that the small molecules are most effective in inhibiting cartilage degradation if they are either positively charged and/or bind strongly to IL-1 alpha, or both. Furthermore, our results showed that the cartilage structural homeostasis can be restored by the small molecule if administered within six days following initial tissue exposure to IL-1 alpha. We finally extended the scope of the computational model by simulating the competitive inhibition of cartilage degradation by the small molecule. Results from this model show that small molecules are more efficient in inhibiting cartilage degradation by binding directly to IL-1 alpha rather than binding to IL-1a receptors. The results from this study can be used as a template for the design and development of more pharmacologically effective osteoarthritis drugs, and to investigate possible therapeutic options.	[Kar, Saptarshi; Smith, David W.] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA USA; [Gardiner, Bruce S.] Murdoch Univ, Dept Phys & Nanotechnol, Murdoch, WA, Australia; [Grodzinsky, Alan J.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	University of Western Australia; Murdoch University; Massachusetts Institute of Technology (MIT)	Smith, DW (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA USA.	david.smith@uwa.edu.au	Gardiner, Bruce/C-8593-2012; Smith, David W/H-5856-2014	Smith, David W/0000-0003-4864-0288; Gardiner, Bruce/0000-0001-8770-5908; Kar, Saptarshi/0000-0002-3788-372X	National Health and Medical Research Council Australia (NHMRC) [1051455]; National Institutes of Health (NIH) [AR060331]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060331] Funding Source: NIH RePORTER	National Health and Medical Research Council Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study is supported by the National Health and Medical Research Council Australia (NHMRC Project Grant 1051455) and the National Institutes of Health (NIH; Grant AR060331)	Ackerman GL., 1990, SERUM SODIUM; Bajpayee AG, 2015, OSTEOARTHRITIS CARTI; Bajpayee AG, 2014, J ORTHOP RES, V32, P1044, DOI 10.1002/jor.22630; Bajpayee AG, 2014, BIOMATERIALS, V35, P538, DOI 10.1016/j.biomaterials.2013.09.091; Barta E, 2006, J THEOR BIOL, V241, P628, DOI 10.1016/j.jtbi.2006.01.004; Bashir A, 1999, MAGNET RESON MED, V41, P857, DOI 10.1002/(SICI)1522-2594(199905)41:5<857::AID-MRM1>3.0.CO;2-E; BASSLEER C, 1992, INT J TISSUE REACT, V14, P231; Bodmer MW, 1996, THERAPEUTIC MODULATI; BROCKLEHURST R, 1984, J BONE JOINT SURG AM, V66A, P95, DOI 10.2106/00004623-198466010-00013; BUSCHMANN MD, 1995, J BIOMECH ENG-T ASME, V117, P179, DOI 10.1115/1.2796000; Cameron M, 1997, AM J SPORT MED, V25, P751, DOI 10.1177/036354659702500605; Catt C J, 2011, Eur Cell Mater, V22, P377; Catterall JB, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3216; Chakraborty Abhijit, 2012, Clin Pharmacokinet, V51, pe1, DOI 10.2165/11599820-000000000-00000; Chan PS, 2006, J RHEUMATOL, V33, P1329; Chevalier X, 2009, ARTHRIT RHEUM-ARTHR, V61, P344, DOI 10.1002/art.24096; CHIN JE, 1990, FASEB J, V4, P1481, DOI 10.1096/fasebj.4.5.2137805; Choi DW, 2003, J PHARMACEUT BIOMED, V31, P1229, DOI 10.1016/S0731-7085(02)00731-8; Church LD, 2008, BIOL-TARGETS THER, V2, P733; Cohen S, 1989, ROLE LYMPHOKINES IMM; Coombe DR, 2008, IMMUNOL CELL BIOL, V86, P598, DOI 10.1038/icb.2008.49; Cussler E. L, 2009, DIFFUSION MASS TRANS; Day RO, 1999, CLIN PHARMACOKINET, V36, P191, DOI 10.2165/00003088-199936030-00002; Dhimolea E, 2010, CANAKINUMAB MABS; DIAMANT B, 1968, EXPERIENTIA, V24, P1195, DOI 10.1007/BF02146615; DiLeo MV, 2009, ANN BIOMED ENG, V37, P222, DOI 10.1007/s10439-008-9587-8; Dimicco MA, 2003, TRANSPORT POROUS MED, V50, P57, DOI 10.1023/A:1020677829069; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Economides AN, 2003, NAT MED, V9, P47, DOI 10.1038/nm811; Einstein A., 1905, ANN PHYS, V4; Fallon EM, 2000, BIOTECHNOL PROGR, V16, P905, DOI 10.1021/bp000097t; Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010; FROELICH CJ, 1993, J IMMUNOL, V151, P7161; Gaisinskaya-Kipnis A, 2014, BIOMACROMOLECULES, V15, P4178, DOI 10.1021/bm501189g; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Georgiev K, 2015, PHARM PROPERTIES MON; Ghosh P, 2005, CURR THER RES CLIN E, V66, P552, DOI 10.1016/j.curtheres.2005.12.012; GUSTAFSSON K, 1988, J REPROD IMMUNOL, V14, P139, DOI 10.1016/0165-0378(88)90065-4; Han E, 2011, BIOPHYS J, V101, P916, DOI 10.1016/j.bpj.2011.07.006; Han L, 2008, BIOPHYS J, V95, P4862, DOI 10.1529/biophysj.107.128389; Henrotin Y, 2010, THER ADV MUSCULOSKEL, V2, P335, DOI 10.1177/1759720X10383076; Hooper NM, 2005, ADAM FAMILY PROTEASE; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; Hunter CJ, 2002, BIORHEOLOGY, V39, P79; Hunziker EB, 1997, MICROSC RES TECHNIQ, V37, P271; Irrechukwu ON, 2007, THE ROLE OF MATRIX C; Jadin KD, 2005, J HISTOCHEM CYTOCHEM, V53, P1109, DOI 10.1369/jhc.4A6511.2005; JEBENS EH, 1959, BLOOD, V20, P58; JENSEN LT, 1993, EUR J CLIN INVEST, V23, P778, DOI 10.1111/j.1365-2362.1993.tb00731.x; Kapoor M, 2011, NAT REV RHEUMATOL, V7, P33, DOI 10.1038/nrrheum.2010.196; Kar S, 2016, ARCH BIOCH BIOPHYSIC; Karsdal MA, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2434; Kilgore KS, 1998, J PHARMACOL EXP THER, V285, P987; Klein TJ, 2007, BIOMECH MODEL MECHAN, V6, P21, DOI 10.1007/s10237-006-0045-y; Klein TJ, 2007, J BIOMECH, V40, P182, DOI 10.1016/j.jbiomech.2005.11.002; Kulkarni Priya, 2014, J Med Case Rep, V8, P137, DOI 10.1186/1752-1947-8-137; Kumagai Kenji, 2010, BMC Clin Pharmacol, V10, P7, DOI 10.1186/1472-6904-10-7; Kumar A, 2015, OSTEOARTHR CARTILAGE, V23, P151, DOI 10.1016/j.joca.2014.09.019; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; Lauffenburger D. A., 1993, RECEPTORS MODELS BIN; Leddy HA, 2003, ANN BIOMED ENG, V31, P753, DOI 10.1114/1.1581879; LESPERANCE LM, 1992, J ORTHOPAED RES, V10, P1, DOI 10.1002/jor.1100100102; Li Y, 2015, OSTEOARTHR CARTILAGE, V23, P266, DOI 10.1016/j.joca.2014.11.006; Liu MY, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-68; Lupia E, 2012, LAB INVEST, V92, P236, DOI 10.1038/labinvest.2011.154; Mantovani A, 1999, CHEMOKINES; MAROUDAS A, 1976, NATURE, V260, P808, DOI 10.1038/260808a0; MAROUDAS A, 1972, Connective Tissue Research, V1, P69, DOI 10.3109/03008207209152058; MARTELPELLETIER J, 1992, ARTHRITIS RHEUM, V35, P530, DOI 10.1002/art.1780350507; Matuska A, 2013, J ORTHOP RES, V31, P1929, DOI 10.1002/jor.22464; McNulty AL, 2013, J ORTHOP RES, V31, P1039, DOI 10.1002/jor.22334; Miller RE, 2010, ARTHRITIS RHEUM-US, V62, P3686, DOI 10.1002/art.27709; Morales TI, 2007, OSTEOARTHR CARTILAGE, V15, P861, DOI 10.1016/j.joca.2007.02.022; Morgen M, 2013, PHARM RES-DORDR, V30, P257, DOI 10.1007/s11095-012-0870-x; Munteanu SE, 2000, ARTHRITIS RHEUM, V43, P2211, DOI 10.1002/1529-0131(200010)43:10<2211::AID-ANR8>3.0.CO;2-D; Munteanu SE, 2002, MATRIX BIOL, V21, P429, DOI 10.1016/S0945-053X(02)00034-3; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Nagase H, 2000, CANC DRUG DISC DEV, P39; Netea MG, 2015, ANNU REV IMMUNOL, V33, P49, DOI 10.1146/annurev-immunol-032414-112306; OWEN SG, 1994, BRIT J CLIN PHARMACO, V38, P349, DOI 10.1111/j.1365-2125.1994.tb04365.x; Pratta MA, 2003, J BIOL CHEM, V278, P45539, DOI 10.1074/jbc.M303737200; Radin A, 2010, J CLIN PHARMACOL, V50, P835, DOI 10.1177/0091270009351882; RAMSDEN L, 1992, EUR J IMMUNOL, V22, P3027, DOI 10.1002/eji.1830221139; Razaq S, 2000, INTERNATIONAL JOURNA, V81, pA24; RINDERKNECHT E, 1978, J BIOL CHEM, V253, P2769; Ropes MW, 1940, J CLIN INVEST, V19, P795, DOI 10.1172/JCI101182; Rovati LC, 2012, THER ADV MUSCULOSKEL, V4, P167, DOI 10.1177/1759720X12437753; Rugstad HE, 1992, IMMUNOPHARMACOLOGY A; Sarkar SK, 2012, CURR BIOL, V22, P1047, DOI 10.1016/j.cub.2012.04.012; Sengers BG, 2007, BIOMATERIALS, V28, P1926, DOI 10.1016/j.biomaterials.2006.12.008; Shapiro EM, 2002, MAGNET RESON MED, V47, P284, DOI 10.1002/mrm.10054; Shulgin B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149154; Smith DW, 2013, J TISSUE ENG REGEN M; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Sujatha M., 2011, KERALA J ORTHOP, V25, P51; Sunaga T, 2012, J VET MED SCI, V74, P707, DOI 10.1292/jvms.11-0511; Troeberg L, 2008, FASEB J, V22, P3515, DOI 10.1096/fj.08-112680; Troeberg L, 2012, BIOCHEM J, V443, P307, DOI 10.1042/BJ20112159; Tugal-Tutkun I, 2017, OCUL IMMUNOL INFLAMM, V25, P62, DOI 10.3109/09273948.2015.1092558; Vempati P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011860; Wayne GJ, 2007, J BIOL CHEM, V282, P20991, DOI 10.1074/jbc.M610721200; Wittwer AJ, 2007, BIOCHEMISTRY-US, V46, P6393, DOI 10.1021/bi7000642; Yamamoto K, 2014, J BIOL CHEM, V289, P6462, DOI 10.1074/jbc.M113.545376; Young DA, 2005, ARTHRITIS RES THER, V7, pR503, DOI 10.1186/ar1702; Zhang L. R., 2013, PLOS ONE, V8; Zhang Lihai, 2008, Molecular & Cellular Biomechanics, V5, P133	106	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168047	10.1371/journal.pone.0168047	http://dx.doi.org/10.1371/journal.pone.0168047			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977731	Green Published, gold			2022-12-27	WOS:000391217400052
J	Lee, XW; Mat-Isa, MN; Mohd-Elias, NA; Aizat-Juhari, MA; Goh, HH; Dear, PH; Chow, KS; Adam, JH; Mohamed, R; Firdaus-Raih, M; Wan, KL				Lee, Xin-Wei; Mat-Isa, Mohd-Noor; Mohd-Elias, Nur-Atiqah; Aizat-Juhari, Mohd Afiq; Goh, Hoe-Han; Dear, Paul H.; Chow, Keng-See; Adam, Jumaat Haji; Mohamed, Rahmah; Firdaus-Raih, Mohd; Wan, Kiew-Lian			Perigone Lobe Transcriptome Analysis Provides Insights into Rafflesia cantleyi Flower Development	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEINS; GLUTAMATE-DEHYDROGENASE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; TARGET GENES; CLASS-I; PETAL; RNA; IDENTIFICATION; CHLOROPLAST	Rafflesia is a biologically enigmatic species that is very rare in occurrence and possesses an extraordinary morphology. This parasitic plant produces a gigantic flower up to one metre in diameter with no leaves, stem or roots. However, little is known about the floral biology of this species especially at the molecular level. In an effort to address this issue, we have generated and characterised the transcriptome of the Rafflesia cantleyi flower, and performed a comparison with the transcriptome of its floral bud to predict genes that are expressed and regulated during flower development. Approximately 40 million sequencing reads were generated and assembled de novo into 18,053 transcripts with an average length of 641 bp. Of these, more than 79% of the transcripts had significant matches to annotated sequences in the public protein database. A total of 11,756 and 7,891 transcripts were assigned to Gene Ontology categories and clusters of orthologous groups respectively. In addition, 6,019 transcripts could be mapped to 129 pathways in Kyoto Encyclopaedia of Genes and Genomes Pathway database. Digital abundance analysis identified 52 transcripts with very high expression in the flower transcriptome of R. cantleyi. Subsequently, analysis of differential expression between developing flower and the floral bud revealed a set of 105 transcripts with potential role in flower development. Our work presents a deep transcriptome resource analysis for the developing flower of R. cantleyi. Genes potentially involved in the growth and development of the R. cantleyi flower were identified and provide insights into biological processes that occur during flower development.	[Lee, Xin-Wei; Mohd-Elias, Nur-Atiqah; Mohamed, Rahmah; Firdaus-Raih, Mohd; Wan, Kiew-Lian] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi, Selangor, Malaysia; [Mat-Isa, Mohd-Noor] Malaysia Genome Inst, Kajang, Selangor, Malaysia; [Aizat-Juhari, Mohd Afiq; Adam, Jumaat Haji] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Environm & Nat Resource Sci, Bangi, Selangor, Malaysia; [Goh, Hoe-Han; Firdaus-Raih, Mohd] Univ Kebangsaan Malaysia, Inst Syst Biol, Bangi, Selangor, Malaysia; [Dear, Paul H.] Mote Res Ltd, Babraham Hall,Babraham Res Campus, Cambridge, England; [Chow, Keng-See] Malaysian Rubber Board, Rubber Res Inst Malaysia, Genom & Bioinformat Ctr, Sungai Buloh, Selangor, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Institute Penyelidikan Getah Malaysia; Malaysian Rubber Board	Wan, KL (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Bangi, Selangor, Malaysia.	klwan@ukm.edu.my	Firdaus-Raih, Mohd/A-9217-2011; Firdaus-Raih, Mohd/H-3286-2019; Goh, Hoe-Han/I-2943-2012; Wan, Kiew-Lian/A-4632-2012	Firdaus-Raih, Mohd/0000-0003-4275-4663; Firdaus-Raih, Mohd/0000-0003-4275-4663; Goh, Hoe-Han/0000-0002-8508-9977; Wan, Kiew-Lian/0000-0003-4027-1211	Universiti Kebangsaan Malaysia [UKM-AP-KPB-18-2010, LAUREATE-2013-001, GUP-2016-008]; Mote Research Limited	Universiti Kebangsaan Malaysia; Mote Research Limited	The work was supported financially by Research University Grants from Universiti Kebangsaan Malaysia (Grant No. UKM-AP-KPB-18-2010, LAUREATE-2013-001 and GUP-2016-008). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Mote Research Limited provided support in the form of salaries for PHD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasiou E, 2007, DEV CELL, V13, P843, DOI 10.1016/j.devcel.2007.10.001; BAKER J, 1988, PLANT MOL BIOL, V11, P277, DOI 10.1007/BF00027385; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Bey M, 2004, PLANT CELL, V16, P3197, DOI 10.1105/tpc.104.026724; Bies N, 1998, J EXP BOT, V49, P1925, DOI 10.1093/jexbot/49.329.1925; BOSTOCK RM, 1992, PLANT PHYSIOL, V98, P1356, DOI 10.1104/pp.98.4.1356; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Cornbier JP, 2008, MOL PLANT MICROBE IN, V21, P1118, DOI 10.1094/MPMI-21-8-1118; Covey PA, 2010, PLANT PHYSIOL, V153, P703, DOI 10.1104/pp.110.155457; Dafny-Yelin M, 2005, PLANTA, V222, P37, DOI 10.1007/s00425-005-1512-x; Dinneny JR, 2004, DEVELOPMENT, V131, P1101, DOI 10.1242/dev.00949; Dubois F, 2003, PLANT PHYSIOL BIOCH, V41, P565, DOI 10.1016/S0981-9428(03)00075-5; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; Dutilleul C, 2008, PLANT PHYSIOL, V147, P239, DOI 10.1104/pp.107.114033; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Flechner A, 1999, FEBS LETT, V447, P200, DOI 10.1016/S0014-5793(99)00285-9; Germain H, 2005, PLANTA, V220, P447, DOI 10.1007/s00425-004-1352-0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross W, 1999, GENE, V230, P7, DOI 10.1016/S0378-1119(99)00059-1; Guo AY, 2008, NUCLEIC ACIDS RES, V36, pD966, DOI 10.1093/nar/gkm841; HILL JP, 1989, CAN J BOT, V67, P2922, DOI 10.1139/b89-375; Huck N, 2003, DEVELOPMENT, V130, P2149, DOI 10.1242/dev.00458; Hugouvieux V, 2009, PLANT PHYSIOL, V151, P768, DOI 10.1104/pp.109.144808; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Irish VF, 1999, CURR TOP DEV BIOL, V41, P133; KUIJT J., 1969, The biology of parasitic flowering plants. University of California Press, Berkeley.; Kumar M, 2015, PHYTOCHEMISTRY, V112, P91, DOI 10.1016/j.phytochem.2014.07.009; LOPEZGOMEZ R, 1992, HORTSCIENCE, V27, P440, DOI 10.21273/HORTSCI.27.5.440; Lu W, 2012, GENE, V503, P65, DOI 10.1016/j.gene.2012.04.042; Mara CD, 2010, PLANT CELL, V22, P690, DOI 10.1105/tpc.109.065946; Meijer W, 1997, FLORA MALESIANA 1, P1; MeloOliveira R, 1996, P NATL ACAD SCI USA, V93, P4718, DOI 10.1073/pnas.93.10.4718; Merkouropoulos G, 2003, PLANTA, V217, P356, DOI 10.1007/s00425-003-1002-y; Molina J, 2014, MOL BIOL EVOL, V31, P793, DOI 10.1093/molbev/msu051; Murthy N, 2007, J BIOL CHEM, V282, P18254, DOI 10.1074/jbc.M701428200; Nais J., 2001, RAFFLESIA WORLD; NODA K, 1994, NATURE, V369, P661, DOI 10.1038/369661a0; Pearce G, 2001, P NATL ACAD SCI USA, V98, P12843, DOI 10.1073/pnas.201416998; Restivo FM, 2004, PLANT SCI, V166, P971, DOI 10.1016/j.plantsci.2003.12.011; Riechmann JL, 1997, MOL BIOL CELL, V8, P1243, DOI 10.1091/mbc.8.7.1243; RIED JL, 1993, PLANT PHYSIOL, V102, P125, DOI 10.1104/pp.102.1.125; Running MP, 1996, DEVELOPMENT, V122, P1261; Sauret-Gueto S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001550; Sawada K, 2004, BIOSCI BIOTECH BIOCH, V68, P873, DOI 10.1271/bbb.68.873; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shiu S.H., 2001, STKE, V2001, pR, DOI DOI 10.1126/SCISIGNAL.1132001RE22; Skopelitis DS, 2006, PLANT CELL, V18, P2767, DOI 10.1105/tpc.105.038323; SKRIVER K, 1990, PLANT CELL, V2, P503, DOI 10.1105/tpc.2.6.503; Szecsi J, 2006, EMBO J, V25, P3912, DOI 10.1038/sj.emboj.7601270; Terce-Laforgue T, 2004, PHYSIOL PLANTARUM, V120, P220, DOI 10.1111/j.0031-9317.2004.0241.x; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wu JS, 2007, PLANT J, V52, P877, DOI 10.1111/j.1365-313X.2007.03289.x; Xi Z, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-227; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu XM, 2006, EMBO J, V25, P900, DOI 10.1038/sj.emboj.7600968; Ye H, 2006, NEW PHYTOL, V171, P285, DOI 10.1111/j.1469-8137.2006.01751.x; Zahn LM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r101; Zik M, 2003, PLANT CELL, V15, P207, DOI 10.1105/tpc.006353	60	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167958	10.1371/journal.pone.0167958	http://dx.doi.org/10.1371/journal.pone.0167958			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977777	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400044
J	Mensah, VA; Gueye, A; Ndiaye, M; Edwards, NJ; Wright, D; Anagnostou, NA; Syll, M; Ndaw, A; Abiola, A; Bliss, C; Gomis, JF; Petersen, I; Ogwang, C; Dieye, T; Viebig, NK; Lawrie, AM; Roberts, R; Nicosia, A; Faye, B; Gaye, O; Leroy, O; Imoukhuede, EB; Ewer, KJ; Bejon, P; Hill, AVS; Cisse, B				Mensah, Victorine A.; Gueye, Aly; Ndiaye, Magatte; Edwards, Nick J.; Wright, Danny; Anagnostou, Nicholas A.; Syll, Massamba; Ndaw, Amy; Abiola, Annie; Bliss, Carly; Gomis, Jules-Francois; Petersen, Ines; Ogwang, Caroline; Dieye, Tandakha; Viebig, Nicola K.; Lawrie, Alison M.; Roberts, Rachel; Nicosia, Alfredo; Faye, Babacar; Gaye, Oumar; Leroy, Odile; Imoukhuede, Egeruan B.; Ewer, Katie J.; Bejon, Philip; Hill, Adrian V. S.; Cisse, Badara		MVVC Grp	Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MALARIA VACCINE; IMMUNIZATION; ANTIBODIES; REGIMEN; NAIVE; MSP1	Malaria transmission is in decline in some parts of Africa, partly due to the scaling up of control measures. If the goal of elimination is to be achieved, additional control measures including an effective and durable vaccine will be required. Studies utilising the prime-boost approach to deliver viral vectors encoding the pre-erythrocytic antigen ME-TRAP (multiple epitope thrombospondin-related adhesion protein) have shown promising safety, immunogenicity and efficacy in sporozoite challenge studies. More recently, a study in Kenyan adults, similar to that reported here, showed substantial efficacy against P. falciparum infection. One hundred and twenty healthy male volunteers, living in a malaria endemic area of Senegal were randomised to receive either the Chimpanzee adenovirus (ChAd63) ME-TRAP as prime vaccination, followed eight weeks later by modified vaccinia Ankara (MVA) also encoding ME-TRAP as booster, or two doses of anti-rabies vaccine as a comparator. Prior to follow-up, antimalarials were administered to clear parasitaemia and then participants were monitored by PCR for malaria infection for eight weeks. The primary endpoint was time-to-infection with P. falciparum malaria, determined by two consecutive positive PCR results. Secondary endpoints included adverse event reporting, measures of cellular and humoral immunogenicity and a meta-analysis of combined vaccine efficacy with the parallel study in Kenyan adults. We show that this pre-erythrocytic malaria vaccine is safe and induces significant immunogenicity, with a peak T-cell response at seven days after boosting of 932 Spot Forming Cells (SFC)/10(6) Peripheral Blood Mononuclear Cells(PBMC) compared to 57 SFC/10(6) PBMCs in the control group. However, a vaccine efficacy was not observed: 12 of 57 ME-TRAP vaccinees became PCR positive during the intensive monitoring period as compared to 13 of the 58 controls (P = 0.80). This trial confirms that vaccine efficacy against malaria infection in adults may be rapidly assessed using this efficient and cost-effective clinical trial design. Further efficacy evaluation of this vectored candidate vaccine approach in other malaria transmission settings and age-de-escalation into the main target age groups for a malaria vaccine is in progress.	[Mensah, Victorine A.; Gueye, Aly; Ndiaye, Magatte; Syll, Massamba; Ndaw, Amy; Abiola, Annie; Gomis, Jules-Francois; Dieye, Tandakha; Faye, Babacar; Gaye, Oumar; Cisse, Badara] Fac Med Univ Cheikh Anta Diop, Dept Parasitol, Dakar, Senegal; [Edwards, Nick J.; Wright, Danny; Anagnostou, Nicholas A.; Bliss, Carly; Lawrie, Alison M.; Roberts, Rachel; Imoukhuede, Egeruan B.; Ewer, Katie J.; Hill, Adrian V. S.] Univ Oxford, Jenner Inst, Churchill Hosp, Ctr Clin Vaccinol & Trop Med, Oxford, England; [Petersen, Ines; Viebig, Nicola K.; Leroy, Odile; Imoukhuede, Egeruan B.] European Vaccine Initiat, Heidelberg, Germany; [Ogwang, Caroline; Bejon, Philip] Kenya Govt Med Res Ctr, Kilifi, Kenya; [Nicosia, Alfredo] ReiThera, Rome, Italy; [Nicosia, Alfredo] CEINGE, Via Gaetano Salvatore, Naples, Italy; [Cisse, Badara] London Sch Hyg & Trop Med, London, England	University of Oxford; Jenner Institute; Kenya Medical Research Institute; CEINGE Biotecnologie Avanzate; University of London; London School of Hygiene & Tropical Medicine	Mensah, VA (corresponding author), Fac Med Univ Cheikh Anta Diop, Dept Parasitol, Dakar, Senegal.	avictorine@outlook.com	Ewer, Katie J/B-4328-2011	Ewer, Katie J/0000-0001-9827-9836; Wright, Daniel/0000-0002-8114-1838; Edwards, Nick/0000-0002-7030-7839; Bliss, Carly/0000-0002-5117-1016	European and Developing Countries Clinical Trials Partnership (EDCTP); EDCTP [IP.2008.31100.001]; Medical Research Council UK; Swedish International Development Cooperation Agency (Sida); Irish Aid; Dakar University Cheikh Anta Diop; ReiThera; National Institute for Health Research [NF-SI-0514-10158, NF-SI-0509-10233] Funding Source: researchfish; Wellcome Trust [104750/Z/14/Z] Funding Source: researchfish	European and Developing Countries Clinical Trials Partnership (EDCTP); EDCTP; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish International Development Cooperation Agency (Sida); Irish Aid(CGIAR); Dakar University Cheikh Anta Diop; ReiThera; National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by an award from the European and Developing Countries Clinical Trials Partnership (EDCTP) and was performed by the Malaria Vectored Vaccines Consortium (MVVC), an integrated project funded by EDCTP (grant number IP.2008.31100.001). Co-funding was also provided by the Medical Research Council UK, the Swedish International Development Cooperation Agency (Sida) and Irish Aid. The work was also supported by the Dakar University Cheikh Anta Diop. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ReiThera (formerly Okairos), provided support in the form of salaries for author AN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Andrews L, 2005, AM J TROP MED HYG, V73, P191, DOI 10.4269/ajtmh.2005.73.191; Baird JK, 2010, LANCET, V376, P1883, DOI 10.1016/S0140-6736(10)61494-8; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Ceesay SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012242; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; Das P, 2010, LANCET, V376, P1515, DOI 10.1016/S0140-6736(10)61551-6; Duncan CJA, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d7728; Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836; Gaye O, 1993, Med Trop (Mars), V53, P479; Hanke T, 2005, VACCINE, V23, P1507, DOI 10.1016/j.vaccine.2004.08.050; Hodgson SH, 2015, J INFECT DIS, V211, P1076, DOI 10.1093/infdis/jiu579; Imoukhuede EB, 2007, AM J TROP MED HYG, V76, P486, DOI 10.4269/ajtmh.2007.76.486; Kimani D, 2014, MOL THER, V22, P1992, DOI 10.1038/mt.2014.109; Kobinger GP, 2006, VIROLOGY, V346, P394, DOI 10.1016/j.virol.2005.10.042; Longley RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11820; Lusingu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014090; Machault V, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-138; Nebie I, 2014, CLIN VACCINE IMMUNOL, V21, P901, DOI 10.1128/CVI.00723-13; Noor AM, 2014, LANCET; O'Hara GA, 2012, J INFECT DIS, V205, P772, DOI 10.1093/infdis/jir850; Ogwang C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2373; Ogwang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057726; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/S1473-3099(10)70262-0; Rampling T, 2016, J INFECT DIS, V214, P772, DOI 10.1093/infdis/jiw244; RTSS Clinical trials partnership, 2012, NEW ENGLAND J MED; Sheehy SH, 2012, MOL THER, V20, P2355, DOI 10.1038/mt.2012.223; Sheehy SH, 2011, MOL THER, V19, P2269, DOI 10.1038/mt.2011.176; Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8; TOP FH, 1971, J INFECT DIS, V124, P155, DOI 10.1093/infdis/124.2.155; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Xiang ZQ, 2002, J VIROL, V76, P2667, DOI 10.1128/JVI.76.6.2667-2675.2002	32	29	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167951	10.1371/journal.pone.0167951	http://dx.doi.org/10.1371/journal.pone.0167951			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978537	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000391217400042
J	Sotgiu, I				Sotgiu, Igor			Conceptions of Happiness and Unhappiness among Italian Psychology Undergraduates	PLOS ONE			English	Article							WELL	The present study aims at investigating the conceptions of happiness and unhappiness in a sample of Italian psychology undergraduates. Participants completed a questionnaire asking them to report the most important things that made them feel happy (happiness components) and those ones that made them feel unhappy (unhappiness components). Different measures of overall happiness and overall unhappiness were also obtained by asking respondents to assess to what extent each reported happiness and unhappiness component was present in their life, and by inviting them to provide a global judgment about their happiness and unhappiness. Results indicated that participants did not conceptualize happiness and unhappiness as perfect antonyms. Indeed, both investigated concepts encompassed a similar set of semantic components; however, the perceived salience of some of them - assessed in terms of frequency of citation and average ranking -s ignificantly varied between happiness and unhappiness. With regard to the measurement of overall happiness and unhappiness, on average, respondents considered themselves as moderately happy and only slightly unhappy. However, a judgmental asymmetry was found when comparing global and specific evaluations of unhappiness. Theoretical and empirical implications of the study are discussed.	[Sotgiu, Igor] Univ Bergamo, Dept Human & Social Sci, Bergamo, Italy	University of Bergamo	Sotgiu, I (corresponding author), Univ Bergamo, Dept Human & Social Sci, Bergamo, Italy.	igor.sotgiu@unibg.it		Holland, Sherri/0000-0003-2860-0668; tester22, sciencv/0000-0002-2791-7842; SOTGIU, Igor/0000-0001-6980-7409				[Anonymous], 2000, J HAPPINESS STUD, DOI DOI 10.1023/A:1010031813405; Averill J. R., 1980, ASSESSMENT MODIFICAT, V6, P7, DOI DOI 10.1007/978-1-4684-3782-9_2; Bruckner Pascal., 2010, PERPETUAL EUPHORIA D; Carbery J, 1998, J SOC PERS RELAT, V15, P393, DOI 10.1177/0265407598153005; Delle Fave A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00030; Delle Fave A, 2009, J POSIT PSYCHOL, V4, P205, DOI 10.1080/17439760902844319; Delle Fave A, 2011, SOC INDIC RES, V100, P185, DOI 10.1007/s11205-010-9632-5; Demir M., 2007, J HAPPINESS STUD, V8, P181, DOI [10.1007/s10902-006-9012-7, DOI 10.1007/S10902-006-9012-7, DOI 10.1007/S10902-006-9034-1]; Demir M, 2013, OXFORD HDB HAPPINESS, P860, DOI [DOI 10.1093/0XF0RDHB/9780199557257.013.0063, DOI 10.1093/OXFORDHB/9780199557257.013.0063]; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; FEHR B, 1984, J EXP PSYCHOL GEN, V113, P464, DOI 10.1037/0096-3445.113.3.464; Galati D., 2006, DIMENSIONS WELL BEIN, P60; Galati D, 1998, REV SEMANTIQUE PRAGM, V4, P139; Galati D., 2004, RICERCHE PSICOLOGIA, V27, P41; Galati D, 2006, SOC SCI INFORM, V45, P601, DOI 10.1177/0539018406069594; Gehm Theodore., 1988, FACETS EMOTION RECEN, P99; Helliwell John, 2012, WORLD HAPPINESS REPO; INGLEHART R, 2000, CULTURE SUBJECTIVE W; Joshanloo M, 2014, J HAPPINESS STUD, V15, P475, DOI 10.1007/s10902-013-9431-1; Keyes CLM, 1998, SOC PSYCHOL QUART, V61, P121, DOI 10.2307/2787065; Kitayama S., 2000, CULTURE SUBJECTIVE W, P113, DOI [10.1007/978-90-481-2352-0_2, DOI 10.1007/978-90-481-2352-0_2]; Lu L., 2001, UNDERSTANDING HAPPIN, V2, P407, DOI DOI 10.1023/A:1013944228205; Mathews Gordon, 2012, INT J WELLBEING, V2, P299, DOI DOI 10.5502/IJW.V2.I4.2; Oishi S, 2013, PERS SOC PSYCHOL B, V39, P559, DOI 10.1177/0146167213480042; Pawelski JO, 2013, OXFORD HDB HAPPINESS, P326; Perez-Nordtvedt Liliana, 2010, J RELIG ETHICS, V45, P714, DOI [10.1111/j.1467-6486.2008.00767.x, DOI 10.1111/J.1467-9795.2010.00455.X]; PETERSON CHRISTOPHER, 2004, CHARACTER STRENGTHS; Rosch E., 2011, CAMBRIDGE ENCY LANGU, P191; Rosch E., 1999, J CONSCIOUSNESS STUD, V6, P61; Ryan RM, 2008, J HAPPINESS STUD, V9, P139, DOI 10.1007/s10902-006-9023-4; Ryff CD, 2008, J HAPPINESS STUD, V9, P13, DOI 10.1007/s10902-006-9019-0; Sauciuc G-A., 2011, THESIS; Schrauf R.W., 2004, J MULTILING MULTICUL, V25, P266, DOI [DOI 10.1080/01434630408666532, 10.1080/01434630408666532]; Schwarz N., 2020, EMOTION SOCIAL JUDGM, P55; Schwarz N, 1991, SUBJECTIVE WELL BEIN, P27; Schwarz N., 1999, WELL BEING FDN HEDON, P61, DOI DOI 10.7758/9781610443258; Seligman MEP., 2011, FLUORISH VISIONARY U; Smith JJ., 1997, J LINGUIST ANTHROPOL, V7, P208, DOI [10.1525/jlin.1997.7.2.208, DOI 10.1525/JLIN.1997.7.2.208]; Smith K. D, 1995, EVERYDAY CONCEPTIONS, P85; Sotgiu I., 2013, PSICOLOGIA FELICITA; Sotgiu I, 2011, J HAPPINESS STUD, V12, P353, DOI 10.1007/s10902-010-9198-6; Srivastava AK, 2012, NEW DIRECTIONS HLTH, P109; STROEBE M, 1992, AM PSYCHOL, V47, P1205, DOI 10.1037/0003-066X.47.10.1205; Sutrop Urmas, 2001, FIELD METHOD, V13, P263; Turk-Smith S., 1995, EVERYDAY CONCEPTIONS, P103; Uchida Y., 2004, J HAPPINESS STUD, V5, P223, DOI DOI 10.1007/S10902-004-8785-9; Uchida Y, 2009, EMOTION, V9, P441, DOI 10.1037/a0015634; VANGOOZEN S, 1993, EUR J SOC PSYCHOL, V23, P89, DOI 10.1002/ejsp.2420230108; Veenhoven R., 2012, INT J WELLBEING, V2, P333, DOI [10.5502/ijw.v2.i4.4, DOI 10.5502/IJW.V2.I4.4]; Waterman AS, 2010, J POSIT PSYCHOL, V5, P41, DOI 10.1080/17439760903435208; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wierzbicka A, 2004, DAEDALUS-US, V133, P34, DOI 10.1162/001152604323049370; Zaleski Z., 2001, LIFE GOALS WELL BEIN, P135	53	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167745	10.1371/journal.pone.0167745	http://dx.doi.org/10.1371/journal.pone.0167745			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977718	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400030
J	Spaulding, HR; Ballmann, CG; Quindry, JC; Selsby, JT				Spaulding, Hannah R.; Ballmann, Christopher G.; Quindry, John C.; Selsby, Joshua T.			Long-Term Quercetin Dietary Enrichment Partially Protects Dystrophic Skeletal Muscle	PLOS ONE			English	Article							UTROPHIN GENE-EXPRESSION; MDX MICE; MUSCULAR-DYSTROPHY; PGC-1-ALPHA; PHENOTYPE; EXERCISE; KINASE; INFLAMMATION; INJURY; AMPK	Duchenne muscular dystrophy (DMD) results from a genetic lesion in the dystrophin gene and leads to progressive muscle damage. PGC-1 alpha pathway activation improves muscle function and decreases histopathological injury. We hypothesized that mild disease found in the limb muscles of mdx mice may be responsive to quercetin-mediated protection of dystrophic muscle via PGC-1 alpha pathway activation. To test this hypothesis muscle function was measured in the soleus and EDL from 14 month old C57, mdx, and mdx mice treated with quercetin (mdxQ; 0.2% dietary enrichment) for 12 months. Quercetin reversed 50% of disease-related losses in specific tension and partially preserved fatigue resistance in the soleus. Specific tension and resistance to contraction-induced injury in the EDL were not protected by quercetin. Given some functional gain in the soleus it was probed with histological and biochemical approaches, however, in dystrophic muscle histopathological outcomes were not improved by quercetin and suppressed PGC-1 alpha pathway activation was not increased. Similar to results in the diaphragm from these mice, these data suggest that the benefits conferred to dystrophic muscle following 12 months of quercetin enrichment were underwhelming. Spontaneous activity at the end of the treatment period was greater in mdxQ compared to mdx indicating that quercetin fed mice were more active in addition to engaging in more vigorous activity. Hence, modest preservation of muscle function (specific tension) and elevated spontaneous physical activity largely in the absence of tissue damage in mdxQ suggests dietary quercetin may mediate protection.	[Spaulding, Hannah R.; Selsby, Joshua T.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Ballmann, Christopher G.; Quindry, John C.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA	Iowa State University; Auburn University System; Auburn University	Selsby, JT (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	jselsby@iastate.edu		Ballmann, Christopher/0000-0002-7839-8894	Duchenne Alliance; Zack Heger Foundation, Pietro's Fight, Race MD; Romito Foundation; Harrison's Fund; Alex's Wish; Two Smiles One Hope Foundation [100065, 100071]	Duchenne Alliance; Zack Heger Foundation, Pietro's Fight, Race MD; Romito Foundation; Harrison's Fund; Alex's Wish; Two Smiles One Hope Foundation	This work was supported by the Duchenne Alliance and its member foundations (Ryan's Quest, Hope for Gus, Team Joseph, Michael's Cause, Duchenne Now, Zack Heger Foundation, Pietro's Fight, Race MD, JB's Keys, Romito Foundation, Harrison's Fund, Alex's Wish, and Two Smiles One Hope Foundation) grants 100065 and 100071 to JS and JQ. The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077; Alexander SPH, 2006, PHYTOTHER RES, V20, P1009, DOI 10.1002/ptr.1975; ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755; Angus LM, 2005, AM J PHYSIOL-CELL PH, V289, pC908, DOI 10.1152/ajpcell.00196.2005; Ballmann C, 2015, EXP PHYSIOL, V100, P12, DOI 10.1113/expphysiol.2014.083360; Boots AW, 2011, CLIN NUTR, V30, P506, DOI 10.1016/j.clnu.2011.01.010; BROOKS SV, 1988, J PHYSIOL-LONDON, V404, P71, DOI 10.1113/jphysiol.1988.sp017279; Bueno CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045699; Camerino GM, 2014, HUM MOL GENET, V23, P5720, DOI 10.1093/hmg/ddu287; Cerletti M, 2003, GENE THER, V10, P750, DOI 10.1038/sj.gt.3301941; Barbin ICC, 2016, J ANAT, V228, P784, DOI 10.1111/joa.12443; Chalkiadaki A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004490; Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008; Dong J, 2014, J LIPID RES, V55, P363, DOI 10.1194/jlr.M038786; ERVASTI JM, 1994, FEBS LETT, V350, P173, DOI 10.1016/0014-5793(94)00748-9; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; Gordon BS, 2013, CLIN NUTR, V32, P104, DOI 10.1016/j.clnu.2012.06.003; Guedes-Dias P, 2013, BBA-MOL BASIS DIS, V1832, P1345, DOI 10.1016/j.bbadis.2013.04.005; Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107; Hollinger K, 2015, EXP PHYSIOL, V100, P1145, DOI 10.1113/EP085339; Hollinger K, 2015, CLIN NUTR, V34, P515, DOI 10.1016/j.clnu.2014.06.008; Hollinger K, 2013, AM J PHYSIOL-REG I, V305, pR13, DOI 10.1152/ajpregu.00221.2012; Hourde C, 2013, AM J PATHOL, V182, P1509, DOI 10.1016/j.ajpath.2013.01.020; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hyzewicz Janek, 2015, J Neuromuscul Dis, V2, P325; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Martin P., 2007, MEASURING BEHAV; Nemoto S, 2005, SIRT1 FUNCTIONALLY I; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Peladeau C, 2016, HUM MOL GENET, V25, P24, DOI 10.1093/hmg/ddv444; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Selsby J, 2010, AM J PHYSIOL-REG I, V299, pR1192, DOI 10.1152/ajpregu.00586.2009; Selsby JT, 2013, J APPL PHYSIOL, V115, P660, DOI 10.1152/japplphysiol.00252.2013; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Selsby JT, 2011, EXP PHYSIOL, V96, P194, DOI 10.1113/expphysiol.2010.054379; Selsby JT, 2016, J PHYSL; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; Tinsley JM, 1996, NATURE, V384, P349, DOI 10.1038/384349a0; Wakefield PM, 2000, GENE THER, V7, P201, DOI 10.1038/sj.gt.3301066; Wineinger MA, 1998, AM J PHYS MED REHAB, V77, P20, DOI 10.1097/00002060-199801000-00004; Zhang Y, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6236; Zhao LR, 2014, INT J MOL MED, V34, P1025, DOI 10.3892/ijmm.2014.1852	47	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168293	10.1371/journal.pone.0168293	http://dx.doi.org/10.1371/journal.pone.0168293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977770	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400089
J	Wu, CJ; Fang, WH; Kao, TW; Chen, YJ; Liaw, FY; Chang, YW; Wang, GC; Peng, TC; Chen, WL				Wu, Chen-Jung; Fang, Wen-Hui; Kao, Tung-Wei; Chen, Ying-Jen; Liaw, Fang-Yih; Chang, Yaw-Wen; Wang, Gia-Chi; Peng, Tao-Chun; Chen, Wei-Liang			Postprandial Glucose as a Risk Factor for Elevated Intraocular Pressure	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; CORNEAL THICKNESS; PLASMA-GLUCOSE; HYPERGLYCEMIA; POPULATION	The aim of this study was to investigate the association between postprandial glucose and intraocular pressure in a relatively healthy population. We examined 1,439 adults getting a health check-up in a health promotion center at Tri-Service General Hospital (TSGH) in Taiwan between 2012 and 2013. All participants underwent examinations to measure metabolic variables and intraocular pressure. Multiple linear regression analyses were performed to assess the relationship between postprandial glucose and intraocular pressure. The levels of postprandial glucose were divided into quartiles with subjects in the lowest quartile being regarded as the reference group to perform quartile-based analysis. Covariate adjustment was designed for three models for further analysis. Subjects with higher quartiles of postprandial glucose level had a higher systolic blood pressure, a greater waist circumference and an elevated fasting glucose level (all p < 0.001). The beta coefficient with adjusted covariates showed a significant positive association between postprandial glucose and intraocular pressure. The trends of intraocular pressure across increasing quartiles of postprandial glucose were statistically significant (all p for trend < 0.001). Thus, higher levels of postprandial glucose positively correlated with elevated intraocular pressure.	[Wu, Chen-Jung; Fang, Wen-Hui; Kao, Tung-Wei; Liaw, Fang-Yih; Chang, Yaw-Wen; Wang, Gia-Chi; Peng, Tao-Chun; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan; [Wu, Chen-Jung; Fang, Wen-Hui; Kao, Tung-Wei; Liaw, Fang-Yih; Chang, Yaw-Wen; Wang, Gia-Chi; Peng, Tao-Chun; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Wu, Chen-Jung] Taoyuan Armed Forces Gen Hosp, Div Family Med, Dept Community Med, Taoyuan, Taiwan; [Kao, Tung-Wei; Liaw, Fang-Yih; Chang, Yaw-Wen; Chen, Wei-Liang] Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan; [Kao, Tung-Wei; Liaw, Fang-Yih; Chang, Yaw-Wen; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Kao, Tung-Wei] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Chen, Ying-Jen] Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chen, Ying-Jen] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chen, Ying-Jen; Chen, Wei-Liang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Taiwan University; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Family Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Triserv Gen Hosp, Dept Family & Community Med, Div Geriatr Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	weiliang0508@gmail.com	Peng, Tao‑Chun/AAY-7035-2020; Chang, Yaw-Wen/AAF-2630-2020	Chang, Yaw-Wen/0000-0002-8436-0518				Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Caccamo G, 2010, ATHEROSCLEROSIS, V211, P672, DOI 10.1016/j.atherosclerosis.2010.03.033; Ceriello A, 2004, ARCH INTERN MED, V164, P2090, DOI 10.1001/archinte.164.19.2090; Ceriello A, 2002, CIRCULATION, V106, P1211, DOI 10.1161/01.CIR.0000027569.76671.A8; Choi J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/141905; Chun YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0112929; Chung HJ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/827516; Coleman AL, 2008, SURV OPHTHALMOL, V53, pS3, DOI 10.1016/j.survophthal.2008.08.006; Critchell CD, 2007, INTENS CARE MED, V33, P2079, DOI 10.1007/s00134-007-0835-4; De Caterina R, 2000, CURR OPIN LIPIDOL, V11, P9; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; Doughty MJ, 2000, SURV OPHTHALMOL, V44, P367, DOI 10.1016/S0039-6257(00)00110-7; Imai K, 2010, INT J OBESITY, V34, P1209, DOI 10.1038/ijo.2010.32; Kahn R, 2001, DIABETES CARE, V24, P775; Kendrick M, 2003, MED HYPOTHESES, V60, P6, DOI 10.1016/S0306-9877(02)00319-5; Ketema EB, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0088-6; Mantravadi AV, 2015, PRIMARY CARE, V42, P437, DOI 10.1016/j.pop.2015.05.008; MAPSTONE R, 1985, BRIT MED J, V291, P93, DOI 10.1136/bmj.291.6488.93; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Memarzadeh F, 2008, AM J OPHTHALMOL, V146, P69, DOI 10.1016/j.ajo.2008.03.015; Pimentel LGM, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/832058; Mori K, 2000, INT J EPIDEMIOL, V29, P661, DOI 10.1093/ije/29.4.661; O'Neill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229; Oh SW, 2005, DIABETES-METAB RES, V21, P434, DOI 10.1002/dmrr.529; Resnikoff S, 2002, B WORLD HEALTH ORGAN, V82, P844; Sato T, 2002, INVEST OPHTH VIS SCI, V43, P170; Shen L, 2016, AM J EPIDEMIOL, V183, P147, DOI 10.1093/aje/kwv204; Shim SH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/425835; Tan GS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1354, DOI 10.1001/archophthalmol.2009.268; Ullal Aarti, 2013, Indian J Endocrinol Metab, V17, pS688, DOI 10.4103/2230-8210.123569; WHITACRE MM, 1993, AM J OPHTHALMOL, V115, P592, DOI 10.1016/S0002-9394(14)71455-2; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Wolever TMS, 1998, DIABETES CARE, V21, P336, DOI 10.2337/diacare.21.3.336; Xu L, 2005, AM J OPHTHALMOL, V140, P913, DOI 10.1016/j.ajo.2005.04.050; Zhao D, 2015, OPHTHALMOLOGY, V122, P72, DOI 10.1016/j.ophtha.2014.07.051; Zhao D, 2014, AM J OPHTHALMOL, V158, P615, DOI 10.1016/j.ajo.2014.05.029	36	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168142	10.1371/journal.pone.0168142	http://dx.doi.org/10.1371/journal.pone.0168142			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977733	gold, Green Published			2022-12-27	WOS:000391217400068
J	Bailey, LD; van de Pol, M				Bailey, Liam D.; van de Pol, Martijn			climwin: An R Toolbox for Climate Window Analysis	PLOS ONE			English	Article							REPRODUCTIVE TRAITS; RESPONSES; WEATHER; PLASTICITY; MODEL; DATE	When studying the impacts of climate change, there is a tendency to select climate data from a small set of arbitrary time periods or climate windows (e.g., spring temperature). However, these arbitrary windows may not encompass the strongest periods of climatic sensitivity and may lead to erroneous biological interpretations. Therefore, there is a need to consider a wider range of climate windows to better predict the impacts of future climate change. We introduce the R package climwin that provides a number of methods to test the effect of different climate windows on a chosen response variable and compare these windows to identify potential climate signals. climwin extracts the relevant data for each possible climate window and uses this data to fit a statistical model, the structure of which is chosen by the user. Models are then compared using an information criteria approach. This allows users to determine how well each window explains variation in the response variable and compare model support between windows. climwin also contains methods to detect type I and II errors, which are often a problem with this type of exploratory analysis. This article presents the statistical framework and technical details behind the climwin package and demonstrates the applicability of the method with a number of worked examples.	[Bailey, Liam D.; van de Pol, Martijn] Australian Natl Univ, Res Sch Biol, Dept Evolut Ecol & Genet, Canberra, ACT, Australia; [van de Pol, Martijn] Netherlands Inst Ecol NIOOKNAW, Dept Anim Ecol, Wageningen, Netherlands	Australian National University	Bailey, LD (corresponding author), Australian Natl Univ, Res Sch Biol, Dept Evolut Ecol & Genet, Canberra, ACT, Australia.	liam.bailey@anu.edu.au	KNAW, NIOO-KNAW/A-4320-2012	KNAW, NIOO-KNAW/0000-0002-3835-159X; van de Pol, Martijn/0000-0003-4102-4079; Bailey, Liam D./0000-0002-8226-9454	Australian Postgraduate Award scholarship; Australian Research Council [FT120100204]	Australian Postgraduate Award scholarship; Australian Research Council(Australian Research Council)	LDB was supported by an Australian Postgraduate Award scholarship and MvdP by the Australian Research Council (http:www.arc.gov.au/; FT120100204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Barton K., 2016, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Biro PA, 2010, P ROY SOC B-BIOL SCI, V277, P71, DOI 10.1098/rspb.2009.1346; Briga M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16600; Brommer JE, 2008, P ROY SOC B-BIOL SCI, V275, P687, DOI 10.1098/rspb.2007.0951; Burnham KP, 2003, MODEL SELECTION MULT; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cayton HL, 2015, ECOLOGY, V96, P1473, DOI 10.1890/15-0131.1; Cayuela H, 2016, GLOBAL CHANGE BIOL, V22, P2676, DOI 10.1111/gcb.13290; Cook BI, 2012, P NATL ACAD SCI USA, V109, P9000, DOI 10.1073/pnas.1118364109; Gienapp P, 2008, MOL ECOL, V17, P167, DOI 10.1111/j.1365-294X.2007.03413.x; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Husby A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000585; Husby A, 2010, EVOLUTION, V64, P2221, DOI 10.1111/j.1558-5646.2010.00991.x; Kruuk LEB, 2015, GLOBAL CHANGE BIOL, V21, P2929, DOI 10.1111/gcb.12926; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Phillimore AB, 2010, P NATL ACAD SCI USA, V107, P8292, DOI 10.1073/pnas.0913792107; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts AMI, 2008, INT J BIOMETEOROL, V52, P463, DOI 10.1007/s00484-007-0141-4; Roberts AMI, 2015, GLOBAL CHANGE BIOL, V21, P2603, DOI 10.1111/gcb.12896; Schaper SV, 2012, AM NAT, V179, pE55, DOI 10.1086/663675; Stopher KV, 2014, ECOLOGY, V95, P3124; Teller BJ, 2016, METHODS ECOL EVOL, V7, P171, DOI 10.1111/2041-210X.12486; Therneau T., 2015, PACKAGE SURVIVAL ANA; van de Pol M, 2016, METHODS ECOL EVOL, V7, P1246, DOI 10.1111/2041-210X.12590; van de Pol M, 2011, AM NAT, V177, P698, DOI 10.1086/659101; van de Pol MV, 2009, ANIM BEHAV, V77, P753, DOI 10.1016/j.anbehav.2008.11.006; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	32	78	78	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167980	10.1371/journal.pone.0167980	http://dx.doi.org/10.1371/journal.pone.0167980			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973534	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000392754300052
J	Liang, ZG; Chen, XQ; Niu, ZJ; Chen, KH; Li, L; Qu, S; Su, F; Zhao, W; Li, Y; Pan, XB; Zhu, XD				Liang, Zhong-Guo; Chen, Xiao-Qian; Niu, Zhi-Jie; Chen, Kai-Hua; Li, Ling; Qu, Song; Su, Fang; Zhao, Wei; Li, Ye; Pan, Xin-Bin; Zhu, Xiao-Dong			Recommendations for Updating T and N Staging Systems for Nasopharyngeal Carcinoma in the Era of Intensity-Modulated Radiotherapy	PLOS ONE			English	Article							7TH EDITION; CONCURRENT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; CANCER; IMRT	Objective The aim of this study was to compare the 2008 Chinese and the 7th edition of the American Joint Committee on Cancer (AJCC) staging systems for nasopharyngeal carcinoma and to provide proposals for updating T and N staging systems of the present staging system. Methods Between January 2007 and December 2012, a cohort of 752 patients with biopsy-proven, newly diagnosed, non-metastatic nasopharyngeal carcinoma who were treated with intensity-modulated radiotherapy were retrospectively analysed. Prognoses were compared by T stage, N stage, and clinical stage according to the two staging systems for overall survival (OS), local relapse-free survival (LRFS), and distant metastasis-free survival (DMFS). Results In terms of both the T and N staging systems, the two current staging systems were comparable in predicting OS. The T classification of the 2008 Chinese staging system was better in predicting LRFS, while the N classification of the 7th edition AJCC staging system was superior in predicting DMFS. In the modern era of intensity-modulated radiotherapy, the staging system should be updated by down-staging the current stage T2 to T1, and it might be rational to merge subcategories N1 and N2. Conclusions The two current staging systems each had advantages in predicting prognosis. It seems reasonable to downstage T2 to T1 and to merge N1 and N2.	[Liang, Zhong-Guo; Chen, Xiao-Qian; Niu, Zhi-Jie; Chen, Kai-Hua; Li, Ling; Qu, Song; Su, Fang; Zhao, Wei; Li, Ye; Pan, Xin-Bin; Zhu, Xiao-Dong] Guangxi Med Univ, Affiliated Tumor Hosp, Canc Inst Guangxi Zhuang Autonomous Reg, Dept Radiat Oncol, Nanning, Peoples R China	Guangxi Medical University	Zhu, XD (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Canc Inst Guangxi Zhuang Autonomous Reg, Dept Radiat Oncol, Nanning, Peoples R China.	zhuxdonggxmu@126.com			Fund of Guangxi Science [0832229]; Major Research Projects of Guangxi Universities [201101ZD004]; Key Project of Guangxi Heath Care [2011076]; Youth Science Fund of Guangxi Medical University [201515]	Fund of Guangxi Science; Major Research Projects of Guangxi Universities; Key Project of Guangxi Heath Care; Youth Science Fund of Guangxi Medical University	This work was sponsored by the Fund of Guangxi Science (no. 0832229), Major Research Projects of Guangxi Universities (no. 201101ZD004), the Key Project of Guangxi Heath Care (no. 2011076), and the Youth Science Fund of Guangxi Medical University (no. 201515), http://www.gxsti.net.cn/zwgk/kjxmgl/xmysgg/612843.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen KH, 2016, ONCOTARGET; Chen L, 2012, RADIOTHER ONCOL, V104, P331, DOI 10.1016/j.radonc.2011.10.009; Ee VPC, 2013, ASIAN PAC J CANCER P, V14, P2243, DOI 10.7314/APJCP.2013.14.4.2243; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lee AWM, 2012, ORAL ONCOL, V48, P1007, DOI 10.1016/j.oraloncology.2012.03.022; Liang SB, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-260; Liang Z, 2014, CURR ONCOL, V21, pE408, DOI 10.3747/co.21.1777; [林少俊 Lin Shaojun], 2015, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V24, P275; Liu XW, 2014, CHIN J CANCER, V33, P511, DOI 10.5732/cjc.014.10017; Mao YP, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0016-8; Pan J, 2013, J RADIOL ONCOL, V2, P233, DOI 10.1007/s13566-013-0088-5; Pan JJ, 2016, CANCER-AM CANCER SOC, V122, P546, DOI 10.1002/cncr.29795; Pan JJ, 2015, AM J CLIN ONCOL-CANC, V38, P189, DOI 10.1097/COC.0b013e31828f5c96; Qiu WZ, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-015-0076-9; Su SF, 2012, INT J RADIAT ONCOL, V82, P327, DOI 10.1016/j.ijrobp.2010.09.011; Su Z, 2016, TUMOR BIOL, V37, P4429, DOI 10.1007/s13277-015-4266-5; Wu Z, 2014, J CANCER RES CLIN, V140, P69, DOI 10.1007/s00432-013-1542-x; Xu TT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001457; [曾雷 Zeng Lei], 2015, [中华放射肿瘤学杂志, Chinese Journal of Radiation Oncology], V24, P285; Zhang L, 2016, ONCOTARGET, V7, P6221, DOI 10.18632/oncotarget.6754; Zhang SX, 2014, BIO-MED MATER ENG, V24, P1117, DOI 10.3233/BME-130911; Zhou GQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22326; Zong JF, 2015, ORAL ONCOL, V51, P254, DOI 10.1016/j.oraloncology.2014.10.012	23	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168470	10.1371/journal.pone.0168470	http://dx.doi.org/10.1371/journal.pone.0168470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973544	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300082
J	Kojima, R; Kobayashi, S; Satuito, CGP; Katsuyama, I; Ando, H; Seki, Y; Senda, T				Kojima, Ryuji; Kobayashi, Seiji; Satuito, Cyril Glenn Perez; Katsuyama, Ichiro; Ando, Hirotomo; Seki, Yasuyuki; Senda, Tetsuya			A Method for Evaluating the Efficacy of Antifouling Paints Using Mytilus galloprovincialis in the Laboratory in a Flow-Through System	PLOS ONE			English	Article							BLUE MUSSEL; LARVAL SETTLEMENT; SCREENING METHOD; METAMORPHOSIS; SUBSTANCES; RECRUITMENT; SUCCESSION; ATTACHMENT; PATTERNS; SURVIVAL	A laboratory test with a flow-through system was designed and its applicability for testing antifouling paints of varying efficacies was investigated. Six different formulations of antifouling paints were prepared to have increasing contents (0 to 40 wt.%) of Cu2O, which is the most commonly used antifouling substance, and each formulation of paint was coated on just one surface of every test plate. The test plates were aged for 45 days by rotating them at a speed of 10 knots inside a cylinder drum. A behavioral test was then conducted using five mussels (Mytilus galloprovincialis) that were pasted onto the coated surface of each aged test plate. The number of the byssus threads produced by each mussel generally decreased with increasing Cu2O content of the paint. The newly designed method was considered valid owing to the high consistency of its results with observations from the field experiment.	[Kojima, Ryuji; Ando, Hirotomo; Senda, Tetsuya] Natl Maritime Res Inst, Dept Marine Environm & Engine Syst, Mitaka, Tokyo, Japan; [Kobayashi, Seiji; Katsuyama, Ichiro] Japan NUS Co Ltd, Dept Environm Risk Consulting, Shinjuku Ku, Tokyo, Japan; [Satuito, Cyril Glenn Perez] Nagasaki Univ, Grad Sch Fisheries Sci & Environm Studies, Nagasaki, Japan; [Seki, Yasuyuki] Chugoku Marine Paints Ltd, Hiroshima R&D Ctr, Otake, Hiroshima, Japan	National Maritime Research Institute; Japan NUS; Nagasaki University	Kojima, R (corresponding author), Natl Maritime Res Inst, Dept Marine Environm & Engine Syst, Mitaka, Tokyo, Japan.	kojima@nmri.go.jp	Satuito, Cyril Glenn/AAA-5753-2020	Satuito, Cyril Glenn/0000-0002-9287-2660	Japan NUS Co., Ltd.; Chugoku Marine Paints, Ltd.; Nippon Foundation [20011965347, 2000070441C99]	Japan NUS Co., Ltd.; Chugoku Marine Paints, Ltd.; Nippon Foundation(Nippon Foundation)	Japan NUS Co., Ltd. provided support in the form of salaries for authors [SK and IK], and Chugoku Marine Paints, Ltd. provided support in the form of salaries for author [YS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Support was also provided by the Nippon Foundation, Project ID: 20011965347, Continued project ID: 2000070441C99.	Aldred N, 2006, J R SOC INTERFACE, V3, P37, DOI 10.1098/rsif.2005.0074; Allan J.A., 1976, Journal moll Stud, V42, P279; [Anonymous], 2007, 151812 ISO; Archambault P, 1999, J EXP MAR BIOL ECOL, V238, P161, DOI 10.1016/S0022-0981(98)00146-4; Arias S, 1999, EUROPEAN COATINGS H, V1571, P122; ASTM Method, 2003, SYSTEMS; Bao WY, 2007, MAR BIOL, V150, P565, DOI 10.1007/s00227-006-0383-4; BAYNE BL, 1964, J ANIM ECOL, V33, P513, DOI 10.2307/2569; Berntsson KM, 2003, BIOFOULING, V19, P187, DOI 10.1080/0892701031000072091; Briand JF, 2009, BIOFOULING, V25, P297, DOI 10.1080/08927010902745316; BROWN CH, 1952, Q J MICROSC SCI, V93, P487; CACERESMARTINEZ J, 1994, MAR ECOL PROG SER, V112, P107, DOI 10.3354/meps112107; Campbell Marnie L, 2011, Biofouling, V27, P631, DOI 10.1080/08927014.2011.593715; Carl C, 2011, BIOFOULING, V27, P859, DOI 10.1080/08927014.2011.605943; Carl C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052358; Carlton JT, 1996, BIOL CONSERV, V78, P97, DOI 10.1016/0006-3207(96)00020-1; Carrington E, 2004, AM MALACOL BULL, V18, P135; Coutts ADM, 2004, NEW ZEAL J MAR FRESH, V38, P215, DOI 10.1080/00288330.2004.9517232; Coutts ADM, 2010, MAR POLLUT BULL, V60, P1533, DOI 10.1016/j.marpolbul.2010.04.015; Coutts ADM, 2010, BIOFOULING, V26, P1, DOI 10.1080/08927010903174599; Da Gama BAP, 2003, BIOFOULING, V19, P161, DOI 10.1080/0892701031000089534; Davidson IC, 2009, BIOFOULING, V25, P645, DOI 10.1080/08927010903046268; Dobretsov S, 2006, BIOFOULING, V22, P43, DOI 10.1080/08927010500504784; Dobretsov SV, 1999, BIOFOULING, V14, P153, DOI 10.1080/08927019909378406; ECHA, 2014, TRANS GUID BIOC PROD; Etoh H, 1996, NIPPON SUISAN GAKK, V62, P796; Filgueira LGPR, 2007, AQUAC RES, V38, P1679, DOI 10.1111/j.1365-2109.2007.01820.x; Finnie AA, 2006, BIOFOULING, V22, P279, DOI 10.1080/08927010600898862; HARADA A, 1984, AGR BIOL CHEM TOKYO, V48, P641, DOI 10.1080/00021369.1984.10866197; Haslbeck E., 2005, J PROTECT COAT LININ, V2005, P34; Haslbeck EG, 1992, SNAME A, V3A, P1; Hayashi Y., 1996, J MAR BIOTECHNOL, V4, P127; Hopkins Grant A, 2010, Biofouling, V26, P613, DOI 10.1080/08927014.2010.502963; INA K, 1989, AGR BIOL CHEM TOKYO, V53, P3319, DOI 10.1080/00021369.1989.10869811; Ina K, 1990, KAGAKU TO SEIBUTU, V2, P132; Japanese Standard Association, 1983, K5630 JIS; KETCHUM BH, 1945, IND ENG CHEM, V37, P456, DOI 10.1021/ie50425a021; KITAJIMA F, 1995, FISHERIES SCI, V61, P578, DOI 10.2331/fishsci.61.578; Kojima R, 2014, J SHIPPING OCEAN ENG, V4, P214; Martin-Rodriguez AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123652; MCGRATH D, 1988, MAR ECOL PROG SER, V47, P103, DOI 10.3354/meps047103; Ohba T, 1999, SESSILE ORGANISMS, V15, P9; Okamura Hideo, 2009, Sessile Organisms, V26, P33; Otani M, 2007, BIOFOULING, V23, P277, DOI 10.1080/08927010701315089; PINEDA J, 1994, MAR ECOL PROG SER, V107, P125, DOI 10.3354/meps107125; Piola RF, 2009, BIOFOULING, V25, P633, DOI 10.1080/08927010903063065; Ralston EA, 2014, BIOFOULING, V30, P459, DOI 10.1080/08927014.2014.894984; Richmond M.D., 1991, Biofouling, V3, P151; Sakaguchi I., 2007, ATTACHING ORGANISMS, P100; SATUITO CG, 1995, FISHERIES SCI, V61, P223, DOI 10.2331/fishsci.61.223; Satuito CG, 2005, BIOFOULING, V21, P217, DOI 10.1080/08927010500375300; Satuito CG, 1993, OEBALIA S, V16, P479; Schultz MP, 2007, BIOFOULING, V23, P331, DOI 10.1080/08927010701461974; Seki Y, 2014, P INT S MAR ENG ISME, P15; Sera Y, 2000, MAR BIOTECHNOL, V2, P314; The CEPE Antifouling Working Group, 2011, EFF EV ANT PROD COND, P1; Thomason JC, 2000, BIOFOULING, V16, P323, DOI 10.1080/08927010009378455; Toupoint N, 2012, ECOLOGY, V93, P1922, DOI 10.1890/11-1292.1; UNDERWOOD AJ, 1994, J MAR BIOL ASSOC UK, V74, P563, DOI 10.1017/S0025315400047676; Waite JH, 1998, MATRIX BIOL, V17, P93, DOI 10.1016/S0945-053X(98)90023-3; Wang C, 2012, BIOFOULING, V28, P249, DOI 10.1080/08927014.2012.671303; Yebra DM, 2006, BIOFOULING, V22, P33, DOI 10.1080/08927010500519097	62	10	10	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168172	10.1371/journal.pone.0168172	http://dx.doi.org/10.1371/journal.pone.0168172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959916	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900045
J	Rickert, E; Wahl, M; Link, H; Richter, H; Pohnert, G				Rickert, Esther; Wahl, Martin; Link, Heike; Richter, Hannes; Pohnert, Georg			Seasonal Variations in Surface Metabolite Composition of Fucus vesiculosus and Fucus serratus from the Baltic Sea	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; FATTY-ACIDS; CHEMICAL-COMPOSITION; SECONDARY METABOLITES; ASCOPHYLLUM-NODOSUM; PHENOLIC-COMPOUNDS; MARINE MACROALGAE; CITRIC-ACID; TEMPERATURE; GROWTH	Perennial macroalgae within the genus Fucus are known to exude metabolites through their outer thallus surface. Some of these metabolites have pro-and/or antifouling properties. Seasonal fluctuations of natural fouling pressure and chemical fouling control strength against micro-and macrofoulers have previously been observed in Fucus, suggesting that control strength varies with threat. To date, a study on the seasonal composition of surface associated metabolites, responsible for much of the fouling control, has not been done. We sampled individuals of the two co-occurring species F. vesiculosus and F. serratus at monthly intervals (six per species and month) during a one-year field study. We analysed the chemical composition of surface associated metabolites of both Fucus species by means of gas chromatography- mass spectrometry (GC-MS) to describe temporal patterns in chemical surface composition. Additionally, we correlated abiotic and biotic parameters recorded monthly within the sampled habitat with the variation in the chemical surface landscape of Fucus. Our study revealed that the chemical surface composition of both Fucus species exhibits substantial seasonal differences between spring/summer and autumn/winter months. Light and temperature explained most of the seasonal variability in surface metabolite composition of both Fucus species. A strong summerly up-regulation of eighteen saccharides and two hydroxy acids in F. vesiculosus as well as of four fatty acids and two saccharides in F. serratus was observed. We discuss how these up-regulated molecules may have a complex effect on associated microfoulers, both promoting or decreasing fouling depending on metabolite and bacterial identity. These seasonal shifts in the surface metabolome seem to exert a compound control of density and composition of the Fucus associated biofilm.	[Rickert, Esther; Wahl, Martin] Helmholtz Ctr Ocean Res Kiel GEOMAR, Dept Marine Ecol, Div Benth Ecol, Kiel, Germany; [Link, Heike] Univ Kiel, Inst Ecosyst Res, Kiel, Germany; [Richter, Hannes; Pohnert, Georg] Friedrich Schiller Univ Jena, Inst Inorgan & Analyt Chem, Dept Bioorgan Analyt, Jena, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel; Friedrich Schiller University of Jena	Rickert, E (corresponding author), Helmholtz Ctr Ocean Res Kiel GEOMAR, Dept Marine Ecol, Div Benth Ecol, Kiel, Germany.	erickert@geomar.de	Wahl, Martin/D-2038-2016; Pohnert, Georg/D-3721-2013	Wahl, Martin/0000-0001-8703-3857; Pohnert, Georg/0000-0003-2351-6336; Link, Heike/0000-0002-8484-845X	German Research Foundation (DFG) [WA 708/24-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This project was funded by the German Research Foundation (DFG) under the project number: WA 708/24-1 (http://www.dfg.de/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala-Diaz RT, 2006, MAR BIOL, V148, P459, DOI 10.1007/s00227-005-0102-6; Abdullah MI, 2004, J MAR BIOL ASSOC UK, V84, P887, DOI 10.1017/S002531540401015Xh; Amade P, 1998, AQUAT TOXICOL, V43, P287, DOI 10.1016/S0166-445X(98)00054-X; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bengtsson MM, 2010, AQUAT MICROB ECOL, V60, P71, DOI 10.3354/ame01409; CARLSON DJ, 1984, LIMNOL OCEANOGR, V29, P1077, DOI 10.4319/lo.1984.29.5.1077; Colvard NB, 2014, J EXP MAR BIOL ECOL, V458, P6, DOI 10.1016/j.jembe.2014.05.001; Culioli G, 2002, BIOCHEM SYST ECOL, V30, P61, DOI 10.1016/S0305-1978(01)00071-0; DALY CG, 1982, J CLIN PERIODONTOL, V9, P386, DOI 10.1111/j.1600-051X.1982.tb02049.x; DAVISON IR, 1987, BRIT PHYCOL J, V22, P77, DOI 10.1080/00071618700650101; DAVISON IR, 1991, J PHYCOL, V27, P2, DOI 10.1111/j.0022-3646.1991.00002.x; de Nys R, 1998, MAR ECOL PROG SER, V162, P79, DOI 10.3354/meps162079; De Rosa S, 2001, Z NATURFORSCH C, V56, P1008; DENYS R, 1995, BIOFOULING, V8, P259, DOI 10.1080/08927019509378279; Dworjanyn SA, 2006, MAR ECOL PROG SER, V318, P153, DOI 10.3354/meps318153; Dworjanyn SA, 1999, MAR BIOL, V133, P727, DOI 10.1007/s002270050514; Egan S, 2013, FEMS MICROBIOL REV, V37, P462, DOI 10.1111/1574-6976.12011; FLEURENCE J, 1994, J APPL PHYCOL, V6, P527, DOI 10.1007/BF02182406; Fong P, 2004, AQUAT BOT, V78, P83, DOI 10.1016/j.aquabot.2003.09.006; Goecke F, 2012, GAYANA BOT, V69, P376, DOI 10.4067/S0717-66432012000200016; Gorley C.K., 2006, GETTING STARTED PRIM; Grosser K, 2012, BIOFOULING, V28, P687, DOI 10.1080/08927014.2012.700306; Haas AF, 2010, AQUAT BIOL, V10, P131, DOI 10.3354/ab00271; Hellio C, 2004, MAR BIOTECHNOL, V6, P67, DOI 10.1007/s10126-003-0020-x; ILVESSALO H, 1989, MAR BIOL, V101, P115, DOI 10.1007/BF00393484; In YW, 2013, J FOOD SAFETY, V33, P79, DOI 10.1111/jfs.12025; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; Kamenarska Z, 2004, BOT MAR, V47, P215, DOI 10.1515/BOT.2004.022; Kamenarska Z, 2002, Z NATURFORSCH C, V57, P584; Khotimchenko SV, 1998, PHYTOCHEMISTRY, V49, P2363, DOI 10.1016/S0031-9422(98)00240-4; Khotimchenko SV, 2002, BOT MAR, V45, P17, DOI 10.1515/BOT.2002.003; Lachnit T, 2013, FEMS MICROBIOL ECOL, V84, P411, DOI 10.1111/1574-6941.12071; Lachnit T, 2011, ENVIRON MICROBIOL, V13, P655, DOI 10.1111/j.1462-2920.2010.02371.x; Lehvo A, 2001, BOT MAR, V44, P345, DOI 10.1515/BOT.2001.044; LONGSTRETH DJ, 1980, PLANT PHYSIOL, V65, P541, DOI 10.1104/pp.65.3.541; Marechal JP, 2004, J EXP MAR BIOL ECOL, V313, P47, DOI 10.1016/j.jembe.2004.07.016; Ferrer-Luque CM, 2010, J ENDODONT, V36, P1673, DOI 10.1016/j.joen.2010.06.009; MASINI RJ, 1995, AQUAT BOT, V49, P239, DOI 10.1016/0304-3770(94)00432-L; McGaw LJ, 2002, FITOTERAPIA, V73, P431, DOI 10.1016/S0367-326X(02)00120-X; Menendez M, 2002, SCI MAR, V66, P355, DOI 10.3989/scimar.2002.66n4355; MIZUTA H, 1992, NIPPON SUISAN GAKK, V58, P2345; Nejrup LB, 2013, EUR J PHYCOL, V48, P295, DOI 10.1080/09670262.2013.830778; Nelson MM, 2002, BOT MAR, V45, P58, DOI 10.1515/BOT.2002.007; Nygard CA, 2008, EUR J PHYCOL, V43, P253, DOI 10.1080/09670260802172627; Nylund GM, 2008, MAR ECOL PROG SER, V369, P39, DOI 10.3354/meps07577; Nylund GM, 2005, MAR ECOL PROG SER, V302, P27, DOI 10.3354/meps302027; Nylund GM, 2010, FEMS MICROBIOL ECOL, V71, P84, DOI 10.1111/j.1574-6941.2009.00791.x; Ouattara B, 1997, INT J FOOD MICROBIOL, V37, P155, DOI 10.1016/S0168-1605(97)00070-6; Pavia H, 2000, HYDROBIOLOGIA, V440, P299, DOI 10.1023/A:1004152001370; Persson F, 2011, BIOFOULING, V27, P579, DOI 10.1080/08927014.2011.589001; PREGNALL AM, 1983, MAR BIOL, V73, P37, DOI 10.1007/BF00396283; RAGAN MA, 1978, J EXP MAR BIOL ECOL, V34, P245, DOI 10.1016/S0022-0981(78)80006-9; Raikar SV, 2001, INDIAN J MAR SCI, V30, P98; Rickert E, 2016, MAR BIOL, V163, DOI 10.1007/s00227-016-2970-3; Rickert E, 2015, BIOFOULING, V31, P363, DOI 10.1080/08927014.2015.1041020; Saha M, 2012, BIOFOULING, V28, P593, DOI 10.1080/08927014.2012.698615; Saha M, 2011, BIOFOULING, V27, P423, DOI 10.1080/08927014.2011.580841; Saha M, 2013, BIOFOULING, V29, P661, DOI 10.1080/08927014.2013.795953; SAND-JENSEN K, 1977, Aquatic Botany, V3, P55, DOI 10.1016/0304-3770(77)90004-3; Sebastianes FLS, 2012, CURR MICROBIOL, V65, P622, DOI 10.1007/s00284-012-0206-4; Seidel V, 2004, INT J ANTIMICROB AG, V23, P613, DOI 10.1016/j.ijantimicag.2003.11.008; SIEBURTH J M, 1969, Journal of Experimental Marine Biology and Ecology, V3, P290, DOI 10.1016/0022-0981(69)90052-5; Sneed JM, 2011, BIOFOULING, V27, P347, DOI 10.1080/08927014.2011.576317; Sneed JM, 2011, FEMS MICROBIOL ECOL, V75, P242, DOI 10.1111/j.1574-6941.2010.01005.x; Stratil SB, 2013, MICROBIOLOGYOPEN, V2, P338, DOI 10.1002/mbo3.79; SUKENIK A, 1987, BIOCHIM BIOPHYS ACTA, V891, P205, DOI 10.1016/0005-2728(87)90216-7; TERRADOS J, 1992, J EXP MAR BIOL ECOL, V162, P199, DOI 10.1016/0022-0981(92)90201-K; TUGWELL S, 1989, J EXP MAR BIOL ECOL, V129, P219, DOI 10.1016/0022-0981(89)90104-4; Vidoudez C, 2012, METABOLOMICS, V8, P654, DOI 10.1007/s11306-011-0356-6; Wada S, 2007, J EXP MAR BIOL ECOL, V349, P344, DOI 10.1016/j.jembe.2007.05.024; Wahl M, 2010, MAR ECOL PROG SER, V411, P33, DOI 10.3354/meps08644; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; Wahl M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00292; WHEELER WN, 1983, J PHYCOL, V19, P92, DOI 10.1111/j.0022-3646.1983.00092.x; Wyatt KH, 2014, FRESHWATER BIOL, V59, P407, DOI 10.1111/fwb.12273; Yff BTS, 2002, J ETHNOPHARMACOL, V79, P101, DOI 10.1016/S0378-8741(01)00380-4	76	18	18	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168196	10.1371/journal.pone.0168196	http://dx.doi.org/10.1371/journal.pone.0168196			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959901	Green Published, Green Accepted, gold			2022-12-27	WOS:000392753900049
J	Cha, E; Lee, KM; Park, KD; Park, KS; Lee, KW; Kim, SM; Lee, J				Cha, Eunju; Lee, Kang Mi; Park, Ki Duk; Park, Kyung Seok; Lee, Kwang-Woo; Kim, Sung-Min; Lee, Jaeick			Hydroxycholesterol Levels in the Serum and Cerebrospinal Fluid of Patients with Neuromyelitis Optica Revealed by LC-Ag+CIS/MS/MS and LC-ESI/MS/MS with Picolinic Derivatization: Increased Levels and Association with Disability during Acute Attack	PLoS One			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; MULTIPLE-SCLEROSIS; HUMAN BRAIN; CHOLESTEROL HOMEOSTASIS; DIAGNOSTIC-CRITERIA; OXIDATION-PRODUCTS; CELL-DEATH; OXYSTEROLS; PLASMA; 27-HYDROXYCHOLESTEROL	Neuromyelitis optica (NMO) is an inflammatory demyelinating disease of the central nervous system (CNS). Hydroxycholesterols (OHCs), metabolites of CNS cholesterol, are involved in diverse cellular responses to inflammation and demyelination, and may also be involved in the pathogenesis of NMO. We aimed to develop a sensitive and reliable method for the quantitative analysis of three major OHCs (24S-, 25-, and 27-OHCs), and to evaluate their concentration in the cerebrospinal fluid (CSF) and serum of patients with NMO. The levels of the three OHCs in the serum and CSF were measured using liquid chromatography-silver ion coordination ionspray tandem mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry with picolinyl ester derivatization, respectively. The linear range was 5-250 ng/mL for 24S- and 27-OHC, and 0.5-25 ng/mL for 25-OHC in serum, and was 0.1-5 ng/mL for 24S- and 27-OHC, and 0.03-1 ng/mL for 25-OHC in CSF. Precision and accuracy were 0.5%-14.7% and 92.5%-109.7%, respectively, in serum, and were 0.8%-7.7% and 94.5%-119.2%, respectively, in CSF. Extraction recovery was 82.7%-90.7% in serum and 68.4%-105.0% in CSF. When analyzed in 26 NMO patients and 23 control patients, the 25-OHC (0.54 +/- 0.96 ng/mL vs. 0.09 +/- 0.04 ng/mL, p = 0.032) and 27-OHC (2.68 +/- 3.18 ng/mL vs. 0.68 +/- 0.25 ng/mL, p = 0.005) were increased in the CSF from NMO patients. When we measured the OHCCSF index that controls the effects of blood-brain barrier disruption on the level of OHC in the CSF, the 27-OHCCSF index was associated with disability (0.723; 95% confidence interval (CI) -0.181, 0.620; p = 0.002), while the 24-OHCCSF index (0.518; 95% CI -1.070, 38.121; p = 0.040) and 25-OHCCSF index (0.677; 95% CI-4.313, 18.532; p = 0.004) were associated with the number of white blood cells in the CSF of NMO patients. Our results imply that OHCs in the CNS could play a role in the pathogenesis of NMO.	[Cha, Eunju; Lee, Kang Mi; Lee, Jaeick] Korea Inst Sci & Technol, Doping Control Ctr, Seoul, South Korea; [Park, Ki Duk] Korea Inst Sci & Technol, Brain Sci Inst, Seoul, South Korea; [Park, Kyung Seok] Seoul Natl Univ, Dept Neurol, Bundang Hosp, Gyeonggi Do, South Korea; [Lee, Kwang-Woo; Kim, Sung-Min] Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea	Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); Seoul National University (SNU); Seoul National University (SNU)	Lee, J (corresponding author), Korea Inst Sci & Technol, Doping Control Ctr, Seoul, South Korea.; Kim, SM (corresponding author), Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea.	sueh916@gmail.com; jaeicklee@kist.re.kr			National Research foundation fund [2014R1A1A2055741]; intramural grant from Korea Institute of Science and Technology (KIST)	National Research foundation fund(National Research Foundation of Korea); intramural grant from Korea Institute of Science and Technology (KIST)	This work was supported by grant NO. "2014R1A1A2055741" from the National Research foundation fund. Ag+CIS work was supported by an intramural grant from Korea Institute of Science and Technology (KIST).	Bayer E, 1999, ANGEW CHEM INT EDIT, V38, P992, DOI 10.1002/(SICI)1521-3773(19990401)38:7<992::AID-ANIE992>3.0.CO;2-K; Benarroch EE, 2008, NEUROLOGY, V71, P1368, DOI 10.1212/01.wnl.0000333215.93440.36; Bjorkhem I, 1998, J LIPID RES, V39, P1594; Bjorkhem I, 2009, MOL ASPECTS MED, V30, P171, DOI 10.1016/j.mam.2009.02.001; Bruck W, 2012, ANN NEUROL, V72, P385, DOI 10.1002/ana.23621; Burkard I, 2004, J LIPID RES, V45, P776, DOI 10.1194/jlr.D300036-JLR200; Choi YK, 2008, FREE RADICAL RES, V42, P544, DOI 10.1080/10715760802146062; Crick PJ, 2015, STEROIDS, V99, P172, DOI 10.1016/j.steroids.2015.02.021; DeBarber AE, 2008, ANAL BIOCHEM, V381, P151, DOI 10.1016/j.ab.2008.05.037; Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200; Diestel A, 2003, J EXP MED, V198, P1729, DOI 10.1084/jem.20030975; DZELETOVIC S, 1995, ANAL BIOCHEM, V225, P73, DOI 10.1006/abio.1995.1110; Eibinger G, 2013, EXP CELL RES, V319, P1828, DOI 10.1016/j.yexcr.2013.03.025; Emanuelsson I, 2012, NEUROSCI LETT, V525, P44, DOI 10.1016/j.neulet.2012.07.057; Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Freemantle E, 2013, INT J NEUROPSYCHOPH, V16, P1241, DOI 10.1017/S1461145712001587; Gilardi F, 2009, NEUROSCIENCE, V164, P530, DOI 10.1016/j.neuroscience.2009.08.003; Griffiths WJ, 2009, J CHROMATOGR B, V877, P2778, DOI 10.1016/j.jchromb.2009.05.017; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Havrilla CM, 2000, J AM CHEM SOC, V122, P8042, DOI 10.1021/ja001180f; Heverin M, 2005, J LIPID RES, V46, P1047, DOI 10.1194/jlr.M500024-JLR200; Hirayama T, 2009, HEPATOL RES, V39, P149, DOI 10.1111/j.1872-034X.2008.00450.x; Honda A, 2008, J LIPID RES, V49, P2063, DOI 10.1194/jlr.D800017-JLR200; Honda A, 2009, J LIPID RES, V50, P350, DOI 10.1194/jlr.D800040-JLR200; Iuliano L, 2015, STEROIDS, V99, P189, DOI 10.1016/j.steroids.2015.01.026; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jiang XT, 2007, RAPID COMMUN MASS SP, V21, P141, DOI 10.1002/rcm.2820; Kim SM, 2011, J NEUROL, V258, P2176, DOI 10.1007/s00415-011-6086-x; Kinoshita M, 2009, NEUROREPORT, V20, P508, DOI 10.1097/WNR.0b013e32832776f4; Koarai A, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-63; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Leoni V, 2005, J LIPID RES, V46, P191, DOI 10.1194/jlr.C400005-JLR200; Leoni V, 2003, J LIPID RES, V44, P793, DOI 10.1194/jlr.M200434-JLR200; Leoni V, 2013, BIOCHEM PHARMACOL, V86, P26, DOI 10.1016/j.bcp.2013.03.015; Lutjohann D, 1996, P NATL ACAD SCI USA, V93, P9799, DOI 10.1073/pnas.93.18.9799; Makoukji J, 2011, J NEUROSCI, V31, P9620, DOI 10.1523/JNEUROSCI.0761-11.2011; Matysik S, 2013, BIOCHIMIE, V95, P489, DOI 10.1016/j.biochi.2012.09.015; Mendiara I, 2012, J SEP SCI, V35, P3308, DOI 10.1002/jssc.201200519; Menendez-Carreno M, 2008, J CHROMATOGR B, V864, P61, DOI 10.1016/j.jchromb.2008.01.036; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Misu T, 2009, J NEUROL NEUROSUR PS, V80, P575, DOI 10.1136/jnnp.2008.150698; Ogundare M, 2010, J BIOL CHEM, V285, P4666, DOI 10.1074/jbc.M109.086678; Papadopoulos MC, 2012, LANCET NEUROL, V11, P535, DOI 10.1016/S1474-4422(12)70133-3; Pittock SJ, 2008, SEMIN NEUROL, V28, P95, DOI 10.1055/s-2007-1019131; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Ratelade J, 2012, ACTA NEUROPATHOL, V123, P861, DOI 10.1007/s00401-012-0986-4; Reiber H, 2001, J NEUROL SCI, V184, P101, DOI 10.1016/S0022-510X(00)00501-3; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Saji E, 2013, ANN NEUROL, V73, P65, DOI 10.1002/ana.23721; Schott HF, 2015, STEROIDS, V99, P139, DOI 10.1016/j.steroids.2015.02.006; Schule R, 2010, J LIPID RES, V51, P819, DOI 10.1194/jlr.M002543; SMITH LL, 1972, J NEUROCHEM, V19, P899, DOI 10.1111/j.1471-4159.1972.tb01406.x; Sodero AO, 2012, EMBO J, V31, P1764, DOI 10.1038/emboj.2012.31; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Tiwari-Woodruff S, 2007, P NATL ACAD SCI USA, V104, P14813, DOI 10.1073/pnas.0703783104; Tiwari-Woodruff S, 2009, J NEUROL SCI, V286, P81, DOI 10.1016/j.jns.2009.04.023; Umetani M, 2011, TRENDS ENDOCRIN MET, V22, P130, DOI 10.1016/j.tem.2011.01.003; VANBEEK TA, 1995, PHYTOCHEM ANALYSIS, V6, P1, DOI 10.1002/pca.2800060102; Waters P, 2008, ARCH NEUROL-CHICAGO, V65, P913, DOI 10.1001/archneur.65.7.913; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Yamanaka K, 2011, J BIOL CHEM, V286, P24666, DOI 10.1074/jbc.M111.236273; Zhang H, 2013, J CLIN INVEST, V123, P2306, DOI 10.1172/JCI67554	64	11	11	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167819	10.1371/journal.pone.0167819	http://dx.doi.org/10.1371/journal.pone.0167819			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942009	Green Submitted, Green Published, gold			2022-12-27	WOS:000392745600033
J	Kollitz, EM; Zhang, GZ; Hawkins, MB; Whitfield, GK; Reif, DM; Kullman, SW				Kollitz, Erin M.; Zhang, Guozhu; Hawkins, Mary Beth; Whitfield, G. Kerr; Reif, David M.; Kullman, Seth W.			Evolutionary and Functional Diversification of the Vitamin D Receptor-Lithocholic Acid Partnership	PLOS ONE			English	Article							LIGAND-BINDING DOMAIN; NUCLEAR RECEPTOR; BILE-ACIDS; CRYSTAL-STRUCTURE; GENOME; INSIGHTS; SALT; PXR; BIOTRANSFORMATIONS; CHEMISTRY	The evolution, molecular behavior, and physiological function of nuclear receptors are of particular interest given their diverse roles in regulating essential biological processes. The vitamin D receptor (VDR) is well known for its canonical roles in calcium homeostasis and skeletal maintenance. Additionally, VDR has received an increased amount of attention due to the discovery of numerous non-calcemic functions, including the detoxification of lithocholic acid. Lithocholic acid is a toxic metabolite of chenodeoxycholic acid, a primary bile acid. The partnership between the VDR and lithocholic acid has been hypothesized to be a recent adaptation that evolved to mediate the detoxification and elimination of lithocholic acid from the gut. This partnership is speculated to be limited to higher vertebrates (birds and mammals), as lower vertebrates do not synthesize the parent compound of lithocholic acid. However, the molecular functions associated with the observed insensitivity of basal VDRs to lithocholic acid have not been explored. Here we characterize canonical nuclear receptor functions of VDRs from select species representing key nodes in vertebrate evolution and span a range of bile salt phenotypes. Competitive ligand binding assays revealed that the receptor's affinity for lithocholic acid is highly conserved across species, suggesting that lithocholic acid affinity is an ancient and non-adaptive trait. However, transient transactivation assays revealed that lithocholic acid-mediated VDR activation might have evolved more recently, as the non-mammalian receptors did not respond to lithocholic acid unless exogenous coactivator proteins were co-expressed. Subsequent functional assays indicated that differential lithocholic acid-mediated receptor activation is potentially driven by differential protein-protein interactions between VDR and nuclear receptor coregulator proteins. We hypothesize that the vitamin D receptor-lithocholic acid partnership evolved as a by-product of natural selection on the ligand-receptor partnership between the vitamin D receptor and the native VDR ligand: 1 alpha, 25-dihydroxyvitamin D-3, the biologically active metabolite of vitamin D-3.	[Kollitz, Erin M.; Kullman, Seth W.] North Carolina State Univ, Dept Biol Sci, Toxicol Program, Raleigh, NC 27695 USA; [Kollitz, Erin M.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Zhang, Guozhu; Reif, David M.] North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC USA; [Hawkins, Mary Beth; Reif, David M.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC USA; [Whitfield, G. Kerr] Univ Arizona, Coll Med, Dept Basic Med Sci, Phoenix, AZ USA	University of North Carolina; North Carolina State University; Duke University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Arizona	Kullman, SW (corresponding author), North Carolina State Univ, Dept Biol Sci, Toxicol Program, Raleigh, NC 27695 USA.	swkullma@ncsu.edu		Kullmam, Seth/0000-0002-6029-2266; Kollitz, Erin/0000-0003-1769-1496; Reif, David/0000-0001-7815-6767	National Science Foundation [IOS818799]; NIEHS [T32-ES007046]; North Carolina State University; Mount Desert Island Biological Laboratory; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES025128, T32ES007329] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); North Carolina State University; Mount Desert Island Biological Laboratory; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Science Foundation Grant #IOS818799, NIEHS Training Grant #T32-ES007046, The Disseration Completion Grant from North Carolina State University, and the Stan and Judy Fellowship from Mount Desert Island Biological Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164; Belorusova AY, 2014, J MED CHEM, V57, P4710, DOI 10.1021/jm5002524; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Broughton RE, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.2ca8041495ffafd0c92756e75247483e; BURMESTER JK, 1988, P NATL ACAD SCI USA, V85, P1005, DOI 10.1073/pnas.85.4.1005; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Ekins S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-103; Escriva H, 2002, MOL BIOL EVOL, V19, P1440, DOI 10.1093/oxfordjournals.molbev.a004207; Goto T, 2003, J LIPID RES, V44, P1643, DOI 10.1194/jlr.M300155-JLR200; Hagey LR, 2013, ADV NUTR, V4, P29, DOI 10.3945/an.112.003061; Hagey LR, 2010, ZOOL SCI, V27, P565, DOI 10.2108/zsj.27.565; Hagey LR, 2010, PHYSIOL BIOCHEM ZOOL, V83, P308, DOI 10.1086/649966; Haussler MR, 2016, VITAM HORM, V100, P165, DOI 10.1016/bs.vh.2015.11.005; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Hofmann AF, 2004, DRUG METAB REV, V36, P703, DOI 10.1081/DMR-200033475; Hofmann AF, 2010, J LIPID RES, V51, P226, DOI 10.1194/jlr.R000042; Howarth DL, 2008, ENDOCRINOLOGY, V149, P2411, DOI 10.1210/en.2007-1256; Howarth DL, 2010, AQUAT TOXICOL, V98, P245, DOI 10.1016/j.aquatox.2010.02.020; Ikura T, 2016, VITAM HORM, V100, P117, DOI 10.1016/bs.vh.2015.10.004; Jurutka PW, 2005, J CELL BIOCHEM, V94, P917, DOI 10.1002/jcb.20359; Kollitz EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122853; Kollitz EM, 2014, ENDOCRINOLOGY, V155, P4641, DOI 10.1210/en.2014-1505; Kozoni V, 2000, CARCINOGENESIS, V21, P999, DOI 10.1093/carcin/21.5.999; Krasowski Matthew D, 2005, Nucl Recept, V3, P2, DOI 10.1186/1478-1336-3-2; Krasowski MD, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-5; Krasowski MD, 2011, MOL CELL ENDOCRINOL, V334, P39, DOI 10.1016/j.mce.2010.06.016; Krasowski MD, 2005, MOL ENDOCRINOL, V19, P1720, DOI 10.1210/me.2004-0427; Leo C, 2000, GENE, V245, P1, DOI 10.1016/S0378-1119(00)00024-X; Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Masuno H, 2013, J LIPID RES, V54, P2206, DOI 10.1194/jlr.M038307; Matsubara T, 2008, DRUG METAB DISPOS, V36, P2058, DOI 10.1124/dmd.108.021501; Motulsky H, 2005, FITTING MODELS BIOLO; Mukhopadhyay S, 2004, CURR SCI INDIA, V87, P1666; NAGENGAST FM, 1995, EUR J CANCER, V31A, P1067, DOI 10.1016/0959-8049(95)00216-6; Ploner A, 2012, R PACKAGE VERSION 26; R Core Team, 2021, R LANGUAGE ENV STAT; Reschly EJ, 2006, CURR DRUG METAB, V7, P349, DOI 10.2174/138920006776873526; Reschly EJ, 2008, J LIPID RES, V49, P1577, DOI 10.1194/jlr.M800138-JLR200; Reschly EJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-222; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rochel N, 2000, MOL CELL, V5, P173, DOI 10.1016/S1097-2765(00)80413-X; Schubert M, 2008, DEV GENES EVOL, V218, P651, DOI 10.1007/s00427-008-0251-y; Singarapu KK, 2011, BIOCHEMISTRY-US, V50, P11025, DOI 10.1021/bi201637p; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Thornton JW, 2001, P NATL ACAD SCI USA, V98, P5671, DOI 10.1073/pnas.091553298	50	9	9	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168278	10.1371/journal.pone.0168278	http://dx.doi.org/10.1371/journal.pone.0168278			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942020	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600062
J	Martial, LC; Aarnoutse, RE; Schreuder, MF; Henriet, SS; Bruggemann, RJM; Joore, MA				Martial, Lisa C.; Aarnoutse, Rob E.; Schreuder, Michiel F.; Henriet, Stefanie S.; Brueggemann, Roger J. M.; Joore, Manuela A.			Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children	PLoS One			English	Article							LC-MS/MS; TACROLIMUS; FEASIBILITY; CREATININE	Dried blood spot (DBS) sampling for the purpose of therapeutic drug monitoring can be an attractive alternative for conventional blood sampling, especially in children. This study aimed to compare all costs involved in conventional sampling versus DBS home sampling in two pediatric populations: renal transplant patients and hemato-oncology patients. Total costs were computed from a societal perspective by adding up healthcare cost, patient related costs and costs related to loss of productivity of the caregiver. Switching to DBS home sampling was associated with a cost reduction of 43% for hemato-oncology patients ((sic)277 to (sic)158) and 61% for nephrology patients ((sic)259 to (sic)102) from a societal perspective (total costs) per blood draw. From a healthcare perspective, costs reduced with 7% for hemato-oncology patients and with 21% for nephrology patients. Total savings depend on the number of hospital visits that can be avoided by using home sampling instead of conventional sampling.	[Martial, Lisa C.; Aarnoutse, Rob E.; Brueggemann, Roger J. M.] Radboud Univ Nijmegen, Med Ctr, Dept Pharm, Nijmegen, Netherlands; [Martial, Lisa C.; Aarnoutse, Rob E.; Brueggemann, Roger J. M.] Radboud Inst Hlth Sci, Nijmegen, Netherlands; [Schreuder, Michiel F.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Nephrol, Radboudumc Amalia Childrens Hosp, Nijmegen, Netherlands; [Henriet, Stefanie S.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Infect Dis & Immunol, Radboudumc Amalia Childrens Hosp, Nijmegen, Netherlands; [Joore, Manuela A.] Maastricht Univ, Med Ctr, Dept Clin Epidemiol & Med Technol Assessment KEMT, Maastricht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Maastricht University	Martial, LC (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pharm, Nijmegen, Netherlands.; Martial, LC (corresponding author), Radboud Inst Hlth Sci, Nijmegen, Netherlands.	lisa.martial@radboudumc.nl	Aarnoutse, R.E./L-4168-2015; Bruggemann, Roger JM/A-7057-2015; Schreuder, Michiel/P-5465-2014	Bruggemann, Roger JM/0000-0002-7618-725X; Schreuder, Michiel/0000-0001-9725-4856; Joore, Manuela/0000-0002-5649-6768	Dutch Government, Rational Pharmacotherapy program from The Netherlands Organisation for Health Research and Development (ZonMW) [836021012]	Dutch Government, Rational Pharmacotherapy program from The Netherlands Organisation for Health Research and Development (ZonMW)	This work was supported by the Dutch Government, Rational Pharmacotherapy program, grant 836021012 from The Netherlands Organisation for Health Research and Development (ZonMW) http//www.zonmw.nl/nl/programmas/programma-detail/goed-gebruik-geneesmiddelen/algemeen/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhireva LN, 2013, ALCOHOL CLIN EXP RES, V37, P1008, DOI 10.1111/acer.12045; Bingley PJ, 2015, DIABETES TECHNOL THE, V17, P867, DOI 10.1089/dia.2015.0133; Bosilkovska M, 2014, CLIN PHARMACOL THER, V96, P349, DOI 10.1038/clpt.2014.83; Bruggemann RJM, 2015, CURR FUNGAL INFECT R, V9, P122, DOI 10.1007/s12281-015-0224-3; Burgos A, 2008, PEDIATRICS, V121, pE1286, DOI 10.1542/peds.2007-2117; Daali Y, 2012, CLIN PHARMACOL THER, V91, P489, DOI 10.1038/clpt.2011.247; Deglon J, 2012, BIOANALYSIS, V4, P1337, DOI [10.4155/bio.12.42, 10.4155/BIO.12.42]; GUTHRIE R, 1963, PEDIATRICS, V32, P338; Hempen CM, 2015, BIOANALYSIS, V7, P2018, DOI 10.4155/bio.15.97; Hoogtanders K, 2007, J PHARMACEUT BIOMED, V44, P658, DOI 10.1016/j.jpba.2006.11.023; Hoogtanders K, 2007, TRANSPLANTATION, V83, P237, DOI 10.1097/01.tp.0000250730.30715.63; Jang SH, 2016, CLIN PHARMACOL THER, V99, P148, DOI 10.1002/cpt.298; KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients, 2009, AM J TRANSPLANTATION, V9; Koop DR, 2013, J CHROMATOGR B, V926, P54, DOI 10.1016/j.jchromb.2013.02.035; Koster RA, 2015, ANAL BIOANAL CHEM, V407, P1585, DOI 10.1007/s00216-014-8415-2; Koster RA, 2013, TALANTA, V115, P47, DOI 10.1016/j.talanta.2013.04.027; Kothare PA, 2016, AAPS J, V18, P519, DOI 10.1208/s12248-015-9860-3; Lynch JF, 1998, MED J AUSTRALIA, V168, P61, DOI 10.5694/j.1326-5377.1998.tb126712.x; Martial LC, 2016, PHARMACOKINETICS TAR; Nederlandse Zorg Autoriteit (NZA), 2015, TAR DBC ZORGPR OV PR; Pannus P, 2013, JAIDS-J ACQ IMM DEF, V64, P134, DOI 10.1097/QAI.0b013e3182a61e63; Rao RN, 2013, J CHROMATOGR B, V932, P34, DOI 10.1016/j.jchromb.2013.06.012; Ritz N, 2016, PEDIAT INFECT DIS J; Sakhi AK, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1275-0; Staatz CE, 2004, CLIN PHARMACOKINET, V43, P623, DOI 10.2165/00003088-200443100-00001; Stove C, 2015, BIOANALYSIS, V7, P1961, DOI 10.4155/bio.15.139; van Boekel GAJ, 2015, TRANSPL INT, V28, P314, DOI 10.1111/tri.12499; van der Elst KCM, 2013, ANTIMICROB AGENTS CH, V57, P4999, DOI 10.1128/AAC.00707-13; Wilhelm AJ, 2014, CLIN PHARMACOKINET, V53, P961, DOI 10.1007/s40262-014-0177-7; Zorginstituut Nederland, 2015, KOST METH KOST REF E	30	29	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167433	10.1371/journal.pone.0167433	http://dx.doi.org/10.1371/journal.pone.0167433			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941974	gold, Green Published, Green Submitted			2022-12-27	WOS:000392745600016
J	Pillai, SM; Sereda, NH; Hoffman, ML; Valley, EV; Crenshaw, TD; Park, YK; Lee, JY; Zinn, SA; Govoni, KE				Pillai, Sambhu M.; Sereda, Nicole H.; Hoffman, Maria L.; Valley, Ellen V.; Crenshaw, Thomas D.; Park, Young-Ki; Lee, Ji-Young; Zinn, Steven A.; Govoni, Kristen E.			Effects of Poor Maternal Nutrition during Gestation on Bone Development and Mesenchymal Stem Cell Activity in Offspring	PLOS ONE			English	Article							MUSCLE DEVELOPMENT; GROWTH; DIFFERENTIATION; MASS; UNDERNUTRITION; METABOLISM; EXPRESSION; PLASTICITY; ADIPOSITY; PATHWAYS	Poor maternal nutrition impairs overall growth and development of offspring. These changes can significantly impact the general health and production efficiency of offspring. Specifically, poor maternal nutrition is known to reduce growth of bone and muscle, and increase adipose tissue. Mesenchymal stem cells (MSC) are multipotent stem cells which contribute to development of these tissues and are responsive to changes in the maternal environment. The main objective was to evaluate the effects of poor maternal nutirtion during gestation on bone and MSC function in offspring. Thirty-six ewes were fed 100%, 60%, or 140% of energy requirements [NRC, 1985] beginning at day 31 +/- 1.3 of gestation. Lambs from ewes fed 100% (CON), 60% (RES) and 140% (OVER) were euthanized within 24 hours of birth (1 day; n = 18) or at 3 months of age (n = 15) and bone and MSC samples were collected. Dual X-ray absorptiometry was performed on bones obtained from day 1 and 3 months. Proliferation, differentiation, and metabolic activity were determined in the MSC isolated from lambs at day 1. Data were analyzed using mixed procedure in SAS. Maternal diet negatively affected offspring MSC by reducing proliferation 50% and reducing mitochondrial metabolic activity. Maternal diet did not alter MSC glycolytic activity or differentiation in culture. Maternal diet tended to decrease expression of P2Y purinoreceptor 1, but did not alter expression of other genes involved in MSC proliferation and differentiation. Maternal diet did not alter bone parameters in offspring. In conclusion, poor maternal diet may alter offspring growth through reduced MSC proliferation and metabolism. Further studies evaluating the potential molecular changes associated with altered proliferation and metabolism in MSC due to poor maternal nutrition are warranted.	[Pillai, Sambhu M.; Sereda, Nicole H.; Hoffman, Maria L.; Valley, Ellen V.; Zinn, Steven A.; Govoni, Kristen E.] Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; [Crenshaw, Thomas D.] Univ Wisconsin, Dept Anim Sci, Madison, WI USA; [Park, Young-Ki; Lee, Ji-Young] Univ Connecticut, Dept Nutr Sci, Storrs, CT USA	University of Connecticut; University of Wisconsin System; University of Wisconsin Madison; University of Connecticut	Govoni, KE (corresponding author), Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA.	kristen.govoni@uconn.edu	Crenshaw, Thomas/H-1073-2013	Crenshaw, Thomas/0000-0001-8886-0264	University of Connecticut Research Funds (UCRF); Storrs Agricultural Experiment Station	University of Connecticut Research Funds (UCRF); Storrs Agricultural Experiment Station	Funded by University of Connecticut Research Funds (UCRF) and Storrs Agricultural Experiment Station.	Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Caplan AI, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/628767; Chen CT, 2012, BBA-GEN SUBJECTS, V1820, P571, DOI 10.1016/j.bbagen.2011.09.013; Cooper C, 1997, ANN RHEUM DIS, V56, P17, DOI 10.1136/ard.56.1.17; Devlin MJ, 2012, BONE, V50, P444, DOI 10.1016/j.bone.2011.06.019; Du M, 2011, J ANIM SCI, V89, P583, DOI 10.2527/jas.2010-3386; Du M, 2010, MEAT SCI, V86, P103, DOI 10.1016/j.meatsci.2010.04.027; Eastell R, 2002, P NUTR SOC, V61, P173, DOI 10.1079/PNS2002160; Estrada JC, 2012, CELL DEATH DIFFER, V19, P743, DOI 10.1038/cdd.2011.172; FIOROTTO ML, 1995, OBES RES, V3, P131, DOI 10.1002/j.1550-8528.1995.tb00130.x; Florencio-Silva R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/421746; Ford SP, 2007, J ANIM SCI, V85, P1285, DOI 10.2527/jas.2005-624; Glynn ERA, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-40; Hoffman ML, 2016, J ANIM SCI, V94, P3093, DOI 10.2527/jas.2016-0570; Hoffman ML, 2016, J ANIM SCI, V94, P789, DOI 10.2527/jas.2015-9933; Hoffman ML, 2014, DOMEST ANIM ENDOCRIN, V49, P39, DOI 10.1016/j.domaniend.2014.05.002; HU CX, 2016, INT J MOL SCI, V17; Impact of Pregnancy Nutrition on Offspring Bone Development, 2015, 112 ABB NUTR RES C; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Jousse C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104896; Kaebisch C, 2015, COMPUT STRUCT BIOTEC, V13, P75, DOI 10.1016/j.csbj.2014.11.003; Knights M, 2001, J ANIM SCI, V79, P1120; Lanham SA, 2008, OSTEOPOROSIS INT, V19, P147, DOI 10.1007/s00198-007-0443-8; Lanham SA, 2008, OSTEOPOROSIS INT, V19, P157, DOI 10.1007/s00198-007-0448-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyublinskaya OG, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/502105; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Mehta G, 2002, CALCIFIED TISSUE INT, V71, P493, DOI 10.1007/s00223-001-2104-9; Ochocki JD, 2013, J CELL BIOL, V203, P23, DOI 10.1083/jcb.201303110; Ohishi M, 2010, J CELL BIOCHEM, V109, P277, DOI 10.1002/jcb.22399; Oreffo ROC, 2003, BONE, V33, P100, DOI 10.1016/S8756-3282(03)00166-2; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Raja JS, 2016, ANIMAL, P1; Reagan MR, 2016, NAT REV RHEUMATOL, V12, P154, DOI 10.1038/nrrheum.2015.160; Reed SA, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-43; Reynolds LP, 2010, J ANIM SCI, V88, pE61, DOI 10.2527/jas.2009-2359; Sawada Rumi, 2006, J Artif Organs, V9, P179, DOI 10.1007/s10047-006-0338-z; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott MA, 2011, STEM CELLS DEV, V20, P1793, DOI 10.1089/scd.2011.0040; Shum LC, 2016, STEM CELLS DEV, V25, P114, DOI 10.1089/scd.2015.0193; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Woo M, 2011, STEM CELLS DEV, V20, P1763, DOI 10.1089/scd.2010.0349; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156	44	14	14	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168382	10.1371/journal.pone.0168382	http://dx.doi.org/10.1371/journal.pone.0168382			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942040	Green Submitted, Green Published, gold			2022-12-27	WOS:000392745600065
J	Kim, KY; Kim, JH; Hong, AR; Seong, MW; Lee, KE; Kim, SJ; Kim, SW; Shin, CS; Kim, SY				Kim, Kyong Young; Kim, Jung Hee; Hong, A. Ram; Seong, Moon-Woo; Lee, Kyu Eun; Kim, Su-Jin; Kim, Sang Wan; Shin, Chan Soo; Kim, Seong Yeon			Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas	PLOS ONE			English	Article							GLAND SCALED SCORE; CLINICAL-PRACTICE GUIDELINE; GERMLINE MUTATIONS; GENE-MUTATIONS; PARAGANGLIOMA; RECURRENCE; METASTASIS; DIAGNOSIS; FEATURES; SOCIETY	Objective Many malignant tumors initially appear benign but subsequently exhibit extensive metastases. Early identification of malignant pheochromocytomas and paragangliomas (PPGLs) before metastasis is important for improved prognosis. However, there are no robust prognostic indices of recurrence and malignancy. The aim of this study was to identify the clinical and histopathological factors that predict malignant PPGLs. Design Retrospective follow-up study. Methods In this study, we included 223 patients with pathologically confirmed PPGLs who were treated between 2000 and 2015 at the Seoul National University Hospital in South Korea. Results Of these patients, 29 were diagnosed with malignancy, 12 of whom presented with metastatic lesions at the initial diagnosis while 17 developed metastases during follow-up. Nineteen patients with recurrent PPGLs consisted of ones with malignant PPGLs (n = 17) and multifocal PPGLs (n = 2) who had VHL and RET mutations. The mean age at presentation for malignant PPGLs was significantly younger than that for benign PPGLs (43.0 vs. 49.0 years, respectively; p = 0.023). Tumor size was not a distinguishing factor between malignant and benign PPGLs (5.0 vs. 4.5 cm, respectively; p = 0.316) nor did it predict recurrence. Of 119 patients with available pheochromocytoma of adrenal gland scaled score (PASS) data, those with malignant PPGLs presented PASS values >= 4. Of 12 parameters of PASS, necrosis, capsular invasion, vascular invasion, cellular monotony, high mitosis, atypical mitotic figures, and nuclear hyperchromasia were significant predictors of malignancy. Conclusions Tumor size did not predict malignancy or recurrence of PPGLs. PPGL patients with characteristic pathologic findings and PASS >= 4 or germline mutations require close follow-up.	[Kim, Kyong Young; Kim, Jung Hee; Hong, A. Ram; Shin, Chan Soo; Kim, Seong Yeon] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Kyong Young; Kim, Seong Yeon] Gyeongsang Natl Univ, Changwon Hosp, Dept Internal Med, Changwon Si, South Korea; [Seong, Moon-Woo] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Lab Med, Seoul, South Korea; [Lee, Kyu Eun; Kim, Su-Jin] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Surg, Seoul, South Korea; [Kim, Sang Wan] Seoul Natl Univ, Seoul Metropolitan Govt Boramae Med Ctr, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Gyeongsang National University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, JH (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Internal Med, Seoul, South Korea.	jhkxingfu@gmail.com	Kim, Su-jin/AAR-5059-2020; Kim, Jung Hee/AAG-1191-2019; Kim, Sang Wan/J-5399-2012	Kim, Su-jin/0000-0001-5511-3596; Kim, Jung Hee/0000-0003-1932-0234; Kim, Sang Wan/0000-0001-9561-9110; Seong, Moon-Woo/0000-0003-2954-3677				Agarwal A, 2010, WORLD J SURG, V34, P3022, DOI 10.1007/s00268-010-0744-5; Amar L, 2005, J CLIN ENDOCR METAB, V90, P2110, DOI 10.1210/jc.2004-1398; Amar L, 2007, J CLIN ENDOCR METAB, V92, P3822, DOI 10.1210/jc.2007-0709; Andersen KF, 2011, CANCER TREAT REV, V37, P111, DOI 10.1016/j.ctrv.2010.07.002; Ayala-Ramirez M, 2011, J CLIN ENDOCR METAB, V96, P717, DOI 10.1210/jc.2010-1946; Brouwers FM, 2006, J CLIN ENDOCR METAB, V91, P4505, DOI 10.1210/jc.2006-0423; Chrisoulidou A, 2007, ENDOCR-RELAT CANCER, V14, P569, DOI 10.1677/ERC-07-0074; de Wailly P, 2012, LANGENBECK ARCH SURG, V397, P239, DOI 10.1007/s00423-011-0850-3; Feng F, 2011, J UROLOGY, V185, P1583, DOI 10.1016/j.juro.2010.12.050; Goldstein RE, 1999, ANN SURG, V229, P755, DOI 10.1097/00000658-199906000-00001; Harari A, 2011, AM J SURG, V201, P693, DOI 10.1016/j.amjsurg.2010.04.012; Kim JH, 2014, CLIN GENET, V86, P482, DOI 10.1111/cge.12304; Kimura N, 2014, ENDOCR-RELAT CANCER, V21, P405, DOI 10.1530/ERC-13-0494; Korevaar TIM, 2011, ENDOCRINE, V40, P354, DOI 10.1007/s12020-011-9545-3; Lenders JWM, 2014, J CLIN ENDOCR METAB, V99, P1915, DOI 10.1210/jc.2014-1498; Neumann HPH, 2004, JAMA-J AM MED ASSOC, V292, P943, DOI 10.1001/jama.292.8.943; ORiordain DS, 1996, WORLD J SURG, V20, P916, DOI 10.1007/s002689900139; Park J, 2011, KOREAN J UROL, V52, P241, DOI 10.4111/kju.2011.52.4.241; Plouin PF, 2016, EUR J ENDOCRINOL, V174, pG1, DOI 10.1530/EJE-16-0033; Plouin PF, 1997, HYPERTENSION, V29, P1133, DOI 10.1161/01.HYP.29.5.1133; Strong VE, 2008, SURGERY, V143, P759, DOI 10.1016/j.surg.2008.02.007; TANAKA S, 1993, INTERNAL MED, V32, P789, DOI 10.2169/internalmedicine.32.789; Thompson L, 2004, PATHOLOGY GENETICS T; Thompson LDR, 2002, AM J SURG PATHOL, V26, P551, DOI 10.1097/00000478-200205000-00002; van der Harst E, 2002, EUR J ENDOCRINOL, V147, P85, DOI 10.1530/eje.0.1470085; van Heerden JA, 1999, ANN SURG, V229, P764; Van Slycke S, 2009, SURGERY, V146, P986, DOI 10.1016/j.surg.2009.10.055; Wu D, 2009, AM J SURG PATHOL, V33, P599, DOI 10.1097/PAS.0b013e318190d12e	28	55	56	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168413	10.1371/journal.pone.0168413	http://dx.doi.org/10.1371/journal.pone.0168413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992508	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000048
J	Evia-Viscarra, ML; Guardado-Mendoza, R; Rodea-Montero, ER				Lola Evia-Viscarra, Maria; Guardado-Mendoza, Rodolfo; Rafael Rodea-Montero, Edel			Clinical and Metabolic Characteristics among Mexican Children with Different Types of Diabetes Mellitus	PLOS ONE			English	Article							C-PEPTIDE; ACCELERATOR HYPOTHESIS; CELL-FUNCTION; ADOLESCENTS; AUTOIMMUNITY; CLASSIFICATION; EPIDEMIOLOGY; PREVALENCE; DIAGNOSIS; WEIGHT	Background Current classification of diabetes mellitus (DM) is based on etiology and includes type 1 (T1DM), type 2 (T2DM), gestational, and other. Clinical and pathophysiological characteristics of T1DM and T2DM in the same patient have been designated as type 1.5 DM (T1.5DM). Objectives The aim of this study was to classify pediatric patients with DM based on pancreatic autoimmunity and the presence or absence of overweight/obesity, and to compare the clinical, anthropometric, and biochemical characteristics between children in the different classes of DM. Methods A sample of 185 patients, recruited (March 2008-April 2015) as part of the Cohort of Mexican Children with DM (CMC-DM); ClinicalTrials.gov, identifier: NCT02722655. The DM classification was made considering pancreatic autoimmunity (via antibodies GAD-65, IAA, and AICA) and the presence or absence of overweight/obesity. Clinical, anthropometric and biochemical variables, grouped by type of DM were compared (Kruskal-Wallis or chi-squared test). Results The final analysis included 140 children; 18.57% T1ADM, 46.43% T1BDM, 12.14% T1.5DM, and 22.86% T2DM. Fasting C-Peptide (FCP), and hs-CRP levels were higher in T1.5DM and T2DM, and the greatest levels were observed in T1.5DM (p<0.001 and 0.024 respectively). Conclusions We clearly identified that the etiologic mechanisms of T1DM and T2DM are not mutually exclusive, and we detailed why FCP levels are not critical for the classification system of DM in children. The findings of this study suggest that T1.5DM should be considered during the classification of pediatric DM and might facilitate more tailored approaches to treatment, clinical care and follow-up.	[Lola Evia-Viscarra, Maria] Hosp Reg Alta Especialidad Bajio, Dept Pediat Endocrinol, Guanajuato, Mexico; [Guardado-Mendoza, Rodolfo; Rafael Rodea-Montero, Edel] Hosp Reg Alta Especialidad Bajio, Dept Res, Guanajuato, Mexico		Rodea-Montero, ER (corresponding author), Hosp Reg Alta Especialidad Bajio, Dept Res, Guanajuato, Mexico.	edel.rodea@hraeb.gob.mx	Rodea-Montero, Edel Rafael/F-8479-2011; Evia-Viscarra, Maria-Lola/F-8546-2011	Rodea-Montero, Edel Rafael/0000-0003-4287-9626; Evia-Viscarra, Maria-Lola/0000-0002-2916-3108; Guardado Mendoza, Rodolfo/0000-0002-6491-7577				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Atkinson MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007641; Brooks-Worrell BM, 2004, J CLIN ENDOCR METAB, V89, P2222, DOI 10.1210/jc.2003-031360; Burke JP, 1999, DIABETES CARE, V22, P1655, DOI 10.2337/diacare.22.10.1655; Copeland KC, 2013, PEDIATRICS, V131, P364, DOI 10.1542/peds.2012-3494; Craig ME, 2014, PEDIATR DIABETES, V15, P4, DOI 10.1111/pedi.12186; Dabelea D, 2011, DIABETOLOGIA, V54, P78, DOI 10.1007/s00125-010-1911-9; Dabelea D, 2011, DIABETES CARE, V34, P1628, DOI 10.2337/dc10-2324; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Donath MY, 2006, P NATL ACAD SCI USA, V103, P12217, DOI 10.1073/pnas.0605480103; Fowler SP, 2013, HUM GENET, V132, P1059, DOI 10.1007/s00439-013-1315-2; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gilliam LK, 2005, J AUTOIMMUN, V25, P244, DOI 10.1016/j.jaut.2005.09.013; Gutierrez JP, 2012, ENCUESTA NACL SALUD; Hathout EH, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e102; Juusola M, 2016, DIABETES CARE, V39, P118, DOI 10.2337/dc15-1027; Klunder-Klunder M, 2011, ARCH MED RES, V42, P515, DOI 10.1016/j.arcmed.2011.09.004; Knerr I, 2005, DIABETOLOGIA, V48, P2501, DOI 10.1007/s00125-005-0033-2; Libman IM, 2003, DIABETES CARE, V26, P2876, DOI 10.2337/diacare.26.10.2876; Libman Ingrid M, 2003, Pediatr Diabetes, V4, P110, DOI 10.1034/j.1399-5448.2003.00012.x; Liese AD, 2006, PEDIATRICS, V118, P1510, DOI 10.1542/peds.2006-0690; Lohmann T, 2000, DIABETES CARE, V23, P1707, DOI 10.2337/diacare.23.11.1707; Ludvigsson J, 2012, PEDIATR DIABETES, V13, P45, DOI 10.1111/j.1399-5448.2011.00807.x; National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents, 2004, PEDIATRICS, V114; Nor NS, 2013, INT J PEDIAT ENDOCRI, V2013, pP23; Oram RA, 2014, DIABETOLOGIA, V57, P187, DOI 10.1007/s00125-013-3067-x; Pettitt DJ, 2014, DIABETES CARE, V37, P402, DOI 10.2337/dc13-1838; Pozzilli P, 2007, PEDIATR DIABETES, V8, P88, DOI 10.1111/j.1399-5448.2007.00338.x; Purushothaman R, 2007, J PEDIATR ENDOCR MET, V20, P981; R Development Core Team, 2006, LANG ENV STAT COMP; Redondo MJ, 2013, PEDIATR DIABETES, V14, P333, DOI 10.1111/pedi.12022; Rosenbloom A, 2000, PEDIATRICS, V105, P671; Umpaichitra V, 2002, J PEDIATR ENDOCR MET, V15, P525; Umpaichitra V, 2001, J CLIN ENDOCR METAB, V86, P1605, DOI 10.1210/jc.86.4.1605; Wilkin TJ, 2001, DIABETOLOGIA, V44, P914, DOI 10.1007/s001250100548; ZEIDLER A, 1982, J CLIN ENDOCR METAB, V54, P949, DOI 10.1210/jcem-54-5-949; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	40	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168377	10.1371/journal.pone.0168377	http://dx.doi.org/10.1371/journal.pone.0168377			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992493	Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000043
J	Minsky, N; Roeder, RG				Minsky, Neri; Roeder, Robert G.			Inhibition of Adhesion Molecule Gene Expression and Cell Adhesion by the Metabolic Regulator PGC-1 alpha	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; THERMOGENIC COACTIVATOR PGC-1; TRANSCRIPTIONAL COACTIVATORS; MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; EXERCISE; DISEASE; MICE; RNA	Cell adhesion plays an important role in determining cell shape and function in a variety of physiological and pathophysiological conditions. While links between metabolism and cell adhesion were previously suggested, the exact context and molecular details of such a cross-talk remain incompletely understood. Here we show that PGC-1 alpha, a pivotal transcriptional co-activator of metabolic gene expression, acts to inhibit expression of cell adhesion genes. Using cell lines, primary cells and mice, we show that both endogenous and exogenous PGC-1 alpha down-regulate expression of a variety of cell adhesion molecules. Furthermore, results obtained using mRNA stability measurements as well as intronic RNA expression are consistent with a transcriptional effect of PGC-1 alpha on cell adhesion gene expression. Interestingly, the L2/L3 motifs of PGC-1 alpha, necessary for nuclear hormone receptor activation, are only partly required for inhibition of several cell adhesion genes by PGC-1 alpha. Finally, PGC-1 alpha is able to modulate adhesion of primary fibroblasts and hepatic stellate cells to extracellular matrix proteins. Our results delineate a cross talk between a central pathway controlling metabolic regulation and cell adhesion, and identify PGC-1 alpha as a molecular link between these two major cellular networks.	[Minsky, Neri; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA.	roeder@rockefeller.edu			Machiah Foundation; Merck; NIH [DK071900]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER	Machiah Foundation; Merck(Merck & Company); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Machiah Foundation Fellowship and a Merck Postdoctoral Fellowship to N.M. and by NIH grant DK071900 to R.G.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Eisele PS, 2013, J BIOL CHEM, V288, P2246, DOI 10.1074/jbc.M112.375253; Elferink CJ, 1996, BIOTECHNIQUES, V20, P470; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Kang CH, 2012, ANN NY ACAD SCI, V1271, P110, DOI 10.1111/j.1749-6632.2012.06738.x; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Minsky N, 2015, P NATL ACAD SCI USA, V112, pE5669, DOI 10.1073/pnas.1516219112; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Olesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032222; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Shema E, 2011, MOL CELL, V42, P477, DOI 10.1016/j.molcel.2011.03.011; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wu YF, 2003, J BIOL CHEM, V278, P8637, DOI 10.1074/jbc.M210910200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	27	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0165598	10.1371/journal.pone.0165598	http://dx.doi.org/10.1371/journal.pone.0165598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27984584	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000004
J	Xi, JY; Ouyang, Q				Xi, J. Y.; Ouyang, Q.			Using Sub-Network Combinations to Scale Up an Enumeration Method for Determining the Network Structures of Biological Functions	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; FEEDBACK LOOPS; TRANSCRIPTION NETWORKS; IN-SILICO; EVOLUTION; DESIGN; MOTIFS; TOPOLOGIES; MODELS	Deduction of biological regulatory networks from their functions is one of the focus areas of systems biology. Among the different techniques used in this reverse-engineering task, one powerful method is to enumerate all candidate network structures to find suitable ones. However, this method is severely limited by calculation capability: due to the brute-force approach, it is infeasible for networks with large number of nodes to be studied using traditional enumeration method because of the combinatorial explosion. In this study, we propose a new reverse-engineering technique based on the enumerating method: sub-network combinations. First, a complex biological function is divided into several sub-functions. Next, the three-node-network enumerating method is applied to search for sub-networks that are able to realize each of the sub-functions. Finally, complex whole networks are constructed by enumerating all possible combinations of sub-networks. The optimal ones are selected and analyzed. To demonstrate the effectiveness of this new method, we used it to deduct the network structures of a Pavlovian-like function. The whole Pavlovian-like network was successfully constructed by combining robust sub-networks, and the results were analyzed. With sub-network combination, the complexity has been largely reduced. Our method also provides a functional modular view of biological systems.	[Xi, J. Y.; Ouyang, Q.] Peking Univ, Ctr Quantitat Biol, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China; [Xi, J. Y.; Ouyang, Q.] Peking Univ, Peking Tsinghua Ctr Life Sci, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China; [Ouyang, Q.] Peking Univ, State Key Lab Artificial Microstruct & Mesoscop P, Sch Phys, Beijing, Peoples R China	Peking University; Peking University; Peking University	Ouyang, Q (corresponding author), Peking Univ, Ctr Quantitat Biol, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China.; Ouyang, Q (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Acad Adv Interdisciplinary Studies, Beijing, Peoples R China.; Ouyang, Q (corresponding author), Peking Univ, State Key Lab Artificial Microstruct & Mesoscop P, Sch Phys, Beijing, Peoples R China.	qi@pku.edu.cn			National Natural Science Foundation of China [11434001, 91530321]; Ministry of Science and Technology of China [2012AA02A702]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by National Natural Science Foundation of China (11434001,91530321) 382 and Ministry of Science and Technology of China (2012AA02A702). JYX and QO received the fundings from the above sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Chau AH, 2012, CELL, V151, P320, DOI 10.1016/j.cell.2012.08.040; Francois P, 2004, P NATL ACAD SCI USA, V101, P580, DOI 10.1073/pnas.0304532101; Francois P, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002585; Francois P, 2010, DEVELOPMENT, V137, P2385, DOI 10.1242/dev.048033; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Karlebach G, 2008, NAT REV MOL CELL BIO, V9, P770, DOI 10.1038/nrm2503; Kwon YK, 2008, BIOINFORMATICS, V24, P1926, DOI 10.1093/bioinformatics/btn337; Li H, 2003, CURR OPIN GENET DEV, V13, P611, DOI 10.1016/j.gde.2003.10.012; Ma WZ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100111; Ma WZ, 2009, CELL, V138, P760, DOI 10.1016/j.cell.2009.06.013; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mazur J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-448; Mckay MD, 2000, TECHNOMETRICS, V42, P55, DOI 10.2307/1271432; Nochomovitz YD, 2006, P NATL ACAD SCI USA, V103, P4180, DOI 10.1073/pnas.0507032103; Peter IS, 2011, CELL, V144, P970, DOI 10.1016/j.cell.2011.02.017; Rong Y, 2011, TOPOLOGY, V4, P1565; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sneppen K, 2010, ANNU REV BIOPHYS, V39, P43, DOI 10.1146/annurev.biophys.093008.131241; Sontag E, 2008, BIOPHYS J, V95, P518, DOI 10.1529/biophysj.107.125021; Stelling J, 2002, NATURE, V420, P190, DOI 10.1038/nature01166; THOMAS R, 1995, B MATH BIOL, V57, P247, DOI 10.1007/BF02460618; Tkacik G, 2009, ENCY COMPLEXITY SYST, P719; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Walczak AM, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.041905; Wang GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040330; Wang W, 2002, P NATL ACAD SCI USA, V99, P16893, DOI 10.1073/pnas.252638199; Warmflash A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/056001; Whitaker WR, 2012, P NATL ACAD SCI USA, V109, P18090, DOI 10.1073/pnas.1209230109; Wu YL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000442; Yan L, 2012, PLOS ONE, V7; Yu YH, 2007, PLOS COMPUT BIOL, V3, P1657, DOI 10.1371/journal.pcbi.0030171; Zhang H., 2013, QUANTITATIVE BIOL, V1, P209; Zhang H, 2014, NATURE COMMUNICATION, V5; Zheng MM, 2016, J THEOR BIOL, V408, P88, DOI 10.1016/j.jtbi.2016.08.005	36	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168214	10.1371/journal.pone.0168214	http://dx.doi.org/10.1371/journal.pone.0168214			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992476	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000031
J	Acevedo, N; Bornacelly, A; Mercado, D; Unneberg, P; Mittermann, I; Valenta, R; Kennedy, M; Scheynius, A; Caraballo, L				Acevedo, Nathalie; Bornacelly, Adriana; Mercado, Dilia; Unneberg, Per; Mittermann, Irene; Valenta, Rudolf; Kennedy, Malcolm; Scheynius, Annika; Caraballo, Luis			Genetic Variants in CHIA and CHI3L1 Are Associated with the IgE Response to the Ascaris Resistance Marker ABA-1 and the Birch Pollen Allergen Bet v 1	PLOS ONE			English	Article							LUMBRICOIDES INFECTION; IMMUNOGLOBULIN-E; ANTIBODY REPERTOIRE; WIDE ASSOCIATION; BINDING FUNCTION; INNATE IMMUNITY; HIGH PREVALENCE; FATTY-ACID; POLYMORPHISMS; ASTHMA	Helminth infections and allergic diseases are associated with IgE hyperresponsiveness but the genetics of this phenotype remain to be defined. Susceptibility to Ascaris lumbricoides infection and antibody levels to this helminth are associated with polymorphisms in locus 13q33-34. We aimed to explore this and other genomic regions to identify genetic variants associated with the IgE responsiveness in humans. Forty-eight subjects from Cartagena, Colombia, with extreme values of specific IgE to Ascaris and ABA-1, a resistance marker of this nematode, were selected for targeted resequencing. Burden analyses were done comparing extreme groups for IgE values. One-hundred one SNPs were genotyped in 1258 individuals of two well-characterized populations from Colombia and Sweden. Two low-frequency coding variants in the gene encoding the Acidic Mammalian Chitinase (CHIA rs79500525, rs139812869, tagged by rs10494133) were found enriched in high IgE responders to ABA-1 and confirmed by genetic association analyses. The SNP rs4950928 in the Chitinase 3 Like 1 gene (CHI3L1) was associated with high IgE to ABA-1 in Colombians and with high IgE to Bet v 1 in the Swedish population. CHIA rs10494133 and ABDH13 rs3783118 were associated with IgE responses to Ascaris. SNPs in the Tumor Necrosis Factor Superfamily Member 13b gene (TNFSF13B) encoding the cytokine B cell activating Factor were associated with high levels of total IgE in both populations. This is the first report on the association between low-frequency and common variants in the chitinases- related genes CHIA and CHI3L1 with the intensity of specific IgE to ABA-1 in a population naturally exposed to Ascaris and with Bet v 1 in a Swedish population. Our results add new information about the genetic influences of human IgE responsiveness; since the genes encode for enzymes involved in the immune response to parasitic infections, they could be helpful for understanding helminth immunity and allergic responses. We also confirmed that TNFSF13B has an important and conserved role in the regulation of total IgE levels, which supports potential evolutionary links between helminth immunity and allergic response.	[Acevedo, Nathalie; Bornacelly, Adriana; Mercado, Dilia; Caraballo, Luis] Univ Cartagena, Immunol Res Inst, Cartagena, Colombia; [Acevedo, Nathalie; Scheynius, Annika] Karolinska Inst, Sci Life Lab, Dept Clin Sci & Educ, Stockholm, Sweden; [Acevedo, Nathalie] Soder Sjukhuset, Sachs Children & Youth Hosp, Stockholm, Sweden; [Unneberg, Per] Stockholm Univ, Sci Life Lab, Dept Biochem & Biophys, Solna, Sweden; [Mittermann, Irene; Valenta, Rudolf] Med Univ Vienna, Dept Pathophysiol & Allergy Res, Div Immunopathol, Ctr Pathophysiol Infectol & Immunol, Vienna, Austria; [Kennedy, Malcolm] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	Universidad de Cartagena; Karolinska Institutet; Sodersjukhuset Hospital; Stockholm University; Medical University of Vienna; University of Glasgow	Caraballo, L (corresponding author), Univ Cartagena, Immunol Res Inst, Cartagena, Colombia.	lcaraballog@unicartagena.edu.co		Valenta, Rudolf/0000-0001-5944-3365; Acevedo, Nathalie/0000-0002-5154-2964; Unneberg, Per/0000-0001-5735-3315; Bornacelly, Adriana/0000-0001-7762-6632; Mittermann, Irene/0000-0002-6240-6730	Administrative Department of Science, Technology and Innovation (Colciencias, Colombia) [680-2009]; University of Cartagena, Colombia; Swedish Research Council; Cancer and Allergy Research Foundation; Karolinska Institutet; Karolinska University Hospital; Wellcome Trust [048488, 042679, WT083625MA]; Austrian Science Fund (FWF) [F4605]; Colciencias [680-2009]; Science for Life Laboratory (SciLifeLab); National Genomics Infrastructure (NGI); Mutation Analysis Facility (MAF) at Karolinska Institutet	Administrative Department of Science, Technology and Innovation (Colciencias, Colombia); University of Cartagena, Colombia; Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer and Allergy Research Foundation; Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet); Wellcome Trust(Wellcome TrustEuropean Commission); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Science for Life Laboratory (SciLifeLab); National Genomics Infrastructure (NGI); Mutation Analysis Facility (MAF) at Karolinska Institutet	This work was funded by the Administrative Department of Science, Technology and Innovation (Colciencias, Colombia) Grant 680-2009, the University of Cartagena, Colombia; grants to AS from the Swedish Research Council, the Cancer and Allergy Research Foundation, and through the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and the Karolinska Institutet and the Karolinska University Hospital, and by grant numbers 048488, 042679, and WT083625MA to MK from the Wellcome Trust, UK. RV research was founded in part by grant F4605 of the Austrian Science Fund (FWF).; We thank all the patients and controls for their voluntary participation in the study. Also we thank Dr. Lena Lundeberg and PhD Catharina Johansson for their support with Swedish cohort recruitment. We acknowledge Colciencias for financial support (Contract 680-2009), the Science for Life Laboratory (SciLifeLab) and the National Genomics Infrastructure (NGI) for sequencing service and the Mutation Analysis Facility (MAF) at Karolinska Institutet for genotyping service.	Acevedo N, 2011, INT ARCH ALLERGY IMM, V154, P195, DOI 10.1159/000321106; Acevedo N, 2009, ALLERGY, V64, P1635, DOI 10.1111/j.1398-9995.2009.02084.x; Acevedo N, 2009, CLIN EXP IMMUNOL, V157, P282, DOI 10.1111/j.1365-2249.2009.03948.x; Acevedo N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078353; Ahumada V, 2015, CLIN EXP ALLERGY, V45, P1189, DOI 10.1111/cea.12513; Alcantara-Neves NM, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-114; Bornacelly A, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-22; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Bottema RWB, 2010, INT ARCH ALLERGY IMM, V153, P259, DOI 10.1159/000314366; Chen YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022202; Choi EH, 2001, GENES IMMUN, V2, P248, DOI 10.1038/sj.gene.6363767; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Cooper PJ, 2000, J INFECT DIS, V182, P1207, DOI 10.1086/315830; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Donnelly LE, 2004, TRENDS PHARMACOL SCI, V25, P509, DOI 10.1016/j.tips.2004.08.002; FERNANDEZCALDAS E, 1993, CLIN EXP ALLERGY, V23, P292, DOI 10.1111/j.1365-2222.1993.tb00325.x; Filbey KJ, 2014, IMMUNOL CELL BIOL, V92, P436, DOI 10.1038/icb.2013.109; Fitzsimmons CM, 2009, TRENDS PARASITOL, V25, P447, DOI 10.1016/j.pt.2009.07.004; Fumagalli M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-264; Gao PS, 2000, J MED GENET, V37, P380; Grencis RK, 2015, ANNU REV IMMUNOL, V33, P201, DOI 10.1146/annurev-immunol-032713-120218; HAGEL I, 1993, CLIN EXP IMMUNOL, V94, P80, DOI 10.1111/j.1365-2249.1993.tb05981.x; Hagel I, 2008, J TROP PEDIATRICS, V54, P354, DOI 10.1093/tropej/fmn032; Hagel Isabel, 2006, Invest. clín, V47, P241; Hise AG, 2003, GENES IMMUN, V4, P524, DOI 10.1038/sj.gene.6364015; Hoerauf A, 2002, MICROBES INFECT, V4, P37, DOI 10.1016/S1286-4579(01)01507-6; Hong XM, 2010, J ALLERGY CLIN IMMUN, V126, P1059, DOI 10.1016/j.jaci.2010.08.029; Hopkin J, 2009, PARASITE IMMUNOL, V31, P267, DOI 10.1111/j.1365-3024.2009.01104.x; Humphreys K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022547; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V120, P84, DOI 10.1016/j.jaci.2007.04.032; KENNEDY MW, 1991, IMMUNOLOGY, V72, P577; KENNEDY MW, 1990, CLIN EXP IMMUNOL, V80, P219, DOI 10.1111/j.1365-2249.1990.tb05237.x; KENNEDY MW, 1995, BIOCHEMISTRY-US, V34, P6700, DOI 10.1021/bi00020a015; Kim KW, 2015, J ALLERGY CLIN IMMUN, V136, P678, DOI 10.1016/j.jaci.2015.03.030; Levin ME, 2008, PEDIAT ALLERG IMM-UK, V19, P449, DOI 10.1111/j.1399-3038.2007.00663.x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li SR, 2004, MOL CELL BIOL, V24, P809, DOI 10.1128/MCB.24.2.809-822.2004; Liang LM, 2015, NATURE, V520, P670, DOI 10.1038/nature14125; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Long X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135360; Lupinek C, 2014, METHODS, V66, P106, DOI 10.1016/j.ymeth.2013.10.008; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Manno N, 2014, CARBOHYD POLYM, V113, P607, DOI 10.1016/j.carbpol.2014.07.011; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McSharry C, 1999, INFECT IMMUN, V67, P484, DOI 10.1128/IAI.67.2.484-489.1999; Mittermann I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156077; Moller M, 2007, HUM MOL GENET, V16, P1828, DOI 10.1093/hmg/ddm131; Moore J, 1999, BIOCHEM J, V340, P337, DOI 10.1042/0264-6021:3400337; Peisong G, 2004, GENES IMMUN, V5, P58, DOI 10.1038/sj.gene.6364030; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Ramsay CE, 1999, HUM GENET, V104, P269, DOI 10.1007/s004390050947; Soto-Quiros ME, 2002, PEDIAT ALLERG IMM-UK, V13, P342, DOI 10.1034/j.1399-3038.2002.02035.x; Souza V, 2014, ALLERGOL IMMUNOPATH, V42, P206, DOI 10.1016/j.aller.2012.12.009; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; TOMLINSON LA, 1989, J IMMUNOL, V143, P2349; Turner JD, 2005, MICROBES INFECT, V7, P990, DOI 10.1016/j.micinf.2005.03.036; Tyagi N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004546; Vergara C, 2013, GENET EPIDEMIOL, V37, P393, DOI 10.1002/gepi.21702; Vergara C, 2009, HUM GENET, V125, P565, DOI 10.1007/s00439-009-0649-2; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Welch JS, 2002, J BIOL CHEM, V277, P42821, DOI 10.1074/jbc.M205873200; Williams-Blangero S, 2002, P NATL ACAD SCI USA, V99, P5533, DOI 10.1073/pnas.082115999; Williams-Blangero S, 2008, J INFECT DIS, V197, P66, DOI 10.1086/524060; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Xia Y, 2000, PARASITOLOGY, V120, P211, DOI 10.1017/S0031182099005363; Zakzuk J, 2013, PEDIAT ALLERG IMM-UK, V24, P788, DOI 10.1111/pai.12161; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	68	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167453	10.1371/journal.pone.0167453	http://dx.doi.org/10.1371/journal.pone.0167453			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977724	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000391217400020
J	Feng, D; Steinke, JM; Krishnan, R; Birrane, G; Pollak, MR				Feng, Di; Steinke, Julia M.; Krishnan, Ramaswamy; Birrane, Gabriel; Pollak, Martin R.			Functional Validation of an Alpha-Actinin-4 Mutation as a Potential Cause of an Aggressive Presentation of Adolescent Focal Segmental Glomerulosclerosis: Implications for Genetic Testing	PLOS ONE			English	Article							HORSESHOE KIDNEY; ACTN4	Genetic testing in the clinic and research lab is becoming more routinely used to identify rare genetic variants. However, attributing these rare variants as the cause of disease in an individual patient remains challenging. Here, we report a patient who presented with nephrotic syndrome and focal segmental glomerulosclerosis (FSGS) with collapsing features at age 14. Despite treatment, her kidney disease progressed to end-stage within a year of diagnosis. Through genetic testing, an Y265H variant with unknown clinical significance in alpha-actinin-4 gene (ACTN4) was identified. This variant has not been seen previously in FSGS patients nor is it present in genetic databases. Her clinical presentation is different from previous descriptions of ACTN4 mediated FSGS, which is characterized by sub-nephrotic proteinuria and slow progression to end stage kidney disease. We performed in vitro and cellular assays to characterize this novel ACTN4 variant before attributing causation. We found that ACTN4 with either Y265H or K255E (a known disease-causing mutation) increased the actin bundling activity of ACTN4 in vitro, was associated with the formation of intracellular aggregates, and increased podocyte contractile force. Despite the absence of a familial pattern of inheritance, these similar biological changes caused by the Y265H and K255E amino acid substitutions suggest that this new variant is potentially the cause of FSGS in this patient. Our studies highlight that functional validation in complement with genetic testing may be required to confirm the etiology of rare disease, especially in the setting of unusual clinical presentations.	[Feng, Di; Pollak, Martin R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Feng, Di; Krishnan, Ramaswamy; Birrane, Gabriel; Pollak, Martin R.] Harvard Med Sch, Boston, MA 02115 USA; [Steinke, Julia M.] Spectrum Hlth, Helen DeVos Childrens Hosp, Div Pediat Nephrol & Transplantat, Grand Rapids, MI USA; [Krishnan, Ramaswamy] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Birrane, Gabriel] Beth Israel Deaconess Med Ctr, Dept Med, Div Expt Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Michigan State University; Michigan State University College of Human Medicine; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Pollak, MR (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA.; Pollak, MR (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mpollak@bidmc.harvard.edu		Birrane, Gabriel/0000-0002-1759-5499	NIH [DK59588, DK54931, T32 DK007199]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007199, R37DK059588, R01DK054931] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants DK59588 and DK54931 (MRP) and T32 DK007199 (DF). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABSON C, 1991, NEPHRON, V58, P124, DOI 10.1159/000186397; [Anonymous], 2016, Nature, V536, P249, DOI 10.1038/536249a; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Cascio S, 2002, J UROLOGY, V167, P2566, DOI 10.1016/S0022-5347(05)65038-0; Choi HJ, 2008, AM J KIDNEY DIS, V51, P834, DOI 10.1053/j.ajkd.2008.01.018; Ehrlicher AJ, 2015, P NATL ACAD SCI USA, V112, P6619, DOI 10.1073/pnas.1505652112; Feng D, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0036-8; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kayatas M, 2007, RENAL FAILURE, V29, P517, DOI 10.1080/08860220701278133; Korbet SM, 2012, J AM SOC NEPHROL, V23, P1769, DOI 10.1681/ASN.2012040389; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Wang JHC, 2016, METHODS MOL BIOL, V1365, P301, DOI 10.1007/978-1-4939-3124-8_16; Weins A, 2005, J AM SOC NEPHROL, V16, P3694, DOI 10.1681/ASN.2005070706; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167	15	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167467	10.1371/journal.pone.0167467	http://dx.doi.org/10.1371/journal.pone.0167467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977723	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400021
J	Liarzi, O; Bar, E; Lewinsohn, E; Ezra, D				Liarzi, Orna; Bar, Einat; Lewinsohn, Efraim; Ezra, David			Use of the Endophytic Fungus Daldinia cf. concentrica and Its Volatiles as Bio-Control Agents	PLOS ONE			English	Article							MUSCODOR-ALBUS; ORGANIC-COMPOUNDS; GROWTH; ANTIMICROBIALS; MYCOTOXINS; ANTIFUNGAL; BIOCONTROL; DIVERSITY; CULTURES; PRODUCT	Endophytic fungi are organisms that spend most of their life cycle within plant tissues without causing any visible damage to the host plant. Many endophytes were found to secrete specialized metabolites and/or emit volatile organic compounds (VOCs), which may be biologically active and assist fungal survival inside the plant as well as benefit their hosts. We report on the isolation and characterization of a VOCs-emitting endophytic fungus, isolated from an olive tree (Olea europaea L.) growing in Israel; the isolate was identified as Daldinia cf. concentrica. We found that the emitted VOCs were active against various fungi from diverse phyla. Results from postharvest experiments demonstrated that D. cf. concentrica prevented development of molds on organic dried fruits, and eliminated Aspergillus niger infection in peanuts. Gas chromatography-mass spectrometry analysis of the volatiles led to identification of 27 VOCs. On the basis of these VOCs we prepared two mixtures that displayed a broad spectrum of antifungal activity. In postharvest experiments these mixtures prevented development of molds on wheat grains, and fully eliminated A. niger infection in peanuts. In light of these findings, we suggest use of D. cf. concentrica and/or its volatiles as an alternative approach to controlling phytopathogenic fungi in the food industry and in agriculture.	[Liarzi, Orna; Ezra, David] Agr Res Org, Dept Plant Pathol & Weed Res, Volcani Ctr, Rishon Leziyyon, Israel; [Bar, Einat; Lewinsohn, Efraim] Newe Yaar Reg Res Ctr, Ramat Yishai, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Ezra, D (corresponding author), Agr Res Org, Dept Plant Pathol & Weed Res, Volcani Ctr, Rishon Leziyyon, Israel.	dezra@volcani.agri.gov.il			Israel's Ministry of Agriculture and Rural Development (MOARD) [132-1252-06]; Israel's Ministry of Economy [47106]	Israel's Ministry of Agriculture and Rural Development (MOARD); Israel's Ministry of Economy	This work was financed by the Chief Scientist of Israel's Ministry of Agriculture and Rural Development (MOARD) (https://agriscience.co.il), under grant number 132-1252-06, and the Chief Scientist of Israel's Ministry of Economy (http://www.matimop.org.il/ocs.html), under grant number 47106. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The grants were given to D.E.	ALLPORT DC, 1960, J CHEM SOC, P654, DOI 10.1039/jr9600000654; Ando H, 2015, J APPL MICROBIOL, V118, P873, DOI 10.1111/jam.12764; Ando H, 2012, FOOD CONTROL, V26, P472, DOI 10.1016/j.foodcont.2012.02.017; ANKE H, 1995, CAN J BOT, V73, pS932, DOI 10.1139/b95-341; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Azevedo Joao Lucio, 2000, EJB Electronic Journal of Biotechnology, V3, P1, DOI 10.2225/vol3-issue1-fulltext-4; Bacon CW, 2000, ENDOPHYTES; Baraka EA, 2002, BIOL, V24, P135; Bashyal B, 1999, MYCOTAXON, V72, P33; Bisignano G, 2001, FEMS MICROBIOL LETT, V198, P9, DOI 10.1111/j.1574-6968.2001.tb10611.x; Bitzer J, 2008, MYCOL RES, V112, P251, DOI 10.1016/j.mycres.2007.07.004; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; BOWLES BL, 1993, J FOOD PROTECT, V56, P795, DOI 10.4315/0362-028X-56.9.795; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Daisy BH, 2002, MICROBIOL-SGM, V148, P3737, DOI 10.1099/00221287-148-11-3737; Davis TS, 2013, J CHEM ECOL, V39, P860, DOI 10.1007/s10886-013-0278-z; Ezra D, 2004, MICROBIOL-SGM, V150, P4023, DOI 10.1099/mic.0.27334-0; Ezra D, 2004, MICROBIOL-SGM, V150, P785, DOI 10.1099/mic.0.26645-0; Ezra D, 2003, PLANT SCI, V165, P1229, DOI 10.1016/S0168-9452(03)00330-3; Fialho MB, 2011, PESQUI AGROPECU BRAS, V46, P137, DOI 10.1590/S0100-204X2011000200004; Garbeva P, 2014, FEMS MICROBIOL ECOL, V87, P639, DOI 10.1111/1574-6941.12252; Groenhagen U, 2013, J CHEM ECOL, V39, P892, DOI 10.1007/s10886-013-0315-y; Hedlund K, 1995, FUNCT ECOL, V9, P869, DOI 10.2307/2389984; Hung R, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0053-8; Inamdar AA, 2010, TOXICOL SCI, V117, P418, DOI 10.1093/toxsci/kfq222; Johannesson H, 2000, MYCOL RES, V104, P275, DOI 10.1017/S0953756299001719; Kanchiswamy CN, 2015, TRENDS PLANT SCI, V20, P206, DOI 10.1016/j.tplants.2015.01.004; Kanchiswamy CN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00151; Korpi A, 2009, CRIT REV TOXICOL, V39, P139, DOI [10.1080/10408440802291497, 10.1080/10408440802291497 ]; Lacey LA, 2009, J ECON ENTOMOL, V102, P43, DOI 10.1603/029.102.0107; Liarzi O., 2013, ADV ENDOPHYTIC RES, P335, DOI [10.1007/978-81-322-1575-2_18, DOI 10.1007/978-81-322-1575-2_18]; Liarzi O., 2016, PLOS ONE IN PRESS; Macias-Rubalcava ML, 2010, J CHEM ECOL, V36, P1122, DOI 10.1007/s10886-010-9848-5; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; Mari M, 2012, POSTHARVEST BIOL TEC, V73, P56, DOI 10.1016/j.postharvbio.2012.05.014; Mari M, 2012, BIOL CONTROL, V60, P132, DOI 10.1016/j.biocontrol.2011.10.013; Mburu DM, 2011, J EXP BIOL, V214, P956, DOI 10.1242/jeb.050419; McAfee BJ, 1999, NAT TOXINS, V7, P283, DOI 10.1002/1522-7189(199911/12)7:6<283::AID-NT70>3.0.CO;2-N; Mends M. T., 2012, J PET ENV BIOTECHNOL, V3, P117, DOI [10.4172, DOI 10.4172/2157-7463.1000117]; Mercier J, 2005, BIOL CONTROL, V32, P401, DOI 10.1016/j.biocontrol.2004.12.002; Mercier J, 2004, POSTHARVEST BIOL TEC, V31, P1, DOI 10.1016/j.postharvbio.2003.08.004; Miller CM, 1998, J APPL MICROBIOL, V84, P937; Morath Shannon U., 2012, Fungal Biology Reviews, V26, P73, DOI 10.1016/j.fbr.2012.07.001; Mousa WK, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00065; Murugesan GR, 2015, POULTRY SCI, V94, P1298, DOI 10.3382/ps/pev075; Pazoutova S, 2013, FUNGAL DIVERS, V60, P107, DOI 10.1007/s13225-013-0238-5; Qin XD, 2008, J ANTIBIOT, V61, P556, DOI 10.1038/ja.2008.74; Rohlfs Marko, 2005, Front Zool, V2, P2, DOI 10.1186/1742-9994-2-2; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Ortiz BL, 2016, J APPL MICROBIOL, V120, P1313, DOI 10.1111/jam.13101; Sopalun K, 2003, MYCOTAXON, V88, P239; Splivallo R, 2007, PHYTOCHEMISTRY, V68, P2584, DOI 10.1016/j.phytochem.2007.03.030; Splivallo R, 2007, NEW PHYTOL, V175, P417, DOI 10.1111/j.1469-8137.2007.02141.x; Stadler M, 2004, MYCOL RES, V108, P257, DOI 10.1017/S0953756204009335; Stadler M, 2014, STUD MYCOL, P1, DOI 10.3114/sim0016; Stinson M, 2003, PLANT SCI, V165, P913, DOI 10.1016/S0168-9452(03)00299-1; Stoev SD, 2015, ENVIRON TOXICOL PHAR, V39, P794, DOI 10.1016/j.etap.2015.01.022; Strobel G, 2003, MICROBIOL MOL BIOL R, V67, P491, DOI 10.1128/MMBR.67.4.491-502.2003; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Strobel G, 2006, J IND MICROBIOL BIOT, V33, P514, DOI 10.1007/s10295-006-0090-7; Strobel G, 2006, CURR OPIN MICROBIOL, V9, P240, DOI 10.1016/j.mib.2006.04.001; Strobel G, 2011, FEMS MICROBIOL LETT, V320, P87, DOI 10.1111/j.1574-6968.2011.02297.x; Strobel GA, 2008, MICROBIOL-SGM, V154, P3319, DOI 10.1099/mic.0.2008/022186-0; Thakeow P, 2008, CHEM SENSES, V33, P379, DOI 10.1093/chemse/bjn005; Ul-Hassan SR, 2012, MICROBIOL-SGM, V158, P465, DOI 10.1099/mic.0.054643-0; Uvidelio F, 2002, MICROBIOLOGY, V148, P2675, DOI [10.1099/00221287-148-9-2675, DOI 10.1099/00221287-148-9-2675]; Walker V, 2001, CLIN CHIM ACTA, V306, P51, DOI 10.1016/S0009-8981(01)00390-4; Webber J. F., 1989, Insect-fungus interactions. 14th Symposium of the Royal Entomological Society of London in collaboration with the British Mycological Society., P161; Wheeler W.B., 2002, PESTICIDES AGR ENV; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wood WF, 2001, BIOCHEM SYST ECOL, V29, P531, DOI 10.1016/S0305-1978(00)00076-4; Worapong J, 2002, MYCOTAXON, V81, P463; Worapong J, 2001, MYCOTAXON, V79, P67; WRIGHT SJL, 1991, LETT APPL MICROBIOL, V13, P130, DOI 10.1111/j.1472-765X.1991.tb00589.x; Yuan ZL, 2012, CRIT REV BIOTECHNOL, V32, P363, DOI 10.3109/07388551.2011.651429; ZERINGUE HJ, 1991, APPL ENVIRON MICROB, V57, P2433, DOI 10.1128/AEM.57.8.2433-2434.1991; ZERINGUE HJ, 1989, J AM OIL CHEM SOC, V66, P581, DOI 10.1007/BF02885452	77	29	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168242	10.1371/journal.pone.0168242	http://dx.doi.org/10.1371/journal.pone.0168242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977739	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400079
J	Bhat, N; Park, J; Zoghbi, HY; Arthur, JSC; Zaret, KS				Bhat, Neha; Park, Jeehye; Zoghbi, Huda Y.; Arthur, J. Simon C.; Zaret, Kenneth S.			The Chromatin Modifier MSK1/2 Suppresses Endocrine Cell Fates during Mouse Pancreatic Development	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; STRESS-INDUCED PHOSPHORYLATION; HISTONE H3; TRANSCRIPTION FACTOR; INSULIN GENE; BETA-CELLS; EXPRESSION; DIFFERENTIATION; PROGENITORS; PDX-1	Type I diabetes is caused by loss of insulin-secreting beta cells. To identify novel, pharmacologically-targetable histone-modifying proteins that enhance beta cell production from pancreatic progenitors, we performed a screen for histone modifications induced by signal transduction pathways at key pancreatic genes. The screen led us to investigate the temporal dynamics of ser-28 phosphorylated histone H3 (H3S28ph) and its upstream kinases, MSK1 and MSK2 (MSK1/2). H3S28ph and MSK1/2 were enriched at the key endocrine and acinar promoters in E12.5 multipotent pancreatic progenitors. Pharmacological inhibition of MSK1/2 in embryonic pancreatic explants promoted the specification of endocrine fates, including the beta-cell lineage, while depleting acinar fates. Germline knockout of both Msk isoforms caused enhancement of alpha cells and a reduction in acinar differentiation, while monoallelic loss of Msk1 promoted beta cell mass. Our screen of chromatin state dynamics can be applied to other developmental contexts to reveal new pathways and approaches to modulate cell fates.	[Bhat, Neha; Zaret, Kenneth S.] Univ Penn, Dept Cell & Dev Biol, Inst Regenerat Med, Perelman Sch Med, Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Park, Jeehye; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Dept Mol & Human Genet, Houston, TX 77030 USA; [Park, Jeehye; Zoghbi, Huda Y.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Arthur, J. Simon C.] Univ Dundee, Sch Life Sci, Med Res Council, Prot Phosphorylat Unit, Dundee, Scotland; [Bhat, Neha] Yale Univ, Dept Internal Med, New Haven, CT USA	University of Pennsylvania; Pennsylvania Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; University of Dundee; Yale University	Zaret, KS (corresponding author), Univ Penn, Dept Cell & Dev Biol, Inst Regenerat Med, Perelman Sch Med, Civ Ctr Blvd, Philadelphia, PA 19104 USA.	zaret@upenn.edu		Arthur, Simon/0000-0002-8135-1958; Zoghbi, Huda/0000-0002-0700-3349	NIH [R37GM36477]; UPenn Institute for Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036477, R37GM036477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027699] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UPenn Institute for Regenerative Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by NIH R37GM36477 to K.S.Z. and the UPenn Institute for Regenerative Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ann O'Brien Jenkins and Naomi Takenaka for help with sample preparation, Justin Becker and Makiko Iwafuchi-Doi for comments on the manuscript, and Eileen Hulme for help in manuscript preparation. The research was supported by NIH R37GM36477 to K.S.Z. and the UPenn Institute for Regenerative Medicine.	Aguayo-Mazzucato C, 2011, DIABETOLOGIA, V54, P583, DOI 10.1007/s00125-010-2026-z; Aramata S, 2005, BBA-GENE STRUCT EXPR, V1730, P41, DOI 10.1016/j.bbaexp.2005.05.009; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Badeaux AI, 2013, NAT REV MOL CELL BIO, V14, P211, DOI 10.1038/nrm3545; Baek SH, 2011, MOL CELL, V42, P274, DOI 10.1016/j.molcel.2011.03.022; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bennett LB, 2010, EPIGENOMICS-UK, V2, P53, DOI 10.2217/EPI.09.43; Cai WL, 2014, NUCLEIC ACIDS RES, V42, P5456, DOI 10.1093/nar/gku173; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; Choi HS, 2005, J BIOL CHEM, V280, P13545, DOI 10.1074/jbc.M410521200; Duncan EA, 2006, J BIOL CHEM, V281, P12521, DOI 10.1074/jbc.M513333200; Dyson MH, 2005, J CELL SCI, V118, P2247, DOI 10.1242/jcs.02373; Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gannon M, 2001, DEV BIOL, V238, P185, DOI 10.1006/dbio.2001.0359; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Goke J, 2013, MOL CELL, V50, P844, DOI 10.1016/j.molcel.2013.04.030; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gu GQ, 2002, DEVELOPMENT, V129, P2447; GUZ Y, 1995, DEVELOPMENT, V121, P11; Hale MA, 2005, DEV BIOL, V286, P225, DOI 10.1016/j.ydbio.2005.07.026; Hale MA, 2014, DEVELOPMENT, V141, P3123, DOI 10.1242/dev.109405; Herrera PL, 2000, DEVELOPMENT, V127, P2317; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; Hyllus D, 2007, GENE DEV, V21, P3369, DOI 10.1101/gad.447007; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; Jacquemin P, 2000, MOL CELL BIOL, V20, P4445, DOI 10.1128/MCB.20.12.4445-4454.2000; Jacquemin P, 2003, DEV BIOL, V258, P105, DOI 10.1016/S0012-1606(03)00115-5; Johansson KA, 2007, DEV CELL, V12, P457, DOI 10.1016/j.devcel.2007.02.010; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kellner WA, 2012, GENOME RES, V22, P1081, DOI 10.1101/gr.136929.111; Kobayashi H, 2002, BIOCHEM BIOPH RES CO, V293, P691, DOI 10.1016/S0006-291X(02)00278-4; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Le Lay J, 2004, J BIOL CHEM, V279, P22228, DOI 10.1074/jbc.M312673200; Lefebvre B, 2002, EMBO REP, V3, P335, DOI 10.1093/embo-reports/kvf066; Lin JW, 2004, DEV BIOL, V274, P490, DOI 10.1016/j.ydbio.2004.07.002; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Maestro MA, 2003, HUM MOL GENET, V12, P3307, DOI 10.1093/hmg/ddg355; Mazzoni EO, 2013, NAT NEUROSCI, V16, P1191, DOI 10.1038/nn.3490; Mellitzer G, 2006, EMBO J, V25, P1344, DOI 10.1038/sj.emboj.7601011; Metzger DE, 2012, DEVELOPMENT, V139, P1447, DOI 10.1242/dev.072892; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Naqvi S, 2012, BIOCHEM J, V441, P347, DOI 10.1042/BJ20110970; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Nishimura W, 2006, DEV BIOL, V293, P526, DOI 10.1016/j.ydbio.2006.02.028; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Pierreux CE, 2006, GASTROENTEROLOGY, V130, P532, DOI 10.1053/j.gastro.2005.12.005; Sander M, 1997, GENE DEV, V11, P1662, DOI 10.1101/gad.11.13.1662; Sawicka A, 2014, GENOME RES, V24, P1808, DOI 10.1101/gr.176255.114; Schaffer AE, 2010, DEV CELL, V18, P1022, DOI 10.1016/j.devcel.2010.05.015; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Solar M, 2009, DEV CELL, V17, P849, DOI 10.1016/j.devcel.2009.11.003; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Szot Gregory L, 2007, J Vis Exp, P255, DOI 10.3791/255; Van Velkinburgh JC, 2005, J BIOL CHEM, V280, P38438, DOI 10.1074/jbc.M508594200; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; WESSEL GM, 1986, J HISTOCHEM CYTOCHEM, V34, P703, DOI 10.1177/34.6.3084626; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Xu CR, 2011, SCIENCE, V332, P963, DOI 10.1126/science.1202845; Xuan SH, 2012, J CLIN INVEST, V122, P3516, DOI 10.1172/JCI63352; Zhang HJ, 2009, MECH DEVELOP, V126, P958, DOI 10.1016/j.mod.2009.09.006; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568; Zhong SP, 2001, J BIOL CHEM, V276, P12932, DOI 10.1074/jbc.M010931200; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	72	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166703	10.1371/journal.pone.0166703	http://dx.doi.org/10.1371/journal.pone.0166703			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973548	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300012
J	Pandolfi, E; Sacripante, R; Cardini, F				Pandolfi, Elisa; Sacripante, Riccardo; Cardini, Flavia			Food-Induced Emotional Resonance Improves Emotion Recognition	PLOS ONE			English	Article							FACIAL EXPRESSIONS; DISGUST; MOOD; SENSITIVITY; RESPONSES; MECHANISMS; SIMULATION; EXPERIENCE; IMITATION; SYNCHRONY	The effect of food substances on emotional states has been widely investigated, showing, for example, that eating chocolate is able to reduce negative mood. Here, for the first time, we have shown that the consumption of specific food substances is not only able to induce particular emotional states, but more importantly, to facilitate recognition of corresponding emotional facial expressions in others. Participants were asked to perform an emotion recognition task before and after eating either a piece of chocolate or a small amount of fish sauce-which we expected to induce happiness or disgust, respectively. Our results showed that being in a specific emotional state improves recognition of the corresponding emotional facial expression. Indeed, eating chocolate improved recognition of happy faces, while disgusted expressions were more readily recognized after eating fish sauce. In line with the embodied account of emotion understanding, we suggest that people are better at inferring the emotional state of others when their own emotional state resonates with the observed one.	[Pandolfi, Elisa; Sacripante, Riccardo; Cardini, Flavia] Anglia Ruskin Univ, Dept Psychol, Cambridge, England	Anglia Ruskin University	Cardini, F (corresponding author), Anglia Ruskin Univ, Dept Psychol, Cambridge, England.	flavia.cardini@anglia.ac.uk		Cardini, Flavia/0000-0003-4301-611X				Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Aharoni R, 2012, EUR EAT DISORD REV, V20, P106, DOI 10.1002/erv.1124; Argyle M., 1975, BODILY COMMUNICATION; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Balconi M, 2013, BRAIN COGNITION, V83, P114, DOI 10.1016/j.bandc.2013.07.003; BOWER GH, 1981, AM PSYCHOL, V36, P129, DOI 10.1037/0003-066X.36.2.129; Budell L, 2010, NEUROIMAGE, V53, P355, DOI 10.1016/j.neuroimage.2010.05.037; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Cardini F, 2013, J EXP PSYCHOL HUMAN, V39, P630, DOI 10.1037/a0031049; Damasio A.R., 2005, DESCARTES ERROR EMOT; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Fini C, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00165; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 2007, NOVART FDN SYMP, V278, P12; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Godard O, 2015, DEV SCI; HAIDT J, 1994, PERS INDIV DIFFER, V16, P701, DOI 10.1016/0191-8869(94)90212-7; Houben K, 2012, APPETITE, V58, P827, DOI 10.1016/j.appet.2012.01.018; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Kuhn S, 2011, SOC COGN AFFECT NEUR, V6, P368, DOI 10.1093/scan/nsq044; LAIRD JD, 1974, J PERS SOC PSYCHOL, V29, P475, DOI 10.1037/h0036125; Lee TW, 2006, SOC COGN AFFECT NEUR, V1, P122, DOI 10.1093/scan/nsl012; Lundqvist D., 1998, KAROLINSKA DIRECTED; Macht M, 2007, APPETITE, V49, P667, DOI 10.1016/j.appet.2007.05.004; Macht M, 2006, APPETITE, V46, P332, DOI 10.1016/j.appet.2006.01.014; Maister L, 2013, EMOTION, V13, P7, DOI 10.1037/a0030884; Mazzurega M, 2011, EXP BRAIN RES, V213, P213, DOI 10.1007/s00221-011-2744-6; Meltzoff AN, 2003, PHILOS T R SOC B, V358, P491, DOI 10.1098/rstb.2002.1261; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Ottley C, 2000, Nurs Stand, V15, P46; Paladino MP, 2010, PSYCHOL SCI, V21, P1202, DOI 10.1177/0956797610379234; Rousmans S, 2000, CHEM SENSES, V25, P709, DOI 10.1093/chemse/25.6.709; Schmid PC, 2010, MOTIV EMOTION, V34, P288, DOI 10.1007/s11031-010-9170-0; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Schwarz N., 1990, MOTIVATION COGNITION, V2, P527, DOI [10.2307/, DOI 10.2307/2072281]; Sel A, 2015, SOC COGN AFFECT NEUR, V10, P1316, DOI 10.1093/scan/nsv009; Soussignan R, 1997, PHYSIOL BEHAV, V62, P745, DOI 10.1016/S0031-9384(97)00187-X; Steiner JE, 2001, NEUROSCI BIOBEHAV R, V25, P53, DOI 10.1016/S0149-7634(00)00051-8; STRACK F, 1988, J PERS SOC PSYCHOL, V54, P768, DOI 10.1037/0022-3514.54.5.768; Terasawa Y, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01314; Terasawa Y, 2014, COGNITION EMOTION, V28, P1435, DOI 10.1080/02699931.2014.888988; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wiltermuth SS, 2009, PSYCHOL SCI, V20, P1, DOI 10.1111/j.1467-9280.2008.02253.x	44	6	6	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167462	10.1371/journal.pone.0167462	http://dx.doi.org/10.1371/journal.pone.0167462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973559	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000392754300030
J	Sasaki, CT; Toman, J; Vageli, D				Sasaki, Clarence T.; Toman, Julia; Vageli, Dimitra			The In Vitro Effect of Acidic-Pepsin on Nuclear Factor KappaB Activation and Its Related Oncogenic Effect on Normal Human Hypopharyngeal Cells	PLOS ONE			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; STAT3 SIGNALING PATHWAYS; NECK-CANCER; EPITHELIAL-CELLS; HEAD; CARCINOMA; GROWTH; CARCINOGENESIS; PH; P53	Background Extra-esophageal carcinogenesis has been widely discussed in relation to the chronic effects of laryngopharyngeal reflux and most prominently with pepsin historically central to this discussion. With refluxate known to include gastric (pepsin) and duodenal (bile) fluids, we recently demonstrated the mechanistic role of NF-kappa B in mediating the preneoplastic effects of acidic-bile. However, the role of pepsin in promoting hypopharyngeal premalignant events remains historically unclear. Here, we investigate the in vitro effect of acidic-pepsin on the NF-kappa B oncogenic pathway to better define its potential role in hypopharyngeal neoplasia. Methods Human hypopharyngeal primary cells (HHPC) and keratinocytes (HHK) were repetitively exposed to physiologic pepsin concentrations (0.1 mg/ml) at pH 4.0, 5.0 and 7.0. Cellular localization of phospho-NF-kappa B and bcl-2 was determined using immunofluorescence and western blotting. NF-kappa B transcriptional activity was tested by luc reporter and qPCR. Analysis of DNA content of pepsin treated HHK and HHPC was performed using Fluorescence-activated- cell sorting assay. To explore a possible dose related effect, pepsin concentration was reduced from 0.1 to 0.05 and 0.01 mg/ml. Results At physiologic concentration, acidic-pepsin (0.1 mg/ml at pH 4.0) is lethal to most normal hypopharyngeal cells. However, in surviving cells, no NF-kappa B transcriptional activity is noted. Acidic-pepsin fails to activate the NF-kappa B or bcl-2, TNF-alpha, EGFR, STAT3, and wnt5a but increases the Tp53 mRNAs, in both HHPC and HHK. Weakly acidic-pepsin (pH 5.0) and neutral-pepsin (pH 7.0) induce mild activation of NF-kappa B with increase in TNF-alpha mRNAs, without oncogenic transcriptional activity. Lower concentrations of pepsin at varying pH do not produce NF-kappa B activity or transcriptional activation of the analyzed genes. Conclusion Our findings in vitro do not support the role of acidic-pepsin in NF-kappa B related hypopharyngeal carcinogenesis.	[Sasaki, Clarence T.; Toman, Julia; Vageli, Dimitra] Yale Sch Med, Dept Surg, Yale Larynx Lab, New Haven, CT 06510 USA	Yale University	Sasaki, CT (corresponding author), Yale Sch Med, Dept Surg, Yale Larynx Lab, New Haven, CT 06510 USA.	clarence.sasaki@yale.edu		Vageli, Dimitra/0000-0002-9852-5790	Charles W. Ohse Award of Yale School of Medicine; Virginia Alden Wright Fund	Charles W. Ohse Award of Yale School of Medicine; Virginia Alden Wright Fund	This study was supported in part by the Charles W. Ohse Award of Yale School of Medicine and the Virginia Alden Wright Fund.	Adams J, 2000, ARCH OTOLARYNGOL, V126, P405, DOI 10.1001/archotol.126.3.405; Allen CT, 2007, HEAD NECK-J SCI SPEC, V29, P959, DOI 10.1002/hed.20615; Altman KW, 2011, LARYNGOSCOPE, V121, P717, DOI 10.1002/lary.21429; Ayazi S, 2010, J AM COLL SURGEONS, V210, P345, DOI 10.1016/j.jamcollsurg.2009.12.006; Campos LA, 2003, FEBS LETT, V538, P89, DOI 10.1016/S0014-5793(03)00152-2; Del Negro A, 2008, ACTA CIR BRAS, V23, P337, DOI 10.1590/S0102-86502008000400007; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Fan YH, 2013, PROTEIN CELL, V4, P176, DOI 10.1007/s13238-013-2084-3; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; GRANDIS JR, 1993, CANCER RES, V53, P3579; Gregory N., 2006, GI MOTILITY ONLINE; Hashibe M, 2007, AM J EPIDEMIOL, V165, P814, DOI 10.1093/aje/kwk066; Herbella FAM, 2015, WORLD J GASTROENTERO, V21, P815, DOI 10.3748/wjg.v21.i3.815; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; Guzman-de la Garza FJ, 2013, CLINICS, V68, P1034, DOI 10.6061/clinics/2013(07)23; Jegu J, 2013, ORAL ONCOL, V49, P9, DOI 10.1016/j.oraloncology.2012.06.018; Johnston N, 2012, LARYNGOSCOPE, V122, P1317, DOI 10.1002/lary.23307; Johnston N, 2009, ANN OTO RHINOL LARYN, V118, P677, DOI 10.1177/000348940911800913; Jordan RCK, 1996, ORAL ONCOL, V32B, P394, DOI 10.1016/S0964-1955(96)00033-4; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Klein JD, 2010, CANCER BIOL THER, V9, P1; KOUFMAN JA, 1991, LARYNGOSCOPE, V101, P1; Langevin SM, 2013, CANCER EPIDEM BIOMAR, V22, P1061, DOI 10.1158/1055-9965.EPI-13-0183; Lee TL, 2008, INT J CANCER, V122, P1987, DOI 10.1002/ijc.23324; Lee TL, 2007, CLIN CANCER RES, V13, P5680, DOI 10.1158/1078-0432.CCR-07-0670; Lu H, 2011, CANCER RES, V71, P6867, DOI 10.1158/0008-5472.CAN-11-2460; MARKS F, 1993, ENVIRON HEALTH PERSP, V101, P95, DOI 10.2307/3431849; McQuaid KR, 2011, ALIMENT PHARM THER, V34, P146, DOI 10.1111/j.1365-2036.2011.04709.x; Molinolo AA, 2009, ORAL ONCOL, V45, P324, DOI 10.1016/j.oraloncology.2008.07.011; Pal S, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-23; PEARSON JP, 1986, GUT, V27, P243, DOI 10.1136/gut.27.3.243; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Qin L, 2015, ONCOTARGET, V6, P10239, DOI 10.18632/oncotarget.3518; Sasaki CT, 2016, HEAD NECK-J SCI SPEC, V38, pE1381, DOI 10.1002/hed.24231; Sasaki CT, 2000, ANN OTO RHINOL LARYN, V109, P2, DOI 10.1177/0003489400109S1001; Schavolt KL, 2007, ONCOGENE, V26, P6125, DOI 10.1038/sj.onc.1210441; SCOTT ML, 1993, GENE DEV, V7, P1266, DOI 10.1101/gad.7.7a.1266; Sen T, 2011, J BIOL CHEM, V286, P43204, DOI 10.1074/jbc.M111.257105; Sereg-Bahar M, 2015, RADIOL ONCOL, V49, P59, DOI 10.2478/raon-2014-0020; Shkeir O, 2013, HEAD NECK-J SCI SPEC, V35, P1542, DOI 10.1002/hed.23191; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; Sriuranpong V, 2003, CANCER RES, V63, P2948; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Ulualp SO, 1999, OTOLARYNG HEAD NECK, V120, P672, DOI 10.1053/hn.1999.v120.a91774; Vageli DP, 2016, ONCOTARGET, V7, P5892, DOI 10.18632/oncotarget.6824; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Walner DL, 1998, ARCH OTOLARYNGOL, V124, P551, DOI 10.1001/archotol.124.5.551; Wassenaar E, 2011, SURG ENDOSC, V25, P3870, DOI 10.1007/s00464-011-1813-z; Wheeler SE, 2010, ONCOGENE, V29, P5135, DOI 10.1038/onc.2009.279; Yang F, 2006, CELL SIGNAL, V18, P679, DOI 10.1016/j.cellsig.2005.06.015	50	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168269	10.1371/journal.pone.0168269	http://dx.doi.org/10.1371/journal.pone.0168269			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973541	gold, Green Submitted, Green Published			2022-12-27	WOS:000392754300071
J	Tobio, A; Alfonso, A; Madera-Salcedo, I; Botana, LM; Blank, U				Tobio, Araceli; Alfonso, Amparo; Madera-Salcedo, Iris; Botana, Luis M.; Blank, Ulrich			Yessotoxin, a Marine Toxin, Exhibits Anti-Allergic and Anti-Tumoural Activities Inhibiting Melanoma Tumour Growth in a Preclinical Model	PLOS ONE			English	Article							OKADAIC ACID; MAST-CELLS; TOXICITY; HOMOYESSOTOXINS; EXOCYTOSIS; RECEPTORS; MECHANISM	Yessotoxins (YTXs) are a group of marine toxins produced by the dinoflagellates Protoceratium reticulatum, Lingulodinium polyedrum and Gonyaulax spinifera. They may have medical interest due to their potential role as anti-allergic but also anti-cancer compounds. However, their biological activities remain poorly characterized. Here, we show that the small molecular compound YTX causes a slight but significant reduction of the ability of mast cells to degranulate. Strikingly, further examination revealed that YTX had a marked and selective cytotoxicity for the RBL-2H3 mast cell line inducing apoptosis, while primary bone marrow derived mast cells were highly resistant. In addition, YTX exhibited strong cytotoxicity against the human B-chronic lymphocytic leukaemia cell line MEC1 and the murine melanoma cell line B16F10. To analyse the potential role of YTX as an anti-cancer drug in vivo we used the well-established B16F10 melanoma preclinical mouse model. Our results demonstrate that a few local application of YTX around established tumours dramatically diminished tumour growth in the absence of any significant toxicity as determined by the absence of weight loss and haematological alterations. Our data support that YTX may have a minor role as an anti-allergic drug, but reveals an important potential for its use as an anti-cancer drug.	[Tobio, Araceli; Madera-Salcedo, Iris; Blank, Ulrich] INSERM, UMRS 1149, Paris, France; [Tobio, Araceli; Alfonso, Amparo; Botana, Luis M.] Univ Santiago de Compostela, Fac Vet, Dept Farmacol, Lugo, Spain; [Tobio, Araceli; Madera-Salcedo, Iris; Blank, Ulrich] CNRS, Ctr Rech Inflammat, ERL, Paris, France; [Tobio, Araceli; Madera-Salcedo, Iris; Blank, Ulrich] Univ Paris Diderot, Sorbonne Paris Cite, Lab Excellence INFLAMEX, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universidade de Santiago de Compostela; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Blank, U (corresponding author), INSERM, UMRS 1149, Paris, France.	ulrich.blank@inserm.fr	TOBIO, ARACELI/AAF-9718-2019; López, Luis M. Botana/AAJ-7111-2021; Madera-Salcedo, Iris/D-8981-2017; TOBIO, ARACELI/P-4157-2015; Alfonso, Amparo/GLN-2591-2022	TOBIO, ARACELI/0000-0002-7445-2507; López, Luis M. Botana/0000-0003-2153-6608; Madera-Salcedo, Iris/0000-0002-0741-9248; Alfonso Rancano, Maria Amparo/0000-0003-1572-9016; Blank, Ulrich/0000-0002-2661-2983	Fundacion Juana de Vega, Spain; ANR France [ANR-12-ISV3-0006-01]; Conacyt Mexico [Conacyt-ANR 188565]; Investissements d'Avenir programme [ANR-11-IDEX-0005-02]; Sorbonne Paris Cite; Laboratoire d'excellence INFLAMEX; DHU Fire; COST Action of the European Community [BM1007]	Fundacion Juana de Vega, Spain; ANR France(French National Research Agency (ANR)); Conacyt Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Investissements d'Avenir programme(French National Research Agency (ANR)); Sorbonne Paris Cite; Laboratoire d'excellence INFLAMEX; DHU Fire; COST Action of the European Community	Dr. Araceli Tobio Ageitos was supported by a postdoctoral fellowship from Fundacion Juana de Vega, Spain. Dr. Iris Madera-Salcedo was supported by an International collaboration grant between ANR France (ANR-12-ISV3-0006-01) and Conacyt Mexico (Conacyt-ANR 188565). This research project has been supported by the Investissements d'Avenir programme ANR-11-IDEX-0005-02, Sorbonne Paris Cite, Laboratoire d'excellence INFLAMEX, and DHU Fire. This work was also supported by the COST Action BM1007 (Mast cells and basophils-targets for innovative therapies) of the European Community.	Alexander J., 2009, EFSA J, V1306, P1; Alfonso A, 2003, BIOCHEM PHARMACOL, V65, P193, DOI 10.1016/S0006-2952(02)01454-5; Alfonso A, 2016, MAR DRUGS, V14, DOI 10.3390/md14020030; [Anonymous], 2014, ADV MOL TOXICOLOGY; Aune T, 2002, TOXICON, V40, P77, DOI 10.1016/S0041-0101(01)00192-1; Aune T., 1989, BIOACT MOL, P461; BANIYASH M, 1981, CANCER RES, V41, P433; Becker JC, 2010, EXP DERMATOL, V19, P157, DOI 10.1111/j.1600-0625.2009.00986.x; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; BOTANA LM, 1994, J LEUKOCYTE BIOL, V55, P798, DOI 10.1002/jlb.55.6.798; Draisci R, 1999, TOXICON, V37, P1187, DOI 10.1016/S0041-0101(98)00254-2; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Fernandez-Araujo A, 2014, INT J BIOCHEM CELL B, V53, P89, DOI 10.1016/j.biocel.2014.04.028; Fernandez-Araujo A, 2015, TOXICOLOGY; Fernandez-Araujo A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00124; Galli SJ, 2016, AM J PATHOL, V186, P212, DOI 10.1016/j.ajpath.2015.07.025; Huo LF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012705; Johnson DB, 2013, CURR TREAT OPTION ON, V14, P280, DOI 10.1007/s11864-013-0226-8; Kobayashi T, 2014, AM J PATHOL, V184, P3120, DOI 10.1016/j.ajpath.2014.07.003; Korsnes MS, 2011, TOXICOL IN VITRO, V25, P1764, DOI 10.1016/j.tiv.2011.09.005; Korsnes MS, 2015, TOXICOL IN VITRO; Lai YW, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0970-3; Lee SH, 2015, MOL MED REP, V12, P2777, DOI 10.3892/mmr.2015.3675; Leira F, 2002, TOXICOL IN VITRO, V16, P23, DOI 10.1016/S0887-2333(01)00095-9; Liu YJ, 2016, ONCOL LETT, V11, P1251, DOI 10.3892/ol.2015.4025; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Ogino Hiroyuki, 1997, Natural Toxins, V5, P255, DOI 10.1002/(SICI)1522-7189(1997)5:6<255::AID-NT6>3.0.CO;2-P; Overwijk W W, 2001, Curr Protoc Immunol, VChapter 20, DOI 10.1002/0471142735.im2001s39; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Pfirsch-Maisonnas S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001309; Pistocchi R, 2012, MAR DRUGS, V10, P140, DOI 10.3390/md10010140; Satake Masayuki, 1997, Natural Toxins, V5, P164; Sos ML, 2014, CELL REP, V8, P1037, DOI 10.1016/j.celrep.2014.07.010; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Talebian F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031442; Tiwari N, 2008, BLOOD, V111, P3665, DOI 10.1182/blood-2007-07-103309; Tobio A, 2012, J CELL BIOCH; Tobio A, 2015, IMMUNOPHARM IMMUNOT, V37, P380, DOI 10.3109/08923973.2015.1064132; Tobio A, 2014, ANTICANCER RES, V34, P3347; Tubaro A, 2008, TOXICON, V51, P1225, DOI 10.1016/j.toxicon.2008.02.011; Tubaro A, 2004, TOXICON, V43, P439, DOI 10.1016/j.toxicon.2004.02.015; Tubaro A, 2003, TOXICON, V41, P783, DOI 10.1016/S0041-0101(03)00032-1; Tubaro A, 2010, TOXICON, V56, P163, DOI 10.1016/j.toxicon.2009.07.038; Vandercappellen J, 2010, MOL CANCER RES, V8, P322, DOI 10.1158/1541-7786.MCR-09-0176; Wang DY, 2015, ONCOLOGY, V29; Xia SH, 2006, P NATL ACAD SCI USA, V103, P12499, DOI 10.1073/pnas.0605394103; Yang LP, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-75	47	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167572	10.1371/journal.pone.0167572	http://dx.doi.org/10.1371/journal.pone.0167572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973568	gold, Green Published, Green Submitted			2022-12-27	WOS:000392754300033
J	Wang, RH; Yuan, XY; Meng, LH; Zhu, BZ; Zhu, HL; Luo, YB; Fu, DQ				Wang, Rui-Heng; Yuan, Xin-Yu; Meng, Lan-Huan; Zhu, Ben-Zhong; Zhu, Hong-liang; Luo, Yun-Bo; Fu, Da-Qi			Transcriptome Analysis Provides a Preliminary Regulation Route of the Ethylene Signal Transduction Component, SlEIN2, during Tomato Ripening	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; GENE FAMILY; RESPONSIVE ELEMENT; PLANT DEVELOPMENT; BINDING PROTEINS; FRUIT; ARABIDOPSIS; RECEPTOR; EIN2; EXPRESSION	Ethylene is crucial in climacteric fruit ripening. The ethylene signal pathway regulates several physiological alterations such as softening, carotenoid accumulation and sugar level reduction, and production of volatile compounds. All these physiological processes are controlled by numerous genes and their expression simultaneously changes at the onset of ripening. Ethylene insensitive 2 (EIN2) is a key component for ethylene signal transduction, and its mutation causes ethylene insensitivity. In tomato, silencing SlEIN2 resulted in a non-ripening phenotype and low ethylene production. RNA sequencing of SlEIN2-silenced and wild type tomato, and differential gene expression analyses, indicated that silencing SlEIN2 caused changes in more than 4,000 genes, including those related to photosynthesis, defense, and secondary metabolism. The relative expression level of 28 genes covering ripening- associated transcription factors, ethylene biosynthesis, ethylene signal pathway, chlorophyll binding proteins, lycopene and aroma biosynthesis, and defense pathway, showed that SlEIN2 influences ripening inhibitor (RIN) in a feedback loop, thus controlling the expression of several other genes. SlEIN2 regulates many aspects of fruit ripening, and is a key factor in the ethylene signal transduction pathway. Silencing SlEIN2 ultimately results in lycopene biosynthesis inhibition, which is the reason why tomato does not turn red, and this gene also affects the expression of several defense-associated genes. Although SlEIN2-silenced and green wild type fruits are similar in appearance, their metabolism is significantly different at the molecular level.	[Wang, Rui-Heng; Yuan, Xin-Yu; Meng, Lan-Huan; Zhu, Ben-Zhong; Zhu, Hong-liang; Luo, Yun-Bo; Fu, Da-Qi] China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Biotechnol, Beijing, Peoples R China	China Agricultural University	Fu, DQ (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Lab Food Biotechnol, Beijing, Peoples R China.	daqifu@cau.edu.cn			National Nature Science Foundation of China [31571898, 31572173]; Education Foundation of Da Bei Nong Group [1061-2413001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Foundation of Da Bei Nong Group	This work was supported by the National Nature Science Foundation of China (grants No. 31571898 and No. 31572173) and the Education Foundation of Da Bei Nong Group (No. 1061-2413001). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams-Phillips L, 2004, PLANT MOL BIOL, V54, P387, DOI 10.1023/B:PLAN.0000036371.30528.26; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; Alonso JM, 1999, SCIENCE, V284, P2148, DOI 10.1126/science.284.5423.2148; Awad MA, 2002, SCI HORTIC-AMSTERDAM, V93, P257, DOI 10.1016/S0304-4238(01)00333-8; Bemer M, 2012, PLANT CELL, V24, P4437, DOI 10.1105/tpc.112.103283; Bewley JD, 2000, J EXP BOT, V51, P529, DOI 10.1093/jexbot/51.344.529; Bisson MMA, 2009, BIOCHEM J, V424, P1, DOI 10.1042/BJ20091102; BRADY CJ, 1987, ANNU REV PLANT PHYS, V38, P155, DOI 10.1146/annurev.pp.38.060187.001103; Bramley PM, 2002, J EXP BOT, V53, P2107, DOI 10.1093/jxb/erf059; Cantu D, 2009, PLANT PHYSIOL, V150, P1434, DOI 10.1104/pp.109.138701; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dong CH, 2010, J BIOL CHEM, V285, P40706, DOI 10.1074/jbc.M110.146605; ECKER JR, 1995, SCIENCE, V268, P667, DOI 10.1126/science.7732375; Fu DQ, 2006, MOL CELLS, V21, P153; Fu DQ, 2005, PLANT J, V43, P299, DOI 10.1111/j.1365-313X.2005.02441.x; Fujisawa M, 2013, PLANT CELL, V25, P371, DOI 10.1105/tpc.112.108118; Fujisawa M, 2012, PLANTA, V235, P1107, DOI 10.1007/s00425-011-1561-2; Gao L, 2016, THEOR APPL GENET, V129, P717, DOI 10.1007/s00122-015-2660-4; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Giorio G, 2008, FEBS J, V275, P527, DOI 10.1111/j.1742-4658.2007.06219.x; GREEN BR, 1991, TRENDS BIOCHEM SCI, V16, P181, DOI 10.1016/0968-0004(91)90072-4; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Jones PR, 1999, J BIOL CHEM, V274, P35483, DOI 10.1074/jbc.274.50.35483; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Karlova R, 2011, PLANT CELL, V23, P923, DOI 10.1105/tpc.110.081273; Kevany BM, 2007, PLANT J, V51, P458, DOI 10.1111/j.1365-313X.2007.03170.x; Klee HJ, 2011, ANNU REV GENET, V45, P41, DOI 10.1146/annurev-genet-110410-132507; Klee HJ, 2002, J EXP BOT, V53, P2057, DOI 10.1093/jxb/erf062; Lashbrook CC, 1998, PLANT J, V15, P243, DOI 10.1046/j.1365-313X.1998.00202.x; Li WY, 2015, CELL, V163, P670, DOI 10.1016/j.cell.2015.09.037; Liu MC, 2015, PLANT PHYSIOL, V169, P2380, DOI 10.1104/pp.15.01361; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Martel C, 2011, PLANT PHYSIOL, V157, P1568, DOI 10.1104/pp.111.181107; Merchante C, 2015, CELL, V163, P684, DOI 10.1016/j.cell.2015.09.036; Nadakuduti SS, 2014, PLANT J, V78, P1022, DOI 10.1111/tpj.12529; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Phan TD, 2007, PLANT PHYSIOL, V144, P1960, DOI 10.1104/pp.107.096347; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Qiao H, 2009, GENE DEV, V23, P512, DOI 10.1101/gad.1765709; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Sakuraba Y, 2015, MOL CELLS, V38, P390, DOI 10.14348/molcells.2015.0039; Senthil-Kumar M, 2014, NAT PROTOC, V9, P1549, DOI 10.1038/nprot.2014.092; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Tieman DM, 2001, PLANT J, V26, P47, DOI 10.1046/j.1365-313x.2001.01006.x; Tieman DM, 1999, PLANT PHYSIOL, V120, P165, DOI 10.1104/pp.120.1.165; Trivedi PK, 2004, PLANT SCI, V167, P1351, DOI 10.1016/j.plantsci.2004.07.005; Velez-Ramirez AI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5549; Wang J, 2007, DNA SEQUENCE, V18, P33, DOI 10.1080/10425170600986738; Wen X, 2012, CELL RES, V22, P1613, DOI 10.1038/cr.2012.145; Yokotani N, 2009, J EXP BOT, V60, P3433, DOI 10.1093/jxb/erp185; Zhang HB, 2004, PLANT MOL BIOL, V55, P825, DOI 10.1007/s11103-005-2140-3; Zhang ZJ, 2009, PLANT PHYSIOL, V150, P365, DOI 10.1104/pp.109.135830; Zhong SL, 2008, J EXP BOT, V59, P965, DOI 10.1093/jxb/ern021	57	13	13	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168287	10.1371/journal.pone.0168287	http://dx.doi.org/10.1371/journal.pone.0168287			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973616	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300073
J	BitMansour, A; Pop, LM; Vitetta, ES				BitMansour, Andrew; Pop, Laurentiu M.; Vitetta, Ellen S.			The Role of Regulatory B Cell-Like Malignant Cells and T-reg Cells in the Mouse Model of BCL1 Tumor Dormancy	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; FOSTERS IMMUNE PRIVILEGE; CANCER DORMANCY; HODGKIN-LYMPHOMA; B10 CELLS; INDUCTION; RESPONSES; ANTIBODY; BLOOD; STATE	Cancer dormancy is a clinical state in which residual tumor cells persist for long periods of time but do not cause detectable disease. In the mouse B cell lymphoma model (BCL1), dormancy can be induced and maintained by immunizing mice with a soluble form of the IgM expressed on the surface of the tumor cells. Immunization induces an anti-idiotype antibody response that maintains dormancy. Mice with dormant tumor have low numbers of BCL1 cells in their spleens that divide and are killed at the same rate. When the anti-Id antibodies wane, the tumor cells grow rapidly and kill the host. Spleens from tumor-bearing mice contain both effector (CD4(+) and CD8(+)) and regulatory T cells (Tregs). In other tumor models, it has been reported that Tregs promote tumor progression by preventing effector cells from killing the tumor. In this report, we demonstrate that the tumor site with rapidly dividing BCL1 cells has fewer Tregs than the tumor site harboring dormant BCL1 cells. In both cases, the Tregs were equally suppressive in vitro. In spleens from mice with actively growing tumor, CD8(+) but not CD4(+) T cells were virtually absent. In vitro analysis demonstrated a tumor-mediated elimination of CD8(+) T cells that was contact dependent and involved the caspase-3 pathway. Most importantly, we found that the BCL1 cells expressed characteristics of B10 regulatory B cells, i.e., they were CD1d hi CD5(+) and secreted high levels of IL-10. These BCL1 tumor cells can inhibit anti-tumor immune responses by depleting CD8(+) effector T cells.	[Vitetta, Ellen S.] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; Univ Texas Southwestern Med Ctr Dallas, Ctr Canc Immunobiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Vitetta, ES (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.	Ellen.Vitetta@utsouthwestern.edu	Pop, Laurentiu/N-5416-2019		Cancer Immunobiology Center; Horchow Foundation; Patigian Chair	Cancer Immunobiology Center; Horchow Foundation; Patigian Chair	The studies described were supported by the Cancer Immunobiology Center, the Horchow Foundation and the Patigian Chair.	Amu S, 2010, J ALLERGY CLIN IMMUN, V125, P1114, DOI 10.1016/j.jaci.2010.01.018; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Belkaid Y, 2005, NAT IMMUNOL, V6, P353, DOI 10.1038/ni1181; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bluestone JA, 2005, CURR OPIN IMMUNOL, V17, P638, DOI 10.1016/j.coi.2005.09.002; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Darrasse-Jeze G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00292; DiLillo DJ, 2010, ANN NY ACAD SCI, V1183, P38, DOI 10.1111/j.1749-6632.2009.05137.x; DiLillo DJ, 2013, LEUKEMIA, V27, P170, DOI 10.1038/leu.2012.165; Farrar JD, 1999, J IMMUNOL, V162, P2842; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; GRONOWICZ ES, 1980, J IMMUNOL, V125, P976; Ishida T, 2006, CANCER RES, V66, P5716, DOI 10.1158/0008-5472.CAN-06-0261; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Kim WY, 2009, ANN ONCOL, V20, P1688, DOI 10.1093/annonc/mdp056; KROLICK KA, 1979, IMMUNOL REV, V48, P81, DOI 10.1111/j.1600-065X.1979.tb00299.x; Layton JE, 1982, B AND T CELL TUMORS, P369; Lim HW, 2005, J IMMUNOL, V175, P4180, DOI 10.4049/jimmunol.175.7.4180; MacKenzie SH, 2008, CURR CANCER DRUG TAR, V8, P98; Maksimow M, 2003, BLOOD, V101, P4022, DOI 10.1182/blood-2002-06-1904; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Meng SD, 2004, CLIN CANCER RES, V10, P8152, DOI 10.1158/1078-0432.CCR-04-1110; Meng S, 2006, P NATL ACAD SCI USA, V103, P17361, DOI 10.1073/pnas.0608113103; Mizoguchi A, 2006, J IMMUNOL, V176, P705, DOI 10.4049/jimmunol.176.2.705; Mizukami Y, 2008, INT J CANCER, V122, P2286, DOI 10.1002/ijc.23392; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Olkhanud PB, 2011, CANCER RES, V71, P3505, DOI 10.1158/0008-5472.CAN-10-4316; Pop LM, 2005, J IMMUNOTHER, V28, P525, DOI 10.1097/01.cji.0000175493.05852.5a; Racila E, 1998, P NATL ACAD SCI USA, V95, P4589, DOI 10.1073/pnas.95.8.4589; RACILA E, 1995, J EXP MED, V181, P1539, DOI 10.1084/jem.181.4.1539; Saito T, 2000, CLIN CANCER RES, V6, P1351; SIU H, 1986, J IMMUNOL, V137, P1376; SLAVIN S, 1978, NATURE, V272, P624, DOI 10.1038/272624a0; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Tsukamoto H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7702; Tutt AL, 2002, J IMMUNOL, V168, P2720, DOI 10.4049/jimmunol.168.6.2720; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Uhr JT, 2001, SEMIN CANCER BIOL, V11, P277, DOI 10.1006/scbi.2001.0383; UHR JW, 1991, CANCER RES, V51, pS5045; Vitetta ES, 1997, BLOOD, V89, P4425, DOI 10.1182/blood.V89.12.4425; VITETTA ES, 1979, J IMMUNOL, V122, P1649; Woo EY, 2001, CANCER RES, V61, P4766; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376; YEFENOF E, 1993, P NATL ACAD SCI USA, V90, P1829, DOI 10.1073/pnas.90.5.1829	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167618	10.1371/journal.pone.0167618	http://dx.doi.org/10.1371/journal.pone.0167618			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959896	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900012
J	Bredow, M; Vanderbeld, B; Walker, VK				Bredow, Melissa; Vanderbeld, Barbara; Walker, Virginia K.			Knockdown of Ice-Binding Proteins in Brachypodium distachyon Demonstrates Their Role in Freeze Protection	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; III ANTIFREEZE PROTEIN; COLD-ACCLIMATION; GENE ENCODES; WINTER RYE; RECRYSTALLIZATION INHIBITION; BITTERSWEET NIGHTSHADE; ELECTROLYTE LEAKAGE; RECEPTOR KINASE; EXPRESSION	Sub-zero temperatures pose a major threat to the survival of cold-climate perennials. Some of these freeze-tolerant plants produce ice-binding proteins (IBPs) that offer frost protection by restricting ice crystal growth and preventing expansion-induced lysis of the plasma membranes. Despite the extensive in vitro characterization of such proteins, the importance of IBPs in the freezing stress response has not been investigated. Using the freeze-tolerant grass and model crop, Brachypodium distachyon, we characterized putative IBPs (BdIRIs) and generated the first 'IBP-knockdowns'. Seven IBP sequences were identified and expressed in Escherichia coli, with all of the recombinant proteins demonstrating moderate to high levels of ice-recrystallization inhibition (IRI) activity, low levels of thermal hysteresis (TH) activity (0.03-0.09 degrees C at 1 mg/mL) and apparent adsorption to ice primary prism planes. Following plant cold acclimation, IBPs purified from wild-type B. distachyon cell lysates similarly showed high levels of IRI activity, hexagonal ice-shaping, and low levels of TH activity (0.15 degrees C at 0.5 mg/mL total protein). The transfer of a microRNA construct to wild-type plants resulted in the attenuation of IBP activity. The resulting knockdown mutant plants had reduced ability to restrict ice-crystal growth and a 63% reduction in TH activity. Additionally, all transgenic lines were significantly more vulnerable to electrolyte leakage after freezing to -10 degrees C, showing a 13-22% increase in released ions compared to wild-type. IBP-knockdown lines also demonstrated a significant decrease in viability following freezing to -8 degrees C, with some lines showing only two-thirds the survival seen in control lines. These results underscore the vital role IBPs play in the development of a freeze-tolerant phenotype and suggests that expression of these proteins in frost-susceptible plants could be valuable for the production of more winter-hardy crops.	[Bredow, Melissa; Vanderbeld, Barbara; Walker, Virginia K.] Queens Univ, Dept Biol, Kingston, ON, Canada; [Walker, Virginia K.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Walker, Virginia K.] Queens Univ, Sch Environm Studies, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; Queens University - Canada	Bredow, M (corresponding author), Queens Univ, Dept Biol, Kingston, ON, Canada.	11mb95@queensu.ca			NSERC Discovery Grant [388335]	NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by the NSERC Discovery Grant(http://www.nserc-crsng.gc.ca/index_eng.asp) to Virginia K. Walker (#388335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Dr. P.L. Davies for use of the Clifton Nanolitre Osmometer and Dr. J. Wan, Dr. S. Yang and Dr. K. Joslin from Performance Plants Inc. for the empty vector control plants used in this study. This work was funded by the NSERC Discovery Grant to Dr. V.K. Walker.	Albrecht C, 2005, PLANT CELL, V17, P3337, DOI 10.1105/tpc.105.036814; Alves SC, 2009, NAT PROTOC, V4, P638, DOI 10.1038/nprot.2009.30; Antikainen M, 1997, PHYSIOL PLANTARUM, V99, P423, DOI 10.1034/j.1399-3054.1997.990310.x; Bajji M, 2002, PLANT GROWTH REGUL, V36, P61, DOI 10.1023/A:1014732714549; Bredow M, 2016, PLANT BIOTECH J; Brodersen P, 2008, SCIENCE, V320, P1185, DOI 10.1126/science.1159151; BURCHAM TS, 1984, BIOPOLYMERS, V23, P1379, DOI 10.1002/bip.360230720; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Colcombet J, 2005, PLANT CELL, V17, P3350, DOI 10.1105/tpc.105.036731; Colton-Gagnon K, 2014, ANN BOT-LONDON, V113, P681, DOI 10.1093/aob/mct283; Doucet D, 2000, EUR J BIOCHEM, V267, P6082, DOI 10.1046/j.1432-1327.2000.01694.x; Doucet D, 2002, EUR J BIOCHEM, V269, P38, DOI 10.1046/j.0014-2956.2001.02628.x; DUMAN JG, 1994, BBA-PROTEIN STRUCT M, V1206, P129, DOI 10.1016/0167-4838(94)90081-7; Fei Yun-Biao, 1994, Acta Botanica Sinica, V36, P649; Fursova OV, 2009, GENE, V429, P98, DOI 10.1016/j.gene.2008.10.016; Gao MH, 2009, CELL HOST MICROBE, V6, P34, DOI 10.1016/j.chom.2009.05.019; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Gong ZY, 1996, J BIOL CHEM, V271, P4106, DOI 10.1074/jbc.271.8.4106; Graham LA, 1997, NATURE, V388, P727, DOI 10.1038/41908; GRIFFITH M, 1992, PLANT PHYSIOL, V100, P593, DOI 10.1104/pp.100.2.593; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Gupta R, 2014, PLOS ONE; Gupta R, 2012, J PROTEOME RES, V11, P2684, DOI 10.1021/pr200944z; Hays LM, 1996, P NATL ACAD SCI USA, V93, P6835, DOI 10.1073/pnas.93.13.6835; Hirano Y, 2008, CRYOBIOLOGY, V57, P46, DOI 10.1016/j.cryobiol.2008.05.006; HON WC, 1995, PLANT PHYSIOL, V109, P879, DOI 10.1104/pp.109.3.879; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Huang T, 2002, PLANT MOL BIOL, V48, P339, DOI 10.1023/A:1014062714786; Iwakawa H, 2013, MOL CELL, V52, P591, DOI 10.1016/j.molcel.2013.10.033; Jinn TL, 2000, GENE DEV, V14, P108; Khanna HK, 2006, PLANT CELL REP, V25, P1336, DOI 10.1007/s00299-006-0191-9; KNIGHT CA, 1994, J CRYST GROWTH, V143, P301, DOI 10.1016/0022-0248(94)90071-X; Kontogiorgos V, 2007, J FOOD BIOCHEM, V31, P139, DOI 10.1111/j.1745-4514.2007.00112.x; KOSTER KL, 1992, PLANT PHYSIOL, V98, P108, DOI 10.1104/pp.98.1.108; Lauersen KJ, 2011, CRYOBIOLOGY, V62, P194, DOI 10.1016/j.cryobiol.2011.03.003; Li C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-65; Lu CF, 2000, PROG BIOCHEM BIOPHYS, V27, P555; MARENTES E, 1993, PHYSIOL PLANTARUM, V87, P499, DOI 10.1111/j.1399-3054.1993.tb02499.x; Middleton AJ, 2014, METHODS MOL BIOL, V1166, P255, DOI 10.1007/978-1-4939-0844-8_19; Middleton AJ, 2012, J MOL BIOL, V416, P713, DOI 10.1016/j.jmb.2012.01.032; Middleton AJ, 2009, FEBS LETT, V583, P815, DOI 10.1016/j.febslet.2009.01.035; Muthukumaran J, 2011, J BIOINFORM SEQ ANAL, V3, P70; Nishimiya Y, 2005, FEBS J, V272, P482, DOI 10.1111/j.1742-4658.2004.04490.x; Pudney PDA, 2003, ARCH BIOCHEM BIOPHYS, V410, P238, DOI 10.1016/S0003-9861(02)00697-5; RAYMOND JA, 1977, P NATL ACAD SCI USA, V74, P2589, DOI 10.1073/pnas.74.6.2589; RUBINSKY B, 1991, BIOCHEM BIOPH RES CO, V180, P566, DOI 10.1016/S0006-291X(05)81102-7; Sandve SR, 2011, PLANT SCI, V180, P69, DOI 10.1016/j.plantsci.2010.07.011; Sandve SR, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-245; Sasaki K, 2012, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00116; Schreiber AW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-285; SCOTT GK, 1985, P NATL ACAD SCI USA, V82, P2613, DOI 10.1073/pnas.82.9.2613; Smallwood M, 1999, BIOCHEM J, V340, P385, DOI 10.1042/0264-6021:3400385; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tomczak MM, 2002, BIOPHYS J, V82, P874, DOI 10.1016/S0006-3495(02)75449-0; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; Uemura M, 2006, PHYSIOL PLANTARUM, V126, P81, DOI 10.1111/j.1399-3054.2005.00594.x; URRUTIA ME, 1992, BIOCHIM BIOPHYS ACTA, V1121, P199, DOI 10.1016/0167-4838(92)90355-H; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Worrall D, 1998, SCIENCE, V282, P115, DOI 10.1126/science.282.5386.115; Yang DSC, 1998, BIOPHYS J, V74, P2142, DOI 10.1016/S0006-3495(98)77923-8; Yu S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00622; Yu YL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-20; Zhang C, 2007, J AGR FOOD CHEM, V55, P7654, DOI 10.1021/jf0715065; Zhang CZ, 2010, PLANTA, V232, P155, DOI 10.1007/s00425-010-1163-4; Zhang DQ, 2004, PROTEIN EXPRES PURIF, V35, P257, DOI 10.1016/j.pep.2004.01.019; Zhao DZ, 2002, GENE DEV, V16, P2021, DOI 10.1101/gad.997902	66	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167941	10.1371/journal.pone.0167941	http://dx.doi.org/10.1371/journal.pone.0167941			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959937	gold, Green Published, Green Submitted			2022-12-27	WOS:000392753900026
J	Sharfi, K; Rosenblum, S				Sharfi, Kineret; Rosenblum, Sara			Executive Functions, Time Organization and Quality of Life among Adults with Learning Disabilities	PLOS ONE			English	Article							WORKING-MEMORY; ACADEMIC-ACHIEVEMENT; CHILDREN; PERFORMANCE; BRAIN; DEFINITION; HEALTH; ADOLESCENTS; INHIBITION; ABILITIES	Purpose This study compared the executive functions, organization in time and perceived quality of life (QoL) of 55 adults with learning disabilities (LD) with those of 55 matched controls (mean age 30 years). Furthermore, relationships and predictive relationships between these variables among the group with LD were examined. Methods All participants completed the Behavioral Rating Inventory of Executive Functions (BRIEFA), the Time Organization and Participation (TOPS, A-C) and the World Health Organization Quality of Life (WHOQOL) questionnaires. Chi-square tests, independent t-tests and MANOVA were used to examine group differences in each of the subscales scores and ratings of each instrument. Pearson correlations and regression predictive models were used to examine the relationships between the variables in the group with LD. Results Adults with LD had significantly poorer executive functions (BRIEF-A), deficient organization in time abilities (TOPS A-B), accompanied with negative emotional response (TOPS-C), and lower perceived QoL (physical, psychological, social and environmental) in comparison to adults without LD. Regression analysis revealed that Initiation (BRIEF-A) significantly predicted approximately 15% of the participants' organization in time abilities (TOPS A, B scores) beyond group membership. Furthermore, initiation, emotional control (BRIEF-A subscales) and emotional responses following unsuccessful organization of time (TOPS-C) together accounted for 39% of the variance of psychological QoL beyond the contribution of group membership. Conclusions Deficits in initiation and emotional executive functions as well as organization in time abilities and emotional responses to impairments in organizing time affect the QoL of adults with LD and thus should be considered in further research as well as in clinical applications.	[Sharfi, Kineret; Rosenblum, Sara] Univ Haifa, Lab Complex Human Act & Participat, Dept Occupat Therapy, Haifa, Israel	University of Haifa	Sharfi, K (corresponding author), Univ Haifa, Lab Complex Human Act & Participat, Dept Occupat Therapy, Haifa, Israel.	kineretsharfi@gmail.com			Israeli Ministry of Science and Technology [3-8634]	Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel)	This study was funded by the Israeli Ministry of Science and Technology, grant number 3-8634. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all those who participated for their cooperation and interest in the study and to the Israeli Ministry of Science and Technology for their support. The ethics committee for human subject research in the faculty of social welfare and health sciences at Haifa University approved this study in October 2010 (confirmation No. 170/10). An informed consent was signed by each participant and afterwards the subjects' personal identifiers were kept separately from the data.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Bailey CE, 2007, ANN NY ACAD SCI, V1118, P122, DOI 10.1196/annals.1412.011; Barkley R.A., 1994, ADHD REPORT, V2, P1; Barkley RA, 2011, J PSYCHOPATHOL BEHAV, V33, P137, DOI 10.1007/s10862-011-9217-x; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Borella E, 2010, J LEARN DISABIL-US, V43, P541, DOI 10.1177/0022219410371676; Braun U, 2015, P NATL ACAD SCI USA, V112, P11678, DOI 10.1073/pnas.1422487112; Brod M, 2006, QUAL LIFE RES, V15, P117, DOI 10.1007/s11136-005-8325-z; Brosnan M, 2002, NEUROPSYCHOLOGIA, V40, P2144, DOI 10.1016/S0028-3932(02)00046-5; Brown TE, 2010, POSTGRAD MED, V122, P42, DOI 10.3810/pgm.2010.09.2200; Bryan T, 2004, LEARN DISABILITY Q, V27, P45, DOI 10.2307/1593631; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Cavendish W, 2013, J LEARN DISABIL-US, V46, P52, DOI 10.1177/0022219412464352; Christopher ME, 2012, J EXP PSYCHOL GEN, V141, P470, DOI 10.1037/a0027375; Cortiella C., 2014, STATE LEARNING DISAB; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Farnworth L., 2003, J OCCUP SCI, V10, P150, DOI [DOI 10.1080/14427591.2003.9686523, https://doi.org/10.1080/14427591.2003.9686523]; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Felce D, 1997, QUALITY LIFE PEOPLE, P56; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Godard J, 2011, PSYCHIAT RES, V190, P244, DOI 10.1016/j.psychres.2011.06.014; Greenhill LL., 2000, LEARNING DISABILITIE; Grinblat N, 2012, THESIS; Hooper SR, 2002, J LEARN DISABIL-US, V35, P57, DOI 10.1177/002221940203500105; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Karande S, 2009, J TROP PEDIATRICS, V55, P160, DOI 10.1093/tropej/fmn099; Katz N, 2011, COGNITION OCCUPATION, P13; Kavale KA, 2000, J LEARN DISABIL-US, V33, P239, DOI 10.1177/002221940003300303; Kavale KA, 1996, J LEARN DISABIL, V29, P226, DOI 10.1177/002221949602900301; Kavale KA, 2009, LEARN DISABILITY Q, V32, P39, DOI 10.2307/25474661; Koven NS, 2010, PERS INDIV DIFFER, V49, P24, DOI 10.1016/j.paid.2010.02.034; KUYKEN W, 1994, INT J MENT HEALTH, V23, P24, DOI 10.1080/00207411.1994.11449286; LACHMAN ME, 1993, INT J BEHAV DEV, V16, P131, DOI 10.1177/016502549301600203; Lezak MD., 2004, NEUROPSYCHOLOGICAL A, V(4th ed.), P429; McDougall J, 2011, DEV NEUROREHABIL, V14, P41, DOI 10.3109/17518423.2010.521795; McDougall J, 2010, DEV NEUROREHABIL, V13, P204, DOI 10.3109/17518421003620525; Morrison F. J., 2010, CHILD DEV INTERSECTI, DOI DOI 10.1037/12059-011; Peleg O, 2009, LEARN DISABILITY Q, V32, P11, DOI 10.2307/25474659; Pyne JM, 1997, PSYCHOPHARMACOL BULL, V33, P23; Rosenblum S, 2013, RES DEV DISABIL, V34, P218, DOI 10.1016/j.ridd.2012.07.011; Rosenblum S, 2012, NEUROPSYCHOL REHABIL, V22, P65, DOI 10.1080/09602011.2011.640465; Rosenblum S, 2010, RES DEV DISABIL, V31, P502, DOI 10.1016/j.ridd.2009.10.016; Rotenberg-Shpigelman S., 2008, ISRAELI J OCCUPATION, V17, pH77; Roth RM., 2005, BRIEF A BEHAV RATING; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Scanlon D, 2013, J LEARN DISABIL-US, V46, P26, DOI 10.1177/0022219412464342; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharfi K, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106657, 10.1371/journal.pone.0108691]; Sharma K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125693; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Stern A, 2013, J ATTEN DISORD, P1; SWANSON HL, 1994, J LEARN DISABIL-US, V27, P34, DOI 10.1177/002221949402700107; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Theofilou P, 2013, EUR J PSYCHOL, V9, P150, DOI 10.5964/ejop.v9i1.337; Toll SWM, 2011, J LEARN DISABIL-US, V44, P521, DOI 10.1177/0022219410387302; Vasic N, 2008, NEUROPSYCHOLOGIA, V46, P640, DOI 10.1016/j.neuropsychologia.2007.09.002; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wilson AM, 2009, J LEARN DISABIL-US, V42, P24, DOI 10.1177/0022219408326216; World Health Organization, 2001, INT CLASS FUNCT DIS; World Health Organization (WHO), 2004, WHO QUAL LIF QUEST W	62	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0166939	10.1371/journal.pone.0166939	http://dx.doi.org/10.1371/journal.pone.0166939			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	27959913	Green Submitted, Green Published, gold			2022-12-27	WOS:000392753900006
J	Allaway, D; Gilham, MS; Colyer, A; Jonsson, TJ; Swanson, KS; Morris, PJ				Allaway, David; Gilham, Matthew S.; Colyer, Alison; Jonsson, Thomas J.; Swanson, Kelly S.; Morris, Penelope J.			Metabolic Profiling Reveals Effects of Age, Sexual Development and Neutering in Plasma of Young Male Cats	PLOS ONE			English	Article							FOOD-INTAKE; BODY-COMPOSITION; GENE-EXPRESSION; RETINOIC ACID; GONADECTOMY; FELININE; WEIGHT; TESTOSTERONE; ENERGY; OVARIOHYSTERECTOMY	Neutering is a significant risk factor for obesity in cats. The mechanisms that promote neuter-associated weight gain are not well understood but following neutering, acute changes in energy expenditure and energy consumption have been observed. Metabolic profiling (GC-MS and UHPLC-MS-MS) was used in a longitudinal study to identify changes associated with age, sexual development and neutering in male cats fed a nutritionally-complete dry diet to maintain an ideal body condition score. At eight time points, between 19 and 52 weeks of age, fasted blood samples were taken from kittens neutered at either 19 weeks of age (Early Neuter (EN), n = 8) or at 31 weeks of age (Conventional Neuter (CN), n = 7). Univariate and multivariate analyses were used to compare plasma metabolites (n = 370) from EN and CN cats. Age was the primary driver of variance in the plasma metabolome, including a developmental change independent of neuter group between 19 and 21 weeks in lysolipids and fatty acid amides. Changes associated with sexual development and its subsequent loss were also observed, with differences at some time points observed between EN and CN cats for 45 metabolites (FDR p< 0.05). Pathway Enrichment Analysis also identified significant effects in 20 pathways, dominated by amino acid, sterol and fatty acid metabolism. Most changes were interpretable within the context of male sexual development, and changed following neutering in the CN group. Felinine metabolism in CN cats was the most significantly altered pathway, increasing during sexual development and decreasing acutely following neutering. Felinine is a testosterone-regulated, felid-specific glutathione derivative secreted in urine. Alterations in tryptophan, histidine and tocopherol metabolism observed in peripubertal cats may be to support physiological functions of glutathione following diversion of S-amino acids for urinary felinine secretion.	[Allaway, David; Gilham, Matthew S.; Colyer, Alison; Morris, Penelope J.] WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England; [Jonsson, Thomas J.] Metabolon Inc, Durham, NC USA; [Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA	Mars; WALTHAM Petcare Science Institute; Metabolon; University of Illinois System; University of Illinois Urbana-Champaign	Allaway, D (corresponding author), WALTHAM Ctr Pet Nutr, Melton Mowbray, Leics, England.	david.allaway@effem.com		Allaway, David/0000-0003-4602-8933; Swanson, Kelly/0000-0001-5518-3076	Mars Petcare UK	Mars Petcare UK	I have read the journal's policy and the authors of this manuscript have the following competing interests: The study was funded by Mars Petcare UK, the employer of DA, MSG, AC & PJM. The study was initiated when KSS was on a sabbatical at WALTHAM (Mars Petcare). These affiliations and funding does not alter our adherence to PLOS ONE policies on sharing data and materials.	Acuna-Castroviejo D, 2014, CELL MOL LIFE SCI, V71, P2997, DOI 10.1007/s00018-014-1579-2; Alexander LG, 2011, BRIT J NUTR, V106, pS19, DOI 10.1017/S0007114511001851; Allaway D, 2013, METABOLOMICS, V9, P1096, DOI 10.1007/s11306-013-0527-8; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; [Anonymous], 2013, PACKAGE VEGAN COMMUN; Beckmann M, 2010, BRIT J NUTR, V103, P1127, DOI 10.1017/S000711450999300X; Belsito KR, 2009, J ANIM SCI, V87, P594, DOI 10.2527/jas.2008-0887; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boldyrev AA, 2013, PHYSIOL REV, V93, P1803, DOI 10.1152/physrev.00039.2012; Bretz F., 2016, MULTIPLE COMP USING; Butterwick RF, 2001, AM J VET RES, V62, P331, DOI 10.2460/ajvr.2001.62.331; Cave NJ, 2007, NEW ZEAL VET J, V55, P113, DOI 10.1080/00480169.2007.36752; Cave NJ, 2007, J ANIM PHYSIOL AN N, V91, P400, DOI 10.1111/j.1439-0396.2006.00667.x; CHAN KM, 1994, CRIT REV FOOD SCI, V34, P403, DOI 10.1080/10408399409527669; Chu K, 2009, JAVMA-J AM VET MED A, V234, P1023, DOI 10.2460/javma.234.8.1023; Colyer A, 2011, BRIT J NUTR, V106, pS146, DOI 10.1017/S000711451100081X; Conforto TL, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-9; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Deusch O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144881; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fettman MJ, 1997, RES VET SCI, V62, P131, DOI 10.1016/S0034-5288(97)90134-X; Flynn MF, 1996, J AM VET MED ASSOC, V209, P1572; Gabbay V, 2010, J CHILD PSYCHOL PSYC, V51, P935, DOI 10.1111/j.1469-7610.2010.02245.x; German AJ, 2006, J NUTR, V136, p2031S, DOI 10.1093/jn/136.7.2031S; Hagen-Plantinga EA, 2014, J ANIM PHYSIOL AN N, V98, P491, DOI 10.1111/jpn.12097; Hoenig M, 2002, AM J VET RES, V63, P634, DOI 10.2460/ajvr.2002.63.634; Hogarth CA, 2012, ANIM REPROD, V9, P742; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; JONES DB, 1989, EUR J CLIN INVEST, V19, P438, DOI 10.1111/j.1365-2362.1989.tb00256.x; Joyce A, 2011, J FELINE MED SURG, V13, P3, DOI 10.1016/j.jfms.2010.11.005; Kanchuk ML, 2003, J NUTR, V133, P1866, DOI 10.1093/jn/133.6.1866; Kanchuk ML, 2002, J NUTR, V132, p1730S, DOI 10.1093/jn/132.6.1730S; Kasimanickam VR, 2013, THERIOGENOLOGY, V79, P10, DOI 10.1016/j.theriogenology.2012.09.001; Kratz EM, 2014, REPROD FERT DEVELOP, V28, P507; Lloyd AJ, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0997-6; Long JZ, 2011, J LIPID RES, V52, P337, DOI 10.1194/jlr.M012153; MANNING BD, 1975, LIFE SCI, V17, P225, DOI 10.1016/0024-3205(75)90507-X; MENENDEZPELAEZ A, 1988, P SOC EXP BIOL MED, V187, P287; Metges CC, 2000, AM J PHYSIOL-ENDOC M, V278, pE868, DOI 10.1152/ajpendo.2000.278.5.E868; Miyazaki M, 2006, CHEM BIOL, V13, P1071, DOI 10.1016/j.chembiol.2006.08.013; Murray JK, 2008, VET REC, V163, P381, DOI 10.1136/vr.163.13.381; Murray JK, 2009, VET REC, V164, P137, DOI 10.1136/vr.164.5.137; Nguyen PG, 2004, AM J VET RES, V65, P1708, DOI 10.2460/ajvr.2004.65.1708; NRC, 2006, NUTR REQ DOGS CATS, V2; PALEKAR AG, 1974, P NATL ACAD SCI USA, V71, P293, DOI 10.1073/pnas.71.2.293; Penafiel R, 2004, AMINO ACIDS, V26, P53, DOI 10.1007/s00726-003-0034-8; Rohrbach BW, 2001, J AM VET MED ASSOC, V218, P1111, DOI 10.2460/javma.2001.218.1111; Rutherfurd KJ, 2002, J BIOL CHEM, V277, P114, DOI 10.1074/jbc.M107728200; Sasaki S, 2015, J BIOL CHEM, V290, P2303, DOI 10.1074/jbc.M114.581892; Scarlett JM, 1998, J AM VET MED ASSOC, V212, P1725; SCHNEIDER R, 1983, J NATL CANCER I, V70, P971; Sha W, 2010, FASEB J, V24, P2962, DOI 10.1096/fj.09-154054; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Spain CV, 2004, JAVMA-J AM VET MED A, V224, P372, DOI 10.2460/javma.2004.224.372; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; STOZICKY F, 1991, ACTA PAEDIATR SCAND, V80, P1139, DOI 10.1111/j.1651-2227.1991.tb11801.x; Stubbs WP, 1996, J AM VET MED ASSOC, V209, P1864; Sullivan R, 2005, BLOOD CELL MOL DIS, V35, P1, DOI 10.1016/j.bcmd.2005.03.005; Tarttelin MF, 1998, PHYSIOL BEHAV, V65, P83, DOI 10.1016/S0031-9384(98)00132-2; Urata Y, 1999, FREE RADICAL BIO MED, V27, P838, DOI 10.1016/S0891-5849(99)00131-8; Vester BM, 2009, ANIMAL, V3, P1287, DOI 10.1017/S1751731109004868; Viant MR, 2007, METABOLOMICS, V3, P453, DOI 10.1007/s11306-007-0092-0; Wei A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089557; Zoran DL, 2010, VET CLIN N AM-SMALL, V40, P221, DOI 10.1016/j.cvsm.2009.10.009	65	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168144	10.1371/journal.pone.0168144	http://dx.doi.org/10.1371/journal.pone.0168144			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942045	gold, Green Published, Green Submitted			2022-12-27	WOS:000392745600055
J	Bjursell, M; Ryberg, E; Wu, TT; Greasley, PJ; Bohlooly-Y, M; Hjorth, S				Bjursell, Mikael; Ryberg, Erik; Wu, Tingting; Greasley, Peter J.; Bohlooly-Y, Mohammad; Hjorth, Stephan			Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation	PLOS ONE			English	Article							CANNABINOID RECEPTOR GPR55; LYSOPHOSPHATIDYLINOSITOL RECEPTOR; POTENTIAL ROLE; MICE; EXPRESSION; OBESITY; IDENTIFICATION; PHARMACOLOGY; HOMEOSTASIS; C57BL/6J	The G-protein coupled receptor 55 (GPR55) is activated by cannabinoids and non-cannabinoid molecules and has been speculated to play a modulatory role in a large variety of physiological and pathological processes, including in metabolically perturbed states. We therefore generated male mice deficient in the gene coding for the cannabinoid/lysophosphatidylinositol (LPI) receptor Gpr55 and characterized them under normal dietary conditions as well as during high energy dense diet feeding followed by challenge with the CB1 receptor antagonist/GPR55 agonist rimonabant. Gpr55 deficient male mice (Gpr55 KO) were phenotypically indistinguishable from their wild type (WT) siblings for the most part. However, Gpr55 KO animals displayed an intriguing nocturnal pattern of motor activity and energy expenditure (EE). During the initial 6 hours of the night, motor activity was significantly elevated without any significant effect observed in EE. Interestingly, during the last 6 hours of the night motor activity was similar but EE was significantly decreased in the Gpr55 KO mice. No significant difference in motor activity was detected during daytime, but EE was lower in the Gpr55 KO compared to WT mice. The aforementioned patterns were not associated with alterations in energy intake, daytime core body temperature, body weight (BW) or composition, although a non-significant tendency to increased adiposity was seen in Gpr55 KO compared to WT mice. Detailed analyses of daytime activity in the Open Field paradigm unveiled lower horizontal activity and rearing time for the Gpr55 KO mice. Moreover, the Gpr55 KO mice displayed significantly faster reaction time in the tail flick test, indicative of thermal hyperalgesia. The BW-decreasing effect of rimonabant in mice on long-term cafeteria diet did not differ between Gpr55 KO and WT mice. In conclusion, Gpr55 deficiency is associated with subtle effects on diurnal/nocturnal EE and motor activity behaviours but does not appear per se critically required for overall metabolism or behaviours.	[Bjursell, Mikael; Wu, Tingting; Bohlooly-Y, Mohammad] AstraZeneca R&D, Discovery Sci Transgen, Molndal, Sweden; [Ryberg, Erik] AstraZeneca R&D, Cardiovasc & Metab Dis CVMD Innovat Med & Early D, Molndal, Sweden; [Greasley, Peter J.] AstraZeneca R&D, CVMD Translat Med Unit, Early Clin Dev, Molndal, Sweden; [Hjorth, Stephan] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden	AstraZeneca; AstraZeneca; AstraZeneca; University of Gothenburg	Hjorth, S (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden.	Stephan.Hjorth@gu.se	Hjorth, Stephan/AAO-4298-2021	Hjorth, Stephan/0000-0002-6980-3691				Balenga NA, 2014, BRIT J PHARMACOL, V171, P5387, DOI 10.1111/bph.12850; Balenga NAB, 2011, ADV PHARMACOL, V62, P251, DOI 10.1016/B978-0-12-385952-5.00004-X; Bjursell M, 2008, AM J PHYSIOL-ENDOC M, V294, pE251, DOI 10.1152/ajpendo.00401.2007; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; DEVANE WA, 1988, MOL PHARMACOL, V34, P605; Gantz I, 1997, GENOMICS, V42, P462, DOI 10.1006/geno.1997.4752; Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103; Imbernon M, 2014, MOL CELL ENDOCRINOL, V383, P159, DOI 10.1016/j.mce.2013.12.011; Kargl J, 2012, J BIOL CHEM, V287, P44234, DOI 10.1074/jbc.M112.364109; Kogan Natalya M, 2007, Dialogues Clin Neurosci, V9, P413; Liu B, 2015, PHARMACOL THERAPEUT, V145, P35, DOI 10.1016/j.pharmthera.2014.06.007; Moreno-Navarrete JM, 2012, DIABETES, V61, P281, DOI 10.2337/db11-0649; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Meadows A, 2016, INT J OBESITY, V40, P417, DOI 10.1038/ijo.2015.209; Moran BM, 2016, ACTA DIABETOL, V53, P177, DOI 10.1007/s00592-015-0826-9; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Naderi N, 2012, NEUROCHEM RES, V37, P778, DOI 10.1007/s11064-011-0672-2; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Perez-Gomez E, 2013, ONCOGENE, V32, P2534, DOI 10.1038/onc.2012.278; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Romero-Zerbo SY, 2011, J ENDOCRINOL, V211, P177, DOI 10.1530/JOE-11-0166; Ross RA, 2009, TRENDS PHARMACOL SCI, V30, P156, DOI 10.1016/j.tips.2008.12.004; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Sawzdargo M, 1999, MOL BRAIN RES, V64, P193, DOI 10.1016/S0169-328X(98)00277-0; Sharir H, 2010, PHARMACOL THERAPEUT, V126, P301, DOI 10.1016/j.pharmthera.2010.02.004; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Shore DM, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00069; Simcocks AC, 2014, DRUG DISCOV TODAY, V19, P1145, DOI 10.1016/j.drudis.2013.12.005; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Whyte LS, 2009, P NATL ACAD SCI USA, V106, P16511, DOI 10.1073/pnas.0902743106; Wu CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060314	34	24	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167965	10.1371/journal.pone.0167965	http://dx.doi.org/10.1371/journal.pone.0167965			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941994	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600041
J	Ziaei, S; Frith, AL; Ekstrom, EC; Naved, RT				Ziaei, Shirin; Frith, Amy Lynn; Ekstrom, Eva-Charlotte; Naved, Ruchira Tabassum			Experiencing Lifetime Domestic Violence: Associations with Mental Health and Stress among Pregnant Women in Rural Bangladesh: The MINIMat Randomized Trial	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; CORTISOL AWAKENING RESPONSE; PSYCHOLOGICAL STRESS; FOOD SUPPLEMENTATION; SALIVARY CORTISOL; MATERNAL DISTRESS; BIRTH-WEIGHT; IMPACT; PREVALENCE; SYMPTOMS	Background Experience of domestic violence has negative mental health consequences for women. The association of cumulative and specific forms of domestic violence, particularly emotional violence and controlling behavior, with common mental disorders and stress has rarely been studied in pregnant women. The aim of this study is to evaluate associations of specific and multiple forms of lifetime domestic violence and controlling behavior with distress and cortisol level during pregnancy in rural Bangladeshi women. Methods and findings In this observational sub-study of larger MINIMat trial, 3504 pregnant women were interviewed using a shortened Conflict Tactic Scale about their lifetime experience of domestic violence including physical, sexual, emotional domestic violence and controlling behavior. Women's levels of emotional distress were assessed using the self-reported questionnaire (SRQ-20) developed by WHO, and levels of morning salivary cortisol were measured in a subsample (n = 1300) of women during week 28-32 of pregnancy. Regression analyses were used to estimate the associations of lifetime physical, sexual, emotional domestic violence and controlling behavior with levels of distress and cortisol during pregnancy. The prevalence of lifetime domestic violence was 57% and emotional distress was 35% in these pregnant women. All forms of domestic violence were associated with higher levels of emotional distress. Women who experienced either emotional violence or controlling behavior had the highest levels of emotional distress. There was a dose-response relationship between cumulative number of the different forms of domestic violence and women's levels of emotional distress. There was no association between women's experience of domestic violence and level of morning salivary cortisol. Conclusion Including emotional violence and controlling behavior as major types of violence in future research and health interventions is warranted. Furthermore, the extent of the negative impacts of domestic violence on pregnant women, multiple forms of violence and their cumulative effects need to be investigated.	[Ziaei, Shirin; Ekstrom, Eva-Charlotte] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Frith, Amy Lynn] Ithaca Coll, Sch Hlth Sci & Human Performance, Ithaca, NY 14850 USA; [Naved, Ruchira Tabassum] Int Ctr Diarrhoeal Dis Res ICDDR B, Dhaka, Bangladesh	Uppsala University; International Centre for Diarrhoeal Disease Research (ICDDR)	Ziaei, S (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden.	Shirin.ziaei@kbh.uu.se	zaiei, shirin/ABC-3245-2021; Frith, Amy/GWZ-4580-2022	Frith, Amy/0000-0001-6772-9793; ziaei, shirin/0000-0001-5396-6624	International Center for Diarrheal Disease Research, Bangladesh; UNICEF; Swedish International Development Cooperation Agency; United Kingdom Medical Research Council; Swedish Research Council; Department for International Development; Japan Society for the Promotion of Science; Child Health and Nutrition Research Initiative; Uppsala University; US Agency for International Development	International Center for Diarrheal Disease Research, Bangladesh; UNICEF; Swedish International Development Cooperation Agency; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Department for International Development; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Child Health and Nutrition Research Initiative; Uppsala University; US Agency for International Development(United States Agency for International Development (USAID))	The MINIMat (Maternal and Infant Nutrition Intervention, Matlab) trial was funded by the International Center for Diarrheal Disease Research, Bangladesh; UNICEF; the Swedish International Development Cooperation Agency; the United Kingdom Medical Research Council; the Swedish Research Council; the Department for International Development; Japan Society for the Promotion of Science; the Child Health and Nutrition Research Initiative; Uppsala University; and the US Agency for International Development.	AGUILAR RJ, 1994, J FAM VIOLENCE, V9, P35, DOI 10.1007/BF01531967; Azziz-Baumgartner E, 2014, VIOLENCE AGAINST WOM, V20, P59, DOI 10.1177/1077801213520579; Beusenberg M, 1994, USERS GUIDE SELF REP; Christian LM, 2012, PROG NEUROBIOL, V99, P106, DOI 10.1016/j.pneurobio.2012.07.003; Coker AL, 2002, J WOMEN HEALTH GEN-B, V11, P465, DOI 10.1089/15246090260137644; Cook Sarah L, 2003, Violence Vict, V18, P641, DOI 10.1891/088667003780928053; de Weerth C, 2005, PSYCHONEUROENDOCRINO, V30, P902, DOI 10.1016/j.psyneuen.2005.05.003; Devries KM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001439; Deyessa Negussie, 2009, Clin Pract Epidemiol Ment Health, V5, P8, DOI 10.1186/1745-0179-5-8; Ellsberg M, 2008, LANCET, V371, P1165, DOI 10.1016/S0140-6736(08)60522-X; Entringer S, 2012, SCI SIGNALING 12, V5; Entringer S, 2009, HORM BEHAV, V55, P292, DOI 10.1016/j.yhbeh.2008.11.006; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Flury M, 2010, SWISS MED WKLY, V140, P23, DOI 10.4414/smw.2010.13099; Frith AL, 2015, MATERN CHILD NUTR, V11, P537, DOI 10.1111/mcn.12047; Frith AL, 2009, AM J CLIN NUTR, V90, P141, DOI 10.3945/ajcn.2008.26817; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Giang KB, 2006, INT J SOC PSYCHIATR, V52, P175, DOI 10.1177/0020764006061251; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Hill A, 2016, INT J GYNECOL OBSTET, V133, P269, DOI 10.1016/j.ijgo.2015.10.023; Hossain MD, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0216-9; Houry D, 2006, AM J EMERG MED, V24, P444, DOI 10.1016/j.ajem.2005.12.026; Ishida K, 2010, SOC SCI MED, V71, P1653, DOI 10.1016/j.socscimed.2010.08.007; Jejeebhoy SJ, 2014, GLOB PUBLIC HEALTH, V9, P678, DOI 10.1080/17441692.2014.916736; Johnson DM, 2008, J ANXIETY DISORD, V22, P793, DOI 10.1016/j.janxdis.2007.08.006; Kabir ZN, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24725; Khan A, 2008, ASIAN STUD REV, V32, P239, DOI [10.1080/10357820802062181, DOI 10.1080/10357820802062181]; Khan NZ, 2008, CHILD CARE HLTH DEV, V34, P657, DOI 10.1111/j.1365-2214.2008.00873.x; Kim HG, 2006, ARCH WOMEN MENT HLTH, V9, P103, DOI 10.1007/s00737-005-0117-5; Kim HK, 2015, PSYCHONEUROENDOCRINO, V51, P35, DOI 10.1016/j.psyneuen.2014.09.013; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Lawrence E, 2012, PARTN ABUSE, V3, P406, DOI 10.1891/1946-6560.3.4.406; Ludermir AB, 2008, SOC SCI MED, V66, P1008, DOI 10.1016/j.socscimed.2007.10.021; Mashreky SR, 2013, ARCH SUICIDE RES, V17, P387, DOI 10.1080/13811118.2013.801809; National Institute of Population Research and Training (NIPORT) MaA and Macro International, 2009, BANGL DEM HLTH SURV; Naved RT, 2009, J HEALTH POPUL NUTR, V27, P477, DOI 10.3329/jhpn.v27i4.3391; Naved RT, 2013, ARCH SEX BEHAV, V42, P595, DOI 10.1007/s10508-012-0045-1; Naved RT, 2008, WOMEN HEALTH ISS, V18, P442, DOI 10.1016/j.whi.2008.07.003; Naved RT, 2008, INT FAM PLAN PERSPEC, V34, P71, DOI 10.1363/ifpp.34.071.08; Newman MS, 2013, INT J MENT HEALTH, V42, P48, DOI 10.2753/IMH0020-7411420403; O'Connor TG, 2014, BIOL PSYCHOL, V96, P35, DOI 10.1016/j.biopsycho.2013.11.002; Obel C, 2005, PSYCHONEUROENDOCRINO, V30, P647, DOI 10.1016/j.psyneuen.2004.11.006; Persson LA, 2012, JAMA-J AM MED ASSOC, V307, P2050, DOI 10.1001/jama.2012.4061; Pico-Alfonso MA, 2004, BIOL PSYCHIAT, V56, P233, DOI 10.1016/j.biopsych.2004.06.001; Pico-Alfonso MA, 2006, J WOMENS HEALTH, V15, P599, DOI 10.1089/jwh.2006.15.599; Raison CL, 2003, AM J PSYCHIAT, V160, P1554, DOI 10.1176/appi.ajp.160.9.1554; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Ruiz-Perez I, 2005, PSYCHOSOM MED, V67, P791, DOI 10.1097/01.psy.0000181269.11979.cd; Sackett L A, 1999, Violence Vict, V14, P105; Saxbe D. E., 2008, HLTH PSYCHOL REV, V2, P163, DOI DOI 10.1080/17437190802530812; Scholte WF, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-116; Seedat S, 2003, PSYCHONEUROENDOCRINO, V28, P796, DOI 10.1016/S0306-4530(02)00086-0; Straus Murray A, 2004, Violence Vict, V19, P507; Taherkhani S, 2014, HEALTH PROMOT PERSPE, V4, P230, DOI 10.5681/hpp.2014.030; Thompson RS, 2006, AM J PREV MED, V30, P447, DOI 10.1016/j.amepre.2006.01.016; Tolman R M, 1989, Violence Vict, V4, P159; Valladares E, 2009, ACTA OBSTET GYN SCAN, V88, P818, DOI 10.1080/00016340903015321; World Health Organization, 2021, VIOL WOM PREV EST 20; Yount KM, 2016, SEX ROLES, V74, P450, DOI 10.1007/s11199-016-0584-3; Zijlmans MAC, 2015, NEUROSCI BIOBEHAV R, V53, P1, DOI 10.1016/j.neubiorev.2015.02.015	61	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168103	10.1371/journal.pone.0168103	http://dx.doi.org/10.1371/journal.pone.0168103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992478	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600036
J	Kal, E; Winters, M; van der Kamp, J; Houdijk, H; Groet, E; van Bennekom, C; Scherder, E				Kal, E.; Winters, M.; van der Kamp, J.; Houdijk, H.; Groet, E.; van Bennekom, C.; Scherder, E.			Is Implicit Motor Learning Preserved after Stroke? A Systematic Review with Meta-Analysis	PLOS ONE			English	Review							BASAL GANGLIA; ATTENTIONAL FOCUS; WORKING-MEMORY; EXPLICIT INFORMATION; REINVESTMENT SCALE; SKILL ACQUISITION; EXTERNAL FOCUS; KNOW-HOW; SEQUENCE; WALKING	Many stroke patients experience difficulty with performing dual-tasks. A promising intervention to target this issue is implicit motor learning, as it should enhance patients' automaticity of movement. Yet, although it is often thought that implicit motor learning is preserved post-stroke, evidence for this claim has not been systematically analysed yet. Therefore, we systematically reviewed whether implicit motor learning is preserved post-stroke, and whether patients benefit more from implicit than from explicit motor learning. We comprehensively searched conventional (MEDLINE, Cochrane, Embase, PEDro, PsycINFO) and grey literature databases (BIOSIS, Web of Science, OpenGrey, British Library, trial registries) for relevant reports. Two independent reviewers screened reports, extracted data, and performed a risk of bias assessment. Overall, we included 20 out of the 2177 identified reports that allow for a succinct evaluation of implicit motor learning. Of these, only 1 study investigated learning on a relatively complex, whole-body (balance board) task. All 19 other studies concerned variants of the serial-reaction time paradigm, with most of these focusing on learning with the unaffected hand (N = 13) rather than the affected hand or both hands (both: N = 4). Four of the 20 studies compared explicit and implicit motor learning post-stroke. Meta-analyses suggest that patients with stroke can learn implicitly with their unaffected side (mean difference (MD) = 69 ms, 95% CI[45.1, 92.9], p <.00001), but not with their affected side (standardized MD = -. 11, 95% CI[-. 45,.25], p =.56). Finally, implicit motor learning seemed equally effective as explicit motor learning post-stroke (SMD = -. 54, 95% CI[-1.37,.29], p =.20). However, overall, the high risk of bias, small samples, and limited clinical relevance of most studies make it impossible to draw reliable conclusions regarding the effect of implicit motor learning strategies post-stroke. High quality studies with larger samples are warranted to test implicit motor learning in clinically relevant contexts.	[Kal, E.; Houdijk, H.; Groet, E.; van Bennekom, C.] Heliomare Rehabil Ctr, Res Dev Dept, Wijk Aan Zee, Netherlands; [Kal, E.; van der Kamp, J.; Houdijk, H.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, MOVE Res Inst, Dept Human Movement Sci, Amsterdam, Netherlands; [Kal, E.; Scherder, E.] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Clin Neuropsychol, Amsterdam, Netherlands; [Winters, M.] Univ Med Ctr Utrecht, Dept Rehabil Nursing Sci & Sports, Utrecht, Netherlands; [van der Kamp, J.] Univ Hong Kong, Inst Human Performance, Hong Kong, Hong Kong, Peoples R China; [van Bennekom, C.] Univ Amsterdam, Acad Med Ctr, Coronel Inst Occupat & Environm Hlth, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Utrecht University; Utrecht University Medical Center; University of Hong Kong; University of Amsterdam; Academic Medical Center Amsterdam	Kal, E (corresponding author), Heliomare Rehabil Ctr, Res Dev Dept, Wijk Aan Zee, Netherlands.; Kal, E (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, MOVE Res Inst, Dept Human Movement Sci, Amsterdam, Netherlands.; Kal, E (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, Dept Clin Neuropsychol, Amsterdam, Netherlands.	e.kal@heliomare.nl	Houdijk, Han/GXV-2986-2022	Houdijk, Han/0000-0002-7069-1973; van der Kamp, John/0000-0002-3826-1973; Kal, Elmar/0000-0002-1481-3016; Winters, Marinus/0000-0001-5742-7441				ABERNETHY B, 1988, J HUM MOVEMENT STUD, V14, P101; Aizenstein HJ, 2004, CEREB CORTEX, V14, P199, DOI 10.1093/cercor/bhg119; ANDERSON JR, 1982, PSYCHOL REV, V89, P369, DOI 10.1037/0033-295X.89.4.369; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baer G, 2001, Physiother Res Int, V6, P135, DOI 10.1002/pri.222; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bapi RS, 2000, EXP BRAIN RES, V132, P149, DOI 10.1007/s002219900332; Beauchet O, 2009, EUR J NEUROL, V16, P786, DOI 10.1111/j.1468-1331.2009.02612.x; BERRY DC, 1988, BRIT J PSYCHOL, V79, P251, DOI 10.1111/j.2044-8295.1988.tb02286.x; Boyd LA, 2009, NEUROBIOL LEARN MEM, V92, P35, DOI 10.1016/j.nlm.2009.02.009; Boyd LA, 2004, NEUROREHAB NEURAL RE, V18, P134, DOI 10.1177/0888439004269072; Boyd LA, 2004, LEARN MEMORY, V11, P388, DOI 10.1101/lm.80104; Boyd LA, 2003, PHYS THER, V83, P976, DOI 10.1093/ptj/83.11.976; Boyd LA, 2001, NEUROSCI LETT, V298, P65, DOI 10.1016/S0304-3940(00)01734-1; Boyd Lara, 2006, J Neurol Phys Ther, V30, P46; Boyd LA, 2007, NEUROREHAB NEURAL RE, V21, P444, DOI 10.1177/1545968307300438; Canning CG, 2006, DISABIL REHABIL, V28, P97, DOI 10.1080/09638280500167712; Chang TT, 2014, CEREBROVASC DIS, V38, P1; Chauvel G, 2012, Q J EXP PSYCHOL, V65, P25, DOI 10.1080/17470218.2011.588714; Deeks J J, 2003, Health Technol Assess, V7, piii; Dirnberger G, 2013, J COGNITIVE NEUROSCI, V25, P2207, DOI 10.1162/jocn_a_00444; Dirnberger G, 2010, NEUROPSYCHOLOGIA, V48, P1200, DOI 10.1016/j.neuropsychologia.2009.12.016; Dovern A, 2011, J NEUROSCI, V31, P8102, DOI 10.1523/JNEUROSCI.6585-10.2011; Durham K, 2009, PHYSIOTHER RES INT, V14, P77, DOI 10.1002/pri.431; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Exner C, 2002, LEARN MEMORY, V9, P376, DOI 10.1101/lm.48402; Fitts PM., 1967, HUM PERFORM; Galea JM, 2010, J COGNITIVE NEUROSCI, V22, P1158, DOI 10.1162/jocn.2009.21259; Gobel EW, 2011, NEUROIMAGE, V58, P1150, DOI 10.1016/j.neuroimage.2011.06.090; Gomez-Beldarrain M, 1998, EXP BRAIN RES, V120, P25, DOI 10.1007/s002210050374; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Hardy L, 1996, BRIT J PSYCHOL, V87, P621, DOI 10.1111/j.2044-8295.1996.tb02612.x; Janacsek K, 2013, CORTEX, V49, P2001, DOI 10.1016/j.cortex.2013.02.012; Johnson L, 2013, PHYS THER, V93, P957, DOI 10.2522/ptj.20120300; Kal E, 2016, DISABIL REHABIL, V38, P1097, DOI 10.3109/09638288.2015.1091858; Kal EC, 2013, HUM MOVEMENT SCI, V32, P527, DOI 10.1016/j.humov.2013.04.001; Kantak SS, 2012, EUR J NEUROSCI, V36, P2710, DOI 10.1111/j.1460-9568.2012.08175.x; Kantak SS, 2012, BEHAV BRAIN RES, V228, P219, DOI 10.1016/j.bbr.2011.11.028; Kleynen M, 2014, INT J REHABIL RES, V37, P277, DOI 10.1097/MRR.0000000000000058; Kleynen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100227; Kleynen M, 2013, CLIN REHABIL, V27, P160, DOI 10.1177/0269215512448381; Koedijker JM, 2007, INT J SPORT PSYCHOL, V38, P227; Koedijker JM, 2011, CONSCIOUS COGN, V20, P245, DOI 10.1016/j.concog.2010.08.002; Korman M, 2003, P NATL ACAD SCI USA, V100, P12492, DOI 10.1073/pnas.2035019100; Lam WK, 2010, J SPORT SCI, V28, P1543, DOI 10.1080/02640414.2010.517543; Liao CM, 2001, J SPORT SCI, V19, P307, DOI 10.1080/02640410152006081; Lohse KR, 2014, NEUROPSYCHOLOGIA, V59, P130, DOI 10.1016/j.neuropsychologia.2014.05.001; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Masters RSW, 2008, SURGERY, V143, P140, DOI 10.1016/j.surg.2007.06.018; MASTERS RSW, 1992, BRIT J PSYCHOL, V83, P343, DOI 10.1111/j.2044-8295.1992.tb02446.x; Maxwell JP, 2001, Q J EXP PSYCHOL-A, V54, P1049, DOI 10.1080/02724980143000073; Maxwell JP, 2000, J SPORT SCI, V18, P111, DOI 10.1080/026404100365180; Meehan SK, 2011, HUM BRAIN MAPP, V32, P290, DOI 10.1002/hbm.21019; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Nys GMS, 2007, CEREBROVASC DIS, V23, P408, DOI 10.1159/000101464; Orrell AJ, 2007, NEUROPSYCHOL REHABIL, V17, P335, DOI 10.1080/09602010600832788; Orrell AJ, 2009, NEUROREHAB NEURAL RE, V23, P177, DOI 10.1177/1545968308317752; Orrell AJ, 2006, PHYS THER, V86, P369, DOI 10.1093/ptj/86.3.369; Orrell AJ, 2006, GAIT POSTURE, V23, P9, DOI 10.1016/j.gaitpost.2004.11.010; 이미영, 2008, [The Journal of Korean Society of Physical Therapy, 대한물리치료학회지], V20, P1; Plummer P, 2013, ARCH PHYS MED REHAB, V94, P2565, DOI 10.1016/j.apmr.2013.08.002; Plummer-D'Amato P, 2008, GAIT POSTURE, V27, P683, DOI 10.1016/j.gaitpost.2007.09.001; Pohl PS, 2006, CLIN REHABIL, V20, P246, DOI 10.1191/0269215506cr916oa; Pohl PS, 2001, PHYS THER, V81, P1780, DOI 10.1093/ptj/81.11.1780; Poolton JM, 2006, J SPORT SCI, V24, P89, DOI 10.1080/02640410500130854; Reber PJ, 2013, NEUROPSYCHOLOGIA, V51, P2026, DOI 10.1016/j.neuropsychologia.2013.06.019; Reisman DS, 2013, NEUROREHAB NEURAL RE, V27, P460, DOI 10.1177/1545968312474118; Rieckmann A, 2009, NEUROPSYCHOL REV, V19, P490, DOI 10.1007/s11065-009-9117-y; Roerdink M, 2006, EXP BRAIN RES, V174, P256, DOI 10.1007/s00221-006-0441-7; Rosser N, 2008, ARCH PHYS MED REHAB, V89, P1633, DOI 10.1016/j.apmr.2008.02.030; Salbach NM, 2001, ARCH PHYS MED REHAB, V82, P1204, DOI 10.1053/apmr.2001.24907; Savin DN, 2014, CLIN NEUROPHYSIOL, V125, P1012, DOI 10.1016/j.clinph.2013.10.044; Shin JC, 2005, BRAIN COGNITION, V58, P75, DOI 10.1016/j.bandc.2004.09.015; Siegert RJ, 2008, BRAIN COGNITION, V67, P351, DOI 10.1016/j.bandc.2008.02.005; Siegert RJ, 2006, NEUROPSYCHOLOGY, V20, P490, DOI 10.1037/0894-4105.20.4.490; Stanley J, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00503; Steenbergen B, 2010, DISABIL REHABIL, V32, P1509, DOI 10.3109/09638288.2010.497035; Sun R, 2005, PSYCHOL REV, V112, P159, DOI 10.1037/0033-295X.112.1.159; Vakil E, 2000, NEUROPSYCHOLOGIA, V38, P1, DOI 10.1016/S0028-3932(99)00058-5; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Verwey WB, 2005, PSYCHOL RES-PSYCH FO, V69, P242, DOI 10.1007/s00426-004-0181-x; Wadden K, 2013, ARCH PHYS MED REHAB, V94, pe29; Wells G.A., NEWCASTLE OTTAWA SCA; Whitehead A., 2002, METAANALYSIS CONTROL; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728; Zinn S, 2007, ARCH PHYS MED REHAB, V88, P173, DOI 10.1016/j.apmr.2006.11.015; 이민부, 2006, [Journal of The Korean Geomorphological Association, 한국지형학회지], V13, P13	91	21	21	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0166376	10.1371/journal.pone.0166376	http://dx.doi.org/10.1371/journal.pone.0166376			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992442	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000005
J	Li, J; Wang, Y; Li, QG; Xue, JJ; Wang, Z; Yuan, X; Tong, JD; Xu, LC				Li, Jing; Wang, Ying; Li, Qing-Guo; Xue, Jin-Jun; Wang, Zhu; Yuan, Xin; Tong, Jian-Dong; Xu, Li-Chun			Downregulation of FBP1 Promotes Tumor Metastasis and Indicates Poor Prognosis in Gastric Cancer via Regulating Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							COLORECTAL-CANCER; GLYCOLYSIS; METABOLISM; BINDING	Background Recent studies indicated that some glycolytic enzymes are complicated, multifaceted proteins rather than simple components of the glycolytic pathway. FBP1 plays a vital role in glucose metabolism, but its role in gastric cancer tumorigenesis and metastasis has not been fully understood. Methods The prognostic value of FBP1 was first studied in The Cancer Genome Atlas (TCGA) database and validated in in-house database. The effect of FBP1 on cell proliferation and metastasis was examined in vitro. Nonparametric test and Log-rank test were used to evaluate the clinical significance of FBP1 expression. Results In the TCGA cohort, FBP1 mRNA level were shown to be predictive of overall survival in gastric cancer (P = 0.029). In the validation cohort, FBP1 expression were inversely correlated with advanced N stage (P = 0.021) and lymphovascular invasion (P = 0.011). Multivariate Cox regression analysis demonstrated that FBP1 was an independent predictor for both overall survival (P = 0.004) and disease free survival (P< 0.001). Functional studies demonstrated that ectopic FBP1 expression inhibited proliferation and invasion in gastric cancer cells, while silencing FBP1 expression had opposite effects (P< 0.05). Mechanically, FBP1 serves as a tumor suppressor by inhibiting epithelial-mesenchymal transition (EMT). Conclusions Downregulation of FBP1 promotes gastric cancer metastasis by facilitating EMT and acts as a potential prognostic factor and therapeutic target in gastric cancer.	[Li, Jing; Wang, Ying; Xue, Jin-Jun; Wang, Zhu; Yuan, Xin; Tong, Jian-Dong] Yangzhou Univ, Clin Sch 2, Yangzhou Peoples Hosp 1, Dept Oncol, Yangzhou, Jiangsu, Peoples R China; [Li, Jing; Xu, Li-Chun] Yangzhou Univ, Coll Med, Res Ctr Canc Prevent & Treatment, Yangzhou, Jiangsu, Peoples R China; [Li, Qing-Guo] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China; [Li, Qing-Guo] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China	Yangzhou University; Yangzhou University; Fudan University; Fudan University	Tong, JD (corresponding author), Yangzhou Univ, Clin Sch 2, Yangzhou Peoples Hosp 1, Dept Oncol, Yangzhou, Jiangsu, Peoples R China.; Xu, LC (corresponding author), Yangzhou Univ, Coll Med, Res Ctr Canc Prevent & Treatment, Yangzhou, Jiangsu, Peoples R China.	drtong_yz@163.com; xzyxyxlc@sohu.com						Alderton GK, 2014, NAT REV CANCER, V14, P575, DOI 10.1038/nrc3810; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Feo S, 2000, FEBS LETT, V473, P47, DOI 10.1016/S0014-5793(00)01494-0; Hamajima N, 2006, CANCER SCI, V97, P1129, DOI 10.1111/j.1349-7006.2006.00290.x; He XX, 2016, ONCOTARGETS THER, V9, P1231, DOI 10.2147/OTT.S99228; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kondaveeti Y, 2015, CANCER LETT, V364, P44, DOI 10.1016/j.canlet.2015.04.025; Li B, 2014, NATURE, V513, P251, DOI 10.1038/nature13557; Li H, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-110; Li QG, 2015, AM J CANCER RES, V5, P2022; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; MITCHELL CJ, 1987, J AM MOSQUITO CONTR, V3, P142; Morabito A, 2009, CRIT REV ONCOL HEMAT, V70, P216, DOI 10.1016/j.critrevonc.2008.08.005; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Qiu ZP, 2015, GASTROENTEROLOGY, V149, P1587, DOI 10.1053/j.gastro.2015.07.050; Seyfried TN, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-7; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Subramanian A, 2000, J BIOL CHEM, V275, P5958, DOI 10.1074/jbc.275.8.5958; Vakiani E, 2012, J CLIN ONCOL, V30, P2956, DOI 10.1200/JCO.2011.38.2994; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xie QP, 2016, J ZHEJIANG UNIV-SC B, V17, P361, DOI 10.1631/jzus.B1500236; Zhang W, 2013, CANCER-AM CANCER SOC, V119, P814, DOI 10.1002/cncr.27826; Zhang Y, 2013, CANCER BIOL THER, V14, P81, DOI 10.4161/cbt.22958	26	23	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167857	10.1371/journal.pone.0167857	http://dx.doi.org/10.1371/journal.pone.0167857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978536	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400036
J	Ranjan, R; Biswal, JK; Subramaniam, S; Singh, KP; Stenfeldt, C; Rodriguez, LL; Pattnaik, B; Arzt, J				Ranjan, Rajeev; Biswal, Jitendra K.; Subramaniam, Saravanan; Singh, Karam Pal; Stenfeldt, Carolina; Rodriguez, Luis L.; Pattnaik, Bramhadev; Arzt, Jonathan			Foot-and-Mouth Disease Virus-Associated Abortion and Vertical Transmission following Acute Infection in Cattle under Natural Conditions	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS; VIRAL PATHWAYS; CARRIER STATE; PATHOGENESIS; LOCALIZATION; LAMBS; RNA; HYBRIDIZATION; EPIDEMIOLOGY; MYOCARDITIS	Foot-and-mouth disease (FMD) is a highly contagious and economically important viral disease of cloven-hoofed animals, including domestic and wild host species. During recent FMD outbreaks in India, spontaneous abortions were reported amongst FMD-affected and asymptomatic cows. The current study was an opportunistic investigation of these naturally occurring bovine abortions to assess causality of abortion and vertical transmission of FMDV from infected cows to fetuses. For this purpose, fetal tissue samples of eight abortuses (heart, liver, kidney, spleen, palatine tonsil, umbilical cord, soft palate, tongue, lungs, and submandibular lymph node) were collected and screened by various detection methods, including viral genome detection, virus isolation, and immunomicroscopy. Amongst these cases, gross pathological changes were observed in 3 abortuses. Gross pathological findings included blood-tinged peritoneal and pleural effusions and myocarditis. Hearts of infected calves had mild to moderate degeneration and necrosis of the myocardium with moderate infiltration by mixed inflammatory cells. Localization of FMDV antigen was demonstrated in lungs and soft palate by immunomicroscopy. FMDV serotype O viral genome was recovered from 7 of 8 cases. Infectious FMDV serotype O was rescued by chemical transfection of the total RNA extracted from three soft palate samples and was sequenced to confirm 100% identity of the VP1 (capsid) coding region with isolates collected from infected cattle during the acute phase of infection. Based upon these findings, it may be concluded that FMDV-associated abortion occurred among the infected pregnant cows included within this study and FMDV was subsequently transmitted vertically to fetuses. This is the first documentation of FMDV-associated abortions in cattle.	[Ranjan, Rajeev; Biswal, Jitendra K.; Subramaniam, Saravanan; Pattnaik, Bramhadev] ICAR Res Complex, Directorate Foot & Mouth Dis, Naini Tal, Uttarakhand, India; [Singh, Karam Pal] IVRI Izatnagar, CADRAD, Bareilly, Uttar Pradesh, India; [Stenfeldt, Carolina; Rodriguez, Luis L.; Arzt, Jonathan] ARS, Foreign Anim Dis Res Unit, USDA, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA; [Stenfeldt, Carolina] Oak Ridge Inst Sci & Educ, PIADC Res Participat Program, Oak Ridge, TN USA	Indian Council of Agricultural Research (ICAR); ICAR - Directorate on Foot & Mouth Disease; Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; United States Department of Agriculture (USDA); Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Ranjan, R (corresponding author), ICAR Res Complex, Directorate Foot & Mouth Dis, Naini Tal, Uttarakhand, India.; Arzt, J (corresponding author), ARS, Foreign Anim Dis Res Unit, USDA, Plum Isl Anim Dis Ctr, Greenport, NY 11944 USA.	drrajraj@gmail.com; jonathan.arzt@ars.usda.gov	Subramaniam, Saravanan/J-8444-2014; Stenfeldt, Carolina/AAG-7940-2021	Pattnaik, Bramhadev/0000-0003-0869-7722; Arzt, Jonathan/0000-0002-7517-7893; Stenfeldt, Carolina/0000-0002-2074-3886; Subramaniam, Saravanan/0000-0003-1737-4976	Indian Council of Agricultural Research, New Delhi; Agricultural Research Service-Current Research information System Project [1940-32000-057-00D]; United States Department of State, Biosecurity Engagement Program through the United States Department of Agriculture, Agricultural Research Service Office of International Research Programs; Plum Island Animal Disease Center Research Participation Program fellowship; PIADC Research Participation Program fellowships; Biological Engagement Program, Department of State	Indian Council of Agricultural Research, New Delhi(Indian Council of Agricultural Research (ICAR)); Agricultural Research Service-Current Research information System Project; United States Department of State, Biosecurity Engagement Program through the United States Department of Agriculture, Agricultural Research Service Office of International Research Programs; Plum Island Animal Disease Center Research Participation Program fellowship; PIADC Research Participation Program fellowships; Biological Engagement Program, Department of State	This work was funded by the Indian Council of Agricultural Research, New Delhi. Additional funding was provided by Agricultural Research Service-Current Research information System Project 1940-32000-057-00D and the United States Department of State, Biosecurity Engagement Program through the United States Department of Agriculture, Agricultural Research Service Office of International Research Programs. The funding sources had no role in study design, data collection and analysis or the decision to publish the work. CS is a recipient of a Plum Island Animal Disease Center Research Participation Program fellowship, administered by the Oak Ridge Institute for Science and Education (ORISE, www.orau.org) through an interagency agreement with the US Department of Energy.; We are thankful to staff of experimental dairy farm for their invaluable cooperation during this study. Technical assistance of Mr. Basant, Uttam Nath Goswami, Shyam Lal Tamta, and Mr. B. D as are highly acknowledged. Steven Pauszek and Michael Eschbaumer areacknowledged for review of the manuscript. CS was a recipient of PIADC Research Participation Program fellowships, administered by the Oak Ridge Institute for Science and Education (ORISE) through an interagency agreement with the U.S. Department of Energy. The Office of International Research Programs, Agricultural Research Service USDA facilitated funding from the Biological Engagement Program, Department of State.	Alexandersen S, 2003, J COMP PATHOL, V129, P268, DOI 10.1016/S0021-9975(03)00045-8; Alexandersen S, 2003, J COMP PATHOL, V129, P1, DOI 10.1016/S0021-9975(03)00041-0; Ali S. M., 2013, Global Veterinaria, V11, P472; AMEDEE AM, 1995, J VIROL, V69, P7982, DOI 10.1128/JVI.69.12.7982-7990.1995; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P305, DOI 10.1111/j.1865-1682.2011.01236.x; Arzt J, 2011, TRANSBOUND EMERG DIS, V58, P291, DOI 10.1111/j.1865-1682.2011.01204.x; Arzt J, 2010, VET PATHOL, V47, P1048, DOI 10.1177/0300985810372509; Arzt J, 2009, J VET DIAGN INVEST, V21, P779, DOI 10.1177/104063870902100604; Belbis G, 2013, VET MICROBIOL, V166, P394, DOI 10.1016/j.vetmic.2013.06.020; Bhattacharyya R, 1996, INDIAN J ANIM SCI, V66, P39; Bisht P, 2014, J VIROL METHODS, V196, P65, DOI 10.1016/j.jviromet.2013.10.041; Biswal J. K., 2015, Indian Journal of Veterinary Pathology, V39, P376, DOI 10.5958/0973-970X.2015.00094.2; Biswal JK, 2012, INDIAN J ANIM SCI, V82, P109; BROWN CC, 1992, CAN J VET RES, V56, P189; Brown CC, 1996, J VIROL, V70, P5638, DOI 10.1128/JVI.70.8.5638-5641.1996; BURROWS R, 1981, J COMP PATHOL, V91, P599, DOI 10.1016/0021-9975(81)90089-X; BURROWS R, 1966, J HYG-CAMB, V64, P81, DOI 10.1017/S0022172400040365; Charleston B, 2011, SCIENCE, V332, P726, DOI 10.1126/science.1199884; DEBELDER AJ, 1993, LANCET, V341, P84, DOI 10.1016/0140-6736(93)92559-C; Geering W. A., 1967, Australian Veterinary Journal, V43, P485, DOI 10.1111/j.1751-0813.1967.tb04774.x; Giridharan P, 2005, J VIROL METHODS, V126, P1, DOI 10.1016/j.jviromet.2005.01.015; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Gulbahar MY, 2007, VET PATHOL, V44, P589, DOI 10.1354/vp.44-5-589; Hemadri D, 2002, VIRUS GENES, V25, P23, DOI 10.1023/A:1020165923805; Juleff N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003434; Kandeil A, 2013, ARCH VIROL, V158, P619, DOI 10.1007/s00705-012-1529-y; Karapinar T, 2010, CAN VET J, V51, P397; Kelly RA, 1996, CIRC RES, V79, P363, DOI 10.1161/01.RES.79.3.363; KHUROO MS, 1995, LANCET, V345, P1025, DOI 10.1016/S0140-6736(95)90761-0; Knowles NJ, 2003, VIRUS RES, V91, P65, DOI 10.1016/S0168-1702(02)00260-5; Knowles NJ, 1994, RPT SESS RES GP STAN, P45; Knowles NJ, 2014, TRANSBOUND EMERG DIS; MacLachlan J, 2011, FENNERS VET VIROLOGY; Meas S, 2002, VET MICROBIOL, V84, P275, DOI 10.1016/S0378-1135(01)00458-8; Mohapatra JK, 2011, J GEN VIROL, V92, P873, DOI 10.1099/vir.0.028555-0; Murphy MLP, 1999, VIRUS RES, V62, P67, DOI 10.1016/S0168-1702(99)00050-7; Nazlioglu M., 1972, Bulletin de l'Office International des Epizooties, V77, P1281; Orsel K, 2009, PREV VET MED, V88, P158, DOI 10.1016/j.prevetmed.2008.09.001; Pacheco JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125698; Pacheco JM, 2010, VET J, V183, P46, DOI 10.1016/j.tvjl.2008.08.023; Ranjan Rajeev, 2014, VirusDisease, V25, P358, DOI 10.1007/s13337-014-0211-2; Reid HW, 2002, VET REC, V150, P791; ROBSON KJH, 1977, J GEN VIROL, V37, P271, DOI 10.1099/0022-1317-37-2-271; Ryan E, 2008, J COMP PATHOL, V138, P108, DOI 10.1016/j.jcpa.2007.12.001; Ryan E, 2008, VET MICROBIOL, V127, P258, DOI 10.1016/j.vetmic.2007.08.029; Samuel AR, 2001, J GEN VIROL, V82, P609, DOI 10.1099/0022-1317-82-3-609; Senturk B, 2005, VET MED-CZECH, V50, P451, DOI 10.17221/5649-VETMED; Singh R, 2008, INDIAN J ANIM SCI, V78, P3; Stenfeldt C, 2016, J VIROL, V90, P6344, DOI 10.1128/JVI.00388-16; Stenfeldt C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143666; Stenfeldt C, 2014, ACTA VET SCAND, V56, DOI 10.1186/s13028-014-0042-6; Subramaniam S, 2015, INFECT GENET EVOL, V30, P59, DOI 10.1016/j.meegid.2014.12.009; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TRAUTWEIN G, 1986, J VET MED B, V33, P260, DOI 10.1111/j.1439-0450.1986.tb00031.x; Valdazo-Gonzalez B, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00242-14; van der Sluijs MTW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081429; WRL-FMD, 2015, WRLFMD Q REP APR JUN; WRL-FMD, 2015, OIE FAO REF LAB NETW; Zhang SJ, 2005, J GEN VIROL, V86, P2721, DOI 10.1099/vir.0.81168-0; Zhang ZD, 2004, J GEN VIROL, V85, P2567, DOI 10.1099/vir.0.80011-0; Zhang ZD, 2001, J COMP PATHOL, V124, P89, DOI 10.1053/jcpa.2000.0431	61	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167163	10.1371/journal.pone.0167163	http://dx.doi.org/10.1371/journal.pone.0167163			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977708	gold, Green Submitted, Green Published			2022-12-27	WOS:000391217400013
J	Yu, C; Hu, XM; Deng, W; Li, Y; Han, GM; Xiong, C				Yu, Cui; Hu, Xingming; Deng, Wen; Li, Yong; Han, Guangming; Xiong, Chao			Response of Bacteria Community to Long-Term Inorganic Nitrogen Application in Mulberry Field Soil	PLOS ONE			English	Article							MICROBIAL COMMUNITY; DIVERSITY; PH; FERTILIZER; BARLEY; MANURE	The bacterial community and diversity in mulberry field soils with different application ages of inorganic nitrogen fertilizer (4Y, 4-year-old; 17Y, 17-year-old; 32Y, 32-year-old) were investigated using next-generation sequencing. The results demonstrated that the application ages of nitrogen fertilizer significantly altered soil bacterial community and diversity. Soil bacterial Shannon diversity index and Chao 1 index decreased with the consecutive application of nitrogen fertilizer, and the 4Y soil exhibited the highest bacterial relative abundance and diversity. Of 45 bacterial genera (relative abundance ratio of genera greater than 0.3%), 18 were significantly affected by the plant age, and seven belong to Acidobacteria. The relative abundances of Acidobacteria Gp 1, Gp4 and Gp6 in the 4Y soil were significantly lower than that of in the 17Y and 32Y soils. However, the relative abundance of Pseudononas sp. in the 4Y soil was significantly higher than that of in the 17Y and 32Y soils. Most microbial parameters were significantly affected by soil pH and organic matter content which were significantly changed by long-term application of inorganic nitrogen fertilizer.	[Yu, Cui; Hu, Xingming; Deng, Wen; Li, Yong; Han, Guangming; Xiong, Chao] Hubei Acad Agr Sci, Ind Crops Inst, Wuhan, Peoples R China	Hubei Academy of Agricultural Sciences	Yu, C; Hu, XM (corresponding author), Hubei Acad Agr Sci, Ind Crops Inst, Wuhan, Peoples R China.	mrsyu888@hotmail.com; 13607121598@163.com			National Natural Science Foundation of China [31300518]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Earmarked Fund for Modern Agro-industry Technology Research System	This study was supported by the National Natural Science Foundation of China, 31300518 to Dr. Cui Yu, and the Earmarked Fund for Modern Agro-industry Technology Research System, CARS-22 to Dr. Xingming Hu.	Blakemore L. C., 1972, Scientific Report, New Zealand Soil Bureau; Bossio DA, 2006, SOIL BIOL BIOCHEM, V38, P1223, DOI 10.1016/j.soilbio.2005.09.027; Chan YK, 2013, APPL SOIL ECOL, V68, P26, DOI 10.1016/j.apsoil.2013.03.004; Chen F, 2009, J PLANT NUTR SOIL SC, V172, P245, DOI 10.1002/jpln.200800093; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Doran JW, 2000, APPL SOIL ECOL, V15, P3, DOI 10.1016/S0929-1393(00)00067-6; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fu QingXia, 2015, Acta Ecologica Sinica - International Journal, V35, P22; Gopalakrishnan S, 2015, 3 BIOTECH, V5, P653, DOI 10.1007/s13205-014-0263-4; Griffiths RI, 2011, ENVIRON MICROBIOL, V13, P1642, DOI 10.1111/j.1462-2920.2011.02480.x; [顾美英 Gu Meiying], 2012, [生态学报, Acta Ecologica Sinica], V32, P3031; Kennedy N, 2005, ENVIRON MICROBIOL, V7, P780, DOI 10.1111/j.1462-2920.2005.00748.x; Lan YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032491; Lanyon L. E., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P247; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Luo PY, 2015, ANN MICROBIOL, V65, P533, DOI 10.1007/s13213-014-0889-9; Lupwayi NZ, 2012, SOIL TILL RES, V118, P139, DOI 10.1016/j.still.2011.11.006; Lupwayi NZ, 2011, AGRON J, V103, P1064, DOI 10.2134/agronj2010.0334; Lupwayi NZ, 2010, APPL SOIL ECOL, V45, P254, DOI 10.1016/j.apsoil.2010.04.013; [马宁宁 Ma Ningning], 2013, [园艺学报, Acta Horticulturae Sinica], V40, P255; Mannisto MK, 2007, FEMS MICROBIOL ECOL, V59, P452, DOI 10.1111/j.1574-6941.2006.00232.x; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nicol GW, 2004, ENVIRON MICROBIOL, V6, P861, DOI 10.1111/j.1462-2920.2004.00627.x; Ogilvie LA, 2008, MICROB ECOL, V56, P525, DOI 10.1007/s00248-008-9372-0; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sarathchandra SU, 2001, SOIL BIOL BIOCHEM, V33, P953, DOI 10.1016/S0038-0717(00)00245-5; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Sradnick A, 2013, APPL SOIL ECOL, V63, P23, DOI 10.1016/j.apsoil.2012.09.011; Yao HY, 2006, PLANT SOIL, V284, P195, DOI 10.1007/s11104-006-0023-2; Yeoh YK, 2016, ENVIRON MICROBIOL, V18, P1338, DOI 10.1111/1462-2920.12925; Yu C, 2015, APPL SOIL ECOL, V86, P30, DOI 10.1016/j.apsoil.2014.09.013; Yu C, 2011, SCI SERICUL, V37, P0899; Zhang NL, 2008, PLANT SOIL, V311, P19, DOI 10.1007/s11104-008-9650-0	33	12	13	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168152	10.1371/journal.pone.0168152	http://dx.doi.org/10.1371/journal.pone.0168152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977728	Green Published, gold			2022-12-27	WOS:000391217400070
J	Calixto, CPG; Simpson, CG; Waugh, R; Brown, JWS				Calixto, Cristiane P. G.; Simpson, Craig G.; Waugh, Robbie; Brown, John W. S.			Alternative Splicing of Barley Clock Genes in Response to Low Temperature	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; ARABIDOPSIS CIRCADIAN CLOCK; NONSENSE-MEDIATED DECAY; MESSENGER-RNAS; GROWTH-STAGES; DECIMAL CODE; PLANT-GROWTH; SR PROTEINS; TRANSCRIPTOME; LANDSCAPE	Alternative splicing (AS) is a regulated mechanism that generates multiple transcripts from individual genes. It is widespread in eukaryotic genomes and provides an effective way to control gene expression. At low temperatures, AS regulates Arabidopsis clock genes through dynamic changes in the levels of productive mRNAs. We examined AS in barley clock genes to assess whether temperature-dependent AS responses also occur in a monocotyledonous crop species. We identify changes in AS of various barley core clock genes including the barley orthologues of Arabidopsis AtLHY and AtPRR7 which showed the most pronounced AS changes in response to low temperature. The AS events modulate the levels of functional and translatable mRNAs, and potentially protein levels, upon transition to cold. There is some conservation of AS events and/or splicing behaviour of clock genes between Arabidopsis and barley. In addition, novel temperature-dependent AS of the core clock gene HvPPD-H1 (a major determinant of photoperiod response and AtPRR7 orthologue) is conserved in monocots. HvPPD-H1 showed a rapid, temperature-sensitive isoform switch which resulted in changes in abundance of AS variants encoding different protein isoforms. This novel layer of low temperature control of clock gene expression, observed in two very different species, will help our understanding of plant adaptation to different environments and ultimately offer a new range of targets for plant improvement.	[Calixto, Cristiane P. G.; Waugh, Robbie; Brown, John W. S.] Univ Dundee, James Hutton Inst, Div Plant Sci, Sch Life Sci, Dundee, Scotland; [Simpson, Craig G.; Waugh, Robbie; Brown, John W. S.] James Hutton Inst, Cell & Mol Sci, Dundee, Scotland	James Hutton Institute; University of Dundee; James Hutton Institute	Brown, JWS (corresponding author), Univ Dundee, James Hutton Inst, Div Plant Sci, Sch Life Sci, Dundee, Scotland.; Brown, JWS (corresponding author), James Hutton Inst, Cell & Mol Sci, Dundee, Scotland.	j.w.s.brown@dundee.ac.uk	Calixto, Cristiane P./L-7471-2017	Calixto, Cristiane P./0000-0002-9935-9325; Simpson, Craig/0000-0002-1723-1492	Biotechnology and Biological Sciences Research Council [BB/G024979/1]; Scottish Government Rural and Environment Science and Analytical Services division (RESAS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); BBSRC [BB/G024979/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Government Rural and Environment Science and Analytical Services division (RESAS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a grant from the Biotechnology and Biological Sciences Research Council [BB/G024979/1 - European Research Area network (ERA-NET) Plant Genomics (Plant Alternative Splicing and Abiotic Stress)] Dr. John W. S. Brown; Scottish Government Rural and Environment Science and Analytical Services division (RESAS) Dr. John W. S. Brown; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) Dr Cristiane P. G. Calixto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Bendix C, 2015, MOL PLANT, V8, P1135, DOI 10.1016/j.molp.2015.03.003; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Boothby TC, 2013, DEV CELL, V24, P517, DOI 10.1016/j.devcel.2013.01.015; Boutz PL, 2015, GENE DEV, V29, P63, DOI 10.1101/gad.247361.114; Bushnell WR, 2010, PHYTOPATHOLOGY, V100, P33, DOI 10.1094/PHYTO-100-1-0033; Calixto CPG, 2015, J MOL EVOL, V80, P108, DOI 10.1007/s00239-015-9665-0; Carvalho RF, 2016, PLANT CELL, V28, P1910, DOI 10.1105/tpc.16.00301; Carvalho RF, 2013, PROTOPLASMA, V250, P639, DOI 10.1007/s00709-012-0448-9; Chamala S, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00033; Colot HV, 2005, MOL BIOL CELL, V16, P5563, DOI 10.1091/mbc.E05-08-0756; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Darracq A, 2013, NEW PHYTOL, V199, P252, DOI 10.1111/nph.12238; Diernfellner A, 2007, FEBS LETT, V581, P5759, DOI 10.1016/j.febslet.2007.11.043; Druka A, 2011, PLANT PHYSIOL, V155, P617, DOI 10.1104/pp.110.166249; Duque P, 2011, PLANT SIGNAL BEHAV, V6, P49, DOI 10.4161/psb.6.1.14063; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; Filichkin SA, 2015, MOL PLANT, V8, P207, DOI 10.1016/j.molp.2014.10.011; Filichkin SA, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-20; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; FRANCKOWIAK JD, 1985, CROP SCI, V25, P883, DOI 10.2135/cropsci1985.0011183X002500050037x; Franckowiak JD, 2007, BARLEY GENETICS NEWS, P247; Gohring J, 2014, PLANT CELL, V26, P754, DOI 10.1105/tpc.113.118075; Haydon MJ, 2013, SEMIN CELL DEV BIOL, V24, P414, DOI 10.1016/j.semcdb.2013.03.007; Hazen SP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r17; Hemming MN, 2008, PLANT PHYSIOL, V147, P355, DOI 10.1104/pp.108.116418; Hotta CT, 2007, PLANT CELL ENVIRON, V30, P333, DOI 10.1111/j.1365-3040.2006.01627.x; Hughes ME, 2012, GENOME RES, V22, P1266, DOI 10.1101/gr.128876.111; Iida K, 2006, MOL BIOL EVOL, V23, P1085, DOI 10.1093/molbev/msj118; Iida K, 2004, NUCLEIC ACIDS RES, V32, P5096, DOI 10.1093/nar/gkh845; Ito S, 2003, PLANT CELL PHYSIOL, V44, P1237, DOI 10.1093/pcp/pcg136; James AB, 2012, PLANT SIGNAL BEHAV, V7, P1219, DOI 10.4161/psb.21491; James AB, 2012, PLANT CELL, V24, P961, DOI 10.1105/tpc.111.093948; Jantasuriyarat C, 2005, PLANT PHYSIOL, V138, P105, DOI 10.1104/pp.104.055624; Johnstone TG, 2016, EMBO J, V35, P706, DOI 10.15252/embj.201592759; Jones H, 2008, MOL BIOL EVOL, V25, P2211, DOI 10.1093/molbev/msn167; Jones MA, 2012, PLANT CELL, V24, P4066, DOI 10.1105/tpc.112.104828; Kalyna M, 2006, NUCLEIC ACIDS RES, V34, P4395, DOI 10.1093/nar/gkl570; Kalyna M, 2012, NUCLEIC ACIDS RES, V40, P2454, DOI 10.1093/nar/gkr932; Kaur P, 2008, FUNCT INTEGR GENOMIC, V8, P375, DOI 10.1007/s10142-008-0085-8; Kornblihtt AR, 2013, NAT REV MOL CELL BIO, V14, P153, DOI 10.1038/nrm3525; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Mandadi KK, 2015, PLANT CELL, V27, P71, DOI 10.1105/tpc.114.133991; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; Mastrangelo AM, 2012, PLANT SCI, V185, P40, DOI 10.1016/j.plantsci.2011.09.006; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McClung C Robertson, 2014, F1000Prime Rep, V6, P2, DOI 10.12703/P6-2; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Michael TP, 2003, P NATL ACAD SCI USA, V100, P6878, DOI 10.1073/pnas.1131995100; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Nicolas M, 2015, CURR BIOL, V25, P1799, DOI 10.1016/j.cub.2015.05.053; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Penfield S, 2008, NEW PHYTOL, V179, P615, DOI 10.1111/j.1469-8137.2008.02478.x; Petrillo E, 2014, SCIENCE, V344, P427, DOI 10.1126/science.1250322; Pose D, 2013, NATURE, V503, P414, DOI 10.1038/nature12633; Reddy ASN, 2007, ANNU REV PLANT BIOL, V58, P267, DOI 10.1146/annurev.arplant.58.032806.103754; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Rogozin IB, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-11; Romanowski A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00437; Russell J, 2016, NAT GENET, V48, P1024, DOI 10.1038/ng.3612; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Schlaen RG, 2015, P NATL ACAD SCI US; Seo PJ, 2014, PLANT CELL, V26, P79, DOI 10.1105/tpc.113.119842; Shalgi R, 2014, CELL REP, V7, P1362, DOI 10.1016/j.celrep.2014.04.044; Shikata H, 2014, P NATL ACAD SCI USA, V111, P18781, DOI 10.1073/pnas.1407147112; Simpson CG, 2008, PLANT J, V53, P1035, DOI 10.1111/j.1365-313X.2007.03392.x; Staiger D, 2013, PLANT CELL, V25, P3640, DOI 10.1105/tpc.113.113803; Syed NH, 2012, TRENDS PLANT SCI, V17, P616, DOI 10.1016/j.tplants.2012.06.001; Thatcher SR, 2014, PLANT CELL, V26, P3472, DOI 10.1105/tpc.114.130773; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Wang XX, 2012, PLANT CELL, V24, P3278, DOI 10.1105/tpc.112.100081; Yang HY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-705; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zakhrabekova S, 2012, P NATL ACAD SCI USA, V109, P4326, DOI 10.1073/pnas.1113009109; Zhang R, 2016, BIORXIV; Zhang RX, 2015, NEW PHYTOL, V208, P96, DOI 10.1111/nph.13545	79	16	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168028	10.1371/journal.pone.0168028	http://dx.doi.org/10.1371/journal.pone.0168028			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959947	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900033
J	Honda, T; Baba, T; Fujimoto, K; Goto, T; Nagao, K; Harada, M; Honda, E; Ichikawa, T				Honda, Tsuyoshi; Baba, Takuro; Fujimoto, Keiko; Goto, Takaharu; Nagao, Kan; Harada, Masafumi; Honda, Eiichi; Ichikawa, Tetsuo			Characterization of Swallowing Sound: Preliminary Investigation of Normal Subjects	PLOS ONE			English	Article							CERVICAL AUSCULTATION; BOLUS VOLUME; DYSPHAGIA; GENDER; VIDEOFLUOROSCOPY; RELIABILITY; VALIDITY; AGE	Objective The purpose of this study was to characterize the swallowing sound and identify the process of sound generation during swallowing in young healthy adults. Methods Thirty-three healthy volunteers were enrolled and allocated into three experimental groups. In experiment 1, a microphone was attached to one of eight cervical sites in 20 subjects, participants swallowed 5 ml water, and the sound waveform was recorded. In experiment 2, 10 subjects swallowed either 0, 5, 10, or 15 ml water during audio recording. In addition, participants consumed the 5 ml bolus in two different cervical postures. In experiment 3, the sound waveform and videofluoroscopy were simultaneously recorded while the three participants consumed 5 ml iopamidol solution. The duration and peak intensity ratio of the waveform were analyzed in all experimental groups. Results The acoustic analysis of the waveforms and videofluoroscopy suggested that the swallowing sound could be divided into three periods, each associated with a stage of the swallowing movement: the oral phase comprising posterior tongue and hyoid bone movement; the pharyngeal phase comprising larynx movement, hyoid bone elevation, epiglottis closure, and passage of the bolus through the esophagus orifice; and the repositioning phase comprising the return of the hyoid bone and larynx to their resting positions, and reopening of the epiglottis. Conclusion Acoustic analysis of swallowing sounds and videofluoroscopy suggests that the swallowing sound could be divided into three periods associated with each process of the swallowing movement: the oral phase comprising the posterior movement of the tongue and hyoid bone; the pharyngeal phase comprising the laryngeal movement, hyoid bone elevation, epiglottis closure, and the bolus passage to the esophagus orifice; and the repositioning phase comprising the repositioning of the hyoid bone and larynx, and reopening of the epiglottis.	[Honda, Tsuyoshi; Baba, Takuro; Fujimoto, Keiko; Goto, Takaharu; Nagao, Kan; Ichikawa, Tetsuo] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Oral & Maxillofacial Prosthodont, Tokushima, Japan; [Harada, Masafumi] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Radiol, Tokushima, Japan; [Honda, Eiichi] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Oral & Maxillofacial Radiol, Tokushima, Japan	Tokushima University; Tokushima University; Tokushima University	Ichikawa, T (corresponding author), Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Oral & Maxillofacial Prosthodont, Tokushima, Japan.	ichi@tokushima-u.ac.jp	Goto, Takaharu/S-5766-2019	Goto, Takaharu/0000-0003-0962-7304				Antunes EB, 2012, GERODONTOLOGY, V29, P247, DOI 10.1111/j.1741-2358.2012.00638.x; Boiron M, 1997, DYSPHAGIA, V12, P86, DOI 10.1007/PL00009524; Borr C, 2007, DYSPHAGIA, V22, P225, DOI 10.1007/s00455-007-9078-3; Bosma J F, 1976, Front Oral Physiol, V2, P78; Carnaby-Mann G, 2008, PHYS MED REH CLIN N, V19, P747, DOI 10.1016/j.pmr.2008.05.008; Cichero JAY, 2002, ANN OTO RHINOL LARYN, V111, P623, DOI 10.1177/000348940211100710; Dantas RO, 2009, DYSPHAGIA, V24, P280, DOI 10.1007/s00455-008-9202-z; HAMLET S L, 1992, Dysphagia, V7, P160, DOI 10.1007/BF02493450; Hammoudi K, 2014, DYSPHAGIA, V29, P468, DOI 10.1007/s00455-014-9529-6; Hirano K, 2001, J JPN STOMATOL SOC, V47, P93; Honda T, 2015, J ORAL HLTH BIOSCI, V28, P21; Horiguchi S., 2011, JMAJ - Japan Medical Association Journal, V54, P31; Karaho T., 1999, J JPN BRONCHOESOPHAG, V50, P396; Leslie P, 2004, DYSPHAGIA, V19, P231, DOI 10.1007/s00455-004-0007-4; LOGEMANN J, 1983, EVALUATION TREATMENT, P113; MACKOWIAK RC, 1967, P SOC EXP BIOL MED, V125, P1149; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; Oguchi K., 2000, JPN J REHAB MED, V38, P383, DOI [10.2490/jjrm1963.37.383, DOI 10.2490/jjrm1963.37.383, DOI 10.2490/JJRM1963.37.383]; Ohyado S, 2013, JPN J GERODONTOLOGY, V28, P331; ROBBINS J, 1992, GASTROENTEROLOGY, V103, P823, DOI 10.1016/0016-5085(92)90013-O; SELLEY W G, 1990, Dysphagia, V4, P227, DOI 10.1007/BF02407270; Smith HA, 1998, AGE AGEING, V29, P99; Takahashi K, 2001, JPN J HEAD NECK CANC, V27, P198; Takahashi Koji, 1994, Dysphagia, V9, P54; Teismann IK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019987; Tohara H, 2003, DYSPHAGIA, V18, P126, DOI 10.1007/s00455-002-0095-y; Youmans SR, 2011, DYSPHAGIA, V26, P374, DOI 10.1007/s00455-010-9323-z; ZENNER PM, 1995, DYSPHAGIA, V10, P27, DOI 10.1007/BF00261276	28	5	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168187	10.1371/journal.pone.0168187	http://dx.doi.org/10.1371/journal.pone.0168187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959902	gold, Green Published, Green Submitted			2022-12-27	WOS:000392753900047
J	Kida, T; Ayabe, S; Omori, K; Nakamura, T; Maehara, T; Aritake, K; Urade, Y; Murata, T				Kida, Taiki; Ayabe, Shinya; Omori, Keisuke; Nakamura, Tatsuro; Maehara, Toko; Aritake, Kosuke; Urade, Yoshihiro; Murata, Takahisa			Prostaglandin D-2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis	PLoS One			English	Article							INHIBITS FIBROBLAST; RECEPTOR; INJURY; PROLIFERATION; MODULATION; EXPRESSION; AGONIST; PGD(2); CELLS; ACID	Pulmonary fibrosis is a progressive and fatal lung disease with limited therapeutic options. Although it is well known that lipid mediator prostaglandins are involved in the development of pulmonary fibrosis, the role of prostaglandin D-2 (PGD(2)) remains unknown. Here, we investigated whether genetic disruption of hematopoietic PGD synthase (H-PGDS) affects the bleomycin-induced lung inflammation and pulmonary fibrosis in mouse. Compared with H-PGDS naive (WT) mice, H-PGDS-deficient mice (H-PGDS(-/-)) represented increased collagen deposition in lungs 14 days after the bleomycin injection. The enhanced fibrotic response was accompanied by an increased mRNA expression of inflammatory mediators, including tumor necrosis factor-alpha, monocyte chemoattractant protein-1, and cyclooxygenase-2 on day 3. H-PGDS deficiency also increased vascular permeability on day 3 and infiltration of neutrophils and macrophages in lungs on day 3 and 7. Immunostaining showed that the neutrophils and macrophages expressed H-PGDS, and its mRNA expression was increased on day 3and 7 in WT lungs. These observations suggest that H-PGDS-derived PGD(2) plays a protective role in bleomycin-induced lung inflammation and pulmonary fibrosis.	[Kida, Taiki; Ayabe, Shinya; Omori, Keisuke; Nakamura, Tatsuro; Maehara, Toko; Murata, Takahisa] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan; [Aritake, Kosuke; Urade, Yoshihiro] Univ Tsukuba, Int Inst Integrat Sleep Med, Tsukuba, Ibaraki 305, Japan	University of Tokyo; University of Tsukuba	Murata, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Radiol, Tokyo, Japan.	amurata@mail.ecc.u-tokyo.ac.jp	Ayabe, Shinya/AAH-6911-2020	Ayabe, Shinya/0000-0003-2737-5315; Murata, Takahisa/0000-0002-3328-0796	Japan Society for the Promotion of Science [25252049]; Foundation for Dietary Scientific Research; Cardiovascular Research Fund; Kurozumi Medical Foundation; Naito Foundation; Suzuken Memorial Foundation; Nipponham Foundation; Sapporo Bioscience Foundation; Japan Foundation for Pediatric Research; Grants-in-Aid for Scientific Research [15J10795] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation for Dietary Scientific Research; Cardiovascular Research Fund; Kurozumi Medical Foundation(Kurozumi Medical Foundation); Naito Foundation(Naito Memorial Foundation); Suzuken Memorial Foundation; Nipponham Foundation; Sapporo Bioscience Foundation; Japan Foundation for Pediatric Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Grant-in-Aid for Scientific Research from The Japan Society for the Promotion of Science, 25252049, http://www.jsps.go.jp/english/index.html; Foundation for Dietary Scientific Research, http://www.z-ssk.org/about/outline.html; Cardiovascular Research Fund, http://www.jcvrf.jp/; Kurozumi Medical Foundation, http://www.kmf.or.jp/index.html; Naito Foundation, https://www.naito-f.or.jp/jp/index.php; Suzuken Memorial Foundation, http://suzukenzaidan.or.jp/index.html; Nipponham Foundation, https://www.miraizaidan.or.jp/public/detail01.html; Sapporo Bioscience Foundation, http://www.sapporoholdings.jp/english/index.html; and Japan Foundation for Pediatric Research, http://www.jfpedres.or.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando M, 2003, AM J RESP CELL MOL, V28, P582, DOI 10.1165/rcmb.2002-0162OC; Angeli W, 2004, J IMMUNOL, V172, P3822, DOI 10.4049/jimmunol.172.6.3822; Ayabe S, 2013, J PHARMACOL SCI, V121, P312, DOI 10.1254/jphs.12275FP; Bringardner BD, 2008, ANTIOXID REDOX SIGN, V10, P287, DOI 10.1089/ars.2007.1897; CLARK JG, 1982, J BIOL CHEM, V257, P8098; Crystal RG, 2002, AM J RESP CRIT CARE, V166, P236, DOI 10.1164/rccm.2201069; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; Failla M, 2009, AM J RESP CELL MOL, V41, P50, DOI 10.1165/rcmb.2007-0438OC; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Gasse P, 2009, AM J RESP CRIT CARE, V179, P903, DOI 10.1164/rccm.200808-1274OC; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; Kohyama T, 2002, AM J PHYSIOL-LUNG C, V283, pL428, DOI 10.1152/ajplung.00432.2001; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Kolb M, 2001, J CLIN INVEST, V107, P1529, DOI 10.1172/JCI12568; Kolodsick JE, 2003, AM J RESP CELL MOL, V29, P537, DOI 10.1165/rcmb.2002-0243OC; Matsuoka T, 2000, SCIENCE, V287, P2013, DOI 10.1126/science.287.5460.2013; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; Murakami S, 2006, AM J PHYSIOL-LUNG C, V290, pL59, DOI 10.1152/ajplung.00042.2005; Murata T, 2013, P NATL ACAD SCI USA, V110, P5205, DOI 10.1073/pnas.1218091110; Murata T, 2011, P NATL ACAD SCI USA, V108, P19802, DOI 10.1073/pnas.1110011108; Nakamura T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8514; Oga T, 2009, NAT MED, V15, P1426, DOI 10.1038/nm.2066; PIGUET PF, 1993, AM J PATHOL, V143, P651; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Sarashina H, 2014, J IMMUNOL, V192, P459, DOI 10.4049/jimmunol.1302080; Tanaka K, 2000, J IMMUNOL, V164, P2277, DOI 10.4049/jimmunol.164.5.2277; Todd NW, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-11; URADE Y, 1990, J BIOL CHEM, V265, P371; van den Brule S, 2010, J PHARMACOL EXP THER, V335, P472, DOI 10.1124/jpet.110.169250; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yoshimura-Uchiyama C, 2004, CLIN EXP ALLERGY, V34, P1283, DOI 10.1111/j.1365-2222.2004.02027.x; Zhu YJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-34	33	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167729	10.1371/journal.pone.0167729	http://dx.doi.org/10.1371/journal.pone.0167729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992456	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600021
J	Liu, R; Zheng, Z; Du, J; Christoffel, KK; Liu, X				Liu, Rong; Zheng, Zheng; Du, Jie; Christoffel, Katherine Kaufer; Liu, Xin			Racial Disparity in the Associations of Cotinine with Insulin Secretion: Data from the National Health and Nutrition Examination Survey, 2007-2012	PLoS One			English	Article							HOMEOSTASIS MODEL ASSESSMENT; BETA-CELL FUNCTION; RESISTANCE HOMA-IR; SERUM COTININE; NICOTINIC RECEPTORS; METABOLIC SYNDROME; GLUCOSE-TOLERANCE; CIGARETTE-SMOKING; SMOKERS; RISK	Background Although relationships between smoking/high cotinine and type 2 diabetes have consistently been observed, few studies have investigated the relationship between cotinine and underlying pathophysiological defects that characterize diabetes aetiology. This study aimed to test the associations between cotinine and measures of insulin resistance or insulin secretion. Methods This analysis included 5,751 non-diabetic adult American from the National Health and Nutrition Examination Survey (NHANES) from 2007-2012. Insulin function was represented with two indexes: insulin resistance index (HOMA-IR) and insulin secretion index (HOMA-B) estimated by homeostasis model assessment. We categorized cotinine levels into quartiles and estimated the odds of HOMA-IR in the 4 th quartile and HOMA-B in the 1 st quartile among cotinine categories using multiple logistic regression models. Results Cotinine concentration was not associated with the risk of high HOMA-IR. Association of cotinine with low HOMA-B existed and differed by race/ethnicity (P for interaction<0.05). High cotinine concentration (in the 4 th quartile) was associated with an increased risk of low HOMA-B compared with low cotinine concentrations(1 st-2 nd quartiles) among white (odds ratio[OR], 1.51 [95% confidence interval[CI], 1.16-1.97]) or black participants ( OR, 2.98 [95% CI, 1.90-4.69]) but not among Mexican ( OR, 1.79 [95% CI, 0.90-3.53]) or other Hispanic( OR, 1.02 [95% CI, 0.56-1.86]) participants. Such associations remained significant even after further adjustment for HOMA-IR. Conclusions High cotinine is associated with decreased insulin secretion function only in white and black non-diabetic U. S. adult population. Results evaluating cotinine in ethnically homogeneous populations may not be broadly generalizable to other racial/ethnic groups.	[Liu, Rong] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis Beijin, Dept Epidemiol, Beijing, Peoples R China; [Zheng, Zheng] Capital Med Univ, Beijing Xuan Wu Hosp, Beijing Inst Geriatr, Dept Neurobiol, Beijing, Peoples R China; [Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Key Lab Remodeling Related Cardiovasc Dis,Minist, Beijing, Peoples R China; [Christoffel, Katherine Kaufer; Liu, Xin] Northwestern Univ Feinberg, Sch Med, Dept Pediat, Mary Ann & J Milburn Smith Child Hlth Res Program, Chicago, IL USA; [Liu, Xin] Chinese Acad Sci, China Gastrointestinal Canc Res Ctr, Beijing Inst Genom, Key Lab Genom & Precis Med, Beijing, Peoples R China; [Liu, Xin] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL USA; [Liu, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University; Northwestern University; Feinberg School of Medicine; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Northwestern University; Feinberg School of Medicine; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, R (corresponding author), Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis Beijin, Dept Epidemiol, Beijing, Peoples R China.	rongliu606@gmail.com; liuxin@big.ac.cn	Liu, Rong/B-8173-2014	Liu, Rong/0000-0001-9674-0561	100 Talents Program of the Chinese Academy of Sciences	100 Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by 100 Talents Program of the Chinese Academy of Sciences (to X Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benowitz NL, 2009, AM J EPIDEMIOL, V169, P236, DOI 10.1093/aje/kwn301; Bernert JT, 1997, CLIN CHEM, V43, P2281; Bruin JE, 2008, TOXICOL SCI, V103, P362, DOI 10.1093/toxsci/kfn012; Bruin JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003371; Caraballo RS, 1998, JAMA-J AM MED ASSOC, V280, P135, DOI 10.1001/jama.280.2.135; Carlsson S, 2004, DIABETOLOGIA, V47, P1953, DOI 10.1007/s00125-004-1554-9; Clair C, 2011, DIABETES CARE, V34, P2250, DOI 10.2337/dc11-0710; Conti-Fine BM, 2000, EUR J PHARMACOL, V393, P279, DOI 10.1016/S0014-2999(00)00036-4; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Daniel M, 2004, DIABETIC MED, V21, P188, DOI 10.1046/j.1464-5491.2003.01064.x; EJIRI K, 1989, DIABETES RES CLIN PR, V6, P53, DOI 10.1016/0168-8227(89)90057-0; Eliasson B, 1996, CIRCULATION, V94, P878, DOI 10.1161/01.CIR.94.5.878; Esteghamati A, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-26; Gao S, 2012, CHINESE MED J-PEKING, V125, P1686, DOI 10.3760/cma.j.issn.0366-6999.2012.10.002; JARVIS MJ, 1988, AM J PUBLIC HEALTH, V78, P696, DOI 10.2105/AJPH.78.6.696; LITHELL HOL, 1991, DIABETES CARE, V14, P203, DOI 10.2337/diacare.14.3.203; Madeira IR, 2008, ARQ BRAS ENDOCRINOL, V52, P1466, DOI 10.1590/S0004-27302008000900010; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mora-Martinez JM, 2004, METAB SYNDR RELAT D, V2, P227, DOI 10.1089/met.2004.2.227; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; NELSON L, 1982, CELL MOTIL CYTOSKEL, V2, P225, DOI 10.1002/cm.970020304; Ostgren CJ, 2000, DIABETIC MED, V17, P445, DOI 10.1046/j.1464-5491.2000.00294.x; Perez-Stable EJ, 1998, JAMA-J AM MED ASSOC, V280, P152, DOI 10.1001/jama.280.2.152; R Core Team, 2013, R LANG ENV STAT COMP; Ronnemaa T, 1996, DIABETES CARE, V19, P1229, DOI 10.2337/diacare.19.11.1229; STAGNER JI, 1986, DIABETES, V35, P849, DOI 10.2337/diabetes.35.8.849; WAGENKNECHT LE, 1990, AM J PUBLIC HEALTH, V80, P1053, DOI 10.2105/AJPH.80.9.1053; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Wongwananuruk T, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/571035; Yamada C, 2011, J DIABETES INVEST, V2, P373, DOI 10.1111/j.2040-1124.2011.00113.x; Yoshikawa H, 2005, METABOLISM, V54, P247, DOI 10.1016/j.metabol.2004.08.020	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167260	10.1371/journal.pone.0167260	http://dx.doi.org/10.1371/journal.pone.0167260			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992538	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600013
J	Bisgaard, LS; Bosteen, MH; Fink, LN; Sorensen, CM; Rosendahl, A; Mogensen, CK; Rasmussen, SE; Rolin, B; Nielsen, LB; Pedersen, TX				Bisgaard, Line S.; Bosteen, Markus H.; Fink, Lisbeth N.; Sorensen, Charlotte M.; Rosendahl, Alexander; Mogensen, Christina K.; Rasmussen, Salka E.; Rolin, Bidda; Nielsen, Lars B.; Pedersen, Tanja X.			Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice	PLOS ONE			English	Article							CD4(+) T-CELLS; RECEPTOR AGONIST; RENAL FIBROSIS; DISEASE; MACROPHAGES; ADHESION; RATS; ALBUMINURIA; DYSFUNCTION; PROGRESSION	Chronic kidney disease (CKD) leads to uremia. CKD is characterized by a gradual increase in kidney fibrosis and loss of kidney function, which is associated with a progressive increase in risk of atherosclerosis and cardiovascular death. To prevent progression of both kidney fibrosis and atherosclerosis in uremic settings, insight into new treatment options with effects on both parameters is warranted. The GLP-1 analogue liraglutide improves glucose homeostasis, and is approved for treatment of type 2 diabetes. Animal studies suggest that GLP-1 also dampens inflammation and atherosclerosis. Our aim was to examine effects of liraglutide on kidney fibrosis and atherosclerosis in a mouse model of moderate uremia (5/6 nephrectomy (NX)). Uremic (n = 29) and sham-operated (n = 14) atherosclerosis-prone low density lipoprotein receptor knockout mice were treated with liraglutide (1000 mu g/kg, s.c. once daily) or vehicle for 13 weeks. As expected, uremia increased aortic atherosclerosis. In the remnant kidneys from NX mice, flow cytometry revealed an increase in the number of monocyte-like cells (CD68(+) F4/80(-)), CD4(+), and CD8(+) T-cells, suggesting that moderate uremia induced kidney inflammation. Furthermore, markers of fibrosis (i.e. Col1a1 and Col3a1) were upregulated, and histological examinations showed increased glomerular diameter in NX mice. Importantly, liraglutide treatment attenuated atherosclerosis (similar to 40%, p < 0.05) and reduced kidney inflammation in NX mice. There was no effect of liraglutide on expression of fibrosis markers and/or kidney histology. This study suggests that liraglutide has beneficial effects in a mouse model of moderate uremia by reducing atherosclerosis and attenuating kidney inflammation.	[Bisgaard, Line S.; Bosteen, Markus H.; Sorensen, Charlotte M.; Nielsen, Lars B.; Pedersen, Tanja X.] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Bisgaard, Line S.; Fink, Lisbeth N.; Rosendahl, Alexander; Mogensen, Christina K.; Rasmussen, Salka E.; Rolin, Bidda] Novo Nordisk, Global Res, Malov, Denmark; [Bosteen, Markus H.; Nielsen, Lars B.] Univ Copenhagen, Hosp Rigshosp, Dept Clin Biochem, Copenhagen, Denmark; [Rosendahl, Alexander] Shire, Med Affairs Nord, Soborg, Denmark	University of Copenhagen; Novo Nordisk; Rigshospitalet; University of Copenhagen	Pedersen, TX (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.	tanjax@sund.ku.dk	Sorensen, Charlotte Mehlin/A-8092-2010; Bisgaard, Line S/F-2004-2018; Fink, Lisbeth/AAN-7830-2020	Sorensen, Charlotte Mehlin/0000-0002-9984-3125; Bisgaard, Line S/0000-0001-6077-4487; 	Novo Nordisk A/S; Innovation Fund Denmark (Ministry of Science, Innovation and Higher education)	Novo Nordisk A/S(Novo Nordisk); Innovation Fund Denmark (Ministry of Science, Innovation and Higher education)	This study was supported by a joint Novo Nordisk A/S and Innovation Fund Denmark (Ministry of Science, Innovation and Higher education) grant. The funder Novo Nordisk A/S provided support in the form of research materials and salaries for authors LSB, SER, CM, AR, and LFIN, but did not have any additional role in the study design, data collection and analysis, or decision to publish. After preparation of the manuscript, employees from Novo Nordisk A/S (not co-authors) read and commented on the manuscript prior to its submission. The specific roles of the authors employed by Novo Nordisk are articulated in the 'author contributions' section.	Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694; Betz B, 2014, NEPHRON EXP NEPHROL, V126, P191, DOI 10.1159/000363300; Bro S, 2006, ARTERIOSCL THROM VAS, V26, P570, DOI 10.1161/01.ATV.0000201060.47945.cb; Bro S, 2004, J AM SOC NEPHROL, V15, P1495, DOI 10.1097/01.ASN.0000128371.33195.7B; Canaud G, 2013, NAT MED, V19, P1288, DOI 10.1038/nm.3313; Cao Q, 2015, J AM SOC NEPHROLOGY; Chaudhuri A, 2012, J CLIN ENDOCR METAB, V97, P198, DOI 10.1210/jc.2011-1508; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Eddy AA, 2011, KIDNEY INT S, V2014, P2; El Nahas AM, 2003, KIDNEY INT, V64, P1553, DOI 10.1046/j.1523-1755.2003.00255.x; Gaspari T, 2013, DIABETES VASC DIS RE, V10, P353, DOI 10.1177/1479164113481817; Gaspari T, 2011, DIABETES VASC DIS RE, V8, P117, DOI 10.1177/1479164111404257; Ghosh SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141109; Guo SH, 2011, KIDNEY INT, V80, P946, DOI 10.1038/ki.2011.249; Hendarto H, 2012, METABOLISM, V61, P1422, DOI 10.1016/j.metabol.2012.03.002; Huang W, 2001, P NATL ACAD SCI USA, V98, P13330, DOI 10.1073/pnas.231476798; Kliem V, 1996, KIDNEY INT, V49, P666, DOI 10.1038/ki.1996.95; Kodera R, 2011, DIABETOLOGIA, V54, P965, DOI 10.1007/s00125-010-2028-x; Laouari D, 2011, J AM SOC NEPHROL, V22, P327, DOI 10.1681/ASN.2010040356; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Macconi D, 2009, J AM SOC NEPHROL, V20, P123, DOI 10.1681/ASN.2007111233; Massy ZA, 2005, J AM SOC NEPHROL, V16, P109, DOI 10.1681/ASN.2004060495; Monroy MA, 2015, FRONT BIOSCI-LANDMRK, V20, P784, DOI 10.2741/4337; Mori Y, 2012, METABOLISM, V61, P379, DOI 10.1016/j.metabol.2011.07.004; Mu W, 2005, J AM SOC NEPHROL, V16, P3651, DOI 10.1681/ASN.2005030297; Nagashima M, 2011, DIABETOLOGIA, V54, P2649, DOI 10.1007/s00125-011-2241-2; Ohashi K, 2007, ARTERIOSCL THROM VAS, V27, P1910, DOI 10.1161/ATVBAHA.107.147645; Pedersen TX, 2013, CARDIOVASC RES, V98, P352, DOI 10.1093/cvr/cvt049; Pedersen TX, 2010, NEPHROL DIAL TRANSPL, V25, P2486, DOI 10.1093/ndt/gfq059; Pedersen TX, 2009, ATHEROSCLEROSIS, V202, P372, DOI 10.1016/j.atherosclerosis.2008.04.041; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Tampe D, 2014, NAT REV NEPHROL, V10, P226, DOI 10.1038/nrneph.2014.14; Tapmeier TT, 2010, KIDNEY INT, V78, P351, DOI 10.1038/ki.2010.177; Tashiro Y, 2014, PEPTIDES, V54, P19, DOI 10.1016/j.peptides.2013.12.015; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Tsuprykov O, 2016, KIDNEY INT, V89, P1049, DOI 10.1016/j.kint.2016.01.016; U.S. Renal Data System, 2013, USRDS 2013 ANN DAT R; Vielhauer V, 2004, KIDNEY INT, V66, P2264, DOI 10.1111/j.1523-1755.2004.66038.x; Wang Y, 2014, BRIT J PHARMACOL, V171, P723, DOI 10.1111/bph.12490; Wang YP, 2001, KIDNEY INT, V59, P975, DOI 10.1046/j.1523-1755.2001.059003975.x; Wicks SE, 2015, BIOCHIMIE	43	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168396	10.1371/journal.pone.0168396	http://dx.doi.org/10.1371/journal.pone.0168396			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992511	gold, Green Published, Green Submitted			2022-12-27	WOS:000392758000046
J	Amini, M; Bashirova, D; Prins, BP; Corpeleijn, E; Bruinenberg, M; Franke, L; van der Harst, P; Navis, G; Wolffenbuttel, BHR; Stolk, RP; Wijmenga, C; Postma, DS; Koppelman, GH; Boezen, HM; Vonk, J; Snieder, H; Alizadeh, BZ				Amini, Marzyeh; Bashirova, Dinara; Prins, Bram P.; Corpeleijn, Eva; Bruinenberg, Marcel; Franke, Lude; van der Harst, Pim; Navis, Gerjan; Wolffenbuttel, Bruce H. R.; Stolk, Ronald P.; Wijmenga, Cisca; Postma, Dirkje S.; Koppelman, Gerard H.; Boezen, H. Marike; Vonk, Judith; Snieder, Harold; Alizadeh, Behrooz Z.		LifeLines Cohort Study	Eosinophil Count Is a Common Factor for Complex Metabolic and Pulmonary Traits and Diseases: The LifeLines Cohort Study	PLOS ONE			English	Article							DIFFERENTIAL LEUKOCYTE COUNTS; BLOOD-CELL COUNTS; AIRWAY EOSINOPHILIA; GENETIC-VARIANTS; HEART-DISEASE; ASTHMA; EXACERBATIONS; INFLAMMATION; INTERLEUKIN-5; DETERMINANTS	There is ongoing debate on the association between eosinophil count and diseases, as previous studies were inconsistent. We studied the relationship of eosinophil count with 22 complex metabolic, cardiac, and pulmonary traits and diseases. From the population-based LifeLines Cohort Study (N = 167,729), 13,301 individuals were included. We focused on relationship of eosinophil count with three classes of metabolic (7 traits, 2 diseases), cardiac (6 traits, 2 diseases), and pulmonary (2 traits, 2 diseases) outcomes. Regression analyses were applied in overall, women and men, while adjusted for age, sex, BMI and smoking. A p-value of < 0.00076 was considered statistically significant. 58.2% of population were women (mean+/-SD 51.3+/-11.1 years old). In overall, one-SD higher of ln-eosinophil count was associated with a 0.04 (+/-SE +/-0.002; p = 6.0x10(-6)) SD higher levels in ln-BMI, 0.06 (+/-0.007; p = 3.1x10-12) SD in ln-TG, 0.04 (+/-0.003; p = 7.0x10(-6)) SD in TC, 0.04 (+/-0.004; p = 6.3x10(-7)) SD in LDL, 0.04 (+/-0.006; p = 6.0x10-6) SD in HbA1c; and with a 0.05 (+/-0.004; p = 1.7x10(-8)) SD lower levels in HDL, 0.05 (+/-0.007; p = 3.4x10(-23)) SD in FEV1, and 0.09 (+/-0.001; p = 6.6x10(-28)) SD in FEV1/ FVC. A higher ln-eosinophil count was associated with 1.18 (95% CI 1.09 +/-1.28; p = 2.0x10(-5)) odds ratio of obesity, 1.29 (1.19 +/-1.39; p = 1.1x10(-10)) of metabolic syndrome, 1.40 (1.25 +/-1.56; p = 2.7x10-9) of COPD and 1.81 (1.61 +/-2.03; p = 1.0x10-23) of asthma. Similar results were found in women. We found no association between ln-eosinophil count either with blood pressure indices in overall, women and men; or with BMI, LDL, HbA1c and obesity in men. In a large population based cohort, we confirmed eosinophil count as a potential factor implicated in metabolic and pulmonary outcomes.	[Amini, Marzyeh; Bashirova, Dinara; Prins, Bram P.; Corpeleijn, Eva; Stolk, Ronald P.; Boezen, H. Marike; Vonk, Judith; Snieder, Harold; Alizadeh, Behrooz Z.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Bruinenberg, Marcel; Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, LifeLines Cohort Study, Groningen, Netherlands; [Franke, Lude; Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van der Harst, Pim] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Navis, Gerjan] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Wolffenbuttel, Bruce H. R.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [Postma, Dirkje S.; Koppelman, Gerard H.; Boezen, H. Marike; Vonk, Judith] Univ Groningen, Univ Med Ctr Groningen, Groningen Res Inst Asthma, Groningen, Netherlands; [Postma, Dirkje S.; Koppelman, Gerard H.; Boezen, H. Marike; Vonk, Judith] Univ Groningen, Univ Med Ctr Groningen, COPD, Groningen, Netherlands; [Koppelman, Gerard H.] Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Amini, M; Alizadeh, BZ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	m.amini@umcg.nl; b.z.alizadeh@umcg.nl	Vonk, Judith M/ABA-3009-2020; Wijmenga, Cisca/AAE-7719-2019; Koppelman, Gerard/AAG-9187-2020; Vonk, Judith/K-8477-2019; Franke, Lude/P-7036-2016	Vonk, Judith M/0000-0001-7531-4547; Wijmenga, Cisca/0000-0002-5635-1614; Vonk, Judith/0000-0001-7531-4547; Prins, Bram/0000-0001-5774-034X; Koppelman, Gerard/0000-0001-8567-3252; Stolk, Ronald/0000-0002-0518-1205; Corpeleijn, Eva/0000-0002-2974-3305; Franke, Lude/0000-0002-5159-8802; Wolffenbuttel, Bruce H.R./0000-0001-9262-6921	Netherlands Organization of Scientific Research NWO [175.010.2007.006]; Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Groningen University Institute for Drug Exploration (GUIDE); UMCG, Groningen, the Netherlands; Digestive Disease Research Institute (DDRI), TUMS, Tehran, Iran	Netherlands Organization of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Economic Structure Enhancing Fund (FES) of the Dutch government; Ministry of Economic Affairs; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; Northern Netherlands Collaboration of Provinces (SNN); Province of Groningen; University Medical Center Groningen; University of Groningen; Dutch Kidney Foundation; Dutch Diabetes Research Foundation; Groningen University Institute for Drug Exploration (GUIDE); UMCG, Groningen, the Netherlands(Netherlands Government); Digestive Disease Research Institute (DDRI), TUMS, Tehran, Iran	The Life Lines Cohort Study is supported by the Netherlands Organization of Scientific Research NWO (grant 175.010.2007.006), the Economic Structure Enhancing Fund (FES) of the Dutch government, the Ministry of Economic Affairs, the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the Northern Netherlands Collaboration of Provinces (SNN), the Province of Groningen, University Medical Center Groningen, the University of Groningen, Dutch Kidney Foundation and Dutch Diabetes Research Foundation. Mrs. M. Amini was supported by Groningen University Institute for Drug Exploration (GUIDE), UMCG, Groningen, the Netherlands, and Digestive Disease Research Institute (DDRI), TUMS, Tehran, Iran.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; [Anonymous], 2012, DIABETES CARE S1, V35, pS4, DOI DOI 10.2337/DC12-S004; Babio N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058354; Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Banos G., 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P137; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Behm CA, 2000, PARASITOL TODAY, V16, P202, DOI 10.1016/S0169-4758(99)01620-8; Belda J, 2001, CHEST, V119, P1011, DOI 10.1378/chest.119.4.1011; Broekema M, 2010, RESP MED, V104, P1254, DOI 10.1016/j.rmed.2010.03.030; Chung FM, 2005, DIABETES CARE, V28, P1710, DOI 10.2337/diacare.28.7.1710; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; de Jong K, 2014, OCCUP ENVIRON MED, V71, P88, DOI 10.1136/oemed-2013-101639; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Gkrania-Klotsas E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013405; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V85, P422, DOI 10.1016/0091-6749(90)90151-S; Gorska K, 2008, J PHYSIOL PHARMACOL, V59, P261; Hospers JJ, 1999, AM J RESP CRIT CARE, V160, P1869, DOI 10.1164/ajrccm.160.6.9811041; Huang ZS, 2001, LIPIDS, V36, P237, DOI 10.1007/s11745-001-0713-9; Jansen DF, 1999, AM J RESP CRIT CARE, V159, P924, DOI 10.1164/ajrccm.159.3.9804024; Jansen H, 2013, J INTERN MED, V273, P283, DOI 10.1111/joim.12010; Janssen I, 2002, ARCH INTERN MED, V162, P2074, DOI 10.1001/archinte.162.18.2074; Jatakanon A, 2000, AM J RESP CRIT CARE, V161, P64, DOI 10.1164/ajrccm.161.1.9809100; Johansson MW, 2014, CLIN EXP ALLERGY, V44, P482, DOI 10.1111/cea.12292; Kim DJ, 2008, J KOREAN MED SCI, V23, P193, DOI 10.3346/jkms.2008.23.2.193; Lacy P, 2001, CURR OPIN ALLERGY CL, V1, P79, DOI 10.1097/00130832-200102000-00014; Lampinen M, 2008, J LEUKOCYTE BIOL, V84, P1392, DOI 10.1189/jlb.0807513; Langholz B, 2005, CASE CONTROL STUDY N, P646; Lee SH, 2011, ALLERGY ASTHMA IMMUN, V3, P236, DOI 10.4168/aair.2011.3.4.236; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li NS, 2014, DIABETES, V63, P3149, DOI 10.2337/db13-1800; Lippi G, 2009, J THROMB THROMBOLYS, V28, P90, DOI 10.1007/s11239-008-0247-5; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Medoff BD, 2009, AM J RESP CELL MOL, V41, P397, DOI 10.1165/rcmb.2008-0415OC; Meng WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049875; Mensinga Tjeert T., 1994, Annals of Epidemiology, V4, P382; MENSINGA TT, 1992, AM REV RESPIR DIS, V146, P638, DOI 10.1164/ajrccm/146.3.638; Menzies-Gow A, 2002, CURR OPIN PULM MED, V8, P33, DOI 10.1097/00063198-200201000-00006; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Institutes of Health Heart Lung and Blood Institute, 2007, NATL TOXICOL PROGRAM, V08-5846, P1; Niccoli G, 2010, ATHEROSCLEROSIS, V211, P606, DOI 10.1016/j.atherosclerosis.2010.02.038; Oda E, 2014, J CLIN TRANSL ENDOCR, V1, P49, DOI 10.1016/j.jcte.2014.05.001; Petsky HL, 2007, COCHRANE DB SYST REV, V2; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Postma DS, 2007, GENDER MED, V4, pS133, DOI 10.1016/S1550-8579(07)80054-4; PRENTICE RL, 1982, AM J EPIDEMIOL, V116, P496, DOI 10.1093/oxfordjournals.aje.a113434; Rothenberg ME, 2001, IMMUNOL REV, V179, P139, DOI 10.1034/j.1600-065X.2001.790114.x; Saetta M, 1996, CLIN EXP ALLERGY, V26, P766, DOI 10.1111/j.1365-2222.1996.tb00606.x; Sampson AP, 2000, CLIN EXP ALLERGY, V30, P22; Saudek CD, 2008, J CLIN ENDOCR METAB, V93, P2447, DOI 10.1210/jc.2007-2174; Scholtens S, 2015, INT J EPIDEMIOL, V44, P1172, DOI 10.1093/ije/dyu229; Shim WS, 2006, DIABETES RES CLIN PR, V73, P284, DOI 10.1016/j.diabres.2006.02.001; Siroux V, 2004, J ALLERGY CLIN IMMUN, V114, P491, DOI 10.1016/j.jaci.2004.05.027; Song JW, 2010, PLAST RECONSTR SURG, V126, P2234, DOI 10.1097/PRS.0b013e3181f44abc; Sriaroon P, 2016, CLIN REV ALLERG IMMU, V50, P252, DOI 10.1007/s12016-014-8444-9; Stolk RP, 2008, EUR J EPIDEMIOL, V23, P67, DOI 10.1007/s10654-007-9204-4; Sweetnam PM, 1997, AM J EPIDEMIOL, V145, P416; Talini D, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-005748; Ullmann N, 2013, ALLERGY, V68, P402, DOI 10.1111/all.12101; Umemoto S, 2000, AM J CARDIOL, V85, P715, DOI 10.1016/S0002-9149(99)00846-2; van den Berge M, 2003, CHEST, V123, p417S, DOI 10.1378/chest.123.3_suppl.417S-a; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Wang XB, 2004, AM J RESP CRIT CARE, V169, P941, DOI 10.1164/rccm.2201011; Weng M, 2011, AM J PHYSIOL-LUNG C, V301, pL927, DOI 10.1152/ajplung.00049.2011; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu W, 2013, INT J MED SCI, V10, P758, DOI 10.7150/ijms.6155; Zhu LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067613	69	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168480	10.1371/journal.pone.0168480	http://dx.doi.org/10.1371/journal.pone.0168480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978545	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400111
J	Chen, TI; Chen, MYC				Chen, Tsung-I; Chen, Michael Yu-Chih			Zinc Is Indispensable in Exercise-Induced Cardioprotection against Intermittent Hypoxia-Induced Left Ventricular Function Impairment in Rats	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; IMPROVES MYOCARDIAL TOLERANCE; OXIDATIVE STRESS; ISCHEMIA-REPERFUSION; INFLAMMATORY MARKERS; CARDIAC-FUNCTION; HEART-FAILURE; TNF-ALPHA; DYSFUNCTION; APOPTOSIS	In obstructive sleep apnea (OSA), recurrent obstruction of the upper airway leads to intermittent hypoxia (IH) during sleep, which can result in impairment of cardiac function. Although exercise can have beneficial effects against IH-induced cardiac dysfunction, the mechanism remains unclear. This study aimed to investigate the interactions of zinc and exercise on IH-triggered left ventricular dysfunction in a rat model that mimics IH in OSA patients. Nine-week-old male Sprague-Dawley rats were randomly assigned to either a control group (CON) or to a group receiving 10 weeks of exercise training (EXE). During weeks 9 and 10, half the rats in each group were subjected to IH for 8 h per day for 14 days (IHCON, IHEXE), whereas the remainder continued to breathe room air. Rats within each of the CON, IHCON, EXE, and IHEXE groups were further randomly assigned to receive intraperitoneal injections of either zinc chloride, the zinc chelator N, N, N', N'-tetrakis(2-pyridylmethyl) ethylenediamine (TPEN), or injection vehicle only. IH induced a lower left ventricular fractional shortening, reduced ejection fraction, higher myocardial levels of inflammatory factors, increased levels oxidative stress, and lower levels of antioxidative capacity, all of which were abolished by zinc treatment. IHEXE rats exhibited higher levels of cardiac function and antioxidant capacity and lower levels of inflammatory factors and oxidative stress than IHCON rats; however, IHEXE rats receiving TPEN did not exhibit these better outcomes. In conclusion, zinc is required for protecting against IH-induced LV functional impairment and likely plays a critical role in exercise-induced cardioprotection by exerting a dual antioxidant and anti-inflammatory effect.	[Chen, Tsung-I] Tzu Chi Univ, Ctr Phys Educ, Off Gen & Basic Educ, Hualien, Taiwan; [Chen, Michael Yu-Chih] Buddhist Tzu Chi Gen Hosp, Dept Cardiol, Hualien, Taiwan; [Chen, Michael Yu-Chih] Tzu Chi Univ, PhD Program Inst Med, Hualien, Taiwan	Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Chen, TI (corresponding author), Tzu Chi Univ, Ctr Phys Educ, Off Gen & Basic Educ, Hualien, Taiwan.	tichen@gms.tcu.edu.tw		Chen, Tsung-I/0000-0003-3533-0846	Ministry of Science and Technology, Taiwan, R.O.C. [MOST-102-2410-H-320-009]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This study was supported by Ministry of Science and Technology (www.most.gov.tw), Taiwan, R.O.C. Grant MOST-102-2410-H-320-009. The receiver of this funding was Tsung-I Chen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves ED, 2013, SLEEP BREATH, V17, P505, DOI 10.1007/s11325-012-0729-8; Baguet JP, 2012, NAT REV CARDIOL, V9, P679, DOI 10.1038/nrcardio.2012.141; Beguin PC, 2005, J APPL PHYSIOL, V99, P1064, DOI 10.1152/japplphysiol.00056.2005; Bicer M, 2012, BRATISL MED J, V113, P199, DOI 10.4149/BLL_2012_046; Carpagnano GE, 2003, CHEST, V124, P1386, DOI 10.1378/chest.124.4.1386; Chao PC, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-33; Chaumont SB, 2001, MED SCI SPORT EXER, V33, P724; Chen L, 2005, AM J RESP CRIT CARE, V172, P915, DOI 10.1164/rccm.200504-560OC; Chen L, 2010, J APPL PHYSIOL, V109, P1675, DOI 10.1152/japplphysiol.01372.2009; Chen MYC, 2015, CHINESE J PHYSIOL, V58, P254, DOI 10.4077/CJP.2015.BAE357; Chen PC, 2013, J NUTR HEALTH AGING, V17, P639, DOI 10.1007/s12603-013-0023-x; Chen S, 2008, J BEIJING SPORT U, V31, P196; Chen TI, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00462; Chen TI, 2014, CELL PHYSIOL BIOCHEM, V33, P513, DOI 10.1159/000358631; Chen TI, 2011, EUR J APPL PHYSIOL, V111, P1939, DOI 10.1007/s00421-010-1824-9; Chen TI, 2011, SLEEP BREATH, V15, P845, DOI 10.1007/s11325-010-0448-y; Dayan A, 2005, ANN CLIN LAB SCI, V35, P73; Demirel HA, 2001, J APPL PHYSIOL, V91, P2205, DOI 10.1152/jappl.2001.91.5.2205; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Fertin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071280; FIELD KJ, 1993, LAB ANIM, V27, P258, DOI 10.1258/002367793780745471; Filgueiras-Rama D, 2013, PULM MED, V2013, DOI 10.1155/2013/426758; Foster GE, 2010, HYPERTENSION, V56, P369, DOI 10.1161/HYPERTENSIONAHA.110.152108; Fukuyama Satoru, 2011, Allergology International, V60, P259, DOI 10.2332/allergolint.09-OA-0167; Ghaemian A, 2011, BIOL TRACE ELEM RES, V143, P1239, DOI 10.1007/s12011-011-8956-6; Guo J, 2011, SCI REP-UK, V1, DOI 10.1038/srep00113; Gupta M, 2014, DERMAT RES PRACT, V2014, DOI 10.1155/2014/709152; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; Hashimoto K, 2009, NEUROSCIENCE, V163, P244, DOI 10.1016/j.neuroscience.2009.05.067; Janssen BJA, 2004, AM J PHYSIOL-HEART C, V287, pH1618, DOI 10.1152/ajpheart.01192.2003; Joyeux-Faure M, 2005, J APPL PHYSIOL, V98, P1691, DOI 10.1152/japplphysiol.01146.2004; Kasai T, 2011, J AM COLL CARDIOL, V57, P119, DOI 10.1016/j.jacc.2010.08.627; KIMBALL TR, 1993, J PEDIATR-US, V122, pS89, DOI 10.1016/S0022-3476(09)90050-6; Kline CE, 2011, SLEEP, V34, P1631, DOI 10.5665/sleep.1422; Kosmala W, 2008, CORONARY ARTERY DIS, V19, P375, DOI 10.1097/MCA.0b013e3282fc617c; Koyama RG, 2012, SLEEP MED, V13, P1028, DOI 10.1016/j.sleep.2012.06.017; Kumar SD, 2012, FREE RADICAL BIO MED, V53, P1595, DOI 10.1016/j.freeradbiomed.2012.07.008; Lai CJ, 2006, J APPL PHYSIOL, V100, P1974, DOI 10.1152/japplphysiol.01051.2005; Lam SY, 2012, HISTOCHEM CELL BIOL, V137, P303, DOI 10.1007/s00418-011-0900-5; Lavie L, 2002, AM J RESP CRIT CARE, V165, P1624, DOI 10.1164/rccm.20110-040OC; Lennon SL, 2004, J APPL PHYSIOL, V96, P1299, DOI 10.1152/japplphysiol.00920.2003; Li B, 2012, TOXICOLOGY MECH METH; Mallet RT, 2006, BASIC RES CARDIOL, V101, P436, DOI 10.1007/s00395-006-0599-y; Minoguchi K, 2005, AM J RESP CRIT CARE, V172, P625, DOI 10.1164/rccm.200412-1652OC; Ni H, 2011, BIOL TRACE ELEM RES, V142, P704, DOI 10.1007/s12011-010-8793-z; Noda A, 2013, PULM MED, V2013, DOI 10.1155/2013/814169; Norman J F, 2000, Sleep Res Online, V3, P121; Ohga E, 1999, J APPL PHYSIOL, V87, P10, DOI 10.1152/jappl.1999.87.1.10; Park AM, 2007, J APPL PHYSIOL, V102, P1806, DOI 10.1152/japplphysiol.01291.2006; Pelin Z, 2013, TURK J PHARM SCI, V10, P415; Penkowa M, 2005, EXP PHYSIOL, V90, P477, DOI 10.1113/expphysiol.2004.029371; Pialoux V, 2011, J PHYSIOL-LONDON, V589, P5529, DOI 10.1113/jphysiol.2011.218156; Powers SK, 2008, FREE RADICAL BIO MED, V44, P193, DOI 10.1016/j.freeradbiomed.2007.02.006; Quindry J, 2005, EXP GERONTOL, V40, P416, DOI 10.1016/j.exger.2005.03.010; Ramar K, 2015, J CLIN SLEEP MED; Ramirez TA, 2012, HYPERTENS RES, V35, P811, DOI 10.1038/hr.2012.32; Roh J, 2016, CIRC RES, V118, P279, DOI 10.1161/CIRCRESAHA.115.305250; Serra AJ, 2010, J PHYSIOL-LONDON, V588, P2431, DOI 10.1113/jphysiol.2010.187310; Shao CH, 2009, J APPL PHYSIOL, V106, P1280, DOI 10.1152/japplphysiol.91280.2008; Siu PM, 2004, FASEB J, V18, P1150, DOI 10.1096/fj.03-1291fje; Smith Simon S, 2007, J Clin Sleep Med, V3, P689; Spina RJ, 1997, AM J PHYSIOL-HEART C, V272, pH995, DOI 10.1152/ajpheart.1997.272.2.H995; Tam CS, 2007, SLEEP, V30, P723, DOI 10.1093/sleep/30.6.723; Thomas JJ, 2012, CLIN EXPT PHARM PHYS; Thorp DB, 2007, AM J PHYSIOL-REG I, V293, pR363, DOI 10.1152/ajpregu.00363.2006; Tomisawa M, 2003, TOXICOL LETT, V142, P111, DOI 10.1016/S0378-4274(03)00018-3; Ueno LM, 2009, SLEEP, V32, P637, DOI 10.1093/sleep/32.5.637; Vgontzas Alexandros N., 2008, Archives of Physiology and Biochemistry, V114, P211, DOI [10.1080/13813450802364627, 10.1080/13813450802364627 ]; Vgontzas AN, 2005, SLEEP MED REV, V9, P211, DOI 10.1016/j.smrv.2005.01.006; Williams A, 2007, SLEEP BREATH, V11, P69, DOI 10.1007/s11325-007-0106-1; Williams AL, 2010, SLEEP BREATH, V14, P51, DOI 10.1007/s11325-009-0279-x; Yang D, 2013, MED SCI MONITOR, V19, P251, DOI 10.12659/MSM.883874; Zhao YM, 2014, STROKE, V45, P1139, DOI 10.1161/STROKEAHA.113.004296; Zhao YG, 2011, TOXICOL LETT, V200, P100, DOI 10.1016/j.toxlet.2010.11.001; Ziada AM, 2009, J HYPERTENS, V27, P1309, DOI 10.1097/HJH.0b013e328329fb55; Zong P, 2004, EXP BIOL MED, V229, P806, DOI 10.1177/153537020422900813	76	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168600	10.1371/journal.pone.0168600	http://dx.doi.org/10.1371/journal.pone.0168600			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977796	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400120
J	Choi, YJ; Ki, EY; Zhang, CQ; Ho, WCS; Lee, SJ; Jeong, MJ; Chan, PKS; Park, JS				Choi, Youn Jin; Ki, Eun Young; Zhang, Chuqing; Ho, Wendy C. S.; Lee, Sung-Jong; Jeong, Min Jin; Chan, Paul K. S.; Park, Jong Sup			Analysis of Sequence Variation and Risk Association of Human Papillomavirus 52 Variants Circulating in Korea	PLOS ONE			English	Article							CERVICAL-CANCER; GENITAL-TRACT; POLYMORPHISM; NEOPLASIA; WOMEN; CLASSIFICATION; TYPE-52; LESIONS; E6	Introduction Human papillomavirus (HPV) 52 is a carcinogenic, high-risk genotype frequently detected in cervical cancer cases from East Asia, including Korea. Materials and Methods Sequences of HPV52 detected in 91 cervical samples collected from women attending Seoul St. Mary's Hospital were analyzed. HPV52 genomic sequences were obtained by polymerase chain reaction (PCR)-based sequencing and analyzed using Seq-Scape software, and phylogenetic trees were constructed using MEGA6 software. Results Of the 91 cervical samples, 40 were normal, 22 were low-grade lesions, 21 were high-grade lesions and 7 were squamous cell carcinomas. Four HPV52 variant lineages (A, B, C and D) were identified. Lineage B was the most frequently detected lineage, followed by lineage C. By analyzing the two most frequently detected lineages (B and C), we found that distinct variations existed in each lineage. We also found that a lineage B-specific mutation K93R (A379G) was associated with an increased risk of cervical neoplasia. Conclusions To our knowledge, we are the first to reveal the predominance of the HPV52 lineages, B and C, in Korea. We also found these lineages harbored distinct genetic alterations that may affect oncogenicity. Our findings increase our understanding on the heterogeneity of HPV52 variants, and may be useful for the development of new diagnostic assays and therapeutic vaccines.	[Choi, Youn Jin; Ki, Eun Young; Lee, Sung-Jong; Jeong, Min Jin; Park, Jong Sup] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Obstet, Seoul, South Korea; [Choi, Youn Jin; Ki, Eun Young; Lee, Sung-Jong; Jeong, Min Jin; Park, Jong Sup] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Gynecol, Seoul, South Korea; [Zhang, Chuqing; Ho, Wendy C. S.; Chan, Paul K. S.] Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Chinese University of Hong Kong	Park, JS (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Obstet, Seoul, South Korea.; Park, JS (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Gynecol, Seoul, South Korea.; Chan, PKS (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	paulkschan@cuhk.edu.hk; jspark@catholic.ac.kr	Choi, Youn Jin/AAS-3301-2021; Chan, Paul KS/J-9360-2013	Chan, Paul KS/0000-0002-6360-4608	National R&D Program for Cancer Control [0720510]; Ministry of Health and Welfare, Republic of Korea; Korean Health Technology R&D Project grant from the Ministry of Health & Welfare, Republic of Korea [HI14C1731]	National R&D Program for Cancer Control(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korean Health Technology R&D Project grant from the Ministry of Health & Welfare, Republic of Korea	The work was supported by Grants of National R&D Program for Cancer Control (0720510), Ministry of Health and Welfare, Republic of Korea and Statistical consultations were supported by a Korean Health Technology R&D Project grant from the Ministry of Health & Welfare, Republic of Korea (HI14C1731).	Aho J, 2003, J INFECT DIS, V188, P1517, DOI 10.1086/379198; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bernard HU, 2005, J CLIN VIROL, V32, pS1, DOI 10.1016/j.jcv.2004.10.021; Castle PE, 2010, CANCER EPIDEM BIOMAR, V19, P1675, DOI 10.1158/1055-9965.EPI-10-0251; Chan PKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107573; Chang YJ, 2011, INT J CANCER, V129, P965, DOI 10.1002/ijc.25724; Chen ZG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020183; Choi IH, 2011, KOREAN J PATHOL, V45, P612, DOI 10.4132/KoreanJPathol.2011.45.6.612; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Formentin A, 2013, INT J CANCER, V132, P1821, DOI 10.1002/ijc.27874; Gagnon S, 2004, J INFECT DIS, V190, P1575, DOI 10.1086/424854; Giannoudis A, 2001, J PATHOL, V193, P295, DOI 10.1002/1096-9896(2000)9999:9999&lt;::AID-PATH809&gt;3.0.CO;2-C; Grodzki M, 2006, CANCER EPIDEM BIOMAR, V15, P820, DOI 10.1158/1055-9965.EPI-05-0864; HWA LEE， KEUN, 2011, Obstetrics & Gynecology Science, V54, P689; Ishizaki A, 2013, J MED VIROL, V85, P1069, DOI 10.1002/jmv.23566; Jones DL, 1996, SEMIN CANCER BIOL, V7, P327, DOI 10.1006/scbi.1996.0042; Kim Tae Eun, 2014, Korean J Pathol, V48, P24, DOI 10.4132/KoreanJPathol.2014.48.1.24; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Scheffner M, 2003, SEMIN CANCER BIOL, V13, P59, DOI 10.1016/S1044-579X(02)00100-1; Schiffman M, 2010, CANCER RES, V70, P3159, DOI 10.1158/0008-5472.CAN-09-4179; Serrano B, 2012, INFECT AGENTS CANCER, V7, DOI 10.1186/1750-9378-7-38; Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Sun ZR, 2012, INT J MOL SCI, V13, P14962, DOI 10.3390/ijms131114962; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wheeler CM, 2009, JNCI-J NATL CANCER I, V101, P475, DOI 10.1093/jnci/djn510; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064; Xin CY, 2001, CANCER LETT, V170, P19, DOI 10.1016/S0304-3835(01)00570-5; Zhang CQ, 2014, J INFECT DIS, V210, P1600, DOI 10.1093/infdis/jiu310; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	34	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168178	10.1371/journal.pone.0168178	http://dx.doi.org/10.1371/journal.pone.0168178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977741	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400073
J	Marateb, HR; Farahi, M; Rojas, M; Maanas, MA; Farina, D				Marateb, Hamid Reza; Farahi, Morteza; Rojas, Monica; Maanas, Miguel Angel; Farina, Dario			Detection of Multiple Innervation Zones from Multi-Channel Surface EMG Recordings with Low Signal-to-Noise Ratio Using Graph-Cut Segmentation	PLOS ONE			English	Article							EXTERNAL ANAL-SPHINCTER; MOTOR UNITS; MUSCLE; ELECTROMYOGRAPHY; CLASSIFICATION; EXTRACTION; LOCATION; POSITION	Knowledge of the location of muscle Innervation Zones (IZs) is important in many applications, e.g. for minimizing the quantity of injected botulinum toxin for the treatment of spasticity or for deciding on the type of episiotomy during child delivery. Surface EMG (sEMG) can be noninvasively recorded to assess physiological and morphological characteristics of contracting muscles. However, it is not often possible to record signals of high quality. Moreover, muscles could have multiple IZs, which should all be identified. We designed a fully-automatic algorithm based on the enhanced image Graph-Cut segmentation and morphological image processing methods to identify up to five IZs in 60-ms intervals of very-low to moderate quality sEMG signal detected with multi-channel electrodes (20 bipolar channels with Inter Electrode Distance (IED) of 5 mm). An anisotropic multilayered cylinder model was used to simulate 750 sEMG signals with signal-to-noise ratio ranging from -5 to 15 dB (using Gaussian noise) and in each 60-ms signal frame, 1 to 5 IZs were included. The micro-and macro-averaged performance indices were then reported for the proposed IZ detection algorithm. In the micro-averaging procedure, the number of True Positives, False Positives and False Negatives in each frame were summed up to generate cumulative measures. In the macro-averaging, on the other hand, precision and recall were calculated for each frame and their averages are used to determine F1-score. Overall, the micro (macro)averaged sensitivity, precision and F1-score of the algorithm for IZ channel identification were 82.7% (87.5%), 92.9% (94.0%) and 87.5% (90.6%), respectively. For the correctly identified IZ locations, the average bias error was of 0.02 +/- 0.10 IED ratio. Also, the average absolute conduction velocity estimation error was 0.41 +/- 0.40 m/s for such frames. The sensitivity analysis including increasing IED and reducing interpolation coefficient for time samples was performed. Meanwhile, the effect of adding power-line interference and using other image interpolation methods on the deterioration of the performance of the proposed algorithm was investigated. The average running time of the proposed algorithm on each 60-ms sEMG frame was 25.5 +/- 8.9 (s) on an Intel dual-core 1.83 GHz CPU with 2 GB of RAM. The proposed algorithm correctly and precisely identified multiple IZs in each signal epoch in a wide range of signal quality and is thus a promising new offline tool for electrophysiological studies.	[Marateb, Hamid Reza; Farahi, Morteza] Univ Isfahan, Fac Engn, Dept Biomed Engn, Esfahan, Iran; [Marateb, Hamid Reza; Rojas, Monica; Maanas, Miguel Angel] Univ Politecn Cataluna, BarcelonaTech, Biomed Engn Res Ctr, Dept Automat Control, Barcelona, Spain; [Rojas, Monica] Univ El Bosque, Dept Bioengn, Bogota, Colombia; [Farina, Dario] Georg August Univ, Univ Med Ctr Gottingen, Bernstein Ctr Computat Neurosci, Dept NeuroRehabil Engn, Gottingen, Germany	University of Isfahan; Universitat Politecnica de Catalunya; Universidad El Bosque; University of Gottingen	Marateb, HR (corresponding author), Univ Isfahan, Fac Engn, Dept Biomed Engn, Esfahan, Iran.; Marateb, HR (corresponding author), Univ Politecn Cataluna, BarcelonaTech, Biomed Engn Res Ctr, Dept Automat Control, Barcelona, Spain.	hamid.reza.marateb@upc.edu	Mañanas, Miguel Angel/AAI-2961-2021; Rojas-Martínez, Mónica/AAJ-6997-2021; Marateb, Hamid Reza/G-5556-2013; Farina, Dario/AAB-2648-2019	Rojas-Martínez, Mónica/0000-0002-9971-3566; Marateb, Hamid Reza/0000-0003-4408-2397; Mananas, Miguel Angel/0000-0001-9836-6083	People Programme (Marie Curie Actions) of the Seventh Framework Programme of the European Union (FP7) [600388]; Agency for Business Competitiveness of the Government of Catalonia; ACCIO; Spanish Ministry of Economy and Competitiveness- Spain [DPI2014-59049-R]	People Programme (Marie Curie Actions) of the Seventh Framework Programme of the European Union (FP7); Agency for Business Competitiveness of the Government of Catalonia; ACCIO; Spanish Ministry of Economy and Competitiveness- Spain	The research leading to these results has received funding from the People Programme (Marie Curie Actions) of the Seventh Framework Programme of the European Union (FP7/2007-2013) under REA grant agreement no. 600388 (TECNIOspring programme), from the Agency for Business Competitiveness of the Government of Catalonia, ACCIO, and from Spanish Ministry of Economy and Competitiveness- Spain (project DPI2014-59049-R).	Afsharipour B., 2014, P IFMBE P, P293, DOI DOI 10.1007/978-3-319-00846-2_73; Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; Allen DP, 2009, J NEUROSCI METH, V177, P303, DOI 10.1016/j.jneumeth.2008.10.019; Barbero M., 2012, ATLAS MUSCLE INNERVA, DOI [10.1007/978-88-470-2463-2, DOI 10.1007/978-88-470-2463-2]; Beck A, 2014, INTRO NONLINEAR OPTI, Vxii; Beck TW, 2012, COMPUT METH PROG BIO, V105, P13, DOI 10.1016/j.cmpb.2010.07.003; Ben Salah M, 2011, IEEE T IMAGE PROCESS, V20, P545, DOI 10.1109/TIP.2010.2066982; Ben Salah M, 2008, LECT NOTES COMPUT SC, V5358, P268, DOI 10.1007/978-3-540-89639-5_26; Bilodeau M, 1997, J ELECTROMYOGR KINES, V7, P87, DOI 10.1016/S1050-6411(96)00024-7; Boykov Y, 2006, HANDBOOK OF MATHEMATICAL MODELS IN COMPUTER VISION, P79, DOI 10.1007/0-387-28831-7_5; Boykov Y, 2001, IEEE T PATTERN ANAL, V23, P1222, DOI 10.1109/34.969114; Brown R, 2014, ANN CLIN TRANSL NEUR, V1, P867, DOI 10.1002/acn3.124; Cescon C, 2006, IEEE INT WORK MED ME, P87; Cescon C, 2014, INT UROGYNECOL J, V25, P1491, DOI 10.1007/s00192-014-2375-0; Cescon C, 2014, INT UROGYNECOL J, V25, P1097, DOI 10.1007/s00192-014-2356-3; Childers MK, 2004, AM J PHYS MED REHAB, V83, pS38, DOI 10.1097/01.PHM.0000141129.23219.42; Chowdhury RH, 2013, SENSORS-BASEL, V13, P12431, DOI 10.3390/s130912431; Couprie C, 2011, IEEE T PATTERN ANAL, V33, P1384, DOI 10.1109/TPAMI.2010.200; DE LUCA CJ, 1979, IEEE T BIO-MED ENG, V26, P313, DOI 10.1109/TBME.1979.326534; Ebdon D., 1985, STAT GEOGRAPHY, Vviii; Farahi M, 2014, 20 C INT SOC EL KIN, P432; Farina D, 2004, IEEE T BIO-MED ENG, V51, P415, DOI 10.1109/TBME.2003.820998; Farina D, 2001, IEEE T BIO-MED ENG, V48, P637, DOI 10.1109/10.923782; Farina D, 2001, MED BIOL ENG COMPUT, V39, P225, DOI 10.1007/BF02344807; Farina D, 2014, J APPL PHYSIOL, V117, P1215, DOI 10.1152/japplphysiol.00162.2014; Felzenszwalb PF, 2011, IEEE T PATTERN ANAL, V33, P721, DOI 10.1109/TPAMI.2010.135; Gallina A, 2013, PHYSIOL MEAS, V34, P1411, DOI 10.1088/0967-3334/34/11/1411; Gazzoni M, 2004, J NEUROSCI METH, V136, P165, DOI 10.1016/j.jneumeth.2004.01.002; Ghaderi P, 2016, IEEE T BIOMEDICAL EN; Gobbo M, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-17; Gonzalez R., 2001, DIGITAL IMAGE PROCES, V2; Groenen P.J.F., 2007, ADV FUZZY CLUSTERING, P53, DOI [10.1002/9780470061190.ch3, DOI 10.1002/9780470061190.CH3]; Gustafsson F, 1996, IEEE T SIGNAL PROCES, V44, P988, DOI 10.1109/78.492552; HEIJMANS HJAM, 1995, SIAM REV, V37, P1, DOI 10.1137/1037001; Hilbe JM., 2007, NEGATIVE BINOMIAL RE, Vxii; Hofmann T, 1998, IEEE T PATTERN ANAL, V20, P803, DOI 10.1109/34.709593; Hogrel JY, 2005, NEUROPHYSIOL CLIN, V35, P59, DOI 10.1016/j.neucli.2005.03.001; HOU HS, 1978, IEEE T ACOUST SPEECH, V26, P508; Jahanmiri-Nezhad F, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00239; Kay S. M., 1993, FUNDAMENTALS STAT SI; Lapatki BG, 2011, CLIN NEUROPHYSIOL, V122, P1611, DOI 10.1016/j.clinph.2010.11.018; Lateva ZC, 2010, J APPL PHYSIOL, V108, P1530, DOI 10.1152/japplphysiol.01163.2009; Lehmann TM, 1999, IEEE T MED IMAGING, V18, P1049, DOI 10.1109/42.816070; Lezoray O, 2012, IMAGE PROCESSING ANA, Vxxiv; LYNN PA, 1979, IEEE T BIO-MED ENG, V26, P564, DOI 10.1109/TBME.1979.326444; MacIntosh BR, 2006, SKELETAL MUSCLE FORM, Vviii; Marateb HR, 2012, MED BIOL ENG COMPUT, V50, P79, DOI 10.1007/s11517-011-0790-7; MASUDA T, 1985, IEEE T BIO-MED ENG, V32, P36, DOI 10.1109/TBME.1985.325614; Meijering EHW, 1999, MED IMAGE COMPUTING; Merletti R, 2003, J ELECTROMYOGR KINES, V13, P37, DOI 10.1016/S1050-6411(02)00082-2; Merletti R, 2001, Exerc Sport Sci Rev, V29, P20, DOI 10.1097/00003677-200101000-00005; Merletti R., 2013, CONVERGING CLIN ENG, P1205; Mesin L, 2009, J ELECTROMYOGR KINES, V19, pE413, DOI 10.1016/j.jelekin.2009.02.002; Mihalik J, 1995, RADIOENGINEERING; Moritani T, 2005, BASIC PHYSL BIOPHYSI, P1; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Nawab SH, 2010, CLIN NEUROPHYSIOL, V121, P1602, DOI 10.1016/j.clinph.2009.11.092; Ostlund N, 2007, J ELECTROMYOGR KINES, V17, P549, DOI 10.1016/j.jelekin.2006.06.002; POGGIO T, 1985, NATURE, V317, P314, DOI 10.1038/317314a0; Rainoldi A, 2004, J NEUROSCI METH, V134, P37, DOI 10.1016/j.jneumeth.2003.10.014; Saitou K, 2000, J Hum Ergol (Tokyo), V29, P35; Smith S.W., 1997, SCI ENG GUIDE DIGITA, V14; Soares FA, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0079-4; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; StataCorp L, 2007, STAT DAT AN STAT SOF; Stegeman DF, 1997, J CLIN NEUROPHYSIOL, V14, P429, DOI 10.1097/00004691-199709000-00009; Turkowski K., 1990, GRAPHICS GEMS, P147, DOI [10.1.1.116.7898, DOI 10.1016/B978-0-08-050753-8.50042-5]; Ullah K, 2014, J ELECTROMYOGR KINES, V24, P860, DOI 10.1016/j.jelekin.2014.05.003; UNSER M, 1991, IEEE T PATTERN ANAL, V13, P277, DOI 10.1109/34.75515; Unser M, 1999, IEEE SIGNAL PROC MAG, V16, P22, DOI 10.1109/79.799930; Veksler O., 1999, EFFICIENT GRAPH BASE; Vieira TMM, 2010, J BIOMECH, V43, P2149, DOI 10.1016/j.jbiomech.2010.03.049; Zhang L, 2011, IEEE T IMAGE PROCESS, V20, P2378, DOI 10.1109/TIP.2011.2109730; Zwarts MJ, 2003, MUSCLE NERVE, V28, P1, DOI 10.1002/mus.10358	74	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167954	10.1371/journal.pone.0167954	http://dx.doi.org/10.1371/journal.pone.0167954			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978535	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400043
J	Wang, GX; Yu, JY; Wen, L; Zhang, L; Mou, KJ; Zhang, D				Wang, Guang-xian; Yu, Jiao-yan; Wen, Li; Zhang, Lei; Mou, Ke-jie; Zhang, Dong			Risk Factors for the Rupture of Middle Cerebral Artery Bifurcation Aneurysms Using CT Angiography	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; MANAGEMENT; MORPHOLOGY; GROWTH; RATIO	Background and Purpose To investigate the clinical and morphological characteristics associated with risk factors for the rupture of bifurcation-type middle cerebral artery aneurysms (MCAAs). Methods A total of 169 consecutive patients with 177 bifurcation-type MCAAs were reviewed from August 2011 to January 2016. Based on the clinical and morphologic characteristics findings, the risk factors of aneurysm rupture were assessed using statistical methods. Results Age, cerebral atherosclerosis, no hypertension, hypertension grade 2 and coronary artery disease (CAD) were negatively correlated with aneurysm rupture. The mean diameter (MD) of the parent and two daughter arteries was negatively correlated with rupture. Aneurysms with irregularity, depth, width, maximum size, aspect ratio, depth-to-width ratio, bottleneck factor, and size ratio were positively correlated with rupture. The multivariate logistic regression model revealed that irregular shape (odds ratio (OR) 2.697) and aspect ratio (OR 3.723) were significantly and positively correlated with rupture, while cerebral atherosclerosis (OR 0.033), CAD (OR 0.080), and MD (OR 0.201) were negatively correlated with rupture. Receiver operating characteristic analysis revealed that the threshold value of the aspect ratio and MD were 0.96 and 2.43 mm, respectively. Conclusions Cerebral atherosclerosis and CAD are protective factors against rupture. Morphological characteristics such as an aneurysm with an irregular shape, a high aspect ratio (> 0.96) and a small MD (< 2.43 mm) are likely better predictors of rupture.	[Wang, Guang-xian; Yu, Jiao-yan; Wen, Li; Zhang, Lei; Zhang, Dong] Third Mil Med Univ, Xinqiao Hosp, Dept Radiol, Chongqing, Peoples R China; [Mou, Ke-jie] Third Mil Med Univ, Xinqiao Hosp, Dept Neurosurg, Chongqing, Peoples R China	Army Medical University; Army Medical University	Zhang, D (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Radiol, Chongqing, Peoples R China.	xqzhangdong@163.com						Bacigaluppi S, 2014, NEUROSURG REV, V37, P1, DOI 10.1007/s10143-013-0501-y; Baharoglu MI, 2012, J NEUROSURG, V116, P871, DOI 10.3171/2011.11.JNS11311; Castro MA, 2009, AM J NEURORADIOL, V30, P297, DOI 10.3174/ajnr.A1323; Dashti R, 2007, SURG NEUROL, V67, P6, DOI 10.1016/j.surneu.2006.08.027; Dhar S, 2008, NEUROSURGERY, V63, P185, DOI 10.1227/01.NEU.0000316847.64140.81; Elsharkawy A, 2013, NEUROSURGERY, V73, P825, DOI 10.1227/NEU.0000000000000116; Elsharkawy A, 2013, NEUROSURGERY, V73, P94, DOI 10.1227/01.neu.0000429842.61213.d5; Greving JP, 2014, LANCET NEUROL, V13, P59, DOI 10.1016/S1474-4422(13)70263-1; Heit JJ, 2015, J NEUROINTERV SURG; Inagawa T, 2010, WORLD NEUROSURG, V73, P155, DOI 10.1016/j.surneu.2009.03.007; Juvela S, 2008, J NEUROSURG, V108, P1052, DOI 10.3171/JNS/2008/108/5/1052; Kang HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142330; Kang HG, 2015, STROKE, V46, P3093, DOI 10.1161/STROKEAHA.115.011351; Lall RR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.2.FOCUS0921; Lin N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079635; Lin N, 2012, J NEUROSURG, V117, P913, DOI 10.3171/2012.7.JNS111766; Lindekleiv H, 2011, NEUROLOGY, V76, P637, DOI 10.1212/WNL.0b013e31820c30d3; Mackey J, 2012, J NEUROSURG, V117, P60, DOI 10.3171/2012.4.JNS111822; Matsukawa H, 2013, J NEUROSURG, V118, P978, DOI 10.3171/2012.11.JNS121210; Mehan WA, 2014, J NEUROINTERV SURG, V6, P761, DOI 10.1136/neurintsurg-2013-010944; Nader-Sepahi A, 2004, NEUROSURGERY, V54, P1343, DOI 10.1227/01.NEU.0000124482.03676.8B; Nahed BV, 2005, NEUROSURGERY, V57, P676, DOI 10.1227/01.NEU.0000175549.96530.59; Prat R, 2007, CLIN NEUROL NEUROSUR, V109, P431, DOI 10.1016/j.clineuro.2007.03.005; Rahman M, 2011, NEUROSURGERY, V68, P155, DOI 10.1227/NEU.0b013e3181ff357c; Rahman M, 2010, STROKE, V41, P916, DOI 10.1161/STROKEAHA.109.574244; Ryu CW, 2011, NEURORADIOLOGY, V53, P883, DOI 10.1007/s00234-010-0804-4; Sadatomo T, 2005, NEUROSURG REV, V28, P196, DOI 10.1007/s10143-005-0379-4; Sadatomo T, 2008, NEUROSURGERY, V62, P602, DOI 10.1227/01.NEU.0000311347.35583.0C; Thompson BG, 2015, STROKE, V46, P2368, DOI 10.1161/STR.0000000000000070; UJIIE H, 1993, STROKE, V24, P1850, DOI 10.1161/01.STR.24.12.1850; Villablanca JP, 2013, RADIOLOGY, V269, P258, DOI 10.1148/radiol.13121188; Wermer MJH, 2007, STROKE, V38, P1404, DOI 10.1161/01.STR.0000260955.51401.cd; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401; You SH, 2010, J NEUROL NEUROSUR PS, V81, P479, DOI 10.1136/jnnp.2008.169573; Yu J, 2010, J INT MED RES, V38, P1785, DOI 10.1177/147323001003800525	36	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0166654	10.1371/journal.pone.0166654	http://dx.doi.org/10.1371/journal.pone.0166654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977691	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400005
J	van den Bogert, CA; Souverein, PC; Brekelmans, CTM; Janssen, SWJ; Koeter, GH; Leufkens, HGM; Bouter, LM				van den Bogert, Cornelis A.; Souverein, Patrick C.; Brekelmans, Cecile T. M.; Janssen, Susan W. J.; Koeter, Gerard H.; Leufkens, Hubert G. M.; Bouter, Lex M.			Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug Trials	PLOS ONE			English	Article							RESEARCH ETHICS COMMITTEE; FOLLOW-UP; RANDOMIZED-TRIALS; RESEARCH PROJECTS; BIAS; ONCOLOGY; WASTE; REGISTRATION; PROTOCOLS; COHORT	The objective of this study was to investigate the occurrence and determinants of non-publication of clinical drug trials in the Netherlands. All clinical drug trials reviewed by the 28 Institutional Review Boards (IRBs) in the Netherlands in 2007 were followed-up from approval to publication. Candidate determinants were the sponsor, phase, applicant, centers, therapeutic effect expected, type of trial, approval status of the drug(s), drug type, participant category, oncology or other disease area, prospective registration, and early termination. The main outcome was publication as peer reviewed article. The percentage of trials that were published, crude and adjusted odds ratio (OR), and 95% confidence interval (CI) were used to quantify the associations between determinants and publication. In 2007, 622 clinical drug trials were reviewed by IRBs in the Netherlands. By the end of follow-up, 19 of these were rejected by the IRB, another 19 never started inclusion, and 10 were still running. Of the 574 trials remaining in the analysis, 334 (58%) were published as peer-reviewed article. The multivariable logistic regression model identified the following determinants with a robust, statistically significant association with publication: phase 2 (60% published; adjusted OR 2.6, 95% CI 1.1-5.9), phase 3 (73% published; adjusted OR 4.1, 95% CI 1.7-10.0), and trials not belonging to phase 1-4 (60% published; adjusted OR 3.2, 95% CI 1.5 to 6.5) compared to phase 1 trials (35% published); trials with a company or investigator as applicant (63% published) compared to trials with a Contract Research Organization (CRO) as applicant (50% published; adjusted OR 1.7; 95% CI 1.1-2.8); and multicenter trials also conducted in other EU countries (68% published; adjusted OR 2.2, 95% CI 1.1-4.4) or also outside the European Union (72% published; adjusted OR 2.0, 95% CI 1.0-4.0) compared to single-center trials (45% published). Trials that were not prospectively registered (48% published) had a lower likelihood of publication compared to prospectively registered trials (75% published; adjusted OR 0.5, 95% CI 0.3-0.8), as well as trials that were terminated early (33% published) compared to trials that were completed as planned (64% published; adjusted OR 0.2, 95% CI 0.1-0.3). The non-publication rate of clinical trials seems to have improved compared to previous inception cohorts, but is still far from optimal, in particular among phase 1, single-center, not prospectively registered, and early terminated trials.	[van den Bogert, Cornelis A.; Souverein, Patrick C.; Leufkens, Hubert G. M.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [van den Bogert, Cornelis A.; Brekelmans, Cecile T. M.; Koeter, Gerard H.] Cent Comm Res Involving Human Subjects CCMO, Bh The Hague, Netherlands; [van den Bogert, Cornelis A.; Janssen, Susan W. J.] Natl Inst Publ Hlth & Environm RIVM, Div Publ Hlth & Hlth Serv, Bilthoven, Netherlands; [Bouter, Lex M.] Vrije Univ Amsterdam Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Souverein, PC (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands.	p.c.souverein@uu.nl	Bouter, Lex/X-1003-2019	Bouter, Lex/0000-0002-2659-5482	Ministry of Health, Welfare and Sports of the Netherlands	Ministry of Health, Welfare and Sports of the Netherlands	The Ministry of Health, Welfare and Sports of the Netherlands provided an unrestricted research grant for this study and had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardy AH, 1998, BRIT J CLIN PHARMACO, V46, P147, DOI 10.1046/j.1365-2125.1998.00759.x; Blumle A, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2008.024521; Briel M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4539; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; Chen RJ, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i637; de Jong JP, 2010, J CLIN EPIDEMIOL, V63, P1342, DOI 10.1016/j.jclinepi.2010.01.018; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Decullier E, 2009, PLOS MED, V6, P202, DOI 10.1371/journal.pmed.1000034; DICKERSIN K, 1992, JAMA-J AM MED ASSOC, V267, P374, DOI 10.1001/jama.267.3.374; Dickersin K, 1997, AIDS EDUC PREV, V9, P15; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; EASTERBROOK PJ, 1991, LANCET, V337, P867, DOI 10.1016/0140-6736(91)90201-Y; EASTERBROOK PJ, 1992, J ROY SOC MED, V85, P71; HEMMINKI E, 1980, BRIT MED J, V280, P833, DOI 10.1136/bmj.280.6217.833; Hewitt C, 2008, BMJ-BRIT MED J, V336, P23, DOI 10.1136/bmj.39379.359560.AD; Hole OP, 2009, EUR J CLIN PHARMACOL, V65, P315, DOI 10.1007/s00228-008-0601-8; Huser V, 2013, J AM MED INFORM ASSN, V20, pE169, DOI 10.1136/amiajnl-2012-001501; Ioannidis JPA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7089; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Jones CW, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6104; Kasenda B, 2014, JAMA-J AM MED ASSOC, V311, P1045, DOI 10.1001/jama.2014.1361; Lampert A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144973; Massey PR, 2016, ONCOLOGIST, V21, P261, DOI 10.1634/theoncologist.2015-0516; Mattila Taina, 2011, Eur Neuropsychopharmacol, V21, P500, DOI 10.1016/j.euroneuro.2010.10.005; Moher D, 2015, LANCET; Moorthy VS, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001819; Nurgat ZA, 2005, BRIT J CANCER, V92, P1001, DOI 10.1038/sj.bjc.6602423; Pich J, 2003, LANCET, V361, P1015, DOI 10.1016/S0140-6736(03)12799-7; Ramsey S, 2008, ONCOLOGIST, V13, P925, DOI 10.1634/theoncologist.2008-0133; Salzberg M, 2012, RAMBAM MAIMONIDES ME, V3, DOI [10.5041/RMMJ.1074, 10.5041/RMMJ.10074]; Shamliyan T, 2012, PEDIATRICS, V129, pE1291, DOI 10.1542/peds.2010-2847; SIMES RJ, 1986, J CLIN ONCOL, V4, P1529, DOI 10.1200/JCO.1986.4.10.1529; Song FJ, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-79; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Stewart LA, 1996, INT J TECHNOL ASSESS, V12, P264, DOI 10.1017/S0266462300009612; Sune P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054583; Tam VC, 2011, J CLIN ONCOL, V29, P3133, DOI 10.1200/JCO.2010.33.3922; Van den Bogert CA, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3899; van den Bogert CA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007827; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027	41	15	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167709	10.1371/journal.pone.0167709	http://dx.doi.org/10.1371/journal.pone.0167709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973571	Green Published, gold			2022-12-27	WOS:000392754300042
J	Wen, KX; Milic, J; El-Khodor, B; Dhana, K; Nano, J; Pulido, T; Kraja, B; Zaciragic, A; Bramer, WM; Troup, J; Chowdhury, R; Ikram, MA; Dehghan, A; Muka, T; Franco, OH				Wen, Ke-xin; Milic, Jelena; El-Khodor, Bassem; Dhana, Klodian; Nano, Jana; Pulido, Tammy; Kraja, Bledar; Zaciragic, Asija; Bramer, Wichor M.; Troup, John; Chowdhury, Rajiv; Ikram, M. Arfam; Dehghan, Abbas; Muka, Taulant; Franco, Oscar H.			The Role of DNA Methylation and Histone Modifications in Neurodegenerative Diseases: A Systematic Review	PLOS ONE			English	Review							MESSENGER-RNA EXPRESSION; PRECURSOR PROTEIN GENE; OXIDE SYNTHASE GENE; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; PROMOTER METHYLATION; ALPHA-SYNUCLEIN; NEUROTROPHIC FACTOR; EPIGENETIC MODIFICATIONS; CARDIOVASCULAR-DISEASE	Importance Epigenetic modifications of the genome, such as DNA methylation and histone modifications, have been reported to play a role in neurodegenerative diseases (ND) such as Alzheimer's disease (AD) and Parkinson's disease (PD). Objective To systematically review studies investigating epigenetic marks in AD or PD. Methods Eleven bibliographic databases (Embase. com, Medline (Ovid), Web-of-Science, Scopus, PubMed, Cinahl (EBSCOhost), Cochrane Central, ProQuest, Lilacs, Scielo and Google Scholar) were searched until July 11th 2016 to identify relevant articles. We included all randomized controlled trials, cohort, case-control and cross-sectional studies in humans that examined associations between epigenetic marks and ND. Two independent reviewers, with a third reviewer available for disagreements, performed the abstract and full text selection. Data was extracted using a pre-designed data collection form. Results Of 6,927 searched references, 73 unique case-control studies met our inclusion criteria. Overall, 11,453 individuals were included in this systematic review (2,640 AD and 2,368 PD outcomes). There was no consistent association between global DNA methylation pattern and any ND. Studies reported epigenetic regulation of 31 genes (including cell communication, apoptosis, and neurogenesis genes in blood and brain tissue) in relation to AD and PD. Methylation at the BDNF, SORBS3 and APP genes in AD were the most consistently reported associations. Methylation of alpha-synuclein gene ( SNCA) was also found to be associated with PD. Seven studies reported histone protein alterations in AD and PD. Conclusion Many studies have investigated epigenetics and ND. Further research should include larger cohort or longitudinal studies, in order to identify clinically significant epigenetic changes. Identifying relevant epigenetic changes could lead to interventional strategies in ND.	[Wen, Ke-xin; Milic, Jelena; Dhana, Klodian; Nano, Jana; Pulido, Tammy; Zaciragic, Asija; Ikram, M. Arfam; Dehghan, Abbas; Muka, Taulant; Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [El-Khodor, Bassem; Troup, John] Metagenics Inc, Res & Dev, Aliso Viejo, CA USA; [Kraja, Bledar] Univ Med, Fac Med, Dept Biomed Sci, Tirana, Albania; [Kraja, Bledar] Univ Hosp Ctr Mother Teresa, Univ Clin Gastrohepatol, Tirana, Albania; [Bramer, Wichor M.] Erasmus MC, Med Lib, Rotterdam, Netherlands; [Chowdhury, Rajiv] Univ Cambridge, Cardiovasc Epidemiol Unit, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England	Erasmus University Rotterdam; Erasmus MC; University Hospital Center Mother Teresa (QSUT); Erasmus University Rotterdam; Erasmus MC; University of Cambridge	Wen, KX; Muka, T (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	k.wen@erasmusmc.nl; t.muka@erasmusmc.nl	Dehghan, Abbas/ABE-7377-2020; Ikram, M. Arfan/AAM-5225-2021; Franco, Óscar H/ABE-2305-2020; Chowdhury, Rajiv/AHB-1253-2022; Bramer, Wichor/P-5044-2014; Dehghan, Abbas/B-9896-2008	Franco, Óscar H/0000-0002-4606-4929; El-Khodor, Bassem/0000-0002-3509-1753; Bramer, Wichor/0000-0003-2681-9180; Zaciragic, Asija/0000-0002-3293-4698; Dehghan, Abbas/0000-0001-6403-016X; Dhana, Klodian/0000-0002-6397-7009; Milic, Jelena/0000-0002-3596-5908	Metagenics Inc.; Erasmus Mundus Western Balkans (ERAWEB) - European Commission; Netherlands Organization for Health Research (NWO) [ZonMW VENI 916.12.154]; EUR Fellowship; MRC [G0800270, MR/L003120/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, RG/13/13/30194] Funding Source: researchfish; Medical Research Council [MR/L003120/1, G0800270] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish	Metagenics Inc.; Erasmus Mundus Western Balkans (ERAWEB) - European Commission; Netherlands Organization for Health Research (NWO); EUR Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was sponsored and funded by Metagenics Inc. Metagenics Inc. had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review or approval of the manuscript. The funder/sponsor did not have the ability to veto publication of study results. KW and TM reported receiving research support from Metagenics Inc. JM, KD, JM, JN, BK and AZ have been financially supported by Erasmus Mundus Western Balkans (ERAWEB), a project funded by the European Commission. Additional support was provided to AD from the Netherlands Organization for Health Research (NWO) (ZonMW VENI 916.12.154) and the EUR Fellowship. BE and JT worked as scientists at Metagenics Inc. OHF reported receiving grants or research support from Metagenics Inc. The funder provided research support for KW, TM and OHF and support in the form of salaries for JT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ai SX, 2014, J NEUROL SCI, V337, P123, DOI 10.1016/j.jns.2013.11.033; AN SJ, 1994, BIOCHEM MOL BIOL INT, V33, P835; Anderson KW, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9098-1; Aquilano K, 2008, NEUROCHEM RES, V33, P2416, DOI 10.1007/s11064-008-9697-6; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Armentero MT, 2011, PHARMACOL THERAPEUT, V132, P280, DOI 10.1016/j.pharmthera.2011.07.004; Bai G, 2015, HUM MOL GENET, V24, P1441, DOI 10.1093/hmg/ddu561; Bajic V, 2015, J ALZHEIMERS DIS, V43, P1251, DOI 10.3233/JAD-141674; Bakulski KM, 2012, J ALZHEIMERS DIS, V29, P571, DOI 10.3233/JAD-2012-111223; Banzhaf-Strathmann J, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-16; Barrachina M, 2009, J NEUROPATH EXP NEUR, V68, P880, DOI 10.1097/NEN.0b013e3181af2e46; Basile AM, 1997, BIOCHEM ARCH, V13, P189; Bednarska-Makaruk M, 2016, EXP GERONTOL, V81, P83, DOI 10.1016/j.exger.2016.05.002; Bernstein AI, 2016, 5 HYDROXYMETHYLATION; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bird T, 2003, ANN NEUROL, V54, pS29, DOI 10.1002/ana.10572; Bollati V, 2011, BRAIN BEHAV IMMUN, V25, P1078, DOI 10.1016/j.bbi.2011.01.017; Brohede J, 2010, J NEUROGENET, V24, P179, DOI 10.3109/01677063.2010.503978; Broom L, 2011, FREE RADICAL BIO MED, V50, P633, DOI 10.1016/j.freeradbiomed.2010.12.026; Cai M, 2011, INT J NEUROSCI, V121, P497, DOI 10.3109/00207454.2011.580866; Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239; Carboni L, 2015, NEUROSCI LETT, V605, P44, DOI 10.1016/j.neulet.2015.08.012; Celarain N, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0202-9; Chan GC, 2005, J IMMUNOL, V175, P3846, DOI 10.4049/jimmunol.175.6.3846; CHANG L, 2014, PLOS ONE, V9; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Chouliaras L, 2013, NEUROBIOL AGING, V34, P2091, DOI 10.1016/j.neurobiolaging.2013.02.021; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Condliffe D, 2014, NEUROBIOL AGING, V35, P1850, DOI 10.1016/j.neurobiolaging.2014.02.002; Coppede F, 2016, MECH AGEING DEV; Coppede F, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00220; Coppieters N, 2014, NEUROBIOL AGING, V35, P1334, DOI 10.1016/j.neurobiolaging.2013.11.031; Coupland KG, 2014, MOVEMENT DISORD, V29, P1606, DOI 10.1002/mds.25784; Curradi M, 2002, MOL CELL BIOL, V22, P3157, DOI 10.1128/MCB.22.9.3157-3173.2002; D'Addario C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039186; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Di Francesco A, 2015, BRAIN BEHAV IMMUN, V45, P139, DOI 10.1016/j.bbi.2014.11.002; Di Francesco A, 2013, J ALZHEIMERS DIS, V37, P3, DOI 10.3233/JAD-130506; Edgunlu TG, 2013, BALK MED J, V30, P268, DOI 10.5152/balkanmedj.2013.7455; Ernst C, 2009, ARCH GEN PSYCHIAT, V66, P22, DOI 10.1001/archpsyc.66.1.22; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Fernandez AF, 2012, GENOME; Ferri E, 2016, J NEUROL SCI, V362, P283, DOI 10.1016/j.jns.2016.02.004; Foraker J, 2015, J ALZHEIMERS DIS, V48, P745, DOI 10.3233/JAD-143060; Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134; Furuya TK, 2012, NEUROCHEM INT, V61, P973, DOI 10.1016/j.neuint.2012.07.014; Gebremedhin KG, 2016, NEUROSCI LETT, V627, P121, DOI 10.1016/j.neulet.2016.05.060; Ghani M, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.07.038; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Graeff J, 2011, PHYSIOL REV, V91, P603, DOI 10.1152/physrev.00012.2010; Granic I, 2009, J ALZHEIMERS DIS, V16, P809, DOI 10.3233/JAD-2009-0976; Grosser C, 2014, NEUROSCI LETT, V566, P241, DOI 10.1016/j.neulet.2014.02.046; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Grundemann J, 2011, METHODS MOL BIOL, V755, P363, DOI 10.1007/978-1-61779-163-5_30; Harrison PJ, 2011, BIOL PSYCHIAT, V69, P102, DOI 10.1016/j.biopsych.2010.09.008; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Henikoff S, 1997, TRENDS GENET, V13, P293, DOI 10.1016/S0168-9525(97)01219-5; Hernandez HG, 2014, AM J ALZHEIMERS DIS, V29, P50, DOI 10.1177/1533317513505132; Hou YP, 2013, ACTA NEUROPSYCHIATR, V25, P66, DOI 10.1111/j.1601-5215.2012.00662.x; Humphries CE, 2015, J ALZHEIMERS DIS, V44, P977, DOI 10.3233/JAD-141989; Ito H, 2007, J NEUROCHEM, V100, P545, DOI 10.1111/j.1471-4159.2006.04222.x; Iwata A, 2014, HUM MOL GENET, V23, P648, DOI 10.1093/hmg/ddt451; Jakovcevski M, 2012, NAT MED, V18, P1194, DOI 10.1038/nm.2828; Januar V, 2015, INT J EPIDEMIOL; Jarome TJ, 2014, PROG MOL BIOL TRANSL, V128, P1, DOI 10.1016/B978-0-12-800977-2.00001-2; Ji HH, 2015, NEUROSCI LETT, V606, P24, DOI 10.1016/j.neulet.2015.08.027; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jowaed A, 2010, J NEUROSCI, V30, P6355, DOI 10.1523/JNEUROSCI.6119-09.2010; Karch Celeste M, 2015, Biol Psychiatry, V77, P43, DOI 10.1016/j.biopsych.2014.05.006; Kaut O, 2014, DEMENT GERIATR COGN, V38, P10, DOI 10.1159/000357126; Kaut O, 2012, NEUROGENETICS, V13, P87, DOI 10.1007/s10048-011-0308-3; Keller S, 2010, ARCH GEN PSYCHIAT, V67, P258, DOI 10.1001/archgenpsychiatry.2010.9; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Kowal SL, 2013, MOVEMENT DISORD, V28, P311, DOI 10.1002/mds.25292; Lardenoije R, 2015, PROG NEUROBIOL, V131, P21, DOI 10.1016/j.pneurobio.2015.05.002; Lashley T, 2014, NEUROPATHOL APPL NEU; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Lin QL, 2012, NEUROSCI LETT, V507, P147, DOI 10.1016/j.neulet.2011.12.007; Luchsinger JA, 2007, ARCH NEUROL-CHICAGO, V64, P86, DOI 10.1001/archneur.64.1.86; Luttmer R, 2013, OBES RES CLIN PRACT, V7, pE106, DOI 10.1016/j.orcp.2012.06.001; Ma SL, 2016, J PSYCHIATR RES, V76, P143, DOI 10.1016/j.jpsychires.2016.02.010; Masliah E, 2013, EPIGENETICS-US, V8, P1030, DOI 10.4161/epi.25865; Mastroeni D., 2016, NEUROEPIGENETICS, V6, P26, DOI DOI 10.1016/J.NEPIG.2016.04.002; Mastroeni D, 2010, NEUROBIOL AGING, V31, P2025, DOI 10.1016/j.neurobiolaging.2008.12.005; Matsumoto L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015522; Matsuyama M, 2005, GENES CELLS, V10, P421, DOI 10.1111/j.1365-2443.2005.00844.x; Mendioroz M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0183-0; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Monti B, 2010, NEUROTOX RES, V17, P130, DOI 10.1007/s12640-009-9090-5; Muka T, 2016, NUTR METAB CARDIOVAS, V26, P553, DOI 10.1016/j.numecd.2016.04.002; Muka T, 2016, INT J CARDIOL, V212, P174, DOI 10.1016/j.ijcard.2016.03.062; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Nagata T, 2015, DEMENT GER COGN D EX, V5, P64, DOI 10.1159/000375367; Narayan PJ, 2015, NEUROBIOL DIS, V74, P281, DOI 10.1016/j.nbd.2014.11.023; Silva PNO, 2008, J ALZHEIMERS DIS, V13, P173; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; Nielsen SS, 2015, PARKINSONISM RELAT D, V21, P355, DOI 10.1016/j.parkreldis.2015.01.007; Nielsen SS, 2012, J PARKINSON DIS, V2, P303, DOI 10.3233/JPD-012129; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pan WH, 1998, NEUROPHARMACOLOGY, V37, P1553, DOI 10.1016/S0028-3908(98)00141-5; Park G, 2016, J BIOL CHEM, V291, P3531, DOI 10.1074/jbc.M115.675488; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Perry RT, 2001, NEUROBIOL AGING, V22, P873, DOI 10.1016/S0197-4580(01)00291-3; Piaceri Irene, 2013, Front Biosci (Elite Ed), V5, P167; Plagg B, 2015, CURR ALZHEIMER RES, V12, P752, DOI 10.2174/1567205012666150710114256; Popat RA, 2011, EUR J NEUROL, V18, P756, DOI 10.1111/j.1468-1331.2011.03353.x; Rao JS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.55; Ribel-Madsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051302; Rickards H, 2005, J NEUROL NEUROSUR PS, V76, pI48, DOI 10.1136/jnnp.2004.060426; Riedl AG, 1998, MOVEMENT DISORD, V13, P212, DOI 10.1002/mds.870130204; Sanchez-Mut JV, 2013, BRAIN, V136, P3018, DOI 10.1093/brain/awt237; Savica R, 2013, JAMA NEUROL, V70, P1396, DOI 10.1001/jamaneurol.2013.3579; Schmitt I, 2015, MOVEMENT DISORD, V30, P1794, DOI 10.1002/mds.26319; SCHMITT M, 1979, ACTA BIOL MED GER, V38, P683; SCHWOB NG, 1990, ANN NEUROL, V28, P91, DOI 10.1002/ana.410280117; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shen SM, 2008, J MOL NEUROSCI, V35, P13, DOI 10.1007/s12031-007-9014-x; Shulman JM, 2011, ANNU REV PATHOL-MECH, V6, P193, DOI 10.1146/annurev-pathol-011110-130242; Siegmund KD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000895; Silva PN, 2014, J ALZHEIMERS DIS, V38, P165, DOI 10.3233/JAD-130428; Song C, 2010, MOL PHARMACOL, V77, P621, DOI 10.1124/mol.109.062174; Song Y, 2014, NEUROSCI LETT, V569, P85, DOI 10.1016/j.neulet.2014.03.076; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Su XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144724; Sun HS, 2013, NEUROPSYCHOPHARMACOL, V38, P124, DOI 10.1038/npp.2012.73; Sung YM, 2013, EXP NEUROL, V239, P192, DOI 10.1016/j.expneurol.2012.10.005; Tan YY, 2014, PARKINSONISM RELAT D, V20, P308, DOI 10.1016/j.parkreldis.2013.12.002; Tan YY, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0052-6; Tannorella P, 2015, NEUROSCI LETT, V600, P143, DOI 10.1016/j.neulet.2015.06.009; Teich AF, 2015, NEUROTHERAPEUTICS, V12, P29, DOI 10.1007/s13311-014-0327-5; Terry MB, 2011, EPIGENETICS-US, V6, P828, DOI 10.4161/epi.6.7.16500; Tomita H, 2004, BIOL PSYCHIAT, V55, P346, DOI 10.1016/j.biopsych.2003.10.013; Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830; Viaggi C, 2009, NEUROPHARMACOLOGY, V56, P1075, DOI 10.1016/j.neuropharm.2009.03.003; Sanchez-Mut JV, 2014, HIPPOCAMPUS, V24, P363, DOI 10.1002/hipo.22245; Villar-Menendez I, 2014, NEUROBIOL DIS, V69, P206, DOI 10.1016/j.nbd.2014.05.030; Wang SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002698; Watson CT, 2016, GENOME MED, V8, DOI 10.1186/s13073-015-0258-8; Wei L, 2014, ARQ BRAS CARDIOL, V102, P481, DOI 10.5935/abc.20140054; West RL, 1995, J MOL NEUROSCI, V6, P141, DOI 10.1007/BF02736773; Wullner U, 2016, J NEUROCHEM; Yu L, 2015, JAMA NEUROL, V72, P15, DOI 10.1001/jamaneurol.2014.3049; Zhang KL, 2012, PROTEOMICS, V12, P1261, DOI 10.1002/pmic.201200010; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	148	66	71	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167201	10.1371/journal.pone.0167201	http://dx.doi.org/10.1371/journal.pone.0167201			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973581	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300020
J	Andradi-Brown, DA; Macaya-Solis, C; Exton, DA; Gress, E; Wright, G; Rogers, AD				Andradi-Brown, Dominic A.; Macaya-Solis, Consuelo; Exton, Dan A.; Gress, Erika; Wright, Georgina; Rogers, Alex D.			Assessing Caribbean Shallow and Mesophotic Reef Fish Communities Using Baited-Remote Underwater Video (BRUV) and Diver-Operated Video (DOV) Survey Techniques	PLOS ONE			English	Article							FLIGHT INITIATION DISTANCE; VISUAL CENSUS; MIGRATION PATTERNS; TEMPERATE; ASSEMBLAGES; DENSITY; PROTECTION; STATIONS; BEHAVIOR; IMPACTS	Fish surveys form the backbone of reef monitoring and management initiatives throughout the tropics, and understanding patterns in biases between techniques is crucial if outputs are to address key objectives optimally. Often biases are not consistent across natural environmental gradients such as depth, leading to uncertainty in interpretation of results. Recently there has been much interest in mesophotic reefs (reefs from 30-150 m depth) as refuge habitats from fishing pressure, leading to many comparisons of reef fish communities over depth gradients. Here we compare fish communities using stereo-video footage recorded via baited remote underwater video (BRUV) and diver-operated video (DOV) systems on shallow and mesophotic reefs in the Mesoamerican Barrier Reef, Caribbean. We show inconsistent responses across families, species and trophic groups between methods across the depth gradient. Fish species and family richness were higher using BRUV at both depth ranges, suggesting that BRUV is more appropriate for recording all components of the fish community. Fish length distributions were not different between methods on shallow reefs, yet BRUV recorded more small fish on mesophotic reefs. However, DOV consistently recorded greater relative fish community biomass of herbivores, suggesting that studies focusing on herbivores should consider using DOV. Our results highlight the importance of considering what component of reef fish community researchers and managers are most interested in surveying when deciding which survey technique to use across natural gradients such as depth.	[Andradi-Brown, Dominic A.; Macaya-Solis, Consuelo; Rogers, Alex D.] Univ Oxford, Dept Zool, Tinbergen Bldg,South Parks Rd, Oxford, England; [Andradi-Brown, Dominic A.; Exton, Dan A.; Gress, Erika; Wright, Georgina] Operat Wallacea, Wallace House, Spilsby, Lincolnshire, England; [Macaya-Solis, Consuelo] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, Santiago, Chile	University of Oxford; Universidad de Chile	Andradi-Brown, DA (corresponding author), Univ Oxford, Dept Zool, Tinbergen Bldg,South Parks Rd, Oxford, England.; Andradi-Brown, DA (corresponding author), Operat Wallacea, Wallace House, Spilsby, Lincolnshire, England.	dominic.andradi-brown@zoo.ox.ac.uk	Exton, Dan/L-5695-2019	Exton, Dan/0000-0001-8885-5828	Fisheries Society of the British Isles PhD Studentship; Operation Wallacea	Fisheries Society of the British Isles PhD Studentship; Operation Wallacea	DAAB was funded by a Fisheries Society of the British Isles (http://www.fsbi.org.uk) PhD Studentship. Operation Wallacea (www.opwall.com) provided fieldwork support for DAAB, EG, GW, DAE and ADR. Operation Wallacea provided support in the form of salaries for authors DAAB, EG, GW and DAE, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'authors contributions' section.	Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andradi-Brown D, 2016, MESOPHOTIC CORAL ECO, P67, DOI DOI 10.1007/S10530-011-0005-Z; Andradi-Brown DA, 2016, REEF ENCOUNTER, V31, P26; Andradi-Brown DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156641; Bejarano I, 2014, CORAL REEFS, V33, P313, DOI 10.1007/s00338-014-1125-6; Bernard ATF, 2012, MAR ECOL PROG SER, V471, P235, DOI 10.3354/meps10039; Bowman A.W., 2014, R PACKAGE SM NONPARA; Box SJ, 2011, P 63 GULF CAR FISH I, P43; Chapman MR, 2000, ENVIRON BIOL FISH, V57, P11, DOI 10.1023/A:1004545724503; Cole RG, 2007, MAR BIOL, V150, P1379, DOI 10.1007/s00227-006-0420-3; de la Moriniere EC, 2003, ESTUAR COAST SHELF S, V57, P1079, DOI 10.1016/S0272-7714(03)00011-8; de la Moriniere EC, 2002, ESTUAR COAST SHELF S, V55, P309, DOI 10.1006/ecss.2001.0907; Doiron S, 2014, TOUR MANAG PERSPECT, V10, P19, DOI 10.1016/j.tmp.2013.12.003; Edgar GJ, 2004, J EXP MAR BIOL ECOL, V308, P269, DOI 10.1016/j.jembe.2004.03.004; English S., 1997, SURVEY MANUAL TROPIC; FEDDERN HENRY A., 1965, BULL MAR SCI, V15, P896; Gobert B, 2005, FISH RES, V73, P159, DOI 10.1016/j.fishres.2004.12.008; Goetze JS, 2015, J EXP MAR BIOL ECOL, V462, P74, DOI 10.1016/j.jembe.2014.10.004; Gotanda KM, 2009, BEHAV ECOL SOCIOBIOL, V63, P1563, DOI 10.1007/s00265-009-0750-5; Harasti D, 2015, J EXP MAR BIOL ECOL, V463, P173, DOI 10.1016/j.jembe.2014.12.003; Harvey E, 2004, MAR FRESHWATER RES, V55, P573, DOI 10.1071/MF03130; Harvey ES, 2012, CORAL REEFS, V31, P939, DOI 10.1007/s00338-012-0955-3; Harvey ES, 2007, MAR ECOL PROG SER, V350, P245, DOI 10.3354/meps07192; HELFMAN GS, 1982, ANIM BEHAV, V30, P317, DOI 10.1016/S0003-3472(82)80042-0; Hinderstein LM, 2010, CORAL REEFS, V29, P247, DOI 10.1007/s00338-010-0614-5; Holmes TH, 2013, LIMNOL OCEANOGR-METH, V11, P337, DOI 10.4319/lom.2013.11.337; Januchowski-Hartley FA, 2012, MAR ECOL PROG SER, V469, P113, DOI 10.3354/meps09971; Januchowski-Hartley FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022761; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Langlois TJ, 2010, AQUAT BIOL, V9, P155, DOI 10.3354/ab00235; Langlois TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045973; Lindfield SJ, 2014, METHODS ECOL EVOL, V5, P1061, DOI 10.1111/2041-210X.12262; Lindfield SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092628; Micheli F, 2014, BIOL CONSERV, V171, P186, DOI 10.1016/j.biocon.2013.12.029; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pelletier D, 2011, FISH RES, V107, P84, DOI 10.1016/j.fishres.2010.10.011; PRIEDE IG, 1994, J MAR BIOL ASSOC UK, V74, P481, DOI 10.1017/S0025315400047615; R Core Team, 2021, R LANGUAGE ENV STAT; Roff G, 2012, TRENDS ECOL EVOL, V27, P404, DOI 10.1016/j.tree.2012.04.007; Sanderson SL, 1986, B MARINE SCI, V39; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Sieber A, 2010, UNDERWATER TECHNOL, V29, DOI 10.3723/ut.29.073; Taylor MD, 2013, FISH RES, V140, P96, DOI 10.1016/j.fishres.2012.12.013; Tessier A, 2013, AQUAT BIOL, V18, P229, DOI 10.3354/ab00506; Thompson AA, 1997, MAR ECOL PROG SER, V154, P53, DOI 10.3354/meps154053; Titus BM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119645; Wand M, 1995, KEMSMOOTH FUNCTIONS; Watson DL, 2007, MAR FRESHW BEHAV PHY, V40, P85, DOI 10.1080/10236240701393263; Watson DL, 2010, MAR BIOL, V157, P1237, DOI 10.1007/s00227-010-1404-x; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010	54	31	31	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168235	10.1371/journal.pone.0168235	http://dx.doi.org/10.1371/journal.pone.0168235			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959907	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900050
J	Chang, JTH; Wang, F; Chapin, W; Huang, RS				Chang, Jeremy T-H.; Wang, Fan; Chapin, William; Huang, R. Stephanie			Identification of MicroRNAs as Breast Cancer Prognosis Markers through the Cancer Genome Atlas	PLOS ONE			English	Article							DOWN-REGULATION; CELL-PROLIFERATION; TUMOR-SUPPRESSOR; DNA-REPAIR; TARGET PREDICTION; HMSH2 EXPRESSION; METASTASIS; INVASION; GENE; MIGRATION	Breast cancer is the second-most common cancer and second-leading cause of cancer mortality in American women. The dysregulation of microRNAs ( miRNAs) plays a key role in almost all cancers, including breast cancer. We comprehensively analyzed miRNA expression, global gene expression, and patient survival from the Cancer Genomes Atlas (TCGA) to identify clinically relevant miRNAs and their potential gene targets in breast tumors. In our analysis, we found that increased expression of 12 mature miRNAs D hsa-miR-320a, hsami-R-361-5p, hsa-miR-103a-3p, hsa-miR-21-5p, hsa-miR-374b-5p, hsa-miR-140-3p, hsami-R-25-3p, hsa-miR-651-5p, hsa-miR-200c-3p, hsa-miR-30a-5p, hsa-miR-30c-5p, and hsa-let-7i-5p D each predicted improved breast cancer survival. Of the 12 miRNAs, miR320a, miR-361-5p, miR-21-5p, miR-103a-3p were selected for further analysis. By correlating global gene expression with miRNA expression and then employing miRNA target prediction analysis, we suggest that the four miRNAs may exert protective phenotypes by targeting breast oncogenes that contribute to patient survival. We propose that miR-320a targets the survival-associated genes RAD51, RRP1B, and TDG; miR-361-5p targets ARCN1; and miR-21-5p targets MSH2, RMND5A, STAG2, and UBE2D3. The results of our stringent bioinformatics approach for identifying clinically relevant miRNAs and their targets indicate that miR-320a, miR-361-5p, and miR-21-5p may contribute to breast cancer survival.	[Chang, Jeremy T-H.] Univ Chicago, Biol Sci Coll Div, Chicago, IL 60637 USA; [Wang, Fan; Huang, R. Stephanie] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Chapin, William] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Huang, RS (corresponding author), Univ Chicago, Dept Med, Chicago, IL 60637 USA.	rhuang@medicine.bsd.uchicago.edu	Wang, Fan/Z-3850-2019	Chang, Jeremy/0000-0002-2680-4934; Huang, R. Stephanie/0000-0002-9862-0368; Chapin, William/0000-0001-9616-8462	National Institutes of Health/NIDDK [2T35DK062719-26]; National Institute of Health [K08GM089941, R21 CA139278, UO1GM61393]; University of Chicago Support Grant [P30 CA14599]; Breast Cancer SPORE Career Development Award [CA125183]; National Center for Advancing Translational Sciences of the National Institute of Health [UL1RR024999]; Circle of Service Foundation Early Career Investigator award; Avon Foundation Research Grant; Conquer Cancer Foundation of ASCO Translational Research Professorship award	National Institutes of Health/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago Support Grant; Breast Cancer SPORE Career Development Award; National Center for Advancing Translational Sciences of the National Institute of Health; Circle of Service Foundation Early Career Investigator award; Avon Foundation Research Grant; Conquer Cancer Foundation of ASCO Translational Research Professorship award	WC received support from National Institutes of Health/NIDDK grant 2T35DK062719-26. RSH received supported from the National Institute of Health [grant K08GM089941, R21 CA139278, UO1GM61393]; University of Chicago Support Grant [#P30 CA14599]; Breast Cancer SPORE Career Development Award [CA125183]; the National Center for Advancing Translational Sciences of the National Institute of Health [UL1RR024999]; Circle of Service Foundation Early Career Investigator award, Avon Foundation Research Grant, and a Conquer Cancer Foundation of ASCO Translational Research Professorship award In Memory of Merrill J. Egorin, MD (awarded to Dr. MJ Ratain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2013, BIOCHEM BIOPH RES CO, V437, P557, DOI 10.1016/j.bbrc.2013.06.114; Bock N, 2000, ANTICANCER RES, V20, P119; Bockhorn J, 2013, BREAST CANCER RES TR, V137, P373, DOI 10.1007/s10549-012-2346-4; Chang CW, 2016, ONCOTARGET, V7, P16462, DOI 10.18632/oncotarget.7656; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054213; Chintamani, 2007, Int Semin Surg Oncol, V4, P5, DOI 10.1186/1477-7800-4-5; D'Ippolito E, 2016, CANC RES; Dalton SR, 2012, EPIGENOMICS-UK, V4, P459, DOI [10.2217/EPI.12.36, 10.2217/epi.12.36]; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Egeland NG, 2015, INT J MOL SCI, V16, P24243, DOI 10.3390/ijms161024243; Evers L, 2014, GENOME MED, V6, DOI 10.1186/gm526; Feng ZM, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1655-5; Fu J, 2014, BIOCHEM BIOPH RES CO, V445, P314, DOI 10.1016/j.bbrc.2014.01.174; Haakensen VD, 2016, INT J CANCER, V139, P1117, DOI 10.1002/ijc.30142; He DX, 2014, MOL PHARMACOL, V86, P536, DOI 10.1124/mol.114.092759; Hemmatzadeh M, 2016, BIOMED PHARMACOTHER, V78, P129, DOI 10.1016/j.biopha.2016.01.026; Huang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100993; Huo D, 2016, ONCOTARGET; Kent OA, 2006, ONCOGENE, V25, P6188, DOI 10.1038/sj.onc.1209913; Kim MS, 2012, NEOPLASMA, V59, P524, DOI 10.4149/neo_2012_067; Knezevic J, 2015, ONCOGENE, V34, P5997, DOI 10.1038/onc.2015.48; Kobayashi H, 2015, BIOCHEM BIOPH RES CO, V467, P121, DOI 10.1016/j.bbrc.2015.09.106; Kuang Y, 2016, ASIAN PAC J TROP MED, V9, P456, DOI 10.1016/j.apjtm.2016.03.025; Le Scodan R, 2010, INT J RADIAT ONCOL, V78, P328, DOI 10.1016/j.ijrobp.2009.07.1735; Lee M, 2014, ONCOGENE, V33, P1818, DOI 10.1038/onc.2013.133; Li J, 2014, NUCLEIC ACIDS RES, V42, P458, DOI 10.1093/nar/gkt839; Li Q, 2014, ONCOGENE, V33, P2589, DOI 10.1038/onc.2013.226; Li WT, 2016, INT J ONCOL, V48, P1155, DOI 10.3892/ijo.2016.3319; Lira D, 2015, EUR REV MED PHARMACO, V19, P3229; Liu DC, 2014, BIOCHEM BIOPH RES CO, V445, P151, DOI 10.1016/j.bbrc.2014.01.140; Liu L, 2014, MOL CANCER RES, V12, P1597, DOI 10.1158/1541-7786.MCR-14-0201; Liu Y, 2015, BREAST CANCER RES TR, V152, P183, DOI 10.1007/s10549-015-3460-x; Lord CJ, 2007, NAT STRUCT MOL BIOL, V14, P461, DOI 10.1038/nsmb0607-461; Lu MR, 2015, SCI REP-UK, V5, DOI 10.1038/srep08735; Lu YH, 2016, BIOCHEM BIOPH RES CO, V473, P1315, DOI 10.1016/j.bbrc.2016.04.069; Ma F, 2015, ONCOTARGET, V6, P17404, DOI 10.18632/oncotarget.3744; Markou A, 2016, CLIN CHEM, V62, P1002, DOI 10.1373/clinchem.2015.253716; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Mittal MK, 2011, J BIOL CHEM, V286, P469, DOI 10.1074/jbc.M110.164384; Nanchari SR, 2015, TUMOR BIOL, V36, P615, DOI 10.1007/s13277-014-2613-6; O'Reilly EA, 2015, BBA CLIN, V3, P257, DOI 10.1016/j.bbacli.2015.03.003; Parplys AC, 2015, CELL CYCLE, V14, P3190, DOI 10.1080/15384101.2015.1055996; Peng B, EPIGENETICS, V1, P138; Petrovic N, 2016, MOL DIAGN THER, V20, P97, DOI 10.1007/s40291-016-0186-3; Polytarchou C, 2012, P NATL ACAD SCI USA, V109, P14470, DOI 10.1073/pnas.1212811109; Qi XM, 2014, FEBS LETT, V588, P3732, DOI 10.1016/j.febslet.2014.08.021; Qian BY, 2009, BREAST CANCER RES TR, V117, P131, DOI 10.1007/s10549-008-0219-7; Qiao Y, 2016, TUMOR BIOL, V37, P10279, DOI 10.1007/s13277-016-4894-4; Sahlberg KK, 2015, CLIN CANCER RES, V21, P1207, DOI 10.1158/1078-0432.CCR-14-2011; Sato S, 2016, CANC RES; Shen SJ, 2014, CHEM RES TOXICOL, V27, P27, DOI 10.1021/tx400305w; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Song CL, 2015, ONCOTARGET, V6, P34968, DOI 10.18632/oncotarget.5198; Song NN, 2016, PAK J PHARM SCI, V29, P679; Spagnoletti I, 2004, ONCOL REP, V11, P845; Sun EH, 2014, EUR REV MED PHARMACO, V18, P2783; Sun JJ, 2016, CELL PHYSIOL BIOCHEM, V38, P777, DOI 10.1159/000443033; Tang J, 2012, INT J MOL SCI, V13, P13414, DOI 10.3390/ijms131013414; Tommasi S, 2016, ONCOTARGET; Vasovcak P, 2012, DNA REPAIR, V11, P616, DOI 10.1016/j.dnarep.2012.04.004; Wang BY, 2015, AM J CANCER RES, V5, P2719; Wang WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064660; Wang Xiaopai, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P631; Wang XW, 2016, BIOINFORMATICS, V32, P1316, DOI 10.1093/bioinformatics/btw002; Wang Y, 2016, ONCOTARGET; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Wolfson Benjamin, 2014, World J Stem Cells, V6, P591, DOI 10.4252/wjsc.v6.i5.591; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu YY, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020013; Xiong J, 2016, BIOCH BIOPHYS RES CO; Xue JY, 2014, WORLD J CLIN ONCOL, V5, P730, DOI 10.5306/wjco.v5.i4.730; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang HP, 2014, ONCOL LETT, V8, P1043, DOI 10.3892/ol.2014.2298; Yang H, 2016, J CANCER, V7, P1152, DOI 10.7150/jca.14745; Yatsuoka T, 1999, INT J PANCREATOL, V25, P97, DOI 10.1385/IJGC:25:2:97; Yu J, 2016, ONCOTARGET; Zadeh MM, 2016, J BREAST CANCER, V19, P45, DOI 10.4048/jbc.2016.19.1.45; Zhang G, 2016, ONCOTARGET; Zhu JW, 2015, EUR J MED CHEM, V96, P196, DOI 10.1016/j.ejmech.2015.04.021; Zhu XS, 2015, SCI REP-UK, V5, DOI 10.1038/srep12460	80	70	74	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168284	10.1371/journal.pone.0168284	http://dx.doi.org/10.1371/journal.pone.0168284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959953	gold, Green Published			2022-12-27	WOS:000392753900055
J	Howie, RN; Durham, EL; Black, L; Bennfors, G; Parsons, TE; Elsalanty, ME; Yu, JC; Weinberg, SM; Cray, JJ				Howie, R. Nicole; Durham, Emily L.; Black, Laurel; Bennfors, Grace; Parsons, Trish E.; Elsalanty, Mohammed E.; Yu, Jack C.; Weinberg, Seth M.; Cray, James J., Jr.			Effects of In Utero Thyroxine Exposure on Murine Cranial Suture Growth	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; THYROID-HORMONE; SKELETAL DEVELOPMENT; BETA-CATENIN; BONE-GROWTH; STEM-CELLS; C-JUN; CRANIOSYNOSTOSIS; MICE; DIFFERENTIATION	Large scale surveillance studies, case studies, as well as cohort studies have identified the influence of thyroid hormones on calvarial growth and development. Surveillance data suggests maternal thyroid disorders (hyperthyroidism, hypothyroidism with pharmacological replacement, and Maternal Graves Disease) are linked to as much as a 2.5 fold increased risk for craniosynostosis. Craniosynostosis is the premature fusion of one or more calvarial growth sites (sutures) prior to the completion of brain expansion. Thyroid hormones maintain proper bone mineral densities by interacting with growth hormone and aiding in the regulation of insulin like growth factors (IGFs). Disruption of this hormonal control of bone physiology may lead to altered bone dynamics thereby increasing the risk for craniosynostosis. In order to elucidate the effect of exogenous thyroxine exposure on cranial suture growth and morphology, wild type C57BL6 mouse litters were exposed to thyroxine in utero (control = no treatment; low similar to 167 ng per day; high similar to 667 ng per day). Thyroxine exposed mice demonstrated craniofacial dysmorphology (brachycranic). High dose exposed mice showed diminished area of the coronal and widening of the sagittal sutures indicative of premature fusion and compensatory growth. Presence of thyroid receptors was confirmed for the murine cranial suture and markers of proliferation and osteogenesis were increased in sutures from exposed mice. Increased Htra1 and Igf1 gene expression were found in sutures from high dose exposed individuals. Pathways related to the HTRA1/IGF axis, specifically Akt and Wnt, demonstrated evidence of increased activity. Overall our data suggest that maternal exogenous thyroxine exposure can drive calvarial growth alterations and altered suture morphology.	[Howie, R. Nicole; Durham, Emily L.; Black, Laurel; Bennfors, Grace; Cray, James J., Jr.] Med Univ South Carolina, Dept Oral Hlth Sci, Charleston, SC USA; [Parsons, Trish E.; Weinberg, Seth M.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA USA; [Elsalanty, Mohammed E.] Augusta Univ, Dept Oral Biol, Augusta, GA USA; [Elsalanty, Mohammed E.] Augusta Univ, Dept Cellular Biol & Anat, Augusta, GA USA; [Elsalanty, Mohammed E.] Augusta Univ, Dept Orthoped Surg, Augusta, GA USA; [Elsalanty, Mohammed E.] Augusta Univ, Dept Oral & Maxillofacial Surg, Augusta, GA USA; [Elsalanty, Mohammed E.; Yu, Jack C.] Augusta Univ, Inst Regenerat & Reparat Med, Augusta, GA USA; [Yu, Jack C.] Augusta Univ, Div Plast Surg, Dept Surg, Augusta, GA USA	Medical University of South Carolina; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Cray, JJ (corresponding author), Med Univ South Carolina, Dept Oral Hlth Sci, Charleston, SC USA.	crayj@musc.edu		Black, Laurel/0000-0003-4530-1133; Durham, Emily/0000-0002-6322-9393; Weinberg, Seth/0000-0001-9467-4556	National Institute of Dental and Craniofacial Research [R03DE023350A]; Cleft Palate Foundation Cleft/Craniofacial Anomalies Grant Award; National Institutes of Health National Institute of Dental and Craniofacial Research [5T32DE017551]; National Institutes of Health National Institute of General Medicine [P30GM103331]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R03DE023350, T32DE017551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG036675] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Cleft Palate Foundation Cleft/Craniofacial Anomalies Grant Award; National Institutes of Health National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health National Institute of General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study utilized the facilities and resources of the MUSC Center for Oral Health Research (COHR). This work was funded in part by the National Institute of Dental and Craniofacial Research [R03DE023350A to JJC], and the Cleft Palate Foundation Cleft/Craniofacial Anomalies Grant Award to JJC. Micro-Computed Tomography scans were made possible by the National Institute on Aging (NIA) 1P01AG036675 (ME). ELD and RNH are funded through a training grant from the National Institutes of Health National Institute of Dental and Craniofacial Research [5T32DE017551]. The MUSC Center for Oral Health Research (COHR), is partially supported by the National Institutes of Health National Institute of General Medicine [P30GM103331].	Akita S, 1996, PLAST RECONSTR SURG, V97, P1, DOI 10.1097/00006534-199601000-00001; AKITA S, 1994, THYROID, V4, P99, DOI 10.1089/thy.1994.4.99; Ardalan M, 2012, PEDIATR NEUROSURG, V48, P152, DOI 10.1159/000346261; ARNAUD E, 1995, J NEUROSURG, V83, P476, DOI 10.3171/jns.1995.83.3.0476; Bassett JHD, 2016, ENDOCR REV, V37, P135, DOI 10.1210/er.2015-1106; Bassett JH, 2016, ENDOCR REV; Borgatti P, 2000, FEBS LETT, V477, P27, DOI 10.1016/S0014-5793(00)01758-0; Browne ML, 2011, BIRTH DEFECTS RES A, V91, P93, DOI 10.1002/bdra.20752; Bu YH, 2010, J ENDOCRINOL, V206, P271, DOI 10.1677/JOE-10-0064; BURR W, 1986, CLIN OBSTET GYNAECOL, V13, P277; Cao X, 2005, MOL ENDOCRINOL, V19, P102, DOI 10.1210/me.2004-0093; Capelo LP, 2008, BONE, V43, P921, DOI 10.1016/j.bone.2008.06.020; Capuco AV, 1999, P SOC EXP BIOL MED, V221, P345, DOI 10.1046/j.1525-1373.1999.d01-91.x; Carmichael S, 2015, AM J MED GENETICS A; Carmichael SL, 2010, BIRTH DEFECTS RES A, V88, P1032, DOI 10.1002/bdra.20717; CHADDUCK WM, 1992, NEUROSURGERY, V30, P867, DOI 10.1227/00006123-199206000-00008; Cray JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069067; Darnerud PO, 1996, TOXICOLOGY, V106, P105, DOI 10.1016/0300-483X(95)03169-G; DULHUNTY AF, 1986, J MUSCLE RES CELL M, V7, P225, DOI 10.1007/BF01753555; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Gauthier K, 2014, ENDOCRINOLOGY, V155, P3206, DOI 10.1210/en.2014-1597; Glanz S, 2016, STEM CELLS DEV, V25, P687, DOI 10.1089/scd.2015.0368; Glinoer D, 1998, THYROID, V8, P859, DOI 10.1089/thy.1998.8.859; Hashmi SS, 2012, BIRTH DEFECTS RES A, V94, P1004, DOI 10.1002/bdra.23077; Heuze Yann, 2014, Curr Genet Med Rep, V2, P135; Jin SW, 2016, J KOREAN NEUROSURG S, V59, P192, DOI 10.3340/jkns.2016.59.3.192; JOHNSTON MC, 1995, CRIT REV ORAL BIOL M, V6, P368, DOI 10.1177/10454411950060040601; JURILOFF DM, 1985, TERATOLOGY, V31, P319, DOI 10.1002/tera.1420310302; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim HY, 2013, BONE RES, V1, DOI 10.4248/BR201302004; Krause K, 2015, EUR THYROID J, V4, P59, DOI 10.1159/000437304; Krude H, 1997, EXP CLIN ENDOCR DIAB, V105, P6, DOI 10.1055/s-0029-1211924; LAMB JC, 1986, TOXICOL APPL PHARM, V84, P115, DOI 10.1016/0041-008X(86)90420-5; LAMBERG BA, 1986, CLIN ENDOCRINOL, V25, P259, DOI 10.1111/j.1365-2265.1986.tb01690.x; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Maruyama T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10526; McNab T, 2005, CLIN INVEST MED, V28, P127; McNabb FMA, 1992, THYROID HORMONES, Vxv; Miller M.T, 2000, CRANIOSYNOSTOSIS DIA, P184; Murphy E, 2004, CLIN ENDOCRINOL, V61, P285, DOI 10.1111/j.1365-2265.2004.02053.x; O'Shea PJ, 2003, MOL ENDOCRINOL, V17, P1410, DOI 10.1210/me.2002-0296; Oppenheimer JH, 1983, MOL BASIS THYROID HO, Vxv; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Parsons TE, 2014, ANAT REC, V297, P826, DOI 10.1002/ar.22899; PENFOLD JL, 1975, J PEDIATR-US, V86, P360, DOI 10.1016/S0022-3476(75)80963-2; PIRINEN S, 1995, ACTA ODONTOL SCAND, V53, P179, DOI 10.3109/00016359509005969; Proff P, 2006, J CRANIO MAXILL SURG, V34, P96, DOI 10.1016/S1010-5182(06)60021-8; Radetti G, 2002, Minerva Pediatr, V54, P383; Rasmussen SA, 2008, AM J MED GENET A, V146A, P149, DOI 10.1002/ajmg.a.32106; Rasmussen SA, 2007, OBSTET GYNECOL, V110, P369, DOI 10.1097/01.AOG.0000270157.88896.76; Reefhuis J, 2011, HUM REPROD, V26, P451, DOI 10.1093/humrep/deq313; Richardson S, 2011, BIRTH DEFECTS RES A, V91, P623, DOI 10.1002/bdra.20823; Robubi A, 2014, BONE JOINT RES, V3, P236, DOI 10.1302/2046-3758.37.2000231; Rybchyn MS, 2011, J BIOL CHEM, V286, P23771, DOI 10.1074/jbc.M111.251116; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Stevens DA, 2003, MOL ENDOCRINOL, V17, P1751, DOI 10.1210/me.2003-0137; THORDARSON G, 1992, BIOL REPROD, V47, P676, DOI 10.1095/biolreprod47.4.676; Twigg SRF, 2015, HUM MOL GENET, V24, pR50, DOI 10.1093/hmg/ddv228; Twigg SRF, 2015, AM J HUM GENET, V97, P359, DOI 10.1016/j.ajhg.2015.07.006; Ulici V, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-40; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vecchione L, 2010, ANAT REC, V293, P32, DOI 10.1002/ar.21024; Wang L, 2010, J BONE MINER RES, V25, P1138, DOI 10.1002/jbmr.5; Williams GR, 2013, EUR THYROID J, V2, P3, DOI 10.1159/000345548; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Wojcicka A, 2013, BBA-GEN SUBJECTS, V1830, P3979, DOI 10.1016/j.bbagen.2012.05.005; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao H, 2015, NAT CELL BIOL, V17, P386, DOI 10.1038/ncb3139; Zimmerman D, 1999, THYROID, V9, P727, DOI 10.1089/thy.1999.9.727	69	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167805	10.1371/journal.pone.0167805	http://dx.doi.org/10.1371/journal.pone.0167805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959899	Green Submitted, Green Published, gold			2022-12-27	WOS:000392753900016
J	Lee, YH; Lai, YH				Lee, Yu-Hsiang; Lai, Yun-Han			Synthesis, Characterization, and Biological Evaluation of Anti-HER2 Indocyanine Green-Encapsulated PEG-Coated PLGA Nanoparticles for Targeted Phototherapy of Breast Cancer Cells	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; DRUG-DELIVERY; ABLATION; AMPLIFICATION; NANOMEDICINE; PEGYLATION; RECEPTOR	Human epidermal growth factor receptor 2 (HER2)-overexpressed breast cancer is known to be more aggressive and resistant to medicinal treatment and therefore to whom an alternative therapeutics is needed. Indocyanine green (ICG) has been widely exploited in breast cancer phototherapy. However, drawbacks of accelerated degradation and short half-life (2-4 min) in blood seriously hamper its use in the clinic. To overcome these challenges, an anti-HER2 ICG-encapsulated polyethylene glycol-coated poly(lactic-co-glycolic acid) nanoparticles (HIPPNPs) were developed in this study. Through the analyses of degradation rate coefficients of ICG with and without polymeric encapsulation, the photostability of HIPPNPentrapped ICG significantly enhanced 4 folds (P < 0.05) while its thermal stabilities at 4 and 37 E C significantly enhanced 5 and 3 (P < 0.05 for each) folds, respectively, under equal lighting and/or heating treatment for 48 h. The target specificity of HIPPNPs to HER2-positive cells was demonstrated based on a 6-fold (P < 0.05) enhancement of uptake efficiency of HIPPNPs in MDA-MB-453/HER2(+) cells within 4 h as compared with that in MCF7/HER2 (-) cells. Moreover, the HIPPNPs with <= 25 mu M ICG equivalent were nontoxic to cells in the absence of light illumination, and enabled to generate similar amount of singlet oxygen and hyperthermia effect as compared with that used by free ICG upon NIR irradiation. After 808 nm-laser irradiation with intensity of 6 W/cm(2) for 5 min, the viability of MDA-MB-453 cells pre-treated by HIPPNPs with <= 5 mu M ICG equivalent for 4 h significantly reduced as compared with that treated by equal concentration of free ICG (P < 0.05) and > 90% of the cells were eradicated while the dose of HIPPNPs was increased to 25 mu M ICG equivalent. In summary, the developed HIPPNPs are anticipated as a feasible tool for use in phototherapy of breast cancer cells with HER2 expression.	[Lee, Yu-Hsiang; Lai, Yun-Han] Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan; [Lee, Yu-Hsiang] Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan, Taiwan	National Central University; National Central University	Lee, YH (corresponding author), Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan.; Lee, YH (corresponding author), Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan, Taiwan.	yuhsianl@ncu.edu.tw			Ministry of Science and Technology, R.O.C. [MOST 105-2221-E-008-014]	Ministry of Science and Technology, R.O.C.	This work was financially supported by Ministry of Science and Technology, R.O.C. (Grant Number: MOST 105-2221-E-008-014; Y.-H. Lee) Website: https://www.most.gov.tw/en/public. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi RJ, 2008, J NEURO-ONCOL, V86, P165, DOI 10.1007/s11060-007-9467-3; BJORNSSON OG, 1983, J CLIN CHEM CLIN BIO, V21, P453; Cheng L, 2014, CHEM REV, V114, P10869, DOI 10.1021/cr400532z; Choudhury A, 2004, Breast Dis, V20, P25; Chu KF, 2014, NAT REV CANCER, V14, P199, DOI 10.1038/nrc3672; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Coffey DS, 2006, JAMA-J AM MED ASSOC, V296, P445, DOI 10.1001/jama.296.4.445; Desmettre T, 2000, SURV OPHTHALMOL, V45, P15, DOI 10.1016/S0039-6257(00)00123-5; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Fishburn CS, 2008, J PHARM SCI-US, V97, P4167, DOI 10.1002/jps.21278; Fiszman GL, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/352182; Gajendiran M, 2014, J MATER CHEM B, V2, P418, DOI 10.1039/c3tb21113d; Goldberg SN, 1996, ACAD RADIOL, V3, P212, DOI 10.1016/S1076-6332(96)80443-0; Haen SP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/160250; Harush-Frenkel O, 2007, BIOCHEM BIOPH RES CO, V353, P26, DOI 10.1016/j.bbrc.2006.11.135; Hauck TS, 2008, ADV MATER, V20, P3832, DOI 10.1002/adma.200800921; Hu CMJ, 2010, MOL PHARMACEUT, V7, P914, DOI 10.1021/mp900316a; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; Jain KK, 2008, MED PRIN PRACT, V17, P89, DOI 10.1159/000112961; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lammers T, 2012, J CONTROL RELEASE, V161, P175, DOI 10.1016/j.jconrel.2011.09.063; Leonard DS, 2002, BRIT J SURG, V89, P262, DOI 10.1046/j.0007-1323.2001.02022.x; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Mastropasqua R, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/343515; Mordon S, 1998, MICROVASC RES, V55, P146, DOI 10.1006/mvre.1998.2068; Mundra V, 2015, J CONTROL RELEASE, V220, P130, DOI 10.1016/j.jconrel.2015.10.029; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Ntziachristos V, 2003, EUR RADIOL, V13, P195, DOI 10.1007/s00330-002-1524-x; Ogris M, 2001, AAPS PHARMSCI, V3, part. no.; Press MF, 2002, J CLIN ONCOL, V20, P3095, DOI 10.1200/JCO.2002.09.094; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Saxena V, 2004, J PHOTOCH PHOTOBIO B, V74, P29, DOI 10.1016/j.jphotobiol.2004.01.002; Saxena V, 2003, J PHARM SCI, V92, P2090, DOI 10.1002/jps.10470; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Shemesh CS, 2015, PHARM RES-DORDR, V32, P1604, DOI 10.1007/s11095-014-1560-7; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Sun C, 2006, J BIOMED MATER RES A, V78A, P550, DOI 10.1002/jbm.a.30781; THOMSEN S, 1991, PHOTOCHEM PHOTOBIOL, V53, P825, DOI 10.1111/j.1751-1097.1991.tb09897.x; Tinoco G, 2013, J CANCER, V4, P117, DOI 10.7150/jca.4925; Yang J, 2007, J MATER CHEM, V17, P2695, DOI 10.1039/b702538f; Zelken JA, 2015, ANN SURG ONCOL, V22, pS1271, DOI 10.1245/s10434-015-4743-5	43	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168192	10.1371/journal.pone.0168192	http://dx.doi.org/10.1371/journal.pone.0168192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942034	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600058
J	Vieira, AR; Rodrigues, ASB; Sequeira, V; Neves, A; Paiva, RB; Paulo, OS; Gordo, LS				Vieira, Ana Rita; Rodrigues, Ana Sofia B.; Sequeira, Vera; Neves, Ana; Paiva, Rafaela Barros; Paulo, Octavio S.; Gordo, Leonel Serrano			Genetic and Morphological Variation of the Forkbeard, Phycis phycis (Pisces, Phycidae): Evidence of Panmixia and Recent Population Expansion along Its Distribution Area	PLOS ONE			English	Article							COD GADUS-MORHUA; STOCK IDENTIFICATION; ATLANTIC COD; HOLISTIC APPROACH; MARINE FISH; BODY SHAPE; GROWTH; SEA; DIVERGENCE; TRACHURUS	The knowledge of population structure of a species is essential to effectively assess and manage fisheries. In the present study, genetics, by mitochondrial DNA cytochrome b sequence analysis, and body geometric morphometrics were used to evaluate the existence of distinct populations of the forkbeard (Phycis phycis), an important commercial species in several European countries, especially Portugal and Spain. For geometric morphometric analysis, specimens were collected in the Northeast Atlantic Ocean-Azores, Madeira and mainland Portugal, and for genetic analysis, these samples were complemented with samples collected in the Mediterranean Sea-Spain, Italy and Croatia, in order to cover the entire distribution area of the species. Body shape of the forkbeard from the Northeast Atlantic was found to be highly variable. This variation was probably associated with different environmental factors between the study areas. Despite morphological variation, a low genetic differentiation between samples from different areas was found, most likely due to gene flow that occurred in the past or with the demographic history of the species. Moreover, the presence of unique haplotypes in the Northeast Atlantic and in the Mediterranean suggests that recent gene flow between populations from these areas should be limited. Altogether, a high haplotype diversity, a low nucleotide diversity, a "star-like" network and the results of the mismatch distribution, indicate a possible signature of recent population expansions, which probably started during the end of the Last Glacial Maximum and led to the colonization of the Northeast Atlantic and the Mediterranean.	[Vieira, Ana Rita; Sequeira, Vera; Neves, Ana; Paiva, Rafaela Barros; Gordo, Leonel Serrano] Univ Lisbon, Fac Ciencias, MARE Marine & Environm Sci Ctr, Lisbon, Portugal; [Vieira, Ana Rita; Neves, Ana; Paiva, Rafaela Barros; Paulo, Octavio S.; Gordo, Leonel Serrano] Univ Lisbon, Fac Ciencias, Dept Biol Anim, Lisbon, Portugal; [Rodrigues, Ana Sofia B.; Paulo, Octavio S.] Univ Lisbon, Fac Ciencias, cE3c, Lisbon, Portugal	Universidade de Lisboa; Universidade de Lisboa; Universidade de Lisboa	Vieira, AR (corresponding author), Univ Lisbon, Fac Ciencias, MARE Marine & Environm Sci Ctr, Lisbon, Portugal.; Vieira, AR (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Anim, Lisbon, Portugal.	arivieira@fc.ul.pt	Paulo, Octávio/D-9921-2011; Sequeira, Vera/B-1673-2012; Vieira, Ana Rita/B-1677-2012; Neves, Ana/B-3611-2012	Paulo, Octávio/0000-0001-5408-5212; Sequeira, Vera/0000-0001-7173-4982; Vieira, Ana Rita/0000-0002-5640-7999; Neves, Ana/0000-0003-3885-2738; Rodrigues, Ana Sofia/0000-0003-4887-3823	Programa Operacional Pesca [PROMAR 31-03-05-FEP-8]; Fundacao para a Ciencia e a Tecnologia [SFRH/BD/73506/2010, SFRH/BD/73879/2010, SFRH/BPD/70200/2010, SFRH/BD/92769/2013, SFRH/BD/80268/2011]	Programa Operacional Pesca; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was partially supported by the Programa Operacional Pesca 2007-2013 (http://www.promar.gov.pt/) through the project PROMAR 31-03-05-FEP-8. Fundacao para a Ciencia e a Tecnologia (http//www.fct.pt/) supported the fellowship attributed to ARV (SFRH/BD/73506/2010), ASBR (SFRH/BD/73879/2010), VS (SFRH/BPD/70200/2010), AN (SFRH/BD/92769/2013) and RBP (SFRH/BD/80268/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaunza P, 2008, FISH RES, V89, P104, DOI 10.1016/j.fishres.2007.09.020; Aboim MA, 2005, MOL ECOL, V14, P1343, DOI 10.1111/j.1365-294X.2005.02518.x; Almada VC, 2001, GLOBAL ECOL BIOGEOGR, V10, P411, DOI 10.1046/j.1466-822X.2001.00244.x; Almada VC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044404; Antonucci F, 2009, J MORPHOL, V270, P843, DOI 10.1002/jmor.10725; ArisBrosou S, 1996, MOL BIOL EVOL, V13, P494, DOI 10.1093/oxfordjournals.molbev.a025610; Arnason E, 2004, GENETICS, V166, P1871, DOI 10.1534/genetics.166.4.1871; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barlow GW, 1961, SYSTEMATIC BIOL; Begg GA, 1999, FISH RES, V43, P1, DOI 10.1016/S0165-7836(99)00062-4; Begg GA, 1999, FISH RES, V43, P35, DOI 10.1016/S0165-7836(99)00065-X; Blake RW, 2005, J FISH BIOL, V67, P834, DOI 10.1111/j.0022-1112.2005.00788.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bookstein F., 1990, P MICHIGAN MORPHOMET; Bookstein F. L., 1997, MORPHOMETRIC TOOL LA; Bookstein FL, 1996, NATO ADV SCI INST SE, V284, P131; Bush ABG, 1999, J GEOPHYS RES-ATMOS, V104, P24509, DOI 10.1029/1999JD900447; Cadrin SX, 2000, REV FISH BIOL FISHER, V10, P91, DOI 10.1023/A:1008939104413; CAMPANA SE, 1995, MAR ECOL PROG SER, V122, P115, DOI 10.3354/meps122115; CARR SM, 1995, MOL ECOL, V4, P79, DOI 10.1111/j.1365-294X.1995.tb00194.x; Catarino D, 2013, DEEP-SEA RES PT II, V98, P160, DOI 10.1016/j.dsr2.2013.02.010; Chow S, 1998, MOL ECOL, V7, P1255; Christensen SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033397; Cimmaruta R, 2008, FISH RES, V89, P114, DOI 10.1016/j.fishres.2007.09.030; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Comesana AS, 2008, FISH RES, V89, P122, DOI 10.1016/j.fishres.2007.09.014; COMYNS BH, 1993, FISH B-NOAA, V91, P210; Crispo E, 2008, J EVOLUTION BIOL, V21, P1460, DOI 10.1111/j.1420-9101.2008.01592.x; CROWLEY TJ, 1981, MAR MICROPALEONTOL, V6, P97, DOI 10.1016/0377-8398(81)90001-3; D'Anatro A, 2011, J ZOOL, V285, P139, DOI 10.1111/j.1469-7998.2011.00823.x; Domingues VS, 2006, MOL PHYLOGENET EVOL, V40, P139, DOI 10.1016/j.ympev.2006.02.009; Domingues VS, 2007, MAR BIOL, V150, P509, DOI 10.1007/s00227-006-0367-4; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2012, FAO YB FISH AQ STAT; Franchini P, 2014, MOL ECOL, V23, P1828, DOI 10.1111/mec.12590; Fu YX, 1997, GENETICS, V147, P915; GATZ A J JR, 1979, Tulane Studies in Zoology and Botany, V21, P91; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hayes A, 2005, QUATERNARY SCI REV, V24, P999, DOI 10.1016/j.quascirev.2004.02.018; Hayes DB, 1996, CAN J FISH AQUAT SCI, V53, P383, DOI 10.1139/f95-273; Hurlbut T, 1998, CAN J FISH AQUAT SCI, V55, P2274, DOI 10.1139/cjfas-55-10-2274; Inada T, 1990, FAO SPECIES CATALOGU, V10, P39; INE, 2013, STAT DAT FISH 2001 2; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Komakhidze A, 1998, 1 INT S FISH EC TRAB, P143; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marcus LF, 1996, NATO ASI SERIES A; MELVIN GD, 1992, CAN J FISH AQUAT SCI, V49, P266, DOI 10.1139/f92-031; METHVEN D A, 1985, Journal of Northwest Atlantic Fishery Science, V6, P9; Monteiro LR, 1999, SYST BIOL, V48, P192, DOI 10.1080/106351599260526; Morato T, 1999, ARQUIPELAGO LIFE MAR, P17; Mousset S, 2004, MOL BIOL EVOL, V21, P724, DOI 10.1093/molbev/msh066; Murta AG, 2008, FISH RES, V89, P152, DOI 10.1016/j.fishres.2007.09.026; Neethling M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-325; Nyboer EA, 2013, BIOL J LINN SOC, V110, P449, DOI 10.1111/bij.12122; PALUMBI SR, 1994, ANNU REV ECOL SYST, V25, P547, DOI 10.1146/annurev.es.25.110194.002555; Panserat S, 2009, AQUACULTURE, V294, P123, DOI 10.1016/j.aquaculture.2009.05.013; PAPACONSTANTINOU C, 1989, FISH RES, V7, P329, DOI 10.1016/0165-7836(89)90065-9; Pina-Martins F, 2008, MOL ECOL RESOUR, V8, P1254, DOI 10.1111/j.1755-0998.2008.02164.x; Planes S, 2001, EVOLUTION, V55, P2263; POGSON GH, 1995, GENETICS, V139, P375; Ripley B. D., 1996, PATTERN RECOGNITION; Robalo JI, 2013, MAR BIOL, V160, P2461, DOI 10.1007/s00227-013-2241-5; Robalo JI, 2012, ECOL EVOL, V2, P153, DOI 10.1002/ece3.77; Rocha LA, 2005, P ROY SOC B-BIOL SCI, V272, P573, DOI 10.1098/2004.3005; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rohlf F.J., 1990, SPECIAL PUBLICATION, V2, p[227, 380]; Rohlf F. J., 2010, TPSDIG VERSION 2; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rouleau S, 2010, FUNCT ECOL, V24, P310, DOI 10.1111/j.1365-2435.2009.01636.x; Santos S, 2006, MOL ECOL, V15, P4361, DOI 10.1111/j.1365-294X.2006.03108.x; Schneider S, 1999, GENETICS, V152, P1079; Sequeira V, 2011, HYDROBIOLOGIA, V669, P133, DOI 10.1007/s10750-011-0655-y; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; Silva SE, 2013, BIOL J LINN SOC, V108, P494, DOI 10.1111/j.1095-8312.2012.02041.x; SLATKIN M, 1991, GENETICS, V129, P555; Stefanni S, 2007, MOL PHYLOGENET EVOL, V42, P38, DOI 10.1016/j.ympev.2006.05.035; Swain DP, 1999, FISH RES, V43, P113, DOI 10.1016/S0165-7836(99)00069-7; TAJIMA F, 1989, GENETICS, V123, P585; TAYLOR EB, 1985, CAN J FISH AQUAT SCI, V42, P2020, DOI 10.1139/f85-249; TITUS K, 1984, AM MIDL NAT, V111, P1, DOI 10.2307/2425535; Turan C, 2004, ICES J MAR SCI, V61, P774, DOI 10.1016/j.icesjms.2004.05.001; Vieira AR, 2016, HELGOLAND MAR RES, V70, DOI 10.1186/s10152-016-0455-x; Vieira AR, 2014, J MAR BIOL ASSOC UK, V94, P623, DOI 10.1017/S0025315413001549; Vieira A, 2014, HYDROBIOLOGIA, V728, P103, DOI 10.1007/s10750-014-1809-5; WEBB PW, 1984, AM ZOOL, V24, P107; Wilks SS, 1932, BIOMETRIKA, V24, P471; WIMBERGER PH, 1992, BIOL J LINN SOC, V45, P197, DOI 10.1111/j.1095-8312.1992.tb00640.x	94	10	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167045	10.1371/journal.pone.0167045	http://dx.doi.org/10.1371/journal.pone.0167045			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941988	Green Submitted, Green Published, gold			2022-12-27	WOS:000392745600007
J	Brinkman, CL; Schmidt-Malan, SM; Karau, MJ; Greenwood-Quaintance, K; Hassett, DJ; Mandrekar, JN; Patel, R				Brinkman, Cassandra L.; Schmidt-Malan, Suzannah M.; Karau, Melissa J.; Greenwood-Quaintance, Kerryl; Hassett, Daniel J.; Mandrekar, Jayawant N.; Patel, Robin			Exposure of Bacterial Biofilms to Electrical Current Leads to Cell Death Mediated in Part by Reactive Oxygen Species	PLoS One			English	Article							PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-EPIDERMIDIS; GENE-EXPRESSION; IRON UPTAKE; REDUCTION; VIABILITY; SYSTEM	Bacterial biofilms may form on indwelling medical devices such as prosthetic joints, heart valves and catheters, causing challenging-to-treat infections. We have previously described the 'electricidal effect', in which bacterial biofilms are decreased following exposure to direct electrical current. Herein, we sought to determine if the decreased bacterial quantities are due to detachment of biofilms or cell death and to investigate the role that reactive oxygen species (ROS) play in the observed effect. Using confocal and electron microscopy and flow cytometry, we found that direct current (DC) leads to cell death and changes in the architecture of biofilms formed by Gram-positive and Gram-negative bacteria. Reactive oxygen species (ROS) appear to play a role in DC-associated cell death, as there was an increase in ROS-production by Staphylococcus aureus and Staphylococcus epidermidis biofilms following exposure to DC. An increase in the production of ROS response enzymes catalase and superoxide dismutase (SOD) was observed for S. aureus, S. epidermidis and Pseudomonas aeruginosa biofilms following exposure to DC. Additionally, biofilms were protected from cell death when supplemented with antioxidants and oxidant scavengers, including catalase, mannitol and Tempol. Knocking out SOD (sodAB) in P. aeruginosa led to an enhanced DC effect. Microarray analysis of P. aeruginosa PAO1 showed transcriptional changes in genes related to the stress response and cell death. In conclusion, the electricidal effect results in death of bacteria in biofilms, mediated, at least in part, by production of ROS.	[Brinkman, Cassandra L.; Schmidt-Malan, Suzannah M.; Karau, Melissa J.; Greenwood-Quaintance, Kerryl; Patel, Robin] Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA; [Hassett, Daniel J.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH USA; [Mandrekar, Jayawant N.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Patel, Robin] Mayo Clin, Dept Med, Div Infect Dis, Rochester, MN 55905 USA	Mayo Clinic; University System of Ohio; University of Cincinnati; Mayo Clinic; Mayo Clinic	Patel, R (corresponding author), Mayo Clin, Dept Lab Med & Pathol, Div Clin Microbiol, Rochester, MN 55905 USA.; Patel, R (corresponding author), Mayo Clin, Dept Med, Div Infect Dis, Rochester, MN 55905 USA.	patel.robin@mayo.edu		Patel, Robin/0000-0001-6344-4141	National Institute of Allergy and Infectious Diseases [R01 AI091594]; National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program [T32 AR56950];  [R01 AR056647]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056950] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases under Award Number R01 AI091594 and the National Institute of Arthritis and Musculoskeletal and Skin Diseases for the Musculoskeletal Research Training Program (T32 AR56950). R.P. is also supported by R01 AR056647. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06; Boulos L, 1999, J MICROBIOL METH, V37, P77, DOI 10.1016/S0167-7012(99)00048-2; Cap M, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/976753; COX CD, 1985, INFECT IMMUN, V48, P130, DOI 10.1128/IAI.48.1.130-138.1985; COX CD, 1980, J BACTERIOL, V142, P581, DOI 10.1128/JB.142.2.581-587.1980; CRONAN JE, 1975, BACTERIOL REV, V39, P232, DOI 10.1128/MMBR.39.3.232-256.1975; Del Pozo JL, 2009, ANTIMICROB AGENTS CH, V53, P4064, DOI 10.1128/AAC.00432-09; del Pozo JL, 2009, ANTIMICROB AGENTS CH, V53, P41, DOI 10.1128/AAC.00680-08; del Pozo JL, 2009, ANTIMICROB AGENTS CH, V53, P35, DOI 10.1128/AAC.00237-08; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Esposito S, 2008, INT J ANTIMICROB AG, V32, P287, DOI 10.1016/j.ijantimicag.2008.03.010; Faure LM, 2013, MICROBIOL-SGM, V159, P1315, DOI 10.1099/mic.0.067645-0; Guttenplan SB, 2013, FEMS MICROBIOL REV, V37, P849, DOI 10.1111/1574-6976.12018; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HASSETT DJ, 1995, J BACTERIOL, V177, P6330, DOI 10.1128/jb.177.22.6330-6337.1995; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Ince D, 2015, J BACTERIOL, V197, P2003, DOI 10.1128/JB.00030-15; Kim J, 2013, FEMS MICROBIOL LETT, V343, P89, DOI 10.1111/1574-6968.12135; Koide T, 2006, J BACTERIOL, V188, P5821, DOI 10.1128/JB.00182-06; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lesniak J, 2002, EMBO J, V21, P6649, DOI 10.1093/emboj/cdf670; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061195; Liu WK, 1997, J ANTIMICROB CHEMOTH, V39, P687, DOI 10.1093/jac/39.6.687; Mishra S, 2012, ARCH BIOCHEM BIOPHYS, V525, P145, DOI 10.1016/j.abb.2012.04.014; Modi N, 2015, BIOPHYS J, V109, P1429, DOI 10.1016/j.bpj.2015.07.035; PAREILLEUX A, 1970, APPL MICROBIOL, V19, P421, DOI 10.1128/AEM.19.3.421-424.1970; Reimmann C, 2001, J BACTERIOL, V183, P813, DOI 10.1128/JB.183.3.813-820.2001; Romling U, 2014, J INTERN MED, V276, P98, DOI 10.1111/joim.12242; Ruiz-Ruigomez Maria, 2016, Int J Bacteriol, V2016, P9727810, DOI 10.1155/2016/9727810; Sandvik EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055118; Schmidt-Malan SM, 2015, ANTIMICROB AGENTS CH, V59, P4610, DOI 10.1128/AAC.00483-15; Stiefel P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0376-x; Ueshima M, 2002, J BIOMED MATER RES, V60, P578, DOI 10.1002/jbm.10113; van der Borden AJ, 2005, BIOMATERIALS, V26, P6731, DOI 10.1016/j.biomaterials.2004.04.052; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Voulhoux R, 2006, J BACTERIOL, V188, P3317, DOI 10.1128/JB.188.9.3317-3323.2006; Weimer RM, 1998, J BACTERIOL, V180, P5357, DOI 10.1128/JB.180.20.5357-5368.1998; Wolcott RD, 2010, J WOUND CARE, V19, P45, DOI 10.12968/jowc.2010.19.2.46966; Yuan ZC, 2005, MOL MICROBIOL, V58, P877, DOI 10.1111/j.1365-2958.2005.04874.x; Yura T, 1996, EXS, V77, P165; Zhao XL, 2014, CURR OPIN MICROBIOL, V21, P1, DOI 10.1016/j.mib.2014.06.008	41	23	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168595	10.1371/journal.pone.0168595	http://dx.doi.org/10.1371/journal.pone.0168595			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992529	Green Submitted, Green Published, gold			2022-12-27	WOS:000392842600077
J	Sinha, J; Cao, Z; Dai, JL; Tang, HY; Partyka, K; Hostetter, G; Simeone, DM; Feng, ZD; Allen, PJ; Brand, RE; Haab, BB				Sinha, Jessica; Cao, Zheng; Dai, Jianliang; Tang, Huiyuan; Partyka, Katie; Hostetter, Galen; Simeone, Diane M.; Feng, Ziding; Allen, Peter J.; Brand, Randall E.; Haab, Brian B.			A Gastric Glycoform of MUC5AC Is a Biomarker of Mucinous Cysts of the Pancreas	PLoS One			English	Article							CLINICAL-IMPLICATIONS; DIFFERENTIAL-DIAGNOSIS; PRECURSOR LESIONS; FLUID BIOMARKER; HIGH-THROUGHPUT; NEOPLASMS; CANCER; CLASSIFICATION; ADENOCARCINOMA; IDENTIFICATION	Molecular indicators to specify the risk posed by a pancreatic cyst would benefit patients. Previously we showed that most cancer-precursor cysts, termed mucinous cysts, produce abnormal glycoforms of the proteins MUC5AC and endorepellin. Here we sought to validate the glycoforms as a biomarker of mucinous cysts and to specify the oligosaccharide linkages that characterize MUC5AC. We hypothesized that mucinous cysts secrete MUC5AC displaying terminal N-acetylglucosamine (GlcNAc) in either alpha or beta linkage. We used antibody-lectin sandwich assays to detect glycoforms of MUC5AC and endorepellin in cyst fluid samples from three independent cohorts of 49, 32, and 66 patients, and we used monoclonal antibodies to test for terminal, alpha-linked GlcNAc and the enzyme that produces it. A biomarker panel comprising the previously-identified glycoforms of MUC5AC and endorepellin gave 96%, 96%, and 87% accuracy for identifying mucinous cysts in the three cohorts with an average sensitivity of 92% and an average specificity of 94%. Glycan analysis showed that MUC5AC produced by a subset of mucinous cysts displays terminal alpha-GlcNAc, a motif expressed in stomach glands. The alpha-linked glycoform of MUC5AC was unique to intraductal papillary mucinous neoplasms (IPMN), whereas terminal beta-linked GlcNAc was increased in both IPMNs and mucinous cystic neoplasms (MCN). The enzyme that synthesizes alpha-GlcNAc, A4GNT, was expressed in the epithelia of mucinous cysts that expressed alpha-GlcNAc, especially in regions with high-grade dysplasia. Thus IPMNs secrete a gastric glycoform of MUC5AC that displays terminal alpha-GlcNAc, and the combined alpha-GlcNAc and beta-GlcNAc glycoforms form an accurate biomarker of mucinous cysts.	[Sinha, Jessica; Cao, Zheng; Tang, Huiyuan; Partyka, Katie; Hostetter, Galen; Haab, Brian B.] Van Andel Res Inst, Grand Rapids, MI 49503 USA; [Dai, Jianliang; Feng, Ziding] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Simeone, Diane M.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Allen, Peter J.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Brand, Randall E.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA	Van Andel Institute; University of Texas System; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Haab, BB (corresponding author), Van Andel Res Inst, Grand Rapids, MI 49503 USA.	brian.haab@vai.org			National Cancer Institute [U01CA152653, U01CA168896]; NATIONAL CANCER INSTITUTE [P30CA008748, U01CA200466, U01CA168896, U01CA152653] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Cancer Institute (Early Detection Research Network, U01CA152653; Alliance of Glycobiologists for Cancer Detection, U01CA168896). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsay NV, 2004, AM J SURG PATHOL, V28, P839, DOI 10.1097/00000478-200407000-00001; Ahmad NA, 2001, AM J GASTROENTEROL, V96, P3295; Basturk O, 2009, ARCH PATHOL LAB MED, V133, P423, DOI 10.1043/1543-2165-133.3.423; Brugge WR, 2004, GASTROENTEROLOGY, V126, P1330, DOI 10.1053/j.gastro.2004.02.013; Cao Z, 2013, MOL CELL PROTEOMICS, V12, P2724, DOI 10.1074/mcp.M113.030700; Cho CS, 2013, ANN SURG ONCOL, V20, P3112, DOI 10.1245/s10434-013-2986-6; Correa-Gallego C, 2013, ANN SURG ONCOL, V20, P4348, DOI 10.1245/s10434-013-3207-z; Distler M, 2013, ANN SURG; Ensink E, 2015, ANAL CHEM, V87, P9715, DOI 10.1021/acs.analchem.5b03159; Fisher WE, 2008, HPB, V10, P483, DOI 10.1080/13651820802291225; Forrester S, 2007, MOL ONCOL, V1, P216, DOI 10.1016/j.molonc.2007.06.001; Fritz S, 2012, ANN SURG, V256, P313, DOI 10.1097/SLA.0b013e31825d355f; Frossard JL, 2003, AM J GASTROENTEROL, V98, P1516, DOI 10.1016/S0002-9270(03)00359-9; Gaddam S, 2015, GASTROINTESTINAL END; Haab BB, 2011, METHODS MOL BIOL, V785, P223, DOI 10.1007/978-1-61779-286-1_15; Haab BB, 2010, ANN SURG, V251, P937, DOI 10.1097/SLA.0b013e3181d7738d; Ito Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078191; Izeradjene K, 2007, CANCER CELL, V11, P229, DOI 10.1016/j.ccr.2007.01.017; Jones M, 2015, GASTROINTESTINAL END; Kanda M, 2013, GUT, V62, P1024, DOI 10.1136/gutjnl-2012-302823; Karasawa F, 2012, J CLIN INVEST, V122, P923, DOI 10.1172/JCI59087; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; Khalid A, 2009, GASTROINTEST ENDOSC, V69, P1095, DOI 10.1016/j.gie.2008.07.033; Kobayashi M, 2014, ACTA HISTOCHEM CYTOC, V47, P45, DOI 10.1267/ahc.13027; Maitra A, 2005, ADV ANAT PATHOL, V12, P81, DOI 10.1097/01.pap.0000155055.14238.25; Maker AV, 2011, CLIN CANCER RES, V17, P1502, DOI 10.1158/1078-0432.CCR-10-1561; Matthaei HH, 2012, CLIN CANC RES OFFICI; Nadig SN, 2012, PANCREAS, V41, P441, DOI 10.1097/MPA.0b013e318229b9b8; Nagula S, 2010, J GASTROINTEST SURG, V14, P1997, DOI 10.1007/s11605-010-1281-0; Nakamura N, 1998, J HISTOCHEM CYTOCHEM, V46, P793, DOI 10.1177/002215549804600702; Nakayama J, 1999, P NATL ACAD SCI USA, V96, P8991, DOI 10.1073/pnas.96.16.8991; Park WG, 2013, GASTROINTESTINAL END; Partyka K, 2012, J PROTEOME RES, V11, P2904, DOI 10.1021/pr2012736; Raty S, 2013, PANCREATOLOGY, V13, P530, DOI 10.1016/j.pan.2013.06.008; Rockacy M, 2013, GASTROENTEROLOGY, V26, P122; Ryu JK, 2011, PANCREATOLOGY, V11, P343, DOI 10.1159/000329183; Sahora K, 2013, ANN SURG, V258, P466, DOI 10.1097/SLA.0b013e3182a18f48; Schaberg KB, 2015, AM J SURG PATHOLOGY; Singh M, 2007, PANCREATOLOGY, V7, P9, DOI 10.1159/000101873; Singhi AD, 2014, CLIN CANCER RES, V20, P4381, DOI 10.1158/1078-0432.CCR-14-0513; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; Springer S, 2015, GASTROENTEROLOGY, V149, P1501, DOI 10.1053/j.gastro.2015.07.041; Thiruvengadam N, 2015, CLIN TRANSL GASTROEN, V6, DOI 10.1038/ctg.2015.17; van der Waaij LA, 2005, GASTROINTEST ENDOSC, V62, P383, DOI 10.1016/S0016-5107(05)01581-6; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Wu J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002543; Yip-Schneider MT, 2014, J AM COLL SURGEONS, V218, P608, DOI 10.1016/j.jamcollsurg.2013.12.019; Zhang MX, 2001, J HISTOCHEM CYTOCHEM, V49, P587, DOI 10.1177/002215540104900505	48	14	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0167070	10.1371/journal.pone.0167070	http://dx.doi.org/10.1371/journal.pone.0167070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992432	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842600010
J	Yu, JL; Yang, L; Liu, XB; Tang, RJ; Wang, Y; Ge, HM; Wu, MT; Zhang, J; Zhao, FG; Luan, S; Lan, WZ				Yu, Jingling; Yang, Lei; Liu, Xiaobing; Tang, Renjie; Wang, Yuan; Ge, Haiman; Wu, Mengting; Zhang, Jiang; Zhao, Fugeng; Luan, Sheng; Lan, Wenzhi			Overexpression of Poplar Pyrabactin Resistance-Like Abscisic Acid Receptors Promotes Abscisic Acid Sensitivity and Drought Resistance in Transgenic Arabidopsis	PLOS ONE			English	Article							EXPRESSION; RESPONSES; TOLERANCE; BINDING; FAMILY	Drought stress is an important environmental factor limiting productivity of plants, especially fast growing species with high water consumption like poplar. Abscisic acid (ABA) is a phytohormone that positively regulates seed dormancy and drought resistance. The PYR1 (Pyrabactin Resistance 1)/ PYRL (PYR-Like)/ RCAR (Regulatory Component of ABA Receptor) (PYR/PYL/RCAR) ABA receptor family has been identified and widely characterized in Arabidopsis thaliana. However, their functions in poplars remain unknown. Here, we report that 2 of 14 PYR/PYL/RCAR orthologues in poplar (Populus trichocarpa) (PtPYRLs) function as a positive regulator of the ABA signal transduction pathway. The Arabidopsis transient expression and yeast two-hybrid assays showed the interaction among PtPYRL1 and PtPYRL5, a Glade A protein phosphatase 2C, and a SnRK2, suggesting that a core signalling complex for ABA signaling pathway exists in poplars. Phenotypic analysis of PtPYRL1 and PtPYRL5 transgenic Arabidopsis showed that these two genes positively regulated the ABA responses during the seed germination. More importantly, the overexpression of PtPYRL1 and PtPYRL5 substantially improved ABA sensitivity and drought stress tolerance in transgenic plants. In summary, we comprehensively uncovered the properties of PtPYRL1 and PtPYRL5, which might be good target genes to genetically engineer drought-Resistant plants.	[Yu, Jingling; Yang, Lei; Liu, Xiaobing; Wang, Yuan; Ge, Haiman; Zhao, Fugeng; Lan, Wenzhi] Nanjing Univ, Nanjing Forestry Univ, Coll Life Sci, Joint Inst Plant Mol Biol,State Key Lab Pharmaceu, Nanjing, Jiangsu, Peoples R China; [Tang, Renjie; Luan, Sheng] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; [Wu, Mengting; Zhang, Jiang] Hubei Univ, Hubei Collaborat Innovat Ctr Green Transformat Bi, Coll Life Sci, Wuhan, Peoples R China	Nanjing Forestry University; Nanjing University; University of California System; University of California Berkeley; Hubei University	Yang, L; Lan, WZ (corresponding author), Nanjing Univ, Nanjing Forestry Univ, Coll Life Sci, Joint Inst Plant Mol Biol,State Key Lab Pharmaceu, Nanjing, Jiangsu, Peoples R China.; Luan, S (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	Leiyang@nju.edu.cn; sluan@berkeley.edu; lanw@nju.edu.cn	Tang, Renjie/X-8372-2019	Tang, Renjie/0000-0003-0323-7348; yang, lei/0000-0003-2009-7316	Natural Science Foundation of Jiangsu Province of China [BK2012306]; National Natural Science Foundation of China [31271626]	Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of Jiangsu Province of China (BK2012306) and National Natural Science Foundation of China grant (31271626).	Arshad M, 2014, TREES-STRUCT FUNCT, V28, P531, DOI 10.1007/s00468-013-0969-7; BATES TR, 1973, J PHARM SCI-US, V62, P2057, DOI 10.1002/jps.2600621241; Boaretto LF, 2014, PLANT PHYSIOL BIOCH, V74, P165, DOI 10.1016/j.plaphy.2013.11.016; Chen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139466; Chen THH, 2002, WEED SCI, V50, P232, DOI 10.1614/0043-1745(2002)050[0232:MGAODR]2.0.CO;2; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Finkelstein Ruth, 2013, Arabidopsis Book, V11, pe0166, DOI 10.1199/tab.0166; Garcia MV, 2007, HEREDITY, V99, P381, DOI 10.1038/sj.hdy.6801012; Gonzalez-Guzman M, 2014, J EXP BOT, V65, P4451, DOI 10.1093/jxb/eru219; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Iyer LM, 2001, PROTEINS, V43, P134, DOI 10.1002/1097-0134(20010501)43:2<134::AID-PROT1025>3.3.CO;2-9; Kim H, 2014, J EXP BOT, V65, P453, DOI 10.1093/jxb/ert397; Lee SC, 2013, MOL PLANT, V6, P528, DOI 10.1093/mp/sss078; Lee SC, 2012, PLANT CELL ENVIRON, V35, P53, DOI 10.1111/j.1365-3040.2011.02426.x; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; LERUDULIER D, 1984, SCIENCE, V224, P1064, DOI 10.1126/science.224.4653.1064; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Monclus R, 2006, NEW PHYTOL, V169, P765, DOI 10.1111/j.1469-8137.2005.01630.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pizzio GA, 2013, PLANT PHYSIOL, V163, P441, DOI 10.1104/pp.113.224162; Song XQ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00612; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Yang T, 2015, PLANT J, V84, P1274, DOI 10.1111/tpj.13080; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	29	28	29	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168040	10.1371/journal.pone.0168040	http://dx.doi.org/10.1371/journal.pone.0168040			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992471	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600029
J	Alexandru, H; Muthuraman, M; Chirumamilla, VC; Koirala, N; Paktas, B; Deuschl, G; Zeuner, KE; Groppa, S				Alexandru, Hanganu; Muthuraman, Muthuraman; Chirumamilla, Venkata Chaitanya; Koirala, Nabin; Paktas, Burcu; Deuschl, Guenther; Zeuner, Kirsten E.; Groppa, Sergiu			Grey Matter Microstructural Integrity Alterations in Blepharospasm Are Partially Reversed by Botulinum Neurotoxin Therapy	PLOS ONE			English	Article							BASAL-GANGLIA; HEMIFACIAL SPASM; FOCAL DYSTONIA; DISCRIMINATION; SUPPLEMENTARY; SEGMENTATION; STIMULATION; ACTIVATION; DISEASE; CORTEX	Objective Benign Essential Blepharospasm (BEB) and hemifacial spasm (HFS) are the most common hyperkinetic movement disorders of facial muscles. Although similar in clinical presentation different pathophysiological mechanisms are assumed. Botulinum Neurotoxin (BoNT) is a standard evidence-based treatment for both conditions. In this study we aimed to assess grey matter microstructural differences between these two groups of patients and compared them with healthy controls. In patients we furthermore tracked the longitudinal morphometric changes associated with BoNT therapy. We hypothesized microstructural differences between the groups at the time point of maximum symptoms representation and distinct longitudinal grey matter dynamics with symptom improvement. Methods Cross-sectional and longitudinal analyses of 3T 3D-T1 MRI images from BEB, HFS patients prior to and one month after BoNT therapy and from a group of age and sex matched healthy controls. Cortical thickness as extracted from Freesurfer was assessed as parameter of microstructural integrity. Results BoNT therapy markedly improved motor symptoms in patients with BEB and HFS. Significant differences of grey matter integrity have been found between the two patients groups. The BEB group showed lower cortical thickness at baseline in the frontal-rostral, supramarginal and temporal regions compared to patients with HFS. In this group BoNT treatment was associated with a cortical thinning in the primary motor cortex and the pre-supplementary motor area (pre-SMA). Contrary patients with HFS showed no longitudinal CT changes. A decreased cortical thickness was attested bilaterally in the temporal poles and in the right superior frontal region in BEB patients in comparison to HC. Patients in the HFS group presented a decreased CT in the left lingual gyrus and temporal pole. Conclusions Although patients with BEB and HFS present clinically with involuntary movements of facial muscles, they exhibited differences in cortical thickness. While BoNT therapy was equally effective in both groups, widespread changes of cortical morphology occurred only in BEB patients. We demonstrated specific disease-and therapy-dependent structural changes induced by BoNT in the studied hyperkinetic conditions.	[Alexandru, Hanganu; Muthuraman, Muthuraman; Paktas, Burcu; Deuschl, Guenther; Zeuner, Kirsten E.; Groppa, Sergiu] Univ Kiel, Dept Neurol, Kiel, Germany; [Muthuraman, Muthuraman; Chirumamilla, Venkata Chaitanya; Koirala, Nabin; Groppa, Sergiu] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Neuroimage Ctr NIC Focus Program Translat Neurosc, Movement Disorders & Neurostimulat,Dept Neurol, Mainz, Germany	University of Kiel; Johannes Gutenberg University of Mainz	Groppa, S (corresponding author), Univ Kiel, Dept Neurol, Kiel, Germany.; Groppa, S (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Neuroimage Ctr NIC Focus Program Translat Neurosc, Movement Disorders & Neurostimulat,Dept Neurol, Mainz, Germany.	segroppa@uni-mainz.de	Deuschl, Gunther/A-7986-2010; Koirala, Nabin/Y-3055-2019; Groppa, Sergiu/A-5711-2019; Groppa, Sergiu/G-4606-2014; Muthuraman, Muthuraman/ABD-2021-2020	Deuschl, Gunther/0000-0002-4176-9196; Koirala, Nabin/0000-0002-8261-8271; Groppa, Sergiu/0000-0002-2551-5655; Muthuraman, Muthuraman/0000-0001-6158-2663	German Research Council [CRC 1193]	German Research Council(German Research Foundation (DFG))	This work was supported by the German Research Council (CRC 1193, project B05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER FG, 1995, J NEUROSURG, V82, P201, DOI 10.3171/jns.1995.82.2.0201; BERARDELLI A, 1985, BRAIN, V108, P593, DOI 10.1093/brain/108.3.593; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Curtis CE, 2005, CEREB CORTEX, V15, P1281, DOI 10.1093/cercor/bhi011; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dresel C, 2011, MOVEMENT DISORD, V26, P1496, DOI 10.1002/mds.23497; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; Etgen T, 2006, J NEUROL NEUROSUR PS, V77, P1017, DOI 10.1136/jnnp.2005.087148; Fahn S, 1985, ADV OPHTHALMIC PLAST, V4, P97; Fiorio M, 2008, J NEUROL NEUROSUR PS, V79, P796, DOI 10.1136/jnnp.2007.131524; FRIED I, 1991, J NEUROSCI, V11, P3656; Granert O, 2011, NEUROIMAGE, V54, P32, DOI 10.1016/j.neuroimage.2010.08.013; Hallett M, 2002, NEUROLOGY, V59, P1306, DOI 10.1212/01.WNL.0000027361.73814.0E; Hallett M, 2008, NEUROLOGY, V71, P1275, DOI 10.1212/01.wnl.0000327601.46315.85; Herz DM, 2014, ANN NEUROL, V75, P829, DOI 10.1002/ana.24138; Horovitz SG, 2012, TRANSL NEURODEGENER, V1, DOI 10.1186/2047-9158-1-12; JANNETTA PJ, 1977, NEUROCHIRURGIE, V20, P145; Martino D, 2011, MOVEMENT DISORD, V26, P1907, DOI 10.1002/mds.23724; Molloy FM, 2003, BRAIN, V126, P2175, DOI 10.1093/brain/awg219; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Obermann M, 2008, EUR J NEUROL, V15, P831, DOI 10.1111/j.1468-1331.2008.02196.x; Obermann M, 2007, MOVEMENT DISORD, V22, P1117, DOI 10.1002/mds.21495; Peller M, 2006, BRAIN, V129, P2697, DOI 10.1093/brain/awl181; Quartarone A, 2006, J NEUROSCI, V26, P716, DOI 10.1523/JNEUROSCI.3948-05.2006; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; SHALE H, 1987, MOVEMENT DISORD, V2, P321, DOI 10.1002/mds.870020411; Simonyan K, 2012, CEREB CORTEX, V22, P417, DOI 10.1093/cercor/bhr120; Simpson DM, 2008, NEUROLOGY, V70, P1699, DOI 10.1212/01.wnl.0000311389.26145.95; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sohn YH, 2004, CLIN NEUROPHYSIOL, V115, P341, DOI 10.1016/j.clinph.2003.10.035; Wolpe N, 2014, BRAIN, V137, P208, DOI 10.1093/brain/awt302	36	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168652	10.1371/journal.pone.0168652	http://dx.doi.org/10.1371/journal.pone.0168652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992533	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000073
J	Burillo, A; Marin, M; Cercenado, E; Ruiz-Carrascoso, G; Perez-Granda, MJ; Oteo, J; Bouza, E				Burillo, Almudena; Marin, Mercedes; Cercenado, Emilia; Ruiz-Carrascoso, Guillermo; Jesus Perez-Granda, Maria; Oteo, Jesus; Bouza, Emilio			Evaluation of the Xpert Carba-R (Cepheid) Assay Using Contrived Bronchial Specimens from Patients with Suspicion of Ventilator-Associated Pneumonia for the Detection of Prevalent Carbapenemases	PLOS ONE			English	Article							GRAM-NEGATIVE BACILLI; KLEBSIELLA-PNEUMONIAE; BACTERIAL PNEUMONIA; ACQUIRED PNEUMONIA; RAPID DETECTION; RECTAL SWABS; IMPACT; ENTEROBACTERIACEAE; MANAGEMENT; THERAPY	There is a critical need for rapid diagnostic methods for multidrug-resistant (MDR) pathogens in patients with a suspicion of ventilator-associated pneumonia (VAP). The Xpert Carba-R detects 5 targets for carbapenemase-producing organisms (bla(KPC), bla(NDM), bla(VIM), bla(OXA-48), and bla(IMP-1)). Our objective was to evaluate the performance of this assay directly on bronchial aspirates and to correlate the cycle number for a positive result (Ct) with the bacterial count. Bronchial aspirates from patients with a suspicion of VAP were spiked with a dilution of 1 of 4 MDR organisms carrying the resistance genes detected by the test prepared to a final concentration of 10(2)-10(5) cfu/ mL. We used a ROC curve and provided areas under the curve (AUC) with their 95% confidence intervals (CI). A point of maximum sensitivity (Se) and specificity (Sp) was derived and validity indices were calculated. One hundred contrived tests were performed. Se and Sp were 100% for all bacterial counts. A positive sample with a Ct <= 24.7 corresponded to a count >= 10(5) cfu/mL; if the Ct was within the range >24.7-<= 26.9, this corresponded to a count >= 10(4) cfu/mL. When the Ct was >26.9, this corresponded to a count <10(4) cfu/ mL. The Xpert Carba-R detects carbapenemase-producing organisms directly in contrived bronchial aspirates. Still, an important issue to consider is that the number of gene copies may vary according to many factors in vivo. If confirmed in further studies, the strong correlation observed between Ct values and the results of semi-quantitative cultures suggests this test could serve to differentiate between infection and colonization in routine clinical practice.	[Burillo, Almudena; Marin, Mercedes; Cercenado, Emilia; Bouza, Emilio] Hosp Gen Univ Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid, Spain; [Burillo, Almudena; Marin, Mercedes; Cercenado, Emilia; Bouza, Emilio] Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain; [Burillo, Almudena; Marin, Mercedes; Cercenado, Emilia; Bouza, Emilio] Univ Complutense Madrid, Sch Med, Dept Med, Madrid, Spain; [Marin, Mercedes; Cercenado, Emilia; Jesus Perez-Granda, Maria; Bouza, Emilio] CIBER Enfermedades Resp CIBERES CB06 06 0058, Madrid, Spain; [Ruiz-Carrascoso, Guillermo] Hosp Univ La Paz, Dept Microbiol, Madrid, Spain; [Jesus Perez-Granda, Maria] Hosp Gen Univ Gregorio Maranon, Dept Anesthesiol, Cardiac Surg Intens Care Unit, Madrid, Spain; [Oteo, Jesus] Inst Salud Carlos III, Antibiot Lab, Dept Bacteriol, Ctr Nacl Microbiol, Majadahonda, Spain	General University Gregorio Maranon Hospital; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital Universitario La Paz; General University Gregorio Maranon Hospital; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Burillo, A (corresponding author), Hosp Gen Univ Gregorio Maranon, Clin Microbiol & Infect Dis Dept, Madrid, Spain.; Burillo, A (corresponding author), Inst Invest Sanitaria Gregorio Maranon, Madrid, Spain.; Burillo, A (corresponding author), Univ Complutense Madrid, Sch Med, Dept Med, Madrid, Spain.	almudena.burillo@gmail.com	Bouza, Emilio/D-8661-2014; GRANDA, MARIA JESUS mjpg PEREZ/L-3040-2015; Ruiz-Carrascoso, Guillermo/AAD-8914-2021	Bouza, Emilio/0000-0001-6967-9267; GRANDA, MARIA JESUS mjpg PEREZ/0000-0002-0613-2122; Ruiz-Carrascoso, Guillermo/0000-0002-8957-6596; Burillo, Almudena/0000-0003-2545-4204; Oteo, Jesus/0000-0003-3327-8263	Cepheid, Sunnyvale, CA; Cepheid	Cepheid, Sunnyvale, CA; Cepheid	This work was supported by a grant from Cepheid, Sunnyvale, CA. Cepheid provided the assay cartridges and paid for the laboratory expenses derived from the work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CLIN INFECT DIS S4, V52, pS384; Arango MV, 2003, ARCH BRONCONEUMOL, V39, P394; Barbier F, 2013, CURR OPIN PULM MED, V19, P216, DOI 10.1097/MCP.0b013e32835f27be; Birgand G, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-30; Centers for Disease Control and Prevention, 2016, VENT ASS EV VAE; Cercenado E, 2012, J CLIN MICROBIOL, V50, P4095, DOI 10.1128/JCM.02409-12; Chambers HF, 2014, CLIN INFECT DIS, V58, P1571, DOI 10.1093/cid/ciu132; Chastre Jean, 2005, Respir Care, V50, P975; Dollow JM, 2014, DRUG DES DEV THER, V8, P175, DOI 10.2147/DDDT.S52446; El Solh AA, 2007, CRIT CARE, V11, DOI 10.1186/cc5917; Hortal J, 2009, CRIT CARE, V13, DOI 10.1186/cc7896; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Kollef MH, 2007, CLIN INFECT DIS, V44, P388, DOI 10.1086/510595; Kollef Marin H, 2005, Respir Care, V50, P714; Kuti EL, 2008, J CRIT CARE, V23, P91, DOI 10.1016/j.jcrc.2007.08.007; Lerner A, 2013, ANTIMICROB AGENTS CH, V57, P1474, DOI 10.1128/AAC.01275-12; Luna CM, 2006, EUR RESPIR J, V27, P158, DOI 10.1183/09031936.06.00049105; Miro E, 2013, EUR J CLIN MICROBIOL, V32, P253, DOI 10.1007/s10096-012-1737-0; Muscedere JG, 2008, J CRIT CARE, V23, P5, DOI 10.1016/j.jcrc.2007.11.012; Oteo J, 2013, ANTIMICROB AGENTS CH, V57, P6344, DOI 10.1128/AAC.01513-13; Oteo J, 2012, J MED MICROBIOL, V61, P864, DOI 10.1099/jmm.0.043190-0; Rello J, 2005, CRIT CARE, V9, P259, DOI 10.1186/cc3014; Sharpe JP, 2015, J AM COLL SURGEONS, V220, P489, DOI 10.1016/j.jamcollsurg.2014.12.016; Soubirou JF, 2014, SCAND J INFECT DIS, V46, P215, DOI 10.3109/00365548.2013.871644; Spellberg B, 2010, CLIN INFECT DIS, V51, pS150, DOI 10.1086/653065; Stenehjem E, 2012, J CLIN MICROBIOL, V50, P2079, DOI 10.1128/JCM.06690-11; Tato M, 2016, J CLIN MICROBIOL, V54, P1814, DOI 10.1128/JCM.00341-16; Tenover FC, 2013, J CLIN MICROBIOL, V51, P3780, DOI 10.1128/JCM.01092-13; van der Zee A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-27; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; York MK, 2010, CLIN MICROBIOLOGY PR	31	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168473	10.1371/journal.pone.0168473	http://dx.doi.org/10.1371/journal.pone.0168473			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992521	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000052
J	Burke, NJ; Napoles, TM; Banks, PJ; Orenstein, FS; Luce, JA; Joseph, G				Burke, Nancy J.; Napoles, Tessa M.; Banks, Priscilla J.; Orenstein, Fern S.; Luce, Judith A.; Joseph, Galen			Survivorship Care Plan Information Needs: Perspectives of Safety-Net Breast Cancer Patients	PLOS ONE			English	Article							AFRICAN-AMERICAN; HEPATITIS-B; EDUCATION; PROGRAM; SUPPORT; LATINA; HEALTH	Purpose Despite the Institute of Medicine's (IOM) 2005 recommendation, few care organizations have instituted standard survivorship care plans (SCPs). Low health literacy and low English proficiency are important factors to consider in SCP development. Our study aimed to identify information needs and survivorship care plan preferences of low literacy, multi-lingual patients to support the transition from oncology to primary care and ongoing learning in survivorship. Methods We conducted focus groups in five languages with African American, Latina, Russian, Filipina, White, and Chinese medically underserved breast cancer patients. Topics explored included the transition to primary care, access to information, knowledge of treatment history, and perspectives on SCPs. Results Analysis of focus group data identified three themes: 1) the need for information and education on the transition between "active treatment" and "survivorship"; 2) information needed (and often not obtained) from providers; and 3) perspectives on SCP content and delivery. Conclusions Our data point to the need to develop a process as well as written information for medically underserved breast cancer patients. An SCP document will not replace direct communication with providers about treatment, symptom management and transition, a communication that is missing in participating safety-net patients' experiences of cancer care. Women turned to peer support and community-based organizations in the absence of information from providers. Implications for Cancer Survivors "Clear and effective" communication of survivorship care for safety-net patients requires dedicated staff trained to address wide-ranging information needs and uncertainties.	[Burke, Nancy J.] Univ Calif Merced, Sch Social Sci Humanities & Arts, Merced, CA 95340 USA; [Burke, Nancy J.; Napoles, Tessa M.; Joseph, Galen] Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA; [Burke, Nancy J.; Banks, Priscilla J.; Joseph, Galen] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Orenstein, Fern S.; Luce, Judith A.] San Francisco Gen Hosp, Breast Care Dispar Program, San Francisco, CA 94110 USA; [Luce, Judith A.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California Merced; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Burke, NJ (corresponding author), Univ Calif Merced, Sch Social Sci Humanities & Arts, Merced, CA 95340 USA.; Burke, NJ (corresponding author), Univ Calif San Francisco, Dept Anthropol Hist & Social Med, San Francisco, CA 94143 USA.; Burke, NJ (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.	Nburke2@ucmerced.edu		Joseph, Galen/0000-0001-9179-7075	Avon Foundation Breast Cancer Disparities Grant [012015037]; Mount Zion Health Fund [20130088]	Avon Foundation Breast Cancer Disparities Grant; Mount Zion Health Fund	Research reported was funded by the Avon Foundation Breast Cancer Disparities Grant (012015037, Luce PI) and the Mount Zion Health Fund (20130088, Burke PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Surgeons Commission on Cancer, 2012, CANC PROGR STAND 201; Ashing-Giwa K, 2013, J CANCER SURVIV, V7, P283, DOI 10.1007/s11764-013-0270-1; Ashing-Giwa KT, 2004, PSYCHO-ONCOLOGY, V13, P408, DOI 10.1002/pon.750; Bernard H. H. R., 2009, ANAL QUALITATIVE DAT; Bucholtz M, 2000, J PRAGMATICS, V32, P1439, DOI 10.1016/S0378-2166(99)00094-6; Burg MA, 2009, J GEN INTERN MED, V24, P467, DOI 10.1007/s11606-009-1012-y; Burke NJ, 2012, QUAL HEALTH RES, V22, P189, DOI 10.1177/1049732311420577; Burke NJ, 2011, J COMMUN HEALTH, V36, P27, DOI 10.1007/s10900-010-9277-y; Burke NJ, 2004, J CANCER EDUC, V19, P244, DOI 10.1207/s15430154jce1904_13; Burke NJ, 2004, ETHNIC HEALTH, V9, P153, DOI 10.1080/1355785042000222860; Burke NJ, ONCOLOGY PROVI UNPUB; Burke NJ, 2008, CANC HLTH DISP SUMM; Chung LK, 2009, CANCER NURS, V32, P236, DOI 10.1097/NCC.0b013e318196c67b; Hawley ST, 2008, PATIENT EDUC COUNS, V73, P363, DOI 10.1016/j.pec.2008.07.036; Hewitt ME, 2007, J CLIN ONCOL, V25, P2270, DOI 10.1200/JCO.2006.10.0826; Hewitt ME, 2006, AM SOC CLIN ONCOLOGY; Kantsiper M, 2009, J GEN INTERN MED, V24, P459, DOI 10.1007/s11606-009-1000-2; Ko CM, 2003, BMC PUBLIC HEALTH, V3, DOI 10.1186/1471-2458-3-27; Marbach TJ, 2011, ONCOL NURS FORUM, V38, P335, DOI 10.1188/11.ONF.335-342; Mathews HF, 2009, CONFRONTING CANC MET, P43; O'Malley DM, 2016, J CANCER EDUC, V31, P63, DOI 10.1007/s13187-014-0775-y; Pasick RJ, 1995, P NAT C HLTH STAT JU; Pratt-Chapman M, CANC SURVIVORSHIP PO; Rechis R, 2011, ESSENTIAL ELEMENTS S; Rust C, 2011, SOC WORK HEALTH CARE, V50, P739, DOI 10.1080/00981389.2011.585703; Salz T, 2012, CA-CANCER J CLIN, V62, P101, DOI 10.3322/caac.20142; Wen KY, 2014, J COMMUNITY SUPPORT, V12, P439, DOI 10.12788/jcso.0095	27	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168383	10.1371/journal.pone.0168383	http://dx.doi.org/10.1371/journal.pone.0168383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992491	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000045
J	Komori, M; Suzuki, H; Hikoya, A; Sawada, M; Hotta, Y; Sato, M				Komori, Miwa; Suzuki, Hiroko; Hikoya, Akiko; Sawada, Mayu; Hotta, Yoshihiro; Sato, Miho			Evaluation of Surgical Strategy Based on the Intraoperative Superior Oblique Tendon Traction Test	PLOS ONE			English	Article							INFERIOR RECTUS RECESSION; TROCHLEAR NERVE PALSY; ANTERIOR TRANSPOSITION; MUSCLE MYECTOMY; MANAGEMENT; SURGERY; TUCK; OVERACTION; ABSENCE	Purpose To clarify the efficacy of a surgical strategy based on the superior oblique tendon traction test. Methods A retrospective chart review was performed between January 2002 and June 2015. During that period, a single inferior oblique muscle (IO) myectomy and a combined IO myectomy and superior oblique muscle (SO) tuck procedure were performed based on SO tendon looseness as revealed by a traction test. The surgical effects of both procedures and the number of operations were analyzed. Results Sixty-five cases were retrieved. Seventy-four surgeries were required. The IO myectomy and simultaneous groups included 48 and 17 cases, respectively. Pre-operative vertical deviation was significantly lower in the IO myectomy (11.8 prism diopters) than in the simultaneous (27.2 prism diopters; Mann-Whitney U-test, P < 0.001) group. The mean induced changes were 9.4 prism diopters and 21.6 prism diopters in the IO myectomy and simultaneous groups, respectively, and the postoperative vertical deviation was not significantly different. On average, 1.13 and 1.18 surgeries per patient were performed in the IO myectomy and simultaneous groups, respectively. Conclusion The simultaneous surgery of inferior oblique myectomy and superior oblique tuck is safe and effective for treating large angle of congenital/idiopathic superior oblique palsy with a lax superior oblique tendon, as determined by the traction test.	[Komori, Miwa; Suzuki, Hiroko; Hikoya, Akiko; Sawada, Mayu; Hotta, Yoshihiro; Sato, Miho] Hamamatsu Univ Sch Med, Dept Ophthalmol, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine	Sato, M (corresponding author), Hamamatsu Univ Sch Med, Dept Ophthalmol, Hamamatsu, Shizuoka, Japan.	mihosato@hama-med.ac.jp	Hotta, Yoshihiro/O-5115-2019	Hotta, Yoshihiro/0000-0003-4052-5066	Japan Society for the Promotion of Science [16K11264]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by research grants from Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (C) (No. 16K11264 to M. Sato) (https:/www.jsps.go.jp/english/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahl RS, 2013, BRIT J OPHTHALMOL, V97, P184, DOI 10.1136/bjophthalmol-2012-301485; Caca I, 2012, J PEDIAT OPHTH STRAB, V49, P103, DOI 10.3928/01913913-20110628-01; Clifford L, 2015, J AAPOS, V19, P406, DOI 10.1016/j.jaapos.2015.07.280; Ghazawy S, 2007, J AAPOS, V11, P601, DOI 10.1016/j.jaapos.2007.06.011; Graf M, 2008, OPHTHALMOLOGE, V105, P931, DOI 10.1007/s00347-007-1678-7; Graf M, 2010, GRAEF ARCH CLIN EXP, V248, P223, DOI 10.1007/s00417-009-1188-1; GUYTON DL, 1981, OPHTHALMOLOGY, V88, P1035; Hatz KB, 2006, EUR J OPHTHALMOL, V16, P10, DOI 10.1177/112067210601600103; Helveston E M, 1996, Trans Am Ophthalmol Soc, V94, P315; HELVESTON EM, 1992, OPHTHALMOLOGY, V99, P1609; HELVESTON EM, 1983, AUST J OPHTHALMOL, V11, P215; Kaeser PF, 2012, J AAPOS, V16, P26, DOI 10.1016/j.jaapos.2011.08.012; Kushner B J, 1997, J AAPOS, V1, P55, DOI 10.1016/S1091-8531(97)90024-0; Kushner BJ, 2000, ARCH OPHTHALMOL-CHIC, V118, P1542; Lee JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156872; Maruo T, 1996, JPN J OPHTHALMOL, V40, P235; MORRIS RJ, 1992, J PEDIATR OPHTHALMOL, V29, P337; Nejad M, 2013, J PEDIAT OPHTH STRAB, V50, P44, DOI 10.3928/01913913-20121113-01; Nucci P, 2006, EUR J OPHTHALMOL, V16, P1; PACHECO EM, 1992, J PEDIATR OPHTHALMOL, V29, P265; Plager D A, 1990, J Pediatr Ophthalmol Strabismus, V27, P136; PLAGER DA, 1992, OPHTHALMOLOGY, V99, P1032; Plager DA, 1999, CLIN STRABISMUS MANA, P219; Rajavi Z, 2011, J PEDIAT OPHTH STRAB, V48, P375, DOI 10.3928/01913913-20110118-04; Sato M, 1999, AM J OPHTHALMOL, V127, P379, DOI 10.1016/S0002-9394(98)00329-8; Sato M, 1998, JPN J OPHTHALMOL, V42, P466; Sato M, 2008, AM J OPHTHALMOL, V146, P385, DOI 10.1016/j.ajo.2008.05.013; SAUNDERS RA, 1986, OPHTHALMOLOGY, V93, P1023; Scotcher SM, 1997, BRIT J OPHTHALMOL, V81, P1031, DOI 10.1136/bjo.81.12.1031; SPRUNGER DT, 1993, J PEDIATR OPHTHALMOL, V30, P145; TOOSI SH, 1979, AM J OPHTHALMOL, V88, P602, DOI 10.1016/0002-9394(79)90522-1; WRIGHT KW, 1992, J PEDIATR OPHTHALMOL, V29, P92; Yang HK, 2015, AM J NEURORADIOL, V36, P774, DOI 10.3174/ajnr.A4202; Yang HK, 2012, OPHTHALMOLOGY, V119, P170, DOI 10.1016/j.ophtha.2011.06.038	34	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168245	10.1371/journal.pone.0168245	http://dx.doi.org/10.1371/journal.pone.0168245			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992486	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000034
J	Setoyama, D; Kato, TA; Hashimoto, R; Kunugi, H; Hattori, K; Hayakawa, K; Sato-Kasai, M; Shimokawa, N; Kaneko, S; Yoshida, S; Goto, Y; Yasuda, Y; Yamamori, H; Ohgidani, M; Sagata, N; Miura, D; Kang, D; Kanba, S				Setoyama, Daiki; Kato, Takahiro A.; Hashimoto, Ryota; Kunugi, Hiroshi; Hattori, Kotaro; Hayakawa, Kohei; Sato-Kasai, Mina; Shimokawa, Norihiro; Kaneko, Sachie; Yoshida, Sumiko; Goto, Yu-ichi; Yasuda, Yuka; Yamamori, Hidenaga; Ohgidani, Masahiro; Sagata, Noriaki; Miura, Daisuke; Kang, Dongchon; Kanba, Shigenobu			Plasma Metabolites Predict Severity of Depression and Suicidal Ideation in Psychiatric Patients-A Multicenter Pilot Analysis	PLOS ONE			English	Article							INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; MASS-SPECTROMETRY; MAJOR DEPRESSION; QUINOLINIC ACID; DISORDER; SCHIZOPHRENIA; BRAIN; RECEPTOR; AGMATINE; METABOLOMICS	Evaluating the severity of depression (SOD), especially suicidal ideation (SI), is crucial in the treatment of not only patients with mood disorders but also psychiatric patients in general. SOD has been assessed on interviews such as the Hamilton Rating Scale for Depression (HAMD)-17, and/or self-administered questionnaires such as the Patient Health Questionnaire (PHQ)-9. However, these evaluation systems have relied on a person's subjective information, which sometimes lead to difficulties in clinical settings. To resolve this limitation, a more objective SOD evaluation system is needed. Herein, we collected clinical data including HAMD-17/PHQ-9 and blood plasma of psychiatric patients from three independent clinical centers. We performed metabolome analysis of blood plasma using liquid chromatography mass spectrometry (LC-MS), and 123 metabolites were detected. Interestingly, five plasma metabolites (3-hydroxybutyrate (3HB), betaine, citrate, creatinine, and gamma-aminobutyric acid (GABA)) are commonly associated with SOD in all three independent cohort sets regardless of the presence or absence of medication and diagnostic difference. In addition, we have shown several metabolites are independently associated with sub-symptoms of depression including SI. We successfully created a classification model to discriminate depressive patients with or without SI by machine learning technique. Finally, we produced a pilot algorithm to predict a grade of SI with citrate and kynurenine. The above metabolites may have strongly been associated with the underlying novel biological pathophysiology of SOD. We should explore the biological impact of these metabolites on depressive symptoms by utilizing a cross species study model with human and rodents. The present multicenter pilot study offers a potential utility for measuring blood metabolites as a novel objective tool for not only assessing SOD but also evaluating therapeutic efficacy in clinical practice. In addition, modification of these metabolites by diet and/or medications may be a novel therapeutic target for depression. To clarify these aspects, clinical trials measuring metabolites before/after interventions should be conducted. Larger cohort studies including non-clinical subjects are also warranted to clarify our pilot findings.	[Setoyama, Daiki; Kang, Dongchon] Kyushu Univ, Grad Sch Med Sci, Dept Clin Chem & Lab Med, Fukuoka, Japan; [Kato, Takahiro A.; Hayakawa, Kohei; Sato-Kasai, Mina; Shimokawa, Norihiro; Kaneko, Sachie; Ohgidani, Masahiro; Sagata, Noriaki; Kanba, Shigenobu] Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka, Japan; [Kato, Takahiro A.; Miura, Daisuke] Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka, Japan; [Hashimoto, Ryota] Osaka Univ, Mol Res Ctr Childrens Mental Dev, United Grad Sch Child Dev, Osaka, Japan; [Hashimoto, Ryota; Yasuda, Yuka; Yamamori, Hidenaga] Osaka Univ, Grad Sch Med, Dept Psychiat, Osaka, Japan; [Kunugi, Hiroshi; Hattori, Kotaro] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo, Japan; [Hattori, Kotaro; Goto, Yu-ichi] Natl Ctr Neurol & Psychiat, Translat Med Ctr, Tokyo, Japan; [Yoshida, Sumiko] Natl Ctr Neurol & Psychiat Hosp, Tokyo, Japan	Kyushu University; Kyushu University; Kyushu University; Osaka University; Osaka University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Kato, TA (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Neuropsychiat, Fukuoka, Japan.; Kato, TA (corresponding author), Kyushu Univ, Innovat Ctr Med Redox Nav, Fukuoka, Japan.	takahiro@npsych.med.kyushu-u.ac.jp	Miura, Daisuke/H-1517-2019; Kunugi, Hiroshi/ABC-5260-2021; Kato, Takahiro/R-7665-2019	Kato, Takahiro/0000-0001-5169-2930	Japan Agency for Medical Research and Development (AMED) [16dk0307047h0002, 16dm0107095h0001]; Japan Society for the Promotion of Science - KAKENHI [26840070, 26713039, 15K15431, 25253041, 25293252, 16H02666]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [25117011, 16H06403]; National Center Biobank Network Project; Center for Clinical and Translational Research (CCTR) of Kyushu University Hospital; Young Principal Investigators' Research Grant of Innovation Center for Medical Redox Navigation, Kyushu University; SENSHIN Medical Research Foundation; Grants-in-Aid for Scientific Research [25117011] Funding Source: KAKEN	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science - KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center Biobank Network Project; Center for Clinical and Translational Research (CCTR) of Kyushu University Hospital; Young Principal Investigators' Research Grant of Innovation Center for Medical Redox Navigation, Kyushu University; SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aid for Scientific Research on (1) The Japan Agency for Medical Research and Development (AMED) (Syogaisya-Taisaku-Sogo-Kenkp-Kaihatsu-Jigyo to SK (16dk0307047h0002); Yugo-Nou to TAK (16dm0107095h0001)), (2) The Japan Society for the Promotion of Science - KAKENHI (to DS (26840070), TAK (26713039 & 15K15431), KD (25253041), and SK (25293252 & 16H02666)), (3) Innovative Areas "Glia Assembly (25117011 to SK) and "Will Dynamics" (16H06403 to TAK) of The Ministry of Education, Culture, Sports, Science, and Technology, Japan, (4) National Center Biobank Network Project (to HK), (5) Center for Clinical and Translational Research (CCTR) of Kyushu University Hospital (to TAK, DK & SK) (6) Young Principal Investigators' Research Grant of Innovation Center for Medical Redox Navigation, Kyushu University (to TAK), (7) SENSHIN Medical Research Foundation (to TAK & SK). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	American Psychiatric Association. Task Force on DSM-IV, 1995, AMERICAN, Vxxvii; Bay-Richter C, 2015, BRAIN BEHAV IMMUN, V43, P110, DOI 10.1016/j.bbi.2014.07.012; Bryleva EY, 2017, NEUROPHARMACOLOGY, V112, P324, DOI 10.1016/j.neuropharm.2016.01.034; Busse M, 2015, EUR ARCH PSY CLIN N, V265, P321, DOI 10.1007/s00406-014-0562-0; Clark N, 2015, NY TIMES; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Cukor D, 2007, J AM SOC NEPHROL, V18, P3042, DOI 10.1681/ASN.2007030345; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2017, CURR TOP BEHAV NEURO, V31, P117, DOI 10.1007/7854_2016_6; Doulalas AD, 2006, ATHEROSCLEROSIS, V186, P121, DOI 10.1016/j.atherosclerosis.2005.06.030; Fakhoury M, 2016, MOL NEUROBIOL, V53, P2778, DOI 10.1007/s12035-015-9152-z; FRANK E, 1991, ARCH GEN PSYCHIAT, V48, P851, DOI 10.1001/archpsyc.1991.01810330075011; Freitas AE, 2014, PROG NEURO-PSYCHOPH, V50, P143, DOI 10.1016/j.pnpbp.2013.12.012; Furukawa TA, 2005, ACTA PSYCHIAT SCAND, V112, P279, DOI 10.1111/j.1600-0447.2005.00587.x; GERNER RH, 1981, AM J PSYCHIAT, V138, P1098; Graff EC, 2016, METABOLISM, V65, P102, DOI 10.1016/j.metabol.2015.10.001; Halaris A, 2007, CNS DRUGS, V21, P885, DOI 10.2165/00023210-200721110-00002; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hattori K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11412; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Horikawa H, 2010, PROG NEURO-PSYCHOPH, V34, P1306, DOI 10.1016/j.pnpbp.2010.07.015; Kaddurah-Daouk R, 2009, NEUROPSYCHOPHARMACOL, V34, P173, DOI 10.1038/npp.2008.174; Kalueff AV, 2007, DEPRESS ANXIETY, V24, P495, DOI 10.1002/da.20262; Kato TA, 2013, CURR MED CHEM, V20, P331; Kato TA, 2011, MINI-REV MED CHEM, V11, P565; Kato TA, 2016, PSYCHIAT CLIN NEUROS, V70, P7, DOI 10.1111/pcn.12360; Kato TA, 2011, LANCET, V378, P1070, DOI 10.1016/S0140-6736(11)61475-X; Kenedi C, 2016, AEROSP MED HUM PERF, V87, P388, DOI 10.3357/AMHP.4474.2016; Koike S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.19; Kroenke K, 2000, PSYCHOSOMATICS, V41, P39, DOI 10.1016/S0033-3182(00)71172-8; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kuehn BM, 2014, JAMA-J AM MED ASSOC, V312, P1727, DOI 10.1001/jama.2014.12816; Kunugi H, 2015, PSYCHIAT CLIN NEUROS, V69, P597, DOI 10.1111/pcn.12299; Liu XY, 2015, J PROTEOME RES, V14, P2322, DOI 10.1021/acs.jproteome.5b00144; Liu YS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2953-2; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Lopez-Vilchez I, 2014, J AFFECT DISORDERS, V159, P39, DOI 10.1016/j.jad.2014.02.022; Mann JJ, 2014, DEPRESS ANXIETY, V31, P814, DOI 10.1002/da.22278; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; Mitchell AJ, 2009, LANCET, V374, P609, DOI 10.1016/S0140-6736(09)60879-5; Mongeau R, 1997, BRAIN RES REV, V23, P145, DOI 10.1016/S0165-0173(96)00017-3; Monji A, 2009, PSYCHIAT CLIN NEUROS, V63, P257, DOI 10.1111/j.1440-1819.2009.01945.x; Mueller N, 2007, MOL PSYCHIATR, V12, P988, DOI 10.1038/sj.mp.4002006; Muller N, 2012, CURR PHARM BIOTECHNO, V13, P1606, DOI 10.2174/138920112800784826; Muller Norbert, 2009, Dialogues Clin Neurosci, V11, P319; Neis VB, 2015, PHARMACOL BIOCHEM BE, V130, P9, DOI 10.1016/j.pbb.2014.12.009; NEU S, 1986, NEW ENGL J MED, V314, P14, DOI 10.1056/NEJM198601023140103; Offermanns S, 2011, PHARMACOL REV, V63, P269, DOI 10.1124/pr.110.003301; Ogawa S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07796; Ota M, 2013, J PSYCHIATR RES, V47, P1383, DOI 10.1016/j.jpsychires.2013.06.010; Otsubo T, 2005, PSYCHIAT CLIN NEUROS, V59, P517, DOI 10.1111/j.1440-1819.2005.01408.x; OWENS MJ, 1994, CLIN CHEM, V40, P288; Plotsky PM, 1998, PSYCHIAT CLIN N AM, V21, P293, DOI 10.1016/S0193-953X(05)70006-X; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rahman M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4944; Sada N, 2015, SCIENCE, V347, P1362, DOI 10.1126/science.aaa1299; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Setoyama D, 2013, GENES CELLS, V18, P1107, DOI 10.1111/gtc.12098; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shopsin B, 2013, ACTA NEUROPSYCHIATR, V25, P113, DOI 10.1111/j.1601-5215.2012.00675.x; Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Weckmann K, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.119; Yoshimi N, 2016, MOL PSYCHIATR, V21, P1504, DOI 10.1038/mp.2015.217; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804	65	64	66	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0165267	10.1371/journal.pone.0165267	http://dx.doi.org/10.1371/journal.pone.0165267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27984586	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000003
J	Ho, VW; Hofs, E; Elisia, I; Lam, V; Hsu, BE; Lai, J; Luk, B; Samudio, I; Krystal, G				Ho, Victor W.; Hofs, Elyse; Elisia, Ingrid; Lam, Vivian; Hsu, Brian E.; Lai, June; Luk, Beryl; Samudio, Ismael; Krystal, Gerald			Trans Retinoic Acid, Transforming Growth Factor beta and Prostaglandin E-2 in Mouse Plasma Synergize with Basophil-Secreted Interleukin-4 to M2 Polarize Murine Macrophages	PLOS ONE			English	Article							T-CELLS; SUPPRESSOR-CELLS; SHIP REPRESSES; M1 MACROPHAGES; ACTIVATION; INDUCTION; GENERATION; SYSTEM; DYSFUNCTION; EXPRESSION	In previous studies we found that macrophages (M Phi s) from SH2-containing inositol-5'phosphatase (SHIP) deficient mice are M2 polarized while their wild type (WT) counterparts are M1 polarized and that this difference in M Phi phenotype can be recapitulated during in vitro derivation from bone marrow if mouse plasma (MP), but not fetal calf serum, is added to standard M-CSF-containing cultures. In the current study we investigated the mechanism by which MP skews SHIP-/- but not +/+ M Phi s to an M2 phenotype. Our results suggest that SHIP-/-basophils constitutively secrete higher levels of IL-4 than SHIP+/+ basophils and this higher level of IL-4 is sufficient to skew both SHIP+/+ and SHIP-/-M Phi s to an M2 phenotype, but only when MP is present to increase the sensitivity of the M Phi s to this level of IL-4. MP increases the IL-4 sensitivity of both SHIP+/+ and -/-M Phi s not by increasing cell surface IL-4 or CD36 receptor levels, but by triggering the activation of Erk and Akt and the production of ROS, all of which play a critical role in sensitizing M Phi s to IL-4-induced M2 skewing. Studies to identify the factor(s) in MP responsible for promoting IL-4-induced M2 skewing suggests that all-trans retinoic acid (ATRA), TGF beta and prostaglandin E-2 (PGE(2)) all play a role. Taken together, these results indicate that basophil-secreted IL-4 plays an essential role in M2 skewing and that ATRA, TGF beta and PGE2 within MP collaborate to dramatically promote M2 skewing by acting directly on M Phi s to increase their sensitivity to IL-4.	[Ho, Victor W.; Hofs, Elyse; Elisia, Ingrid; Lam, Vivian; Hsu, Brian E.; Lai, June; Luk, Beryl; Samudio, Ismael; Krystal, Gerald] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada	British Columbia Cancer Agency	Krystal, G (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC, Canada.	gkrystal@bccrc.ca	Samudio, Ismael/D-3581-2013	Samudio, Ismael/0000-0001-8676-1035; Krystal, Gerald/0000-0002-1961-6281	Canadian Cancer Society; Lotte & John Hecht Memorial Foundation [3968]; NCI C [016107]; Terry Fox Foundation Program [018006]; BC Cancer Foundation; BC Cancer Agency	Canadian Cancer Society(Canadian Cancer Society (CCS)); Lotte & John Hecht Memorial Foundation; NCI C(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Terry Fox Foundation Program; BC Cancer Foundation; BC Cancer Agency	The research was supported by the Canadian Cancer Society, the Lotte & John Hecht Memorial Foundation Grant ID #3968, NCI C grant #016107 and Terry Fox Foundation Program grant #018006, with core support from the BC Cancer Foundation and the BC Cancer Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; BENSASSON SZ, 1990, P NATL ACAD SCI USA, V87, P1421, DOI 10.1073/pnas.87.4.1421; Blunt MD, 2012, CURR OPIN PHARMACOL, V12, P444, DOI 10.1016/j.coph.2012.02.015; Boorsma CE, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/769214; Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brown SD, 2012, ALCOHOL CLIN EXP RES, V36, P1952, DOI 10.1111/j.1530-0277.2012.01825.x; CHAM BE, 1976, J LIPID RES, V17, P176; DaCosta BS, 2004, MOL PHARM, V65, P744, DOI DOI 10.1124/M0L.65.3.744; DAMEN JE, 1995, EMBO J, V14, P5557, DOI 10.1002/j.1460-2075.1995.tb00243.x; Denzel A, 2008, NAT IMMUNOL, V9, P733, DOI 10.1038/ni.1621; Desmedt M, 1998, J IMMUNOL, V160, P5300; Eruslanov E, 2011, INT IMMUNOPHARMACOL, V11, P848, DOI 10.1016/j.intimp.2011.01.033; Eruslanov E, 2010, J LEUKOCYTE BIOL, V88, P839, DOI 10.1189/jlb.1209821; Feng JW, 2000, J LIPID RES, V41, P688; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Gallo P, 2010, IMMUNOL LETT, V133, P70, DOI 10.1016/j.imlet.2010.07.004; GORSCH SM, 1992, CANCER RES, V52, P6949; Guo YX, 2015, PHYSIOL REV, V95, P125, DOI 10.1152/physrev.00032.2013; Hamilton MJ, 2010, J IMMUNOL, V185, P4545, DOI 10.4049/jimmunol.1002045; Han WGH, 2010, EUR J IMMUNOL, V40, P2731, DOI 10.1002/eji.201040574; Hebenstreit D, 2006, CYTOKINE GROWTH F R, V17, P173, DOI 10.1016/j.cytogfr.2006.01.004; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Heusinkveld M, 2011, J IMMUNOL, V187, P1157, DOI 10.4049/jimmunol.1100889; Ho VW, 2014, CARCINOGENESIS, V35, P2291, DOI 10.1093/carcin/bgu147; Khan Shaukat A, 2012, BMC Res Notes, V5, P636, DOI 10.1186/1756-0500-5-636; Kuroda E, 2011, J IMMUNOL, V186, P323, DOI 10.4049/jimmunol.1002778; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; Lo HM, 2014, FOOD FUNCT, V5, P140, DOI 10.1039/c3fo60309a; Mamidi S, 2012, IMMUNOBIOLOGY, V217, P593, DOI 10.1016/j.imbio.2011.10.022; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez TN, 2012, ANTIOXID REDOX SIGN, V16, P920, DOI 10.1089/ars.2011.4033; Morrison AC, 2002, J IMMUNOL, V168, P853, DOI 10.4049/jimmunol.168.2.853; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Obrochta KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099435; Ostman A, 2011, J BIOCHEM, V150, P345, DOI 10.1093/jb/mvr104; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Ruhl R, 2008, NUTRITION, V24, P1224, DOI 10.1016/j.nut.2008.05.022; Salagianni M, 2012, CIRCULATION, V126, P952, DOI 10.1161/CIRCULATIONAHA.111.067678; SCHALKWIJK CG, 1992, EUR J BIOCHEM, V210, P169, DOI 10.1111/j.1432-1033.1992.tb17405.x; Sinha P, 2005, J IMMUNOL, V174, P636, DOI 10.4049/jimmunol.174.2.636; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Surace MJ, 2013, AM J CLIN EXP IMMUNO, V2, P117; Traore K, 2008, J CELL PHYSIOL, V216, P276, DOI 10.1002/jcp.21403; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; YOSHIMOTO T, 1994, J EXP MED, V179, P1285, DOI 10.1084/jem.179.4.1285; Zhang Y, 2013, CELL RES, V23, P898, DOI 10.1038/cr.2013.75; Zhou XL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-210	51	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168072	10.1371/journal.pone.0168072	http://dx.doi.org/10.1371/journal.pone.0168072			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977740	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400054
J	Huang, N; Wang, L; Hu, YS; Tian, HF; Niu, Z				Huang, Ni; Wang, Li; Hu, Yongsen; Tian, Haifeng; Niu, Zheng			Spatial Variation of Soil Respiration in a Cropland under Winter Wheat and Summer Maize Rotation in the North China Plain	PLOS ONE			English	Article							SPECTRAL VEGETATION INDEXES; CO2 EFFLUX; ECOSYSTEM RESPIRATION; TEMPERATURE-DEPENDENCE; CLUSTER-ANALYSIS; ABIOTIC FACTORS; BOREAL FOREST; WATER-CONTENT; PHOTOSYNTHESIS; PRODUCTIVITY	Spatial variation of soil respiration (R-s) in cropland ecosystems must be assessed to evaluate the global terrestrial carbon budget. This study aims to explore the spatial characteristics and controlling factors of Rs in a cropland under winter wheat and summer maize rotation in the North China Plain. We collected R-s data from 23 sample plots in the cropland. At the late jointing stage, the daily mean R-s of summer maize (4.74 mu mol CO2 m(-2) s(-1)) was significantly higher than that of winter wheat (3.77 mu mol CO2 m(-2) s(-1)). However, the spatial variation of R-s in summer maize (coefficient of variation, CV = 12.2%) was lower than that in winter wheat (CV = 18.5%). A similar trend in CV was also observed for environmental factors but not for biotic factors, such as leaf area index, aboveground biomass, and canopy chlorophyll content. Pearson's correlation analyses based on the sampling data revealed that the spatial variation of R-s was poorly explained by the spatial variations of biotic factors, environmental factors, or soil properties alone for winter wheat and summer maize. The similarly non-significant relationship was observed between R-s and the enhanced vegetation index (EVI), which was used as surrogate for plant photosynthesis. EVI was better correlated with fieldmeasured leaf area index than the normalized difference vegetation index and red edge chlorophyll index. All the data from the 23 sample plots were categorized into three clusters based on the cluster analysis of soil carbon/nitrogen and soil organic carbon content. An apparent improvement was observed in the relationship between R-s and EVI in each cluster for both winter wheat and summer maize. The spatial variation of R-s in the cropland under winter wheat and summer maize rotation could be attributed to the differences in spatial variations of soil properties and biotic factors. The results indicate that applying cluster analysis to minimize differences in soil properties among different clusters can improve the role of remote sensing data as a proxy of plant photosynthesis in semi-empirical R-s models and benefit the acquisition of R-s in cropland ecosystems at large scales.	[Huang, Ni; Wang, Li; Hu, Yongsen; Tian, Haifeng; Niu, Zheng] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Tian, Haifeng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, L (corresponding author), Chinese Acad Sci, Inst Remote Sensing & Digital Earth, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.	wangli@radi.ac.cn	Wang, Li/P-9811-2018; niu, zheng/M-9923-2017	Wang, Li/0000-0002-2929-4255; 	National Natural Science Foundation of China [41301498]; Youth Innovation Promotion Association CAS [2014052]; Special Foundation for Young Scientists from the director of the Institute of Remote Sensing and Digital Earth, Chinese Academy of Sciences; National High Technology Research and Development Program of China (863Program) [2014AA06A511]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association CAS; Special Foundation for Young Scientists from the director of the Institute of Remote Sensing and Digital Earth, Chinese Academy of Sciences; National High Technology Research and Development Program of China (863Program)(National High Technology Research and Development Program of China)	This work was supported by the National Natural Science Foundation of China (41301498), the Youth Innovation Promotion Association CAS (2014052), the Special Foundation for Young Scientists from the director of the Institute of Remote Sensing and Digital Earth, Chinese Academy of Sciences, and the National High Technology Research and Development Program of China (863Program) (2014AA06A511).	Alexandrov GA, 2007, ECOL MODEL, V200, P189, DOI 10.1016/j.ecolmodel.2006.07.012; Amos B, 2006, SOIL SCI SOC AM J, V70, P1489, DOI 10.2136/sssaj2005.0216; Asner GP, 2004, GLOBAL CHANGE BIOL, V10, P844, DOI 10.1111/j.1529-8817.2003.00766.x; Aubrey DP, 2009, NEW PHYTOL, V184, P35, DOI 10.1111/j.1469-8137.2009.02971.x; Balogh J, 2011, SOIL BIOL BIOCHEM, V43, P1006, DOI 10.1016/j.soilbio.2011.01.017; Chang CT, 2014, BIOGEOSCIENCES, V11, P6173, DOI 10.5194/bg-11-6173-2014; Chen DM, 2013, J ECOL, V101, P1322, DOI 10.1111/1365-2745.12119; Chen Z, 2015, AGR FOREST METEOROL, V203, P180, DOI 10.1016/j.agrformet.2015.01.012; Cook FJ, 2008, SOIL BIOL BIOCHEM, V40, P1013, DOI 10.1016/j.soilbio.2007.12.012; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Ding WX, 2007, SOIL SCI SOC AM J, V71, P944, DOI 10.2136/sssaj2006.0160; Eugster W, 2010, AGR ECOSYST ENVIRON, V139, P346, DOI 10.1016/j.agee.2010.09.001; Everitt B, 2009, QUAL QUANT, V14, P75; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Geng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034968; Giammanco S, 2009, B VOLCANOL, V71, P201, DOI 10.1007/s00445-008-0218-x; Gitelson, 2003, GEOPHYS RES LETT, V30; Han GX, 2007, SOIL BIOL BIOCHEM, V39, P418, DOI 10.1016/j.soilbio.2006.08.009; Hanesch M, 2001, PHYS CHEM EARTH PT A, V26, P885, DOI 10.1016/S1464-1895(01)00137-5; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Hashimoto S, 2015, BIOGEOSCIENCES DISCU, V12, P4331, DOI DOI 10.5194/BGD-12-4331-; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Huang N., 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0105150, DOI 10.1371/JOURNAL.PONE.0105150]; Huang N, 2014, J GEOPHYS RES-ATMOS, V119, P6393, DOI 10.1002/2013JD020515; Huang N, 2013, PLANT SOIL, V367, P535, DOI 10.1007/s11104-012-1488-9; Huang N, 2013, ECOL INDIC, V26, P117, DOI 10.1016/j.ecolind.2012.10.027; Huang N, 2012, AGR FOREST METEOROL, V160, P80, DOI 10.1016/j.agrformet.2012.03.005; Huang W, 2007, PRECIS AGRIC, V8, P187, DOI 10.1007/s11119-007-9038-9; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Irisarri JGN, 2012, J VEG SCI, V23, P114, DOI 10.1111/j.1654-1103.2011.01326.x; Jagermeyr J, 2014, GLOBAL CHANGE BIOL, V20, P1191, DOI 10.1111/gcb.12443; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Janssens IA, 2001, GLOBAL CHANGE BIOL, V7, P269, DOI 10.1046/j.1365-2486.2001.00412.x; Jiang JS, 2015, SOIL TILL RES, V150, P139, DOI 10.1016/j.still.2015.02.002; Jiang Y, 2015, CHEM ERDE GEOCHEMIST, V75; Katayama A, 2009, AGR FOREST METEOROL, V149, P1666, DOI 10.1016/j.agrformet.2009.05.007; Kaufman L, 1990, J AM STAT ASS; Keeney R.D., 1982, METHODS SOIL ANAL, P101; Kuzyakov Y, 2005, J PLANT NUTR SOIL SC, V168, P503, DOI 10.1002/jpln.200421703; Kuzyakov Y, 2010, GLOBAL CHANGE BIOL, V16, P3386, DOI 10.1111/j.1365-2486.2010.02179.x; Levy-Varon JH, 2012, OECOLOGIA, V169, P211, DOI 10.1007/s00442-011-2182-y; Moitinho MR, 2015, SOIL TILL RES, V148, P127, DOI 10.1016/j.still.2014.12.012; Nguyen C, 2003, AGRONOMIE, V23, P375, DOI 10.1051/agro:2003011; Olsson P, 2005, GLOBAL CHANGE BIOL, V11, P1745, DOI 10.1111/j.1365-2486.2005.001033.x; Ortega RA, 2007, COMPUT ELECTRON AGR, V58, P49, DOI 10.1016/j.compag.2006.12.011; Parkin TB, 2005, J HYDROMETEOROL, V6, P812, DOI 10.1175/JHM459.1; Phillips SC, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2008JG000858; Prolingheuer N, 2010, BIOGEOSCIENCES, V12, P9137; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Rayment MB, 2000, SOIL BIOL BIOCHEM, V32, P35, DOI 10.1016/S0038-0717(99)00110-8; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; Shi PL, 2006, AGR FOREST METEOROL, V137, P220, DOI 10.1016/j.agrformet.2006.02.008; Sims DA, 2008, REMOTE SENS ENVIRON, V112, P1633, DOI 10.1016/j.rse.2007.08.004; Sims DA, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2006JG000162; Song XY, 2009, PRECIS AGRIC, V10, P471, DOI 10.1007/s11119-009-9108-2; Stadler A, 2015, EUROPEAN J AGRONOMY, P8; Supit I, 2012, AGR FOREST METEOROL, V164, P96, DOI 10.1016/j.agrformet.2012.05.005; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Turner DP, 2004, BIOSCIENCE, V54, P573, DOI 10.1641/0006-3568(2004)054[0573:IRSAEP]2.0.CO;2; Vargas R, 2011, NEW PHYTOL, V191, P1006, DOI 10.1111/j.1469-8137.2011.03771.x; Vargas R, 2011, BIOGEOCHEMISTRY, V102, P1, DOI 10.1007/s10533-010-9462-1; Wagle P, 2014, BIOENERG RES, V7, P789, DOI 10.1007/s12155-014-9434-8; Wang B, 2014, BIOGEOSCIENCES, V11, P259, DOI 10.5194/bg-11-259-2014; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Zhang CP, 2014, SOIL BIOL BIOCHEM, V75, P113, DOI 10.1016/j.soilbio.2014.04.013; Zhang Q, 2013, AGR FOREST METEOROL, V180, P34, DOI 10.1016/j.agrformet.2013.04.028; Zhao CJ, 2007, NEW ZEAL J AGR RES, V50, P735	71	1	1	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168249	10.1371/journal.pone.0168249	http://dx.doi.org/10.1371/journal.pone.0168249			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977743	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400080
J	Mijiti, M; Mijiti, P; Axier, A; Amuti, M; Zhu, GH; Cheng, XJ; Kadeer, K; Wang, XX; Geng, D; Maimaitili, A				Mijiti, Maimaitili; Mijiti, Peierdun; Axier, Aximujiang; Amuti, Maiwulanjiang; Zhu Guohua; Cheng Xiaojiang; Kadeer, Kaheerman; Wang Xixian; Geng, Dangmurenjiafu; Maimaitili, Aisha			Incidence and Predictors of Angiographic Vasospasm, Symptomatic Vasospasm and Cerebral Infarction in Chinese Patients with Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							OF-THE-LITERATURE; TRANSCRANIAL DOPPLER; CLINICAL-TRIALS; OUTCOME EVENT; FISHER SCALE; RISK-FACTORS; ISCHEMIA; ASSOCIATION; REPAIR; BLOOD	Introduction Cerebral vasospasm (CVS) is the most common neurological complication after aneurysmal subarachnoid hemorrhage (aSAH) and associated with poor functional outcome and mortality. Reports on incidence and predictors of CVS in Chinese patients with aSAH were scarce. We aimed to estimate the incidence and predictors of angiographic vasospasm (AV), symptomatic vasospasm (SV), and cerebral infarction in Chinese patients with aSAH. Methods We retrospectively reviewed the medical records of 542 consecutive aSAH patients admitted to neurosurgery department of the First Affiliated Hospital of Xinjiang Medical University in Urumqi city of China between January 1, 2011 and December 31, 2015. AV, SV and cerebral infarction were defined based on clinical data and neuroimaging findings. Univariate and multivariate analyses were performed to identify predictors of AV, SV or cerebral infarction. Results 343 (63.3%) patients fulfilled the inclusion and exclusion criteria. Of them, 182(53.1%) developed AV, 99 (28.9%) developed SV, and 87 (25.4%) developed cerebral infarction. A history of hypertension, poor modified Fisher grade (3-4) and poor Hunt-Hess grade (4-5) on admission were common risk factors for AV, SV and cerebral infarction. Patients from Uyghur ethnic group or other minorities were less likely to develop AV, SV or cerebral infarction, compared to those from Han ethic group after adjustment of other potential confounders. Additionally, age-53 years, leukocyte count >= 11x10(9)/L on admission and being current or former smokers were independent risk factors of cerebral infarction. Leukocyte count >= 11x 10(9)/L on admission and aneurysm size >= 10 mm were independent risk factors of SV. Serum glucose level >= 7.0 mmol/L on admission was an independent risk factor of AV. Conclusion Risk factors of different definitions of CVS were diverse in Chinese patients with aSAH; however, risk factors of SV and cerebral infarction seem to be similar. We recommend early and aggressive therapy in these patients at-risk of CVS.	[Mijiti, Maimaitili; Axier, Aximujiang; Zhu Guohua; Cheng Xiaojiang; Kadeer, Kaheerman; Wang Xixian; Geng, Dangmurenjiafu; Maimaitili, Aisha] Xinjiang Med Univ, Dept Neurosurg, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China; [Mijiti, Peierdun] Xinjiang Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Urumqi, Xinjiang, Peoples R China; [Amuti, Maiwulanjiang] Peoples Hosp Kashi, Dept Neurosurg, Kashi, Xinjiang, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Geng, D (corresponding author), Xinjiang Med Univ, Dept Neurosurg, Affiliated Hosp 1, Urumqi, Xinjiang, Peoples R China.	aximjan9@126.com			Regional Science Fund Project of Xinjiang, China [81160150]	Regional Science Fund Project of Xinjiang, China	This study was financially supported by the Regional Science Fund Project of Xinjiang, China (No.81160150).	Carrera E, 2009, NEUROSURGERY, V65, P316, DOI 10.1227/01.NEU.0000349209.69973.88; Charpentier C, 1999, STROKE, V30, P1402, DOI 10.1161/01.STR.30.7.1402; Claassen J, 2001, STROKE, V32, P2012, DOI 10.1161/hs0901.095677; Crowley RW, 2011, STROKE, V42, P919, DOI 10.1161/STROKEAHA.110.597005; Etminan N, 2013, ACTA NEUROCHIR SUPPL, V115, P33, DOI 10.1007/978-3-7091-1192-5_8; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; Fergusen S, 2007, NEUROSURGERY, V60, P658, DOI 10.1227/01.NEU.0000255396.23280.31; Frontera JA, 2009, CORD C P, V40, P1963, DOI DOI 10.1161/STR0KEAHA.108.544700; Frontera JA, 2006, NEUROSURGERY, V59, P21, DOI 10.1227/01.NEU.0000218821.34014.1B; Harrod CG, 2005, NEUROSURGERY, V56, P633, DOI 10.1227/01.NEU.0000156644.45384.92; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; Inagawa T, 2016, WORLD NEUROSURG, V85, P56, DOI 10.1016/j.wneu.2015.08.052; Inagawa T, 2014, NEUROL MED-CHIR, V54, P465, DOI 10.2176/nmc.oa.2013-0169; Jabbarli R, 2015, EUR J NEUROL, V22, P941, DOI 10.1111/ene.12686; Kale SP, 2013, J STROKE CEREBROVASC, V22, P22, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.024; Kanamaru K, 2016, ACTA NEUROCHIR SUPPL, V121, P167, DOI 10.1007/978-3-319-18497-5_30; Kanamaru Kenji, 2015, Acta Neurochir Suppl, V120, P291, DOI 10.1007/978-3-319-04981-6_49; Kasius KM, 2010, CEREBROVASC DIS, V29, P576, DOI 10.1159/000306645; KASSELL NF, 1985, STROKE, V16, P562, DOI 10.1161/01.STR.16.4.562; Ko SB, 2011, STROKE, V42, P669, DOI 10.1161/STROKEAHA.110.600775; Korbakis G, 2016, NEUROCRIT CARE, V24, P428, DOI 10.1007/s12028-015-0212-z; Kozak N, 2016, TURK NEUROSURG, V26, P545, DOI 10.5137/1019-5149.JTN.14408-15.1; Krejza J, 2005, RADIOLOGY, V236, P621, DOI 10.1148/radiol.2362031662; Kumar A, 2013, NEUROSURGERY, V73, P617, DOI 10.1227/NEU.0000000000000057; Kumar G, 2016, J NEUROSURG, V124, P1257, DOI 10.3171/2015.4.JNS15428; Lasner TM, 1997, NEUROSURGERY, V87, P381, DOI [10.3171/jns.1997.87.3.0381, DOI 10.3171/JNS.1997.87.3.0381]; Lysakowski C, 2001, STROKE, V32, P2292, DOI 10.1161/hs1001.097108; Macdonald RL, 2003, J NEUROSURG, V99, P644, DOI 10.3171/jns.2003.99.4.0644; McGirt MJ, 2003, J NEUROSURG, V98, P1222, DOI 10.3171/jns.2003.98.6.1222; Mocco J, 2006, NEUROSURGERY, V58, P305, DOI 10.1227/01.NEU.0000195009.02412.E8; Naidech AM, 2010, NEUROCRIT CARE, V12, P181, DOI 10.1007/s12028-009-9311-z; Oyama Katie, 2004, Crit Care Nurse, V24, P58; Pearl JD, 2008, ACTA NEUROCHIR SUPPL, V105, P207; Qureshi AI, 2000, CRIT CARE MED, V28, P984, DOI 10.1097/00003246-200004000-00012; Rabinstein AA, 2005, STROKE, V36, P992, DOI 10.1161/01.STR.0000163090.59350.5a; Roos YBWEM, 2000, J NEUROL NEUROSUR PS, V68, P337, DOI 10.1136/jnnp.68.3.337; Su FW, 2010, J NEUROL, V257, P264, DOI 10.1007/s00415-009-5306-0; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Turowski B, 2015, CLIN NEURORADIOL, V25, P205, DOI 10.1007/s00062-015-0444-5; Vergouwen MDI, 2011, NEUROCRIT CARE, V15, P308, DOI 10.1007/s12028-011-9586-8; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Wong GKC, 2016, ACTA NEUROCHIR SUPPL, V121, P157, DOI 10.1007/978-3-319-18497-5_28; Yousef K, 2010, NEUROCRIT CARE, V13, P366, DOI 10.1007/s12028-010-9408-4; Zafar SF, 2016, J CLIN NEUROPHYSIOL, V33, P235, DOI 10.1097/WNP.0000000000000276	44	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168657	10.1371/journal.pone.0168657	http://dx.doi.org/10.1371/journal.pone.0168657			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977801	Green Submitted, gold, Green Published			2022-12-27	WOS:000391217400125
J	Falk, AR; Kaye, TG; Zhou, ZH; Burnham, DA				Falk, Amanda R.; Kaye, Thomas G.; Zhou, Zhonghe; Burnham, David A.			Laser Fluorescence Illuminates the Soft Tissue and Life Habits of the Early Cretaceous Bird Confuciusornis	PLOS ONE			English	Article							PRIMARY FEATHER RACHISES; POOR FLIGHT ABILITY; WING TIP SLOTS; AVIAN FLIGHT; ARCHAEOPTERYX; EVOLUTION; PROPATAGIUM; REDUCTION; SHAPE; DRAG	In this paper we report the discovery of non-plumage soft tissues in Confuciusornis, a basal beaked bird from the Early Cretaceous Jehol Biota in northeastern China. Various soft tissues are visualized and interpreted through the use of laser-stimulated fluorescence, providing much novel anatomical information about this early bird, specifically reticulate scales covering the feet, and the well-developed and robust pro-and postpatagium. We also include a direct comparison between the forelimb soft tissues of Confuciusornis and modern avian patagia. Furthermore, apparently large, fleshy phalangeal pads are preserved on the feet. The reticulate scales, robust phalangeal pads as well as the highly recurved pedal claws strongly support Confuciusornis as an arboreal bird. Reticulate scales are more rounded than scutate scales and do not overlap, thus allowing for more flexibility in the toe. The extent of the pro-and postpatagium and the robust primary feather rachises are evidence that Confuciusornis was capable of powered flight, contrary to previous reports suggesting otherwise. A unique avian wing shape is also reconstructed based on plumage preserved. These soft tissues combined indicate an arboreal bird with the capacity for shortterm (non-migratory) flight, and suggest that, although primitive, Confuciusornis already possessed many relatively advanced avian anatomical characteristics.	[Falk, Amanda R.] Ctr Coll Danville, Dept Biol, Danville, KY 40422 USA; [Kaye, Thomas G.] Burke Museum Hist & Culture, Seattle, WA USA; [Zhou, Zhonghe] Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Burnham, David A.] Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; [Burnham, David A.] Univ Kansas, Biodivers Inst, Lawrence, KS 66045 USA	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Kansas; University of Kansas	Falk, AR (corresponding author), Ctr Coll Danville, Dept Biol, Danville, KY 40422 USA.	amanda.falk@centre.edu			U.S. State Department; University of Kansas Natural History Museum and Biodiversity Institute; University of Kansas Department of Geology; National Basic Research Program of China (973 Program) [2012CB821906]; National Natural Science Foundation of China	U.S. State Department; University of Kansas Natural History Museum and Biodiversity Institute; University of Kansas Department of Geology; National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	ARF was funded in part by a Fulbright Grant from the U.S. State Department, a Panorama small grant from the University of Kansas Natural History Museum and Biodiversity Institute, and the University of Kansas Department of Geology. Z. Zhou was supported by the National Basic Research Program of China (973 Program; 2012CB821906), the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann T, 2012, J EXP BIOL, V215, P405, DOI 10.1242/jeb.059451; Barrett PM, 2006, INTEGR ZOOL, V1, P15, DOI 10.1111/j.1749-4877.2006.00006.x; Baumel J. J., 1993, HDB AVIAN ANATOMY NO, P45; Baumel JJ, 1993, HDB AVIAN ANATOMY, P189; Birkmann H, 1996, J PALEONTOL, V70, P1084, DOI 10.1017/S0022336000038774; Brown RE, 1996, J EXP ZOOL, V276, P112, DOI 10.1002/(SICI)1097-010X(19961001)276:2<112::AID-JEZ4>3.0.CO;2-R; BROWN RE, 1995, J MORPHOL, V225, P91, DOI 10.1002/jmor.1052250108; BROWN RE, 1994, J MORPHOL, V219, P205, DOI 10.1002/jmor.1052190209; BRUSH AH, 1985, J EXP ZOOL, V236, P303, DOI 10.1002/jez.1402360307; Burnham DA, 2011, J SYST PALAEONTOL, V9, P103, DOI 10.1080/14772019.2010.522201; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chiappe Luis M., 1999, Bulletin of the American Museum of Natural History, V242, P1; HOMBERGER DG, 1986, ZOOMORPHOLOGY, V106, P103, DOI 10.1007/BF00312112; Kaye TG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125923; Larsson HCE, 2002, J EXP ZOOL, V294, P146, DOI 10.1002/jez.10153; Martin LD, 2005, CURR SCI INDIA, V89, P1089; Martin LD, 1998, NATURWISSENSCHAFTEN, V85, P286, DOI 10.1007/s001140050501; Navalon G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14864; Nudds RL, 2010, SCIENCE, V328, P887, DOI 10.1126/science.1188895; O'Connor JK, 2012, GEOSCIENCES, V2, P157, DOI 10.3390/geosciences2030157; Paul GS, 2010, SCIENCE, V330, DOI 10.1126/science.1192963; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Perez-Tris J, 2001, J AVIAN BIOL, V32, P207, DOI 10.1111/j.0908-8857.2001.320301.x; Peters DS, 1999, J ORNITHOL, V140, P41, DOI 10.1007/BF02462087; Proctor NS, 1993, MANUAL ORNITHOLOGY; Sachs G, 2006, J THEOR BIOL, V239, P93, DOI 10.1016/j.jtbi.2005.07.016; SAVILE DBO, 1957, EVOLUTION, V11, P212, DOI 10.2307/2406051; Schopf JW, 2011, TOP GEOBIOL, V36, P241, DOI 10.1007/978-94-007-0680-4_10; Schopf JW, 2006, ASTROBIOLOGY, V6, P1, DOI 10.1089/ast.2006.6.1; TUCKER VA, 1993, J EXP BIOL, V180, P285; TUCKER VA, 1995, J EXP BIOL, V198, P775; Wang X, 2011, J EVOLUTION BIOL, V24, P1226, DOI 10.1111/j.1420-9101.2011.02253.x; Zhang F, 1998, VERT PALASICA, V35, P126; Zhang ZH, 2009, J ORNITHOL, V150, P783, DOI 10.1007/s10336-009-0399-x; Zheng XT, 2010, SCIENCE, V330, DOI 10.1126/science.1193223; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420; Zhou ZH, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P237; Zhou ZH, 2008, J ANAT, V212, P565, DOI 10.1111/j.1469-7580.2008.00880.x; Zinoviev AV, 2009, PALEONTOL J+, V43, P444, DOI 10.1134/S0031030109040145	39	20	22	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167284	10.1371/journal.pone.0167284	http://dx.doi.org/10.1371/journal.pone.0167284			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973609	gold, Green Published, Green Submitted			2022-12-27	WOS:000392754300022
J	Urabe, CT; Tanaka, G; Aihara, K; Mimura, M				Urabe, Chiyori T.; Tanaka, Gouhei; Aihara, Kazuyuki; Mimura, Masayasu			Parameter Scaling for Epidemic Size in a Spatial Epidemic Model with Mobile Individuals	PLOS ONE			English	Article							MEASLES METAPOPULATION DYNAMICS; PANDEMIC INFLUENZA; LATTICE MODEL; SPREAD; STRATEGIES; PERSISTENCE; NETWORK	In recent years, serious infectious diseases tend to transcend national borders and widely spread in a global scale. The incidence and prevalence of epidemics are highly influenced not only by pathogen-dependent disease characteristics such as the force of infection, the latent period, and the infectious period, but also by human mobility and contact patterns. However, the effect of heterogeneous mobility of individuals on epidemic outcomes is not fully understood. Here, we aim to elucidate how spatial mobility of individuals contributes to the final epidemic size in a spatial susceptible-exposed-infectious-recovered (SEIR) model with mobile individuals in a square lattice. After illustrating the interplay between the mobility parameters and the other parameters on the spatial epidemic spreading, we propose an index as a function of system parameters, which largely governs the final epidemic size. The main contribution of this study is to show that the proposed index is useful for estimating how parameter scaling affects the final epidemic size. To demonstrate the effectiveness of the proposed index, we show that there is a positive correlation between the proposed index computed with the real data of human airline travels and the actual number of positive incident cases of influenza B in the entire world, implying that the growing incidence of influenza B is attributed to increased human mobility.	[Urabe, Chiyori T.; Tanaka, Gouhei; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Tanaka, Gouhei; Aihara, Kazuyuki] Univ Tokyo, Grad Sch Engn, Tokyo, Japan; [Mimura, Masayasu] Meiji Univ, Meiji Inst Adv Study Math Sci, Tokyo, Japan	University of Tokyo; University of Tokyo; Meiji University	Urabe, CT (corresponding author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.	chiyori@iis.u-tokyo.ac.jp	Tanaka, Gouhei/Y-3230-2019	Tanaka, Gouhei/0000-0002-6223-4406; Urabe, Chiyori T./0000-0001-5815-4289	Commissioned Research program of the Ministry of Health, Labour and Welfare, Japan [H26-ShinkoJitsuyoka-General-016]; CREST; JST; JSPS KAKENHI Grant [15H05707]; Aihara Project; FIRST program from JSPS	Commissioned Research program of the Ministry of Health, Labour and Welfare, Japan; CREST(Core Research for Evolutional Science and Technology (CREST)); JST(Japan Science & Technology Agency (JST)); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Aihara Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); FIRST program from JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by the Commissioned Research program of the Ministry of Health, Labour and Welfare, Japan (H26-ShinkoJitsuyoka-General-016), CREST, JST and JSPS KAKENHI Grant Number 15H05707 (KA), and the Aihara Project, the FIRST program from JSPS, initiated by CSTP (CTU, GT, and KA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajardi P, 2011, PLOS ONE, V6; Balcan D, 2010, J COMPUT SCI-NETH, V1, P132, DOI 10.1016/j.jocs.2010.07.002; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Bell D, 2006, EMERG INFECT DIS, V12, P81; BOCCARA N, 1992, J PHYS A-MATH GEN, V25, P2447, DOI 10.1088/0305-4470/25/9/018; BOLKER B, 1995, PHILOS T R SOC B, V348, P309, DOI 10.1098/rstb.1995.0070; Caley P, 2008, J R SOC INTERFACE, V5, P631, DOI 10.1098/rsif.2007.1197; Colizza V, 2006, P NATL ACAD SCI USA, V103, P2015, DOI 10.1073/pnas.0510525103; Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Eubank S, 2004, NATURE, V429, P180, DOI 10.1038/nature02541; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferreira SC, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041125; Finkenstadt B, 1998, P ROY SOC B-BIOL SCI, V265, P211, DOI 10.1098/rspb.1998.0284; Fuks H, 2001, DISCRETE DYN NAT SOC, V6, P191, DOI 10.1155/S1026022601000206; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Grais RF, 2003, EUR J EPIDEMIOL, V18, P1065, DOI 10.1023/A:1026140019146; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9; Hall IM, 2007, EPIDEMIOL INFECT, V135, P1133, DOI 10.1017/S0950268806007783; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Hufnagel L, 2004, P NATL ACAD SCI USA, V101, P15124, DOI 10.1073/pnas.0308344101; Keeling MJ, 2000, NATURE, V407, P903, DOI 10.1038/35038073; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mills HL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003561; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Pearson K, 1905, NATURE, V72, P294, DOI 10.1038/072294b0; Rhodes CJ, 1996, J THEOR BIOL, V180, P125, DOI 10.1006/jtbi.1996.0088; Rhodes CJ, 1997, THEOR POPUL BIOL, V52, P101, DOI 10.1006/tpbi.1997.1323; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Ruan ZY, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036117; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Saito MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072866; Shu P., 2015, CHAOS, V25; Shu P, 2016, ARXIV160202050; Tanaka G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05522; Tang M, 2009, EPL, V87; Truscott J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002699; Tsai MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013292; White SH, 2007, APPL MATH COMPUT, V186, P193, DOI 10.1016/j.amc.2006.06.126; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341; Yashima K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098518	47	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168127	10.1371/journal.pone.0168127	http://dx.doi.org/10.1371/journal.pone.0168127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973605	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300057
J	Wilkie, H; Nicol, L; Gossner, A; Hopkins, J				Wilkie, Hazel; Nicol, Louise; Gossner, Anton; Hopkins, John			Mucosal Expression of T Cell Gene Variants Is Associated with Differential Resistance to Teladorsagia circumcincta	PLOS ONE			English	Article							GASTROINTESTINAL NEMATODES; HELMINTH-PARASITES; IMMUNE REGULATION; BLACKFACE SHEEP; INFECTED SHEEP; HOST IMMUNITY; ROR-GAMMA; MECHANISMS; LAMBS; TH2	Resistance of sheep to the gastrointestinal nematode Teladorsagia circumcincta is a heritable characteristic. Control of parasite colonization and egg production is strongly linked to IgA antibody levels regulated by Th2 T cell activation within lymphoid tissue; and persistently- infected susceptible animals develop an inflammatory Th1/Th17 response within the abomasum that fails to control infection. Differential T cell polarization therefore is associated with parasite resistance and/or susceptibility and is controlled by a specific set of transcription factors and cytokine receptors. Transcript variants of these genes have been characterized in sheep, while in humans and mice different variants of the genes are associated with inflammatory diseases. RT-qPCR was used to quantify mucosal expression of the transcript variants of the sheep genes in trickle-infected animals with defined phenotypic traits. Genes that encode full-length GATA3 and IL17RB were shown to be significantly increased in resistant sheep that had controlled parasite infection. Expression levels of both were significantly negatively correlated with abomasal worm count (a parameter of susceptibility) and positively correlated with body weight (a parameter of resistance). These data show that polarized Th2 T cells within the abomasal mucosa play an important role in the maintenance of resistance.	[Hopkins, John] Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland; Univ Edinburgh, RD SVS, Easter Bush, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Hopkins, J (corresponding author), Univ Edinburgh, Roslin Inst, Easter Bush, Midlothian, Scotland.	john.hopkins@ed.ac.uk	Hopkins, John/C-7756-2013	Hopkins, John/0000-0002-9530-8037; Wilkie, Hazel/0000-0002-6586-4518	Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant [BB/J004227/1]; BBSRC Industrial CASE scholarship; Sheep Improved Genetics Ltd; AHDB Beef and Lamb [BB/J012653/1]; BBSRC Doctoral Training Grant [BB/D526245/1]; Natural Environment Research Council (NERC) through its 'Post-Genomics and Proteomics' programme [NE/D000645/1]; BBSRC [BBS/E/D/20231762, BBS/E/D/20231760] Funding Source: UKRI; NERC [NE/D000645/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20231762, BBS/E/D/20231760, 1232400] Funding Source: researchfish; Natural Environment Research Council [NE/D000645/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Industrial CASE scholarship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Sheep Improved Genetics Ltd; AHDB Beef and Lamb; BBSRC Doctoral Training Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (NERC) through its 'Post-Genomics and Proteomics' programme(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This project was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) Institute Strategic Programme Grant to The Roslin Institute (BB/J004227/1), by a BBSRC Industrial CASE scholarship to JH, for HW, sponsored by Sheep Improved Genetics Ltd (no funding was obtained from SIG Ltd) and supported by AHDB Beef and Lamb (Grant BB/J012653/1). LN was a BBSRC postgraduate student funded by the BBSRC Doctoral Training Grant BB/D526245/1. This does not alter our adherence to PLOS ONE policies on sharing data. The initial work was funded by the Natural Environment Research Council (NERC) through its 'Post-Genomics and Proteomics' programme (grant NE/D000645/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angkasekwinai P, 2013, INFECT IMMUN, V81, P3731, DOI 10.1128/IAI.00646-13; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Armour J, 1996, VET PARASITOLOGY; Beraldi D, 2008, INT J PARASITOL, V38, P1567, DOI 10.1016/j.ijpara.2008.04.011; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Coltman DW, 2001, PARASITOLOGY, V122, P571, DOI 10.1017/S0031182001007570; Craig NM, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-87; Davies G, 2006, HEREDITY, V96, P252, DOI 10.1038/sj.hdy.6800788; Dawson H, 2009, INFECT IMMUN, V77, P2576, DOI 10.1128/IAI.00827-07; Gossner A, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-68; Gossner AG, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-26; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Grencis RK, 2015, ANNU REV IMMUNOL, V33, P201, DOI 10.1146/annurev-immunol-032713-120218; Hayes KS, 2004, IMMUNOL REV, V201, P75, DOI 10.1111/j.0105-2896.2004.00193.x; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; Lacroux C, 2006, VET RES, V37, P607, DOI 10.1051/vetres:2006022; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Licona-Limon P, 2013, IMMUNITY, V39, P744, DOI 10.1016/j.immuni.2013.07.020; Lynch KW, 2004, NAT REV IMMUNOL, V4, P931, DOI 10.1038/nri1497; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Massacand JC, 2009, P NATL ACAD SCI USA, V106, P13968, DOI 10.1073/pnas.0906367106; McSorley HJ, 2013, INT J PARASITOL, V43, P301, DOI 10.1016/j.ijpara.2012.11.011; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Meeusen ENT, 2005, VET IMMUNOL IMMUNOP, V108, P121, DOI 10.1016/j.vetimm.2005.07.002; Neill DR, 2010, IMMUNOL CELL BIOL, V88, P502, DOI 10.1038/icb.2010.43; Nicol L, 2016, VET RES, V47, DOI 10.1186/s13567-016-0314-4; Patel N, 2009, INT J PARASITOL, V39, P13, DOI 10.1016/j.ijpara.2008.08.003; Pei C, 2016, INFECT IMMUN; Pena MT, 2006, VET PARASITOL, V138, P240, DOI 10.1016/j.vetpar.2005.12.026; Pernthaner A, 2005, INFECT IMMUN, V73, P2175, DOI 10.1128/IAI.73.4.2175-2183.2005; Sayers G., 2005, Animal Health Research Reviews, V6, P159, DOI 10.1079/AHR2005108; Shaw RJ, 2012, VET PARASITOL, V186, P109, DOI 10.1016/j.vetpar.2011.11.051; Stear MJ, 1999, VET IMMUNOL IMMUNOP, V72, P213, DOI 10.1016/S0165-2427(99)00134-8; Strain SAJ, 2002, PARASITOLOGY, V124, P545, DOI 10.1017/S0031182002001531; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wilkie H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149644; Wilkie H, 2015, VET PARASITOL, V212, P206, DOI 10.1016/j.vetpar.2015.08.023; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhu JF, 2006, CELL RES, V16, P3, DOI 10.1038/sj.cr.7310002; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	44	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168194	10.1371/journal.pone.0168194	http://dx.doi.org/10.1371/journal.pone.0168194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973603	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300064
J	Fuller, M; Li, XR; Fisch, R; Bughara, M; Wicksteed, B; Kovatcheva-Datchary, P; Layden, BT				Fuller, Miles; Li, Xiaoran; Fisch, Robert; Bughara, Moneb; Wicksteed, Barton; Kovatcheva-Datchary, Petia; Layden, Brian T.			FFA2 Contribution to Gestational Glucose Tolerance Is Not Disrupted by Antibiotics	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; HUMAN GUT MICROBIOTA; FATTY-ACID RECEPTOR; ANTIMICROBIAL DEFENSE; INSULIN-RESISTANCE; HOST; RESPONSES; PROMOTES; GPR43; MICE	During the insulin resistant phase of pregnancy, the mRNA expression of free fatty acid 2 receptor (Ffar2) is upregulated and as we recently reported, this receptor contributes to insulin secretion and pancreatic beta cell mass expansion in order to maintain normal glucose homeostasis during pregnancy. As impaired gestational glucose levels can affect metabolic health of offspring, we aimed to explore the role of maternal Ffar2 expression during pregnancy on the metabolic health of offspring and also the effects of antibiotics, which have been shown to disrupt gut microbiota fermentative activity (the source of the FFA2 ligands) on gestational glucose homeostasis. We found that maternal Ffar2 expression and impaired glucose tolerance during pregnancy had no effect on the growth rates, ad lib glucose and glucose tolerance in the offspring between 3 and 6 weeks of age. To disrupt short chain fatty acid production, we chronically treated WT mice and Ffar2(-/-) mice with broad range antibiotics and further compared their glucose tolerance prior to pregnancy and at gestational day 15, and also quantified cecum and plasma SCFAs. We found that during pregnancy antibiotic treatment reduced the levels of SCFAs in the cecum of the mice, but resulted in elevated levels of plasma SCFAs and altered concentrations of individual SCFAs. Along with these changes, gestational glucose tolerance in WT mice, but not Ffar2(-/-) mice improved while on antibiotics. Additional data showed that gestational glucose tolerance worsened in Ffar2(-/-) mice during a second pregnancy. Together, these results indicate that antibiotic treatment alone is inadequate to deplete plasma SCFA concentrations, and that modulation of gut microbiota by antibiotics does not disrupt the contribution of FFA2 to gestational glucose tolerance.	[Fuller, Miles; Li, Xiaoran; Fisch, Robert; Bughara, Moneb; Wicksteed, Barton; Layden, Brian T.] Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA; [Kovatcheva-Datchary, Petia] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden; [Layden, Brian T.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA; [Layden, Brian T.] Univ Illinois, Dept Med, Div Endocrinol Diabet & Metab, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; University of Gothenburg; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Layden, BT (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Endocrinol Metab & Mol Med, Chicago, IL 60611 USA.; Layden, BT (corresponding author), Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA.; Layden, BT (corresponding author), Univ Illinois, Dept Med, Div Endocrinol Diabet & Metab, Chicago, IL USA.	blayde1@uic.edu		Bughrara, Moneb/0000-0002-1100-6518	National Institutes of Health [R01DK104927-01A1]; University of Chicago DRC [P30DK020595]; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Career Development [1IK2BX001587-01]; American Heart Association [15PRE25750015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM079300] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago DRC; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Career Development; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	BTL is supported by the National Institutes of Health under award number, R01DK104927-01A1, The University of Chicago DR&C (P30DK020595) and Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Career Development (Grant no. 1IK2BX001587-01). MF is supported by the American Heart Association under award number 15PRE25750015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bellamy L, SCI DIR LANCET, V373, P1773; Borthakur A, 2012, AM J PHYSIOL-GASTR L, V303, pG1126, DOI 10.1152/ajpgi.00308.2012; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Carvalho BM, 2012, DIABETOLOGIA, V55, P2823, DOI 10.1007/s00125-012-2648-4; Chen YF, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0262-8; Ellekilde M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05922; Fuller M, 2015, AM J PHYSIOL-ENDOC M, V309, pE840, DOI 10.1152/ajpendo.00171.2015; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Hendrickx APA, 2015, MBIO, V6, DOI 10.1128/mBio.01346-15; Hwang I, 2015, FASEB J, V29, P2397, DOI 10.1096/fj.14-265983; Kahraman S, 2014, AM J PHYSIOL-ENDOC M, V307, pE906, DOI 10.1152/ajpendo.00210.2014; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Karnik SK, 2007, SCIENCE, V318, P806, DOI 10.1126/science.1146812; Kelder T, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.18; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008; Layden BT, 2010, J ENDOCRINOL, V207, P265, DOI 10.1677/JOE-10-0298; Layden BT, 2013, TRANSL RES, V161, P131, DOI 10.1016/j.trsl.2012.10.007; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; McNelis JC, 2015, DIABETES, V64, P3203, DOI 10.2337/db14-1938; Ornoy A, 2015, BIRTH DEFECTS RES C, V105, P53, DOI 10.1002/bdrc.21090; Pedersen J., 1968, ARCH DIS CHILD, V43, P391, DOI DOI 10.1136/ADC.43.229.391-A; Priyadarshini M, 2016, TRENDS ENDOCRIN MET, V27, P653, DOI 10.1016/j.tem.2016.03.011; Priyadarshini M, 2015, MOL ENDOCRINOL, V29, P1055, DOI 10.1210/me.2015-1007; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Tang C, 2015, NAT MED, V21, P173, DOI 10.1038/nm.3779; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167837	10.1371/journal.pone.0167837	http://dx.doi.org/10.1371/journal.pone.0167837			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959892	gold, Green Published, Green Submitted			2022-12-27	WOS:000392753900017
J	Zaki, AI; Badran, EF; El-Khamy, SE				Zaki, Amira Ibrahim; Badran, Ehab F.; El-Khamy, Said E.			Two Novel Space-Time Coding Techniques Designed for UWB MISO Systems Based on Wavelet Transform	PLOS ONE			English	Article								In this paper two novel space-time coding multi-input single-output (STC MISO) schemes, designed especially for Ultra-Wideband (UWB) systems, are introduced. The proposed schemes are referred to as wavelet space-time coding (WSTC) schemes. The WSTC schemes are based on two types of multiplexing, spatial and wavelet domain multiplexing. In WSTC schemes, four symbols are transmitted on the same UWB transmission pulse with the same bandwidth, symbol duration, and number of transmitting antennas of the conventional STC MISO scheme. The used mother wavelet (MW) is selected to be highly correlated with transmitted pulse shape and such that the multiplexed signal has almost the same spectral characteristics as those of the original UWB pulse. The two WSTC techniques increase the data rate to four times that of the conventional STC. The first WSTC scheme increases the data rate with a simple combination process. The second scheme achieves the increase in the data rate with a less complex receiver and better performance than the first scheme due to the spatial diversity introduced by the structure of its transmitter and receiver. The two schemes use Rake receivers to collect the energy in the dense multipath channel components. The simulation results show that the proposed WSTC schemes have better performance than the conventional scheme in addition to increasing the data rate to four times that of the conventional STC scheme.	[Zaki, Amira Ibrahim; Badran, Ehab F.; El-Khamy, Said E.] Arab Acad Sci Technol & Maritime Transport, Dept Elect & Commun Engn, Alexandria, Egypt	Egyptian Knowledge Bank (EKB); Arab Academy for Science, Technology & Maritime Transport	Badran, EF (corresponding author), Arab Acad Sci Technol & Maritime Transport, Dept Elect & Commun Engn, Alexandria, Egypt.	ebadran@aast.edu	Elkhamy, Said/AAO-4680-2020; Badran, Ehab Farouk/C-5103-2016; El-Khamy, Said/AAE-6748-2020	Elkhamy, Said/0000-0002-5582-3827; Badran, Ehab Farouk/0000-0001-9984-2475; 				Akansu AN., 2010, PHYS COMMUNICATION, V3, P1, DOI [DOI 10.1016/J.PHYCOM.2009.07.001, 10.1016/j.phycom.2009.07.001]; Alamouti SM, 1998, IEEE J SELECT AREAS, V16; Badran EF, 2009, SIGNAL IMAGE VIDEO P, V3, P35, DOI 10.1007/s11760-008-0057-4; Chernogo L. F., 2000, 8 INT C MATH METH EL; Choi JD, 2002, IEEE J SELECTED AREA, V20; El-Khamy S. E., 1996, P NAT RAD SCI C NRSC; El-Kholy SA, 2012, INT J PAVEMENT ENG, V13, P244, DOI 10.1080/10298436.2011.623780; Emmanuel L., 2010, COMPUTERS ELECT ENG, V36; Foerster J., 2003, P 6 INT S WIR PERS M, P116; Gershman AB, 2005, SPACE-TIME PROCESSING FOR MIMO COMMUNICATIONS, P1, DOI 10.1002/0470010045; Ghavami M, 2004, ULTRA WIDEBAND SIGNA; Hassen Fadel S., 2008, J ENG DEV, V12; Hosseini H., 2010, SIGNAL PROCESSING IN, V4, P75; Kaiser T., 2009, IEEE P, V97; Kattoush A. H., 2010, DIGITAL SIGNAL PROCE, V20; Kim Y., 2005, IEEE COMMUNICATIONS, V9; Lakshmanan M. K., 2006, WIRELESS PERSONAL CO, V37; Liu H., 2005, IEEE T WIRELESS COMM, V4; Mielczarek B., 2003, IEEE 58 VEH TECHN C, V3; Mucchi Lorenzo, 2009, International Journal of Ultra Wideband Communications and Systems, V1, P49, DOI 10.1504/IJUWBCS.2009.026449; Nguyen H, 2009, VEH TECHN C VTC; Oliveira H. M., 2003, 20 S BRAS TEL RIO DE; Oppermann I., 2004, UWB THEORY APPL; Win M. Z., 2000, IEEE J SELECTED AREA, V18; Xu DT, 2016, IET COMMUN, V10, P292, DOI 10.1049/iet-com.2015.0229; Yajnanarayana V., 2013, ELECT COMPUTING COMM, P1; Yang L., 2004, IEEE T COMMUNICATION, V52; Yu L, 2006, DESIGN COMPLEX WAVEL; Zhang YB, 2009, EURASIP J WIREL COMM, DOI 10.1155/2009/571903	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167990	10.1371/journal.pone.0167990	http://dx.doi.org/10.1371/journal.pone.0167990			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959939	Green Submitted, gold, Green Published			2022-12-27	WOS:000392753900032
J	Gerber, EM; Sadeh, B; Ward, A; Knight, RT; Deouell, LY				Gerber, Edden M.; Sadeh, Boaz; Ward, Andrew; Knight, Robert T.; Deouell, Leon Y.			Non-Sinusoidal Activity Can Produce Cross-Frequency Coupling in Cortical Signals in the Absence of Functional Interaction between Neural Sources	PLoS One			English	Article							OSCILLATORY ACTIVITY; THETA-OSCILLATIONS; GAMMA-POWER; CORTEX; PHASE; MEMORY; EXCITABILITY; ALPHA; EEG	The analysis of cross-frequency coupling (CFC) has become popular in studies involving intracranial and scalp EEG recordings in humans. It has been argued that some cases where CFC is mathematically present may not reflect an interaction of two distinct yet functionally coupled neural sources with different frequencies. Here we provide two empirical examples from intracranial recordings where CFC can be shown to be driven by the shape of a periodic waveform rather than by a functional interaction between distinct sources. Using simulations, we also present a generalized and realistic scenario where such coupling may arise. This scenario, which we term waveform-dependent CFC, arises when sharp waveforms (e.g., cortical potentials) occur throughout parts of the data, in particular if they occur rhythmically. Since the waveforms contain both low-and high-frequency components, these components can be inherently phase-aligned as long as the waveforms are spaced with appropriate intervals. We submit that such behavior of the data, which seems to be present in various cortical signals, cannot be interpreted as reflecting functional modulation between distinct neural sources without additional evidence. In addition, we show that even low amplitude periodic potentials that cannot be readily observed or controlled for, are sufficient for significant CFC to occur.	[Gerber, Edden M.; Deouell, Leon Y.] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Sadeh, Boaz; Ward, Andrew; Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Deouell, Leon Y.] Hebrew Univ Jerusalem, Dept Psychol, Jerusalem, Israel	Hebrew University of Jerusalem; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Hebrew University of Jerusalem	Gerber, EM (corresponding author), Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel.	edden.gerber@gmail.com	Deouell, Leon Y./W-9624-2019	Gerber, Edden/0000-0001-6704-0013	NINDS [R37 NS021135-27]; US-Israel Binational Research Foundation [2013070]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021135] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); US-Israel Binational Research Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by NINDS Grant R37 NS021135-27 to RTK, and the US-Israel Binational Research Foundation Grant 2013070 to RTK and LYD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aru J, 2015, CURR OPIN NEUROBIOL, V31, P51, DOI 10.1016/j.conb.2014.08.002; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Brazier D. R. S. M. A. B., 1961, FED NEWS, P646; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P390, DOI 10.1162/jocn.2008.21020; Cole S. R., 2016, BIORXIV, P49304; Crowell AL, 2012, BRAIN, V135, P615, DOI 10.1093/brain/awr332; Delorme A., J NEUROSCI METHODS, V134, P9; Demiralp T, 2007, INT J PSYCHOPHYSIOL, V64, P24, DOI 10.1016/j.ijpsycho.2006.07.005; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Jensen O, 2014, TRENDS NEUROSCI, V37, P357, DOI 10.1016/j.tins.2014.04.001; KASDIN NJ, 1995, P IEEE, V83, P802, DOI 10.1109/5.381848; KOZELKA JW, 1990, J CLIN NEUROPHYSIOL, V7, P191, DOI 10.1097/00004691-199004000-00004; Kramer MA, 2008, J NEUROSCI METH, V170, P352, DOI 10.1016/j.jneumeth.2008.01.020; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lisman J, 2008, SCHIZOPHRENIA BULL, V34, P974, DOI 10.1093/schbul/sbn060; Little Simon, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS44, DOI 10.1016/S1353-8020(13)70013-0; Lozano-Soldevilla D, 2016, FRONT COMPUT NEUROSC, V10, DOI 10.3389/fncom.2016.00087; Mormann F, 2005, HIPPOCAMPUS, V15, P890, DOI 10.1002/hipo.20117; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Penny WD, 2008, J NEUROSCI METH, V174, P50, DOI 10.1016/j.jneumeth.2008.06.035; Phipson B, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1585; Sadeh B, 2014, COGNITIVE ELECTROPHYSIOLOGY OF ATTENTION: SIGNALS OF THE MIND, P268, DOI 10.1016/B978-0-12-398451-7.00021-X; Szczepanski SM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001936; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Vanhatalo S, 2004, P NATL ACAD SCI USA, V101, P5053, DOI 10.1073/pnas.0305375101; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Yamawaki N, 2008, NEUROSCIENCE, V151, P386, DOI 10.1016/j.neuroscience.2007.10.021	31	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167351	10.1371/journal.pone.0167351	http://dx.doi.org/10.1371/journal.pone.0167351			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27941990	Green Submitted, gold, Green Published			2022-12-27	WOS:000392745600013
J	Yang, L; Yang, HL; Tu, ZC; Wang, XL				Yang, Lin; Yang, Hui-lin; Tu, Zong-cai; Wang, Xiao-lan			High-Throughput Sequencing of Microbial Community Diversity and Dynamics during Douchi Fermentation	PLOS ONE			English	Article							GRADIENT GEL-ELECTROPHORESIS; LACTIC-ACID BACTERIA; SOLID-STATE FERMENTATION; MOLECULAR-IDENTIFICATION; ENVIRONMENTAL-CONDITIONS; GUT MICROBIOTA; CHINESE DOUCHI; SOYBEAN PASTE; PCR-DGGE; SOIL	Douchi is a type of Chinese traditional fermented food that is an important source of protein and is used in flavouring ingredients. The end product is affected by the microbial community present during fermentation, but exactly how microbes influence the fermentation process remains poorly understood. We used an Illumina MiSeq approach to investigate bacterial and fungal community diversity during both douchi-koji making and fermentation. A total of 181,443 high quality bacterial 16S rRNA sequences and 221,059 high quality fungal internal transcribed spacer reads were used for taxonomic classification, revealing eight bacterial and three fungal phyla. Firmicutes, Actinobacteria and Proteobacteria were the dominant bacterial phyla, while Ascomycota and Zygomycota were the dominant fungal phyla. At the genus level, Staphylococcus and Weissella were the dominant bacteria, while Aspergillus and Lichtheimia were the dominant fungi. Principal coordinate analysis showed structural separation between the composition of bacteria in koji making and fermentation. However, multivariate analysis of variance based on unweighted UniFrac distances did identify distinct differences (p < 0.05), and redundancy analysis identified two key genera that are largely responsible for the differences in bacterial composition between the two steps. Staphylococcus was enriched in koji making, while Corynebacterium was enriched in fermentation. This is the first investigation to integrate douchi fermentation and koji making and fermentation processes through this technological approach. The results provide insight into the microbiome of the douchi fermentation process, and reveal a structural separation that may be stratified by the environment during the production of this traditional fermented food.	[Yang, Lin; Yang, Hui-lin; Tu, Zong-cai; Wang, Xiao-lan] Jiangxi Normal Univ, Key Lab Protect & Utilizat Subtrop Plant Resource, Nanchang, Jiangxi, Peoples R China	Jiangxi Normal University	Wang, XL (corresponding author), Jiangxi Normal Univ, Key Lab Protect & Utilizat Subtrop Plant Resource, Nanchang, Jiangxi, Peoples R China.	xlwang08@aliyun.com			China Agricultural Science and Technology Achievements Transformation Project; Natural Science Foundation of Jiangxi Province [20142BAB214008, 20151BAB204003]; Development Foundation of Key Lab of Protection and Utilization of Subtropic Plant Resources [YRD201405]	China Agricultural Science and Technology Achievements Transformation Project; Natural Science Foundation of Jiangxi Province(Natural Science Foundation of Jiangxi Province); Development Foundation of Key Lab of Protection and Utilization of Subtropic Plant Resources	This work was supported by China Agricultural Science and Technology Achievements Transformation Project(2014), by the Natural Science Foundation of Jiangxi Province (20142BAB214008, 20151BAB204003) and by the Development Foundation of Key Lab of Protection and Utilization of Subtropic Plant Resources (YRD201405).; This work was supported by a China Agricultural Science and Technology Achievements Transformation Project (2014), by the Natural Science Foundation of Jiangxi Province (grant Nos. 20142BAB214008 and 20151BAB204003) and by the Development Foundation of the Key Lab of Protection and Utilization of Subtropical Plant Resources (grant No. YRD201405).	Aldrete-Tapia A, 2014, FOOD MICROBIOL, V44, P136, DOI 10.1016/j.fm.2014.05.022; Balachandar D, 2014, COMMUN SOIL SCI PLAN, V45, P189, DOI 10.1080/00103624.2013.841919; Burgess SA, 2010, INT J FOOD MICROBIOL, V144, P215, DOI 10.1016/j.ijfoodmicro.2010.09.027; Chen C, 2015, J APPL MICROBIOL, V119, P1324, DOI 10.1111/jam.12917; Chen J, 2007, FOOD CHEM, V103, P1091, DOI 10.1016/j.foodchem.2006.10.003; Chen TT, 2014, J FOOD SCI, V79, pM653, DOI 10.1111/1750-3841.12417; Chen TT, 2012, J SCI FOOD AGR, V92, P2171, DOI 10.1002/jsfa.5604; Chen TT, 2011, FOOD SCI BIOTECHNOL, V20, P1633, DOI 10.1007/s10068-011-0225-0; Chen TT, 2011, INT J FOOD SCI TECH, V46, P1878, DOI 10.1111/j.1365-2621.2011.02696.x; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; Cuecas A, 2014, MICROB ECOL, V68, P729, DOI 10.1007/s00248-014-0437-y; Dineen SM, 2010, J APPL MICROBIOL, V109, P1886, DOI 10.1111/j.1365-2672.2010.04816.x; Ezeokoli OT, 2016, INT J FOOD MICROBIOL, V220, P58, DOI 10.1016/j.ijfoodmicro.2016.01.003; Filleron A, 2014, J MICROBIOL METH, V98, P67, DOI 10.1016/j.mimet.2013.12.022; Furuhata K, 2010, BIOCONTROL SCI, V15, P81, DOI 10.4265/bio.15.81; Georgieva R, 2009, INT DAIRY J, V19, P696, DOI 10.1016/j.idairyj.2009.06.006; Huang XQ, 2015, MICROBIOL RES, V181, P33, DOI 10.1016/j.micres.2015.08.004; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Igarashi H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107909; Ishida H, 1998, BIOL PHARM BULL, V21, P62, DOI 10.1248/bpb.21.62; Jeyaram K, 2008, INT J FOOD MICROBIOL, V122, P259, DOI 10.1016/j.ijfoodmicro.2007.12.026; Juan MY, 2010, FOOD MICROBIOL, V27, P918, DOI 10.1016/j.fm.2010.05.009; Juste A, 2014, FOOD MICROBIOL, V39, P39, DOI 10.1016/j.fm.2013.10.010; Kemp PF, 2004, FEMS MICROBIOL ECOL, V47, P161, DOI 10.1016/S0168-6496(03)00257-5; Kim JH, 2005, FOOD CONTROL, V16, P43, DOI 10.1016/j.foodcont.2003.11.004; Kim Joo-Shin, 2008, Preventive Nutrition and Food Science, V13, P12; Kim T, 2010, CURR MICROBIOL, V60, P315, DOI 10.1007/s00284-009-9542-4; Kim TW, 2009, INT J FOOD MICROBIOL, V131, P265, DOI 10.1016/j.ijfoodmicro.2009.03.001; Koort J, 2006, INT J FOOD MICROBIOL, V109, P164, DOI 10.1016/j.ijfoodmicro.2006.01.021; Kyselkova M, 2008, ANTON LEEUW INT J G, V94, P439, DOI 10.1007/s10482-008-9261-z; Leite AMO, 2012, FOOD MICROBIOL, V31, P215, DOI 10.1016/j.fm.2012.03.011; Li P, 2015, APPL ENVIRON MICROB, V81, P5144, DOI 10.1128/AEM.01325-15; Garcia NFL, 2015, ELECTRON J BIOTECHN, V18, P314, DOI 10.1016/j.ejbt.2015.05.007; Liu BH, 2012, BIOINFORMATICS, V28, P2870, DOI 10.1093/bioinformatics/bts563; Liu CJ, 2012, J ZHEJIANG UNIV-SC B, V13, P298, DOI 10.1631/jzus.B1100221; Liu WJ, 2015, ANN MICROBIOL, V65, P1741, DOI 10.1007/s13213-014-1013-x; Luckow T, 2004, FOOD QUAL PREFER, V15, P751, DOI 10.1016/j.foodqual.2003.12.007; Marsh AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069371; MESSINA MJ, 1994, NUTR CANCER, V21, P113, DOI 10.1080/01635589409514310; Mills DK, 2007, SOIL SCI SOC AM J, V71, P572, DOI 10.2136/sssaj2006.0147; Mohammadi P, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.22249; MOMOSE H, 1978, AGR BIOL CHEM TOKYO, V42, P1911, DOI 10.1080/00021369.1978.10863274; Montel MC, 2014, INT J FOOD MICROBIOL, V177, P136, DOI 10.1016/j.ijfoodmicro.2014.02.019; Ndagano D, 2011, J FOOD SCI, V76, pM305, DOI 10.1111/j.1750-3841.2011.02257.x; Nicolaisen MH, 2002, J MICROBIOL METH, V50, P189, DOI 10.1016/S0167-7012(02)00026-X; O'Sullivan DJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0596-0; Pires ACC, 2012, APPL ENVIRON MICROB, V78, P5520, DOI 10.1128/AEM.00386-12; Polka J, 2015, FOOD MICROBIOL, V46, P342, DOI 10.1016/j.fm.2014.08.023; Quigley L, 2012, APPL ENVIRON MICROB, V78, P5717, DOI 10.1128/AEM.00918-12; Ranjard L, 2001, APPL ENVIRON MICROB, V67, P4479, DOI 10.1128/AEM.67.10.4479-4487.2001; Saratale GD, 2011, BIODEGRADATION, V22, P905, DOI 10.1007/s10532-010-9450-0; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shen ZZ, 2015, BIOL FERT SOILS, V51, P553, DOI 10.1007/s00374-015-1002-7; Tang J, 2015, J IMMUNOL METHODS, V421, P112, DOI 10.1016/j.jim.2015.04.004; Van Hamme JD, 2003, MICROBIOL MOL BIOL R, V67, P503, DOI 10.1128/MMBR.67.4.503-549.2003; Wang W, 2016, MICROBIOL RES, V182, P59, DOI 10.1016/j.micres.2015.10.003; Xie ZF, 2014, BIORESOURCE TECHNOL, V161, P29, DOI 10.1016/j.biortech.2014.03.014; You J, 2016, APPL MICROBIOL BIOT, V100, P1469, DOI 10.1007/s00253-015-7073-4; Yovita Siti P, 2005, THESIS; Zhao JX, 2009, INT J FOOD SCI TECH, V44, P2526, DOI 10.1111/j.1365-2621.2009.02079.x; Zheng XW, 2014, INT J FOOD MICROBIOL, V182, P57, DOI 10.1016/j.ijfoodmicro.2014.05.008	61	51	53	7	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168166	10.1371/journal.pone.0168166	http://dx.doi.org/10.1371/journal.pone.0168166			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992473	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600039
J	De Toni, L; Garolla, A; Menegazzo, M; Magagna, S; Di Nisio, A; Sabovic, I; Rocca, MS; Scattolini, V; Filippi, A; Foresta, C				De Toni, Luca; Garolla, Andrea; Menegazzo, Massimo; Magagna, Sabina; Di Nisio, Andrea; Sabovic, Iva; Rocca, Maria Santa; Scattolini, Valentina; Filippi, Andrea; Foresta, Carlo			Heat Sensing Receptor TRPV1 Is a Mediator of Thermotaxis in Human Spermatozoa	PLOS ONE			English	Article							SPERM PLASMA-MEMBRANE; CALCIUM ACCUMULATION; VANILLOID RECEPTORS; ACROSOME REACTION; BOAR SPERMATOZOA; FERTILIZATION; CAPSAICIN; CHANNELS; CAPACITATION; ANANDAMIDE	The molecular bases of sperm thermotaxis, the temperature-oriented cell motility, are currently under investigation. Thermal perception relies on a subclass of the transient receptor potential [TRP] channels, whose member TRPV1 is acknowledged as the heat sensing receptor. Here we investigated the involvement of TRPV1 in human sperm thermotaxis. We obtained semen samples from 16 normozoospermic subjects attending an infertility survey programme, testis biopsies from 6 patients with testicular germ cell cancer and testis fine needle aspirates from 6 patients with obstructive azoospermia undergoing assisted reproductive technologies. Expression of TRPV1 mRNA was assessed by RT-PCR. Protein expression of TRPV1 was determined by western blot, flow cytometry and immunofluorescence. Sperm motility was assessed by Sperm Class Analyser. Acrosome reaction, apoptosis and intracellular-Ca2+ content were assessed by flow cytometry. We found that TRPV1 mRNA and protein were highly expressed in the testis, in both Sertoli cells and germ-line cells. Moreover, compared to no-gradient controls at 31 degrees C or 37 degrees C (Ctrl 31 degrees C and Ctrl 37 degrees C respectively), sperm migration towards a temperature gradient of 31 - 37 degrees C (T gradient) in non-capacitated conditions selected a higher number of cells (14,9 +/- 4,2x10(6) cells T gradient vs 5,1 +/- 0,3x10(6) cells Ctrl 31 degrees C and 5,71 +/- 0,74x10(6) cells Ctrl 37 degrees C; P = 0,039). Capacitation amplified the migrating capability towards the T gradient. Sperms migrated towards the T gradient showed enriched levels of both TRPV1 protein and mRNA. In addition, sperm cells were able to migrate toward a gradient of capsaicin, a specific agonist of TRPV1, whilst capsazepine, a specific agonist of TRPV1, blocked this effect. Finally, capsazepine severely blunted migration towards T gradient without abolishing. These results suggest that TRPV1 may represent a facilitating mediator of sperm thermotaxis.	[De Toni, Luca; Garolla, Andrea; Menegazzo, Massimo; Magagna, Sabina; Di Nisio, Andrea; Sabovic, Iva; Rocca, Maria Santa; Foresta, Carlo] Univ Padua, Unit Androl & Reprod Med, Dept Med, Padua, Italy; [Sabovic, Iva] IRCCS Ist Oncol Veneto IOV, Padua, Italy; [Scattolini, Valentina] Univ Padua, Dept Med, Padua, Italy; [Scattolini, Valentina] Venetian Inst Mol Med, Padua, Italy; [Filippi, Andrea] Univ Padua, Dept Phys & Astron G Galilei, Padua, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; Veneto Institute Molecular Medicine; University of Padua	Foresta, C (corresponding author), Univ Padua, Unit Androl & Reprod Med, Dept Med, Via Giustiniani, Padua, Italy.	carlo.foresta@unipd.it	menegazzo, massimo/AAD-2548-2022; Santa Rocca, Maria/AAB-9909-2022; Santa Rocca, Maria/AAS-5445-2020; Di Nisio, Andrea/AAI-3161-2020; Garolla, Andrea/AFS-1388-2022; Garolla, Andrea/AAC-4607-2022	Santa Rocca, Maria/0000-0002-4794-9745; Garolla, Andrea/0000-0003-4736-9051; Garolla, Andrea/0000-0003-4736-9051; De Toni, Luca/0000-0003-4958-5217; Di Nisio, Andrea/0000-0002-7251-9210; Scattolini, Valentina/0000-0002-0855-9402				Armon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028359; Bahat A, 2003, NAT MED, V9, P149, DOI 10.1038/nm0203-149; Bahat A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041915; Bahat A, 2010, BIOL REPROD, V82, P606, DOI 10.1095/biolreprod.109.080127; BALDI E, 1991, J ANDROL, V12, P323; Bernabo N, 2010, MOL CELL ENDOCRINOL, V323, P224, DOI 10.1016/j.mce.2010.02.025; Bettella A, 2005, ASIAN J ANDROL, V7, P289, DOI 10.1111/j.1745-7262.2005.00043.x; Boryshpolets S, 2015, HUM REPROD, V30, P884, DOI 10.1093/humrep/dev002; Caterina MJ, 2003, PAIN, V105, P5, DOI 10.1016/S0304-3959(03)00259-8; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; COHENDAYAG A, 1995, P NATL ACAD SCI USA, V92, P11039, DOI 10.1073/pnas.92.24.11039; DAVID A, 1972, International Journal of Gynecology and Obstetrics, V10, P52; De Petrocellis L, 2000, FEBS LETT, V483, P52, DOI 10.1016/S0014-5793(00)02082-2; De Toni L, 2016, J CLIN ENDOCR METAB, V101, P953, DOI 10.1210/jc.2015-3967; deLamirande E, 1997, MOL HUM REPROD, V3, P175, DOI 10.1093/molehr/3.3.175; Eisenbach M, 2006, NAT REV MOL CELL BIO, V7, P276, DOI 10.1038/nrm1893; Eisenbach M, 1999, BIOESSAYS, V21, P203, DOI 10.1002/(SICI)1521-1878(199903)21:3<203::AID-BIES4>3.0.CO;2-T; Eisenbach M, 1999, REV REPROD, V4, P56, DOI 10.1530/revreprod/4.1.56; Fadini GP, 2016, DIABETES, V65, P1061, DOI 10.2337/db15-0863; Flesch FM, 2000, BBA-REV BIOMEMBRANES, V1469, P197, DOI 10.1016/S0304-4157(00)00018-6; Foresta C, 2014, HUM REPROD, V29, P1134, DOI 10.1093/humrep/deu075; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; Garolla A, 2013, HUM REPROD, V28, P877, DOI 10.1093/humrep/det020; Gervasi MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016993; Hail N, 2003, APOPTOSIS, V8, P251, DOI 10.1023/A:1023620821878; Jimenez-Gonzalez C, 2006, HUM REPROD UPDATE, V12, P253, DOI 10.1093/humupd/dmi050; Jung A, 2007, ANDROLOGIA, V39, P203, DOI 10.1111/j.1439-0272.2007.00794.x; Kasvandik S, 2015, PROTEOMICS, V15, P1906, DOI 10.1002/pmic.201400297; Klionsky L, 2006, J PHARMACOL EXP THER, V319, P192, DOI 10.1124/jpet.106.108092; Lewis SEM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047704; Maccarrone M, 2005, J CELL SCI, V118, P4393, DOI 10.1242/jcs.02536; Miller S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107151; Mizrak SC, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-52; Moiseenkova-Bell VY, 2009, J GEN PHYSIOL, V133, P239, DOI 10.1085/jgp.200810123; Naziroglu M, 2015, NEUROSCIENCE, V293, P55, DOI 10.1016/j.neuroscience.2015.02.041; Oh U, 1996, J NEUROSCI, V16, P1659; Ottaviano G, 2013, EUR ARCH OTO-RHINO-L, V270, P3079, DOI 10.1007/s00405-013-2441-0; Perez-Cerezales S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16146; Schuel H, 2002, MOL REPROD DEV, V63, P376, DOI 10.1002/mrd.90021; Shimada M, 2008, DEVELOPMENT, V135, P2001, DOI 10.1242/dev.020461; Teves ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008211; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wu CC, 2006, MUTAT RES-FUND MOL M, V601, P71, DOI 10.1016/j.mrfmmm.2006.06.015; Yu JM, 2012, HUM REPROD, V27, P25, DOI 10.1093/humrep/der377; Zuccarello D, 2011, INT J ANDROL, V34, pE554, DOI 10.1111/j.1365-2605.2011.01158.x; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	48	33	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167622	10.1371/journal.pone.0167622	http://dx.doi.org/10.1371/journal.pone.0167622			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992447	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000013
J	Holko, P; Kawalec, P; Mossakowska, M; Pilc, A				Holko, Przemyslaw; Kawalec, Pawel; Mossakowska, Malgorzata; Pilc, Andrzej			Health-Related Quality of Life Impairment and Indirect Cost of Crohn's Disease: A Self-Report Study in Poland	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; WORK PRODUCTIVITY; ECONOMIC EVALUATIONS; INFORMAL CARE; ULCERATIVE-COLITIS; FOLLOW-UP; QUESTIONNAIRE; VALIDITY; BURDEN; DETERMINANTS	Background and Aims Evidence on indirect cost of Crohn's disease (CD) is available but typically provides information on the loss of productivity at paid work of patients. In the present study, the quality of life and indirect costs of CD patients were assessed (overall and by disease severity). Methods A self-report questionnaire-based study among adult Polish patients with CD was performed. We collected data on patients' characteristics, quality of life, loss of productivity, consumption of medical resources, and out-of-pocket expenses. The disease severity was determined using the patient's version of the Harvey-Bradshaw index. Productivity costs were assessed from the social perspective, using a human capital approach. The cost of absenteeism, presenteeism and permanent work disability was valuated using the gross domestic product per worker. The patients' productivity loss at unpaid work was measured by time inputs of others to assist patients. The productivity loss among informal caregivers and patients' productivity loss at unpaid work were valuated with the average wage in Poland. The results were adjusted for confounders. Results The responses from 200 patients (47% in remission) were analysed. The mean utility index was 0.839 (SD 0.171). The total indirect cost was estimated at (sic)462.47 per patient per month (24.0%, absenteeism; 35.0%, work disability; 30.4%, presenteeism; 0.4%, productivity loss at unpaid work; and 10.4%, informal care). A significant correlation of the quality of life and productivity losses with disease severity was observed. Compared with active disease, the remission subgroup had a higher utility index by 16% (p<0.001) and lower indirect costs by 71% (p = 0.003) for absenteeism, 41% (p = 0.030) for presenteeism, 76% (p<0.001) for productivity loss at unpaid work, and 75% (p<0.001) for informal care. Conclusions Our study revealed the social burden of CD and high dependency of indirect costs and quality of life on the severity of CD in Poland.	[Holko, Przemyslaw; Kawalec, Pawel] Jagiellonian Univ, Coll Med, Drug Management Dept, Krakow, Poland; [Mossakowska, Malgorzata] Polish Assoc Supporting People Inflammatory Bowel, Warsaw, Poland; [Mossakowska, Malgorzata] Int Inst Mol & Cell Biol, Warsaw, Poland; [Pilc, Andrzej] Polish Acad Sci, Dept Neurobiol, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Polish Academy of Sciences	Holko, P (corresponding author), Jagiellonian Univ, Coll Med, Drug Management Dept, Krakow, Poland.	p.holko@uj.edu.pl	Holko, Przemyslaw/H-5720-2011; Pilc, Andrzej/A-3948-2008	Holko, Przemyslaw/0000-0002-6821-4078; Pilc, Andrzej/0000-0002-4045-0597	fund for statuary activities of Drug Management Department, Jagiellonian University	fund for statuary activities of Drug Management Department, Jagiellonian University	The author(s) received no specific funding for this work. This work was supported from the fund for statuary activities of Drug Management Department, Jagiellonian University.	Belotti F, 2015, STATA J, V15, P3, DOI 10.1177/1536867X1501500102; Benedini V, 2012, CLINICOECONOMIC OUTC, V4, P209, DOI 10.2147/CEOR.S31114; Binion DG, 2011, CAN J GASTROENTEROL, V25, P492, DOI 10.1155/2011/938194; Bouwmans C, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-217; Burisch J, 2013, J CROHNS COLITIS, V7, P322, DOI 10.1016/j.crohns.2013.01.010; Busch K, 2014, J CROHNS COLITIS, V8, P1362, DOI 10.1016/j.crohns.2014.06.006; Central Statistical Office of Poland, 2015, AV WAG 3 Q 2015; Central Statistical Office of Poland, 2016, GROSS DOM PROD 2015; Central Statistical Office of Poland, 2016, LAB FORC SURV POL 3; Evertsz' FB, 2013, J CLIN GASTROENTEROL, V47, P850, DOI 10.1097/MCG.0b013e31828b2196; Feagan BG, 2010, ALIMENT PHARM THER, V31, P1276, DOI 10.1111/j.1365-2036.2010.04303.x; Gibson PR, 2014, J CROHNS COLITIS, V8, P598, DOI 10.1016/j.crohns.2013.11.017; Golicki D, 2015, POL ARCH MED WEWN, V125, P18, DOI 10.20452/pamw.2638; Golicki D, 2010, VALUE HEALTH, V13, P289, DOI 10.1111/j.1524-4733.2009.00596.x; Gomollon Garcia F, 2012, J CROHNS COLITIS, V6, pS115; Gregori D, 2011, INT J QUAL HEALTH C, V23, P331, DOI 10.1093/intqhc/mzr010; Havik K, 2014, EC PAPERS, V535; Jacobs P, 2011, J RHEUMATOL, V38, P55, DOI 10.3899/jrheum.110901; Jo C, 2014, CLIN MOL HEPATOL, V20, P327, DOI 10.3350/cmh.2014.20.4.327; Juan J, 2003, DIGEST LIVER DIS, V35, P853, DOI 10.1016/j.dld.2003.07.002; Kawalec P, 2015, EXPERT REV PHARM OUT, V15, P253, DOI 10.1586/14737167.2015.1011130; Koopmanschap MA, 2008, PHARMACOECONOMICS, V26, P269, DOI 10.2165/00019053-200826040-00001; Krol M, 2015, PHARMACOECONOMICS, V33, P123, DOI 10.1007/s40273-014-0218-y; Krol M, 2014, PHARMACOECONOMICS, V32, P335, DOI 10.1007/s40273-014-0132-3; Mesterton J, 2009, INFLAMM BOWEL DIS, V15, P1882, DOI 10.1002/ibd.20939; Michael MD, 2014, EUR J HEALTH ECON, V15, pS121, DOI 10.1007/s10198-014-0603-7; Noyes K, 2007, MED DECIS MAKING, V27, P327, DOI 10.1177/0272989X07301822; Odes S, 2006, GASTROENTEROLOGY, V131, P719, DOI 10.1053/j.gastro.2006.05.052; Polish Health Technology Assessment Agency, 2012, AOTMOT4351222012 POL; President of the National Health Fund of Poland, 2016, ORD DET COND CONCL I; Reilly MC, 2008, CLIN THER, V30, P393, DOI 10.1016/j.clinthera.2008.02.016; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Stark R, 2006, PHARMACOECONOMICS, V24, P797, DOI 10.2165/00019053-200624080-00006; Tang K, 2015, PHARMACOECONOMICS, V33, P31, DOI 10.1007/s40273-014-0209-z; The National Health Fund of Poland, 2016, SIZ REF COST AM REIM; van den Berg B, 2006, SOC SCI MED, V62, P835, DOI 10.1016/j.socscimed.2005.06.046; van den Berg Bernard, 2004, Eur J Health Econ, V5, P36, DOI 10.1007/s10198-003-0189-y; van der Valk ME, 2014, GUT, V63, P72, DOI 10.1136/gutjnl-2012-303376; Vegh Z, 2015, J CROHNS COLITIS, V9, P747, DOI 10.1093/ecco-jcc/jjv099; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wladysiuk M, 2014, VALUE HEALTH, V17, pA382, DOI 10.1016/j.jval.2014.08.2627; World Health Organization Collaborating Centre for Drug Statisctics Methodology, 2016, ATC DDD IND; Zhang W, 2011, SOC SCI MED, V72, P185, DOI 10.1016/j.socscimed.2010.10.026	43	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168586	10.1371/journal.pone.0168586	http://dx.doi.org/10.1371/journal.pone.0168586			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992531	gold, Green Published			2022-12-27	WOS:000392758000061
J	Yang, WL; Zhu, XY; Zhu, N; Su, CY; Han, QF; Wang, T; Zhang, AH				Yang, Wen-Ling; Zhu, Xue-Yan; Zhu, Ning; Su, Chun-Yan; Han, Qing-Feng; Wang, Tao; Zhang, Ai-Hua			What's the Optimal Lipids Level for Dialysis Patients? A Cohort Study from a Chinese Dialysis Center in a University Hospital	PLOS ONE			English	Article							ATHEROSCLEROTIC CARDIOVASCULAR EVENTS; DENSITY-LIPOPROTEIN CHOLESTEROL; CHRONIC KIDNEY-DISEASE; MANAGING DYSLIPIDEMIA; NON-HDL; HEMODIALYSIS; ABNORMALITIES; POPULATION; GUIDELINES	Background With lipid level being a major contributing factor for cardiovascular health, the high cardiovascular mortality among dialysis patients has raised substantial concerns in regard to the optimal lipid level in these patient population. Objective To explore the optimal lipid level for the survival of dialysis patients. Methods The lipid profile was measured for each patient. All participants were followed throughout the course of the study. Cox proportional hazards analysis was performed to analyze the prognostic value of lipid level on the survival of these patients. Results In our study that included 311 stable maintenance dialysis patients, 54.98% of the participants had LDL-C level >= 100 mg/dl and 82.91% of the patients with triglycerides >= 200 mg/dl had non-HDL level >= 130 mg/dl. During the follow-up period of 48.0 (18.0, 55.5) months, 149 (47.91%) participants died. Among those who died, 59 patients died of cardiovascular disease (CVD) and 33 patients died of ischemic CVD (12.0, 4.7, and 2.7 events per 100 patient-years, respectively). Patients with LDL-C 100-130 mg/dl or non-HDL 130-160 mg/dl had a lower all-cause mortality rate than those who did not meet these criteria. After adjusting for the traditional and ESRD-related risk factors, non-HDL was found to be the independent risk factor for the all-cause mortality. Compared to those patients with non-HDL 130-160 mg/dl, patients with non-HDL < 100 mg/dl, 100-130 mg/dl, 160-190 mg/dl, or >= 190 mg/dl all had higher all-cause mortality: HR (95% CI) 3.207 (1.801, 5.713), 2.493 (1.485, 4.184), 2.476 (1.423, 4.307), and 1.917 (1.099, 3.345), respectively. There were no differences in nutrition, comorbidity, and inflammation indices among the patients with different non-HDL groups. However, patients with non-HDL of 130-160 mg/dl had the lowest corrected calcium and calcium phosphate product values as compared with other non-HDL groups. Conclusion Our study demonstrated that non-HDL 130-160 mg/dl might be the most appropriate lipid level in our dialysis patients. Our follow-up data also showed that patients with higher lipid level had poorer prognosis, just as in the general population.	[Yang, Wen-Ling; Zhu, Ning; Su, Chun-Yan; Han, Qing-Feng; Wang, Tao; Zhang, Ai-Hua] Peking Univ, Hosp 3, Dept Nephrol, Beijing, Peoples R China; [Zhu, Xue-Yan] Jilin Med Univ, Dept Nephrol, Changchun, Jilin Province, Peoples R China	Peking University; Jilin Medical University	Zhang, AH (corresponding author), Peking Univ, Hosp 3, Dept Nephrol, Beijing, Peoples R China.	hanqingfeng@sina.com; zgbjrose9985@yahoo.com			peking university third hospital; Atherosclerosis Clinical medical research special funds projects by Chinese Medical Association [09010030158]	peking university third hospital; Atherosclerosis Clinical medical research special funds projects by Chinese Medical Association	Funded by the seed money of the peking university third hospital and Atherosclerosis Clinical medical research special funds projects by Chinese Medical Association (grant number: 09010030158) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2011, LANCET, V377, P2181, DOI 10.1016/S0140-6736(11)60739-3; Bolton K, 2005, AM J KIDNEY DIS, V45, pS7, DOI 10.1053/j.ajkd.2005.01.016; Chae JW, 2011, NEPHRON CLIN PRACT, V117, pC379, DOI 10.1159/000321525; Chan DT, 2008, ATHEROSCLEROSIS, V196, P823, DOI 10.1016/j.atherosclerosis.2007.01.023; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chawla V, 2010, CLIN J AM SOC NEPHRO, V5, P1582, DOI 10.2215/CJN.01450210; Collins AJ, 2003, AM J KIDNEY DIS, V41, pV, DOI 10.1016/S0272-6386(03)80001-X; Echida Y, 2012, CLIN EXP NEPHROL, V16, P767, DOI 10.1007/s10157-012-0615-5; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Keane WF, 2005, CARDIOL CLIN, V23, P363, DOI 10.1016/j.ccl.2005.03.004; Kim C-G, 2014, ELECTRON J DIFFER EQ, V2014, P38, DOI DOI 10.1159/000367803; Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.1E; Lupton JR, 2016, J CLIN LIPIDOL, V10, P72, DOI 10.1016/j.jacl.2015.09.006; Marz W, 2011, CLIN J AM SOC NEPHRO, V6, P1316, DOI 10.2215/CJN.09121010; Navaneethan SD, 2009, COCHRANE DATABASE SY, VD4289; Nogueira J, 2007, CLIN J AM SOC NEPHRO, V2, P766, DOI 10.2215/CJN.04131206; Patwardhan VG, 2015, J CLIN LIPIDOL, V9, P652, DOI 10.1016/j.jacl.2015.05.007; Pennell P, 2006, CLIN NEPHROL, V66, P336; Quaschning T, 2001, AM J KIDNEY DIS, V38, pS14, DOI 10.1053/ajkd.2001.27384; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; Shoji T, 2006, THER APHER DIAL, V10, P305, DOI 10.1111/j.1744-9987.2006.00382.x; Shoji T, 2014, CLIN EXP NEPHROL, V18, P257, DOI 10.1007/s10157-013-0871-z; Shoji T, 2011, CLIN J AM SOC NEPHRO, V6, P1112, DOI 10.2215/CJN.09961110; Sidhu Manavjot S, 2010, Adv Perit Dial, V26, P47; Snyder JJ, 2009, AM J NEPHROL, V30, P44, DOI 10.1159/000201014; Stone NJ, 2014, ANN INTERN MED, V160, P339, DOI 10.7326/M14-0126; Tonelli M, 2014, ANN INTERN MED, V160, P182, DOI 10.7326/M13-2453; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Weiner DE, 2004, J GEN INTERN MED, V19, P1045, DOI 10.1111/j.1525-1497.2004.40049.x; Zoppellaro G, 2012, AM J KIDNEY DIS, V59, P135, DOI 10.1053/j.ajkd.2011.07.027	31	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167258	10.1371/journal.pone.0167258	http://dx.doi.org/10.1371/journal.pone.0167258			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992532	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000012
J	Amoroso, G; Ventura, T; Cobcroft, JM; Adams, MB; Elizur, A; Carter, CG				Amoroso, Gianluca; Ventura, Tomer; Cobcroft, Jennifer M.; Adams, Mark B.; Elizur, Abigail; Carter, Chris G.			Multigenic Delineation of Lower Jaw Deformity in Triploid Atlantic Salmon (Salmo salar L.)	PLOS ONE			English	Article							VERTEBRAL DEFORMITIES; SKELETAL ANOMALIES; TRANSGENIC MICE; COL2A1 GENE; BONE; GROWTH; CARTILAGE; PERFORMANCE; GALECTIN-3; MUTATIONS	Lower jaw deformity (LJD) is a skeletal anomaly affecting farmed triploid Atlantic salmon (Salmo salar L.) which leads to considerable economic losses for industry and has animal welfare implications. The present study employed transcriptome analysis in parallel with real-time qPCR techniques to characterise for the first time the LJD condition in triploid Atlantic salmon juveniles using two independent sample sets: experimentally-sourced salmon (60 g) and commercially produced salmon (100 g). A total of eleven genes, some detected/identified through the transcriptome analysis (fbn2, gal and gphb5) and others previously determined to be related to skeletal physiology (alp, bmp4, col1a1, col2a1, fgf23, igf1, mmp13, ocn), were tested in the two independent sample sets. Gphb5, a recently discovered hormone, was significantly (P < 0.05) down-regulated in LJD affected fish in both sample sets, suggesting a possible hormonal involvement. In-situ hybridization detected gphb5 expression in oral epithelium, teeth and skin of the lower jaw. Col2a1 showed the same consistent significant (P < 0.05) down-regulation in LJD suggesting a possible cartilaginous impairment as a distinctive feature of the condition. Significant (P < 0.05) differential expression of other genes found in either one or the other sample set highlighted the possible effect of stage of development or condition progression on transcription and showed that anomalous bone development, likely driven by cartilage impairment, is more evident at larger fish sizes. The present study improved our understanding of LJD suggesting that a cartilage impairment likely underlies the condition and col2a1 may be a marker. In addition, the involvement of gphb5 urges further investigation of a hormonal role in LJD and skeletal physiology in general.	[Amoroso, Gianluca; Cobcroft, Jennifer M.; Adams, Mark B.; Carter, Chris G.] Univ Tasmania, IMAS, Private Bag 49, Hobart, Tas, Australia; [Ventura, Tomer; Cobcroft, Jennifer M.; Elizur, Abigail] Univ Sunshine Coast, Sch Sci & Engn, Genecol Res Ctr, Locked Bag 4, Maroochydore, Qld, Australia	University of Tasmania; University of the Sunshine Coast	Amoroso, G (corresponding author), Univ Tasmania, IMAS, Private Bag 49, Hobart, Tas, Australia.	gianluca.amoroso@utas.edu.au	Carter, Chris Guy/A-3438-2008; Adams, Mark/P-7598-2019; Cobcroft, Jennifer/E-3331-2013; Amoroso, Gianluca/J-3911-2019; Ventura, T./H-9832-2019	Carter, Chris Guy/0000-0001-5210-1282; Adams, Mark/0000-0002-5737-5474; Cobcroft, Jennifer/0000-0002-2398-9267; Amoroso, Gianluca/0000-0003-2985-4205; Ventura, T./0000-0002-0777-2367; Elizur, Abigail/0000-0002-2960-302X	Commonwealth Government's Collaborative Research Network (CRN) Program; Institute for Marine and Antarctic Studies (IMAS); University of Tasmania; IMAS "Tasmania Graduate Research Scholarship"; University of the Sunshine Coast CRN Research Fellowship	Commonwealth Government's Collaborative Research Network (CRN) Program; Institute for Marine and Antarctic Studies (IMAS); University of Tasmania; IMAS "Tasmania Graduate Research Scholarship"; University of the Sunshine Coast CRN Research Fellowship	This research was supported by the Commonwealth Government's Collaborative Research Network (CRN) Program funding and the Institute for Marine and Antarctic Studies (IMAS). The authors would like to thank Petuna, Shaun Slevec and Ryan Wilkinson for their support. Ylenia Pennacchi and Deborah Leonard are thanked for technical assistance during experiments and samplings. Stephen Battaglene is thanked for his contribution to the development of this research. GA was supported by a University of Tasmania and IMAS "Tasmania Graduate Research Scholarship" and JC was supported by a University of the Sunshine Coast CRN Research Fellowship.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Amoroso G, 2016, J FISH DIS, V39, P1509, DOI 10.1111/jfd.12492; Amoroso G, 2016, J FISH DIS, V39, P449, DOI 10.1111/jfd.12438; Arteaga-Solis E, 2011, MATRIX BIOL, V30, P188, DOI 10.1016/j.matbio.2011.03.004; Bai H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107050; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Bassett JHD, 2015, ENDOCRINOLOGY, V156, P3098, DOI 10.1210/en.2014-1943; BENFEY TJ, 1984, CAN J FISH AQUAT SCI, V41, P980, DOI 10.1139/f84-112; Benfey TJ, 2001, ICES J MAR SCI, V58, P525, DOI 10.1006/jmsc.2000.1019; Bhat R, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-6; Bikle Daniel D, 2012, Curr Mol Pharmacol, V5, P135; Bodo E, 2010, ENDOCRINOLOGY, V151, P1633, DOI 10.1210/en.2009-0306; Boglione C, 2013, REV AQUACULT, V5, pS121, DOI 10.1111/raq.12016; BRUNO DW, 1990, VET REC, V126, P402; CHEAH KSE, 1985, P NATL ACAD SCI USA, V82, P2555, DOI 10.1073/pnas.82.9.2555; CHEAH KSE, 1991, MAMM GENOME, V1, P171, DOI 10.1007/BF00351064; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cobcroft JM, 2013, AQUACULTURE, V396, P51, DOI 10.1016/j.aquaculture.2013.02.027; DiGirolamo DJ, 2012, NAT REV RHEUMATOL, V8, P674, DOI 10.1038/nrrheum.2012.157; Donahue LR, 2003, J BONE MINER RES, V18, P1612, DOI 10.1359/jbmr.2003.18.9.1612; ERLEBACHER A, 1995, CELL, V80, P371, DOI 10.1016/0092-8674(95)90487-5; Fjelldal PG, 2016, AQUACULT NUTR, V22, P72, DOI 10.1111/anu.12238; Fjelldal PG, 2012, AQUACULT NUTR, V18, P610, DOI 10.1111/j.1365-2095.2011.00918.x; Fraser TWK, 2015, J FISH DIS, V38, P75, DOI 10.1111/jfd.12206; Fraser TWK, 2013, AQUACULTURE, V416, P255, DOI 10.1016/j.aquaculture.2013.09.034; GAROFALO S, 1991, P NATL ACAD SCI USA, V88, P9648, DOI 10.1073/pnas.88.21.9648; Gillis JA, 2006, J FISH BIOL, V68, P1133, DOI 10.1111/j.0022-1112.2006.00998.x; Golub EE., 2007, CURR OPIN ORTHOP, V18, P444, DOI [10.1097/BCO.0b013e3282630851, 10.1084/jem.93.5.415, DOI 10.1084/JEM.93.5.415]; Guevremont M, 2004, ANN RHEUM DIS, V63, P636, DOI 10.1136/ard.2003.007229; Guntur AR, 2013, BONEKEY REPORTS, V2; Hsu SY, 2002, MOL ENDOCRINOL, V16, P1538, DOI 10.1210/me.16.7.1538; Hu D, 2008, DEV DYNAM, V237, P3727, DOI 10.1002/dvdy.21781; Hughes D., 1992, 1992 SALTAS RES DEV, P17; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; JOHNSTONE R, 1991, CAN TECH REP FISH AQ, V1789, P00015; Jungalwalla P.J, 1991, CANADIAN TECHNICAL R, V1789, P47; Karsenty G, 1995, Int Rev Immunol, V12, P177, DOI 10.3109/08830189509056711; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kuivaniemi H, 1997, HUM MUTAT, V9, P300, DOI 10.1002/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; LI SW, 1995, GENE DEV, V9, P2821, DOI 10.1101/gad.9.22.2821; Li YJ, 2009, LAB INVEST, V89, P26, DOI 10.1038/labinvest.2008.111; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Lijalad M, 2009, AQUACULTURE, V290, P145, DOI 10.1016/j.aquaculture.2009.01.039; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu W, 2005, DEV BIOL, V283, P282, DOI 10.1016/j.ydbio.2005.04.019; MURRAY LW, 1989, AM J HUM GENET, V45, P5; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Ohshima S, 2003, ARTHRITIS RHEUM-US, V48, P2788, DOI 10.1002/art.11287; Parsons KJ, 2009, ANNU REV GENET, V43, P369, DOI 10.1146/annurev-genet-102808-114917; Pendas AM, 1997, GENOMICS, V40, P222, DOI 10.1006/geno.1996.4554; Piferrer F, 2009, AQUACULTURE, V293, P125, DOI 10.1016/j.aquaculture.2009.04.036; Prockop DJ, 1997, BRIT J RHEUMATOL, V36, P827; Ramirez F, 2009, EXTRACELLULAR MICROF, V21, P616, DOI [10.1016/j.ceb.2009.05.005, DOI 10.1016/J.CEB.2009.05.005]; Rani PU, 1999, DEV DYNAM, V214, P26, DOI 10.1002/(SICI)1097-0177(199901)214:1<26::AID-DVDY3>3.0.CO;2-V; Richards AJ, 2010, HUM MUTAT, V31, pE1461, DOI 10.1002/humu.21257; Robinson PN, 2000, J MED GENET, V37, P9, DOI 10.1136/jmg.37.1.9; Rossert J, 2000, NEPHROL DIAL TRANSPL, V15, P66, DOI 10.1093/ndt/15.suppl_6.66; Sadler J, 2001, AQUACULTURE, V198, P369, DOI 10.1016/S0044-8486(01)00508-7; Sadler J., 2000, THESIS; Sahlman J, 2004, ARTHRITIS RHEUM-US, V50, P3153, DOI 10.1002/art.20552; Savontaus M, 2004, Orthod Craniofac Res, V7, P216, DOI 10.1111/j.1601-6343.2004.00304.x; Stock M, 2003, J BIOL CHEM, V278, P17360, DOI 10.1074/jbc.M207631200; STOCKWELL RA, 1979, BIOL CARTILAGE CELLS; Suazo J, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-163; Tahimic Candice G T, 2013, Front Endocrinol (Lausanne), V4, P6, DOI 10.3389/fendo.2013.00006; Tang SY, 2012, J BONE MINER RES, V27, P1936, DOI 10.1002/jbmr.1646; Tanikawa R, 2010, BIOCHEM BIOPH RES CO, V394, P317, DOI 10.1016/j.bbrc.2010.02.175; Taylor JF, 2014, AQUACULTURE, V432, P163, DOI 10.1016/j.aquaculture.2014.05.014; Taylor JF, 2013, AQUACULTURE, V410, P41, DOI 10.1016/j.aquaculture.2013.06.004; TILLER GE, 1990, P NATL ACAD SCI USA, V87, P3889, DOI 10.1073/pnas.87.10.3889; Upholt WB, 1989, COLLAGEN, VV, P31; Venegas Felipe, 2003, Int. J. Morphol., V21, P211, DOI 10.4067/S0717-95022003000300005; Ventura Tomer, 2011, ISRN Endocrinol, V2011, P476283, DOI 10.5402/2011/476283; VIKKULA M, 1994, ANN MED, V26, P107; Vinik Y, 2015, ELIFE, V4, DOI 10.7554/eLife.05914; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; WHYTE MP, 1994, ENDOCR REV, V15, P439, DOI 10.1210/er.15.4.439; Witten PE, 2003, J ANAT, V203, P435, DOI 10.1046/j.1469-7580.2003.00239.x; Witten PE, 2002, INT J DEV BIOL, V46, P719; Xue F, 2014, ORTHOD CRANIOFAC RES, V17, P144, DOI 10.1111/ocr.12038; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Ytteborg Elisabeth, 2010, BMC Physiology, V10, P12, DOI 10.1186/1472-6793-10-12; Ytteborg Elisabeth, 2010, BMC Physiology, V10, P13, DOI 10.1186/1472-6793-10-13	84	5	5	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168454	10.1371/journal.pone.0168454	http://dx.doi.org/10.1371/journal.pone.0168454			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977809	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000391217400109
J	Charette, MF; Oh, YS; Maric-Bilkan, C; Scott, LL; Wu, CC; Eblen, M; Pearson, K; Tolunay, HE; Galis, ZS				Charette, Marc F.; Oh, Young S.; Maric-Bilkan, Christine; Scott, Lindsey L.; Wu, Charles C.; Eblen, Matthew; Pearson, Katrina; Tolunay, H. Eser; Galis, Zorina S.			Shifting Demographics among Research Project Grant Awardees at the National Heart, Lung, and Blood Institute (NHLBI)	PLOS ONE			English	Article								The present study was initiated because of concerns expressed by NHLBI-funded midcareer investigators regarding perceived difficulties in the renewal of their grant awards. This led us to ask: "Are mid-career investigators experiencing disproportionate difficulties in the advancement of their professional careers?" Our portfolio analysis indicates that there has been a significant and evolving shift in the demographics of research project grant (RPG) awardees at NHLBI. In 1998, mid-career (ages 41-55) investigators constituted approximately 60% of all investigators with the remaining 40% being equally divided between early-stage (ages 24-40) investigators and established (ages 56 to 70 and older) investigators. However, since 1998, the proportion of established RPG awardees has been increasing in a slowly progressive and strikingly linear fashion. At the same time the proportion of early-stage awardees fell precipitously until 2006 and then stabilized. During the same period, the proportion of mid-career awardees, which had been relatively stable through 2006, began to fall significantly. In examining potential causes of these demographic shifts we have identified certain inherent properties within the RPG award system that appear to promote an increasingly more established awardee population and a persistent decrease in the proportion of mid-career investigators. A collateral result of these demographic shifts, when combined with level or declining funding, is a significant reduction in the number of RPG awards received by NHLBI mid-career investigators and a corresponding decrease in the number of independent research laboratories.	[Charette, Marc F.; Oh, Young S.; Maric-Bilkan, Christine; Tolunay, H. Eser; Galis, Zorina S.] NHLBI, Vasc Biol & Hypertens Branch, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA; [Scott, Lindsey L.; Wu, Charles C.; Pearson, Katrina] NIH, Stat Anal & Reporting Branch, Off Planning Anal & Commun, Off Extramural Res, Bldg 10, Bethesda, MD 20892 USA; [Eblen, Matthew] Ctr Dis Control & Prevent, Off Publ Hlth Sci Serv, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; Centers for Disease Control & Prevention - USA	Charette, MF (corresponding author), NHLBI, Vasc Biol & Hypertens Branch, Div Cardiovasc Sci, Bldg 10, Bethesda, MD 20892 USA.	marc.charette@nih.gov		Charette, Marc/0000-0002-9405-4645				Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; [Anonymous], FISC YEARS 2016 2020, P8; Daniels RJ, 2015, P NATL ACAD SCI USA, V112, P313, DOI 10.1073/pnas.1418761112; Kaiser J., 2014, SCI NEWS; National Institute of General Medical Sciences, 2016, NIGMS FEEDB LOOP BLO; National Institutes of Health Office of Extramural Research, 2016, MAN RES MICH LAUER M; National Institutes of Health Office of Extramural Research, 2014, MOR PHYS SCI WORKF S; National Institutes of Health Office of Extramural Research, 2015, MOR DAT AG WORKF SAL	8	16	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168511	10.1371/journal.pone.0168511	http://dx.doi.org/10.1371/journal.pone.0168511			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978544	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400115
J	Frohlich, J; Senturk, D; Saravanapandian, V; Golshani, P; Reiter, LT; Sankar, R; Thibert, RL; DiStefano, C; Huberty, S; Cook, EH; Jeste, SS				Frohlich, Joel; Senturk, Damla; Saravanapandian, Vidya; Golshani, Peyman; Reiter, Lawrence T.; Sankar, Raman; Thibert, Ronald L.; DiStefano, Charlotte; Huberty, Scott; Cook, Edwin H.; Jeste, Shafali S.			A Quantitative Electrophysiological Biomarker of Duplication 15q11.2-q13.1 Syndrome	PLOS ONE			English	Article							ANGELMAN-SYNDROME; EEG; DYNAMICS; AUTISM; ABNORMALITIES; OSCILLATIONS; MIDAZOLAM; SYNAPSE	Background Duplications of 15q11.2-q13.1 (Dup15q syndrome) are highly penetrant for autism spectrum disorder (ASD). A distinct electrophysiological (EEG) pattern characterized by excessive activity in the beta band has been noted in clinical reports. We asked whether EEG power in the beta band, as well as in other frequency bands, distinguished children with Dup15q syndrome from those with non-syndromic ASD and then examined the clinical correlates of this electrophysiological biomarker in Dup15q syndrome. Methods In the first study, we recorded spontaneous EEG from children with Dup15q syndrome (n = 11), age-and-IQ-matched children with ASD (n = 10) and age-matched typically developing (TD) children (n = 9) and computed relative power in 6 frequency bands for 9 regions of interest (ROIs). Group comparisons were made using a repeated measures analysis of variance. In the second study, we recorded spontaneous EEG from a larger cohort of individuals with Dup15q syndrome (n = 27) across two sites and examined age, epilepsy, and duplication type as predictors of beta power using simple linear regressions. Results In the first study, spontaneous beta1 (12-20 Hz) and beta2 (20-30 Hz) power were significantly higher in Dup15q syndrome compared with both comparison groups, while delta (1-4 Hz) was significantly lower than both comparison groups. Effect sizes in all three frequency bands were large (vertical bar d vertical bar > 1). In the second study, we found that beta2 power was significantly related to epilepsy diagnosis in Dup15q syndrome. Conclusions Here, we have identified an electrophysiological biomarker of Dup15q syndrome that may facilitate clinical stratification, treatment monitoring, and measurement of target engagement for future clinical trials. Future work will investigate the genetic and neural underpinnings of this electrophysiological signature as well as the functional consequences of excessive beta oscillations in Dup15q syndrome.	[Frohlich, Joel; Saravanapandian, Vidya; DiStefano, Charlotte; Huberty, Scott; Jeste, Shafali S.] Univ Calif Los Angeles, Semel Inst Neurosci, Ctr Autism Res & Treatment, 760 Westwood Plaza,Suite A7-452, Los Angeles, CA 90095 USA; [Senturk, Damla] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Room 21-254C CHS, Los Angeles, CA 90024 USA; [Golshani, Peyman] David Geffen Sch Med, Dept Neurol & Psychiat, 710 Westwood Plaza, Los Angeles, CA USA; [Reiter, Lawrence T.] Univ Tennessee, Ctr Hlth Sci, Dept Neurol, 855 Monroe Ave,Link 415, Memphis, TN 38163 USA; [Reiter, Lawrence T.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, 855 Monroe Ave,Link 415, Memphis, TN 38163 USA; [Sankar, Raman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Sankar, Raman] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Thibert, Ronald L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Cook, Edwin H.] Univ Illinois, Dept Psychiat, MC 747, Chicago, IL 60612 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Frohlich, J (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci, Ctr Autism Res & Treatment, 760 Westwood Plaza,Suite A7-452, Los Angeles, CA 90095 USA.	joelfrohlich@gmail.com	Jeste, Shafali S/N-2350-2017; Reiter, Lawrence/H-4161-2019; Frohlich, Joel/AAC-3214-2020	Jeste, Shafali S/0000-0003-2955-6902; Reiter, Lawrence/0000-0002-4100-2630; Frohlich, Joel/0000-0001-8382-4344; Huberty, Scott/0000-0003-2637-031X; SARAVANAPANDIAN, VIDYA/0000-0001-5825-612X	National Institute of Mental Health of the National Institutes of Health [T32MH073526]; Dup15q Alliance [20144605]; National Institute of General Medical Sciences [R01 GM111378-01A1]; National Institute of Mental Health [K23MH094517-01]; National Institute of Child Health and Human Development [U54HD087101]; NIMH [K23M H094517-01]; IDDRC [U54HD087101]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111378] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH094517, T32MH073526] Funding Source: NIH RePORTER	National Institute of Mental Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Dup15q Alliance; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); IDDRC; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JF was supported by the National Institute of Mental Health of the National Institutes of Health under Award Number T32MH073526. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also funded by grant 20144605 from the Dup15q Alliance (SSJ received funding) (http://www.dup15q.org), R01 GM111378-01A1 from the National Institute of General Medical Sciences (DS received funding) (https://www.nigms.nih.gov), National Institute of Mental Health K23MH094517-01 (SSJ received funding) (https://www.nimh.nih.gov), and National Institute of Child Health and Human Development U54HD087101 (SSJ and PG received funding) (https://www.nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We warmly thank the children and families who participated in this research for making this work possible. We especially thank Andrei Irimia and Iman Mohammad-Rezazadeh for their assistance with EEG signal processing and Amaya Miquelajauregui for giving her thoughts and insights on this manuscript. Joel Frohlich was supported by the National Institute of Mental Health of the National Institutes of Health under Award Number T32MH073526. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health This work was also funded by grant 20144605 from the Dup15q Alliance, to whom we extend our sincere gratitude, as well as R01 GM11137801A1 from the National Institute of General Medical Sciences NIGMS (NIH), NIMH K23M H094517-01, and IDDRC U54HD087101.	Al Ageeli E, 2014, EUR J MED GENET, V57, P5, DOI 10.1016/j.ejmg.2013.10.008; Berrios J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10702; BUCHSBAUM MS, 1985, BIOL PSYCHIAT, V20, P832, DOI 10.1016/0006-3223(85)90208-2; Buzsaki G., 2006, RHYTHMS BRAIN; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; Cook EH, 1997, AM J HUM GENET, V60, P928; Crunelli V, 2002, NAT REV NEUROSCI, V3, P371, DOI 10.1038/nrn811; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dindot SV, 2008, HUM MOL GENET, V17, P111, DOI 10.1093/hmg/ddm288; DiStefano C, 2016, J NEURODEVELOPMENTAL, V8, P1; DOMINO EF, 1989, PSYCHOPHARMACOL BULL, V25, P460; Elliot C., 2007, DIFFERENTIAL ABILITI; Errington AC, 2011, J NEUROSCI, V31, P8669, DOI 10.1523/JNEUROSCI.0317-11.2011; Fain G. L., 1999, MOL CELLULAR PHYSL N; Feshchenko VA, 1997, NEUROPSYCHOBIOLOGY, V35, P211, DOI 10.1159/000119347; Gaetz W, 2011, NEUROIMAGE, V55, P616, DOI 10.1016/j.neuroimage.2010.12.077; Gaugler T, 2014, NAT GENET, V46, P881, DOI 10.1038/ng.3039; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Hogart A, 2010, NEUROBIOL DIS, V38, P181, DOI 10.1016/j.nbd.2008.08.011; Jeste SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9874; Jeste SS, 2015, CURR OPIN NEUROL; Judson MC, 2016, NEURON, V90, P56, DOI 10.1016/j.neuron.2016.02.040; LANCEL M, 1994, BRAIN RES, V646, P85, DOI 10.1016/0006-8993(94)90060-4; Loscher W, 2012, EPILEPSIA, V53, P12, DOI 10.1111/epi.12025; Macdonald RL, 1991, SEMINARS NEUROSCIENC; McEvoy K, 2015, BRAIN IMAGING BEHAV, V9, P104, DOI 10.1007/s11682-014-9343-7; MODY I, 1994, TRENDS NEUROSCI, V17, P517, DOI 10.1016/0166-2236(94)90155-4; Mody I, 2001, NEUROCHEM RES, V26, P907, DOI 10.1023/A:1012376215967; Mullen E., 1989, INFANT MULLEN SCALES; Muthaffar O, 2015, ANN M AM EP SOC 2015; NICKEL B, 1989, NEUROPHARMACOLOGY, V28, P799, DOI 10.1016/0028-3908(89)90170-6; Nutt DJ, 2001, BRIT J PSYCHIAT, V179, P390, DOI 10.1192/bjp.179.5.390; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; Pillai J, 2006, EPILEPSIA, V47, P14, DOI 10.1111/j.1528-1167.2006.00654.x; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Poyares D, 2004, J PSYCHIATR RES, V38, P327, DOI 10.1016/j.jpsychires.2003.10.003; Robinson AA, 2015, J CHILD NEUROL, V30, P58, DOI 10.1177/0883073814530498; Roid G.H., 1997, LEITER INT PERFORMAN; Roid GH., 2003, STANFORD BINET INTEL, V5th; Schaefer GB, 2013, GENET MED, V15, P669, DOI 10.1038/gim.2013.32; Scoles HA, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-19; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Tammimies K, 2015, JAMA-J AM MED ASSOC, V314, P895, DOI 10.1001/jama.2015.10078; Urraca N, 2013, AUTISM RES, V6, P268, DOI 10.1002/aur.1284; van Lier H, 2004, NEUROPHARMACOLOGY, V47, P163, DOI 10.1016/j.neuropharm.2004.03.017; Veauthier J, 2009, SEIZURE-EUR J EPILEP, V18, P392, DOI 10.1016/j.seizure.2009.02.001; Voytek B, 2015, J NEUROSCI, V35, P13257, DOI 10.1523/JNEUROSCI.2332-14.2015; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Wisor JP, 2002, BRAIN RES, V955, P221, DOI 10.1016/S0006-8993(02)03467-4; Zimmerman I., 2011, PRESCHOOL LANGUAGE S	50	33	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167179	10.1371/journal.pone.0167179	http://dx.doi.org/10.1371/journal.pone.0167179			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977700	Green Published, gold			2022-12-27	WOS:000391217400015
J	Hosotsubo, M; Magota, T; Egusa, M; Miyawaki, T; Matsumoto, T				Hosotsubo, Miyu; Magota, Tetsuro; Egusa, Masahiko; Miyawaki, Takuya; Matsumoto, Takuya			Fabrication of Artificial Food Bolus for Evaluation of Swallowing	PLOS ONE			English	Article							DYSPHAGIA; VISCOSITY; TEXTURE; MASTICATION; PHYSIOLOGY; TRANSPORT; VOLUME	Simple and easy methods to evaluate swallowing are required because of the recently increased need of rehabilitation for dysphagia. "Artificial food bolus", but not "artificial food", would be a valuable tool for swallowing evaluation without considering the mastication effect which is altered according to the individual's oral condition. Thus, this study was carried out to fabricate artificial bolus resembling natural food bolus. The mechanical property and the volume change of food bolus in normal people were firstly investigated. Thirty healthy adults without dysphagia were selected and asked to chew four sample foods (rice cake, peanut, burdock, and gummy candy). The results indicated that Young's modulus of bolus before swallowing was below 150 kPa. The bolus volume before swallowing was below 400 mm(3). In addition, the saliva component ratio of each bolus was approximately 30wt%, and the average saliva viscosity of research participants was approximately 10 mPa.s. Based on the obtained data, artificial food bolus was designed and fabricated by using alginate hydrogel as a visco-elastic material and gelatin solution as a viscotic material with a ratio of 7: 3 based on weight. Consequently, the swallowing time of fabricated artificial food bolus was measured among the same participants. The results indicated the participants swallowed fabricated food bolus with similar manner reflecting their mechanical property and volume. Thus, this artificial food bolus would be a promising tool for evaluation of swallowing.	[Hosotsubo, Miyu; Magota, Tetsuro; Egusa, Masahiko] Okayama Univ Hosp, Ctr Special Needs Dent, Kita Ku, Shikata Cho, Okayama, Japan; [Hosotsubo, Miyu; Magota, Tetsuro; Miyawaki, Takuya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Dent Anesthesiol, Kita Ku, Shikata Cho, Okayama, Japan; [Hosotsubo, Miyu; Magota, Tetsuro; Matsumoto, Takuya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biomat, Kita Ku, Shikata Cho, Okayama, Japan	Okayama University; Okayama University; Okayama University	Matsumoto, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biomat, Kita Ku, Shikata Cho, Okayama, Japan.	tmatsu@md.okayama-u.ac.jp		Miyawaki, Takuya/0000-0002-6378-2623				Bailey AJ, 1998, J SOC LEATH TECH CH, V82, P104; Chen JS, 2013, ARCH ORAL BIOL, V58, P293, DOI 10.1016/j.archoralbio.2012.10.014; Cichero Julie A Y, 2013, Curr Phys Med Rehabil Rep, V1, P280; Costa Milton M. B., 2007, Arq. Gastroenterol., V44, P297, DOI 10.1590/S0004-28032007000400004; de Loubens C, 2011, J THEOR BIOL, V280, P180, DOI 10.1016/j.jtbi.2011.04.016; Glassburn DL, 1998, DYSPHAGIA, V13, P218, DOI 10.1007/PL00009575; Inokuchi H, 2014, DYSPHAGIA, V29, P685, DOI 10.1007/s00455-014-9562-5; Kim IS, 2005, ARCH PHYS MED REHAB, V86, P1986, DOI 10.1016/j.apmr.2005.05.004; KOHLER PF, 1985, ARTHRITIS RHEUM-US, V28, P1128, DOI 10.1002/art.1780281008; Lucas PW, 2004, J TEXTURE STUD, V35, P159, DOI 10.1111/j.1745-4603.2004.tb00831.x; Marciani L, 2001, AM J PHYSIOL-GASTR L, V280, pG1227, DOI 10.1152/ajpgi.2001.280.6.G1227; Molfenter SM, 2013, DYSPHAGIA, V28, P226, DOI 10.1007/s00455-012-9437-6; Nagasaki N, 2003, J COOKERY SCI JPN, V36, P364; Narita K, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1249-3; Nicosia MA, 2001, J BIOMECH, V34, P1537, DOI 10.1016/S0021-9290(01)00147-6; Palmer JB, 2007, PHYSIOL BEHAV, V91, P66, DOI 10.1016/j.physbeh.2007.01.018; POUDEROUX P, 1995, GASTROENTEROLOGY, V108, P1418, DOI 10.1016/0016-5085(95)90690-8; Rogus-Pulia NM, 2015, HEAD NECK-J SCI SPEC, V37, P1122, DOI 10.1002/hed.23720; Rosenbek JC, 1996, DYSPHAGIA, V11, P225, DOI 10.1007/BF00265206; Saha D, 2010, J FOOD SCI TECH MYS, V47, P587, DOI 10.1007/s13197-010-0162-6; Schimmel M, 2007, J ORAL REHABIL, V34, P671, DOI 10.1111/j.1365-2842.2007.01773.x; Steele CM, 2015, DYSPHAGIA, V30, P2, DOI 10.1007/s00455-014-9578-x; Stokes JR, 2013, CURR OPIN COLLOID IN, V18, P349, DOI 10.1016/j.cocis.2013.04.010; Swan K, 2015, QUAL LIFE RES, V24, P2447, DOI 10.1007/s11136-015-0990-y; Tsuru H, 1966, J JAPAN PROSTHODONTI, V10, P163; Uchida M, 2012, J CLIN WELFARE, V9, P34; Waldman AS, 1998, J CHEM EDUC, V75, P1430; Yagishita K., 1981, JAPANESE J PEDIATRIC, V19, P489; Yamada Y, 2005, JAPANESE J IN PRESS, V9, P23; Yoshikawa M, 2011, DYSPHAGIA, V26, P232, DOI 10.1007/s00455-010-9291-3; Zoungrana OR, 2000, EXP BRAIN RES, V132, P500, DOI 10.1007/s002210000361	31	7	7	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168378	10.1371/journal.pone.0168378	http://dx.doi.org/10.1371/journal.pone.0168378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977775	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400103
J	Masuda, T; Wan, J; Yerrabelli, A; Berlinicke, C; Kallman, A; Qian, J; Zack, DJ				Masuda, Tomohiro; Wan, Jun; Yerrabelli, Anitha; Berlinicke, Cindy; Kallman, Alyssa; Qian, Jiang; Zack, Donald J.			Off Target, but Sequence-Specific, shRNA-Associated Trans-Activation of Promoter Reporters in Transient Transfection Assays	PLOS ONE			English	Article							ROD PHOTORECEPTOR DEVELOPMENT; RNA INTERFERENCE; MAMMALIAN-CELLS; RETINAL DISEASE; GENE-EXPRESSION; HOMEOBOX GENE; CRX; NRL; RHODOPSIN; PROTEIN	Transient transfection promoter reporter assays are commonly used in the study of transcriptional regulation, and can be used to define and characterize both cis-acting regulatory sequences and trans-acting factors. In the process of using a variety of reporter assays designed to study regulation of the rhodopsin (rho) promoter, we discovered that rhodopsin promoter-driven reporter expression could be activated by certain species of shRNA in a gene-target-independent but shRNA sequence-specific manner, suggesting involvement of a specific shRNA associated pathway. Interestingly, the shRNA-mediated increase of rhodopsin promoter activity was synergistically enhanced by the rhodopsin transcriptional regulators CRX and NRL. Additionally, the effect was cell line-dependent, suggesting that this pathway requires the expression of cell-type specific factors. Since microRNA (miRNA) and interferon response-mediated processes have been implicated in RNAi off-target phenomena, we performed miRNA and gene expression profiling on cells transfected with shRNAs that do target a specific gene but have varied effects on rho reporter expression in order to identify transcripts whose expression levels are associated with shRNA induced rhodopsin promoter reporter activity. We identified a total of 50 miRNA species, and by microarray analysis, 320 protein-coding genes, some of which were predicted targets of the identified differentially expressed miRNAs, whose expression was altered in the presence of shRNAs that stimulated rhodopsin-promoter activity in a non-gene-targeting manner. Consistent with earlier studies on shRNA off-target effects, a number of interferon response genes were among those identified to be upregulated. Taken together, our results confirm the importance of considering off-target effects when interpreting data from RNAi experiments and extend prior results by focusing on the importance of including multiple and carefully designed controls in the design and analysis of the effects of shRNA on transient transfection-based transcriptional assays.	[Masuda, Tomohiro; Wan, Jun; Yerrabelli, Anitha; Berlinicke, Cindy; Qian, Jiang; Zack, Donald J.] Johns Hopkins Univ, Sch Med, Wilmer Inst, Dept Ophthalmol, Baltimore, MD 21205 USA; [Kallman, Alyssa; Zack, Donald J.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21218 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Zack, Donald J.] Univ Paris 06, Inst Vis, Paris, France	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; UDICE-French Research Universities; Sorbonne Universite	Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Inst, Dept Ophthalmol, Baltimore, MD 21205 USA.; Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21218 USA.; Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.; Zack, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.; Zack, DJ (corresponding author), Univ Paris 06, Inst Vis, Paris, France.	donzack@gmail.com	Wan, Jun/AAN-1337-2020; Wan, Jun/H-7132-2013	Wan, Jun/0000-0001-9286-6562; Wan, Jun/0000-0001-9286-6562	NIH [EY009769, P30EY001765, EY012543, EY02687]; Foundation Fighting Blindness; Guerrieri Family Foundation; NATIONAL EYE INSTITUTE [P30EY001765] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); Guerrieri Family Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grants from NIH [EY009769, P30EY001765, EY012543, and EY02687], (https://www.nih.gov/) to DJZ, the Foundation Fighting Blindness (http://www.blindness.org/) and a generous gifts from the Guerrieri Family Foundation and from Mr. and Mrs. Robert and Clarice Smith. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Arora S, 2013, MOL GENET GENOMICS, V288, P77, DOI 10.1007/s00438-013-0734-z; Baek ST, 2014, NEURON, V82, P1255, DOI 10.1016/j.neuron.2014.04.036; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; CHABRE M, 1989, EUR J BIOCHEM, V179, P255, DOI 10.1111/j.1432-1033.1989.tb14549.x; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Ehlert EM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-20; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fellmann C, 2014, NAT CELL BIOL, V16, P10, DOI 10.1038/ncb2895; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Garriga P, 2002, FEBS LETT, V528, P17, DOI 10.1016/S0014-5793(02)03241-6; Goerke AR, 2008, METAB ENG, V10, P187, DOI 10.1016/j.ymben.2008.04.001; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Gu S, 2014, NUCLEIC ACIDS RES, V42, P12169, DOI 10.1093/nar/gku854; Gu S, 2011, P NATL ACAD SCI USA, V108, P9208, DOI 10.1073/pnas.1018023108; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Herrera-Carrillo E, 2015, RNA BIOL, V12, P447, DOI 10.1080/15476286.2015.1022024; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; Mockenhaupt S, 2015, P NATL ACAD SCI USA, V112, pE4007, DOI 10.1073/pnas.1510476112; Morrow EM, 1998, TRENDS CELL BIOL, V8, P353, DOI 10.1016/S0962-8924(98)01341-5; Naash MI, 2004, J COMP NEUROL, V478, P149, DOI 10.1002/cne.20283; Ng L, 2011, J NEUROSCI, V31, P11118, DOI 10.1523/JNEUROSCI.1709-11.2011; Onishi A, 2010, NAT NEUROSCI, V13, P1059, DOI 10.1038/nn.2618; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Ros XBD, 2016, METHODS, V103, P157, DOI 10.1016/j.ymeth.2016.04.003; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Singh S, 2011, PHARM RES-DORDR, V28, P2996, DOI 10.1007/s11095-011-0608-1; Sioud M, 2007, ADV DRUG DELIVER REV, V59, P153, DOI 10.1016/j.addr.2007.03.006; Song HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118549; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160; Zhou NN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117357	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167867	10.1371/journal.pone.0167867	http://dx.doi.org/10.1371/journal.pone.0167867			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977714	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400038
J	Sumner, P; Vivian-Griffiths, S; Boivin, J; Williams, A; Bott, L; Adams, R; Venetis, CA; Whelan, L; Hughes, B; Chambers, CD				Sumner, Petroc; Vivian-Griffiths, Solveiga; Boivin, Jacky; Williams, Andrew; Bott, Lewis; Adams, Rachel; Venetis, Christos A.; Whelan, Leanne; Hughes, Bethan; Chambers, Christopher D.			Exaggerations and Caveats in Press Releases and Health-Related Science News	PLOS ONE			English	Article							PUBLIC-RELATIONS; COVERAGE; JOURNALISM; QUALITY	Background Exaggerated or simplistic news is often blamed for adversely influencing public health. However, recent findings suggested many exaggerations were already present in university press releases, which scientists approve. Surprisingly, these exaggerations were not associated with more news coverage. Here we test whether these two controversial results also arise in press releases from prominent science and medical journals. We then investigate the influence of mitigating caveats in press releases, to test assumptions that caveats harm news interest or are ignored. Methods and Findings Using quantitative content analysis, we analyzed press releases (N = 534) on biomedical and health-related science issued by leading peer-reviewed journals. We similarly analysed the associated peer-reviewed papers (N = 534) and news stories (N = 582). Main outcome measures were advice to readers and causal statements drawn from correlational research. Exaggerations in press releases predicted exaggerations in news (odds ratios 2.4 and 10.9, 95% CIs 1.3 to 4.5 and 3.9 to 30.1) but were not associated with increased news coverage, consistent with previous findings. Combining datasets from universities and journals (996 press releases, 1250 news), we found that when caveats appeared in press releases there was no reduction in journalistic uptake, but there was a clear increase in caveats in news (odds ratios 9.6 and 9.5 for caveats for advice and causal claims, CIs 4.1 to 24.3 and 6.0 to 15.2). The main study limitation is its retrospective correlational nature. Conclusions For health and science news directly inspired by press releases, the main source of both exaggerations and caveats appears to be the press release itself. However we find no evidence that exaggerations increase, or caveats decrease, the likelihood of news coverage. These findings should be encouraging for press officers and scientists who wish to minimise exaggeration and include caveats in their press releases.	[Sumner, Petroc; Vivian-Griffiths, Solveiga; Chambers, Christopher D.] Cardiff Univ, CUBRIC, Sch Psychol, Cardiff, S Glam, Wales; [Sumner, Petroc; Vivian-Griffiths, Solveiga; Boivin, Jacky; Bott, Lewis; Adams, Rachel; Whelan, Leanne; Hughes, Bethan; Chambers, Christopher D.] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales; [Williams, Andrew] Cardiff Univ, Sch Journalism Media & Cultural Studies, Cardiff, S Glam, Wales; [Venetis, Christos A.] UNSW, Sch Womens & Childrens Hlth, Kensington, NSW, Australia; [Venetis, Christos A.] Univ Wollongong, Fac Sci Med & Hlth, Grad Sch Med, Wollongong, NSW, Australia	Cardiff University; Cardiff University; Cardiff University; University of New South Wales Sydney; University of Wollongong	Sumner, P (corresponding author), Cardiff Univ, CUBRIC, Sch Psychol, Cardiff, S Glam, Wales.; Sumner, P (corresponding author), Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales.	sumnerp@cardiff.ac.uk	Boivin, Jacky/A-1666-2010; Venetis, Christos/G-3719-2013	Boivin, Jacky/0000-0001-9498-1708; Adams, Rachel/0000-0002-8053-0671; Venetis, Christos/0000-0001-9591-7222; Bott, Lewis/0000-0002-4926-1231	ESRC [ES/M000664/1]; Cardiff University; Economic and Social Research Council [1444793, ES/M000664/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Cardiff University; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was supported by grants from the ESRC (ES/M000664/1) and Cardiff University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer MW, 2008, JOURNALISM SCI SOC; Boyce Tammy, 2007, HLTH RISK NEWS MMR V; Brechman J, 2009, SCI COMMUN, V30, P453, DOI 10.1177/1075547009332649; Castell S, 2015, PUBLIC ATTITUDES SCI, P1; Cooper BEJ, 2012, PUBLIC UNDERST SCI, V21, P664, DOI 10.1177/0963662511401782; Gandy OH, 1982, AGENDA SETTING; Hansen AS., 2016, PUBLIC UNDERST SCI; Hardin JW, 2012, GEN ESTIMATING EQUAT; Kiernan V., 2006, EMBARGOED SCI; Leveson B., 2012, INQUIRY CULTURE PRAC, p[22, 80, 690, 1803]; Lewis J, 2001, CONSTRUCTING PUBLIC; Lewis J, 2008, JOURNALISM STUD, V9, P1, DOI 10.1080/14616700701767974; Nelkin D., 1995, SELLING SCI; Ramsay ME, 2013, ARCH DIS CHILD, V98, P752, DOI 10.1136/archdischild-2013-304292; Samuel G, 2015, PUBLIC UNDERST SCI; Schwartz LM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.d8164; Schwartz LM, 2004, ANN INTERN MED, V140, P226, DOI 10.7326/0003-4819-140-3-200402030-00015; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Sumner P, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7015; Taylor JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127848; Wang MTM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145294; Weitkamp E, 2014, JOURNAL PRACT, V8, P871, DOI 10.1080/17512786.2013.865966; Williams A., 2009, MAPPING FIELD SPECIA; Williams A, 2015, ROUT INT HANDB, P197; Woloshin S, 2009, ANN INTERN MED, V150, P613, DOI 10.7326/0003-4819-150-9-200905050-00007; Yavchitz A, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001308	26	63	63	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168217	10.1371/journal.pone.0168217	http://dx.doi.org/10.1371/journal.pone.0168217			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978540	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000391217400078
J	Boyer, KA; Andriacchi, TP				Boyer, Katherine A.; Andriacchi, Thomas P.			The Nature of Age-Related Differences in Knee Function during Walking: Implication for the Development of Knee Osteoarthritis	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; TIBIOFEMORAL KINEMATICS; GAIT; MECHANICS; JOINT; SYSTEMS; COORDINATION; DEFICIENT; STRENGTH; GENDER	Background Changes in knee kinematics have been identified in the early stages of osteoarthritis (OA). However, there is a paucity of information on the nature of kinematic change that occur with aging prior to the development of OA, This study applied a robust statistical method (Principal Component Analysis) to test the hypothesis that coupling between primary (flexion) and secondary (anterior-posterior translation, internal-external rotation) joint motions in walking would differ for age groupings of healthy subjects. Methods Seventy-four healthy participants divided into three groups with mean ages of 24 +/- 2.3 years (younger), 48 +/- 4.7years (middle-age) and 64 +/- 2.4 years (older) were examined. Principal Component Analysis was used to characterize and statistically compare the patterns of knee joint movement and their relationships in walking. Results There were significant differences between the younger group and both the middle-age and older groups in the knee frontal plane angle and the coupling between knee flexion (PC1, p <= 0.04) and the relative magnitudes of secondary plane motions in early and late stance (PC3, p<0.01). Two additional principal components (PC2, p = 0.03 and PC5, p<0.01) described differences in early stance knee flexion and relationship with secondary plane motion through-out stance for the older compared with middle-age group. Conclusions It appears there are changes in knee kinematics that occur with aging. The kinematic differences were identified for middle-aged as well as older adults suggesting midlife changes in neuromuscular physiology or behavior may have important consequences. These kinematic measures offer the potential to identify early markers for the risk of developing knee OA with aging.	[Boyer, Katherine A.] Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA; [Boyer, Katherine A.] Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA; [Andriacchi, Thomas P.] Stanford Univ, Dept Mech Engn, Stanford, CA USA; [Andriacchi, Thomas P.] Stanford Univ, Dept Orthoped Surg, Stanford, CA USA; [Andriacchi, Thomas P.] Palo Alto Vet Affairs Hlth Care Syst, Palo Alto, CA USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Stanford University; Stanford University	Boyer, KA (corresponding author), Univ Massachusetts, Dept Kinesiol, Amherst, MA 01003 USA.; Boyer, KA (corresponding author), Univ Massachusetts, Dept Mech & Ind Engn, Amherst, MA 01003 USA.	kboyer@kin.umass.edu			National Institutes of Aging [AR049792-06]	National Institutes of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding for collection of the data was provided by the National Institutes of Aging AR049792-06 to Andriacchi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Administration on Aging, 2014, PROF OLD AM 2014; Alexander EJ, 2001, J BIOMECH, V34, P355, DOI 10.1016/S0021-9290(00)00192-5; Andriacchi TP, 2006, CURR OPIN RHEUMATOL, V18, P514, DOI 10.1097/01.bor.0000240365.16842.4e; Andriacchi TP, 2015, ANN BIOMED ENG, V43, P376, DOI 10.1007/s10439-014-1117-2; Andriacchi TP, 2009, J BONE JOINT SURG AM, V91A, P95, DOI 10.2106/JBJS.H.01408; Andriacchi TP, 1998, J BIOMECH ENG-T ASME, V120, P743, DOI 10.1115/1.2834888; Beijersbergen CMI, 2013, AGEING RES REV, V12, P618, DOI 10.1016/j.arr.2013.03.001; Bohannon RW, 2007, PHYS THER, V87, P1642, DOI 10.2522/ptj.20060037; Boyer KA, 2012, GAIT POSTURE, V36, P149, DOI 10.1016/j.gaitpost.2012.02.007; Chu CR, 2015, J ORTHOP RES, V33, P939, DOI 10.1002/jor.22817; Cofre Lizama LE, 2011, GAIT POSTURE, V33, P484, DOI 10.1016/j.gaitpost.2010.12.030; Daffertshofer A, 2004, CLIN BIOMECH, V19, P415, DOI 10.1016/j.clinbiomech.2004.01.005; DeVita P, 2000, J APPL PHYSIOL, V88, P1804, DOI 10.1152/jappl.2000.88.5.1804; Dyrby CO, 2004, J ORTHOP RES, V22, P794, DOI 10.1016/j.orthres.2003.11.003; Favre J, 2014, OSTEOARTHR CARTILAGE, V22, P464, DOI 10.1016/j.joca.2013.12.014; Georgoulis AD, 2003, AM J SPORT MED, V31, P75, DOI 10.1177/03635465030310012401; Hagemeister N, 2005, J BIOMECH, V38, P1926, DOI 10.1016/j.jbiomech.2005.05.013; Kozanek M, 2009, J BIOMECH, V42, P1877, DOI 10.1016/j.jbiomech.2009.05.003; LAFORTUNE MA, 1992, J BIOMECH, V25, P347, DOI 10.1016/0021-9290(92)90254-X; Laxafoss E, 2013, SKELETAL RADIOL, V42, P531, DOI 10.1007/s00256-012-1509-z; Lindle RS, 1997, J APPL PHYSIOL, V83, P1581, DOI 10.1152/jappl.1997.83.5.1581; NIGG BM, 1994, GAIT POSTURE, V2, P213, DOI DOI 10.1016/0966-6362(94)90106-6; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; Peres-Neto PR, 2005, COMPUT STAT DATA AN, V49, P974, DOI 10.1016/j.csda.2004.06.015; Scanlan SF, 2014, KNEE, V21, P74, DOI 10.1016/j.knee.2013.06.003; Scanlan SF, 2010, J BIOMECH, V43, P1817, DOI 10.1016/j.jbiomech.2010.02.010; Shelburne KB, 2006, J ORTHOP RES, V24, P1983, DOI 10.1002/jor.20255; St-Onge N, 2004, KNEE SURG SPORT TR A, V12, P203, DOI 10.1007/s00167-003-0420-5; Zhang LQ, 2003, GAIT POSTURE, V17, P34, DOI 10.1016/S0966-6362(02)00052-8	31	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167352	10.1371/journal.pone.0167352	http://dx.doi.org/10.1371/journal.pone.0167352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973527	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300024
J	Curral, L; Marques-Quinteiro, P; Gomes, C; Lind, PG				Curral, Luis; Marques-Quinteiro, Pedro; Gomes, Catarina; Lind, Pedro G.			Leadership as an Emergent Feature in Social Organizations: Insights from A Laboratory Simulation Experiment	PLOS ONE			English	Article							COMPLEXITY LEADERSHIP; BEHAVIORS; FUTURE	Recent theoretical contributions have suggested a theory of leadership that is grounded in complexity theory, hence regarding leadership as a complex process (i.e., nonlinear; emergent). This article tests if complexity leadership theory promotes efficiency in work groups. 40 groups of five participants each had to complete four decision making tasks using the city simulation game SimCity4. Before engaging in the four decision making tasks, participants received information regarding what sort of leadership behaviors were more adequate to help them perform better. Results suggest that if complexity leadership theory is applied, groups can achieve higher efficiency over time, when compared with other groups where complexity leadership is not applied. This study goes beyond traditional views of leadership as a centralized form of control, and presents new evidence suggesting that leadership is a collective and emergent phenomenon, anchored in simple rules of behavior.	[Curral, Luis] Univ Lisbon, Fac Psicol, Ctr Invest Ciencia Psicol, Lisbon, Portugal; [Marques-Quinteiro, Pedro] ISPA IU, William James Ctr Res, Lisbon, Portugal; [Gomes, Catarina] Univ Lisbon, Inst Super Ciencias Sociais & Polit, Ctr Adm & Polit Publ, Lisbon, Portugal; [Lind, Pedro G.] Univ Osnabruck, Inst Phys, Osnabruck, Germany	Universidade de Lisboa; Instituto Superior Psicologia Aplicada (ISPA); Universidade de Lisboa; University Osnabruck	Curral, L (corresponding author), Univ Lisbon, Fac Psicol, Ctr Invest Ciencia Psicol, Lisbon, Portugal.	lcurral@psicologia.ulisboa.pt	Gomes, Catarina/AAV-7391-2021; Marques-Quinteiro, Pedro/K-1896-2015; Marques-Quinteiro, Pedro/AAI-9402-2020; lind, pedro/G-5124-2010; Curral, Luis/C-2921-2013	Gomes, Catarina/0000-0002-2741-0582; Marques-Quinteiro, Pedro/0000-0001-9385-8476; Marques-Quinteiro, Pedro/0000-0001-9385-8476; lind, pedro/0000-0002-8176-666X; Curral, Luis/0000-0001-7730-7877	Fundacao Portuguesa para a Ciencia e Tecnologia [EXPL/MHC-PSO/1400/2013, CPO/00713, UID/CPO/00713/2013]; Fundação para a Ciência e a Tecnologia [UID/CPO/00713/2013, EXPL/MHC-PSO/1400/2013] Funding Source: FCT	Fundacao Portuguesa para a Ciencia e Tecnologia; Fundação para a Ciência e a Tecnologia	LC (EXPL/MHC-PSO/1400/2013), PMQ (CPO/00713), and CG (Ref. UID/CPO/00713/2013) were all funded by Fundacao Portuguesa para a Ciencia e Tecnologia (http://www.fct.pt/index.phtml.en).	Avolio BJ, 2009, ANNU REV PSYCHOL, V60, P421, DOI 10.1146/annurev.psych.60.110707.163621; Bass B. M., 1990, BASS STOGDILLS HDB L; Bijleveld E, 2011, J EXP SOC PSYCHOL, V47, P865, DOI 10.1016/j.jesp.2011.03.002; Boos M, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003541; Carte TA, 2006, GROUP DECIS NEGOT, V15, P323, DOI 10.1007/s10726-006-9045-7; Fitzgerald L, 2013, LEADERSHIP QUART, V24, P227, DOI 10.1016/j.leaqua.2012.10.012; Guastello SJ, 2007, LEADERSHIP QUART, V18, P357, DOI 10.1016/j.leaqua.2007.04.005; Hannah ST, 2009, LEADERSHIP QUART, V20, P897, DOI 10.1016/j.leaqua.2009.09.006; Hazy JK, 2015, LEADERSHIP-LONDON, V11, P79, DOI 10.1177/1742715013511483; KARAU SJ, 1993, J PERS SOC PSYCHOL, V65, P681, DOI 10.1037/0022-3514.65.4.681; Kates RW, 2006, P NATL ACAD SCI USA, V103, P14653, DOI 10.1073/pnas.0605726103; Kickul J, 2000, J BUS PSYCHOL, V15, P27, DOI 10.1023/A:1007714801558; Livingston D, 2009, PROCEEDINGS OF THE 5TH EUROPEAN CONFERENCE ON MANAGEMENT LEADERSHIP AND GOVERNANCE, P102; Lord RG, 2011, ORGAN PSYCHOL REV, V1, P104, DOI 10.1177/2041386610384757; Marion Russ, 2003, EMERGENCE, V5, P54, DOI DOI 10.1207/S15327000EM0501_06; Markowitz H. M., 2000, MEAN VARIANCE ANAL P; McGrath JE, 2000, PERS SOC PSYCHOL REV, V4, P95, DOI 10.1207/S15327957PSPR0401_8; Mintzberg Henry, 1993, STRUCTURE 5 DESIGNIN; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Pope S. B., 2000, TURBULENT FLOWS, DOI DOI 10.1017/CBO9780511840531; Pugliese F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137234; Randall KR, 2011, J APPL PSYCHOL, V96, P525, DOI 10.1037/a0022622; Rego L., 2008, STEPPING VOID; Uhl-Bien M, 2007, LEADERSHIP QUART, V18, P298, DOI 10.1016/j.leaqua.2007.04.002; Uhl-Bien M, 2009, LEADERSHIP QUART, V20, P631, DOI 10.1016/j.leaqua.2009.04.007	26	5	6	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166697	10.1371/journal.pone.0166697	http://dx.doi.org/10.1371/journal.pone.0166697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973596	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300011
J	Gonzales-Andres, C; Lopes, PFM; Cortes, J; Sanchez-Lizaso, JL; Pennino, MG				Gonzales-Andres, Cristina; Lopes, Priscila F. M.; Cortes, Jorge; Luis Sanchez-Lizaso, Jose; Grazia Pennino, Maria			Abundance and Distribution Patterns of Thunnus albacares in Isla del Coco National Park through Predictive Habitat Suitability Models	PLOS ONE			English	Article							NINO SOUTHERN-OSCILLATION; MARINE PROTECTED AREAS; YELLOWFIN TUNA; EL-NINO; OCEANIC ISLAND; BIGEYE TUNA; COSTA-RICA; CONSERVATION; BIODIVERSITY; COMPLEXITY	Information on the distribution and habitat preferences of ecologically and commercially important species is essential for their management and protection. This is especially important as climate change, pollution, and overfishing change the structure and functioning of pelagic ecosystems. In this study, we used Bayesian hierarchical spatial-temporal models to map the Essential Fish Habitats of the Yellowfin tuna (Thunnus albacares) in the waters around Isla del Coco National Park, Pacific Costa Rica, based on independent underwater observations from 1993 to 2013. We assessed if observed changes in the distribution and abundance of this species are related with habitat characteristics, fishing intensity or more extreme climatic events, including the El Nino Southern Oscillation, and changes on the average sea surface temperature. Yellowfin tuna showed a decreasing abundance trend in the sampled period, whereas higher abundances were found in shallow and warmer waters, with high concentration of chlorophyll- a, and in surrounding seamounts. In addition, El Nino Southern Oscillation events did not seem to affect Yellowfin tuna distribution and abundance. Understanding the habitat preferences of this species, using approaches as the one developed here, may help design integrated programs for more efficient management of vulnerable species.	[Gonzales-Andres, Cristina; Luis Sanchez-Lizaso, Jose] Univ Alicante, Dept Marine Sci & Appl Biol, Alicante, Spain; [Gonzales-Andres, Cristina; Grazia Pennino, Maria] Univ Valencia, Dept Estat & Invest Operat, SMEG, Valencia, Spain; [Lopes, Priscila F. M.; Grazia Pennino, Maria] Univ Fed Rio Grande do Norte, Dept Ecol, Fisheries Ecol Management & Econ Unit FEME, Natal, RN, Brazil; [Cortes, Jorge] Univ Costa Rica, Ctr Invest Ciencias Mar & Limnol CIMAR, San Jose, Costa Rica	Universitat d'Alacant; University of Valencia; Universidade Federal do Rio Grande do Norte; Universidad Costa Rica	Gonzales-Andres, C (corresponding author), Univ Alicante, Dept Marine Sci & Appl Biol, Alicante, Spain.; Gonzales-Andres, C (corresponding author), Univ Valencia, Dept Estat & Invest Operat, SMEG, Valencia, Spain.	cristinacap80@hotmail.com	Cortés, Jorge/AAC-9782-2020; Lopes, Priscila/H-2028-2012; Grazia, Maria/E-3454-2015; Lizaso, José Luis L Sánchez/J-4939-2017	Cortés, Jorge/0000-0001-7004-8649; Lopes, Priscila/0000-0002-6774-5117; Grazia, Maria/0000-0002-7577-2617; Lizaso, José Luis L Sánchez/0000-0002-3927-5699	Marine Stewardship Council	Marine Stewardship Council	The study was funded by "Marine Stewardship Council" in its Scholarship Program. The author who receives the funds was the main author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Gonzalez J, 2008, REV BIOL TROP S2, V56, P49; Sibaja-Cordero JA, 2008, REV BIOL TROP, V56, P113; Alfaro EJ, 2016, REV BIOL TROP, V64, pS59; Alverson F. G., 1963, Bulletin Inter-American Tropical Tuna Commission, V7, P293; Arias A, 2016, ORYX, V50, P18, DOI 10.1017/S0030605314000337; Brenes C, 2016, REV BIOL TROP, V64, pS121; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Cortes J., 2008, COSTA RICA REV BIOL, V56, P1; Cortes J, 2012, REV BIOL TROP, V60, P131; Cubero-Pardo P., 2013, ANALISIS PESQUERIA A; Dagorn L, 2006, AQUAT LIVING RESOUR, V19, P85, DOI 10.1051/alr:2006008; De Anda-Montanez JA, 2004, DEEP-SEA RES PT II, V51, P575, DOI 10.1016/j.dsr2.2004.05.013; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Ely B, 2005, EVOL BIOL, V5, P1; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fonteneau A., 1991, AQUAT LIVING RESOUR; Friedlander AM, 2012, REV BIOL TROP, V60, P321; Game ET, 2009, TRENDS ECOL EVOL, V24, P360, DOI 10.1016/j.tree.2009.01.011; Gratwicke B, 2005, J FISH BIOL, V66, P650, DOI 10.1111/j.0022-1112.2005.00629.x; Pennino MG, 2013, J SEA RES, V83, P209, DOI 10.1016/j.seares.2013.03.005; Haedrich R. L., 2003, COPEIA, V2, P422, DOI [10.1643/0045-8511(2003)003[0422:BR]2.0.CO;2, DOI 10.1643/0045-8511(2003)003[0422:BR]2.0.CO;2]; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Holland Kim N., 2007, Fish and Aquatic Resources Series, V12, P189; HOLLAND KN, 1990, FISH B-NOAA, V88, P493; Holland KN, 1999, FISH B-NOAA, V97, P392; ICCAT: International Commission for the Conservation of Atlantic Tunas, 2002, REP BIENN PER 2000 2; IOTC: Indian Ocean Tuna Commision, 2004, 6 SESS IOTC WORK PAR; Alvarado JJ, 2012, REV BIOL TROP, V60, P129; Kessler WS, 2006, PROG OCEANOGR, V69, P181, DOI 10.1016/j.pocean.2006.03.009; Lauria V, 2015, SCI REP-UK, V5, DOI 10.1038/srep13245; Lauria V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117006; Lavelle JW, 2010, OCEANOGRAPHY, V23, P90, DOI 10.5670/oceanog.2010.64; Lehodey P, 1997, NATURE, V389, P715, DOI 10.1038/39575; Lizano OG., 2008, COSTA RICA REV BIOL, V56, P31; Lizano OG, 2012, REV BIOL TROP, V60, P43; Lopez-Garro A, 2016, COSTA RICA REV BI S1, V64, pS249; Louzao M, 2011, J APPL ECOL, V48, P121, DOI 10.1111/j.1365-2664.2010.01910.x; McPhaden MJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048275; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Morato T, 2010, P NATL ACAD SCI USA, V107, P9707, DOI 10.1073/pnas.0910290107; Moreno JID, 2000, ICES J MAR SCI, V57, P1091, DOI 10.1006/jmsc.2000.0705; Mug-Villanueva, 2002, ANALISIS TENDENCIAS; Munoz F, 2013, STOCH ENV RES RISK A, V27, P1171, DOI 10.1007/s00477-012-0652-3; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Ortega G. S, 1998, ANALISIS FLUCTUACION; Pauly D, 2007, AMBIO, V36, P290, DOI 10.1579/0044-7447(2007)36[290:TSAUPD]2.0.CO;2; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Quiroz Z. C., 2005, BIOMETRICS, V71, P2082; R Dev. Team, 2015, R LANG ENV STAT COMP; Rojas W, 2012, REV BIOL TROP, V60, P15; Roos M, 2011, BAYESIAN ANAL, V6, P259, DOI 10.1214/11-BA609; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sbrocco E.J., 2013, ECOLOGY, V94, P979, DOI DOI 10.1890/12-1358.1; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Starr RM, 2012, REV BIOL TROP, V60, P347; Torres-Orozco E, 2006, FISH B-NOAA, V104, P197; Trujillo P, 1950, 201531 U BRIT COL; Vianna GMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095565; White ER, 2015, CONSERV BIOL, V29, P1186, DOI 10.1111/cobi.12478; Williams I. D., 2011, J MAR BIOL, V2011, P14, DOI DOI 10.1155/2011/826234; Yu J.Y., 2012, GEOPHYS RES LETT, V39; Zuur AF, 2009, STAT BIOL HLTH, P579	63	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168212	10.1371/journal.pone.0168212	http://dx.doi.org/10.1371/journal.pone.0168212			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973538	gold, Green Published			2022-12-27	WOS:000392754300065
J	Iturbe-Ormaetxe, I; Ponti, G; Tomas, J				Iturbe-Ormaetxe, Inigo; Ponti, Giovanni; Tomas, Josefa			Myopic Loss Aversion under Ambiguity and Gender Effects	PLOS ONE			English	Article							PROSPECT-THEORY; EQUITY PREMIUM; RISK-TAKING	Experimental evidence suggests that the frequency with which individuals get feedback information on their investments has an effect on their risk-taking behavior. In particular, when they are given information sufficiently often, they take less risks compared with a situation in which they are informed less frequently. We find that this result still holds when subjects do not know the probabilities of the lotteries they are betting upon. We also detect significant gender effects, in that the frequency with which information is disclosed mostly affects male betting behavior, and that males become more risk-seeking after experiencing a loss.	[Iturbe-Ormaetxe, Inigo; Ponti, Giovanni; Tomas, Josefa] Univ Alicante, Dept Fundamentos Anal Econ, Alicante 03071, Spain; [Ponti, Giovanni] Univ Chicago, Dept Econ, 1126 East 59th St, Chicago, IL 60637 USA; [Ponti, Giovanni] LUISS Guido Carli, Dipartimento Econ & Finanza, Viale Romania 32, I-00197 Rome, Italy	Universitat d'Alacant; University of Chicago; Luiss Guido Carli University	Ponti, G (corresponding author), Univ Alicante, Dept Fundamentos Anal Econ, Alicante 03071, Spain.; Ponti, G (corresponding author), Univ Chicago, Dept Econ, 1126 East 59th St, Chicago, IL 60637 USA.; Ponti, G (corresponding author), LUISS Guido Carli, Dipartimento Econ & Finanza, Viale Romania 32, I-00197 Rome, Italy.	giuba@ua.es	Iturbe-Ormaetxe, Iñigo/H-4674-2015; Tomas, Josefa/AAA-5416-2019	Iturbe-Ormaetxe, Iñigo/0000-0002-2385-2471; Tomas, Josefa/0000-0001-8280-5547; Ponti, Giovanni/0000-0003-1680-3580	Spanish Ministry of Economic Development [ECO2012-34928, ECO2015-65820-P]; Italian Ministry of University and Research (MIUR) [PRIN 20103S5RN3 002]; Generalitat Valenciana [3/086, PROMETEO/2013/037]; Instituto Valenciano de Investigaciones Economicas (IVIE)	Spanish Ministry of Economic Development; Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Instituto Valenciano de Investigaciones Economicas (IVIE)	Financial support from the Spanish Ministry of Economic Development (grants ECO2012-34928, ECO2015-65820-P), Italian Ministry of University and Research (MIUR, grant PRIN 20103S5RN3 002), Generalitat Valenciana (Research Projects Grupos 3/086 and PROMETEO/2013/037), and Instituto Valenciano de Investigaciones Economicas (IVIE) is gratefully acknowledged. The funders cited above had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellemare C, 2005, ECON LETT, V87, P319, DOI 10.1016/j.econlet.2004.12.011; BENARTZI S, 1995, Q J ECON, V110, P73, DOI 10.2307/2118511; Blavatskyy P, 2009, ECON LETT, V104, P43, DOI 10.1016/j.econlet.2009.03.023; Blavatskyy PR, 2010, THEOR DECIS, V68, P159, DOI 10.1007/s11238-009-9143-5; Charness G, 2012, J ECON BEHAV ORGAN, V83, P50, DOI 10.1016/j.jebo.2011.06.007; Charness G, 2010, ECON INQ, V48, P133, DOI 10.1111/j.1465-7295.2009.00219.x; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Filippin A, 2016, MANAGE SCI, V62, P3138, DOI 10.1287/mnsc.2015.2294; Gneezy U, 1997, Q J ECON, V112, P631, DOI 10.1162/003355397555217; Hopfensitz A., 2009, 09087 TSE; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kliger D, 2009, J ECON BEHAV ORGAN, V71, P361, DOI 10.1016/j.jebo.2009.03.020; Langer T, 2005, J ECON BEHAV ORGAN, V56, P25, DOI 10.1016/j.jebo.2003.01.005; MEHRA R, 1985, J MONETARY ECON, V15, P145, DOI 10.1016/0304-3932(85)90061-3; Nelson JA, 2016, FEM ECON, V22, P114, DOI 10.1080/13545701.2015.1057609; Thaler RH, 1997, Q J ECON, V112, P647, DOI 10.1162/003355397555226; THALER RH, 1990, MANAGE SCI, V36, P643, DOI 10.1287/mnsc.36.6.643; TVERSKY A, 1971, PSYCHOL BULL, V76, P105, DOI 10.1037/h0031322	20	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0161477	10.1371/journal.pone.0161477	http://dx.doi.org/10.1371/journal.pone.0161477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973545	gold, Green Published, Green Submitted			2022-12-27	WOS:000392754300001
J	Ma, Y; Dong, M; Zhou, KH; Mita, C; Liu, JP; Wayne, PM				Ma, Yan; Dong, Ming; Zhou, Kehua; Mita, Carol; Liu, Jianping; Wayne, Peter M.			Publication Trends in Acupuncture Research: A 20-Year Bibliometric Analysis Based on PubMed	PLOS ONE			English	Article							LOW-BACK-PAIN; CHINESE MEDICINE; PRIMARY-CARE; MANAGEMENT; QUALITY; METAANALYSIS; COMPLEMENTARY; LABOR	Objective Acupuncture has become popular and widely practiced in many countries around the world. Despite the large amount of acupuncture-related literature that has been published, broader trends in the prevalence and scope of acupuncture research remain underexplored. The current study quantitatively analyzes trends in acupuncture research publications in the past 20 years. Methods A bibliometric approach was used to search PubMed for all acupuncture-related research articles including clinical and animal studies. Inclusion criteria were articles published between 1995 and 2014 with sufficient information for bibliometric analyses. Rates and patterns of acupuncture publication within the 20 year observational period were estimated, and compared with broader publication rates in biomedicine. Identified eligible publications were further analyzed with respect to study type/design, clinical condition addressed, country of origin, and journal impact factor. Results A total of 13,320 acupuncture-related publications were identified using our search strategy and eligibility criteria. Regression analyses indicated an exponential growth in publications over the past two decades, with a mean annual growth rate of 10.7%. This compares to a mean annual growth rate of 4.5% in biomedicine. A striking trend was an observed increase in the proportion of randomized clinical trials (RCTs), from 7.4% in 1995 to 20.3% in 2014, exceeding the 4.5% proportional growth of RCTs in biomedicine. Over the 20 year period, tions). Other top rankings with respect to medical focus were arthritis, neoplasms/cancer, pregnancy or labor, mood disorders, stroke, nausea/vomiting, sleep, and paralysis/palsy. Acupuncture research was conducted in 60 countries, with the top 3 contributors being China (47.4%), United States (17.5%), and United Kingdom (8.2%). Retrieved articles were published mostly in complementary and alternative medicine (CAM) journals with impact factors ranging between 0.7 and 2.8 in the top 20 journals, followed by journals specializing in neuroscience, pain, anesthesia/analgesia, internal medicine and comprehensive fields. Conclusion Acupuncture research has grown markedly in the past two decades, with a 2-fold higher growth rate than for biomedical research overall. Both the increases in the proportion of RCTs and the impact factor of journals support that the quality of published research has improved. While pain was a consistently dominant research focus, other topics gained more attention during this time period. These findings provide a context for analyzing strengths and gaps in the current state of acupuncture research, and for informing a comprehensive strategy for further advancing the field.	[Ma, Yan] PLA, Air Force Gen Hosp, Sleep Ctr, Beijing, Peoples R China; [Ma, Yan] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02115 USA; [Dong, Ming] IBM Corp, Software Dev Lab, Littleton, MA USA; [Zhou, Kehua] Daemen Coll, Dept Hlth Care Studies, Amherst, NY USA; [Zhou, Kehua] Daemen Coll, Phys Therapy Wound Care Clin, Amherst, NY USA; [Mita, Carol] Harvard Med Sch, Countway Lib Med, Reference & Educ Serv, Boston, MA USA; [Liu, Jianping] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China; [Wayne, Peter M.] Brigham & Womens Hosp, Div Prevent Med, Osher Ctr Integrat Med, 75 Francis St, Boston, MA 02115 USA; [Wayne, Peter M.] Harvard Med Sch, Boston, MA USA	Air Force General Hospital PLA; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; International Business Machines (IBM); Harvard University; Harvard Medical School; Beijing University of Chinese Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ma, Y (corresponding author), PLA, Air Force Gen Hosp, Sleep Ctr, Beijing, Peoples R China.; Ma, Y (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Interdisciplinary Med & Biotechnol, Boston, MA 02115 USA.	dr.yan.ma@gmail.com		Ma, Yan/0000-0003-1173-2920; Liu, Jianping/0000-0002-0320-061X; MITA, CAROL/0000-0003-3059-1369				Abaraogu UO, 2015, J ACUPUNCT MERIDIAN, V8, P220, DOI 10.1016/j.jams.2015.06.010; [Anonymous], 2015, PUBMED HELP NCBI HEL; [Anonymous], 2014, MEDLINE PUBMED RES G; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Bauer BA, 2015, CHIN J INTEGR MED, V21, P569, DOI 10.1007/s11655-015-2101-x; Berman BM, 2010, NEW ENGL J MED, V363, P454, DOI 10.1056/NEJMct0806114; Bould MD, 2010, ANAESTHESIA, V65, P799, DOI 10.1111/j.1365-2044.2010.06424.x; Cho SH, 2010, BJOG-INT J OBSTET GY, V117, P907, DOI 10.1111/j.1471-0528.2010.02570.x; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Clarke TC, 2015, NATL HLTH STAT REPOR, P1; De Bellis N., 2009, BIBLIOMETRICS CITATI; Deare JC, 2013, COCHRANE DB SYST REV, V5; DeShazo JP, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-7; Dogan RI, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap018; Durieux V, 2010, RADIOLOGY, V255, P342, DOI 10.1148/radiol.09090626; Ernst E, 1998, BRIT DENT J, V184, P443, DOI 10.1038/sj.bdj.4809654; Ernst E, 1998, ARCH INTERN MED, V158, P2235, DOI 10.1001/archinte.158.20.2235; Ezzo J, 2014, COCHRANE DB SYST REV, V11; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; GARFIELD E, 1970, NATURE, V227, P669, DOI 10.1038/227669a0; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; Glanville J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d1028; Han JS, 2011, NEUROSCI BIOBEHAV R, V35, P680, DOI 10.1016/j.neubiorev.2010.08.006; Harris CS, 2015, AM J MED, V128, P331, DOI 10.1016/j.amjmed.2014.10.042; Highfield ES, 2003, COMPLEMENT THER MED, V11, P177, DOI 10.1016/S0965-2299(03)00069-4; Huang DM, 2011, CHIN J INTEGR MED, V17, P386, DOI 10.1007/s11655-011-0611-8; Hunter PR, 2009, LANCET, V373, P630, DOI 10.1016/S0140-6736(09)60397-4; Kim KH, 2013, ACUPUNCT MED, V31, P228, DOI 10.1136/acupmed-2012-010257; Langevin HM, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/180805; Lee H, 2004, AM J OBSTET GYNECOL, V191, P1573, DOI 10.1016/j.ajog.2004.05.027; Lee JH, 2013, CLIN J PAIN, V29, P172, DOI 10.1097/AJP.0b013e31824909f9; Linde K, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001218.pub2; Liu L, 2015, EVID-BASED COMPL ALT, V2015; Lu ZY, 2011, DATABASE-OXFORD, DOI 10.1093/database/baq036; Lundeberg Thomas, 2007, Acupunct Med, V25, P100; Ma Y, 2015, SLEEP MED; Ma Y, 2016, COMPLEMENT THER MED, V29, pA1, DOI 10.1016/j.ctim.2016.05.003; Ma Y, 2016, FRONT MED-PRC, V10, P28, DOI 10.1007/s11684-016-0434-2; Ma Y, 2014, FRONT MED-PRC, V8, P279, DOI 10.1007/s11684-014-0367-6; Macfarlane GJ, 2012, RHEUMATOLOGY, V51, P2224, DOI 10.1093/rheumatology/kes200; MacPherson H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000261; Manheimer E, 2005, ANN INTERN MED, V142, P651, DOI 10.7326/0003-4819-142-8-200504190-00014; Manheimer E, 2007, ANN INTERN MED, V146, P868, DOI 10.7326/0003-4819-146-12-200706190-00008; Mayhew E, 2007, RHEUMATOLOGY, V46, P801, DOI 10.1093/rheumatology/kel406; McKenzie B., 2011, POPULAR IS ACUPUNCTU; Michalopoulos A, 2005, CHEST, V128, P3993, DOI 10.1378/chest.128.6.3993; Paley CA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007753.pub3; Quinn N, 2013, PEDIATRICS, V132, P406, DOI 10.1542/peds.2013-0283; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Salehi A, 2015, J EVIDENCE BASED COM; Schnyer R, 2008, J ALTERN COMPLEM MED, V14, P859, DOI 10.1089/acm.2008.SAR-2; Shin HC, 2016, LARYNGOSCOPE; Shuaib W, 2015, AM J CARDIOL, V115, P972, DOI 10.1016/j.amjcard.2015.01.029; Stener-Victorin Elisabet, 2006, Acupunct Med, V24, P157; Sun Y, 2008, ANESTH ANALG, V107, P2038, DOI 10.1213/ane.0b013e318187c76a; Tsai PS, 2016, EUROPEAN J CANC CARE; Weightman AL, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1083; Wieland LS, 2013, SYST REV, V2, DOI 10.1186/2046-4053-2-51; Xu H, 2011, CHIN J INTEGR MED, V17, P163, DOI 10.1007/s11655-011-0661-y; Yang GY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120655; Young H., 1983, ALA GLOSSARY LIB INF; Zhao L, 2011, CHIN J INTEGR MED, V17, P580, DOI 10.1007/s11655-011-0709-z; Zhou KH, 2015, ACUPUNCT MED, V33, P485, DOI 10.1136/acupmed-2015-010911	63	82	95	3	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168123	10.1371/journal.pone.0168123	http://dx.doi.org/10.1371/journal.pone.0168123			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973611	gold, Green Published			2022-12-27	WOS:000392754300056
J	Pontoppidan, M; Klest, SK; Sandoy, TM				Pontoppidan, Maiken; Klest, Sihu K.; Sandoy, Trondur Moller			The Incredible Years Parents and Babies Program: A Pilot Randomized Controlled Trial	PLOS ONE			English	Article							CHILD CONDUCT PROBLEMS; BEHAVIOR PROBLEMS; EARLY PREVENTION; YOUNG-CHILDREN; INTERVENTION; RISK; SKILLS; DEPRESSION; DISORDER; FAMILIES	Introduction Infancy is an important period of life; adverse experiences during this stage can have both immediate and lifelong impacts on the child's mental health and well-being. This study evaluates the effects of offering the Incredible Years Parents and Babies (IYPB) program as a universal intervention. Method We conducted a pragmatic, two-arm, parallel pilot randomized controlled trial; 112 families with newborns were randomized to the IYPB program (76) or usual care (36) with a 2: 1 allocation ratio. The primary outcome was parenting confidence at 20 weeks(Karitane Parenting Confidence Scale and Parental Stress Scale). Secondary outcomes include measures of parent health, parent-child relationship, infant development, parent-child activities, and network. Interviewers and data analysts were blind to allocation status. Multiple linear-regression analyses were used for evaluating the effects of the intervention. Results There were no intervention effects on the primary outcomes. Only one effect was detected for secondary outcomes, intervention mothers reported a significantly smaller network than control mothers (beta = -0.15 [-1.85,-0.28]). When examining the lowest-functioning mothers in moderator analyses, we found that intervention mothers reported significantly higher parent stress (beta = 5.33 [0.27,10.38]), lower parenting confidence (beta = -2.37 [-4.45,-0.29]), and worse mental health than control mothers (beta = -18.62 [-32.40,-4.84]). In contrast, the highest functioning intervention mothers reported significantly lower parent stress post-intervention (beta = -6.11 [-11.07,-1.14]). Conclusion Overall, we found no effects of the IYPB as a universal intervention for parents with infants. The intervention was developed to be used with groups of low functioning families and may need to be adapted to be effective with universal parent groups. The differential outcomes for the lowest and highest functioning families suggest that future research should evaluate the effects of delivering the IYPB intervention to groups of parents who have similar experiences with parenting and mental health.	[Pontoppidan, Maiken; Sandoy, Trondur Moller] SFI Danish Natl Ctr Social Res, Dept Child & Family, Copenhagen, Denmark; [Pontoppidan, Maiken] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark; [Klest, Sihu K.] Arctic Univ Norway, Univ Tromso, Fac Hlth Sci, Tromso, Norway	University of Copenhagen; UiT The Arctic University of Tromso	Pontoppidan, M (corresponding author), SFI Danish Natl Ctr Social Res, Dept Child & Family, Copenhagen, Denmark.	mpo@sfi.dk	Pontoppidan, Maiken/X-2204-2019	Pontoppidan, Maiken/0000-0002-9491-3665	TrygFonden [7-12-0195 MP]	TrygFonden	This work was supported by TrygFonden grant nr 7-12-0195 MP. https://www.trygfonden.dk/english. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronen ET, 1996, J AM ACAD CHILD PSY, V35, P1665, DOI 10.1097/00004583-199612000-00019; Axberg U, 2007, NORD J PSYCHIAT, V61, P143, DOI 10.1080/08039480701226120; Baker-Henningham H, 2012, BRIT J PSYCHIAT, V201, P101, DOI 10.1192/bjp.bp.111.096834; Barlow J, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002964.pub2; Barlow J, 2013, COCHRANE DATABASE SY; Bayer JK, 2010, ARCH DIS CHILD, V95, P187, DOI 10.1136/adc.2009.168302; Bech P, 2003, INT J METH PSYCH RES, V12, P85, DOI 10.1002/mpr.145; Bech P., 2004, QUAL LIFE NEWSL, V32, P15; Bech P., 2011, KLIN PSYKOMETRI; BERRY JO, 1995, J SOC PERS RELAT, V12, P463, DOI 10.1177/0265407595123009; Bywater T, 2009, BRIT J PSYCHIAT, V195, P318, DOI 10.1192/bjp.bp.108.056531; Carrell SE, 2013, ECONOMETRICA, V81, P855, DOI 10.3982/ECTA10168; Cicchetti D, 1998, DEV PSYCHOPATHOL, V10, P283, DOI 10.1017/S0954579498001618; Corby B., 2006, J SOCIOL SOC WELFARE, V302, P460; Crncec R, 2008, RES NURS HEALTH, V31, P442, DOI 10.1002/nur.20271; Crncec R, 2010, J NURS MEAS, V18, P210, DOI 10.1891/1061-3749.18.3.210; DICKIE JR, 1980, CHILD DEV, V51, P1248, DOI 10.2307/1129567; Dishion TJ, 2008, CHILD DEV, V79, P1395, DOI 10.1111/j.1467-8624.2008.01195.x; Dodge KA, 2014, AM J PUBLIC HEALTH, V104, pS136, DOI 10.2105/AJPH.2013.301361; Doherty WJ, 2006, J FAM PSYCHOL, V20, P438, DOI 10.1037/0893-3200.20.3.438; Drugli MB, 2010, J CHILD PSYCHOL PSYC, V51, P559, DOI 10.1111/j.1469-7610.2009.02178.x; Evans Sue, 2015, Community Pract, V88, P46; Field T, 1998, PREV MED, V27, P200, DOI 10.1006/pmed.1998.0293; Fonagy P, 1998, INFANT MENT HEALTH J, V19, P124, DOI 10.1002/(SICI)1097-0355(199822)19:2<124::AID-IMHJ4>3.0.CO;2-O; Furlong M, 2013, EVIDENCE BASED CHILD, P693; Gardner F, 2006, J CHILD PSYCHOL PSYC, V47, P1123, DOI 10.1111/j.1469-7610.2006.01668.x; Geffner R, 2003, EFFECTS INTIMATE PAR, V2; Gridley N, 2015, CHILD CARE HLTH DEV, V41, P103, DOI 10.1111/cch.12153; Griffith N, 2011, EVALUATING INCREDIBL; Grogaard J, 2007, DYPE SPOR DVD; Gross D, 2003, J CONSULT CLIN PSYCH, V71, P261, DOI 10.1037/0022-006X.71.2.261; Hackney M., 1996, HEALTH VISIT, V69, P103; Heckman JJ, 2007, REV AGR ECON, V29, P446, DOI 10.1111/j.1467-9353.2007.00359.x; Heckman JJ., 2008, BIG IDEAS CHILD INVE, P49; Hiscock H, 2008, BMJ-BRIT MED J, V336, P318, DOI 10.1136/bmj.39451.609676.AE; Hjaelmhof-Larsen SF, 2015, POLITIK PRAKSIS EN K; Hoivik MS, 2013, SCAND J CARING SCI, V27, P733, DOI 10.1111/j.1471-6712.2012.01060.x; Hurlburt MS, 2013, CHILD ABUSE NEGLECT, V37, P531, DOI 10.1016/j.chiabu.2012.10.008; Hutchings J, 2007, BMJ-BRIT MED J, V334, P678, DOI 10.1136/bmj.39126.620799.55; Hutchings J, 2012, SCHOOL PSYCHOL INT, V33, P285, DOI 10.1177/0143034311415899; Jones Catrin H, 2012, Community Pract, V85, P26; Jones CH, OUTCOMES COMP STUDY; Joyce AS, 2007, INT J GROUP PSYCHOTH, V57, P269, DOI 10.1521/ijgp.2007.57.3.269; Kan ML, 2014, VIOLENCE VICTIMS, V29, P967, DOI 10.1891/0886-6708.VV-D-12-00162; Little M, 2012, INT J CONFL VIOLENCE, V6, P260; Maimburg RD, 2015, SEX REPROD HEALTHC, V6, P95, DOI 10.1016/j.srhc.2015.01.003; Marcynyszyn LA, 2011, CHILD YOUTH SERV REV, V33, P747, DOI 10.1016/j.childyouth.2010.11.021; Menting ATA, 2013, CLIN PSYCHOL REV, V33, P901, DOI 10.1016/j.cpr.2013.07.006; Offord DR, 1998, J AM ACAD CHILD PSY, V37, P686, DOI 10.1097/00004583-199807000-00007; Olds DL, 2007, J CHILD PSYCHOL PSYC, V48, P355, DOI 10.1111/j.1469-7610.2006.01702.x; Olsen LR, 2003, PSYCHOL MED, V33, P351, DOI 10.1017/S0033291702006724; Perrin EC, 2014, JAMA PEDIATR, V168, P16, DOI 10.1001/jamapediatrics.2013.2919; Pidano AE, 2014, J CHILD FAM STUD, P1898; Piquero AR, 2008, CAMPBELL SYST REV, V11; Pontoppidan M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011706; Pontoppidan M, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0859-y; Presnall N, 2014, J AM ACAD CHILD PSY, V53, P879, DOI 10.1016/j.jaac.2014.04.024; Rasmussen A, 2015, EVALUERING PROJEKT; Reedtz C, INCREASED POSITIVE P; Reedtz C, 2011, SCAND J PSYCHOL, V52, P131, DOI 10.1111/j.1467-9450.2010.00854.x; rnec R., 2008, KARITANE PARENTING C; Roia A, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-222; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Rubin DB., 2004, MULTIPLE IMPUTATION; Santelices MP, 2011, CHILD CARE HLTH DEV, V37, P203, DOI 10.1111/j.1365-2214.2010.01161.x; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Schulz KF, 2010, ANN INTERN MED, V152, P726, DOI 10.7326/0003-4819-152-11-201006010-00232; Scott S, 2014, AM J PSYCHIAT, V171, P649, DOI 10.1176/appi.ajp.2014.13050697; Shapiro AF, 2011, AM J ORTHOPSYCHIAT, V81, P337, DOI 10.1111/j.1939-0025.2011.01102.x; Squires J., 2015, ASQ SE 2 USERS GUIDE; Squires JK, 2002, PARENT COMPLETED CHI; Sundhedsstyrelsen, 2011, VEJLEDNING OM FOREBY; Trillingsgaard T, 2014, SCAND J PSYCHOL, V55, P538, DOI 10.1111/sjop.12155; van Doesum KTM, 2008, CHILD DEV, V79, P547, DOI 10.1111/j.1467-8624.2008.01142.x; Vlismas W, 2013, EARLY CHILD DEV CARE, V183, P1669, DOI 10.1080/03004430.2012.746968; Webster-Stratton C., 2011, INCREDIBLE BABIES A, V2 nd ed.; Webster-Stratton CH, 2010, CLINICAL HANDBOOK OF ASSESSING AND TREATING CONDUCT PROBLEMS IN YOUTH, P117, DOI 10.1007/978-1-4419-6297-3_5; Weissman MM, 1997, ARCH GEN PSYCHIAT, V54, P932; Welsh BC, 2007, VICTIMS OFFENDERS, V2, P125, DOI 10.1080/15564880701263114; Yalom ID, 2005, THEORY PRACTICE GROU; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	81	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167592	10.1371/journal.pone.0167592	http://dx.doi.org/10.1371/journal.pone.0167592			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27974857	Green Submitted, Green Published, gold			2022-12-27	WOS:000392754300035
J	Kim, JA; Hwang, B; Park, SN; Huh, S; Im, K; Choi, S; Chung, HY; Huh, J; Seo, EJ; Lee, JH; Bang, D; Lee, DS				Kim, Jung-Ah; Hwang, Byungjin; Park, Si Nae; Huh, Sunghoon; Im, Kyongok; Choi, Sungbin; Chung, Hye Yoon; Huh, JooRyung; Seo, Eul-Ju; Lee, Je-Hwan; Bang, Duhee; Lee, Dong Soon			Genomic Profile of Chronic Lymphocytic Leukemia in Korea Identified by Targeted Sequencing	PLOS ONE			English	Article							RAPID DISEASE PROGRESSION; ACUTE MYELOID-LEUKEMIA; CHROMOSOMAL-ABERRATIONS; TRANSCRIPTION FACTORS; RECURRENT MUTATIONS; HIGH-THROUGHPUT; NOTCH1; SUSCEPTIBILITY; TRANSFORMATION; FEATURES	Chronic lymphocytic leukemia (CLL) is extremely rare in Asian countries and there has been one report on genetic changes for 5 genes (TP53, SF3B1, NOTCH1, MYD88, and BIRC3) by Sanger sequencing in Chinese CLL. Yet studies of CLL in Asian countries using Next generation sequencing have not been reported. We aimed to characterize the genomic profiles of Korean CLL and to find out ethnic differences in somatic mutations with prognostic implications. We performed targeted sequencing for 87 gene panel using next-generation sequencing along with G-banding and fluorescent in situ hybridization (FISH) for chromosome 12, 13q14.3 deletion, 17p13 deletion, and 11q22 deletion. Overall, 36 out of 48 patients (75%) harbored at least one mutation and mean number of mutation per patient was 1.6 (range 0-6). Aberrant karyotypes were observed in 30.4% by G-banding and 66.7% by FISH. Most recurrent mutation (>10% frequency) was ATM (20.8%) followed by TP53 (14.6%), SF3B1 (10.4%), KLHL6 (8.3%), and BCOR (6.25%). Mutations of MYD88 was associated with moderate adverse prognosis by multiple comparisons (P = 0.055). Mutation frequencies of MYD88, SAMHD1, EGR2, DDX3X, ZMYM3, and MED12 showed similar incidence with Caucasians, while mutation frequencies of ATM, TP53, KLHL6, BCOR and CDKN2A tend to be higher in Koreans than in Caucasians. Especially, ATM mutation showed 1.5 fold higher incidence than Caucasians, while mutation frequencies of SF3B1, NOTCH1, CHD2 and POT1 tend to be lower in Koreans than in Caucasians. However, mutation frequencies between Caucasians and Koreans were not significantly different statistically, probably due to low number of patients. Collectively, mutational profile and adverse prognostic genes in Korean CLL were different from those of Caucasians, suggesting an ethnic difference, while profile of cytogenetic aberrations was similar to those of Caucasians.	[Kim, Jung-Ah; Chung, Hye Yoon; Lee, Dong Soon] Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea; [Hwang, Byungjin; Huh, Sunghoon; Bang, Duhee] Yonsei Univ, Dept Chem, Seoul, South Korea; [Park, Si Nae; Im, Kyongok; Lee, Dong Soon] Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea; [Choi, Sungbin] Univ British Columbia, Sci, Vancouver, BC, Canada; [Huh, JooRyung] Univ Ulsan, Dept Pathol, Asan Med Ctr, Coll Med, Seoul, South Korea; [Seo, Eul-Ju] Univ Ulsan, Dept Lab Med, Coll Med, Asan Med Ctr, Seoul, South Korea; [Lee, Je-Hwan] Univ Ulsan, Dept Internal Med, Coll Med, Asan Med Ctr, Seoul, South Korea	Seoul National University (SNU); Yonsei University; Seoul National University (SNU); University of British Columbia; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan	Lee, DS (corresponding author), Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul, South Korea.; Bang, D (corresponding author), Yonsei Univ, Dept Chem, Seoul, South Korea.; Lee, DS (corresponding author), Seoul Natl Univ, Canc Res Inst, Coll Med, Seoul, South Korea.	duheebang@gmail.com; soonlee@snu.ac.kr		Kim, Jung Ah/0000-0001-6934-1987	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [NRF-2014R1A2A1A10052286]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A02062419]; Cancer Research Institute, Seoul National University	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Cancer Research Institute, Seoul National University	Support was provided by: Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (NRF-2014R1A2A1A10052286) [http://www.nrf.re.kr/] (to DSL); Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A02062419) [http://www.nrf.re.kr/] (to JAK); and a research grant from Cancer Research Institute, Seoul National University (2013) [http://cri.snu.ac.kr/] (to JAK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; AHN Y-O, 1991, Journal of Korean Medical Science, V6, P299; Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernasconi P, 2008, BRIT J HAEMATOL, V142, P695, DOI 10.1111/j.1365-2141.2008.07245.x; Chang YH, 2006, LEUKEMIA RES, V30, P695, DOI 10.1016/j.leukres.2005.10.013; Chen PM, 1997, ACTA HAEMATOL-BASEL, V97, P196; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Devalliere J, 2012, FASEB J, V26, P2592, DOI 10.1096/fj.11-193383; Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219; Dores GAM, 2007, BRIT J HAEMATOL, V139, P809, DOI 10.1111/j.1365-2141.2007.06856.x; ELROUBY S, 1993, BLOOD, V82, P3452; Fabbri G, 2013, J EXP MED, V210, P2273, DOI 10.1084/jem.20131448; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Fuchs O, 2008, BLOOD CELL MOL DIS, V40, P401, DOI 10.1016/j.bcmd.2007.11.005; Gale RP, 2000, LEUKEMIA RES, V24, P665, DOI 10.1016/S0145-2126(00)00038-2; Goemans BF, 2005, LEUKEMIA, V19, P1536, DOI 10.1038/sj.leu.2403870; Gonzalez-Gascon YMI, 2015, HEMATOL ONCOL, V17; Grever MR, 2007, J CLIN ONCOL, V25, P799, DOI 10.1200/JCO.2006.08.3089; Grossmann V, 2013, BLOOD, V122, P521; Gunawardana C, 2008, BRIT J HAEMATOL, V142, P606, DOI 10.1111/j.1365-2141.2008.07226.x; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hyde RK, 2011, NAT GENET, V43, P926, DOI 10.1038/ng.949; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lan Q, 2010, EUR J HAEMATOL, V85, P492, DOI 10.1111/j.1600-0609.2010.01518.x; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Lee S, 1999, ICRA '99: IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION, VOLS 1-4, PROCEEDINGS, P1, DOI 10.1109/ROBOT.1999.769891; Lee SJ, 2016, LEUKEMIA LYMPHOMA, V57, P585, DOI 10.3109/10428194.2015.1068307; Matsuda A, 2005, BLOOD, V106, P2633, DOI 10.1182/blood-2005-01-0040; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Nelson BP, 2007, AM J CLIN PATHOL, V128, P323, DOI 10.1309/21TN2RUWKR827UW2; Oesper L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r80; Perez-Garcia A, 2013, BLOOD, V122, P2425, DOI 10.1182/blood-2013-05-500850; Piazza R, 2013, NAT GENET, V45, P18, DOI 10.1038/ng.2495; Puente XS, 2015, NATURE, V526, P519, DOI 10.1038/nature14666; Puiggros A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/435983; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Rocquain J, 2010, AM J HEMATOL, V85, P717, DOI 10.1002/ajh.21798; Rossi D, 2012, BRIT J HAEMATOL, V158, P426, DOI 10.1111/j.1365-2141.2012.09155.x; Rossi D, 2011, BLOOD, V117, P3391, DOI 10.1182/blood-2010-09-302174; Sellar RS, 2015, BRIT J HAEMATOL, V170, P282, DOI 10.1111/bjh.13291; Silva FPG, 2003, ONCOGENE, V22, P538, DOI 10.1038/sj.onc.1206141; Skowronska A, 2012, HAEMATOL-HEMATOL J, V97, P142, DOI 10.3324/haematol.2011.048827; Sutton LA, 2015, HAEMATOLOGICA, V100, P370, DOI 10.3324/haematol.2014.109777; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tamura K, 2001, EUR J HAEMATOL, V67, P152, DOI 10.1034/j.1600-0609.2001.5790514.x; Tenedini E, 2014, LEUKEMIA, V28, P1052, DOI 10.1038/leu.2013.302; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Tijchon E, 2013, LEUKEMIA, V27, P541, DOI 10.1038/leu.2012.293; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Wu SJ, 2013, ANN HEMATOL, V92, P799, DOI 10.1007/s00277-013-1700-x; Xia Y, 2015, ONCOTARGET, V6, P5426, DOI 10.18632/oncotarget.3101; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; Yoon JH, 2014, HEMATOL ONCOL, V32, P169, DOI 10.1002/hon.2103; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zenz T, 2008, BLOOD, V112, P3322, DOI 10.1182/blood-2008-04-154070	58	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167641	10.1371/journal.pone.0167641	http://dx.doi.org/10.1371/journal.pone.0167641			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959900	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900013
J	Masuda, R; Hatakeyama, M; Yokoyama, K; Tanaka, M				Masuda, Reiji; Hatakeyama, Makoto; Yokoyama, Katsuhide; Tanaka, Masaru			Recovery of Coastal Fauna after the 2011 Tsunami in Japan as Determined by Bimonthly Underwater Visual Censuses Conducted over Five Years	PLOS ONE			English	Article							FISH ASSEMBLAGES; BENTHIC COMMUNITIES; SEA; BAY; IMPACTS; CORAL; REEF; DISTURBANCE; ZOOPLANKTON; POPULATIONS	Massive tsunamis induce catastrophic disturbance in marine ecosystems, yet they can provide unique opportunities to observe the process of regeneration. Here, we report the recovery of fauna after the 2011 tsunami in northeast Japan based on underwater visual censuses performed every two months over five years. Both total fish abundance and species richness increased from the first to the second year after the tsunami followed by stabilization in the following years. Short-lived fish, such as the banded goby Pterogobius elapoides, were relatively abundant in the first two years, whereas long-lived species, such as the black rockfish Sebastes cheni, increased in the latter half of the survey period. Tropical fish species were recorded only in the second and third years after the tsunami. The body size of long-lived fish increased during the survey period resulting in a gradual increase of total fish biomass. The recovery of fish assemblages was slow at one site located in the inner bay, where the impact of the tsunami was the strongest. Apart from fish, blooms of the moon jellyfish Aurelia sp. occurred only in the first two years after the tsunami, whereas the abundances of sea cucumber Apostichopus japonicus and abalone Haliotis discus hannai increased after the second year. Although we lack quantitative data prior to the tsunami, we conclude that it takes approximately three years for coastal reef fish assemblages to recover from a heavy disturbance such as a tsunami and that the recovery is dependent on species-specific life span and habitat.	[Masuda, Reiji] Kyoto Univ, Maizuru Fisheries Res Stn, Maizuru, Kyoto, Japan; [Yokoyama, Katsuhide] Tokyo Metropolitan Univ, Hachioji, Tokyo, Japan; [Tanaka, Masaru] Int Inst Adv Studies, Kyoto, Japan	Kyoto University; Tokyo Metropolitan University	Masuda, R (corresponding author), Kyoto Univ, Maizuru Fisheries Res Stn, Maizuru, Kyoto, Japan.	reiji@kais.kyoto-u.ac.jp	Yokoyama, Katsuhide/AAM-7655-2021	Yokoyama, Katsuhide/0000-0003-1576-6239	Mitsui Co., Ltd. [K11-F1-037]; JSPS KAKENHI [25249068]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Science and Technology Agency	Mitsui Co., Ltd.(Mitsui & Co., LTD.); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by the Mitsui & Co., Ltd. Environmental Fund (K11-F1-037) for MH (https://www.mitsui.com/jp/ja/csr/contribution/environment/fund/), JSPS KAKENHI Grant Number 25249068 for KY (http://www.jsps.go.jp/english/e-grants/index.html), the Tohoku Ecosystem-Associated Marine Science (TEAMS) project from the Ministry of Education, Culture, Sports, Science and Technology, Japan for RM (http://www.i-teams.jp/e/about/), and CREST Program from the Japan Science and Technology Agency for RM (http://www.jst.go.jp/kisoken/crest/en/project/33/e33_13.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2015, MAR ENVIRON RES, V112, P86, DOI 10.1016/j.marenvres.2015.09.011; Ackerman JL, 2000, MAR ECOL PROG SER, V206, P227, DOI 10.3354/meps206227; Bates AE, 2014, NAT CLIM CHANGE, V4, P62, DOI 10.1038/NCLIMATE2062; Clarke KR, 1998, OECOLOGIA, V113, P278, DOI 10.1007/s004420050379; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Daufresne M, 2007, OECOLOGIA, V151, P544, DOI 10.1007/s00442-006-0655-1; Desmond JS, 2002, ESTUARIES, V25, P552, DOI 10.1007/BF02804890; Eby LA, 2004, ESTUARIES, V27, P342, DOI 10.1007/BF02803390; Emslie MJ, 2008, MAR ECOL PROG SER, V371, P177, DOI 10.3354/meps07657; Fox RJ, 2008, CORAL REEFS, V27, P605, DOI 10.1007/s00338-008-0359-6; Froese F., 2009, FISHBASE; Glynn PW, 2014, MAR ECOL PROG SER, V495, P233, DOI 10.3354/meps10594; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Hinz H, 2009, ECOL APPL, V19, P761, DOI 10.1890/08-0351.1; Hirase S, 2016, MAR ECOL-EVOL PERSP, V37, P1161, DOI 10.1111/maec.12377; HIROSE T, 1974, Bulletin of Tohoku National Fisheries Research Institute, V33, P87; Kamimura Y, 2014, ICHTHYOL RES, V61, P108, DOI 10.1007/s10228-013-0381-8; Kanaya G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135125; Krishnankutty N, 2006, CURR SCI INDIA, V90, P772; Lefevre CD, 2015, MAR ECOL PROG SER, V537, P205, DOI 10.3354/meps11457; Lomovasky BJ, 2011, J SEA RES, V65, P205, DOI 10.1016/j.seares.2010.10.002; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Masuda R, 2008, ENVIRON BIOL FISH, V82, P387, DOI 10.1007/s10641-007-9300-z; Masuda R, 2010, FISH B-NOAA, V108, P162; Masuda R, 2009, HYDROBIOLOGIA, V616, P269, DOI 10.1007/s10750-008-9598-3; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Nakabo T., 2013, FISHES JAPAN PICTORI; Nakayama Kouji, 2013, Aquabiology (Tokyo), V35, P582; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Ohata R, 2011, FISHERIES SCI, V77, P207, DOI 10.1007/s12562-010-0320-9; Oksanen J., 2016, PACKAGE VEGAN; Paltzat DL, 2008, AQUACULTURE, V275, P124, DOI 10.1016/j.aquaculture.2007.12.014; Panchenko V.V., 2011, J ICHTHYOL+, V51, P217, DOI [10.1134/S0032945211010103, DOI 10.1134/S0032945211010103]; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Pommer CD, 2016, MAR ECOL PROG SER, V548, P47, DOI 10.3354/meps11649; Purcell SW, 2013, FISH FISH, V14, P34, DOI 10.1111/j.1467-2979.2011.00443.x; R Core Team, 2012, R LANG ENV STAT COMP; Sakurai M, 2010, B KAGOSHIMA JUNSHIN, V40, p67 ; Seike K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065417; Sekigawa Takeshi, 2002, Suisan Zoshoku, V50, P395; Shinomiya A, 1985, THESIS; SHIOGAKI M, 1981, JPN J ICHTHYOL, V28, P70; Shoji J, 2005, MAR BIOL, V147, P863, DOI 10.1007/s00227-005-1579-8; Shoji J, 2016, J OCEANOGR, V72, P91, DOI 10.1007/s10872-015-0311-7; Smith TM, 2016, MAR ECOL PROG SER, V542, P97, DOI 10.3354/meps11531; Takami H, 2013, FISH OCEANOGR, V22, P113, DOI 10.1111/fog.12008; TANNER JE, 1994, ECOLOGY, V75, P2204, DOI 10.2307/1940877; The 2011 Tohoku Earthquake Tsunami Joint Survey Group (TETJSG), 2011, J JAPAN SOC CIVIL B, V67, P63, DOI DOI 10.2208/KAIGAN.67.63; THISTLE D, 1981, MAR ECOL PROG SER, V6, P223, DOI 10.3354/meps006223; Urabe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062779; Whanpetch N, 2010, ESTUAR COAST SHELF S, V87, P246, DOI 10.1016/j.ecss.2010.01.001; Yamada Yuichiro, 2012, Aquabiology (Tokyo), V34, P556; YAMASHITA Y, 1984, B JPN SOC SCI FISH, V50, P189; Yatsuya K, 2008, J APPL PHYCOL, V20, P797, DOI 10.1007/s10811-007-9293-1; Yokoyama K, 2012, J JAPAN SOC CIVIL EN, V68, p1391 ; Yoshida G, 2001, FISHERIES SCI, V67, P1023, DOI 10.1046/j.1444-2906.2001.00357.x; Zama A., 2001, FISH FAUNA MIYAGI PR	58	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168261	10.1371/journal.pone.0168261	http://dx.doi.org/10.1371/journal.pone.0168261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942028	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600060
J	Wells, LJ; Gillespie, SM; Rotshtein, P				Wells, Laura Jean; Gillespie, Steven Mark; Rotshtein, Pia			Identification of Emotional Facial Expressions: Effects of Expression, Intensity, and Sex on Eye Gaze	PLOS ONE			English	Article							HUMAN AMYGDALA RESPONSES; PSYCHOPATHIC TRAITS; FACES; RECOGNITION; ATTENTION; FEAR; JUDGMENTS; GENDER; ACCURACY; AUTISM	The identification of emotional expressions is vital for social interaction, and can be affected by various factors, including the expressed emotion, the intensity of the expression, the sex of the face, and the gender of the observer. This study investigates how these factors affect the speed and accuracy of expression recognition, as well as dwell time on the two most significant areas of the face: the eyes and the mouth. Participants were asked to identify expressions from female and male faces displaying six expressions (anger, disgust, fear, happiness, sadness, and surprise), each with three levels of intensity (low, moderate, and normal). Overall, responses were fastest and most accurate for happy expressions, but slowest and least accurate for fearful expressions. More intense expressions were also classified most accurately. Reaction time showed a different pattern, with slowest response times recorded for expressions of moderate intensity. Overall, responses were slowest, but also most accurate, for female faces. Relative to male observers, women showed greater accuracy and speed when recognizing female expressions. Dwell time analyses revealed that attention to the eyes was about three times greater than on the mouth, with fearful eyes in particular attracting longer dwell times. The mouth region was attended to the most for fearful, angry, and disgusted expressions and least for surprise. These results extend upon previous findings to show important effects of expression, emotion intensity, and sex on expression recognition and gaze behaviour, and may have implications for understanding the ways in which emotion recognition abilities break down.	[Wells, Laura Jean; Gillespie, Steven Mark; Rotshtein, Pia] Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England	University of Birmingham	Gillespie, SM (corresponding author), Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England.	steven.gillespie@ncl.ac.uk		Rotshtein, Pia/0000-0002-0301-9511; Gillespie, Steven/0000-0001-7789-5381	Economic and Social Research Council [ES/L002337/1]; ESRC [ES/L002337/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	SMG and PR were supported by a research grant from by the Economic and Social Research Council [ES/L002337/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RB, 2015, EMOT REV, V7, P5, DOI 10.1177/1754073914544407; Adolphs R, 2004, J COGNITIVE NEUROSCI, V16, P453, DOI 10.1162/089892904322926782; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; BABCHUK WA, 1985, ETHOL SOCIOBIOL, V6, P89, DOI 10.1016/0162-3095(85)90002-0; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Becker DV, 2007, J PERS SOC PSYCHOL, V92, P179, DOI 10.1037/0022-3514.92.2.179; Bediou B, 2005, PSYCHIAT RES, V133, P149, DOI 10.1016/j.psychres.2004.08.008; Blair RJR, 2004, PERS INDIV DIFFER, V37, P1111, DOI 10.1016/j.paid.2003.10.008; Boraston Z, 2007, NEUROPSYCHOLOGIA, V45, P1501, DOI 10.1016/j.neuropsychologia.2006.11.010; Brody LR, 2016, HDB EMOTIONS, P369; Calder AJ, 2000, J EXP PSYCHOL HUMAN, V26, P527, DOI 10.1037/0096-1523.26.2.527; Calder AJ, 1996, VIS COGN, V3, P81, DOI 10.1080/713756735; Dadds MR, 2008, J AM ACAD CHILD PSY, V47, P455, DOI 10.1097/CHI.0b013e31816407f1; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Eisenbarth H, 2008, PSYCHIAT RES, V159, P189, DOI 10.1016/j.psychres.2007.09.001; Eisenbarth H, 2011, EMOTION, V11, P860, DOI 10.1037/a0022758; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; EKMAN P, 1993, AM PSYCHOL, V48, P384, DOI 10.1037/0003-066X.48.4.384; EKMAN P, 1992, PSYCHOL SCI, V3, P34, DOI 10.1111/j.1467-9280.1992.tb00253.x; EKMAN P, 1992, PSYCHOL REV, V99, P550, DOI 10.1037/0033-295X.99.3.550; Ekman P., 2003, ISHK, VReprint edition; Ekman P., 1974, CULTURE PERSONALITY, P8; Ekman P, 1971, NEBRASKA S MOTIVATIO, P207; Elfenbein HA, 2002, PSYCHOL BULL, V128, P203, DOI 10.1037//0033-2909.128.2.203; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Frith C, 2009, PHILOS T R SOC B, V364, P3453, DOI 10.1098/rstb.2009.0142; Gillespie SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143120; Gillespie SM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00552; Grimshaw GM, 2004, BRAIN COGNITION, V54, P248, DOI 10.1016/j.bandc.2004.02.029; Guo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042585; Hall JA, 2004, EMOTION, V4, P201, DOI 10.1037/1528-3542.4.2.201; HALL JA, 1978, PSYCHOL BULL, V85, P845, DOI 10.1037/0033-2909.85.4.845; Hall JK, 2010, COGNITION EMOTION, V24, P629, DOI 10.1080/02699930902906882; Hampson E, 2006, EVOL HUM BEHAV, V27, P401, DOI 10.1016/j.evolhumbehav.2006.05.002; Hess U, 1997, J NONVERBAL BEHAV, V21, P241, DOI 10.1023/A:1024952730333; Hoffmann H, 2010, ACTA PSYCHOL, V135, P278, DOI 10.1016/j.actpsy.2010.07.012; Horgan, 2000, GENDER EMOTION SOCIA, P97, DOI DOI 10.1017/CBO9780511628191.006; KIRITA T, 1995, ACTA PSYCHOL, V89, P149, DOI 10.1016/0001-6918(94)00021-8; KIROUAC G, 1983, PERCEPT MOTOR SKILL, V57, P683, DOI 10.2466/pms.1983.57.3.683; Kotsia I, 2008, IMAGE VISION COMPUT, V26, P1052, DOI 10.1016/j.imavis.2007.11.004; Le Gal PM, 2002, PERCEPT PSYCHOPHYS, V64, P230, DOI 10.3758/BF03195789; Leppanen JM, 2003, J PSYCHOPHYSIOL, V17, P113, DOI 10.1027//0269-8803.17.3.113; Loughland CM, 2002, BIOL PSYCHIAT, V52, P338, DOI 10.1016/S0006-3223(02)01356-2; Marsh AA, 2008, NEUROSCI BIOBEHAV R, V32, P454, DOI 10.1016/j.neubiorev.2007.08.003; Matsumoto D, 2001, ASIAN J SOC PSYCHOL, V4, P113, DOI 10.1111/j.1467-839X.2001.00080.x; Montagne Barbara, 2005, Cogn Process, V6, P136, DOI 10.1007/s10339-005-0050-6; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 2002, NEUROIMAGE, V17, P214, DOI 10.1006/nimg.2002.1220; Motley M, 1988, W J SPEECH COMMUN, V51, P1; Munoz LC, 2009, J AM ACAD CHILD PSY, V48, P554, DOI 10.1097/CHI.0b013e31819c2419; OHMAN A, 1995, J PSYCHOPHYSIOL, V9, P99; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Ohman A, 1993, HDB EMOTIONS, P511; Palermo R, 2004, BEHAV RES METH INS C, V36, P634, DOI 10.3758/BF03206544; Park B, 2005, PERS SOC PSYCHOL REV, V9, P108, DOI 10.1207/s15327957pspr0902_2; Pelphrey KA, 2002, J AUTISM DEV DISORD, V32, P249, DOI 10.1023/A:1016374617369; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Plant EA, 2004, SEX ROLES, V51, P187, DOI 10.1023/B:SERS.0000037762.10349.13; Rahman Q, 2004, BRAIN COGNITION, V54, P179, DOI 10.1016/j.bandc.2004.01.002; Rotshtein P, 2010, HUM BRAIN MAPP, V31, P1089, DOI 10.1002/hbm.20921; ROTTER NG, 1988, J NONVERBAL BEHAV, V12, P139, DOI 10.1007/BF00986931; Schmidt KL, 2001, YEARB PHYS ANTHROPOL, V44, P3, DOI 10.1002/ajpa.20001; Schurgin MW, 2014, J VISION, V14, DOI 10.1167/14.13.14; Smith DT, 2004, CURR BIOL, V14, P792, DOI 10.1016/j.cub.2004.04.035; Smith FW, 2009, PSYCHOL SCI, V20, P1202, DOI 10.1111/j.1467-9280.2009.02427.x; Smith ML, 2005, PSYCHOL SCI, V16, P184, DOI 10.1111/j.0956-7976.2005.00801.x; Sullivan S, 2007, J GERONTOL B-PSYCHOL, V62, pP53, DOI 10.1093/geronb/62.1.P53; Susskind JM, 2008, NAT NEUROSCI, V11, P843, DOI 10.1038/nn.2138; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; TUCKER JS, 1993, J NONVERBAL BEHAV, V17, P103, DOI 10.1007/BF01001959; TUCKER JS, 1988, J NONVERBAL BEHAV, V12, P87, DOI 10.1007/BF00986927; Vassallo S, 2009, J VISION, V9, DOI 10.1167/9.3.11; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Whalen PJ, 2001, EMOTION, V1, P70, DOI 10.1037/1528-3542.1.1.70; Whalen PJ, 2004, SCIENCE, V306, P2061, DOI 10.1126/science.1103617; Whalen PJ, 1998, J NEUROSCI, V18, P411; Zebrowitz LA, 2010, J PERS SOC PSYCHOL, V98, P175, DOI 10.1037/a0017990	79	80	83	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168307	10.1371/journal.pone.0168307	http://dx.doi.org/10.1371/journal.pone.0168307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27942030	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600064
J	Wiesmeier, M; Gautam, S; Kirschnek, S; Hacker, G				Wiesmeier, Michael; Gautam, Sanjivan; Kirschnek, Susanne; Haecker, Georg			Characterisation of Neutropenia-Associated Neutrophil Elastase Mutations in a Murine Differentiation Model In Vitro and In Vivo	PLoS One			English	Article							SEVERE CONGENITAL NEUTROPENIA; UNFOLDED PROTEIN RESPONSE; PLURIPOTENT STEM-CELLS; CYCLIC NEUTROPENIA; CATHEPSIN-G; ELANE MUTATIONS; MICE; APOPTOSIS; GLUCOSE-6-PHOSPHATASE-BETA; GRANULOPOIESIS	Severe congenital neutropenia (SCN) is characterised by a differentiation block in the bone marrow and low neutrophil numbers in the peripheral blood, which correlates with increased risk of bacterial infections. Several underlying gene defects have been identified in SCN patients. Mutations in the neutrophil elastase (ELANE) gene are frequently found in SCN and cyclic neutropenia. Both mislocalization and misfolding of mutant neutrophil elastase protein resulting in ER stress and subsequent induction of the unfolded protein response (UPR) have been proposed to be responsible for neutrophil survival and maturation defects. However, the detailed molecular mechanisms still remain unclear, in part due to the lack of appropriate in vitro and in vivo models. Here we used a system of neutrophil differentiation from immortalised progenitor lines by conditional expression of Hoxb8, permitting the generation of mature near-primary neutrophils in vitro and in vivo. NE-deficient Hoxb8 progenitors were reconstituted with murine and human forms of typical NE mutants representative of SCN and cyclic neutropenia, and differentiation of the cells was analysed in vitro and in vivo. ER stress induction by NE mutations could be recapitulated during neutrophil differentiation in all NE mutant-reconstituted Hoxb8 cells. Despite ER stress induction, no change in survival, maturation or function of differentiating cells expressing either murine or human NE mutants was observed. Further analysis of in vivo differentiation of Hoxb8 cells in a murine model of adoptive transfer did not reveal any defects in survival or differentiation in the mouse. Although the Hoxb8 system has been found to be useful for dissection of defects in neutrophil development, our findings indicate that the use of murine systems for analysis of NE-mutation-associated pathogenesis is complicated by differences between humans and mice in the physiology of granulopoiesis, which may go beyond possible differences in expression and activity of neutrophil elastase itself.	[Wiesmeier, Michael; Gautam, Sanjivan; Kirschnek, Susanne; Haecker, Georg] Univ Freiburg, Inst Med Microbiol & Hyg, Med Ctr, Fac Med, Freiburg, Germany; [Gautam, Sanjivan] Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany; [Gautam, Sanjivan] Univ Freiburg, Fac Biol, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Kirschnek, S (corresponding author), Univ Freiburg, Inst Med Microbiol & Hyg, Med Ctr, Fac Med, Freiburg, Germany.	susanne.kirschnek@uniklinik-freiburg.de			MOTI-VATE Promotionskolleg der Medizinischen Fakultat Freiburg - Else Kroner Fresenius-Stiftung	MOTI-VATE Promotionskolleg der Medizinischen Fakultat Freiburg - Else Kroner Fresenius-Stiftung	MW was supported the MOTI-VATE Promotionskolleg der Medizinischen Fakultat Freiburg funded by Else Kroner Fresenius-Stiftung (https://www.uniklinik-freiburg.de/medizin2/motivate.html; http://www.ekfs.de/de/wissenschaftliche-foerderung/nachwuchsfoerderung/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson KF, 2003, NAT GENET, V35, P90, DOI 10.1038/ng1224; Boztug K, 2009, NEW ENGL J MED, V360, P32, DOI 10.1056/NEJMoa0805051; Chao JR, 2008, NATURE, V452, P98, DOI 10.1038/nature06604; Cheung YY, 2007, J CLIN INVEST, V117, P784, DOI 10.1172/JCI30443; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; Endo M, 2005, J BIOCHEM, V138, P501, DOI 10.1093/jb/mvi143; Gautam S, 2013, CELL DEATH DIFFER, V20, P1068, DOI 10.1038/cdd.2013.39; Germeshausen M, 2013, HUM MUTAT, V34, P905, DOI 10.1002/humu.22308; Grenda DS, 2007, BLOOD, V110, P4179, DOI 10.1182/blood-2006-11-057299; Grenda DS, 2002, BLOOD, V100, P3221, DOI 10.1182/blood-2002-05-1372; Hiramoto T, 2013, P NATL ACAD SCI USA, V110, P3023, DOI 10.1073/pnas.1217039110; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Horwitz MS, 2007, BLOOD, V109, P1817, DOI 10.1182/blood-2006-08-019166; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kirschnek S, 2011, CELL DEATH DIFFER, V18, P1805, DOI 10.1038/cdd.2011.69; Klein C, 2007, NAT GENET, V39, P86, DOI 10.1038/ng1940; Klein C, 2011, ANNU REV IMMUNOL, V29, P399, DOI 10.1146/annurev-immunol-030409-101259; Kollner I, 2006, BLOOD, V108, P493, DOI 10.1182/blood-2005-11-4689; Korkmaz B, 2005, J IMMUNOL, V175, P3329, DOI 10.4049/jimmunol.175.5.3329; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Li FQ, 2001, J BIOL CHEM, V276, P14230, DOI 10.1074/jbc.M010279200; Massullo P, 2005, BLOOD, V105, P3397, DOI 10.1182/blood-2004-07-2618; Morishima T, 2014, HAEMATOLOGICA, V99, P19, DOI 10.3324/haematol.2013.083873; Nanua S, 2011, BLOOD, V117, P3539, DOI 10.1182/blood-2010-10-311704; Nayak RC, 2015, J CLIN INVEST, V125, P3103, DOI 10.1172/JCI80924; Newburger PE, 2010, PEDIATR BLOOD CANCER, V55, P314, DOI 10.1002/pbc.22537; Owen CA, 1997, AM J PHYSIOL-LUNG C, V272, pL385, DOI 10.1152/ajplung.1997.272.3.L385; OWEN CA, 1995, J CELL BIOL, V131, P775, DOI 10.1083/jcb.131.3.775; Pannicke U, 2009, NAT GENET, V41, P101, DOI 10.1038/ng.265; Person RE, 2003, NAT GENET, V34, P308, DOI 10.1038/ng1170; Redecke V, 2013, NAT METHODS, V10, P795, DOI [10.1038/nmeth.2510, 10.1038/NMETH.2510]; Skokowa J, 2006, NAT MED, V12, P1191, DOI 10.1038/nm1484; Skokowa J, 2009, ANN NY ACAD SCI, V1176, P94, DOI 10.1111/j.1749-6632.2009.04963.x; Tidwell T, 2014, BLOOD, V123, P562, DOI 10.1182/blood-2013-07-513242; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865; Xia J, 2008, CURR OPIN HEMATOL, V15, P1, DOI 10.1097/MOH.0b013e3282f13cd2	37	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168055	10.1371/journal.pone.0168055	http://dx.doi.org/10.1371/journal.pone.0168055			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942017	gold, Green Published, Green Submitted			2022-12-27	WOS:000392745600049
J	du Plessis, J; Korf, H; van Pelt, J; Windmolders, P; Vander Elst, I; Verrijken, A; Hubens, G; Van Gaal, L; Cassiman, D; Nevens, F; Francque, S; van der Merwe, S				du Plessis, Johannie; Korf, Hannelie; van Pelt, Jos; Windmolders, Petra; Vander Elst, Ingrid; Verrijken, An; Hubens, Guy; Van Gaal, Luc; Cassiman, David; Nevens, Frederik; Francque, Sven; van der Merwe, Schalk			Pro-Inflammatory Cytokines but Not Endotoxin-Related Parameters Associate with Disease Severity in Patients with NAFLD	PLoS One			English	Article							FATTY LIVER-DISEASE; TOLL-LIKE RECEPTORS; NONALCOHOLIC STEATOHEPATITIS; GUT MICROBIOTA; INSULIN-RESISTANCE; INTESTINAL PERMEABILITY; GENE-EXPRESSION; OBESITY; MICE; PATHOGENESIS	Intestinal dysbiosis and elevated lipopolysaccharides (LPS) levels have been implicated in the development of obesity, insulin resistance and non-alcoholic steatohepatitis (NASH). In order to determine if LPS levels are elevated in patients with NASH compared to patients with non-alcoholic fatty liver (NAFL) and, if elevated LPS levels correlated with histological severity of non-alcoholic fatty liver disease (NAFLD) we compared LPS, markers of LPS bioactivity and pro-inflammatory cytokines/chemokines in patients undergoing bariatric surgery. At the time of surgery a liver biopsy was taken allowing the stratification into well-delineated subgroups including: No NAFL/NAFL; NASH; NASH with fibrosis and NASH cirrhotics, using the NAFLD Activity Score (NAS). Anthropometric data and plasma were collected for assessment of LPS, lipopolysaccharide binding protein (LBP), soluble CD14 (sCD14), intestinal-type fatty acid binding protein (iFABP), Toll-like receptors 2 and 4 (TLR2, 4) and a panel of cytokines/chemokines. Similar analysis was performed on plasma from a cohort of healthy controls. Our data indicate elevated levels of LPS, LBP, sCD14, iFABP and TLR2,4 in obese patients compared to healthy controls, however, these parameters remained unaltered within patients with limited liver disease (NAFL) compared to NASH/NASH with fibrosis subgroups. Hierarchic cluster analysis using endotoxin-related parameters failed to discriminate between lean controls, NAFLD. While similar cluster analysis implementing inflammation-related parameters clearly distinguished lean controls, NALFD subgroups and NASH cirrhotics. In addition, LPS levels was not associated with disease severity while TNF alpha, IL8, and CCL3 featured a clear correlation with transaminase levels and the histological severity of NALFD. In conclusion our data indicate a stronger correlation for circulating inflammatory-rather than endotoxin-related parameters in progression of NAFLD and highlights the need for additional larger studies in unravelling further mechanistic insights.	[du Plessis, Johannie; Korf, Hannelie; van Pelt, Jos; Windmolders, Petra; Vander Elst, Ingrid; Cassiman, David; Nevens, Frederik; van der Merwe, Schalk] Katholieke Univ Leuven, Dept Clin & Expt Med, Lab Hepatol, Leuven, Belgium; [Korf, Hannelie] Katholieke Univ Leuven, Dept Clin & Expt Med, Translat Res Ctr Gastrointestinal Disorders TARGI, Leuven, Belgium; [Verrijken, An] Univ Antwerp, Univ Antwerp Hosp, Dept Endocrinol Diabetol & Metab, Antwerp, Belgium; [Hubens, Guy] Univ Antwerp, Univ Antwerp Hosp, Dept Abdominal Surg, Antwerp, Belgium; [Van Gaal, Luc; Francque, Sven] Univ Antwerp, Univ Antwerp Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium; [Cassiman, David; Nevens, Frederik; van der Merwe, Schalk] Katholieke Univ Leuven, Div Liver & Biliopancreat Disorders, Dept Internal Med, Leuven, Belgium	KU Leuven; KU Leuven; University of Antwerp; University of Antwerp; University of Antwerp; KU Leuven	van der Merwe, S (corresponding author), Katholieke Univ Leuven, Dept Clin & Expt Med, Lab Hepatol, Leuven, Belgium.; van der Merwe, S (corresponding author), Katholieke Univ Leuven, Div Liver & Biliopancreat Disorders, Dept Internal Med, Leuven, Belgium.	schalk.vandermerwe@uzleuven.be	; Cassiman, David/H-6813-2014	Van der Merwe, Schalk/0000-0002-9891-2686; Cassiman, David/0000-0002-6154-0970; Korf, Hannelie/0000-0003-3540-0138; van Pelt, Jos/0000-0001-6903-4338	Flanders fund for scientific research (FWO klinisch mandaat); FWO; European Union [LSHM-CT-2005-018734, 305707]; European Association	Flanders fund for scientific research (FWO klinisch mandaat)(FWO); FWO(FWO); European Union(European Commission); European Association	Schalk van der Merwe, Frederik Nevens, David Cassiman and Sven Francque are recipients of Flanders fund for scientific research (FWO klinisch mandaat). Hannelie Korf is a recipient of FWO post-doctoral mandate. Research at the department of Endocrinology, Diabetology and Metabolism and the department of Gastroenterology and Hepatology of the Antwerp University Hospital (Belgium) was supported by the European Union: FP6 (HEPADIP Contract LSHM-CT-2005-018734) and FP7-HEALTH (RESOLVE nr. 305707). Johannie du Plessis is a recipient of an European Association for the Study of the Liver (EASL) scholarship.	Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; DeMinicis S, 2014, HEPATOLOGY, V59, P1738, DOI 10.1002/hep.26695; du Plessis J, 2015, GASTROENTEROLOGY, V149, P635, DOI 10.1053/j.gastro.2015.05.044; Du Plessis J, 2013, J HEPATOL, V58, P1125, DOI 10.1016/j.jhep.2013.01.038; Engstler AJ, 2016, GUT, V65, P1564, DOI 10.1136/gutjnl-2014-308379; Francque SMA, 2012, CLIN GASTROENTEROL H, V10, P1162, DOI 10.1016/j.cgh.2012.06.019; Garcia-Martinez I, 2016, J CLIN INVEST, V126, P859, DOI 10.1172/JCI83885; Gonzalez-Quintela A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054600; Harte AL, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-15; Heinrichs D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066106; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim JS, 2012, PEDIATR OBES, V7, P158, DOI 10.1111/j.2047-6310.2011.00014.x; Le Roy T, 2013, GUT, V62, P1787, DOI 10.1136/gutjnl-2012-303816; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Miele L, 2009, HEPATOLOGY, V49, P1877, DOI 10.1002/hep.22848; Moschen AR, 2013, TRENDS ENDOCRIN MET, V24, P537, DOI 10.1016/j.tem.2013.05.009; Mouzaki M, 2013, HEPATOLOGY, V58, P120, DOI 10.1002/hep.26319; Musso G, 2010, CURR OPIN LIPIDOL, V21, P76, DOI 10.1097/MOL.0b013e3283347ebb; Ogawa Y, 2013, PLOS ONE, V7; Phillips CM, 2013, REV ENDOCR METAB DIS, V14, P219, DOI 10.1007/s11154-013-9252-x; Ruiz AG, 2007, OBES SURG, V17, P1374; Sandler NG, 2011, GASTROENTEROLOGY, V141, P1220, DOI 10.1053/j.gastro.2011.06.063; Spruss A, 2009, HEPATOLOGY, V50, P1094, DOI 10.1002/hep.23122; Testro AG, 2009, J GASTROEN HEPATOL, V24, P943, DOI 10.1111/j.1440-1746.2009.05854.x; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Verdam FJ, 2011, J CLIN GASTROENTEROL, V45, P149, DOI 10.1097/MCG.0b013e3181e12c24; Verrijken A, 2014, HEPATOLOGY, V59, P121, DOI 10.1002/hep.26510; Wigg AJ, 2001, GUT, V48, P206, DOI 10.1136/gut.48.2.206; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Yuan JY, 2014, J GASTROEN HEPATOL, V29, P1292, DOI 10.1111/jgh.12510; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093	39	42	42	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0166048	10.1371/journal.pone.0166048	http://dx.doi.org/10.1371/journal.pone.0166048			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992443	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600008
J	Liu, B; Cai, JH; Zhu, J; Zheng, HL; Zhang, Y; Wang, LL				Liu, Bo; Cai, Jinhua; Zhu, Jin; Zheng, Helin; Zhang, Yun; Wang, Longlun			Diffusion Tensor Imaging for Evaluating Biliary Atresia in Infants and Neonates	PLOS ONE			English	Article							LIVER FIBROSIS; CIRRHOTIC SEVERITY; WEIGHTED MRI; DIAGNOSIS; QUANTIFICATION; INDEXES	Background Preliminary studies have shown that diffusion tensor imaging (DTI) is helpful in evaluating liver disorders. However, there is no published literature on the use of DTI in the diagnosis of biliary atresia (BA). This study aimed to investigate the diagnostic value of the liver average apparent diffusion coefficient (ADC) and fractional anisotropy (FA) measured using DTI for BA in neonates and infants. Methods Fifty-nine patients with infant jaundice were included in this study. DTI was performed with b factors of 0 and 1000 s/mm(2). Liver fibrosis in the BA group was determined and graded (F0, F1, F2, F3, F4) based on the pathological findings. Statistical analyses were performed to determine the diagnostic accuracy of DTI for BA. Results The ADC value was significantly lower in the BA group [(1.262 +/- 0.127) x10(-3) mm(2)/s] than in the non-BA group [(1.430 +/- 0.149) x10(-3) mm(2)/s, (P<0.001)]. The area under the receiver operating characteristic curve was 0.805 +/- 0.058 (P<0.001) for ADC. With a cut-off value of 1.317x10(-3) mm(2)/s, ADC achieved a sensitivity of 75% and a specificity of 81.5% for the differential diagnosis of BA and non-BA. In the BA group, the ADC value was significantly correlated with fibrotic stage. Further analysis showed that the ADC value of stage F0 was significantly higher than that of stages F1, F2, F3 and F4, whereas there were no significant differences among stages F1, F2, F3 and F4. Conclusion Hepatic ADC measured with DTI can be used as an adjunct to other noninvasive imaging methods in the differential diagnosis of BA and non-BA. ADC was helpful in detecting liver fibrosis but not in differentiating the fibrotic grades.	[Liu, Bo; Cai, Jinhua; Zheng, Helin; Zhang, Yun; Wang, Longlun] Chongqing Med Univ, Childrens Hosp, Dept Radiol, Chongqing, Peoples R China; [Zhu, Jin] Chongqing Med Univ, Childrens Hosp, Dept Pathol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Cai, JH (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Radiol, Chongqing, Peoples R China.	cai_jinhua@126.com		Cai, Jinhua/0000-0001-7971-8936				Aube C, 2004, J RADIOL, V85, P301; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bulow R, 2013, EUR RADIOL, V23, P1281, DOI 10.1007/s00330-012-2700-2; Chen L, 2015, ONCOTARGET, V6, P42530, DOI 10.18632/oncotarget.6466; Chen X, 2014, RADIOLOGY, V271, P113, DOI 10.1148/radiol.13131572; Cheung JS, 2010, J MAGN RESON IMAGING, V32, P1141, DOI 10.1002/jmri.22367; Dedic T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143939; Do RKG, 2010, AM J ROENTGENOL, V195, P671, DOI 10.2214/AJR.09.3448; HARBIN WP, 1980, RADIOLOGY, V135, P273, DOI 10.1148/radiology.135.2.7367613; Hsiao CH, 2008, HEPATOLOGY, V47, P1233, DOI 10.1002/hep.22182; Hwang SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149681; Ichikawa T, 1998, AM J ROENTGENOL, V170, P397, DOI 10.2214/ajr.170.2.9456953; Khalil BA, 2010, EUR J PEDIATR, V169, P395, DOI 10.1007/s00431-009-1125-7; Kim T, 1999, AM J ROENTGENOL, V173, P393, DOI 10.2214/ajr.173.2.10430143; Koinuma M, 2005, J MAGN RESON IMAGING, V22, P80, DOI 10.1002/jmri.20344; Lee Y, 2015, MAGN RESON MED, V73, P1602, DOI 10.1002/mrm.25253; Lewin M, 2007, HEPATOLOGY, V46, P658, DOI 10.1002/hep.21747; Lien TH, 2011, HEPATOLOGY, V53, P202, DOI 10.1002/hep.24023; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088268; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Mo YH, 2012, J FORMOS MED ASSOC, V111, P482, DOI 10.1016/j.jfma.2011.06.024; Mo YH, 2011, EUR J RADIOL, V80, pE253, DOI 10.1016/j.ejrad.2010.11.002; Peng SSF, 2015, EUR RADIOL, V25, P2992, DOI 10.1007/s00330-015-3716-1; Peng SSF, 2014, J PEDIATR GASTR NUTR, V59, P403, DOI 10.1097/MPG.0000000000000433; Perman William H, 2009, Top Magn Reson Imaging, V20, P99, DOI 10.1097/RMR.0b013e3181c0d772; Poyraz AK, 2012, J MAGN RESON IMAGING, V35, P1108, DOI 10.1002/jmri.23519; Shen QL, 2015, WORLD J GASTROENTERO, V21, P6931, DOI 10.3748/wjg.v21.i22.6931; Taouli B, 2007, AM J ROENTGENOL, V189, P799, DOI 10.2214/AJR.07.2086; Tosun M, 2013, EUR J RADIOL, V82, P203, DOI 10.1016/j.ejrad.2012.09.009; Wang J, 2015, ONCOTARGET, V6, P7325, DOI 10.18632/oncotarget.2621; Wang WL, 2015, ONCOTARGET, V6, P20252, DOI 10.18632/oncotarget.3857; Wang Yi, 2011, AJR Am J Roentgenol, V196, P553, DOI 10.2214/AJR.10.4580; Yang CT, 2011, ASIAN J SURG, V34, P168, DOI 10.1016/j.asjsur.2011.11.006	36	3	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168477	10.1371/journal.pone.0168477	http://dx.doi.org/10.1371/journal.pone.0168477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992499	Green Published, gold, Green Submitted			2022-12-27	WOS:000392842600065
J	Corley, SM; Tsai, SY; Wilkins, MR; Weickert, CS				Corley, Susan M.; Tsai, Shan-Yuan; Wilkins, Marc R.; Weickert, Cynthia Shannon			Transcriptomic Analysis Shows Decreased Cortical Expression of NR4A1, NR4A2 and RXRB in Schizophrenia and Provides Evidence for Nuclear Receptor Dysregulation	PLOS ONE			English	Article							RETINOIC-ACID-RECEPTOR; DORSOLATERAL PREFRONTAL CORTEX; ESTROGEN-RECEPTOR; MESSENGER-RNA; NGFI-B; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; X-RECEPTOR; TUMOR INITIATION; SPLICE VARIANT	Many genes are differentially expressed in the cortex of people with schizophrenia, implicating factors that control transcription more generally. Hormone nuclear receptors dimerize to coordinate context-dependent changes in gene expression. We hypothesized that members of two families of nuclear receptors (NR4As), and retinoid receptors (RARs and RXRs), are altered in the dorsal lateral prefrontal cortex (DLPFC) of people with schizophrenia. We used next generation sequencing and then qPCR analysis to test for changes in mRNA levels for transcripts encoding nuclear receptors: orphan nuclear receptors (3 in the NR4A, 3 in the RAR, 3 in the RXR families and KLF4) in total RNA extracted from the DLPFC from people with schizophrenia compared to controls (n = 74). We also correlated mRNA levels with demographic factors and with estimates of antipsychotic drug exposure (schizophrenia group only). We tested for correlations between levels of transcription factor family members and levels of genes putatively regulated by these transcription factors. We found significantly down regulated expression of NR4A1 (Nurr 77) and KLF4 mRNAs in people with schizophrenia compared to controls, by both NGS and qPCR (p = or < 0.01). We also detected decreases in NR4A2 (Nurr1) and RXRB mRNAs by using qPCR in the larger cohort (p< 0.05 and p< 0.01, respectively). We detected decreased expression of RARG and NR4A2 mRNAs in females with schizophrenia (p< 0.05). The mRNA levels of NR4A1, NR4A2 and NR4A3 were all negative correlated with lifetime estimates of antipsychotic exposure. These novel findings, which may be influenced by antipsychotic drug exposure, implicate the orphan and retinoid nuclear receptors in the cortical pathology found in schizophrenia. Genes down stream of these receptors can be dysregulated as well, but the direction of change is not immediately predictable based on the putative transcription factor changes.	[Corley, Susan M.; Wilkins, Marc R.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Syst Biol Initiat, Sydney, NSW, Australia; [Tsai, Shan-Yuan; Weickert, Cynthia Shannon] Schizophrenia Res Inst, Randwick, NSW, Australia; [Tsai, Shan-Yuan; Weickert, Cynthia Shannon] Neurosci Res Australia, Randwick, NSW, Australia; [Tsai, Shan-Yuan; Weickert, Cynthia Shannon] Univ New South Wales Sydney, Sch Psychiat, Sydney, NSW, Australia	University of New South Wales Sydney; Neuroscience Research Australia; University of New South Wales Sydney	Corley, SM (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Syst Biol Initiat, Sydney, NSW, Australia.	s.corley@unsw.edu.au	Corley, Susan/R-6407-2019	Corley, Susan/0000-0003-0605-6411; Shannon Weickert, Cynthia/0000-0002-4560-0259	Australian Federal Government; NCRIS; New South Wales State Government Science Leveraging Fund; Research Attraction and Acceleration Program; University of New South Wales; Schizophrenia Research Institute (NSW Ministry of Health); Schizophrenia Research Institute (Macquarie Group Foundation); Neuroscience Research Australia; National Health and Medical Research Council (Australia) Senior Research Fellowship [1021970]; Australia Project Grant [568807]; Cowled Postgraduate Research Scholarship in Brain Research; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA)) [R28AA012725]; Lundbeck Australia Advisory Board; Astellas Pharma Inc., Japan; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725] Funding Source: NIH RePORTER	Australian Federal Government(Australian Government); NCRIS(Australian GovernmentDepartment of Industry, Innovation and Science); New South Wales State Government Science Leveraging Fund; Research Attraction and Acceleration Program; University of New South Wales; Schizophrenia Research Institute (NSW Ministry of Health); Schizophrenia Research Institute (Macquarie Group Foundation); Neuroscience Research Australia; National Health and Medical Research Council (Australia) Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australia Project Grant; Cowled Postgraduate Research Scholarship in Brain Research; Schizophrenia Research Institute; National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA))(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Lundbeck Australia Advisory Board; Astellas Pharma Inc., Japan(Astellas Pharmaceuticals); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	MRW and SC acknowledge support from the Australian Federal Government's Super Science and NCRIS Schemes, from the New South Wales State Government Science Leveraging Fund and Research Attraction and Acceleration Program and from the University of New South Wales. This work was supported by Schizophrenia Research Institute (utilizing infrastructure funding from the NSW Ministry of Health and the Macquarie Group Foundation), the University of New South Wales, and Neuroscience Research Australia. CSW is a recipient of a National Health and Medical Research Council (Australia) Senior Research Fellowship (#1021970) Australia Project Grant No. 568807. Shan-Yuan Tsai is supported by The Cowled Postgraduate Research Scholarship in Brain Research. Tissues were received from the New South Wales Brain Tissue Resource Centre at the University of Sydney which is supported by the Schizophrenia Research Institute and National Institute of Alcohol Abuse and Alcoholism (NIH (NIAAA) R28AA012725). The authors received additional funding from the Lundbeck Australia Advisory Board and Astellas Pharma Inc., Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnisalo P, 2002, J BIOL CHEM, V277, P35118, DOI 10.1074/jbc.M201707200; Allen KM, 2016, AUST NZ J PSYCHIAT, V50, P473, DOI 10.1177/0004867415589793; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beaudry G, 2000, J NEUROCHEM, V75, P1694, DOI 10.1046/j.1471-4159.2000.0751694.x; Bertolino A, 2009, BRAIN, V132, P417, DOI 10.1093/brain/awn248; Biddie SC, 2010, TRENDS ENDOCRIN MET, V21, P3, DOI 10.1016/j.tem.2009.08.006; Bobes Julio, 2007, Dialogues Clin Neurosci, V9, P215; Chao LC, 2012, J LIPID RES, V53, P2610, DOI 10.1194/jlr.M029355; Cohen O, 2015, MOL PSYCHIAT; Ethier I, 2004, NEUROPSYCHOPHARMACOL, V29, P335, DOI 10.1038/sj.npp.1300318; Fillman SG, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.8; Fillman SG, 2013, MOL PSYCHIATR, V18, P206, DOI 10.1038/mp.2012.110; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 2000, CANCER RES, V60, P6488; Gilbert F, 2006, BIOL PSYCHIAT, V60, P538, DOI 10.1016/j.biopsych.2006.04.023; Goodman AB, 1998, P NATL ACAD SCI USA, V95, P7240, DOI 10.1073/pnas.95.13.7240; Hawk JD, 2011, BRAIN RES BULL, V85, P21, DOI 10.1016/j.brainresbull.2011.02.001; Hawk JD, 2012, J CLIN INVEST, V122, P3593, DOI 10.1172/JCI64145; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Huang CC, 2005, CANCER BIOL THER, V4, P1401, DOI 10.4161/cbt.4.12.2355; Jagannathan V, 2011, MOL CELL ENDOCRINOL, V334, P91, DOI 10.1016/j.mce.2010.06.012; Jiang W, 2009, CANCER BIOL THER, V8, P285, DOI 10.4161/cbt.8.3.7486; Kaalund SS, 2014, MOL PSYCHIATR, V19, P1258, DOI 10.1038/mp.2013.165; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; Kempermann G, 2008, CURR OPIN PSYCHIATR, V21, P290, DOI 10.1097/YCO.0b013e3282fad375; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klinge CM, 1997, NUCLEIC ACIDS RES, V25, P1903, DOI 10.1093/nar/25.10.1903; Kozlovsky N, 2004, J NEURAL TRANSM, V111, P1583, DOI 10.1007/s00702-004-0166-3; Krezel W, 1999, NEUROSCIENCE, V89, P1291, DOI 10.1016/S0306-4522(98)00342-X; Krezel W, 1998, SCIENCE, V279, P863, DOI 10.1126/science.279.5352.863; Kuzawa CW, 2014, P NATL ACAD SCI USA, V111, P13010, DOI 10.1073/pnas.1323099111; Laganiere J, 2005, MOL ENDOCRINOL, V19, P1584, DOI 10.1210/me.2005-0040; Langlois MC, 2001, NEUROSCIENCE, V106, P117, DOI 10.1016/S0306-4522(01)00248-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee SK, 1998, MOL ENDOCRINOL, V12, P1184, DOI 10.1210/me.12.8.1184; Lee YM, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/210604; Lefebvre P, VITAMINS HORMONES, P199; Lefebvre P, 2010, TRENDS ENDOCRIN MET, V21, P676, DOI 10.1016/j.tem.2010.06.009; Levesque D, 2007, TRENDS NEUROSCI, V30, P22, DOI 10.1016/j.tins.2006.11.006; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu M, 2005, ONCOGENE, V24, P4362, DOI 10.1038/sj.onc.1208661; Maheux J, 2005, J PHARMACOL EXP THER, V313, P460, DOI 10.1124/jpet.104.080184; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Nunez SB, RECENT PROGR HORMONE, V50, P409; Paillasse MR, 2015, MED HYPOTHESES, V84, P135, DOI 10.1016/j.mehy.2014.12.003; Pearen MA, 2013, MOL ENDOCRINOL, V27, P1897, DOI 10.1210/me.2013-1205; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Perlman WR, 2004, BIOL PSYCHIAT, V56, P844, DOI 10.1016/j.biopsych.2004.09.006; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Peters R, 2006, POSTGRAD MED J, V82, P84, DOI 10.1136/pgmj.2005.036665; Pols TWH, 2008, PIGM CELL MELANOMA R, V21, P342, DOI 10.1111/j.1755-148X.2008.00469.x; Qin S, 2012, MOL CELL BIOL, V32, P4297, DOI 10.1128/MCB.00838-12; Qin S, 2011, P NATL ACAD SCI USA, V108, P21117, DOI 10.1073/pnas.1112351109; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Ross-Innes CS, 2010, GENE DEV, V24, P171, DOI 10.1101/gad.552910; Rousseau C, 2003, J STEROID BIOCHEM, V86, P1, DOI 10.1016/S0960-0760(03)00255-3; Sacchetti P, 2002, J BIOL CHEM, V277, P35088, DOI 10.1074/jbc.M205816200; SEGARS JH, 1993, MOL CELL BIOL, V13, P2258, DOI 10.1128/MCB.13.4.2258; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Serretti A, 2004, CURR MED CHEM, V11, P343, DOI 10.2174/0929867043456043; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi JH, 2012, J BIOL CHEM, V287, P10799, DOI 10.1074/jbc.M111.321836; Sinclair D, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-84; Sinclair D, 2011, NEUROPSYCHOPHARMACOL, V36, P2698, DOI 10.1038/npp.2011.160; Smith AG, 2008, J BIOL CHEM, V283, P12564, DOI 10.1074/jbc.M800480200; Song MR, 1998, BIOCHEM J, V336, P711, DOI 10.1042/bj3360711; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Webster MJ, 2002, MOL PSYCHIATR, V7, P985, DOI 10.1038/sj.mp.4001139; Weickert CS, 2003, MOL PSYCHIATR, V8, P592, DOI 10.1038/sj.mp.4001308; Weickert CS, 2008, HUM MOL GENET, V17, P2293, DOI 10.1093/hmg/ddn130; Weickert CS, 2010, AUST NZ J PSYCHIAT, V44, P59, DOI 10.3109/00048670903393662; Wong J, 2009, J BIOL CHEM, V284, P18824, DOI 10.1074/jbc.M109.013243; Xing GQ, 2006, SCHIZOPHR RES, V84, P36, DOI 10.1016/j.schres.2005.11.006; Yu F, 2011, ONCOGENE, V30, P2161, DOI 10.1038/onc.2010.591; Zetterstrom RH, 1996, MOL ENDOCRINOL, V10, P1656, DOI 10.1210/me.10.12.1656; Zheng B, 2009, J BIOL CHEM, V284, P22773, DOI 10.1074/jbc.M109.026989	79	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0166944	10.1371/journal.pone.0166944	http://dx.doi.org/10.1371/journal.pone.0166944			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992436	Green Published, gold, Green Submitted			2022-12-27	WOS:000392758000011
J	Chen, CC; Liang, CJ; Leu, YL; Chen, YL; Wang, SH				Chen, Chin-Chuan; Liang, Chan-Jung; Leu, Yann-Lii; Chen, Yuh-Lien; Wang, Shu-Huei			Viscolin Inhibits In Vitro Smooth Muscle Cell Proliferation and Migration and Neointimal Hyperplasia In Vivo	PLOS ONE			English	Article							MYELOLEUKEMIC U937 CELLS; II-INDUCED APOPTOSIS; POTENT ANTIINFLAMMATORY AGENT; ENDOTHELIAL PROGENITOR CELLS; ACTIVATED PROTEIN-KINASE; LECTIN-INDUCED APOPTOSIS; KAPPA-B; HEPATOCARCINOMA CELLS; VISCUM-COLORATUM; SUPEROXIDE ANION	Viscolin, an extract of Viscum coloratum, has anti-inflammatory and anti-proliferative properties against harmful stimuli. The aim of the study was to examine the anti-proliferative effects of viscolin on platelet derived growth factor-BB (PDGF)-treated human aortic smooth muscle cells (HASMCs) and identify the underlying mechanism responsible for these effects. Viscolin reduced the PDGF-BB-induced HASMC proliferation and migration in vitro; it also arrested HASMCs in the G0/G1 phase by decreasing the protein expression of Cyclin D1, CDK2, Cyclin E, CDK4, and p21(Cip1) as detected by Western blot analysis. These effects may be mediated by reduced PDGF-induced phosphorylation of ERK1/2, JNK, and P38, but not AKT as well as inhibition of PDGF-mediated nuclear factor (NF)-kappa B p65 and activator protein 1 (AP-1)/c-fos activation. Furthermore, viscolin pre-treatment significantly reduced neointimal hyperplasia of an endothelial-denuded femoral artery in vivo. Taken together, viscolin attenuated PDGF-BB-induced HASMC proliferation in vitro and reduced neointimal hyperplasia in vivo. Thus, viscolin may represent a therapeutic candidate for the prevention and treatment of vascular proliferative diseases.	[Chen, Chin-Chuan; Leu, Yann-Lii] Chang Gung Univ, Grad Inst Nat Prod, Taoyuan, Taiwan; [Chen, Chin-Chuan; Leu, Yann-Lii] Chang Gung Univ, Hlth Aging Res Ctr, Chinese Herbal Med Res Team, Taoyuan, Taiwan; [Chen, Chin-Chuan] Chang Gung Mem Hosp, Tissue Bank, Taoyuan, Taiwan; [Liang, Chan-Jung] Kaohsiung Med Univ, CLGR, Kaohsiung, Taiwan; [Liang, Chan-Jung] Kaohsiung Med Univ Hosp, CLB, Kaohsiung, Taiwan; [Leu, Yann-Lii] Chang Gung Mem Hosp, Ctr Tradit Chinese Med, Taoyuan, Taiwan; [Chen, Yuh-Lien; Wang, Shu-Huei] Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chang Gung Memorial Hospital; National Taiwan University	Wang, SH (corresponding author), Natl Taiwan Univ, Dept Anat & Cell Biol, Coll Med, Taipei, Taiwan.	shwang@ntu.edu.tw	Chen, Chin-Chuan/G-3094-2013	Chen, Chin-Chuan/0000-0002-8938-3209; WANG, SHU-HUEI/0000-0002-9208-3135; Chen, Yuh-Lien/0000-0002-6498-4008	National Science Council	National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council.	Camici GG, 2010, EUR HEART J, V31, P236, DOI 10.1093/eurheartj/ehp259; Choi SH, 2004, ARCH PHARM RES, V27, P68, DOI 10.1007/BF02980049; Conley KE, 2007, CURR OPIN CLIN NUTR, V10, P688, DOI 10.1097/MCO.0b013e3282f0dbfb; Golias CH, 2004, INT J CLIN PRACT, V58, P1134, DOI 10.1111/j.1742-1241.2004.00284.x; Graf K, 1997, HYPERTENSION, V29, P334, DOI 10.1161/01.HYP.29.1.334; Hoshi S, 2000, J BIOL CHEM, V275, P883, DOI 10.1074/jbc.275.2.883; Hwang TL, 2006, FREE RADICAL BIO MED, V41, P1433, DOI 10.1016/j.freeradbiomed.2006.08.001; Imanishi T, 2006, ATHEROSCLEROSIS, V189, P288, DOI 10.1016/j.atherosclerosis.2005.12.031; Jung HY, 2012, J MED FOOD, V15, P621, DOI 10.1089/jmf.2010.1469; Kim MS, 2003, LIFE SCI, V73, P1231, DOI 10.1016/S0024-3205(03)00418-1; Kim MS, 2000, GEN PHARMACOL-VASC S, V34, P349, DOI 10.1016/S0306-3623(01)00072-6; Kim WH, 2004, MOL PHARMACOL, V66, P1383, DOI 10.1124/mol.104.001347; Kuo PC, 2012, CHEM PHARM BULL, V60, P557, DOI 10.1248/cpb.60.557; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Leu YL, 2006, CHEM PHARM BULL, V54, P1063, DOI 10.1248/cpb.54.1063; Liang CJ, 2011, FREE RADICAL BIO MED, V51, P1337, DOI 10.1016/j.freeradbiomed.2011.06.023; Lyu SY, 2002, ARCH PHARM RES, V25, P93, DOI 10.1007/BF02975269; Nelson PR, 1998, J VASC SURG, V27, P117, DOI 10.1016/S0741-5214(98)70298-8; Obata H, 1996, BIOCHEM BIOPH RES CO, V224, P27, DOI 10.1006/bbrc.1996.0979; Ota H, 2009, J AM COLL CARDIOL, V53, P2298, DOI 10.1016/j.jacc.2009.01.072; Park R, 2000, BIOCHEM PHARMACOL, V60, P1685, DOI 10.1016/S0006-2952(00)00482-2; Raines EW, 2004, CYTOKINE GROWTH F R, V15, P237, DOI 10.1016/j.cytogfr.2004.03.004; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sata M, 2000, J MOL CELL CARDIOL, V32, P2097, DOI 10.1006/jmcc.2000.1238; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Su CS, 2006, BIOORG MED CHEM LETT, V16, P6155, DOI 10.1016/j.bmcl.2006.09.046; Wang SH, 2009, ARTERIOSCL THROM VAS, V29, P816, DOI 10.1161/ATVBAHA.109.184739; Weiss RH, 2000, J BIOL CHEM, V275, P10285, DOI 10.1074/jbc.275.14.10285; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2; Zhang H, 2012, J NANOMATER, V2012, DOI [10.1155/2012/217412, 10.1186/2049-1891-3-26]; Zhang Po, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P1021	31	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168092	10.1371/journal.pone.0168092	http://dx.doi.org/10.1371/journal.pone.0168092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977759	gold, Green Submitted, Green Published			2022-12-27	WOS:000391217400058
J	Kwon, J; Nayakankuppam, D				Kwon, JaeHwan; Nayakankuppam, Dhananjay			Two Different Views on the World Around Us: The World of Uniformity versus Diversity	PLOS ONE			English	Article							IMPLICIT THEORIES; JUDGMENTS; PROBABILITY; PERSONALITY; PREFERENCES; LIKELIHOOD	We propose that when individuals believe in fixed traits of personality (entity theorists), they are likely to expect a world of "uniformity." As such, they easily infer a population statistic from a small sample of data with confidence. In contrast, individuals who believe in malleable traits of personality (incremental theorists) are likely to presume a world of "diversity," such that they "hesitate" to infer a population statistic from a similarly sized sample. In four laboratory experiments, we found that compared to incremental theorists, entity theorists estimated a population mean from a sample with a greater level of confidence (Studies 1a and 1b), expected more homogeneity among the entities within a population (Study 2), and perceived an extreme value to be more indicative of an outlier (Study 3). These results suggest that individuals are likely to use their implicit self-theory orientations (entity theory versus incremental theory) to see a population in general as a constitution either of homogeneous or heterogeneous entities.	[Kwon, JaeHwan] Baylor Univ, Dept Mkt, Hankamer Sch Business, Waco, TX 76798 USA; [Nayakankuppam, Dhananjay] Univ Iowa, Dept Mkt, Tippie Coll Business, Iowa City, IA USA	Baylor University; University of Iowa	Kwon, J (corresponding author), Baylor Univ, Dept Mkt, Hankamer Sch Business, Waco, TX 76798 USA.	JaeHwan_Kwon@baylor.edu		Kwon, JaeHwan/0000-0002-0796-3139				BARHILLEL M, 1980, ACTA PSYCHOL, V44, P211, DOI 10.1016/0001-6918(80)90046-3; Chesney DL, 2012, MEM COGNITION, V40, P420, DOI 10.3758/s13421-011-0155-3; Chiu CY, 1997, J PERS SOC PSYCHOL, V73, P19, DOI 10.1037/0022-3514.73.1.19; DWECK CS, 1995, PSYCHOL INQ, V6, P267, DOI 10.1207/s15327965pli0604_1; ERDLEY CA, 1993, CHILD DEV, V64, P863, DOI 10.2307/1131223; Kushnir T, 2010, PSYCHOL SCI, V21, P1134, DOI 10.1177/0956797610376652; Kwon J, J ADVERT IN PRESS; Kwon J, 2015, J CONSUM RES, V42, P316, DOI 10.1093/jcr/ucv019; Levy SR, 1998, J PERS SOC PSYCHOL, V74, P1421, DOI 10.1037//0022-3514.74.6.1421; Lickel B, 2001, PERS SOC PSYCHOL REV, V5, P129, DOI 10.1207/S15327957PSPR0502_4; Mishra A, 2009, PSYCHOL SCI, V20, P867, DOI 10.1111/j.1467-9280.2009.02371.x; Obrecht NA, 2007, PSYCHON B REV, V14, P1147, DOI 10.3758/BF03193104; Park JK, 2010, J CONSUM RES, V37, P655, DOI 10.1086/655807; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; Windschitl PD, 2002, J BEHAV DECIS MAKING, V15, P19, DOI 10.1002/bdm.401; Yorkston EA, 2010, J MARKETING, V74, P80, DOI 10.1509/jmkg.74.1.80	17	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168589	10.1371/journal.pone.0168589	http://dx.doi.org/10.1371/journal.pone.0168589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977788	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400119
J	Madoshi, BP; Kudirkiene, E; Mtambo, MMA; Muhairwa, AP; Lupindu, AM; Olsen, JE				Madoshi, Balichene P.; Kudirkiene, Egle; Mtambo, Madundo M. A.; Muhairwa, Amandus P.; Lupindu, Athumani M.; Olsen, John E.			Characterisation of Commensal Escherichia coli Isolated from Apparently Healthy Cattle and Their Attendants in Tanzania	PLOS ONE			English	Article							VIRULENCE FACTORS; ANTIMICROBIAL RESISTANCE; ANTIBIOTIC-RESISTANCE; FOOD ANIMALS; STRAINS; PCR; IDENTIFICATION; PREVALENCE; HUMANS; GENES	While pathogenic types of Escherichia coli are well characterized, relatively little is known about the commensal E. coli flora. In the current study, antimicrobial resistance in commensal E. coli and distribution of ERIC-PCR genotypes among isolates of such bacteria from cattle and cattle attendants on cattle farms in Tanzania were investigated. Seventeen E. coli genomes representing different ERIC-PCR types of commensal E. coli were sequenced in order to determine their possible importance as a reservoir for both antimicrobial resistance genes and virulence factors. Both human and cattle isolates were highly resistant to tetracycline (40.8% and 33.1%), sulphamethazole-trimethoprim (49.0% and 8.8%) and ampicillin (44.9% and 21.3%). However, higher proportion of resistant E. coli and higher frequency of resistance to more than two antimicrobials was found in isolates from cattle attendants than isolates from cattle. Sixteen out of 66 ERIC-PCR genotypes were shared between the two hosts, and among these ones, seven types contained isolates from cattle and cattle attendants from the same farm, suggesting transfer of strains between hosts. Genome-wide analysis showed that the majority of the sequenced cattle isolates were assigned to phylogroups B1, while human isolates represented phylogroups A, C, D and E. In general, in silico resistome and virulence factor identification did not reveal differences between hosts or phylogroups, except for lpfA and iss found to be cattle and B1 phylogroup specific. The most frequent plasmids replicon genes found in strains from both hosts were of IncF type, which are commonly associated with carriage of antimicrobial and virulence genes. Commensal E. coli from cattle and attendants were found to share same genotypes and to carry antimicrobial resistance and virulence genes associated with both intra and extraintestinal E. coli pathotypes.	[Madoshi, Balichene P.; Muhairwa, Amandus P.; Lupindu, Athumani M.] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania; [Madoshi, Balichene P.] Livestock Training Agcy, Mpwapwa Campus, Mpwapwa, Dodoma, Tanzania; [Kudirkiene, Egle; Olsen, John E.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark; [Mtambo, Madundo M. A.] Tanzania Ind Res Dev Org, TIRDO Complex, Dar Es Salaam, Tanzania	Sokoine University of Agriculture; University of Copenhagen	Olsen, JE (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark.	jeo@sund.ku.dk	Kudirkiene, Egle/ABG-5736-2021; Madoshi, Balichene/AAG-9707-2020; Olsen, John Elmerdahl/N-9271-2019	Olsen, John Elmerdahl/0000-0001-6225-6587	Ministry of Foreign affairs of Denmark through the Danish International Development Agency (DANIDA) [12-P02-TAN]	Ministry of Foreign affairs of Denmark through the Danish International Development Agency (DANIDA)	The authors appreciate the Ministry of Foreign affairs of Denmark through the Danish International Development Agency (DANIDA) for financial support (12-P02-TAN). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABULREESH HH, 2014, INT J BIOL, V6, pNIL32, DOI DOI 10.5539/ijb.v6n2p31; Akiyama Y, 2015, FOOD HYG SAFE SCI, V56, P118, DOI 10.3358/shokueishi.56.118; Anderson MA, 2006, APPL ENVIRON MICROB, V72, P6914, DOI 10.1128/AEM.01029-06; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Ben Sallem R, 2015, J CHEMOTHERAPY, V27, P114, DOI 10.1179/1973947814Y.0000000172; Blum SE, 2013, VET MICROBIOL, V163, P305, DOI 10.1016/j.vetmic.2012.12.037; Brinas L, 2002, ANTIMICROB AGENTS CH, V46, P3156, DOI 10.1128/AAC.46.10.3156-3163.2002; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chase-Topping ME, 2012, EMERG INFECT DIS, V18, P439, DOI 10.3201/eid1803.111236; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Clermont O, 2011, INFECT GENET EVOL, V11, P654, DOI 10.1016/j.meegid.2011.02.005; Contreras-Moreira B, 2013, APPL ENVIRON MICROB, V79, P7696, DOI 10.1128/AEM.02411-13; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; da Costa MM, 2008, BRAZ J MICROBIOL, V39, P741, DOI 10.1590/S1517-838220080004000027; Dahms C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143326; de Jong J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-677; Deng Y, 2011, CLIN MICROBIOL INFEC, V17, P1740, DOI 10.1111/j.1469-0691.2011.03472.x; Dogan B, 2012, VET MICROBIOL, V159, P163, DOI 10.1016/j.vetmic.2012.03.033; Escobar-Paramo P, 2006, ENVIRON MICROBIOL, V8, P1975, DOI 10.1111/j.1462-2920.2006.01077.x; Gordon DM, 2015, ENV MICROBIOL REP, V7, P642, DOI 10.1111/1758-2229.12300; Hong PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025042; Huasai S, 2012, BRAZ J MICROBIOL, V43, P528, DOI 10.1590/S1517-83822012000200013; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Johnson JR, 2005, J CLIN MICROBIOL, V43, P6064, DOI 10.1128/JCM.43.12.6064-6072.2005; Jouini A, 2013, J FOOD PROTECT, V76, P323, DOI 10.4315/0362-028X.JFP-12-251; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Le Bouguenec C, 1999, VET RES, V30, P317; Leimbach A, 2013, CURR TOP MICROBIOL, V358, P3, DOI 10.1007/82_2012_303; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Mohapatra BR, 2007, FEMS MICROBIOL LETT, V277, P98, DOI 10.1111/j.1574-6968.2007.00948.x; Mora A, 2011, INT J ANTIMICROB AG, V37, P16, DOI 10.1016/j.ijantimicag.2010.09.012; Mora A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-132; Mosquito S, 2015, SCI WORLD J, V2015, DOI [10.1155/2015/610403, DOI 10.1155/2015/610403]; NATARO JP, 1995, J INFECT DIS, V171, P465, DOI 10.1093/infdis/171.2.465; Nyholm O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135936; Peirano G, 2013, J MED MICROBIOL, V62, P525, DOI 10.1099/jmm.0.048983-0; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Reiss G, 2006, J AM GERIATR SOC, V54, P680, DOI 10.1111/j.1532-5415.2006.00682.x; Sargeant JA, 2004, PREV VET MED, V66, P175, DOI 10.1016/j.prevetmed.2004.09.007; Scott TM, 2002, APPL ENVIRON MICROB, V68, P5796, DOI 10.1128/AEM.68.12.5796-5803.2002; Silvestro L, 2004, EPIDEMIOL INFECT, V132, P915, DOI 10.1017/S0950268804002390; Smati M, 2013, APPL ENVIRON MICROB, V79, P5005, DOI 10.1128/AEM.01423-13; Sousa C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03278; Szmolka A, 2012, VET MICROBIOL, V156, P110, DOI 10.1016/j.vetmic.2011.09.030; Tahamtan Y, 2010, IRAN J MICROBIOL, V2, P9; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tartof SY, 2005, J CLIN MICROBIOL, V43, P5860, DOI 10.1128/JCM.43.12.5860-5864.2005; Telli M, 2010, FEMS MICROBIOL LETT, V306, P117, DOI 10.1111/j.1574-6968.2010.01945.x; Toma C, 2003, J CLIN MICROBIOL, V41, P2669, DOI 10.1128/JCM.41.6.2669-2671.2003; Tristram SG, 2008, J ANTIMICROB CHEMOTH, V61, P509, DOI 10.1093/jac/dkm523; van den Bogaard AE, 2001, J ANTIMICROB CHEMOTH, V47, P763, DOI 10.1093/jac/47.6.763; Vargas M, 1999, J CLIN MICROBIOL, V37, P3608, DOI 10.1128/JCM.37.11.3608-3611.1999; Vila J, 2000, J INFECT DIS, V182, P1780, DOI 10.1086/317617; Wei GF, 2004, J MICROBIOL METH, V59, P91, DOI 10.1016/j.mimet.2004.06.007; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wu GH, 2012, VET MICROBIOL, V160, P197, DOI 10.1016/j.vetmic.2012.05.029; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhao J., 2011, WORLD HLTH DIGEST ME, V8, P8; Zhao JJ, 2010, ANTIMICROB AGENTS CH, V54, P4219, DOI 10.1128/AAC.00139-10	67	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168160	10.1371/journal.pone.0168160	http://dx.doi.org/10.1371/journal.pone.0168160			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977751	Green Published, gold			2022-12-27	WOS:000391217400071
J	Matsuzaka, Y; Tanihata, J; Komaki, H; Ishiyama, A; Oya, Y; Ruegg, U; Takeda, S; Hashido, K				Matsuzaka, Yasunari; Tanihata, Jun; Komaki, Hirofumi; Ishiyama, Akihiko; Oya, Yasushi; Ruegg, Urs; Takeda, Shin-ichi; Hashido, Kazuo			Characterization and Functional Analysis of Extracellular Vesicles and Muscle-Abundant miRNAs (miR-1, miR-133a, and miR-206) in C2C12 Myocytes and mdx Mice	PLOS ONE			English	Article							INDUCED CARDIOMYOCYTE APOPTOSIS; EXOSOME-MEDIATED TRANSFER; HUMAN SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; NEUTRAL SPHINGOMYELINASE-2; MULTIVESICULAR ENDOSOMES; HORIZONTAL TRANSFER; SERUM BIOMARKERS; MESSENGER-RNAS; STEM-CELLS	Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disorder. Here, we show that the CD63 antigen, which is located on the surface of extracellular vesicles (EVs), is associated with increased levels of muscle-abundant miRNAs, namely myomiRs miR-1, miR-133a, and miR-206, in the sera of DMD patients and mdx mice. Furthermore, the release of EVs from the murine myoblast C2C12 cell line was found to be modulated by intracellular ceramide levels in a Ca2+-dependent manner. Next, to investigate the effects of EVs on cell survival, C2C12 myoblasts and myotubes were cultured with EVs from the sera of mdx mice or C2C12 cells overexpressing myomiRs in presence of cellular stresses. Both the exposure of C2C12 myoblasts and myotubes to EVs from the serum of mdx mice, and the overexpression of miR-133a in C2C12 cells in presence of cellular stress resulted in a significant decrease in cell death. Finally, to assess whether miRNAs regulate skeletal muscle regeneration in vivo, we intraperitoneally injected GW4869 (an inhibitor of exosome secretion) into mdx mice for 5 and 10 days. Levels of miRNAs and creatine kinase in the serum of GW4869-treated mdx mice were significantly downregulated compared with those of controls. The tibialis anterior muscles of the GW4869-treated mdx mice showed a robust decrease in Evans blue dye uptake. Collectively, these results indicate that EVs and myomiRs might protect the skeletal muscle of mdx mice from degeneration.	[Matsuzaka, Yasunari; Hashido, Kazuo] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Adm Sect Radiat Protect, Kodaira, Tokyo, Japan; [Tanihata, Jun; Takeda, Shin-ichi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Kodaira, Tokyo, Japan; [Komaki, Hirofumi; Ishiyama, Akihiko] Natl Ctr Neurol & Psychiat, Dept Child Neurol, Kodaira, Tokyo, Japan; [Oya, Yasushi] Natl Ctr Neurol & Psychiat, Dept Neurol, Kodaira, Tokyo, Japan; [Ruegg, Urs] Univ Geneva, Geneva Lausanne Sch Pharmaceut Sci, Dept Pharmacol, Geneva, Switzerland; [Ruegg, Urs] Univ Lausanne, Geneva, Switzerland	National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan; University of Geneva; University of Lausanne	Hashido, K (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Adm Sect Radiat Protect, Kodaira, Tokyo, Japan.	hashido@ncnp.go.jp		RUEGG, Urs/0000-0001-6078-8280	Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP. [25-5]	Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP.(National Center for Neurology & Psychiatry - Japan)	Intramural Research Grant (25-5) for Neurological and Psychiatric Disorders of NCNP.	Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; BODENSTEINER JB, 1978, NEUROLOGY, V28, P439, DOI 10.1212/WNL.28.5.439; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; Cacchiarelli D, 2010, CELL METAB, V12, P341, DOI 10.1016/j.cmet.2010.07.008; Cazzella V, 2012, MOL THER, V20, P2134, DOI 10.1038/mt.2012.178; Choi JS, 2016, J CONTROL RELEASE, V222, P107, DOI 10.1016/j.jconrel.2015.12.018; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Clarke CJ, 2006, BBA-BIOMEMBRANES, V1758, P1893, DOI 10.1016/j.bbamem.2006.06.025; Dakhlallah D, 2015, J CARDIOVASC PHARM, V65, P241, DOI 10.1097/FJC.0000000000000183; Deng ZL, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-115; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Drawnel FM, 2012, J CELL BIOL, V199, P783, DOI 10.1083/jcb.201111095; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Ekstrom EJ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-88; Forterre A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084153; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Guller I, 2010, J PHYSIOL-LONDON, V588, P4075, DOI 10.1113/jphysiol.2010.194175; He B, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-22; Honda A, 2007, J MUSCLE RES CELL M, V28, P243, DOI 10.1007/s10974-007-9122-9; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; Izarra A, 2014, STEM CELL REP, V3, P1029, DOI 10.1016/j.stemcr.2014.10.010; Kajimoto T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3712; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kubota S, 2015, ONCOL REP, V33, P67, DOI 10.3892/or.2014.3605; Lane RE, 2015, SCI REP-UK, V5, DOI 10.1038/srep07639; Lee S, 2013, ADV EXP MED BIOL, V768, P97, DOI 10.1007/978-1-4614-5107-5_7; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Li AY, 2015, MOL CELL BIOCHEM, V400, P173, DOI 10.1007/s11010-014-2273-2; Li S, 2015, J HUM GENET, V60, P709, DOI 10.1038/jhg.2015.96; Li XH, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.29; Mallouk N, 2000, P NATL ACAD SCI USA, V97, P4950, DOI 10.1073/pnas.97.9.4950; Malm C, 2004, J PHYSIOL-LONDON, V556, P983, DOI 10.1113/jphysiol.2003.056598; Matsuzaka Y, 2015, RNA DIS, V2, P558; Matsuzaka Y, 2014, ENVIRON HEALTH PREV, V19, P452, DOI 10.1007/s12199-014-0405-7; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Mizuno H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018388; Mouisel E, 2010, MUSCLE NERVE, V41, P809, DOI 10.1002/mus.21624; Nakasa T, 2010, J CELL MOL MED, V14, P2495, DOI 10.1111/j.1582-4934.2009.00898.x; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200; Roberts TC, 2013, NUCLEIC ACIDS RES, V41, P9500, DOI 10.1093/nar/gkt724; Roberts TC, 2012, MOL THER-NUCL ACIDS, V1, DOI 10.1038/mtna.2012.26; Savina A, 2005, TRAFFIC, V6, P131, DOI 10.1111/j.1600-0854.2004.00257.x; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Shamseddine Achraf A, 2015, Adv Biol Regul, V57, P24, DOI 10.1016/j.jbior.2014.10.002; Singh R, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-256; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sultan Ambreen, 2008, J Ayub Med Coll Abbottabad, V20, P7; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Takeshima Y, 2010, J HUM GENET, V55, P379, DOI 10.1038/jhg.2010.49; Tamai K, 2010, BIOCHEM BIOPH RES CO, V399, P384, DOI 10.1016/j.bbrc.2010.07.083; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandebrouck C, 2002, J CELL BIOL, V158, P1089, DOI 10.1083/jcb.200203091; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Wang K, 2010, NUCLEIC ACIDS RES, V38, P7248, DOI 10.1093/nar/gkq601; Wang L, 2014, N-S ARCH PHARMACOL, V387, P197, DOI 10.1007/s00210-013-0929-1; ZATZ M, 1991, J NEUROL SCI, V102, P190, DOI 10.1016/0022-510X(91)90068-I; Zeringer Emily, 2013, World J Methodol, V3, P11, DOI 10.5662/wjm.v3.i1.11; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhu HY, 2011, AM J CARDIOVASC DIS, V1, P138	66	34	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0167811	10.1371/journal.pone.0167811	http://dx.doi.org/10.1371/journal.pone.0167811			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977725	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400034
J	Huang, H; Harle, K; Movellan, J; Paulus, M				Huang, He; Harle, Katia; Movellan, Javier; Paulus, Martin			Using Optimal Control to Disambiguate the Effect of Depression on Sensorimotor, Motivational and Goal-Setting Functions	PLOS ONE			English	Article							PSYCHOMOTOR RETARDATION; SYMPTOMS; MOTOR; DISORDERS	Differentiating the ability from the motivation to act is of central importance to psychiatric disorders in general and depression in particular. However, it has been difficult to develop quantitative approaches to relate depression to poor motor performance in goal-directed tasks. Here, we use an inverse optimal control approach to provide a computational framework that can be used to infer and factorize performance deficits into three components: sensorimotor speed, goal setting and motivation. Using a novel computer-simulated driving experiment, we found that (1) severity of depression is associated with both altered sensorimotor speed and motivational function; (2) moderately to severely depressed individuals show an increased distance from the stop sign indicating aversive learning affecting goal setting functions. Taken together, the inverse optimal control framework can disambiguate on an individual basis the sensorimotor from the motivational dysfunctions in depression, which may help to develop more precisely targeted interventions.	[Huang, He] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Huang, He; Movellan, Javier] Univ Calif San Diego, Machine Percept Lab, La Jolla, CA 92093 USA; [Huang, He; Paulus, Martin] Laureate Inst Brain Res, Tulsa, OK 74136 USA; [Harle, Katia; Paulus, Martin] Univ Calif San Diego, Dept Psychiat, La Jolla, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Laureate Institute for Brain Research, Inc.; University of California System; University of California San Diego	Huang, H (corresponding author), Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA.; Huang, H (corresponding author), Univ Calif San Diego, Machine Percept Lab, La Jolla, CA 92093 USA.; Huang, H (corresponding author), Laureate Inst Brain Res, Tulsa, OK 74136 USA.	crane081@gmail.com						AHRENS AH, 1987, COGNITIVE THER RES, V11, P665, DOI 10.1007/BF01176004; Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; American Psychiatric Association, 2013, DSM 5 DIAGN CLASS DI, V5th, DOI [DOI 10.1176/APPI.BOOKS.9780890425596.X00DIAGNOSTICCLASSIFICATION, DOI 10.1176/APPI.BOOKS.9780890425596.DSM05]; ATHANS M, 1971, IEEE T AUTOMAT CONTR, VAC16, P529, DOI 10.1109/TAC.1971.1099818; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Beck AT., 1996, BECK DEPRESSION INVE, pb9; Bennabi D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/158746; BOBROW JE, 1985, INT J ROBOT RES, V4, P3, DOI 10.1177/027836498500400301; Buyukdura JS, 2011, PROG NEURO-PSYCHOPH, V35, P395, DOI 10.1016/j.pnpbp.2010.10.019; Caligiuri MP, 2000, J AFFECT DISORDERS, V57, P83, DOI 10.1016/S0165-0327(99)00068-3; Clery-Melin ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023178; Davis AS, 2010, INT J NEUROSCI, V120, P352, DOI 10.3109/00207450802335594; Dickson JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064512; Dunn AL, 2005, AM J PREV MED, V28, P1, DOI 10.1016/j.amepre.2004.09.003; Huang HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140419; Huys QJM, 2016, NAT NEUROSCI, V19, P404, DOI 10.1038/nn.4238; KANFER R, 1983, J ABNORM PSYCHOL, V92, P319, DOI 10.1037/0021-843X.92.3.319; Kessler RC, 2010, CURR TOP BEHAV NEURO, V2, P21, DOI 10.1007/7854_2009_9; Maddox WT, 2012, COGNITION, V125, P118, DOI 10.1016/j.cognition.2012.06.011; Montague PR, 2012, TRENDS COGN SCI, V16, P72, DOI 10.1016/j.tics.2011.11.018; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Ng AY, 2000, ALGORITHMS INVERSE R; Ramaekers JG, 2003, J CLIN PSYCHIAT, V64, P20, DOI 10.4088/JCP.v64n0106; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Schrijvers D, 2008, J AFFECT DISORDERS, V109, P1, DOI 10.1016/j.jad.2007.10.019; Seidel EM, 2010, PSYCHIAT RES, V177, P124, DOI 10.1016/j.psychres.2010.02.001; Shilyansky C, 2016, LANCET PSYCHIAT, V3, P425, DOI 10.1016/S2215-0366(16)00012-2; Smoski MJ, 2008, J BEHAV THER EXP PSY, V39, P567, DOI 10.1016/j.jbtep.2008.01.004; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Strand M C, 2016, Forensic Sci Rev, V28, P79; Street H, 2002, AUST PSYCHOL, V37, P95, DOI 10.1080/00050060210001706736; Talbott WA, 2012, INFOMAX MODELS OCULO; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Todorov E, 2012, MUJOCO PHYS ENGINE M; Treadway MT, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004887, 10.1371/journal.pone.0006598]; Trew JL, 2011, CLIN PSYCHOL REV, V31, P1156, DOI 10.1016/j.cpr.2011.07.007; Watson D, 2009, ANNU REV CLIN PSYCHO, V5, P221, DOI 10.1146/annurev.clinpsy.032408.153510; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6	38	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167960	10.1371/journal.pone.0167960	http://dx.doi.org/10.1371/journal.pone.0167960			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973592	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300051
J	Li, HQ; Fang, MS; Xu, MZ; Li, SH; Du, J; Li, WY; Chen, H				Li, Huqun; Fang, Maosheng; Xu, Mingzhen; Li, Shihong; Du, Juan; Li, Weiyong; Chen, Hui			Chronic Olanzapine Treatment Induces Disorders of Plasma Fatty Acid Profile in Balb/c Mice: A Potential Mechanism for Olanzapine-Induced Insulin Resistance	PLOS ONE			English	Article							STEAROYL-COA DESATURASE; ATYPICAL ANTIPSYCHOTICS; WEIGHT-GAIN; DELTA-5 DESATURASE; RATS RELATIONSHIP; RISK; PALMITATE; INCREASE; INFLAMMATION; ASSOCIATION	Background Atypical antipsychotics such as olanzapine cause metabolic side effects leading to obesity and insulin resistance. The underlying mechanisms remain elusive. In this study we investigated the effects of chronic treatment of olanzapine on the fatty acid composition of plasma in mice. Methods Twenty 8-week female Balb/c mice were randomly assigned to two groups: the OLA group and the control group. After treatment with olanzapine (10 mg/kg/day) or vehicle intraperitoneally for 8 weeks, fasting glucose, insulin levels and oral glucose tolerance test were determined. Effects on plasma fatty acid profile and plasma indices of D5 desaturase, D6 desaturase and SCD1 activity were also investigated. Results Chronic administration of olanzapine significantly elevated fasting glucose and insulin levels, impaired glucose tolerance, but did not increase body weight. Total saturated fatty acids and n-6 polyunsaturated fatty acids were significantly increased and total monounsaturated fatty acids were significantly decreased, while total n-3 polyunsaturated fatty acids showed no prominent changes. Chronic olanzapine treatment significantly up-regulated D6 desaturase activity while down-regulating D5 desaturase activity. Palmitic acid (C16: 0), dihomo-gamma linolenic acid (C20:3n-6) and D6 desaturase were associated with an increase probability of insulin resistance, whereas nervonic acid (C24: 1) and SCD1 were significantly associated with a lower insulin resistance probability. Conclusions All results indicated that such drug-induced effects on fatty acid profile in plasma were relevant for the metabolic adverse effects associated with olanzapine and possibly other antipsychotics. Further studies are needed to investigate geneticand other mechanisms to explain how plasma fatty acids regulate glucose metabolism and affect the risk of insulin resistance.	[Li, Huqun; Xu, Mingzhen; Li, Shihong; Li, Weiyong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pharm, Wuhan, Peoples R China; [Fang, Maosheng] Wuhan Mental Hlth Ctr, Wuhan, Peoples R China; [Du, Juan] Hubei Univ Chinese Med, Coll Pharm, Wuhan, Peoples R China; [Chen, Hui] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan, Peoples R China	Huazhong University of Science & Technology; Hubei University of Chinese Medicine; Huazhong University of Science & Technology	Li, WY (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pharm, Wuhan, Peoples R China.; Chen, H (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Infect Dis, Wuhan, Peoples R China.	wenzhang_sci@163.com; shining119@163.com			Natural Science Foundation of China [81573509]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Grant 81573509) awarded to WY Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022662; Aravagiri M, 1999, BIOPHARM DRUG DISPOS, V20, P369, DOI 10.1002/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6; Araya J, 2010, OBESITY, V18, P1460, DOI 10.1038/oby.2009.379; Baptista T, 2008, CNS DRUGS, V22, P477, DOI 10.2165/00023210-200822060-00003; Bjermo H, 2010, CURR OPIN CLIN NUTR, V13, P703, DOI 10.1097/MCO.0b013e32833ec41b; Boyda HN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053459; Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chen XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21454; Chow LS, 2013, METABOLISM, V62, P100, DOI 10.1016/j.metabol.2012.06.004; Coll T, 2008, J BIOL CHEM, V283, P11107, DOI 10.1074/jbc.M708700200; Cooper GD, 2005, PSYCHOPHARMACOLOGY, V181, P80, DOI 10.1007/s00213-005-2224-4; Erkkila A, 2008, PROG LIPID RES, V47, P172, DOI 10.1016/j.plipres.2008.01.004; Hahn M, 2011, SCHIZOPHR RES, V131, P90, DOI 10.1016/j.schres.2011.06.004; Han E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154683; Hara T, 2013, REV PHYSIOL BIOCH P, V164, P77, DOI 10.1007/112_2013_13; Henderson DC, 2007, J CLIN PSYCHIAT, V68, P18; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Jacobs S, 2015, AM J CLIN NUTR, V102, P155, DOI 10.3945/ajcn.114.102707; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Kashyap S, 2003, DIABETES, V52, P2461, DOI 10.2337/diabetes.52.10.2461; Krachler B, 2008, NUTR METAB CARDIOVAS, V18, P503, DOI 10.1016/j.numecd.2007.04.005; Kroger J, 2012, CURR OPIN LIPIDOL, V23, P4, DOI 10.1097/MOL.0b013e32834d2dc5; Lankinen MA, 2015, DIABETOLOGIA, V58, P2533, DOI 10.1007/s00125-015-3730-5; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Ma WJ, 2015, AM J CLIN NUTR, V101, P153, DOI 10.3945/ajcn.114.092601; Mann S, 2013, PHARMACOL BIOCHEM BE, V103, P717, DOI 10.1016/j.pbb.2012.12.002; Mayneris-Perxachs J, 2014, CLIN NUTR, V33, P90, DOI 10.1016/j.clnu.2013.03.001; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; McNamara RK, 2011, SCHIZOPHR RES, V129, P66, DOI 10.1016/j.schres.2011.03.016; McNamara RK, 2011, SCHIZOPHR RES, V129, P57, DOI 10.1016/j.schres.2011.03.006; McNamara RK, 2009, SCHIZOPHR RES, V107, P150, DOI 10.1016/j.schres.2008.09.027; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Newcomer JW, 2005, CNS DRUGS, V19, P1; Ntambi JM, 1999, J LIPID RES, V40, P1549; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Pardo V, 2015, J BIOL CHEM, V290, P11663, DOI 10.1074/jbc.M115.649483; Patterson E, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/539426; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Roden M, 2012, DIABETES, V61, P2397, DOI 10.2337/db12-0662; Sacher J, 2008, NEUROPSYCHOPHARMACOL, V33, P1633, DOI 10.1038/sj.npp.1301541; Salto LM, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010052; Sears B, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0123-1; Senn JJ, 2006, J BIOL CHEM, V281, P26865, DOI 10.1074/jbc.M513304200; Sessler AM, 1996, J BIOL CHEM, V271, P29854, DOI 10.1074/jbc.271.47.29854; Sethom MM, 2011, PROSTAG LEUKOTR ESS, V85, P137, DOI 10.1016/j.plefa.2011.06.006; Shobo M, 2011, BEHAV BRAIN RES, V216, P561, DOI 10.1016/j.bbr.2010.08.046; Simopoulos AP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030128; Tan CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23873; Teff KL, 2013, DIABETES, V62, P3232, DOI 10.2337/db13-0430; Vidarsdottir S, 2010, J CLIN ENDOCR METAB, V95, P118, DOI 10.1210/jc.2008-1815; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001	52	5	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167930	10.1371/journal.pone.0167930	http://dx.doi.org/10.1371/journal.pone.0167930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973621	Green Published, gold, Green Submitted			2022-12-27	WOS:000392754300048
J	Morvai, B; Nanuru, S; Mul, D; Kusche, N; Milne, G; Szekely, T; Komdeur, J; Miklosi, A; Pogany, A				Morvai, Boglarka; Nanuru, Sabine; Mul, Douwe; Kusche, Nina; Milne, Gregory; Szekely, Tamas; Komdeur, Jan; Miklosi, Adam; Pogany, Akos			Diurnal and Reproductive Stage-Dependent Variation of Parental Behaviour in Captive Zebra Finches	PLOS ONE			English	Article							DIFFERENTIAL-ALLOCATION; INCUBATION BEHAVIOR; BIPARENTAL CARE; WILD; FEMALE; ATTRACTIVENESS; TEMPERATURE; COOPERATION; SYNCHRONY; CONFLICT	Parental care plays a key role in ontogeny, life-history trade-offs, sexual selection and intrafamilial conflict. Studies focusing on understanding causes and consequences of variation in parental effort need to quantify parental behaviour accurately. The applied methods are, however, diverse even for a given species and type of parental effort, and rarely validated for accuracy. Here we focus on variability of parental behaviour from a methodological perspective to investigate the effect of different samplings on various estimates of parental effort. We used nest box cameras in a captive breeding population of zebra finches, Taeniopygia guttata, a widely used model system of sexual selection, intra-familial dynamics and parental care. We investigated diurnal and reproductive stage-dependent variation in parental effort (including incubation, brooding, nest attendance and number of feedings) based on 12h and 3h continuous video-recordings taken at various reproductive stages. We then investigated whether shorter (1h) sampling periods provided comparable estimates of overall parental effort and division of labour to those of longer (3h) sampling periods. Our study confirmed female-biased division of labour during incubation, and showed that the difference between female and male effort diminishes with advancing reproductive stage. We found individually consistent parental behaviours within given days of incubation and nestling provisioning. Furthermore, parental behaviour was consistent over the different stages of incubation, however, only female brooding was consistent over nestling provisioning. Parental effort during incubation did not predict parental effort during nestling provisioning. Our analyses revealed that 1h sampling may be influenced heavily by stochastic and diurnal variation. We suggest using a single longer sampling period (3h) may provide a consistent and accurate estimate for overall parental effort during incubation in zebra finches. Due to the large within-individual variation, we suggest repeated longer sampling over the reproductive stage may be necessary for accurate estimates of parental effort post-hatching.	[Morvai, Boglarka; Kusche, Nina; Miklosi, Adam; Pogany, Akos] Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary; [Nanuru, Sabine; Mul, Douwe; Komdeur, Jan] Univ Groningen, Groningen Inst Evolut Life Sci, Behav & Physiol Ecol, Groningen, Netherlands; [Milne, Gregory; Szekely, Tamas] Univ Bath, Dept Biol & Biochem, Bath, Avon, England	Eotvos Lorand University; University of Groningen; University of Bath	Pogany, A (corresponding author), Eotvos Lorand Univ, Dept Ethol, Budapest, Hungary.	akos.pogany@ttk.elte.hu	Komdeur, Jan/X-1261-2019; Pogány, Ákos/AAF-2637-2020; Morvai, Boglárka/GPG-4272-2022	Komdeur, Jan/0000-0002-9241-0124; Pogány, Ákos/0000-0001-9498-0158; Morvai, Boglárka/0000-0001-6360-9284; Milne, Gregory/0000-0002-9594-3321	Hungarian Scientific Research Fund [OTKA K109337]; Hungarian Academy of Sciences (MTA-ELTE Comparative Ethology Research Group) [MTA 01 031]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences (MTA-ELTE Comparative Ethology Research Group)	This study received funding from the Hungarian Scientific Research Fund (OTKA K109337) and the Hungarian Academy of Sciences (MTA-ELTE Comparative Ethology Research Group, MTA 01 031). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlRashidi M, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-1; Arnold KE, 2016, ANIM BEHAV, V113, P69, DOI 10.1016/j.anbehav.2015.12.013; Bartlett TL, 2005, AUK, V122, P835, DOI 10.1642/0004-8038(2005)122[0835:DOLIAB]2.0.CO;2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; Canty A., 2015, BOOT BOOTSTRAP R S P; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Davison AC, 1997, BOOTSTRAP METHODS TH, DOI [DOI 10.2307/1271471, 10.1017/CBO9780511802843]; Forstmeier W, 2007, MOL ECOL, V16, P4039, DOI 10.1111/j.1365-294X.2007.03444.x; Foster VS, 2007, ETHOLOGY, V113, P511, DOI 10.1111/j.1439-0310.2007.01350.x; Gilby AJ, 2013, ANIM BEHAV, V85, P1329, DOI 10.1016/j.anbehav.2013.03.023; Gilby AJ, 2011, ANIM BEHAV, V82, P479, DOI 10.1016/j.anbehav.2011.05.022; Gilby AJ, 2011, ANIM BEHAV, V81, P289, DOI 10.1016/j.anbehav.2010.10.020; Gorman HE, 2003, ANIM BEHAV, V65, P745, DOI 10.1006/anbe.2003.2120; Gorman HE, 2005, J AVIAN BIOL, V36, P413; Griffith SC, 2010, EMU, V110, P1, DOI 10.1071/MU09057; Grunst ML, 2016, J AVIAN BIOL, V47, P57, DOI 10.1111/jav.00758; Harper DGC., 1994, RINGING MIGR, V15, P84, DOI DOI 10.1080/03078698.1994.9674078; Harrison F, 2009, J EVOLUTION BIOL, V22, P1800, DOI 10.1111/j.1420-9101.2009.01792.x; Hill DL, 2014, J EXP BIOL, V217, P1326, DOI 10.1242/jeb.095323; Hill DL, 2011, BEHAV ECOL SOCIOBIOL, V65, P2049, DOI 10.1007/s00265-011-1214-2; Klug H, 2014, ECOL EVOL, V4, P2330, DOI 10.1002/ece3.1083; Kosztolanyi A, 2009, BEHAV ECOL, V20, P446, DOI 10.1093/beheco/arn140; Lendvai AZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141194; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Mainwaring MC, 2011, BEHAV ECOL SOCIOBIOL, V65, P2261, DOI 10.1007/s00265-011-1235-x; Mariette MM, 2015, AM NAT, V185, P270, DOI 10.1086/679441; Mariette MM, 2012, J AVIAN BIOL, V43, P131, DOI 10.1111/j.1600-048X.2012.05555.x; Mariette MM, 2011, AUK, V128, P26, DOI 10.1525/auk.2011.10117; Martin P., 2007, MEASURING BEHAV INTR, V3; Murphy MT, 2015, J FIELD ORNITHOL, V86, P41, DOI 10.1111/jofo.12087; Parker GA, 2002, PHILOS T R SOC B, V357, P295, DOI 10.1098/rstb.2001.0950; Peter A, 2015, SOLOMON CODER SIMPLE; Pogany A, 2014, BEHAVIOUR, V151, P1885, DOI 10.1163/1568539X-00003221; Pogany A, 2012, AUK, V129, P773, DOI 10.1525/auk.2012.12080; Pooley EL, 2014, ANIM BEHAV, V97, P153, DOI 10.1016/j.anbehav.2014.09.012; R Core Team, 2021, R LANGUAGE ENV STAT; Rehling A, 2012, ANIM BEHAV, V83, P35, DOI 10.1016/j.anbehav.2011.10.003; Reynolds JD, 2002, PHILOS T R SOC B, V357, P269, DOI 10.1098/rstb.2001.0930; Riebel K, 2009, ADV STUD BEHAV, V40, P197, DOI 10.1016/S0065-3454(09)40006-8; Royle N, 2012, EVOLUTION OF PARENTAL CARE, pXIV; Royle NJ, 2006, ANIM BEHAV, V72, P123, DOI 10.1016/j.anbehav.2005.09.023; Royle NJ, 2002, NATURE, V416, P733, DOI 10.1038/416733a; Suarez ME, 1996, POULTRY SCI, V75, P924, DOI 10.3382/ps.0750924; Tzschentke B, 1999, ORNIS FENNICA, V76, P189; Walter I, 2009, J EXP BIOL, V212, P2328, DOI 10.1242/jeb.029009; ZANN R, 1991, EMU, V91, P107, DOI 10.1071/MU9910107; Zann RA., 1996, ZEBRA FINCH SYNTHESI	49	9	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167368	10.1371/journal.pone.0167368	http://dx.doi.org/10.1371/journal.pone.0167368			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973549	Green Submitted, Green Published, gold			2022-12-27	WOS:000392754300026
J	Luby, CH; Dawson, JC; Goldman, IL				Luby, Claire H.; Dawson, Julie C.; Goldman, Irwin L.			Assessment and Accessibility of Phenotypic and Genotypic Diversity of Carrot (Daucus carota L. var. sativus) Cultivars Commercially Available in the United States	PLOS ONE			English	Article							GENETIC-STRUCTURE; R-PACKAGE; INTELLECTUAL PROPERTY; POPULATIONS; RIGHTS	Increased use of intellectual property rights over plant germplasm has led to a complicated landscape for exchange among plant breeders. Our goal was to examine phenotypic and genotypic diversity present in commercially available carrot (Daucus carota L. var. sativus) germplasm in relation to the freedom to operate-the ability for plant breeders to access and use crop genetic diversity. A collection of 140 commercially available carrot cultivars were grown in replicated field trials in the Madison, WI area in 2013 and 2014. Phenotypic measurements were recorded for leaf and root characteristics. Illumina sequencing was used to conduct genotyping by sequencing analysis on all cultivars to understand the range of genetic diversity present. Additionally, the intellectual property rights associated with each cultivar was noted to determine the freedom to operate. We found that although one-third of the commercially available US carrot cultivars in our study are restricted through some form of intellectual property rights, the genetic and phenotypic variability of the protected cultivars does not represent a completely separate group from the available material. Phenotypic analyses including ANOVA and principal components analysis, suggest that many of the traits differed significantly based on market class, but not by whether the cultivar had freedom to operate. The principal components and F-st analyses on the genotyping by sequencing data revealed that carrot market classes (F-st = 0.065) and freedom to operate classes (F-st = 0.023) were not genetically distinct, and that principle components 1 and 2 account for only 10.1% of the total genotypic variation, implying that cultivated carrot germplasm in the US forms an unstructured population. Our findings suggest that the genetic diversity present in carrot cultivars that have freedom to operate is potentially large enough to support carrot breeding efforts in most market classes given present levels of intellectual property protection.	[Luby, Claire H.; Dawson, Julie C.; Goldman, Irwin L.] Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Luby, CH (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.	cluby@wisc.edu			Clif Bar Family Foundation Seed Matters program; North Central SARE graduate student grant [GNC13-175]	Clif Bar Family Foundation Seed Matters program; North Central SARE graduate student grant	CHL received a graduate student fellowship from the Clif Bar Family Foundation Seed Matters program < http://seedmatters.org/about-us/programs/seed-matters-graduate-fellowships/> that supported her work on this project. CHL and ILG received a North Central SARE graduate student grant (GNC13-175) in 2013 < http://www.northcentralsare.org/>. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2009, FORDHAM LAW REV, V77, P2275; Arscott SA, 2010, COMPR REV FOOD SCI F, V9, P223, DOI 10.1111/j.1541-4337.2009.00103.x; BANGA O., 1963, Genetica Agraria, V17, P357; BANGA O., 1957, EUPHYTICA, V6, P64; Baranski R, 2012, GENET RESOUR CROP EV, V59, P163, DOI 10.1007/s10722-011-9777-3; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bradeen JM, 2002, J AM SOC HORTIC SCI, V127, P383, DOI 10.21273/JASHS.127.3.383; Brothwell D, 1969, FOOD ANTIQUITY SURVE; Clotault J, 2010, THEOR APPL GENET, V121, P659, DOI 10.1007/s00122-010-1338-1; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Holland J.B., 2003, PLANT BREEDING REV, V22, DOI DOI 10.1002/9780470650202.CH2; Howard PH, 2015, CROP SCI, V55, P2489, DOI 10.2135/cropsci2014.09.0669; Iorizzo M, 2013, AM J BOT, V100, P930, DOI 10.3732/ajb.1300055; Jombart, 2020, HIERFSTAT ESTIMATION; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521; Jondle RJ, 2015, CROP SCI, V55, P2496, DOI 10.2135/cropsci2014.10.0693; Kloppenburg JR., 2005, 1 SEED POLITICAL EC; Kuznetsova A., 2015, R PACKAGE VERSION PA; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Lence SH, 2016, EUR REV AGRIC ECON, V43, P1, DOI 10.1093/erae/jbv007; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Luby CH, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8050479; Morrell CH, 1998, BIOMETRICS, V54, P1560, DOI 10.2307/2533680; Murphy DJ, 2007, PLANT BREEDING AND BIOTECHNOLOGY: SOCIETAL CONTEXT AND THE FUTURE OF AGRICULTURE, P1; Odong TL, 2011, THEOR APPL GENET, V123, P195, DOI 10.1007/s00122-011-1576-x; Pardey P, 2013, NAT BIOTECHNOL, V31, P25, DOI 10.1038/nbt.2467; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Pritchard JK, 2000, GENETICS, V155, P945; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Shim SI, 2000, THEOR APPL GENET, V101, P227, DOI 10.1007/s001220051473; Simon P. W., 2000, Plant Breeding Reviews, V19, P157; Stolarczyk J., 2011, Chronica Horticulturae, V51, P13; van de Wouw M, 2010, THEOR APPL GENET, V120, P1241, DOI 10.1007/s00122-009-1252-6	35	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167865	10.1371/journal.pone.0167865	http://dx.doi.org/10.1371/journal.pone.0167865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959910	Green Published, Green Submitted, gold			2022-12-27	WOS:000392753900020
J	Ghinescu, R; Schachtman, TR; Ramsey, AK; Gratton, G; Fabiani, M				Ghinescu, Rodica; Schachtman, Todd R.; Ramsey, Ashley K.; Gratton, Gabriele; Fabiani, Monica			Conflict Adaptation and Cue Competition during Learning in an Eriksen Flanker Task	PLoS One			English	Article							COGNITIVE CONTROL; EXECUTIVE CONTROL; INFORMATION; ACTIVATION; ATTENTION; STIMULI; MODEL	Two experiments investigated competition between cues that predicted the correct target response to a target stimulus in a response conflict procedure using a flanker task. Subjects received trials with five-character arrays with a central target character and distractor flanker characters that matched (compatible) or did not match (incompatible) the central target. Subjects' expectancies for compatible and incompatible trials were manipulated by presenting pre-trial cues that signaled the occurrence of compatible or incompatible trials. On some trials, a single cue predicted the target stimulus and the required target response. On other trials, a second redundant, predictive cue was also present on such trials. The results showed an effect of competition between cues for control over strategic responding to the target stimuli, a finding that is predicted by associative learning theories. The finding of competition between pre-trial cues that predict incompatible trials, but not cues that predict compatible trials, suggests that different strategic processes may occur during adaptation to conflict when different kinds of trials are expected.	[Ghinescu, Rodica] Lincoln Univ, Dept Social & Behav Sci, Jefferson City, MO USA; [Schachtman, Todd R.] Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA; [Ramsey, Ashley K.] Truman State Univ, Dept Psychol, Kirksville, MO USA; [Gratton, Gabriele; Fabiani, Monica] Univ Illinois, Dept Psychol, Champaign, IL USA	Lincoln University - Missouri; University of Missouri System; University of Missouri Columbia; University of Illinois System; University of Illinois Urbana-Champaign	Schachtman, TR (corresponding author), Univ Missouri, Dept Psychol Sci, Columbia, MO 65211 USA.	schachtmant@missouri.edu		Schachtman, Todd/0000-0003-2312-0323; Gratton, Gabriele/0000-0003-3634-7463; Fabiani, Monica/0000-0002-7579-2773	National Institutes of Health [MH59039-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors received support from the National Institutes of Health (Grant MH59039-01 to GG).	Abrahamse E, 2016, PSYCHOL BULL, V142, P693, DOI 10.1037/bul0000047; ALLPORT DA, 1968, BRIT J PSYCHOL, V59, P395, DOI 10.1111/j.2044-8295.1968.tb01154.x; Bartholow BD, 2010, PSYCHOPHYSIOLOGY, V47, P201, DOI 10.1111/j.1469-8986.2009.00955.x; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Duthoo W, 2013, PSYCHON B REV, V20, P798, DOI 10.3758/s13423-013-0390-7; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Ghinescu R, 2010, MEM COGNITION, V38, P197, DOI 10.3758/MC.38.2.197; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Larkin MJW, 1998, J EXP PSYCHOL LEARN, V24, P1331, DOI 10.1037/0278-7393.24.6.1331; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Millett R., 1988, Proceedings of the 1988 DCLASS Conference, P51, DOI 10.1016/S0079-7421(08)60038-9; Moris J, 2014, J EXP PSYCHOL GEN, V143, P77, DOI 10.1037/a0030919; PEARCE JM, 1987, PSYCHOL REV, V94, P61, DOI 10.1037/0033-295X.94.1.61; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; PRICE PC, 1995, J EXP PSYCHOL LEARN, V21, P1639, DOI 10.1037/0278-7393.21.6.1639; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; RESCORLA RA, 1973, J COMP PHYSIOL PSYCH, V85, P331, DOI 10.1037/h0035046; RESCORLA RA, 1985, J EXP PSYCHOL ANIM B, V11, P356, DOI 10.1037/0097-7403.11.3.356; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; Shanks DR, 1998, J EXP PSYCHOL LEARN, V24, P1353, DOI 10.1037/0278-7393.24.6.1353; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tapia M, 2016, EXP PSYCHOL, V63, P287, DOI 10.1027/1618-3169/a000332; Wagner A. R., 1969, FUNDAMENTAL ISSUES A, P90	28	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167119	10.1371/journal.pone.0167119	http://dx.doi.org/10.1371/journal.pone.0167119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27941977	Green Submitted, Green Published, gold			2022-12-27	WOS:000392745600009
J	Levac, DE; Glegg, SMN; Sveistrup, H; Colquhoun, H; Miller, P; Finestone, H; DePaul, V; Harris, JE; Velikonja, D				Levac, Danielle E.; Glegg, Stephanie M. N.; Sveistrup, Heidi; Colquhoun, Heather; Miller, Patricia; Finestone, Hillel; DePaul, Vincent; Harris, Jocelyn E.; Velikonja, Diana			Promoting Therapists' Use of Motor Learning Strategies within Virtual Reality-Based Stroke Rehabilitation	PLOS ONE			English	Article							PHYSICAL-THERAPY; CHILDREN; INTERVENTIONS; RELIABILITY; INSTRUMENT	Purpose Therapists use motor learning strategies (MLSs) to structure practice conditions within stroke rehabilitation. Virtual reality (VR)-based rehabilitation is an MLS-oriented stroke intervention, yet little support exists to assist therapists in integrating MLSs with VR system use. Method A pre-post design evaluated a knowledge translation (KT) intervention incorporating interactive e-learning and practice, in which 11 therapists learned how to integrate MLSs within VR-based therapy. Self-report and observer-rated outcome measures evaluated therapists' confidence, clinical reasoning and behaviour with respect to MLS use. A focus group captured therapists' perspectives on MLS use during VR-based therapy provision. Results The intervention improved self-reported confidence about MLS use as measured by confidence ratings (p <0.001). Chart-Stimulated Recall indicated a moderate level of competency in therapists' clinical reasoning about MLSs following the intervention, with no changes following additional opportunities to use VR (p =.944). On the Motor Learning Strategy Rating Instrument, no behaviour change with respect to MLS use was noted (p = 0.092). Therapists favoured the strategy of transferring skills from VR to real-life tasks over employing a more comprehensive MLS approach. Conclusion The KT intervention improved therapists' confidence but did not have an effect on clinical reasoning or behaviour with regard to MLS use during VR-based therapy.	[Levac, Danielle E.] Northwestern Univ, Bouve Coll Hlth Sci, Dept Phys Therapy Movement Sci & Rehabil, Boston, MA 60208 USA; [Glegg, Stephanie M. N.] Sunny Hill Hlth Ctr Children, Therapy Dept, Vancouver, BC, Canada; [Sveistrup, Heidi; Harris, Jocelyn E.] Univ Ottawa, Fac Hlth Sci, Sch Rehabil Sci, Ottawa, ON, Canada; [Colquhoun, Heather] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Miller, Patricia] McMaster Univ, Fac Hlth Sci, Sch Rehabil Sci, Hamilton, ON, Canada; [Finestone, Hillel] Eiisabeth Bruyere Hosp & Bruyere Continuing Care, Physiat, Ottawa, ON, Canada; [DePaul, Vincent] Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada; [Velikonja, Diana] Hamilton Hlth Sci, Reg Rehabil Ctr, Hamilton, ON, Canada	Northeastern University; Northwestern University; University of Ottawa; University of Toronto; McMaster University; Queens University - Canada; McMaster University	Levac, DE (corresponding author), Northwestern Univ, Bouve Coll Hlth Sci, Dept Phys Therapy Movement Sci & Rehabil, Boston, MA 60208 USA.	d.levac@northeastern.edu	Harris, Jocelyn Ellen/ABE-7420-2021; Levac, Danielle/O-9008-2015	Harris, Jocelyn Ellen/0000-0002-3293-1833; Levac, Danielle/0000-0001-7356-9335; Glegg, Stephanie/0000-0002-8164-6983	Ontario Ministry of Health and Long-Term Care; Ontario Stroke Network; Canadian Institutes of Health Research; Canadian Child Health Clinician Scientist Program; NeuroDevNet	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Ontario Stroke Network; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Child Health Clinician Scientist Program; NeuroDevNet	This project has been generously funded, by a grant from the Ontario Ministry of Health and Long-Term Care, administered and supported by the Ontario Stroke Network (www.ontariostrokenetwork.ca), to DEL, SMNG, HS, HC, PM, HF, VD, and JEH. The views expressed do not necessarily reflect those of the Ministry or the Ontario Stroke Network. Dr. Levac's postdoctoral fellowship was supported by the Canadian Institutes of Health Research, the Canadian Child Health Clinician Scientist Program and NeuroDevNet.	Baker R, 2015, COCHRANE DB SYST REV, V29; Barker M, 2015, KNOWLEDGE PRAC UNPUB; Darekar A, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0035-3; Fisher BE, 2014, J NEUROL PHYS THER, V38, P149, DOI 10.1097/NPT.0000000000000043; Glegg SMN, DISABI REHA IN PRESS; Glegg SMN, 2012, J CYBERTHER REHABIL, V5; Glegg SMN, 2014, NEUROREHABILITATION, V35, P563, DOI 10.3233/NRE-141152; Glegg SMN, 2014, DISABIL REHABIL-ASSI, V9, P89, DOI 10.3109/17483107.2013.799236; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jones CA, 2015, PHYS THER, V95, P663, DOI 10.2522/ptj.20130512; Kamath T, 2012, PHYS OCCUP THER PEDI, V32, P288, DOI 10.3109/01942638.2012.672551; Kaminker MK, 2004, PHYS THER, V84, P919, DOI 10.1093/ptj/84.10.919; Kleim JA, 2008, J SPEECH LANG HEAR R, V51, pS225, DOI 10.1044/1092-4388(2008/018); Kleynen M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135522; Krakauer JW, 2006, CURR OPIN NEUROL, V19, P84, DOI 10.1097/01.wco.0000200544.29915.cc; Laver K, 2012, EUR J PHYS REHAB MED, V48, P523; Laver KE, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008349.pub2, 10.1002/14651858.CD008349.pub3, 10.1002/14651858.CD008349.pub4]; Levac D, 2015, PHYS THER, V95, P648, DOI 10.2522/ptj.20130500; Levac D, 2013, PEDIATR PHYS THER, V25, P53, DOI 10.1097/PEP.0b013e3182750c28; Levac D, 2012, PHYS OCCUP THER PEDI, V32, P180, DOI 10.3109/01942638.2011.616266; Levac D, 2012, RES DEV DISABIL, V33, P214, DOI 10.1016/j.ridd.2011.09.007; Levac D, 2011, PHYS THER, V91, P689, DOI 10.2522/ptj.20100415; Levac DE, 2013, PHYSIOTHER THEOR PR, V29, P504, DOI 10.3109/09593985.2012.762078; Levac DE, BMC HLTH SE IN PRESS; Levac DE, 2012, ARCH PHY MEDREHABIL; Levin MF, 2008, P 8 INT C VIRT REH; Levin MF, 2015, PHYS THER, V95, P415, DOI 10.2522/ptj.20130579; Levin MF, 2012, NEUROL THER, V1, DOI 10.1007/s40120-012-0003-9; Levin MF, 2011, EXPERT REV NEUROTHER, V11, P153, DOI 10.1586/ERN.10.201; MacDermid JC, 2006, IMPLEMENT SCI, V1, DOI 10.1186/1748-5908-1-14; Mathur S, 2005, PHYS THER, V85, P226, DOI 10.1093/ptj/85.3.226; Rizzo A, 2005, PRESENCE-TELEOP VIRT, V14, P119, DOI 10.1162/1054746053967094; Salvatori P, 2000, Can J Occup Ther, V67, P51; Saposnik G, 2011, STROKE, V42, P1380, DOI 10.1161/STROKEAHA.110.605451; Schmidt R. A, 2011, MOTOR CONTROL LEARNI; Schmidt RA., 1991, CONT MANAGEMENT MOTO, P49; Schoemaker M. M., 2013, THESIS; Scott SD, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-70; Squires JE, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0152-6; Subramanian SK, 2010, NEUROREHAB NEURAL RE, V24, P113, DOI 10.1177/1545968309349941; Sveistrup Heidi, 2004, J Neuroeng Rehabil, V1, P10, DOI 10.1186/1743-0003-1-10; Tatla SK, 2015, JMIR SERIOUS GAMES, V3, DOI 10.2196/games.3401; Wilson PN, 1997, DISABIL REHABIL, V19, P213, DOI 10.3109/09638289709166530; Winstein C, 2014, J NEUROL PHYS THER, V38, P190, DOI 10.1097/NPT.0000000000000046	45	24	26	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168311	10.1371/journal.pone.0168311	http://dx.doi.org/10.1371/journal.pone.0168311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI9QC	27992492	gold, Green Submitted, Green Published			2022-12-27	WOS:000392842600047
J	Melo, AHN; Macedo, MA				Nunes Melo, Adolfo Henrique; Macedo, Marcelo Andrade			Permanent Data Storage in ZnO Thin Films by Filamentary Resistive Switching	PLOS ONE			English	Article							EPITAXIAL-GROWTH; MEMRISTOR; BEHAVIOR; OXIDE	Resistive memories are considered the most promising candidates for the next generation of non-volatile memory; however, attention has so far been limited to rewritable memory features for applications in resistive random access memories (RRAM). In this article, we provide a new insight into the applicability of resistive memories. The characteristics of non-rewritable resistive memories (NRRM) were investigated. Devices with Pt/ZnO/ITO architecture were prepared using magnetron sputtering, upon which various bipolar and unipolar resistive switching tests were performed. The results showed excellent distinction between the high resistance state (HRS) and low resistance state (LRS), with RHRS/RLRS = 5.2 x 10(11) for the Pt/ZnO/ITO device with deposition time of 1 h. All samples were stable for more than 10(4) s, indicating that the devices have excellent applicability in NRRMs.	[Nunes Melo, Adolfo Henrique; Macedo, Marcelo Andrade] Univ Fed Sergipe, Dept Phys, Sao Cristovao, Sergipe, Brazil	Universidade Federal de Sergipe	Melo, AHN (corresponding author), Univ Fed Sergipe, Dept Phys, Sao Cristovao, Sergipe, Brazil.	adolfohnmelo@gmail.com	Macedo, Marcelo/ABF-2394-2020	Macedo, Marcelo/0000-0002-7396-6194; Nunes Melo, Adolfo Henrique/0000-0003-1207-7104				Asmar RA, 2005, J CRYST GROWTH, V279, P394, DOI 10.1016/j.jcrysgro.2005.02.035; Bae S, 2015, J ELECTRON MATER, V44, P4175, DOI 10.1007/s11664-015-3935-x; Ben Yahia S, 2008, SPECTROCHIM ACTA A, V71, P1234, DOI 10.1016/j.saa.2008.03.032; Chang WY, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2834852; Dugaiczyk L, 2013, CHEM PHYS LETT, V575, P112, DOI 10.1016/j.cplett.2013.05.005; Huang CH, 2013, ACS APPL MATER INTER, V5, P6017, DOI 10.1021/am4007287; Jin CM, 2005, MAT SCI ENG B-SOLID, V117, P348, DOI 10.1016/j.mseb.2004.12.003; Kang YH, 2011, SOLID STATE COMMUN, V151, P1739, DOI 10.1016/j.ssc.2011.08.036; Kim DS, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.174430; LAMPERT MA, 1956, PHYS REV, V103, P1648, DOI 10.1103/PhysRev.103.1648; Lee JW, 2015, SOLID STATE COMMUN, V209, P11, DOI [10.1016/j.ssc.2015.02.019, 10.1016/j.ssc.2015.02.045]; Lee S, 2010, J APPL PHYS, V108, DOI 10.1063/1.3489882; Li HX, 2013, THIN SOLID FILMS, V537, P279, DOI 10.1016/j.tsf.2013.04.028; Lin CL, 2015, MICROELECTRON ENG, V136, P15, DOI 10.1016/j.mee.2015.03.027; Melo AHN, 2014, ADV MATER RES-SWITZ, V975, P238, DOI 10.4028/www.scientific.net/AMR.975.238; Park G, 2016, OBSERVATION ELECT FI, V222103, P0; Pearton SJ, 2005, PROG MATER SCI, V50, P293, DOI 10.1016/j.pmatsci.2004.04.001; Qi J, 2012, ACS NANO, V6, P1051, DOI 10.1021/nn204809a; Ramachandran S, 2006, J CRYST GROWTH, V291, P212, DOI 10.1016/j.jcrysgro.2006.02.010; Santos DAA, 2015, MATER RES BULL, V66, P147, DOI 10.1016/j.materresbull.2015.02.051; Snure M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2749487; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Tapily K, 2010, ECS TRANSACTIONS, V33, P117, DOI 10.1149/1.3485248; Tiwari A, 2002, J MATER RES, V17, P2480, DOI 10.1557/JMR.2002.0361; Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023; Yang JJ, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/21/215201; Yang YC, 2009, J APPL PHYS, V106, DOI 10.1063/1.3273329; Zhang R, 2014, J NON-CRYST SOLIDS, V406, P102, DOI 10.1016/j.jnoncrysol.2014.09.055	28	13	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168515	10.1371/journal.pone.0168515	http://dx.doi.org/10.1371/journal.pone.0168515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992513	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600073
J	Zhang, ZX; Tian, X; Bai, YG; Liu, HF; Niu, XL; Wang, ZW; Wang, Q				Zhang, Zhixin; Tian, Xun; Bai, Yuguang; Liu, Huifang; Niu, Xueli; Wang, Zhiwei; Wang, Qian			Field Sandbur (Cenchrus pauciflorus) Seeds in the Same Bur Respond Differently to Temperature and Water Potential in Relation to Germination in a Semi-Arid Environment, China	PLOS ONE			English	Article							THERMAL TIME; ALIEN; INVASION; DESERT; DORMANCY; MODEL; SIZE	The success of a biological invasion relies on the environment and is closely linked to factors such as water and temperature. Invasive plant species display different seed characteristics, including shape. Field sandbur (Cenchrus pauciflorus) is a globally widespread invasive species capable of adapting to broad environmental conditions. However, its germination response to water and temperature still remains unclear. C. pauciflorus contains two seeds in the same bur that differ in size: big seeds (M) and small seeds (P). Separate greenhouse experiments were conducted under different temperature regimes (0/10 degrees C, 5/15 degrees C, 10/20 degrees C, 15/25 degrees C, 18/28 degrees C, 20/30 degrees C and 25/35 degrees C) and water potentials (-1.50Mpa, -1.00Mpa, -0.75Mpa, -0.50Mpa, -0.25Mpa and OMpa) for M and P seeds. The results support the hypothesis that germination of C. pauciflorus is significantly influenced by seed type, temperature and water potential. M and P seeds responded differently to varied alternative temperatures and water potentials. However, M and P seeds were more sensitive to water potential than to temperature. Optimal conditions for M and P seed germination were measured at 25/35 degrees C (night temperature/day temperature) and 20/30 degrees C, respectively. In contrast, the highest germination rate was observed for the OMpa of the water potential treatment. Additionally, base temperature (T-base) and base water potential (W-base) were lower for M (7.7 degrees C, -1.11Mpa at 10/20 degrees C, and -1.07Mpa at 20/, base, 30 degrees C) than for P (9.4 degrees C, -0.92Mpa at 10/20 degrees C, and -0.52Mpa at 20/30 degrees C). These different germination strategies of M and P seeds with respect to temperature and water potential increased overall plant propagation. These results indicate that tropical and subtropical regions water potentials beyond -0.50Mpa (10/20 degrees C) or -1.00Mpa (20/30 degrees C) face a potential risk of C. pauciflorus invasion.	[Zhang, Zhixin; Liu, Huifang; Niu, Xueli] Lanzhou Univ, State Key Lab Grassland Agroecosyst, Lanzhou, Gansu, Peoples R China; [Zhang, Zhixin; Niu, Xueli] Lanzhou Univ, Coll Pastoral Agr Sci & Technol, Lanzhou, Gansu, Peoples R China; [Tian, Xun] Inner Mongolia Univ Nationalities, Coll Life Sci, Tongliao, Inner Mongolia, Peoples R China; [Bai, Yuguang] Univ Saskatchewan, Coll Agr & Bioresources, Saskatoon, SK, Canada; [Wang, Zhiwei; Wang, Qian] Guizhou Acad Agr Sci, Guizhou Inst Prataculture, Guiyang, Guizhou, Peoples R China	Lanzhou University; Lanzhou University; Inner Mongolia University for Nationalities; University of Saskatchewan; Guizhou Academy of Agricultural Sciences	Tian, X (corresponding author), Inner Mongolia Univ Nationalities, Coll Life Sci, Tongliao, Inner Mongolia, Peoples R China.	tianxun@imun.edu.cn			State Key Basic Research Program 973 [2014 -CB138706]; National Natural Science Foundation of China [31360574, 31301922, 31570332]; Natural Science Foundation of Inner Mongolia [2011MS0403]	State Key Basic Research Program 973(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia	The research was supported by the following projects: State Key Basic Research Program 973 (2014 -CB138706), http://program.most.gov.cn/; the National Natural Science Foundation of China (31360574, 31301922, 31570332), http://www.nsfc.gov.cn/; Natural Science Foundation of Inner Mongolia (2011MS0403), http://nsbr.nmkjt.gov.cn/.	Acosta JM, 2014, WEED RES, V54, P584, DOI 10.1111/wre.12114; [Anonymous], 1991, WORLDS WORST WEEDS D; Bradley BA, 2010, BIOL INVASIONS, V12, P1855, DOI 10.1007/s10530-009-9597-y; Brandel M, 2004, FLORA, V199, P228, DOI 10.1078/0367-2530-00150; Cui JY, 2007, ARID LAND RES MANAG, V21, P165, DOI 10.1080/15324980701426306; Dana E, 2001, PLANT INVADERS SPAIN; Du Gm, 1995, DISTRIBUTION HARMFUL; Durr C, 2015, AGR FOREST METEOROL, V200, P222, DOI 10.1016/j.agrformet.2014.09.024; Ebrahimi E, 2012, WEED RES, V52, P50, DOI 10.1111/j.1365-3180.2011.00896.x; EMMERICH WE, 1990, AGRON J, V82, P1103, DOI 10.2134/agronj1990.00021962008200060015x; Fandrich L, 2005, WEED SCI, V53, P594, DOI 10.1614/WS-05-03R1.1; Fenner M., 1985, SEED ECOLOGY, P87; Flores J, 2001, J ARID ENVIRON, V47, P485, DOI 10.1006/jare.2000.0728; Fumanal B, 2007, ANN BOT-LONDON, V100, P305, DOI 10.1093/aob/mcm108; Gomez JM, 2004, EVOLUTION, V58, P71, DOI 10.1111/j.0014-3820.2004.tb01574.x; Belo RG, 2014, IND CROP PROD, V62, P537, DOI 10.1016/j.indcrop.2014.09.029; Gritti ES, 2006, J BIOGEOGR, V33, P145, DOI 10.1111/j.1365-2699.2005.01377.x; Guillemin JP, 2013, WEED RES, V53, P76, DOI 10.1111/wre.12000; Hu XW, 2015, AM J BOT, V102, P649, DOI 10.3732/ajb.1400507; Imbert E, 1997, OIKOS, V79, P325, DOI 10.2307/3546016; Luo J, 2012, WEED RES, V52, P112, DOI 10.1111/j.1365-3180.2011.00898.x; Lv LY, 2011, PRATACULT SCI, V1, P21; Mifsud S, CENTRAL MEDITERRANEA, V5, P6; Na C, 2011, SEED, V3, P9; Parsons W.T., 2001, NOXIOUS WEEDS AUSTR, Vsecond; Perglova I, 2009, PRESLIA, V81, P357; Pysek Petr, 2007, V193, P97; Quattrocchi U., 2006, CRC WORLD DICT GRASS; Schlaepfer DR, 2010, NEW PHYTOL, V185, P1087, DOI 10.1111/j.1469-8137.2009.03114.x; SCHONBECK MW, 1980, PLANT PHYSIOL, V65, P1149, DOI 10.1104/pp.65.6.1149; Song WJ, 2005, WEED RES, V45, P467, DOI 10.1111/j.1365-3180.2005.00477.x; Trudgill DL, 2005, ANN APPL BIOL, V146, P1, DOI 10.1111/j.1744-7348.2005.04088.x; Venable DL, 1998, EVOLUTION, V52, P344, DOI 10.1111/j.1558-5646.1998.tb01636.x; Wainwright CE, 2013, BIOL INVASIONS, V15, P2253, DOI 10.1007/s10530-013-0449-4; Wang R, 2004, ENVIRON EXP BOT, V51, P183, DOI 10.1016/j.envexpbot.2003.10.001; Weber E, 2008, BIOL INVASIONS, V10, P1411, DOI 10.1007/s10530-008-9216-3; Wen B, 2015, WEED RES, V55, P155, DOI 10.1111/wre.12134; Bin W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141567; Windauer LB, 2011, ANN BOT, P242; Windauer LB, 2012, ANN BOT-LONDON, V109, P265, DOI 10.1093/aob/mcr242; Xu HG, 2006, BIOL INVASIONS, V8, P1495, DOI 10.1007/s10530-005-5841-2; Xu J, 2011, CHINESE J GRASSLAND, V2, P5; Zhang ZX, 2012, PRATACULT SCI, V12, P21; Zhang ZX, 2011, PRATACULT SCI, V2, P5; Zhao Y, 2010, PRATACULT SCI, V4, P21; Zhu M. X., 2011, Middle East Journal of Scientific Research, V8, P479	46	3	7	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168394	10.1371/journal.pone.0168394	http://dx.doi.org/10.1371/journal.pone.0168394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992496	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600054
J	van Grieken, RA; Verburg, HF; Koeter, MWJ; Stricker, J; Nabitz, UW; Schene, AH				van Grieken, Rosa A.; Verburg, Hanka F.; Koeter, Maarten W. J.; Stricker, Jessica; Nabitz, Udo W.; Schene, Aart H.			Helpful Factors in the Treatment of Depression from the Patient's, Carer's and Professional's Perspective: A Concept Map Study	PLOS ONE			English	Article							SELF-MANAGEMENT; RECOVERY; ADHERENCE; OUTCOMES; BELIEFS	Objective Depression research has resulted in knowledge about neurobiology, pharmacological strategies and short-term cost-effective treatments. However, more than two-thirds of all depressed patients experience insufficient improvement. Therefore, a better understanding of what patients, carers and professionals perceive as most helpful in the treatment of depression is needed. Methods Concept mapping, a mixed-method design, was used to identify the patients (n = 33), carers (n = 22) and professionals (n = 50) perspectives. In six brainstorm sessions, the patients, carers and professionals generated 795 ideas, which were condensed into 55 unique statements. Subsequently, 100 participants prioritized and sorted these statements, which were analysed by multidimensional scaling and cluster analysis and visualized as a two-dimensional map. Results The 55 statements were clustered in 10 factors and further grouped into four main-factors (meta-clusters): 'Professional therapist', 'Treatment content', 'Structured treatment process' and 'Treatment organisation'. Patients and carers prioritized 'Treatment organisation' higher than professionals, but overall there was considerable agreement about the factors of treatment the participants perceived as most helpful including factors related to the therapeutic relationship and the 'creation of hope'. Conclusions Our study identified factors of depression treatment perceived as helpful according to patients, carers and professionals. Findings suggest that in a scientific era with emphasis on biological psychiatry, not only patients and carers, but also professionals consider aspecific factors the most helpful. Further studies might show that factors we found to be helpful in the treatment for depression, can be generalized to mental health treatment in general.	[van Grieken, Rosa A.; Verburg, Hanka F.; Koeter, Maarten W. J.; Stricker, Jessica] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Program Mood Disorders, Amsterdam, Netherlands; [Nabitz, Udo W.] Arkin Mental Hlth Care Serv, Dept Res & Qual, Amsterdam, Netherlands; [Schene, Aart H.] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, Nijmegen, Netherlands; [Schene, Aart H.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen	Schene, AH (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, Nijmegen, Netherlands.; Schene, AH (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands.	aart.schene@radboudumc.nl						American Psychiatric Association (APA), 2010, PRACTICE GUIDELINE T, V3rd; Badger TA, 1996, WESTERN J NURS RES, V18, P149, DOI 10.1177/019394599601800204; Bultman DC, 2000, PATIENT EDUC COUNS, V40, P173, DOI 10.1016/S0738-3991(99)00083-X; Comer J. S., 2013, BERGIN GARFIELDS HDB, Vsixth, P21; Constantino MJ, 2011, J CLIN PSYCHOL, V67, P184, DOI 10.1002/jclp.20754; de Vries G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085038; Deen TL, 2011, ADM POLICY MENT HLTH, V38, P345, DOI 10.1007/s10488-010-0322-z; Driessen E, 2013, AM J PSYCHIAT, V170, P1041, DOI 10.1176/appi.ajp.2013.12070899; Fava GA, 2007, PSYCHOTHER PSYCHOSOM, V76, P260, DOI 10.1159/000104701; Geers AL, 2013, J PERS SOC PSYCHOL, V105, P549, DOI 10.1037/a0034005; Gelhorn HL, 2011, PRIM CARE COMPANION, V13, P5; GRAWE K, 1995, PSYCHOTHERAPEUT, V40, P130; Greenberg RP, 2006, CLIN PSYCHOL REV, V26, P657, DOI 10.1016/j.cpr.2005.03.002; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hansson M, 2012, NORD J PSYCHIAT, V66, P290, DOI 10.3109/08039488.2011.644807; Kane M., 2007, CONCEPT MAPPING PLAN, V50; Lambert M.J., 1992, HDB PSYCHOTHERAPY IN, V1 ed, P94; Lewis L, 2003, BIOL PSYCHIAT, V53, P635, DOI 10.1016/S0006-3223(02)01789-4; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Nabitz U, 2017, EVAL PROGRAM PLANN, V60, P202, DOI 10.1016/j.evalprogplan.2016.08.012; Prins MA, 2008, CLIN PSYCHOL REV, V28, P1038, DOI 10.1016/j.cpr.2008.02.009; Rosas SR, 2012, EVAL PROGRAM PLANN, V35, P236, DOI 10.1016/j.evalprogplan.2011.10.003; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Severens P., 1995, HDB CONCEPT MAPPING; Spijker J, 2013, MULTIDISCIPLINAIRE R; Thomas ML, 2006, CONTEMP FAM THER, V28, P201, DOI 10.1007/s10591-006-9000-4; Tomba E, 2012, PSYCHIAT CLIN N AM, V35, P87, DOI 10.1016/j.psc.2011.11.003; TROCHIM WMK, 1989, EVAL PROGRAM PLANN, V12, P1, DOI 10.1016/0149-7189(89)90016-5; van Grieken RA, 2015, HEALTH EXPECT, V18, P1339, DOI 10.1111/hex.12112; van Grieken RA, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0331-7; van Grieken RA, 2014, J AFFECT DISORDERS, V167, P153, DOI 10.1016/j.jad.2014.05.065; van Schaik DJF, 2004, GEN HOSP PSYCHIAT, V26, P184, DOI 10.1016/j.genhosppsych.2003.12.001; Winter SE, 2013, PATIENT PREFER ADHER, V7, P1047, DOI 10.2147/PPA.S52746; Yeung A., 2010, SELF MANAGEMENT DEPR	34	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167719	10.1371/journal.pone.0167719	http://dx.doi.org/10.1371/journal.pone.0167719			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992453	gold, Green Submitted, Green Published			2022-12-27	WOS:000392758000015
J	Liao, YH; Tang, JS; Liu, JB; Xie, A; Yang, M; Johnson, M; Wang, XY; Deng, QJ; Chen, HX; Xiang, XJ; Liu, TQ; Chen, XG; Song, M; Hao, W				Liao, Yanhui; Tang, Jinsong; Liu, Jianbin; Xie, An; Yang, Mei; Johnson, Maritza; Wang, Xuyi; Deng, Qijian; Chen, Hongxian; Xiang, Xiaojun; Liu, Tieqiao; Chen, Xiaogang; Song, Ming; Hao, Wei			Decreased Thalamocortical Connectivity in Chronic Ketamine Users	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; NONMEDICAL USE; THALAMUS; ADDICTION; CORTEX; BRAIN; SCHIZOPHRENIA; NEUROBIOLOGY; MATTER	Disintegration in thalamocortical integration suggests its role in the mechanistic 'switch' from recreational to dysregulated drug seeking/addiction. In this study, we aimed to address whether thalamic nuclear groups show altered functional connectivity within the cerebral cortex in chronic ketamine users. One hundred and thirty subjects (41 ketamine users and 89 control subjects) underwent rsfMRI (resting-state functional Magnetic Resonance Imaging). Based on partial correlation functional connectivity analysis we partitioned the thalamus into six nuclear groups that correspond well with human histology. Then, in the area of each nuclear group, the functional connectivity differences between the chronic ketamine user group and normal control group were investigated. We found that the ketamine user group showed significantly less connectivity between the thalamic nuclear groups and the cortical regions-of-interest, including the prefrontal cortex, the motor cortex/supplementary motor area, and the posterior parietal cortex. However, no increased thalamic connectivity was observed for these regions as compared with controls. This study provides the first evidence of abnormal thalamocortical connectivity of resting state brain activity in chronic ketamine users. Further understanding of pathophysiological mechanisms of the thalamus in addiction (ketamine addiction) may facilitate the evaluation of much-needed novel pharmacological agents for improved therapy of this complex disease.	[Liao, Yanhui; Tang, Jinsong; Yang, Mei; Wang, Xuyi; Deng, Qijian; Chen, Hongxian; Xiang, Xiaojun; Liu, Tieqiao; Chen, Xiaogang; Hao, Wei] Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth,Key Lab Psychiat & Mental Hlth H, China Natl Clin Res Ctr Mental Hlth Disorders,Nat, Changsha, Hunan, Peoples R China; [Liao, Yanhui; Tang, Jinsong; Johnson, Maritza] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 760 Westwood Plaza, Los Angeles, CA 90024 USA; [Liu, Jianbin; Xie, An] Peoples Hosp Hunan Prov, Dept Radiol, Changsha, Hunan, Peoples R China; [Yang, Mei] Hunan Brain Hosp, Dept Addict Med, Changsha, Hunan, Peoples R China; [Yang, Mei] Shenzhen Kangning Hosp, Shenzhen Mental Hlth Ctr, Dept Addict Med, Shenzhen, Peoples R China; [Song, Ming] Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Beijing, Peoples R China; [Song, Ming] Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China	Central South University; University of California System; University of California Los Angeles; Chinese Academy of Sciences; Institute of Automation, CAS; Chinese Academy of Sciences; Institute of Automation, CAS	Tang, JS; Hao, W (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Mental Hlth,Key Lab Psychiat & Mental Hlth H, China Natl Clin Res Ctr Mental Hlth Disorders,Nat, Changsha, Hunan, Peoples R China.; Tang, JS (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 760 Westwood Plaza, Los Angeles, CA 90024 USA.; Song, M (corresponding author), Chinese Acad Sci, Inst Automat, Brainnetome Ctr, Beijing, Peoples R China.; Song, M (corresponding author), Chinese Acad Sci, Inst Automat, Natl Lab Pattern Recognit, Beijing, Peoples R China.	tangjinsonghn@gmail.com; msong@nlpr.ia.ac.cn; weihaochangsha@gmail.com	liu, tieqiao/GSE-2327-2022		Natural Science Foundation of China [81100996, 81671325, 81101040, 81471380, 81371480, 81371465, 81130020]; Beijing Municipal Science & Technology Commission [Z161100000216152]; Hunan Province '225' training project	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Hunan Province '225' training project	This work was supported by the Natural Science Foundation of China (Grant No. 81100996 and 81671325 to Y.L., 81101040 and 81471380 to M.S., 81371480 to J.T., 81371465 to T.L., 81130020 to W.H.) and Beijing Municipal Science & Technology Commission (No. Z161100000216152 to M.S.). J.T. was funded by Hunan Province '225' training project for high-level health professionals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balleine BW, 2015, BRAIN RES, V1628, P104, DOI 10.1016/j.brainres.2014.12.023; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Chan KWS, 2013, ADDICT BEHAV, V38, P2128, DOI 10.1016/j.addbeh.2013.01.014; DOMINO EF, 1965, CLIN PHARMACOL THER, V6, P279; Driesen NR, 2013, MOL PSYCHIATR, V18, P1199, DOI 10.1038/mp.2012.194; Gu H, 2010, NEUROIMAGE, V53, P593, DOI 10.1016/j.neuroimage.2010.06.066; Haber S, 2001, NEUROSCIENTIST, V7, P315, DOI 10.1177/107385840100700408; Hoeflich A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv040; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Jansen KLR, 2000, J PSYCHOACTIVE DRUGS, V32, P419, DOI 10.1080/02791072.2000.10400244; Jansen KLR, 2001, J PSYCHOACTIVE DRUGS, V33, P151, DOI 10.1080/02791072.2001.10400480; Kelly C, 2011, BIOL PSYCHIAT, V69, P684, DOI 10.1016/j.biopsych.2010.11.022; Li SJ, 2000, MAGNET RESON MED, V43, P45, DOI 10.1002/(SICI)1522-2594(200001)43:1<45::AID-MRM6>3.0.CO;2-0; Liang HJ, 2013, ADDICT BEHAV, V38, P2661, DOI 10.1016/j.addbeh.2013.06.017; Liao YH, 2012, NEUROSCI LETT, V522, P36, DOI 10.1016/j.neulet.2012.06.009; Liao YH, 2011, BIOL PSYCHIAT, V69, P42, DOI 10.1016/j.biopsych.2010.08.030; Liao YH, 2010, BRAIN, V133, P2115, DOI 10.1093/brain/awq131; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Ma N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016560; Ma N, 2010, NEUROIMAGE, V49, P738, DOI 10.1016/j.neuroimage.2009.08.037; Morgan CJA, 2006, PSYCHOPHARMACOLOGY, V188, P408, DOI 10.1007/s00213-006-0572-3; Morgan CJA, 2012, ADDICTION, V107, P27, DOI 10.1111/j.1360-0443.2011.03576.x; Mottola C A, 1993, Decubitus, V6, P56; Pal R, 2013, DRUG ALCOHOL DEPEN, V132, P189, DOI 10.1016/j.drugalcdep.2013.02.005; Scheidegger M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044799; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Sutherland MT, 2012, NEUROIMAGE, V62, P2281, DOI 10.1016/j.neuroimage.2012.01.117; Tang WK, 2015, SUBST ABUS, V36, P67, DOI 10.1080/08897077.2014.935560; Tsai GC, 2002, ANNU REV PHARMACOL, V42, P165, DOI 10.1146/annurev.pharmtox.42.082701.160735; Urbano FJ, 2009, BIOL PSYCHIAT, V66, P769, DOI 10.1016/j.biopsych.2009.04.026; Vollenweider FX, 2010, NAT REV NEUROSCI, V11, P642, DOI 10.1038/nrn2884; Weiss F, 2005, CURR OPIN PHARMACOL, V5, P9, DOI 10.1016/j.coph.2004.11.001; Welsh RC, 2010, SCHIZOPHRENIA BULL, V36, P713, DOI 10.1093/schbul/sbn145; Woodward ND, 2012, AM J PSYCHIAT, V169, P1092, DOI 10.1176/appi.ajp.2012.12010056; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Zhang DY, 2008, J NEUROPHYSIOL, V100, P1740, DOI 10.1152/jn.90463.2008; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182; Zhang S, 2014, NEUROIMAGE-CLIN, V4, P585, DOI 10.1016/j.nicl.2014.01.015	40	19	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0167381	10.1371/journal.pone.0167381	http://dx.doi.org/10.1371/journal.pone.0167381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977717	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400018
J	Shamsudhin, N; Laeubli, N; Atakan, HB; Vogler, H; Hu, CZ; Haeberle, W; Sebastian, A; Grossniklaus, U; Nelson, BJ				Shamsudhin, Naveen; Laeubli, Nino; Atakan, Huseyin Baris; Vogler, Hannes; Hu, Chengzhi; Haeberle, Walter; Sebastian, Abu; Grossniklaus, Ueli; Nelson, Bradley J.			Massively Parallelized Pollen Tube Guidance and Mechanical Measurements on a Lab-on-a-Chip Platform	PLOS ONE			English	Article							CELL-WALL; CYTOMECHANICAL PROPERTIES; SPERM DELIVERY; PLANT-CELLS; GROWTH; ARABIDOPSIS; TRANSCRIPTOME; INCOMPATIBILITY; QUANTIFICATION; GERMINATION	Pollen tubes are used as a model in the study of plant morphogenesis, cellular differentiation, cell wall biochemistry, biomechanics, and intra-and intercellular signaling. For a "systems- understanding" of the bio-chemo-mechanics of tip-polarized growth in pollen tubes, the need for a versatile, experimental assay platform for quantitative data collection and analysis is critical. We introduce a Lab-on-a-Chip (LoC) concept for high-throughput pollen germination and pollen tube guidance for parallelized optical and mechanical measurements. The LoC localizes a large number of growing pollen tubes on a single plane of focus with unidirectional tip-growth, enabling high-resolution quantitative microscopy. This species- independent LoC platform can be integrated with micro-/nano-indentation systems, such as the cellular force microscope (CFM) or the atomic force microscope (AFM), allowing for rapid measurements of cell wall stiffness of growing tubes. As a demonstrative example, we show the growth and directional guidance of hundreds of lily (Lilium longiflorum) and Arabidopsis (Arabidopsis thaliana) pollen tubes on a single LoC microscopy slide. Combining the LoC with the CFM, we characterized the cell wall stiffness of lily pollen tubes. Using the stiffness statistics and finite-element-method (FEM)-based approaches, we computed an effective range of the linear elastic moduli of the cell wall spanning the variability space of physiological parameters including internal turgor, cell wall thickness, and tube diameter. We propose the LoC device as a versatile and high-throughput phenomics platform for plant reproductive and development biology using the pollen tube as a model.	[Shamsudhin, Naveen; Laeubli, Nino; Atakan, Huseyin Baris; Hu, Chengzhi; Nelson, Bradley J.] ETH, Multiscale Robot Lab, Zurich, Switzerland; [Vogler, Hannes; Grossniklaus, Ueli] Univ Zurich, Dept Plant & Microbial Biol, Zurich, Switzerland; [Vogler, Hannes; Grossniklaus, Ueli] Zurich Basel Plant Sci Ctr, Zurich, Switzerland; [Haeberle, Walter; Sebastian, Abu] IBM Res Zurich, Ruschlikon, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; International Business Machines (IBM)	Hu, CZ; Nelson, BJ (corresponding author), ETH, Multiscale Robot Lab, Zurich, Switzerland.; Grossniklaus, U (corresponding author), Univ Zurich, Dept Plant & Microbial Biol, Zurich, Switzerland.; Grossniklaus, U (corresponding author), Zurich Basel Plant Sci Ctr, Zurich, Switzerland.	huc@ethz.ch; grossnik@botinst.uzh.ch; bnelson@ethz.ch	Grossniklaus, Ueli/E-9995-2016; vogler, hannes/K-8487-2012; Hu, Chengzhi/H-6903-2018; Nelson, Bradley/B-7761-2013; Läubli, Nino F./ABE-8136-2020; Sebastian, Abu/C-1652-2009	Grossniklaus, Ueli/0000-0002-0522-8974; vogler, hannes/0000-0002-6552-4708; Hu, Chengzhi/0000-0002-8627-2335; Nelson, Bradley/0000-0001-9070-6987; Läubli, Nino F./0000-0003-2894-2385; Sebastian, Abu/0000-0001-5603-5243	Research and Technology Development project MecanX by SystemsX.ch, the Swiss Initiative in Systems Biology; IBM Research - Zurich	Research and Technology Development project MecanX by SystemsX.ch, the Swiss Initiative in Systems Biology; IBM Research - Zurich	The authors acknowledge the financial support through the Research and Technology Development project MecanX, funded by SystemsX.ch, the Swiss Initiative in Systems Biology (www.systemsx.ch). IBM Research - Zurich provided support in the form of salaries for authors A.S. and W.H., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agudelo CG, 2013, PLANT J, V73, P1057, DOI 10.1111/tpj.12093; Altartouri B, 2014, CURRENT OPINION PL C, V23C, P76; Arata H, 2014, BIOCHEM SOC T, V42, P320, DOI 10.1042/BST20130258; BEDINGER P, 1992, PLANT CELL, V4, P879, DOI 10.1105/tpc.4.8.879; Benkert R, 1997, PROTOPLASMA, V198, P1, DOI 10.1007/BF01282125; Beyeler F, 2007, J MICROELECTROMECH S, V16, P7, DOI 10.1109/JMEMS.2006.885853; Beyeler F, 2009, J MICROELECTROMECH S, V18, P433, DOI 10.1109/JMEMS.2009.2013387; Bhargav SDB, 2015, MECH MACH THEORY, V91, P258, DOI 10.1016/j.mechmachtheory.2015.04.002; Boavida LC, 2007, PLANT J, V52, P570, DOI 10.1111/j.1365-313X.2007.03248.x; Boyer JS, 2009, FUNCT PLANT BIOL, V36, P383, DOI 10.1071/FP09048; Burri JT, 2016, DUAL AXIS CELL UNPUB; Busch W, 2012, NAT METHODS, V9, P1101, DOI [10.1038/NMETH.2185, 10.1038/nmeth.2185]; Chebli Y, 2012, PLANT PHYSIOL, V160, P1940, DOI 10.1104/pp.112.199729; Cheung AY, 2013, MOL PLANT, V6, P995, DOI 10.1093/mp/sst108; Cooper JR, 2009, PROC IEEE MICR ELECT, P208, DOI 10.1109/MEMSYS.2009.4805355; Cosgrove DJ, 1997, P NATL ACAD SCI USA, V94, P5504, DOI 10.1073/pnas.94.11.5504; Dresselhaus T, 2011, ANN BOT-LONDON, V108, P727, DOI 10.1093/aob/mcr017; Esch EW, 2015, NAT REV DRUG DISCOV, V14, P248, DOI 10.1038/nrd4539; Fayant P, 2010, PLANT CELL, V22, P2579, DOI 10.1105/tpc.110.075754; Feijo JA, 2004, CURR OPIN PLANT BIOL, V7, P589, DOI 10.1016/j.pbi.2004.07.014; Felekis D, 2011, MICRO NANO LETT, V6, P311, DOI 10.1049/mnl.2011.0024; Felekis D, 2015, INT J ROBOT RES, P1; Geitmann A, 2004, SEX PLANT REPROD, V17, P9, DOI 10.1007/s00497-004-0210-3; Geitmann A, 2004, BIOPHYS J, V86, P3314, DOI 10.1016/S0006-3495(04)74379-9; Grobei MA, 2009, GENOME RES, V19, P1786, DOI 10.1101/gr.089060.108; Haduch-Sendecka A, 2014, PLANTA, V240, P263, DOI 10.1007/s00425-014-2083-5; Hepler PK, 2006, PLANT CELL MONOGR, V3, P47, DOI 10.1007/7089_043; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Horade M, 2014, MICROELECTRON ENG, V118, P25, DOI 10.1016/j.mee.2014.01.017; Jiang HW, 2014, LAB CHIP, V14, P1281, DOI 10.1039/c3lc51326b; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Lang V, 2015, PLANT MOL BIOL, V87, P69, DOI 10.1007/s11103-014-0261-2; Lew RR, 2011, NAT REV MICROBIOL, V9, P509, DOI 10.1038/nrmicro2591; Loraine AE, 2013, PLANT PHYSIOL, V162, P1092, DOI 10.1104/pp.112.211441; Lord E, 2000, TRENDS PLANT SCI, V5, P368, DOI 10.1016/S1360-1385(00)01744-1; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Malho R, 2000, ANN BOT-LONDON, V85, P59, DOI 10.1006/anbo.1999.0991; Meister A, 2009, NANO LETT, V9, P2501, DOI 10.1021/nl901384x; MONEY NP, 1993, PLANTA, V190, P426; Nezhad AS, 2013, P NATL ACAD SCI USA, V110, P8093, DOI 10.1073/pnas.1221677110; Nezhad AS, 2013, LAB CHIP, V13, P2599, DOI [10.1039/c3lc00012e, 10.1039/c31c00012e]; Parre E, 2005, PLANTA, V220, P582, DOI 10.1007/s00425-004-1368-5; Parton RM, 2003, J CELL SCI, V116, P2707, DOI 10.1242/jcs.00468; Pina C, 2005, PLANT PHYSIOL, V138, P744, DOI 10.1104/pp.104.057935; Prado AM, 2004, DEVELOPMENT, V131, P2707, DOI 10.1242/dev.01153; Raman A, 2011, NAT NANOTECHNOL, V6, P809, DOI [10.1038/nnano.2011.186, 10.1038/NNANO.2011.186]; Rato C, 2004, PLANT J, V38, P887, DOI 10.1111/j.1365-313X.2004.02091.x; ROSEN WG, 1964, AM J BOT, V51, P61, DOI 10.2307/2440065; Rounds CM, 2010, PLANT PHYSIOL, V152, P736, DOI 10.1104/pp.109.150896; Routier-Kierzkowska AL, 2013, CURR OPIN PLANT BIOL, V16, P25, DOI 10.1016/j.pbi.2012.11.002; Routier-Kierzkowska AL, 2012, PLANT PHYSIOL, V158, P1514, DOI 10.1104/pp.111.191460; Smith AE, 2000, P NATL ACAD SCI USA, V97, P9871, DOI 10.1073/pnas.97.18.9871; Sun Y, 2002, INT J ROBOT RES, V21, P861, DOI 10.1177/0278364902021010833; Takayama S, 2001, NATURE, V411, P1016, DOI 10.1038/35082637; Vogler F, 2014, PLANT REPROD, V27, P153, DOI 10.1007/s00497-014-0247-x; Vogler H, 2013, PLANT J, V73, P617, DOI 10.1111/tpj.12061; Weber A, 2015, J EXP BOT, V66, P3229, DOI 10.1093/jxb/erv135; Wilsen KL, 2007, BIOSCIENCE, V57, P835, DOI 10.1641/b571006; Yakubov GE, 2016, J EXP BOT, V67, P2799, DOI 10.1093/jxb/erw117; Yetisen AK, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/5/054018; Zerzour R, 2009, DEV BIOL, V334, P437, DOI 10.1016/j.ydbio.2009.07.044; Zhang T, 2016, PLANT J, V85, P179, DOI 10.1111/tpj.13102; Zhao LM, 2005, BIOTECHNOL PROGR, V21, P292, DOI 10.1021/bp0497233	63	26	26	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168138	10.1371/journal.pone.0168138	http://dx.doi.org/10.1371/journal.pone.0168138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977748	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000391217400067
J	Yeasmin, AMST; Waliullah, TM; Kondo, A; Kaneko, A; Koike, N; Ushimaru, T				Yeasmin, Akter M. S. T.; Waliullah, Talukdar Muhammad; Kondo, Akihiro; Kaneko, Atsuki; Koike, Naoki; Ushimaru, Takashi			Orchestrated Action of PP2A Antagonizes Atg13 Phosphorylation and Promotes Autophagy after the Inactivation of TORC1	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; VACUOLE TARGETING PATHWAY; KINASE SIGNALING PATHWAY; SACCHAROMYCES-CEREVISIAE; REGULATES AUTOPHAGY; ALZHEIMERS-DISEASE; AMYLOID-BETA; OKADAIC ACID; CELL-GROWTH; YEAST	Target of rapamycin complex 1 (TORC1) phosphorylates autophagy-related Atg13 and represses autophagy under nutrient-rich conditions. However, when TORC1 becomes inactive upon nutrient depletion or treatment with the TORC1 inhibitor rapamycin, Atg13 dephosphorylation occurs rapidly, and autophagy is induced. At present, the phosphatases involved in Atg13 dephosphorylation remain unknown. Here, we show that two protein phosphatase 2A (PP2A) phosphatases, PP2A-Cdc55 and PP2A-Rts1, which are activated by inactivation of TORC1, are required for sufficient Atg13 dephosphorylation and autophagy induction after TORC1 inactivation in budding yeast. After rapamycin treatment, dephosphorylation of Atg13, activation of Atg1 kinase, pre-autophagosomal structure (PAS) formation and autophagy induction are all impaired in PP2A-deleted cells. Conversely, overexpression of non-phosphorylatable Atg13 suppressed defects in autophagy in PP2A mutant. This study revealed that the orchestrated action of PP2A antagonizes Atg13 phosphorylation and promotes autophagy after the inactivation of TORC1.	[Yeasmin, Akter M. S. T.; Waliullah, Talukdar Muhammad; Ushimaru, Takashi] Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka, Japan; [Kaneko, Atsuki; Koike, Naoki; Ushimaru, Takashi] Shizuoka Univ, Fac Sci, Suruga Ku, Shizuoka, Japan	Shizuoka University; Shizuoka University	Ushimaru, T (corresponding author), Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, Shizuoka, Japan.; Ushimaru, T (corresponding author), Shizuoka Univ, Fac Sci, Suruga Ku, Shizuoka, Japan.	takashi.ushimaru@gmail.com	Talukdar, Muhammad Waliullah/O-5971-2016	Talukdar, Muhammad Waliullah/0000-0001-9951-2871; Akter, Mst Yeasmin/0000-0002-1246-617X	Ministry of Education, Science, Sports, and Culture of Japan [19370082, 23570225]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Science, Sports, and Culture of Japan (No. 19370082 and 23570225).	Banreti A, 2012, AUTOPHAGY, V8, P623, DOI 10.4161/auto.19081; BLANKSON H, 1995, EXP CELL RES, V218, P522, DOI 10.1006/excr.1995.1187; Budovskaya YV, 2004, J BIOL CHEM, V279, P20663, DOI 10.1074/jbc.M400272200; Caccamo A, 2010, J BIOL CHEM, V285, P13107, DOI 10.1074/jbc.M110.100420; Evans DRH, 1997, GENETICS, V145, P227; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Fujioka Y, 2014, NAT STRUCT MOL BIOL, V21, P513, DOI 10.1038/nsmb.2822; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Heideker J, 2007, CELL CYCLE, V6, P3058, DOI 10.4161/cc.6.24.5100; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Huang D, 2007, MOL MICROBIOL, V66, P303, DOI 10.1111/j.1365-2958.2007.05914.x; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782; Jiang Y, 2006, MICROBIOL MOL BIOL R, V70, P440, DOI 10.1128/MMBR.00049-05; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kawamata T, 2008, MOL BIOL CELL, V19, P2039, DOI 10.1091/mbc.E07-10-1048; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Magnaudeix A, 2013, NEUROBIOL AGING, V34, P770, DOI 10.1016/j.neurobiolaging.2012.06.026; Mao K, 2011, J CELL BIOL, V193, P755, DOI 10.1083/jcb.201102092; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Noda T, 2008, METHOD ENZYMOL, V451, P33, DOI 10.1016/S0076-6879(08)03203-5; Reggiori F, 2013, GENETICS, V194, P341, DOI 10.1534/genetics.112.149013; RONNE H, 1991, MOL CELL BIOL, V11, P4876, DOI 10.1128/MCB.11.10.4876; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; Samari HR, 2005, BIOCHEM J, V386, P237, DOI 10.1042/BJ20040609; Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Shintani T, 2001, J BIOL CHEM, V276, P30452, DOI 10.1074/jbc.M102346200; Sontag JM, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00016; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Stephan JS, 2009, P NATL ACAD SCI USA, V106, P17049, DOI 10.1073/pnas.0903316106; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Tan CC, 2014, NEUROBIOL AGING, V35, P941, DOI 10.1016/j.neurobiolaging.2013.11.019; Tate JJ, 2009, J BIOL CHEM, V284, P2522, DOI 10.1074/jbc.M806162200; Umekawa M, 2012, J BIOL CHEM, V287, P16300, DOI 10.1074/jbc.M112.344952; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Yang ZF, 2010, MOL CELL, V38, P250, DOI 10.1016/j.molcel.2010.02.033; Yeh YY, 2010, GENETICS, V185, P871, DOI 10.1534/genetics.110.116566; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Yorimitsu T, 2009, AUTOPHAGY, V5, P616, DOI 10.4161/auto.5.5.8091; Zabrocki P, 2002, MOL MICROBIOL, V43, P835, DOI 10.1046/j.1365-2958.2002.02786.x; Zuzuarregui A, 2012, NAT METHODS, V9, P594, DOI [10.1038/NMETH.2017, 10.1038/nmeth.2017]	55	36	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0166636	10.1371/journal.pone.0166636	http://dx.doi.org/10.1371/journal.pone.0166636			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973551	Green Submitted, Green Published, gold			2022-12-27	WOS:000392754300010
J	Li, PZ; Ying, J; Yang, GJ; Li, AF; Wang, J; Lu, JW; Wang, JR; Xu, T; Yi, HG; Li, KW; Jin, SG; Bao, QY; Zhang, KB				Li, Peizhen; Ying, Jun; Yang, Guangjian; Li, Aifang; Wang, Jian; Lu, Junwan; Wang, Junrong; Xu, Teng; Yi, Huiguang; Li, Kewei; Jin, Shouguang; Bao, Qiyu; Zhang, Kaibo			Structure-Function Analysis of the Transmembrane Protein AmpG from Pseudomonas aeruginosa	PLOS ONE			English	Article							BETA-LACTAMASE INDUCTION; ESCHERICHIA-COLI; GENE; EXPRESSION; SEQUENCE; MUTATIONS; RELEASE; LEVEL; PCR	AmpG is a transmembrane protein with permease activity that transports meuropeptide from the periplasm to the cytoplasm, which is essential for the induction of the ampC encoding beta-lactamase. To obtain new insights into the relationship between AmpG structure and function, comparative genomics analysis, secondary and tertiary structure modeling, site-directed mutational analyses and genetic complementation experiments were performed in this study. AmpGs from different genera of bacteria (Escherichia coli, Vibrio cholerae and Acinetobacter baumannii) could complement AmpG function in Pseudomonas aeruginosa. The minimal inhibitory concentration (MIC) to ampicillin is 512 mu g/ml for wild type strain PAO1, while it is 32 mu g/ml for an ampG deletion mutant strain (PAO1 Delta ampG) with a corresponding decrease in the activity of the ampC-encoded beta-lactamase. Site-directed mutagenesis of conserved AmpG residues (G29, A129, Q131 and A197) resulted in a loss of function, resulting in a loss of resistance to ampicillin in PAO1 Delta ampG. The G29A, G29V, A129T, A129V, A129D, A197S and A197D mutants had lower resistance to ampicillin and significantly decreased activity of the AmpC beta-lactamase. The G29A, G29V, A129V, A197S and A197D mutants had decreased ampG mRNA transcript levels. The A129T and A129D mutants had normal ampG mRNA transcript levels, but the function of the protein was drastically reduced. Our experimental results demonstrate that the conserved amino acids played essential roles in maintaining the function of AmpG. Combined with the AmpG structural information, these critical amino acids can be targeted for the development of new anti-bacterial agents.	[Li, Peizhen; Ying, Jun; Yang, Guangjian; Li, Aifang; Wang, Jian; Xu, Teng; Yi, Huiguang; Li, Kewei; Bao, Qiyu; Zhang, Kaibo] Wenzhou Med Univ, Sch Lab Med & Life Sci, Inst Biomed Informat, Wenzhou, Peoples R China; [Lu, Junwan; Zhang, Kaibo] Lishui Coll, Sch Med, Lishui, Peoples R China; [Wang, Junrong] Wenling Womens & Childrens Hosp, Wenling, Peoples R China; [Jin, Shouguang] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	Wenzhou Medical University; Lishui University; State University System of Florida; University of Florida	Bao, QY; Zhang, KB (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Inst Biomed Informat, Wenzhou, Peoples R China.; Zhang, KB (corresponding author), Lishui Coll, Sch Med, Lishui, Peoples R China.	baoqy@genomics.cn; 893286261@qq.com	Jin, Shouguang/N-5548-2016; Bao, Qiyu/AAH-6113-2020	Bao, Qiyu/0000-0001-6523-8763	Natural Science Foundation of Zhejiang Province [LY14C060005]; Science and Technology Foundation of National Health and Family Planning Commission of China [WKJ2012-2-032]; National Natural Science Foundation of China [81401702, 81501808, 81501780]; Science and Technology Foundation of Wenling City [W201195, W201075, 2016C31BE0029]; NIH [R21-AI119043]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Science and Technology Foundation of National Health and Family Planning Commission of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Foundation of Wenling City; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was funded by grants from the Natural Science Foundation of Zhejiang Province (LY14C060005), the Science and Technology Foundation of National Health and Family Planning Commission of China (WKJ2012-2-032), the National Natural Science Foundation of China (81401702, 81501808, 81501780), the Science and Technology Foundation of Wenling City (W201195, W201075, 2016C31BE0029), and the NIH (R21-AI119043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adin DM, 2009, J BACTERIOL, V191, P2012, DOI 10.1128/JB.01547-08; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Cheng QM, 2002, J BACTERIOL, V184, P6434, DOI 10.1128/JB.184.23.6434-6436.2002; Dietz H, 1997, ANTIMICROB AGENTS CH, V41, P2113, DOI 10.1128/AAC.41.10.2113; Garcia DL, 2008, J BACTERIOL, V190, P3799, DOI 10.1128/JB.01194-07; Hanson ND, 2002, J ANTIMICROB CHEMOTH, V49, P1011, DOI 10.1093/jac/dkf052; Huang YW, 2010, ANTIMICROB AGENTS CH, V54, P2583, DOI 10.1128/AAC.01283-09; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Klepeis JL, 2005, COMPUT CHEM ENG, V29, P423, DOI 10.1016/j.compchemeng.2004.07.017; Komolafe O O, 2003, Malawi Med J, V15, P63; Kong KF, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-328; KORFMANN G, 1989, ANTIMICROB AGENTS CH, V33, P1946, DOI 10.1128/AAC.33.11.1946; Langaee TY, 2000, ANTIMICROB AGENTS CH, V44, P583, DOI 10.1128/AAC.44.3.583-589.2000; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MITCHELL P, 1957, NATURE, V180, P134, DOI 10.1038/180134a0; Park JT, 2008, MICROBIOL MOL BIOL R, V72, P211, DOI 10.1128/MMBR.00027-07; Roberts RR, 2009, CLIN INFECT DIS, V49, P1175, DOI 10.1086/605630; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHMIDT H, 1995, MICROBIOL-SGM, V141, P1085, DOI 10.1099/13500872-141-5-1085; Schmidtke AJ, 2008, ANTIMICROB AGENTS CH, V52, P3922, DOI 10.1128/AAC.00341-08; Simner PJ, 2011, DIAGN MICR INFEC DIS, V69, P326, DOI 10.1016/j.diagmicrobio.2010.10.029; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Trepanier S, 1997, ANTIMICROB AGENTS CH, V41, P2399, DOI 10.1128/AAC.41.11.2399; Wang HL, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-6; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Yang TC, 2013, FEMS MICROBIOL LETT, V340, P101, DOI 10.1111/1574-6968.12071; Ying JC, 2015, INT J BIOL SCI, V11, P11, DOI 10.7150/ijbs.10320; Zamorano L, 2011, ANTIMICROB AGENTS CH, V55, P1990, DOI 10.1128/AAC.01688-10; Zhang Y, 2010, ANTIMICROB AGENTS CH, V54, P4772, DOI 10.1128/AAC.00009-10	33	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168060	10.1371/journal.pone.0168060	http://dx.doi.org/10.1371/journal.pone.0168060			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959942	Green Submitted, Green Published, gold			2022-12-27	WOS:000392753900036
J	Shah, SN; Gelderman, MP; Lewis, EMA; Farrel, J; Wood, F; Strader, MB; Alayash, AI; Vostal, JG				Shah, Sandeep N.; Gelderman, Monique P.; Lewis, Emily M. A.; Farrel, John; Wood, Francine; Strader, Michael Brad; Alayash, Abdu I.; Vostal, Jaroslav G.			Evaluation of Stem Cell-Derived Red Blood Cells as a Transfusion Product Using a Novel Animal Model	PLOS ONE			English	Article							HUMAN ERYTHROID PROGENITORS; EX-VIVO GENERATION; HEMATOPOIETIC STEM; FETAL-HEMOGLOBIN; IN-VITRO; HEREDITARY PERSISTENCE; GENE-EXPRESSION; CORD BLOOD; ENUCLEATION; MICE	Reliance on volunteer blood donors can lead to transfusion product shortages, and current liquid storage of red blood cells (RBCs) is associated with biochemical changes over time, known as 'the storage lesion'. Thus, there is a need for alternative sources of transfusable RBCs to supplement conventional blood donations. Extracorporeal production of stem cellderived RBCs (stemRBCs) is a potential and yet untapped source of fresh, transfusable RBCs. A number of groups have attempted RBC differentiation from CD34(+) cells. However, it is still unclear whether these stemRBCs could eventually be effective substitutes for traditional RBCs due to potential differences in oxygen carrying capacity, viability, deformability, and other critical parameters. We have generated ex vivo stemRBCs from primary human cord blood CD34(+) cells and compared them to donor-derived RBCs based on a number of in vitro parameters. In vivo, we assessed stemRBC circulation kinetics in an animal model of transfusion and oxygen delivery in a mouse model of exercise performance. Our novel, chronically anemic, SCID mouse model can evaluate the potential of stemRBCs to deliver oxygen to tissues (muscle) under resting and exercise-induced hypoxic conditions. Based on our data, stem cell-derived RBCs have a similar biochemical profile compared to donor-derived RBCs. While certain key differences remain between donor-derived RBCs and stemRBCs, the ability of stemRBCs to deliver oxygen in a living organism provides support for further development as a transfusion product.	[Shah, Sandeep N.; Gelderman, Monique P.; Lewis, Emily M. A.; Farrel, John; Vostal, Jaroslav G.] US FDA, Lab Cellular Hematol, Div Hematol Res & Review, Off Blood Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Wood, Francine; Strader, Michael Brad; Alayash, Abdu I.] US FDA, Lab Biochem & Vasc Biol, Div Hematol Res & Review, Off Blood Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Vostal, JG (corresponding author), US FDA, Lab Cellular Hematol, Div Hematol Res & Review, Off Blood Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Jaroslav.Vostal@fda.hhs.gov			FDA Critical Path research funding	FDA Critical Path research funding	Funding for this project came through FDA Critical Path research funding.	Akinsheye I, 2011, BLOOD, V118, P19, DOI 10.1182/blood-2011-03-325258; [Anonymous], 2013, 2011 NATL BLOOD COLL; Anstee DJ, 2012, CURR OPIN HEMATOL, V19, P163, DOI 10.1097/MOH.0b013e328352240a; Baek EJ, 2009, TRANSFUSION, V49, P2285, DOI 10.1111/j.1537-2995.2009.02303.x; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Betz T, 2009, P NATL ACAD SCI USA, V106, P15320, DOI 10.1073/pnas.0904614106; Beutler E., 1995, OSMOTIC FRAGILITY; Beutler E, 1983, OSMOTIC FRAGILITY; Buehler PW, 2004, TRANSFUSION, V44, P1516, DOI 10.1111/j.1537-2995.2004.04081.x; Can A, 2012, JOVE-J VIS EXP, V59, P3638, DOI DOI 10.3791/3638; CONLEY CL, 1963, BLOOD, V21, P261, DOI 10.1182/blood.V21.3.261.261; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Darling RC, 1941, J CLIN INVEST, V20, P739, DOI 10.1172/JCI101267; Dhabangi A, 2015, JAMA-J AM MED ASSOC, V314, P2514, DOI 10.1001/jama.2015.13977; di Prampero PE, 1999, RESP PHYSIOL, V118, P103, DOI 10.1016/S0034-5687(99)00083-3; Fujimi A, 2008, INT J HEMATOL, V87, P339, DOI 10.1007/s12185-008-0062-y; Gelderman MP, 2010, TRANSFUSION MED, V20, P341, DOI 10.1111/j.1365-3148.2010.01016.x; Gelderman MP, 2015, HAEMATOLOGICA, V100, P611, DOI 10.3324/haematol.2014.117325; Gelderman MP, 2011, TRANSFUSION, V51, P1096, DOI 10.1111/j.1537-2995.2010.02972.x; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Goo YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097390; Griffiths RE, 2012, BLOOD, V119, P6296, DOI 10.1182/blood-2011-09-376475; GUEST GM, 1948, BLOOD, V3, P541, DOI 10.1182/blood.V3.5.541.541; Heaven MR, 2016, J MASS SPECTROM, V51, P1, DOI 10.1002/jms.3716; Jin H, 2014, BIOMED RES INT, V2014; Jin HM, 2011, INT J MOL SCI, V12, P4770, DOI 10.3390/ijms12084770; Jung K, 2004, J ETHNOPHARMACOL, V93, P75, DOI 10.1016/j.jep.2004.03.022; Khodabux CM, 2013, TRANSFUSION, V53, P3230, DOI 10.1111/trf.12169; Kirby BS, 2014, AM J PHYSIOL-HEART C, V307, pH1737, DOI 10.1152/ajpheart.00542.2014; Kuphal KE, 2007, J PAIN, V8, P989, DOI 10.1016/j.jpain.2007.08.001; Lapillonne H, 2010, HAEMATOL-HEMATOL J, V95, P1651, DOI 10.3324/haematol.2010.023556; Leberbauer C, 2005, BLOOD, V105, P85, DOI 10.1182/blood-2004-03-1002; Leparc GF, 2015, CANCER CONTROL, V22, P6; Lu SJ, 2008, BLOOD, V112, P4475, DOI 10.1182/blood-2008-05-157198; McGrath KE, 2008, BLOOD, V111, P2409, DOI 10.1182/blood-2007-08-107581; Migliaccio AR, 2012, CELL STEM CELL, V10, P115, DOI 10.1016/j.stem.2012.01.001; Miharada K, 2006, NAT BIOTECHNOL, V24, P1255, DOI 10.1038/nbt1245; Mountford J, 2010, BRIT J HAEMATOL, V149, P22, DOI 10.1111/j.1365-2141.2010.08079.x; Ngo DA, 2012, BRIT J HAEMATOL, V156, P259, DOI 10.1111/j.1365-2141.2011.08916.x; Park YK, 2010, P NATL ACAD SCI USA, V107, P1289, DOI 10.1073/pnas.0910785107; Patel S, 2015, J CLIN DIAGN RES, V9, pOD9, DOI 10.7860/JCDR/2015/12878.6548; Rousseau GF, 2014, BIOTECHNOL J, V9, P28, DOI 10.1002/biot.201200368; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Singh VK, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00026; Strader MB, 2014, J BIOL CHEM, V289, P22342, DOI 10.1074/jbc.M114.568980; Tao ZY, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-251; Timmins NE, 2011, TISSUE ENG PART C-ME, V17, P1131, DOI [10.1089/ten.tec.2011.0207, 10.1089/ten.TEC.2011.0207]; Zhang X, 2007, BIOL RES, V40, P41, DOI 10.4067/S0716-97602007000100005; Zimring JC, 2011, TRANSFUSION, V51, P435, DOI 10.1111/j.1537-2995.2010.03024.x	50	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0166657	10.1371/journal.pone.0166657	http://dx.doi.org/10.1371/journal.pone.0166657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959920	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900004
J	Storch, K; Dickreuter, E; Artati, A; Adamski, J; Cordes, N				Storch, Katja; Dickreuter, Ellen; Artati, Anna; Adamski, Jerzy; Cordes, Nils			BEMER Electromagnetic Field Therapy Reduces Cancer Cell Radioresistance by Enhanced ROS Formation and Induced DNA Damage	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MAGNETIC-FIELDS; NEUROBLASTOMA-CELLS; TUMOR-GROWTH; RESISTANCE; EXPOSURE; PROLIFERATION; MECHANISMS; APOPTOSIS; LEVEL	Each year more than 450,000 Germans are expected to be diagnosed with cancer subsequently receiving standard multimodal therapies including surgery, chemotherapy and radiotherapy. On top, molecular-targeted agents are increasingly administered. Owing to intrinsic and acquired resistance to these therapeutic approaches, both the better molecular understanding of tumor biology and the consideration of alternative and complementary therapeutic support are warranted and open up broader and novel possibilities for therapy personalization. Particularly the latter is underpinned by the increasing utilization of noninvasive complementary and alternative medicine by the population. One investigated approach is the application of low-dose electromagnetic fields (EMF) to modulate cellular processes. A particular system is the BEMER therapy as a Physical Vascular Therapy for which a normalization of the microcirculation has been demonstrated by a low-frequency, pulsed EMF pattern. Open remains whether this EMF pattern impacts on cancer cell survival upon treatment with radiotherapy, chemotherapy and the molecular-targeted agent Cetuximab inhibiting the epidermal growth factor receptor. Using more physiological, three-dimensional, matrix-based cell culture models and cancer cell lines originating from lung, head and neck, colorectal and pancreas, we show significant changes in distinct intermediates of the glycolysis and tricarboxylic acid cycle pathways and enhanced cancer cell radiosensitization associated with increased DNA double strand break numbers and higher levels of reactive oxygen species upon BEMER treatment relative to controls. Intriguingly, exposure of cells to the BEMER EMF pattern failed to result in sensitization to chemotherapy and Cetuximab. Further studies are necessary to better understand the mechanisms underlying the cellular alterations induced by the BEMER EMF pattern and to clarify the application areas for human disease.	[Storch, Katja; Dickreuter, Ellen; Cordes, Nils] Tech Univ Dresden, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany; [Storch, Katja; Dickreuter, Ellen; Cordes, Nils] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Storch, Katja; Dickreuter, Ellen; Cordes, Nils] Helmholtz Zentrum Dresden Rossendorf, Inst Radiooncol, Dresden, Germany; [Artati, Anna; Adamski, Jerzy] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Genome Anal Ctr, Inst Expt Genet, Neuherberg, Germany; [Adamski, Jerzy] Tech Univ Munich, Lehrstuhl Expt Genet, Freising Weihenstephan, Germany; [Adamski, Jerzy] German Ctr Diabet Res DZD eV, Munich, Germany; [Cordes, Nils] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Radiat Oncol, Dresden, Germany; [Cordes, Nils] German Canc Consortium DKTK, Dresden, Germany; [Cordes, Nils] German Canc Res Ctr, Heidelberg, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Cordes, N (corresponding author), Tech Univ Dresden, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany.; Cordes, N (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany.; Cordes, N (corresponding author), Helmholtz Zentrum Dresden Rossendorf, Inst Radiooncol, Dresden, Germany.; Cordes, N (corresponding author), Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Radiat Oncol, Dresden, Germany.; Cordes, N (corresponding author), German Canc Consortium DKTK, Dresden, Germany.; Cordes, N (corresponding author), German Canc Res Ctr, Heidelberg, Germany.	Nils.Cordes@OncoRay.de		Adamski, Jerzy/0000-0001-9259-0199; Cordes, Nils/0000-0001-5684-629X	BEMER Int. AG (Liechtenstein); Deutsche Krebshilfe [108976]; European Union (RADIATE) [642623]; EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen [100066308]; German Federal Ministry of Education and Research (BMBF)	BEMER Int. AG (Liechtenstein); Deutsche Krebshilfe(Deutsche Krebshilfe); European Union (RADIATE); EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	The research and authors were in part supported by the BEMER Int. AG (Liechtenstein) and grants from the Deutsche Krebshilfe (108976 to N.C.), the European Union (RADIATE; GA No. 642623 to N.C.) and the EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen (100066308). This work was also supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research and authors were in part supported by the BEMER Int. AG (Liechtenstein) and grants from the Deutsche Krebshilfe (108976 to N.C.), the European Union (RADIATE; GA No.642623 to N.C.) and the EFRE Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen (100066308). This work was also supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). We are grateful to R. Grenman for providing UTSCC15 cell line.	Al-Dimassi S, 2014, CLIN TRANSL ONCOL, V16, P511, DOI 10.1007/s12094-014-1162-1; Baharara J, 2015, CYTOTECHNOLOGY; Bohn Wolfgang, 2013, J Complement Integr Med, V10, pS1, DOI 10.1515/jcim-2013-0036; Bohn Wolfgang, 2013, J Complement Integr Med, V10, pS5, DOI 10.1515/jcim-2013-0037; Buckner CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124136; Cameron IL, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-23; Cameron IL, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0125-5; Crocetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072944; Delle Monache S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061484; Destefanis M, 2015, INT J RADIAT BIOL, V91, P964, DOI 10.3109/09553002.2015.1101648; Duan YQ, 2014, FOOD FUNCT, V5, P2289, DOI [10.1039/c4fo00250d, 10.1039/C4FO00250D]; Eke I., 2015, J BIOL METHODS, V2, P31, DOI [DOI 10.14440/JBM.2015.96, 10.14440/jbm.2015.96]; Eke I, 2016, INT J ONCOL, V48, P313, DOI 10.3892/ijo.2015.3230; Eke I, 2015, SEMIN CANCER BIOL, V31, P65, DOI 10.1016/j.semcancer.2014.07.009; Eke I, 2013, CANCER RES, V73, P297, DOI 10.1158/0008-5472.CAN-12-2021; Eke I, 2012, J CLIN INVEST, V122, P1529, DOI 10.1172/JCI61350; Elson E, 2009, ELECTROMAGN BIOL MED, V28, P275, DOI [10.1080/15368370903114271, 10.3109/15368370903114271]; Falone S, 2007, INT J BIOCHEM CELL B, V39, P2093, DOI 10.1016/j.biocel.2007.06.001; Francisco AC, 2013, INT J MOL SCI, V14, P14974, DOI 10.3390/ijms140714974; GORCZYNSKA E, 1991, ENVIRON RES, V55, P188, DOI 10.1016/S0013-9351(05)80175-6; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jiang Y, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/4927035; Karagiannis TC, 2004, CELL MOL LIFE SCI, V61, P2137, DOI 10.1007/s00018-004-4174-0; Kim J, 2010, BIOCHEM BIOPH RES CO, V400, P739, DOI 10.1016/j.bbrc.2010.08.140; Kirson ED, 2004, CANCER RES, V64, P3288, DOI 10.1158/0008-5472.CAN-04-0083; Marchesi N, 2014, J CELL PHYSIOL, V229, P1776, DOI 10.1002/jcp.24631; Miao XD, 2015, J ORTHOP SURG RES, V10, DOI 10.1186/s13018-015-0247-z; Patruno A, 2012, J CELL PHYSIOL, V227, P2767, DOI 10.1002/jcp.23024; Phillips J L, 2009, Pathophysiology, V16, P79, DOI 10.1016/j.pathophys.2008.11.005; Piatkowski J, 2009, MULT SCLER, V15, pS255; Piatkowski J, 2011, ALTERN THER HEALTH M, V17, P22; Reubold TF, 2012, CELL SIGNAL, V24, P1420, DOI 10.1016/j.cellsig.2012.03.007; Rihova B, 2011, J DRUG TARGET, V19, P890, DOI 10.3109/1061186X.2011.622403; Ruiz-Gomez MJ, 2009, ELECTROMAGN BIOL MED, V28, P201, DOI 10.1080/15368370802608696; Ruiz-Gomez MJ, 2002, BIOELECTROMAGNETICS, V23, P578, DOI 10.1002/bem.10054; Storch K, 2010, CANCER RES, V70, P3925, DOI 10.1158/0008-5472.CAN-09-3848; Tannock IF, 2001, CANCER METAST REV, V20, P123, DOI 10.1023/A:1013125027697; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Tofani S, 2001, BIOELECTROMAGNETICS, V22, P419, DOI 10.1002/bem.69; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; Walther M, 2007, ELECTROMAGN BIOL MED, V26, P179, DOI 10.1080/15368370701580814; Wen JA, 2011, BIOELECTROMAGNETICS, V32, P322, DOI 10.1002/bem.20646; Winker R, 2005, MUTAT RES-GEN TOX EN, V585, P43, DOI 10.1016/j.mrgentox.2005.04.013; Wolf FI, 2005, BBA-MOL CELL RES, V1743, P120, DOI 10.1016/j.bbamcr.2004.09.005; Yao CG, 2008, IEEE ENG MED BIO, P1044, DOI 10.1109/IEMBS.2008.4649338	45	30	33	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167931	10.1371/journal.pone.0167931	http://dx.doi.org/10.1371/journal.pone.0167931			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959944	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900024
J	Watanabe, K; Bizen, N; Sato, N; Takebayashi, H				Watanabe, Keisuke; Bizen, Norihisa; Sato, Noboru; Takebayashi, Hirohide			Endoplasmic Reticulum-Localized Transmembrane Protein Dpy19L1 Is Required for Neurite Outgrowth	PLOS ONE			English	Article							NEURONAL MIGRATION; C-MANNOSYLTRANSFERASE; MICROTUBULES; NETWORK; GLOBOZOOSPERMIA; ORGANIZATION; DELETION; ELEGANS; AXON; LIS1	The endoplasmic reticulum (ER), including the nuclear envelope, is a continuous and intricate membrane-bound organelle responsible for various cellular functions. In neurons, the ER network is found in cell bodies, axons, and dendrites. Recent studies indicate the involvement of the ER network in neuronal development, such as neuronal migration and axonal outgrowth. However, the regulation of neural development by ER-localized proteins is not fully understood. We previously reported that the multi-transmembrane protein Dpy19L1 is required for neuronal migration in the developing mouse cerebral cortex. A Dpy19L family member, Dpy19L2, which is a causative gene for human Globozoospermia, is suggested to act as an anchor of the acrosome to the nuclear envelope. In this study, we found that the patterns of exogenous Dpy19L1 were partially coincident with the ER, including the nuclear envelope in COS-7 cells at the level of the light microscope. The reticular distribution of Dpy19L1 was disrupted by microtubule depolymerization that induces retraction of the ER. Furthermore, Dpy19L1 showed a similar distribution pattern with a ER marker protein in embryonic mouse cortical neurons. Finally, we showed that Dpy19L1 knockdown mediated by siRNA resulted in decreased neurite outgrowth in cultured neurons. These results indicate that transmembrane protein Dpy19L1 is localized to the ER membrane and regulates neurite extension during development.	[Watanabe, Keisuke; Bizen, Norihisa; Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan; [Watanabe, Keisuke; Sato, Noboru] Niigata Univ, Grad Sch Med & Dent Sci, Div Gross Anat & Morphogenesis, Niigata, Japan	Niigata University; Niigata University	Watanabe, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan.; Watanabe, K (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Gross Anat & Morphogenesis, Niigata, Japan.	watak@med.niigata-u.ac.jp	Takebayashi, Hirohide/AAO-1693-2020; LARIJANI, Professor Banafshe/H-3909-2015	LARIJANI, Professor Banafshe/0000-0003-4735-1169	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [25123703]; MEXT [25117001, 15K06736]; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was funded by a Grant-in-Aid for Scientific Research on Innovative Areas, "Neural Diversity and Neocortical Organization" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT; http://www.mext.go.jp/english/) [25123703] (to KW), a Grant-in-Aid for Scientific Research on Innovative Areas, "Glial assembly" from MEXT [25117001] (to HT), a Grant-in-Aid for Scientific Research (C) from MEXT [15K06736] (to KW) and a grant from Takeda Science Foundation (to KW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara Y, 2001, J NEUROSCI RES, V65, P236, DOI 10.1002/jnr.1147; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; BROADWELL RD, 1983, J HISTOCHEM CYTOCHEM, V31, P1077, DOI 10.1177/31.9.6309951; Buettner FFR, 2013, MOL CELL, V50, P295, DOI 10.1016/j.molcel.2013.03.003; Carson AR, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-45; COLE NB, 1995, CURR OPIN CELL BIOL, V7, P55, DOI 10.1016/0955-0674(95)80045-X; Du HP, 2001, GENETICS, V158, P197; ElInati E, 2012, HUM MOL GENET, V21, P3695, DOI 10.1093/hmg/dds200; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Friedman JR, 2011, TRENDS CELL BIOL, V21, P709, DOI 10.1016/j.tcb.2011.07.004; Harbuz R, 2011, AM J HUM GENET, V88, P351, DOI 10.1016/j.ajhg.2011.02.007; Honigberg L, 2000, DEVELOPMENT, V127, P4655; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Valenzuela JI, 2011, MOL CELL NEUROSCI, V48, P269, DOI 10.1016/j.mcn.2011.07.001; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; Koscinski I, 2011, AM J HUM GENET, V88, P344, DOI 10.1016/j.ajhg.2011.01.018; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Middelkoop TC, 2012, DEV BIOL, V361, P338, DOI 10.1016/j.ydbio.2011.10.029; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Niwa Y, 2016, MOL BIOL CELL, V27, P744, DOI 10.1091/mbc.E15-06-0373; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Pierre V, 2012, DEVELOPMENT, V139, P2955, DOI 10.1242/dev.077982; Ramirez OA, 2011, TRENDS CELL BIOL, V21, P219, DOI 10.1016/j.tcb.2010.12.003; Renvoise B, 2010, CURR OPIN NEUROBIOL, V20, P531, DOI 10.1016/j.conb.2010.07.001; RIVAS RJ, 1995, J NEUROSCI, V15, P981; Rosenberg SS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004259; Shim SY, 2008, J NEUROSCI, V28, P3604, DOI 10.1523/JNEUROSCI.5278-07.2008; Smith DS, 2000, NAT CELL BIOL, V2, P767, DOI 10.1038/35041000; Smith EN, 2009, MOL PSYCHIATR, V14, P755, DOI 10.1038/mp.2009.43; Sutherland DJ, 2014, TRENDS NEUROSCI, V37, P424, DOI 10.1016/j.tins.2014.05.008; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Watanabe K, 2011, DEVELOPMENT, V138, P4979, DOI 10.1242/dev.068155; Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhu PP, 2006, HUM MOL GENET, V15, P1343, DOI 10.1093/hmg/ddl054	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167985	10.1371/journal.pone.0167985	http://dx.doi.org/10.1371/journal.pone.0167985			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959946	Green Submitted, gold, Green Published			2022-12-27	WOS:000392753900030
J	Kliemann, BS; Levin, AS; Moura, ML; Boszczowski, I; Lewis, JJ				Kliemann, Breno S.; Levin, Anna S.; Luisa Moura, M.; Boszczowski, Icaro; Lewis, James J.			Socioeconomic Determinants of Antibiotic Consumption in the State of Sao Paulo, Brazil: The Effect of Restricting Over-The-Counter Sales	PLOS ONE			English	Article							RESISTANCE; IMPACT; ASSOCIATION; COUNTRIES	Background Improper antibiotic use is one of the main drivers of bacterial resistance to antibiotics, increasing infectious diseases morbidity and mortality and raising costs of healthcare. The level of antibiotic consumption has been shown to vary according to socioeconomic determinants (SED) such as income and access to education. In many Latin American countries, antibiotics could be easily purchased without a medical prescription in private pharmacies before enforcement of restrictions on over-the-counter (OTC) sales in recent years. Brazil issued a law abolishing OTC sales in October 2010. This study seeks to find SED of antibiotic consumption in the Brazilian state of Sao Paulo (SSP) and to estimate the impact of the 2010 law. Methods Data on all oral antibiotic sales having occurred in the private sector in SSP from 2008 to 2012 were pooled into the 645 municipalities of SSP. Linear regression was performed to estimate consumption levels that would have occurred in 2011 and 2012 if no law regulating OTC sales had been issued in 2010. These values were compared to actual observed levels, estimating the effect of this law. Linear regression was performed to find association of antibiotic consumption levels and of a greater effect of the law with municipality level data on SED obtained from a nationwide census. Results Oral antibiotic consumption in SSP rose from 8.44 defined daily doses per 1,000 inhabitants per day (DID) in 2008 to 9.95 in 2010, and fell to 8.06 DID in 2012. Determinants of a higher consumption were higher human development index, percentage of urban population, density of private health establishments, life expectancy and percentage of females; lower illiteracy levels and lower percentage of population between 5 and 15 years old. A higher percentage of females was associated with a stronger effect of the law. Conclusions SSP had similar antibiotic consumption levels as the whole country of Brazil, and they were effectively reduced by the policy.	[Kliemann, Breno S.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Populat Hlth, London, England; [Kliemann, Breno S.] Univ Fed Parana, Hlth Sci Sect, Course Med, Curitiba, Parana, Brazil; [Levin, Anna S.; Luisa Moura, M.; Boszczowski, Icaro] Univ Sao Paulo, Hosp Clin, Infect Control Dept, Sao Paulo, Brazil; [Levin, Anna S.] Univ Sao Paulo, Dept Infect Dis, Fac Med, Sao Paulo, Brazil; [Levin, Anna S.] Univ Sao Paulo, LIM54, Fac Med, Sao Paulo, Brazil; [Lewis, James J.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; Universidade Federal do Parana; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of London; London School of Hygiene & Tropical Medicine	Kliemann, BS (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Populat Hlth, London, England.; Kliemann, BS (corresponding author), Univ Fed Parana, Hlth Sci Sect, Course Med, Curitiba, Parana, Brazil.	brenokliemann@gmail.com	Levin, Anna S/C-8831-2012; Levin, Anna S./AAJ-1712-2021; Boszczowski, Icaro/ACH-0889-2022; Boszczowski, Icaro/AAF-9675-2022; Moura, Maria Luisa/N-5654-2015	Levin, Anna S/0000-0003-2427-8368; Levin, Anna S./0000-0003-2427-8368; Moura, Maria Luisa/0000-0003-1013-8233; Lewis, James/0000-0002-8603-2761	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/19128-1]; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil [240720/2013-0]; UK Medical Research Council [MR/K012126/1]; Medical Research Council [MR/K007467/1, MR/K012126/1] Funding Source: researchfish; MRC [MR/K007467/1] Funding Source: UKRI	FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was partially funded by FAPESP - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (grant #2011/19128-1) - http://www.fapesp.br/. The author BSK received a scholarship grant by CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (grant #240720/2013-0) - http://www.cnpq.br/. The author JJL receives salary support from the UK Medical Research Council (MR/K012126/1) - http://www.mrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminov RI, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00134; [Anonymous], 2015, GUID ATC CLASS DDD A; Bavestrello L, 2002, REV MED CHILE, V130, P1265; Bebell LM, 2014, GLOB HEART, V9, P347, DOI 10.1016/j.gheart.2014.08.009; Covvey JR, 2014, J ANTIMICROB CHEMOTH, V69, P835, DOI 10.1093/jac/dkt439; Filippini M, 2006, HEALTH POLICY, V78, P77, DOI 10.1016/j.healthpol.2005.09.009; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Instituto Brasileiro de Geografia e Estatistica, 1990, GEOGR; Kiffer CRV, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-17; Llor C, 2014, THER ADV DRUG SAF, V5, P229, DOI 10.1177/2042098614554919; Lopez Jose J, 2009, Rev Salud Publica (Bogota), V11, P432; Luis BF, 2011, REV CHIL INFECTOL, V28, P107, DOI /S0716-10182011000200001; Marra F, 2010, CAN J INFECT DIS MED, V21, pE99, DOI 10.1155/2010/965268; Masiero G, 2010, INT J PUBLIC HEALTH, V55, P469, DOI 10.1007/s00038-010-0167-y; Matuz M, 2006, BRIT J CLIN PHARMACO, V61, P96, DOI 10.1111/j.1365-2125.2005.02525.x; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Moura ML, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001605; Nicolini P, 2006, CIENCIA SAUDE COLETI, V13, P689; De Miranda EJP, 2014, REV INST MED TROP SP, V56, P313, DOI 10.1590/S0036-46652014000400009; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Ramay BM, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0011-3; Rivas P, 2011, REV PANAM SALUD PUBL, V30, P592, DOI 10.1590/S1020-49892011001200016; Rocha MC, 2012, REV PAUL PEDIATR, V30, P471; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Santa-Ana-Tellez Y, 2013, PLOS ONE, V8; Santa-Ana-Tellez Y, 2015, ANTIMICROB AGENTS CH, V59, P105, DOI 10.1128/AAC.03629-14; Schmid B, 2010, REV SAUDE PUBL, V44, P1039, DOI 10.1590/S0034-89102010000600008; Ternhag A, 2014, SCAND J INFECT DIS, V46, P888, DOI 10.3109/00365548.2014.954264; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; WHO, 2001, WHO GLOB STRAT CONT; Wirtz VJ, 2013, TROP MED INT HEALTH, V18, P665, DOI 10.1111/tmi.12096; Wirtz VJ, 2010, REV PANAM SALUD PUBL, V27, P219, DOI 10.1590/S1020-49892010000300009; World Health Organization, 2015, GLOB HLTH OBS DAT	33	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167885	10.1371/journal.pone.0167885	http://dx.doi.org/10.1371/journal.pone.0167885			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8HA	27941993	gold, Green Accepted, Green Published			2022-12-27	WOS:000392745600036
J	Peck, DT; Smith, ML; Seeley, TD				Peck, David T.; Smith, Michael L.; Seeley, Thomas D.			Varroa destructor Mites Can Nimbly Climb from Flowers onto Foraging Honey Bees	PLOS ONE			English	Article							PARASITIC MITE; JACOBSONI OUD; COLONIES; AGE; HYMENOPTERA; POPULATION; SURVIVAL; BEHAVIOR; LARVAE	Varroa destructor, the introduced parasite of European honey bees associated with massive colony deaths, spreads readily through populations of honey bee colonies, both managed colonies living crowded together in apiaries and wild colonies living widely dispersed in natural settings. Mites are hypothesized to spread between most managed colonies via phoretically riding forager bees when they engage in robbing colonies or they drift between hives. However, widely spaced wild colonies show Varroa infestation despite limited opportunities for robbing and little or no drifting of bees between colonies. Both wild and managed colonies may also exchange mites via another mechanism that has received remarkably little attention or study: floral transmission. The present study tested the ability of mites to infest foragers at feeders or flowers. We show that Varroa destructor mites are highly capable of phoretically infesting foraging honey bees, detail the mechanisms and maneuvers by which they do so, and describe mite behaviors post-infestation.	[Peck, David T.; Smith, Michael L.; Seeley, Thomas D.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	Cornell University	Peck, DT (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	dtp36@cornell.edu		Peck, David/0000-0002-4650-6811; Smith, Michael/0000-0002-3454-962X	National Science Foundation's Graduate Research Fellowship Program [DGE-1144153]; Hatch Grant from the Cornell University Agricultural Experiment Station [NYC-191400]	National Science Foundation's Graduate Research Fellowship Program(National Science Foundation (NSF)); Hatch Grant from the Cornell University Agricultural Experiment Station	This research was supported by the National Science Foundation's Graduate Research Fellowship Program (DGE-1144153 to DTP and MLS) (www.nsf.gov). This research was also supported by a Hatch Grant (Project No. NYC-191400) from the Cornell University Agricultural Experiment Station (to TDS) (cuaes.cals.cornell.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; BowenWalker PL, 1997, PARASITOLOGY, V114, P151, DOI 10.1017/S0031182096008323; COLWELL RK, 1985, NAT HIST, V94, P56; Delfinado-Baker M., 1992, International Journal of Acarology, V18, P315; Department of Agriculture and Water Services Australia, 2016, HON BEES CROP POLL V; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Eickwort George C., 1994, P218; EWALD PW, 1995, J PARASITOL, V81, P659, DOI 10.2307/3283951; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Fries I, 2006, APIDOLOGIE, V37, P564, DOI 10.1051/apido:2006031; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Guzman-Novoa E, 2010, APIDOLOGIE, V41, P443, DOI 10.1051/apido/2009076; Hartwig A, 1987, P 31 INT C AP WARS P, P229; Ish-Am G, 1985, THESIS, P57; Isle of Man Government, 2015, BEE KEEP OFF DIS FRE; Kather R, 2015, CHEMOECOLOGY, V25, P215, DOI 10.1007/s00049-015-0191-8; Kather R, 2015, J CHEM ECOL, V41, P178, DOI 10.1007/s10886-015-0548-z; Kevan PG, 2006, AM BEE J, V146, P694; KEVAN PG, 1990, BEE WORLD, V71, P119, DOI 10.1080/0005772X.1990.11099048; KIMSEY LS, 1984, J ZOOL, V204, P541, DOI 10.1111/j.1469-7998.1984.tb02386.x; KORPELA S, 1992, J APICULT RES, V31, P157, DOI 10.1080/00218839.1992.11101278; KRAUS B, 1986, APIDOLOGIE, V17, P257, DOI 10.1051/apido:19860307; Kuenen LPS, 1997, J INSECT BEHAV, V10, P213, DOI 10.1007/BF02765554; Land BB, 2004, ETHOLOGY, V110, P1, DOI 10.1046/j.1439-0310.2003.00947.x; LE CONTE Y, 1987, APIDOLOGIE, V18, P305, DOI 10.1051/apido:19870402; LE CONTE Y, 1989, SCIENCE, V245, P638, DOI 10.1126/science.245.4918.638; LEES AD, 1948, J EXP BIOL, V25, P145; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Pernal SF, 2005, EXP APPL ACAROL, V37, P1, DOI 10.1007/s10493-005-1117-x; Pettis JS, 2003, INT J ACAROL, V29, P291, DOI 10.1080/01647950308684342; RICKLI M, 1992, NATURWISSENSCHAFTEN, V79, P320, DOI 10.1007/BF01138711; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Schwarz HH, 1997, INSECT SOC, V44, P303, DOI 10.1007/s000400050051; Seeley TD, 1995, WISDOM HIVE, P76; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Seeley TD, 2015, APIDOLOGIE, V46, P716, DOI 10.1007/s13592-015-0361-2; Thorp RW, 2000, PLANT SYST EVOL, V222, P211, DOI 10.1007/BF00984103	37	30	31	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167798	10.1371/journal.pone.0167798	http://dx.doi.org/10.1371/journal.pone.0167798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942015	gold, Green Published			2022-12-27	WOS:000392745600031
J	Alvarez-Marin, R; Lopez-Rojas, R; Marquez, JA; Gomez, MJ; Molina, J; Cisneros, JM; Ortiz-Leyba, C; Aznar, J; Garnacho-Montero, J; Pachon, J				Alvarez-Marin, Rocio; Lopez-Rojas, Rafael; Antonio Marquez, Juan; Jose Gomez, Maria; Molina, Jose; Miguel Cisneros, Jose; Ortiz-Leyba, Carlos; Aznar, Javier; Garnacho-Montero, Jose; Pachon, Jeronimo			Colistin Dosage without Loading Dose Is Efficacious when Treating Carbapenem-Resistant Acinetobacter baumannii Ventilator-Associated Pneumonia Caused by Strains with High Susceptibility to Colistin	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; RISK-FACTORS; ATTRIBUTABLE MORTALITY; MULTIDRUG-RESISTANT; CLINICAL-FEATURES; MULTIPLEX PCR; INFECTION; IMPACT; METHANESULFONATE	Objectives This study aims to analyze the mortality and the length of ICU stay (LOS) of A. baumannii VAP compared to respiratory colonization in patients with mechanical ventilation (MV). Methods A prospective cohort study was performed in an ICU of adult patients (February 2010-June 2011). One hundred patients on MV with A. baumannii in lower respiratory airways were recruited, and classified as VAP or airways colonization according to CPIS criteria, with a punctuation >= 6. LOS, 30-days mortality, A. baumannii bacteremia, and clinical features including antibiotic therapy were recorded. Multivariate analysis (linear and Cox regression) and survival analysis (Kaplan-Meier curves) were performed. Results Fifty-seven VAP and 43 colonized A. baumannii patients were analyzed. Among the A. baumannii strains, 99% were non-susceptible to carbapenems and the MIC90 of colistin was 0.12 mg/l. Therapy was appropriate in 94.6% of VAP patients, most of them with colistin 6 MIU/day, although in 13 (23.6%) cases colistin was started 48 hours after the onset of VAP. Mortality was similar in both groups (VAP 24.6% vs. colonized 27.9%, p = 0.7). Bacteremia and acute kidney insufficiency were associated with decreased survival (p = 0.02 and p = 0.04, respectively) in VAP patients. LOS was 21.5 (11.5-42.75) vs. 9 (6-22) days for VAP and colonized patients (p = 0.004). VAP (p = 0.003) and age (p = 0.01) were independently related to a longer LOS. Conclusions Multidrug-resistant A. baumannii VAP treated with colistin does not have a different mortality compared to lower airways colonization, among patients on mechanical-ventilation, in a setting of high susceptibility to colistin of A. baumannii.	[Alvarez-Marin, Rocio; Lopez-Rojas, Rafael; Jose Gomez, Maria; Molina, Jose; Miguel Cisneros, Jose; Aznar, Javier; Pachon, Jeronimo] Univ Seville, Univ Hosp Virgen Rocio & Virgen Macarena, CSIC,Infect Dis Res Grp, Inst Biomed Seville IBiS,Clin Unit Infect Dis Mic, Seville, Spain; [Antonio Marquez, Juan; Ortiz-Leyba, Carlos] Univ Seville, Univ Hosp Virgen Rocio, CSIC, Inst Biomed Seville IBiS,Clin Unit Crit Care & Em, Seville, Spain; [Garnacho-Montero, Jose] Univ Hosp Virgen Macarena, Clin Unit Crit Care, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Hospital Universitario Virgen Macarena	Alvarez-Marin, R; Pachon, J (corresponding author), Univ Seville, Univ Hosp Virgen Rocio & Virgen Macarena, CSIC,Infect Dis Res Grp, Inst Biomed Seville IBiS,Clin Unit Infect Dis Mic, Seville, Spain.	rocioalma@gmail.com; pachon@us.es	Garnacho-Montero, Jose/R-9496-2019; Pachon, Jeronimo/M-4337-2014; IBIS, TUBERCULOSIS/O-9334-2015; Cisneros, José Miguel/ABI-6103-2020	Garnacho-Montero, Jose/0000-0003-2542-7601; Cisneros, José Miguel/0000-0001-5001-672X; Pachon, Jeronimo/0000-0002-8166-5308; Alvarez Marin, Rocio/0000-0002-7101-2514; Molina Gil-Bermejo, Jose/0000-0002-4243-0215	Instituteo de SaludCarlos III [PS09/01427, CM14/00179]; Plan Nacional de I+D+i; Subdireccion General de Redes y Centros de Investigacion Cooperativa; Ministerio de Economia y Competitividad; Spanish Network for Research in Infectious Diseases - European Development Regional Fund "A way to achieve Europe" ERDF [REIPI RD12/0015/0001]	Instituteo de SaludCarlos III; Plan Nacional de I+D+i; Subdireccion General de Redes y Centros de Investigacion Cooperativa; Ministerio de Economia y Competitividad(Spanish Government); Spanish Network for Research in Infectious Diseases - European Development Regional Fund "A way to achieve Europe" ERDF	The present study has been granted by the Instituto de SaludCarlos III (PS09/01427) and supported by Plan Nacional de I+D+i and Instituto de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competitividad, Spanish Network for Research in Infectious Diseases (REIPI RD12/0015/0001) - co-financed by European Development Regional Fund "A way to achieve Europe" ERDF. RAM has a Rio Hortega grant from the Instituto de Salud Carlos III (CM14/00179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrafiotis M, 2011, INT J TUBERC LUNG D, V15, P1154, DOI 10.5588/ijtld.10.0498; Arvaniti K, 2012, CRIT CARE, V16, DOI 10.1186/cc11383; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Chaari A, 2013, INT J INFECT DIS, V17, pE1225, DOI 10.1016/j.ijid.2013.07.014; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cheah SE, 2016, ANTIMICROB AGENTS CH, V60, P3921, DOI 10.1128/AAC.02927-15; Dudhani RV, 2009, 49 INT C ANT AG CHEM, P41; Ellington MJ, 2007, J ANTIMICROB CHEMOTH, V59, P321, DOI 10.1093/jac/dkl481; Falagas ME, 2007, CRIT CARE, V11, DOI 10.1186/cc5911; Forrest A, 2014, INT C ANT AG CHEM 20; Garnacho J, 2003, CRIT CARE MED, V31, P2478, DOI 10.1097/01.CCM.0000089936.09573.F3; Garonzik SM, 2011, ANTIMICROB AGENTS CH, V55, P3284, DOI 10.1128/AAC.01733-10; Kalil AC, 2016, CLIN INFECT DIS, V63, P575, DOI 10.1093/cid/ciw504; Karnik ND, 2013, EUR J CLIN PHARMACOL, V69, P1429, DOI 10.1007/s00228-013-1493-9; Kim WY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150642; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KOLLEF MH, 1995, CHEST, V108, P1655, DOI 10.1378/chest.108.6.1655; KOLLEF MH, 1993, JAMA-J AM MED ASSOC, V270, P1965, DOI 10.1001/jama.270.16.1965; Landersdorfer CB, 2015, SEMIN RESP CRIT CARE, V36, P126, DOI 10.1055/s-0034-1398390; Liu CP, 2014, J MICROBIOLIMMUNOL I; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mao YX, 2013, J INT MED RES, V41, P1120, DOI 10.1177/0300060513489477; Markou N, 2008, CLIN THER, V30, P143, DOI 10.1016/j.clinthera.2008.01.015; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nation RL, 2016, CLIN INFECT DIS, V62, P552, DOI 10.1093/cid/civ964; Ozgur ES, 2014, AM J INFECT CONTROL, V42, P206, DOI 10.1016/j.ajic.2013.09.003; Pachon-Ibanez ME, 2010, ANTIMICROB AGENTS CH, V54, P1165, DOI 10.1128/AAC.00367-09; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Plachouras D, 2009, ANTIMICROB AGENTS CH, V53, P3430, DOI 10.1128/AAC.01361-08; Playford EG, 2007, J HOSP INFECT, V65, P204, DOI 10.1016/j.jhin.2006.11.010; PUGIN J, 1991, AM REV RESPIR DIS, V143, P1121, DOI 10.1164/ajrccm/143.5_Pt_1.1121; Rodriguez-Bano J, 2004, INFECT CONT HOSP EP, V25, P819, DOI 10.1086/502302; Ruiz M, 2007, CLIN MICROBIOL INFEC, V13, P1192, DOI 10.1111/j.1469-0691.2007.01825.x; Sorli L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-380; Tseng CC, 2012, AM J INFECT CONTROL, V40, P648, DOI 10.1016/j.ajic.2011.08.017; Tsuji BT, 2016, ANTIMICROB AGENTS CH, V60, P3913, DOI 10.1128/AAC.02831-15; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Yahav D, 2012, CLIN MICROBIOL INFEC, V18, P18, DOI 10.1111/j.1469-0691.2011.03734.x; Zheng YL, 2013, AM J INFECT CONTROL, V41, pE59, DOI 10.1016/j.ajic.2013.01.006	39	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168468	10.1371/journal.pone.0168468	http://dx.doi.org/10.1371/journal.pone.0168468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992528	gold, Green Published, Green Submitted			2022-12-27	WOS:000392842600063
J	Schonberger, B; Chen, XC; Mager, S; Ludewig, U				Schoenberger, Brigitte; Chen, Xiaochao; Mager, Svenja; Ludewig, Uwe			Site-Dependent Differences in DNA Methylation and Their Impact on Plant Establishment and Phosphorus Nutrition in Populus trichocarpa	PLOS ONE			English	Article							PHOSPHATE-STARVATION RESPONSE; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; EPIGENETIC INHERITANCE; SMALL RNAS; GENOME; MICRORNAS; DRM; METHYLTRANSFERASES; TRANSCRIPTION	The propagation via clonal stem cuttings is a frequent practice in tree plantations. Despite their clonal origin, the trees establish differently according to weather, temperature and nutrient availability, as well as the presence of various stresses. Here, clonal Populus trichocarpa (cv. Muhle Larson) cuttings from different sites were transferred into a common, fully nutrient supplied environment. Despite identical underlying genetics, stem cuttings derived from sites with lower phosphorus availability established worse, independent of phosphorus (P) level after transplantation. Differential growth of material from the sites was reflected in differences in the whole genome DNA methylome. Methylation differences were sequence context-dependent, but differentially methylated regions (DMRs) were apparently unrelated to P nutrition genes. Despite the undisputed negative general correlation of DNA promoter methylation with gene repression, only few of the top-ranked DMRs resulted in differential gene expression in roots or shoots. However, differential methylation was associated with site-dependent, different total amounts of microRNAs (miRNAs), with few miRNAs sequences directly targeted by differential methylation. Interestingly, in roots and shoots, the miRNA amount was dependent on the previous habitat and changed in roots in a habitat-dependent way under phosphate starvation conditions. Differentially methylated miRNAs, together with their target genes, showed P-dependent expression profiles, indicating miRNA expression differences as a P-related epigenetic modification in poplar. Together with differences in DNA methylation, such epigenetic mechanisms may explain habitat or seasonal memory in perennials and site-dependent growth performances.	[Schoenberger, Brigitte; Chen, Xiaochao; Mager, Svenja; Ludewig, Uwe] Univ Hohenheim, Crop Sci Inst, Dept Nutr Crop Physiol, Stuttgart, Germany	University Hohenheim	Ludewig, U (corresponding author), Univ Hohenheim, Crop Sci Inst, Dept Nutr Crop Physiol, Stuttgart, Germany.	u.ludewig@uni-hohenheim.de			Deutsche Forschungsgemeinschaft (DFG) [SPP1685, Lu673/18-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) in the Priority Program SPP1685 under grant Lu673/18-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceituno FF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-438; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Bergmann W., 1993, ERNAHRUNGSSTORUNGEN, V3; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Calderon-Vazquez C, 2011, PLANT PHYSIOL, V156, P1067, DOI 10.1104/pp.111.174987; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Chiou TJ, 2011, ANNU REV PLANT BIOL, V62, P185, DOI 10.1146/annurev-arplant-042110-103849; Ci D, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00921; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dai Xinbin, 2011, Nucleic Acids Res, V39, pW155, DOI 10.1093/nar/gkr319; Douhovnikoff V, 2015, PLANT ECOL, V216, P227, DOI 10.1007/s11258-014-0430-z; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Feng SH, 2011, CURR OPIN PLANT BIOL, V14, P179, DOI 10.1016/j.pbi.2010.12.002; Finnegan EJ, 2000, CURR OPIN GENET DEV, V10, P217, DOI 10.1016/S0959-437X(00)00061-7; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Guarino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131480; Hansen KD, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r83, 10.1186/gb-2012-13-10-R83]; Holliday R, 2006, EPIGENETICS-US, V1, P76, DOI 10.4161/epi.1.2.2762; Janssen A, 2012, ZUCHTUNG ERTRAGSLEIS, V8; Kankel MW, 2003, GENETICS, V163, P1109; Kawakatsu T, 2016, CELL, V166, P492, DOI 10.1016/j.cell.2016.06.044; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Latzel V, 2010, EVOL ECOL, V24, P1537, DOI 10.1007/s10682-010-9385-2; Lei KJ, 2016, PLANT CELL PHYSIOL, V57, DOI 10.1093/pcp/pcv197; Lewis JD, 2010, NEW PHYTOL, V187, P438, DOI 10.1111/j.1469-8137.2010.03307.x; Liang CY, 2013, PLANT PHYSIOL, V161, P1347, DOI 10.1104/pp.112.208934; Liang D, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-S1-S9; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Medvedeva YA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-119; Mirouze M, 2009, NATURE, V461, P427, DOI 10.1038/nature08328; Ong-Abdullah M, 2015, NATURE, V525, P533, DOI 10.1038/nature15365; Peng MS, 2007, PLANT J, V50, P320, DOI 10.1111/j.1365-313X.2007.03050.x; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Puzey JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033034; Raj S, 2011, P NATL ACAD SCI USA, V108, P12521, DOI 10.1073/pnas.1103341108; Roberts Justin T, 2014, Mob Genet Elements, V4, pe29255; Saze H, 2003, NAT GENET, V34, P65, DOI 10.1038/ng1138; Saze H, 2011, CURR OPIN PLANT BIOL, V14, P81, DOI 10.1016/j.pbi.2010.08.017; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; Secco D, 2015, ELIFE, V4, DOI 10.7554/eLife.09343; Seymour DK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004785; Sjodin A, 2009, NEW PHYTOL, V182, P1013, DOI 10.1111/j.1469-8137.2009.02807.x; Smith AP, 2010, PLANT PHYSIOL, V152, P217, DOI 10.1104/pp.109.145532; Song YP, 2015, J EXP BOT, V66, P1891, DOI 10.1093/jxb/eru531; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Taghavi S, 2005, APPL ENVIRON MICROB, V71, P8500, DOI 10.1128/AEM.71.12.8500-8505.2005; Takuno S, 2012, MOL BIOL EVOL, V29, P219, DOI 10.1093/molbev/msr188; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; van den Driessche R, 2000, NEW FOREST, V19, P143, DOI 10.1023/A:1006607410673; VDLUFA, 2000, BEST KALKB ACK GRUNL; VDLUFA, 1997, HDB LANDW VERS UNT M; Verhoeven KJF, 2014, EVOLUTION, V68, P644, DOI 10.1111/evo.12320; Vining KJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-27; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Xu M, 2011, ANAL BIOCHEM, V408, P337, DOI 10.1016/j.ab.2010.08.044; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zemach A, 2010, P NATL ACAD SCI USA, V107, P18729, DOI 10.1073/pnas.1009695107; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhang YJ, 2005, NUCLEIC ACIDS RES, V33, pW701, DOI 10.1093/nar/gki383; Zhou FF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-14; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	75	21	22	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0168623	10.1371/journal.pone.0168623	http://dx.doi.org/10.1371/journal.pone.0168623			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992519	Green Submitted, Green Published, gold			2022-12-27	WOS:000392842600081
J	Soh, Z; Nishikawa, S; Kurita, Y; Takiguchi, N; Tsuji, T				Soh, Zu; Nishikawa, Shinya; Kurita, Yuichi; Takiguchi, Noboru; Tsuji, Toshio			A Mathematical Model of the Olfactory Bulb for the Selective Adaptation Mechanism in the Rodent Olfactory System	PLOS ONE			English	Article							GLOMERULAR LAYER; FEEDBACK-CONTROL; ODOR MIXTURES; RAT; ORGANIZATION; PATTERNS; QUALITY	To predict the odor quality of an odorant mixture, the interaction between odorants must be taken into account. Previously, an experiment in which mice discriminated between odorant mixtures identified a selective adaptation mechanism in the olfactory system. This paper proposes an olfactory model for odorant mixtures that can account for selective adaptation in terms of neural activity. The proposed model uses the spatial activity pattern of the mitral layer obtained from model simulations to predict the perceptual similarity between odors. Measured glomerular activity patterns are used as input to the model. The neural interaction between mitral cells and granular cells is then simulated, and a dissimilarity index between odors is defined using the activity patterns of the mitral layer. An odor set composed of three odorants is used to test the ability of the model. Simulations are performed based on the odor discrimination experiment on mice. As a result, we observe that part of the neural activity in the glomerular layer is enhanced in the mitral layer, whereas another part is suppressed. We find that the dissimilarity index strongly correlates with the odor discrimination rate of mice: r = 0.88 (p = 0.019). We conclude that our model has the ability to predict the perceptual similarity of odorant mixtures. In addition, the model also accounts for selective adaptation via the odor discrimination rate, and the enhancement and inhibition in the mitral layer may be related to this selective adaptation.	[Soh, Zu; Kurita, Yuichi; Tsuji, Toshio] Hiroshima Univ, Inst Engn, Dept Syst Cybernet, Higashihiroshima, Japan; [Nishikawa, Shinya] Hiroshima Univ, Grad Sch Engn, Dept Syst Cybernet, Higashihiroshima, Japan; [Takiguchi, Noboru] Kanazawa Univ, Grad Sch Nat Sci & Technol, Div Mat Sci, Kanazawa, Ishikawa, Japan	Hiroshima University; Hiroshima University; Kanazawa University	Soh, Z; Tsuji, T (corresponding author), Hiroshima Univ, Inst Engn, Dept Syst Cybernet, Higashihiroshima, Japan.	sozu@bsys.hiroshima-u.ac.jp; tsuji@bsys.hiroshima-u.ac.jp	Soh, Zu/J-3875-2015; Takiguchi, Noboru/F-3419-2014; Tsuji, Toshio/D-6210-2011; Kurita, Yuichi/D-6196-2011	Soh, Zu/0000-0001-7182-9383; Takiguchi, Noboru/0000-0001-7266-0276; Tsuji, Toshio/0000-0002-7689-3963; Kurita, Yuichi/0000-0002-7848-1460	Japan Society for the Promotion of Science KAKENHI [26730144, 25540125]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 26730144 (ZS) and 25540125 (TT) (URL: https://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanasova B, 2005, CHEM SENSES, V30, P209, DOI 10.1093/chemse/bji016; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Boyd AM, 2012, NEURON, V76, P1161, DOI 10.1016/j.neuron.2012.10.020; Cleland TA, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00005; ERDI P, 1993, BIOL CYBERN, V69, P57, DOI 10.1007/BF00201408; Fletcher ML, 2009, J NEUROPHYSIOL, V102, P817, DOI 10.1152/jn.00020.2009; Giraudet P, 2002, J NEUROPHYSIOL, V88, P829, DOI 10.1152/jn.2002.88.2.829; Goyert HF, 2007, BRAIN RES BULL, V72, P1, DOI 10.1016/j.brainresbull.2006.12.010; Grossman KJ, 2008, EUR J NEUROSCI, V27, P2676, DOI 10.1111/j.1460-9568.2008.06213.x; HABERLY LB, 1978, J COMP NEUROL, V181, P781, DOI 10.1002/cne.901810407; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Haddad R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000740; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Johnson BA, 2005, J COMP NEUROL, V483, P205, DOI 10.1002/cne.20409; Johnson BA, 2002, J COMP NEUROL, V449, P180, DOI 10.1002/cne.10284; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2007, J COMP NEUROL, V503, P1, DOI 10.1002/cne.21396; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; LI Z, 1989, BIOL CYBERN, V61, P379, DOI 10.1007/BF00200803; Linster C, 2009, LEARN MEMORY, V16, P452, DOI 10.1101/lm.1403509; Maresh A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002640; Miyamichi K, 2013, NEURON, V80, P1232, DOI 10.1016/j.neuron.2013.08.027; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Naritsuka H, 2009, J COMP NEUROL, V515, P409, DOI 10.1002/cne.22063; Sakano H, 2010, NEURON, V67, P530, DOI 10.1016/j.neuron.2010.07.003; Snitz K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003184; Soh Z, 2014, CHEM SENSES, V39, P91, DOI 10.1093/chemse/bjt057; Soh Z, 2011, CHEM SENSES, V36, P413, DOI 10.1093/chemse/bjq147; Takiguchi N, 2008, CHEM SENSES, V33, P283, DOI 10.1093/chemse/bjm086; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; YAMAGUCHI M, 1981, P NATL ACAD SCI-BIOL, V78, P5817, DOI 10.1073/pnas.78.9.5817; Yamazaki K, 1999, P NATL ACAD SCI USA, V96, P1522, DOI 10.1073/pnas.96.4.1522; Youngentob SL, 2006, BEHAV NEUROSCI, V120, P1337, DOI 10.1037/0735-7044.120.6.1337	33	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2016	11	12							e0165230	10.1371/journal.pone.0165230	http://dx.doi.org/10.1371/journal.pone.0165230			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI9QC	27992433	Green Published, Green Submitted, gold			2022-12-27	WOS:000392842600003
J	Cao, F; Perfetti, CA				Cao, Fan; Perfetti, Charles A.			Neural Signatures of the Reading-Writing Connection: Greater Involvement of Writing in Chinese Reading than English Reading	PLOS ONE			English	Article							WRITTEN WORD PRODUCTION; VISUAL RECOGNITION; FUNCTIONAL-ANATOMY; BRAIN; CORTEX; FMRI; METAANALYSIS; PERCEPTION; SYSTEM; MOTOR	Research on cross-linguistic comparisons of the neural correlates of reading has consistently found that the left middle frontal gyrus (MFG) is more involved in Chinese than in English. However, there is a lack of consensus on the interpretation of the language difference. Because this region has been found to be involved in writing, we hypothesize that reading Chinese characters involves this writing region to a greater degree because Chinese speakers learn to read by repeatedly writing the characters. To test this hypothesis, we recruited English L1 learners of Chinese, who performed a reading task and a writing task in each language. The English L1 sample had learned some Chinese characters through character-writing and others through phonological learning, allowing a test of writing-on-reading effect. We found that the left MFG was more activated in Chinese than English regardless of task, and more activated in writing than in reading regardless of language. Furthermore, we found that this region was more activated for reading Chinese characters learned by character-writing than those learned by phonological learning. A major conclusion is that writing regions are also activated in reading, and that this reading-writing connection is modulated by the learning experience. We replicated the main findings in a group of native Chinese speakers, which excluded the possibility that the language differences observed in the English L1 participants were due to different language proficiency level.	[Cao, Fan] Michigan State Univ, Dept Communicat Sci & Disorders, E Lansing, MI 48824 USA; [Perfetti, Charles A.] Univ Pittsburgh, Learning Res & Dev Ctr, Pittsburgh, PA 15260 USA	Michigan State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cao, F (corresponding author), Michigan State Univ, Dept Communicat Sci & Disorders, E Lansing, MI 48824 USA.; Perfetti, CA (corresponding author), Univ Pittsburgh, Learning Res & Dev Ctr, Pittsburgh, PA 15260 USA.	fcao@msu.edu; perfetti@pitt.edu			Michigan State University	Michigan State University	This work was supported by faculty start-up grant awarded to Dr. Fan Cao by Michigan State University.	ANDERSON SW, 1990, BRAIN, V113, P749, DOI 10.1093/brain/113.3.749; BABCOCK MK, 1988, AM J PSYCHOL, V101, P111, DOI 10.2307/1422797; Beeson PM, 2003, APHASIOLOGY, V17, P647, DOI 10.1080/02687030344000067; Bolger DJ, 2005, HUM BRAIN MAPP, V25, P92, DOI 10.1002/hbm.20124; Bolger DJ, 2008, HUM BRAIN MAPP, V29, P1416, DOI 10.1002/hbm.20476; Booth JR, 2002, NEUROIMAGE, V16, P7, DOI 10.1006/nimg.2002.1081; Botthali F, 2014, J NEUROSCI, V34, P15402, DOI 10.1523/JNEUROSCI.4918-13.2014; Cao F, 2015, DEVELOPMENTAL SCI, V18, P785, DOI 10.1111/desc.12245; Cao F, 2013, HUM BRAIN MAPP, V34, P1670, DOI 10.1002/hbm.22017; Cao F, 2010, CEREB CORTEX, V20, P1223, DOI 10.1093/cercor/bhp186; Cao F, 2009, HUM BRAIN MAPP, V30, P797, DOI 10.1002/hbm.20546; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Cloutman L, 2009, ANN NEUROL, V66, P249, DOI 10.1002/ana.21693; Cohen L, 2004, NEUROIMAGE, V23, P1256, DOI 10.1016/j.neuroimage.2004.07.052; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Decety J, 1996, COGNITIVE BRAIN RES, V3, P87, DOI 10.1016/0926-6410(95)00033-X; Exner S, 1881, UNTERSUCHUNGENUBER L; Farias D, 2006, BRAIN LANG, V97, P53, DOI 10.1016/j.bandl.2005.07.074; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Gandour J, 2002, J COGNITIVE NEUROSCI, V14, P1076, DOI 10.1162/089892902320474526; Gerlach C, 2000, NEUROPSYCHOLOGIA, V38, P1693, DOI 10.1016/S0028-3932(00)00082-8; Gil-Robles S, 2013, NEUROSURGERY, V72, P678, DOI 10.1227/NEU.0b013e318282a361; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; Harrington GS, 2007, HUM BRAIN MAPP, V28, P450, DOI 10.1002/hbm.20286; Higashiyama Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134131; Hillis AE, 2004, NEUROCASE, V10, P175, DOI 10.1080/13554790490497274; Hillis AE, 2003, NAT NEUROSCI, V6, P19, DOI 10.1038/nn982; Jamal NI, 2012, HUM BRAIN MAPP, V33, P235, DOI 10.1002/hbm.21208; James KH, 2006, NEUROPSYCHOLOGIA, V44, P2937, DOI 10.1016/j.neuropsychologia.2006.06.026; James KH, 2012, TRENDS NEUROSCI EDUC, V1, P32, DOI 10.1016/j.tine.2012.08.001; James KH, 2009, COGN NEUROPSYCHOL, V26, P91, DOI 10.1080/02643290802425914; James KH, 2010, DEVELOPMENTAL SCI, V13, P279, DOI 10.1111/j.1467-7687.2009.00883.x; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Kellenbach ML, 2003, J COGNITIVE NEUROSCI, V15, P30, DOI 10.1162/089892903321107800; Kersey AJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00567; Kucera H., 1967, COMPUTATIONAL ANAL P; Kuo WJ, 2004, NEUROIMAGE, V21, P1721, DOI 10.1016/j.neuroimage.2003.12.007; Libertus ME, 2009, NEUROIMAGE, V44, P1404, DOI 10.1016/j.neuroimage.2008.10.027; Liu Y, 2003, HUM BRAIN MAPP, V18, P167, DOI 10.1002/hbm.10090; Longcamp M, 2006, NEUROIMAGE, V33, P681, DOI 10.1016/j.neuroimage.2006.06.042; Longcamp M, 2005, NEUROPSYCHOLOGIA, V43, P1801, DOI 10.1016/j.neuropsychologia.2005.01.020; Longcamp M, 2003, NEUROIMAGE, V19, P1492, DOI 10.1016/S1053-8119(03)00088-0; Longcamp M, 2008, J COGNITIVE NEUROSCI, V20, P802, DOI 10.1162/jocn.2008.20504; Longcamp M, 2011, HUM BRAIN MAPP, V32, P1250, DOI 10.1002/hbm.21105; Mecklinger A, 2002, CEREB CORTEX, V12, P1115, DOI 10.1093/cercor/12.11.1115; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Nakamura K, 2000, BRAIN, V123; Nakamura K, 2012, P NATL ACAD SCI USA, V109, P20762, DOI 10.1073/pnas.1217749109; Nelson JR, 2009, HUM BRAIN MAPP, V30, P810, DOI 10.1002/hbm.20551; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Perfetti CA, 2005, PSYCHOL REV, V112, P43, DOI 10.1037/0033-295X.112.1.43; Planton S, 2013, CORTEX, V49, P2772, DOI 10.1016/j.cortex.2013.05.011; Price CJ, 2000, J ANAT, V197, P335, DOI 10.1046/j.1469-7580.2000.19730335.x; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Prinz W, 2005, EXPT APPROACHES ACTI, P165; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; Purcell JJ, 2014, COGN NEUROPSYCHOL, V31, P482, DOI 10.1080/02643294.2014.909399; Purcell JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00239; Purcell JJ, 2011, NEUROIMAGE, V55, P750, DOI 10.1016/j.neuroimage.2010.11.042; Rapp B, 2011, J COGNITIVE NEUROSCI, V23, P4067, DOI 10.1162/jocn_a_00109; Rapp B, 2011, J COGNITIVE NEUROSCI, V23, P1180, DOI 10.1162/jocn.2010.21507; Roux FE, 2010, CORTEX, V46, P1204, DOI 10.1016/j.cortex.2010.03.001; Roux FE, 2009, ANN NEUROL, V66, P537, DOI 10.1002/ana.21804; Rueckl JG, 2015, P NATL ACAD SCI USA, V112, P15510, DOI 10.1073/pnas.1509321112; Sharma N, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00564; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; Tan LH, 2005, HUM BRAIN MAPP, V25, P83, DOI 10.1002/hbm.20134; Tan LH, 2005, P NATL ACAD SCI USA, V102, P8781, DOI 10.1073/pnas.0503523102; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Tan LH, 2013, P NATL ACAD SCI USA, V110, P1119, DOI 10.1073/pnas.1213586110; Tokunaga H, 1999, NEUROREPORT, V10, P3315, DOI 10.1097/00001756-199911080-00012; Tso R. V. Y., 2012, J VISION, P2463	73	27	29	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168414	10.1371/journal.pone.0168414	http://dx.doi.org/10.1371/journal.pone.0168414			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992505	gold, Green Submitted, Green Published			2022-12-27	WOS:000392758000049
J	Levin, L; Jensen, P; Kreimer, P				Levin, Luciano; Jensen, Pablo; Kreimer, Pablo			Does Size Matter? The Multipolar International Landscape of Nanoscience	PLOS ONE			English	Article							SCIENCE-AND-TECHNOLOGY; NANOTECHNOLOGY RESEARCH; SEARCH STRATEGY; INNOVATION; COUNTRIES; EVOLUTION; SYSTEMS; BRAZIL; TRADE	How do different countries tackle nanoscience research? Are all countries similar except for a trivial size effect, as science is often assumed to be universal? Or does size dictate large differences, as large countries are able to develop activities in all directions of research, while small countries have to specialize in some specific niches? Alternatively, is size irrelevant, as all countries have followed different historical paths, leading to different patterns of specialisation? Here, we develop an original method that uses a bottom-up definition of scientific subfields to map the international structure of any scientific field. Our analysis shows that nanoscience research does not show a universal pattern of specialisation, homothetic of that of a single global leader (e.g., the United States). Instead, we find a multipolar world, with four main ways of doing nanosciences.	[Levin, Luciano] Univ Nacl La Pampa, Inst Estudios Sociohist, Santa Rosa, Argentina; [Jensen, Pablo] ENS Lyon, UMR 5672, Lab Phys & 912, Lyon, France; [Kreimer, Pablo] Univ Maimonides, Ctr Ciencia Tecnol & Sociedad, CONICET, Buenos Aires, DF, Argentina	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Ecole Normale Superieure de Lyon (ENS de LYON); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Jensen, P (corresponding author), ENS Lyon, UMR 5672, Lab Phys & 912, Lyon, France.	pablo.jensen@ens-lyon.fr	Levin, Luciano/I-7034-2015	Levin, Luciano/0000-0001-7209-805X; Kreimer, Pablo/0000-0002-6737-8556				Arora SK, 2013, SCIENTOMETRICS, V95, P351, DOI 10.1007/s11192-012-0903-6; Avila-Robinson A, 2013, SCIENTOMETRICS, V95, P829, DOI 10.1007/s11192-012-0939-7; BALASSA B, 1965, MANCH SCH ECON SOC, V33, P99, DOI 10.1111/j.1467-9957.1965.tb00050.x; Bassecoulard E, 2007, SCIENTOMETRICS, V70, P859, DOI 10.1007/s11192-007-0315-1; Bergstron C, 2008, MAPS RANDOM WALKS CO, V105, P1118; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bu┬rner K., 2010, ATLAS SCI VISUALIZIN; Campbell D., 2013, COUNTRY REGIONAL SCI; Costinot A, 2012, REV ECON STUD, V79, P581, DOI 10.1093/restud/rdr033; Cunningham S., 2011, P PORTL INT C MAN EN; Dore JC, 1996, J AM SOC INFORM SCI, V47, P588, DOI 10.1002/(SICI)1097-4571(199608)47:8<588::AID-ASI3>3.0.CO;2-P; E. U, 2006, EM SCI TECHN PRIOR P; de Almeida ECE, 2013, SCIENTOMETRICS, V97, P287, DOI 10.1007/s11192-013-0967-y; Glanzel W, 2001, SCIENTOMETRICS, V51, P69, DOI 10.1023/A:1010512628145; Gorjiara T, 2014, SCIENTOMETRICS, V100, P121, DOI 10.1007/s11192-014-1287-6; Grauwin S, 2012, J AM SOC INF SCI TEC, V63, P1327, DOI 10.1002/asi.22644; Grauwin S, 2011, SCIENTOMETRICS, V89, P943, DOI 10.1007/s11192-011-0482-y; Huang C, 2011, J TECHNOL TRANSFER, V36, P145, DOI 10.1007/s10961-009-9149-8; Islam N, 2010, TECHNOVATION, V30, P229, DOI 10.1016/j.technovation.2009.10.002; Jin BH, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P497; Joerges Bernward, 2001, INSTRUMENTATION SCI; KESSLER MM, 1963, AM DOC, V14, P10, DOI 10.1002/asi.5090140103; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Klavans R, 2009, J AM SOC INF SCI TEC, V60, P455, DOI 10.1002/asi.20991; Kreimer P., 2007, Science, Technology & Society, V12, P49, DOI 10.1177/097172180601200104; Kreimer P., 2012, POUVOIRS LOCAUX, VIII, P25; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Leydesdorff L, 2005, CURR SCI INDIA, V89, P1510; Leydesdorff L, 2005, SCIENTOMETRICS, V63, P617, DOI 10.1007/s11192-005-0231-1; Liu N, 2015, SCIENTOMETRICS, V102, P1895, DOI 10.1007/s11192-014-1508-z; MacLeod Roy, 2001, NATURE EMPIRE SCI CO, V15; May RM, 1997, SCIENCE, V275, P793, DOI 10.1126/science.275.5301.793; MIQUEL JF, 1995, SCIENTOMETRICS, V33, P149, DOI 10.1007/BF02020566; Miyazaki K, 2007, TECHNOVATION, V27, P661, DOI 10.1016/j.technovation.2007.05.009; Mogoutov A, 2007, RES POLICY, V36, P893, DOI 10.1016/j.respol.2007.02.005; Moya-Anegon F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083222; Ovalle-Perandones MA, 2013, SCIENTOMETRICS, V97, P59, DOI 10.1007/s11192-013-1028-2; PCAST, 2014, C 3 ASS NAT NAN IN; Porter AL, 2008, J NANOPART RES, V10, P715, DOI 10.1007/s11051-007-9266-y; Porter AL, 2009, J NANOPART RES, V11, P1023, DOI 10.1007/s11051-009-9607-0; Pouris A, 2007, SCIENTOMETRICS, V70, P541, DOI 10.1007/s11192-007-0301-7; Rafols I, 2010, J AM SOC INF SCI TEC, V61, P1871, DOI 10.1002/asi.21368; Rafols I, 2010, SCIENTOMETRICS, V82, P263, DOI 10.1007/s11192-009-0041-y; Ricardo D., 1821, PRINCIPLES POLITICAL; Salomon J-J., 1994, UNCERTAIN QUEST SCI; Salomon JJ, 1988, ECRIVAIN PUBLIC ORDI; Sant'Anna LD, 2014, SCIENTOMETRICS, V100, P675, DOI 10.1007/s11192-014-1300-0; Schummer J, 2007, SCIENTOMETRICS, V70, P669, DOI 10.1007/s11192-007-0307-1; Shelton RD, 2004, SCIENTOMETRICS, V60, P353, DOI 10.1023/B:SCIE.0000034379.75236.d9; Small H, 1999, J AM SOC INFORM SCI, V50, P799, DOI 10.1002/(SICI)1097-4571(1999)50:9<799::AID-ASI9>3.0.CO;2-G; Tong WM, 2005, P SOC PHOTO-OPT INS, V5751, P46, DOI 10.1117/12.607236; Viola P, 2010, INT SCI TECHNOLOGY S; Zhao YL, 2014, FRONT PHYS-BEIJING, V9, P257, DOI 10.1007/s11467-013-0324-x	53	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0166914	10.1371/journal.pone.0166914	http://dx.doi.org/10.1371/journal.pone.0166914			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8LN	27992439	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000392758000010
J	Galluzzi, L; Diotallevi, A; De Santi, M; Ceccarelli, M; Vitale, F; Brandi, G; Magnani, M				Galluzzi, Luca; Diotallevi, Aurora; De Santi, Mauro; Ceccarelli, Marcello; Vitale, Fabrizio; Brandi, Giorgio; Magnani, Mauro			Leishmania infantum Induces Mild Unfolded Protein Response in Infected Macrophages	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; CELL-SURVIVAL; ENDOTHELIAL-CELLS; INDUCED APOPTOSIS; GENE-EXPRESSION; TRANSLATION; CONTRIBUTES; ACTIVATION; REPRESSION; INDUCTION	The Leishmaniases are a group of parasitic diseases caused by protozoa of the Leishmania genus affecting both humans and other vertebrates. Leishmania is an intracellular pathogen able to confer resistance to apoptosis in the early phase of macrophages infection by activation of host PI3K/Akt pathway and inhibition of caspase-3 activation. Intracellular pathogens hijack organelles such as ER to facilitate survival and replication, thus eliciting ER stress and activating/modulating the unfolded protein response (UPR) in the host cell. The UPR is aimed to mitigate ER stress, thereby promoting cell survival. However, prolonged ER stress will activate the apoptotic pathway. The aim of this study was to investigate the ER stress response in Leishmania-infected macrophages to gain insights about the mechanisms underlying the apoptosis resistance in parasitized cells. Macrophages differentiated from human monocytic cell lines (U937 and THP-1) and murine primary macrophages were infected with Leishmania infantum MHOM/TN/80/IPT1 (WHO international reference strain). Several ER stress/autophagy expression markers, as well as cell survival/apoptosis markers (phospho-Akt and cleaved caspase-3) were evaluated by qPCR and/or by western blotting. As ER stress positive control, cells were treated with tunicamycin or dithiothreitol (DTT). The gene expression analyses showed a mild but significant induction of the ER stress/autophagy markers. The western blot analyses revealed that the Leishmania infection induced Akt phosphorylation and significantly inhibited the induction of caspase-3 cleavage, eIF2 alpha phosphorylation and DDIT3/CHOP expression in tunicamycin and DTT treated cells. The mild but significant increase in ER stress expression markers and the delay/attenuation of the effects of ER stress inducers in infected cells support the hypothesis that L. infantum could promote survival of host cells by inducing a mild ER stress response. The host ER stress response could be not only a common pathogenic mechanism among Leishmania species but also a target for development of new drugs.	[Galluzzi, Luca; Diotallevi, Aurora; De Santi, Mauro; Ceccarelli, Marcello; Brandi, Giorgio; Magnani, Mauro] Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy; [Vitale, Fabrizio] Ist Zooprofilatt Sperimentale Sicily A Mirri, Palermo, Italy	University of Urbino	Galluzzi, L (corresponding author), Univ Urbino Carlo Bo, Dept Biomol Sci, Urbino, Italy.	luca.galluzzi@uniurb.it	De Santi, Mauro/F-5401-2013; Diotallevi, Aurora/ABB-2931-2021; Galluzzi, Luca/G-3969-2012; Magnani, Mauro/A-1919-2008; Vitale, Fabrizio/I-6015-2016	De Santi, Mauro/0000-0003-2983-8344; Diotallevi, Aurora/0000-0001-5456-1821; Galluzzi, Luca/0000-0002-1747-526X; Magnani, Mauro/0000-0001-6456-6626; Vitale, Fabrizio/0000-0002-5527-1890	Italian Ministry of Health [2014 IZS SI 03/14, H78F15000030001]	Italian Ministry of Health(Ministry of Health, Italy)	This work was partially supported by Italian Ministry of Health (Ricerca corrente 2014 IZS SI 03/14; code H78F15000030001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akarid K, 2004, J LEUKOCYTE BIOL, V76, P95, DOI 10.1189/jlb.1001877; Bettigole SE, 2015, ANNU REV IMMUNOL, V33, P107, DOI 10.1146/annurev-immunol-032414-112116; Buates S, 2001, J IMMUNOL, V166, P3416, DOI 10.4049/jimmunol.166.5.3416; Calegari-Silva TC, 2009, IMMUNOL LETT, V127, P19, DOI 10.1016/j.imlet.2009.08.009; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Castelli G, 2014, J PARASITOL, V100, P228, DOI 10.1645/13-253.1; Ceccarelli M, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0460-3; Ceccarelli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088845; Cullinan SB, 2004, J BIOL CHEM, V279, P20108, DOI 10.1074/jbc.M314219200; De Santi M, 2015, ANTI-CANCER AGENT ME, V15, P896; Dias-Teixeira KL, 2016, FASEB J, V30, P1557, DOI 10.1096/fj.15-281550; Duque GA, 2015, CURR OPIN MICROBIOL, V26, P32, DOI 10.1016/j.mib.2015.04.007; Galluzzi L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043249; Hamanaka RB, 2009, ONCOGENE, V28, P910, DOI 10.1038/onc.2008.428; Inacio P, 2015, EMBO REP, V16, P955, DOI 10.15252/embr.201439979; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Kennedy D, 2014, FEBS OPEN BIO, V4, P813, DOI 10.1016/j.fob.2014.09.004; Li B, 2011, CELL SIGNAL, V23, P35, DOI 10.1016/j.cellsig.2010.07.019; Lim YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028531; Lisi S, 2005, J EUKARYOT MICROBIOL, V52, P211, DOI 10.1111/j.1550-7408.2005.00026.x; Luz NF, 2012, J IMMUNOL, V188, P4460, DOI 10.4049/jimmunol.1103072; Margariti A, 2013, J BIOL CHEM, V288, P859, DOI 10.1074/jbc.M112.412783; Martin D, 2014, J BIOL CHEM, V289, P30625, DOI 10.1074/jbc.M114.571984; Martinon F, 2011, CURR OPIN IMMUNOL, V23, P35, DOI 10.1016/j.coi.2010.10.016; Mattson MP, 2008, AGEING RES REV, V7, P1, DOI 10.1016/j.arr.2007.08.007; Menotta M, 2012, J BIOL CHEM, V287, P41352, DOI 10.1074/jbc.M112.344473; Mercado G, 2013, TRENDS MOL MED, V19, P165, DOI 10.1016/j.molmed.2012.12.005; Mollereau B, 2014, J CELL COMMUN SIGNAL, V8, P311, DOI 10.1007/s12079-014-0251-9; Mollereau B, 2013, MOL CELL BIOL, V33, P2372, DOI 10.1128/MCB.00315-13; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Ovalle-Bracho C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128934; Pal S, 2006, J CELL BIOL, V174, P1047, DOI 10.1083/jcb.200603152; Podinovskaia M, 2015, FUTURE MICROBIOL, V10, P111, DOI 10.2217/fmb.14.103; Preston AM, 2013, J CELL SCI, V126, P4253, DOI 10.1242/jcs.130336; Real F, 2014, CELL MICROBIOL, V16, P1549, DOI 10.1111/cmi.12311; Reale S, 1999, J CLIN MICROBIOL, V37, P2931, DOI 10.1128/JCM.37.9.2931-2935.1999; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; van 't Wout EFA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004946; Vivarini AD, 2011, FASEB J, V25, P4162, DOI 10.1096/fj.11-185165; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yamamoto M, 2011, J EXP MED, V208, P1533, DOI 10.1084/jem.20101660; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4	45	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168339	10.1371/journal.pone.0168339	http://dx.doi.org/10.1371/journal.pone.0168339			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978534	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400095
J	Pabbidi, MR; Ji, X; Maxwell, JT; Mignery, GA; Samarel, AM; Lipsius, SL				Pabbidi, M. R.; Ji, X.; Maxwell, J. T.; Mignery, G. A.; Samarel, A. M.; Lipsius, S. L.			Inhibition of cAMP-Dependent PKA Activates beta(2)-Adrenergic Receptor Stimulation of Cytosolic Phospholipase A(2) via Raf-1/MEK/ERK and IP3-Dependent Ca2+ Signaling in Atrial Myocytes	PLOS ONE			English	Article							PROTEIN-KINASE-C; ARACHIDONIC-ACID RELEASE; CARDIAC-MUSCLE-CELLS; VENTRICULAR MYOCYTES; ADENYLYL-CYCLASE; HEART-FAILURE; MESSENGER-RNA; NO RELEASE; CAVEOLAE; PHOSPHORYLATION	We previously reported in atrial myocytes that inhibition of cAMP-dependent protein kinase (PKA) by laminin (LMN)-integrin signaling activates beta(2)-adrenergic receptor (beta(2)-AR) stimulation of cytosolic phospholipase A(2) (cPLA(2)). The present study sought to determine the signaling mechanisms by which inhibition of PKA activates beta(2)-AR stimulation of cPLA(2). We therefore determined the effects of zinterol (0.1 mu M; zint-beta(2)-AR) to stimulate I-Ca,I- L in atrial myocytes in the absence (+ PKA) and presence (-PKA) of the PKA inhibitor (1 mu M) KT5720 and compared these results with atrial myocytes attached to laminin (+ LMN). Inhibition of Raf-1 (10 mu M GW5074), phospholipase C (PLC; 0.5 mu M edelfosine), PKC (4 mu M chelerythrine) or IP3 receptor (IP3R) signaling (2 mu M 2-APB) significantly inhibited zint-beta(2)-AR stimulation of ICa, L in-PKA but not + PKA myocytes. Western blots showed that zint-beta(2)-AR stimulation increased ERK1/2 phosphorylation in-PKA compared to + PKA myocytes. Adenoviral (Adv) expression of dominant negative (dn)-PKC alpha, dn-Raf-1 or an IP3 affinity trap, each inhibited zint-beta(2)-AR stimulation of ICa, L in + LMN myocytes compared to control + LMN myocytes infected with Adv-beta gal. In + LMN myocytes, zint-beta(2)-AR stimulation of ICa, L was enhanced by adenoviral overexpression of wild-type cPLA(2) and inhibited by double dn-cPLA2 S505A/S515A mutant compared to control + LMN myocytes infected with Adv-beta gal. In-PKA myocytes depletion of intracellular Ca2+ stores by 5 mu M thapsigargin failed to inhibit zint-beta(2)-AR stimulation of ICa, L via cPLA(2). However, disruption of caveolae formation by 10 mM methyl-beta-cyclodextrin inhibited zint-beta(2)-AR stimulation of ICa, L -PKA myocytes significantly more than in + PKA myocytes. We conclude that inhibition of PKA removes inhibition of Raf-1 and thereby allows beta(2)-AR stimulation to act via PKCa/Raf-1/MEK/ERK1/2 and IP3-mediated Ca2+ signaling to stimulate cPLA(2) signaling within caveolae. These findings may be relevant to the remodeling of beta-AR signaling in failing and/or aging heart, both of which exhibit decreases in adenylate cyclase activity.	[Pabbidi, M. R.] Univ Mississippi, Med Ctr, Dept Pharmacol, Jackson, MS 39216 USA; [Ji, X.; Maxwell, J. T.; Mignery, G. A.; Lipsius, S. L.] Loyola Univ, Med Ctr, Dept Physiol, Maywood, IL 60153 USA; [Samarel, A. M.] Loyola Univ, Med Ctr, Dept Med, Maywood, IL 60153 USA	University of Mississippi; University of Mississippi Medical Center; Loyola University Chicago; Loyola University Chicago	Pabbidi, MR (corresponding author), Univ Mississippi, Med Ctr, Dept Pharmacol, Jackson, MS 39216 USA.	mpabbidi@umc.edu	Samarel, Allen/Q-9810-2019		NIH [HL079038, HL62426-Project 4]; AHA [13SDG14000006]; Dr.Ralph and Marian Falk Medical Research Trust	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Dr.Ralph and Marian Falk Medical Research Trust	This work was supported by NIH grants HL079038 (S.L.L.), HL62426-Project 4 and AHA Scientist Development Grant (13SDG14000006) (M.R.P.) and a grant from the Dr.Ralph and Marian Falk Medical Research Trust (A.M.S.).	Ait-Mamar B, 2005, J BIOL CHEM, V280, P18881, DOI 10.1074/jbc.M410305200; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; BRISTOW MR, 1989, MOL PHARMACOL, V35, P295; BRODDE OE, 1995, J CARDIOVASC PHARM, V26, P20, DOI 10.1097/00005344-199507000-00004; Carpenter L, 2001, J BIOL CHEM, V276, P5368, DOI 10.1074/jbc.M010036200; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Domeier TL, 2008, AM J PHYSIOL-HEART C, V294, pH596, DOI 10.1152/ajpheart.01155.2007; Farrell SR, 2008, MECH AGEING DEV, V129, P735, DOI 10.1016/j.mad.2008.09.017; FUJIMOTO T, 1992, J CELL BIOL, V119, P1507, DOI 10.1083/jcb.119.6.1507; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Goel A, 2003, CLIN CANCER RES, V9, P383; HAFNER S, 1994, MOL CELL BIOL, V14, P6696; Heidkamp MC, 2001, CIRC RES, V89, P882, DOI 10.1161/hh2201.099434; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hirabayashi T, 2004, BIOL PHARM BULL, V27, P1168, DOI 10.1248/bpb.27.1168; Iijima Y, 2002, J BIOL CHEM, V277, P23065, DOI 10.1074/jbc.M200328200; ISHIKAWA Y, 1994, J CLIN INVEST, V93, P2224, DOI 10.1172/JCI117219; Kohno Michiaki, 2003, Prog Cell Cycle Res, V5, P219; Lefkowitz RJ, 2002, MOL PHARMACOL, V62, P971, DOI 10.1124/mol.62.5.971; Liu YC, 2007, CLIN EXP PHARMACOL P, V34, P1173, DOI 10.1111/j.1440-1681.2007.04696.x; Luciani MG, 2007, CARCINOGENESIS, V28, P2207, DOI 10.1093/carcin/bgm101; Magne S, 2001, J BIOL CHEM, V276, P39539, DOI 10.1074/jbc.M100954200; MARZO KP, 1991, CIRC RES, V69, P1546, DOI 10.1161/01.RES.69.6.1546; Moschella PC, 2007, J MOL CELL CARDIOL, V43, P754, DOI 10.1016/j.yjmcc.2007.09.015; Nalli AD, 2014, CELL BIOCHEM BIOPHYS, V70, P867, DOI 10.1007/s12013-014-9992-6; Pabbidi MR, 2009, J PHYSIOL-LONDON, V587, P4785, DOI 10.1113/jphysiol.2009.179226; Pavicevic Z, 2008, J LIPID RES, V49, P724, DOI 10.1194/jlr.M700419-JLR200; Pavoine C, 1999, J BIOL CHEM, V274, P628, DOI 10.1074/jbc.274.2.628; Ping PP, 1999, AM J PHYSIOL-HEART C, V276, pH1468, DOI 10.1152/ajpheart.1999.276.5.H1468; POWIS G, 1992, CANCER RES, V52, P2835; Rybin VO, 2000, J BIOL CHEM, V275, P41447, DOI 10.1074/jbc.M006951200; SCHNITZER JE, 1995, P NATL ACAD SCI USA, V92, P1759, DOI 10.1073/pnas.92.5.1759; Smart EJ, 2002, METHOD ENZYMOL, V353, P131; Taylor RP, 2003, ACTA PHYSIOL SCAND, V178, P107, DOI 10.1046/j.1365-201X.2003.01132.x; Tselentakis EV, 2006, J SURG RES, V135, P68, DOI 10.1016/j.jss.2006.03.024; Uddin S, 2010, INT J CANCER, V126, P382, DOI 10.1002/ijc.24757; van Rossum DB, 2009, CELL CALCIUM, V45, P535, DOI 10.1016/j.ceca.2009.02.008; Wang LC, 2013, MOL MED REP, V8, P1465, DOI 10.3892/mmr.2013.1676; Wang YZ, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/1/015001; Wang YG, 2005, J PHYSIOL-LONDON, V567, P143, DOI 10.1113/jphysiol.2005.090035; Wang YG, 2002, J GEN PHYSIOL, V119, P69, DOI 10.1085/jgp.119.1.69; Wang YG, 2000, J PHYSIOL-LONDON, V526, P57, DOI 10.1111/j.1469-7793.2000.t01-1-00057.x; Wang YG, 2000, J PHYSIOL-LONDON, V527, P3, DOI 10.1111/j.1469-7793.2000.t01-2-00003.x; Wu X, 2006, CIRC RES, V99, P283, DOI 10.1161/01.RES.0000233386.02708.72; Yan L, 2007, CELL, V130, P247, DOI 10.1016/j.cell.2007.05.038; Zamah AM, 2002, J BIOL CHEM, V277, P31249, DOI 10.1074/jbc.M202753200; Zima AV, 2004, J PHYSIOL-LONDON, V555, P607, DOI 10.1113/jphysiol.2003.058529	50	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168505	10.1371/journal.pone.0168505	http://dx.doi.org/10.1371/journal.pone.0168505			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977772	gold, Green Submitted, Green Published			2022-12-27	WOS:000391217400114
J	Saunders-Hastings, P; Reisman, J; Krewski, D				Saunders-Hastings, Patrick; Reisman, Jane; Krewski, Daniel			Assessing the State of Knowledge Regarding the Effectiveness of Interventions to Contain Pandemic Influenza Transmission: A Systematic Review and Narrative Synthesis	PLOS ONE			English	Review							NEURAMINIDASE INHIBITOR TREATMENT; A H1N1; METHODOLOGICAL QUALITY; INTERNATIONAL AIRPORT; SEASONAL INFLUENZA; MEASUREMENT TOOL; SURGE CAPACITY; HAND HYGIENE; VACCINES; MORTALITY	Background Influenza pandemics occur when a novel influenza strain, to which humans are immunologically naive, emerges to cause infection and illness on a global scale. Differences in the viral properties of pandemic strains, relative to seasonal ones, can alter the effectiveness of interventions typically implemented to control seasonal influenza burden. As a result, annual control activities may not be sufficient to contain an influenza pandemic. Purpose This study seeks to inform pandemic policy and planning initiatives by reviewing the effectiveness of previous interventions to reduce pandemic influenza transmission and infection. Results will inform the planning and design of more focused in-depth systematic reviews for specific types of interventions, thus providing the most comprehensive and current understanding of the potential for alternative interventions to mitigate the burden of pandemic influenza. Methods A systematic review and narrative synthesis of existing systematic reviews and meta-analyses examining intervention effectiveness in containing pandemic influenza transmission was conducted using information collected from five databases (PubMed, Medline, Cochrane, Embase, and Cinahl/EBSCO). Two independent reviewers conducted study screening and quality assessment, extracting data related to intervention impact and effectiveness. Results and Discussion Most included reviews were of moderate to high quality. Although the degree of statistical heterogeneity precluded meta-analysis, the present systematic review examines the wide variety of interventions that can impact influenza transmission in different ways. While it appears that pandemic influenza vaccination provides significant protection against infection, there was insufficient evidence to conclude that antiviral prophylaxis, seasonal influenza cross-protection, or a range of non-pharmaceutical strategies would provide appreciable protection when implemented in isolation. It is likely that an optimal intervention strategy will employ a combination of interventions in a layered approach, though more research is needed to substantiate this proposition.	[Saunders-Hastings, Patrick; Reisman, Jane; Krewski, Daniel] Univ Ottawa, McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON, Canada	University of Ottawa	Saunders-Hastings, P (corresponding author), Univ Ottawa, McLaughlin Ctr Populat Hlth Risk Assessment, Ottawa, ON, Canada.	psaun076@uottawa.ca						Bahia L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-440; Barbisch DF, 2006, ACAD EMERG MED, V13, P1098, DOI 10.1197/j.aem.2006.06.041; Bitar D, 2009, EUROSURVEILLANCE, V14; Breteler JK, 2013, VACCINE, V31, P5168, DOI 10.1016/j.vaccine.2013.08.056; Chien YW, 2010, J INFECT DIS, V202, P1639, DOI 10.1086/657144; Cowling BJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-82; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Cruz AT, 2012, DISASTER MED PUBLIC, V6, P113, DOI 10.1001/dmp.2012.16; Demicheli V, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub5; Fielding JE, 2014, INFLUENZA OTHER RESP, V8, P142, DOI 10.1111/irv.12216; Gilca R, 2011, PEDIATRICS, V128, pE1084, DOI 10.1542/peds.2010-3492; Hale MJ, 2012, EMERG INFECT DIS, V18, P866, DOI 10.3201/eid1805.111080; Hollenbeck JE, 2016, INFECT GENET EVOL, V38, P44, DOI [10.1016/j.meegid.2015.12.002, 10.]; Hu J, 2016, FRONT AGRIC SCI ENG, V3, P11, DOI 10.15302/J-FASE-2016092; Humphries MO, 2014, WAR HIST, V21, P55, DOI 10.1177/0968344513504525; Jackson Charlotte, 2013, BMJ Open, V3, DOI 10.1136/bmjopen-2012-002149; Jefferson T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004879.pub3; Jefferson T, 2014, COCHRANE DATABASE SY; Jefferson T, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006207.pub4; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Jordan EO., 1927, EPIDEMIC INFLUENZA S; Lau JTF, 2003, J EPIDEMIOL COMMUNIT, V2003, P57; Li JH, 2016, J CHIN MED ASSOC, V79, P281, DOI 10.1016/j.jcma.2015.10.009; Li XC, 2014, 2014 INTERNATIONAL CONFERENCE ON SECURITY, PATTERN ANALYSIS, AND CYBERNETICS (SPAC), P20, DOI 10.1109/SPAC.2014.6982650; Li ZY, 2015, HUM VACC IMMUNOTHER, V11, P1337, DOI 10.4161/21645515.2014.985495; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2012, PEDIATRICS, V129, pS63, DOI 10.1542/peds.2011-0737D; Lorenzetti Diane L, 2014, COCHRANE DATABASE SY; Lowen Anice, 2009, PLoS Curr, V1, pRRN1002; Madhav Nita., 2013, MSP H AIRCURRENTS MO; Mahmud S, 2011, VACCINE, V29, P7975, DOI 10.1016/j.vaccine.2011.08.068; Malik VS, 2011, AM J CLIN NUTR, V94, P1161, DOI 10.3945/ajcn.111.025676; Manzoli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024384; Meltzer MI, 2015, CLIN INFECT DIS, V60, pS52, DOI 10.1093/cid/civ089; Michiels B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060348; Michiels B, 2011, VACCINE, V29, P9159, DOI 10.1016/j.vaccine.2011.08.008; Mitchell MD, 2010, CRIT CARE MED, V38, P1398, DOI 10.1097/CCM.0b013e3181de45db; Mizumoto K, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-4; MOGABGAB WJ, 1970, J AMER MED ASSOC, V211, P1672, DOI 10.1001/jama.211.10.1672; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Murray KA, 2016, FOOD MICROBIOL FOOD, P31, DOI 10.1007/978-3-319-24442-6_2; Muthuri SG, 2016, INFLUENZA OTHER RESP, V10, P192, DOI 10.1111/irv.12363; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Muthuri SG, 2013, J INFECT DIS, V207, P553, DOI 10.1093/infdis/jis726; Nap RE, 2007, EMERG INFECT DIS, V13, P1714, DOI 10.3201/eid1311.070103; Nishiura H, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-111; Ortiz JR, 2013, CRIT CARE MED, V41, P1345, DOI 10.1097/CCM.0b013e3182771386; Ortqvist A, 2011, CLIN INFECT DIS, V52, P1203, DOI 10.1093/cid/cir182; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; PATTERSON KD, 1991, B HIST MED, V65, P4; Remschmidt C, 2014, VACCINE, V32, P1678, DOI 10.1016/j.vaccine.2014.01.060; Rodrigo C, 2015, J INFECT DIS, V212, P183, DOI 10.1093/infdis/jiu645; Rudd KE, 2012, AM J RESP CRITICAL C, V185; Schultz CH, 2006, ACAD EMERG MED, V13, P1153, DOI 10.1197/j.aem.2006.06.033; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Shea BJ, 2009, J CLIN EPIDEMIOL, V62, P1013, DOI 10.1016/j.jclinepi.2008.10.009; Smith V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-15; Suess T, 2011, EPIDEMIOL INFECT, V139, P1895, DOI 10.1017/S0950268810003006; Torner N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1890-3; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; Van Buynder PG, 2010, INFLUENZA OTHER RESP, V4, P171, DOI 10.1111/j.1750-2659.2010.00146.x; Velasco RP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030333; Venkatesan S, 2016, INT J INFECT DIS, V45, P248, DOI 10.1016/j.ijid.2016.02.555; Waring J, 1971, HIST MED S CAROLINA; Watson SJ, 2015, J VIROL, V89, P9920, DOI 10.1128/JVI.00840-15; Wong VWY, 2014, EPIDEMIOL INFECT, V142, P922, DOI 10.1017/S095026881400003X; Wu JA, 2010, NEW ENGL J MED, V363, P2416, DOI 10.1056/NEJMoa1006736; Yamada T, 2012, J OBSTET GYNAECOL RE, V38, P130, DOI 10.1111/j.1447-0756.2011.01644.x; Yang JJ, 2015, AER ADV ENG RES, V21, P63; Yin JK, 2011, INFLUENZA OTHER RESP, V5, P299, DOI 10.1111/j.1750-2659.2011.00229.x; Yin JK, 2012, VACCINE, V30, P3209, DOI 10.1016/j.vaccine.2012.02.048; Yu HJ, 2012, EMERG INFECT DIS, V18, P758, DOI 10.3201/eid1805.110356	74	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168262	10.1371/journal.pone.0168262	http://dx.doi.org/10.1371/journal.pone.0168262			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977760	Green Submitted, Green Published, gold			2022-12-27	WOS:000391217400084
J	Shimizu, M; Tanaka, M; Atomi, Y				Shimizu, Miho; Tanaka, Mikihito; Atomi, Yoriko			Small Heat Shock Protein alpha B-Crystallin Controls Shape and Adhesion of Glioma and Myoblast Cells in the Absence of Stress	PLOS ONE			English	Article							SKELETAL-MUSCLE; MITOCHONDRIAL-FUNCTION; TUBULIN; MIGRATION; CYTOSKELETON; HYPERTROPHY; ASSOCIATION; MECHANISM; ACTIN; LENS	Cell shape and adhesion and their proper controls are fundamental for all biological systems. Mesenchymal cells migrate at an average rate of 6 to 60 mu m/hr, depending on the extracellular matrix environment and cell signaling. Myotubes, fully differentiated muscle cells, are specialized for power-generation and therefore lose motility. Cell spreading and stabilities of focal adhesion are regulated by the critical protein vinculin from immature myoblast to mature costamere of differentiated myotubes where myofibril Z-band linked to sarcolemma. The Z-band is constituted from microtubules, intermediate filaments, cell adhesion molecules and other adapter proteins that communicate with the outer environment. Mesenchymal cells, including myoblast cells, convert actomyosin contraction forces to tension through mechanoresponsive adhesion assembly complexes as Z-band equivalents. There is growing evidence that microtubule dynamics are involved in the generation of contractile forces; however, the roles of microtubules in cell adhesion dynamics are not well determined. Here, we show for the first time that alpha B-crystallin, a molecular chaperon for tubulin/microtubules, is involved in cell shape determination. Moreover, knockdown of this molecule caused myoblasts and glioma cells to lose their ability for adhesion as they tended to behave like migratory cells. Surprisingly, aB-crystallin knockdown in both C6 glial cells and L6 myoblast permitted cells to migrate more rapidly (2.7 times faster for C6 and 1.3 times faster for L6 cells) than dermal fibroblast. On the other hand, overexpression of aB-crystallin in cells led to an immortal phenotype because of persistent adhesion. Position of matured focal adhesion as visualized by vinculin immuno-staining, stress fiber direction, length, and density were clearly aB-crystallin dependent. These results indicate that the small HSP aB-crystallin has important roles for cell adhesion, and thus microtubule dynamics are necessary for persistent adhesion.	[Shimizu, Miho; Atomi, Yoriko] Tokyo Univ Agr & Technol, Grad Sch Engn, Mat Hlth Sci Lab, Tokyo, Japan; [Tanaka, Mikihito] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Tanaka, Mikihito] Waseda Univ, Grad Sch Polit Sci, Tokyo, Japan	Tokyo University of Agriculture & Technology; University of Tokyo; Waseda University	Atomi, Y (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Engn, Mat Hlth Sci Lab, Tokyo, Japan.	yatomi@cc.tuat.ac.jp	Atomi, Yoriko/AAF-4783-2019; Shimizu, Miho/O-9903-2019	Atomi, Yoriko/0000-0003-3808-6543; Shimizu, Miho/0000-0003-4070-8209	Japan Society for the Promotion of Science [10480004, 11167218, 12308001, 13022213, 21650171, 23650416, 26560323]; Japan Space Utilization Promotion Center [FY1999-2001]; Japan Space Forum [FY1997-2000]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Space Utilization Promotion Center; Japan Space Forum	YA received Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (#10480004: https://kaken.nii.ac.jp/d/p/10480004.ja.html; #11167218: https://kaken.nii.ac.jp/d/p/11167218.ja.html; #12308001: https://kaken.nii.ac.jp/d/p/12308001.ja.html; #13022213: https://kaken.nii.ac.jp/d/p/13022213.ja.html; #21650171: https://kaken.nii.ac.jp/d/p/21650171.ja.html; #23650416: https://kaken.nii.ac.jp/d/p/23650416.ja.html; #26560323: https://kaken.nii.ac.jp/d/p/26560323.ja.html), Research grant from Japan Space Utilization Promotion Center (FY1999-2001), and Research grant from Japan Space Forum (FY1997-2000).	Arac A, 2011, P NATL ACAD SCI USA, V108, P13287, DOI 10.1073/pnas.1107368108; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; ATOMI Y, 1991, J BIOCHEM-TOKYO, V110, P812, DOI 10.1093/oxfordjournals.jbchem.a123665; ATOMI Y, 1991, BIOCHEM BIOPH RES CO, V181, P1323, DOI 10.1016/0006-291X(91)92083-V; Atomi Y, 2000, J APPL PHYSIOL, V88, P1355, DOI 10.1152/jappl.2000.88.4.1355; Bai F, 2004, MOL CELL BIOCHEM, V265, P115, DOI 10.1023/B:MCBI.0000044365.48900.82; Bailey AP, 2015, CELL, V163, P340, DOI 10.1016/j.cell.2015.09.020; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BENDA P, 1968, SCIENCE, V161, P370, DOI 10.1126/science.161.3839.370; Bonakdar N, 2015, EXP CELL RES, V331, P331, DOI 10.1016/j.yexcr.2014.10.001; Bullard B, 2004, J BIOL CHEM, V279, P7917, DOI 10.1074/jbc.M307473200; Case LB, 2015, NAT CELL BIOL, V17, P880, DOI 10.1038/ncb3180; Chao CC, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.414; Collin L, 2008, BIOL CELL, V100, P243, DOI 10.1042/BC20070123; Dimou L, 2014, PHYSIOL REV, V94, P709, DOI 10.1152/physrev.00036.2013; Ellis RJ, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0398; Ferreira MM, 2015, INTEGR BIOL-UK, V7, P569, DOI 10.1039/c5ib00060b; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Fujita Y, 2004, J CELL SCI, V117, P1719, DOI 10.1242/jcs.01021; Gangalum RK, 2011, J BIOL CHEM, V286, P3261, DOI 10.1074/jbc.M110.160135; Gangalum RK, 2009, INVEST OPHTH VIS SCI, V50, P3283, DOI 10.1167/iovs.08-3052; Giampieri S, 2009, NAT CELL BIOL, V11, P1287, DOI 10.1038/ncb1973; Greenlee M, 2016, MOL BIOL CELL, V27; Guo AH, 2010, J INVEST DERMATOL, V130, P2320, DOI 10.1038/jid.2010.96; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Houck SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011795; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; IWAKI T, 1994, J CELL BIOL, V125, P1385, DOI 10.1083/jcb.125.6.1385; Kampinga HH, 2012, INT J BIOCHEM CELL B, V44, P1706, DOI 10.1016/j.biocel.2012.06.005; Knight B, 2000, CURR BIOL, V10, P576, DOI 10.1016/S0960-9822(00)00486-3; Kobayashi T, 1997, ZOOL SCI, V14, P595, DOI 10.2108/zsj.14.595; Kuznetsov AV, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00082; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lepekhin EA, 2001, J NEUROCHEM, V79, P617, DOI 10.1046/j.1471-4159.2001.00595.x; Lorea-Hernandez JJ, 2016, GLIA, V64, P603, DOI 10.1002/glia.22951; Martinac B, 2014, BBA-BIOMEMBRANES, V1838, P682, DOI 10.1016/j.bbamem.2013.07.015; McGreal RS, 2012, BBA-GEN SUBJECTS, V1820, P921, DOI 10.1016/j.bbagen.2012.04.004; Menconi M, 2008, J CELL BIOCHEM, V105, P353, DOI 10.1002/jcb.21833; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607; Ng DHJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115213; Ohto-Fujita E, 2007, CELL STRESS CHAPERON, V12, P163, DOI 10.1379/CSC-255.1; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Pereira MBM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6159; Peterson Courtney M, 2012, J Aging Res, V2012, P194821, DOI 10.1155/2012/194821; Pletjushkina OJ, 2001, CELL MOTIL CYTOSKEL, V48, P235, DOI 10.1002/cm.1012.abs; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Pullar CE, 2005, J CELL SCI, V118, P2023, DOI 10.1242/jcs.02330; Quinlan RA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0091; Ray PS, 2001, FASEB J, V15, P393, DOI 10.1096/fj.00-0199com; Reddy VS, 2015, CURR MOL MED, V15, P47, DOI 10.2174/1566524015666150114112853; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Sakurai T, 2005, FASEB J, V19, P1199, DOI 10.1096/fj.04-3060fje; SARABIA V, 1990, BIOCHEM CELL BIOL, V68, P536, DOI 10.1139/o90-076; Schmidt T, 2012, HISTOCHEM CELL BIOL, V138, P407, DOI 10.1007/s00418-012-0964-x; Shao W, 2013, NATURE, V494, P90, DOI 10.1038/nature11748; Sharples AP, 2011, CURR OPIN CLIN NUTR, V14, P230, DOI 10.1097/MCO.0b013e3283457ade; SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320; Stehbens SJ, 2014, NAT CELL BIOL, V16, P558, DOI 10.1038/ncb2975; Stephens DJ, 2012, J CELL SCI, V125, P2795, DOI 10.1242/jcs.097675; Su SP, 2011, BBA-PROTEINS PROTEOM, V1814, P647, DOI 10.1016/j.bbapap.2011.03.014; Valeyev Najl V., 2006, In Silico Biology, V6, P545; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Volkenhoff A, 2015, CELL METAB, V22, P437, DOI 10.1016/j.cmet.2015.07.006; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wojtowicz I, 2015, DEVELOPMENT, V142, P994, DOI 10.1242/dev.115352; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yamamoto S, 2014, BIOCHEM BIOPH RES CO, V455, P241, DOI 10.1016/j.bbrc.2014.10.151	73	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							0168136	10.1371/journal.pone.0168136	http://dx.doi.org/10.1371/journal.pone.0168136			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977738	gold, Green Published, Green Submitted			2022-12-27	WOS:000391217400066
J	Viard, JP; Assuied, A; Levy, Y; Souberbielle, JC; Thiebaut, R; Carrat, F; Chene, G; Launay, O; Richert, L				Viard, Jean-Paul; Assuied, Alex; Levy, Yves; Souberbielle, Jean-Claude; Thiebaut, Rodolphe; Carrat, Fabrice; Chene, Genevieve; Launay, Odile; Richert, Laura			No Positive Association between Vitamin D Level and Immune Responses to Hepatitis B and Streptococcus pneumoniae Vaccination in HIV-Infected Adults	PLOS ONE			English	Article							INFLUENZA VACCINE; PNEUMOCOCCAL VACCINATION; D SUPPLEMENTATION; IMMUNOGENICITY; EFFICACY; IMPACT	Objective To assess whether higher 25-hydroxyvitamin D (25OHD) levels are associated with subsequent better immune responses to hepatitis B and Streptococcus pneumoniae vaccination in HIV-infected patients. Methods 25OHD was measured on stored baseline plasma samples from two randomized vaccine trials in HIV-infected adults: the ANRS HB03 VIHVAC B trial and an immunological sub-study of the ANRS 114-PNEUMOVAC trial. In ANRS HB03 VIHVAC B, participants received three or four doses of recombinant HBV vaccine strategies. Anti-HBs IgG titers were measured four weeks after the last injection. Associations between baseline 25OHD levels and ordered IgG response categories were analyzed in multivariable proportional odds models. In the ANRS 114-PNEUMOVAC sub-study, two strategies of pneumococcal vaccination were tested, cellular immune responses were measured at repeated time points, and IgG responses four weeks after the last vaccine injection. Exploratory statistical analyses were performed on this sub-study data set. Results Three hundred and thirty-nine ANRS HB03 VIHVAC B and 25 ANRS 114-PNEUMOVAC sub-study participants were included in the analyses. Median age in each of the two studies was 43 years, 68% were male, and 77-92% on antiretroviral treatment. Median 25OHD level was 18 ng/mL (IQR: 12-25) and 24 ng/mL (IQR: 13-32) in the two trial populations, respectively. In the multivariable model, there was no significant association between baseline 25OHD level and vaccine responses in ANRS HB03 VIHVAC B (proportional odds ratio 0.83 per 10 ng/mL 25OHD increase; 95% confidence interval 0.65-1.07, p = 0.14). Exploratory analyses of ANRS 114-PNEUMOVAC showed consistent results. Conclusion This study does not support a positive association between 25OHD and immune responses to hepatitis B or pneumococcal vaccination in HIV-infected patients.	[Viard, Jean-Paul] AP HP, Hotel Dieu, Ctr Diagnost & Therapeut, Paris, France; [Viard, Jean-Paul] Fac Med Paris Descartes, EA 7327, Paris, France; [Assuied, Alex; Thiebaut, Rodolphe; Chene, Genevieve; Richert, Laura] Ctr INSERM U1219, INSERM, ISPED, Bordeaux, France; [Assuied, Alex; Thiebaut, Rodolphe; Chene, Genevieve; Richert, Laura] Univ Bordeaux, ISPED, Ctr INSERM U1219, Bordeaux, France; [Levy, Yves] INSERM U955, Equipe 16, Creteil, France; [Levy, Yves] Univ Paris Est, Fac Med, Creteil, France; [Levy, Yves; Thiebaut, Rodolphe; Richert, Laura] Vaccine Res Inst, Creteil, France; [Levy, Yves] Hop H Mondor Chenevier, AP HP, Serv Immunol Clin & Malad Infect, Creteil, France; [Souberbielle, Jean-Claude] Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Paris, France; [Thiebaut, Rodolphe; Chene, Genevieve; Richert, Laura] CHU Bordeaux, Pole Sante Publ, Bordeaux, France; [Thiebaut, Rodolphe; Richert, Laura] INRIA SISTM, Talence, France; [Carrat, Fabrice] INSERM U1136, Paris, France; [Carrat, Fabrice] St Antoine Hosp, AP HP, Paris, France; [Launay, Odile] INSERM, I REIVAC, CIC 1417, F CRIN, Paris, France; [Launay, Odile] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Launay, Odile] Cochin Hosp, AP HP, CIC Cochin Pasteur, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Viard, JP (corresponding author), AP HP, Hotel Dieu, Ctr Diagnost & Therapeut, Paris, France.; Viard, JP (corresponding author), Fac Med Paris Descartes, EA 7327, Paris, France.	jean-paul.viard@aphp.fr	Viard, Jean-Paul/O-6467-2017; Carrat, Fabrice/AAU-8480-2020; chene, genevieve/H-8665-2014; Richert, Laura/T-5801-2019; Thiebaut, Rodolphe/T-6803-2019	Viard, Jean-Paul/0000-0001-5946-8896; Carrat, Fabrice/0000-0002-8672-7918; chene, genevieve/0000-0002-8368-6460; Thiebaut, Rodolphe/0000-0002-5235-3962; Richert, Laura/0000-0002-7682-2225	ANRS; Pfizer	ANRS(ANRSFrench National Research Agency (ANR)); Pfizer(Pfizer)	ANRS HB03 VIHVAC-B trial was sponsored and funded by ANRS. Sanofi Pasteur-MSD provided the vaccines used in the trial. ANRS 114 Pneumovac trial was sponsored and funded by ANRS and realized with the support of Pfizer. This study was funded by ANRS (www.anrs.fr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoun B, 2012, PEDIATR NEPHROL, V27, P2161, DOI 10.1007/s00467-012-2273-y; Bergman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065835; Cooper C, 2011, HIV CLIN TRIALS, V12, P275, DOI 10.1310/hct1205-275; Coussens AK, 2012, P NATL ACAD SCI USA, V109, P15449, DOI 10.1073/pnas.1200072109; Crum-Cianflone NF, 2016, VACCINE, V34, P5040, DOI 10.1016/j.vaccine.2016.06.019; Fabre-Mersseman V, 2014, AIDS, V28, P2677, DOI 10.1097/QAD.0000000000000472; HADLER SC, 1986, NEW ENGL J MED, V315, P209, DOI 10.1056/NEJM198607243150401; HOLLIS BW, 1993, CLIN CHEM, V39, P529; Kriesel JD, 1999, VACCINE, V17, P1883, DOI 10.1016/S0264-410X(98)00476-9; Launay O, 2011, JAMA-J AM MED ASSOC, V305, P1432, DOI 10.1001/jama.2011.351; Lesprit P, 2007, AIDS, V21, P2425, DOI 10.1097/QAD.0b013e3282887e91; Leuridan E, 2011, CLIN INFECT DIS, V53, P68, DOI 10.1093/cid/cir270; Mehta S, 2009, J INFECT DIS, V200, P1022, DOI 10.1086/605699; Momplaisir Florence, 2012, J AIDS Clin Res, V3, P152; Pedrono G, 2009, J CLIN EPIDEMIOL, V62, P1054, DOI 10.1016/j.jclinepi.2008.10.014; Peelen E, 2013, EUR J CLIN MICROBIOL, V32, P61, DOI 10.1007/s10096-012-1714-7; Peelen E, 2011, AUTOIMMUN REV, V10, P733, DOI 10.1016/j.autrev.2011.05.002; Principi N, 2013, HUM VACC IMMUNOTHER, V9, P969, DOI 10.4161/hv.23540; Rabian C, 2010, CLIN INFECT DIS, V50, P1174, DOI 10.1086/651418; Sadarangani SP, 2015, EXPERT REV VACCINES, V14, P1427, DOI 10.1586/14760584.2015.1082426; Science M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083553; Sundaram ME, 2013, VACCINE, V31, P2057, DOI 10.1016/j.vaccine.2013.02.028; Viard JP, 2011, AIDS, V25, P1305, DOI 10.1097/QAD.0b013e328347f6f7; Zitt E, 2012, VACCINE, V30, P931, DOI 10.1016/j.vaccine.2011.11.086	24	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168640	10.1371/journal.pone.0168640	http://dx.doi.org/10.1371/journal.pone.0168640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977797	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400124
J	Chiu, CC; Lu, ML; Huang, MC; Chen, PY; Lin, YK; Lin, SK; Chen, CH				Chiu, Chih-Chiang; Lu, Mong-Liang; Huang, Ming-Chyi; Chen, Po-Yu; Lin, Yen-Kuang; Lin, Shih-Ku; Chen, Chun-Hsin			Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study	PLOS ONE			English	Article							INDUCED WEIGHT-GAIN; TYPE-2 DIABETES-MELLITUS; TRIAL; ANTIPSYCHOTICS; ABNORMALITIES; METAANALYSIS; CHOLESTEROL; DISORDER	Background Metformin has been used for alleviating metabolic abnormalities in patients with schizophrenia. The lowest dose of metformin to treat metabolic abnormalities in clozapine-treated patients is 1000 mg/d. This study was designed to determine whether metformin at 500 mg/d and 1000 mg/d is effective in improving the metabolic profiles of clozapine-treated patients with pre-existing metabolic abnormalities, and whether its effectiveness depends on metformin dosage. Methods In this 12-week, randomized, double-blind, placebo-controlled trial, metformin at 500 mg/d or 1000 mg/d was prescribed to clozapine-treated patients with schizophrenia who had preexisting metabolic abnormalities. The recruited patients underwent physical and laboratory evaluations at weeks 4, 8, and 12. The outcomes were any changes in metabolic traits. Results Among the 96 clozapine-treated patients with schizophrenia screened for the trial, 55 patients with pre-existing metabolic abnormalities were randomly assigned to placebo (n = 18), metformin dosage at 500 mg/d (n = 18), and metformin dosage at 1000 mg/d (n = 19) groups. The body weight (BW) of patients in the metformin 1000 mg/d group significantly decreased, by a mean of 0.97 kg over the 12 week trial period. Moreover, patients in the metformin at 500 mg/d and 1000 mg/d groups had a significant decrease in body mass index (BMI) after 12 weeks, with the mean decrease being 0.70 and 0.50 kg/m(2),respectively. No significant changes were observed in the other metabolic parameters of patients in the three groups. Conclusions Our results demonstrated that a low metformin dosage of either 500 mg/d or 1000 mg/d for 12 weeks slightly reduced the BW and BMI of clozapine- treated patients with pre-existing metabolic abnormalities. A longer period of treatment with a larger sample is warranted to determine the factors that influence the metformin treatment response.	[Chiu, Chih-Chiang; Lu, Mong-Liang; Huang, Ming-Chyi; Chen, Po-Yu; Lin, Shih-Ku; Chen, Chun-Hsin] Taipei City Hosp, Dept Psychiat, Taipei City Psychiat Ctr, Taipei, Taiwan; [Chiu, Chih-Chiang; Huang, Ming-Chyi; Lin, Shih-Ku] Taipei Med Univ, Sch Med, Dept Psychiat, Coll Med, Taipei, Taiwan; [Lu, Mong-Liang; Chen, Chun-Hsin] Taipei Med Univ, Wan Fang Hosp, Dept Psychiat, Taipei, Taiwan; [Chen, Po-Yu] Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan; [Lin, Yen-Kuang] Taipei Med Univ, Ctr Biostat, Taipei, Taiwan	Taipei City Hospital; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Taipei Medical University	Chen, CH (corresponding author), Taipei City Hosp, Dept Psychiat, Taipei City Psychiat Ctr, Taipei, Taiwan.	chunhsin57@yahoo.com.tw	Huang, Ming-Chyi/W-9515-2019	Lu, Mong-Liang/0000-0003-3184-6554	Taipei City Government [10201-62-046]; Taipei Medical University-Wan Fang Hospital [103-TMUWFH-11]; Ministry of Science and Technology [MOST 103-2320-B-038-022-MY3]	Taipei City Government; Taipei Medical University-Wan Fang Hospital; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	The study was supported by grants from Taipei City Government (10201-62-046), Taipei Medical University-Wan Fang Hospital (103-TMUWFH-11) and the Ministry of Science and Technology (MOST 103-2320-B-038-022-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Borruel S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114112; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Carrizo E, 2009, SCHIZOPHR RES, V113, P19, DOI 10.1016/j.schres.2009.05.007; Chen CH, 2013, J CLIN PSYCHIAT, V74, pE424, DOI 10.4088/JCP.12m08186; Glueck CJ, 2001, METABOLISM, V50, P856, DOI 10.1053/meta.2001.24192; Hebrani P, 2015, J RES MED SCI, V20, P364; Huang MC, 2009, ACTA PSYCHIAT SCAND, V120, P274, DOI 10.1111/j.1600-0447.2009.01401.x; Jarskog LF, 2013, AM J PSYCHIAT, V170, P1032, DOI 10.1176/appi.ajp.2013.12010127; KANE J, 1988, ARCH GEN PSYCHIAT, V45, P789; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Maayan L, 2010, NEUROPSYCHOPHARMACOL, V35, P1520, DOI 10.1038/npp.2010.21; Mizuno Y, 2014, SCHIZOPHRENIA BULL, V40, P1385, DOI 10.1093/schbul/sbu030; Newcomer JW, 2005, CNS DRUGS, V19, P1; Rosenheck R, 1999, SCHIZOPHRENIA BULL, V25, P709, DOI 10.1093/oxfordjournals.schbul.a033412; Setter SM, 2003, CLIN THER, V25, P2991, DOI 10.1016/S0149-2918(03)90089-0; Siskind DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156208; Stroup TS, 2009, SCHIZOPHR RES, V107, P1, DOI 10.1016/j.schres.2008.10.011; Tandon R, 2008, SCHIZOPHR RES, V100, P20, DOI 10.1016/j.schres.2007.11.033; Wu RR, 2008, JAMA-J AM MED ASSOC, V299, P185, DOI 10.1001/jama.2007.56-b; Wu RR, 2012, AM J PSYCHIAT, V169, P813, DOI 10.1176/appi.ajp.2012.11091432; Wulffele MG, 2004, J INTERN MED, V256, P1, DOI 10.1111/j.1365-2796.2004.01328.x; Zheng W, 2015, J CLIN PSYCHOPHARM, V35, P499, DOI 10.1097/JCP.0000000000000392	23	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0168347	10.1371/journal.pone.0168347	http://dx.doi.org/10.1371/journal.pone.0168347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973619	Green Submitted, gold, Green Published			2022-12-27	WOS:000392754300079
J	Dalzon, B; Lebas, C; Jimenez, G; Gutjahr, A; Terrat, C; Exposito, JY; Verrier, B; Lethias, C				Dalzon, Bastien; Lebas, Celia; Jimenez, Gina; Gutjahr, Alice; Terrat, Celine; Exposito, Jean-Yves; Verrier, Bernard; Lethias, Claire			Poly(Lactic Acid) Nanoparticles Targeting alpha 5 beta 1 Integrin as Vaccine Delivery Vehicle, a Prospective Study	PLOS ONE			English	Article							HUMAN FIBRONECTIN; CELL-ADHESION; RGD; SURFACE; SITES; FORMULATION; RESPONSES; THERAPY	Biodegradable polymeric nanoparticles are vehicles of choice for drug delivery and have the ability to encapsulate and present at their surface different molecules of interest. Among these bio-nanocarriers, poly(lactic acid) (PLA) nanoparticles have been used as adjuvant and vehicle for enhanced vaccine efficacy. In order to develop an approach to efficient vaccine delivery, we developed nanoparticles to target alpha 5 beta 1 positive cells. We first overproduced, in bacteria, human fibronectin FNIII9/10 recombinant proteins possessing an integrin alpha 5 beta 1 binding site, the RGDS sequence, or a mutated form of this site. After having confirmed the integrin binding properties of these recombinant proteins in cell culture assays, we were able to formulate PLA nanoparticles with these FNIII9/10 proteins at their surface. We then confirmed, by fluorescence and confocal microscopy, an enhanced cellular uptake by alpha 5 beta 1(+) cells of RGDS-FNIII9/10 coated PLA nanoparticles, in comparison to KGES-FNIII9/10 coated or non-coated controls. As a first vaccination approach, we prepared PLA nanoparticles co-coated with p24 (an HIV antigen), and RGDS-or KGES-FNIII9/10 proteins, followed by subcutaneous vaccine administration, in mice. Although we did not detect improvements in the apparent humoral response to p24 antigen in the serum of RGDS/p24 nanoparticle-treated mice, the presence of the FNIII proteins increased significantly the avidity index of anti-p24 antibodies compared to p24-nanoparticle-injected control mice. Future developments of this innovative targeted vaccine are discussed.	[Dalzon, Bastien; Lebas, Celia; Jimenez, Gina; Gutjahr, Alice; Terrat, Celine; Exposito, Jean-Yves; Verrier, Bernard; Lethias, Claire] Univ Lyon 1, Inst Biol & Chim Prot, Federat Rech,Gerland Lyon Sud, SFR BioSci Unite Mixte Serv 3444 US8, Lyon, France; [Dalzon, Bastien; Lebas, Celia; Jimenez, Gina; Gutjahr, Alice; Terrat, Celine; Exposito, Jean-Yves; Verrier, Bernard; Lethias, Claire] CNRS, Lab Biol Tissulaire & Ingn Therapeut, Unite Mixte Rech, Lyon, France; [Jimenez, Gina] Univ Lyon 1, CNRS, INSERM, UMR 5310,U1217,Inst NeuroMyogene, Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Exposito, JY (corresponding author), Univ Lyon 1, Inst Biol & Chim Prot, Federat Rech,Gerland Lyon Sud, SFR BioSci Unite Mixte Serv 3444 US8, Lyon, France.	jy.exposito@ibcp.fr	Dalzon, Bastien/GPP-4184-2022; verrier, bernard/J-4094-2017	verrier, bernard/0000-0002-8478-7095	AFM doctoral fellowship; ANRT PhD fellowship; Fondation Pierre Berge - Sidaction; FP7 European grants [241904, 280873]; HIVERA; InvivoGen	AFM doctoral fellowship; ANRT PhD fellowship(French National Research Agency (ANR)); Fondation Pierre Berge - Sidaction; FP7 European grants; HIVERA; InvivoGen	GJ is supported by an AFM doctoral fellowship, AG by an ANRT PhD fellowship in collaboration with InvivoGen, whereas JYE and BV are supported by grants from the Fondation Pierre Berge - Sidaction, two FP7 European grants CUT'HIVAC (No. 241904) and ADITEC (No. 280873) and HIVERA support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CAS, 2006, INT IMMUNOL, V18, P1295, DOI 10.1093/intimm/dxl062; AOTA S, 1994, J BIOL CHEM, V269, P24756; Bobbala S, 2016, PHARM RES-DORDR, V33, P2078, DOI 10.1007/s11095-016-1979-0; Burrows L, 1999, BIOCHEM J, V344, P527, DOI 10.1042/0264-6021:3440527; Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733; Elefteriou F, 1999, EUR J BIOCHEM, V263, P840, DOI 10.1046/j.1432-1327.1999.00563.x; Feng YZ, 2004, BIOCHEMISTRY-US, V43, P15811, DOI 10.1021/bi049174+; FESSI H, 1989, INT J PHARM, V55, pR1, DOI 10.1016/0378-5173(89)90281-0; Garg A, 2009, INT J PHARMACEUT, V366, P201, DOI 10.1016/j.ijpharm.2008.09.016; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GOODWIN AE, 1995, J IMMUNOL METHODS, V187, P213, DOI 10.1016/0022-1759(95)00187-6; GRENZ H, 1993, J CELL SCI, V105, P739; Guillon C, 2007, VACCINE, V25, P7491, DOI 10.1016/j.vaccine.2007.08.060; Hussein HAM, 2015, ARCH VIROL, V160, P2669, DOI 10.1007/s00705-015-2579-8; Jancic C, 1998, IMMUNOLOGY, V95, P283; Johnson KJ, 1999, J BIOL CHEM, V274, P15473, DOI 10.1074/jbc.274.22.15473; Kankaanpaa P, 2015, NANOSCALE, V7, P17889, DOI 10.1039/c5nr06218g; Kenny FN, 2015, CELL TISSUE RES, V360, P571, DOI 10.1007/s00441-014-2064-9; Khanbeigi RA, 2012, J CONTROL RELEASE, V162, P259, DOI 10.1016/j.jconrel.2012.07.019; Kim H, 2016, J BIOMED NANOTECHNOL, V12, P536, DOI 10.1166/jbn.2016.2189; Legaz S, 2016, NANOTOXICOLOGY, V16, P1; Legaz S, 2015, PROTEIN EXPRES PURIF, V113, P94, DOI 10.1016/j.pep.2015.05.009; Li B, 2011, MOL CANCER RES, V9, P702, DOI 10.1158/1541-7786.MCR-10-0484; Liard C, 2012, J INVEST DERMATOL, V132, P615, DOI 10.1038/jid.2011.346; Liard C, 2011, VACCINE, V29, P6379, DOI 10.1016/j.vaccine.2011.04.080; Mann JFS, 2014, J VIROL, V88, P6959, DOI 10.1128/JVI.00183-14; MARDON HJ, 1994, FEBS LETT, V340, P197, DOI 10.1016/0014-5793(94)80137-1; Mittal A, 2013, DEV BIOL, V381, P73, DOI 10.1016/j.ydbio.2013.06.010; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; Pavot V, 2014, NANOMEDICINE-UK, V9, P2703, DOI [10.2217/NNM.14.156, 10.2217/nnm.14.156]; Pavot V, 2014, J IMMUNOL, V193, P5781, DOI 10.4049/jimmunol.1402184; Pavot V, 2013, J CONTROL RELEASE, V167, P60, DOI 10.1016/j.jconrel.2013.01.015; Pereira M, 2007, TISSUE ENG, V13, P567, DOI 10.1089/ten.2006.0228; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Pike DB, 2010, ADV DRUG DELIVER REV, V62, P167, DOI 10.1016/j.addr.2009.11.027; Primard C, 2010, BIOMATERIALS, V31, P6060, DOI 10.1016/j.biomaterials.2010.04.021; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; Saini V, 2010, J DRUG TARGET, V18, P212, DOI 10.3109/10611860903386920; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Stolzoff M, 2015, BIOMACROMOLECULES, V16, P1958, DOI 10.1021/acs.biomac.5b00336; Thomas C, 2011, MOL PHARMACEUT, V8, P405, DOI 10.1021/mp100255c; Torrano AA, 2013, NANOMEDICINE-UK, V8, P1815, DOI 10.2217/nnm.12.178; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Waithman J, 2016, EUR J IMMUNOL, V46, P543, DOI 10.1002/eji.201646293; Wang F, 2013, INT J MOL SCI, V14, P13447, DOI 10.3390/ijms140713447	45	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167663	10.1371/journal.pone.0167663	http://dx.doi.org/10.1371/journal.pone.0167663			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8KC	27973577	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300037
J	Rhead, R; Masimirembwa, C; Cooke, G; Takaruza, A; Nyamukapa, C; Mutsimhi, C; Gregson, S				Rhead, Rebecca; Masimirembwa, Collen; Cooke, Graham; Takaruza, Albert; Nyamukapa, Constance; Mutsimhi, Cosmas; Gregson, Simon			Might ART Adherence Estimates Be Improved by Combining Biomarker and Self-Report Data?	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; NEVIRAPINE PLASMA-CONCENTRATIONS; ANTIRETROVIRAL THERAPY; CLINICAL-TRIALS; CYP2B6; PHARMACOGENETICS; RIFAMPICIN; EFAVIRENZ; REGIMENS; AFRICA	Background As we endeavour to examine rates of viral suppression in PLHIV, reliable data on ART adherence are needed to distinguish between the respective contributions of poor adherence and treatment failure on high viral load. Self-reported data are susceptible to response bias and although biomarker data on drug presence and concentration can provide a superior, alternative method of measurement, complications due to drug-drug interactions and genetic variations can cause some inaccuracies. We investigate the feasibility of combining both biomarker and self-report data to produce a potentially more accurate measure of ART adherence. Methods Data were taken from a large general-population survey in the Manicaland province, Zimbabwe, conducted in 2009-2011. HIV-infected adults who had initiated ART (N = 560) provided self-report data on adherence and dried blood spot samples that were analysed for traces of ART medication. A new three-category measure of ART adherence was constructed, based on biomarker data but using self-report data to adjust for cases with abnormally low and high drug concentrations due to possible drug-drug interactions and genetic factors, and was assessed for plausibility using survey data on socio-demographic correlates. Results 94.3% (528/560) and 92.7% (519/560) of the sample reported faithful adherence to their medication and had traces of ART medication, respectively. The combined measure estimated good evidence of ART adherence at 69% and excellent evidence of adherence at 53%. The regression analysis results showed plausible patterns of ART adherence by socio-demographic status with men and younger participants being more likely to adhere poorly to medication, and higher socio-economic status individuals and those living in more urban locations being more likely to adhere well. Conclusion Biomarker and self-reported measures of adherence can be combined in a meaningful way to produce a potentially more accurate measure of ART adherence. Results indicate that ART adherence in Manicaland is at best 69%, which not only allows for considerable room for improvement but also suggests that the area may be falling short of the UNAIDS' 90% target regarding viral suppression. Increased efforts are needed to improve ART adherence particularly amongst the young male population in rural areas of east Zimbabwe.	[Rhead, Rebecca; Gregson, Simon] Imperial Coll London, Dept Infect Dis Epidemiol, London, England; [Masimirembwa, Collen; Mutsimhi, Cosmas] African Inst Biomed Res & Technol, Harare, Zimbabwe; [Cooke, Graham] Imperial Coll London, Dept Med, London, England; [Takaruza, Albert; Nyamukapa, Constance] Biomed Res & Training Inst, Harare, Zimbabwe	Imperial College London; Imperial College London; Biomedical Research Training Institute	Rhead, R (corresponding author), Imperial Coll London, Dept Infect Dis Epidemiol, London, England.	r.rhead@imperial.ac.uk		Gregson, Simon/0000-0003-2707-0714; Nyamukapa, Constance/0000-0001-6779-4069; Rhead, Rebecca/0000-0002-5863-604X; Masimirembwa, Collen/0000-0002-4053-212X	Wellcome Trust [084401/Z/07/B]	Wellcome Trust(Wellcome TrustEuropean Commission)	The Manicaland Project is funded by Wellcome Trust https://wellcome.ac.uk/funding. Grant Number: 084401/Z/07/B. Recipient is SG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajose O, 2012, AIDS, V26, P929, DOI 10.1097/QAD.0b013e328351f5b2; [Anonymous], 2014, HIV AIDS JUNPO 90 90; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Branch RA, 2000, CLIN PHARMACOL THER, V68, P401, DOI 10.1067/mcp.2000.110561; Burman WJ, 1999, CLIN INFECT DIS, V28, P419, DOI 10.1086/515174; Cohen K, 2008, J ANTIMICROB CHEMOTH, V61, P389, DOI 10.1093/jac/dkm484; Cohen K, 2010, CURR OPIN HIV AIDS, V5, P61, DOI 10.1097/COH.0b013e3283339309; Cupp-Vickery JR, 2001, J MOL BIOL, V311, P101, DOI 10.1006/jmbi.2001.4803; de Truchis P, 2016, J ANTIMICROB CHEMOTH, V71, P3222, DOI 10.1093/jac/dkw286; Dhoro M, 2013, CURR HIV RES, V11, P481, DOI 10.2174/1570162X113119990048; Edelbroek PM, 2009, THER DRUG MONIT, V31, P327, DOI 10.1097/FTD.0b013e31819e91ce; Erickson DA, 1999, DRUG METAB DISPOS, V27, P1488; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Golin CE, 2002, J GEN INTERN MED, V17, P756, DOI 10.1046/j.1525-1497.2002.11214.x; Gregson S, 2006, SCIENCE, V311, P664, DOI 10.1126/science.1121054; Gregson S, 2011, POPUL DEV REV, V37, P333, DOI 10.1111/j.1728-4457.2011.00413.x; Haas DW, 2005, J INFECT DIS, V192, P1931, DOI 10.1086/497610; Haas DW, 2004, AIDS, V18, P2391; Harries AD, 2001, LANCET, V358, P410, DOI 10.1016/S0140-6736(01)05551-9; Liechty CA, 2003, AIDS, V17, P1383, DOI 10.1097/00002030-200306130-00013; Manosuthi W, 2009, CLIN INFECT DIS, V48, P1752, DOI 10.1086/599114; Manzou R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086060; Matimba A, 2008, EUR J HUM GENET, V16, P780, DOI 10.1038/ejhg.2008.49; Mcdade TW, 2007, DEMOGRAPHY, V44, P899, DOI 10.1353/dem.2007.0038; Mehlotra RK, 2007, BRIT J CLIN PHARMACO, V64, P391, DOI 10.1111/j.1365-2125.2007.02884.x; Mei JV, 2001, J NUTR, V131, p1631S, DOI 10.1093/jn/131.5.1631S; Melbourne K M, 1999, AIDS Read, V9, P329; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Montaner JSG, 1998, JAMA-J AM MED ASSOC, V279, P930, DOI 10.1001/jama.279.12.930; Pearson CR, 2007, AIDS BEHAV, V11, P161, DOI 10.1007/s10461-006-9133-3; Penzak SR, 2007, HIV MED, V8, P86, DOI 10.1111/j.1468-1293.2007.00432.x; Pozniak AL, 1999, AIDS, V13, P435, DOI 10.1097/00002030-199903110-00001; Ribera E, 2001, J ACQ IMMUN DEF SYND, V28, P450, DOI 10.1097/00042560-200112150-00007; Rotger M, 2007, CLIN PHARMACOL THER, V81, P557, DOI 10.1038/sj.clpt.6100072; Rotger Margalida, 2005, Pharmacogenet Genomics, V15, P1, DOI 10.1097/01213011-200501000-00001; Schaefer R, 2016, SPATIAL PATTER UNPUB; Schur N, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20063; Simoni JM, 2014, AIDS BEHAV, V18, P2285, DOI 10.1007/s10461-014-0905-x; ter Heine R, 2008, J INT AIDS SOC, V11, pP242; Vanhove GF, 1996, JAMA-J AM MED ASSOC, V276, P1955, DOI 10.1001/jama.276.24.1955; Wang J, 2006, PHARMACOGENET GENOM, V16, P191; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011	42	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2016	11	12							e0167852	10.1371/journal.pone.0167852	http://dx.doi.org/10.1371/journal.pone.0167852			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8KC	27973550	Green Published, Green Submitted, gold			2022-12-27	WOS:000392754300046
J	Amiri, M; Khosravi, A; Riyahi, L; Naderi, S				Amiri, Mohammad; Khosravi, Ahmad; Riyahi, Leila; Naderi, Shima			The Impact of Setting the Standards of Health Promoting Hospitals on Hospital Indicators in Iran	PLOS ONE			English	Article								Hospitals play a critical role in the health promotion of the society. This study aimed to determine the impact of establishing standards of health promoting hospitals on hospital indicators in Shahroud. This applied study was a quasi-experimental one which was conducted in 2013. Standards of health promoting hospitals were established as an intervention procedure in the Fatemiyeh hospital. Parameters of health promoting hospitals were compared in intervention and control hospitals before and after of intervention (6 months). The data were analyzed using chi-square and t-test. With the establishment of standards for health promotion hospitals, standard scores in intervention and control hospitals were found to be 72.26 +/- 4.1 and 16.26 +/- 7.5, respectively. T-test showed a significant difference between the mean scores of the hospitals under study (P = 0.001). The chi-square test also showed a significant relationship between patient satisfaction before and after the intervention so that patients' satisfaction was higher after the intervention (P = 0.001). Commenting on the short-term or long-term positive impacts of establishing standards of health promoting hospitals on all hospital indicators is a bit difficult but preliminary results show the positive impact of the implementation of standards in case hospitals which has led to the improvement of many indicators in the hospital.	[Amiri, Mohammad] Shahroud Univ Med Sci, Sch Publ Hlth, Shahroud, Iran; [Khosravi, Ahmad] Shahroud Univ Med Sci, Ctr Hlth Related Social & Behav Sci Res, Shahroud, Iran; [Riyahi, Leila] Islamic Azad Univ, Dept Hlth Serv Management, Sci & Res Branch, Tehran, Iran; [Naderi, Shima] Shahroud Univ Med Sci, Shahroud, Iran	Shahroud University Medical Sciences; Shahroud University Medical Sciences; Islamic Azad University; Shahroud University Medical Sciences	Naderi, S (corresponding author), Shahroud Univ Med Sci, Shahroud, Iran.	shima.naderi68@gmail.com	Amiri, Mohammd -/P-6088-2018	Amiri, Mohammd -/0000-0003-2151-8530; naderi, shima/0000-0003-3530-4824; zam zam, shirin/0000-0002-2010-1445				Delobelle Peter, 2010, Glob Health Promot, V17, P33, DOI 10.1177/1757975910363929; Garcia-Barbero M, 2005, HLTH PROMOTION HOSP; Groene O, 2010, OXFORD U J, P221; Habibi sola A, 2007, IRANIAN J AGEING, V2, P331; Haynes C, 2008, BIOMED CENTRAL PUBLI; Heydarnia M, 2009, PEJOUHANDEH RES J, V14, P183; Jackson SF, 2006, HEALTH PROMOT INT, V21, P75, DOI 10.1093/heapro/dal054; Johnson A, 2001, HEALTH PROMOT INT, V16, P281, DOI 10.1093/heapro/16.3.281; Kar S. S., 2012, National Journal of Community Medicine, V3, P558; Keshavrz M. N., 2013, RAZI J MED SCI, V20, P36; Khowaja A. R., 2011, Eastern Mediterranean Health Journal, V17, P738; Khowaja AR, 2010, J PAK MED ASSOC, V60, P274; Kumar Sanjiv, 2012, Indian J Community Med, V37, P5, DOI 10.4103/0970-0218.94009; Kumpalanon J., 2012, AM J HLTH SCI, V3, P43; Lin Y-W, 2010, HLTH PROMOTION INT A; Lin YW, 2009, PATIENT EDUC COUNS, V76, P248, DOI 10.1016/j.pec.2008.12.025; McHugh C, 2010, HEALTH PROMOT INT, V25, P230, DOI 10.1093/heapro/daq010; Miseviciene I, 2012, HLTH PROMOTION INT A; Nikpajouh A, 2006, IMPLEMENTING HLTH PR; Oppedal K, 2011, EUR J PUBLIC HEALTH, V21, P744, DOI 10.1093/eurpub/ckq148; Polluste K, 2007, HEALTH PROMOT INT, V22, P327, DOI 10.1093/heapro/dam032; Pongthavornkamol K, 2014, PAC RIM INT J NURS R, V18, P125; Tonnesen H, 2007, BIOMED CENTRAL PUBLI; Whitehead D, 2005, J CLIN NURS, V14, P20, DOI 10.1111/j.1365-2702.2004.01012.x; WHO Regional Office for Europe, 2007, INT NETW HLTH PROM H; Yaghoubi M, 2014, J HLTH POLICY SUSTAI, V1, P23; Yaghoubi Maryam, 2013, J Educ Health Promot, V2, P41, DOI 10.4103/2277-9531.115840; Zahiri M, 2010, JUNDISHAPUR J HLTH S, V2, P75; Zarei F, 2013, J FASA U MED SCI, V3, P215	29	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167459	10.1371/journal.pone.0167459	http://dx.doi.org/10.1371/journal.pone.0167459			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	27959930	Green Submitted, Green Published, gold			2022-12-27	WOS:000392753900008
J	Xu, YF; Wu, JY; Yin, CC; Mao, YD				Xu, Yaofang; Wu, Jiayi; Yin, Chang-Cheng; Mao, Youdong			Unsupervised Cryo-EM Data Clustering through Adaptively Constrained K-Means Algorithm	PLOS ONE			English	Article							ELECTRON-MICROSCOPY IMAGES; SINGLE-PARTICLES; BIOLOGICAL MACROMOLECULES; ANGSTROM RESOLUTION; RECONSTRUCTION; PROJECTIONS; CLASSIFICATION; HETEROGENEITY; COMPLEXES; SOFTWARE	In single-particle cryo-electron microscopy (cryo-EM), K-means clustering algorithm is widely used in unsupervised 2D classification of projection images of biological macromolecules. 3D ab initio reconstruction requires accurate unsupervised classification in order to separate molecular projections of distinct orientations. Due to background noise in single-particle images and uncertainty of molecular orientations, traditional K-means clustering algorithm may classify images into wrong classes and produce classes with a large variation in membership. Overcoming these limitations requires further development on clustering algorithms for cryo-EM data analysis. We propose a novel unsupervised data clustering method building upon the traditional K-means algorithm. By introducing an adaptive constraint term in the objective function, our algorithm not only avoids a large variation in class sizes but also produces more accurate data clustering. Applications of this approach to both simulated and experimental cryo-EM data demonstrate that our algorithm is a significantly improved alterative to the traditional K-means algorithm in single-particle cryo-EM analysis.	[Xu, Yaofang; Yin, Chang-Cheng] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biophys, Beijing, Peoples R China; [Wu, Jiayi; Mao, Youdong] Peking Univ, Ctr Quantitat Biol, Sch Phys, Inst Condensed Matter Phys,State Key Lab Artifici, Beijing, Peoples R China; [Mao, Youdong] Harvard Med Sch, Dept Microbiol & Immunobiol, Dana Farber Canc Inst, Intel Parallel Comp Ctr Struct Biol, Boston, MA USA	Peking University; Peking University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Yin, CC (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Biophys, Beijing, Peoples R China.; Mao, YD (corresponding author), Peking Univ, Ctr Quantitat Biol, Sch Phys, Inst Condensed Matter Phys,State Key Lab Artifici, Beijing, Peoples R China.; Mao, YD (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Dana Farber Canc Inst, Intel Parallel Comp Ctr Struct Biol, Boston, MA USA.	ccyin@hsc.pku.edu.cn; youdong_mao@dfci.harvard.edu	吴, 家怡/GSI-7419-2022; Mao, Youdong/AFJ-2673-2022	Mao, Youdong/0000-0001-9302-2257	grant of the Thousand Talents Plan of China; National Natural Science Foundation of China [91530321]; Intel Parallel Computing Center program; National Science Foundation under NSF [1541959]; NIH, Center for HIV/AIDS Vaccine Immunology and Immunogen Design (CHAVI-ID) [AI100645]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645] Funding Source: NIH RePORTER	grant of the Thousand Talents Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Intel Parallel Computing Center program; National Science Foundation under NSF(National Science Foundation (NSF)); NIH, Center for HIV/AIDS Vaccine Immunology and Immunogen Design (CHAVI-ID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by a grant of the Thousand Talents Plan of China (YM), by a grant from National Natural Science Foundation of China 91530321 (YM), by the Intel Parallel Computing Center program (YM). The cryo-EM experiments were performed in part at the Center for Nanoscale Systems at Harvard University, a member of the National Nanotechnology Coordinated Infrastructure Network (NNCI), which is supported by the National Science Foundation under NSF award no. 1541959. The cryo-EM facility was funded through the NIH grant AI100645, Center for HIV/AIDS Vaccine Immunology and Immunogen Design (CHAVI-ID). The data processing was performed in part in the Sullivan supercomputer, which is funded in part by a gift from Mr. and Mrs. Daniel J. Sullivan, Jr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloise D, 2009, MACH LEARN, V75, P245, DOI 10.1007/s10994-009-5103-0; Bai XC, 2015, TRENDS BIOCHEM SCI, V40, P49, DOI 10.1016/j.tibs.2014.10.005; Banerjee A, 2006, DATA MIN KNOWL DISC, V13, P365, DOI 10.1007/s10618-006-0040-z; Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576; Bhamre T, 2016, J STRUCT BIOL, V195, P72, DOI 10.1016/j.jsb.2016.04.013; CROWTHER RA, 1970, PROC R SOC LON SER-A, V317, P319, DOI 10.1098/rspa.1970.0119; de la Rosa-Trevin JM, 2013, J STRUCT BIOL, V184, P321, DOI 10.1016/j.jsb.2013.09.015; Elad N, 2008, J STRUCT BIOL, V162, P108, DOI 10.1016/j.jsb.2007.11.007; Elmlund D, 2012, J STRUCT BIOL, V180, P420, DOI 10.1016/j.jsb.2012.07.010; Elmlund D, 2010, STRUCTURE, V18, P777, DOI 10.1016/j.str.2010.06.001; Elmlund H, 2013, STRUCTURE, V21, P1299, DOI 10.1016/j.str.2013.07.002; Fischer N, 2015, NATURE, V520, P567, DOI 10.1038/nature14275; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1982, J MOL BIOL, V161, P134, DOI 10.1016/0022-2836(82)90282-0; Frank J, 2006, 3 DIMENSIONAL ELECT, Vxiv; Frank J, 2006, 3 DIMENSIONAL ELECT; GONCHAROV AB, 1988, ULTRAMICROSCOPY, V25, P317, DOI 10.1016/0304-3991(88)90006-X; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Jaitly N, 2010, BIOINFORMATICS, V26, P2406, DOI 10.1093/bioinformatics/btq456; Ludtke SJ, 2004, STRUCTURE, V12, P1129, DOI 10.1016/j.str.2004.05.006; Macqueen J., 1967, P 5 BERK S MATH STAT, P281; Malinen MI, 2014, LECT NOTES COMPUT SC, V8621, P32, DOI 10.1007/978-3-662-44415-3_4; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; Penczek PA, 1996, ULTRAMICROSCOPY, V63, P205, DOI 10.1016/0304-3991(96)00037-X; Penczek PA, 2010, IMAGE RESTORATION CR, P35; Penczek PA, 2011, STRUCTURE, V19, P1582, DOI 10.1016/j.str.2011.10.003; SCHATZ M, 1990, ULTRAMICROSCOPY, V32, P255, DOI 10.1016/0304-3991(90)90003-5; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van Heel M., 1980, Pattern Recognition in Practice. Proceedings of an International Workshop, P235; van Heel M, 1997, SCANNING MICROSC, V11, P195; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; VANHEEL M, 1985, EMBO J, V4, P2389, DOI 10.1002/j.1460-2075.1985.tb03944.x; VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/0304-3991(81)90059-0; Vargas J, 2014, BIOINFORMATICS, V30, P2891, DOI 10.1093/bioinformatics/btu404; Wu J, ARXIV 2016 1604 0453; Yang ZF, 2012, STRUCTURE, V20, P237, DOI 10.1016/j.str.2011.12.007; Zhang LM, 2015, SCIENCE, V350, P404, DOI 10.1126/science.aac5789; Zhang W, 2008, STRUCTURE, V16, P1770, DOI 10.1016/j.str.2008.10.011; Zhao ZZ, 2014, J STRUCT BIOL, V186, P153, DOI 10.1016/j.jsb.2014.03.003; Zhu SZ, 2010, KNOWL-BASED SYST, V23, P883, DOI 10.1016/j.knosys.2010.06.003	45	4	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0167765	10.1371/journal.pone.0167765	http://dx.doi.org/10.1371/journal.pone.0167765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959895	Green Submitted, gold, Green Published			2022-12-27	WOS:000392753900015
J	Belle, L; Fransolet, G; Somja, J; Binsfeld, M; Delvenne, P; Drion, P; Hannon, M; Beguin, Y; Ehx, G; Baron, F				Belle, Ludovic; Fransolet, Gilles; Somja, Joan; Binsfeld, Marilene; Delvenne, Philippe; Drion, Pierre; Hannon, Muriel; Beguin, Yves; Ehx, Gregory; Baron, Frederic			Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease	PLoS One			English	Article							STEM-CELL TRANSPLANTATION; REGULATORY T-CELLS; CONSENSUS DEVELOPMENT PROJECT; DOSE-DEPENDENT MANNER; WORKING GROUP-REPORT; CHRONIC GVHD; MARROW TRANSPLANTATION; KINASE INHIBITOR; CLINICAL-TRIALS; IN-VITRO	Background Sclerodermatous chronic Graft-versus-Host Disease (scl-cGVHD) is one of the most severe form of cGVHD. The Platelet-derived Grotwth Factor (PDGF) and the Transforming Growth Factor-beta (TGF-beta) play a significant role in the fibrosing process occurring in scl-cGVHD. This prompted us to assess the impact of the PDGF-r and c-Abl tyrosine kinase inhibitor imatinib on scl-cGVHD. Methods To assess the impact of imatinib on T cell subset proliferation in vivo, Balb/cJ recipient mice were lethally (7 Gy) irradiated and then injected with 10x10(6) bone marrow cells from B10.D2 mice on day 0. Fourteen days later, 70x10(6) carboxyfluorescein succinimidyl ester (CFSE)labeled splenocytes from B10.D2 mice were infused and imatinib or sterile water was administered for 5 days. To induce severe scl-cGVHD, Balb/cJ mice were injected i.v. with 10.10(6) bone marrow cells and 70.10(6) splenocytes from B10.D2 donor mice after 7 Gy irradiation. Mice were then given sterile water or imatinib from day +7 after transplantation to the end of the experiment (day +52). Results Imatinib decreased the proliferation of total T cells (P = 0.02), CD8+ T cells (P = 0.01), and of regulatory T cells (Tregs) (P = 0.02) in the spleen. In the severe scl-cGVHD model, imatinib-treated mice had significantly lower levels of PDGF-r phosphorylation than control mice on day 29 after transplantation (P = 0.008). However, scl-cGVHD scores were similar between vehicle-and imatinib-treated mice during the whole experiment, while there was a suggestion for less weight loss in imatinib-treated mice that reached statistical significance at day +52 following transplantation (P = 0.02). Conclusions Imatinib had a limited impact in murine scl-cGVHD despite significant inhibition of PDGF-r.	[Belle, Ludovic; Fransolet, Gilles; Binsfeld, Marilene; Hannon, Muriel; Beguin, Yves; Ehx, Gregory; Baron, Frederic] Univ Liege, Hematol Res Unit, GIGA I, Liege, Belgium; [Somja, Joan; Delvenne, Philippe] Univ Liege, Dept Pathol, Liege, Belgium; [Drion, Pierre] Univ Liege, GIGA R, Liege, Belgium; [Beguin, Yves; Baron, Frederic] CHU Liege, Dept Med, Div Hematol, Liege, Belgium	University of Liege; University of Liege; University of Liege; University of Liege	Fransolet, G (corresponding author), Univ Liege, Hematol Res Unit, GIGA I, Liege, Belgium.	gilles.fransolet@ulg.ac.be	Binsfeld, Marilene/AAG-9121-2020; Ehx, Gregory/AAH-1706-2021	Ehx, Gregory/0000-0002-7018-1770	National Fund for Scientific Research (FNRS) [PDR T.0069.15-7/7]; Leon Fredericq fund; Anti-Cancer Center at the University of Liege; Belgian Federation Against Cancer	National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Leon Fredericq fund; Anti-Cancer Center at the University of Liege; Belgian Federation Against Cancer	This study was supported by funds from: the National Fund for Scientific Research (FNRS, grant PDR T.0069.15-7/7), the Leon Fredericq fund and Anti-Cancer Center at the University of Liege, and the Belgian Federation Against Cancer. LB, GF, GE were/are Televie Research Assistant and FB is Senior Research Associate at the National Fund for Scientific Research (FNRS) Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai S, 2016, CLIN CANCER RES, V22, P319, DOI 10.1158/1078-0432.CCR-15-1443; Balachandran VP, 2011, NAT MED, V17, P1094, DOI 10.1038/nm.2438; Baron F, 2004, SPRINGER SEMIN IMMUN, V26, P71, DOI 10.1007/s00281-004-0165-3; Baron F, 2012, LEUKEMIA, V26, P2462, DOI 10.1038/leu.2012.135; Baron F, 2002, BIOL BLOOD MARROW TR, V8, P351, DOI 10.1053/bbmt.2002.v8.pm12171481; Belle L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052564; Binsfeld M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113764; Blazar BR, 2012, NAT REV IMMUNOL, V12, P443, DOI 10.1038/nri3212; Bleakley M, 2004, NAT REV CANCER, V4, P371, DOI 10.1038/nrc1365; Castermans E, 2011, HAEMATOL-HEMATOL J, V96, P298, DOI 10.3324/haematol.2010.029702; Chen J, 2007, INT J ONCOL, V31, P1133; Chu YW, 2008, BIOL BLOOD MARROW TR, V14, P365, DOI 10.1016/j.bbmt.2007.12.002; Cuende J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1983; Cwynarski K, 2004, LEUKEMIA, V18, P1332, DOI 10.1038/sj.leu.2403401; de Masson A, 2012, BLOOD, V120, P5089, DOI 10.1182/blood-2012-09-453928; Demetri GD, 2009, CLIN CANCER RES, V15, P5910, DOI 10.1158/1078-0432.CCR-09-0542; Druker BJ, 2004, ADV CANCER RES, V91, P1, DOI 10.1016/S0065-230X(04)91001-9; Duarte RF, 2014, BONE MARROW TRANSPL, V49, P49, DOI 10.1038/bmt.2013.129; Dubovsky JA, 2014, J CLIN INVEST, V124, P4867, DOI 10.1172/JCI75328; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; Flynn R, 2015, BLOOD, V125, P4085, DOI 10.1182/blood-2014-08-595470; Fransolet G, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0281-2; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Hannon M, 2015, CLIN CANCER RES, V21, P3131, DOI 10.1158/1078-0432.CCR-14-3374; Hannon M, 2014, TRANSFUSION, V54, P353, DOI 10.1111/trf.12279; Hoffmann P, 2002, J EXP MED, V196, P389, DOI 10.1084/jem.20020399; Inamoto Y, 2013, BLOOD, V121, P5098, DOI 10.1182/blood-2012-10-464198; JAFFEE BD, 1983, CELL IMMUNOL, V77, P1, DOI 10.1016/0008-8749(83)90001-1; Larmonier N, 2008, J IMMUNOL, V181, P6955, DOI 10.4049/jimmunol.181.10.6955; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; Magro L, 2008, BONE MARROW TRANSPL, V42, P757, DOI 10.1038/bmt.2008.252; Magro L, 2009, BLOOD, V114, P719, DOI 10.1182/blood-2009-02-204750; Miklos DB, 2005, BLOOD, V105, P2973, DOI 10.1182/blood-2004-09-3660; Olivieri A, 2013, BLOOD, V122, P4111, DOI 10.1182/blood-2013-05-494278; Pidala J, 2011, BLOOD, V117, P4651, DOI 10.1182/blood-2010-11-319509; Pirson L, 2006, STEM CELLS, V24, P1814, DOI 10.1634/stemcells.2005-0290; Poulin JF, 2003, BLOOD, V102, P4600, DOI 10.1182/blood-2003-05-1428; Reddy P, 2012, BIOL BLOOD MARROW TR, V18, pS17, DOI 10.1016/j.bbmt.2011.10.034; Rodgers CJ, 2013, BONE MARROW TRANSPL, V48, P323, DOI 10.1038/bmt.2012.96; Seggewiss R, 2005, BLOOD, V105, P2473, DOI 10.1182/blood-2004-07-2527; Servais S, 2016, EXPERT OPIN INV DRUG, P1; Shulman HM, 2006, BIOL BLOOD MARROW TR, V12, P31, DOI 10.1016/j.bbmt.2005.10.023; Toubert A, 2012, TISSUE ANTIGENS, V79, P83, DOI 10.1111/j.1399-0039.2011.01820.x; WEIDEN PL, 1981, NEW ENGL J MED, V304, P1529, DOI 10.1056/NEJM198106183042507; Zerr P, 2012, AM J PATHOL, V181, P1672, DOI 10.1016/j.ajpath.2012.07.017; Zhao DC, 2008, BLOOD, V112, P2129, DOI 10.1182/blood-2008-02-140277	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167997	10.1371/journal.pone.0167997	http://dx.doi.org/10.1371/journal.pone.0167997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942010	gold, Green Published, Green Submitted			2022-12-27	WOS:000392745600044
J	Fontaine, V; Monteiro, E; Brazhnikova, E; Lesage, L; Balducci, C; Guibout, L; Feraille, L; Elena, PP; Sahel, JA; Veillet, S; Lafont, R				Fontaine, Valerie; Monteiro, Elodie; Brazhnikova, Elena; Lesage, Laetitia; Balducci, Christine; Guibout, Louis; Feraille, Laurence; Elena, Pierre-Paul; Sahel, Jose-Alain; Veillet, Stanislas; Lafont, Rene			Norbixin Protects Retinal Pigmented Epithelium Cells and Photoreceptors against A2E-Mediated Phototoxicity In Vitro and In Vivo	PLOS ONE			English	Article							SINGLET-OXYGEN GENERATION; LIGHT-INDUCED DAMAGE; PHASE-II ENZYMES; OXIDATIVE-STRESS; LIPOFUSCIN ACCUMULATION; ANIMAL-MODEL; MOUSE MODEL; RPE CELLS; A2E; DEGENERATION	The accumulation of N-retinylidene-N-retinylethanolamine (A2E, a toxic by-product of the visual pigment cycle) in the retinal pigment epithelium (RPE) is a major cause of visual impairment in the elderly. Photooxidation of A2E results in retinal pigment epithelium degeneration followed by that of associated photoreceptors. Present treatments rely on nutrient supplementation with antioxidants. 9'-cis-Norbixin (a natural diapocarotenoid, 97% purity) was prepared from Bixa orellana seeds. It was first evaluated in primary cultures of porcine retinal pigment epithelium cells challenged with A2E and illuminated with blue light, and it provided an improved photo-protection as compared with lutein or zeaxanthin. In Abca4(-/-) Rdh8(-/-) mice (a model of dry AMD), intravitreally-injected norbixin maintained the electroretinogram and protected photoreceptors against light damage. In a standard rat blue-light model of photodamage, norbixin was at least equally as active as phenyl-N-tert-butylnitrone, a free radical spin-trap. Chronic experiments performed with Abca4(-/-) Rdh8(-/-) mice treated orally for 3 months with norbixin showed a reduced A2E accumulation in the retina. Norbixin appears promising for developing an oral treatment of macular degeneration. A drug candidate (BIO201) with 9'-cis-norbixin as the active principle ingredient is under development, and its potential will be assessed in a forthcoming clinical trial.	[Fontaine, Valerie; Monteiro, Elodie; Brazhnikova, Elena; Lesage, Laetitia; Sahel, Jose-Alain] Sorbonne Univ, UPMC Univ Paris, INSERM, CNRS,Inst Vis, Paris, France; [Balducci, Christine; Guibout, Louis; Veillet, Stanislas; Lafont, Rene] Parc BIOCITECH, Biophytis, Romainville, France; [Feraille, Laurence; Elena, Pierre-Paul] IRIS Pharma, La Gaude, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Fontaine, V (corresponding author), Sorbonne Univ, UPMC Univ Paris, INSERM, CNRS,Inst Vis, 17 Rue Moreau, Paris, France.	valerie.fontaine@inserm.fr	Sahel, Jose-Alain/F-3172-2017; LAFONT, Rene/GYA-4891-2022	Sahel, Jose-Alain/0000-0002-4831-1153; LESAGE, LAETITIA/0000-0001-8592-2482	European FEDER grant [PRESAGE 41583]; City of Paris [2012 DDEEES 103G]; City of Paris; Biophytis; Iris Pharma; FEDER grant (Fonds Europeen pour le DEveloppement Regional)	European FEDER grant; City of Paris(Region Ile-de-France); City of Paris(Region Ile-de-France); Biophytis; Iris Pharma; FEDER grant (Fonds Europeen pour le DEveloppement Regional)	This manuscript results from a collaborative work between one public laboratory (Institut de la Vision) and two private companies (Biophytis and Iris Pharma). Financial support came from the private companies, a European FEDER grant (PRESAGE 41583) and a grant from the City of Paris (no 2012 DDEEES 103G). The experimental work was shared between the three organisations. Biophytis and Iris Pharma participated to the design and realization of the experiments. They declare, however, that their potential commercial interests had no impact on the scientific conduct of the study or the analysis/ interpretation of data. The grant providers (FEDER and City of Paris) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The City of Paris grant supported in particular the salaries of the three engineers (EM, EB, LL). PPE and LF are employees of Iris Pharma, while CB, LG, SV and RL are employees of Biophytis.; This work was supported by Biophytis and Iris Pharma. Part of this work was supported by a FEDER grant (Fonds Europeen pour le DEveloppement Regional) and the City of Paris (grant to the Institut de la Vision).	Anderson OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067263; Arnault E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071398; Aronow ME, 2014, CURR OPIN OPHTHALMOL, V25, P186, DOI 10.1097/ICU.0000000000000046; Asai A, 2005, J AGR FOOD CHEM, V53, P7302, DOI 10.1021/jf0509355; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Bernstein PS, 2016, PROG RETIN EYE RES, V50, P34, DOI 10.1016/j.preteyeres.2015.10.003; Bhosale P, 2009, ARCH BIOCHEM BIOPHYS, V483, P175, DOI 10.1016/j.abb.2008.09.012; Bian QN, 2012, FREE RADICAL BIO MED, V53, P1298, DOI 10.1016/j.freeradbiomed.2012.06.024; Buschini E, 2015, CLIN OPHTHALMOL, V9, P563, DOI 10.2147/OPTH.S59724; Chen Y, 2012, ADVANCES IN OPHTHALM, P427; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; De S, 2002, J GEN PHYSIOL, V120, P147, DOI 10.1085/jgp.20028566; Dillon J, 2004, EXP EYE RES, V79, P537, DOI 10.1016/j.exer.2004.06.024; Dobri N, 2013, INVEST OPHTH VIS SCI, V54, P85, DOI 10.1167/iovs.12-10050; Dwyer MA, 2011, MOL ENDOCRINOL, V25, P360, DOI 10.1210/me.2010-0392; Eldred GE, 1995, GERONTOLOGY, V41, P15; Ferrington DA, 2016, PROG RETIN EYE RES, V51, P69, DOI 10.1016/j.preteyeres.2015.09.002; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Forest DL, 2015, DIS MODEL MECH, V8, P421, DOI 10.1242/dmm.017236; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Goto T, 2012, J AGR FOOD CHEM, V60, P11952, DOI 10.1021/jf303639f; Guha S, 2014, ADV EXP MED BIOL, V801, P105, DOI 10.1007/978-1-4614-3209-8_14; Gutierrez DB, 2010, PHOTOCH PHOTOBIO SCI, V9, P1513, DOI 10.1039/c0pp00230e; Hagiwara A, 2003, FOOD CHEM TOXICOL, V41, P1157, DOI 10.1016/S0278-6915(03)00104-2; Hammer M, 2006, MOL VIS, V12, P1348; Hanneken A, 2006, INVEST OPHTH VIS SCI, V47, P3164, DOI 10.1167/iovs.04-1369; Hanus J, 2016, BRIT J OPHTHALMOL, V100, P122, DOI 10.1136/bjophthalmol-2015-306972; Herzlich AA, 2008, PPAR RES, V2008, DOI 10.1155/2008/389507; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Iriyama A, 2009, J CELL PHYSIOL, V220, P469, DOI 10.1002/jcp.21792; Jang YP, 2005, PHOTOCHEM PHOTOBIOL, V81, P529, DOI 10.1562/2004-12-14-RA-402.1; Julien S, 2012, NEUROBIOL AGING, V33, P2390, DOI 10.1016/j.neurobiolaging.2011.12.009; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kam JH, 2015, EXP EYE RES, V135, P59, DOI 10.1016/j.exer.2015.03.023; Kanofsky JR, 2003, PHOTOCHEM PHOTOBIOL, V77, P235, DOI 10.1562/0031-8655(2003)077<0235:SOGFA>2.0.CO;2; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Kaufman Y, 2011, J BIOL CHEM, V286, P7958, DOI 10.1074/jbc.M110.178640; Kaulmann A, 2014, NUTR RES, V34, P907, DOI 10.1016/j.nutres.2014.07.010; Kijlstra A, 2012, PROG RETIN EYE RES, V31, P303, DOI 10.1016/j.preteyeres.2012.03.002; Kinnunen K, 2012, ACTA OPHTHALMOL, V90, P299, DOI 10.1111/j.1755-3768.2011.02179.x; Kroes R, 2004, WHO FOOD ADDITIVE SE, V52; Leonarduzzi G, 2010, PHARMACOL THERAPEUT, V128, P336, DOI 10.1016/j.pharmthera.2010.08.003; Levy LW, 1997, ANALYST, V122, P977, DOI 10.1039/a701304c; Li ZR, 2013, MOL VIS, V19, P1656; Liu J, 2008, INVEST OPHTH VIS SCI, V49, P772, DOI 10.1167/iovs.07-0675; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2012, NAT CHEM BIOL, V8, P170, DOI 10.1038/nchembio.759; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Malek G, 2014, CELL MOL LIFE SCI, V71, P4617, DOI 10.1007/s00018-014-1709-x; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Miyake S, 2014, BIOCHEM BIOPH RES CO, V446, P535, DOI 10.1016/j.bbrc.2014.02.135; Nociari MM, 2014, P NATL ACAD SCI USA, V111, pE1402, DOI 10.1073/pnas.1400530111; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Penn J, 2015, DIS MODEL MECH, V8, P131, DOI 10.1242/dmm.017194; Petrukhin Konstantin, 2013, Drug Discov Today Ther Strateg, V10, pe11; Pinazo-Duran MD, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/901686; Puntel A, 2015, BIOMATERIALS, V44, P103, DOI 10.1016/j.biomaterials.2014.12.019; Qin S, 2007, DRUG DEVELOP RES, V68, P213, DOI 10.1002/ddr.20185; Querques G, 2014, OPHTHALMIC RES, V52, P107, DOI 10.1159/000363187; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Ramkumar HL, 2013, J NUTR, V143, P1129, DOI 10.3945/jn.112.169649; Ranchon I, 2001, INVEST OPHTH VIS SCI, V42, P1375; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Rozanowska M, 1998, FREE RADICAL BIO MED, V24, P1107, DOI 10.1016/S0891-5849(97)00395-X; Santos AAA, 2002, FOOD CHEM, V77, P393, DOI 10.1016/S0308-8146(01)00363-6; Sawada O, 2014, EXP EYE RES, V123, P27, DOI 10.1016/j.exer.2014.04.003; Schutt F, 2000, INVEST OPHTH VIS SCI, V41, P2303; Scotter MJ, 1998, J AGR FOOD CHEM, V46, P1031, DOI 10.1021/jf970063+; Sparrow JR, 2014, ADV EXP MED BIOL, V801, P593, DOI 10.1007/978-1-4614-3209-8_75; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Stiles M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145305; Takahashi N, 2009, BIOCHEM BIOPH RES CO, V390, P1372, DOI 10.1016/j.bbrc.2009.10.162; Tao SS, 2015, FREE RADICAL BIO MED, V89, P690, DOI 10.1016/j.freeradbiomed.2015.08.028; Tokarz P, 2013, BIOGERONTOLOGY, V14, P461, DOI 10.1007/s10522-013-9463-2; Tomita H, 2005, INVEST OPHTH VIS SCI, V46, P427, DOI 10.1167/iovs.04-0946; Toops KA, 2015, MOL BIOL CELL, V26, P1, DOI 10.1091/mbc.E14-05-1028; Tsuruma K, 2012, MOL NUTR FOOD RES, V56, P713, DOI 10.1002/mnfr.201100607; Umigai N, 2011, PHYTOMEDICINE, V18, P575, DOI 10.1016/j.phymed.2010.10.019; Veillet S, 2015, United States patent, Patent No. [US 2012/149775, 2012149775]; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P1251, DOI 10.1562/2006-04-01-RA-864; Washington I, 2016, ADV EXP MED BIOL, V854, P347, DOI 10.1007/978-3-319-17121-0_46; Wielgus AR, 2010, PHOTOCH PHOTOBIO SCI, V9, P1505, DOI 10.1039/c0pp00133c; Wu WQ, 2015, MOL NUTR FOOD RES, V59, P1663, DOI 10.1002/mnfr.201500109; Wu YL, 2011, J AM CHEM SOC, V133, P849, DOI 10.1021/ja107195u; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Yamauchi M, 2011, EUR J PHARMACOL, V650, P110, DOI 10.1016/j.ejphar.2010.09.081; Yoon KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041309; Zampatti S, 2014, NUTR RES, V34, P95, DOI 10.1016/j.nutres.2013.10.011; Zhang J, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.330; Zhang JY, 2015, J CLIN INVEST, V125, P2781, DOI 10.1172/JCI80950; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou JL, 2015, J BIOL CHEM, V290, P27215, DOI 10.1074/jbc.M115.680363; Zou X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.190; 郭朋辉, 2009, [中草药, Chinese Traditional and Herbal Drugs], V40, P782	98	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167793	10.1371/journal.pone.0167793	http://dx.doi.org/10.1371/journal.pone.0167793			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992460	Green Published, Green Submitted, gold			2022-12-27	WOS:000392758000017
J	Lanzoni, O; Fokin, SI; Lebedeva, N; Migunova, A; Petroni, G; Potekhin, A				Lanzoni, Olivia; Fokin, Sergei I.; Lebedeva, Natalia; Migunova, Alexandra; Petroni, Giulio; Potekhin, Alexey			Rare Freshwater Ciliate Paramecium chlorelligerum Kahl, 1935 and Its Macronuclear Symbiotic Bacterium "Candidatus Holospora parva"	PLOS ONE			English	Article							IN-SITU; SP-NOV; PHYLOGENETIC-RELATIONSHIPS; OLIGONUCLEOTIDE PROBES; CILIOPHORA; BURSARIA; ENDOSYMBIONTS; ELEGANS; GENUS; IDENTIFICATION	Ciliated protists often form symbioses with many diverse microorganisms. In particular, symbiotic associations between ciliates and green algae, as well as between ciliates and intracellular bacteria, are rather wide-spread in nature. In this study, we describe the complex symbiotic system between a very rare ciliate, Paramecium chlorelligerum, unicellular algae inhabiting its cytoplasm, and novel bacteria colonizing the host macronucleus. Paramecium chlorelligerum, previously found only twice in Germany, was retrieved from a novel location in vicinity of St. Petersburg in Russia. Species identification was based on both classical morphological methods and analysis of the small subunit rDNA. Numerous algae occupying the cytoplasm of this ciliate were identified with ultrastructural and molecular methods as representatives of the Meyerella genus, which before was not considered among symbiotic algae. In the same locality at least fifteen other species of "green" ciliates were found, thus it is indeed a biodiversity hot-spot for such protists. A novel species of bacterial symbionts living in the macronucleus of Paramecium chlorelligerum cells was morphologically and ultrastructurally investigated in detail with the description of its life cycle and infection capabilities. The new endosymbiont was molecularly characterized following the full-cycle rRNA approach. Furthermore, phylogenetic analysis confirmed that the novel bacterium is a member of Holospora genus branching basally but sharing all characteristics of the genus except inducing connecting piece formation during the infected host nucleus division. We propose the name "Candidatus Holospora parva" for this newly described species. The described complex system raises new questions on how these microorganisms evolve and interact in symbiosis.	[Lanzoni, Olivia; Fokin, Sergei I.; Petroni, Giulio; Potekhin, Alexey] Univ Pisa, Dept Biol, Pisa, Italy; [Fokin, Sergei I.] St Petersburg State Univ, Fac Biol, Dept Invertebrate Zool, St Petersburg, Russia; [Lebedeva, Natalia] St Petersburg State Univ, Ctr Core Facil Culture Collect Microorganisms, St Petersburg, Russia; [Migunova, Alexandra; Potekhin, Alexey] St Petersburg State Univ, Fac Biol, Dept Microbiol, St Petersburg, Russia	University of Pisa; Saint Petersburg State University; Saint Petersburg State University; Saint Petersburg State University	Potekhin, A (corresponding author), Univ Pisa, Dept Biol, Pisa, Italy.	giulio.petroni@unipi.it; alexey.potekhin@spbu.ru	Petroni, Giulio/B-6086-2008; Ale[andra, Migunova/G-1106-2015; Potekhin, Alexey A./K-3633-2013	Petroni, Giulio/0000-0001-9572-9897; Ale[andra, Migunova/0000-0001-6151-5719; Potekhin, Alexey A./0000-0003-4162-5923; Lanzoni, Olivia/0000-0002-3930-8462	European Commission FP7-PEOPLE-IRSES project CINAR PATHOBACTER [247658]; PRIN grant from Italian Research Ministry (MIUR) [2012A4F828 002]; St Petersburg RFBR mobility grant [16-34-50043]; Pisa mobility grant of St Petersburg State University [1.42.1450.2015]; RFBR [16-04-01195]; RSF [16-14-10157]; European Commission FP7 post grant Open Access Pilot Open AIRE	European Commission FP7-PEOPLE-IRSES project CINAR PATHOBACTER; PRIN grant from Italian Research Ministry (MIUR)(Ministry of Education, Universities and Research (MIUR)); St Petersburg RFBR mobility grant; Pisa mobility grant of St Petersburg State University; RFBR(Russian Foundation for Basic Research (RFBR)); RSF(Russian Science Foundation (RSF)); European Commission FP7 post grant Open Access Pilot Open AIRE	This work was supported by European Commission FP7-PEOPLE-2009-IRSES project CINAR PATHOBACTER (247658, cordis.europa.eu): mobility support to OL SF NL GP AP; PRIN grant (2012A4F828 002, prin.miur.it) from the Italian Research Ministry (MIUR) to GP for general research; work in St Petersburg 2016 RFBR mobility grant (16-34-50043, rffi.ru) to OL AP; work in Pisa 2015 mobility grant 1.42.1450.2015 of St Petersburg State University (spbu.ru) to AP; algae studies and infection experiments were supported by RFBR (grant 16-04-01195,rffi.ru) to AP; sequencing was done with a support from RSF (grant 16-14-10157, grant.rscf.ru) to AP. The publication costs were covered by European Commission FP7 post grant Open Access Pilot Open AIRE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN R, 1991, NATURE, V351, P161, DOI 10.1038/351161a0; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Andreoli I, 2009, ZOOL SCR, V38, P651, DOI 10.1111/j.1463-6409.2009.00395.x; Andreyeva V.M., 1998, SOIL AEROPHILIC GREE; Banerji A, 2015, J ANIM ECOL, V84, P723, DOI 10.1111/1365-2656.12317; BERNINGER UG, 1986, J PROTOZOOL, V33, P557, DOI 10.1111/j.1550-7408.1986.tb05662.x; BORCHSENIUS ON, 1983, TSITOLOGIYA+, V25, P91; Boscaro V, 2013, MICROB ECOL, V65, P255, DOI 10.1007/s00248-012-0110-2; Boscaro V, 2012, MOL PHYLOGENET EVOL, V65, P1004, DOI 10.1016/j.ympev.2012.09.001; Bykova SV., 2013, NEWS SAMARA SCI CTR, V15, P2224; Castelli M, 2016, CURR MICROBIOL, V72, P723, DOI 10.1007/s00284-016-1006-z; Castelli M, 2015, EUR J PROTISTOL, V51, P98, DOI 10.1016/j.ejop.2014.11.006; Chatton E, 1933, CR SOC BIOL, V114, P988; Cole JR, 2014, NUCL ACIDS RES; Coleman AW, 2005, J EUKARYOT MICROBIOL, V52, P68, DOI 10.1111/j.1550-7408.2005.3327r.x; CORLISS JO, 1953, STAIN TECHNOL, V28, P97, DOI 10.3109/10520295309105108; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dohra H, 2014, FEMS MICROBIOL LETT, V359, P16, DOI 10.1111/1574-6968.12577; Driscoll T, 2013, GENOME BIOL EVOL, V5, P621, DOI 10.1093/gbe/evt036; Duncan AB, 2015, ECOLOGY, V96, P284, DOI 10.1890/14-0137.1; Dusi E, 2015, EVOLUTION, V69, P1069, DOI 10.1111/evo.12638; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esteban GF, 2010, PROTIST, V161, P621, DOI 10.1016/j.protis.2010.08.002; Fawley MW, 2005, PHYCOLOGIA, V44, P35, DOI 10.2216/0031-8884(2005)44[35:DAEOSC]2.0.CO;2; Ferla MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083383; Ferrantini F., 2007, J EUKARYOT MICROBIOL, V54, p75a; Finlay BJ, 1996, FEMS MICROBIOL ECOL, V20, P229; FOISSNER W, 1991, EUR J PROTISTOL, V27, P313, DOI 10.1016/S0932-4739(11)80248-8; FOKIN S, 1993, EUR J PROTISTOL, V29, P390, DOI 10.1016/S0932-4739(11)80401-3; Fokin S, 2006, ZOOL SCR, V35, P289, DOI 10.1111/j.1463-6409.2006.00231.x; FOKIN S, 1993, ARCH PROTISTENKD, V143, P319, DOI 10.1016/S0003-9365(11)80328-3; Fokin S., 1999, J EUKARYOT MICROBIOL, V46, P11; Fokin SI, 2012, EUR J PROTISTOL, V48, P138, DOI 10.1016/j.ejop.2011.12.001; Fokin Sergei I., 2011, Protistology, V6, P227; Fokin SI, 2009, MICROBIOL MONOGR, V12, P161, DOI 10.1007/978-3-540-92677-1_7; FOKIN SI, 1991, TSITOLOGIYA+, V33, P135; Fokin SI, 2004, EUR J PROTISTOL, V40, P225, DOI 10.1016/j.ejop.2004.02.001; Fokin SI, 1999, J EUKARYOT MICROBIOL, V46, P416, DOI 10.1111/j.1550-7408.1999.tb04622.x; Fokin SI., 1989, CYTOLOGY, V31, P839; Fokin SI., 1996, EUR J PROTISTOL S1, V3, P19, DOI DOI 10.1016/S0932-4739(96)80072-1; Fokin SI, 2015, 7 EUR C PROT SEV SPA; Fokin SI, 2004, INT REV CYTOL, P181; Fried J, 2007, J EUKARYOT MICROBIOL, V54, P381, DOI 10.1111/j.1550-7408.2007.00277.x; Fucikova K, 2014, PHYCOL RES, V62, P294, DOI 10.1111/pre.12062; Gelei J., 1925, Allattani Kozlemenyek Budapest, V22, P121; Georgiades K, 2011, PLOS ONE; Gillespie JJ, 2012, INTERCELLULAR PATHOGENS II: RICKETTSIALES, P84, DOI 10.1128/9781555817336.ch3; GORTZ HD, 1980, PROTISTOLOGICA, V16, P591; Greuter D, 2016, NUCL ACIDS RES; GROMOV BV, 1981, INT J SYST BACTERIOL, V31, P348, DOI 10.1099/00207713-31-3-348; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hess S, 2016, APPL ENVIRON MICROB, V82, P659, DOI 10.1128/AEM.02680-15; Holzinger A, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00327; Hori M, 2008, J EUKARYOT MICROBIOL, V55, P515, DOI 10.1111/j.1550-7408.2008.00352.x; Hoshina R, 2006, ACTA PROTOZOOL, V45, P377; Hoshina R, 2016, PROTIST, V167, P174, DOI 10.1016/j.protis.2016.02.004; Kahl A., 1935, Dahl Die Tierwelt Deutschlands, V30, P651; KARAKASHIAN SJ, 1965, EVOLUTION, V19, P368, DOI 10.2307/2406447; Karpagam R, 2015, ENERG FUEL, V29, P143, DOI 10.1021/ef501969a; KAWAKAMI H, 1978, J PROTOZOOL, V25, P217, DOI 10.1111/j.1550-7408.1978.tb04399.x; Krenek S, 2015, ORG DIVERS EVOL, V15, P215, DOI 10.1007/s13127-015-0207-9; Kreutz Martin, 2006, Protozoological Monographs, V3, P1; Kreutz M, 2012, J EUKARYOT MICROBIOL, V59, P548, DOI 10.1111/j.1550-7408.2012.00638.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MANZ W, 1992, SYST APPL MICROBIOL, V15, P593, DOI 10.1016/S0723-2020(11)80121-9; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; Millot L, 2006, CRYOBIOLOGY, V52, P161, DOI 10.1016/j.cryobiol.2005.10.014; Montagna M, 2013, APPL ENVIRON MICROB, V79, P3241, DOI 10.1128/AEM.03971-12; Muller O. F., 1786, ANIMACULA INFUSORIA; Neustupa J, 2013, INT J SYST EVOL MICR, V63, P377, DOI 10.1099/ijs.0.047944-0; NICHOLS HW, 1965, J PHYCOL, V1, P34, DOI 10.1111/j.1529-8817.1965.tb04552.x; OSSIPOV DV, 1980, CYTOLOGY, V22, P922; Petroni G, 2003, MICROBIAL ECOL, V45, P156, DOI 10.1007/s00248-002-2016-x; Petroni G, 2002, MOL PHYLOGENET EVOL, V22, P118, DOI 10.1006/mpev.2001.1030; Pitsch G, 2016, J EUKARYOTIC MICROBI; PREER JR, 1982, INT J SYST BACTERIOL, V32, P140, DOI 10.1099/00207713-32-1-140; PREER LB, 1969, J PROTOZOOL, V16, P570, DOI 10.1111/j.1550-7408.1969.tb02315.x; Proschold T, 2011, ENVIRON MICROBIOL, V13, P350, DOI 10.1111/j.1462-2920.2010.02333.x; Quast C., 2013, NUCL ACIDS RES; Rautian MS, 2013, INT J SYST EVOL MICR, V63, P1930, DOI 10.1099/ijs.0.046631-0; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosati G, 2004, J EUKARYOT MICROBIOL, V51, P49, DOI 10.1111/j.1550-7408.2004.tb00160.x; Schulz F, 2015, ENV MICROBIOLOGY; Serra V, 2016, FRONTIERS MICROBIOLO; Shi XB, 1997, J EUKARYOT MICROBIOL, V44, P134, DOI 10.1111/j.1550-7408.1997.tb05950.x; SKOVORODKIN IN, 1990, TSITOLOGIYA+, V32, P301; Struder-Kypke MC, 2000, MOL PHYLOGENET EVOL, V14, P122, DOI 10.1006/mpev.1999.0686; Struder-Kypke MC, 2010, SYST BIODIVERS, V8, P131, DOI 10.1080/14772000903507744; Summerer M, 2008, J PHYCOL, V44, P77, DOI 10.1111/j.1529-8817.2007.00455.x; Szokoli F, 2016, APPL ENV MICROBIOLOG; Szokoli F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145743; Vakkerov-Kouzova ND, 2011, MICROBIOLOGY+, V80, P728, DOI 10.1134/S0026261711050171; VANETTEN JL, 1982, P NATL ACAD SCI-BIOL, V79, P3867; Vannini C, 2004, INT J SYST EVOL MICR, V54, P1151, DOI 10.1099/ijs.0.02759-0; Vuxanovici A, 1960, STUDII CERC BIOL BIO, V12, P353; Wichterman R, 1953, BIOL PARAMECIUM; Wichterman R., 1986, BIOL PARAMECIUM, V2nd ed., DOI DOI 10.1007/978-1-4757-0372-6; WIEMANN M, 1989, EUR J PROTISTOL, V25, P100, DOI 10.1016/S0932-4739(89)80021-5; Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330; Yashchenko VV, 2012, EUR J PROTISTOL, V48, P149, DOI 10.1016/j.ejop.2011.05.002; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	102	27	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0167928	10.1371/journal.pone.0167928	http://dx.doi.org/10.1371/journal.pone.0167928			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992463	Green Published, gold			2022-12-27	WOS:000392758000018
J	Shakib, MN; Moghavvemi, M; Mahadi, WNL				Shakib, Mohammed Nazmus; Moghavvemi, Mahmoud; Mahadi, Wan Nor Liza			Optimization of Planar Monopole Wideband Antenna for Wireless Communication System	PLOS ONE			English	Article							LOW-PROFILE	In this paper, a new compact wideband monopole antenna is presented for wireless communication applications. This antenna comprises of a new radiating patch, a new arcshaped strip, microstrip feed line, and a notched ground plane. The proposed radiating patch is combined with a rectangular and semi-circular patch and is integrated with a partial ground plane to provide a wide impedance bandwidth. The new arc-shaped strip between the radiating patch and microstrip feed line creates an extra surface on the patch, which helps further widen the bandwidth. Inserting one step notch on the ground plane further enhances the bandwidth. The antenna has a compact size of 16x20x1.6mm(3). The measured result indicated that the antenna achieves a 127% bandwidth at VSWR <= 2, ranging from 4.9GHz to 22.1GHz. Stable radiation patterns with acceptable gain are achieved. Also, a measured bandwidth of 107.7% at VSWR <= 1.5 (5.1-17GHz) is obtained, which is suitable for UWB outdoor propagation. This antenna is compatible with a good number of wireless standards, including UWB band, Wimax 5.4 GHz band, MVDDS (12.2-12.7GHz), and close range radar and satellite communication in the X-band (8-12GHz), and Ku band (12-18GHz).	[Shakib, Mohammed Nazmus; Moghavvemi, Mahmoud] Univ Malaya, Ctr Res Appl Elect, Fac Engn, Kuala Lumpur, Malaysia; [Moghavvemi, Mahmoud; Mahadi, Wan Nor Liza] Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia; [Moghavvemi, Mahmoud] Univ Sci & Culture, Tehran, Iran	Universiti Malaya; Universiti Malaya	Moghavvemi, M (corresponding author), Univ Malaya, Ctr Res Appl Elect, Fac Engn, Kuala Lumpur, Malaysia.; Moghavvemi, M (corresponding author), Univ Malaya, Dept Elect Engn, Fac Engn, Kuala Lumpur, Malaysia.; Moghavvemi, M (corresponding author), Univ Sci & Culture, Tehran, Iran.	mahmoud@um.edu.my	Moghavvemi, Mahmoud/B-8912-2010; MAHADI, WAN NOR LIZA/AAD-7114-2019	Moghavvemi, Mahmoud/0000-0001-6447-4203; 	Ministry of Higher Education of Malaysia [FRGS/2/2014/TK03/UM/01/1 (FP003-2014B)]; Bright Spark Grant of the University of Malaya [BSP/APP/1133/2012]; PPP Grant of the University of Malaya [PG131-2013A]	Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia); Bright Spark Grant of the University of Malaya; PPP Grant of the University of Malaya	This work was supported by the Ministry of Higher Education of Malaysia, project no - FRGS/2/2014/TK03/UM/01/1 (FP003-2014B) and the Bright Spark Grant (No: BSP/APP/1133/2012), PPP Grant (No: PG131-2013A) of the University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelraheem AM, 2016, INT J MICROW WIREL T, V8, P283, DOI 10.1017/S1759078714001524; Al-Zayed AS, 2016, INT J MICROW WIREL T, V8, P319, DOI 10.1017/S1759078714001627; Cordeschi N, 2015, VEH COMMUN, V2, P1, DOI 10.1016/j.vehcom.2014.08.004; Cordeschi N, 2013, COMPUT NETW, V57, P3479, DOI 10.1016/j.comnet.2013.08.002; Ellis MS, 2014, ELECTRON LETT, V50, P654, DOI 10.1049/el.2014.0298; George N, 2015, MICROW OPT TECHN LET, V57, P621, DOI 10.1002/mop.28910; Gozasht F, 2014, 2014 INTERNATIONAL WORKSHOP ON ANTENNA TECHNOLOGY: "SMALL ANTENNAS, NOVEL EM STRUCTURES AND MATERIALS, AND APPLICATIONS" (IWAT), P332, DOI 10.1109/IWAT.2014.6958679; Kundu S, 2014, 2014 FIRST INTERNATIONAL CONFERENCE ON AUTOMATION, CONTROL, ENERGY & SYSTEMS (ACES-14), P27; Kwon DH, 2007, IEEE T ANTENN PROPAG, V55, P72, DOI 10.1109/TAP.2006.888393; Malheiros-Silveira GN, 2015, MICROW OPT TECHN LET, V57, P28, DOI 10.1002/mop.28763; Mehmood A., 2014, NETW PROTOC ALGORITH, V6, P60, DOI DOI 10.5296/NPA.V6I4.6028; Nakano H, 2010, IEEE T ANTENN PROPAG, V58, P1511, DOI 10.1109/TAP.2010.2044345; Peng HX, 2014, PROG ELECTROMAGN RES, V144, P185, DOI 10.2528/PIER13120409; Qu SW, 2007, IEEE ANTENN WIREL PR, V6, P40, DOI 10.1109/LAWP.2007.891515; Shakib MN, 2016, J COMPUT ELECTRON, V15, P627, DOI 10.1007/s10825-015-0741-x; Shakib MN, 2014, SCI WORLD J, DOI 10.1155/2014/874241; Shakib MN, 2015, IEEE ANTENN WIREL PR, V14, P1790, DOI 10.1109/LAWP.2015.2423931; Shojafar M, 2016, 2016 IEEE S COMP COM, P1; Song H. H., 2013, 2013 Abstracts IEEE International Conference on Plasma Science (ICOPS), DOI 10.1109/PLASMA.2013.6635166; Song HT, 2011, 2011 INTERNATIONAL CONFERENCE ON ELECTRONICS, COMMUNICATIONS AND CONTROL (ICECC), P1; Suryawanshi DR, 2014, CONTR INSTR COMM COM, P1; Xu DT, 2016, IET COMMUN, V10, P292, DOI 10.1049/iet-com.2015.0229; Yeoh WS, 2015, IEEE ANTENN WIREL PR, V14, P1085, DOI 10.1109/LAWP.2015.2394295; Zhu FG, 2013, INT J RF MICROW C E, V23, P290, DOI 10.1002/mmce.20673	24	3	3	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2016	11	12							e0168013	10.1371/journal.pone.0168013	http://dx.doi.org/10.1371/journal.pone.0168013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8LN	27992466	Green Submitted, Green Published, gold			2022-12-27	WOS:000392758000023
J	Buendia-Roldan, I; Ruiz, V; Sierra, P; Montes, E; Ramirez, R; Vega, A; Salgado, A; Vargas, MH; Mejia, M; Pardo, A; Selman, M				Buendia-Roldan, Ivette; Ruiz, Victor; Sierra, Patricia; Montes, Eduardo; Ramirez, Remedios; Vega, Anita; Salgado, Alfonso; Vargas, Mario H.; Mejia, Mayra; Pardo, Annie; Selman, Moises			Increased Expression of CC16 in Patients with Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							CELL SECRETORY PROTEIN; CHRONIC HYPERSENSITIVITY PNEUMONITIS; CLASSIFICATION CRITERIA; INTERSTITIAL PNEUMONIA; AMERICAN-COLLEGE; SERUM-LEVELS; COHORT; CLARA; BIOMARKERS; DIAGNOSIS	Idiopathic pulmonary fibrosis (IPF) is a devastating disease of unknown etiology. The pathogenic mechanisms are unclear, but evidence indicates that aberrantly activated alveolar epithelial cells secrete a variety of mediators which induce the migration, proliferation and activation of fibroblasts and finally the excessive accumulation of extracellular matrix with the consequent destruction of the lung parenchyma. CC16 (approved symbol SCGB1A1), a putative anti-inflammatory protein produced by "club" cells in the distal airways, has not been evaluated in IPF lungs. In this study, we determined the serum and bronchoalveolar lavage (BAL) levels as well as the lung cell localization of this protein. Also, we explored the usefulness of serum levels of CC16 for the differential diagnosis of IPF (n = 85), compared with non-IPF interstitial lung diseases [chronic hypersensitivity pneumonitis (cHP; n = 85) and connective tissue diseases (CTD-ILD; n = 85)]. CC16 was significantly increased in serum and BAL fluids of IPF patients and was found not only in club cells but also in alveolar epithelial cells. When compared with non-IPF patients and controls, serum levels were significantly increased (p< 0.0001). Sensitivity and specificity for CC16 (cut-off 41ng/mL) were 24% and 90%, positive predictive value 56% and negative predictive value 69%. These findings demonstrate that CC16 is upregulated in IPF patients suggesting that may participate in its pathogenesis. Although higher than the serum levels of non-IPF patients it shows modest sensitivity to be useful as a potential biomarker for the differential diagnosis.	[Buendia-Roldan, Ivette; Ruiz, Victor; Sierra, Patricia; Montes, Eduardo; Vega, Anita; Salgado, Alfonso; Vargas, Mario H.; Mejia, Mayra; Selman, Moises] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico; [Ramirez, Remedios; Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico	Selman, M (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico.	mselmanl@yahoo.com.mx	Ruiz, Victor/DSX-5036-2022; Vargas, Mario H./ABC-8393-2020	Vargas, Mario H./0000-0002-8420-980X; Salgado, Alfonso/0000-0001-8102-3690; Ruiz, Victor/0000-0003-0440-2093; Buendia, Ivette/0000-0002-8230-0749	CONACYT [SALUD-2011-1-162010]; National Institute of Respiratory Diseases, Mexico	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institute of Respiratory Diseases, Mexico	This study was supported by CONACYT SALUD-2011-1-162010 and by the National Institute of Respiratory Diseases, Mexico. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Akram KM, 2013, EUR RESPIR J, V41, P683, DOI 10.1183/09031936.00213411; Gioldassi XM, 2004, J PHARMACEUT BIOMED, V34, P823, DOI 10.1016/S0731-7085(03)00570-3; Guerra S, 2015, LANCET RESP MED, V3, P613, DOI 10.1016/S2213-2600(15)00196-4; Guerra S, 2013, LANCET RESP MED, V1, P779, DOI 10.1016/S2213-2600(13)70220-0; Hambly N, 2015, RESPIROLOGY, V20, P1010, DOI 10.1111/resp.12569; Hasegawa M, 2011, J RHEUMATOL, V38, P877, DOI 10.3899/jrheum.100591; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kokuho N, 2015, COPD, V12, P347, DOI 10.3109/15412555.2014.948994; Laucho-Contreras ME, 2015, EUR RESPIR J, V45, P1544, DOI 10.1183/09031936.00134214; Ley B, 2014, AM J PHYSIOL-LUNG C, V307, pL681, DOI 10.1152/ajplung.00014.2014; Morell F, 2013, LANCET RESP MED, V1, P685, DOI 10.1016/S2213-2600(13)70191-7; Neogi T, 2010, ARTHRITIS RHEUM-US, V62, P2582, DOI 10.1002/art.27580; Ohno Y, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0546-8; Oikonomou A, 2013, INSIGHTS IMAGING, V4, P9, DOI 10.1007/s13244-012-0207-7; Olewicz-Gawlik A, 2016, REV BRAS REUMATOL, V56, P309, DOI [10.1016/j.rbre.2015.07.005, 10.1016/j.rbr.2015.04.001]; Pardo A, 2005, PLOS MED, V2, P891, DOI 10.1371/journal.pmed.0020251; Park JH, 2007, AM J RESP CRIT CARE, V175, P705, DOI 10.1164/rccm.200607-912OC; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Robin M, 2002, EUR RESPIR J, V20, P1152, DOI 10.1183/09031936.02.02042001; Selman M, 2006, AM J RESP CRIT CARE, V173, P188, DOI 10.1164/rccm.200504-644OC; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Selman M, 2012, AM J RESP CRIT CARE, V186, P314, DOI 10.1164/rccm.201203-0513CI; Shiboski SC, 2012, ARTHRIT CARE RES, V64, P475, DOI 10.1002/acr.21591; Takemura T, 2012, HISTOPATHOLOGY, V61, P1026, DOI 10.1111/j.1365-2559.2012.04322.x; White ES, 2016, AM J RESPIR CRIT CAR	29	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168552	10.1371/journal.pone.0168552	http://dx.doi.org/10.1371/journal.pone.0168552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27977812	Green Submitted, gold, Green Published			2022-12-27	WOS:000391217400116
J	Gao, XY; Zhao, YX; Su, YS; Liu, K; Yu, XC; Cui, CX; Yang, ZK; Shi, H; Jing, XH; Zhu, B				Gao, Xinyan; Zhao, Yuxue; Su, Yangshuai; Liu, Kun; Yu, Xiaochun; Cui, Changxiang; Yang, Zhaokun; Shi, Hong; Jing, Xianghong; Zhu, Bing			beta(1/2) or M-2/3 Receptors Are Required for Different Gastrointestinal Motility Responses Induced by Acupuncture at Heterotopic or Homotopic Acupoints	PLOS ONE			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; GASTRIC-ACID-SECRETION; SMOOTH-MUSCLE; ELECTRICAL-STIMULATION; NEURAL MECHANISM; URINARY-BLADDER; M-3; CONTRACTIONS; ANTAGONISTS; SUBTYPES	Acupuncture at homotopic acupoints or heterotopic acupoints is known to either inhibit or facilitate gastrointestinal motility, depending on the acupoint location. However, little effort has been made to investigate the roles of specific receptors (such as adrenergic and muscarinic acetylcholine receptors) in mediating the effects of acupuncture at heterotopic and homotopic acupoints. Different adrenergic receptor subtypes or cholinergic receptor subtypes are predominantly expressed in various sections of the gut, resulting in variations between the effects of acupuncture at heterotopic or homotopic acupoints on gastrointestinal motility. Here, we investigated the role of beta(1)/beta(2) receptors and M-2/M-3 receptors in gastrointestinal motility regulated by acupuncture at ST37, a heterotopic acupoint, and ST25, a homotopic acupoint, by simultaneously recording intraluminal pressures in the distal colon and stomach or jejunum and examining fecal phenol red excretion in beta(1/2) receptor-knockout mice and M-2/3 receptor-knockout mice. We found that knockout of the M-2/3 receptor significantly inhibited ST37 acupuncture-induced enhancement of gastric motility, jejunal motility, and colonic motility. Additionally, knocking out of the beta(1/2) receptor significantly diminished the ST25 acupuncture-induced inhibition of gastric motility and jejunal motility without significantly altering the enhancement of colonic motility induced by acupuncture at ST25. Acupuncture at ST37 significantly accelerated gastrointestinal transition in beta(1/2) receptorknockout mice and their wild-type littermates. However, this acceleration of gastrointestinal transition was markedly diminished in M-2/3 receptor-knockout mice relative to their wild-type littermates. Acupuncture at ST25 significantly increased gastrointestinal transition in beta(1/2) receptor-knockout mice and significantly decreased gastrointestinal transition in M-2/3 receptor- knockout mice without altering gastrointestinal transition in wild-type littermates of either. Our study revealed that M-2/3 receptors are required for the gastrointestinal motility associated with whole gastrointestinal transition enhanced by acupuncture at heterotopic acupoints, whereas beta(1/2) receptors are required for the same gastrointestinal motility processes inhibited by acupuncture at homotopic acupoints. Therefore, our findings reveal important biological mechanisms underlying acupuncture treatment of disorders involving gastrointestinal motility dysfunction.	[Gao, Xinyan; Zhao, Yuxue; Su, Yangshuai; Liu, Kun; Yu, Xiaochun; Cui, Changxiang; Yang, Zhaokun; Shi, Hong; Jing, Xianghong; Zhu, Bing] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing, Peoples R China; [Cui, Changxiang] Peoples Hosp Ri Zhao, Rizhao, Peoples R China	China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS	Jing, XH; Zhu, B (corresponding author), China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Beijing, Peoples R China.	jxhtjb@263.net; zhubing@mail.cintcm.ac.cn	Gao, Xinyan/HHN-8438-2022; Jing, Xianghong/HHS-4003-2022	Liu, Kun/0000-0002-1388-3514	National Basic Research Program of China [2011CB505201, 2014CB543103]; National Natural Science Foundation of China [81173345, 81130063]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China granted to BZ (No.2011CB505201) and to XG (No. 2014CB543103), and by National Natural Science Foundation of China granted to XG (No. 81173345) and to BZ (No. 81130063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSSON H, 1983, DIGEST DIS SCI, V28, P590, DOI 10.1007/BF01299918; AHLUWALIA NK, 1994, GUT, V35, P1356, DOI 10.1136/gut.35.10.1356; Ahluwalia NK, 1993, J GASTROINTEST MOTIL, V5, P177; Aihara T, 2005, AM J PHYSIOL-GASTR L, V288, pG1199, DOI 10.1152/ajpgi.00514.2004; Broccardo A, 2005, PEPTIDES, V26, P1590, DOI 10.1016/j.peptides.2005.02.018; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Chang CS, 2001, DIGESTION, V64, P184, DOI 10.1159/000048860; Chiba T, 2002, NEUROGASTROENT MOTIL, V14, P535, DOI 10.1046/j.1365-2982.2002.00357.x; DePonti F, 1996, PHARMACOL THERAPEUT, V69, P59, DOI 10.1016/0163-7258(95)02031-4; Eglen RM, 1996, PHARMACOL REV, V48, P531; Ehlert FJ, 2003, LIFE SCI, V74, P355, DOI 10.1016/j.lfs.2003.09.023; Ehlert FJ, 1997, LIFE SCI, V61, P1729, DOI 10.1016/S0024-3205(97)00433-5; Ehlert FJ, 1997, MUSCARINIC RECEPTOR, P87; Ehlert Frederick J, 2012, Handb Exp Pharmacol, P343, DOI 10.1007/978-3-642-23274-9_15; Gao X, 2015, NEUROGASTROENT MOTIL, V27, P1817, DOI 10.1111/nmo.12694; Goyal RK, 1996, NEW ENGL J MED, V334, P1106, DOI 10.1056/NEJM199604253341707; HEDGES A, 1969, BRIT J PHARMACOL, V37, pP547; Hutchinson DS, 2001, BRIT J PHARMACOL, V132, P433, DOI 10.1038/sj.bjp.0703828; Kaan SK, 1996, EUR J PHARMACOL, V317, P115, DOI 10.1016/S0014-2999(96)00705-4; KOIZUMI K, 1980, BRAIN RES, V182, P85, DOI 10.1016/0006-8993(80)90832-X; Li YQ, 2007, WORLD J GASTROENTERO, V13, P709, DOI 10.3748/wjg.v13.i5.709; Li YQ, 2006, WORLD J GASTROENTERO, V12, P7642, DOI 10.3748/wjg.v12.i47.7642; LI YY, 1992, AM J GASTROENTEROL, V87, P1372; Lin XM, 1997, AM J GASTROENTEROL, V92, P1527; Lomasney KW, 2014, AM J PHYSIOL-GASTR L, V307, pG241, DOI 10.1152/ajpgi.00401.2013; Luo D, 2008, DIGEST DIS SCI, V53, P689, DOI 10.1007/s10620-007-9929-7; LUX G, 1994, GUT, V35, P1026, DOI 10.1136/gut.35.8.1026; Matsui M, 2000, P NATL ACAD SCI USA, V97, P9579, DOI 10.1073/pnas.97.17.9579; Matsui M, 2002, J NEUROSCI, V22, P10627; MCINTYRE AS, 1992, ALIMENT PHARM THERAP, V6, P125; Mule F, 2010, J PHYSIOL SCI, V60, P75, DOI 10.1007/s12576-009-0060-8; Ouyang H, 2004, ALIMENT PHARM THER, V20, P831, DOI 10.1111/j.1365-2036.2004.02196.x; Qin QG, 2014, WORLD J GASTROENTERO, V20, P18271, DOI 10.3748/wjg.v20.i48.18271; SATO A, 1993, NEUROSCI RES, V18, P53, DOI 10.1016/0168-0102(93)90105-Y; SATO A, 1992, J MANIP PHYSIOL THER, V15, P57; Stengel PW, 2003, J PHARMACOL EXP THER, V304, P675, DOI 10.1124/jpet.102.042283; Stengel PW, 2002, AM J PHYSIOL-REG I, V282, pR1443, DOI 10.1152/ajpregu.00486.2001; Stengel PW, 2000, J PHARMACOL EXP THER, V292, P877; Tache Y, 2002, HDB AUTONOMIC NERVOU, P474; Tada H, 2003, DIGEST DIS SCI, V48, P59, DOI 10.1023/A:1021730314068; Takahashi T, 2011, NEUROMODULATION, V14, P8, DOI 10.1111/j.1525-1403.2010.00295.x; Takahashi T, 2006, J GASTROENTEROL, V41, P408, DOI 10.1007/s00535-006-1773-6; Tobin G, 1995, J AUTON PHARMACOL, V15, P451, DOI 10.1111/j.1474-8673.1995.tb00410.x; Unno T, 2005, BRIT J PHARMACOL, V146, P98, DOI 10.1038/sj.bjp.0706300; Unno T, 2006, BRIT J PHARMACOL, V149, P1022, DOI 10.1038/sj.bjp.0706955; Wallis RM, 1999, LIFE SCI, V64, P395, DOI 10.1016/S0024-3205(98)00585-2; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Yang B, 2015, MOL MED REP, V11, P2735, DOI 10.3892/mmr.2014.3039; Yin JY, 2010, AUTON NEUROSCI-BASIC, V157, P31, DOI 10.1016/j.autneu.2010.03.007; Yoshimoto S, 2012, DIGEST DIS SCI, V57, P1213, DOI 10.1007/s10620-012-2040-8; Yu O, 1997, DIGEST DIS SCI, V42, P1146, DOI 10.1023/A:1018877318101; Zhao YX, 2015, J TRADIT CHIN MED, V35, P227, DOI 10.1016/S0254-6272(15)30033-9	52	12	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168200	10.1371/journal.pone.0168200	http://dx.doi.org/10.1371/journal.pone.0168200			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG7HN	27978539	Green Published, Green Submitted, gold			2022-12-27	WOS:000391217400075
J	Noorman, F; van Dongen, TTCF; Plat, MCJ; Badloe, JF; Hess, JR; Hoencamp, R				Noorman, Femke; van Dongen, Thijs T. C. F.; Plat, Marie-Christine J.; Badloe, John F.; Hess, John R.; Hoencamp, Rigo			Transfusion:-80 degrees C Frozen Blood Products Are Safe and Effective in Military Casualty Care	PLOS ONE			English	Article							OPERATION ENDURING FREEDOM; TRAUMA PATIENTS; WHOLE-BLOOD; PLATELET MICROPARTICLES; CONTROL RESUSCITATION; TRANSFUSION MEDICINE; APHERESIS PLATELETS; MASSIVE TRANSFUSION; BATTLE CASUALTIES; IRAQI FREEDOM	Introduction The Netherlands Armed Forces use -80 degrees C frozen red blood cells (RBCs), plasma and platelets combined with regular liquid stored RBCs, for the treatment of (military) casualties in Medical Treatment Facilities abroad. Our objective was to assess and compare the use of -80 degrees C frozen blood products in combination with the different transfusion protocols and their effect on the outcome of trauma casualties. Materials and Methods Hemovigilance and combat casualties data from Afghanistan 2006-2010 for 272 (military) trauma casualties with or without massive transfusions (MT: >= 6 RBC/24hr, N = 82 and non-MT: 1-5 RBC/24hr, N = 190) were analyzed retrospectively. In November 2007, a massive transfusion protocol (MTP; 4: 3: 1 RBC:Plasma:Platelets) for ATLS (R) class III/IV hemorrhage was introduced in military theatre. Blood product use, injury severity and mortality were assessed pre-and post-introduction of the MTP. Data were compared to civilian and military trauma studies to assess effectiveness of the frozen blood products and MTP. Results No ABO incompatible blood products were transfused and only 1 mild transfusion reaction was observed with 3,060 transfused products. In hospital mortality decreased post-MTP for MT patients from 44% to 14% (P = 0.005) and for non-MT patients from 12.7% to 5.9% (P = 0.139). Average 24-hour RBC, plasma and platelet ratios were comparable and accompanying 24-hour mortality rates were low compared to studies that used similar numbers of liquid stored (and on site donated) blood products. Conclusion This report describes for the first time that the combination of -80 degrees C frozen platelets, plasma and red cells is safe and at least as effective as standard blood products in the treatment of (military) trauma casualties. Frozen blood can save the lives of casualties of armed conflict without the need for in-theatre blood collection. These results may also contribute to solutions for logistic problems in civilian blood supply in remote areas.	[Noorman, Femke; Badloe, John F.] Minist Def, Mil Blood Bank, Leiden, Netherlands; [van Dongen, Thijs T. C. F.] Minist Def, Utrecht, Netherlands; [van Dongen, Thijs T. C. F.] Univ Med Ctr Utrecht, Div Surg, Dept Trauma, Utrecht, Netherlands; [Plat, Marie-Christine J.] Minist Def, Expert Ctr Force Hlth Protect, Doorn, Netherlands; [Hess, John R.] Harborview Med Ctr, Transfus Serv, Seattle, WA USA; [Hoencamp, Rigo] Minist Def, Leiden, Netherlands; [Hoencamp, Rigo] Leiden Univ, Med Ctr, Alrijne Med Ctr Leiderdorp, Dept Surg, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Harborview Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Dongen, TTCF (corresponding author), Minist Def, Mil Blood Bank, Leiden, Netherlands.	f.noorman@mindef.nl; t.t.c.vandongen-4@umcutrecht.nl	Hoencamp, Rigo/AAL-4984-2021	Kubickova, Karolina/0000-0002-9556-3185; Noorman, Femke/0000-0002-4891-2047				Allen CJ, 2015, AM SURGEON, V81, P663; Beckett Andrew, 2015, Can J Surg, V58, pS153; Bohonek M, 2010, TRANSFUSION, V50, P1007, DOI 10.1111/j.1537-2995.2009.02532.x; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Chandler MH, 2012, SEMIN CARDIOTHORAC V, V16, P153, DOI 10.1177/1089253212452344; Cotton BA, 2008, J TRAUMA, V64, P1177, DOI 10.1097/TA.0b013e31816c5c80; Dumont LJ, 2013, TRANSFUSION, V53, P128, DOI 10.1111/j.1537-2995.2012.03735.x; Ellis AM, 2010, ADF HLTH, V11, P25; Hakre S, 2011, TRANSFUSION, V51, P473, DOI 10.1111/j.1537-2995.2010.02906.x; Harr JN, 2013, J TRAUMA ACUTE CARE, V74, P756, DOI 10.1097/TA.0b013e3182826d7e; Henkelman S, 2015, VOX SANG, V108, P103, DOI 10.1111/vox.12218; Hess JR, 2008, TRANSFUSION MED, V18, P143, DOI 10.1111/j.1365-3148.2008.00855.x; Hess JR, 2005, CRIT CARE, V9, pS10, DOI 10.1186/cc3780; Hirshberg A, 2003, J TRAUMA, V54, P454, DOI 10.1097/01.TA.0000053245.08642.1F; Hoencamp R, 2014, WORLD J SURG, V38, P2551, DOI 10.1007/s00268-014-2645-5; Hoencamp R, 2014, WORLD J SURG, V38, P1713, DOI 10.1007/s00268-014-2462-x; Hoencamp R, 2014, INJURY, V45, P1028, DOI 10.1016/j.injury.2014.02.012; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holley A, 2013, ANAESTH INTENS CARE, V41, P10, DOI 10.1177/0310057X1304100104; Idenburg FJ, 2015, WORLD J SURG, V39, P2413, DOI 10.1007/s00268-015-3136-z; Inaba K, 2011, J TRAUMA, V71, P1766, DOI 10.1097/TA.0b013e31823bdbf9; Johansson PI, 2009, VOX SANG, V96, P111, DOI 10.1111/j.1423-0410.2008.01130.x; Johnson L, 2014, TRANSFUSION; Johnson L, 2014, TRANSFUSION, V54, P1917, DOI 10.1111/trf.12578; Kautza BC, 2012, J TRAUMA ACUTE CARE, V72, P106, DOI 10.1097/TA.0b013e3182410a3c; Khuri SF, 1999, J THORAC CARDIOV SUR, V117, P172, DOI 10.1016/S0022-5223(99)70483-6; Langan NR, 2014, JAMA SURG, V149, P904, DOI 10.1001/jamasurg.2014.940; Lelkens CCM, 2006, TRANSFUS APHER SCI, V34, P289, DOI 10.1016/j.transci.2005.11.008; Markov NP, 2012, J VASC SURG, V56, P728, DOI 10.1016/j.jvs.2012.02.048; Matijevic N, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.29338; Mittag D, 2015, TRANSFUSION, V55, P2197, DOI 10.1111/trf.13138; Morton AP, 2013, J SURG RES, V179, P5, DOI 10.1016/j.jss.2012.05.054; Muller MCA, 2015, TRANSFUSION, V55, P164, DOI 10.1111/trf.12816; Neuhaus SJ, 2010, MED J AUSTRALIA, V192, P203, DOI 10.5694/j.1326-5377.2010.tb03479.x; Noorman F, 2014, TRANSFUSION, V54, p74A; Noorman F, 2012, TRANSFUSION, V52, p33A; Olszewski A, 2014, INT MARIT HEALTH, V65, P23, DOI 10.5603/MH.2014.0006; Perkins JG, 2011, TRANSFUSION, V51, P242, DOI 10.1111/j.1537-2995.2010.02818.x; Perkins JG, 2009, J TRAUMA, V66, pS77, DOI 10.1097/TA.0b013e31819d8936; Pidcoke HF, 2012, J TRAUMA ACUTE CARE, V73, pS445, DOI 10.1097/TA.0b013e3182754796; Pommerening MJ, 2015, SURGERY, V158, P618, DOI 10.1016/j.surg.2015.06.014; Raynel S, 2015, TRANSFUSION, V55, P2422, DOI 10.1111/trf.13165; Reade MC, 2013, ANAESTH INTENS CARE, V41, P804; Reade MC., 2012, PILOT MULTICENTRE BL; Schreiber MA, 2015, ANN SURG, V262, P426, DOI 10.1097/SLA.0000000000001404; Shaz BH, 2010, TRANSFUSION, V50, P493, DOI 10.1111/j.1537-2995.2009.02414.x; Slichter SJ, 2014, TRANSFUS MED REV, V28, P212, DOI 10.1016/j.tmrv.2014.09.001; Slichter SJ, 2014, PHASE 1 SAFETY STUDY; Snyder CW, 2009, J TRAUMA, V66, P358, DOI 10.1097/TA.0b013e318196c3ac; Sparrow RL, 2015, TRANSFUS MED REV, V29, P120, DOI 10.1016/j.tmrv.2014.09.007; Spinella PC, 2012, TRANSFUSION, V52, P1146, DOI 10.1111/j.1537-2995.2012.03594.x; Stanworth SJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9394; Strandenes G, 2014, SHOCK, V41, P70, DOI 10.1097/SHK.0000000000000150; Stubbs JR, 2016, TRANSFUSION, V56, pS173, DOI 10.1111/trf.13501; Thiels Cornelius A, 2015, Air Med J, V34, P104, DOI 10.1016/j.amj.2014.10.011; Torrance HDT, 2015, J TRAUMA ACUTE CARE, V78, P535, DOI 10.1097/TA.0000000000000534; Valeri CR, 2006, TRANSFUSION, V46, p1S, DOI 10.1111/j.1537-2995.2006.00922.x; VALERI CR, 1989, TRANSFUSION, V29, P429, DOI 10.1046/j.1537-2995.1989.29589284145.x; Valeri CR, 2000, VOX SANG, V79, P168, DOI 10.1159/000031236; VALERI CR, 1974, NEW ENGL J MED, V290, P353, DOI 10.1056/NEJM197402142900702; Valeri CR, 2005, TRANSFUSION, V45, P1829, DOI 10.1111/j.1537-2995.2005.00614.x; van Dongen TT, 2015, INJURY, V39; Windelov NA, 2014, J TRAUMA ACUTE CARE, V77, P692, DOI 10.1097/TA.0000000000000437	63	51	51	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0168401	10.1371/journal.pone.0168401	http://dx.doi.org/10.1371/journal.pone.0168401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8JY	27959967	Green Published, gold, Green Submitted			2022-12-27	WOS:000392753900063
J	Park, HJ; Ahn, JY; Jung, HY; Lee, JH; Jung, KW; Kim, DH; Choi, KD; Song, HJ; Lee, GH; Kim, JH; Han, S				Park, Hee Jung; Ahn, Ji Yong; Jung, Hwoon-Yong; Lee, Jeong Hoon; Jung, Kee Wook; Kim, Do Hoon; Choi, Kee Don; Song, Ho June; Lee, Gin Hyug; Kim, Jin-Ho; Han, Seungbong			Clinical Characteristics and Outcomes of Gastric Cancer Patients Aged over 80 Years: A Retrospective Case-Control Study	PLOS ONE			English	Article							OLDER; CARCINOMA; PROGNOSIS; RESECTION; SURGERY; YOUNG	Background and Aims The average human life expectancy is increasing worldwide, thus the proportion of elderly gastric cancer patients is also increasing. In this case-control study, we investigated the clinical and oncologic outcomes of gastric cancer in patients over 80 years old. Methods From January 2004 to December 2010, 291 patients aged over 80 years old (case group) were diagnosed and treated with gastric cancer at Asan Medical Center, Seoul, Korea. From the same period, 291 patients aged 18 to 80 years old were selected as the control group. The clinical findings and clinical outcomes of gastric cancer were retrospectively reviewed and compared between the two groups. Results There were significant differences in the overall 5-year survival rate between the case and control groups (30.9% vs. 73.8%, respectively; P<0.001). In patients who received the curative treatment, overall 3- and 5-year survival rates showed 74.3% and 57.9% in case group and 91.6% and 86.5% in the control group. When analysis was confined to resectable elderly patients with a favorable performance, the curative resection group showed significantly better overall 3-and 5-year survival rates than the conservative treatment group (73.7% and 58.8% vs. 29.8% and 0%, respectively). Conclusions Although elderly gastric cancer patients show an advanced stage at diagnosis and poor prognosis compared with non-elderly patients, elderly patients with good performance could benefit from curative resection. Thus, the clinical decision whether to undergo curative resection or conservative management should be made on an individualized basis.	[Park, Hee Jung; Ahn, Ji Yong; Jung, Hwoon-Yong; Lee, Jeong Hoon; Jung, Kee Wook; Kim, Do Hoon; Choi, Kee Don; Song, Ho June; Lee, Gin Hyug; Kim, Jin-Ho] Univ Ulsan, Asan Digest Dis Res Inst, Dept Gastroenterol, Coll Med,Asan Med Ctr, Seoul, South Korea; [Han, Seungbong] Univ Ulsan, Coll Med, Dept Clin Epidemiol & Biostat, Asan Med Ctr, Seoul, South Korea	University of Ulsan; University of Ulsan	Jung, HY (corresponding author), Univ Ulsan, Asan Digest Dis Res Inst, Dept Gastroenterol, Coll Med,Asan Med Ctr, Seoul, South Korea.	hyjung@amc.seoul.kr	Ahn, Ji Yong/AGO-1695-2022					Ahn JY, 2011, GASTROINTEST ENDOSC, V74, P485, DOI 10.1016/j.gie.2011.04.038; Arai Tomio, 2004, Gastric Cancer, V7, P154; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Canedo P, 2007, HELICOBACTER, V12, P45, DOI 10.1111/j.1523-5378.2007.00564.x; Endo S, 2013, INT J CLIN ONCOL, V18, P1014, DOI 10.1007/s10147-012-0482-9; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fransen GAJ, 2004, ALIMENT PHARM THERAP, V20, P1045, DOI 10.1111/j.1365-2036.2004.02251.x; FUJIMOTO S, 1994, SURGERY, V115, P516; Fujiwara S, 2012, HEPATO-GASTROENTEROL, V59, P620, DOI 10.5754/hge10269; HALLISSEY MT, 1990, BRIT MED J, V301, P513, DOI 10.1136/bmj.301.6751.513; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Kitamura K, 1996, BRIT J CANCER, V73, P798, DOI 10.1038/bjc.1996.139; Kunisaki C, 2006, AM J SURG, V191, P216, DOI 10.1016/j.amjsurg.2005.09.001; LAUREN P, 1965, ACTA PATHOL MIC SC, P6431; Liang YX, 2013, WORLD J GASTROENTERO, V19, P6568, DOI 10.3748/wjg.v19.i39.6568; Maehara Y, 1996, CANCER-AM CANCER SOC, V77, P1774, DOI 10.1002/(SICI)1097-0142(19960501)77:9<1774::AID-CNCR3>3.0.CO;2-C; Milne AN, 2009, HUM GENET, V126, P615, DOI 10.1007/s00439-009-0722-x; Ministry of health labour and welfare, 2012, ABR LIF TABL JAP 201; Mita K, 2013, J GASTROINTEST SURG, V17, P2067, DOI 10.1007/s11605-013-2364-5; MITSUDOMI T, 1989, WORLD J SURG, V13, P225, DOI 10.1007/BF01658407; National institute on aging U.S. department of health and human services, 2011, WHY POP AG MAT GLOB; Peleteiro B, 2011, BRIT J CANCER, V104, P198, DOI 10.1038/sj.bjc.6605993; Soetikno R, 2005, J CLIN ONCOL, V23, P4490, DOI 10.1200/JCO.2005.19.935; Statistics Korea, 2012, AV LIF SPAN KOR	24	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167615	10.1371/journal.pone.0167615	http://dx.doi.org/10.1371/journal.pone.0167615			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942044	Green Published, gold, Green Submitted			2022-12-27	WOS:000392745600023
J	Cardoso, ARP; Araujo, MAL; Andrade, RFV; Saraceni, V; Miranda, AE; Dourado, MIC				Paulo Cardoso, Ana Rita; Leite Araujo, Maria Alix; Vieira Andrade, Roumayne Fernandes; Saraceni, Valeria; Miranda, Angelica E.; Costa Dourado, Maria Ines			Underreporting of Congenital Syphilis as a Cause of Fetal and Infant Deaths in Northeastern Brazil	PLOS ONE			English	Article							MATERNAL SYPHILIS; PREGNANCY; OUTCOMES; STATE	Introduction Of all syphilis-related pregnancy outcomes, fetal death is certainly the most common one, being directly related to the availability, accessibility and quality of prenatal care. The present study aimed to analyze the underreporting of fetal and infant deaths and other maternal factors associated with congenital syphilis (CS) death. Methods This cross-sectional study integrated data of infants that were diagnosed and/or died of CS from the Sistema de Informacao de Agravos de Notificacao-Sinan (Notifiable Diseases Information System) and the Sistema de Informacao de Mortalidade-SIM (Mortality Information System) in Fortaleza, Northeastern Brasil to identify unreported cases of congenital syphilis. We assessed data during the period from 2007 to 2013. Results The underreporting of CS as a cause of fetal or infant death increased from 41 to 415 cases (90.1%) during 2007-2013. Exactly 3,209 cases of CS were identified in Sinan and 6,578 deaths in SIM. After database linkage, we identified 382 cases that were reported in the SIM and SINAN databases consisting of 309 fetal deaths and 73 infant deaths related to CS. From the children notified at Sinan that born alive, 3.0% (78/2,542) died; Out of these, 39 (50.0%) were early and 25 (32.1%) were late neonatal deaths. The proportion of death by CS increased from 0.62 to 5.8 from 2007 to 2013. At logistic regression, the variable that maintained statistical significance with fetal and infant death outcomes was the presence of CS signs and/or symptoms at birth (OR = 3.20; IC 95% 1.54-6.62; p = 0.002). Conclusions Neonatal and Infant deaths following CS-associated live births are underreported in Northeastern Brazil. Data base linkage identified unreported fetal and neonatal deaths due to CS leading to an increased awareness of fetal/infant mortality due to this infection.	[Paulo Cardoso, Ana Rita; Leite Araujo, Maria Alix; Vieira Andrade, Roumayne Fernandes] Univ Fortaleza, Collect Hlth Post Grad Program, Fortaleza, Ceara, Brazil; [Saraceni, Valeria] Rio de Janeiro Municipal Secretary Hlth, Rio De Janeiro, Brazil; [Miranda, Angelica E.] Univ Fed Espirito Santo, Dept Social Med, Vitoria, Spain; [Costa Dourado, Maria Ines] Univ Fed Bahia, Inst Collect Heath, Salvador, BA, Brazil	Universidade Fortaleza; Universidade Federal da Bahia	Cardoso, ARP (corresponding author), Univ Fortaleza, Collect Hlth Post Grad Program, Fortaleza, Ceara, Brazil.	rita_cardoso84@hotmail.com	Miranda, Angelica/AAE-5571-2021; Dourado, Ines/Q-6535-2016	Dourado, Ines/0000-0003-1675-2146; Miranda, Angelica/0000-0002-5556-8379	Cearense Foundation for Research Support; National Research Council - FUNCAP / CNPq	Cearense Foundation for Research Support; National Research Council - FUNCAP / CNPq	The study was funded by the Cearense Foundation for Research Support and the National Research Council - FUNCAP / CNPq whose grant amounts were R$ 83.421,50. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasil Ministerio da Saude. Secretaria de Vigilancia em Saude, 2015, B EP SIL; Bronhara Bruna, 2008, Rev. bras. epidemiol., V11, P709, DOI 10.1590/S1415-790X2008000400017; Ceara. Governo do Estado do Ceara. Secretaria da Saude, 2013, COORD PROM PROT SAUD; da Silva ZP, 2009, CAD SAUDE PUBLICA, V25, P1981, DOI 10.1590/S0102-311X2009000900012; Campos ALD, 2010, CAD SAUDE PUBLICA, V26, P1747, DOI 10.1590/S0102-311X2010000900008; de Araujo CL, 2012, REV SAUDE PUBL, V46, P479, DOI 10.1590/S0034-89102012000300010; Soeiro CMD, 2014, CAD SAUDE PUBLICA, V30, P715, DOI 10.1590/0102-311X00156312; do Nascimento MI, 2012, REV BRAS GINECOL OBS, V34, P56, DOI 10.1590/S0100-72032012000200003; Magalhaes DMD, 2013, CAD SAUDE PUBLICA, V29, P1109, DOI 10.1590/S0102-311X2013001000008; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Kamb ML, 2010, OBSTET GYNECOL INT, V2010, DOI 10.1155/2010/312798; Kuznik A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001545; Domingues RMSM, 2013, REV SAUDE PUBL, V47, P147, DOI 10.1590/S0034-89102013000100019; Ministerio da Saude, 2001, MAN PROC SIST INF MO; Ministerio da Saude (BR), 2009, MAN VIG OB INF FET C, V2; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Organizacao Mundial da Saude (OMS), 2001, CLASS EST INT DOENC; Owusu-Edusei K, 2014, SEX TRANSM DIS, V41, P103, DOI 10.1097/OLQ.0000000000000085; Qin JB, 2014, SEX TRANSM DIS, V41, P13, DOI 10.1097/OLQ.0000000000000062; Saraceni Valéria, 2005, Cad. Saúde Pública, V21, P1244, DOI 10.1590/S0102-311X2005000400027; Saraceni V, 2012, CAD SAUDE PUBLICA, V28, P490, DOI 10.1590/S0102-311X2012000300009; Serruya SJ, 2015, SEX HEALTH, V12, P164, DOI 10.1071/SH14191; WHO, 2012, GLOB INC PREV SEL CU; World Health Organization, 2011, METH SURV MON CONG S	24	9	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0167255	10.1371/journal.pone.0167255	http://dx.doi.org/10.1371/journal.pone.0167255			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27941983	Green Published, gold			2022-12-27	WOS:000392745600011
J	Swann, JW; Woods, K; Wu, Y; Glanemann, B; Garden, OA				Swann, James W.; Woods, Kelly; Wu, Ying; Glanemann, Barbara; Garden, Oliver A.			Characterisation of the Immunophenotype of Dogs with Primary Immune-Mediated Haemolytic Anaemia	PLOS ONE			English	Article							REGULATORY T-CELLS; BLOOD MONONUCLEAR-CELLS; FUNCTIONAL-CHARACTERIZATION; AUTOIMMUNE-DISEASES; CYTOKINE PRODUCTION; TH17 CELLS; INTERLEUKIN-10; RESPONSES; ENTEROPATHY; MODULATION	Background Immune-mediated haemolytic anaemia (IMHA) is reported to be the most common autoimmune disease of dogs, resulting in significant morbidity and mortality in affected animals. Haemolysis is caused by the action of autoantibodies, but the immunological changes that result in their production have not been elucidated. Aims To investigate the frequency of regulatory T cells (Tregs) and other lymphocyte subsets and to measure serum concentrations of cytokines and peripheral blood mononuclear cell expression of cytokine genes in dogs with IMHA, healthy dogs and dogs with inflammatory diseases. Animals 19 dogs with primary IMHA, 22 dogs with inflammatory diseases and 32 healthy control dogs. Methods Residual EDTA-anti-coagulated blood samples were stained with fluorophore-conjugated monoclonal antibodies and analysed by flow cytometry to identify Tregs and other lymphocyte subsets. Total RNA was also extracted from peripheral blood mononuclear cells to investigate cytokine gene expression, and concentrations of serum cytokines (interleukins 2, 6 10, CXCL-8 and tumour necrosis factor a) were measured using enhanced chemiluminescent assays. Principal component analysis was used to investigate latent variables that might explain variability in the entiredataset. Results There was no difference in the frequency or absolute numbers of Tregs among groups, nor in the proportions of other lymphocyte subsets. The concentrations of pro-inflammatory cytokines were greater in dogs with IMHA compared to healthy controls, but the concentration of IL-10 and the expression of cytokine genes did not differ between groups. Principal component analysis identified four components that explained the majority of the variability in the dataset, which seemed to correspond to different aspects of the immune response. Conclusions The immunophenotype of dogs with IMHA differed from that of dogs with inflammatory diseases and from healthy control dogs; some of these changes could suggest abnormalities in peripheral tolerance that permit development of autoimmune disease. The frequency of Tregs did not differ between groups, suggesting that deficiency in the number of these cells is not responsible for development of IMHA.	[Swann, James W.; Glanemann, Barbara; Garden, Oliver A.] Royal Vet Coll, Dept Clin Sci & Serv, Hawskhead Lane, Hatfield, Herts, England; [Swann, James W.; Woods, Kelly; Wu, Ying; Garden, Oliver A.] Royal Vet Coll, Immune Regulat Lab, London, England	University of London; University of London Royal Veterinary College; University of London; University of London Royal Veterinary College	Garden, OA (corresponding author), Royal Vet Coll, Dept Clin Sci & Serv, Hawskhead Lane, Hatfield, Herts, England.; Garden, OA (corresponding author), Royal Vet Coll, Immune Regulat Lab, London, England.	ogarden@rvc.ac.uk		Swann, James/0000-0001-7988-9997	Kennel Club Charitable Trust; Biotechnology and Biological Sciences Research Council [BB/M009513/1]	Kennel Club Charitable Trust; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by a grant from the Kennel Club Charitable Trust (https://kccharitabletrust.org.uk) awarded to JWS. There was no grant number for this award. KW was supported by a grant from the Biotechnology and Biological Sciences Research Council (number BB/M009513/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2002, J LEUKOCYTE BIOL, V71, P1; Ahmad E, 2011, J INVEST ALLERG CLIN, V21, P297; BARKER RN, 1991, CLIN EXP IMMUNOL, V85, P33, DOI 10.1111/j.1365-2249.1991.tb05678.x; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Berentsen S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/363278; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao DJ, 2004, ARTHRITIS RES THER, V6, pR335, DOI 10.1186/ar1192; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; Corato A, 1997, VET IMMUNOL IMMUNOP, V59, P191, DOI 10.1016/S0165-2427(97)00032-9; Davidson N J, 2000, Int Rev Immunol, V19, P91, DOI 10.3109/08830180009048392; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Ellis JS, 2013, IMMUNOLOGY, V139, P179, DOI 10.1111/imm.12065; Elson CJ, 2000, CURR OPIN IMMUNOL, V12, P664, DOI 10.1016/S0952-7915(00)00160-6; Fagiolo E, 1996, AUTOIMMUNITY, V24, P147, DOI 10.3109/08916939608995360; Fagiolo E, 1999, IMMUNOL INVEST, V28, P347, DOI 10.3109/08820139909062268; Fagiolo E, 2002, AUTOIMMUNITY, V35, P39, DOI 10.1080/08916930290005891; FAGIOLO E, 1994, IMMUNOL INVEST, V23, P449, DOI 10.3109/08820139409066839; Garden OA, 2011, INT IMMUNOPHARMACOL, V11, P576, DOI 10.1016/j.intimp.2010.11.003; Giltiay NV, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3918; Hall AM, 2002, BLOOD, V100, P4529, DOI 10.1182/blood-2002-05-1383; Hall AM, 2012, HAEMATOL-HEMATOL J, V97, P1494, DOI 10.3324/haematol.2011.060822; Han L, 2015, FRONT MED-PRC, V9, P10, DOI 10.1007/s11684-015-0388-9; Ireland SJ, 2015, CYTOKINE, V73, P236, DOI 10.1016/j.cyto.2015.01.009; Jiao Z, 2007, SCAND J RHEUMATOL, V36, P428, DOI 10.1080/03009740701482800; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Kjelgaard-Hansen M, 2011, J VET INTERN MED, V25, P76, DOI 10.1111/j.1939-1676.2010.0642.x; Knueppel A, 2011, EXP ANIM TOKYO, V60, P471, DOI 10.1538/expanim.60.471; KOJIMA A, 1981, IMMUNOGENETICS, V14, P15, DOI 10.1007/BF00344296; Lawson CA, 2006, RHEUMATOLOGY, V45, P1210, DOI 10.1093/rheumatology/kel089; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; LLORENTE L, 1993, EUR CYTOKINE NETW, V4, P421; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; McCullough S, 2003, VET CLIN N AM-SMALL, V33, P1295, DOI 10.1016/j.cvsm.2003.08.003; McManus PM, 2001, J AM VET MED ASSOC, V218, P1308, DOI 10.2460/javma.2001.218.1308; Miller MA, 2007, CURR MED CHEM, V14, P1409, DOI 10.2174/092986707780831131; Mitchell KD, 2009, J VET INTERN MED, V23, P585, DOI 10.1111/j.1939-1676.2009.0282.x; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Mqadmi A, 2005, BLOOD, V105, P3746, DOI 10.1182/blood-2004-12-4692; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Piek CJ, 2011, VET IMMUNOL IMMUNOP, V144, P346, DOI 10.1016/j.vetimm.2011.08.010; Pietschmann P, 2003, EXP GERONTOL, V38, P1119, DOI 10.1016/S0531-5565(03)00189-X; Pinheiro D, 2011, IMMUNOLOGY, V132, P111, DOI 10.1111/j.1365-2567.2010.03346.x; RIVAS AL, 1992, CLIN IMMUNOL IMMUNOP, V64, P36, DOI 10.1016/0090-1229(92)90057-U; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sakaguchi S, 2009, INT IMMUNOL, V21, P1105, DOI 10.1093/intimm/dxp095; Saxena A, 2015, CYTOKINE, V74, P27, DOI 10.1016/j.cyto.2014.10.031; Swann JW, 2016, VET J, V207, P13, DOI 10.1016/j.tvjl.2015.10.022; Titmarsh HF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137377; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Ward FJ, 2008, BLOOD, V111, P680, DOI 10.1182/blood-2007-07-101345; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Xu L, 2012, EXP HEMATOL, V40, P994, DOI 10.1016/j.exphem.2012.08.008; Zanella A, 2014, HAEMATOLOGICA, V99, P1547, DOI 10.3324/haematol.2014.114561	60	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2016	11	12							e0168296	10.1371/journal.pone.0168296	http://dx.doi.org/10.1371/journal.pone.0168296			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EI8HA	27942026	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000392745600063
J	Zhang, YN; Tang, ET; Du, ZQ				Zhang, Yanni; Tang, En-Tzu; Du, Zhiqiang			Detection of MET Gene Copy Number in Cancer Samples Using the Droplet Digital PCR Method	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; C-MET; AMPLIFICATION; QUANTITATION; EXPRESSION; TISSUE; HER2	Purpose The analysis of MET gene copy number (CN) has been considered to be a potential bio-marker to predict the response to MET-targeted therapies in various cancers. However, the current standard methods to determine MET CN are SNP 6.0 in the genomic DNA of cancer cell lines and fluorescence in situ hybridization (FISH) in tumor models, respectively, which are costly and require advanced technical skills and result in relatively subjective judgments. Therefore, we employed a novel method, droplet digital PCR (ddPCR), to determine the MET gene copy number with high accuracy and precision. Methods The genomic DNA of cancer cell lines or tumor models were tested and compared with the MET gene CN and MET/CEN-7 ratio determined by SNP 6.0 and FISH, respectively. Results In cell lines, the linear association of the MET CN detected by ddPCR and SNP 6.0 is strong (Pearson correlation = 0.867). In tumor models, the MET CN detected by ddPCR was significantly different between the MET gene amplification and non-amplification groups according to FISH (mean: 15.4 vs 2.1; P = 0.044). Given that MET gene amplification is defined as MET CN >5.5 by ddPCR, the concordance rate between ddPCR and FISH was 98.0%, and Cohen's kappa coefficient was 0.760 (95% CI, 0.498-1.000; P < 0.001). Conclusions The results demonstrated that the ddPCR method has the potential to quantify the MET gene copy number with high precision and accuracy as compared with the results from SNP 6.0 and FISH in cancer cell lines and tumor samples, respectively.	[Zhang, Yanni; Tang, En-Tzu; Du, Zhiqiang] Amgen Biopharmaceut Res & Dev Shanghai Co Ltd, Shanghai, Peoples R China		Du, ZQ (corresponding author), Amgen Biopharmaceut Res & Dev Shanghai Co Ltd, Shanghai, Peoples R China.	zhiqiang@amgen.com	Zhang, Ying/O-2727-2019		Amgen Inc.	Amgen Inc.(Amgen)	This study was funded by Amgen Inc. All authors are employees of Amgen Inc. The funder provided support in the form of salaries for YZ, ET, and ZD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the Author Contributions section.	An X, 2014, CANCER-AM CANCER SOC, V120, P675, DOI 10.1002/cncr.28454; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Heredia NJ, 2013, METHODS, V59, pS20, DOI 10.1016/j.ymeth.2012.09.012; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Hong SJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-138; Huang JT, 2015, CLIN CHEM, V61, P290, DOI 10.1373/clinchem.2014.230227; Inoue T, 2004, CANCER SCI, V95, P803, DOI 10.1111/j.1349-7006.2004.tb02185.x; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Park WS, 1999, CANCER RES, V59, P307; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Wong CM, 2002, CLIN CANCER RES, V8, P2266; Yakicier MC, 2001, ONCOGENE, V20, P5232, DOI 10.1038/sj.onc.1204674	16	61	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 14	2016	11	1							e0146784	10.1371/journal.pone.0146784	http://dx.doi.org/10.1371/journal.pone.0146784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB4CC	27977794	Green Submitted, Green Published, gold			2022-12-27	WOS:000368459300044
J	Zhang, Y; Thomas, T; Brussel, MJG; van Maarseveen, MFAM				Zhang, Ying; Thomas, Tom; Brussel, M. J. G.; van Maarseveen, M. F. A. M.			Expanding Bicycle-Sharing Systems: Lessons Learnt from an Analysis of Usage	PLOS ONE			English	Article							SHARED BICYCLES; IMPACT; PROGRAM; WEATHER	Bike-sharing programs, with initiatives to increase bike use and improve accessibility of urban transit, have received increasing attention in growing number of cities across the world. The latest generation of bike-sharing systems has employed smart card technology that produces station-based data or trip-level data. This facilitates the studies of the practical use of these systems. However, few studies have paid attention to the changes in users and system usage over the years, as well as the impact of system expansion on its usage. Monitoring the changes of system usage over years enables the identification of system performance and can serve as an input for improving the location-allocation of stations. The objective of this study is to explore the impact of the expansion of a bicycle-sharing system on the usage of the system. This was conducted for a bicycle-sharing system in Zhongshan (China), using operational usage data of different years following system expansion. To this end, we performed statistical and spatial analyses to examine the changes in both users and system usage between before and after the system expansion. The findings show that there is a big variation in users and aggregate usage following the system expansion. However, the trend in spatial distribution of demand shows no substantial difference over the years, i.e. the same high-demand and low-demand areas appear. There are decreases in demand for some old stations over the years, which can be attributed to either the negative performance of the system or the competition of nearby new stations. Expanding the system not only extends the original users' ability to reach new areas but also attracts new users to use bike-sharing systems. In the conclusions, we present and discuss the findings, and offer recommendations for the further expansion of system.	[Zhang, Ying; Brussel, M. J. G.; van Maarseveen, M. F. A. M.] Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, Enschede, Netherlands; [Thomas, Tom] Univ Twente, Ctr Transport studies, Enschede, Netherlands	University of Twente; University of Twente	Zhang, Y (corresponding author), Univ Twente, Fac Geoinformat Sci & Earth Observat ITC, Enschede, Netherlands.	y.zhang-4@utwente.nl	Zhang, Ying/O-2727-2019		China Scholarship Council [2011627129]; ITC Research Fund [93002823]	China Scholarship Council(China Scholarship Council); ITC Research Fund	This work was supported by the China Scholarship Council (No. 2011627129, www.csc.edu.cn) and co-funded by ITC Research Fund (No. 93002823, www.itc.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beecham R, 2014, TRANSPORT PLAN TECHN, V37, P83, DOI 10.1080/03081060.2013.844903; Borgnat P, 2011, ADV COMPLEX SYST, V14, P415, DOI 10.1142/S0219525911002950; Buck D., 2012, P TRANSPORTATION RES; Corcoran J, 2014, J TRANSP GEOGR, V41, P292, DOI 10.1016/j.jtrangeo.2014.09.003; Corcoran J, 2014, J TRANSP GEOGR, V41, P268, DOI 10.1016/j.jtrangeo.2014.09.005; Daddio D. W., 2012, THESIS; DeMaio P., 2009, PUBLIC TRANSPORTATIO, V12, P16; El-Assi W, 2015, TRANSPORTATION, DOI [10.1007/s11116-015-9669-z:1-25, DOI 10.1007/S11116-015-9669-Z:1~25]; Faghih-Imani A, 2016, J TRANSP GEOGR, V54, P218, DOI 10.1016/j.jtrangeo.2016.06.008; Faghih-Imani A, 2015, J TRANSP GEOGR, V44, P53, DOI 10.1016/j.jtrangeo.2015.03.005; Faghih-Imani A, 2014, J TRANSP GEOGR, V41, P306, DOI 10.1016/j.jtrangeo.2014.01.013; Fishman E, 2013, TRANSPORT REV, V33, P148, DOI 10.1080/01441647.2013.775612; Frade I, 2014, PROCD SOC BEHV, V111, P518, DOI 10.1016/j.sbspro.2014.01.085; Froehlich J. E., 2009, 21 INT JOINT C ART I; Fuller D, 2012, PREV MED, V54, P74, DOI 10.1016/j.ypmed.2011.09.021; Gebhart K, 2014, TRANSPORTATION, V41, P1205, DOI 10.1007/s11116-014-9540-7; Gonzalez F, 2016, TRANSPORTATION, V43, P407, DOI 10.1007/s11116-015-9581-6; Goodman A, 2014, J TRANSPORT GEOGRAPH, V41; Iori M, 2016, COMPUT OPER RES; Jappinen S, 2013, APPL GEOGR, V43, P13, DOI 10.1016/j.apgeog.2013.05.010; Jensen P, 2010, TRANSPORT RES D-TR E, V15, P522, DOI 10.1016/j.trd.2010.07.002; Kadri A, 2016, COMPUTERS IND ENG; Kaltenbrunner A, 2010, PERVASIVE MOB COMPUT, V6, P455, DOI 10.1016/j.pmcj.2010.07.002; Keijer MJN, 2000, TRANSPORT PLAN TECHN, V23, P215, DOI 10.1080/03081060008717650; Krizek KJ, 2009, J URBAN PLAN DEV, V135, P66, DOI 10.1061/(ASCE)0733-9488(2009)135:2(66); Lathia N, 2012, TRANSPORT RES C-EMER, V22, P88, DOI 10.1016/j.trc.2011.12.004; Martens K, 2007, TRANSPORT RES A-POL, V41, P326, DOI 10.1016/j.tra.2006.09.010; Nair R, 2013, INT J SUSTAIN TRANSP, V7, P85, DOI 10.1080/15568318.2012.660115; Neumann-Saavedra BA, 2015, TRANSP RES PROC, V10, P355, DOI 10.1016/j.trpro.2015.09.085; O'Brien O, 2014, J TRANSP GEOGR, V34, P262, DOI 10.1016/j.jtrangeo.2013.06.007; Pucher J, 2010, PREV MED, V50, pS106, DOI 10.1016/j.ypmed.2009.07.028; Rixey RA, 2013, TRANSPORT RES REC, P46, DOI 10.3141/2387-06; Shaheen SA, 2010, TRANSPORT RES REC, P159, DOI 10.3141/2143-20; Vogel M, 2014, J TRANSP GEOGR, V41, P280, DOI 10.1016/j.jtrangeo.2014.07.005; Vogel P., 2011, PROCEDIA SOC BEHAV S, V20, P514, DOI DOI 10.1016/J.SBSPR0.2011.08.058; Wang XZ, 2016, J URBAN PLAN DEV, V142, DOI 10.1061/(ASCE)UP.1943-5444.0000273; Zhao J, 2015, TRANSPORT RES C-EMER, V58, P251, DOI 10.1016/j.trc.2015.01.030; Zhao JB, 2014, TRANSPORT POLICY, V35, P253, DOI 10.1016/j.tranpol.2014.06.008; ZhongshanStatisticsBureau, 2014, ZHONGSH STAT YB 2014; Zhou XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137922	40	61	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2016	11	12							e0168604	10.1371/journal.pone.0168604	http://dx.doi.org/10.1371/journal.pone.0168604			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EG7HN	27977794	Green Published, gold, Green Submitted			2022-12-27	WOS:000391217400121
